<SEC-DOCUMENT>0001493152-21-007194.txt : 20210330
<SEC-HEADER>0001493152-21-007194.hdr.sgml : 20210330
<ACCEPTANCE-DATETIME>20210330164708
ACCESSION NUMBER:		0001493152-21-007194
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		71
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210330
DATE AS OF CHANGE:		20210330

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LifeMD, Inc.
		CENTRAL INDEX KEY:			0000948320
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
		IRS NUMBER:				760238453
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39785
		FILM NUMBER:		21786659

	BUSINESS ADDRESS:	
		STREET 1:		800 THIRD AVENUE, SUITE 2800
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		(866) 351-5907

	MAIL ADDRESS:	
		STREET 1:		800 THIRD AVENUE, SUITE 2800
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CONVERSION LABS, INC.
		DATE OF NAME CHANGE:	20180622

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Immudyne, Inc.
		DATE OF NAME CHANGE:	20120514

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IMMUDYNE INC
		DATE OF NAME CHANGE:	19950720
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>form10-k.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>WASHINGTON,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
10-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Mark
One)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<B>X</B>]
<B>ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended <B><U>December 31, 2020</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]
<B>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the transition period from __________________________ to __________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission
file number <B><U>000-55857</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="form10-k_01.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B><U>LIFEMD,
INC.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>CONVERSION
LABS, INC.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name if applicable)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Delaware</U></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>76-0238453</U></B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">State
    or Other Jurisdiction</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    Incorporation or Organization</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>800
        Third Avenue, Suite 2800</U></B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>New
        York, New York</U></B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>10022</U></B></FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of Principal Executive Offices)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>(855)
743-6478</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>(Registrant&rsquo;s
telephone number, including area code)</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title
    of each class</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trading
    symbol(s)</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
                                         of exchange</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>on
        which registered</B></FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Stock, par value $.01 per share</FONT></P></TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LFMD</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Nasdaq Capital Market</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(g) of the Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>None</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Title
of class)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes [&nbsp;&nbsp;]
No [<B>X</B>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes [&nbsp;&nbsp;]
No [<B>X</B>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. Yes [<B>X</B>] No [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant
to Rule 405 of Regulation S-T (&sect; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that
the registrant was required to submit such files). Yes [<B>X</B>] No [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (&sect; 229.405 of this chapter) is not
contained herein, and will not be contained, to the best of registrant&rsquo;s knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer&rdquo;
&ldquo;smaller reporting company,&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer [&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer [&nbsp;&nbsp;]</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated
    filer [X]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company [X]</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company [&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has filed a report on and attestation to its management&rsquo;s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">[&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes <B>[&nbsp;&nbsp;]</B> No [<B>X</B>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registrant had 25,906,754 shares of common stock outstanding as of March 30, 2021. The aggregate market value of the common stock
held by non-affiliates of the registrant as of June 30, 2020 was $82,837,083, as computed by reference to the closing price of
such common stock on such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LIFEMD,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2020
FORM 10-K ANNUAL REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A HREF="#p_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PART I</B></FONT></A></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_01"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 1. BUSINESS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_02"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 1A. RISK FACTORS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">13</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_03"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 1B. UNRESOLVED STAFF COMMENTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_04"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 2. PROPERTIES</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_05"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 3. LEGAL PROCEEDINGS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_06"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 4. MINE SAFETY DISCLOSURES</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A HREF="#p_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PART II</B></FONT></A></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#a_07"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 5. MARKET FOR REGISTRANT&rsquo;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_08"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 6. SELECTED FINANCIAL DATA</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#a_09"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 7. MANAGEMENT&rsquo;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#b_01"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#b_02"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#b_03"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#b_04"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 9A. CONTROLS AND PROCEDURES</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#b_05"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 9B. OTHER INFORMATION</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A HREF="#p_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PART III</B></FONT></A></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#b_06"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#b_07"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 11. EXECUTIVE COMPENSATION</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">53<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="#b_08"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#b_09"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><A HREF="#b_10"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES</FONT>&nbsp;</A></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A HREF="#p_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PART IV</B></FONT></A></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#b_11"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">54<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#b_12"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURES</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORWARD-LOOKING
STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CAUTIONARY
STATEMENT FOR PURPOSES OF THE &ldquo;SAFE HARBOR&rdquo; PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion should be read in conjunction with the financial statements and related notes contained elsewhere in this
Annual Report on Form 10-K. Certain statements made in this discussion are &ldquo;forward-looking statements&rdquo; within the
meaning of 27A of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), and Section 21E of the Securities
Exchange Act of 1934, as amended. These statements are based upon beliefs of, and information currently available to, the Company&rsquo;s
management as well as estimates and assumptions made by the Company&rsquo;s management. Readers are cautioned not to place undue
reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. When used herein,
the words &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;forecast,&rdquo;
&ldquo;future,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;predict,&rdquo; &ldquo;project,&rdquo; &ldquo;target,&rdquo;
&ldquo;potential,&rdquo; &ldquo;will,&rdquo; &ldquo;would,&rdquo; &ldquo;could,&rdquo; &ldquo;should,&rdquo; &ldquo;continue&rdquo;
or the negative of these terms and similar expressions as they relate to the Company or the Company&rsquo;s management identify
forward-looking statements. Such statements reflect the current view of the Company with respect to future events and are subject
to risks, uncertainties, assumptions, and other factors, including the risks relating to the Company&rsquo;s business, industry,
and the Company&rsquo;s operations and results of operations. Should one or more of these risks or uncertainties materialize,
or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed,
estimated, expected, intended, or planned.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee
future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities
laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements
to actual results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
consolidated financial&nbsp; statements are prepared in accordance with accounting principles generally accepted in the United
States (&ldquo;GAAP&rdquo;). These accounting principles require us to make certain estimates, judgments and assumptions. We believe
that the estimates, judgments and assumptions upon which we rely are reasonable based upon information available to us at the
time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported
amounts of assets and liabilities as of the date of the consolidated financial&nbsp; statements as well as the reported amounts
of revenues and expenses during the periods presented. Our consolidated financial&nbsp; statements would be affected to the extent
there are material differences between these estimates and actual results. The following discussion should be read in conjunction
with our financial statements and notes thereto appearing elsewhere in this report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
forward-looking statements made in this report are based only on events or information as of the date on which the statements
are made in this report. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking
statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made
or to reflect the occurrence of unanticipated events. You should read this report and the documents we refer to in this report
and have filed as exhibits to this report completely and with the understanding that our actual future results may be materially
different from what we expect. These risks include, by way of example and without limitation:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to successfully commercialize our products on a large enough scale to generate
                                         profitable operations;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to maintain and develop relationships with customers and suppliers;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to successfully integrate acquired businesses or new brands;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         impact of competitive products and pricing;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">supply
                                         constraints or difficulties;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
                                         economic and business conditions;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">business
                                         interruptions resulting from geo-political actions, including war, and terrorism or disease
                                         outbreaks (such as the recent outbreak of COVID-19, or the novel coronavirus);</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to continue as a going concern;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         need to raise additional funds in the future;</FONT></TD></TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to successfully recruit and retain qualified personnel;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to successfully implement our business plan;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to successfully acquire, develop or commercialize new products and equipment;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">being
                                         able to scale our telehealth platform built to improve the experience and medical care
                                         provided to patients across the country;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">intellectual
                                         property claims brought by third parties; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         impact of any industry regulation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results,
levels of activity, or performance. Readers are urged to carefully review and consider the various disclosures made by us in this
report and in our other reports filed with the Securities and Exchange Commission (&ldquo;SEC&rdquo;). We undertake no obligation
to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes
in the future operating results over time except as required by law. We believe that our assumptions are based upon reasonable
data derived from and known about our business and operations. No assurances are made that actual results of operations or the
results of our future activities will not differ materially from our assumptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this Annual Report on Form 10-K and unless otherwise indicated, the terms &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo;
and &ldquo;our&rdquo; refer to LifeMD, Inc. (formerly known as Conversion Labs, Inc.), our wholly-owned subsidiary Conversion
Labs PR, LLC (formerly Immudyne PR LLC, now &ldquo;Conversion Labs PR&rdquo;), a Puerto Rico limited liability company (&ldquo;Conversion
Labs PR&rdquo;, or &ldquo;CLPR&rdquo;) and our majority-owned subsidiary LegalSimpli Software, LLC, a Puerto Rico limited
liability company (&ldquo;LegalSimpli&rdquo;). Unless otherwise specified, all dollar amounts are expressed in United States dollars.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="p_001"></A>PART
I</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="a_01"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
1. BUSINESS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Business
Overview and Strategy</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">LifeMD is a direct-to-patient
telehealth company that provides a smarter, cost-effective and convenient way of accessing healthcare.
We believe the traditional model of visiting a doctor&rsquo;s office, receiving a physical prescription, visiting a local
pharmacy, and returning to see a doctor for follow up care or prescription refills is inefficient, costly to patients, and discourages
many patients from seeking much needed medical care. The U.S. healthcare system is undergoing a paradigm shift, thanks to new
technologies and the emergence of direct-to-patient healthcare. Direct-to-patient telemedicine companies, like our company,
connect consumers to licensed healthcare professionals for care across numerous indications, including concierge care, men&rsquo;s
sexual health and dermatology, among others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
telemedicine platform helps patients access licensed providers for diagnoses, virtual care, and prescription medications,
often delivered on a recurring basis. In addition to our telemedicine offerings, we sell nutritional supplements and
other over-the-counter products. Many of our products are available on a subscription or membership basis, where a patient
can subscribe to receive regular shipments of prescribed medications or products. This creates convenience and often discounted
pricing opportunities for patients and recurring revenue streams for us. Our patient acquisition strategy combines
strategic brand-building media placements and direct response advertising methods across highly scalable marketing channels
(i.e. national TV, streaming TV, streaming audio, podcast, print, magazines, online search, social media, and digital).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
inception, we have helped more than 300,000 customers and patients, providing them greater access to high-quality, convenient,
and affordable care in all 50 states. Our telemedicine revenue increased 208% in 2020 vs. the prior year. Total revenue
from recurring subscriptions is approximately 80%. In addition to our telehealth business, we own 85.6% of PDFSimpli, a rapidly
growing SaaS platform for converting, signing, editing and sharing PDF documents. This business has also seen 165% year over
year growth, with recurring revenue of 100%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Many people can relate
to the hassle and inconvenience of seeking medical care. We believe that telemedicine platforms like ours will fundamentally shift
how patients access healthcare in the U.S., by necessity and by preference. With the average wait time to see a physician in the
U.S. now at greater than 29 days, according to a 2018 Merritt Hawkins Survey, and the U.S. projected to have a significant shortfall
of licensed physicians by 2030, we believe the U.S. healthcare infrastructure must change to accommodate patients. Timely
and convenient access to healthcare and prescription medications is a critical factor in improving quality of care and patient
outcomes. Our mission is to radically change healthcare with our portfolio of direct-to-patient telehealth brands
that encompass on-demand medical treatment, online pharmacy and over-the-counter products. We want our brands to be top-of-mind
for consumers considering telehealth.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United States, healthcare spending is currently $4.0 trillion and is expected to grow to $6.2 trillion by 2028, according
to the Centers for Medicare and Medicaid Services. Physician services and prescription medications account for approximately 30%
of healthcare spending, or over $1 trillion annually, and we believe that we have the infrastructure, medical expertise,
and technical know-how to shift a substantial portion of this market to an online, virtual format. Our platforms are fast
and convenient, and we believe the adoption of our services has increased rapidly because of these features, including
lower out-of-pocket costs for patients and the satisfaction of a simple healthcare process. We believe the opportunities are immense
and that we are well positioned to capitalize on these large scale economic shifts in healthcare.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">We
believe that brand innovation, customer acquisition and service excellence form the heart of our business. As is
exemplified with our first brand, Shapiro MD, we have built a full line of proprietary OTC products for male and female hair loss,
FDA approved OTC minoxidil, an FDA-cleared medical device, and now a personalized telemedicine offering that gives consumers access
to virtual medical treatment and, when appropriate, a full line of oral and topical prescription medications for hair loss.
Our men&rsquo;s telemedicine brand, Rex MD, currently offers treatment for erectile dysfunction, and will soon offer treatments
for additional indications present in men&rsquo;s health. We have built a platform that allows us to efficiently launch
telehealth and wellness product lines wherever we determine there is a market need. Our platform is supported by a driven team
of digital marketing and branding experts, data analysts, designers, and engineers focused on building enduring brands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Our
Brand Portfolio</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have built a strategic portfolio of wholly-owned telehealth brands that address large unmet needs in men&rsquo;s health,
hair loss and dermatology. We also are preparing to launch a concierge care offering under the LifeMD brand. We continue to scale
our offerings in a calculated manner, ensuring that each brand or indication we launch will enhance current and future patients&rsquo;
experiences with our platform.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
process across each brand and condition that we treat is to guide the patient through a medical intake process and product selection,
after which a licensed U.S. physician within our network conducts a virtual consultation and, if appropriate, prescribes necessary
prescription medications and/or recommends over-the-counter products. Prescription and over the counter products are filled by
pharmacy fulfillment partners and shipped directly to the patient. The number of patients and customers we serve across the nation
continues to increase at a robust pace, with more than 300,000 individuals having purchased our products
and services to date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hair
Loss: ShapiroMD</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Launched
in 2017, ShapiroMD offers virtual medical treatment, prescription medications, patented over-the-counter products, and
an FDA approved medical device for male and female hair loss. ShapiroMD has emerged as a leading destination for hair loss
treatment across the U.S. and has had more than 200,000 customers and patients since inception. In Q1 2021, ShapiroMD greatly
enhanced its telemedicine offering for female hair loss with the addition of topical compounded medications to its product portfolio.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 21, 2020, ConsumersAdvocate.org ranked ShapiroMD as the third best hair loss treatment provider in the United
States, ahead of other household brands such as Bosley, Keeps and Rogaine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Men&rsquo;s
Health: RexMD</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Launched in 2019, RexMD
is a men&rsquo;s telehealth brand offering virtual medical treatment from licensed providers for a variety of
Men&rsquo;s health needs. After consultation with a physician, if appropriate, we dispense and ship prescription medications
and over-the-counter products directly to patients. We initially launched in the erectile dysfunction treatment market.
We intend to expand beyond the Sexual health market and launch additional treatment areas in Men&rsquo;s health
in the first half of 2021. Our vision for RexMD is to become a leading telehealth destination for men.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">We
intend to launch additional indications for many other Men&rsquo;s health conditions in the first half of 2021. Our vision for
RexMD is to become a leading telehealth destination for Men&rsquo;s health.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><B>Dermatology:
NavaMD</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">Launching
in the first quarter of 2021, Nava MD is a female-oriented tele-dermatology and skincare brand that will offer virtual medical
treatment from dermatologists and other providers, and, if appropriate, prescription oral and compounded topical medications to
treat many common dermatological conditions. In addition to the brand&rsquo;s telemedicine offerings, NavaMD&rsquo;s proprietary
products leverage intellectual property and proprietary formulations licenseed from Restorsea, a leading medical grade skincare
technology platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">Restoresea&rsquo;s
clinically proven skincare technology platform is the result of more than $50 million invested in R&amp;D and intellectual property
development and has received 35 patents along with broad industry and academic acclaim, with its breakthrough clinical results
having been published in the peer-reviewed Journal of Drugs in Dermatology and Journal of Clinical and Aesthetic Dermatology.
Nava MD will be one the first direct-to-consumer product lines to offer this advanced skincare technology. Nava MD will be positioned
as an online skincare and telehealth brand that will offer tele-dermatology services to patients in 47 states.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Immune
Health: iNR Wellness MD</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Launched
in 2018, iNR Wellness MD is a supplement for immune and digestive support. The iNR Wellness product line is a daily nutritional
supplement that contains yeast, oat, and mushroom beta glucans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Majority
Owned Subsidiary: PDFSimpli</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PDFSimpli
is an online software-as-a-service (SAAS) platform that allows users to create, edit, convert, sign and share PDF documents. PDFSimpli
was acquired through the purchase of 51% of the membership interests of LegalSimpli Software, LLC, a Puerto Rico limited liability
company, which operates a marketing-driven software solutions business. As of December 30, 2020, PDFSimpli was ranked in the top
4,339 websites globally, in which it was also ranked in the top 1,200 for specific countries with more than 9.5 million registrants
globally. Since its launch, PDFSimpli has converted or edited over 9 terabytes of documents for customers from the legal, financial,
real-estate and academic sectors. PDFSimpli had over 62,600 active subscriptions as of December 30, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Customers</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
customer base includes men and women seeking hair loss treatment and men&rsquo;s health issues. In 2021, we expect to broaden
this customer base to also include skincare and dermatology products for men and women as well as concierge medicine
services. No single customer accounted for more than 10% of net sales for the years ended December 31, 2020 and
2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Industry
Overview and Market Opportunity</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are focused on revolutionizing the way that patients access healthcare to positively impact their long-term health and satisfaction.
In the United States, healthcare spending is currently $4.0 trillion and is expected to grow to $6.2 trillion by 2028, according
to the Centers for Medicare &amp; Medicaid Services. Despite this growing spend, the existing healthcare system is fragmented
and inefficient, lacks price transparency, and is generally unfriendly to the consumer. In addition, a myriad of issues related
to insurance coverage and other cost barriers stand in the way of many Americans getting the treatment they need in a timely and
efficient manner. Patients are at the mercy of a multitude of gatekeepers at every level &ndash; with the service provider, in
acquiring medication, and in the insurance reimbursement process &ndash; leading to confusion and frustration for consumers. A
2018 <I>Journal of Patient Experience </I>paper found that among 9,166 patients surveyed through the national Medical Expenditure
Panel Survey Database, only 28% of respondents rated their satisfaction with their healthcare experience as &ldquo;optimal;&rdquo;
61% of respondents rated their satisfaction as &ldquo;average;&rdquo; and 11% said &ldquo;poor.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that telehealth platforms like LifeMD will fundamentally shift how patients think about and access
healthcare in the U.S. &ndash; by necessity and by preference. With the average wait time to see a physician in the U.S. now &gt;29
days according to a 2018 Merritt Hawkins Survey and the U.S. projected to have a significant shortfall of licensed physicians
by 2030, the U.S. healthcare infrastructure must change to accommodate patients. At the same time, consumers are ready
for better options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe we are in the early stages of the digitization of healthcare; additionally, telehealth&rsquo;s adoption has been
rapidly expedited by the emergence of the global coronavirus pandemic. Doctors across the U.S. were forced to close offices and
adopt telehealth in short order as the novel coronavirus took hold of the U.S. in 2020. Telehealth, and, more specifically,
direct-to-consumer telehealth, has since cemented itself as a mainstream way to access healthcare. A July 2020 report
from the U.S. Department of Health and Human Services found that 43.5% of Medicare primary care visits were provided via telehealth
in April 2020, an increase from less than 0.5% in February of that year prior to the onset of regional stay-at-home restrictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telehealth&rsquo;s
</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">novel approach to offering convenient healthcare helps bridge
many of the inefficiencies that plague the U.S. healthcare system today. Telehealth enables more efficient allocation and utilization
of existing clinical resources that might otherwise go unused. With an aging population requiring more complex care and
a younger generation that is accustomed to digital technology, telehealth offers an efficient way to leverage finite resources.
A <I>Journal of General Internal Medicine</I> article from 2016 evaluated patient satisfaction with U.S. telehealth services in
comparison to in-office visits: between 94% and 99% of survey respondents reported being &ldquo;very satisfied&rdquo; with all
telehealth attributes, and over 70% of respondents would use telehealth again and would recommend telehealth to someone else.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shift to Direct-to-Patient telehealth is in its nascent stage, and we believe we have developed the internal infrastructure,
medical expertise, and industry know-how to capitalize on the opportunity to penetrate this large, open, and growing market.
Physician services and prescription medications account for approximately 30% of healthcare spending, over $1 trillion annually,
and according to a market study by Alliance Bernstein in 2018, 70% of the retail prescription drug market will shift
online within the next 5 years, a $200 billion economic shift. The broader global telemedicine market is projected to grow at
a 19.3% CAGR through 2026.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Our
Growth Strategy</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have achieved rapid growth since our transformation into a healthcare focused company in 2018, with a compounded annual
growth rate in revenue of nearly 100% since 2018 and growth accelerating to 208% in 2020 as compared to 2019. We believe this
validates our significant long-term investments in developing our human capital, technology, brand-awareness, operations
and customer acquisition. Our continued investment in, and expansion of our core brands and their offerings will further
increase opportunities to acquire new customers and increase the lifetime value of our customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
continue to invest heavily in the experience our customers have with our products and their overall satisfaction with our products
and our company, and we expect customer repurchase rates and overall customer retention to grow further as we allocate more resources
and focus to this component of the business. While we are proud of our accomplishments to date, we believe the most exciting opportunities
for our growth story are ahead of us, and we intend to pursue the following strategies to help us achieve this growth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Continue
to Grow Our Market Share in Indications We Already Treat </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
remains a large and unaddressed market within hair-loss, erectile dysfunction, Men&rsquo;s health, and dermatology into
which we intend to aggressively scale in 2021 and beyond. We plan to continue to build a robust operational infrastructure to
enable us to not only provide better patient care but drive better unit economics for our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Launch
New Treatments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to leverage our existing infrastructure to launch new products within and around our existing brands.
 In the first quarter 2021, we are launching our dermatology and skincare brand, NavaMD. Additionally, a multitude of opportunities
exist to expand our product offerings under our current brand portfolio, and we plan to deploy new products and services in 2021
and beyond that will meet the needs of our existing customer base. In men&rsquo;s health, for example, we intend to address ED-adjacent
indications including common sexually transmitted infections (STI).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Launch
and Scale LifeMD Concierge Care</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to launch LifeMD, our cash-pay subscription-based concierge care service, in the first half of 2021. We believe that LifeMD
will make virtual and on-demand concierge healthcare available at a price that is affordable to almost anyone. We intend to offer
our LifeMD concierge service to our existing patient population, new patients that we acquire for condition-specific treatment,
and plan to run national and global direct-response marketing campaigns to rapidly increase awareness of the LifeMD offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pursue
Opportunities for Joint Ventures, Partnerships, and Inorganic Growth Initiatives </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our business model &ndash; direct-to-patient telemedicine &ndash; will be disruptive to the world of traditional
healthcare services, pharmaceutical products, medical devices, and diagnostics. Our proven ability to launch and scale telemedicine
offerings in a capital-efficient manner will likely be valuable to organizations in the traditional healthcare market segment
seeking to take advantage of this new delivery model. We believe we are well-positioned to form joint ventures and partnerships
with existing traditional healthcare companies, and we are currently exploring avenues and partners for new ventures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Drive
Continued Operational Excellence</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are committed to improving productivity and profitability through a number of operational initiatives designed to grow our revenue
and expand our margins. Overall, we expect that business profitability will be driven by continued net revenue growth in conjunction
with gross margin improvements, continued marketing efficiencies, and generating operating leverage. We believe there is opportunity
for continued improvement in gross margins, marketing efficiencies, and operating leverage through these key initiatives:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Optimize
Price</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
investment in human capital and technology, we intend to continue building a data-based understanding of price elasticity dynamics,
promotional strategies and other price management tools to drive optimized pricing for us and our partners. Based on the strength
of our brands and the value proposition of our products, we believe we have pricing power in the market that will only increase
through economies of scale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Reduce
Product Returns</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
continue to evolve our return policies and believe we have the opportunity to reduce customer return rates. We have identified
several opportunities that span policy change, process improvement and consumer education to reduce return rates and increase
overall customer satisfaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Invest
in Supply Chain</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to continue to make significant investments in our supply chain to meet the requirements of our growing business. Our supply
chain is instrumental to both supporting growth and improving business performance. While we currently partner with a number of
third-party manufacturing and logistics companies, physician networks, and prescription medication fulfillment companies, we are
evaluating opportunities to build our own internal capabilities in these areas.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate that growth of our products and services will span entirely new markets in healthcare, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
<B>Services and Content</B>: We plan to offer services that provide customers the opportunity to interact with telemedicine in
new ways, including digital apps, counseling and family consultations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
<B>Use Cases</B>: We believe we can broaden the range of use cases addressed by market need, including the treatment of new conditions
with the launch of new brands, including our first quarter 2021 launch of NavaMD, and the expansion of existing brand offerings
to covering complementary clinical indications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Competition</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
markets we sell into are large and highly competitive. Numerous online brands compete with us for customers throughout the U.S.
and internationally in the hair loss, immune support, men&rsquo;s health and document management verticals. We also compete with
traditional mass merchandisers, drug store chains, independent pharmacies and health food stores.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
competitors include, among others, Teledoc, Ro, Thirty Madison, Inc., Icebreaker Health, Inc., Hims &amp; Hers Health, Inc. and
GoodRx, Inc. Many of our competitors are substantially larger and more experienced than us, have longer operating histories, higher
visibility and brand recognition and have materially greater financial and other resources than us. We may not be able to successfully
compete with them in the marketplace.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Competitive
Strengths</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
take a patient-focused approach to telemedicine, with an emphasis on the quality-of-care we deliver to our patients. Our human
capital and know-how, proprietary technology platform, and unique product offerings represent meaningful strengths that we believe
will enable us to maintain and grow our market-leading position in the U.S.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
key competitive strengths include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>High-Quality
Care</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
telemedicine platform is designed to give consumers more control over their healthcare spending; greater convenience in how and
when they pursue or receive care; and better outcomes as hurdles to healthcare services are removed for the care or medications
patients need. We are committed to exceptional care and an exceptional customer service experience for our patients and customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Direct-To-Consumer
Know-How</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
actively seek to acquire, license, and develop brands and products with large, untapped e-commerce potential and proven business
models. We acquire our patients in an efficient manner through an omni-channel marketing approach that includes digital advertising
through platforms like Facebook and Google, social media platforms, as well as more traditional media channels like television
and radio. Since our inception in 2015, we have invested heavily in recruiting experts in direct response marketing and customer
acquisition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proprietary
and Scalable Technology Platform</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
in-house telemedicine infrastructure is continually being improved as we scale, and this flexible infrastructure can be repurposed
for any variety of existing or future telemedicine brands. This flexible platform allows for rapid development and scale of new
telemedicine brands as we identify attractive specialty verticals. Additional key capabilities of this platform include proprietary
staffing algorithms for case-load balancing, full CRM functionality, synchronous and asynchronous communications, and more.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
<B>Patient Care Center </B>: We launched a dedicated patient care center in November 2020 staffed by LifeMD employees which
currently spans approximately 100 employees and is led by an experienced operations and customer experience leader. We
believe the hands-on capabilities of the patient care center will continue to add significantly to our company&#8217;s
performance through increased conversions, customer ratings and retention.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
<B>Drive Marketing Efficiencies:</B> Marketing investments are the result of a disciplined process and are measured against both
growth and profitability targets. As we continue to grow and scale, we believe we will continue to improve the efficiency of our
marketing investments and improve our return on advertising spend. As our budgets and pool of talent continues to grow,
we believe this will result in cheaper media rates and improvements to our proprietary models that
inform the strategic decisions that drive product offerings, customer acquisition, retention, and brand awareness.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Management
Team</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management team has deep experience in healthcare services, technology, and direct-to-consumer and traditional advertising such
that we believe we are uniquely positioned to expand our patient-base while providing quality services and product offerings at
efficient customer-acquisition costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Intellectual
Property</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
regard our trademarks, copyrights, domain names, trade dress, trade secrets, proprietary technologies and similar intellectual
property as important to our success, and we rely on trademark and copyright law, trade-secret protection and confidentiality
and/or license agreements with our employees, customers, partners and others to protect our proprietary rights. We have licensed
in the past, and expect that we may license in the future, certain proprietary rights, technologies or copyrighted materials from
third-parties and we rely on those third-parties to defend their proprietary rights, copyrights and technologies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time-to-time, we register our principal brand names in the United States and certain foreign countries. Our material trademarks
include ShapiroMD<SUP>&reg;</SUP> and iNRWellnessMD<SUP>&reg;</SUP>. Trademark applications are in process for RexMD
and SOSRx. The steps we take to protect our proprietary rights in our brand names may not be adequate to prevent the misappropriation
of our brand names in the United States or abroad. Existing trademark laws afford only limited practical protection for our product
lines. The laws and the level of enforcement of such laws in certain foreign countries where we market our products often do not
protect our proprietary rights in our products to the same extent as the laws of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely primarily on proprietary trade secrets and extensive experience to operate our online direct response marketing platform.
We have two U.S. patents relating to our Shapiro MD products&rsquo; method for treatment of hair loss with a combination of natural
ingredients with one granted on March 24, 2015 and the other on January 3, 2017. In order to protect the confidentiality of our
intellectual property, including trade secrets, know-how and other proprietary technical and business information, it is our policy
to limit access to such information to those who require access in order to perform their functions and to enter into agreements
with employees, consultants and vendors to contractually protect such information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Manufacturing</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
use third parties to manufacture and package our products according to the formulas and packaging guidelines we dictate. In order
to minimize costs, we may elect to purchase raw or bulk materials directly from our suppliers and have them shipped to our manufacturers
so that we may incur only tableting, encapsulating and/or packaging costs and avoid the additional costs associated with purchasing
the finished product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not experienced any material adverse effect on our business as a result of shortages of raw materials or packaging materials
used in the manufacturing of our products. An unexpected interruption or a shortage in supply could adversely affect our business
derived from these products. We are not substantially dependent on any raw material supplier or packaging supplier since alternative
sources of materials, with equal quality, could be quickly obtained if any of our current suppliers cease to supply us adequately.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Government
and Environmental Regulation</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is heavily regulated by the FDA and the FTC. The FDA enforces the FDCA and Dietary Supplement Health and Education Act
(&ldquo;DSHEA&rdquo;) as they pertain to foods, food ingredients, cosmetics and dietary supplement production and marketing. Dietary
supplements are regulated as a category of food, not as drugs. We are not required to obtain FDA pre-market approval to sell our
products in the United States under current laws. Our hair loss and scarring products are regulated as cosmetics under the Federal
Food, Drug and Cosmetic Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA imposes GMP guidelines to ensure that dietary supplements are produced in a quality manner, do not contain contaminants or
impurities and are accurately labeled. GMPs include requirements for establishing quality control procedures, designing and constructing
manufacturing plants, testing ingredients and finished products and record keeping and handling of consumer product complaints.
The FDA has broad authority to enforce the provisions of federal law applicable to dietary supplements and cosmetics, including
the power to monitor claims made in product labeling, to seize adulterated or misbranded products or unapproved new drugs, to
request product recall, to enjoin further manufacture or sale of a product, to issue warning letters and to institute criminal
proceedings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising
and product claims regarding the efficacy of products are also regulated by the FTC. The FTC regulates the advertising of dietary
supplements, cosmetics and other health-related products to ensure that any advertising is truthful and not misleading, and that
an advertiser maintains adequate substantiation for all product claims. FTC enforcement actions may result in consent decrees,
cease and desist orders, judicial injunctions and the payment of fines with respect to advertising claims that are found to be
unsubstantiated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
current U.S. regulations, our products must comply with certain labeling requirements enforced by the FDA and FTC, but otherwise
generally are not required to receive regulatory approval prior to introduction into the U.S. market. We believe we are in compliance
with all material government regulations applicable to our products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the foregoing, our operations and those of our partners are subject to federal, state and local government laws and
regulations, including those relating to the practice of medicine, telemedicine and the prescribing of prescription medications.
We believe we are in substantial compliance with all material governmental regulations applicable to our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Employees</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, we had 56 full-time employees. In addition, we use the services of consultants and third-party service providers,
where needed. None of our employees are represented by a union or covered by a collective bargaining agreement. We have not experienced
any work stoppages, and we consider our relationship with our employees to be good.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>COVID-19
Response</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 11, 2020, the United States declared a national emergency in response to the COVID-19 pandemic. Subsequently,
states enacted stay-at-home orders to slow the spread of the virus that causes COVID-19, and reduce the burden on the U.S. health
care system. In response to COVID-19, our senior leadership assessed the impact across our entire team. Our objective was to ensure
the health, safety and well-being of our employees, customers, and the communities we service. Our response to COVID-19 and financial
performance in 2020 was a direct result of the dedication and strength of our team members, our strong culture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Corporate
History</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LifeMD,
Inc. was formed in the State of Delaware on May 24, 1994, under our prior name, Immudyne, Inc. We changed our name to Conversion
Labs, Inc. on June 22, 2018 and then subsequently, on February 22, 2021, we changed our name to LifeMD, Inc. Further, in connection
with changing our name, we changed our trading symbol to LFMD. On April 1, 2016, with respect to a limited liability company operating
agreement with joint venture partners for one of our skincare products under the legal name Immudyne PR LLC (&ldquo;Immudyne PR&rdquo;),
such original operating agreement of Immudyne PR was amended and restated and we increased our ownership and voting interest in
Immudyne PR to 78.2%. Concurrent with the name change of the parent company to Conversion Labs, Inc. completed in 2018, Immudyne
PR was renamed to Conversion Labs PR LLC (now known as &ldquo;Conversion Labs PR&rdquo;). On April 25, 2019, the operating agreement
of Conversion Labs PR was amended and restated in its entirety to increase the Company&rsquo;s ownership and voting interest in
Conversion Labs PR to 100%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2018, the Company closed the strategic acquisition of 51% of LegalSimpli Software, LLC (&ldquo;LegalSimpli&rdquo;), a software
as a service (SaaS) application for converting, editing, signing and sharing PDF documents. In addition to LegalSimpli Software&rsquo;s
growth business model, this acquisition added deep search engine optimization and search engine marketing expertise to the Company.
Effective January 22, 2021, we consummated a transaction to restructure the ownership of LegalSimpli (the &ldquo;LSS Restructuring&rdquo;).
To affect the LSS Restructuring, Conversion Labs PR entered into a series of agreements as further described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Membership
Interest Exchange Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
January 22, 2021 (the &ldquo;Effective Date&rdquo;), in furtherance of the LSS Restructuring, CLPR entered into a
Membership Interest Exchange Agreement with LegalSimpli, (the &ldquo;Exchange Agreement&rdquo;), pursuant to which CLPR exchanged
a promissory note dated May 8, 2019 with an outstanding balance of $375,823 (the &ldquo;CLPR Note&rdquo;), issued by LegalSimpli
in favor of CLPR, for 37,531 newly issued membership interests of LegalSimpli (the &ldquo;Exchange&rdquo;). Upon consummation
of the Exchange the CLPR Note was extinguished.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Membership
Interest Purchase Agreements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the Effective Date, in furtherance of the LSS Restructuring, CLPR entered into a Membership Interest Purchase Agreement with LegalSimpli,
(the &ldquo;CLPR MIPA&rdquo;), pursuant to which CLPR purchased 12,000 membership interests of LegalSimpli for an aggregate purchase
price of $300,000. The CLPR MIPA provides that the transaction may be completed in three (3) tranches with a purchase price of
$100,000 per tranche to be made at the sole discretion of CLPR. Payment for the first tranche of $100,000 was made upon execution
of the CLPR MIPA. Payments for the second and third tranches are due on the 60-day anniversary and the 120-day anniversary of
the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrently,
in furtherance of the LSS Restructuring, CLPR entered into two Membership Interest Purchase Agreements (the &ldquo;Founding Members
MIPAs&rdquo;) with two founding members of LegalSimpli (the &ldquo;Founding Members&rdquo;) whereby CLPR purchased from the Founding
Members an aggregate of 2,183 membership interests of LegalSimpli for an aggregate purchase price of $225,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the consummation of the LSS Restructuring, CLPR increased its ownership of LegalSimpli from 51% to approximately 85.58% on a fully-diluted
basis. LegalSimpli entered into an amendment to its operating agreement (the &ldquo;LSS Operating Agreement Amendment&rdquo;)
to reflect the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LegalSimpli
Option Agreements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrently,
CLPR entered into option agreements with Sean Fitzpatrick (the &ldquo;Fitzpatrick Option Agreement&rdquo;) and Varun Pathak (the
&ldquo;Pathak Option Agreement&rdquo; and, together with Fitzpatrick Option Agreement, the &ldquo;Option Agreements&rdquo;), pursuant
to which CLPR granted options to purchase membership interest units of LegalSimpli. The Fitzpatrick Option Agreement
grants Sean Fitzpatrick the option to purchase 10,300 membership interest units of LegalSimpli for an exercise price of $1.00
per membership interest unit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fitzpatrick Options vest in accordance with the following (i) 3,434 membership interests upon LegalSimpli achieving $2,500,000
of gross sales in any fiscal quarter (ii) 3,434 membership interests upon LegalSimpli achieving $4,000,000 of gross sales in any
fiscal quarter and (iii) 3,434 membership interests upon LegalSimpli achieving $8,000,000 of gross sales with a ten percent (10%)
net profit margin in any fiscal quarter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Pathak Options shall vest in accordance with the following (i) 700 membership interests upon LegalSimpli achieving $2,500,000
of gross sales in any fiscal quarter (ii) 700 membership interests upon LegalSimpli achieving $,4,000,000 of gross sales in any
fiscal quarter and (iii) 700 membership interests upon LegalSimpli achieving $8,000,000 of gross sales with a ten percent (10%)
net profit margin in any fiscal quarter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
vesting, the Fitzpatrick Options and the Pathak Options provide for the potential re-purchase of up to an additional 13.25% of
LegalSimpli by Fitzpatrick and Pathak in the aggregate with CLPR ownership ratably reduced to approximately 72.98%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Available
Information</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other reports and amendments to these
reports that we file with or furnish to the SEC at their website, www.sec.gov, are also available free of charge at our website,
https://ir.lifemd.com/, as soon as reasonably practicable after we electronically file these reports with, or furnish these reports
to the SEC. The content of this website is not part of this Annual Report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of these reports or documents may also be obtained by writing to: Investor Relations; c/o LifeMD, Inc., 800 Third Avenue, Suite
2800, New York, NY 10022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_02"></A>ITEM
1A. RISK FACTORS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Risks
Related to our Business and Industry</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
have generated net losses, we anticipate increasing expenses in the future, we have not yet achieved profitability, and we may
not be able to achieve or maintain profitability.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have incurred net losses on an annual basis since our inception. We incurred net losses of $60.5 million and $3.5 million
in the years ended December 31, 2020 and 2019, respectively. We had an accumulated deficit of approximately $80.2 million
as of December 31, 2020. We expect our costs will increase substantially in the foreseeable future and we expect our losses will
continue as we expect to invest significant additional funds towards growing our platform, growing our provider network, enhancing
our pharmacy fulfillment system, and operating as a public company and as we continue to invest in increasing our customer base,
hiring additional employees, and developing new products and technological capabilities to enhance our customers&rsquo; experience
on our platform. These efforts may prove more expensive than we currently anticipate, and we may not succeed in increasing our
revenue sufficiently to offset these higher expenses. To date, we have financed our operations principally from the sale of our
equity, revenue from our platform, and the incurrence of indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
cash flows from operations were negative or insignificant for the years ended December 31, 2019 and 2020. We may not generate
positive cash flows from operations or achieve profitability in any given period, and our limited operating history may make it
difficult to evaluate our current business and our future prospects. We cannot assure you that we will be able to achieve profitability,
on either a quarterly or annual basis, or that profitability, if achieved, will be sustained. Our ability to meet our long-term
business objectives likely will be dependent upon establishing increased cash flow from operations or securing other sources of
financing. If our losses continue, however, our liquidity may be severely impaired, our stock price may fall, and our shareholders
may lose all or a significant portion of their investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have encountered and will continue to encounter risks and difficulties frequently experienced by growing companies in rapidly
changing and highly regulated industries, including increasing expenses as we continue to grow our business. If we are not able
to achieve or maintain positive cash flow in the long term, we may require additional financing, which may not be available on
favorable terms or at all and/or which would be dilutive to our stockholders. If we are unable to successfully address these risks
and challenges as we encounter them, our business, results of operations, and financial condition would be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
limited operating history and evolving business make it difficult to evaluate our current business and future prospects and increases
the risk of your investment.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
limited operating history and evolving business make it difficult to evaluate our current business and future prospects and plan
for our future growth. We began offering direct to consumer products and services in 2016. Since that time, our business has expanded
and we have increased the ways that we can address customer needs. We have encountered and will continue to encounter significant
risks and uncertainties frequently experienced by new and growing companies in rapidly changing and heavily regulated industries,
such as attracting new customers and healthcare providers (sometimes referred to herein as &ldquo;providers&rdquo;), to our platform,
retaining our customers and encouraging them to utilize new offerings we make available, increasing the number of conditions that
can be treated by providers through our platform, competition from other companies, whether online healthcare providers or traditional
healthcare providers, hiring, integrating, training and retaining skilled personnel, verifying the identity of customers and credentials
of providers serving our customers, developing new solutions, determining prices for our solutions, unforeseen expenses, challenges
in forecasting accuracy, and new or adverse regulatory developments affecting the use of telehealth, pharmaceutical products,
or other aspects of the healthcare industry. Additional risks include our ability to effectively manage growth and process, store,
protect, and use personal data in compliance with governmental regulation, contractual obligations, and other legal obligations
related to privacy and security. If our assumptions regarding these and other similar risks and uncertainties that relate to our
business, which we use to plan our business, are incorrect or change as we gain more experience operating our platform or expand
into the treatment of new conditions, or if we do not address these challenges successfully, our operating and financial results
could differ materially from our expectations and our business could suffer. Similar risks apply to our subsidiary cloud-based
software as a service business that is exposed to many of the risks typically experienced by a new and growing company including
ability to attract new customers, entrance of competitors, and other risk factors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
telehealth market is immature and volatile, and if it does not develop, if it develops more slowly than we expect, if it encounters
negative publicity or if our solution does not drive customer engagement, the growth of our business will be harmed.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to our telehealth services, the telehealth market is relatively new and unproven, and it is uncertain whether it will achieve
and sustain high levels of demand, consumer acceptance and market adoption. The outbreak of the COVID-19 pandemic has increased utilization
of telehealth services, but it is uncertain whether such increase in demand will continue. Our success will depend to a substantial extent
on the willingness of our customers to use, and to increase the frequency and extent of their utilization of, our telemedicine platform,
as well as on our ability to continue to grow our existing business and expand into new indications. Negative publicity concerning our
platform or brands, or the telehealth market as a whole, could limit market acceptance of our offerings. If our customers do not perceive
the benefits of our telemedicine products and services, or if our products do not drive customer retention, then our market may not develop,
or it may develop more slowly than we expect. Similarly, individual and healthcare industry concerns, negative publicity regarding
patient confidentiality and privacy in the context of telehealth, and resistance from third party payors could limit market acceptance
of our healthcare services. If any of these events occurs, it could have a material adverse effect on our business, financial condition,
and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
may not be successful in launching treatments for new indications.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
initial offerings focused on men and women seeking solutions for hair loss and men seeking treatment for erectile
dysfunction. A substantial majority of our annual revenue to date has come from these two indications. We will continue to launch
several indications within our current brands of focus and also launch new brands, including a tele-dermatology brand focused
on skincare. This part of our business is new and still developing. We have less experience marketing to patients within these
new verticals, and as a result, our efforts to attract new customers may not be as successful.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>If
we are unable to expand the scope of our offerings, including the number and type of products and services that we offer, the
number and quality of healthcare providers serving our customers, and the number and types of conditions capable of being treated
through our platform, our business, financial condition, and results of operations may be materially and adversely affected.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
provide customers with access to non-prescription products, telehealth-based medical consultations with providers, and applicable
pharmaceutical products prescribed by the providers for specific medical conditions. In order for our business to continue growing
and expanding, we need to continue expanding the scope of products and services we offer our customers, including telehealth consultations
and prescription and non-prescription medication for additional conditions. The introduction of new products, services, or technologies
by market participants, including us, can quickly make existing products and services offered by us obsolete and unmarketable.
Additionally, changes in laws and regulations (or enforcement thereof) could impact the usefulness of our platform and could necessitate
changes or modifications to our platform or offerings to accommodate such changes. We invest substantial resources in researching
and developing new offerings and enhancing our solutions by incorporating additional features, improving functionality, and adding
other improvements to meet our customers&rsquo; evolving demands. The success of any enhancements or improvements to our services
or any new offerings depends on a number of factors, including timely completion, competitive pricing, adequate quality testing,
integration with new and existing technologies, and overall market acceptance. We may not succeed in developing, marketing, and
delivering on a timely and cost-effective basis enhancements or improvements to our services or any new offerings that respond
to continued changes in market demands or new customer requirements, and any enhancements or improvements to our services or any
new offerings may not achieve market acceptance. Since developing enhancements to our services and the launch of new offerings
can be complex, the timetable for the release of new offerings and enhancements to our existing services is difficult to predict,
and we may not launch new offerings and updates as rapidly as our current or prospective customers require or expect. Any new
offerings or service enhancements that we develop may not be introduced in a timely or cost-effective manner, may contain errors
or defects, or may not achieve the broad market acceptance necessary to generate sufficient revenue. Moreover, even if we introduce
new offerings, we may experience a decline in revenue of our existing offerings that is not offset by revenue from the new offerings.
In addition, we may lose existing customers who choose a competitor&rsquo;s products and services. This could result in a temporary
or permanent revenue shortfall and adversely affect our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>If
we are unable to successfully market to new customers and retain existing customers, or if evolving privacy, healthcare or other
laws prevent or limit our marketing activities, our business, financial condition, and results of operations could be harmed.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
generate revenue from our platform by selling non-prescription health and personal care products directly to consumers and offering
consumers access to telehealth consultations with providers and certain prescription medications that may be prescribed by the
providers in connection with the telehealth consultations. Unless we are able to acquire new customers, and retain existing customers,
our business, financial condition, and results of operations may be harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to acquire new customers and patients, and to incentivize existing customers and patients to purchase more of our offerings,
we use social media platforms, search engine marketing, emails, text messages, our Patient Care Center, influencers, and many
other online and offline marketing strategies to reach new customers and patients. State and federal laws and regulations governing
the privacy and security of personal information, including healthcare data, are evolving rapidly and could impact our ability
to identify and market to potential and existing customers. Similarly, certain federal and state laws regulate, and in some cases
limit, the use of discounts, promotions, and other marketing strategies in the healthcare industry. If federal, state, or local
laws governing our marketing activities become more restrictive or are interpreted by governmental authorities to prohibit or
limit these activities, our ability to attract new customers and retain customers would be affected and our business could be
materially harmed. In addition, any failure, or perceived failure, by us, to comply with any federal, state, or local laws or
regulations governing our marketing activities could adversely affect our reputation, brand, and business, and may result in claims,
proceedings, or actions against us by governmental entities, consumers, suppliers or others, or other liabilities or may require
us to change our operations and/or cease using certain marketing strategies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
to social networking or advertising platforms&rsquo; terms of use, terms of service, or traffic algorithms that limit promotional
communications, impose restrictions that would limit our ability or our customers&rsquo; ability to send communications through
their platforms, disruptions, or downtime experienced by these platforms or reductions in the use of or engagement with social
networking or advertising platforms by customers and potential customers could also harm our business. As laws and regulations
rapidly evolve to govern the use of these channels, the failure by us, our employees, or third parties acting at our direction
to abide by applicable laws and regulations in the use of these channels could adversely affect our reputation or subject us to
fines or other penalties. In addition, our employees or third parties acting at our direction may knowingly or inadvertently make
use of social media in ways that could lead to the loss or infringement of intellectual property, as well as the public disclosure
of proprietary, confidential or sensitive personal information of our business, employees, consumers or others. Any such inappropriate
use of social media, emails and text messages could also cause reputational damage and adversely affect our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
we use emails, phone calls, and text messages to communicate with customers and we collect consumer data, including email addresses
and phone numbers, to further our marketing efforts with such consenting consumers. If we fail to adequately or accurately collect
such data or if our data collection systems are breached or information therein is misused, our business, financial condition,
and results of operations could be harmed. Further, any failure, or perceived failure, by us, or any third parties processing
such data, to comply with privacy policies or with any federal or state healthcare, privacy, or consumer protection-related laws,
regulations, industry self-regulatory principles, industry standards or codes of conduct, regulatory guidance, orders to which
we may be subject, or other legal obligations relating to privacy or consumer protection could adversely affect our reputation,
brand, and business, and may result in claims, proceedings, or actions against us by governmental entities, consumers, suppliers
or others or other liabilities or may require us to change our operations and/or cease using certain data sets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
business relies heavily on Facebook, Google, Amazon and many other social networks and search engines for customer acquisition,
and any changes and restrictions to the advertising policy of these platforms could materially adversely affect our net revenue
and business.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is highly dependent upon online advertising platforms for promoting our brands and products. Changes to advertising policies
by these platforms could restrict or eliminate our ability to run advertisements for our products which would adversely impact
our business. Changes in advertising costs could dramatically increase our customer acquisition costs, which could adversely affect
profitability and result in us having to raise more capital to grow our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>If
we are unable to expand our marketing infrastructure, we may fail to increase the usage of our platform to meet our forecasts.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
first launched our e-commerce platform in 2016 and our telemedicine platform in December of 2019. As a result, we have only limited
experience marketing our offerings and engaging customers at our current scale. We derive a substantial majority of our revenue
from customers&rsquo; and patients&rsquo; subscription-based purchases of prescription and over the counter products made available
through our platform. We expect to expand the conditions for which customers can seek treatment from providers, including fulfillment
of prescription medication, through our platform and, as a result, new customer acquisition is integral to our business. Our financial
condition and results of operations are and will continue to be highly dependent on the ability of our marketing function to adequately
promote, market, and attract customers to our platform and offerings in a manner that complies with applicable laws and regulations
and at a cost that does not exceed our current budget allocated to marketing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
key element of our business strategy is the continued expansion of our marketing infrastructure, including our Patient Care Center,
to drive customer and patient acquisition and retention. As we increase our marketing efforts in connection with the expansion
of our platform offerings, we will need to further expand the reach of our marketing networks. Our future success will depend
largely on our ability to continue to hire, train, retain, and motivate a skilled marketing workforce with significant industry-specific
knowledge in various areas, including direct-to-consumer business models, ecommerce, technology, healthcare, and the regulatory
restrictions related thereto, as well as the competitive landscape for our solutions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are unable to expand our marketing capabilities, we may not be able to effectively expand the scope of our platform to attract
new customers and give our existing customers additional treatment options. Relatedly, if any of our marketing platforms significantly
increase their advertising fees, our ability to expand our marketing reach will be greatly impeded. Any such failure could adversely
affect our reputation, revenue, and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
revenue growth depends on consumers&rsquo; willingness to adopt our products, and the failure of our offerings to achieve and
maintain market acceptance could result in us achieving revenue below our expectations, which could cause our business, financial
condition, and results of operation to be materially and adversely affected.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
growth is highly dependent upon the adoption by consumers of our products, and we are subject to a risk of any reduced demand
for our products. If the market for our products does not gain broad market acceptance or develops more slowly than we expect,
our business, prospects, financial condition and operating results will be harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current business strategy is highly dependent on our platform and offerings achieving and maintaining market acceptance. Market
acceptance and adoption of our model and the products and services we make available depend on educating potential customers who
may find our services and these products and services useful, as well as potential partners, suppliers, and providers, as to the
distinct features, ease-of-use, positive lifestyle impact, cost savings, and other perceived benefits of our offerings as compared
to those of competitors. If we are not successful in demonstrating to existing and potential customers the benefits of our services,
our revenue may decline or we may fail to increase our revenue in line with our forecasts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Achieving
and maintaining market acceptance of our model and our services could be negatively impacted by many factors, including, to the
extent they arise:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">perceived
                                         risks associated with the use of our platform, telehealth or similar technologies generally,
                                         including those related to privacy and customer data;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         inability to expand into new conditions and to attract providers qualified to treat those
                                         conditions;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
                                         developments that affect our business, including in healthcare, data privacy and security,
                                         and consumer protection;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">competitors
                                         offering telehealth options or technologies for customers and the rate of acceptable
                                         of those solutions as compared to our platform;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">perceived
                                         difficulty or complexity of obtaining a medical consultation or prescription on our platform;
                                         and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">negative
                                         reviews of providers treating our customers.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our business model and the services and products we make available may be perceived by potential customers, providers,
suppliers, and partners to be less trustworthy or effective than traditional medical care or competitive telehealth options, and
people may be unwilling to change their current health regimens or adopt our offerings. Consumers who have healthcare insurance
coverage may not wish to use the platform to access healthcare services or products for which insurance reimbursement is not available.
Moreover, we believe that providers can be slow to change their treatment practices or approaches because of perceived liability
risks or distrust of departures from traditional practice. Accordingly, we may face resistance to our offerings from brick-and-mortar
providers until there is overwhelming evidence to convince them to alter their current approach.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
market for our model and services is new, rapidly evolving, and increasingly competitive, as the healthcare industry in the United
States is undergoing significant structural change and consolidation, which makes it difficult to forecast demand for our solutions.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market for our products is relatively new, rapidly evolving, characterized by rapidly changing technologies, price competition,
additional competitors, evolving government regulation and industry standards, and changing consumer demands and behaviors. We
are expanding our business by offering access to consultation and treatment options for new conditions, and it is uncertain whether
our offerings will achieve and sustain high levels of demand and market adoption. Our future financial performance depends in
part on growth in this market, our ability to market effectively and in a cost-efficient manner, and our ability to adapt to emerging
demands of our customers. It is difficult to predict the future growth rate and size of our target market. Negative publicity
concerning telehealth generally, our offerings, customer success on our platform, or our market as a whole could limit market
acceptance of our business model and services. If our customers do not perceive the benefits of our offerings, or if our offerings
do not drive customer use and enrollment, then our market and our customer base may not continue to develop, or they may develop
more slowly than we expect. Our success depends in part on the willingness of providers and healthcare organizations to partner
with us, increase their use of telehealth, and our ability to demonstrate the value of our technology to providers, as well as
our existing and potential customers. If providers, healthcare organizations or regulators work in opposition to us or if we are
unable to reduce healthcare costs or drive positive health outcomes for our customers, then the market for our services may not
continue to develop, or it might develop more slowly than we expect. Similarly, negative publicity regarding customer confidentiality
and privacy in the context of telehealth could limit market acceptance of our business model and services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
healthcare industry in the United States is continually undergoing or threatened with significant structural change and is rapidly
evolving. We believe demand for our offerings has been driven in part by rapidly growing costs in the traditional healthcare system,
difficulties accessing the healthcare system, patient stigma associated with sensitive medical conditions, the movement toward
patient-centricity and personalized healthcare, and advances in technology. Widespread acceptance of personalized healthcare enabled
by technology is critical to our future growth and success. A reduction in the growth of technology-enabled personalized healthcare
could reduce the demand for our services and result in a lower revenue growth rate or decreased revenue. Additionally, the majority
of our revenue is driven by products and services offered through our platform on a subscription basis, and the adoption of subscription
business models is still relatively new, especially in the healthcare industry. If customers do not shift to subscription business
models and subscription health management tools do not achieve widespread adoption, or if there is a reduction in demand for subscription
products and services or subscription health management tools, our business, financial condition, and results of operations could
be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
if healthcare or healthcare benefits trends shift or entirely new technologies are developed that replace existing offerings,
our existing or future services could be rendered obsolete and require that we materially change our technology or business model.
If we are unable to do so, our business could be adversely affected. In addition, we may experience difficulties with software
development, industry standards, design or marketing that could delay or prevent our development, introduction, or implementation
of new options on our platform and any enhancements thereto. Any such difficulties may have an adverse effect on our business,
financial condition, and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Competitive
platforms or other technological breakthroughs for the monitoring, treatment, or prevention of medical conditions may adversely
affect demand for our offerings.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to achieve our strategic objectives will depend, among other things, on our ability to enable fast and efficient telehealth
consultations, maintain comprehensive and affordable offerings, and deliver an accessible and reliable platform that is more appealing
and user-friendly than available alternatives. Our competitors, as well as a number of other companies and providers, within and
outside the healthcare industry, are pursuing new devices, delivery technologies, sensing technologies, procedures, treatments,
drugs, and other therapies for the monitoring and treatment of medical conditions. Any technological breakthroughs in monitoring,
treatment, or prevention of medical conditions that we could not similarly leverage could reduce the potential market for our
offerings, which could significantly reduce our revenue and our potential to grow certain aspects of our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
introduction by competitors of solutions or offerings that are or claim to be superior to our platform or offerings may create
market confusion, which may make it difficult for potential customers to differentiate between the benefits of our offerings and
competitive solutions. In addition, the entry of multiple new products may lead some of our competitors to employ pricing strategies
that could adversely affect the pricing of products and services we make available. If a competitor develops a product or business
that competes with, or is perceived to be superior to our offerings, or if a competitor employs strategies that place downward
pressure on pricing within our industry, our revenue may decline significantly or may not increase in line with our forecasts,
either of which could adversely affect our business, financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
operate in highly competitive markets and face competition from large, well-established healthcare providers and more traditional
retailers and pharmaceutical providers with significant resources, and, as a result, we may not be able to compete effectively.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
markets for healthcare are intensely competitive, subject to rapid change and significantly affected by new product and technological
introductions and other market activities of industry participants. We compete directly not only with other established telehealth
providers but also traditional healthcare providers, pharmacies, and large retailers that sell non-prescription products, including,
for example, nutritional supplements, vitamins, and hair care treatments. Our current competitors include traditional healthcare
providers expanding into the telehealth market, incumbent telehealth providers, as well as new entrants into our market that are
focused on direct-to-consumer healthcare. Our competitors include enterprise-focused companies who may enter the direct-to-consumer
healthcare industry, as well as direct-to-consumer healthcare providers. Many of our current and potential competitors may have
greater name and brand recognition, longer operating histories, significantly greater resources than we do and may be able to
offer products and services similar to those offered on our platform at more attractive prices than we can. Further, our current
or potential competitors may be acquired by third parties with greater available resources, which has recently occurred in our
industry. As a result, our competitors may be able to respond more quickly and effectively than we can to new or changing opportunities,
technologies, standards, or customer requirements and may have the ability to initiate or withstand substantial price competition.
In addition, our competitors have established, and may in the future establish, cooperative relationships with vendors of complementary
products, technologies, or services to increase the availability of their solutions in the marketplace.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
competitors or alliances may emerge that have greater market share, a larger customer base, more widely adopted proprietary technologies,
greater marketing expertise, and greater financial resources, which could put us at a competitive disadvantage. For example, some
state and federal regulatory authorities lowered certain barriers to the practice of telehealth in order to make remote healthcare
services more accessible in response to the COVID-19 pandemic. Although it is unclear whether these regulatory changes will be
permanent or that they will have a long-term impact on the adoption of telehealth services by the general public or legislative
and regulatory authorities, these changes may result in greater competition for our business. The lower barriers to entry may
allow various new competitors to enter the market more quickly and cost effectively than before the COVID-19 pandemic. Additionally,
we believe that the COVID-19 pandemic has introduced many new users to telehealth and further reinforced its benefits to potential
competitors. We believe this may drive additional industry consolidation or collaboration involving competitors that may create
competitors with greater resources and access to potential customers. The COVID-19 pandemic may also cause various traditional
healthcare providers to evaluate and eventually pursue telehealth options that can be paired with their in-person capabilities.
These industry changes could better position our competitors to serve certain segments of our current or future markets, which
could create additional price pressure. In light of these factors, even if our offerings are more effective than those of our
competitors, current or potential customers may accept competitive solutions in lieu of purchasing from us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to compete effectively depends on our ability to distinguish our company and our offerings from our competitors and their
products, and includes factors such as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">accessibility,
                                         ease of use and convenience;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">price
                                         and affordability;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">personalization;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">brand
                                         recognition;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">long-term
                                         outcomes;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">breadth
                                         and efficacy of offerings;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">market
                                         penetration;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">marketing
                                         resources and effectiveness;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">partnerships
                                         and alliances;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">relationships
                                         with providers, suppliers, and partners; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
                                         compliance recourses.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are unable to successfully compete with existing and potential competitors, our business, financial condition, and results
of operations could be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
have experienced rapid growth in recent periods and expect to continue to invest in our growth for the foreseeable future. If
we fail to manage our growth effectively, we may be unable to execute our business plan, maintain high levels of service, or adequately
address competitive challenges.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have recently experienced a period of rapid growth in our headcount and operations. Our revenue grew from $12.5 million for the year
ended December 31, 2019 to $37.3 million for the year ended December 31, 2020. Our number of full-time employees has increased significantly
over the last few years, from 26 employees as of December 31, 2019 to 56 &nbsp;employees as of December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate that we will continue to significantly expand our operations and headcount in the near term as we continue to scale
domestically. We also anticipate entering the international market to meet perceived demand for our offerings. <FONT STYLE="background-color: white">We
are continually executing a number of growth initiatives, strategies and operating plans designed to enhance our business. The
anticipated benefits from these efforts are based on several assumptions that may prove to be inaccurate. Moreover, we may not
be able to successfully complete these growth initiatives, strategies and operating plans and realize all of the benefits, including
growth targets and cost savings, that we expect to achieve, or it may be more costly to do so than we anticipate.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
growth has placed, and future growth will place, a significant strain on our management, administrative, operational, and financial
infrastructure. Our success will depend in part on our ability to manage this growth effectively and execute our business plan.
To manage the expected growth of our operations and personnel, we will need to continue to improve our operational, financial,
and management controls, and our reporting systems and procedures, and we will need to ensure that we maintain high levels of
patient care and support. Failure to effectively manage growth and execute our business plan could result in difficulty or delays
in increasing the size of our customer base, declines in quality of patient care, support, or satisfaction, increases in costs,
difficulties in introducing new products or features, or other operational difficulties, and any of these difficulties could adversely
affect our business performance and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>If
we fail to develop widespread brand awareness cost-effectively, our business may suffer.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that developing and maintaining widespread awareness of our brand in a cost-effective manner is critical to achieving
widespread adoption of our solution and attracting new customers. Our brand promotion activities may not generate consumer awareness
or increase revenue, and even if they do, any increase in revenue may not offset the expenses we incur in building our brand.
If we fail to successfully promote and maintain our brand, or incur substantial expenses in doing so, we may fail to attract or
retain customers necessary to realize a sufficient return on our brand-building efforts or to achieve the widespread brand awareness
that is critical for broad client adoption of our brands. In addition, any factor that diminishes our reputation or that of our
management, including failing to meet the expectations of our customers, providers, or partners, could harm our reputation and
brand and make it substantially more difficult for us to attract new customers, providers, and partners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>If
we are unable to attract and retain high quality healthcare providers for our customers, our business, financial condition, and
results of operations may be materially and adversely affected.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success depends on our continued ability to maintain customer access to a network of qualified healthcare providers, which include
medical doctors, physician assistants, and nurse practitioners. If we are unable to recruit and retain licensed physicians and
other qualified providers to perform services on our platform, it could have a material adverse effect on our business and ability
to grow and could adversely affect our results of operations. In any particular market, providers could demand higher payments
or take other actions that could result in higher medical costs, less attractive service for our customers, or difficulty meeting
regulatory requirements. The failure to maintain or to secure new cost-effective arrangements with third party medical groups
and independent providers on our platform may result in a loss of, or inability to grow, our customer base, higher costs, less
attractive service for our customers and/or difficulty in meeting regulatory requirements, any of which could have a material
adverse effect on our business, financial condition, and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Any
failure to offer high-quality support may adversely affect our relationships with customers and healthcare providers, and in turn
our business, financial condition, and results of operations.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
using our platform, our customers depend on our patient care and support, including our Patient Care Center, to resolve issues
in a timely manner. We may be unable to respond quickly enough to accommodate short-term increases in demand for patient care
and support. We also may be unable to modify the nature, scope, and delivery of our offerings or patient care and support to compete
with changes in solutions provided by our competitors. Increased customer demand for support could increase costs and adversely
affect our business, financial condition, and results of operations. Our revenue is highly dependent on our reputation and on
positive recommendations from our customers, providers, and partners. Any failure to maintain high-quality patient care and support
or a market perception that we do not maintain high-quality patient care and support, could adversely affect our reputation, our
ability to sell the offerings on our platform, and in turn our business, financial conditions, and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
face risk that may arise from acquisitions and investments, which could result in operating difficulties, dilution, and other
harmful consequences that may adversely impact our business, financial condition, and results of operations. Additionally, if
we are not able to identify and successfully acquire suitable businesses, our results of operations and prospects could be harmed.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may pursue inorganic methods of growth, including strategic acquisitions and mergers in the future, to add complementary or strategic
companies, products, solutions, technologies, or revenue. These transactions could be material to our results of operations and
financial condition. We also expect to continue to evaluate and enter into discussions regarding a wide array of potential strategic
transactions. The identification of suitable acquisition candidates can be difficult, time-consuming, and costly, and we may not
be able to complete acquisitions on favorable terms, if at all. The process of integrating an acquired company, business, or technology
may create unforeseen operating difficulties and expenditures. The related areas where we face risks include, but are not limited
to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">diversion
                                         of management time and focus from operating our business to addressing acquisition integration
                                         challenges;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">loss
                                         of key employees of the acquired company and other challenges associated with integrating
                                         new employees into our culture, as well as reputational harm if integration is not successful;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
                                         in integrating and managing the combined operations, technologies, technology platforms,
                                         and products of the acquired companies, and realizing the anticipated economic, operational
                                         and other benefits in a timely manner, which could result in substantial costs and delays
                                         or other operational, technical, or financial problems;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
                                         complexities of integrating or managing the combined operations or expanding into other
                                         industries or parts of the healthcare industry;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">assumption
                                         of contractual obligations that contain terms that are not beneficial to us, require
                                         us to license or waive intellectual property rights, or increase our risk for liabilities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                         to successfully further develop the acquired technology or realize our intended business
                                         strategy;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">uncertainty
                                         of entry into markets in which we have limited or no prior experience or in which competitors
                                         have stronger market positions;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">unanticipated
                                         costs associated with pursuing acquisitions;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                         to find commercial success with the products or services of the acquired company;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulty
                                         of transitioning the acquired technology onto our existing platforms and maintaining
                                         the security standards for such technology consistent with our other solutions;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                         to successfully onboard customers or maintain brand quality of acquired companies;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">responsibility
                                         for the liabilities of acquired businesses, including those that were not disclosed to
                                         us or exceed our estimates, as well as, without limitation, liabilities arising out of
                                         their failure to maintain effective data protection and privacy controls and comply with
                                         applicable regulations;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                         to generate the expected financial results related to an acquisition on a timely manner
                                         or at all; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
                                         accounting charges to the extent intangibles recorded in connection with an acquisition,
                                         such as goodwill, trademarks, client relationships, or intellectual property, are later
                                         determined to be impaired and written down in value.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
acquisitions could also result in expenditures of significant cash, dilutive issuances of our equity securities, the incurrence
of debt, restrictions on our business, contingent liabilities, amortization expenses, or write-offs of goodwill, any of which
could harm our financial condition. In addition, any acquisitions we announce could be viewed negatively by customers, providers,
partners, suppliers, or investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
competition within our industry for acquisitions of business, technologies and assets may become intense. Even if we are able
to identify an acquisition that we would like to consummate, we may not be able to complete the acquisition on commercially reasonable
terms or the target may be acquired by another company. We may enter into negotiations for acquisitions that are not ultimately
consummated. Those negotiations could result in diversion of management time and significant out-of-pocket costs. If we fail to
evaluate and execute acquisitions successfully, we may not be able to realize the benefits of these acquisitions, and our results
of operations could be harmed. If we are unable to successfully address any of these risks, our business, financial condition,
or results of operations could be harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Expansion
into international markets can be a driver of long-term growth, when we expand into international markets, we will face additional
business, political, legal, regulatory, operational, financial, and economic risks, any of which could increase our costs and
hinder such growth.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expanding
our business to attract customers, providers and suppliers in countries other than the United States is an opportunity for growth
for us going-forward. An important part of targeting international markets is increasing our brand awareness and establishing
relationships with partners internationally. Doing business internationally involves a number of risks, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">uncertain
                                         legal and regulatory requirements applicable to telehealth and prescription medication;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         inability to replicate our domestic business structure consistently outside of the United
                                         States, especially as it relates to our contractual arrangement with affiliated professional
                                         entities;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">multiple,
                                         conflicting and changing laws and regulations such as tax laws, privacy, and data protection
                                         laws and regulations, export and import restrictions, employment laws, regulatory requirements
                                         and other governmental approvals, permits, and licenses;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtaining
                                         regulatory approvals or clearances where required for the sale of our offerings, products,
                                         devices, and services in various countries;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">requirements
                                         to maintain data and the processing of that data on servers located within the United
                                         States or in such countries;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">protecting
                                         and enforcing our intellectual property rights;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">logistics
                                         and regulations associated with prescribing medicine online and engaging with partner
                                         pharmacies to ship the prescribed medication;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">natural
                                         disasters, political and economic instability, including wars, terrorism, social or political
                                         unrest, including civil unrest, protests, and other public demonstrations, outbreaks
                                         of disease, pandemics or epidemics, boycotts, curtailment of trade, and other market
                                         restrictions; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
                                         and compliance risks that relate to maintaining accurate information and control over
                                         activities subject to regulation under the U.S. Foreign Corrupt Practices Act (the &#8220;FCPA&#8221;),
                                         and comparable laws and regulations in other countries.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to expand our business and to attract talented employees, customers, providers, partners, and suppliers in various international
markets will require considerable management attention and resources and is subject to the particular challenges of supporting
a rapidly growing business in an environment of multiple languages, cultures, customs, legal systems, alternative dispute resolution
systems, regulatory systems, and commercial infrastructures. Entering new international markets will be expensive, our ability
to successfully gain market acceptance in any particular market is uncertain and the distraction of our senior management team
could harm our business, financial condition, and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Economic
uncertainty or downturns, particularly as it impacts particular industries, could adversely affect our business and results of
operations.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
recent years, the United States and other significant markets have experienced cyclical downturns, and worldwide economic conditions
remain uncertain. This has been the case in 2020 as a result of the COVID-19 pandemic. Economic uncertainty and associated macroeconomic
conditions make it extremely difficult for our partners, suppliers, and us to accurately forecast and plan future business activities,
and could cause our customers to slow spending on our offerings and could limit the ability of our pharmacy partners to purchase
sufficient quantities of pharmaceutical products from suppliers, which could adversely affect our ability to fulfill customer
orders and attract new providers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
significant downturn in the domestic or global economy may cause our customers to pause, delay, or cancel spending on our platform
or seek to lower their costs by exploring alternative providers or our competitors. To the extent purchases of our offerings are
perceived by customers and potential customers as discretionary, our revenue may be disproportionately affected by delays or reductions
in general healthcare spending. Also, competitors may respond to challenging market conditions by lowering prices and attempting
to lure away our customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot predict the timing, strength, or duration of any economic slowdown or any subsequent recovery generally, or in any particular
industry. If the conditions in the general economy and the markets in which we operate worsen from present levels, our business,
financial condition, and results of operations could be materially adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
COVID-19 pandemic has increased interest in and customer use of telehealth solutions, including our platform, and we cannot guarantee
that this increased interest will continue after the pandemic.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
World Health Organization declared a global emergency on January 30, 2020 with respect to the outbreak of COVID-19 and then characterized
it as a pandemic on March 11, 2020. The outbreak has spread globally, causing companies and various local, state, federal, and
international jurisdictions to impose restrictions, such as quarantines, closures, cancellations, and travel restrictions. The
duration of the business disruptions, travel restrictions and related financial impact cannot be reasonably estimated at this
time. As the COVID-19 pandemic is ongoing, the complete impact of the pandemic is still unknown and rapidly evolving.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to COVID-19, telehealth has seen a steep increase in use across the industry, in part due to governmental waivers of statutory
and regulatory restrictions that have historically limited how telehealth may be used in delivering care in certain jurisdictions.
We do not know if this relaxation of regulatory barriers resulting from COVID-19 will remain or for how long. There is renewed
focus on telehealth among legislatures and regulators due to COVID-19 and the expanded use of telehealth that could result in
regulatory changes inconsistent with or that place additional restrictions on our current business model or operations in certain
jurisdictions. If customer adoption of telehealth generally, or our platform in particular materially decreases as the COVID-19
restrictions are lifted, or if COVID-19 results in regulatory changes that limit our current activities, our industry, business,
and results of operations could be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
business depends on continued and unimpeded access to the internet and mobile networks.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to deliver our internet-based and mobile-application based services depends on the development and maintenance of the
infrastructure of the internet by third parties. This includes maintenance of a reliable network backbone with the necessary speed,
data capacity, bandwidth capacity, and security. Our services are designed to operate without interruption. However, we may experience
future interruptions and delays in services and availability from time to time. In the event of a catastrophic event with respect
to one or more of our systems or those of our service providers, we may experience an extended period of system unavailability,
which could negatively impact our relationship with customers, providers, partners, and suppliers. To operate without interruption,
both we and our service providers must guard against:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">damage
                                         from fire, power loss, natural disasters, and other force majeure events outside our
                                         control;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">communications
                                         failures;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">software
                                         and hardware errors, failures, and crashes;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">security
                                         breaches, computer viruses, hacking, denial-of-service attacks, and similar disruptive
                                         problems; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
                                         potential interruptions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also rely on software licensed from third parties in order to offer our services. These licenses are generally commercially available
on varying terms. However, it is possible that this software may not continue to be available on commercially reasonable terms,
or at all. Any loss of the right to use any of this software could result in delays in the provisioning of our services until
equivalent technology is either developed by us, or, if available, is identified, obtained and integrated. Furthermore, our use
of additional or alternative third-party software would require us to enter into license agreements with third parties, and integration
of our software with new third-party software may require significant work and require substantial investment of our time and
resources. Also, any undetected errors or defects in third-party software could prevent the deployment or impair the functionality
of our software, delay new updates or enhancements to our solution, result in a failure of our solution, and injure our reputation.
The occurrence of any of the foregoing events could have an adverse impact on our business, financial condition, and results of
operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cyber
security risks and the failure to maintain the integrity of data belonging to our Company could expose us to data loss, litigation
and liability, and our reputation could be significantly harmed.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
collect and retain large volumes of data relating to our business and from our customers for business purposes, including for
transactional and promotional purposes, and our various information technology systems enter, process, summarize, and report such
data. The integrity and protection of this data is critical to our business. We are subject to significant security and privacy
regulations, as well as requirements imposed by the credit card industry. Maintaining compliance with these evolving regulations
and requirements could be difficult and may increase our expenses. In addition, a penetrated or compromised data system or the
intentional, inadvertent or negligent release or disclosure of data could result in theft, loss or fraudulent or unlawful use
of data relating to our company or our employees, independent distributors or preferred customers, which could harm our reputation,
disrupt our operations, or result in remedial and other costs, fines or lawsuits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Any
disruption of service at Amazon Web Services, partner pharmacies or other third-party service providers could interrupt access
to our platform or delay our customers&rsquo; ability to seek treatment.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently host our platform, serve our customers, and support our operations in the United States using Amazon Web Services (&ldquo;AWS&rdquo;),
a provider of cloud infrastructure services, as well as through partner pharmacies and other third-party service providers, including
shipping providers and contract manufacturers. We do not have control over the operations of the facilities of partner pharmacies,
AWS, or other third-party service providers. Such facilities are vulnerable to damage or interruption from earthquakes, hurricanes,
floods, fires, cyber security attacks, terrorist attacks, power losses, telecommunications failures, and similar events. The occurrence
of a natural disaster or an act of terrorism, a decision to close the facilities without adequate notice, or other unanticipated
problems could result in lengthy interruptions in our ability to generate revenue through customer purchases on the platform.
The facilities also could be subject to break-ins, computer viruses, sabotage, intentional acts of vandalism, and other misconduct.
Our platform&rsquo;s continuing and uninterrupted performance is critical to our success. Because our platform is used by our
customers to engage with providers who can diagnose, manage, and treat medical conditions, and pharmacies who can fulfill and
ship prescription medication, it is critical that our platform be accessible without interruption or degradation of performance.
Customers may become dissatisfied by any system failure that interrupts our ability to provide our platform or access to the products
and services offered through our platform to them. Outages and partner pharmacy closures could lead to claims of damages from
our customers, providers, partners, suppliers, and others. We may not be able to easily switch our AWS operations to another cloud
provider if there are disruptions or interference with our use of AWS. Sustained or repeated system failures could reduce the
attractiveness of our offerings to customers and result in contract terminations, thereby reducing revenue. Moreover, negative
publicity arising from these types of disruptions could damage our reputation and may adversely impact use of our platform. We
may not carry sufficient business interruption insurance to compensate us for losses that may occur as a result of any events
that cause interruptions in our platform. Thus, any such disruptions could have an adverse effect on our business and results
of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of our partner pharmacies, shipping providers, contract manufacturers, nor AWS have an obligation to renew their agreements with
us on commercially reasonable terms, or at all. If we are unable to renew our agreements with these third-party service providers
on commercially reasonable terms, if our agreements with these providers are prematurely terminated, we may experience costs or
downtime in connection with the transfer to, or the addition of, such new providers. If these third-party service providers were
to increase the cost of their services, we may have to increase the price of our offerings, and our results of operations may
be adversely impacted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
depend on a number of other companies to perform functions critical to our ability to operate our platform, generate revenue from
customers, and to perform many of the related functions.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
depend on third party medical groups and their providers to deliver quality healthcare consultations and services through our
platform. Through our platform, providers are able to prescribe medication fulfilled by a partner pharmacy. Any interruption in
the availability of a sufficient number of providers or supply from our partner pharmacies could materially and adversely affect
our ability to satisfy our customers and ensure they receive consultation services and any medication that they have been prescribed.
If we were to lose our relationship with one of the third party medical groups, we cannot guarantee that we will be able to ensure
access to a sufficient network of providers. Similarly, if we were to lose our relationship with one of our partner pharmacies
in the near term before our own affiliated pharmacy is operational at scale and able to service all geographies, we cannot guarantee
that we will be able to find, diligence, and engage with a replacement partner in a timely manner. Our ability to service customer
requirements could be materially impaired or interrupted in the event that our relationship with a third party medical group or
partner pharmacy is terminated. We also depend on cloud infrastructure providers, payment processors, suppliers of non-prescription
products and packaging, and various others that allow our platform to function effectively and serve the needs of our customers.
Difficulties with our significant partners and suppliers, regardless of the reason, could have a material adverse effect on our
business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
payments system depends on third party service providers and is subject to evolving laws and regulations.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have engaged third-party service providers to perform underlying card processing and currency exchange. If these service providers
do not perform adequately or if our relationships with these service providers were to terminate, our ability to accept orders
through the platform could be adversely affected and our business could be harmed. In addition, if these service providers increase
the fees they charge us, our operating expenses could increase and if we respond by increasing the fees we charge to our customers,
we could lose some of our customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
laws and regulations related to payments are complex and vary across different jurisdictions in the United States and globally.
As a result, we are required to spend significant time and effort to comply with those laws and regulations. Any failure or claim
of our failure to comply, or any failure by our third-party service providers to comply, could cost us substantial resources,
could result in liabilities, or could force us to stop offering third-party payment systems. As we expand the availability of
payments via third parties or offer new payment methods to our customers in the future, we may become subject to additional regulations
and compliance requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
through our agreement with our third-party credit card processor, we are indirectly subject to payment card association operating
rules and certification requirements, including the Payment Card Industry Data Security Standard. We are also subject to rules
governing electronic funds transfers. Any change in these rules and requirements could make it difficult or impossible for us
to comply. Any such difficulties or failures with respect to the payment systems we utilize may have an adverse effect on our
business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
pricing decisions may adversely affect our ability to attract new customers, healthcare providers, and other partners.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have limited experience determining the optimal prices for our offerings. As competitors introduce new solutions that compete with our
offerings, especially in the telehealth market where we face significant competition, we may be unable to attract new customers or
partners at the same price or based on the same pricing models as we have used historically. Pricing decisions may also impact the
mix of adoption among our services and products and negatively impact our overall revenue. As a result, in the future we may be required
to reduce our prices, which could adversely affect our revenue, gross profit, profitability, financial position, and cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
depend on our talent to grow and operate our business, and if we are unable to hire, integrate, develop, motivate and retain our
personnel, we may not be able to grow effectively.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success depends in large part on our ability to attract and retain high-quality management in marketing, engineering, operations,
healthcare, regulatory, legal, finance and support functions. Competition for qualified employees is intense in our industry,
and the loss of even a few qualified employees, or an inability to attract, retain and motivate additional highly skilled employees
required for the planned expansion of our business could harm our results of operations and impair our ability to grow. To attract
and retain key personnel, we use various measures, including an equity incentive program for key executive officers and other
employees. These measures may not be enough to attract and retain the personnel we require to operate our business effectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
we continue to grow, we may be unable to continue to attract or retain the personnel we need to maintain our competitive position.
In addition to hiring new employees, we must continue to focus on retaining our best talent. Competition for these resources,
particularly for engineers, is intense. We may need to invest significant amounts of cash and equity for new and existing employees
and we may never realize returns on these investments. If we are not able to effectively increase and retain our talent, our ability
to achieve our strategic objectives will be adversely impacted, and our business will be harmed. The loss of one or more of our
key employees, and any failure to have in place and execute an effective succession plan for key employees, could seriously harm
our business. Employees may be more likely to leave us if the shares of our capital stock they own, or the shares of our capital
stock underlying their equity incentive awards have significantly reduced in value, or the vested shares of our capital stock
they own or vested shares of our capital stock underlying their equity incentive awards have significantly appreciated. Many of
our employees may receive significant proceeds from sales of our equity in the public markets once the applicable lock-up restrictions
expire, which may reduce their motivation to continue to work for us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
permit most of our employees to work remotely should their particular positions allow. While we believe that most of our operations
can be performed remotely, there is no guarantee that we will be as effective while working remotely because our team is dispersed
and many employees may have additional personal needs to attend to or distractions in their remote work environment. To the extent
our current or future remote work policies result in decreased productivity, harm our company culture, or otherwise negatively
affect our business, our financial condition and results of operations could be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
are at risk that the non-prescription inventory that we store may become damaged, facility disruption may also harm our business.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hold non-prescription inventory at some of our facilities. A natural disaster, fire, power interruption, work stoppage or other
calamity at this facility would significantly disrupt our ability to deliver our products and operate our business. If any material
amount of our facility, machinery, or inventory were damaged or unusable, we would be unable to meet our obligations to customers
and wholesale partners, which could materially adversely affect our business, financial condition, and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Risks
Related to Governmental Regulation</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Government
regulation of healthcare creates risks and challenges with respect to our compliance efforts and our business strategies.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
healthcare industry is subject to changing political, economic and regulatory influences that may affect companies like ours.
During the past several years, the healthcare industry has been subject to an increase in governmental regulation and subject
to potential disruption due to legislative initiatives and government regulation, as well as judicial interpretations thereof.
While these regulations may not directly impact us or our offerings in every instance, they will affect the healthcare industry
as a whole and may impact customer use of our services. We currently accept payments only from our customers - not any third-party
payors, such as government healthcare programs or health insurers. Because of this approach, we are not subject to many of the
laws and regulations that impact many other participants in healthcare industry. If the government asserts broader regulatory
control over companies like us, or if we determine that we will facilitate payment from and/or participate in third-party payor
programs, the complexity of our operations and our compliance obligations will materially increase.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>If
we fail to comply with applicable healthcare and other governmental regulations, we could face substantial penalties, our business,
financial condition, and results of operations could be adversely affected, and we may be required to restructure our operations;
and any changes to federal, state or international laws or regulations applicable to our company could adversely affect our business.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is subject to a variety of federal, state, local, and international laws and regulations that carry substantial criminal
and civil fines and penalties. Under our current business model, we accept payments only from our customers, and not
from any third party payors, such as government healthcare programs or health insurers. Because of this approach, we are not subject
to many of the laws and regulations that impact many other participants in healthcare industry. If the government asserts broader
regulatory control over companies like ours or if we determine that we will change our business model and accept payment from
and/or participate in third-party payor programs, the complexity of our operations and our compliance obligations will materially
increase. Failure to comply with any applicable federal, state, and local laws and regulations could have a material adverse effect
on our business, financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
within the narrowed band of applicable healthcare laws and regulations, because of the breadth of these laws and the narrowness
of available statutory and regulatory exemptions, it is possible that some of our activities could be subject to challenge under
one or more of such laws. Any action brought against us for violations of these laws or regulations, even if successfully defended,
could cause us to incur significant legal expenses and divert our management&rsquo;s attention from the operation of our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we have adopted policies and procedures designed to comply with these laws and regulations and conduct internal reviews of our
compliance with these laws, our compliance is also subject to governmental review. The growth of our business and sales organization
and our future expansion outside of the United States may increase the potential of violating these laws or our internal policies
and procedures. The risk of being in violation of these or other laws and regulations is further increased by the fact
that many have not been fully interpreted by the regulatory authorities or the courts, and their provisions are open to a variety
of interpretations. Any action brought against us for violation of these or other laws or regulations, even if we successfully
defend against it, could cause us to incur significant legal expenses and divert our management&rsquo;s attention from the operation
of our business. If our operations are found to be in violation of any of the federal, state, and foreign laws described above
or any other current or future fraud and abuse or other healthcare laws and regulations that apply to us, we may be subject to
penalties, including significant criminal, civil, and administrative penalties, damages, and fines, disgorgement, additional reporting
requirements and oversight, imprisonment for individuals and exclusion from participation in government healthcare programs, such
as Medicare and Medicaid, as well as contractual damages and reputational harm. We could also be required to curtail or cease
our operations. Any of the foregoing consequences could seriously harm our business and our financial results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to offer access to telehealth services internationally is subject to the applicable laws governing remote care and the
practice of medicine in the applicable jurisdiction. Each country&rsquo;s interpretation and enforcement of these laws is evolving
and could vary significantly. We cannot provide assurance that we have accurately interpreted each such law and regulation. Moreover,
these laws and regulations may change significantly as this manner of providing services and products evolves. New or revised
laws and regulations (or interpretations thereof) could have a material adverse effect on our business, financial condition, and
results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
may be subject to environmental, health and safety laws, which could increase our costs and restrict our operations in the future.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations may be subject to environmental, health and safety laws and regulations in each of the jurisdictions in which we operate.
These laws and regulations concern, among other things, the generation, handling, transportation and disposal of hazardous substances
or wastes, the clean-up of hazardous substance releases, and the emission or discharge of materials into the air or water. Although
we currently incur limited expenditures in connection with these environmental, health and safety laws and regulations, if we
fail to comply with the requirements of such laws and regulations or if such laws change significantly in the future, we could
incur substantial additional costs to alter our manufacturing processes and/or adjust our supply chain management. Such changes
could also result in significant inventory obsolescence. Compliance with environmental, health and safety requirements could also
restrict our ability to expand our facilities in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>In
the U.S., we conduct business in a heavily regulated industry and if we fail to comply with these laws and government regulations,
we could incur penalties or be required to make significant changes to our operations or experience adverse publicity, which could
have a material adverse effect on our business, financial condition, and results of operations.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
U.S. healthcare industry is heavily regulated and closely scrutinized by federal, state and local governments. Comprehensive statutes
and regulations govern the manner in which we provide and bill for services and collect reimbursement from governmental programs
and private payors, our contractual relationships with our providers, vendors and customers, our marketing activities and other
aspects of our operations. Of particular importance are:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         federal physician self-referral law, commonly referred to as the Stark Law, that, subject
                                         to limited exceptions, prohibits physicians from referring Medicare or Medicaid patients
                                         to an entity for the provision of certain &#8220;designated health services&#8221; if
                                         the physician or a member of such physician&#8217;s immediate family has a direct or
                                         indirect financial relationship (including an ownership interest or a compensation arrangement)
                                         with the entity, and prohibit the entity from billing Medicare or Medicaid for such designated
                                         health services;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         federal Anti-Kickback Statute that prohibits the knowing and willful offer, payment,
                                         solicitation or receipt of any bribe, kickback, rebate or other remuneration for referring
                                         an individual, in return for ordering, leasing, purchasing or recommending or arranging
                                         for or to induce the referral of an individual or the ordering, purchasing or leasing
                                         of items or services covered, in whole or in part, by any federal healthcare program,
                                         such as Medicare and Medicaid. A person or entity does not need to have actual knowledge
                                         of the statute or specific intent to violate it to have committed a violation. In addition,
                                         the government may assert that a claim including items or services resulting from a violation
                                         of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes
                                         of the False Claims Act;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         criminal healthcare fraud provisions of the federal Health Insurance Portability and
                                         Accountability Act of 1996, as amended by the Health Information Technology for Economic
                                         and Clinical Health Act, or HITECH, and their implementing regulations, which we collectively
                                         refer to as HIPAA, and related rules that prohibit knowingly and willfully executing
                                         a scheme or artifice to defraud any healthcare benefit program or falsifying, concealing
                                         or covering up a material fact or making any material false, fictitious or fraudulent
                                         statement in connection with the delivery of or payment for healthcare benefits, items
                                         or services. Similar to the federal Anti-Kickback Statute, a person or entity does not
                                         need to have actual knowledge of the statute or specific intent to violate it to have
                                         committed a violation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available, it is possible that some
of our business activities could be subject to challenge under one or more of such laws. Achieving and sustaining compliance with
these laws may prove costly. Failure to comply with these laws and other laws can result in civil and criminal penalties such
as fines, damages, overpayment, recoupment, imprisonment. The risk of our being found in violation of these laws and regulations
is increased by the fact that many of them have not been fully interpreted by the regulatory authorities or the courts, and their
provisions are sometimes open to a variety of interpretations. Our failure to accurately anticipate the application of these laws
and regulations to our business or any other failure to comply with regulatory requirements could create liability for us and
negatively affect our business. Any action against us for violation of these laws or regulations, even if we successfully defend
against it, could cause us to incur significant legal expenses, divert our management&rsquo;s attention from the operation of
our business and result in adverse publicity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
enforce compliance with the federal laws, the U.S. Department of Justice and the U.S. Department of Health and Human Services
Office of Inspector General, or OIG, have recently increased their scrutiny of healthcare providers, which has led to a number
of investigations, prosecutions, convictions and settlements in the healthcare industry. Dealing with investigations can be time-
and resource-consuming and can divert management&rsquo;s attention from the business. Any such investigation or settlement could
increase our costs or otherwise have an adverse effect on our business. In addition, because of the potential for large monetary
exposure under the federal False Claims Act, which provides for treble damages and penalties of $11,463 to $22,927 per false claim
or statement, healthcare providers often resolve allegations without admissions of liability for significant and material amounts
to avoid the uncertainty of treble damages that may be awarded in litigation proceedings. Such settlements often contain additional
compliance and reporting requirements as part of a consent decree, settlement agreement or corporate integrity agreement. Given
the significant size of actual and potential settlements, it is expected that the government will continue to devote substantial
resources to investigating healthcare providers&rsquo; compliance with the healthcare reimbursement rules and fraud and abuse
laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
laws, regulations and standards governing the provision of healthcare services may change significantly in the future. We cannot
assure you that any new or changed healthcare laws, regulations or standards will not materially adversely affect our business.
We cannot assure you that a review of our business by judicial, law enforcement, regulatory or accreditation authorities will
not result in a determination that could adversely affect our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>State
legislative and regulatory changes specific to the area of telehealth law may present the third party medical groups and independent
physicians on our platform with additional requirements and state compliance costs, which may create additional operational complexity
and increase costs.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
third party medical groups and independent physicians&rsquo; ability to provide telehealth services to patients in a particular
jurisdiction is dependent upon the laws that govern the provision of remote care, the practice of medicine and healthcare delivery
in general in that jurisdiction. Laws and regulations governing the provision of telehealth services are evolving at a rapid pace
and are subject to changing political, regulatory, and other influences. Some states&rsquo; regulatory agencies or medical boards
may have established rules or interpreted existing rules in a manner that limits or restricts providers&rsquo; ability to provide
telehealth services or for physicians to supervise nurse practitioners and physician assistants remotely. Additionally, there
may be limitations placed on the modality through which telehealth services are delivered. For example, some states specifically
require synchronous (or &ldquo;live&rdquo;) communications and restrict or exclude the use of asynchronous telehealth modalities,
which is also known as &ldquo;store-and-forward&rdquo; telehealth. However, other states do not distinguish between synchronous
and asynchronous telehealth services. Because this is a developing area of law and regulation, we continually monitor our compliance
in every jurisdiction in which we operate. However, we cannot be assured that our third party medical groups&rsquo; or independent
providers&rsquo; activities and arrangements, if challenged, will be found to be in compliance with the law or that a new or existing
law will not be implemented, enforced, or changed in manner that is unfavorable to our business model. We cannot predict the regulatory
landscape for those jurisdictions in which we operate and any significant changes in law, policies, or standards, or the interpretation
or enforcement thereof, could occur with little or no notice. The majority of the consultations provided through our platform
are asynchronous consultations for customers located in jurisdictions that permit the use of asynchronous telehealth. If there
is a change in laws or regulations related to our business, or the interpretation or enforcement thereof, that adversely affects
our structure or operations, including greater restrictions on the use of asynchronous telehealth or remote supervision of nurse
practitioners or physician assistants, it could have a material adverse effect on our business, financial condition, and results
of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Evolving
government regulations and enforcement activities may require increased costs or adversely affect our results of operations.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
a regulatory climate that is uncertain, our operations may be subject to direct and indirect adoption, expansion or reinterpretation
of various laws and regulations. This risk is especially acute in the healthcare industry given the level of government spending,
oversight and control over the industry as a whole. Compliance with these evolving laws, regulations and interpretations may require
us to change our practices at an undeterminable and possibly significant initial monetary and annual expense. These additional
monetary expenditures may increase future overhead, which could have a material adverse effect on our results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
could be laws and regulations applicable to our business that we have not identified or that, if changed, may be costly to us,
and we cannot predict all the ways in which implementation of such laws and regulations may affect us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the states in which we operate, we believe we are in material compliance with all applicable material regulations, but, due to
the uncertain regulatory environment, certain states may determine that we are in violation of their laws and regulations. If
we must remedy such violations, we may be required to modify our business and services in such states in a manner that undermines
our platform&rsquo;s attractiveness to customers, we may become subject to fines or other penalties or, if we determine that the
requirements to operate in compliance in such states are overly burdensome, we may elect to terminate our operations in such states.
In each case, our revenue may decline and our business, financial condition, and results of operations could be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the introduction of new products, services, or solutions to our platform may require us to comply with additional, yet undetermined,
laws and regulations. Compliance may require obtaining appropriate federal, state, or local licenses or certificates, increasing
our security measures, and expending additional resources to monitor developments in applicable rules and ensure compliance. The
failure to adequately comply with these future laws and regulations may delay or possibly prevent our products or services from
being offered to customers, which could have a material adverse effect on our business, financial condition, and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Changes
in public policy that mandate or enhance healthcare coverage could have a material adverse effect on our business, operations,
and/or results of operations.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
mission is to make healthcare accessible, affordable, and convenient for everyone. It is reasonably possible that our business
operations and results of operations could be materially adversely affected by public policy changes at the federal, state, or
local level, which include mandatory or enhanced healthcare coverage. Such changes may present us with new marketing and other
challenges, which may, for example, cause use of our products and services to decrease or make doing business in particular states
less attractive. If we fail to adequately respond to such changes, including by implementing effective operational and strategic
initiatives, or do not do so as effectively as our competitors, our business, operations, and results of operations may be materially
adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot predict the enactment or content of new legislation and regulations or changes to existing laws or regulations or their
enforcement, interpretation or application, or the effect they will have on our business or results of operations, which could
be materially adverse. Even if we could predict such matters, we may not be able to reduce or eliminate the potential adverse
impact of public policy changes that could fundamentally change the dynamics of our industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Changes
in insurance and healthcare laws, as well as the potential for further healthcare reform legislation and regulation, have created
uncertainty in the healthcare industry and could materially affect our business, financial condition, and result of operations.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Patient Protection and Affordable Care Act as amended by the Health Care and Education Reconciliation Act, each enacted in March
2010, generally known as the &ldquo;Health Care Reform Law,&rdquo; significantly expanded health insurance coverage to uninsured
Americans and changed the way healthcare is financed by both governmental and private payers. Since then, the Health Care Reform
Law has prompted legislative efforts to significantly modify or repeal the Health Care Reform Law, which may impact how the federal
government responds to lawsuits challenging the Health Care Reform Law. We cannot predict what further reform proposals, if any,
will be adopted, when they may be adopted, or what impact they may have on our business. While we currently only accept payments
from customers&mdash;not any third parties or insurance providers&mdash;and our business model may not be directly impacted by
healthcare reform, healthcare reform will impact the healthcare industry in which we operate. If we are required to comply with
the Health Care Reform Law and fail to comply or are unable to effectively manage such risks and uncertainties, our financial
condition and results of operations could be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
products we sell and our third-party suppliers are subject to FDA regulations and other state and local requirements, and if we
or our third party suppliers fail to comply with federal, state, and local requirements, our ability to fulfill customers&rsquo;
orders through our platform could be impaired.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
products available through our platform, and the third-party suppliers and manufacturers of these products, are subject to extensive
regulation by the FDA and state and local authorities, including pharmaceuticals, over-the-counter drugs, over-the-counter devices,
cosmetics, and dietary supplements. These authorities can enforce regulations related to methods and documentation of the testing,
production, compounding, control, quality assurance, labeling, packaging, sterilization, storage, and shipping of products. Government
regulations specific to pharmaceuticals are wide ranging and govern, among other things: the ability to bring a pharmaceutical
to market, the conditions under which it can be sold, the conditions under which it must be manufactured, and permissible claims
that may be made for such product. Failure to meet&mdash;or significant changes to&mdash;any federal, state, or local requirements
attendant to the sales and marketing of a regulated product could result in enforcement actions, impede our ability to provide
access to affected products, and have a material adverse effect on our business, financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
may be subject to fines, penalties, and injunctions if we are determined to be promoting the use of products for unapproved uses.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
of the products available through our platform require approval by the FDA and are subject to the limitations placed by FDA on
the approved uses in the product prescribing information. While providers are legally permitted to prescribe medications for off-label
uses, and although we believe our product promotion is conducted in material compliance with FDA and other regulations, if the
FDA determines that our product promotion constitutes promotion of an unapproved use of an approved product or of an unapproved
product, the FDA could request that we modify our product promotion or subject us to regulatory and/or legal enforcement actions,
including the issuance of a warning letter, injunction, seizure, civil fine, and criminal penalties. It is also possible that
other federal, state, or foreign enforcement authorities might take action if they consider the product promotion to constitute
promotion of an unapproved use of an approved product or of an unapproved product, which could result in significant fines or
penalties under other statutes, such as laws prohibiting false claims for reimbursement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
information that we provide to healthcare providers, customers, and our partners could be inaccurate or incomplete, which could
harm our business, financial condition, and results of operations.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
collect and transmit healthcare-related information to and from our customers, providers, and partner pharmacies in connection
with the telehealth consultations conducted by the providers and prescription medication fulfillment by our partner pharmacies.
If the data that we provide to our customers, providers, or partner pharmacies are incorrect or incomplete or if we make mistakes
in the capture or input of these data, our reputation may suffer and we could be subject to claims of liability for resulting
damages. While we maintain insurance coverage, this coverage may prove to be inadequate or could cease to be available to us on
acceptable terms, if at all. Even unsuccessful claims could result in substantial costs and the diversion of management resources.
A claim brought against us that is uninsured or under-insured could harm our business, financial condition, and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
use, disclosure, and other processing of personally identifiable information, including health information, is subject to federal,
state, and foreign privacy and security regulations, and our failure to comply with those regulations or to adequately secure
the information we hold could result in significant liability or reputational harm and, in turn, a material adverse effect on
our customers, providers, and revenue.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerous
state and federal laws and regulations govern the collection, dissemination, use, privacy, confidentiality, security, availability,
integrity, and other processing of health information and other types of personal data or personally identifiable information
(&ldquo;PII&rdquo;). We believe that, because of our operating processes, we are not a covered entity or a business associate
under HIPAA, which establishes a set of national privacy and security standards for the protection of protected health information
by health plans, healthcare clearinghouses, and certain healthcare providers, referred to as covered entities, and the business
associates with whom such covered entities contract for services. Notwithstanding that we do not believe that we meet the definition
of a covered entity or business associate under HIPAA, we have executed business associate agreements with certain other parties
and have assumed obligations that are based upon HIPAA-related requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have developed and maintained policies and procedures with respect to health information and personal information that we use
or disclose in connection with our operations, including the adoption of administrative, physical, and technical safeguards to
protect such information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to HIPAA, numerous other federal, state, and foreign laws and regulations protect the confidentiality, privacy, availability,
integrity and security of health information and other types of PII, including the California Confidentiality of Medical Information
Act. These laws and regulations in many cases are more restrictive than, and may not be preempted by, HIPAA and its implementing
rules. These laws and regulations are often uncertain, contradictory, and subject to changed or differing interpretations, and
we expect new laws, rules and regulations regarding privacy, data protection, and information security to be proposed and enacted
in the future. This complex, dynamic legal landscape regarding privacy, data protection, and information security creates significant
compliance issues for us, the Affiliated Medical Groups and the providers and potentially exposes us to additional expense, adverse
publicity, and liability. While we have implemented data privacy and security measures in an effort to comply with applicable
laws and regulations relating to privacy and data protection, some health information and other PII or confidential information
is transmitted to us by third parties, who may not implement adequate security and privacy measures, and it is possible that laws,
rules, and regulations relating to privacy, data protection, or information security may be interpreted and applied in a manner
that is inconsistent with our practices or those of third parties who transmit health information and other PII or confidential
information to us. If we or these third parties are found to have violated such laws, rules or regulations, it could result in
government-imposed fines, orders requiring that we or these third parties change our or their practices, or criminal charges,
which could adversely affect our business. Complying with these various laws and regulations could cause us to incur substantial
costs or require us to change our business practices, systems, and compliance procedures in a manner adverse to our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also publish statements to our customers through our privacy policy that describe how we handle health information or other PII.
If federal or state regulatory authorities or private litigants consider any portion of these statements to be untrue, we may
be subject to claims of deceptive practices, which could lead to significant liabilities and consequences, including, without
limitation, costs of responding to investigations, defending against litigation, settling claims, and complying with regulatory
or court orders. Any of the foregoing consequences could seriously harm our business and our financial results. Furthermore, the
costs of compliance with, and other burdens imposed by, the laws, regulations and policies that are applicable to us may limit
customers&rsquo; use and adoption of, and reduce the overall demand for, our platform. Any of the foregoing consequences could
have a material adverse impact on our business and our financial results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Public
scrutiny of internet privacy and security issues may result in increased regulation and different industry standards, which could
deter or prevent us from providing services to our customers, thereby harming our business.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
regulatory framework for privacy and security issues worldwide is evolving and is likely to remain in flux for the foreseeable
future. Various government and consumer agencies have also called for new regulation and changes in industry practices. Practices
regarding the registration, collection, processing, storage, sharing, disclosure, use and security of personal and other information
by companies offering an online service like our platform have recently come under increased public scrutiny.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
example, the California Consumer Privacy Act (&ldquo;CCPA&rdquo;), which went into effect on January 1, 2020, requires, among
other things, covered companies to provide new disclosures to California consumers and afford such consumers new abilities to
opt-out of certain sales of personal information. Similar legislation has been proposed or adopted in other states. Aspects of
the CCPA and these other state laws and regulations, as well as their enforcement, remain unclear, and we may be required to modify
our practices in an effort to comply with them. Additionally, a new privacy law, the California Privacy Rights Act (&ldquo;CPRA&rdquo;),
was passed on November 3, 2020 and will enter into force on January 1, 2023, with a look-back to January 2022. The CPRA will significantly
modify the CCPA, potentially resulting in further uncertainty and requiring us to incur additional costs and expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business, including our ability to operate and to expand internationally, could be adversely affected if legislation or regulations
are adopted, interpreted, or implemented in a manner that is inconsistent with our current business practices and that require
changes to these practices, the design of our websites, mobile applications, solutions, features, or our privacy policies. In
particular, the success of our business has been, and we expect will continue to be, driven by our ability to responsibly gather
and use data from data subjects. Therefore, our business could be harmed by any significant change to applicable laws, regulations,
or industry standards or practices regarding the storage, use, or disclosure of data our customers or providers share with us,
or regarding the manner in which the express or implied consent of customers or providers for such collection, analysis, and disclosure
is obtained. Such changes may require us to modify our platform, possibly in a material manner, and may limit our ability to develop
new offerings, functionality or features.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>If
our security measures fail or are breached and unauthorized access to a consumer&rsquo;s data is obtained, our services may be
perceived as insecure, we may incur significant liabilities, our reputation may be harmed, and we could lose sales and customers.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
services involve the storage and transmission of customers&rsquo; and our vendors&rsquo; proprietary information, sensitive or
confidential data, including valuable intellectual property and personal information of employees, consumers, customers and others,
as well as the protected health information, or PHI, of our customers. Because of the extreme sensitivity of the information we
store and transmit, the security features of our computer, network, and communications systems infrastructure are critical to
the success of our business. A breach or failure of our security measures could result from a variety of circumstances and events,
including third-party action, employee negligence or error, malfeasance, computer viruses, cyber-attacks by computer hackers,
failures during the process of upgrading or replacing software and databases, power outages, hardware failures, telecommunication
failures, user errors, or catastrophic events. Information security risks have generally increased in recent years because of
the proliferation of new technologies and the increased sophistication and activities of perpetrators of cyber-attacks. As cyber
threats continue to evolve, we may be required to expend additional resources to further enhance our information security measures
and/or to investigate and remediate any information security vulnerabilities. If our security measures fail or are breached, it
could result in unauthorized persons accessing sensitive consumer or partner data (including PHI), a loss of or damage to our
data, an inability to access data sources, or process data or provide our services to our customers. Such failures or breaches
of our security measures, or our inability to effectively resolve such failures or breaches in a timely manner, could severely
damage our reputation, adversely affect customers, vendors or investor confidence in us, and reduce the demand for our services
from existing and potential customers. In addition, we could face litigation, damages for contract breach, monetary penalties,
or regulatory actions for violation of applicable laws or regulations, and incur significant costs for remedial measures to prevent
future occurrences and mitigate past violations. Although we maintain insurance covering certain security and privacy damages
and claim expenses, we may not carry insurance or maintain coverage sufficient to compensate for all liability and in any event,
insurance coverage would not address the reputational damage that could result from a security incident.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may experience cyber-security and other breach incidents that remain undetected for an extended period. Because techniques used
to obtain unauthorized access or to sabotage systems change frequently and generally are not recognized until launched, we may
be unable to anticipate these techniques or to implement adequate preventive measures. If an actual or perceived breach of our
security occurs, or if we are unable to effectively resolve such breaches in a timely manner, the market perception of the effectiveness
of our security measures could be harmed and we could lose sales, customers, and vendors which could have a material adverse effect
on our business, operations, and financial results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Failure
to comply with anti-bribery, anti-corruption, and anti-money laundering laws could subject us to penalties and other adverse consequences.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the FCPA and other anti-corruption, anti-bribery, and anti-money laundering laws in the jurisdictions in which
we do business, both domestic and abroad. These laws generally prohibit us and our employees from improperly influencing government
officials or commercial parties in order to obtain or retain business, direct business to any person or gain any improper advantage.
The FCPA and similar applicable anti-bribery and anti-corruption laws also prohibit our third-party business partners, representatives,
and agents from engaging in corruption and bribery. We and our third-party business partners, representatives, and agents may
have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities.
We may be held liable for the corrupt or other illegal activities of these third-party business partners and intermediaries, our
employees, representatives, contractors, channel partners, and agents, even if we do not explicitly authorize such activities.
These laws also require that we keep accurate books and records and maintain internal controls and compliance procedures designed
to prevent any such actions. While we have policies and procedures to address compliance with such laws, we cannot assure that
our employees and agents will not take actions in violation of our policies or applicable law, for which we may be ultimately
held responsible. Our exposure for violating these laws will increase as we expand internationally and as we commence sales and
operations in foreign jurisdictions. Any violation of the FCPA or other applicable anti-bribery, anti-corruption, and anti-money
laundering laws could result in whistleblower complaints, adverse media coverage, investigations, imposition of significant legal
fees, loss of export privileges, severe criminal or civil sanctions, or suspension or debarment from U.S. government contracts,
substantial diversion of management&rsquo;s attention, drop in stock price, or overall adverse consequences to our business, all
of which may have an adverse effect on our reputation, business, financial condition, and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Risks
Related to Intellectual Property</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Failure
to protect or enforce our intellectual property rights could harm our business and results of operations. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
intellectual property includes a combination of patent, copyright, service mark, trademark, and trade secret laws, as well as
confidentiality procedures and contractual restrictions, to establish and protect our proprietary rights, all of which provide
only limited protection. We cannot assure you that any patents will issue with respect to our currently pending patent applications,
in a manner that gives us the protection that we seek, if at all, or that any future patents issued to us will not be challenged,
invalidated or circumvented. Our currently issued patents and any patents that we may issue in the future, with respect to pending
or future patent applications, may not provide sufficient broad protection or they may not prove to be enforceable in actions
against alleged infringers. Also, we cannot assure you that any future service mark registrations will be issued with respect
to pending or future applications or that any registered service marks will be enforceable or provide adequate protection of our
proprietary rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, from time to time we make our technology and other intellectual property available to others under license agreements,
including open source license agreements and trademark licenses under agreements with our partners for the purpose of co-branding
or co-marketing our products or services. We endeavor to enter into agreements with our employees and contractors and agreements
with parties with whom we do business in order to limit access to and disclosure of our proprietary information. We cannot be
certain that the steps we have taken will prevent unauthorized use of our technology or the reverse engineering of our technology.
Moreover, others may independently develop technologies that are competitive to ours or infringe our intellectual property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
strive to protect our intellectual property rights by relying on federal, state, and common law rights and other rights provided
under foreign laws. These laws are subject to change at any time and could further restrict our ability to protect or enforce
our intellectual property rights. In addition, the existing laws of certain foreign countries in which we operate may not protect
our intellectual property rights to the same extent as do the laws of the United States. The enforcement of our intellectual property
rights also depends on our legal actions against these infringers being successful, but we cannot be sure these actions will be
successful, even when our rights have been infringed. Furthermore, effective patent, trademark, service mark, copyright and trade
secret protection may not be available in every country in which our services are available over the Internet. We may, over time,
increase our investment in protecting innovations through investments in filings, registrations, or similar steps to protect our
intellectual property, and these processes are expensive and time-consuming.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
may be in the future subject to claims that we violated intellectual property rights of others, which are extremely costly to
defend and could require us to pay significant damages and limit our ability to operate.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Companies
in our industry, and other intellectual property rights holders seeking to profit from royalties in connection with grants of
licenses, own large numbers of patents, copyrights, trademarks, and trade secrets and frequently enter into litigation based on
allegations of infringement or other violations of intellectual property rights. Our future success depends in part on not infringing
upon the intellectual property rights of others. We have in the past and may in the future receive notices that claim we have
misappropriated, infringed, or otherwise misused other parties&rsquo; intellectual property rights. We may be unaware of the intellectual
property rights of others that may cover some or all of our technology. Because patent applications can take years to issue and
are often afforded confidentiality for some period of time, there may currently be pending applications, unknown to us, that later
result in issued patents that could cover our technology.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
intellectual property claim against us or parties indemnified by us, regardless of merit, could be time consuming and expensive
to settle or litigate and could divert our management&rsquo;s attention and other resources. These claims also could subject us
to significant liability for damages and could result in our having to stop using technology, content, branding, or business methods
found to be in violation of another party&rsquo;s rights. We might be required or may opt to seek a license for rights to intellectual
property held by others, which may not be available on commercially reasonable terms, or at all. Even if a license is available,
we could be required to pay significant royalties, which would increase our operating expenses. We may also be required to develop
alternative non-infringing technology, content, branding or business methods, which could require significant effort and expense,
be infeasible, or make us less competitive in the market. Such disputes could also disrupt our business, which would adversely
impact our customer satisfaction and ability to attract customers. Some of our competitors may be able to sustain the costs of
complex patent litigation more effectively than we can because they have substantially greater resources. If we cannot license
or develop technology, content, branding, or business methods for any allegedly infringing aspect of our business, we may be unable
to compete effectively. Additionally, we may be obligated to indemnify our customers in connection with litigation and to obtain
licenses or refund subscription fees, which could further exhaust our resources. In the case of infringement or misappropriation
caused by technology that we obtain from third parties, any indemnification or other contractual protections we obtain from such
third parties, if any, may be insufficient to cover the liabilities we incur as a result of such infringement or misappropriation.
Any of these results could harm our results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
may be subject to legal proceedings and litigation, including intellectual property disputes, which are costly to defend and could
materially harm our business and results of operations.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be party to lawsuits and legal proceedings in the normal course of business. These matters are often expensive and disruptive
to normal business operations. We may face allegations, lawsuits, and regulatory inquiries, audits, and investigations regarding
data privacy, security, labor and employment, consumer protection, practice of medicine, and intellectual property infringement,
including claims related to privacy, patents, publicity, trademarks, copyrights, and other rights. A portion of the technologies
we use incorporates open source software, and we may face claims claiming ownership of open source software or patents related
to that software, rights to our intellectual property or breach of open source license terms, including a demand to release material
portions of our source code or otherwise seeking to enforce the terms of the applicable open source license. We may also face
allegations or litigation related to our acquisitions, securities issuances, or business practices, including public disclosures
about our business. Litigation and regulatory proceedings, and particularly the healthcare regulatory and class action matters
we could face, may be protracted and expensive, and the results are difficult to predict. Certain of these matters may include
speculative claims for substantial or indeterminate amounts of damages and include claims for injunctive relief. Additionally,
our litigation costs could be significant. Adverse outcomes with respect to litigation or any of these legal proceedings may result
in significant settlement costs or judgments, penalties and fines, or require us to modify our solution or require us to stop
offering certain features, all of which could negatively impact our acquisition of customers and revenue growth. We may also become
subject to periodic audits, which could likely increase our regulatory compliance costs and may require us to change our business
practices, which could negatively impact our revenue growth. Managing legal proceedings, litigation and audits, even if we achieve
favorable outcomes, is time-consuming and diverts management&rsquo;s attention from our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
results of regulatory proceedings, litigation, claims, and audits cannot be predicted with certainty, and determining reserves
for pending litigation and other legal, regulatory and audit matters requires significant judgment. There can be no assurance
that our expectations will prove correct, and even if these matters are resolved in our favor or without significant cash settlements,
these matters, and the time and resources necessary to litigate or resolve them, could harm our reputation, business, financial
condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>If
we incur product liability claims, such claims could increase our costs; adversely affect our reputation, business and results
of operations; and we may not be able to maintain or obtain insurance.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business involves third-party medical providers performing medical consultations and, if warranted, prescribing medication to our customers.
This activity, as well as the sale of other products on our platform, exposes us to the risk of negligence and product liability
claims.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
of our products are designed for human consumption and use, and we face liability claims if the use of our products is alleged to have
resulted in injury or death claims may be made by customers, third-party service providers or manufacturers of products and services
we make available. To date, we have not (i) conducted any product recalls, (ii) received any product liability claims from third parties,
or (iii) received any reports from an end consumer of any adverse effect resulting from our products. A product recall or liability claim
against us could result in increased costs and could adversely affect our reputation with our customers, which, in turn, could have an
adverse effect on our business, financial condition and results of operations. While we do maintain product liability insurance coverage,
this insurance is subject to deductibles and coverage limitations, and we cannot be sure that we will be able to maintain insurance coverage
at acceptable costs or in a sufficient amount, that our insurer will not disclaim coverage as to a future claim or that a product liability
claim would not otherwise adversely affect our business, financial condition and results of operations. The cost of any product liability
litigation or other proceeding, even if resolved in our favor, could be substantial, could divert management attention, and may result
in adverse publicity or result in reduced acceptance of our platform and offerings. These liabilities could prevent or interfere with
our growth and expansion efforts. Uncertainties resulting from the initiation and continuation of product liability litigation or other
proceedings could have an adverse effect on our ability to compete in the marketplace.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
rely on data center providers, Internet infrastructure, bandwidth providers, third-party computer hardware and software, other
third parties and our own systems for providing services to our customers and vendors, and any failure or interruption in the
services provided by these third parties or our own systems could expose us to litigation and negatively impact our relationships
with customers, adversely affecting our brand and our business.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we control and have access to our servers, we do not control the operation of these facilities. The cloud vendor and the owners
of our data center facilities have no obligation to renew their agreements with us on commercially reasonable terms, or at all.
If we are unable to renew these agreements on commercially reasonable terms, or if one of our cloud vendors or data center operators
is acquired, we may be required to transfer our servers and other infrastructure to a new vendor or a new data center facility,
and we may incur significant costs and possible service interruption in connection with doing so. Problems faced by our cloud
vendors or third-party data center locations with the telecommunications network providers with whom we or they contract or with
the systems by which our telecommunications providers allocate capacity among their customers, including us, could adversely affect
the experience of our customers. Our cloud vendors or third-party data center operators could decide to close their facilities
without adequate notice. In addition, any financial difficulties, such as bankruptcy faced by our cloud vendors or third-party
data centers operators or any of the service providers with whom we or they contract may have negative effects on our business,
the nature and extent of which are difficult to predict.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
if our cloud or data centers vendors are unable to keep up with our growing needs for capacity, this could have an adverse effect
on our business. For example, a rapid expansion of our business could affect the service levels at our cloud vendors or data centers
or cause such cloud systems or data centers and systems to fail. Any changes in third-party service levels at our cloud vendors
or data centers or any disruptions or other performance problems with our solution could adversely affect our reputation and may
damage our customers&rsquo; stored files or result in lengthy interruptions in our services. Interruptions in our services may
reduce our revenue, cause us to issue refunds to customers for prepaid and unused subscriptions, subject us to potential liability
or adversely affect client renewal rates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our ability to deliver our Internet-based services depends on the development and maintenance of the infrastructure
of the Internet by third parties. This includes maintenance of a reliable network backbone with the necessary speed, data capacity,
bandwidth capacity and security. Our services are designed to operate without interruption in accordance with our service level
commitments. However, we have experienced and expect that we may experience future interruptions and delays in services and availability
from time to time. In the event of a catastrophic event with respect to one or more of our systems, we may experience an extended
period of system unavailability, which could negatively impact our relationship with customers. To operate without interruption,
both we and our service providers must guard against:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">damage
                                         from fire, power loss, natural disasters and other force majeure events outside our control;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">communications
                                         failures;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">software
                                         and hardware errors, failures and crashes;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">security
                                         breaches, computer viruses, hacking, denial-of-service attacks and similar disruptive
                                         problems;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">business
                                         interruptions resulting from geo-political actions, including war, and terrorism or disease
                                         outbreaks (such as the recent outbreak of COVID-19, or the novel coronavirus); and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
                                         potential interruptions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
exercise limited control over third-party vendors, which increases our vulnerability to problems with technology and information
services they provide. Interruptions in our network access and services may in connection with third-party technology and information
services reduce our revenue, cause us to issue refunds to customers for prepaid and unused subscription services, subject us to
potential liability or adversely affect client renewal rates. Although we maintain a security and privacy damages insurance policy,
the coverage under our policies may not be adequate to compensate us for all losses that may occur related to the services provided
by our third-party vendors. In addition, we may not be able to continue to obtain adequate insurance coverage at an acceptable
cost, if at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Risks
Related to Our Results of Operations and Additional Capital Requirements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our results of operations, as well as our key metrics, may fluctuate on a quarterly and annual basis, which may result in
us failing to meet the expectations of industry and securities analysts or our investors.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
results of operations have in the past and could in the future vary significantly from quarter-to-quarter and year-to-year and
may fail to match the expectations of securities analysts because of a variety of factors, many of which are outside of our control
and, as a result, should not be relied upon as an indicator of future performance. As a result, we may not be able to accurately
forecast our results of operations and growth rate. Any of these events could cause the market price of our common stock to fluctuate.
Factors that may contribute to the variability of our results of operations include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">new
                                         developments on our platform or in our product offerings;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to attract and retain providers to our platform;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                         in our pricing policies and those of our competitors;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to execute our plans to add treatment options and provider expertise for additional
                                         medical conditions;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">long-term
                                         treatment outcomes of customers on our platform;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">medical,
                                         technological, or other innovations in our industry or in connection with specific products
                                         that we make available on our platform;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to maintain relationships with customers, partners, and suppliers;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to retain key members of our executive leadership team;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">breaches
                                         of security or privacy;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         amount and timing of operating costs and capital expenditures related to the expansion
                                         of our business;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">costs
                                         related to litigation, investigations, regulatory enforcement actions, or settlements;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                         in the legislative or regulatory environment, including with respect to practice of medicine,
                                         telehealth, privacy or data protection, or enforcement by government regulators, including
                                         fines, orders, or consent decrees;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
                                         by competitors or other third parties of significant new products or acquisitions or
                                         entrance into certain markets;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to make accurate accounting estimates and appropriately recognize revenue for
                                         our platform and offerings for which there are no relevant comparable products;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">instability
                                         in the financial markets;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">global
                                         economic conditions;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         duration and extent of the COVID-19 pandemic; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">political,
                                         economic and social instability, including terrorist activities, and any disruption these
                                         events may cause to the global economy.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
impact of one or more of the foregoing and other factors may cause our results of operations to vary significantly. As such, we
believe that quarter-to-quarter comparisons of our results of operations may not be meaningful and should not be relied upon as
an indication of future performance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
rely significantly on revenue from customers purchasing subscription-based prescription products and may not be successful in
expanding our offerings.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date the majority of our revenue has been, and we expect it to continue to be, derived from customers who purchase subscription-based
prescription products through the platform. In our subscription arrangements, customers select a cadence at which they wish to
receive product shipments. These customers generate a substantial majority of our revenue. The introduction of competing offerings
with lower prices for consumers, fluctuations in prescription prices, changes in consumer purchasing habits, including an increase
in the use of mail-order prescriptions, changes in the regulatory landscape, and other factors could result in changes to our
contracts or a decline in our revenue, which may have an adverse effect on our business, financial condition, and results of operations.
Because we derive a vast majority of our revenue from customers who purchase subscription-based prescription products, any material
decline in the use of such offerings could have a pronounced impact on our future revenue and results of operations, particularly
if we are unable to expand our offerings overall.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
will incur increased costs and demands upon management as a result of complying with the laws and regulations affecting public
companies, which could adversely affect our business, results of operations, and financial condition.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a public company, we will be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;), the listing standards of NASDAQ, and other applicable securities rules and regulations. We expect that the requirements
of these rules and regulations will continue to increase our legal, accounting and financial compliance costs, make some activities
more difficult, time-consuming and costly, and place significant strain on our personnel, systems, and resources. For example,
the Exchange Act requires, among other things, that we file annual, quarterly, and current reports with respect to our business
and results of operations. As a result of the complexity involved in complying with the rules and regulations applicable to public
companies, our management&rsquo;s attention may be diverted from other business concerns, which could harm our business, results
of operations, and financial condition. Although we have already hired additional employees to assist us in complying with these
requirements, we may need to hire more employees in the future or engage outside consultants, which will increase our operating
expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, changing laws, regulations, and standards relating to corporate governance and public disclosure are creating uncertainty
for public companies, increasing legal and financial compliance costs, and making some activities more time-consuming. These laws,
regulations and standards are subject to varying interpretations, in many cases due to their lack of specificity, and, as a result,
their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could
result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure
and governance practices. We intend to invest substantial resources to comply with evolving laws, regulations and standards, and
this investment may result in increased general and administrative expenses and a diversion of management&rsquo;s time and attention
from business operations to compliance activities. If our efforts to comply with new laws, regulations and standards differ from
the activities intended by regulatory or governing bodies due to ambiguities related to their application and practice, regulatory
authorities may initiate legal proceedings against us and our business may be harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also expect that being a public company and these new rules and regulations will make it more expensive for us to obtain director
and officer liability insurance, and we may be required to accept reduced coverage or incur substantially higher costs to obtain
coverage. These factors could also make it more difficult for us to attract and retain qualified members of our board of directors,
particularly to serve on our audit committee and compensation committee, and qualified executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certain
U.S. state tax authorities may assert that we have a state nexus and seek to impose state and local income and sales taxes which
could harm our results of operations.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is a risk that certain state tax authorities where we do not currently file a state income tax return or collect sales tax could
assert that we are liable for state and local income and sales taxes based upon income, sales, or gross receipts allocable to
such states. States are becoming increasingly aggressive in asserting a nexus for state income and sales tax purposes. If a state
tax authority successfully asserts that our activities give rise to a nexus, we could be subject to state and local taxation,
including penalties and interest attributable to prior periods. Such tax assessments, penalties and interest may adversely impact
our results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Risks
Related to our Patient Care Center</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>In
the past we have, and in the future we may actively employ social media and Patient Care Center activities as part of our marketing
strategy, which could give rise to regulatory violations, liability, breaches of data security or reputational damage.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Despite
our efforts to monitor evolving social media communication guidelines and comply with applicable laws and regulations, there is
risk that the use of social media by us, our employees or our customers to communicate about our products or business may cause
us to be found in violation of applicable requirements, including requirements of regulatory bodies such as the FDA and the Federal
Trade Commission. For example, adverse events, product complaints, off-label usage by physicians, unapproved marketing or other
unintended messages could require an active response from us, which may not be completed in a timely manner and could result in
regulatory action by a governing body. In addition, our employees may knowingly or inadvertently make use of social media in ways
that may not comply with our social media policy or other legal or contractual requirements, which may give rise to liability,
lead to the loss of trade secrets or other intellectual property, or result in public exposure of personal information of our
employees, clinical trial patients, customers, and others. Furthermore, negative posts or comments about us or our products in
social media could seriously damage our reputation, brand image and goodwill.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A
material disruption in our information systems, including our website and Patient Care Center, could adversely affect our business
or operating results and lead to reduced net sales and reputational damage.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on our information systems to process transactions, summarize our results of operations and manage our business. In particular,
our website and our Patient Care Center are important parts of our integrated connected customer strategy, and customers use these
systems as information sources on the range of products available to them and as a way to order our products. Therefore, the reliability
and capacity of our information systems is critical to our operations and the implementation of our growth initiatives. However,
our information systems are subject to damage or interruption from planned upgrades in technology interfaces, power outages, computer
and telecommunications failures, computer viruses, cyber-attacks, or other security breaches, and catastrophic events such as
fires, floods, earthquakes, tornadoes, hurricanes, acts of war or terrorism, and usage errors by our employees. If our information
systems are damaged or cease to function properly, we may have to make a significant investment to fix or replace them, and we
may suffer losses of critical data and/or interruptions or delays in our operations. In addition, to keep pace with changing technology,
we must continuously implement new information technology systems as well as enhance our existing systems. Moreover, the successful
execution of some of our growth strategies, in particular the expansion of our connected customer and online capabilities, is
dependent on the design and implementation of new systems and technologies, and/or the enhancement of existing systems. Any material
disruption in our information systems, delays or difficulties in implementing or integrating new systems, or enhancing or expanding
current systems, could have an adverse effect on our business (in particular our Patient Care Center and online operations), and
our operating results and could lead to reduced net sales and reputational damage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Any
significant interruptions in the operations of our Patient Care Center could cause us to lose sales and disrupt our ability to
process orders and deliver our solutions in a timely manner.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on our Patient Care Center to sell our products, respond to customer service and technical support requests, and process
orders. Any significant interruption in the operation of these facilities, including an interruption caused by our failure to
successfully expand or upgrade our systems or to manage these expansions or upgrades, could reduce our ability to receive and
process orders and provide products and services, which could result in lost and cancelled sales and damage to our brand and reputation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
we grow, we will need more capacity from our existing Patient Care Center. If our Patient Care Center operators do not convert
inquiries into sales at expected rates, our ability to generate revenue could be impaired. Training and retaining qualified Patient
Care Center operators is challenging, and if we do not adequately train our Patient Care Center personnel, they may convert inquiries
into sales at an acceptable rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Risks
Related to Our Common Stock</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
charter documents and Delaware law could make it more difficult for a third party to acquire us and discourage a takeover.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation, as amended, Bylaws, and Delaware law contain certain provisions that may have the effect of deterring
or discouraging, among other things, a non-negotiated tender or exchange offer for shares of Common Stock, a proxy contest for
control of our company, the assumption of control of our company by a holder of a large block of Common Stock, and the removal
of the management of our company. Such provisions also may have the effect of deterring or discouraging a transaction which might
otherwise be beneficial to stockholders. Our certificate of incorporation also may authorize our board of directors, without stockholder
approval, to issue one or more series of preferred stock, which could have voting and conversion rights that adversely affect
or dilute the voting power of the holders of Common Stock. Delaware law also imposes conditions on certain business combination
transactions with &ldquo;interested stockholders.&rdquo; Our Bylaws authorize our Board of Directors to fill vacancies or newly
created directorships. A majority of the directors then in office may elect a successor to fill any vacancies or newly created
directorships. Such provisions could limit the price that investors might be willing to pay in the future for shares of our Common
Stock and impede the ability of the stockholders to replace management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
elimination of monetary liability against our directors, officers, and employees under Delaware law and the existence of indemnification
rights to our directors, officers, and employees may result in substantial expenditures by us and may discourage lawsuits against
our directors, officers, and employees. We also may have entered into contractual indemnification obligations under employment
agreements with our executive officers. The foregoing indemnification obligations could result in our incurring substantial expenditures
to cover the cost of settlement or damage awards against directors and officers, which we may be unable to recoup. These provisions
and resultant costs may also discourage us from bringing a lawsuit against our directors and officers for breaches of their fiduciary
duties and may similarly discourage the filing of derivative litigation by our stockholders against our directors and officers
even though such actions, if successful, might otherwise benefit our company and our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
currently do not intend to pay dividends on our common stock. As a result, your only opportunity to achieve a return on your investment
is if the price of our common stock appreciates.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently do not expect to declare or pay dividends on our common stock. In addition, in the future we may enter into agreements
that prohibit or restrict our ability to declare or pay dividends on our common stock. As a result, your only opportunity to achieve
a return on your investment will be if the market price of our common stock appreciates and you sell your shares at a profit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>You
may experience dilution of your ownership interest due to the future issuance of additional shares of our common stock.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are in a capital intensive business and we may not have sufficient funds to finance the growth of our business or to support our
projected capital expenditures. As a result, we will require additional funds from future equity or debt financings, including
sales of preferred shares or convertible debt, to complete the development of new projects and pay the general and administrative
costs of our business. We may in the future issue our previously authorized and unissued securities, resulting in the dilution
of the ownership interests of holders of our common stock. We are currently authorized to issue 100,000,000 shares of common stock
and 5,000,000 shares of preferred stock. Additionally, the Board may subsequently approve increases in authorized common stock.
The potential issuance of such additional shares of common or preferred stock or convertible debt may create downward pressure
on the trading price of our common stock. We may also issue additional shares of common stock or other securities that are convertible
into or exercisable for common stock in future public offerings or private placements for capital raising purposes or for other
business purposes. The future issuance of a substantial number of common shares into the public market, or the perception that
such issuance could occur, could adversely affect the prevailing market price of our common shares. A decline in the price of
our common shares could make it more difficult to raise funds through future offerings of our common shares or securities convertible
into common shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>If
and when a larger trading market for our securities develops, the market price of such securities is still likely to be highly
volatile and subject to wide fluctuations, and you may be unable to resell your securities at or above the price at which you
acquired them.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
stock market in general and the market for smaller health service companies in particular have experienced extreme volatility
that has often been unrelated to the operating performance of particular companies. The market price for our securities may be
influenced by many factors that are beyond our control, including, but not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
                                         or anticipated changed in our operating results;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to execute our business plan;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">variations
                                         in our quarterly results;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                         in expectations relating to our products, plans, and strategic position or those of our
                                         competitors or customers;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
                                         or introduction of technological innovations or new products by us or our competitors;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">market
                                         conditions within our market;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         sale of even small blocks of Common Stock by stockholders;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">price
                                         and volume fluctuations in the overall stock market from time to time;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
                                         volatility in the market price and trading volume of public companies in general and
                                         small emerging companies in particular;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                         in investor perceptions;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         level and quality of any research analyst coverage of our Common Stock, changes in earnings
                                         estimates or investment recommendations by securities analysis, or our failure to meet
                                         such estimates;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                         financial guidance we may provide to the public, any changes in such guidance, or our
                                         failure to meet such guidance;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">various
                                         market factors or perceived market factors, including rumors, whether or not correct,
                                         involving us, our customers, or our competitors;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">future
                                         sales of our Common Stock;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Introductions
                                         of new products or new pricing policies by us or by our competitors;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">acquisitions
                                         or strategic alliances by us or by our competitors;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">litigation
                                         involving us, our competitors, or our industry;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory,
                                         legislative, political, and other developments that may affect us, our customers, and
                                         the purchasers of our products;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         gain or loss of significant customers;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         volume and timing of customers&#8217; orders;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">recruitment
                                         or departure of key personnel;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">developments
                                         with respect to intellectual property rights;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         international acceptance;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">market
                                         conditions in our industry, the business success of our customers, and economy as a whole;
                                         and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
                                         global economic and political instability.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading price of our shares might also decline in reaction to events that affect other companies in our industry, even if these
events do not directly affect us. Each of these factors, among others, could harm the value of your investment in our securities.
In the past, following periods of volatility in the market, securities class-action litigation has often been instituted against
companies. Such litigation, if instituted against us, could result in substantial costs and diversion of management&rsquo;s attention
and resources, which could materially and adversely affect our business, operating results and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>If
securities or industry analysts do not publish or cease publishing research or reports about us, or publish inaccurate or unfavorable
reports about, our business or our market, or if they change their recommendations regarding our stock adversely, our stock price
and trading volume could decline.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading market for our common stock, to some extent, will be influenced by the research and reports that industry or securities
analysts may publish about us, our business, our market or our competitors. We do not have any control over these analysts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise
of warrants, and issuance of incentive stock grants may have a dilutive effective on our stock, and negatively impact the price of our
Common Stock.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020 we had 3,550,471 warrants outstanding. Each warrant provides the holder the right to purchase
up to one share of our Common Stock at a predetermined exercise price. The outstanding warrants consist of one warrant
to purchase one share of Common Stock at exercise prices ranging from of $1.40 to $5.75 per share
over the next two to ten years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">As
of December 31, 2020 we had a total of 4,232,400 stock options outstanding under our various option categories, including (1)
service-based options, (2) performance-based options, and (3) options issued under our newly formed 2020 Equity and Incentive
Plan. Each option provides the holder the right to purchase up to one share of our Common Stock at a predetermined exercise price.
The outstanding options consist of one option to purchase one share of Common Stock at exercise prices ranging from of $0.80 to
$9.24 per share over the next ten years.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 8, 2021,</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> the shareholders of the Company approved the 2020
Equity and Incentive Plan (&ldquo;the Plan&rdquo;). Under the Plan, 1,500,000 shares of common stock were reserved
and authorized to be issued. As of March 29, 2021, there are no shares remaining to be issued under the Plan.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that any of the outstanding warrants and options described above are exercised, dilution, to the interests of our stockholders
may occur. For the life of such warrants and options, the holders will have the opportunity to profit from a rise in the price of the
Common Stock with a resulting dilution in the interest of the other holders of Common Stock. The existence of such warrants and options
may adversely affect the market price of our Common Stock and the terms on which we can obtain additional financing, and the holders
of such warrants and options can be expected to exercise them at a time when we would, in all likelihood, be able to obtain additional
capital by an offering of our unissued capital stock on terms more favorable to us than those provided by such warrants and options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Effect
of Issuance of Preferred Stock</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation, as amended allows us to issue Preferred Stock with voting, liquidation, and dividend rights senior
to those of the Common Stock without the approval of our stockholders. The issuance of Preferred Stock could have the effect of
making it more difficult for a third party to acquire a majority of the outstanding stock of our company and result in the dilution
of the value of the then current stockholders&rsquo; Common Stock. We have no current plans to issue additional shares of Preferred
Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_03"></A>ITEM
1B. UNRESOLVED STAFF COMMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_04"></A>ITEM
2. PROPERTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
our facilities are leased domestically including an office space located in Puerto Rico, a U.S. territory. A description of our
leased premises is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
Executive Offices:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.15in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Located
                                         at 800 Third Avenue, Suite 2800, New York, NY 10022 (Began February 2019)</FONT></TD>
</TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Month-to-month
                                         lease</FONT></TD>
</TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Virtual
                                         office with no actual office space, but have the ability to lease conference space from
                                         time-to-time</FONT></TD>
</TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monthly
                                         costs of $99 per month</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
Space:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.15in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Located
                                         in Puerto Rico</FONT></TD>
</TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Month-to-month
                                         lease</FONT></TD>
</TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
                                         of approximately 1,000 sq. ft.</FONT></TD>
</TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monthly
                                         costs are $5,000 per month</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
and Support Center:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.15in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Located
                                         in Huntington Beach, California.</FONT></TD>
</TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three-year
                                         lease ending February 28, 2023</FONT></TD>
</TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
                                         of 1,248 sq. ft.</FONT></TD>
</TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monthly
                                         costs of $2,235 from July 1, 2020 &ndash; February 28, 2021 and $2,302 from March 1,
                                         2021 &ndash; February 28, 2022.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patient
Care</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> Center:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.15in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Located
                                         in Greenville, South Carolina</FONT></TD>
</TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three
                                         year lease ending September 30, 2023</FONT></TD>
</TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists
                                         of 5,084 sq ft</FONT></TD>
</TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
                                         costs of $101,680 with an annual increment of 2.5%</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our existing facilities are adequate for current and presently foreseeable operations. In general, our properties
are well maintained and are being utilized for their intended purposes. Additional space may be required as we expand our business
activities. We do not foresee any significant difficulties in obtaining additional facilities if deemed necessary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_05"></A>ITEM
3. LEGAL PROCEEDINGS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may become involved in various lawsuits and legal proceedings arising in the ordinary course of business. Litigation is subject
to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may have an adverse
effect on our business, financial conditions or operating results. Future litigation may be necessary to defend ourselves and
our customers by determining the scope, enforceability and validity of third-party proprietary rights or to establish our proprietary
rights. We are currently not aware of any such legal proceedings or claims that will have, individually or in the aggregate, a
material adverse effect on our business, financial condition or operating results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_06"></A>ITEM
4. MINE SAFETY DISCLOSURES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Options: NewSection; Value: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="p_002"></A>PART
II</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_07"></A>ITEM
5. MARKET FOR REGISTRANT&rsquo;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Market
Information</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
December 9, 2020, our common shares were traded under the OTC Market Group&rsquo;s OTCQB. Since December 10, 2020, our common
stock has been listed for trading on the Nasdaq Capital Market (&ldquo;Nasdaq CM&rdquo;) under the symbol &ldquo;CVLB,&rdquo;
until February 22, 2021 when we changed our symbol to &ldquo;LFMD.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Approximate
Number of Equity Security Holders</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 30, 2021, there were approximately 340 holders of record of our common stock, and the last reported sale price of our
common stock on the Nasdaq CM on March 26, 2021 was $19.24. A significant number of shares of our common stock are
held in either nominee name or street name brokerage accounts, and consequently, we are unable to determine the total number of beneficial
owners of our stock. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Dividend
Policy</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not paid and do not expect to declare or pay any cash dividends on our common stock in the foreseeable future. We currently
expect to retain all future earnings for use in the operation and expansion of our business. The declaration and payment of any
cash dividends in the future will be determined by our Board of Directors, in its discretion, and will depend on a number of factors,
including our earnings, capital requirements, overall financial condition and contractual restrictions, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Recent
Sales of Unregistered Securities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Other than any sales
that were already disclosed under a Current Report on Form 8-K during the year ended December 31, 2020, there
have been no sales of unregistered securities by the Company as of such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_08"></A>ITEM
6. SELECTED FINANCIAL DATA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_09"></A>ITEM
7. MANAGEMENT&rsquo;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations is intended to provide information
necessary to understand our audited consolidated financial statements for the period ended December 31, 2020 and highlight certain
other information which, in the opinion of management, will enhance a reader&rsquo;s understanding of our financial condition,
changes in financial condition and results of operations. In particular, the discussion is intended to provide an analysis of
significant trends and material changes in our financial position and the operating results of our business during the fiscal
year ended December 31, 2020, as compared to the fiscal year ended December 31, 2019. This discussion should be read in conjunction
with our consolidated financial statements for the two-year period ended December 31, 2020 and related notes included elsewhere
in this Annual Report on Form 10-K. These historical financial statements may not be indicative of our future performance. This
Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations contains numerous forward-looking
statements, all of which are based on our current expectations and could be affected by the uncertainties and risks described
throughout this filing, particularly in &ldquo;Item 1A. Risk Factors.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Overview</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LifeMD,
Inc. is a diversified online direct-to-patient marketing and telemedicine company with a portfolio of health and wellness brands.
Our products are marketed and sold directly to consumers through advertisements on Facebook, Google, Amazon, and other social
media and e-commerce platforms. Secondarily, we also sell our products through third party partner channels. We market branded
and generic prescription drugs that are then sold and shipped (via GoGoMeds) online directly to consumers in all 50 states and
the District of Columbia.  We have also established relationships with independent physicians in 50 states that provide
virtual consultations to our patients. Since inception, we have treated over 300,000 patients nationwide. We operate our business
using a proprietary telehealth technology platform that facilitates a compliant relationship between the patient, provider and
pharmacy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Developments
in 2020</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key
developments in our business during 2020 are described below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financing
Transactions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Beginning
May 21, 2020 through May 27, 2020, we issued convertible promissory notes (the &ldquo;May 2020 Notes&rdquo;) to five (5) accredited
investors (each a &ldquo;May 2020 Investor&rdquo;, and collectively, the &ldquo;May 2020 Investors&rdquo;). The aggregate principal
amount of the May 2020 Notes is $1,000,000 for which we received gross proceeds of $1,000,000. The May 2020 Notes may be converted
into shares of our common stock at any time following the date of issuance at a conversion price of $2.50 per share, subject to
adjustment. During the week ended November 6, 2020, all accredited investors agreed to convert the May 2020 Notes (the &ldquo;Note
Conversions&rdquo;) pursuant to the terms therein. On November 24, 2020, the Company issued an aggregate of 447,763 shares of
common stock related to the Note Conversions at $2.50 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2020, we issued 294,120 shares of common stock to an investor for $250,000 in cash consideration. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000
shares of our Series B Preferred Stock was established on August 27, 2020. The shares of Series B Preferred Stock have a stated
value of $1,000 per share (the &ldquo;Series B Stated Value&rdquo;) and are convertible into Common Stock at the election of the
holder of the Series B Preferred Stock, at a price of $3.25 per share, subject to adjustment (the &ldquo;Conversion Price&rdquo;).
Each holder of Series B Preferred Stock shall be entitled to receive, with respect to each share of Series B Preferred Stock then
outstanding and held by such holder, dividends at the rate of thirteen percent (13%) per annum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 28, 2020, we entered into a securities purchase agreement (the &ldquo;Purchase Agreement&rdquo;) with an accredited
investor, to purchase from us an aggregate of 3,500 units (the &ldquo;Units&rdquo;), at a purchase price of $1,000 per Unit,
each consisting of (i) one share of Series B Convertible Preferred Stock, and (ii) a warrant to purchase 400 shares of common
stock of the Company. As a result of the Purchase Agreement, we recorded a deemed dividend to the holders of the Series B Preferred
Stock of $3,500,000 for the value of the warrants and beneficial conversion feature in excess of the purchase price. Additionally,
we recorded accrued dividend of $155,822 for the Series B Preferred Stock 13% dividend feature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2020, we received aggregate proceeds of $25,000 for the sale of warrants from the Warrant Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 9, 2020, we effectuated a 1-for-5 reverse stock split (the &ldquo;Stock Split&rdquo;) of our issued and outstanding shares
of common stock that became effective in the market on October 14, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 3, 2020, we consummated an initial closing of a private placement offering (the &ldquo;Offering&rdquo;), whereby pursuant
to the securities purchase agreement (the &ldquo;November Purchase Agreement&rdquo;) entered into by the Company and certain
accredited investors on October 30, 2020 (each an &ldquo;Investor&rdquo; and collectively, the &ldquo;Investors&rdquo;) we sold
to such Investors an aggregate of 3,044,529 shares (the &ldquo;Shares&rdquo;) of our common stock, par value $0.01 per share for
an aggregate purchase price of $14,461,513 (the &ldquo;Purchase Price&rdquo;). The Purchase Price was funded on November 3, 2020
and resulted in net proceeds to the Company of approximately $13.5 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 19, 2020, we consummated the second and final closing of the Offering, whereby pursuant to the November Purchase Agreement
entered into by us and the accredited investor on November 19, 2020, we sold to such accredited investor 323,892 shares
(the &ldquo;Shares&rdquo;) of the Company&rsquo;s common stock for a purchase price of $1,538,487 which was funded on November
19, 2020 and resulted in net proceeds to the Company of approximately $1.4 million. The aggregate gross proceeds to the Company
from the Offering was $16,000,000, or approximately $14.9 million, net of offering related expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
the year ended December 31, 2020, we issued an aggregate of 534,774 shares of common stock related to the cashless exercise of
options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
the year ended December 31, 2020, we issued an aggregate of 535,600 shares of common stock for the exercise of stock options for
cash proceeds of $302,400.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
the year ended December 31, 2020</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, we issued a
total of 1,472,556 shares of common stock for the cashless exercise of warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2020, we issued a total of 2,722,187 shares of common stock for share liability totaling $2,181,453.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Listing
on NASDAQ Capital Market</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company listed
its shares of common stock for trading on the Nasdaq Capital Market beginning December 10, 2020.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Appointment of Board of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 16, 2020, our Board of Directors appointed Dr. Elanor C. Mariano as a member of the Board, effective October 16, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 6, 2020, our Board of Directors appointed Mr. Roberto Simon as a member of the Board, effective November 6, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Results
of Operations</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Comparison
of the Year Ended December 31, 2020 to the Year Ended December 31, 2019</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Revenue</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
financial results for the year ended December 31, 2020 are summarized as follows in comparison to the year ended December
31, 2019:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: center">$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>% of</I></B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Sales</I></B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: center">$</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>% of</I></B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Sales</I></B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 44%; text-align: left">Product revenues, net</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">30,556,163</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">81.9</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">9,919,506</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">79.6</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Software revenues, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,732,747</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,539,129</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20.4</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Service revenues, net</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">5,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">9,943</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total revenues, net</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">37,293,910</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">100</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">12,468,578</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">100</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Cost of product revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,572,490</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23.0</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,371,295</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19.0</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Cost of software revenue</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">334,952</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">0.9</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">154,013</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1.3</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total cost of revenue</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">8,907,442</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">23.9</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,525,308</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">20.3</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Gross profit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">28,386,468</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">76.1</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">9,943,270</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">79.7</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Selling &amp; marketing expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">41,669,475</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">111.7</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,916,217</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">71.5</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">General and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,206,675</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">113.2</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,398,751</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19.2</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other operating expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,166,697</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">724,270</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.8</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Customer service expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">716,325</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.9</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">570,763</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4.6</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Development costs</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">446,749</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1.2</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">222,877</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1.8</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">86,205,921</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">231.1</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">12,832,878</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">102.9</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Operating loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(57,819,453</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-155.0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,889,608</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-23.2</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other expense, net</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,582,398</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-6.9</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(761,150</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-6.1</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net loss before provision for income taxes</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(60,401,851</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-162.0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,650,758</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-29.3</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Provision for Income taxes</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">122,500</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-0.3</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(122,500</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-1.0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net loss attributable to noncontrolling interests</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,877,408</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-5.0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(391,055</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-3.1</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net loss attributable to LifeMD, Inc.</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(58,646,943</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-157.3</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(3,137,203</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-25.2</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45; Value: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
for the year ended December 31, 2020 were approximately $37.3 million, an increase of 199% compared to approximately $12.5 million
for the year ended December 31, 2019. The increase in revenues was attributable to both the increase in product revenue of 208%
and an increase in software revenue of 165%. Product revenue accounts for 82% of total revenue and has increased in the year ended
December 31, 2020 due to an increase in online sales demand, with the majority of the growth of our telemedicine brands, RexMD
and ShapiroMD. Software revenue accounts for 18% of total revenue and has steadily increased year over year due to a combination
of higher demand, increased market awareness, enhanced digital capabilities and continued marketing campaign expansion. While
a portion of our growth could be attributable to the COVID-19 pandemic, management strongly believes our growth is primarily a
result of the strength of our healthcare brands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
cost of revenues consists of the cost of (1) product revenues, which primarily include product material costs and fulfillment costs directly
attributable to the production of our products held for sale and (2) the cost of software revenue consisting primarily of information
technology fees related to providing the services made available on our online platform. Total cost of revenue increased by approximately
252% to approximately $8.9 million for the year ended December 31, 2020 compared to approximately $2.5 million for the
year ended December 31, 2019. The combined cost of increase was due to increased product costs related to our improved product sale volumes
when compared to the prior year&rsquo;s period ended December 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
profit increased by approximately 185% to approximately $28.4 million for the year ended December 31,2020 compared to approximately
$9.9 million for the year ended December 31, 2019, as a result of increased combined sales, partially offset by a percentage increases
in our costs to produce product revenues. Product costs increased to 23% of associated product revenues experienced during the
year ended December 31, 2020, from 19% of associated product revenues during the year ended December 31, 2019. Gross profit as a percentage
of revenues was 76% for the year ended December 31, 2020 compared to 80% for the year ended December 31, 2019. The decrease of
4% in gross profit was principally attributable to higher product costs incurred during the year ended December 31, 2020, resulting
from the use of new suppliers, at slightly higher costs, resulting from the impact of COVID-19 related disruptions to our product supply
chain, causing increased costs to procure our production inputs. The new suppliers were also required to supplement our increased production
needs to meet our increased product demand. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Operating
Expenses</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year Ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 68%; text-align: left">Selling and marketing expenses</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">41,669,475</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">8,916,217</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">General and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,206,675</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,398,751</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other operating expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,166,697</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">724,270</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Customer service expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">716,325</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">570,763</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Development costs</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">446,749</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">222,877</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total operating expenses</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">86,205,921</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">12,832,878</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 46; Value: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
expenses for the year ended December 31, 2020 were approximately $86.2 million, as compared to approximately $12.8 million
for the year ended December 31, 2019. This represents an increase of 573%, or $73.4 million. The increase is primarily
attributable to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
                                            and marketing expenses: This mainly consists of online marketing and advertising expenses,
                                            as well as merchant processing fees. During the year ended December 31,2020, the Company
                                            had an increase of approximately $32.8 million, or 367% in selling and marketing costs
                                            resulting from additional sales and marketing initiatives to drive the current year ended
                                            December 31, 2020 sales growth reported above and is expected to maintain sustained revenue
                                            growth in future years, based on the Company&rsquo;s recurring revenue subscription-based
                                            sales model.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
                                            and administrative expenses: During the year period ended December 31, 2020, stock-based
                                            compensation was $37.0 million, (1) with the majority related to stock compensation expense
                                            attributable to the attainment of a performance threshold in the period, (2) coupled with
                                            the issuance expense associated with the probability of future performance threshold attainment.
                                            This category also consists of payroll expenses for executive management, amortization expense
                                            and legal and professional fees. During the year ended December 31, 2020, the Company has
                                            had an increase of approximately $39.8 million in general and administrative expenses,
                                            primarily related to the increase in stock-based compensation costs referenced above, and
                                            other increases in infrastructure expenses incurred to support the sales volume increases.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                                         operating expenses: This consists of rent, insurance, royalty expense, bank charges and
                                         IT services for our online products. During the year ended December 31, 2020, the Company
                                         had an increase of approximately $442,000, or 61%, primarily related to increases in
                                         the general cost environment necessary to support the Company&rsquo;s sales growth, as
                                         well as a bad debt charge of approximately $133,000 in 2020.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
                                         service expenses: This consists of payroll and benefit expenses related to the Company&rsquo;s
                                         customer service department located in Puerto Rico and South Carolina. During the year
                                         ended December 31, 2020, the Company had an increase of approximately $146,000, primarily
                                         related to increases in headcount in the Company&rsquo;s customer service department.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Development
                                         costs: This mainly relates to third-party technology services for developing and maintaining
                                         our online platforms. During the year ended December 31, 2020, the Company had an increase
                                         of approximately $224,000, primarily resulting from technology platform improvements
                                         for LegalSimpli and amortization expenses at CLPR.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Other
Expenses</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year Ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; width: 68%; text-align: left">Interest expense, net</TD><TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">1,667,536</TD><TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">761,150</TD><TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">Loss on debt settlement</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">914,862</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,582,398</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">761,150</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
expense, which consists of interest expense and loss on debt settlement, for the year ended December 31, 2020 increased
by approximately $1.8 million compared to the year ended December 31, 2019. The increase in other expense, interest expense,
is primarily attributable to the increased use of debt during 2020 and the acceleration of debt discount in 2020 of $500,145.
Loss on debt settlement is attributable to the issuance of common share and warrant in exchange for debt during the year ended
December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Working
Capital </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 85%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">December 31, 2020</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2019</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 56%; text-align: left">Current assets</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 18%; text-align: right">12,063,395</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 18%; text-align: right">2,747,102</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">13,490,096</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,975,442</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Working capital</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1,426,701</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1,228,340</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Working
capital (deficit) increased by only $198,361 during the year ended December 31, 2020. The increase in current assets is
primarily attributable to an increase in cash of approximately $8.1 million, an increase in accounts receivable of approximately
$551,000, and inventory and product deposits (combined increase of approximately $981,000). Current liabilities increased by $9.5
million which was primarily attributable to an increase in accounts payable and accrued liabilities as a result of the Company
extending payables and credit terms with vendors during the year ended December 31, 2020. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 47; Value: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Liquidity
and Capital Resources</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year
    Ended December 31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(60,524,351</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,528,258</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash (used in) provided by operating
    activities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(12,131,614</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">251,408</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash (used in) investing
    activities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(798,136</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(100,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash provided
    by financing activities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">21,002,201</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">775,123</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net &nbsp;increase
    in cash</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,072,451</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">926,531</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
inception, the Company has funded operations through the collections from revenues provided by the sales of its products, issuances
of common and preferred stock&nbsp;, receipt of loans and advances from officers and directors and the issuance of convertible
notes to third-party investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities was approximately $12.1 million for the year ended December 31, 2020, as compared with net cash
provided by operating activities of approximately $251,000 for the year ended December 31, 2019. The significant factors contributing
to the cash used in operations during the year ended December 31, 2020, include the net loss of approximately $60.5 million (inclusive
of $37.0 million in non-cash stock based compensation charges), principally offset by the Company&rsquo;s increase in accounts payable
of approximately $9.5 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in investing activities for the year ended December 31, 2020 was approximately $798,000, as compared with net cash used
in investing activities of $100,000 for the year ended December 31, 2019. Net cash used in investing activities was primarily
due to continued payments on the Company&rsquo;s purchase of LegalSimpli of $400,000 and the cash paid for capitalized software
costs of approximately $398,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by financing activities for the year ended December 31, 2020 was approximately $21.0 million as compared with net
cash provided by financing activities of approximately $775,000 for the year ended December 31, 2019. During the year ended December
31, 2020, financing activities consisted of net proceeds from private placement of $14.9 million, cash proceeds from issuance
of Series B Preferred Stock of $2.9 million, cash proceeds from notes payable of $2.4 million, cash proceeds from the sale of
common stock of $2.3 million, cash proceeds from the sales of warrants of $622,763 and proceeds from the exercise of stock options
of approximately $300,000, which were offset primarily by the repayment of notes payable of approximately $2.5 million during
the year ended December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Liquidity
and Capital Resources Outlook</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has funded operations in the past through the sales of its products, issuance of common stock and through loans and advances
from officers and directors. The Company&rsquo;s continued operations are dependent upon obtaining an increase in its sale volumes
which the company has been successful in achieving to date. See Note 5 for a further discussion of a private placement
offering, which closed on November 3, 2020, with final closing on November 19, 2020, yielding $16 million in gross proceeds to
the Company before deduction of placement fees and other offering expenses, resulting in $14.9 million in net proceeds. The Company
intends to use the net proceeds for customer acquisition, as well as for general corporate purposes.  </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
on February 11, 2021, the Company consummated the closing of a private placement offering (See Note 10) yielding gross proceeds
of $14,000,008, and resulted in net proceeds to the Company of approximately $13.4 million after deducting fees payable to the
placement agent and other estimated offering expenses payable by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Critical
Accounting Policies and Estimates</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
significant accounting policies are more fully described in the notes to our consolidated financial  statements. We
believe that the accounting policies below are critical for one to fully understand and evaluate our financial condition and results
of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48; Value: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Revenue
Recognition</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records revenue under the adoption of ASC 606 by analyzing exchanges with its customers using a five-step analysis:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify
    the contract</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify
    performance obligations</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determine
    the transaction price</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocate
    the transaction price</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognize
    revenue</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Company&rsquo;s product-based contracts with customers, the Company has determined that there is one performance obligation,
which is the delivery of the product; this performance obligation is transferred at a discrete point in time. The Company generally
records sales of finished products once the customer places and pays for the order, with the product being simultaneously shipped
by a third-party fulfillment service provider; in limited cases, title does not pass until the product reaches the customer&rsquo;s
delivery site, in these limited cases, recognition of revenue should be deferred until that time, however the Company does not
have a process to properly record the recognition of revenue if orders are not immediately shipped, and deems the impact to be
immaterial. In all cases, delivery is considered to have occurred when title and risk of loss have transferred to
the customer, which is usually commensurate upon shipment of the product. In the case of its product-based contracts, the Company
provides a subscription sensitive service based on the recurring shipment of products and records the related revenue under the
subscription agreements subsequent to receiving the monthly product order, recording the revenue at the time it fulfills the shipment
obligation to the customer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
its product-based contracts with customers, the Company records an estimate for provisions of discounts, returns, allowances,
customer rebates and other adjustments for its product shipments, and are reflected as contra revenues in arriving at reported
net revenues. The Company&rsquo;s discounts and customer rebates are known at the time of sale, correspondingly, the Company reduces
gross product sales for such discounts and customer rebates. The Company estimates customer returns and allowances based on information
derived from historical transaction detail, and accounts for such provisions, as contra revenue, during the same period in which
the related revenues are earned. The Company has determined that the population of its product-based contracts with customers
are homogenous, supporting the ability to record estimates for returns and allowances to be applied to the entire product-based
portfolio population.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company, through its majority-owned subsidiary LegalSimpli, offers a subscription based service providing a suite of software
applications to its subscribers, principally on a monthly subscription basis. The software suite allows the subscriber/user to
convert almost any type of document to another electronic form of editable document, providing ease of editing. For these subscription-based
contracts with customers, the Company offers an initial 14-day trial period which is billed at $1.95, followed by a monthly subscription,
or a yearly subscription to the Company&rsquo;s software suite dependent on the subscriber&rsquo;s enrollment selection. The Company
has estimated that there is one product and one performance obligation that is delivered over time, as the Company allows the
subscriber to access the suite of services for the time period of the subscription purchased. The Company allows the customer
to cancel at any point during the billing cycle, in which case the customers subscription will not be renewed for the following
month or year depending on the original subscription. The Company records the revenue over the customers subscription period for
monthly and yearly subscribers or at the end of the initial 14 day service period for customers who purchased the initial subscription,
as the circumstances dictate. The Company offers a discount for the monthly or yearly subscriptions being purchased, which is
deducted at the time of payment at the initiation of the contract term, therefore the Contract price is fixed and determinable
at the contract initiation. Monthly and annual subscriptions for the service are recorded net of the Company&rsquo;s known discount
rates. As of December 31, 2020 and December 31, 2019, the Company has accrued contract liabilities, as deferred revenue, of approximately
$917,000 and $110,000, respectively, which represent obligations on in-process monthly or yearly contracts with customers and
a portion attributable to the yet to be recognized initial 14-day trial period collections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49; Value: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
discounts, returns and rebates on product revenues during the year ended December 31, 2020 and 2019 approximated $3.3 million and $1.29
million, respectively. Customer discounts and allowances on software revenues during the year ended December 31, 2020 and 2019 approximated
$1,062,000 and $241,000, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Capitalized
Software Costs</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company capitalizes certain internal payroll costs and third-party costs related to internally developed software and amortizes
these costs using the straight-line method over the estimated useful life of the software, generally three years. The Company
does not sell internally developed software other than through the use of subscription service. Certain development costs not
meeting the criteria for capitalization, in accordance with Accounting Standards Codification (&ldquo;ASC&rdquo;) <I>ASC 350-40
Internal-Use Software</I>, are expensed as incurred. As of December 31, 2020 and 2019, the Company capitalized $438,136 and $0
related to internally developed software costs which is amortized over the useful life and included in development costs on our
statement of operations.  </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Intangible
Assets</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets are comprised of a customer relationship asset and purchased license with an estimated useful life of three years and ten
years, respectively. Intangible assets are amortized over their estimated lives using the straight-line method. Costs incurred
to renew or extend the term of recognized intangible assets are capitalized and amortized over the useful life of the asset.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Income
Taxes</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company files corporate federal and state tax returns. Conversion Labs PR and LegalSimpli file tax returns in Puerto Rico, both
are limited liability companies and file separate tax returns with any tax liabilities or benefits passing through to its members.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records current and deferred taxes in accordance with Accounting Standards Codification (&ldquo;ASC&rdquo;) 740, &ldquo;Accounting
for Income Taxes.&rdquo; This ASC requires recognition of deferred tax assets and liabilities for temporary differences between
tax basis of assets and liabilities and the amounts at which they are carried in the consolidated financial  statements,
based upon the enacted rates in effect for the year in which the differences are expected to reverse. The Company establishes
a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. The Company periodically
assesses the value of its deferred tax asset, a majority of which has been generated by a history of net operating losses and
management determines the necessity for a valuation allowance. ASC 740 also provides a recognition threshold and measurement attribute
for the financial statement recognition of a tax position taken or expected to be taken in a tax return. Using this guidance,
a company may recognize the tax benefit from an uncertain tax position in its financial statements only if it is more likely-than-not
(i.e., a likelihood of more than 50%) that the tax position will be sustained on examination by the taxing authorities, based
on the technical merits of the position. The Company&rsquo;s tax returns for all years since December 31, 2016, remain open to
audit by all related taxing authorities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock-based
Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the provisions of ASC 718, &ldquo;Share-Based Payment&rdquo;. Under this guidance compensation cost generally
is recognized at fair value on the date of the grant and amortized over the respective vesting or service period. The fair value
of options at the date of grant is estimated using the Black-Scholes option pricing model. The expected option life is derived
from assumed exercise rates based upon historical exercise patterns and represents the period of time that options granted are
expected to be outstanding. The expected volatility is based upon historical volatility of the Company&rsquo;s common stock shares
using weekly price observations over an observation period that approximates the expected life of the options. The risk-free rate
approximates the U.S. Treasury yield curve rate in effect at the time of grant for periods similar to the expected option life.
Due to limited history of forfeitures, the Company has elected to account for forfeitures as they occur. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of the assumptions require significant judgment and any changes could have a material impact in the determination of stock-based
compensation expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50; Value: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<!-- Field: Split-Segment; Name: 1 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recently
Issued Accounting Standards</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2017, the FASB issued ASU No. 2017-11, &ldquo;Earnings Per Share (Topic 260) and Derivatives and Hedging (Topic 815) - Accounting
for Certain Financial Instruments with Down Round Features&rdquo; (&ldquo;ASU 2017-11&rdquo;). Equity-linked instruments, such
as warrants, and convertible instruments may contain down round features that result in the strike price being reduced on the
basis of the pricing of future equity offerings. Under ASU 2017-11, a down round feature will no longer require a freestanding
equity-linked instrument (or embedded conversion option) to be classified as a liability that is remeasured at fair value through
the income statement (i.e. marked-to-market). However, other features of the equity-linked instrument (or embedded conversion
option) must still be evaluated to determine whether liability or equity classification is appropriate. Equity classified instruments
are not marked-to-market. For earnings per share (&ldquo;EPS&rdquo;) reporting, the ASU requires companies to recognize the effect
of the down round feature only when it is triggered by treating it as a dividend and as a reduction of income available to common
shareholders in basic EPS. The amendments in this ASU are effective for all entities for fiscal years, and interim periods within
those fiscal years, beginning after December 15, 2019. This standard was adopted on January 1, 2020 and did not have a material
impact on the Company&rsquo;s financial position, results of operations or cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Application
of New or Revised Accounting Standards&mdash;Not Yet Adopted</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU 2020-06, &ldquo;<I>Debt &ndash; Debt with Conversion and Other Options (Subtopic 470-20) and
Derivatives and Hedging &ndash; Contracts in Entity&rsquo;s Own Equity (Subtopic 815-40); Accounting for Convertible Instruments
and Contracts in an Entity&rsquo;s Own Equity </I>(&ldquo;ASU 2020-06&rdquo;)&rdquo;, which addresses issues identified as a result
of the complexities associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and
equity. This update addresses, among other things, the number of accounting models for convertible debt instruments and convertible
preferred stock, targeted improvements to the disclosures for convertible instruments and earnings-per-share (&ldquo;EPS&rdquo;)
guidance and amendments to the guidance for the derivatives scope exception for contracts in an entity&rsquo;s own equity, as
well as the related EPS guidance. This update applies to all entities that issue convertible instruments and/or contracts in an
entity&rsquo;s own equity. This guidance is effective for financial statements issued for fiscal years beginning after December
15, 2021, and interim periods within those fiscal years. Early adoption is permitted, but no earlier than for fiscal years beginning
after December 15, 2020, including interim periods within those fiscal years. FASB specified that an entity should adopt the guidance
as of the beginning of its annual fiscal year, or January 1, 2021, should the Company elect to early adopt. The Company is currently
evaluating the impact the adoption of ASU 2020-06 could have on the Company&rsquo;s financial statements and disclosures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Off-Balance
Sheet Arrangements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial
condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital
resources that is material to stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="b_01"></A>ITEM
7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="b_02"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information called for by Item 8 is included following the &ldquo;Index to Financial Statements&rdquo; on page F-1 contained in
this Annual Report on Form 10-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="b_03"></A>ITEM
9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 51; Value: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="b_04"></A>ITEM
9A. CONTROLS AND PROCEDURES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Evaluation
of Disclosure Controls and Procedures</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain disclosure controls and procedures (as that term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange
Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;)) that are designed to ensure that information required to be disclosed
in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the
SEC&rsquo;s rules and forms, and that such information is accumulated and communicated to our management, including our chief
executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosures. In designing
disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit
relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based
in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed
in achieving its stated goals under all potential future conditions. Any controls and procedures, no matter how well designed
and operated, can provide only reasonable, not absolute, assurance of achieving the desired control objectives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management, with the participation of our chief executive officer and chief financial officer, has evaluated the effectiveness
of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based
upon that evaluation and subject to the foregoing, our chief executive officer and chief financial officer concluded that, our
disclosure controls and procedures were not effective due to the material weaknesses in internal control over financial reporting
described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Management&rsquo;s
Annual Report on Internal Control Over Financial Reporting</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
of our Company and its consolidated subsidiaries is responsible for establishing and maintaining adequate internal control over
financial reporting. The Company&rsquo;s internal control over financial reporting is a process designed under the supervision
of its chief executive and chief financial officers and effected by the Company&rsquo;s Board of Directors, management and other
personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of its consolidated
financial statements for external reporting purposes in accordance with U.S. generally accepted accounting principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. In addition, projections
of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes
in conditions or that the degree of compliance with the policies or procedures may deteriorate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Material
Weakness in Internal Control over Financial Reporting</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
assessed the effectiveness of the Company&rsquo;s internal control over financial reporting as of December 31, 2020, based on
the framework established in Internal Control&mdash;Integrated Framework (2013) issued by the Committee of Sponsoring Organizations
of the Treadway Commission. Based on this assessment, management has determined that the Company&rsquo;s internal control over
financial reporting was not effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
material weakness, as defined in the standards established by the Sarbanes-Oxley Act of 2002 (the &ldquo;Sarbanes-Oxley Act&rdquo;),
is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable
possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a
timely basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ineffectiveness of the Company&rsquo;s internal control over financial reporting was due to the following material weaknesses
which are indicative of many small companies with small number of staff:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">inadequate
    segregation of duties consistent with control objectives;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">insufficient
    written policies and procedures for accounting and financial reporting with respects to the requirements and application of
    both U.S. GAAP and SEC Guidelines;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">inadequate
    security and restricted access to computer systems including a disaster recovery plan;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">lack
    of formal written policy for the approval, identification and authorization of related party transactions; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
    written whistleblower policy.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 52; Value: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Management&rsquo;s
Plan to Remediate the Material Weakness</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
has been implementing and continues to implement measures designed to ensure that control deficiencies contributing to the material
weaknesses are remediated, such that these controls are designed, implemented, and operating effectively. The remediation actions
planned include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">continue
    to search for and evaluate qualified independent outside directors;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    recent addition of functioning audit committee;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">re-design
    of our accounting processes and control procedures;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify
    gaps in our skills base and the expertise of our staff required to meet the financial reporting requirements of a publicly-traded
    company;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">review
    and improve current accounting policies and procedures and develop a thorough document detailing said policies and procedures
    with respects to the requirements and application of both U.S. GAAP and SEC Guidelines;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify
    and remedy gaps in our security and restricted access policies to computer systems and implement a disaster recovery plan;
    and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">develop
    a written whistleblower policy.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are committed to maintaining a strong internal control environment and believe that these remediation efforts will represent significant
improvements in our control environment. Our management will continue to monitor and evaluate the relevance of our risk-based
approach and the effectiveness of our internal controls and procedures over financial reporting on an ongoing basis and is committed
to taking further action and implementing additional enhancements or improvements, as necessary and as funds allow.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management&rsquo;s
report on internal control over financial reporting was not subject to attestation by the Company&rsquo;s registered public accounting
firm pursuant to rules of the Securities and Exchange Commission that permit a Smaller Reporting Company to provide only Management&rsquo;s
report in this annual report, which may increase the risk that weaknesses or deficiencies in our internal control over financial
reporting go undetected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Changes
in Internal Control over Financial Reporting</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange
Act) during the fiscal quarter ended December 31, 2020 that materially affected, our internal control over financial reporting
as of that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="b_05"></A>ITEM
9B. OTHER INFORMATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="p_003"></A>PART
III</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="b_06"></A>ITEM
10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information relating to our Board of Directors, Executive Officers, and Corporate Governance required by this item is incorporated
by reference to our 2021 proxy statement, to be filed within 120 days of our fiscal year end (December 31, 2020) and such information
is incorporated herein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="b_07"></A>ITEM
11. EXECUTIVE COMPENSATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
information required by this </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">item is incorporated
by reference to our 2021 proxy statement, to be filed within 120 days of our fiscal year end (December 31, 2020) and such information
is incorporated herein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="b_08"></A>ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
information required by this </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">item is incorporated
by reference to our 2021 proxy statement, to be filed within 120 days of our fiscal year end (December 31, 2020) and such information
is incorporated herein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="b_09"></A>ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
information required by this </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">item is incorporated
by reference to our 2021 proxy statement, to be filed within 120 days of our fiscal year end (December 31, 2020) and such information
is incorporated herein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="b_10"></A>ITEM
14. PRINCIPAL ACCOUNTANT FEES AND SERVICES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
information required by this </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">item is incorporated
by reference to our 2021 proxy statement, to be filed within 120 days of our fiscal year end (December 31, 2020) and such information
is incorporated herein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 53; Value: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="p_004"></A>PART
IV</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="b_11"></A>ITEM
15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
following exhibits are included as part of this Annual Report:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="5" STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Incorporated
    by Reference</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 0.75in; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    Number</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 0.1in; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    Description</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 0.1in; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 0.5in; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 0.1in; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 0.5in; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 0.1in; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 0.5in; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filing
    Date/Period End Date</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000121390018008343/fs12018ex3-5_immudyne.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Amendment of Certificate of Incorporation of Conversion Labs, Inc. effective June 15, 2018.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6/27/2018</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000121390019026229/def14a1219_conversionlabs.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Amendment of Certificate of Incorporation of Conversion Labs, Inc. effective December 16, 2019.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEF 14C</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/16/2019</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000121390018004229/f8k040918bex3-1_immudyne.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bylaws of Immudyne, Inc. effective April 9, 2018.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/10/2018</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000121390020001789/f8k012020ex3-1_conversi.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Amendment of Certificate of Incorporation of Conversion Labs, Inc. effective January 21, 2020.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/24/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220019512/ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Amendment to Articles of Incorporation, filed October 9, 2020</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/15/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220016307/ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Withdrawal of Series A Preferred Stock</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/19/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315221004461/ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Amendment</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/22/2021</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220016971/ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Designations of the Series B Convertible Preferred Stock</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/31/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000121390019016270/f8k081519ex4-1_conversion.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Convertible Note.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/19/2019</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000121390019016270/f8k081519ex4-2_conversion.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Warrant.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/19/2019</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315220009918/ex4-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Convertible Redeemable Promissory Note</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/27/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220020442/ex4-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of PA Warrant</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/4/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315221001050/ex4-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion Labs, Inc. 2020 Equity Incentive Plan</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/14/2021</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315221001050/ex4-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Non-Qualified Option Agreement (Non-Employee Director Awards)</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/14/2021</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315221001050/ex4-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Non-Qualified Option Agreement (Employee Awards)</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/14/2021</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315221001050/ex4-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Restricted Stock Award Agreement</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/14/2021</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9*</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex4-9.htm">Description of Securities</A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1<SUP>#</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000121390018014569/f8k072318ex10-2_conversion.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Agreement by and between the Company and Mr. Sean Fitzpatrick, dated July 23, 2018.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/29/2018</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2<SUP>#</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000121390019004530/f8k020919ex10-2_conversion.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Agreement by and between the Company and Mr. Juan Manuel Pi&ntilde;ero Dagnery, dated April 1, 2019.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/20/2019</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3<SUP>#</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000121390019015776/f10q0619ex10-10_conversion.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Agreement by and between the Company and Mr. Stefan Galluppi, dated March 18, 2019.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/14/2019</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000121390019016270/f8k081519ex10-1_conversion.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Securities Purchase Agreement.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/19/2019</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000121390019016270/f8k081519ex10-2_conversion.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Lock-Up Agreement.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/19/2019</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000121390019008332/f8k050819ex10-1_conversion.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Promissory Note, dated May 8, 2019 by and between LegalSimpli Software, LLC and Conversion Labs PR LLC.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/13/2019</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000121390019008332/f8k050819ex10-2_conversion.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Agreement, dated May 8, 2019 and between LegalSimpli Software, LLC and Conversion Labs PR LLC.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/13/2019</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000121390019014093/f8k042519ex10-1_conversion.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Membership Interest Purchase Agreement by and between the Company, Conversion Labs PR LLC, Taggart International Trust and American Nutra Tech LLC, dated April 25, 2019.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/31/2019</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000121390019014093/f8k042519ex10-2_conversion.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second Amended and Restated Limited Liability Company Operating Agreement of Conversion Labs PR.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/31/2019</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000121390019010276/f8k052719ex10-1_conversion.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating Agreement of Conversion Labs RX, LLC.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6/7/2019</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 54; Value: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</FONT></TD>
    <TD STYLE="width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000121390019010276/f8k052719ex10-4_conversion.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strategic Partnership Agreement, dated May 31, 2019, by and between Conversion Labs RX, LLC and Specialty Medical Drugstore (d/b/a GoGo Meds).</FONT></A></TD>
    <TD STYLE="width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD STYLE="width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6/7/2019</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000121390019004530/f8k020919ex10-1_conversion.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment to Kalkstein Consulting Agreement.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/20/2019</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000121390019010276/f8k052719ex10-2_conversion.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consulting Agreement, dated May 31, 2019, by and between Conversion Labs, Inc. and Harborside Advisors, LLC.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6/7/2019</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000121390019010276/f8k052719ex10-3_conversion.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consulting Agreement, dated May 31, 2019, by and between Conversion Labs, Inc. and Happy Walters.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6/7/2019</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000121390019004530/f8k020919ex10-1_conversion.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment to Kalkstein Consulting Agreement, by and between Conversion Labs, Inc. and Robert Kalkstein</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/20/2019</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16<SUP>#</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000121390020001789/f8k012020ex10-1_conversi.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fitzpatrick Amendment by and between the Company and Mr. Sean Fitzpatrick.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/24/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17<SUP># </SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000121390020001789/f8k012020ex10-2_conversi.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Agreement by and between the Company and Mr. Nicholas Alvarez</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/24/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220009421/ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alpha 2019 Note Repayment and Warrant Amendment</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/19/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220009421/ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alpha 2018 Warrant Amendment.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/19/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220009421/ex10-5.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brio 2019 Note Repayment and Warrant Amendment</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/19/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220009421/ex10-6.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brio 2018 Warrant Amendment</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/19/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220009421/ex10-7.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Purchase Agreement</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/19/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220009421/ex10-8.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consulting Agreement by and between the Company and Auxo Technology Labs</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/19/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220014114/ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Secured Convertible Promissory Note, dated July 27, 2020</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/28/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220016971/ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form Securities Purchase Agreement</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/31/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.26</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220016971/ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Warrant</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/31/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220016971/ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Registration Rights Agreement</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/31/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.28</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220016971/ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Consulting Agreement</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/31/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.29</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220016971/ex10-5.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Warrant Purchase Agreement</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/31/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.30</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220016971/ex10-6.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Consulting Warrant</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/31/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.31</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220016971/ex10-7.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Purchased Warrant</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/31/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.32</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220018539/ex16-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Letter from Borgers dated September 28, 2020</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/29/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.33</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315220018632/ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended Consulting Agreement</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9/30/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.34</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220019842/ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director Agreement, dated October 21, 2020</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/22/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.35</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220020442/ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Securities Purchase Agreement</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/4/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.36</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220020442/ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Registration Rights Agreement</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/4/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.37</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220020442/ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Lock-Up Agreement</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/4/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.38</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220020933/ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director Agreement, dated November 6, 2020</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/10/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.39<SUP>#</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220022570/ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Employment Agreement, dated November 20, by and between Conversion Labs, Inc. and Eric H. Yecies</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/25/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.40<SUP>#</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220022915/ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Agreement, dated November 27, 2020, by and between Conversion Labs, Inc. and Brad Roberts</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/3/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.41</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220022915/ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consulting Agreement, dated November 27, 2020, by and between Conversion Labs, Inc. and JDM Investments, LLC</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/3/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.42<SUP>#</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220023418/ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Amended and Restated Employment Agreement, dated December 8, 2020, by and between Conversion Labs, Inc. and Nicholas Alvarez</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/11/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.43<SUP>#</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315220024368/ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Employment Agreement, dated December 21, 2020, by and between Conversion Labs, Inc. and Brad Roberts</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/28/2020</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.44<SUP>#</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315221000746/ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Agreement, dated January 5, 2021, by and between Conversion Labs, Inc. and Bryant Hussey</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/11/2021</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.45<SUP>#</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315221001049/ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Agreement, dated January 11, 2021, by and between Conversion Labs, Inc. and Anthony Puopolo</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/14/2021</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.46</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315221001825/ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of CVLB PR Exchange Agreement</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/26/2021</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 55; Value: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.47</FONT></TD>
    <TD STYLE="width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315221001825/ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of CVLB PR MIPA</FONT></A></TD>
    <TD STYLE="width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/26/2021</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.48</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221001825/ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Founding Members MIPA</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/26/2021</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.49</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315221002040/ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment to LSS Operating Agreement</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/28/2021</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.50</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315221002040/ex10-5.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fitzpatrick Option Agreement</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/28/2021</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.51</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315221002040/ex10-6.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pathak Option Agreement</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/28/2021</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.52<SUP>#</SUP></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315221003253/ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Agreement, dated February 4, 2021, by and between Conversion Labs, Inc. and Marc Benathen</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/10/2021</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.53</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315221003475/ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Securities Purchase Agreement</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/12/2021</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.54</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/0000948320/000149315221003475/ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Registration Rights Agreement</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/12/2021</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.55#</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/948320/000149315221002670/ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Agreement, dated January 14, 2021, by and between Conversion Labs, Inc. and Corey Deutsch</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/4/2021</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.56#*</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><A HREF="ex10-56.htm">Consulting Service Agreement, dated April 1, 2020, by and between the Company and JLS Ventures, LLC</A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1*</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex21-1.htm">List of Subsidiaries</A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1*</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="ex31-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2*</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="ex31-2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1**</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="ex32-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 1350 Certification of Chief Executive Officer.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2**</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><A HREF="ex32-2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 1350 Certification of Chief Financial Officer.</FONT></A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS*</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Instance Document</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH*</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension Schema Document</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL*</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension Calculation Linkbase
    Document</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF*</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension Definition Linkbase
    Document</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB*</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension Label Linkbase Document</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE*</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension Presentation Linkbase
    Document</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>#
Indicates management contract or compensatory plan, contract or arrangement.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>*
Filed herewith.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>**Furnished
herewith</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 56; Value: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="b_12"></A>SIGNATURES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report
to be signed on its behalf by the undersigned, thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LIFEMD,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    Justin Schreiber</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Justin
    Schreiber</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
    Chief Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 30, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    Marc Benathen</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marc
    Benathen</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 30, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf
of the registrant and in the capacities and on the dates indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Justin Schreiber</I></FONT></TD>
    <TD STYLE="vertical-align: top; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Justin Schreiber </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President, Chief Executive Officer and Director
    </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March 30, 2021 </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Stefan Galluppi</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp; Stefan Galluppi</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp; Chief Technology
    Officer and Director</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Date: March 30, 2021
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    John R. Strawn, Jr.</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John R. Strawn,
    Jr.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March 30, 2021</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    Roberto Simon</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roberto
    Simon</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 30, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    Dr. Elanor Mariano</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Elanor Mariano</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 30, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    Happy Walters</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Happy
    Walters</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 30, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    Bertrand Velge</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bertrand
    Velge</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 30, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    Joseph DiTrolio</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph
    DiTrolio, M.D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    and Chief Medical Officer (U.S.)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 30, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 57; Value: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LIFEMD,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
FINANCIAL STATEMENTS AS OF DECEMBER 31, 2020</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>TABLE
OF CONTENTS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#f_01"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPORTS OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED
    FINANCIAL STATEMENTS:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#f_02"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Balance Sheets</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#f_03"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Operations</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#f_04"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Changes in Deficit</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#f_05"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Cash Flows</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#f_06"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to Consolidated Financial Statements</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-8
to F-35</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 58; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="f_01"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the Board of D<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">irectors
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders of LifeMD, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Opinion
on the Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheet of LifeMD, Inc. (the &ldquo;Company&rdquo;) as of December 31, 2020
and the related consolidated statement of operations, changes in stockholders&rsquo; deficit, and cash flows for the year
ended December 31, 2020 and the related notes (collectively referred to as the &ldquo;consolidated financial
statements&rdquo;). In our opinion, the consolidated financial statements present fairly, in all material respects, the
financial position of the Company as of December 31, 2020, and the results of its operations and its cash flows for the year
ended December 31, 2020, in conformity with accounting principles generally accepted in the United States of
America.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Basis
for Opinion</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements are the responsibility of the Company&rsquo;s management. Our responsibility is to express an
opinion on the Company&rsquo;s consolidated financial statements based on our audit. We are a public accounting firm registered
with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to
the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and
Exchange Commission and the PCAOB.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether
due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over
financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting,
but not for the purpose of expressing an opinion on the effectiveness of the Company&rsquo;s internal control over financial reporting.
Accordingly, we express no such opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis,
evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the
accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the
consolidated financial statements. We believe that our audit provides a reasonable basis for our opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Critical
Audit Matters</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements
that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that
are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments.
The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken
as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit
matters or on the accounts or disclosures to which they relate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock
Based Compensation &ndash; Initial Measurement of Fair Value </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Description
of the Matter </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in Note 2 of the consolidated financial statements, the Company measures stock-based awards at fair value and recognizes
compensation expense related to such awards over the respective vesting or service period. The Company uses the Black-Scholes
option pricing model to determine the fair value of the awards. Certain inputs in the model used for determination of fair value
of the awards of the Company, such as the expected term, volatility, and fair value of stock, require management to make significant
judgments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>How
We Addressed the Matter in Our Audit</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
assessed the appropriateness of judgments made by management in determining key assumptions related to the awards, such as service
inception date based on the multi-year performance conditions and volatility. We tested the accuracy of the data used in measuring
the awards by agreeing the underlying inputs, such as grant date, grant price, performance targets and vesting terms, among others
to award letters. We determined whether performance targets were satisfied in accordance with the contractual conditions, and
recalculated grant date fair value by multiplying that earned quantity of awards by the grant price</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Going
Concern &ndash; Assessing the Company&rsquo;s Ability to Continue as a Going Concern </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Description
of the Matter </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in Note 1 of the consolidated financial statements, the Company has adequate cash on hand, which will provide sufficient
liquidity to finance the operating activities of the Company for twelve months from the issuance of these consolidated financial
statements. We determined that the Company&rsquo;s ability to continue as a going concern is a critical audit matter due to significant
management&rsquo;s judgments and assumptions used in estimating future cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>How
We Addressed the Matter in Our Audit </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
reviewed forecasted information, assessed reasonableness of the forecasted operating results and uses and sources of cash used
in management&rsquo;s assessment. This testing included inquiries with management, comparison of prior period forecasts to actual
results, assessment of available financing, consideration of positive and negative evidence impacting management&rsquo;s forecasts,
market and industry factors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
Friedman LLP</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&rsquo;s auditor since 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marlton,
New Jersey</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
30, 2021</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the shareholders and the board of directors of Conversion Labs, Inc. (now LifeMD, Inc.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Opinion
on the Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheet of Conversion Labs, Inc. (the &ldquo;Company&rdquo;) as of December 31,
2019, the related statement of operations, stockholders&rsquo; equity (deficit), and cash flows for the year then ended, and the related
notes (collectively referred to as the &ldquo;financial statements&rdquo;). In our opinion, the financial statements present fairly,
in all material respects, the financial position of the Company as of December 31, 2019, and the results of its operations and
its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Basis
for Opinion</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&rsquo;s management. Our responsibility is to express an opinion on the Company&rsquo;s
financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight
Board (United States) (&ldquo;PCAOB&rdquo;) and are required to be independent with respect to the Company in accordance with the
U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error
or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial
reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not
for the purpose of expressing an opinion on the effectiveness of the Company&rsquo;s internal control over financial reporting.
Accordingly, we express no such opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to
error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.
We believe that our audit provides a reasonable basis for our opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Substantial
Doubt about the Company&rsquo;s Ability to Continue as a Going Concern</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed
in Note 1 to the financial statements, the Company&rsquo;s significant operating losses raise substantial doubt about its ability
to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of
this uncertainty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s
BF Borgers CPA PC</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BF
Borgers CPA PC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
served as the Company&rsquo;s auditor from 2018 to 2020</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lakewood,
CO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
30, 2020</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LIFEMD,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="f_02"></A>CONSOLIDATED
BALANCE SHEETS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">ASSETS</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Current Assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,179,075</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,106,624</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts receivable,
    net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">648,421</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">97,448</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Product deposit</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">816,765</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">150,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Inventory, net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,264,258</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">950,059</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    current assets</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">154,876</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">442,971</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total Current Assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,063,395</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,747,102</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-current assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Right of use asset,
    net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">274,437</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">23,625</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Capitalized software,
    net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">375,983</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intangible
    assets, net</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">339,840</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">675,452</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total non-current assets</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">990,260</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">699,077</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total Assets</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13,053,655</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,446,179</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">LIABILITIES AND STOCKHOLDERS&rsquo;
    DEFICIT</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Current Liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts payable
    and accrued expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,794,084</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,051,156</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Notes payable, net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">779,132</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">814,734</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Deferred
    revenue</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">916,880</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">109,552</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total Current Liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13,490,096</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,975,442</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Long-term Liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Lease Liability</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">285,323</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">29,978</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Contingent consideration
    on purchase of LegalSimpli</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">100,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">500,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Deferred
    tax liability</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">70,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total Liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13,875,419</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,575,420</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Commitments and contingencies (Note
    7)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Mezzanine Equity</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Preferred Stock, $0.0001 per value;
    4,996,500 and 5,000,000 shares authorized Series B Preferred Stock, $0.0001 per value; 5,000 and 0 shares authorized, 3,500 and 0
    shares issued and outstanding as of December 31, 2020 and 2019, respectively; liquidation value approximately, $1,045 and $0 per
    share at December 31, 2020 and 2019, respectively</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,655,822</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stockholders&rsquo; Deficit</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock, $0.01 par value;
    100,000,000 shares authorized, 23,433,663 and 10,680,730 shares issued, 23,330,623 and 10,577,690 outstanding as of December
    31, 2020 and 2019, respectively</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">234,337</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">106,807</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additional paid-in
    capital</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">77,779,370</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15,663,626</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accumulated
    deficit</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(80,151,905</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(16,594,917</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,138,198</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(824,484</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Treasury stock,
    103,040 and 103,040 shares, at cost</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(163,701</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(163,701</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total LifeMD, Inc.
    Stockholders&rsquo; Deficit</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,301,899</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(988,185</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-controlling
    interest</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,175,687</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(141,056</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    Stockholders&rsquo; Deficit</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,477,586</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,129,241</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    Liabilities and Stockholders&rsquo; Deficit</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13,053,655</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,446,179</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LIFEMD,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="f_03"></A>CONSOLIDATED
STATEMENTS OF OPERATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year
    Ended December 31,</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net Revenues</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Product revenues, net</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">30,556,163</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,919,506</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Software revenues, net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,732,747</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,539,129</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Service revenues,
    net</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,943</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total Revenues, net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">37,293,910</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,468,578</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cost of product revenue</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,572,490</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,371,295</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cost of software
    revenue</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">334,952</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">154,013</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cost of revenues</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,907,442</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,525,308</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Gross
    Profit</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">28,386,468</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,943,270</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Selling &amp; marketing expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">41,669,475</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,916,217</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">General and administrative expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">42,206,675</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,398,751</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other operating expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,166,697</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">724,270</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Customer service expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">716,325</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">570,763</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Development Costs</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">446,749</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">222,877</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">86,205,921</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,832,878</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating Loss</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(57,819,453</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,889,608</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Other Expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest expense,
    net</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,667,536</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(761,150</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Loss on debt settlement</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(914,862</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">(2,582,398</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">(761,150</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net Loss before provision
    for income taxes</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(60,401,851</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,650,758</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Provision for
    income taxes</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">122,500</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(122,500</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net Loss</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(60,524,351</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,528,258)</FONT></TD><TD STYLE="text-align: left"></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net (loss) attributable
    to noncontrolling interests</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,877,408</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(391,055</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss attributable
    to LifeMD, Inc.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(58,646,943</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,137,203</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Deemed distribution
    to holders of common and Series B Preferred stock</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,716,021</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss attributable to LifeMD, Inc. common stockholders</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(63,362,964</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,137,203</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Basic loss per
    share attributable to LifeMD, Inc. common stockholders</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4.44</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.32</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Diluted loss
    per share attributable to LifeMD, Inc. common stockholders</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4.44</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.32</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted Average number of common shares outstanding:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Basic</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">14,275,153</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,897,745</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Diluted</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">14,275,153</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,897,745</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LIFEMD,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="f_04"></A>CONSOLIDATED
STATEMENTS OF CHANGES IN STOCKHOLDERS&rsquo; DEFICIT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="21" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LifeMD,
    Inc.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="5" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paid-in</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasury</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noncontrolling</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Deficit)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 29%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    at December 31, 2018</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,156,461</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,564</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,110,507</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12,140,670</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(163,701</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">897,700</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(77,962</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">819,738</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    issued for services</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">200</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,800</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    compensation</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">731,215</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">733,215</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">733,215</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agreement
    to issue shares for non-controlling interest in CVLB PR</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">890,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,317,044</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(417,044</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">417,044</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    issued in conjunction with stock</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,825</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,825</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,825</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    issued in conjunction with debt</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">569,146</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">569,146</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">569,146</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase
    of common stock</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">304,269</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,043</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">326,133</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">329,176</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">329,176</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions
    to non-controlling interest</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(89,083</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(89,083</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,137,203</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,137,203</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(391,055</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,528,258</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance,
    December 31, 2019</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,680,730</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">106,807</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,663,626</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16,594,917</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(163,701</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(988,185</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(141,056</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,129,241</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    compensation</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,656,141</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,656,141</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,656,141</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    issued for services</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,900,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,276,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,305,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,305,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale
    of warrants</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of warrants</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">379,957</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,800</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">618,963</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">622,763</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">622,763</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    of stock options</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">535,600</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,356</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">297,044</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">302,400</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">302,400</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cashless
    exercise of warrants</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,472,556</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,726</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,726</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cashless
    exercise of stock options</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">534,774</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,348</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,348</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale
    of common stock</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">294,120</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,941</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">247,059</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale
    of stock in private placement, net</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,368,421</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,684</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,866,536</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,900,220</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,900,220</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    issued for share liability (proceeds received in prior period)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,722,187</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,222</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,154,231</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,181,453</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,181,453</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock issued for debt exchange agreement</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">96,923</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">969</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,163,893</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,164,862</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,164,862</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock issued for conversion of debt</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">447,763</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,478</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,114,930</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,119,408</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,119,408</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distribution
    to non-controlling interest</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(157,223</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(157,223</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deemed
    dividend from down-round provision in common stock shares yet to be issued</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(194,024</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(194,024</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(194,024</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deemed
    dividend from warrant price adjustments</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,216,021</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,216,021</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deemed
    dividend from warrants issued and BCF with Series B Preferred Stock</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,500,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,500,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rounding
    due to reverse split</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">632</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss - year ended December 31, 2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(58,646,943</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(58,646,943</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,877,408</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(60,524,351</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance,
    December 31, 2020</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,433,663</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">234,337</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">77,779,370</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(80,151,905</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(163,701</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,301,899</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,175,687</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,477,586</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LIFEMD,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="f_05"></A>CONSOLIDATED
STATEMENTS OF CASH FLOWS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year
    Ended December 31,</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">CASH FLOWS FROM OPERATING
    ACTIVITIES</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net Loss</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(60,524,351</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,528,258</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Adjustments to reconcile net loss to
    net cash (used in) provided by operating activities:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amortization of
    debt discount</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">817,118</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">622,256</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amortization of
    capitalized software</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">62,153</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amortization of intangibles</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">335,612</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">335,613</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Acceleration of
    debt discount</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">500,145</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Loss on debt settlement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">914,862</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating lease
    payments</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,533</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,353</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock issued for
    services</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">18,305,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">16,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock compensation
    expense</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">18,656,141</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">733,215</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Deferred tax liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(70,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">66,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Changes in Assets
    and Liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts receivable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(550,973</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,605</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Product deposit</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(666,765</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(116,695</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Inventory</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(314,199</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">72,557</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other current assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">95,595</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(172,965</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Deferred revenue</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">807,328</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">33,568</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts payable
    and accrued expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,496,187</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,182,159</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash (used in)
    provided by operating activities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(12,131,614</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">251,408</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">CASH FLOWS FROM INVESTING
    ACTIVITIES</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash paid for capitalized software costs</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(398,136</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payment to seller for contingent consideration</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(400,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(100,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash used in
    investing activities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(798,136</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(100,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">CASH FLOWS FROM FINANCING
    ACTIVITIES</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash proceeds from private placement
    offering, net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">14,900,220</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash proceeds from Series B Preferred
    Stock</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,892,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proceeds from convertible notes payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,350,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,093,279</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash proceeds from sale of common stock</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,338,349</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash proceeds from exercise of warrants</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">622,763</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash proceeds from exercise of options</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">302,400</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash proceed from sale of warrants</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">25,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payment of debt issuance costs</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(15,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Distributions to non-controlling interest</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(157,223</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(89,085</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proceeds from note payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">242,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Repayment of notes payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,498,808</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(295,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Purchase of shares and warrants</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">349,999</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Debt issuance costs</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(284,070</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash provided
    by financing activities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">21,002,201</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">775,123</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net  increase in cash</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,072,451</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">926,531</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash at beginning of year</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,106,624</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">180,093</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash at end of year</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,179,075</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,106,624</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><U>Cash paid for interest</U></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash paid during the period for interest</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,665,171</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">80,660</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-decoration: underline; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-cash
    investing and financing activitites:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Issuance of company stock for investment
    in subsidiary</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">900,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Cashless exercise of warrants</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">49,551</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Deemed dividend from warrant price adjustments</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,289,657</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Deemed distribution from warrants issued
    with Series B Preferred Stock</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,500,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock yet to be issued for capitalized
    costs</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">40,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Deemed distribution from down-round
    provision on unissued shares</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">194,022</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liability to issue common stock</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">76,348</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Debt issuance costs for liability to
    issue shares</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">219,450</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Conversion of convertible note payable
    and interest for Series B Preferred Stock</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">607,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock issued for capitalized costs</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,675</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrants issued in relation to debt</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">569,147</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock issued for conversion of
    debt</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,119,408</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Debt Exchange Agreement</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">250,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Right of Use asset</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">274,437</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Right of Use lease liability</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">285,323</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 64; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LIFEMD,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="f_06"></A>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE YEARS ENDED DECEMBER 31, 2020 AND 2019</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
1 &ndash; NATURE OF THE ORGANIZATION AND BUSINESS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Corporate
History</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LifeMD,
Inc. was formed in the State of Delaware on May 24, 1994, under its prior name, Immudyne, Inc. The Company changed its name to
Conversion Labs, Inc. on June 22, 2018 and then subsequently, on February 22, 2021, it changed its name to LifeMD, Inc. </FONT>Effective
February 22, 2021, the trading symbol for the Company&rsquo;s common stock, par value $0.01 per share on The Nasdaq Stock Market
LLC changed from &ldquo;CVLB&rdquo; to &ldquo;LFMD&rdquo;.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2016, the original operating agreement of Immudyne PR LLC (&ldquo;Immudyne PR&rdquo;), a joint venture to market
the Company&rsquo;s skincare products, was amended and restated and the Company increased its ownership and voting
interest in Immudyne PR to 78.2%. Concurrent with the name change of the parent company to Conversion Labs, Inc., Immudyne
PR was renamed to Conversion Labs PR LLC (now known as &ldquo;Conversion Labs PR&rdquo;). On April 25, 2019, the operating agreement
of Conversion Labs PR was amended and restated in its entirety to increase the Company&rsquo;s ownership and voting interest in
Conversion Labs PR to 100%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2018, the Company closed the strategic acquisition of 51% of LegalSimpli Software, LLC (&ldquo;LegalSimpli&rdquo;), a software
as a service (SaaS) application for converting, editing, signing and sharing PDF documents. In addition to LegalSimpli Software&rsquo;s
growth business model, this acquisition added deep search engine optimization and search engine marketing expertise to the Company.
Effective January 22, 2021, the Company consummated a transaction to restructure the ownership of LegalSimpli (the &ldquo;LSS
Restructuring&rdquo;) (See Note 10).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Nature
of Business</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">LifeMD is a direct-to-patient
telehealth company that provides a smarter, cost-effective and convenient way of accessing healthcare.
The Company believes that the traditional model of visiting a doctor&rsquo;s office, receiving a physical prescription,
visiting a local pharmacy, and returning to see a doctor for follow up care or prescription refills is inefficient, costly
to patients, and discourages many patients from seeking much needed medical care. The U.S. healthcare system is undergoing
a paradigm shift, thanks to new technologies and the emergence of direct-to-patient healthcare. Direct-to-patient telemedicine
companies, like the Company, connect consumers to licensed healthcare professionals for care across numerous indications,
including concierge care, men&rsquo;s sexual health and dermatology, among others.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company&rsquo;s telemedicine
platform helps patients access licensed providers for diagnoses, virtual care, and prescription medications, often
delivered on a recurring basis. In addition to its telemedicine offerings, it sells nutritional supplements and other
over-the-counter products. Many of its products are available on a subscription or membership basis, where a patient
can subscribe to receive regular shipments of prescribed medications or products. This creates convenience and often discounted
pricing opportunities for patients and recurring revenue streams for it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Company believes that brand innovation, customer acquisition and service excellence form the heart of its business. As is exemplified
with its first brand, Shapiro MD, it has built a full line of proprietary OTC products for male and female hair loss, FDA
approved OTC minoxidil, an FDA-cleared medical device, and now a personalized telemedicine offering that gives consumers access
to virtual medical treatment and, when appropriate, a full line of oral and topical prescription medications
for hair loss. The Company&rsquo;s men&rsquo;s telemedicine brand, Rex MD, currently offers treatment for erectile dysfunction,
and will soon offer treatments for additional indications present in men&rsquo;s health. The Company has built
a platform that allows it to efficiently launch telehealth and wellness product lines wherever it determines
there is a market need.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 65; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Business
and Subsidiary History </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2018, Conversion Labs closed the strategic acquisition of 51% of LegalSimpli Software, LLC (&ldquo;LegalSimpli&rdquo;), a
software as a service (SaaS) application for converting, editing, signing and sharing PDF documents. In addition to LegalSimpli&rsquo;s
growth business model, this acquisition added deep search engine optimization and search engine marketing expertise to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
early 2019, the Company had launched a service-based business under the name Conversion Labs Media LLC, which was to be used to
run e-commerce marketing campaigns for other online businesses. However, this business initiative was terminated in early 2019
in order to focus on its core business as well as the expansion of our telehealth opportunities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2019, a strategic joint venture with GoGoMeds.com (GoGoMeds) was formed in order to help facilitate the launch of our telemedicine
business. GoGoMeds is a nationwide pharmacy licensed to dispense prescription medications directly to consumers in all 50 states
and the District of Columbia. However, on August 7, 2020, the Company terminated its Strategic Partnership Agreement with
GoGoMeds. The joint venture with GoGoMeds had not initiated activities, and its termination did not have an impact on the Company&rsquo;s
operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
Labs Rx, LLC (&ldquo;CVLB Rx&rdquo;), a Puerto Rico limited liability company, had no activity during the year ended December
31, 2020 and was dissolved during the period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, the terms &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo; and &ldquo;our&rdquo; refer to LifeMD,
Inc. (formerly known as Conversion Labs, Inc.), our wholly subsidiary Conversion Labs PR, LLC (formerly Immudyne PR LLC, now &ldquo;Conversion
Labs PR&rdquo;), a Puerto Rico limited liability company (&ldquo;Conversion Labs PR&rdquo;, or &ldquo;CLPR&rdquo;) and our majority-owned
subsidiaries LegalSimpli Software, LLC, a Puerto Rico limited liability company (&ldquo;LegalSimpli&rdquo;). Unless otherwise
specified, all dollar amounts are expressed in United States dollars.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Reverse
Stock Split</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 9, 2020, the Company filed a Certificate of Amendment to its Articles of Incorporation with the Secretary of State of
Delaware (the &ldquo;Amendment&rdquo;) in order to effectuate a 1-for-5 reverse stock split of the Company&rsquo;s issued and
outstanding shares of common stock (the &ldquo;Reverse Split&rdquo; or &ldquo;Split&rdquo;). The Reverse Split was approved by
the Financial Industry Regulatory Authority (FINRA) and became effective in the market on October 14, 2020 (the &ldquo;Effective
Date&rdquo;). All references to common shares and common share data in these financial statements and elsewhere in this Form 10-K
as of December 31, 2020 and 2019, and for the years then ended, reflect the Reverse Stock Split.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 66; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Liquidity</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has funded operations in the past through the sales of its products, issuance of common stock and through loans and advances
from officers and directors. The Company&rsquo;s continued operations are dependent upon obtaining an increase in its sale volumes
and the continued financial support from officers and directors, obtaining funding from third-party sources or the issuance of
additional shares of common stock. See Note 5 for a further discussion of the private placement offering, which closed in November
2020, yielding approximately $14.9 million in net proceeds to the Company after deduction of placement fees and other offering
expenses. The Company intends to use the net proceeds to expedite growth initiatives, as well as for general corporate purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 11, 2021, the Company consummated the closing of a private placement offering (the &ldquo;February 2021 Offering&rdquo;),
whereby pursuant to the securities purchase agreement (the &ldquo;February 2021 Purchase Agreement&rdquo;) entered into by the
Company and certain accredited investors on February 11, 2021 the Investors purchased 608,696 shares of the Company&rsquo;s common
stock par value $0.01 per share at a purchase price of $23.00 per share for aggregate gross proceeds of approximately 14.0 million
(the &ldquo;Purchase Price&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Price was funded on the closing date and resulted in net proceeds to the Company of approximately $13.4 million after
deducting fees payable to the placement agent and other estimated offering expenses payable by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Going
Concern Evaluation</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The accompanying
consolidated financial statements have been prepared on the basis that the Company will continue as a going concern, which
assumes the realization of assets and the satisfaction of liabilities in the normal course of business. The Company
prepared its financial statements for the year ended December 31, 2019 assuming the Company would continue as a going
concern, with an explanatory note that the Company&rsquo;s significant operating losses raise substantial doubt about its
ability to continue as a going concern. As of December 31, 2020, the Company has an accumulated deficit approximating $80.2
million and has experienced significant losses from its operations. Although the Company is showing significant positive
revenue trends, the Company expects to incur further losses through the end of 2021. Additionally, the Company expects its
burn rate of cash to continue through the first quarter of 2021; however, the Company expects this burn rate to improve in
future quarters. To date, the Company has been funding operations primarily through the sale of equity in private placements.
Management is unable to predict if and when we will be able to generate significant positive cash flow or achieve
profitability. There can be no assurances that we will be successful in increasing revenues, improving operational
efficiencies or that financing will be available or, if available, that such financing will be available under favorable
terms.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has a current
cash balance of approximately $12 million as of the filing date, which includes the $13.4 million of net proceeds from the February
2021 Offering noted above<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</FONT> Based on the Company&rsquo;s
projected cash requirements, management estimates that it will utilize approximately $10 million through the next 12 months from
the filing date of this report. The Company reviewed its forecasted operating results and uses and sources of cash used in management&rsquo;s
assessment, which included the available financing, consideration of positive and negative evidence impacting management&rsquo;s
forecasts, market and industry factors. Positive indicators that lead to its conclusion that it will have sufficient cash over
the next 12 months following the date of this report include (1) its continued strengthening of our revenues and improvement of
operational efficiencies across the business, (2) the expected improvement in its cash burn rate in the first quarter of 2021
and over the next 12 months, (3) overall investor interest in its equity securities which it believes will enable it to successfully
complete future capital raises and (4) the overall market value of the telemedicine industry and how it believes that will continue
to drive interest in the Company.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Principles
of Consolidation</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates the need to consolidate affiliates based on standards set forth in ASC 810 Consolidation (&ldquo;ASC 810&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, CLPR and its majority owned
subsidiary, LegalSimpli. The non-controlling interest in LegalSimpli represents the 49 % equity interest held by other members
of the subsidiary as of December 31, 2020 and 2019. Subsequent to year end, the Company purchased an additional 36% of LegalSimpli
for a total 85%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
significant intercompany transactions and balances have been eliminated in consolidation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Variable
Interest Entities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows ASC 810-10-15 guidance with respect to accounting for variable interest entities (each, a &ldquo;VIE&rdquo;).
These entities do not have sufficient equity at risk to finance their activities without additional subordinated financial support
from other parties or whose equity investors lack any of the characteristics of a controlling financial interest. A variable interest
is an investment or other interest that will absorb portions of a VIE&rsquo;s expected losses or receive portions of its expected
residual returns and are contractual, ownership, or pecuniary in nature and that change with changes in the fair value of the
entity&rsquo;s net assets. A reporting entity is the primary beneficiary of a VIE and must consolidate it when that party has
a variable interest, or combination of variable interests, that provides it with a controlling financial interest. A party is
deemed to have a controlling financial interest if it meets both of the power and losses/benefits criteria. The power criterion
is the ability to direct the activities of the VIE that most significantly impact its economic performance. The losses/benefits
criterion is the obligation to absorb losses from, or right to receive benefits from, the VIE that could potentially be significant
to the VIE. The VIE model requires an ongoing reconsideration of whether a reporting entity is the primary beneficiary of a VIE
due to changes in facts and circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 810-10-25-37 and as amended by ASU 2009-17, the Company determines whether any legal entity in which the Company
becomes involved is a VIE and subject to consolidation. The Company conducts an assessment on an ongoing basis for each VIE including
(1) the power to direct activities of the VIE that most significantly impact the VIE&rsquo;s economic performance, and (2) the
obligation to absorb losses or right to receive benefits from the VIE that could potentially be significant to the VIE. As a result,
the Company determined that three (3) entities were VIEs and subject to consolidation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
    Labs Media, LLC (&ldquo;CVLB Media&rdquo;), a Puerto Rico limited liability company,</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
    Labs Rx, LLC (&ldquo;CVLB Rx&rdquo;), a Puerto Rico limited liability company (dissolved in 2020), and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
    Labs Asia Limited, a Hong Kong company (&ldquo;Conversion Labs Asia&rdquo;).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CVLB
Media, CVLB Rx and Conversion Labs Asia are all considered immaterial as of December 31, 2020 and 2019. CVLB Rx had no activity
during the year ended December 31, 2020 and was dissolved during the period. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Use
of Estimates</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United
States of America which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Some of
the more significant estimates required to be made by management include the determination of reserves for accounts receivable,
returns and allowances, the valuation of inventory and stockholders&rsquo; equity-based transactions. Actual results could differ
from those estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
continuing impact on business activity brought about by the Coronavirus pandemic (&ldquo;COVID-19&rdquo;) continues to evolve,
globally in macro terms, and in micro terms, as such affects the Company. As a result, many of our estimates and assumptions for
the year ended December 31, 2020 were subject to an increased level of judgment and may carry a higher degree of variability and
volatility. In future periods, subsequent to December 31, 2020, when additional information becomes available, which may differ
from our current assumptions, may subject our estimates to material change in future periods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Reclassifications</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
reclassifications have been made to conform the prior year&rsquo;s data to the current presentation. These reclassifications have
no effect on previously reported operating loss, stockholders&rsquo; deficit or cash flows. Given the increase in the Company&rsquo;s
software business and to conform the Company&rsquo;s presentation of operating results to industry standards, the Company has
changed their categories for reporting operations, as result the Company has made reclassifications to the prior year presentation
in order to conform it to the current periods&rsquo; presentation. The reclassification includes $745,288 of merchant processing
fees reclassified from cost of revenues to selling and marketing expenses for the year ended December 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Revenue
Recognition</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records revenue under the adoption of ASC 606 by analyzing exchanges with its customers using a five-step analysis:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify
    the contract</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify
    performance obligations</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determine
    the transaction price</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocate
    the transaction price</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognize
    revenue</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 68; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the Company&rsquo;s product-based contracts with customers, the Company has determined that there is one performance obligation,
which is the delivery of the product; this performance obligation is transferred at a discrete point in time. The Company generally
records sales of finished products once the customer places and pays for the order, with the product being simultaneously shipped
by a third-party fulfillment service provider; in limited cases, title does not pass until the product reaches the customer&rsquo;s
delivery site, in these limited cases, recognition of revenue should be deferred until that time, however the Company does not
have a process to properly record the recognition of revenue if orders are not immediately shipped, and deems the impact to be
immaterial. In all cases, delivery is considered to have occurred when title and risk of loss have transferred
to the customer, which is usually commensurate upon shipment of the product. In the case of its product-based contracts, the Company
provides a subscription sensitive service based on the recurring shipment of products and records the related revenue under the
subscription agreements subsequent to receiving the monthly product order, recording the revenue at the time it fulfills the shipment
obligation to the customer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
its product-based contracts with customers, the Company records an estimate for provisions of discounts, returns, allowances,
customer rebates and other adjustments for its product shipments, and are reflected as contra revenues in arriving at reported
net revenues. The Company&rsquo;s discounts and customer rebates are known at the time of sale, correspondingly, the Company reduces
gross product sales for such discounts and customer rebates. The Company estimates customer returns and allowances based on information
derived from historical transaction detail, and accounts for such provisions, as contra revenue, during the same period in which
the related revenues are earned. The Company has determined that the population of its product-based contracts with customers
are homogenous, supporting the ability to record estimates for returns and allowances to be applied to the entire product-based
portfolio population. Customer discounts, returns and rebates on product revenues approximated $3,321,000 and $1,292,000, respectively,
during the year ended December 31, 2020 and 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company, through its majority-owned subsidiary LegalSimpli, offers a subscription based service providing a suite of software
applications to its subscribers, principally on a monthly subscription basis. The software suite allows the subscriber/user to
convert almost any type of document to another electronic form of editable document, providing ease of editing. For these subscription-based
contracts with customers, the Company offers an initial 14-day trial period which is billed at $1.95, followed by a monthly subscription,
or a yearly subscription to the Company&rsquo;s software suite dependent on the subscriber&rsquo;s enrollment selection. The Company
has estimated that there is one product and one performance obligation that is delivered over time, as the Company allows the
subscriber to access the suite of services for the time period of the subscription purchased. The Company allows the customer
to cancel at any point during the billing cycle, in which case the customers subscription will not be renewed for the following
month or year depending on the original subscription. The Company records the revenue over the customers subscription period for
monthly and yearly subscribers or at the end of the initial 14 day service period for customers who purchased the initial subscription,
as the circumstances dictate. The Company offers a discount for the monthly or yearly subscriptions being purchased, which is
deducted at the time of payment at the initiation of the contract term, therefore the Contract price is fixed and determinable
at the contract initiation. Monthly and annual subscriptions for the service are recorded net of the Company&rsquo;s known discount
rates. As of December 31, 2020 and December 31, 2019, the Company has accrued contract liabilities, as deferred revenue, of approximately
$917,000 and $110,000, respectively, which represent obligations on in-process monthly or yearly contracts with customers and
a portion attributable to the yet to be recognized initial 14-day trial period collections. Customer discounts and allowances
on software revenues approximated $1,062,000 and $242,000, respectively, during the year ended December 31, 2020 and 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 69; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2020 and 2019, the Company had the following disaggregated revenue:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year
    Ended December 31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Product revenues
    by Brand for CVLB PR:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 48%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shapiro MD</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17,289,687</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">46</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,019,956</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">72</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Innate</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,041</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">49,258</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">iNR Wellness</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">247,350</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">738,965</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Scarology</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">44,332</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">51,131</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Rex MD</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,969,753</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">60,197</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total product
    revenue for CVLB PR</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">30,556,163</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">82</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,919,507</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">80</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Software revenue for LegalSimpli, net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,732,747</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">18</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,539,129</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Services revenue for CVLB Media</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,943</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total Revenues,
    net</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">37,293,910</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">100</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,468,578</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">100</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Accounts
Receivable</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable principally consist of amounts due from third-party merchant processors, who process our subscription revenues; the merchant
accounts balance receivable represents the charges processed by the merchants that have not yet been deposited with the Company. The
unsettled merchant receivable amount normally represents processed sale transactions from the final one to three days of the month, with
collections being made by the Company within the first week of the following month. As of year end there is also a fully reserved
accounts receivable for one wholesale agent relationship transaction. There will be no further wholesale agent sales in the future. Management
determines the need, if any, for an allowance for future credits to be granted to customers, by regularly evaluating aggregate customer
refund activity, coupled with the consideration and current economic conditions in its evaluation of an allowance for future refunds
and chargebacks. As of December 31, 2020 and 2019, the Company had an allowance for bad debt, attributable to the single agent relationship
amounting to approximately $133,000 and $0, respectively. As of December 31, 2020 and December 31, 2019, the reserve for sales returns
and allowances was approximately $349,000 and $84,000, respectively. For all periods presented, as noted above, the sales returns and
allowances were recorded as contra assets in arriving at presented accounts receivable, net.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Inventory</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020 and 2019, inventory primarily consisted of finished goods related to the Company&rsquo;s brands included
in the product revenue section of the table above. Inventory is maintained at the Company&rsquo;s third-party warehouse location
in Wyoming and at the Amazon fulfillment center. The Company also maintains inventory at a related-party warehouse in
Pennsylvania. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
is valued at the lower of cost or net realizable value with cost determined on a first-in, first-out (&ldquo;FIFO&rdquo;) basis.
Management compares the cost of inventory with the net realizable value and an allowance is made for writing down inventory to
net realizable, if lower. As of December 31, 2020 and December 31, 2019, the Company recorded an inventory reserve in the amount
of $57,481 and $12,500, respectively. The increase in our inventory reserve mainly is attributable to the lack of marketability
for our INR Wellness product line.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020 and 2019, the Company&rsquo;s inventory consisted of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Finished Goods - Products</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,172,624</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">925,017</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Raw materials and packaging components</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">149,115</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">37,542</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Inventory reserve</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(57,481</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(12,500</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total Inventory
    - net</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,264,258</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">950,059</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Product
Deposit</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of our vendors require deposits when a purchase order is placed for goods or fulfillment services. These deposits typically range
from 10% to 33% of the total purchased amount. Our vendors include a credit memo within their final invoice, recognizing the deposit
amount previously paid. As of December 31, 2020, and December 31, 2019, the Company has approximately $816,765 and $150,000,
respectively, of product deposits with multiple vendors for the purchase of raw materials or finished goods. The Company&rsquo;s
history of product deposits with its inventory vendors, creates an implicit purchase commitment equaling the total expected product
acceptance cost in excess of the product deposit. As of December 31, 2020 and December 31, 2019, the Company approximates its
implicit purchase commitments to be $1.6 million and $300,000, respectively. As of December 31, 2020, and December
31, 2019, the vast majority of these product deposits are with one vendor that manufacturers the Company&rsquo;s finished goods
inventory for its Shapiro hair care product line.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 70; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Capitalized
Software Costs </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company capitalizes certain internal payroll costs and third-party costs related to internally developed software and amortizes
these costs using the straight-line method over the estimated useful life of the software, generally three years. The Company
does not sell internally developed software other than through the use of subscription service. Certain development costs not
meeting the criteria for capitalization, in accordance with Accounting Standards Codification (&ldquo;ASC&rdquo;) <I>ASC 350-40
Internal-Use Software</I>, are expensed as incurred. As of December 31, 2020 and 2019, the Company capitalized $438,136 and $0
related to internally developed software costs which is amortized over the useful life and included in development costs on our
statement of operations.  </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Intangible
Assets</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets are comprised of a customer relationship asset (with original cost of approximately $1,007,000) and a purchased license
(with a cost of $200,000) with an estimated useful life of three and ten years, respectively. Intangible
assets are amortized over their estimated lives using the straight-line method. Costs incurred to renew or extend the term of
recognized intangible assets are capitalized and amortized over the useful life of the asset.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Impairment
of Long-Lived Assets</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets are evaluated for impairment whenever events or changes in circumstances have indicated that an asset may not be recoverable
and are grouped with other assets to the lowest level for which identifiable cash flows are largely independent of the cash flows
of other groups of assets and liabilities (asset group). If the sum of the projected undiscounted cash flows (excluding interest
charges) of an asset group is less than its carrying value and the fair value of an asset group is also less than its carrying
value, the assets will be written down by the amount by which the carrying value of the asset group exceeded its fair value. However,
the carrying amount of a finite-lived intangible asset can never be written down below its fair value. Any loss would be recognized
in income from continuing operations in the period in which the determination is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Paycheck
Protection Program</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2020, the Company received aggregate loan proceeds in the amount of approximately $249,000 under the
Paycheck Protection Program (&ldquo;PPP&rdquo;). The PPP, established as part of the Coronavirus Aid, Relief and Economic Security
Act (&ldquo;CARES Act&rdquo;), provides for loans to qualifying businesses for amounts up to 2.5 times of the average monthly
payroll expenses of the qualifying business. The loans and accrued interest are forgivable after eight weeks as long as the borrower
uses the loan proceeds for eligible purposes, including payroll, benefits, rent and utilities, and maintains its payroll levels.
The amount of loan forgiveness will be reduced if the borrower terminates employees or reduces salaries during the eight-week
period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unforgiven portion of the PPP loan is payable over two years at an interest rate of 1%, with a deferral of payments for the first
six months. The Company intends to use the proceeds for purposes consistent with the PPP. While the Company currently believes
that its use of the loan proceeds will meet the conditions for forgiveness of the loan, we cannot assure you that we will not
take actions that could cause the Company to be ineligible for forgiveness of the loan, in whole or in part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 71; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Income
Taxes</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company files corporate federal, state and local tax returns. Conversion Labs PR and LegalSimpli file tax returns in Puerto Rico,
both are limited liability companies and file separate tax returns with any tax liabilities or benefits passing through to its
members.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records current and deferred taxes in accordance with Accounting Standards Codification (&ldquo;ASC&rdquo;) 740, &ldquo;Accounting
for Income Taxes.&rdquo; This ASC requires recognition of deferred tax assets and liabilities for temporary differences between
tax basis of assets and liabilities and the amounts at which they are carried in the financial statements, based upon the enacted
rates in effect for the year in which the differences are expected to reverse. The Company establishes a valuation allowance when
necessary to reduce deferred tax assets to the amount expected to be realized. The Company periodically assesses the value of
its deferred tax asset, a majority of which has been generated by a history of net operating losses and management determines
the necessity for a valuation allowance. ASC 740 also provides a recognition threshold and measurement attribute for the financial
statement recognition of a tax position taken or expected to be taken in a tax return. Using this guidance, a company may recognize
the tax benefit from an uncertain tax position in its financial statements only if it is more likely-than-not (i.e., a likelihood
of more than 50%) that the tax position will be sustained on examination by the taxing authorities, based on the technical merits
of the position. The Company&rsquo;s tax returns for all years since December 31, 2017, remain open to audit by all related taxing
authorities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Stock-Based
Compensation</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the provisions of ASC 718, &ldquo;Share-Based Payment&rdquo;. Under this guidance compensation cost generally
is recognized at fair value on the date of the grant and amortized over the respective vesting or service period. The fair value
of options at the date of grant is estimated using the Black-Scholes option pricing model. The expected option life is derived
from assumed exercise rates based upon historical exercise patterns and represents the period of time that options granted are
expected to be outstanding. The expected volatility is based upon historical volatility of the Company&rsquo;s common shares using
weekly price observations over an observation period that approximates the expected life of the options. The risk-free interest
rate approximates the U.S. Treasury yield curve rate in effect at the time of grant for periods similar to the expected option
life. Due to limited history of forfeitures, the Company has elected to account for forfeitures as they occur. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of the assumptions require significant judgment and any changes could have a material impact in the determination of stock-based
compensation expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Earnings
(Loss) Per Share</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify; text-indent: 35.65pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings (loss) per common share is based on the weighted average number of shares outstanding during each period presented. Convertible
securities, warrants and options to purchase common stock are included as common stock equivalents only when dilutive. Potential
common stock equivalents are excluded from dilutive earnings per share when the effects would be antidilutive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify; text-indent: 35.65pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the provisions of ASC 260, &ldquo;Diluted Earnings per Share&rdquo;. In computing diluted EPS, basic EPS is adjusted
for the assumed issuance of all potentially dilutive securities. The dilutive effect of call options, warrants and share-based
payment awards is calculated using the &ldquo;treasury stock method,&rdquo; which assumes that the &ldquo;proceeds&rdquo; from
the exercise of these instruments are used to purchase common shares at the average market price for the period. The dilutive
effect of traditional convertible debt and preferred stock is calculated using the &ldquo;if-converted method.&rdquo; Under the
if-converted method, securities are assumed to be converted at the beginning of the period, and the resulting common shares are
included in the denominator of the diluted EPS calculation for the entire period being presented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 72; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify; text-indent: 35.65pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
following table summarizes the number of shares of common stock issuable pursuant to our convertible securities that were excluded
from the diluted per share calculation because the effect of including these potential shares was antidilutive even though the
exercise price could be less than the average market price of the common shares:</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Year</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ended</B></FONT></P></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Year</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ended</B></FONT></P></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Series B</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
    Preferred Stock</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,076,923</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Convertible notes</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,165,126</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock options</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,232,400</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,374,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrants</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,560,188</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,265,324</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Potentially
    dilutive securities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,869,511</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,804,451</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Fair
Value of Financial Instruments</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying value of the Company&rsquo;s financial instruments, including cash, accounts receivable, accounts payable and accrued
expenses and the face amount of notes payable approximate fair value for all periods presented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Concentrations
of Risk</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company grants credit in the normal course of business to its customers. The Company periodically performs credit analysis and
monitors the financial condition of its customers to reduce credit risk.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company monitors its positions with, and the credit quality of, the financial institutions with which it invests. The Company,
at times, maintains balances in various operating accounts in excess of federally insured limits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are dependent on certain third-party manufacturers, although we believe that other contract manufacturers could be quickly secured
if any of our current manufacturers cease to perform adequately. As of December 31, 2020 and 2019, we utilized two (2) suppliers
for fulfillment services, two (2) suppliers for manufacturing finished goods, one (1) supplier for packaging and bottles and one
(1) supplier for labeling. For the year ended December 31, 2020 and 2019, we purchased 100% of our finished goods from two (2)
manufacturers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Recently
Adopted Accounting Pronouncements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2017, the FASB issued ASU No. 2017-11, &ldquo;Earnings Per Share (Topic 260) and Derivatives and Hedging (Topic 815)- Accounting
for Certain Financial Instruments with Down Round Features&rdquo; (&ldquo;ASU 2017-11&rdquo;). Equity-linked instruments, such
as warrants and convertible instruments, may contain down round features that result in the strike price being reduced on the
basis of the pricing of future equity offerings. Under ASU 2017-11, a down round feature will no longer require a freestanding
equity-linked instrument (or embedded conversion option) to be classified as a liability that is remeasured at fair value through
the income statement (i.e. marked-to-market). However, other features of the equity-linked instrument (or embedded conversion
option) must still be evaluated to determine whether liability or equity classification is appropriate. Equity classified instruments
are not marked-to-market. For earnings per share (&ldquo;EPS&rdquo;) reporting, the ASU requires companies to recognize the effect
of the down round feature only when it is triggered by treating it as a dividend and as a reduction of income available to common
shareholders in basic EPS. The amendments in this ASU are effective for all entities for fiscal years, and interim periods within
those fiscal years, beginning after December 15, 2019. This standard was adopted on January 1, 2020 and did not have a material
impact on the Company&rsquo;s financial position, results of operations or cash flows. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Application
of New or Revised Accounting Standards&mdash;Not Yet Adopted</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU 2020-06, &ldquo;<I>Debt &ndash; Debt with Conversion and Other Options (Subtopic 470-20) and
Derivatives and Hedging &ndash; Contracts in Entity&rsquo;s Own Equity (Subtopic 815-40); Accounting for Convertible Instruments
and Contracts in an Entity&rsquo;s Own Equity </I>(&ldquo;ASU 2020-06&rdquo;)&rdquo;, which addresses issues identified as a result
of the complexities associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and
equity. This update addresses, among other things, the number of accounting models for convertible debt instruments and convertible
preferred stock, targeted improvements to the disclosures for convertible instruments and earnings-per-share (&ldquo;EPS&rdquo;)
guidance and amendments to the guidance for the derivatives scope exception for contracts in an entity&rsquo;s own equity, as
well as the related EPS guidance. This update applies to all entities that issue convertible instruments and/or contracts in an
entity&rsquo;s own equity. This guidance is effective for financial statements issued for fiscal years beginning after December
15, 2021, and interim periods within those fiscal years. Early adoption is permitted, but no earlier than for fiscal years beginning
after December 15, 2020, including interim periods within those fiscal years. FASB specified that an entity should adopt the guidance
as of the beginning of its annual fiscal year, or January 1, 2021, should the Company elect to early adopt. The Company is currently
evaluating the impact the adoption of ASU 2020-06 could have on the Company&rsquo;s financial statements and disclosures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 73; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
Recent Accounting Pronouncements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
other accounting standards updates that have been issued or proposed by the FASB that do not require adoption until a future date
are not expected to have a material impact on the consolidated financial statements upon adoption.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
3 &ndash; INTANGIBLE ASSETS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the Company has the following amounts related to intangible assets:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intangible
    Assets as at:</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amortizable</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Life</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Amortizable Intangible Assets</I></B></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 42%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Customer
    Relationship Asset</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,006,840</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,006,840</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; width: 16%"><FONT STYLE="font-family: Times New Roman, Times, Serif">3 years</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Purchased Licenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">200,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">200,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">10 years</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Less:
    Accumulated amortization</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(867,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(531,388</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total Net Amortizable
    Intangible Assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">339,840</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">675,452</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate amortization expense of the Company&rsquo;s intangible assets for the year ended December 31, 2020 and 2019 was approximately
$335,612,  respectively. Amortization expense for 2021 will be approximately $339,840.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
4 &ndash; NOTES PAYABLE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 29, 2018, the Company entered into a securities purchase agreement (the &ldquo;Purchase Agreement&rdquo;) with Alpha Capital
Anstalt (&ldquo;Alpha&rdquo;) and Brio Capital Master Fund Ltd. (&ldquo;Brio&rdquo;), (collectively, the &ldquo;2018 SPAs&rdquo;).
Pursuant to the terms of the Purchase Agreement, the Company issued and sold the 2018 SPAs senior secured convertible notes in
the aggregate original principal amount of $550,000 (collectively, the &ldquo;Alpha and Brio Notes&rdquo;), and warrants to purchase
up to 478,261 shares of the Company&rsquo;s common stock (collectively the &ldquo;Alpha and Brio Warrants&rdquo;). The Alpha and
Brio Notes matured on May 2019. Interest on the outstanding principal amount of the Alpha and Brio Notes had compounded annually
at the annual rate of twelve percent (12%), subject to adjustments through to their maturity date. The Alpha and Brio Notes were
convertible into the Company&rsquo;s common stock, at the option of the holder, at any time following issuance, unless the conversion
or share issuance under the conversion would cause the holder to beneficially own in excess of 4.99% of the Company&rsquo;s common
stock. The conversion price for the principal and interest, if any, in connection with voluntary conversion by the Holder shall
be $1.15 per share of Common Stock, subject to adjustment as defined in the Alpha and Brio Notes. Alpha and Brio have converted
$344,642 of these notes including $9,922 of interest as of December 31, 2019, leaving a balance of $187,308<B>.</B> As of December
31, 2020, these notes have been paid off.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 15, 2019, the Company entered into securities purchase agreements (the &ldquo;August 2019 Purchase Agreements&rdquo;) with
two accredited investor Alpha and Brio. Pursuant to the terms of the August 2019 Purchase Agreements, the Company issued
and sold to the investors convertible promissory notes for the aggregate original principal amount of $1,291,000 (collectively
the &ldquo;August 2019 Notes&rdquo;), and warrants to purchase up to 935,870 shares of the Company&rsquo;s common stock (the &ldquo;August
2019 Warrants&rdquo;). The August 2019 Notes matured on August 15, 2020 and accrued interest at a rate of twelve percent (12%)
per annum, subject to adjustments, prior to maturity, as defined therein. The August 2019 Notes may be converted into shares of
the Company&rsquo;s common stock, at the discretion of the holder, at any time following issuance, unless the conversion or share
issuance under the conversion would cause the holder to beneficially own shares in excess of 4.99% of the Company&rsquo;s common
stock. The conversion price for the principal and interest, if any, in connection with voluntary conversion by the investors shall
be $1.15 per share of common stock, subject to adjustment as defined therein. In conjunction with the August 2019 Notes, the Company
issued the August 2019 Warrants with an exercise price of $1.40 per share. The fair value of August 2019 Warrants was determined
to be $569,147 based on the use of Black-Scholes pricing model. The August 2019 Warrants were evaluated by management and deemed
to be equity-linked awards subject to ASC 815 <I>Derivatives and Hedging.</I> The August 2019 Notes contained an original issue
discount of 20% or $215,250 which is the difference between the note&rsquo;s face amount of $1,111,500 and the cash proceeds received
from the investors. As part of this financing, the Company paid debt issuance costs $284,070 which are placed as a contra-debt
account and were amortized over the life of the loan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 74; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 25, 2020, the Company entered into a Note Repayment and Warrant Amendment Agreement with Alpha and Brio, whereby the
Company agreed to repay the outstanding balance of Alpha and Brio&rsquo;s August 2019 Notes in the amount of $1,291,000. As a
result of this transaction, the Company accelerated debt discounts for warrants, issuance costs and original issue discount of
$500,145, which was recognized through interest expense on the accompanying consolidated statement of operations. As of December
31, 2020 and December 31, 2019, the gross balance payable for these notes was $0 and $1,291,000, respectively. As of December
31, 2020 and December 31, 2019, the Company has cumulatively amortized $568,322 and $404,393 of the debt discounts costs including
debt issuance costs, original issue discount, and discount for warrants issued in connection with the debt transaction, all of
which is included in interest expense on the accompanying consolidated statement of operations. As of December 31, 2020 and December
31, 2019, the net balance payable for these notes was $0 and $627,426, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 18, 2020, the Company entered into two purchase agreements (the &ldquo;C6 Purchase Agreements&rdquo;) for the purchase
and sale of future revenue with C6 Capital, LLC (&ldquo;C6&rdquo;). Pursuant to the terms of the C6 Purchase Agreements, the Company
issued and sold to C6 two loan agreements in the aggregate original principal amount of $1,020,000. These loans contain an original
purchase discount of 18%, or $270,000, in total, or $135,000 per each of the two agreements. C6 paid $375,000 per loan agreement
for a total of $750,000. The Company paid debt issuance costs to C6 of $7,500 per agreement, or $15,000 in total, which was placed
as a contra-debt account and will be amortized over the life of the loan. The loan agreements require the Company to pay all future
receipts of the Company without recourse until such time as the purchased amount has been repaid. The loan agreements require
the Company to make a daily average payment of $8,094 during the term of such agreements. As of December 31, 2020, the Company
has made $1,020,000 in principal payments under these loan agreements. As of December 31, 2020, the gross balance payable for
these loan agreements was $0, and the balance of the loan net of discounts was $0. For the year ended December 31, 2020, the Company
has amortized $285,000 of debt discount through interest expense on the accompanying consolidated statement of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
May 21, 2020 through May 27, 2020 the Company, issued convertible promissory notes (the &ldquo;May 2020 Notes&rdquo;) to five
(5) accredited investors (each a &ldquo;May 2020 Investor&rdquo;, and collectively, the &ldquo;May 2020 Investors&rdquo;). The
aggregate principal amount of the May 2020 Notes is $1,000,000 for which the Company received gross proceeds of $1,000,000. The
May 2020 Notes were due and payable six months from the date of issuance. The May 2020 Notes entitle each holder to 12% interest
upon Maturity, or $120,000. The May 2020 Notes may be converted into shares of the Company&rsquo;s common stock at any time following
the date of issuance at a conversion price of $2.50 per share, subject to adjustment. During the week ended November 6, 2020,
all accredited investors exercised their conversion rights under the May 2020 Notes. On November 24, 2020, the Company issued
an aggregate of 447,763 shares of common stock related to the Note Conversions at $2.50 per share, totaling $1,119,408.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an inducement to enter into the transaction, the Company issued an aggregate of 133,000 shares of the Company&rsquo;s restricted
common stock to the May 2020 Investors at a fair value of approximately $219,450, which was included in interest expense for the
year ended December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 75; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2020, the Company and its subsidiaries received three loans in the aggregate amount of approximately $259,182 (the
&ldquo;PPP Loan&rdquo;) under the new Paycheck Protection Program legislation administered by the U.S. Small Business Administration.
These loans bear interest at one percent per annum (1.0%) and mature five years from the date of the first disbursement. The proceeds
of the PPP Loan must be used for payroll costs, lease payments on agreements entered into before February 15, 2020 and utility
payments under lease agreements entered into before February 1, 2020. At least 60% of the proceeds must be used for payroll costs
and certain other expenses and no more than 40% may be used on non-payroll expenses. Proceeds from the PPP Loan used by the Company
for the approved expense categories may be fully forgiven by the Small Business Administration if the Company satisfies applicable
employee headcount and compensation requirements. The Company currently believes that a majority of the PPP Loan proceeds will
qualify for debt forgiveness; however, there can be no assurance that the Company will qualify for forgiveness from the Small
Business Administration until it occurs. As at December 31, 2020, the $259,182 PPP loan proceeds are reflected on the Company&rsquo;s
consolidated balance sheet as current liabilities, within notes payable, net.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2020, the Company received proceeds of $500,000 under a short-term working capital loan with Chase Bank. The terms of
the loan include a service charge of $19,950 (3.99%). The total balance of $519,950  as of December 31, 2020, included
in notes payable, net, on the accompanying consolidated balance  sheet, and was repaid in full in January 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 27, 2020, the Company issued a secured convertible promissory note in the principal amount of up to $1,500,000 to an accredited
investor. The Company received $600,000 in aggregate gross proceeds. Any additional advances under this note would require the
approval of the lender in its sole discretion. This note accrues interest at a rate of one and one-quarter percent (1.25%) per
month and carried a maturity date of January 24, 2021. The note balance of $607,500, including accrued interest of $7,500, was
repaid in full on August 28, 2020 with the issuance of Series B Convertible Preferred Stock (see Note 5).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
interest expense on notes payable, inclusive of amortization of debt discounts, amounted to $1,667,536 and $761,150 for the year
ended December 31, 2020 and 2019, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
5 &ndash; STOCKHOLDERS&rsquo; EQUITY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has authorized the issuance of up to 100,000,000 shares of common stock, $0.01 par value, and 5,000,000 shares of preferred
stock, $0.0001 par value, of which 5,000 shares are designated as Series B Convertible Preferred Stock and 4,996,500  shares
of preferred stock remain undesignated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 9, 2020, the Company effectuated a 1-for-5 reverse stock split (the &ldquo;Stock Split&rdquo;) of the Company&rsquo;s
issued and outstanding shares of common stock that became effective in the market on October 14, 2020 (see Note 1). In connection
with the Stock Split, the Company issued approximately 632 shares for rounding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Series
B Convertible Preferred Stock</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 27, 2020, the Secretary of State of the State of Delaware delivered confirmation of the effective filing of the Company&rsquo;s
Certificate of Designations of the Series B Convertible Preferred Stock, which established 5,000 shares of the Company&rsquo;s
Series B Preferred Stock, having such designations, rights and preferences as set forth therein (the &ldquo;Series B Designations&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of Series B Preferred Stock have a stated value of $1,000 per share (the &ldquo;Series B Stated Value&rdquo;) and are convertible
into Common Stock at the election of the holder of the Series B Preferred Stock, at a price of $3.25 per share, subject to adjustment
(the &ldquo;Conversion Price&rdquo;). Each holder of Series B Preferred Stock shall be entitled to receive, with respect to each
share of Series B Preferred Stock then outstanding and held by such holder, dividends at the rate of thirteen percent (13%) per
annum (the &ldquo;<U>Preferred Dividends</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 76; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Preferred Dividends shall accrue and be cumulative from and after the date of issuance of any share of Series B Preferred Stock
on a daily basis computed on the basis of a 365-day year and compounded quarterly. The Preferred Dividends are payable only when,
as, and if declared by the Board of Directors of the Company (the &ldquo;Board&rdquo;) and the Company has no obligation to pay
such Preferred Dividends; <U>provided</U>, <U>however</U>, if the Board determines to pay any Preferred Dividends, the Company
shall pay such dividends in kind in a number of additional shares of Series B Preferred Stock (the &ldquo;PIK Shares&rdquo;) equal
to the quotient of (i) the aggregate amount of the Preferred Dividends being paid by the Company in respect of the shares of Series
B Preferred Stock held by such holder, <U>divided by</U> (ii) the Series B Issue Price (as defined in the Series B Designations);
<U>provided</U>, <U>further</U>, that, at the election of the purchasers holding a majority of the shares of Series B Preferred
Stock then outstanding, in their sole discretion, such Preferred Dividends shall be paid in cash or a combination of cash and
PIK Shares. Notwithstanding the foregoing, the Preferred Dividends may be paid in cash at the election of the Company if, and
only if, (A) the purchasers holding a majority of the shares of Series B Preferred Stock then outstanding consent in writing to
the payment of any specific dividend in cash, or (B) at any time following the twenty-four (24) month anniversary of the Closing,
(i) the prevailing VWAP of the Common Stock over the trailing ninety (90)-day period is equal to or greater than $15.00  per
share (subject to adjustments for stock splits, stock dividends, recapitalizations, reorganizations, reclassifications, combinations,
reverse stock splits or other similar events), and (ii) the average trading volume of the Common Stock over the trailing ninety
(90)-day period is equal to or greater than 40,000 shares of Common Stock per day, or (C) at any time following the thirty-six
(36) month anniversary of the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of Series B Preferred Stock rank senior to the Common Stock with respect to payment of dividends and rights upon liquidation
and will vote together with the holders of the Common Stock on an as-converted basis, subject to beneficial ownership limitations,
on each matter submitted to a vote of holders of Common Stock (whether at a meeting of shareholders or by written consent). In
addition, as further described in the Series B Designations, if at least 30% of the number of shares of Series B Preferred Stock
sold at the Closing are outstanding, the Company will not take certain corporate actions without the affirmative vote at a meeting
(or the written consent with or without a meeting) of the purchasers holding a majority of the shares of Series B Preferred Stock
then outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
at any time following the twelve (12)-month anniversary of the Closing (A) the prevailing VWAP (as defined in the Series B Designations)
of the Common Stock over the trailing ninety (90)-day period is equal to or greater than $15.00 per share ($3.00 pre-split)(subject
to adjustments for stock splits, stock dividends, recapitalizations, reorganizations, reclassifications, combinations, reverse
stock splits or other similar events), and (B) the average trading volume of the Common Stock over the trailing ninety (90)-day
period is equal to or greater than 40,000 shares (200,000 pre-split) of Common Stock per day, the Company shall have the right,
but not the obligation, in its sole discretion, to elect to convert all, but not less than all, of the then-outstanding shares
of Series B Preferred Stock into Common Stock by delivering written notice of such election (the &ldquo;Forced Conversion Notice&rdquo;)
to the holders of the Series B Preferred Stock within ten (10) Business Days following the satisfaction of the criteria of clauses
(A) and (B) above (a &ldquo;Forced Conversion&rdquo;). On the Forced Conversion Date (as defined in the Series B Designations),
each share of Series B Preferred Stock shall be converted into the number of fully paid and non-assessable shares of Common Stock
equal to the quotient of: (x) the sum of (1) the Series B Issue Price, <U>plus</U> (2) any accrued but unpaid dividends on such
share of Series B Preferred Stock as of immediately prior to the conversion thereof, including the Preferred Dividends, <U>divided
by</U> (y) the Conversion Price of such share of Series B Preferred Stock in effect at the time of conversion. The Forced Conversion
Notice shall state (i) the number of shares of Series B Preferred Stock held by such Holder that are proposed to be converted,
and (ii) the date on which such Forced Conversion shall occur, which date shall be the thirtieth (30<SUP>th</SUP>) day following
the date such Forced Conversion Notice is deemed given (a &ldquo;Forced Conversion Date&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a Forced Conversion, a holder may elect, in its sole discretion and in lieu of the Forced Conversion, to have each
then-outstanding share of Series B Preferred Stock held by such holder be redeemed by the Company (a &ldquo;<U>Forced Conversion
Redemption</U>&rdquo;) by delivering written notice to the Company (a &ldquo;<U>Forced Conversion Redemption Notice</U>&rdquo;
and the date such Holder delivers such notice to the Corporation, a &ldquo;<U>Forced Conversion Redemption Notice Date</U>&rdquo;)
prior to the Forced Conversion Date, which notice shall state (A) the number of shares of Series B Preferred Stock that are to
be redeemed, (B) the date on which such Forced Conversion Redemption shall occur, which date shall be the tenth (10th) Business
Day following the applicable Forced Conversion Redemption Notice Date (the &ldquo;<U>Forced Conversion Redemption Date</U>&rdquo;)
and (C) the wire instructions for the payment of the applicable amount owed to such holder. Each share of Series B Preferred Stock
that is the subject of a Forced Conversion Redemption shall be redeemed by the Company in cash at a price per share equal to the
sum of (1) the Series B Issue Price, <U>plus</U> (2) any accrued but unpaid dividends on such share of Series B Preferred Stock,
including the Preferred Dividends (the &ldquo;<U>Per Share Forced Conversion Redemption Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 77; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
any time (A) after December 31, 2020, if a sufficient number of shares of Common Stock are not available to effect the conversion
of the Series B Preferred Stock outstanding into Common Stock and the exercise of the Warrants, each holder shall have the right,
in its sole and absolute discretion (in addition to and not to the exclusion of any remedy such holder may have at law or in equity),
to require that the Company redeem (an &ldquo;Optional Redemption&rdquo;), to the fullest extent permitted by law and out of funds
lawfully available therefor, all or any portion of such holder&rsquo;s Series B Preferred Stock then outstanding by delivering
written notice thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Securities
Purchase Agreement</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 28, 2020, the Company entered into a securities purchase agreement (the &ldquo;Purchase Agreement&rdquo;) with an investor
(the &ldquo;Investor&rdquo;), to purchase from the Company an aggregate of 3,500 units (the &ldquo;Units&rdquo;), at a purchase
price of $1,000 per Unit, each consisting of (i) one share of Series B Convertible Preferred Stock, and (ii) a warrant to purchase
400 shares of common stock of the Company. The warrants are exercisable immediately upon issuance, have a 5 year term, an exercise
price of $4.60 per share, and provide for a cashless exercise. The aggregate purchase price for the Units is $3,500,000, of
which (i) $2,892,500 is being paid in cash at the closing of the transaction and (ii) $607,500, is being paid by the conversion
of the outstanding principal and interest due on the Secured Convertible Promissory Note (the &ldquo;Note&rdquo;) issued by the
Company to the Investor on July 27, 2020. The Purchase Agreement provides that the Investor may not sell, transfer or otherwise
dispose of the Series B Preferred Stock or warrants (or the shares of Common Stock issuable thereunder) for a period of one year
following the closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the Purchase Agreement, the Company recorded a deemed dividend to the holders of the Series B Preferred Stock of $3,500,000
for the value of the warrants and beneficial conversion feature in excess of the purchase price. Additionally, the company recorded
this instrument in the mezzanine section of the accompanying consolidated balance sheet of $3,500,000  for the value
of the Series B Preferred Stock redemption feature. This balance was increased by $155,822 for the 13% dividend accrued for the
Series B Preferred stockholders for a balance of $3,655,822 as of December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Warrant
Purchase Agreement</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrently,
the Company entered into a warrant purchase agreement (the &ldquo;Warrant Purchase Agreement&rdquo;) with CL1 to purchase from
the Company (i) a warrant to purchase 500,000 shares of Common Stock, at an exercise price equal to the closing price of the Common
Stock immediately prior of $5.20 per share (the &ldquo;Class A Warrant&rdquo;), for a purchase price of $15,000, and (ii) a warrant
to purchase 250,000 shares of Common Stock, at an exercise price of $5.75 per share (the &ldquo;Class B Warrant&rdquo; and, together
with the Class A Warrant, the &ldquo;Purchased Warrants&rdquo;), for a purchase price of $10,000. Each of the Purchased Warrants
have a five-year term. Each of the Purchase Warrants is immediately exercisable as to fifty percent (50%) of the shares issuable
thereunder and the remaining fifty percent (50%) shall become exercisable on the date that is six months following the issue date
of each Purchased Warrant, subject to a repurchase right in favor of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Purchased Warrants was approximately $4,743,893 (which was included as part of the deemed dividend
calculation above), which was determined by the Black-Scholes Pricing Model with the following assumptions: dividend yield of
0%, term of 5 years, volatility of 161.4%, and risk-free rate of 0.28%.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Consulting
Agreement &ndash; August 2020</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 31, 2020, the Company entered into a consulting agreement (the &ldquo;CL1 Consulting Agreement&rdquo;) with a consultant
(&ldquo;CL1&rdquo; or &ldquo;Consultant&rdquo;), to which Consultant will assist the Company with, among other things, general
operations of the business, marketing and branding, and recruiting talent in connection with the Company&rsquo;s men&rsquo;s sexual
health, hair loss and PDF businesses (the &ldquo;Services&rdquo;). As compensation for the Services, Consultant shall receive
from the Company two warrants (&ldquo;Consulting Warrant 1&rdquo; and &ldquo;Consulting Warrant 2&rdquo; collectively, the &ldquo;Consulting
Warrants&rdquo;), that entitle Consultant to purchase up to an aggregate of 750,000 of Common Stock of the Company according to
the terms and conditions outlined therein, including any restrictions on exercisability. During the five-year term of Consulting
Warrant 1, Consultant may purchase up to an aggregate of 500,000 shares of Common Stock, at an exercise price equal to the closing
price of the Common Stock immediately prior to the Closing of $5.20 per share, and Consulting Warrant 1 becomes exercisable as
to such shares of Common Stock in 18 equal monthly installments beginning on the date that is six months following the issue date
or immediately prior to the consummation of a change of control of the Company. During the five-year term of Consulting Warrant
2, Consultant may purchase up to an aggregate of 250,000 shares of Common Stock, at an exercise price of $5.75 per share, and
Consulting Warrant 2 becomes exercisable as to such shares of Common Stock on the date that is 24 months following the issue date
or immediately prior to the consummation of a change of control of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 78; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The fair value of the
warrants above Consulting Warrants was approximately $4,743,893, which was determined by the Black-Scholes Pricing Model
with the following assumptions: dividend yield of 0%, term of 5 years, volatility of 161.4%, and risk-free rate of 0.28%. Total
amortization of the Consulting Warrants for the year ended December 31, 2020 was $790,649 and is reflected in stock-based
compensation, with unamortized costs of $3,953,244 remaining at December 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Private
Placement Offering &ndash; November 2020</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 3, 2020, the Company consummated an initial closing of a private placement offering (the &ldquo;Offering&rdquo;), whereby
pursuant to the securities purchase agreement (the &ldquo;Purchase Agreement&rdquo;) entered into by the Company and certain accredited
investors on October 30, 2020 (each an &ldquo;Investor&rdquo; and collectively, the &ldquo;Investors&rdquo;) the Company sold
to such Investors an aggregate of 3,044,529 shares (the &ldquo;Shares&rdquo;) of the Company&rsquo;s common stock, par value $0.01
per share (the &ldquo;Common Stock&rdquo;), for an aggregate purchase price of approximately $14.46 million (the &ldquo;Purchase
Price&rdquo;). The Purchase Price was funded on November 3, 2020 (the &ldquo;Closing Date&rdquo;) and resulted in net proceeds
to the Company of approximately $13.5 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Purchase Agreement, the Company agreed, for a period of 90 days from the closing date, not to issue or enter into any agreement
to issue any shares of common stock or common stock equivalents with the exception of certain exempt issuances as provided therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BTIG,
LLC (the &ldquo;Placement Agent&rdquo;) acted as exclusive placement agent for the Offering and received cash compensation equal
to 6% of the Purchase Price and warrants to purchase 91,336  shares of the Company&rsquo;s common stock, at an initial
exercise price of $4.75 per share, subject to adjustment for any reorganization, recapitalization, non-cash dividend, stock split,
reverse stock split or other similar transaction (the &ldquo;PA Warrants&rdquo;). The PA Warrants may be exercised on a &ldquo;cashless&rdquo;
basis and will expire on November 3, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 19, 2020, the Company consummated the second and final closing (&ldquo;Final Closing&rdquo;) of the Offering, whereby
pursuant to the Purchase Agreement entered into by the Company and an accredited investor on November 19, 2020 (the &ldquo;Investor&rdquo;)
the Company sold to the Investor 323,892 shares (the &ldquo;Shares&rdquo;) of the Company&rsquo;s common stock for a purchase
price of approximately $1.54 million (the &ldquo;Purchase Price&rdquo;). The Purchase Price was funded on November 19, 2020 (the
&ldquo;Closing Date&rdquo;) and resulted in net proceeds to the Company of approximately $1.4 million. The aggregate gross
proceeds to the Company from the Offering was $16 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Purchase Agreement, the Company agreed, for a period of 90 days from the closing date, not to issue or enter into any agreement
to issue any shares of common stock or common stock equivalents with the exception of certain exempt issuances as provided therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BTIG,
LLC (the &ldquo;Placement Agent&rdquo;) acted as exclusive placement agent for the Offering and received cash compensation equal
to 6% of the Purchase Price. In connection with the Final Closing the Placement Agent received warrants to purchase 9,717 shares
of the Company&rsquo;s common stock, at an initial exercise price of $4.75 per share, subject to adjustment for any reorganization,
recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction (the &ldquo;PA Warrants&rdquo;).
The PA Warrants expire on November 19, 2025 and may be exercised on a &ldquo;cashless&rdquo; basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Convertible
Promissory Notes</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Beginning
May 21, 2020 through May 27, 2020 the Company, issued convertible promissory notes (the &ldquo;May 2020 Notes&rdquo;) to five
(5) accredited investors (each a &ldquo;May 2020 Investor&rdquo;, and collectively, the &ldquo;May 2020 Investors&rdquo;). The
aggregate principal amount of the May 2020 Notes is $1,000,000 for which the Company received gross proceeds of $1,000,000. The
May 2020 Notes may be converted into shares of the Company&rsquo;s common stock at any time following the date of issuance at
a conversion price of $2.50 per share, subject to adjustment. During the week ended November 6, 2020, all accredited investors
agreed to convert the May 2020 Notes (the &ldquo;Note Conversions&rdquo;) pursuant to the terms therein. On November 24, 2020,
the Company issued an aggregate of 447,763 shares of common stock related to the Note Conversions at $2.50 per share, resulting
in the total principal and interest conversion of $1,119,408.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 79; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Options
and Warrants</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
the year ended December 31, 2020, the Company issued an aggregate of 535,600 shares of common stock related to the exercise of
options for total proceeds of $302,400.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
the year ended December 31, 2020, the Company issued an aggregate of 534,774 shares of common stock related to cashless exercise
of options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
the year ended December 31, 2020, the Company issued an aggregate of 1,472,556 shares of common stock related to cashless exercise
of warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
the year ended December 31, 2019, the Company issued warrants in conjunction with stock with a value of $20,825.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
the year ended December 31, 2019, the Company issued warrants in conjunction with debt with a value of $569,146.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Membership
interest purchase agreement</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
 July 31, 2019 the Company entered into a certain membership interest purchase agreement (the &ldquo;MIPA&rdquo;) by
and between the Company, Conversion Labs PR, LLC (&ldquo;CVLB PR&rdquo;), a majority owned subsidiary, Taggart International Trust,
an entity controlled by the Company&rsquo;s Chief Executive Officer, Mr. Justin Schreiber, and American Nutra Tech LLC, a company
controlled by its Chief Technology and Operating Officer, Mr. Stefan Galluppi (&ldquo;Mr. Schreiber, Taggart International Trust,
Mr. Galluppi and American Nutra Tech LLC each a &ldquo;Related Party&rdquo; and collectively, the &ldquo;Related Parties&rdquo;).
Pursuant to the MIPA, the Company purchased 21.83333% of the membership interests (the &ldquo;Remaining Interests&rdquo;) of CVLB
PR from the Related Parties, bringing the Company&rsquo;s ownership of CVLB PR to 100%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
consideration for the Company&rsquo;s purchase of the Remaining Interests from the Related Parties, Mr. Schreiber and Mr. Galluppi
agreed to cancel all potential issuances of restricted stock and or options related to their employment with the Company, in exchange
for the immediate issuance of 500,000 shares of the Company&rsquo;s restricted common stock to each of Mr. Schreiber and Mr. Galluppi
(the &ldquo;Initial Issuances&rdquo;) (equal to 1,000,000 shares in the aggregate). Mr. Schreiber and Mr. Galluppi were also entitled
to additional issuances pursuant to certain milestones as follows: (i) 500,000 shares of the Company&rsquo;s Common Stock to each
of Mr. Schreiber and Mr. Galluppi (1 million shares in the aggregate) on the business day following a consecutive ninety (90)
day period, during which the Company&rsquo;s Common Stock shall have traded at an average price per share equal to or higher than
$2.50 (the &ldquo;First Milestone&rdquo;), and (ii) an additional 500,000 shares of the Company&rsquo;s Common Stock to each of
Mr. Schreiber and Mr. Galluppi (1 million shares in the aggregate) following a consecutive ninety (90) day period during which
the Common Stock shall have traded at an average price per share equal to or higher than $3.75 (the &ldquo;Second Milestone&rdquo;
and, together with the First Milestones, the &ldquo;Milestones&rdquo;). Having achieved the Milestones, the Company, on December
9, 2020, issued an aggregate of 1,000,000 shares of the Company&rsquo;s Common Stock to each of Mr. Schreiber and Mr. Galluppi
(the &ldquo;Milestone Shares&rdquo;) (2 million shares in the aggregate). The Milestone Shares are subject to the previously disclosed
180 day Lock-Up Agreement each of Mr. Schreiber and Mr. Galluppi signed on November 3, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recorded an aggregate expense of $18,060,000 reflected in general and administrative expenses during the year ended December
31, 2020 for the issuance of these 2,000,000 shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Common
Stock</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Common
Stock Transactions During the Year Ended December 31, 2020:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
the year ended December 31, 2020, the Company issued an aggregate of 2,900,000 shares of common stock related to stock issued
for services totaling $18,305,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2020, the company received aggregate proceeds of $25,000 for the sale of warrants from the Warrant Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 80; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2020, the Company issued a total of 379,957 shares of common stock from the exercise of warrants and
cash proceeds of $622,763.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
the year ended December 31, 2020, the Company issued an aggregate of 535,600 shares of common stock related to the exercise of
options for total proceeds of $302,400.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2020, the Company issued a total of 1,472,556 shares of common stock for the cashless exercise of
2,902,631 warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
the year ended December 31, 2020, the Company issued an aggregate of 534,774 shares of common stock related to cashless exercise
of options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2020, the Company issued 294,120 shares of common stock to an investor for $250,000 in cash consideration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2020, the Company issued 2,722,187 shares of common stock for share liability of $2,181,453.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 24, 2020, the Company issued an aggregate of 447,763 shares of common stock related to the Note Conversions at $2.50
per share, totaling $1,119,408.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 7, 2020, the Company issued a noteholder, who is also a director, 96,923 common shares in connection with an Exchange
Agreement dated September 22, 2020 (See Note 8). &nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
October 14, 2020, the Company issued an aggregate of approximately 632 shares for rounding in connection with the 1 for 5 reverse
stock split.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Common
Stock Transactions During the Year Ended December 31, 2019</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2019, the Company issued 304,269 shares of common stock to various third-party investors for cash
proceeds of $350,001. In conjunction with one of the stock purchases, the Company issued warrants valued at $20,825 which based
on the terms of the warrants, the Company has bifurcated and treated as equity. In addition to the above stock issued, the Company
has issued 20,000 shares of common stock to a consultant for services rendered, which were valued at $16,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Noncontrolling
Interest</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2020 and 2019, the net loss attributed to the non-controlling interest amounted to $1,877,408 and
$391,055, respectively. During the year ended December 31, 2020 and 2019, the Company paid distributions to non-controlling shareholders
of $157,223 and $89,083, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 25, 2019, the Company entered into an LLC Membership Unit purchase agreement with entities owned by the Company&rsquo;s
Chief Executive Officer and Chief Technology Officer, and Conversion Labs PR, and simultaneously purchased the remaining 21.8%
interest of Conversion Labs PR from the Company&rsquo;s Chief Executive officer and Chief Technology Officer. Subsequent to the
agreement&rsquo;s closing, the Company now wholly-owns 100% of Conversion Labs PR. In order to consummate this transaction, the
Company agreed to issue 1,000,000 shares of common stock based on the issuance price of $0.90 per share, equal to $900,000 to
the Company&rsquo;s Chief Executive Officer and Chief Technology Officer. The shares were issued on August 6, 2019. The difference
between the value of the stock issued and net book value of the transfer to accumulated deficit was recognized in non-controlling
interest in 2019 for a charge of $417,044.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 81; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Stock
Options</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2020
Equity Incentive Plan (the &ldquo;2020 Plan&rdquo;)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 8, 2021, the Company approved the Company&rsquo;s 2020 Equity Incentive Plan (the &ldquo;2020 Plan&rdquo;). Approval of
the 2020 Plan was included as Proposal 1 in the Company&rsquo;s definitive proxy statement for its Special Meeting of Shareholders
filed with the Securities and Exchange Commission on December 7, 2020. The 2020 Plan provides for the issuance of up to 1,500,000
shares of the Company&rsquo;s common stock to the Company&rsquo;s employees, non-employee directors, consultants and advisors.
Awards under the 2020 Plan can be granted in the form of stock options, non-qualified and incentive options, stock appreciation
rights, restricted stock, and restricted stock units. The 2020 Plan will be administered by the Compensation Committee of the
Company&rsquo;s Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
forms of award agreements to be used in connection with awards made under the 2020 Plan to the Company&rsquo;s executive officers
and non-employee directors are:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Non-Qualified Option Agreement (Non-Employee Director Awards)</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Non-Qualified Option Agreement (Employee Awards); and</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Restricted Stock Award Agreement.</FONT></TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously,
the Company had granted service-based stock options and performance-based stock options separate from this plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 20, 2020, the Company approved the transition of its Chief Acquisition Officer, to the role of President of LegalSimpli
(&ldquo;President&rdquo;). In connection with this change in role , the Company amended that certain services agreement entered
into on July 23, 2018, by and between the Company and its President, to (i) decrease the number of options to purchase the Company&rsquo;s
common stock previously granted from 1,000,000 options to 500,000 options , 130,000 of which are fully vested as of the effective
date and (ii) amend the vesting schedule for the remaining 370,000 performance options to include four performance metrics that,
if met, each trigger the vesting of 92,500 options. As a result of amendment, the Company cancelled 500,000 service based options
with an exercise price of $1.50.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2020, the Company issued an aggregate of 1,539,000 stock options to employees and advisory
board members. These stock options have a contractual term of 10 years and vest in increments
which fully vest the options over a two to three year period, dependent on the specific agreements&rsquo; terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Director
Appointments</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
October 21, 2020, the Board of Directors (the &ldquo;Board&rdquo;) of the Company, appointed a new director to the Board.</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the appointment to the Board, the
director shall receive a one-time grant of 20,000 shares of the Company&rsquo;s common stock. In addition, the new director will
be eligible to participate in any duly authorized stock option plan adopted by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
November 6, 2020, the Board of the Company, appointed a new director to the Board. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the appointment to the Board, the director shall receive a one-time grant of 20,000 of the Company&rsquo;s common
stock. In addition, the new director will be eligible to participate in any duly authorized stock option plan adopted by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Appointment
of Chief Compliance Officer</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
November 20, 2020, the board of directors of the Company appointed a new Chief Compliance Officer and General Counsel (our &ldquo;CCO&rdquo;).
In connection with the CCO appointment, our CCO entered into an employment agreement with the Company, which includes a stock
options to purchase up to 200,000 shares of the Company&rsquo;s common stock with an aggregate value of $1,765,837. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 82; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Appointment
of Chief Operating Officer</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
November 27, 2020, we appointed a new Chief Operating Officer (&ldquo;COO&rdquo;). </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the appointment, our COO entered into an Employment Agreement (the &ldquo;Employment Agreement&rdquo;) with the
Company. In connection with his appointment, our COO was granted was granted: (i) Stock Options (the &ldquo;Stock Options&rdquo;)
to purchase up to 200,000 shares of the Company&rsquo;s common stock, with 35,000 of the Stock Options scheduled to vest upon
the Company&rsquo;s shareholders approving a bona fide employee stock option plan (the &ldquo;Plan&rdquo;), and the remaining
165,000 Stock Options to vest in equal monthly tranches, based on the passage of time, over the 30 months following the approval
of the Plan; and (ii) upon the approval of the Plan, a grant of 10,000 restricted stock units of the Company&rsquo;s common stock
(the &ldquo;RSUs&rdquo;), which shall vest upon the one-year anniversary of the Amended and Restated Employment Agreement. The
aggregate value of the Stock Options was $1,384,883.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Appointment
of Chief Acquisition Officer</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 8, 2020, the Company entered into an Amended and Restated Employment Agreement (the &ldquo;Amended CAO Employment Agreement&rdquo;)
with the Company&rsquo;s current Chief Acquisition Officer, (our &ldquo;CAO&rdquo;), amending and restating in its entirety the
Employment Agreement between the Company and our CAO, dated July 26, 2018. Pursuant to the Amended CAO Employment Agreement, our
CAO&rsquo;s has been granted options to purchase up to 200,000 shares of Common Stock of the Company (the &ldquo;CAO Options&rdquo;),
which shall vest at a rate of 5,555 options each month for thirty-five (35) consecutive months beginning on the Effective Date,
with the final 5,575 shares vesting on December 8, 2023. The aggregate value of these options was $1,497,885.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
under the Amended CAO Employment Agreement, our CAO is eligible to receive up to three hundred thousand (300,000) restricted stock
units of the Company&rsquo;s common stock, par value $0.01 (the &ldquo;RSU&rsquo;s&rdquo;), subject to the Company&rsquo;s Telemedicine
Brands (as defined in the Amended CAO Employment Agreement) achieving certain revenue milestones. The RSU&rsquo;s, if, and to
the extent issued, will vest upon the earlier of a Change of Control (as defined in the Amended CAO Employment Agreement) or December
8, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of outstanding options activity for our new 2020 Plan for the year ended December 31, 2020:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options
    Outstanding Number of Shares</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise
    Price per Share</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Average Remaining Contractual Life</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Average Exercise Price per Share</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance, December 31, 2019</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 26%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">839,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.80
                                         &ndash; 9.24</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.00</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.54</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercised</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cancelled/Forfeited/Expired</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 11pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 11pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance at December 31, 2020</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">839,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.80
                                         &ndash; 9.24</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9.75</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">7.<FONT STYLE="font-family: Times New Roman, Times, Serif">54</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 11pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercisable December 31, 2019</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercisable at December 31, 2020</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">76,222</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.80
                                         &ndash; 9.24</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">9.77</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.74</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
compensation expense under the above service-based option plan was approximately $341,729 and $0 for the years ended December
31, 2020 and 2019, respectively, with unamortized expense remaining of approximately $5,942,861 as of December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 83; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of outstanding service-based options activity (prior to the establishment of our 2020 Plan above)
for the year ended December 31, 2020:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options
    Outstanding Number of Shares</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise
    Price per Share</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Average Remaining Contractual Life</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Average Exercise Price per Share</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 26%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance,
    December 31, 2019</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,009,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00 -
    2.00</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.22
                                         years</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.50</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">700,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15 - 7.50</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.76
                                         </FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">years</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.85</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,175,600</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.80</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">
    - 2.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.97
                                         </FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">years</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.11</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancelled/Forfeited/Expired</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(305,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00 - 2.00</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.52
                                         years</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.54</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    at December 31, 2020</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,228,400</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.80
    </FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">- 7.50</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15
                                         </FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">years</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.11</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable December
    31, 2019</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,361,083</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00 - 2.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.76
                                         years</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.25</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable at December
    31, 2020</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">1,570,428</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00 &ndash; 7.50</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.57
                                         </FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">years</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right">1.67</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Total compensation
expense under the above service-based option plan was approximately $559,512 and $76,000 for the year ended December 31, 2020
and 2019, respectively, with unamortized expense remaining of approximately $1,548,089 as of December 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of outstanding performance-based options activity for the year ended December 31, 2020:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options
    Outstanding Number of Shares</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise
    Price per Share</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Average Remaining Contractual Life</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Average Exercise Price per Share</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 26%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    at December 31, 2019</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,365,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.25 &ndash;
    2.00</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.34
                                         years</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.70</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancelled/Expired</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(200,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.50</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.06
                                         years</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.50</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    at December 31, 2020</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,165,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.25
    &ndash; 2.00</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.97
                                         years</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.80</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable December
    31, 2019</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">635,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.25 &ndash; 2.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.63
                                         years</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable at December
    31, 2020</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">635<FONT STYLE="font-family: Times New Roman, Times, Serif">,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.25 &ndash; 2.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.38
                                         years</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">No compensation expense
was recognized on the performance-based options above for the years ended December 31, 2020 and 2019, as the performance terms
have not been met or are not probable.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Warrants</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of outstanding and exercisable warrants activity during the year ended December 31, 2020:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrants
    Outstanding Number of Shares</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise
    Price per Share</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Average Remaining Contractual Life</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Average Exercise Price per Share</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    at December 31, 2019</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,265,324</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00 &ndash;
    2.50</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.77
                                         years</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.25</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,209,596</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.65 &ndash; 5.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.56
                                         years</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.87</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised/Expired</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,924,449</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.65 &ndash; 0.70</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.82
                                         years</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.96</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    at December 31, 2020</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,550,471</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: right">1.40 &ndash; 5.75</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.59
                                         years</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.56</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable December
    31, 2019</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,066,049</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00 &ndash; 2.50</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.24
                                         years</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.55</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable December
    31, 2020</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,144,700</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.40</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">
    &ndash; 5.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.67
                                         </FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">years</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.29</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
</TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 84; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>August
2020 Warrant Inducement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
August 2020, the Company offered an inducement to all 26 warrant holders of our $2.00 strike price warrants, which total 526,846
common stock warrants outstanding, by offering a reduced exercise price of $1.75 (a $0.25 discount) for these warrants if they
are immediately exercised. <FONT STYLE="background-color: white">For the year ended December 31, 2020, there were 379,957 of these
warrants exercised, and none forfeited or adjusted. The Company accounted for the warrant inducement as a deemed dividend based
on the difference in the Black-Scholes value of the warrants immediately before and immediately after the inducement. The significant
assumptions used in the Company included common stock volatility of 148.49%, risk free rate of 0.14%, a weighted average term
of 1.6 years and the current stock price of the Company as of the date of inducement. Based on the Black-Scholes valuation method
the Company recorded a deemed dividend to additional paid in capital and retained earnings on the inducement of approximately
$73,636 and received proceeds from the warrants exercised of approximately $623,000 during the year ended December 31, 2020.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Alpha
Capital Anstalt (&ldquo;Alpha&rdquo;) Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 25, 2020, the Company and Alpha entered into a Note Repayment and Warrant Amendment Agreement (the &ldquo;2018 Alpha
Amendment&rdquo;) whereby the Company agreed to (i) repay the outstanding balance of the convertible promissory note issued in
favor of Alpha, effective on May 29, 2018, in the amount of $224,145, including principal and interest (the &ldquo;2018 Alpha
Note&rdquo;) and (ii) amend the exercise price of the warrant (the &ldquo;2018 Alpha Warrant&rdquo;) issued to Alpha in connection
with the 2018 Alpha Note on May 29, 2018. The 2018 Alpha Warrant originally provided for the purchase of up to 391,304 shares
of the Company&rsquo;s common stock at an exercise price of $1.40 per share, none of which have been exercised as of the date
of the 2018 Alpha Amendment. Pursuant to the terms of the 2018 Alpha Warrant and in connection with the 2018 Alpha Amendment,
the Company revised the exercise price of the Alpha 2018 Warrant from $1.40 per share to $0.68 per share and increased the number
of shares issuable under the Alpha 2018 Warrant from 391,304 to 811,594 shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 25, 2020, the Company and Alpha entered into a Note Repayment and Warrant Amendment Agreement (the &ldquo;2019 Alpha
Amendment&rdquo;) whereby the Company agreed to (i) repay the outstanding balance of the convertible promissory note issued in
favor of Alpha on August 15, 2019 in the amount of $520,000, including principal and interest (the &ldquo;August 2019 Alpha Note&rdquo;)
and (ii) amend the exercise price of the August 2019 Warrant issued to Alpha in connection with the 2019 Alpha Note on August
15, 2019. The August 2019 Warrant issued to Alpha originally provided for the purchase of up to 365,217 shares of the Company&rsquo;s
common stock at an exercise price of $1.40 per share, none of which have been exercised as of the date of the 2019 Alpha Amendment.
Pursuant to the 2019 Alpha Amendment, Alpha has agreed to the reduction of the exercise price from $1.40 to $1.15, subject to
further adjustment. As a result of the above described reduction of the exercise price and the application of certain provisions
of the 2019 Alpha Warrant, the amount of shares that may be purchased upon exercise of the 2019 Alpha Warrant after giving effect
to the foregoing is increased to 757,488 shares of the Company&rsquo;s common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 7, 2020, the Company agreed to further amend August 2019 Warrant issued to Alpha on August 15, 2019, as amended on February
25, 2020 (the &ldquo;Second Alpha Warrant Amendment&rdquo;). Specifically, pursuant to anti-dilution provisions contained therein,
the Company agreed to amend the August 2019 Warrant issued to Alpha in order to increase the amount of shares able to be purchased
thereunder by an additional 331,401 shares of the Company&rsquo;s common stock or an aggregate of up to 1,088,889 shares (the
&ldquo;Alpha Warrant Shares&rdquo;). On the same day, Alpha exercised, on a cashless basis, all of the August 2019 Warrants issued
to Alpha, as amended, resulting in the issuance of 391,466 shares of the Company&rsquo;s common stock to Alpha, with no effect
on the Company&rsquo;s statement of operations. Upon Alpha&rsquo;s cashless exercise, the August 2019 Warrants issued to Alpha
are no longer in force or effect and no additional issuances will be due or owing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the above transactions, the Company has recorded a deemed dividend to Alpha for the price adjustments of the August
2019 Warrant issued to Alpha of $915,479 which is recorded in the statement of changes in stockholder&rsquo;s equity as an increase
in additional paid in capital and a reduction of accumulated deficit. During the month of March 2020, Alpha exercised a portion
of their warrants in a cashless exercise, whereby Alpha exercised 267,223 common stock warrants to obtain 90,231 shares of common
stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 85; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Brio
Master Fund (&ldquo;Brio&rdquo;) Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 25, 2020, the Company, and Brio entered into a Warrant Amendment Agreement to amend the exercise price of the warrant
issued to Brio on May 29, 2018. The Brio 2018 Warrant originally provided for the purchase of up to 86,957 shares of the Company&rsquo;s
common stock at an exercise price of $1.40 per share, none of which have been issued as of the date of the 2018 Brio Warrant Amendment.
Pursuant to the 2018 Brio Warrant Amendment, the Company agreed to revise the exercise price of the 2018 Brio Warrant from $1.40
per share to $0.68 per share and increased the number of shares issuable under the 2018 Brio Warrant from 86,957 to 93,398 shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 25, 2020, the Company, and Brio entered into a Note Repayment and Warrant Amendment Agreement whereby the Company agreed
to (i) repay the outstanding balance of the Convertible Promissory Note issued in favor of Brio on August 15, 2019 in the amount
of $162,500, including principal and interest and (ii) amend the exercise price of the warrant issued to Brio in connection with
the 2019 Brio Note on August 15, 2019. The Brio 2019 Warrant originally provide for the purchase of up to 114,130 shares of the
Company&rsquo;s common stock at an exercise price of $1.40 per share, none of which have been exercised as of the date of the
2019 Brio Amendment. Pursuant to the 2019 Brio Amendment, Brio has agreed to the reduction of the exercise price of $1.40 to $1.15,
subject to further adjustment. As a result of the above described reduction of the exercise price and the application of certain
provisions of the 2019 Brio Warrant, the amount of shares that may be purchased upon exercise of the 2019 Brio Warrant after giving
effect to the foregoing is increased to 236,715 shares of the Company&rsquo;s common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 7, 2020, the Company agreed to further amend those certain warrants issued to Brio on August 15, 2019, as amended on February
25, 2020. Specifically, pursuant to anti-dilution provisions therein, the Company agreed to amend the 2019 Brio Warrant in order
to increase the amount of shares able to be purchased thereunder by an additional 103,562 shares of the Company&rsquo;s common
stock or an aggregate of up to 340,278. On the same day, Brio exercised on a cashless basis the Brio Warrants in full resulting
in the issuance of 103,562 shares of the Company&rsquo;s common stock to Brio with no effect on the Company&rsquo;s statement
of operations. Upon Brio&rsquo;s cashless exercise, the 2019 Brio Warrants are no longer in force or effect and no additional
issuances will be due or owing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the above transactions, the Company has recorded a deemed dividend to Brio for the price adjustments of the Brio warrants
of $226,906 which is recorded in the statement of changes in stockholder&rsquo;s equity as an increase in additional paid in capital
and a reduction of accumulated deficit. During the month of March 2020, Brio exercised a portion of their warrants in a cashless
exercise, whereby Alpha exercised 100,000 common stock warrants to obtain 57,547 shares of common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Amended
Consulting Agreement</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 29, 2020 (the &ldquo;Effective Date&rdquo;), the parties entered into an amendment to the Consulting Agreement (the
&ldquo;Amended Consulting Agreement&rdquo;) with Blue Horizon Consulting, LLC (&ldquo;Blue Horizon&rdquo;) primarily to change
the compensation for services provided by the Consultant. Under the Amended Consulting Agreement, Blue Horizon may receive an
aggregate of up to 2,000,000 shares of the Company&rsquo;s common stock, subject to adjustment, upon the Company reaching certain
revenue milestones. Happy Walters, a member of the Company&rsquo;s Board, is the sole owner of Blue Horizon. The Amended Consulting
Agreement was approved by the Company&rsquo;s disinterested directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the Amended Consulting Agreement, the Company recorded stock compensation expense of $15,900,000 during the year ended
December 31, 2020, representing the fair value of the 2,000,000 shares of common stock earned under the Amended Consulting Agreement
during the year. No shares remain unearned under the Amended Consulting Agreement as of December 31, 2020. A total of 800,000
common shares of the total 2,000,000 shares earned were issued under the Amended Consulting Agreement on October 16, 2020, with
the remaining 1,200,000 shares issued on February 24, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Stock-based
Compensation</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total stock-based compensation expense related to common stock issued for services, Service-Based Stock Options, Performance-Based
Stock Options and Warrants issued for service amounted to approximately $36,961,141 and $733,215 for the year ended December 31,
2020 and 2019, respectively. Such amounts are included in general and administrative expenses in the consolidated statement of
operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 86; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
6&ndash; LEASES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company primarily leases office space and other equipment using month to month terms. Conversion Labs PR utilizes office space
in Puerto Rico, which is subleased from the Company&rsquo;s President and CEO, on a month to month basis, incurring rental expense
of approximately $4,000 to $5,000 a month for this office space.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which supersedes all existing guidance on accounting for leases
in ASC Topic 840. ASU 2016-02 is intended to provide enhanced transparency and comparability by requiring lessees to record right-of-use
assets and corresponding lease liabilities on the balance sheet. ASU 2016-02 will continue to classify leases as either finance
or operating, with classification affecting the pattern of expense recognition in the statement of income. ASU 2016-02 is effective
for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. We have reviewed ASC
842 and have determined the following impact on our financial statements:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 72%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Right of Use Asset</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 24%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">274,437</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Lease liability</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">285,323</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2018, the Company entered into a 3-year agreement to lease office space in Huntington Beach, California beginning on
March 2, 2018. The rent is payable on a monthly basis in the amount of $2,106 for the first twelve months, $2,149 for the second
twelve months and $2,235 for the third twelve months; the lease expired on February 28, 2021, and was extended through February
28, 2023. A security deposit of $2,235 was paid for this lease. The Company has classified this as an operating lease and have
recorded the straight-line lease expense in the accompanying statement of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2021, the Company entered into a 3-year agreement to lease office space in Greenville, South Carolina beginning on October
1, 2020. The rent is payable on a monthly basis in the amount of $8,473 for the first twelve months, $8,685 for the second twelve
months and $8,902 for the third twelve months; the lease expires on September 30, 2023. No security deposit was paid for the lease.
The Company has classified this as an operating lease and have recorded the straight-line lease expense in the accompanying statement
of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
7 - COMMITMENTS AND CONTINGENCIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Royalty
Agreements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2016, Conversion Labs PR entered into a sole and exclusive license, royalty and advisory agreement with Pilaris Laboratories,
LLC (&ldquo;Pilaris&rdquo;) relating to Pilaris&rsquo; PilarisMax shampoo formulation and conditioner. The term of the agreement
will be the life of the US Patent held by Pilaris, ten years. As consideration for granting Conversion Labs PR this license,
Pilaris will receive on quarterly basis, 10% of the net income collected by the licensed products based on the following formula:
Net Income = total income &ndash; cost of goods sold &ndash; advertising and operating expenses directly related to the marketing
of the licensed products. In addition, Conversion Labs PR shall pay Pilaris a performance fee of $50,000 on the 180-day anniversary
of the agreement and an additional $50,000 performance fee on the 365-day anniversary of the agreement. For the year ended December
31, 2018, the Company capitalized the license fee in the amount of $100,000, as the purchase of the fee is deemed an asset purchase
under ASC 805. In April 2017, the Company issued 43,478 shares of common stock and warrants to purchase 21,739 shares of common
stock, pursuant to a subscription agreement, for the stated consideration and satisfaction of obligation to pay $50,000 on the
180-day anniversary of the execution of this agreement. As of December 31, 2020 and 2019, $0 and $0, respectively was included
in accounts payable and accrued expenses in regard to this agreement, as no sales occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2018, the Company entered into a license agreement (the &ldquo;Alphabet Agreement&rdquo;) with M.ALPHABET, LLC (&ldquo;Alphabet&rdquo;),
pursuant to which Alphabet agreed to license its PURPUREX business which consists of methods and compositions developed by Alphabet
for the treatment of purpura, bruising, post-procedural bruising and traumatic bruising (the &ldquo;Product Line&rdquo;). Pursuant
to the license granted under the Alphabet Agreement, Conversion Labs PR obtains an exclusive license to incorporate (i) any intellectual
property rights related to the Product Line and (ii) all designs, drawings, formulas, chemical compositions and specifications
used or useable in the Product Line into one or more products manufactured, sold, and/or distributed by Alphabet for the treatment
of purpura, bruising, post-procedural bruising and traumatic bruising and for all other fields of use or purposes (the &ldquo;Licensed
Product(s)&rdquo;), and to make, have made, advertise, promote, market, sell, import, export, use, offer to sell and distribute
the Licensed Product(s) throughout the world with the exception of China, Hong Kong, Japan, and Australia (the &ldquo;License&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 87; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall pay Alphabet a royalty equal to 13% of Gross Receipts (as defined in the Agreement) realized from the sales of Licensed
Products. Further, so long as the Agreement is not previously terminated, the Company, also agreed to pay Alphabet $50,000 on
the 120-day anniversary of the Agreement and an additional $50,000 on the 360-day anniversary of the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
execution of the Alphabet Agreement, Alphabet was granted a 10-year stock option to purchase 20,000 shares of the Company&rsquo;s
common stock at an exercise price of $2.50. Further, if Licensed Products have gross receipts of $7,500,000 in any calendar year,
the Company will grant Alphabet an option to purchase 20,000 shares of the Company&rsquo;s common stock at an exercise price of
$2.50; (ii) if Licensed Products have gross receipts of $10,000,000 in any calendar year, the Company will grant Alphabet an additional
option to purchase 20,000 shares of the Company&rsquo;s common stock at an exercise price of $2.50 and (iii) If Licensed Products
have gross receipts of $20,000,000 in any calendar year, the Company will grant Alphabet an option to purchase 40,000 shares of
the Company&rsquo;s common stock at an exercise price of $3.75. The likelihood of meeting these performance goals for the licensed
products are remote and, therefore, the Company has not recognized any compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Purchase
Commitments</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of the Company&rsquo;s vendors require product deposits when a purchase order is placed for goods or fulfillment services related
to inventory requirements. The Company&rsquo;s history of product deposits with its inventory vendors, creates an implicit purchase
commitment equaling the total expected product acceptance cost in excess of the product deposit. As of December 31, 2020 and December
31, 2019, the Company approximates its implicit purchase commitments to be $1.6&nbsp; million and $300,000, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Employment
and Consulting Agreements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has entered into various agreements with officers, directors, employees and consultants that expire in terms of one to
five years. See Note 8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Legal
Matters</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the normal course of business operations, the Company may become involved in various legal matters. As of December 31, 2020, the
Company&rsquo;s management does not believe that there are any potential legal matters that could have an adverse effect on the
Company&rsquo;s consolidated financial position.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
8 &ndash; RELATED PARTY TRANSACTONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Chief
Executive Officer</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
Labs PR utilizes office space in Puerto Rico, which is subleased from the President and CEO, and incurs expense of approximately
$4,000 to $5,000 a month for this office space for which the Company and the CEO do not have a written lease agreement. Payments
to JLS Ventures, an entity wholly owned by our CEO, for rent on Conversion Labs PR&rsquo;s Puerto Rico office space amounted to
$45,000 and $52,000 for the year ended December 31, 2020 and 2019, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
Labs PR utilizes BV Global Fulfillment, owned by a related person of the Company&rsquo;s CEO to warehouse a portion of the Company&rsquo;s
finished goods  inventory and for fulfillment services. The Company pays a monthly fee of $13,000 to $16,000 for fulfillment
services and reimburses BV Global Fulfillment for their direct costs associated with shipping the Company&rsquo;s products. As
of December 31, 2020 and 2019, the Company owed BV Global Fulfillment $58,943  and $53,026, respectively, which are
included in accounts payable and accrued liabilities on the accompanying consolidated balance sheets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 88; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Promissory
Note with Director</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 23, 2020, the Company received proceeds of $250,000 for a promissory note to a director. The promissory note is non-interest
bearing and matures in July 2021. This promissory note was cancelled in exchange for 96,923 restricted shares of the Company&rsquo;s
common stock and a common stock purchase warrant to purchase 500,000 shares of the Company&rsquo;s common stock at $4.65 per share
as part of an Exchange Agreement dated September 22, 2020. The Company issued the shares of common stock and the purchase warrant
on October 7, 2020 and cancelled the note, resulting in the reduction of notes payable of $250,000 with a loss on debt settlement
of $914,862 for the year ended December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>Consulting</I></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
<FONT STYLE="background-color: white"><I>Agreement with Chief Operating Officer</I></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
November 27, 2020</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, the Company entered into a
consulting agreement (the &ldquo;Consulting Agreement&rdquo;) with JDM Investments, LLC (&ldquo;JDM&rdquo;), an entity solely
owned by our COO, whereby JDM will provide consulting services in support of the Company&rsquo;s day-to-day call center operations.
The Consulting Agreement is for a term of thirty-six months and is renewable for additional twelve month periods upon the mutual
agreement of the Company and JDM. As compensation for the services, JDM will receive a monthly fee of $17,000 and shall be eligible
to receive a metric based performance bonus for each calendar quarter during the term of the Consulting Agreement in accordance
with metrics to be mutually agreed upon by the Company and JDM.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
9 &ndash; INCOME TAXES</B> </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the Company has approximately $10.7 million of operating loss carryforwards for federal income tax
reporting purposes that may be applied against future taxable income. Portions of the net operating loss carryforwards will begin
to expire in the year 2021 if not utilized prior to that date, expiring during various year through 2038. There is no provision
for income taxes because the Company has historically incurred operating losses and maintains a full valuation allowance against
its net deferred tax assets. The net operating loss carryforwards could be subject to limitation in any given year in the event
of a change in ownership as defined by IRC Section 382.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
valuation allowance overall increased by approximately $1,269,000 and $148,000 during the year ended 2020 and 2019, respectively.
The Company has fully reserved the deferred tax asset resulting from available net operating loss carryforwards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
income tax provision charged to continuing operations for the years ended December 31, 2020 and 2019 was as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Current:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 52%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">U.S.
    federal</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">152,100</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(152,100</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">State
    and local</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">40,400</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(40,400</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">192,500</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(192,500</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Deferred:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">U.S. federal</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(70,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">70,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">State
    and local</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(70,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">70,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; padding-bottom: 2.5pt">Provision for income taxes</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">122,500</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(122,500</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provision for income taxes differs from the expected amount of income tax expense (benefit) determined by applying
a combined U.S. federal and state (Puerto Rico) income tax rate of 25% to pretax income (loss) for the years ended December 31,
2020 and 2019 as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Computed &ldquo;expected&rdquo;
    tax expense (benefit)</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(12,684,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(783,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Increase (decrease) in income taxes
    resulting from:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Permanent differences</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">7,765,000</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Apportionment of
    Puerto Rico income</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">3,607,000</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">380,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nondeductible expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">140,000</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">173,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Change in valuation
    allowance</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right">1,269,000</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">148,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">25,500</P></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(<FONT STYLE="font-family: Times New Roman, Times, Serif">47,500</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">122,500</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(122,500</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 89; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
deferred tax liabilities consist of the following components as of December 31, 2020 and 2019:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Deferred tax Liability:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 60%; padding-bottom: 1.5pt; padding-left: 5.4pt">Other</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 16%; border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 16%; border-bottom: Black 1.5pt solid; text-align: right">70,000</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">70,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5.4pt">Deferred tax assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: 10pt; padding-left: 5.4pt">Stock-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">716,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">716,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: 10pt; padding-left: 5.4pt">Temporary differences</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">113,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: 10pt; padding-left: 5.4pt">Net operating loss carryforwards</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,151,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">951,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,980,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,711,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 5.4pt">Less valuation allowance</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,980,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,711,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">70,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
10 &ndash; SUBSEQUENT EVENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has evaluated subsequent events through the date these consolidated financial statements were issued and has identified
the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Appointment
of Chief Digital Officer</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 5, 2021, the board of directors of the Company (the &ldquo;Board&rdquo;) appointed Mr. Bryant Hussey as the Company&rsquo;s Chief
Digital Officer. In connection with the appointment, Mr. Hussey entered into an Employment Agreement (the &ldquo;Employment Agreement&rdquo;)
with the Company. Pursuant to the Employment Agreement, Mr. Hussey was granted a Stock Option to purchase up to 200,000 shares of the
Company&rsquo;s common stock, scheduled to vest in equal monthly tranches, based on the passage of time, over the 36 months following
the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Appointment
of Chief Medical Officer</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 11, 2021, the Board appointed Dr. Anthony Puopolo as the Company&rsquo;s Chief Medical Officer. In connection with the
appointment, Mr. Puopolo entered into an Employment Agreement. Pursuant to the Employment Agreement, Mr. Puopolo was granted a
Stock Option to purchase up to 200,000 shares of the Company&rsquo;s common stock (the &ldquo;Stock Options&rdquo;). 5,555 of
the Stock Options shall vest in equal monthly tranches, based on the passage of time, over the 30 months following the approval
of the Effective Date, with the remaining 5,575 Stock Options scheduled to vest on January 11, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>LegalSimpli
Software Restructuring Transaction</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
January 22, 2021, the Company consummated a transaction to restructure the ownership of LegalSimpli Software, LLC, a Puerto Rico
limited liability company (&ldquo;LSS&rdquo;), a majority-owned subsidiary of the Company (the &ldquo;LSS Restructuring&rdquo;).
To affect the LSS Restructuring the Company&rsquo;s wholly-owned subsidiary Conversion Labs PR LLC, a Puerto Rico limited liability
company (&ldquo;CVLB PR&rdquo;) entered into a series of membership interest exchange agreements, pursuant to which, CVLB PR exchanged
that certain a promissory note, dated May 8, 2019 with an outstanding balance of $375,823 (the &ldquo;CVLBPR Note&rdquo;), issued
by LSS in favor of CVLB PR, for 37,531 newly issued membership interests of LSS (the &ldquo;Exchange&rdquo;). Upon consummation
of the Exchange the CVLBPR Note was extinguished.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 90; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
furtherance of the LSS Restructuring, CVLB PR entered into a Membership Interest Purchase Agreement with LSS, (the &ldquo;CVLB
PR MIPA&rdquo;), pursuant to which CVLB PR purchased 12,000 membership interests of LSS for an aggregate purchase price of $300,000.
The CVLB PR MIPA provides that the transaction may be completed in three (3) tranches with a purchase price of $100,000 per tranche
to be made at the sole discretion of CVLB PR. Payment for the first tranche of $100,000 was made upon execution of the CVLB PR
MIPA. Payments for the second and third tranches are due on the 60-day anniversary and the 120-day anniversary of the Effective
Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrently,
in furtherance of the LSS Restructuring, CVLB PR entered into two Membership Interest Purchase Agreements (the &ldquo;Founding
Members MIPAs&rdquo;) with two founding members of LSS (the &ldquo;Founding Members&rdquo;) whereby CVLB PR purchased from the
Founding Members an aggregate of 2,183 membership interests of LSS for an aggregate purchase price of $225,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the consummation of the LSS Restructuring, CVLB PR increased its ownership of LSS from 51% to approximately 85.58% on a
fully diluted basis. LSS entered into an amendment to its operating agreement (the &ldquo;LSS Operating Agreement Amendment&rdquo;)
to reflect the change in ownership.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Appointment
of Chief Business Officer</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 3, 2021, the Board appointed Corey Deutsch (&ldquo;Deutsch&rdquo;), the Company&rsquo;s current Head of Corporate Development,
to serve as the Company&rsquo;s Chief Business Officer. Pursuant to the Employment Agreement, Mr. Deutsch was granted a stock
option to purchase up to 200,000 shares of the Company&rsquo;s common stock (the &ldquo;Employee Stock Options&rdquo;). The Stock
Options were to vest in equal monthly tranches, based on the passage of time, over the 36 months following the Effective Date.
Upon termination of Mr. Deutsch without cause, the Company shall pay or provide to Mr. Deutsch severance pay equal to his then
current monthly base salary for four months from the date of termination, during which time Mr. Deutsch shall continue to receive
all employee benefits and employee benefit plans as described in the Employment Agreement. As a full-time employee of the Company,
Mr. Deutsch will be eligible to participate in all of the Company&rsquo;s benefit programs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Appointment
of Chief Financial Officer</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 4, 2021, the Board appointed Mr. Marc Benathen as the Company&rsquo;s Chief Financial Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Appointment, Mr. Benathen entered into an Employment Agreement with the Company. To induce Mr. Benathen to
enter into the Employment Agreement, Mr. Benathen was granted a signing bonus of 15,000 restricted stock units of the Company&rsquo;s
common stock (the &ldquo;RSUs&rdquo;). The RSU&rsquo;s vest in accordance with the following: (i)3,750 of the RSUs vesting on
the Effective Date (ii) 3,750 RSUs on February 4, 2022 (iii) 3,750 RSU&rsquo;s on February 4, 2023 and (iv) 3,750 RSU&rsquo;s
on February 4, 2024. In addition to the RSU&rsquo;s, Mr. Benathen received stock options to purchase up to 200,000 shares of the
Company&rsquo;s common stock. The Stock Options shall vest in equal monthly tranches, based on the passage of time, over the 36
months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 18, 2021, we issued 3,750 common shares under this Employment Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 91; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Securities
Purchase Agreement</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
February 11, 2021, the Company consummated the closing of a private placement offering (the &ldquo;February 2021 Offering&rdquo;),
whereby pursuant to the securities purchase agreement (the &ldquo;February 2021 Purchase Agreement&rdquo;) entered into by the
Company and certain accredited investors on February 11, 2021 the Investors purchased 608,696 shares of the Company&rsquo;s common
stock par value $0.01 per share at a purchase price of $23.00 per share for aggregate gross proceeds of $14,000,008 (the &ldquo;Purchase
Price&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Purchase Price was funded on the closing date and resulted in net proceeds to the Company of approximately $13.4 million after
deducting fees payable to the placement agent and other estimated offering expenses payable by the Company.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BTIG,
LLC, the Placement Agent, acted as exclusive placement agent for the February 2021 Offering and received cash compensation equal
to 3% of the Purchase Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Registration
Rights Agreement</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 11, 2021, in connection with the Purchase Agreement, the Company entered into a registration rights agreement with the
Investors (the &ldquo;Registration Rights Agreement&rdquo;). The Registration Rights Agreement requires the Company to use its
reasonable best efforts to register the resale of the Shares by the Investors on Form S-1 to be filed with the Securities and
Exchange Commission (&lsquo;SEC&rdquo;), under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), within
60 business days from the Closing Date, and to use its reasonable best efforts to have such registration statement declared effective
by the SEC as soon as practicable, but not later than 120 days from the Closing Date (or 150 days from the Closing Date in the
event that such registration statement is subject to a full review by the SEC).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Stock
Option Exercise</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">During
February and March 2021, the Company issued an aggregate of approximately 660,645 shares of common stock
pursuant to the cashless exercise of an outstanding stock options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>PPP
Loan Forgiveness</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the January, February and March 2021, the Company had a total of $125,643 of its PPP loans forgiven by the SBA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 92; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.9
<SEQUENCE>2
<FILENAME>ex4-9.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.9</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>DESCRIPTION
OF REGISTRANT&rsquo;S SECURITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>REGISTERED
PURSUANT TO SECTION 12 OF THE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>SECURITIES
EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below is the description of each class of securities of LifeMD, Inc. (the &ldquo;Company&rdquo;) outstanding as of December
31, 2020. The following description summarizes the most important terms of these securities. This summary does not purport to
be complete and is qualified in its entirety by the provisions of our Certificate of Incorporation and our Bylaws, copies of which
have been previously filed with the Securities and Exchange Commission and are incorporated by reference into the Annual Report
on Form 10-K for the year ended December 31, 2020. You should refer to our Certificate of Incorporation, Bylaws and the applicable
provisions of the Delaware General Corporation Law for a complete description.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
stock, par value $0. 01 per share (the &ldquo;Common Stock&rdquo;) is the only class of our securities currently registered under
Section 12 of the Securities Exchange Act of 1934 (the &ldquo;Exchange Act&rdquo;). Our Common Stock is quoted on the The Nasdaq
Stock Market under the symbol &ldquo;LFMD.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Authorized
Common Stock</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
authorized Common Stock consists of 100,000,000 shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Dividend
Rights</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Common Stock shall be entitled to receive, when and as declared by the Board of Directors, out of funds legally
available therefor, dividends payable in cash, stock or otherwise. We have not paid and do not expect to declare or pay any cash
dividends on our common stock in the foreseeable future. We currently expect to retain all future earnings for use in the operation
and expansion of our business. The declaration and payment of any cash dividends in the future will be determined by our Board
of Directors, in its discretion, and will depend on a number of factors, including our earnings, capital requirements, overall
financial condition and contractual restrictions, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Voting
Rights</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
stockholder is entitled to one vote for each share of common stock held by such shareholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
Preemptive or Similar Rights</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is not entitled to preemptive rights, and is not subject to conversion, redemption or sinking fund provisions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Right
to Receive Liquidation Distributions</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of the Common Stock shall be entitled to receive, when and as declared by the Board of Directors, out of funds legally
available therefor, dividends payable in cash, stock or otherwise. Upon any liquidation, dissolution or winding up of the Company,
whether voluntary or involuntary, the net assets of the Company shall be distributed pro rata to the holders of the Common Stock
in accordance with their respective rights and interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Transfer
Agent and Registrar</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent and registrar for our Common Stock is Worldwide Stock Transfer, LLC, One University Plaza, Suite 505, Hackensack,
NJ 07601.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.56
<SEQUENCE>3
<FILENAME>ex10-56.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 10.56</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-56_01.jpg" ALT="" STYLE="height: 867px; width: 670px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="text-align: center; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-56_02.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="text-align: center; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-56_03.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="text-align: center; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-56_04.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="text-align: center; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-56_05.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="text-align: center; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-56_06.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="text-align: center; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-56_07.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="text-align: center; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-56_08.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="text-align: center; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="text-align: center; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="text-align: center; break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex10-56_09.jpg" ALT="" STYLE="height: 868px; width: 670px">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 9; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="text-align: center; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>4
<FILENAME>ex21-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-right: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
21.1</B></FONT></P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subsidiaries
    of LifeMD, Inc.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subsidiary
    Name</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jurisdiction
    of Incorporation</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LegalSimpli
    Software, LLC</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Puerto
    Rico</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
    Labs PR LLC</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Puerto
    Rico</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: red"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>ex31-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exhibit
31.1 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>LIFEMD,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CEO
CERTIFICATE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>PURSUANT
TO SECTION 302</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">I,
Justin Schreiber, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">I
    have reviewed this Annual Report on Form 10-K of LifeMD, Inc. for the year ended December 31, 2020;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
    to the period covered by this report;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Based
    on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
    material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods
    presented in this report;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and
    procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined
    in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to
    us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Designed
    such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
    our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
    statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Evaluated
    the effectiveness of the Registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
    about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based
    on such evaluation; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">d.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Disclosed
    in this report any change in the Registrant&rsquo;s internal control over financial reporting that occurred during the Registrant&rsquo;s
    most recent fiscal quarter (the Registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially
    affected, or is reasonably likely to materially affect, the Registrant&rsquo;s internal control over financial reporting;
    and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control
    over financial reporting, to the Registrant&rsquo;s auditors and the audit committee of the Registrant&rsquo;s board of directors
    (or persons performing the equivalent functions):</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">All
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
    are reasonably likely to adversely affect the Registrant&rsquo;s ability to record, process, summarize and report financial
    information; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Any
    fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant&rsquo;s
    internal control over financial reporting.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">March
    30, 2021</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>/s/
    Justin Schreiber</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Justin
    Schreiber</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Chief
    Executive Officer (Principal Executive Officer)</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>ex31-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exhibit
31.2 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>LIFEMD,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CFO
CERTIFICATE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>PURSUANT
TO SECTION 302</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">I,
Marc Benathen, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">I
    have reviewed this Annual Report on Form 10-K of LifeMD, Inc. for the year ended December 31, 2020;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
    to the period covered by this report;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Based
    on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
    material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods
    presented in this report;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and
    procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined
    in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Designed
    such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to
    us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Designed
    such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
    our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
    statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Evaluated
    the effectiveness of the Registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
    about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based
    on such evaluation; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">d.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Disclosed
    in this report any change in the Registrant&rsquo;s internal control over financial reporting that occurred during the Registrant&rsquo;s
    most recent fiscal quarter (the Registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially
    affected, or is reasonably likely to materially affect, the Registrant&rsquo;s internal control over financial reporting;
    and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control
    over financial reporting, to the Registrant&rsquo;s auditors and the audit committee of the Registrant&rsquo;s board of directors
    (or persons performing the equivalent functions):</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">All
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
    are reasonably likely to adversely affect the Registrant&rsquo;s ability to record, process, summarize and report financial
    information; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Any
    fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant&rsquo;s
    internal control over financial reporting.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">March
    30, 2021</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>/s/
    Marc Benathen</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Marc
    Benathen</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Chief
    Financial Officer (Principal Financial and Accounting Officer)</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>ex32-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exhibit
32.1 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>LIFEMD,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CERTIFICATION
PURSUANT TO</B><BR>
<B>18 U.S.C. SECTION 1350</B><BR>
<B>AS ADOPTED PURSUANT TO</B><BR>
<B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
connection with this Annual Report on Form 10-K of LifeMD, Inc. (the &ldquo;Company&rdquo;) for the year ended December 31, 2020
as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), the undersigned, in the capacity
and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that to her knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    information contained in the Report fairly presents, in all material respects, the financial condition and results of operation
    of the Company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">March
    30, 2021</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>/s/
    Justin Schreiber</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Justin
    Schreiber</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Chief
    Executive Officer (Principal Executive Officer)</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>ex32-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exhibit
32.2 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>LIFEMD,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CERTIFICATION
PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>18
U.S.C. SECTION 1350</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>AS
ADOPTED PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
connection with this Annual Report on Form 10-K of LifeMD, Inc. (the &ldquo;Company&rdquo;) for the year ended December 31, 2020
as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), the undersigned, in the capacity
and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that to his knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    information contained in the Report fairly presents, in all material respects, the financial condition and results of operation
    of the Company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">March
    30, 2021</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>/s/
    Marc Benathen</I></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Marc
    Benathen</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Chief
    Financial Officer (Principal Financial and Accounting Officer)</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="width: 50%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>form10-k_01.jpg
<TEXT>
begin 644 form10-k_01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  T .P# 2(  A$! Q$!_\0
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M_P!O\:S+^RU#P5K%QK&F0-=:5=-NNK5>L9Z[A[=>?P/K6_8>-O#]_ LBZE#
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&BBD4?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ex10-56_01.jpg
<TEXT>
begin 644 ex10-56_01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2X Z8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *XNQ\4ZGXJUG4[3PY]BM[+3)OL\U_>1-,)91]Y$C5TX''S%OP
M[UVE>9>#K&[^'5_KFG:C8WT^FWE\UY9WMG:R7((8<HZ1AF4C Y(P?6A;Z]OQ
M_P"&![:'4:MXGE\,:'JNJZ_;QI;V07RFMF)^T9X& ?NDL<8R<=<UESZ[XOM/
M"S>)IK?2F@2W^U2:6L<BRK'MW$>?O(+ <X\L#M[U9\<Z!<^.O NHZ7!&UK-(
M5>V,_P N]E(89'50<8YY]JS[[6=1OO LNB1Z%J@UZ:Q^RM;M:.(4=DVEO/(\
MHJ,YX8GVS2=[.V^EOZ]1JUU?;K_7H-\0^,]>_P"$8TWQ-X3MK._L;B,32V<\
M+^=L )<JRN!D 8QM/0G)Z5LVGB&Y\16FAZIX>OK$:;?,1,MQ;/)(,*S$ K(H
M4C:5Y!YY[8-#P_81>#-,\->&Y([RXEAC8236]E-)$&;.2752JC<3U(P.3@5%
MI_A"]\-^/5N-);_BG;^22XGM?^?:YV,-R>BMDY]P/:KTYK+:[M_EZ?UU(N^6
M[W_K\?ZZ$]CXPO-;U[5['3+C2XYM,G> Z;=!A/<;0/G#AL(I)X.Q_P ,U3\<
M>+?$?AVX\."Q_LQ4U>YBM)([JUD=H7;JV5E7(&?NX'3K6?XV\-:5XC6>ZNM"
MU6R\21O(MA>Z? Y:0J<1LSIE5!PO^L*D<X('-.\;^'_$%WX:\'7DD,FH7^C7
M=O<Z@D W/)M WE1_$<CH.3FE&WNW[J_Z_P#![%O=V[/^O\NYVUXVNIJ6FQ6]
M[IRP2#%R)+)V9F R2A$H"@^A#8]37->$/%'B/6?''B#1-1ETHVVC.B,]O9R(
M\V\$@@M*P7&/0Y]JZ>TU!-7N8+J"VO([>!79FN;62!MQ&-H1U#'C)SC'3K7G
M7@_4&TOXB^,]4O=)UV*RU&6%K67^QKIO,"@@\",D=>X%$?BU[/\ 2WZB?PZ>
M7_!/2]536I# FD7%C;\L9I;NW:8 8X"JKIR3WSVKAO OBSQAXPM;N\,FB)'9
M:E]DE@6SE#21J5W,KF8A3@G *GI7;66L"YTRZU&2WO8[=';RTDLY5F** ,B(
MKO.3D@;<FN!^"L-WI^GZY:7^FZC933:C+=1BZLI8E:-@H!#,H&>.F<^U$=W?
MM^J_0'\/S_S-'3/%'B:\^*&J>%I)](%K8VZW'G+92;W# 87_ %V 1N&3WQT&
M>$T3QSK$/C.7PWXI@LH3<E_[+O;:)TCN-C%65@SMAN,XS_,5F:++-%\<M>U2
M32]733[JR2"&Y;3+@(SH%R,[.GRG!Z'MU%;UWHECX]\)SVCQWUE<0W4LUK<3
MVDMO+!+O9DD4.JDC!'3Z<'HH_"GY:_>_QV_I@_BDO/3[E^%[_P!(M7?BBZ\+
M>%=2UOQ+<VEPEM*T<26-JT)<AB@&&D?))QZ >]6+&X\7W-A'J4B:2ADA$BZ8
M8Y X)&0IN-V,_P#;+_&N8UGP?K_BWX2-H^I-#%KRS/,3TCDD61L<]@PYS[U)
MXDU_Q'=>%(H- MM;T[Q/&J#[+_9N^%FXW!IGC:+ &2"''/Y4/2_?3[K;_>"U
M:^?YGH&GS3W&FVL]U#Y%Q)$KRQ?W&(!*_@>*X[1O&6H>(O[2GTJ72Y'LI983
MI,@87(V,5#,^[ SC(79[;JZG08=0M]"LTU6ZDN=0\I3<22! =Y&2/D 7 / P
M.@ZGK7FGB_PM9ZX!J=CHFJ:3XT)+VUQ:0NJNX. TDJYC"D?WB&QP?2F])_UW
M_'_+42UB;7B/Q1XETWXB:+X<LI])6VU9)'26>RD=X-BY(.)E#9(_V<9[UT%I
M+XBDTR]E?4-(F8HLEE=0V<BQD<[@\9E)/3@AAUKS_P ;6G]H?$WPM)J6AW^I
MZ=86\D>HNNDS3P[F3C&$(<9P?ESCZBNVT_6K*'2KFSL-+U>'3M/M51#)IEPC
M/GA4C0H'; '.%XR/>I?\-VWU_/3_ (!2UDOE_7^9Q>G_ !'\6S?#5_&\RZ))
M!!*5EL5MI8V90X7*RF5AGD'!6MWQSXSU_0_">F^)](ALET^81-=Q7EL[RPK)
MC##;(H.,@$'\Z\U\/^%-=A^'UI>6EAJW]JZ3=M<W&BZA;S_9[N,MD;8Y!L+@
M#(V#/XXKVM3;>./!EQ;W-C>6:7MNT,MO>6[PR1,5Z88#.">"..*J>B;72WY?
MKKZ"6Z3\_P _T_$DO;K69X=).CWVFEK@!IGFM'=73 )= )1M'L=WWASWKG=)
M\4>)+OXIZEX6N)=*-E80+<F6.SD6216QA>92 1NZX.<=!GBU\+].UG3_  A:
MP:]&4N[3?:1 YSY2.0&Y]>/J M8.A/./CKKNHOIFJI87EG';0W,FG3K&SKMR
M-Q3 'RGDX!]>13TY[+;7\M"=>2[WT_/4Z"Q\4ZGXJUG4[3PY]BM[+3)OL\U_
M>1-,)91]Y$C5TX''S%OP[T[Q5KGB30_"VL:G%%IL<NG*)4,D;RI<ICG@,IC.
M>V6QCOGC$\'6-W\.K_7-.U&QOI]-O+YKRSO;.UDN00PY1TC#,I&!R1@^M:WQ
M#N9[[X=:S;PZ;J$DUW"T%M%%:O+)(2,Y*H"4'7EL>^*SEI"Z[+[]/^":*W/9
M]_P'>&]6\4ZQIVD:A)?Z)(MW##<W%G'8RQR1Q/UVN9F&1SU7G!IX\6W%_P",
M]0T"QO--M)]/V9M[U&:6[W*&S&0Z[5&<9P_T'?"\#S:9X>\/:9'9^&]5M]:N
M+:WMKM5T6>)3(."\CF,*<$DEMW2K?C3P]H?B1[C^W-!U**\AD\NQU'3[=Y)'
MXRI!C#%0&)'[P!<C(K2I92=MM?Z7<B.JU.[T^6YGT^"6\@6WN60&6)6W!&[@
M' S]<#-<QX[\<)X,.D,T DBNKQ(KER"1#">"^1T.<8S[UI>$(-5T_P %Z;#K
MTCRZC#;CSV)WN2.@.,[FQ@'&<GUKB?$FG:AXX\.^(9E9[.TE41K;7N@W/VD"
M/E"AWJ3ELMPC8W8/H)G[LO0<=5KU/0/$6OV7AGP_=ZU?,WV:VCWD)R7)X"CW
M)('XUE:5>>+-4TVWU8II5M'/$)4TV2*0R $94-/NPIZ9_=G'O7&6>GZK\0O@
MR_AS4+._TW6K:*-";^TDB61HVRA#, ""% ..0>W3.GJNM^(&\$PV.EVVMZ;X
MHMX$58(].\Z&1P "#,T;1;>ISN!Z?2G)6O\ AZ=PCJE^))XY\8^)?#/A72=9
MM[?3X)[F:."YL[J%Y#&[YZ.LB],8Z<]<BK0\5ZYH_C[2_#6L)87L6J0O)!<V
M,#PM$5!)#HSOD>X-<I\1K+Q!>?#70M-OX-5U37&N8;F[^SV9D\O .\;H$"#!
M.!SD^_6K=A%J'@[QXNIK8:OK&@:O" EU):37%YIY'\#;E,H3V/Y9'+BO>:?=
M_E_GL_D*6VG;]?\ +I\S3G\6>)Q\2K[PN+[1+>U@L3?BZET^5BJ;@-K#SP.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"O?VOV[3K
MFS^T3V_GQ/%YUN^R2/<"-R-V89R#V-</_P *L_ZGWQS_ .#C_P"PKT"B@#S_
M /X59_U/OCG_ ,''_P!A1_PJS_J??'/_ (./_L*] HH \_\ ^%6?]3[XY_\
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M_P"PKT"B@#S_ /X59_U/OCG_ ,''_P!A1_PJS_J??'/_ (./_L*] HH \_\
M^%6?]3[XY_\ !Q_]A1_PJS_J??'/_@X_^PKT"B@#S_\ X59_U/OCG_P<?_84
M?\*L_P"I]\<_^#C_ .PKT"B@#S__ (59_P!3[XY_\''_ -A1_P *L_ZGWQS_
M .#C_P"PKT"B@#S_ /X59_U/OCG_ ,''_P!A1_PJS_J??'/_ (./_L*] HH
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MPM7N;J58H4^\Q^N /<D\8[T>8>1/161:^)M)O+*YNHIY%2U8),DMO)%*C'&
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M^L8[>UD$UO\ O6560]901]_/(' /? +)]"U1M'TJ[L;#5-/U^"SCM1)#<P;
M5!XG4N5>/(S\H9L-Q@UVFI:SI>C1)+JFI6=C&YVJUU.L08^@+$9HO-8TS3[%
M;V]U&SMK1R L\TZI&Q/3#$XYI+_+]?\ ,+?U]W^1S=UIFK0^*=1O$L?M,6HZ
M5';>;'(BK%*AD)W!B&P=XP0#TYQUK,TG2_$%E-X)BNM$D(TNV>"ZEM[F)XTR
M@13\S*Q^[D@*<9X+5WEWJ%E8637MY=V]O:* 6GFD"( >A+$X[BLQ?&/A=Y(8
MT\2:.TD^/*47T1,F3@;1NYY!''>FGK_7G_FQ/5?UY?Y(Y:^T;7%\ >(]%BTB
M6>YN;FY^S^7/$!*LLC.K?,PP &P<X.1P#UJ[$NL?\)?<ZFWAS4%MWT=+=<S6
MV3*I9RN/-_VL9Z9!YQS747NMZ3IUW!:7VJ65K<W!Q##/<(CR'./E!.3SQQ5!
M_''A*-V1_%.B*RG!4ZA$"#Z?>I;JW];6*;UO_6]SA'FU7PMX7\*LWA_5O[7L
MH);8I:VJ7Q084'=''*,J2%(8,"-O/7![#P!<P3^'-D5KJMK(D\C31ZI:F"7>
M[%R=N2 I+<8)XXZT:Y>^#;D6EUJ>NV5JTL>ZWN(]6-HTL?\ LNCJ67/N16UI
M%YIE[8K+I-[;WEMG'G03B8,1QR^3D_4YJKMWN)]"EK2W4K7$,VB)J^E20*K6
MRM'YC/ELC;(54KC'5A[ UQUUX)U*'PG#%9Z9:7:VNHM>V^AW\BR1>25*^06;
M*@C<6'4 \9(&:] 76-,;4)-/74;0WL:[GMA.OF*/4KG(%02>)=!BU0:9)K>F
MIJ!8)]E:Z02[CT&S.<G(XQ4KR XB_P!%U2?P7#;67@BTTFYEU&WGDL=.F@PB
MQR*Q=V^122%P N>W/IU/BJPU2]TVTOM%C5-8LYDF@CF8 ,#\KQL0<8*D]#U
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MMO%$5]HJ7MJT\RM>_OHVLYD& 28R2ZN5Z% .1\QK<;Q/X?34_P"S&US3%O\
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M P7<9",%0[8QD!<9[TFK:WK^EZ9;M+/IB71MGN))&M)'$C#D1)"LI<'!Y;+
M8Z<UHCP=I8TR&PS<&*&[^UQDN"RMN)V9Q]S:2F/[O'O5B^\.P7VKC4?M=W!(
MUL;66.)EV31DDX.5)&"2<J5/KFB6VG]?T]/D)>?]?TM?4PG\5ZQ=7OARWLK2
MQB76K![E9)G=S'(L8;:5&/ERR\YR>>!UJ.?Q1XHGO98](T+[:EE*+>ZV&+9+
M(%4L%=YT:/!)ZQMGCUK1MO!%O:WFB7$>K:F?['@\BW1FB*LI #;LQY)( '!'
M3C!YI+[P%IUYXD.MQW^K64TA5KF"RO6AANB!@>8HZ\ #@C/>J=N;3:[_ #T_
M 2O;7>R_X)U(Y )&/:N8M-9UG59%OM,CLI=-6\>UDMV5A-M20H\@DW!1@@G9
MM.1WR<5TX   ' %<JG@#3(/$<NL6U]JML)I/.FL(+UDM99#U=HQU)[C.#Z5*
MW'T*=[XMU,:/J'B*Q2S?2=.GFCFMI(V\Z5(FVNRN&PIR&(4J<X'(SQ-_PD6N
MWWB?4-)TVWTQ4@M;>[@>X>0^:DC$$-@#8<*V,!L<=>@OR^#[*2YNRMU>1V-Z
MYDNM/5D\B9SU)RI89QR%8 ]P<FI8?#T-CXDO/$7V^^>6:!8GM]L9C$:9*JH5
M-_!)/4DY_"A6Z_UI_F#\OZU_R.<M_&&OGPV/$%U!IJ6]O>R6MW:Q!V8JLWE;
MTD) XZX*<^J]*TKOQ#JUR-8N=&%CY&CRM%-#<HQ>X945V"N& C^]@$JV?:LK
MP3HHU'2YC?MJT4":E<3_ -GW5L8(W)G:2-\/&'/&TX#;<]1G-=)=^%+6XO[J
MZAO;VT6]&+V"W=1'<_+MRV5)4XXRA4\#GBF_Z^Y?K<>E_+_@O]#'M/%NKZUK
MJ66E06$=O/I<.I6\MP79F5V *L!C:<;NF>Q]J7_A*]3B\4V%C.+$P7=Y+:-;
MQ1LTD&U797:8,4RP0'855AN[X-:]OX6M[7Q-_;<-]=JPMEM%M0(A"D2\A0 F
M[KS][/X<57B\$V4/V55O]0\JTO7O+>/S$Q&S!MR@A<E3O;J21G@BFK7\O^"_
MTL2KVU_K3_,PDUKQ)I>F^,]5:XT^_P#[/NI#% \+PX"1HWW@S9 7^' R>=PS
MQN/KFHZCJ(TK29+."\CL8KR:6ZA:5/WA(55574_PMDYXXX.:DOO!UK>VNM6R
MZAJ%O#JYS<+$T9"DJ%;;N0XW!0#G..V,T]_"D9:SGAU74;>_M8!;_;8C%YDT
M0.=KJ8RA&?\ 9!';&326WW?E_F/_ (/YK]#&@\;:C>C0/L]A:(;^]GL+OS)6
M/DRQ!\[ !\RYC/)([<=QN>&=7O-2_M2VO_(:YTZ]:U>6!"B2#:KA@I9BO#@8
MR>E0W'@VTEDTEK>^O;--,F:XBC@\LB21L[F<NC$D[FS@C[Q/7!%K1/#JZ)=Z
ME<)J5[='4)_M$JW BVJ^ ,KL13T"CDGIZYR:?U\O^"#\OZW_ . 1^([_ %/3
M#I]S:2VBV1NHXKP30,[A'8*&4AU"X) .0>N>V#EV^NZW+?:WIKW.G"[@FB%@
MXLWVM&[;2S+YN6PP=3@K]W/?%=-J>GP:MI=SI]SO$-Q&T;E#A@".H/8CJ#51
M/#UDFIV&H R^?96[6\9+Y#JV.6]3P>?]H^M)>?\ 7]6_%@_+^OZ_0R'US69M
M3\2Z7BRMI+"RBFM;A5:3<7#_ #,I*X^Y]T'CU-8MB^J2VG@&6ZNK:XNY=SK(
M(60 &U8_,-S%B.Y!&?\ 9KJX?#$46OZCJSZC>RMJ$*P2VS^4(@BYV[<(&&-S
M?Q'KSGC%.+P5% ^C&+6]5":1Q;QEH65AMVX;,>3\GR\$<<]>::>WR_\ ;O\
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MODGK1_7Y_P"0/?\ KR_S/4Z*\VTT/>:)JVA))HUJUN(Q_:.FKOM)6WDE)(^
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M=]:6ERLL]C((KF, @QL0& .?8]1Q6/KU_H;Z_I^C:G>6.^[BEC-I/*H:17
M&TG)S@@>N*GJBNC+U_J&J6^L6%K:6%G/:W)(>>2\:-TQR<((V#<=/F&3Z=:U
MZX72+?5M#\367A^Z62ZTV))9=.OF.2(]N/)D/]Y<C![K[@US/AB72K[Q=!%J
M6J:S'XM@E?[39_88U#J"0<RK!N: @Y :3ICOBFM=%_7_  W4'I=L]@HKR_4?
M"M@T>L^&;/2;-7BF75['_15V+D=,XQDR(5(_N-CI79>&?L>HV[>(H;**&;4T
M1]_E!9#&% 4,<9/<\^M"U5_Z_J]U\@>G]?UTU*OB;Q+JOA^_L1'H]I/IMU.E
MNU[+?M%Y#L<#>HB;@G !!ZGG'6KM[JNK1^(K?3K#2[2ZMFC$EQ<27IC: 9QR
M@C;.><<\X.<8S5GQ!#IMSH%]#K#PII[PLL[S.$55/<L>!]:Y_P"&>H6^I^";
M2YCU&._O67_2Y?-5W\P< /CH0H7CTI+KY _S.RJ*Y:9+65K=(WF"$QK(Q52V
M. 2 2![X->5KY5SI,)C$*?$"&\7S.<7)'G_-G^(P;"?]D#'I5[13H-QXW\82
M7-[;RK8W$-S&\MX6\ADC.\@EOE"LQ!'09QQTI/;Y/\E_G]Z'L_Z[M?I]QU_@
M_6I_$7A6QU:ZBCBFN59FCB)*KAB,#/)X%;E>,> =6T)[#P[#X@.ERH%<:3.[
MHXCG#Y=&S]V3E".>F,8/7UJPU>PU26\CLKE9GLYC;W"@$&.0#)!S]:I_U^!/
ME_74Q]3\5OH?B2TL-4LHX=.O<K;Z@DY8!QM&V52@V EL [B,XZ9JYJ&HZQ!K
M5O966FV,]O-$S^=-?/$RE<9&T1-_>7G/KZ<Y^N76@WOB:UT'4[NR=[JRGC:S
MEE7>X9H\#;G/.#CZ''2J.@IJ^E>*K?0=262YM;:UF>QU$G)DBW1CRY/^FB^O
M<8/7-)*]OZ_K^OFWI_7]?U^%_P />)]2U6]UBRU/2;73;G32 8Q?&4N",J^?
M+4!".AY/!R!BM#P[J6K:K9&ZU/2[>P5CF%8KLSEU_O',:;0>".IYYQ7)^.KK
M1;#QCX<EN]3MK.:XD:VO5>X2/S;4JS 2 _P>8BC/N1WKT,$$ C&.V*:VO\ON
M![V^9B^(=??018L-/EN8[JZBMFD6156(NX4$YY/7L#T[58U;57L9+:UM8$N;
M^[9E@A>3RU.U<LS-@D*..0">1Q7._$K4K"PTO2EO+VVMBVJVCJ)I53*K,I8C
M)Z <D]JMZVT%GXGT7Q%/<1IIL5M/;RSL1Y<?F;&5RW0*=F,].1ZT+5?/] >_
MR_4N?\)/&NFF5[9A?"Z%D;0."?/)&%W?W<$-NQ]WG&>*FL=9GG%W;W-B(M2M
M=GF6\,OF*P?[K*Y"Y4\C) QM/%<=_9LGVY_$Y+?81KXO1\A.8/(\CS/IGYL_
MW>:U+74M.MM=U[Q=-?0+HHM+>!+K=F.0H78E6Z,/WB@8SDY%&EKO_AM%_P '
M^D'I_6K_ *_X<U[#7KM]5N=+U/35MKR*W^TQ_9IS/'-'G'#%4(8'J".XP31#
MKM]%KUOIFIZ9';"\5VM)H;GS@VP9*N"J[&P<\;AP>:P/#/Q!\)^(=5O+JSU/
MSKH6YDEW021I:VZ<_,SJ!U.3@]3Z#-,T7XB^$?$WBR&&RU-KJ_&^&TMTMI1M
M'5Y"Q4+R%]>@]210EJE_77^OO$]F_P"OZ_X!Z!6?>:@Z:A!IUJJ-=2J96+_=
MCC! +''4DG '?GTIVFZQI^L+<M87*SBVG>VFV@C9(IPRG-8]BDJ_$;63-]R3
M3K4PY[@/+NQ^)&?J*2W&]F/\0>));+1;B^TE+:Y-M=);S^:Y 7+*K8P#N(+#
MC([\\5T=>/7I\.Z'X7\3QE=/T^[?6/+?"K"Y7SD9%)&#C;EA[9(Z&M.2]MH/
M%GBFR\,7=I]MGT6.>&"VF7,EQ^\^? ZN5*'/7E2>U)/2_P#6R8[:_P!=['IU
M4+O5[2RU*RL)IX8Y[S=Y*R2!"^W&0N?O-R.!VSZ5P/PZE\.WVM37>CZMK$U\
ML16^M;BQCMT1R1GS2D"!Y 1C)9CR>V:]&GL[6ZE@EN+:&62!]\+R1AC&V,94
MGH<$C(JFK6)3O<QY_%VF1:.-0AF2[$DXMH8;602/),3@1^@;U!Z<YZ4]=5UB
MW>,ZAHL20RS)$CVMWYQ0,<;I 47;U'W2W/MS6)XRT<6<VA:S8V&ZWTS4C=W<
M%K%\S*ZLK2!5&68$ACW/-=%I_B31M7.W2]2MKYP0&2VD#M'_ +X'W?QQ^=);
M7_KI_P $;_K\?^ :M%>37'DW.E7JR")/'\-XYMR>+DCSOW>W^(P;",X^7&<]
MZ=J$OAV;Q/XX@O[VRF TV&1H[BZ$BQRKYF2 S':58ITQM)'0GD;LK^5_P3_X
M'J.VMOZWM_P?0]7HKRG2]6T7^UO UR-3LA>:CI[Q7<PN5$LY\L!59L[B?,#
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MP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN?)OMFD2>7<C[(^_. <JN-Q&"#G&,<].:3?5@EV()="O]4\2Z=J>HVVGV_\
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MW-OL+)9O&FU%*Y!?@[MW&X$8P*K:9XGO[OP]X;CO=16WO-7FFA>\2)!M*[R
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M";F)4$J"3]ULYXQ=?P'X?DL[RT>&^,%Y,)[A#J5S\[CO_K/IT]!Z##+JQO\
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M08 .UF4$$8&*C'3XD_[W_MHE=(?"&AEF/V-L-<_:PGVB38LN<[E7=A<DDD
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** ,G7- AU]+:.XO+^"&&3>\=I<M"LXP04DV\LO/2M55"J%4 *
M!@ =J6B@"O>V<=_;FWF9Q$Q^=4;&\?W3['OBIU544*H 4#  ' %+10 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD/\ L@G)_"L#Q'XHL;77;+P\=>M],N;I'=Y_.A\R+&W8H60$98MQD'(!QZ@
MZRBL74M:M_"OAU;S7=1A9HU6-IV B$TAX&!DXS]>.3TJS+K^C06MK<S:M81V
M]V0+>5[E LQ/0(2<-^%'H!HT53OM6TW3!";_ %"TM!,X2+SYEC\QCV7)Y/L*
MQ;S6I]-\:B&^U&U@T;^S7N3YBB,1LKHNYI">GS>V/>@&=-159M1L4BBE:]MQ
M',I:)S*N'4#=E3GD8YX[4D&I6-U8"_M[VVFLRI87$<JM&0.IW XQ0!:HK!U7
M6DN_".HZGX=U2QF>&!WCN(R+B/*C)'RL 3QCKQ[]*EL]<M;7POIVI:SJ-M:B
M:WB:2>YD6)2[*#U.!R3TH V:*KS7]G;V+7T]W!%:*N\SO(%C"^NX\8]ZJW'B
M'1+/3X-0N=8T^"RGP(;B6Y18Y,C/RL3@\#M0!I452&KZ8U_%8#4;0WDT?FQV
MXG7S'3^\%SDKQU'%27^H6>F6C7-]>6]I " 9;B0(@)Z9)(% %FBN3\&^(9[[
M1KJ?6M0M6F34I[1)0!$CA'VJ%!)ZX]2>>M:PU&VEOH;N+7+0V)M7D,"LA$@!
M'[T/G.U1D'M\W-']?A<#6HK)3Q1X?DL#?IKNF-9B00_:%NXS'O/1=V<;O;K5
MI]6TV/44TY]0M%OI%WI;-,HE9?4+G)'X4 7**I3ZSI=K(L=QJ5G"[2B!5DG5
M29#T0 G[WMUHU=[J/1[R2RFCAN4A9HY)(_,52!GE<C/YTF[*XTKNQ=HK#\,Z
M[!J>D:<DU_;2ZI)8PW$\*R+Y@W*#N*#D D^F*T(M6TV?49=/BU"UDOHAF2V2
M93(@]2N<BJDK.Q*::NBY15*+6-,N-1ETZ#4K.2_B&9+9)U:1!ZL@.1U%<IIW
MC(:3HVI7?B?4[7=!JSV,4FP0*W*A0 2<=2223@9.<"E_7XV'_7X7.XHKE1XC
M\CQ5<&[U>P&A'3H[N&4[41=S[=QE+$,#C@C Y[]:W[S5=.T^R%[>W]K;6AQB
M>:94C.>GS$XYH#K8MT53O-7TW3K);V^U&TMK1L;9YYE2,YZ?,3CFG2ZG80Q1
M2RWUM'',"T;M*H#@#<2#GG@$\=J +5%4)=;TF![5)M4LHVN^;8/<(#-_N9/S
M?A5^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHI&8*I9B H&22>!0 M%1PSQ7,*S02I+$X
MRKHP96'L14E !1110 4444 %>:_\(E?W^E^(- EA:*VLWE;29FZ%I")4*_\
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MRN7O-2MM \0:7-*J12OK<\KR2[<X"B21S@9//'7OV[.BDM%8;U.,O;6Y\/\
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M5MX?:UN'*ZQJ3V;EB;*0Q-'\QR?FV>9USU?O6R    , 4EHE_7;_ ""6K?\
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M;=-D,*!$7). /<]:FIMZW)Z6/&(]/N8$TP77AS4(Y8/%$UVCK8-+MMRS$D%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MYE*<$;3&>,'<,XW<?=J75O".LZE'87L'B8Z?K]I&T1O[:R4QS1L02K0NS ]
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M<7%K<1E561[ZS$S$]W7#*%<]C@@$# [5%J_A)=6ALK:6X@:"U9&66:VWW*;
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M.O-=3K6D1:YHTVGW$C)Y@4K+&!F-U(974'/(8 \^E#V_KLO^"-_%Y?\ !?\
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MZ)/-:S3:-I\DMH +=WM4+0@'("$CY<'TJL?!OA8PO"?#6C^4[B1D^PQ;689
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MJ%_K6FZ7<V=M>WD4,][)Y5M&Q^:5O0 <]QSVH OT444 %%%% !1110 4444
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M/N'ND6(QGS9GSN=RR,23N;H0.>G P]+Z_P!?TOQ)6B_KM_F6-9^V?\(+J/\
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MP'&5(S@ Y'%3-<R:\BH.S3?=?F<UI_B+6(M!T;2= TU[NZ@TJUGF;9$X"LI
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **S]9UJQ\/Z;)J.I/+':1?ZR2."278/4A%)
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MER8Y4Z-@D'K[@U;H **** "BBB@ HHHH ***165AE2",D9!H 6BBB@ HHHH
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M )ZD+M&?PXHU6J_IK8>G7^D]S.T"ZBUB:[UN!P]O/MAMG!R#&@R3_P!]LX_
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MI7DWW=PZ)?UN><PIJ&H>#KO1[J.UM-"OM7NH)]1$K221@W+GF/: @)&T/N8
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M4.VI7P^?_ ?_  /N&_Z_#_@G-:1K>N3:_:VK:D]Q'?Z9-<"66U06Z3(4 ,.
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M1ALGS-PV)L^7Y,#< P.<Y&*U+36-4MO$&C17-\]U!J.ER7,D1B11')&(SE,
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M?RMI$JN@!9\DD?,>@&/>II/ F@2V^HP/!>&+4G#W:?VC<8E(X_YZ<#&!@8&
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MI5 50!G &.3FB^G]=E_D-ZRO_6[%HHHI %%%% !1110 4444 %%%% !1110
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M<LN,&3 W=..M)?#_ %_7^0WN0KXI\/.EJZZ]I;)=N4MF%Y&1,P(!"<_,<D#
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MI^GW_AS5;-X/[5BM;I5"RN4:79Z_)D#()!R#QCK6YX0T^]TKPCI=AJ#[[J"
M(^3G;Z+GO@8&?:N)F,UMX3L-.N=)U1Y8=<\R5$T^64>6+EI"WRJ<KM(.>AS@
M9((%)+FMZ?F0V^73S_(](L]2L=0A>:RO;>YBC<H[PRJZJPZ@D'@CTIMAJNG:
MJDCZ=?VMXL3E)#;S+($;T.TG!]J\_OX+_4+WQO;Z;97XEN%MWA#V\UNESY8
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M*** "BBB@ HHHH **** "BBB@ HHHH ***BN6G2UE:UCCDG"DQI+(45F[ L
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M@6A@7GAZYN[/15_M"..[TN=9EE%N2DF$9"-A;(RK'G<<'GGI6/>>"=7O-/\
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M&+1S%(HW-M9(MC @J#D'&#5?7FUBZUCPU>V_AG4I8[&1Y[A1-:AEW1.FSF8
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M"5&W,GZ?F_T-NUU#3Y=8TJUDU:7^U!8F3["LN1(C!<R.N.H(X)(ZGK4S^+]
MBN6AGU**WP_E++.K10N^<%$E8!'8$$$*21BL1+?5I/%GAJ\;0KR.VM=/E@N)
M&E@Q$[[, @2$G&PYV@]1C/..6L-;>+6["PNM#\3Q:587\DT#II):)6+. S7"
MR'=%AST0'U)%4[.5O7\S-:1OY+\CTB;Q/I$&J)ITERXG>00AO(D,0D/1#*%V
M!_\ 9+9Y''-93>--)NI-?L[N:[TV#3B89;R6"2%5RJY99&7:#EQM&<GJ 00:
MRM4T?7;V[D<Z7+NM]9@NHA!<11P2PAURV P9G"CGS!U'RYP*MW.G:Q GC*./
M2I+@:D!);-%-&-Y:!8BOS,N""I)S@8Z9/%0_@;\G^G_!-(_%;T_/7]#?.LZ=
MIVD64SW-Q/%+"IA*PR3S3+@?-L12['!!)QQGG%-/BW0!!93'5;<+?.8[8%OF
MD8<%0O4$'@@CCO7/6NGZU8/X?UE-*N)I+333876G>;")5R4^="7V'E.1O&01
MW&*IW.@:Q:7%C<0Z5<W)FUYM4GBBFA MH]A3;\SKECD,=N1G=STS;2YOG^O^
M6IG&_*O3]/\ /0[*W\1:7<V5S=QW#B.UD\J99(721'XPIC90V3D8&.<C&<U=
MM+R&^@$L/F!>,K+$T;+D X*L 0<$<$5QEKHMU?WWBN'5="O%LM0NXI8&^T1*
MSA$1=RE)"RL"FX9QVZ'BMOPG;:O:V,\>J2W3Q^;_ **+UHWN$CP.)&C)4G.<
M$$G&,G-)?Y%/1Z%J]\2:3IUXMK=7+(Y949A"[1QLV-HD< K&3D8W$9R,4W4?
M$VDZ3.8KVY="N/,=8)'CAST\QU4K'G_:(KG'M_%.F>(=0LX=!LM9T74[G[1]
MIGNUB^S9505="K%QE>,?I4DFEZQ83^(;*/36U"VUEWFBN5EC58&:)4*RAB&V
M@KP5#<'&.*72_P#7I_P1];?UZ_\  .@NO$VCVE\]B]Z'O$@^T&V@1II?+]0B
M D]> !D_A5"^\;:;;3Z((%NKJ'5F/E36]K+*H4*3GY5)SD#CJ!DG !K*LM*U
M31O$^G;-+O;VSL=$^PF[66 >;("K#AI W.W'(ZD=N:J:'H^N6ND^%C-HTT<^
MFW<_GPO/#G9(K@."KD%07&><\' />K*_E_P6O\G\R&W;^NR?^9UQ\3Z0-533
M3<N+AY#$C>1)Y32#.4$NW9OX/R[L\=*I_P#"2>'K&XUJ]EU]3':/&EVLDV8K
M5N0%7CAB>H&3FL&?1]?N;^WN)=,D$EIK7V@+#<1QV[PDL-ZJ#EFP06+C=G..
M,57US3=>NU\<10>'KU_[5MTAM'$]N%<JA0GF7('.>0#CMGBI7]?A_F_N+TO;
MT_7_ (!V]GKVFWU_)8V\[&X2(3;7B= Z'^)&8 ..0"5)QWI+?Q#IEUJ/V&.:
M03L,Q^9!(B3 #),;LH63 Y^4G%<S)8ZM>^+-.G?1KZVM#H\MG+<&6#]S(Y0C
M@2$G&PC(!Y(ZC)&9X5\,:C:R-87W@G0M-EM[=H4UZS:(23$J5W(BIO4G/))'
M?K3>FWG^O_ ^\E>?E^G_  30\1>(EG\0^&HM+U*[6-M3$%PB1,L-PI1B<2%<
M/@J!\C$#)![5WE><'1_$LNG>$[$:-&DFAWD1FD>Z013(D3)O0C+8YZ,H.>.G
M->CT-)+3N_T"]W\O\PHHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "D=UC0N[!549+$X %+6?KEO!=Z#?P7,,<
MT+V[AHY%#*W!Z@U,G:+8XJ[2+L4L<\*30R+)$ZAD=#D,#T((ZBGUQ/A;7YK/
M3_#&F75DL=O>:8K07 GRVZ.-2P9-N%&#D$,?<"IM,\<OJFK6\$&AZ@UC<@F&
M[%K<+CY207WQ+&%., K(V<BM)*TFEY_@1%WBF=A2,RHI9F"J!DDG  KC['QU
M)=:3+JT^BS6]A#)-#*?.62594D"*@C4'<6)(&TGD=\BGV/C"ZOK;5/M'AR^!
MM83*B^3*B7"\_*&N(XL-W(P1@]34/17+MJ=7#-%<P)/!*DL4BADD1@RL#T((
MZBGUQ^G^+3(GAZSL-#,:ZII_VFW F1(8@J@^7P,\;EY"XP>,]*VO#NM'7M+-
MT]O]GFCGEMYH@^\+)&Y1L-@9&1P<#Z"J:LWY?YV)6QK5&;B$7 MS-'YY4N(]
MPW%1P3CKCD<^]8GC74M0TCPAJ-_IB0M=0Q$J97*A1W(P#DCL/UK$<7L/CRTN
MTTNR_M:;1I?-1+@A&*RQ[0TOEAB/?8<9Z=Z2_K[K@W;^O.QW5%<B_CN$^'M.
MU""PGDN]01S%:+'+)M*</N,4;MM!XW!#U'3-;7A_6)-;TI;N;3[FQEWLCPW$
M3H<@]5WJK%3U!*CZ#I189J45P?ARWM?&L^MZAKUG%>10ZE+9VUI<J)(H4B^7
M(1AC<3DEL9Y [5NS-;>%87,7FS-?W:1VULTA.)& 7:I.=J@*6]AG [4=/ZZ@
M;JHJ%BJ@%CEB!U/O3JX^]\;W&E6NK+J.C$:EIUL+QK:UNED26$DC>KN$X&#D
M%0?0'(JROB>_;6(=-&DPB6[LC=V;&[^5MNT,LGR?)RZX*[\^U']?U]P?U_7W
MHZ>BN/3QR\ECHMQ'H\KMJ5V]D^)UV02JS*02<%AE&P0O0<XZ59A\4W?_ !,+
M2XT<C5;)X5:VMYC+&ZRG"2!]@(0<[B5RNT\'N[?U]W^:#^OS_P F=/17%?\
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MN%7;N.-QD!]L4K7&U;^OZ[,ZVBN7C\5WEQX@U'2H=$D!L/L[3237*+F.3.7
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M-X9;F6YWQ6QAPTCEF&"[<9/']:WZ*5P>IA:MX?GN];M-:T^^CM=0MH)+=3/
M9HFC<J3E0RG.5&"&_ U4E\&QI':7%A>F#5;:XEN5O)(A()'E_P!8'0%<J>.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?]3[XY_\''_V%>@44 >?_P#"K/\ J??'/_@X_P#L*/\ A5G_ %/OCG_P<?\
MV%>@44 >?_\ "K/^I]\<_P#@X_\ L*/^%6?]3[XY_P#!Q_\ 85Z!10!P]A\-
MOL.HVUY_PFOC*X\B5)?)N-5WQR;2#M==O*G&".XKN*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-"'@(A8D\>Y-"U!Z'4453N-6TVSO8+*YU"T@NKC_ %,$LRJ\G^ZI.3^%6R0
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M89);BRN&5)&(4P-N*YP,@\@<>_%6+F5=+\96$<05(M5CE650,!I8P&5OKMW
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MR,[\DB,1N/-C.X94E@#QR<UZ+HPO9=!MTU*"VM[KR]DD=H6\H8X!3< 0",$
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MBAO%N,R NVU&>/: $8XY#$\C('.+[^'IFUFPU'^T7=H+5[6X$L08SJQ5B<C
M4Y7T(P2 !P10M/!;P6EOI,VHI/H5K,DUM:M;XE78VY$:3=AD!Q@;0> "3SFM
M+_UW?Z;"UU_KI_GN.MO%]U=7NJ11Z',L.EW1@NG:==X41[PZJN=V?E&,Y^;Z
MBM+P[K?]OZ<E\@M#!(,H]K=>>N,]"=JX;U&.#QDU5T3P[?:5J6N7DNIP3'5)
M_/ CM#&86"!%Y+MNX4=AD^G2I-)\-IIVO7VKLUJ)KI1&RVEMY"L <AI!N;>_
M;=QQQBI7Z?B-^7<C@N/[3\9W\+ -'I4,0B1NGFR!B6_!0H![9;UKD;Z]U+7O
M 6J76N:?8%K;4\6QBE,I5DN=G 9%VX P&!YR3\O2NQ\@:3XKN+YE(M=3CBC=
MPO"3)D+N/8,K  ],KCN*S+OP9J$FA7VDVFM00PW-\UVK2V)D**TGFE#B1<G?
MWXXXQGFA;+Y?GK^ ^_\ 6EF76\7"ROM7MM4LC;G3[9+M3#(9C+$Y8 8V@A\J
M1M&>HP31X?\ %-SK.I3V=QHMY:!$,D<[V]PD;+G&"988\/SG W#WJM=^#;G4
M]8U.ZU+4K>6TU#3UL98(;1HW4+DAU<R-@[F)^[Z>F3<\,Z#K>CF4:OXHN-93
M[L"26T</EK_M%>7;W)_"FO/^M_\ @"?E_6W_  1][8Z_)J6I/:W&GBUFM MJ
MTJ.9(YO1L'!C/4XPV3]*Y#Q+I-LWBSPM)JGABQUB_DL[A;J&UMX2KLJQXQYS
M*"JDG&3D9KTZN9UG0-9OO$ECJ]CJ]A;"RCDCBBGT]YL[P-Q9A,F?NC& ,>]3
MU7]=_P#,??\ KM_D<UX8U.RT/7_$QEMY=!T^UMDN%T>8 %%7<7G0(2@5CQA"
M1D<X)KIX?$UU%JMA:ZII:6D.I9%E,ESYI+A=^R1=J[&P#C!8<'GIF"/P4M[?
M7^H>(+Q-0N[RR-@PA@\B*. DDA5+,<DGJ6/3M4]CX8NEFT\ZKJ:7\>F,6LL6
MWE.#L*!I&W$.P4GH%'.<57:_];_CL)];?UM_P2&+Q?/_ ,)%9Z9<Z8D"WQF%
ML#<_Z1^[!)+PE1M4XX(9NHSC-06'CJ2ZTF75[C1Y+6PA>>&5GN$:198W"*FT
M<$L<@$-C(]\T6G@J]M9-.D&LQ-)874LZR?8OGF#HR_O3O^9_FSN&,XZ4[3_!
M$D7A74-"U'4DN%N[B2Y$]O;F%HI'D,F0&=\X;!'TYS26W]=U^EPZ_P!>?ZV,
MORI[CXLV#ZAIEM:SSZ/=(YAF\PR)YD> S;5.1D\<@9X)K=L_!>GV4FBM!&T8
MTI94A'VB1\1N#F+D_,O(Y;GY13;?PMJ#>)-/UW4-<\ZZL[>2V*6]JL4<RL0?
MF#%B#P"<$9([#BNEEEC@B>65PD: LS,<  =Z=[)?UU?^8;O^NQA>'YQ!JNL:
M*I BL9(WMU_N12)D+] P<#T&!VKF/B!X5T!+?3[MM'L9+JZUNU\^>2W1I) \
MHW*S$9*XXQTQ76Z%:R->:GJTJ&,W\JF)&7:PB10JY'J?F;!Z!@#S5;Q9X>U#
MQ#%8Q6>I6MDEM<QW1\ZS:8N\;!E'$B8''(YSZBEUBWY!W^?Y&-XF\-Z+HMEI
MTNF:1:VY_MFTE6."%$"OO525& %)  /3-:G_  F*VJ:NNIV)AN-.FBB,=L[7
M'G>;CR]N$#$G."H4D=LU9\1:'J6M6>GPV^I6MK);7$5S([V;2K(R$,  )%VC
M(]2?>LRZ\#W&I76NO?ZK&8=4\IHQ;6IBEMGBQY;JYD8$C&?NC)].E'2WK^G_
M  16UOZ?K_P#1\->)+G7);J&ZTBZL7@"L)'AG6*0'/"M-%&Q88Y&WN.37+:_
MI_AB+XC3/JOAQ+[[1I@D8PZ2UTQD\PC<VQ&(;& &/IUKK?#6D:SI5O(NM>(Y
MM:F)PCM:QP*B^FU.I]R3^%,71-5'C)M;.IV9M6@%M]E^Q-OV EA^\\W&[<>N
MW&.,=Z&M5_70?1_UU,;P[<Z]H?A&UAN;&2:YEN)C"M]<E%MH-S,@FE <@[<
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MQ?7ES/>:?;M*)YBZA@F2P!Z$YY]<"EU5I6\>^'HV7-L(+J3)' E 0#\=K/\
MF:J4;2Y?ZZ_Y"3NKFK>ZF;+3[F86YN+NW@$SVL,B[CUX!; ['DXZ4_2-0&JZ
M-8ZB(_*%U DP3.=NY0<9[]:XTV-I%XW\6733W"R_V?"P5KR382R2Y^0MM/"\
M<<<XQS4.@-/87'@?R;NZ9+[3&2>%YF,;!(59<)]U2#QD $CKFDMON_\ ;O\
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M?9[4A#=R;"6$F?DW;3PO QQSC'-6?$4UW!XP\*B&_N8[>XN9HIK9& CDQ"[
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M^O0UO^$-\+_9FMO^$;T?R&<2&+[#%M+@$!L;<9P3S[ULK'&D2Q(BK&J[0@&
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MM)U"^^Q6]R_V@IYD:R021B9/[T990)!R.5)'(KF]'U6'Q9XEU ?:=:M9--O
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6?KO_(OZE_UZR_\
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M1V"G<%]F/I73T5)1YP-$UZZ377729K>1M;AU.V2XGBVW*)Y8*91VVD^62-P
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M>\N8I;3RH(]ODS>8&\W(Y^7JN#QSUKEO%D.JW'B;PY/8Z'>7EOIUTUQ--%+
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MW@*_,K !E8,K#!P.0 1V(K(;P);"WL((-8U6".RO'O8@K1-^\9F;!WQG@;V
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M"1@DCT&:-/E_P_\ P"=?GI_7YE;0IC%XB\0:8,^3#+%/$N.%$J98#_@2L?\
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M.TA<@YJ7_P  2U_K^NIZK16/X5BMX/#5E':7=]=VVPF*:^7;*ZDDC(VK@<X
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M/4$ BN;N7T&"30DNX-.3P9)8R8S&BV?V@LA4OQLP1NP3QG/?%):_UY,;VO\
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M<ZR1E%YAD\B1T?=NSM8=C6_KLCZ3XF@U'=I^HF41P"RN<)?)T+&!A][/#,@
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M0]'T5+K3(X-'O(9K:Z.]VFCCSM#QX&".!PYSUXZ'T&BJ<FY<W]=Q))1Y>G_
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M^W2[47*Y!_<]?D'_ 'T>F.?0Z*/Z_+_)!;^OO_S9R4FA:W%J>I7-I_9_EZO
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M8YQGG&:DHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?)_I8'\.G='KNJ>,=.T&XDL9EN[N6SMEN+UX%4BWBZ>8^YAUP3A=S>U0WGQ
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>Z7XHN['2[J<W%UIJV\<@>0_>V2,"4![@>IP15J?PK<K?:D^G:FEK9ZJ2U[
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M/I_74.H4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<_V)I/\ :W]J_P!EV7]I8Q]L^SIYV,8^_C=TXZ]*=!I&F6M_-?V^G6D5Y/\
MZVXC@59)/]Y@,G\:$]K_ -:O_,3Z_P!=/Z9Y=XEOH]1\"7.MW]_,EVNJI!+
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MI<=T4%Y("LN]U)1@=R# 'RJ0..E=7J6DZ;K%NL&J:?:7T*MO6.ZA650W3(#
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M2O\ U\U_D4G_ %]_^9D6S7-MXXM;-+^\:*^TB2>;S)C(!(K1JKHK95#ACPH
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MF#M#G )[9(!XK+CT"W;2[NTO$@NGO7,MV9H0Z2,<?P'C    .<!1G-+S_KH
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MZ!8R#O88P5).>Q&,GBII+'5KWQ9IT[Z-?6UH='ELY;@RP?N9'*$<"0DXV$9
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M&<!\;=V,G;G/!XK'N$U1/B!/J*:'>S62Z6;99DE@ >3=OP 9 W/W<D#GVYK
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M!INKW[^*]1T6^^S.(;:*ZAD@C9,*[.NQ@6.2"GWAC.>@K=<.8V",%?!VEAD
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M%Y';M=3+! K'F1V. J@<GK^%7Z\ZU36)M=\$Z/>W,<:3C7+>&01@A2T=UL)
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M2\0Z)HLD<>JZQI]B\@W(MU<I$6'J Q&:T$=)8UDC971@&5E.00>A!KDO'_\
MJO#O_8<M?YFNOI+:_G_E_F#WL%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !4-W ]S:R0Q7,MJ[C FA"ET]QO
M5E_,&IJS]=OKG3-!O[ZTABFGMX&E6.5RBMM&3D@$]!Z4I-)78TFW9'.P_#R&
M#1K32X_$.LBWM+H74/%MN5PVX<^3R-Q)_'TXJY)X-26?6I3KFJ ZO&(YP!;X
M10,#9^ZX^7*\YX/K@UK:%?R:IX?T[4)E19;JVCF=4SM!902!GMS6AVXJI*S<
M7_73]"8N]I+^NOZF!;^%+>W;2'&H7SS:7"T$<I:,-+$V,H^U ,?*O*@'Y>O7
M-2+P-;QV-W;/K&J2FXO5OQ,QA#Q3@[MR[8PIY X8,..E7/"VLWVLVVH-J$%O
M!/:WTMKLMW9UPF.=Q )Z^@^E;U%V]?ZUU"RM;M^ET<O?>![2^LM8M6U/4HUU
M9E:Z9'CR<*JG&Y"!D*,\<=L5T5K"UM:10//).T:!3+*%#/CN=H S] !4U%*_
M09@+X7"^+6\1?VQJ)G:+R#;D0>5Y620G^KW8R<YW9]\<56UOP)I^M:W'JXU#
M5M.O JQS/IMXT'VA%.0LF.HY/3!]ZZBBA:6\@[F%#X7B@\3MKJ:C>B4VPM1;
MGRO*6,<@#Y-W7G)8G/MQ68_P_BDTJ]TY_$&L-%>78O)7Q;;O,!#<?N< $A3C
M'\([9!["BC^OQO\ F']?A;\CG#X5*ZS=ZO\ VUJKW%Q9BT=%,"C: <%2(P0P
M+,V<]3Z8 V-+M9;+2[:UGN)KF2*,(9IF#.^.[$ 9/J<#-6Z* .5G\"V\EE%:
M0ZSJMM!%>F]C2)HCM?>7 ^>-OE#$GGGG!)  $S>"[.>YUJ2]O;V]AUB,1W-M
M-Y0C  PNTHBL"!P/F/Y\UTE%']?E_D@_K^OO,#PUX3@\,I*L6J:OJ!?A3J-X
MT_E+_=0' 4?AGID\5OT44-W RO$6AIXCT6?2I;VZM(+A2DS6WE[G0@@KEU8
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]3TI D5T1N&'4<+*O.X9/45E^)--L'^/?A^>_L;=X)].D"M-"&$DRDD8R.7
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MV. H'))HV DHK EUVZ_X2/1K2&" Z=J-O),)F=O-!500-N, 88<Y/?CO6_0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MP^(X+/\ LZ87+VK%+T6_[L*#_JO,['OM]!FM2D 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56AL+6WO+B[AA
M6.>XV^<RY&\@8!(Z9QQGK@#TJS10!7M;&VLC,UO$$:>0RRMDEG8]R3R>P'H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
+!1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ex10-56_02.jpg
<TEXT>
begin 644 ex10-56_02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2X Z0# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ )P,FL"SUR7
M4;"74DGL[*P>0):37 W>8 V"Q^90 V#M&?0GKMK<FC\V"2,'&]2N?3(KRZZT
MN[O_ (9:5HEKI7V_5](NK>*6%&B5H&B<$OF1EQN0<$=0X[$FA;_=^>OW ]OO
M_+]3T"[N[P&\&G3V-S/ $86ARK@<Y#,&."V/E.T8P>O:QI6I6^L:7;ZA:,6@
MG0.N1@CU!]P<@_2N2T*";1/%7BS5K[26TS2[OR9TN'>':S(N')".3DDYY'/U
MK8\$6%QIWA.TBND=)I&EG:-^J>9(SA3[@,!0MON_43W_ *\CH:IZO<W5GHU[
M=65M]JNH8'>& ''F. 2%_$U<JMJ!NQI]P;!8VN]A\D2'"ENV3@X'X4GL4MSF
M?"FK2:W;V]W9>(UU)2_^G6\T,:/;G:?D55"LF&QP^XX[UMOXATR/44L7GD66
M1MB.8)/*9\XV"7;LW9!^7=GVKGI]!DU'QAI^K1:"^EWMI+FYU 2Q[;J(J08P
M$8LX)QRZKC&1Z5D:+X8U#3?$IMKOP1H5Y MR]Q'XA9HA, 7++N387:09QG('
M&<U6[_K^OO)V7]?U]QU;^.?#H61H[]K@1S- WV6WEG_>*NYE^13D@<\>A]#5
MJV\3:9=VFG7=NUW)!J+;;9Q8S_-[M\GR#'.6P".<XK*\&V>HVM[XB?4-+GLT
MO=2:Y@,LD3;D**O\#M@_*>OJ*?X=T75-/N=2L[MU&F0.R:65(W"-_F.<=-I.
MQ?84NGRO_P  ;_7^F:L7B'3)=22P6>03R9\HO!(L<I R0DA4(Y !.%)/!JQJ
M.J6FE0++=R. [;$2.)I9)&P3A40%F. 3@ \ UP/@WPUJ&D:I!9W_ ('T&/[$
M,)X@A:(23@# 8($WAR.I)'))YKJ_$L.HS2Z8;*T:>)+DFX:$QB>)2I :,R$
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MDV,*6)/EJ>>.@&>IQ@'%"TAU2+XD7EXVBWG]GS645HMX98"NY&=BQ7S-^#N
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MJV/C)]6MK"2^M;VSCMF19D5K9T9CN(8@%3OYVDGY>AJ6DU_79/\ S7R*V?\
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M287*W"VKIEE0.<.Z%0#D#'#$<CC!K9\!6]_8>#=.T[4M.GL;FSA6%EE>-]Y
M^\IC=ACZX/M6+K6DZVMCXVM;72);LZL ;5XYXE#;H%C(.]AC!4DY[$8R>*N2
M2E;I_P %?\$<+7N^_P"K.ITO7M/O9QI\=PS7D<"RLKQNN]"!\RLP <9X)4D
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MNW!.X,O08!7 '(Z5VFR__P"$<,8M[8:A]EVB%G+Q>9M^Z6P,KGO@4MH-]?\
M@?YCWDE_6Z(K#Q/I&IW$L%M<N)(X_.(F@DB#1_WT+J Z?[2Y'3FK=AJEKJ2%
M[8RXZ_O8'B)&<9 < D'L1P>U<9IFB:H=:M+R[TBX,,FD2V=S%<W,6U&W(0BI
M&Q15(# ;1TQG'%:OA?2M1TG4+JW#Z@NBH@6WAU&:.9U?/6-E+-Y>.SG.>F!3
MLOZ]7_P";O\ K^O4ZJBBBD,**** "BBB@ HHHH **** "BBB@ HHHH ****
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M/:7<MOYI&.9!&RA^@^\#6S10!D7_ (9TK4KBPGN(IP]@^^V\FZEB6-NF=J,
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"Z3NO+^SD:2X=&\Q0T:RD;CTVJ V.,#FO2+;7-(O9?*M-5L9Y!*8=L5PC'S
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M>N>G0<U<^"-5N=)\26#:Y9 :W.96<:<W[D%0I 'G<\*N#Q@YZYP+;7.VMO\
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M=:PX/!6KP:?X?M?[=LF_L>Y-P'.FM^^X8 $>=QP[<\\XZ8P5'?7^M7^EAO\
MK[O\S:\7ZM'HWA^6[GTLZE '19(<H% + !FW=@<= 3[5#=>);Q=?O=&L](\R
MXM[-;I)9[E8XI 3C&5#,.01RO4=,<U8\5Z)<^(M!ETRVO8;,RLI>66W,W"D-
M@ .O.0.<^O%4CX=UD^(KC6!K%AOFL%LQ'_9SX4C)WY\[GYF)QZ8&<\TM;/\
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MOL(+O[//;^:@?R;A-DB9[,.QJQ0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %8M[X=6]\26&M'4[Z*2R5DCMXQ%Y1#8W9RA;G Z
M,.G&.:VJ*/, HHHH H:SI8UG3)+%KV]LQ(5/GV4YBE7!!X8=,XP?8U/8V4&G
M64-I;JPBB7:NYBQ/N2>23U)/)JQ10 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2%6B/R,2-RM@'GH>:-1L;";0M+N[+PMK]O)+K=O=LNH0375R K*))&YD*#:
M.2"<=*]<HH3L_N_"W^0WKOY_C?\ S/.?&%L^FZ[:W_\ 86MZAH\ELT1BT*:6
M&6"4N6+,D;H6#YY)Z%?>D:QL--\2>$&MM U"VB@MIXY,V<MPT,;K\D<DJAQU
MSP6.,^G->CT4EI_7K_F#U_KT_P CQ^T06?@>TM[?1=4A>+Q$+@0QZ1<*RPBY
M+AMHCR%\LC^77BN]\86][<Z;8SV<#W"6U]#<W%JJ_--$IR0 <9(.&QWVXJ_H
MVOVFNF^%I'<)]BN3;2B>(QDN%!X!YQAAR0/RK4IMO3Y/\%_D'5_/]?\ ,\K\
M6Z>=8L/$^J6NF7LEG>Z4EO';/ITOFSW09MK^45W@K\HW%1V.<#->AZ)% FE6
M\L-MY#R1)Y@:$Q.2JA?F! .1C'/85HT4+16_KK_F#U=_ZZ?Y'E<EKJ4'AAM.
M31]1GO+3Q%]K:.. @/$;HRAD=L(V5/8\=\56O( N@?$*&TT348I;VYW6R1Z5
M,#*3&@RN$Y^=7)(X[]""?7:3<NXKD;@,XSSBA-K^O\/_ ,B@>KO_ %U_S.)$
M\\7B2ZO+G3K^YM-1TZ&*R<6CMY9&_?&ZD9CR2IRX [$\5Q]I::KI/AGPQ<ZE
MX<\17%K:V<EK/:Z9/)%<Q2%@0^V*12RL!C!.1CH*]GJM<7GV>YM8/LUQ+]H<
MIYD2;EBPI;+GL#C'U(I?U^?^;#9?UV2_1'G<VF65KK?@@VGA[4;>&WDG9Q-;
M2W#P1R(^%DE&\#+G.TL<9S7I4,,5O"D,$:111J%1$4*J@=  .@I]%.^EA6"B
MBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *CN/^/:7_</\JDJ*ZMX[NUEMI3((Y5*,8Y&C;!]&4@@^X(-*2NFA
MIV9YYX?N[M/ 7A2RM-0EM7GL2VVTB22Y?:!C:'5D"\_,6P.5&035VUU?6+KP
MYX9U^?4IH(VE2/48(X8MLH=B@8Y5BN&VYVD#!/M6[:^#-"LH;&*WMIT6P#"V
M/VR8LBMC*;B^2AP/D)*\#BK,?AO28M#FT5+,#3I@RO#O8Y#')&<Y'7L>.V*M
MN[;_ *W_ ,A/7^O4YO3[W5)KW4]&FUR]^TO<Q2V-QY4 <6K9R0/*VG_5R#D'
MC;TS77Z@UW'IERU@B2WBQ,8%D. SX^4$_6FC2[%=0AOEMU%S#";>-QGY8R0=
MN.G8?Y-698TFB:.091A@C.,BI>U@6]SSV_UHZA\/O$UI=3:@NH0:;*T]MJ-N
MD<J95N044(Z=@5STY.:TX=3U'3?$L5C-J*2VD^CO> 3HB);O&4'!4 ["&R=Q
M8\<&M:Z\(Z->V=[:W,-S+'>\7#->S%W7).S?OW!.3\@.WD\<TUO!NB/>0W4L
M-U++%;&T7SKZ=U,1&"C*SD,#WR#D@'J!3OI_79K\[#Z)?UNO\F8WAW5]6D\3
MQV-W>7-W:W.FF[#SP1QJ) Z@B+:JOL^;^,9Z<GFL*#_DEOAK_L,6W_I77<0^
M$=%MVA>."X\R"![:*5KR9G6-B"5#%\]ACG*XXQ4'_"":!_9$&E>3>BRMYO/B
MC&I7(*OG((;S,\'D#. >1S332E?T_!W_ "(L[??^5OS-C5?^01>_]<'_ /03
M7G_A>[U/2/"G@BYBOI)[2]B@M);%HDVJ&C)#H0-V1MYR2,9X%>D[%,>PC<N,
M$-SD>^>M9>G^&M)TJ<36=JR%!B)&F=TA&,8C1B5C&.R 5*TO_7?_ #*>J.8\
M/ZKXJUZ[M-9AN--72)92DULUWN*+DC 06X990< @RD9SQR*Z/Q5K7]@:&U[O
M2/,T,/FR#*Q>9(J;SR.!NS^%5[;P)X8M/$C^(;?1K>/57))G7=U/5@N=H8\\
M@9Y-;=[96VHV4UG>01SVTRE)(I%RK*>Q%'1!U?\ 7]?\ YC5-0U;PMH>J7L^
MHKJ<*I&UI)/&@D0LVUBXC55*+N4Y SC.3WJ*\O=;T;7(=-756ODU&TN)H9KF
MV0FUDC"D<1A R'=T/.<?,<UJZ)X*\-^'=.N=/TO28(+6Z!$Z-F3S1SPQ8DD<
MGBI;?PKI-K;30117(66,Q%FO)F=$/5$<ONC7@<*0.*'MI_6G^>M_(%Y_UJOZ
MMYG,:+K^LRIX+O;K4#,NMQ%+FW\E%C5O):0.N!N#97'WL8["K^G:U>OK=SI6
MKSZC87EQ)*+56@C,#H =I@D"G+8PQ5R3P> *OP^!]!@33$BAO%72SFS7^T;C
M$7_D3D8R,'/!QTXK231+!-02]\N1ID&(_,G=TCX()1"Q53@D9 !QQ52LWIY_
M\ 6OY'GNEWNN:3X7\)M#K4LZ:CJ*P7'VJ&-W"L6.%8!<?=.=P8G=U&*Z&W?6
M;;QBNC7.O7%S%+I,DV_R(4*2"15#KA.N#T.1GMVK0D\#Z!(ELAM;A4M9C<0+
M'>SH(W))R KCH2<#H,G&,FM&]T33[^^MKVXA8W-L&6.1)70[6QE6VD;E.!\K
M9''2I_K\+?F-^7]:M_D<):>)]?O]$\/V$%W"=3U**X=KN>9+=F,<@4!#Y,B%
MB#DC9T!Q6TNH:^AT?0M1NK>#4[TS^=>66)-B1C("[T"^80RYRF."<=*N7?P^
M\)WNAC1I]$MFL!*9A&NY2'/5MX(;)[G/-6V\):$VD6FE+IZQ6EFP:V6!VB:%
MO[R.I#*>3R#DY-/^OZ_K4#$\!(\>K^+TDG,[KJV#*0 6Q!%R0.,^N,?04[QE
MJNI6C7:Z;J,T4EK8FZ6"SACDD9AN_P!;YBE5C..,,K'#8Z5T.FZ!I6CW-U<V
M%E%#<79#7$HR7E(Z;F/)IE[X<TK4+Y[VYMF:>2 V\A69T66/GY752 V,G&0<
M9.,4I7:5NWZ#C9-MG/ZGXAU&RDTZ^O!>V^D26:2R75E LT:2D'=YRD%U094@
MKCODUUUP99;"1K.:-)6C)BE9-Z@XX) (R/;(^M9[^&=)DLH;(P3"UB14$2W,
MJJZ@$!7 ;YQR<AL@]ZT+EF@LI6AMGG9$.R&(J&?CA1N(4?B0*)O1V\Q1OI?R
M."T[7=>_X1WPWK\^I-<M?7$5M<V8MXUC82.5WK@;PPX/WB, \=Z=;:_KT=GX
MGU.ZU%)DT.\N%%M%:A4FC6%653R6&"0<@GH?48O> _#(T_0-.?4],N;74K52
MGESW/F(K<_.B*[1J2&(W !NN:WM+\-Z7HYO39PS?Z:YDN1-<RS"1B,$D.QZC
MCZ 4WU_KM_P?O!6O_7=_\#[C"T1?%E](\UYJMDNFWL!:&:UNDGDC<X*F+-LB
M[<9X?>>G-,\/W]_J-O!ID^O7C:OI]S(-1*PP N$/"D>7@*P9",8."><BM;0/
M _AKPO>7-WHNDPVD]S_K'4L3C.<#).T>PP*U;?2[*UU"[OX+9$N[S9]HE'63
M:,+GZ"CT%TU.,T#5?%6O75IK,-QIJZ1+*4FMFN]QC7)&-@@#+*#@$&4C.>.1
MBK_PD'B"/09]4GU1'FL]<^Q-%%;(D4T9G6(A@=S#@DC# YZY'%=-;^ _"]KX
MC?Q!!H\$>JODF=2PY/5@N=H8\\@9YZTP^ ?#YT^6Q,-\;:6X%TZ'4[GYI0<[
ML^9G.>>O4 ]0*%I;^NJ_2_WE/K_71_\  ^XR8(=4B\1>,;FVUNX\R%(_)BN(
MHY(4)BW#@*K<<X 8=><FFV>NZY>1>"#]OC1-7M2UV1;J79_)W[@<X'/;;U]1
MQ733>&=*GENI7AF$MU"L$SI=2HSJHP#D,/FP2-WWL<9JK#X)T. Z9Y45ZO\
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDTL<$+S3.J1QJ6=V.
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MI6MEN@7M)441-]TEF4*,^A.>#Q4EIX@TV]OVL8II!.%+J)8)(Q*HQEHV90)
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M6 7<"NXD#&01UXJFFM!7-^BN1O=0U?1X--TRZOTFN;[4?LB7RQKN2(JS@LN
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M7VGK=2:K#;2-&//9X7( W';& W7.$ (Z8IVO_7I_F)Z;_P!;_P"1W;,%4LQ
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M+C3-2B@CFOK6,S/$XC/(CP@;]YD';T !&::5_P"O3_,/Z_K[CTXLH(!(!8X
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MQ(P2 0P4\]Z>J_KM_D'G_6HS_A$-%,^I3/;SRMJ:>7=K+>32+(O^ZSD#'08
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MR:K>)<-;H 2(86=N>F1V^IP!WJ"+Q/9G4+RSNH;BR:UMQ=E[D*%DAYRXPQ(
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MDMI%TR-0JP17$D?RCH"RL&(]B>:DT_78=2BDGAM;K[*N[RY\*ZS!>I4*Q;V
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MD$?-MZ>G-48?'VFW$>E>19:E+-JEJ]W;0K;C)55)*[L[=WL&/4=CFEV_KO\
MY/[@[_UV_P T:<GAC2)=*.G/;.T!D$Q;SY/-,@QA_-W;]_ ^;=GCK56\\$>'
M[Z.X2XLYBMS(DL^V[F3S'0 *6VN,_=7ZD G)&:M6OB"*\OGM8+*[;R@GGOA
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M $#9CDC@YXQ@\GH3^(X]7TN:\\'W#Z1!,39RQ:O;O#;[\KYD<6U9",,<*S'
MZ =*]3LK@7NGV]R4VB>)9-F<XW#./?K5>RT'1]-NY;NQTFQM;F;_ %DT%NB.
M_P!6 R?QJ]5+7I_FR59QT_K0Y7_A%-;FU33M0NGT^:\LM1DG^U/+(SR0LKJ%
M"[<1X#+\BD@[<YS7/ZLVOW&N:@UCX6DU/0/MPFE-KK%O%#,Z;<LR.N\,K)R
MR@D<YKUJL_\ L'1SJ@U/^R;#^T!_R]?9D\W_ +[QG]:E:6\O^!_D-ZK^O/\
MS.9N]'\07>NZMJ=O9Z<+>_TM+.%)[QTD5AN.7 B('^L(P"?N^_#++P_XAM[C
MPDTMOI?EZ/;M#<E;V0ELH$R@\D9X4'DCDX[9/86DUS-Y_P!IM/L^R5DC_>!_
M,0='XZ9].U6:+]OZW_S8/7?^MO\ (\BCF\0'5ENH_"4M]X=COGNH'M=7MA;L
M2Y(F6,J)"W.=N_:6Y Z5Z!XLTZ34M#_<1M)/:W$-Y'&.KF)P^WZD CZFKD&@
M:-;:D^I0:3817[_?N8[9%E;ZL!D]!WK1H6B2[?U^@/5M_P!=?\S"U>U?7],L
MKO2+F!;B&=+BVFD!*C^%P0.>49QCUJ/3?#LFF^([N[CE3^SY8T=(>=PG"[&<
M]N4"_CFMMVM[.)Y&V1(6W,<8RQXR?4GBF>=<_P!I>1]D_P!%\K?]I\P??SC9
MMZ].<T>@=-3AKWPSXHN]#\067V;1UEU._6YC/VZ7:B#9D']SU_=CI_>/3'-R
M31?&5CX@EO=$O='CLM19);ZVO5EE,$H558PE=NX$*/O;>GO7;52CO)4%Y)?6
MXM8()"(Y#*&$L>T'?@?=Y)&#SQ[T+3^OD)_U^9CW6D:O#XCO=4L?L4ZW.G);
M%;B5HR)$9R/NJPP=YR>V.ASQBV/AGQ):VO@Z!X-*/]B$BX9;V3YQY;1Y0>3Z
M-NP<<C&>]=M)/=+J,$*6F^U=':2X\P#RV&-J[>ISD\]L>]6::;7]>O\ FQO7
M1_U_5CC-'T3Q?HNK-90:CI4WAL2O+'YT4ANT#,6\L$';@$XW')QVJ[X-T?5=
M'AU1=4CLU:[OY;Q/LMPTH'F'.T[D7IQSW]JZ:BDM >O]?UW.<OM'U.V\3MKN
MCBTF>>V6UN;:[E:)2%8LKJZJV"-S#&WG/48K&3P;J=AJ?A^2R^Q2P6-W<WMT
M\L[HSR3[]P10C# W\9;MCWKO**:=OZ_KN#U,/QAIE]K7A+4M+TY;<W-Y T -
MQ*T:*&&"<JK'CTQSZBLEM!UJ[\2V-Y=VVG+9)I<EA<".\D9P7VDE1Y0! V8Y
M(SG/&,'LJ*7E_6UOR87_ *^Y_H<79^%M4?3M*T74GLWT[2IX98;F*1_.G$7W
M R%0$.0N2&;.#P,\;.@:7>Z7/JB3M;M;7%Y)<PM&6+D/@D,",#!R."<^W2M*
MUFNI9;I;BT\A(Y=L+>8&\Y, [\#[O)(P?3WK-MO$/VCQ?>>'VL98FMK5+D7#
MNI656) V@$GJ#UP>.G>G=M^O_#BMIZ?U^IDWWAO6$N?$$>FR636>MHS2-.[+
M);R^4(\J I#J0HZ[<<_>Z4W3/#&LZ5=Z'<+/87+VFFG3K@G?$ N5*N@^;<1M
MP02,]<CI79UB:AX@-AXFTC1C8RN-1$FVYWJ$0HI8C'WB>G8#GKVI+M_6S_2X
MWKJ_ZV_R1RUKX/\ $=G:^&;8R:5<)I-[)=.WFR1$JRN @&UMQ^<G=\O0#'>M
MC4-)UY_%]SJEK;:;):MIILXQ+>.CEL[LD")@!GCJ>.?:NLK%U/Q"MA<:6D-H
M]U#?W7V4SHZA(FYZY.3]T] >G)%#UT_K56#S_K1W.:L/#'B.TM/!L#P:4?[#
M)%PPO9/G'EF/*?N>N&W8..1CWK"NY=?DUBXFMO"4NH^'DU W0:UUBW2"5E<'
MS/+9=^X%<[=X4MG@YS7KE9;:-H5G>RZRVF:?#=JI:2]^SH), <DOC/0>M/F;
ME=A;2W]=?\RGXQTS4-=\)W6G:;';_:+I0O\ I4K1J@R"3E58D\=,?C63J'AC
M5M;URYDU""PATZ\T@Z=,8;QWE1F^8LH,0! )QU''/M7; Y&17/ZOXH;2=9M-
M,70]3O9KM6,#VS6X1]HRP^>52"!ZC'/&:7]?A8//^MTRG!H6LWLVDMK/V$G1
MW,L$EM,^;E_+* NI4>6,,20"_/?US;?PMXAB^'^MZ&\6E_;=0EN60B\D\M1,
MS$Y;RLY7=Z<^U=9I>K2ZC+/%<:3?:=+"%.R[,1WALX*F-W'8]\UI4W=_/_.X
M)VM;H<='H_B$>)=&U-K72Q%9:=):RJ+Z0L7?8<K^YY \L=<?>/''-/2_#?B:
MTT2SL9O[."17\T]Q!%>RA;B*1F?!<1!@5+?=P0V.2,XKO:*+O^O6XK:6_K:Q
MYX_@[7;7PW#I5C%I#"'6/MZ*9WA18Q.90H C;!_AQC ZY/2NK\3Z(WB/PS>:
M5YP@>X0 /C<%((;VR,BMBJ=W>2I974FGP"]N8,J+<2!-SX!V[CP.HHOT_KI_
MDA];_P!=?\V9$&BW]_JD6IZPMK!/;VLMK#%:2M*H$A7<Y9E7GY1A<<<\GMC6
M/A+7[>T\+6[7&FQ?V#*1O'F2^?%Y9CSC"[6(;ID@'N>E=V"2H)&#W%+1=K^O
M7_-ANK')V'ABXT_Q+)J=E;6EA$\;F:*VN9/+O)6'5XRNV,@\[AN8YY]\6T\+
M>*;?3-'M6MM'+6.K2:@Y%_+AE9G8*/W'7]X1_P !'KQVNLZQ%HEFEU/;7<\1
ME6-OLL)D,8)^^P'(4=SVK1H3M_7S!_U^1P4WA+7[NXU^7SK&QFNKZ&^L+B&9
MYC&\2JH$B%%&"%YP3]XCG&3L6&G^(;_0;BU\61Z'>2S?(;:UCD$#)WW%\DD_
M0 >AKI:*72P/>YQ=IX/F3P[=:;>V5E>6\DWFP:=<7DLD=L HPJ3,F\?,,YV_
M+G %;OA[3;S2-"CM+FX-S.A<IOF9]BDDK'YC#<P48&XC)QT[5KT4 >=GPOXI
M/AR*Q-MH_P!I36?[2.+^79M\[SMN?)SG)V]/?VK1D\,:M%!K.EVK63:7K#RR
M222RN);5I5PX50I$@SDC+)C/>NSHHWT_KI_DAW=[_P!?UJ<L?#E[8^((+S3#
M;-:?V:NGR+/(P>,(259<*=_7!!*^N>U8NC>$/$>F7GA3SWTJX@T:"6&1TEDC
M9A( O"E&!V@9SD9)Z+7H=%.^M_ZZ_P";%TM_71?HCE-9\,37^OVVI6<-M:72
M2(7U&*X=)C&I!V-&%VR@C</F; R#@U;B@74/&QU% &AL+1K42#HTDCJS ?[H
M1<^[8[&N@ID<4<,:QQ(L:+P%48 _"DM >ISNM:9K%UXKT74;*"Q>UL!+YGGW
M3QNQD7;P!&PXP#UY]NM<\OA7Q0OAF'3OL^C_ &B/6?[1)^WR["GG^=MSY&<Y
M.WI[^U>C4R6:.!5:5PH9@@SW). /SH3MM_6M_P P>O\ 7E;]3+\0VFJ7VD>3
MIDT<-SYB,ZM*T8D0$%D\Q063(XW 9%<G>>"]8&B^);#3X=)C75YTEC0S.BQ_
M(@;)$9R<H>WS9R<=*]#K'\4:[_PC7AR\UC[%+>+:IO:*-U4X[G+'H/Q/H#1>
MW]>G^2&M=/ZZF4+35;3Q=_PD&HII5KIL>FBWG?[<Q,9!WEOFB5=H/&21QSQT
MIOA"RMFO]2U"PO8[O2?.==/,1#(@?#S;&!P5,GY8(KJ"D-_8[+B%)(9X\/%(
M RLI'((/!%20PQ6T*0P1)%$@VHB*%51Z #I3V?\ 7<G1K3^M#$U_1KR[U#3-
M6TQX1?Z>TFV*X9ECF1UPR%@"5Z @X.,=*R[OPE>W>E:[*7MH]6U62&8H'9H8
MS$%VINV@D?*<MM'7IQ7944OZ_+_)#_K\_P#,Y-M.\2'Q1<ZG]ETIH7T[[+&O
MVV16WY+<_NB ,G&<YP,XYVC$M/"7C#2=%T232+O2(=8T^U-E-%</)+;7$600
M20JLK C/ [XS7H]%&W]>O^;#^OZ^XY"_T7Q%>ZUX9OI3IDQTUY);MQ+)%N9T
M*$1IL;@9SRV3[=:Z^HYIHX$#RN$4LJ@GU)  _$D"I*=] "BBBD 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5F^(1
M,?#NHFWNIK69;=V2:';O0@9XW CMZ5I50UN"[NM$O+>QC@DN9HFC19Y3&GS#
M&2P5B, YZ&IG?E=BH6YE<XG3I;P0>#;NTU2^GN-4A6.]#7+2JT?D%C(%8E59
M6"_, ,DX.<U3TR^U6V^&MQXB_M/4;J_A^TPLTDNY0GV@J92F-NY%!(P .V,8
M Z_POX:@TK0(+>]TO3([]K9+>\DME#BX"KM&YBBEL@=".,XYK6T_2--TFV:W
MTW3[2S@8Y:*VA6-2?7"@"M9M<SM_6M_RT^9G"_*K_P!:?U]QRZ1/:>*["QL+
MZ^N],U6SGEN1)>R2F/&W;(CEBR9W$84@=",8KF=*E;PW\-IM2M+RX@,NIRPW
M%U<S37*01?:G4OL,@QQU*E3SDG(KTJVT+2+.WN+>UTJQ@AN<^?'%;HJRYX.X
M 8;/O4,&C^'M LKDV^FZ7IMI(O\ I!C@CAC8#^_@ $<GK4?U^-_^ 5V_KI;_
M ()Q^F1ZA<>']1AT7Q?I^NLTD7EQP7,J!!G+Q^>9I9%9AT^;*]L=K4E[J>KZ
M(BZ997JW%E>>7?:9<:@8IV"H#M2=6.[JK?>P<X)'(KKK71M*L[#[%::;9069
M)/D0P*L9SWV@8I#HFDG31IQTRR^PJI46WV=/* ]-N,8_"FP1R5UK,U]+X/OK
M&\U"VM[G4GMKBTE*C=A9,JY ))5DP,-@^_!JA>W][=^'M?UM+^\M]<TJ[F2&
MUCN&$:A6Q'&T.=K[UVG)!)W\$<5VK:/X?UB*TG?3=,O8[?\ X]9#!'((L'^
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M=>!]7N=/UVT.NV*C5KQ;IF_LUSY> HVC]]S]Q.?KZC GIK_6J_2XY:[?UO\
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M(Y( Y'OANH^.Y+/4&M[70[^]2!Q'<F"VN)&5L D(4A:-\9YRZXP:M#PQJ/\
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M@]YHTG]H:?-#'<6T-PK(%EX2178*2A/'W<Y[=ZZJQGNYXY3>68M665E0+*)
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M>+^VK(KH/&3I[#SQL,?_ #V^7Y"?7GGIQ6OIT1O_ !%=:T!_HPMUM;9BN#(
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MKWFG^)+1]=L\:W('+_V<V81L5,?Z[YCM5>>.<G'. HM+^O./_!-':UOZZ_\
M +NO>,SI5X;2QTNZU">-%DF6*"X8*K9P 8H9!OX^ZQ4<CFNCL[G[98P70AFA
M\Z-7\N9"CID9PRGH1W%<IJ7@[6+C4K?5-+\4R:3?M#'!?-!9I)%<JF<$1R%M
MC<G!RV!ZUU\,9B@2-I&D*J 7?JQ]31T(U.!A^U6'Q.\42Z1IEM<7#V%G))&\
MWD!SF4$E@K98@#J.W)%;-OXP.KP68T.R2YO+FU^UF&ZG\A8DW;<,P5SNW;@
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M_&_^7XH'I^/X6_S_  9Z;2-G:=N,XXS7GEAX;TWQ!;^(]*@BMIO"]PL1T_8
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MV_KI_FA7LK_UU_R9V=%<-J'BO78(_%4D4&G1+H1$BAM\IGC\OS,'E=K$8YY
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M)^E-MMW8625C#3P'IRV]C;-?:DUO877VJTB$X00G#?("@#%?F/4D]LXXI$\
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MX 9.,]< $_2BSO;74;6.ZLKF&YMI!E)H) Z,/8C@T/5-?UU7ZAV_KM_D<3X
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6WFDWTME92P/(!ILMM(EPT0.$E24OMD4XR<*,9Z\<]K2Z)AUL%%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH ***B@N8+I"]O/',@8J6C<, 1U''>@"6
MBBB@ HHHH ***"<#)Z4 %%9]KKNCWUQ-;VFJV-Q/"0)8H;A':,YQA@#D<^M:
M% !1110 4444 %%%% !1110 456L+^VU.RCO+.3S(),[7VD9P<'@\]15F@ H
MHJIJ.IVNEVWGW32;<X"Q0O*[=^$0%CQSP.E %NBH+*\M]1LH;RTE66WF0/'(
MO1@>]3T %%5K_4;'2[5KK4+RWM+=2 9;B58T!/3DD"I89X;B)98)4EC8 AD8
M,"/J* )**** "BJU_J%KIEM]HO)?+BWI'NVD_,S!5' [D@59H **** "BBJ=
MYJVFZ=-!#>ZA:6TL[;84GF5&D/HH)Y/TH N44@8,,J01ZBEH **H:9K6FZT+
MEM-O([I;:8P2M&<A9  2N>AQD=*OT %%%% !1110 4452U#6-/TI[5+Z[C@>
M[F$$",>9'/0 =3_2@"[145Q<16EM+<3MLBB0N[8)PH&2<"EMYX[JVBN(6W12
MH'1L$9!&0>: )***C%Q URUL)HS.BAVB##<%)(!(ZX.#S[&@"2BBB@ HHHH
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MX\U"WW\[PP;=U(8$$\]:T=-TN#2X95B9Y)9I#+//)@O*Y &YL #. !P
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M)+>S6VGV][:I/)=7%N[0%V _=[PP$1R0<MG/0 FKLG@U)9]:E.N:H#J\8CG
M%OA% P-G[KCY<KSG@^N#5D>&0-#ATG^U]1,$<2P.Q\G=+&,C:W[O X.,J <
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ME/Z#%VX\*6-SHUQI[S7(>XF6YENU91,TRE2LF=NW(*+QMQ@8QBFK7U_K5?\
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M R1QZ8ZJD]4OE^0=6%%%%(84444 %%%% !1110 4444 %%%% !1110 4444
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M;^((XXT_U,:(+A'"HK$X4+DX!X STKK8]5TZ7XN""._M7F;1@JQK,I8GS-^
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M@H?[O=MHXZT=%YAU:['445Q_P[*Q:5J-BKQ_Z)J,\:QQ1LD<:;LJJJ2=JX/
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M[?0(HXI1#*]JN25\QLL/PW'Z5P^E_P!GW%UX;N/#XB37%FC36D!Q/Y?E-O\
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M>9K.:,RRXB$GWEC;!^Z7&T[?5L5/I]]X<N_ASILNK7&F3Z0UM#'*]PR/!N
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MF >U/\>:K8Z3J6F3>(K4S>&'CE2Z9H#-$DQ*>69$ .1@.!P>2.^*&K6_KO\
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MY-4XV^]_@'6W]?UH34445(!1110 4444 %%%% !1110 4444 %%%% !1110
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ML.?+B0("QR3CN3W)ZDU/10 4444 %%%% !1110 4444 %%%% !1110 4444
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M_K^M0\PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#EOB-KUWX9\ ZMJMCC[5#&%B8C.QF8+NQ[9S^%85KX*TB7X=1WTD0;6I-/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:A82+'/$DOFH0RAE9'VJ2"#W .0>*=OZ^[_,+_U]_P#D;-%%%(8444$X&30
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MCRG"X&,GDU;NO"*WUQK*W-ZSV6K0)'-"(P'5U7;N#YXXP<8X(SG'%=+12Z6
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MK7]WJPU/[*5DN699T-R596C'R$A,G.,C'4 8KTV<RK!(8$1Y@IV*[E59NP)
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M4IMW%L%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'KCUK6^'^JMJ-SJLUW8:U::E<R+/-_:&FM9QN H0>4I=^  ,Y8G)],4+6_\
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MR 6PC_,267 #C&3SQS7^'WF_\5+YQ0R_VW/O*9VD[4Z9II:O^NJ0F]%_7?\
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M<07 !QNY48P<#(QCTQ7244 8$_A.UE@T\0WVH6]W8 B&^2??.0V-P<R!@X;
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MV'AK4]2TA+:ZEL'*2"9R$!7&[&T')&>G'.>127E_6WZV#^OS_P""=&    ,
M5S-]X*M;W3]4L5U34K>WU&<S2K"\?REL;@NY#PQ )SD^A )%=*IRH/J*6@%L
M<X?"$,NL-J-WJE_=[[+[#+;S+#Y4L1'.X+&#DGG@CGVXIOAKP59^%Y9&MM3U
MBZC(VPP7MZTL5NO]V->@],G)QWKI:* L5[^PM=4L)[&]@2>UG0I)&XR&!K,T
M_P .M88B.M:I=6:@*EK<O&RJ!T&\()&_X$YSWS4?A_6K[4]5UVSO;>WA.G7:
MPQ^2[/N4HK@DD#G##C''OUK?H\P?8P[OPO;W&J37]O?7UC)<H$NTMG0)<@#
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M;8]Y'S%B,AACT##M5[^T-'N/!.K:AX$-\+%I8GECLK4Q*B!@)?(1TV[MH)(
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MQ."2C<$[GV'()R2,'I5/PO/X3NX]5O;/7=7$RV<BZE%<6Z621$CDRR1PQ@R
MC ;<6Y/O7KM%)K1K^NO^?X M/Z]/\CBOAA;6$G@O2=3@V27LMC%#<3+(69BN
M3AN>H+'WYKG+BZT^3Q)::I!Y$-Q!KIM[F27+7H0[QL8C!2(G&U#NR-IKUBBK
M;O+F%;W;'E4NJ&>;QT-&NDN)TU&V>>.UDW2^0$B6;:%YS@...<@CK5M1H@U6
MZNO#US9P>')=+G.IR6<_E0I+E=AW(0$DQOR00V.O:O2J*E[6\OTM_P 'U*OK
M?^NG^7W'CN@ZEHUM!\.+N+4+);^YC-O<3&=3)(ODL-CL3DCS-HP>C8'6G^%Y
MM*O?%]NFHZKK47BZWE;[1:?88U# $YS,L&YH2#D!I.F.^*]?HJG*\K^OXDVT
ML<EXRECAO]&.J+&WATR2K?\ FC,0)3]V9<\>7G=G=QG;FN&U]K2RT2\\B^2#
M0SK5D=($=T4C9"4\T1X(#1C+$#E1R1TKV:BI6G]>:?Z#>O\ 7K_F8TMEH]AX
M:O4C:.UTV2.6:21)S&H#Y9F#@C:#DG((QVKS/1-2T:YM_APL^K6\CO%+%-$U
M[PQ,;##)NP26.WD9.<=\5[+10M'?^NO^8/56_KH<5\.+[3I[+6;/3;JUDMK7
M5)UABMY%98HB<J% Z+][';KBL.QU70[CQ.^FZ]!>6_BV'47DMY(K:1I)(?,)
MC"R!2!"4PI!('7//->HT4T[-,'LT>4:C]GNK#6XKWRD\;PW4S::3\MR1N_<^
M2>ICV[00/E^]N[T^\ET.;QAXKMM7O;*;&D02307-T'C24>9N(1F(7'R'@#&0
M>">?5**72W];6_X/J.^M_P"M[_\  ]#S'0[F+59OA[>&[-VTVGS13GSRZ.RP
M@,&7.W<"6!.,]0:QC_9EEX1M[,V\0N]*\3;_ +-#;[Y;6,W9881064%.F!R.
MF:],AT.Y;7EU+4=02[%NTILD%N(VA63 (9@Q#X P#@=3G-;=5S:\WG?\;_YD
M6TY?ZV:/&]8N] E@^(S2:A:RRP!9;?S[K>T,OE<% S$HPD.!C!!X&.E7M6\0
M^'I-0B7Q8&GTR^LK?^RKV.%[A/-PP?RR@;;+D@A@,\#FO5J*E:*W];6+;OK_
M %T_R.!N;'1E^(6B75[:Q-(^DN(;F[A'G-(KQX.XC(<*6/8@;CQS7/:-J-M_
MPBL7V:\6\T:#Q!.NI%9S.1;%WV%SDDIG823U7KQFO7Z*=_Z^=Q)6_KRL>0:\
M-/M/#/C&32;N"W\,M81O9-:W/EP_:_FRL14@8.$RJ\$G&,YK:TS4-$@^)&EQ
MZ=>V(:_T9FE$,REKEPT9C+8.7;;OP3DX![5Z+10G;^O)K]?P!ZK^O+_+\3C?
M$NFZ?9>([+6I-+M[@WL;Z9<Y@5C('&8]W'(RNSZ/SP*J^$]&M;>8Z%<:?;E?
M#]S))!(8% _>8:-UXX(#,"1SE0:[RBDM/Z_KS^\'K_7]=+'C##0M0\%ZW'YM
MIJ%K9^(TE9I91<^7#YT8+LS%CMV;ADGIGM6M?3^%;GQ/XALIIM+-I;Z' JV[
MNBQQ[6E(^0\#;N0CCC(Z9%>HT4?9Y?ZV2_0I2L[_ -;W.3\-ZA=:G\+;&ZTZ
MZCNM0;3 $E+A\SB/&&/J&&#[USFF#3KFY\.3: L2ZV)436D'$QB\IO,%R.I.
MX#!?OTKT^BJ;O)R[_P#!_#4A*T5$\8D/AW1/!M]!C3].N6\1+',%"P/M6\#*
M"1@X$?S#T7D<5JR7L%MKGC;3_#-Q +DV$-Q':V4B;VE^?S&11G]YC9SCJ5SU
MKU*BE?2W];)?I^)3=W_7>YXK;W'A2;PKXGO])U_52PL9%N4F@2QCCGZKN:**
M(-+NP.I)R0<@UTC:3IUQX#TZ^LKS2X#+%!+<M>_O+6Y\N(J4FYP .>>Q49SC
M%>C44O\ @?@+_@G/Z#?3:KX2,T=HEI,RRHB12;XRP) >-B!E">5.!P16):Z!
M!XA^$6F6,]M!/<16$;0B:,.$N$7C@]]P(/U(KNZI66G"PGG,$A%O,QD\@CA'
M)RQ4]@3DD>ISQ3;WM_5@6EC@%6TN-9MM>M=+A6'Q-:'3WW6P#;]NX,X(Y!'F
M YZA%JUJ'_",P>/+31;J33([2WT69&LY'18U7<C;60\8VAFP1T&>V:]"HI/_
M #_7\KL5OT_3_)'B#:U8R^"/#CZIJD__  CBI/;WEQ:PQ7:Q2AQY2RH\<@V[
M<X^7(./6MR\TOP^^D>#9I=^I:4NI,$N=6MEW>6\<F%P47:A?8%&T#A<=J]3H
MIIV=Q_\ !/&M=U'0+C2O']V+ZQ>ZM;R.2U<S+NAE$,:JR<_*VY67(YR".V*D
M\4:CHM[XC\OQ'K&HVUE=10OH]Q8V<=S'+E>3&_DR,LN[/*$<%:]AHHOM_72P
MV[NYYI';Z/J'Q3FTR[NC=;M&AWP7%T2XE#[A\N?E?:JL0H'KBM[QE+'#?Z,=
M46-O#I>5;_S1F($IB,RYX\O.[.[C.W-=;12[?UW_ ,Q=_P"NB_R/&=?:TLM$
MO/(OD@T,ZU9'2!'=%(V0E/-$>" T8RQ Y4<D=*]#UBUTC3/!&JB&2.SL'AEF
M\R.X,:AGRV0X(QECV/>NCHI25XN/];6&G:2?];GE&AZCHEMJG@*6UO[!;N\T
MYX9W6==\W[M0JL<Y;#@@ ]""!Z4U?*N=)A,8A3X@0WB^9SBY(\_YL_Q&#83_
M +(&/2O6:*MRO*_G^M_^!Z$)65OZVM_P?4XGPK8:59^./%?EV5I#J#72.&2%
M5D\IHHR3D#.TN&/H6![UD^(;BPEO?%5OKR1&_C@9M'29?F,7D<F'/\6XON*\
MXQGC%>F45$E=6\K&BE:5_.YY7HYTZVU;P;?WD$=M'<Z%)8R27,'E&60>4!$V
MX D\/@'J,XS6)I]SI,,'A&SDF^R>5KEY$UM*SP1F$F4C"'"LO*#< 0,XSU%>
MWT5;E>5W_6K?ZLS2M&WE^ECS6\'A[0_B):Z=_:$5G;KH,\+0O?LGE*&0KC+_
M "':&.1@X!/:L/1=3T2VTCX?WRZE9+?/>-!-<-<J960I)N1F)SMW%,@\9([D
M5[-123M9_P!;M_J4_P"ONM_P3R*_N-(NM>N+ ZGIZ:P^JX;5!J4=O,D D!-O
M\LBS XR@51M/7(S7KBJ$15&2 ,#))/YGK7'-X M+K4YY]2M]"U"*8LS27&C(
MUV2?6;=@XZ#Y.F/2NQ551%11A5& /04E\*0/XFQ:*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JVH7;6&GSW2
M6L]V8E+>1;[?,?'9=Q S^-6:*3VT!'.V_BZ&YN]%@73+Y4U> S6\[&'8N%W%
M6Q(3NQ@\ CGKP<3MXD1;6*1M.O1<3RO%;6F8C+.4!)*D/M"X!.68=LXR*QY/
M"&H#2W@@O($N;2]$VF2$'$,6\MM;\&=..P6M'5] N6GTB_TEX1>:4'2.*X9E
MCFC90K*S $J>%(;!Z=*K3^OZ^0?U_7YD4WCO2K;3S=7,%]%(EVEE-;&W+20R
MMC:'VDJ <C#9P<C!-8^I7B3?$3PS?20WED!'?1RQW3E%Q&HP^W<5QR2&[@T:
MSX.UB_M+N>!-/&HZC?VMU<J]RXCB2#80J-Y9+D[3R0OWNG&*L^*O"NI^)-?T
M>=H;-;&UBE6<B]DCE5I !E,1D?*5!!)&?04NS_K9@]FO+]4=1I.HR:I9_:)-
M-O+ %L+'=>7N8?WAL=N#[X/M7-74W]E_$.^NHK6]O'?24D,$,FXDB0@[0[!%
MX [C..YK=\/+KL>F+%X@%DUW'\HEM)6<2CLS!D7:WJ!D?3I6;<Z=KW_"77FI
MP6NFO:/I_P!EA#WDB2%@2V6 B( ).."< 9YZ4I:/3S_(%JM?ZU+8\5V4]A87
M.GP7-_)?P?:+>V@"+*T8QECO95&-PSDCDX&:@/C2P^RV-REI>O'=7HL7PB*U
MM,6V[9%9@1S_ '0WKTQ6+HOA/7]%L=#NHAISZGIMFUA+ ;F3R;B(E2&$GEY1
M@5S]PCDCWJW<^#[LZ5,]M);'4Y=635G5V80LZLO[O=@D#:H&['7G':K=K^7_
M  ?\A.]M/ZT?ZV^\MWWCK3],BUJ2]LM0B&DNBS 1+(7#C*LNQC\I'=MN.^*N
M/XFC61(?[-O_ +1+,8HH66-&E  )D4LX!0!AWSU&,\5S&O\ A#Q)J</B46\N
ME8UJ*&,12/(OE%% +;PIR.HQMYZY'2NBUW0VUO18+>[TNPNYHUW".2Z>,1RC
M #),J%E(YY"@U*VU'U_KR-Z*3S8E?8R;AG:XP1]17!?$K5X[KP7X@M+:WOI!
M;0,);NW?9'#* &"L0X9NHR &7^]BNQT2RN=.T:UL[N[>[GB3:TSDDMZ9)Y.!
MQD\G&37):IX0UJ?2/$6AV4]@-/U9Y9HYY6<2PO(064J%(9<Y(;((SC!ZT/?^
MNZ'%]?ZZEW5O'^A>&4M[6^N4,RPH\J"XA1HT(X;:[JS=#P@8^U:<'B:*XU^/
M2H].O2LUM]JAO,Q>3+'QROS[NK 8V]_3FL&3P_XSTS5A>:%J>C,EY'$-0BO;
M>78LB*%,D05L\J -I;''6MCQ)H%[J\.G265_]EOK28%KCINB8;95P.Y4Y'N!
MZ4WJ_G_G_P  E*RMY?Y?\%?</'B@&V@(TC4#>W =XK & S.BD OGS-@7D<EA
MG(K/U7QMY>B6E_I6FW5VTNH1V4T/R1R0/O"LK!V W=ASCD'..:NZKHM\FMV.
MMZ-]F:YMK=[1[6YD:..6)BI^^JL5(*\?*<Y(]ZH3^$;P:5,UO);'4I]6CU25
M79A$65U.P-@D#:H&<=><=J%;^O7_ "!WMI_6C_4DUKXC:!X?NA;:A,(YD56N
M(S<0![?(!&Y#(&;@_P#+,/1XMUF"YT'5K&V@O;G;9LTT]F^P6^4+(6;<K<X!
MPN3@\C!J"?1/&&G^(Y[S0=1TC[!J#I+>0W\4C&*0*%+1;2,Y"C@D8Q3KSPUK
M,<^OQ:?-926FMQDRO<.R202^4(\@!2'4[1_=QSUZ5$E>#[Z_U_P2XM*2^7]?
M\ V/"!SX+T,GK]@@_P#0!6=8^,'?4O$*:CIMQ9V.E2;/M+M&RGY%;HK%MS;L
M@ 'C'(/%;'AW3[G2?#NGZ==S133VL"PM)"A16"C P"2>@'?\NE8-]X0N]0;Q
M);27$$=KJDL5S!,I8R12HB 97@8!C4YSSDC ZUK-IS;Z:_G_ )7,Z:M!)[Z&
MQ8^(XKO53IES8WFGWC(TL,=T$_?1@@%D*,PXR,@D,,\BH?%VO7/A[1DN[6PE
MO))+F&#;&R#;O<+GYF /7 ]R,X&2(K71]3OM<L-6UM+.*;3HY8X5M)GD$ADV
M@NVY5V\*?E^;K]XU:\4Z3<ZSH;6UFT*W*3PSQB8D(QCD5]I(!(!VXS@XST-3
MV_KK_D4M_P"NW^9A-=M8^.[J^73]1EFFT=)7LUD5W4B0@@ OY:G &<, 2.YJ
M_?\ C_0=/T>PU)[E66_B\ZVB>>*!Y$XR<S.B\9&1NSZ9IDFG>(O^$JNM36UT
MM[=].^RQ@WDBL7!+9(\H@#)QU)P,]\##M/"7C#2=%T232+O2(=8T^U-E-%</
M)+;7$60020JLK C/ [XS26W]=W_P!^?];([C1=9L=?TF#4].F$MK."48>Q((
M_ @BN-UG68M,\7W"^)[O4-.L7*#2KV":2.U&5^82E3MW[L_ZP%<8QWKN-/6]
M2QB&HRPRWFW]ZT"%(]W^R"2<?4FLF_M-;=;R!(-+U&SNI,"&\=XQ%&5 (.$<
M2<@G&%ZXS0]]!+;4CU/Q/I_A71[(ZI?QSSR1@1EIX8C<$ ;F#2,B=P>HZ\57
M@^(6BWB:6;)+NZ;4C*L @BW#=&&+*7SLS\I'#'/!Z<U0NO!^MZ5IFB-X7U&S
M74M*@:VVWZ-Y$\3;25(7YEP5!&/3%6+O1?$U[J_AF^NCI,SZ=))+=M'+)$"7
M0IMC0JW !SEFY/I3T;^?^?\ P V7R-.P\4_;M6;3CHFJ6T@M1=A[A8D5E/08
M\PL&SD$$#!'.,C-:/7=-O]<T1+O2M0MM2GCEDM!.@Q&N/FRR,4)( X!)&1P*
MG\2^'KG6+K3+FQO/LD]M*5F?G]Y;N,21_4X4@]B,TS6-*U6Z\6:'?VD-D;&Q
M$HE,MPZ2'S%VG:HC(. ,\L,]..M+M_7?_@('L_Z[%B+Q1;2ZC;6XL[T6]T[1
M6]Z47R9'&<J,-O'W3@E0IQP3D5GM\1O#H\01Z.+R)I9)OLXD6XA(\W=MV% _
MF Y&,E-OO5?PWH7BW0;M-,;4M*G\.0%O(9H7^V;"21&3D)@=-V"2.P[+HVB>
M+M%U<V46I:5+X:$KRQ^;%(;N,,Q;RP0=F!G 8Y..U-;K^O\ A@?6QO6.KP:R
M9XX[.=K3>\(G;88Y<9#8 8L!D$?,!GMD<U!HMTT6JZEHCR-(++RY86=BS>5(
M#@$GKAE89],=ZH6WA>6U\6KJUK#;:?$=SW9M;A\7A8$?/"5"*0<-OR6.,5;T
M:!;KQ%J^MHH\F=8K6%_^>BQ[B6'MN=@/7;GO0OT!DFMWC2:KIFB1R&,WIDDF
M*MAO)C W 'L2S(/7!..:;J'B2ST;S(DL;N:ULPJW4MM&ICM1@$;@6!/!!P@8
M@8R!4>NVZVNOZ/KK_P"IM1+;SL3Q''(!\Y]@R*">P)/:LVXT+Q7I_BB[OO#N
MHZ5_9NI2+-=PZA%([1.%"EHMA&<A1PQ&,4ET_K^M ?\ 7XW-C4?%%O82W"16
M-[?+:A6NWM$1A;@C(+ L"W'.$#'&..16/J+VU[XZ\(ZE:SO+%<P7!1EE;RW3
MRP5(7.W/S'G&>:LG0M8T[5]4GTMK*>VU;:]P+J1XWAD"!"ZA58." /E^7D=>
M>*\?A;4-,U'PK%ID=I+IVC0/"[W%RR2ON4*2%$9'&,_>&<XXZT*VG]='?] >
MS7]=/^"5_"^H:?X;T7Q!<7MT8;2WUF=!)<3ECR5507<^N!DG\:T](\?:)K-G
M=3VTA\RV=(Y($DCF;<YP@!B=T.X^C<=\5EQ>$]?FT?58)9K&POI=3.I6,]O,
M\ZH^0=KAD3CC!QG(8],58FT+Q;K?AIHM9U+2K;6(9X[BTDTZ%S"CH<C?O.6S
MT. ,9H6VO9?DO^"#WT[O\W_5R75_&DUIH%_=6^C7ZW]I)'%):3>4'C\P@*^0
MY1AS_"QYX..<6I-7T]_$VGPSZ7?IK7V&6:"-E VI\N]-X;RRV0O1CCCD U4E
MTCQ9K'A&\L]<N=&_M.0HT*V22+ -K!AN9LL<XZ@<>AJQ<Z7K=QXST?5O)T_[
M+:VTL,W^DN'S(5)VKY>"%V#JPSGH,4TM?Z[/]0_K\5^A-9>+#?Z.=0AT+5,B
M[-I]F8P"7<&VL?\ 6[<!@1USQG&.:JW7Q&\.VFNII4EY&93,+=G6XA.R4MMV
M&/?YG7N$*^]6K/P]<VGC"]U-;L?V;<(LJVG/%SC8S^PV!1CU)-9NG:'XNT;7
M9;>QU+2G\-S7#W&+B*1KJ'>Q9D3!"D9)P6SC/3BA;J_]?UN#V=OZ_K8JVU\O
MAWQ%XTOEL]0OXXFMI7A@<2R &-F8J)'' Y.T'Z"NFB\0":YTN&/3;QO[0@,X
M<-"5@4 ??(D_VA]W<.:S+2WN]&\0>(=9UI]+M=)NQ$5F:\.4"#8-X9%49!S]
MXXZ<]:;X)T]+:QNKJWNUN;(NT6FO_"MLK$J >XW%@".JJM*.VO1?YZ?D#W?K
M_D=;7&W^LW.IZMXA\/S:7>QV=O9*PNHYT0997.<JX<9V@# SP<XS71:'/J-Q
MI,,FJI:K>G(D^R,QB;!."I8 X(P>:Q[[1M876-:O=/%C*FH64<*K<2O&5=-X
MYPK?*0^<]>,8YR)FM&O)_EH-/5>J_/4@\):_"NE^'=)FMKJ.2YTV-X)Y%7RY
MBB+N4<[@1G/( (Z$T^#XC>';CQ!%H\5Y&\LTAACD2XA8-(,Y38',BG@\L@'O
MR*I67A[Q##<>$S+;Z7Y>D6[07)6]D);<@3*#R1G@ \D<G';)F\.Z)XOT._33
M6U+2I_#<!;R&:&3[8$SE8\YV8'3=R<#IZ:R:<V_-_G_D9Q34$NNGY?YG0Z])
MJ46BW$FDVHNKU0"EN9A%YHR-RASPI(R >QK%UKQ#JGAZSU;5+S21]AM-/$\4
MHN@Q,N.8BF/7G?Z&NLJGJNFVVLZ3=Z;>(6MKJ)HI #@X(QQ[UF[V=C16NKF)
MIF@W%UIEM?WNKZD=5E@#--%<ND4;,,X6'/E$#.!N5C@<DTX>*(;"^_L.2VU"
M^U.UM(YIS!;G#@D*64L1NY))QGH>_%.TBV\3Z;!!IMP=-O+:%/+2_:9TF*CA
M2T.PJ3C&2'&?05%#HVKI\0I-:=+,V!L%LPWVAO..&+[BGE[1R<8W>_M5NW-I
MMJ2K\NNY'=?$;P[::ZFE27D9E,PMV=;B$[)2VW88]_F=>X3'O5T^++0:K%9_
M8[WR);DVBWNU/)\\9RF-V\'@\[=OO65IVA^+M&UV6WL=2TI_#<UP]QBXBD:Z
MAWL69$P0I&2<%LXSTXJ*?PKK=U?PW=R^GSW-KJGVJ"ZEED+&#D; FW$952!A
M20V,D@DU*Z7&^MB:/Q9]KM/$W]L:+?PZ=I\KP.R!92Z;%R,1L7R=Q;., 'KP
M<:%GXBMXKK1M+MM(U 6]]:B2VN,Q>4B!0=K$R;L@$<8.>V<'%270-9BL_%%M
M;?8)5U1WDMS)*\9!>-4(?"-C&TD8SG...M%WX;U6]\%Z98I<6]CK6G^2T$\3
MM)&CI\I.2JDADW C'\6/>A?Y?K?\1?\ !_2Q:O\ QK8:38/=:G!+8_OW@@CN
M9[>,W!7J48R[ .#]YE/M6AX?\0Z?XFTI=1TV7?"7:-AN5BKJ<%<J2I^H)![$
MUD^(?#VKR1:7=^&[ZV@U/35:.,7JLT4\; !E?;R,E5.1SD5MZ.FJKIL7]M2V
MDE^>9?L:,L2GT7<22/<]?;I374;Z''^+IKS0?%5GKUK>7OV.WB,FHVGVB1HG
MA+*A<1D[5* [N ,X-3?$;4;HZ(+?3;R:WP\$MQ-;2E'\MI50*&4@C=D\CLI]
M:VKJPU.[\2,TUE8/H[VKVSLUT_FL&P3^[\O;U&/O]#GVK N_!FKV_@H:'83V
MU]<M/&SW-]<-$1'&ZF-1MC;.%15[=SR326ROW_7^F'5_UT_I&]J6OVOAR(6B
M6>HWOV:W$TWE.)'BA&1O=I7!?[IZ%FXZ5"_BBX;Q=8:7;Z7<S65S9&Z^U*T8
M4#<H!(9PP !YXSR, X-5-<\/:UKTDR7:V#V=QIYA-L]P[);3G.7 V 2@Y49;
M:5V\#DU-;>']4CU+1[J5[)EATUK"[56?C)0[DX^;[A'.WKGMBC7K_6C_ %M]
MXGY?UM_P1ME\1_#NH:Y'I5O=I)),2L$D<\,@D8 DC8CF13@'[RKGMVIK>-](
MU+0[JZ;3=7DTSRYTGD%F_&P['4J/G4\GL.ASC%1^&M'\9:'*NFW.HZ3=:%:I
MLM7\J07;J/N(YSL ' R Q('K4>E>'=>LO!.L:5+#IIO;V6YDBV7<AC'G,Q(9
MO*R-H;LISCM2E\+MV*C\2OW--_$MEINF6"V6FWUTCV0N4M[<)OB@ 'S,7< X
MR!@$GV-9NLS6VH>)_ ^JVTDK1W$TI3YV"LC6[L"4SC/3G&:0^&M<NK'3[&^7
M3I;)-.^R36QN)&C20# D V 2@C'RL%V]LTD?ASQ!$G@Y!'ID@T8#[2WVF1-W
M[HQ'8/+.>"6YQTQQUK33FOY__)?\#[_NS5^6WE_E_P $Z.RU>/6/M$=O;W2V
MX=X5NE*;7(R&*X8L,$$98#GID5F6OAR]A;1EDUC4[B*T66*X2ZF5Q<Q,#@2@
M#YW'R_-[-ZTRU\+RVWBU=6M8;;3XVW-=_9;AR+UF!'SPE0BD':V_)8XQ75U"
MV3+ZV,/1;IHM5U+1'D:067ERPL[%F\J0' )/7#*PSZ8[UN5R(6]>\U_7]*%G
MY\J0VMH]V6$4HC))8E><%G8#'7;[UU<3.\*-(FQRH++G.#W%/H'4P8_%]G+J
MMO9BSO1#<3R6T%X43R9)H]VY  V\$;&Y*@''!Z5 GCO39;9;M+/4?L?VW[%+
M.\ C$,FX(-RL0V"Q X4X[X'-9I\*:Y+J>GZA<OI\][8ZC).+J261FDA974*%
MVXCQN7Y5)!VYSFJDOA;Q1)X:O=/^S:.)[C5QJ /V^7:$\T2E<^1G.5"].^>V
M"*VE_P"M5^E_N&[=/ZW_ .!]_P!VUXPU6*31=8TV&VOKAX[1S/-:/L%L2A92
MS;E;L.%R<'D8-:/A Y\%Z&3U^P0?^@"L:[\-ZTLNO)8M8?9M<C+3&61P]M-Y
M0C.W"D.IVCKM(Y//2N@\.Z?<Z3X=T_3KN:*:>U@6%I(4**P48& 23T [_ETH
M6S^7ZB>Z^?Z%,^++0:K%9_8[WR);DVBWNU/)\\9RF-V\'@\[=OO7+"RC^R?$
M>V\VYV+*9%/VF3>I^SJ_#;MP&X],XQQC'%7Y_"NMW5_#=W+Z?/<VNJ?:H+F6
M60L8.1L";<1E5(&%)#8R2"33QH'B$+XO_P!'TO.L'-M_ILGR_NQ%\_[KC@;N
M,\\>]1)7@^]G^G_!^XN+2EY77YO]#HO#7_(K:1_UY0_^@"J$7C.QN;J\M[>P
MU6;['<&VN62T8^6P0OG;]X@@8! .21Z@UI:!;7=EX?L+2^2%+FW@2)Q!(9$^
M48R"54\XSTK&T'2-:TS5/$E[<0:>?[1N/M%ND=TYY6-4"N3&,9VY)&<9Z&M*
MCO*37G^9E35H)/R%TOQ#H]KX7TV?2K.[:"\=X[*S  FD8%B1\[ #[K'YF&/;
MI67XJUFQU[PE?-"FH0S6%S")8WCEAV2>8H*%A\DG!.0I8=/:LVZL/$&A>$=%
MTJ+3K.\URWNI)+>.SU%8Y-F&)DC:6,+D;P"&4C![YX=9V'B35/"5_I7_  CL
M>FZG)=QSW$FH:FDHGRP8OOAC(W'8!MVJ ""/2E_P/SC_ ,$KI]__ +=^>AU%
MYXO6WAUI(],O#?:9;"Y^SR>6OG1G=M=3NQMRK9!PPQTZ9=IWB=Y[32DGTR\%
M_>0^:UONAW*@ S(<28VY(P 2W/3@XH3^'];OO$6KW<\6GPVFH:4MB&CNGDD1
MAO.[:8P",N1][H,]\!;_ ,+W6J>'M/MK[3].FO[2)4CFCNY86MV  +1RJF[H
M,XPN>A]:7_ _7_@!_7Y?\$Z]&WQJ^UEW '##!'UK"\7:]<^'M&2[M;"6\DDN
M88-L;(-N]PN?F8 ]<#W(S@9(ELO[8L[ZPL)I[:\M4LPMQ<,6%PTPXW[?N[3@
M]\Y_&CQ3I-SK.AM;6;0K<I/#/&)B0C&.17VD@$@';C.#C/0T]+^5_P!0CY_U
MH5#J^GOXJAA?3+Y=;737F164 "/<FZ,-N\MFW;>A(&.H[\OJ6K7'B3PCH6K7
M=A=V,HUFUV*TZ[74S@=$<A@!Q\X!R,X[UTTNE:U)XZL=7,5A]BBL9+60BX<2
M9=E;(3R\$ H!]X9SGC&#D7'A?Q$OA/3-(@32Y9+&_CG#27,D8>..7S!TC;#-
MP",8'7)Z41W3]/\ TK_(3V=OZ]W_ #-37_B'X?\ #E^UG?74?FQX,X6XA5H0
M1D$HSAVR#_ K&NH1UDC5T8,C %2.XKCKG1/%UAXEN+SP_?Z2NG:A(LMW!J$<
MCM#(%"EHMA&<A1P2!Q[UV2@A0"VX@<GUI+8;W%HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***JZG<&TTJ[N
M5F@A:*%W$EP<1H0"06/]WUH;L-*[L6J*\^M=:UU+G5[9;^XE"Z4+ZWFO[-%V
MOE@0JH$8IQP' ;W-6=)UG5OMWA62ZOVN(]8L&>>$Q(JHZQJX9,#=DY(()(]
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M,/$V@FQBOAK>FFSED\J.X^UQ^6[_ -T-G!;VZU333M_7]:$IW2?]=_U*&M>
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MLUO@1<-#-(KL#V#AMRCV4@4G@/5K_6O#/VO4IXY[H7=Q"TD<812$E91A<G'
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M-<_:PGVB38LN<[E7=A<DDD  ')SFJ[^ _#\EG>6CPWQ@O)A/<(=2N?G<=_\
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M[5N1Q)#$L4:!(T4*JJ,  = *HS:_HUO>QV4VK6$=W)'YJ0/<H'9,$[@I.2,
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M!;O([0K)SRL9.Q<DDG &3R>:OZ=H]OIVH:C=P1F-[Z19)0)&8,P&W=@G"DC
MP,#@4D_B/0[5;1KC6=.B6\&;8R72*)QQRF3\W4=/6K$6J:?/J$VGPWUK)>P
M--;),IDC!Z%E!R!R.OK0!%>:'I]_?P7UQ"QN8$:-725TRC=58*0'7_9;(K/M
M_!.@VEUI]Q;VL\<FGILM=MY,%C4]1MWX.> <@Y  / Q7044+0#GM9\"^&/$.
MK6^J:KH\%S>V^ DK%AD#H& (# >C UT(  P.!111TL'F%%%% !1110 4444
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MN6A6<8(*2;>67GI6JJA5"J % P .U%_Z^[\[#_K\_P#,6BBBD 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"_MKVVFLRI87$<JM&0.IW XQ6!XW.I6]MIFI6&GRZE'87@GN;*$ R2Q[&7*
M_>92P8#VK)N4GU30HM5TWP[J-BAU2*^O+"[C59[E5QN/EAC@\*P'!)3IZI#?
M]?U_6YV-MK6E7FGMJ%KJ=G/9+G=<Q3JT8QURP.*:-=T=A=E=5L3]C&ZZQ<)^
MX&,Y?GY1CUKSOQ?I\>JZ5XMUM+*1--ET8+Y=W:-$TEPA<B39( P*C #$#MCI
M7164/]J^)=%O;.SN+>'3K26"YDGMFA#[@FV-=P&\9!;*Y7C@\T[?U\G_ )?B
M#T_KT_S_  -X>)M!-C%?#6]--G+)Y4=Q]KC\MW_NALX+>W6K']JZ<\QMTU&U
M\_Y@$$REAM +<9[9&?3(KE])T^YM?$4^AO'G2=/D^WV[ YXDW;8L>BMYA'H-
MF.E9O@_3]/3P_P"(4N]"F2W%_=30P3Z5(I:%^!LC*9.0"-H&?;FI>S?E?^OQ
M';7Y_P!?H=E;ZA;:;H$%UJFM6DL2(!)J$C)%'(>F[KM&3[UG^+-5O;+1K*_T
MJ[@5'O;9'8QB02122*AVG.!][.<'^M<,NM6OA;P%X-U'4Q-936&Z'R;ZUGB3
M?Y3*0V(V9?9@I'7\(;2ZT*]\!S3:(JZG->:U%<7@TS3I7*?Z0LK*P$>\JJ9P
M6 SV'.*NRYO1_JA>OG^O^1Z7>^*=#L='OM4DU2T>TL25G>.97V./X#@_>S@8
MZY-*/%&A#2[;4I=9TZ*TN3MBF>[0([=U5LX)!R,#TKB]5BN-0U7QQ;6>GWY-
MYH\<5N6LI8XY9%60%5=E"D_,@Z\]NAQ>U.2XU":WCATZ_MOM.DO$EW]B=W8G
MK$58%8CP#F1>>@[U+TC?^MG_ )#M=_UY?YFCK&OW.F>.-)MIK^UAT6XL[B:;
MS%"[3'M^8R$XV_,.PZ=3FG>*-;NH-,TC4-%U"V:UN-0MHI'1!*)HI)%4[&S@
M=>N#[8ZUS]G;W5F?!&L7.F7PM;#3'M[E5M7DFBD9(P,Q*"_56Z#C'-1:K87.
MGZ*7%A?>7=^(H;^&UM[.25H(5D0L66,-MSM9\''WL=>*NR4K=G_[=_D3=M7[
MK]'^IZ'=ZMIMA<P6UYJ%K;SW!Q#%-,J-*?103D_A4E]?V>F6CW=_=P6ELF-\
MT\@C1<G RQ.!S7FNNVA'BO4;;6/#GB35['5&0VTNEW4R0A-BJ8YD65%7!!.6
M'.?:O2I+2*YT]K2>,&*2+RW1CNX(P1D]:C7EN/3FL5HM?T:>\ALXM7L)+J>,
M310I<H7D0C(95SDK@9R.*0^(=%73#J;:QIXL VPW1N4\K=G&-^<9SQUKCUM]
M<ALM*U,65S)?Z1,=.*,OS7$)/EM)Q_"<1/GML-:6I0W.C>(](U&2"ZO-+M[.
M6VD^SP-,\4K%")-B LV0I!(!(SZ$TW;I_75?A;YAZ_U_7Y'3G4+);:*Y:\MQ
M!*5$<IE7:Y;A<'.#GMZUS2^(9Y/B!#:1ZE:2Z))I<MT/+5<*Z2*I)DR<@9/3
M&.<YKE-6T62VTNU9M*N94D\2I?6<$5@\K6MOO4N2%4[ <,V#C[V,9R*M>)K>
M]7QY;MHEG<PK%IDFXII\P@F8RK*T1D5<*7 ;Y@<@GGDX(N_K^5_P_0.EOZWL
M=\GB#19-/34$U>P:RD?RTN5N4,;/G&T-G!.>,5H*RNH9&#*>A!R#7%W\XUG0
M].U:P.LZ)<V@9HXVTJ1RAP 8W@V[F'(Y7T.&KHM'?4+CP];M>P1VE\T6'2,8
M56[$#G'8XYQG%)Z)^0+6WF3Q:KIT^H2Z?#J%K)>PC=);),ID0>I4'(_&D35]
M,DU)]-CU&T>_1=S6JSJ95'J4SD#\*X?PI<7<PT[0]4\*:G;ZKI*,HU-HU%KN
M*E3(LFX%RP))&T\GG'6H+;3[Z[\-Z-H+V%W!KNFWL,LMW);,(QMDS)*LV-K;
MUW< [CNP0.:=M?Z^\'U_K^KG?7&M:5:-MN=3LX6\T0XDG53YAZ)R?O'TZU)#
MJ=A<75Q:PWUM+<6V//B256>+/3< <K^->77UO&ND?$:"ST34$-Z^;5(])G7S
MF,2J2N(^?W@8DC_>Z'-;;-#>>--+633+Y[&71);:7SM,F$669"$<LFT<*W#=
M.AZTNE_ZV;_2PWH_Z[K_ #_ [*'6]*N+Q+.#4[*6Z=/,6!+A6=DSC<%!R1GO
M0^JZ>[/;QZG:+<$. /-4LI4#)VY[9!/U%><>&X!JG@KPII]E97$5Q9W$5TTY
MM66..-68L5DQM8LN5VJ2?FY %6/#6FZ>/"GB6*YT"98?MMW+;P3:3("8GX79
M&4R<XZ 9'<42T3]/\O\ /\ 6Z7G_ )_Y?B=U!J-K8Z38R7^L6LOFJB+=NZ1K
M<.1P5YQ\W4 5)+(6U:T*:G$D1B<FTPI:;[N'!SD!<'IP=WM7#V5K<CP1X:O+
M>?5=,U+3[%8-ITR68$X16CDAV[R,J.1C@9SBE?=_PF7AZ^U'09H;@Z1-%?FV
MTZ26-2VPK&75"".'PN3C..XS4E:3]7^I,=OE_D=RFL:7)=0VJ:E9M<3!C%$L
MZEY IPVT9R<$$''2G2ZII\.H1:?+?VL=[,"T=LTRB1P.I"YR?PKR[31]B\(^
M&H(]'U2&2VULS21II-P#'&'<[B!'P-KJ/T[$"MXQ\2>';'6=>\.:GJ-M;IJ5
MQ%+</>V\S/$ D>/+58F1U^7C++@YZTNMOZZ?Y_@/O_75_P"7XGKM[>VVFV,U
M[>3I!;0(7DDD.%51W)KE!XN74;_PU?:9JEFVCWQE%RJA6*LL+/AGSA=N!D8S
M[]JZ(Q6\OAPQ:8L1MGM2MLL  0J5^7;CC&,8KA[29PG@&WGTK5 ;1<3[M.F9
M8F$!C&XA2%^?N?3/3!H2][^O,EM\NG];'?P:E87.GC4(+VVELBI87$<JM&0.
MIW XQ2V.H66J6JW6GWEO=V[$A9;>59$..N""17F+Q:A<^']6:STK5I%AUY[U
M[-8Y[*6XMV/_ "R<A#G/S84YRN#UKK? \=F]E=WUGHNMZ7]JD!D769I'GE91
MC=AY'(&,#DC..F,4EKK_ %T_KY%/0GN-<O+_ %^[T/1#:K/91(]W=7*F1(6?
ME4"*REF(!)^88&.N:O6EWJ-M+<)K'V18(84<7L1,:.3G=E6)V8P.-QZ]:YY(
M9_"?C/6M3DL;NZTO6!%*9K2!IW@E1=A5HT!8J1@@J#CG.*?X[=-:^'6L)'I=
MW<B:V(MHFLI&D>0CY2(MN]2#CD@8/IUHVC<:5Y6.E?6M*CMKBY?4[);>W.V>
M5IU"Q' .&.<#@@\^M.DU?3(M,&I2:C:)8%0PNFG41$'H=^<8_&N$\26DL.FZ
M%JMMHNJ7=G"I%]:Z89;6[SY859 %*.Q7:5VD]&]JFAABM-(T273_  ]JMC#+
M?O/NO5FNKBU9T8&1XP[MEMQ'S$A=V2.U.VK1*>B?D=+JGC#0=)L[&[N=5LUM
M[Z14MY3.H1P>K!LXV@<YZ=/6IFU&UM+N^N[O7;1;*.&)C%(R(+<'=\[/GHW&
M,\?+Q7$:=97UCX>L$EL-08V7B*2:4FV^=HVEDPX5!R/F4DJ,<^@.-?1(H5^(
M_B0KIES;PW=K;[I&L9(XI9%W[_WFW8QPR\Y.>V<&BV]O/\D_U8WI_7FT=(GB
M'1)(K26/6-/:.\<QVKK<H1.P."J'/S'/89J:+5M-GU&73XM0M9+Z(9DMDF4R
M(/4KG(KG/"]GJMNUYI%U;F&STIFAT^X(XE1AE",_W%(3/<Y]*YSP;98U:QL=
M5\,>)(]6TPDF_GO9GL=V"IDCW2E3N!/RA3C..*%9O^OZ]0>B.M\:ZIKFBZ0E
M_HD=I.Z2JLEM/$S-*"1PC!QM.,]0<\=*OG7K:7PU'K5I^^BGA62W4'F1FQM7
MZDD"JOBF^2TBL%:WO9B;R)S]ELI;C:JL"2?+5L?CU[5C:;I=YHE_J$%Q#)_P
MC]E*U[8B&-Y'9I0<Q[%!)",7( !^^O\ =J?LO^OZ\@ZK^OZ_R-'PIX@NKSP;
M!KWB&[TZW69/-9HT,$4*],,SNV>0>>/I5W5/%VAZ3HL.K3ZG:&RGD6.&99E*
M2,QP,-G!'4D]@">U<=HL]Q#X"\-PG2-0$]I=*D[3:?/OM#AOW@BP&D'(7(RH
MW9.=I%)_9]_#X0U6W-CJ$LD.NI=G=;8>6,7"2%E50-WR@GY1VQUJ[7E]WZ?Y
MA_P?U_R1WLVNZ/;QVDDVJV,:7F/LS/<(!/GIL)/S9]JEGU33[67RKB^MH9,J
M-DDRJ<L<*,$]SP/6O.O$D+CQ1>'5?#?B75M-U2.)8&TJYE14&W:T4T:RHH&<
MMN;^\0>E:&C:9:I\2=5!T6:.VDTZUB\R6RD,;RQEB?WK+M<@;/FR<X'.126O
MX@]#KK6Y2'^T9KG5[>>&*8D_<06J[5^1B#_P+)P?FK&\5^(7'@+4=;\-:K92
M-!&SI<1A;A#MZ@8;&?<YQZ&N8M%%I9^)H[;0+SR6UR*YB0Z=/&JI^[_?*@53
M)M=&.U>3CG@\QZE:WT/AGQY;M9:I<RW\P>W<6#%IMT,8&%1>F01TXQ\QS0K:
M?+_VW_-C6_\ 7F>E2:G96K6T5W>V\,]P/W22RJK2$#)V@GG\*N5PVOK>JT&L
MZ++?K>2VJ0_89M-DEANE^8JCC :$\D;F*@9Y!KMXR[1(9%".5!90<X/IFADK
M9#J***0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHJMJ-ZFFZ;=7TJ.\=O$TK*@RQ"C. /7BAZ#2N[$L\\-K"TU
MQ+'%$@RSR,%51[DU)UK@O$]]%XB^&.IWDT%A-%Y'G0O;W N8]P/!#%5PPX/3
MC/6MZU\03_VY=:5=Z=Y3Q6@O(#%+YIECR5((P-K@CH"P.>M&U[_UI<F^UOZU
ML;Q( ))P!U)JO_:-C]GCN/MEOY,CB-)/-7:S$[=H.<$YXQZUSVF^)3K.KS:#
MJ>F6T3361N1"+@3'RB0I2:,HNQOF^[\PZ\\5Q\-I;'X8^$W-O$7M]7MQ"VP9
MCS=8.WTXXXII7=GY?B[ WI]_Y7/5;BY@M(&GN9HX84&6DD8*H^I-2]:XWXIP
M0S_#O4C+"DAC\MTWJ#M;>O(ST/)Y]ZO_ /"3M8:I)8ZQ9I9K]DDNX)XY_-62
M*/&_=\J[6&X<<CWI+9_UTN/JDOZUL='17*Z'XPGUC6!9OH=_;V\L9DAN7M;A
M%& #B3S(452<\;6<'!YZ9U=4U::UNX-/L+:*YU&XC>6.*:;RD"(5#,S!6(Y9
M0,*>3^- +4U:*YS_ (26YDCL;:+2RFL7:RLMG=2^6J",X9F<*QVY*X(4YW#@
M<XHS>//L^FM-)I$YO(-1CTZ[MDF0B"1RH5MQQN4[E((&>>0.<.P?U_7W'8U'
M/<0VL#SW$T<,,8W/)(P55'J2>!7-R>,#9-KD>I6202Z7'',?+G,B/%)D*Q;:
M-OW3NX( YR:;K/B,6_@:YUFYTJVU*W$(=X;6Y2:&1".3O8+E1_NY] :7_ _$
M.MCJ2RA=Q("XSG/&*R+O1]-UYX[TW=\R[-BM9:I<0QD GM%(JDY)YQGMVJIJ
MFJ&]DN=&L]-M[[9;*]['<2[$2-P0% VMO8@'Y3@8ZD9KF/"OB5="^&WAJW@L
MY;N]GLR\4,<4S@*K8);R8Y&4?,!G:1FCO_7?_(.B_KHG^IU7_"&Z7_S]:Y_X
M/;W_ ./4?\(;I?\ S]:Y_P"#V]_^/5G+XXN9)-%@7P]>Q3ZH\T:K='R!&\:L
M<$, ^#MR#M'!SUXJ._\ 'MQ9R^3%X?O;F> *+V&WAGF,;E0Q1&CA:-V&X9W.
ME.P&HW@_244LUYK:J!DDZ]>@ ?\ ?ZFP^%-&N84F@O\ 698G&Y'37[UE8>H(
MFYJ'7=5.I6VIZ7::;#?10VV;X7,FP('0D*%*MN?&#M.T<CFG> %9OAKX?5&V
ML=.B ;&<'8.:71O^NO\ D';^NW^9/_PANE_\_6N?^#V]_P#CU'_"&Z7_ ,_6
MN?\ @]O?_CU5K6Q\606ND^:^B2S0&47B 2JL@.=C(QR5?@;B0?O-C/>M_P )
MEJ2:;IUY/H]G%Y^H&QND-^Q-LPDV _ZGYAD?[/4<X.0[:V0>9I?\(;I?_/UK
MG_@]O?\ X]1_PANE_P#/UKG_ (/;W_X]3KGQ#-9"4SV<1$EXMG8B*X+-<.>N
MX% $QSG!;A3]#F7_ (YGT>SU8:GHQ&HZ;;"[:VM;E9$EA)(WJ[!#@8.05!]
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MNE_\_6N?^#V]_P#CU<KKU]+K.K^"]4?3((K:35$:SN3+NF:-HG.&7:-@.%.
MS9P,X(Q6U)X[)UE+6TT:_N[/[0;9[F&UN"58/L+ B'RR@.<GS,\'BG9[=?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MLS()'C*E0J"1=J_(HZGC/.3FM;2_$!U+Q#K&DM8RV[::8LR.ZGS0X)! &<#
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M"Q Z#O7'?\)X_P#PCB:N=$N5SJ/V"2$S1YA/F^7N8@X(W=EW?ES0FV_ZZ_\
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M,^V!750>$M!B6%I=)LKFYC@$'VFX@625DV[<%VRQ&WCDGBDOA_KLU^H2U?\
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M6"W"K%=-;1VS_.0S%3^]+ #",I7Y>2-U=Y8V%GIEJMK86D%I;K]V*",1H/H
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M3TB^7S_X HZR5_+_ ()Q/_"2MJ=YX1U>*ZO[6TNS(L]H\+1JY\AF'RLH9^<
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M@U[=V>J3:;IEO=O;6YMHHVDG,9VNS&1& 4MD   \9SSBNDTVW%KIEM +6WM
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M;_NW954=)<G[F>,\$=\@9+^&]>O/##A_#D<ES:ZQ/J"Z;J;P/%>1R,_RY5G
M8!\@M@ CN*II7=OZUM^6HHZI-^7Y?YG?Q>(]*FTZ2^6Y*PQOY3K)$Z2*YQA#
M&P#ACD87&3D<<U@^$]4GU#QEXF0WUY<6B"V:"*Y0QF'<K$J$*J5Y]1GCFJ$.
MAZFNE:9J%GX3T_1KFSOQ=2:/93Q_OEV,ARZJJ;_FR >/E^]SQJ^'K#6(_&>N
MZK>6"6UEJ$5OY0>=6E5D7!5E7([GG=U'&1S0EK]_Z">WW?FS0USQ1;:'JNE6
M$UO=R-?R,@:"UDE"@*3_  *><@<>F3T%37?BC1[*]%K<73(YD$1D\ES$CG&%
M:4+L5CD<,0>1ZU6\065]-K&@7UG:_:5L[ES,HD52JO$R!OF(R 2,XYQT!Z5S
M\WA_6/[#USPL;%YH-2FGDAU(2Q[(UE8L?,4D/N4DXVJ0<#D=DOZ^]?IJ/K_7
MG_P#O)D,D$B+(\;,I D3&Y>.HR",_4&N)\">*(6\-:5!JVH7$M_<R2HL]Q&Y
M61A*P"^9MV;L 87(/H*[:&+RK>.+<6V(%W-U.!C)K@=.\-:M_P (W:>%KJR:
M*.UO5N7U 2H8W59_- 0 []W0?,H Y.3W:^)KT_/_ "$]E_73_,ZZ?Q#IEM?Q
MV<T\B2.XC60P2>3O)P$,NW8&SQM+9]JMZA>QZ;I]Q>S)*\<$9D98HS(Y '90
M"2:\\L?"^H6'BN:&X\$Z%J=K+>/=1Z],T0FB#.7PZE"[.I. 00, <BO1;Z%K
MBPN(4QODB9%STR014ROR76Y2MS6>QQ/_  DK:G>>$=7BNK^UM+LR+/:/"T:N
M?(9A\K*&?G &"5/;)KJK;Q#IEWI9U&"=WMP[1D>2XDWKD%/+(W[N#\N,^U<E
M:6>NP?\ "%PR>'[K;IB[+J1+B B/]R8L\R D9.[C/'OQ67=>'-=O]*OI#X<C
MEFAUJ348M/U-X'BO8G4KL.UG"L,Y!; !Q[U<K7:6VOYK]"(WW?E^3_4]'TW5
M;/5X&FLY68(^R1)(VC>-L [61@&4X(."!U%5]6\1Z7HA OIY%.W>PB@DE\M/
M[[[%.Q>#\S8''6J?@^RDM-)9I?#&G^'9)7W-963HX]-S,BJI/TSTZ^F=XITO
M5]4O[ZVALI&L[C36ABGMI4B8R_-\LK$A]O(VA>,EMW:IEIL7'7?^M3=_X2/3
M/[0DL%EF>Y2V^U[4MI&#Q<?,A"X?J.%)//2LN]\=Z7;V^C7-NE[=6^JS&.*2
M&RF? 4,3E0NX'Y2,8SU., FJEIIVL6FN:)J+:6SJNDFQGC2:/,#Y1@6)(ROR
MD';N/L:H:9H.OV6@>&8Y],C:?3-2>62&&Y5F,3+(N[)P 09!D G@<9/%59<U
MOZW:_*Q,7=7?]:7_ #NBYI7B*'2-3\1IK&J74L,6I(D3RQEQ CQ1L VQ<(@+
M$;FP/4YKI=3U_3M(*B[EEW%=Y6"WDF95_O,$4E5_VC@>]<-J>FZ_>:-XWMD\
M.W@EU28&T'VBWPX\I(\Y\W@90GG!P1WR!MQ6^KZ=XBEUB/2+F[@U&T@AEMEE
MA$MH\>[KN<*5._G:Q((X!S2Z?UV_S*EN_P"NQK7'B[0+9[>-]3A>2X@-S"D.
M96DB )+@*"2, _6M:&XBN+:.YB<-#(@=6Z94C(//M7GNG>&]7T?6_"B#3Y[F
MWL$NFN;B.6+9&TYR$4,P8A?]WIC&>E>A7'F&VE$*HTNP[ _W2V.,^U)Z*_J)
M;V,BV\7:'=3RQ)?;#'";C?-$\2/$.LB.ZA749&64D<BEM/%FB7\UE':WOFB]
M#?9I!$_ERD9)4/C;NP"=N<X&<8KE=-TG7+75=(U671[HO;Z=<6T\ N(%5&)C
M*K%&KA%0[2%Z'INQC-5K#2]?M]"\&6LGAV]\W3+PR70$]M\BA'7(_>\YW@\=
M@?;-65[?UN_^ #VO_6W](T?B!XB6'23#IFI7=O>0WENLC6\3>6P:55:-I=I4
M'#9VA@W'I7>5YGJ&@>)&\(7/AR#2UGECOQ<Q7C7*+%.AN?-YYWJX'7*D<<$]
M*]*C+F-3(JJY W*IR >^#@9_*DOA_KL@>_\ 7<=1112 **** "BBB@ HHHH
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ML6HP6#RXNIT>2--I^95QN.<8&-PZ^M5)/#FD3>(8]>EL(GU2*+R8[ELDHG/
M'0'D\XSS67#K6N6WBS3M%U&#3VBNK:XF\^W9]Q,;  ;6^[\K+W/.>G>@OBS6
MBVGW,=MI\L.HWSV45F[/%+ 4+Y9W&_<<(<J$7&>O>A=+?UT&_P"OS.IT_6-.
MU9[I;"[BN3:S&"?RSD)(.JD^HS5ZO.;C5=1T*7QMJUD+4QV=_'--',C,94%O
M%N52"-IQT8[OI6O;7.LR_$>_B%[;-IT6GP3+;&V._P"<R# ??@'*@DE3Q@8&
M,DMI_7:XVK-_UU2_4ZJYN8+.UEN;F5(8(D+R2.V%50,DD]A46G:C::MI\-_8
MSK/:S+NCE4'##U&:Y'2_%6I7FNQZ9>?8I$NK"6XVVT;_ .C.A4-&9=S)*?GP
M2NW&.1R*RO!^KZGHG@;PG<O]DETJX\JT>(1L)D:1RJN'W;2,D97:/7/:A+]/
MS:_03T7]=KG?:=K6FZM+=QZ?>17+6DODS^6<A''52>F:OUY_!K(T+5/&=X(&
MN)#J=M#%$K*I=WBB51EB .3W(^M;_AK4/$=W+=1Z[I)M$0*89\1IYF<Y4HDT
MN,<<[N<]!BA+3Y ]&=#17)WVJ>(;?4=:LHY]-$D=JESINZTD.\%B&1_WHW'(
M49&/O@^U+9>)+F;2+?6)KBV^QPZ:;J^1+5@^\ \*?,.W!5P5(8\=:5]+_P!=
M?\AVUM_73_,ZNJ>J:M8:)ITNH:G=Q6MI%C?+(< 9.!^M<VOB35[.71;J_2PD
ML=9=(HHX$=9+:1T+*&<L1(#C&0JX]#7/ZMKFM^(/AGXBO+N'3X+>.WOK::*(
MNSAXR54JQP".&SD#M]*&FK^7^=@C9M>9Z;%(DT22QG*.H93CJ#TJMJNEVFM:
M;-I]\LK6TPVR+',\18>FY"#@]QGFL/P_JMYJD*75A<6DNDV\/DM#Y#>>\R##
M -OPHS@8*Y/T(-.\)^)O[?259;NU-Y%S/9"!X)K8D\*Z.Q)[_-@ \$"G*.K1
M,6[)F]86,&FV,-E;>8((5V())6D8#T+,23^)JEJ'B?P_I%U]FU+7=,LKC:&\
MJYNXXWP>APQ!Q6K7&>+'OH_&?A9M.M[>XN?]*Q'<3M"A'EC/S*CG_P =I-W:
M\QVLCI=,UO2=:21]*U.ROTC(#M:W"2A2>@.TG%0Z5X<TC0[B]N--L(K>:]E,
MUS(N2TCDDY)/;)/'09JBJ^(9=,U&YBMM-L];+!(A(7G@95 *@L!&Q!W-S@8)
MZ'%9>@^+-2O].O-8O9+)+#3[8B[MTMV$XN$7+X(D8!/[O!)SG.,$FUWY?U_7
M<$F]/,[0(JLS!0&;J0.33JX[2?$7B.6Z>YU/0GM]':W:<3GR08<+N ^2>0R9
MYY"ICCCGBW8:AXCOX;>]C_LTV-]:F:)EC8M:,5#)O^<><#GG:$Q^M#TW_K^K
M FF=-4%[>6^G6,][=2>7;P1M)(^"=J@9)P.3^%<;8^+-8N=-\'WSBQ"ZO.8+
MN-87R#L=@R'?\OW.A#=>HJJFM>)-+TWQGJK7&GW_ /9]U(8H'A>' 2-&^\&;
M("_PX&3SN&>!JW]>G^8UNEW_ .#_ ),]!CD66-9$.58!@?4&G5RTNM:M;>(-
M'%S<Z=%I&H0G[UNPD$P0,$W^9C!&XCY?X<=\U!>^(-;LK6SM8X8=0U34#+);
M_9K945(5P0622==Q^9<@.O7IQ3:L2M4=A4-U=6]C:2W5U,D-O"A>261L*BCJ
M2:H>'[O5;S2EDUK3C8WH=E:/<AW 'A@%=PN1_#N./4]:R-$\4'6+F_LKBXMX
M;R(2%M.>!X;B%!P"=S'S 3_&H"\XYZU,M+V[#6ITEC?6VI6,%[9RB:VG0212
M+G#*>A&:L5YYX1U?4=.T?P3:2"U>PU*T$ 54;S8W6(N&W9P00I&W:,>IJ]_P
ME>IQ>*;"QG%D8+N\EM&MXHV:2#:KLKM,&*98(#L*JPW=\&KE&TK+S_ /Z_/_
M "-A_&?AR/3;S46U>V%G9S&WGF!)59, [!_>/(X&?2MQ6#*&'0C(KR[5?^10
M^)?_ %^2?^B(J[O7=1N=(\*7FI6<$,\]K;&81S.45@HR>0">@/\ ];K4NRCS
M/R_%7!*\N5>?YV->LK4_#NG:O?65[>)<M/9/YEN8[N6((WKM1@"<$CD'@D=#
M61:>(]176],MK];0VVHZ<]VODHP:%D"%@26.X'?QP,8[]:J#Q?J2:7I?B.1+
M-M$U"6*,0+&PGA65@J.7W%6Y*Y7:,9/)QR[-/^N]OS%?2_\ 6U_R.WJO?W]I
MI=C->WUQ';VL*[I)9&PJCW-<YX2FUB?5O$1U"_MKB"+4&BB1+9D9<)&1\Q<C
M&#C&,YR<\XJOX@U:]U.P\2VNGM:QVNFP20W/G1LSRL8=Y"D, F R\D-GD8'6
MIDVHW7:Y45S2MYV-RYO-&UJPM["X<3VVL6[>4FUQYT97)Y&"ORGO@U;TO2K'
M1=.AT_3;6.UM(1B.*,8 _P 3[UR>@:S?6</@O2TM[<V5]IH+2EV,@9(@<!<8
M Y'.3WX'6K.D^*+C6)-1LQ>6=IJ<2R%;*>U=)K<#@,RE_P!ZN?XEVCM[U4UR
MN272_P"#(@^9)OR_$Z^J-WK&GV%P8+NZ2%Q;O<MOR%6)" S%N@ R.]<-I/B/
MQ#I_A/PC-</87KZO/%#),R/&T8==P^7<P=N&RV5'3Y:VX]9UN/Q+#H>IPZ?L
METV:Y,ULSY9U=5QM;[HPWJWU'=235_*_X*Y2WU_K6QT6G:C::MI\-_8SK/:S
M+NCE4'##U&:M5YCX/U?4]$\"^$[E_LDNE7'E6CQ"-A-&TCE5</NP1DC*[1ZY
M[5HW/BO7;?PYK=[OTUKG2]3^RY^RN$EBR@Z>9E6^?KDCCI5-6=E_6R_5"O;?
M^M_\CO:*XI=4U.Q\8^)+J\O[=]*L+&&?[.MLV\+MD;AM^,Y!R=ISQTQS9T#6
MO$^H:JGV_0F@TN>+S$G)A4Q' (&4GD,@//.U,<<<\2M?Z]?\@O\ U]W^9U;,
M%4LQ 4#))[53TO5K#6[%;W3+J.ZM69E66,Y5BIP<'OR*P-6GUG_A8FBVMK?V
MT5B]I/+)#);,Y8JT8/S!QSAL XP.<AL\8>D:OJ.BZ3'<Q"U>RE\0W%K-$R,9
M&\RZ90RMD!<$]"#D=Q32O_7G8IJRO_6S?Z'I%%<5+XH\17FJR?V)H3W>GV]T
MUM*Q\D;RK;7(=IU9,<\&)LX'/.:Z'7-5.F16D<7E_:;VY6VA,N=@8@G)QUP%
M/'&3@9&<TNEQ=;&I17+W.N:OHNFN=7@M)+I[V*TM)H 8XY_,( 8H68I@DY&X
MYV\=:S]3\5:[H3:G8W46FWE_!I[ZC;2QB2".2-#AU927(89&.<-G^&AZ:_UW
M&E=V_KL=Q17()KVMQ7VD17+:?Y6LPD6S1P/FWF$6_P"?+_O%.&Z;", <YS45
MEKOB&YT]K.2XTM->34C:2*+.0Q*@&[=M\W)RGS!MV.0,=Z=G>W];V)335_ZV
MN=I5:PO[;4[*.\LY/,@DSM?:1G!P>#SU%<QHNN^(]7N=55;;2D_LZ_EM6C,D
MGS@1AE(?'!W,,_+T)].667BO5-0\-:'=+#:P7VJW#P&1D:2"W(\P@D94MG8
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M^5<Q&4, ,E0%=?F]#G%9)\1W\7B(027=BVF7&GM<VTB6K[O, !*EO,P?E.X
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MAS'(0!N3$8'0#@@CCIUKEO$7ABXTKPG9Z%8:MJOV59G=KI],CU *I!_=O B
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9J6F:SX2\'V=]+:WQN+1T)OI!):F10HVNO/F3#C:N0?O'/')9V_KO+_(//\
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M5]\4/3<2U-^BL7PUXHTWQ592W.G2;O)D\J5-Z/L; .-R,R-P1RK$5S&LW?\
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MK?D<KX:TC6M)D\037<&GF2_O'N[=(KIV&2BJ%<F,8^Z.0#UZ<<YVF>%==M=
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M@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(6%QL5D"@MNV@JJ_-DE>O?KI_#NE3RVLIM?+>UA:" PR-%LC./E&TCC@$>A
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M5(XH^/E$8;9@X&>.<#-:MU;QW=K+;2F01RJ48QR-&V#Z,I!!]P0:):QLO/\
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M0+MR2(W4(S9P>%P03@&M^T\+Z58W=]=0)=":^<27#/>S/N8=" SD*1@ 8Q@
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M=Y27",WE_P![ .=OOTKD;NTC\2:U;ZA%IL\%G!I]S;W\=[9-$)=P79'M<#>
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MWET585D;3YHX]^[>%+,@4$*>A(P>.O%4;"RNAX%T!A+JNDZEI4&S<NGO.-P
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !02
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M&F>-;G4;^2 >'M26%H6F@E^S3Q[L#.QS-%&BL>V&8>XIO3^O7_(A:J_]=/\
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M@$ MO1CT)& 1U^F-JN7O?%5[I>E6;ZAI&S5KL,4L;=Y;D*%ZEFBA9@.0"0A
M)'UI;/Q9<7]C:"'2)H=4N6E5+2\+VZ_N_O/N=-^SE<'9GYAP.<'D'F=/17+R
M^*;^W_L;[3HOD&^O393K)<$-"XW89!LQ(AVD@DJ<$<=<9NL^+M872?$"V>GV
MD5YIEY%:[FNV*NDFPAP?+R&PXXP<'/)QR?U^7^:#^OS_ ,F=JUS EQ';M-&L
M\BEDC+ ,P&,D#J0,C/U%2US,NLSIXGT[3;G0X1J,UC--%=>>&C4KMW1J^W?@
MDKDE1VX.,4W3_$6L7^E/-_8]E%J"7S6C6C:@V!M."Q?R<YQ\P&WE<'/.*=OZ
M^=@?]?F=117'OX[9M82VM-%O[NS^T?9GN(;6X8JP?86!$/EE <Y/F \'BNJN
MIS:VDUP(I)C$C/Y<2[G? SA1W)I=+AUL345R^F^+FGU/4+#4+2"VEL[47C?9
M[KS\1DGAP54HXQ]W!'N:;9^+KN6]TVWN-$D']J1-/:-;W*28C 4DRA]FUL,.
M%W_7BC^OS_R?W!_7]?>CJJ*XZQ\=276DRZM/HLUO80R30RGSEDE65) BH(U!
MW%B2!M)Y'?(I;/QT6@U";4M&OK2.U57206MQMFW-M5%\V&-C)DCY0#U&": .
MPHKD++QO)):ZI/?Z+>VL=C ;@2&WN%CD49XS-%&0W<C! !SD\UO:+J3ZMIT5
MV1:%)%#*]I<^?$V?1MJD]NPZT :-%%<K9^+KF?7K?2Y],BMWO())K96NOWP"
M8XFC* QYSP06H#S.JHKFO!&J:OJ^AO=ZO!:QN;B94,$[29"R,N""B[<8P.3D
M#/'2F3:AJTWCUM'-I92:3]@\UR\[!R&8J24V$-TQC(X).>U#WM_6UP3TO_6]
MCI(+B&YB$L$L<L9)&^-@PR#@C(]""*DKSWPIK#Z%H.CVHTV,:=<ZC<6:R)*%
M:)C-)LQ&%P4XQ]X$>A%:4GCLG64M;31K^[L_M!MGN8;6X)5@^PL"(?+* YR?
M,SP>*=M=/ZV_S%?37^M_\CL**Q/&&L3>'_!^K:M;QB2:UMGDC4]-V.,^W>J6
ME>$M*DTJUN+RW%SJDEN#)J3G_2=S#+%9?O)R3@*0!V%+N/L=117/2:G=6,L>
MA:3;1:C?VEHDDOVBX,"A.57+!&^9MK8&,<')'%4D\=)/'HKVVEW$@U*ZDLW+
M2(OV:9-VY&Y))RC=!CCKTR[=@]37N/#UO=^((=7FN[]C"@5+3[2PM@P)(<QC
M@MSU/H/2M>N,F\;WEMIFK7<VCQ!M'N/*OT6\) 3:K;HCY>7.U@<,$[C-6Y/%
M&HS:YJ6DZ?H?FSV4$5PKW-VL23HY;[NU7(/RG&0,XYQP2NG]>H/?^O0O^(/#
MJ^(4M$?4KVS%K.MPOV41?,ZG*D[T;H>PQUYS6R. !G/O7*R^,9)M#L]3TW3E
MDCN+9[EWO;C[/#"%(#(\@5P'R3@8P=IYXIMOXU:_ET..RTF9_P"V+)KN&269
M$1<*#M;&3_$,D#H>,]*=FM/Z_K0//^OZU.LHKC)O&M^/#L>KP:-;,D5V]I?+
M+?%%MRLGEEPPB.] <DG"G'..N->>6;6;W5-&GT^WDTP6XCDF^UL&=G7F,J$&
MW@YW!L\CCT3OT_KK^H==?ZUL;E%<S<ZC#X/T[1=)#P,\I6VB>\N6BC^4#CS"
M&);'W5/)QU[UT<3L\2LZ;&(R5SG'XT_0/4?3(XDB#;!C<=Q).23]37*6OC:6
M<:I<2Z-);V6EW4L%W(]PA= D8?<%&=V<@8!SR/?$FC^,+C4]1GMIM!U"")8F
MFBF^RW"JP&/E;S88P'.> I8<'FE_7Z@=517)V'C.2;5+BPO]/CMY8[$WZI!<
M^=(L8(&V1-BE'Y'R_,.O/%3VGC""7PS)KTRVK6BKN0V5T)]Y+85,E5PY) QT
M!.,GK1;^OP_,+_U^)NWULUY8S6RW$ML94*^="%+IGN-P(_,&JN@:-'X>T.UT
MF&ZN+F&U01QO<;-X4= =JJ.!QTSZYK.7Q+>VVJ_V;J>DK#=3023V8MKH2BX"
M8RF65-K\C@Y'^UQ533O&TM]%H%U)I7D66LN88W-P&DCDVLPR@7&TA#SNR#VQ
MS379=?\ @_\ !!_U_7H:^C>'K?19;J9+N_O)[ERS2WMRTS*N20BYX5!DX _6
MM*&Y@N#(()HY3&^R38X;8V,X..AP1Q[US1\7S1>(K'3;G34@AOYY;> O<XN"
MR!B7:$J,1G8<,&/5>.:YSP_J<OABP\4W5KI4,FF6FLW#W CE$;11A5),:!2&
MQU(ROMFDOZ^]+]0:M_7K_D=UJ=I!JKK:IJ4UK>6Y$RFUE7S$R" 2K!E(Y/WE
M(JQ8V+6D:^=>3WLX7:;BX"!R,YQA%51^ %<E;2V%A\1]=U(+%% VC6]S-*J@
M;\/+\Q]3M Y/H*O:'XPGUC6!9OH=_;V\L9DAN7M;A%& #B3S(452<\;6<'!Y
MZ9:7]??_ ) ^_P#73_,ZJBL/Q+XA;P]%8.+"6[%W>16F4D51&78 $YY/7L#^
M'6LO4O&EWIS"U.AS2ZDJ^9-;Q">=$C+,JG?##)RP7(#!?K2 ["BN=_X2:XN_
MLEOIFELVH7%J+M[:^D-MY"$XQ)\K,&SD !3]TY(JE:^-I+N71&CTP+;:G>3V
M;,]QB2%X]_.T*0P/EG^(8R.M.SO;^OZT Z^BN4B\:>79ZM+?V!BEL-0%BL5J
MSW!F8JI4@*@;H_("DC!ZU6C\>NFBWM]J&D36#VSQH&N5GAMWWG /F2PHP4'[
MQV<=LTOZ_K[P.THKDO$&N:W;VNC/IMK8.UW?1PONO6",""WRNL9X)!&2.@Z<
M\=7N81;G7Y@N2JG//H/6CI<!U%<E9>,[B?6!IUQI BGFL7O;>".Z#3[5V_)+
M&RKY3G<,<D<'D8I-.\;2WT6@W4FE>19:RYAC<W :2.3:S#*!<;2$/.[(/;'-
M.S_KY_Y ]#J9[F"UB,MQ-'#&#@O(P4?F:EKS/Q[J1UWPN;F'3K>338=1@6&\
M>7,GF+<*C,J;>%^\N[=D^F#FO3*2VO\ UM<'H_Z[V"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J&\CFFLYH
M[:6.*9T*H\D9=5)'4J""1[9'UJ:BDU=6!:'$:=X)U;3T\-1_VY921Z)N5?\
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M["'Q'X3T^YTS5;87>F:O=7"2!1.F6DE&'56!P4DR.1U!Y'7TRBFG;^O.X/\
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M@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
H !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ex10-56_03.jpg
<TEXT>
begin 644 ex10-56_03.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2X Z0# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2>VQIT@AF\"*VEZFBVUC+%=#^R[@",M&%P_R<993U]CT(-.W]??_ )?B*_\
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M=HC%=6,2NNT1JI20EE\O#*6!S_$<<T+6W]?U_P  'I<[=]>T>-KQ7U6Q5K$
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M_K9,'H[?UO8?1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDMD<2E6QRH(P&KGK#QIYFJ7%EJEI!9&.Q-_E+KS&CB! (F4JIC?GI\PX//%
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M<7MLD)BL8;JSC(@&, NRD/+@?[2U%:>"]5M+?PQ#_;=FZZ$3@_V<P,XV%/\
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M/^'[W5A92W@M8S*T,3JI*CJ<L0, <^OH#5R.Y:33ENDA9V:(2")2,DD9V@G
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M.<Y3CY3GGCO5^_TZQU6U:UU&RM[RV8@F&XB61"1T.&!%5-\WWO\ ,:=I7?\
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M^7KR>?>M"\TK3M0L197MA:W-H,8@FA5XQCI\I&.*+Z?UVM^>HGO_ %WO_P
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M<8(R<]>:M?$BTAN_#, F>9574;3F*=XCS.BGE2.Q/T.".0#73M86;W4-TUI
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M-R*%5O+9E<C&0Q&/J#WK"L]-\0Q?\(C+_8A!TBWD@NDDNHP6_=JFY,$@YQD
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MVY/CA(?#UZPU2V2&T;SK<"0B,QD\RY YSSC@'OQ2?]?='_-_<./Q+^NK_P"
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MFGMIZ_G8'T^7Y-_H>A45QUKXCU^"RCBUG2X[.^N;Q+2TDEV*DNY2Q8HDLFW
M5N-_S<<C/$/B6Z\46_@_4?.GL;>ZBGCC2[A@8I/$S*"1&9"4/S$'+'IQC/"_
MK\O\P_K\_P#([>BN4BU77D\17^C3W6FN\>F)=PSI9N@60LRG<IE.Y<KG (/.
M,]ZH1>+-8N_"FBZBC:=:SWUFT\DLD+S*9  1&D*N)&)!8Y!.-O0YHZ7_ *Z_
MY,=G_7R_S.KO-:TW3[^SL+J\BBN[UBMM"3\TA R<#T'KTJ_7 WNJMKEG\/\
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M2;MV<8 8!> ,CCKSD) =?17F^G:EXOMO <VKQZAIMU+#<SO*)-/D+>4LSAR
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M+<8+W=Y=F:<$$%2&88&" 0,8]CDUTE%*X&)-X:AEU2'41?7L=PEN;:9D=/\
M2(\YP^5XP22"NW&<=.*I:=X$T[218"QOM2B%G ]N-TXD\R)B"4;>#@9 (V;<
M?2MK4-2%E9WDT4+W4UK%YK6\3*&8<XY8@#H>I[4ND:@-5T:QU$1^4+J!)@F<
M[=R@XSWZT?U^?_!#^OZ_ PQX&MDL]$M8=7U.*+1Y!);A6B8L0I4;MT9Z*2,#
M'7/7FNGD<1QL[!B%!)VJ6/X <GZ"G5!>7<-A8SWEP^R""-I9&]%49)_(4-Z:
MC6K.$\$Z*-1TN8W[:M% FI7$_P#9]U;&"-R9VDC?#QASQM. VW/49S73Z1X:
MBTB_U2[%_>73:E+YLZ7 BVAL!1C:BG 4 <D_GS4^E:AJ5[+(;O3$MK8HLEO-
M'<B7S%;LPV@JPXR.1SPQK4IO^OR_05[Z_P!=_P!3GK+PE9::856[O9K"T?S;
M6QE96BMV .-F%WG&3@,S <8 P*Y[PEI"ZO#JOVQM7@M7U2>=K&YM6@BG5I-R
M,?,C#D<#A6 _O"O0J*5];@]K?UU_S.6U7P'IVI^(!K2:AJ^GW+!1<+I]ZT"7
M(7[HD Y.!QP15[3_  U%IWB&_P!934+R22]1(W@D\KRU5,[ N$#<9/4GKSFM
MNJ]_-<V]A--9VOVNX1"8X/,$?F'TW'@?6A:;!N84D47@S2)!:6.KZM'/<MMM
M;=5E:/S&+'&2H";B<EB<9ZX'%WPOHT>@Z!;V21")AEW0-N"LQSM![A>%'LHK
M7!)4$C![BEH R/$GA^+Q-I)TVXO+JV@:17<VVS<^T[@"75N,@'C!XZU%J/AH
M:EJ&D7LFK:A'+IC;XQ&(<2L5*DOF,]5)'RX'/&#@UN56O[L6%A-=>1+/Y:Y$
M4(!=SV5<D#)/')%&P;GE[Z)X@O/&-Q?V>O7-E>"5WB@N_"ZS;$S]S[7@#:1C
MH_ XZBNRF\'?:;G5[B37-35]5@6"=$$&U%&<!,Q$C@L.2?O'O@B%?'$S:I<:
M8OA+73>6\*SRQ!K0D(Q(!SY^#DJ>!SQ6CI?B/^T]=N]-_L^>W$%K#<I+*R_O
M5DW8P%)Q@J1S@\=.]"7NV&WK<;9^%;>RFTN==0OI)M/MVM5=V0&6(D$*X5 .
M"J\K@\<YR<V4T*+^UH=1GN[JYDMT*VZ3;-L.1AB"JAB2/[Q/MBM6BFVV[DI)
M*Q2U;2[?6M)NM-NBX@N(RCF-MK >H-8EWX)@O5O#+K&J>=>62V4\P:(,\8+<
MX\O:"0[#@8YR #S5^\\110WTUC8V%YJEW!M,\5F(QY6X9&YI'10<<XSG&#BK
MFGZG#J7V@1)-&]O)Y4J31E&5MH;'/7AAR.#VI;HJ[3,B'P>D6IZ5?-K.I2OI
MMNUM'&X@V2(V-V_$0.3M7H1]T>^:[_#[3)+:"S>^U,V-K<K<VMJ+@*MLRYP$
M90' YZ%CCH,#BNLHIW>_]=_S%;2W]=AKN(HV=@Q502=JECQZ <FO/_!.BC4=
M+F-^VK10)J5Q/_9]U;&"-R9VDC?#QASQM. VW/49S7H5%).P=+&)I'AJ+2+_
M %2[%_>73:E+YLZ7 BVAL!1C:BG 4 <D_GS45AX0L]/:"-;N\EL;602VEC*Z
M&*W89QMPH<@9. S,!Q@# KH** .?E\'Z9<66K6-RUQ/9ZG(TLL#R86-FP24(
M (.0#R3@],54L_A_ID.@W>CWU]JVKV]T K/J5XTSH!R AX"8(!X .0/2NKHH
M Y>R\"V5KH-[I$^J:SJ$=Y&8WFO[UI9$4]D)X7'L.PSFK,_A<7&K:5J+ZQJ7
MFZ:K!%_<E92W#%\QYY''RD =@*L:[K;:+]@(L9+A+J[CM6=751%O8*&.3D]>
M@!_#K6O3N]_Z_K46FW]?UH<]%X.L8961;J\.G&;[0--9D, DW[]P^7?][G;N
MV^U4[CP%!<VFN6TFN:MY>LR"2YQ]GR. N%_=<#:%'.>GKDG>UK4FT?1;O44M
M);LVT9D,,3*K,!R>6(' Y_#O67#XJ:74]!LSILJIJ]L;A9_-4I&0FXIC[Q/(
MYP!SU[4EV7]=?T_ ;=M?Z_K7\3=M86MK2*!YY)VC0*990H9\=SM &?H *R;[
MPQ#>7U]>1ZA?6DM[;+;S?9V3&%W88!E;YL,P].>F0")O$NM-X>T&YU1;*2\$
M !:.-U7 [DECT'MD^@-:JG*@^HH>MVP6FARR>!UB.CF/Q!JZ-I,+0VQ MC\I
M&T[LP\G;@?@.^2;.F>#[#3O#,^@2W%U?V,YD+BZ*;OG8LV"BKW)/M70T4V[W
M\_\ AP2ML8UAX<AM)UGN;Z\U&:.-H87O"A,4;8RHV*N<[1RV6XZU0M_ FG01
M:5$;[4I(M*F\VR4W 3RA@@)E I90"1R22."2*ZBF331V\+S3.$CC4L[-T '4
MT786Z'E+Z)X@O/&-Q?V>O7-E>"5WB@N_"ZS;$S]S[7@#:1CH_ XZBNNN/!"W
M<>MK/KNJ?\3E0MRJ^1A0!MPF8L@;?EYR<<]>:U!KC?\ "5KH9LI%5K1KI;HN
MNU\,JE0H.?XNIQ[9K7I)>ZE_7]:!?6YS[^%(RUG/#JNHV]_:P"W^VQ&+S)H@
M<[74QE",_P"R".V,FGS>$[!H-.2VEN+.33YFF@F@92^YL[]V]6#;MQSD=\\&
MMVL?5=8N;:Z6PTRSBO=0,+7'DRS^2OE@@'YMK?,2>!C'!R11<+:%(^!],^PZ
MC:K<WZ_;[I;MY/M!8QRJP=60,"HP0.QSCG-='&GEQJFYGP,;F.2?<TD+O)!&
M\D31.R@M&Q!*G'0D<<>U<U_PF$GV3Q%-_8USOT638T/FQ[YAL#[@=VT#:<]<
MX[9XH;LO3]-!I7V_JY8U'PG!J$NJNNI:A:?VG$L5P+=TQP"NX;D;!*G:>W<
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M7I]<VM1\-#4M0TB]DU;4(Y=,;?&(Q#B5BI4E\QGJI(^7 YXP<5N447 Y2\\
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MN=2EES,Y=]P$J3Q?<^4;6+ @CK6O#=27VLZ;HE_K,D]O_98NEN[65K8WT@8
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M>'HY;65-"TM9+08MG6TC!AY)^0X^7DD\=S26_P!WX7_S!JZ^_P#&W^11^(!
M\!:UDX_T8C^59%Y>OH?B35D?5;J&S.B&\DDF=IQ#(K%?,1"<#C^%< XZ5V&H
M:7I^KVWV;4K&VO;?<&\JYA61<CH<,",U5C\,Z!%=+=1Z'IJ7"Q^4)5M(PX3;
MMVYQG&WC'3'%']?A8?5/^M[G*:$L[^)KS2;FYOX[2[TR.<1RZG(\V\L064AB
M8B1CY4<@=L4_PUMNW_X1VXNM4>_T.Y9[F5[Z?=*.L19M^65PP.TY4;2,5V%I
MHVEZ>8C9:;9VQB0QQF&!4V(3DJ,#@9YQ5E((8YI)4B19)<>8X4 OC@9/?%._
M]?/073^OF>8>&=8FUG7+2\F\:6$&H>>T5SHVV02G!(,7EM.4X_OK$#\N>F:Z
MGXD6\=Q\/M8$K2*J0%\I*T?(/<J1D>W2MY-(TR/4WU)-.M%OW7:UTL"B5AZ%
M\9(_&K,T,5Q"\,T:212*5='4%6!Z@@]12Z+^NW^0^K?]=?\ ,XJ33K:7QI8:
M?'=7?D+HTZEEO)#*1YL?67=OSGONSQ^%8,OB2]_X0_PS'?ZW'I\%]YT-QJ5V
M)""R$A%9XY(V4D G?N'*\]:] /A?P\TXG.A:89EB\D2&TCW"/;MVYQG;MXQT
MQQ3X_#FAPZ9)ID6C:<EA(VY[5;5!$Q]2F,$\#M0_Z^]O]1)6_KR2_-%3P>6.
M@(#K\&N()&"7D .PKGA0Q=RVWIDL3ZG.:PKG1;6[^*SF6?4!NTGS<1:C<1@-
MYNW@*X &!]T<9YQGFNVMK:"SMH[>U@C@@C7:D42!54>@ X JBWAW0VU7^U6T
M;3SJ.X-]K-JGG9QC._&<XXZT/65_ZVL'2W];GGD.J-:^$_"U]=ZS=1/'K302
MRS7\@W1>=(I63+?.  H^;./QK67E?B1_O?\ MHE=DFC:5'-),FFV:RRRB:1Q
M H9Y ,!R<<M@GGK5?_A%O#V+L?V#I>+SFY_T./\ ?\[OGX^;GGGO2DKQ:[I_
MBE_E^)47RM/T_!M_K8Y)T&BZ=X8\3R75\+&&UAAOH5NY1"J-& LIC#;3M;&>
M,88D\@&NK\-V3VNF&>62[:6[=KADN;B24Q!CD(-[': "!@<9!JG=Z%?&>UTO
M3H])LO#*I_I%O';D2L=V=B $(JGN<9Z^N1TE6Y7N^[?YW_,B*LDNR1P+1/=^
M*?%=I>Z[J*06T%O<0!+LP_9\JY)&S;E00.&R#WS65>ZIJ>I^&XY)[J]35K?0
MTO98HKEK18)"&Q([*<N6VG]V59?EYQD5TMMX9N+GQGJFIZQI>D7%E-Y)M2TA
MFDB>+< VUH@%)#=0W&,<YS71W&E:==W275S86LUQ&AC262%6=5/502,@'N*C
M[*7E_G_P"T[2=^_^7_!.4-_>R^(_!\RZE.\%Y:2F:W5E$4CK$#N.!DG)]<<#
MBN6UV_AOO!>F>(+_ %&1+J36+9;F-[HB&#9<C*&,G8NP#EL \<FO3&\.Z&]Q
M:W#Z-IS3VBA;:0VJ%H0.0$.,J!VQ4AT323=RW9TNR-S*5,DWV=-[E?NDMC)Q
MV]*N_O7\[_C?_@$I:6?;]+?\$Q'U7Q'>Z]/I<OA5X]#D#H-7BU5%8KM)#*BX
M=23QP<CK7*6FK/#X?\ 7MWK-S%++=F"XDEOG D4I)Q("V'.Y5&6!.>.]>JU0
MCT72[=WEM]+LDE:4SEE@52TN,;R0/O<XW=>:E:?UZ_YE?U^!YVLM^OA+6-17
M6]2N-6TW5)X;0M=$>:1(%6-XUPC;NF"O&>,5ZDI)4%A@XY%<GX4\,36$UY=Z
MUIFD_;WO)KBWN+=S,\:R-N*[FC4C'MU]JZVGT2]/R0GJV_7\PHHHI %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %,
MEEC@A>:9UCBC4L[L<!0.22:?5'64NY=$OH["&WFNV@=88K@9C=B#@-['O2>P
MTKLI0^+M#FCNW:],"VD8EF-U#)!MC/ <>8HW*<<,,@^M2V7B72-1N[>VM;IG
MDN8//@)A=4E3C)5B K$9&0#D=P*Y%=)UN*ZN[Y=(U"8W6BFU9)KJ#S%E#'Y0
MH<1J/FS\I P/7BGV%AK<=SX*$F@7J+IUJ\-VYFMR(F,8CSQ+DCY<\9X([Y K
M^OS_ ,E]Y-_Z^[_-_<2^./$2K%8PZ9J=W#/'JEM%*8(F$4H:4*\9E*[21SE5
M;/KQ7>=!DUYG=:#XF/A*T\/PZ4LL^GZA#.MW)=(L5RB3>9G/+JWKE>N<;J]+
M!.T%@-V.0#FC[/\ 79#>_P#7=G-6GBGPW:6$U[_PD*SVL]^T*2RR[QYIQ^ZC
MXY [ 9QSS4[>-?#RS"$ZB//(E(@\I_-Q&2'.S;NP-I[<XXS7%W>D^(;G0=1M
M%\-WRRW&OI?H&GML>4)4<D_O>N$(QZD>^.EU>UU.Y\=^'+^'2;E[.TBG\^;S
M(0(S*% &"^3C&3@$>F:2V7]=+_GH#TO\_P _\C7G\3Z1;>29+EQ', 1,MO(T
M29 (WN%VQY!&-Q'6DA\3Z7<7>HVL1O#-IR[KE#83C:/]G*?/G' 7.>V:XR^\
M,:A#XQO'?P3H?B"RO[@3+J-VT2RVHV@%7#(S. 1\NWZ<5T>L:-J;^)+"\TPQ
MK:W$?V75 <#,2_,K#OG[R?1_:A:V\PV-&?Q-I=M9P74CW6V>/S4C2RF:79W8
MQ!"Z@9&20,9J27Q#I<6G07ZW7GV]P-T'V:-IVE'7Y$0%FQWP.*RKVTU/3/&#
MZW:6$NI6MU9I:RP0RQK)"R,S!@)&52IWG/.>!P>W/_\ ".^)O#,>G:GHMI#J
MEQ"]W]HTUK@0C9<2B3$;GY05( Y'/-&G]?/_ (&OF!V4GB;24TR#4%N6F@N"
M1"+>%Y9)",Y C12Y(P<C'&#G&*YO7=?$NL^#]0T[5;@Z9=W4L<L40^64")S\
MR[=Y8,N-OKVS5NYM]:EBT9_[#BME,LC7<-A-$9;8L."LCA1@DMO*X;GC/.<:
MS\-:W9:7X?D_LYGDT;4KF=K87*O)-&_FA2K,<$X=3\S ]<X--;W?<6MC3\7:
M['J/P\UG4-$U2YMIK2-MS1H8I8W7DHZNNY.".P.",&NAO-=L=*AB-Y)-DJ"W
ME6\DVP'^)]BG8O!^9L#@\UR>NZ#JUWX;\4SP:;*]_K:HD5BDL0:(*@4%V+!<
M]<X8]L9JIKV@ZI+KT6K+X(TSQ!!>6T,4EMJ4D"36+KG/S$.I7GD*3R.*.EOZ
MV'_P?S1Z1%+'/"DT3K)'(H9'4Y# \@@UCMXOT 7<]K_:<32P3"";8&98I""0
MK,!A?NGJ>/QK4LH!;6,$"P0P".-5$, PD>!]U>!P.G05S&@VNIVOB_Q1?7.D
M7,5M>/$ULYDA/F^6FPX <D9/(SCCKBD]_O!;7]"_I6LZ/%X;&I0:O+>Z>TLF
MRYD+2L[&0C:N!EOF^50 <@ #-9'BKQ)9W_A#5CH^MO;:A:0^<\41$5Q& 1P\
M;C>@.>X!]"*QUBU'1_AZOV_0=32]MM5:YA@MQ%/*=T[2*RHDA#X#8*Y!Z_6J
M=O>:AKWACQ+!#H.OMK>I;6DBO+%;%&&U4#1B20C: HS\Y;)].CTOZ6_]M_X-
M_03V^_\ 7_@'H<?B33)&O(DEF>:SA$TL2V\F]D(X9!M_> X(RF1GBD\,>((?
M$VA6^J00W$*S*&V30/&1D9XW ;A@CYER#V-8\4&J7'CL7SZ+=P6<FDBV,\DL
M!"2%M^"%D+<=,@'GVYK2\&6E[IWA+3M/U"U-O<6D*P,ID5]VT8W J2,'&1W]
M0.E"V_KN_P#@!T_KLA;GQ1;6WBZU\/M;W9EFMVF\U+65T'S* -P4@#DY).!Q
MD\U,?%&CKJ*6+73"5W,22&%Q"T@."@EV["^01MW9XZ55O;&^'C>PU&&U,MH;
M&6VDD$BKY3%T8$@\D84],\X[<USR>'=8D\,)X1GLY!'#<I(FK++&4:-9A(#C
M.\28X^[C/.ZA=/ZZ_P"6OF#Z_P!=/\]#T%V"(S'.%&3@$G\AUK#C\8Z')86E
MZMS/]GN[G[)$YM)AB7=LVL"F4.[CYL<UNUYM+X?\0Q^'Y-*M]*62:WUS[?'+
M)<HD4T9N#-P1EA@'!RO7IFA6OKY?GK^ WM?^MO\ ,[N/5[.6_DLD>0RQD*Q\
ME_+W?W0^-I;U .1WJ%_$.F1ZBEB\\BRR-L1S!)Y3/G&P2[=F[(/R[L^U87]B
MZA:>*X[S2H[ZTCN)C)?HUQ')9RKT)"$[UD/!!4*.N[-8FB>&-0TWQ*;:[\$:
M%>0+<O/'XA9HA, 7++N387:09QG('&<TEK:X/K8]+) !). .I-8MMXNT.ZGE
MB2^V&.$W&^:)XD>(=9$=U"NHR,LI(Y%:]QYAMI1"J-+L.P/]TMCC/M7G^FZ3
MKEKJND:K+H]T7M].N+:> 7$"JC$QE5BC5PBH=I"]#TW8QFCO_7<:_K\#JK3Q
M9HE_-91VM[YHO0WV:01/Y<I&25#XV[L G;G.!G&*Y_XC>(5MO#.H0Z=J5W;7
M]N4)DM8VV@[ERC2;2JDALXR&Z8K,L-+U^WT+P9:R>';WS=,O#)= 3VWR*$=<
MC][SG>#QV!]LR:KH'B)_"FN>&[?3?M#W-T]S;WS7""-U>82;6!.\, 2.A&!U
MSQ3LK_/]5^E_N%_7_I7_  /O/2$Y1?I7#?$;Q"MMX9U"'3M2N[:_MRA,EK&V
MT'<N4:3:54D-G&0W3%=K;F4VT1G18YM@WHC[@K8Y .!D>^!7G>JZ!XB?PIKG
MANWTW[0]S=/<V]\UP@C=7F$FU@3O# $CH1@=<\4?:_KN@C\/]=F==:ZCI<OB
M*^CCU=Y;RVMHQ<VGFYC@')#$8PK'///0"K=OK>GW%I)="9XH(U+N]Q$\("C^
M+YP,KQP>A[5S=O9:I-XTU&YO="D^QW.DQ6I?SXFB=U+LRCYM^T[\ E!T/ XJ
M@WA?7CI6K:7IMS>V]D$0V,>J3),5F1PX"LA9O*.,$.2?08ZG]?BP7]?<C;U?
M7;;5/#>N)I>H7=I>VELTA/D-#,F 2K!94Y4[2-P&#S@YJS8:W;V'A?2;B_FG
MDFFM(FVQQ23RR'8"Q"(&9NN2<?6L?SO$^K>'=9;4_",-E?R6C6T26][%-+<$
M@@')VJJ#)."Q/)X]66NGZU8/X?UE-*N)I+333876G>;")5R4^="7V'E.1O&0
M1W&*2Z_+\G_P!=OG^G_!.E'B/2GTV&_BN3/;SOY<?D1/*[-SE=B@MD8.1CC!
MSC%3W6KV=G:"YD:5D;.U(8))9&P<'$:*6..^!Q7)MX3<Z;>SW-M?_:KC4)=0
M@33[E(YK5B H"LS!"2!D@DKDGKUK/UWP]XBN+#1=0N]&T[Q->6:S17&GWWE+
MYB.P*.&8%!* J[B.#EL4#1Z#87]KJ=FEW9S++ ^0&&1R#@@@\@@@@@\@BN8\
M5^((+76]*T.;^TEBO#(T[65M<ERH0X"R1+D?-@G:<@ 9P#6WX<M#9:)!$VCV
M6D,<L;&S*F.(GME54$^I 'X]:R-?CU-O&>@W=KHEY=VEF)O.GBE@4#S%"C >
M16.,9/'3IGI3:]Y(5_=;+&C>)-!6&+3[;6WOFAE>V,\I,A+HN\JT@&W(7N3S
M@\D@UHV>OZ;>WDEI%-(D\:E]D\$D.]!@%DWJ-Z\CYER.1S7*Z7H.JWNF>,[&
M[L9]-.K7,TEM+*\3_*\:H"0CMW7D'L:J^'/#E]/:7]I?>"-$\.3M:O;?VEI[
MQ%YBPQE%1 47O\QSQT]$^_E^G^8[*]O,[!-;T_4YYM-MKNX@NFB8QN8'C+#'
MWXFD7;)C(.5W#D9KGO"?BJWM?#.@PZO=WL]_J#21Q2FVEF,KAVX+HI4' SSC
M &> *I>#M(U+3+AS??#[0]/N+. J-0TYX?,NVQC$:A5*;O\ ;8?X3:=H]ZGP
MN^QZC;R:5?V!>XB>:2-O+D1S(CY1F&WL1G/48IZ)M]-/S?Z!J[+^MO\ ,[*U
MU:TO-1N[&$SF>T($V^WD1 2,C#LH5N/[I-&I:M9Z1"DEV\GSG:D<,+S2.<9.
MU$!9L#DX' J#P]!<1:1'->H$OKH_:+E1_"[?P_\  1A?^ U3\10:C-?Z6;2S
M>>V61Q<26[1K/%E< JSD87KN*G=TQWI--.P)W5R<^+-!%O83G4X%34&*6NXD
M-*PX("]<@\'(X[U+;>(=*NK*ZNTNMD5HYCN//C:)HF&#AE<!AD$$<<Y&,YKB
M(-&UZQT?P[9#0KJ8V&L27,I2ZA?$6^3#%GD!8D2 ]SP<X/62?1->O+[Q!-'I
M,T!?5;6_MA//$$N5A" I\CL5)V$C< .F<<@/3^OE_F_N#I_7G_DOO-'1-8EU
M'XDZE%'>WTEA_9L4R6US"T/DN9&4X1E5AD*#E@3SP<&NEUW54T30[S4761A!
M$S 1PO*<XXRJ G'J>@')K TRSUJ;X@SZY<:6+2PN-,CMRLUPAE1U=FQM0L#U
M_O8Z=>0-KQ.ES+X9U&"SLY;RXGMWB2&)D4DL",Y=E&!G)Y_.IG?DTWM_F5&S
MGKMI^AA>'M4L(M*@UZ>^UEI;V%%DM9XKA_,EVAF:*%E+>O\ JQMQVXS6PWC#
MP^EE:W;ZI"L5U,+>'=D.TN<;-A&X,#U! ([XKG[>PUNW3PWJZ:1<F;3;1[*Y
MTYYH1(RLJ#?&0Y0G*#@L,@GIT-#5O#NLF-KJVTJXGEOM>M]2DMDEA'V:.,("
M&+. 6(4GY21GOW.CMS6Z7_7_ "U\C.-^5-[V_3_/3S/0;#4+;4[075I(7B+,
MF61D(*DJ00P!&""*HWWB;2--O5M+JY=)"RHS+!(T<;-C:'=5*H3D8W$9S6LI
M)4$@@D=#VK@?$NC:YJDNM1)ITC(TD$UFUO/'%',$*$B3Y@[29!&&^3 7'.:C
MK_7D5T;_ *ZG2W7BS1+2YO;9[[S+BR57N8;>)YI(@>A*H"??IP.33E\4:3)J
M]II<<\TES=P^? 4M96CDCQG<) NS'([]QZBN>EM]9'BOQ!>_V!>/!<Z7%;PN
MDUOB21/,) S("/\ 6#!('0].,P?V=J5C\.]!F^S&RUS1TA2*&=U(D< 1M'E&
M8$."0.>ZG&136WW?C?\ X'W@]]/ZT3_S.STW5K35A<&T,Y$$K0R&6WDB^=>"
M!O4;A[C(JM>^)M'L-2.FSWFZ_$)G^RPQO+*4'<(@+'Z8R:MZ99_V?IL%KNWL
MB_._]]SRS?B23^-<KKUS/:?$G19K>QFO7&F7?[F%T5R/,AZ;V5?S(HMK;^M@
M6S9N)XKT61=.9+MW349##;.L$A5I!G*,0N$;@\-@\'T-12^-/#]O#>2W.H"W
M6SN!:S?:(GB(E(R% 906R.1MR".E8$_AO5+73;2[BM3<74>N-JLMG%(@8(VX
M;%9B%+ ,"<D G/-9FOZ#XEN;?Q1%!HAF35+VUFMS'=1[P$$>[<&(  V$<,3D
M],<T+^O_ "7_ #?W!T_KS_R7WG9GQEX?%XMF=0'VMW=%MQ$YE8H,MA-NX].#
MCGC&<U8@\1Z3<:8VH1W6;=9/*8-&ZR"3.-AC(WA\D?+C/M6!XGN9X_$GA"XC
ML9I91)<,;4.@D_U#94$MLS_P+'O52;PSJYG;7X(,7AU9-1_LUI5&4$/DE"P)
M7S,9;KC.!GO0MM?ZU#K_ %YG56?B/2KZRN+N&Y(CMCMG26)XY(CZ-&P#@GL"
M.<\5/'J]G)9&[W2I&,?++!)')D]!L90V3Z8S7.+X?DU:_P!8U/4=.GAAU&U@
MM?L#3()0(V8ERR,5#?-QAOX>HSQD7WAGQ#>^&Y;<Q&_2TO(Y[+3]<>*1IHU!
M#1RLF5(.<J2200"Q]$P.ZTS5[+5XI)+.1R8VV21RPO%)&<9PR. R\8/(Z4NI
M:M9Z1"DEV\GSG:D<,+S2.<9.U$!9L#DX' K'\%V4MKILLD_A/3O#4LK\VED\
M;EL?Q.T:JN?0<_7G E\10:C-?Z6;2S>>V61Q<26[1K/%E< JSD87KN*G=TQW
MH>]D",WQ!JWVV+PSJ6D:K.+2XU2*)UA(59E).0^1N&"N,9'<$58T>:['Q"\1
M6LU]<3VZ6UK+%%*PVPEC)D* !Q\HZY/O7/1Z-KUCX=T*P70KJ=[+6&N9/+NH
M7(B$KL&+/("20X(ZGKG!Z]#I=MJ*?$+6[R;2[B*QN;6"*&Y:2(JS1E\\!RPS
MO&,KV.<<9I6O]_Y1_P"")W_+\V:GB6^TZPT"ZEU34WTVU9=ANHY-CH3TV'!.
M[TP":9/XHT6TNI[-KWS;JVB$LL$,;S2JAZ$H@+=\],XYJKX[L[[4?!6J6&G6
M4EY=74)BCCC=%Y/<EV48'US[5EQ+K'_"7W.IMX<U!;=]'2W7,UMDRJ6<KCS?
M]K&>F0><<U'1_P!=/\]"OZ_%$OBCQ;9P6^B);RW<MKJTZ@S65O/(6A*,QV-$
MI(8X' .[&2.F1?36-(\,6:6MUJ5_,BCS#)<QRSO C$E?-<*2BCD9D(/')XKD
M[33O$%IX>\%VK>&;]YM(G$ETJ3VO 6-TX)F .2P(]LYP>*WC8ZOIFLZVT6F2
M:A::R5D1UFC4V[^6(RL@9A\GR@Y7<>3QZT]+V\_TM_PX;V_KJ_\ @&O>>+M!
ML;I[6?4HO/2W^U-'&&D98N/G(4'CD?AST!J)_&OAU(KF4:DLD5K,(+B2&-Y%
MA?\ VRH(4#NQP!W(KGM"\/:IHGBO0XS97$]CI^B_8'OO,BVM(61LA2^_'RD?
M=]/K574M,UZZTWQW!'X>O=^K$"SS/;8?]TL>3^]X&5)Y[>_%#2O_ %WM^6HE
MKOY'<0:]IMQ?SV*7!$\,?G,)(G16C_OJS *ZCN5) [U!9^*=(U"6>*VFG>6&
M+S]C6LJ-)'_?C#*/,7W3(.1ZUSES;Z]+XFL;VW\/SA$T:6U+7,L!C29RC*KA
M9"2OR8.T'J,9ZAVA:1J\/B73=2N-.NHH_P"S'M9_/N(L0OO0@+'&Q4*0&QM'
M89QQ1;]?U_R7WBN[7]/T_P""6;?QAHVN:)I]W<WUYI7VF]1($:.2!YG#_*@W
M+\ZD8#;<CD\BMK4?$VDZ3.8KVY>,KCS'6"1XX<]/,=5*QY_VB*X^XTK7HO!6
MD:6NA7$]S9:C#(ZQ3P<I'-O+ LZC!'0=<]0.M:+Z9K%E/XALX],>^MM:=YHI
MQ-&H@9HE0I*&(. 5X*A^.,<<CVT_K1?\'[A]?Z[O_@'077B;1[2^>Q>]#WB0
M?:#;0(TTOE^H1 2>O  R?PJ]8WUMJ=C#>V<RS6TRAXY%Z,#7&V6E:IHWB?3M
MFEWM[9V.B?83=K+ /-D!5APT@;G;CD=2.W-:O@.TO]/\(VMEJ5A+97,#.&CE
M>-L@L6!!1F&.?7/!HLM;?UJU^5F*[TO_ %HG^>AH:MXCTO1"!?3R*=N]A%!)
M+Y:?WWV*=B\'YFP..M,G\4Z+;W;69OEENEM_M/D6Z--(8^,,%0$G.> !D_A6
M+XITO5]4O[ZVALI&L[C36ABGMI4B8R_-\LK$A]O(VA>,EMW:JUA;ZW;>)M.O
M)O#]YY-OHIM'9)[<CS<JVT9D!_AQG&,D<XYJ5_7W/_+\1O3;^MO\_P #J&\0
M:6-)@U-;KS+6X ,)BC9WER,X5%!9CP> ,\'BL'P+J%Q?WOB837]S>10ZGL@-
MP-K(AB1MNW VX+'C /KS61HND>(-.TGP[=MHUP;C2WN(Y[!KB$/(LIXD0ARA
M(Z89EZM^.[X2TW5K#6/$EQJ%I%!!?WHN;<B8,Y'EJI#*!@8V]<GJ>/6E:[]/
M\O\ @B>W]>?_  /O-36K[3;:YTRWO=4>SGGNE^S11R;6N&'\! !)7D9_#FL#
MXC>(4LO">L0V.I75KJ,%N9!+:Q,1&P (5Y-I5"01P2&.>*O>,[?4;EM$^P:7
M<7WV?48[F;R9(EV(F<_ZQUR3GC&>AZ5A:QH7B!_#_BG0+?33<_VG)-/;7IN$
M"?O,?(X)#!AT& 1@#D=*E?K_ )?\'[BEH_Z\_P#@?>==/KMCI=G;M>R3%FC5
MF,5O),4!'WGV*=J\'YFP.#S3=0\5Z+IBHUS>'8T:REX87E5(V^Z[LBD(IP?F
M; X//%<7K7AW6!K5OJ4G@O1?$:7-K##-!=31[K)T!!*R2)\R'/0#.1G%6_$?
MA_6+^TU33;;2DBMYM)$%K]@ECAC\P!OW<ARKE02 H V8)SC-4][^8HK9/R_0
M[.YUBQM;F.WDDD,DB>9^[A>0*O/S,5!"#@X+$ XXJ_7$ZWHNHSI::AIMKJ%I
MKB6Z0I-:W,7EC&2%G5SAD!Z[0S?,<5VD>_RD\TJ9-HW%>F>^*+"3V'4444AA
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !115+6-3@T71KS4[D,8;2%IG"CDA1GB@:5W8;<:UIMKJUKI4UY$M_=!FA
MM\Y=P 23CL.#R:FL=0M=1BDEM)?,2.5X6.TC#HQ5AR.Q!KA[]]5D\;^#IM0:
MS8RFZ>*.!&7R\P?=9B3N_P!X!?\ =JU%XPU-O"%QJEQ:0Q7,5_+:2FWADN8X
M%1RAD*C:[@8[;>O:GTU_K6PM]O+\F_T.WJAJ6M:;H[6JZA>1V[74RP0*QYD=
MC@*H')Z_A6./$IOX],M])O\ 3;BXU%97ANU5I(0L8&3M# DY(&W<,<\\5F^*
M)-2D\-:7_:T$,5VNM6BMY)RC@7"@.!DE<C!VDDC.,GK0EJEY_K85]+_UL_\
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M<] .Y)]!6$WBEX_%G]DW<L&G[M@MX;J%@;HL 28Y0VPD?,NS!.1G.#4WC_\
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M02&4D,!@94C. #D<5T5%'2P=;E+2M*MM'TBWTRV,K6T$?EIYTK2-M]"Q.?\
M"LS3?"%EIAMXH[J\ELK1@]I92NIBMV&>5PH9NI^^S8[8KH**=W>X6TL<I:H/
M$/BV/4I=%OK(:3YT"37:!/M#,0,H QW( "02!U&.]='>VSWEE+;QW4UJTBX$
MT(0NGTWJR_F#5BBE;2P=;G*Z?X*ETS3;?3;?Q3KGV"!!&L!%J 4'\.X0!_Q#
M ^]6M2\)PZI!JL-SJ5]LU%43 $7^C*O01$QG'KSD@\C!YKH**'KN&QR.I_#Z
MSU7[!--K6N1:A9Q^3_:%K=B&XFCSG9(44 C\ ??K4VM^ ],UK[%)]LU2PO+.
M/RH[VQO&CG*'DJS\E@2,G/.<\\UU%% &'+X6M6N=,N8;N^@N-/1HDE64.\L;
M8W+(7#%LE02>&R."*K0>"--M=,2RM[K4(Q'??;XY?M&]DEW$G;N!4*<G(QCD
MGKS72T47_K\0,2Q\.)8^([S6EU*^EDNXDB>"7RS&%3.W&$#Y&6Y+'.><\8GT
MKP_8:-<ZE<6B,'U"<W$VXY ;&,*.PSDX]6/K6I10!RNB^ =-T'5Y+VRO]6%N
M6+1Z<]ZQM(F/)*Q_7GG..V*V=8T>'68;=)9YX'M[A+B*6 @,KKT^\""""0<C
MO6C11V#S.?N/"5K->W-Q#?7UHEXNV]@@D79<_+MRVY2P;;QN0J3W-;D=O%%;
M+;QQJD*($5%& % P /PJ2BCI8/,Y7_A!H$L-*LH=:U6&#3)A+;JK0GID*IW1
MG(4$@=^>23@T2> ]/NEUI+Z^O[R+5I%EFCD:-1&ZX"M&416!4*H&2>GKDUU5
M%&_]?UV07_K^O5F+X<\.1>'+-K==3U3478Y,^I71GDQV )P /8 4NJ^&[74[
MZ'48[BZL-2A0QI>6C*)-A.2K!@RLN>S*<=L5LT4/74%H9O\ 8L$VFS66H33:
MBL\1AF>YVYD4C!&$"J/P JE:^%DM@I;5M1N)88WCM)9VC9K4, #L^3#' '+A
MC[\G._10!R,/@&&#3M+LDU[5Q%IMR;F XM\[SG[W[GD#+?\ ?1]L9/C#PX=,
M\-^);BWNM8U&XU@KFV2V$V'&T J(8@P 50,DXXYY.:]$HH_K\O\ )!_7Y_YL
MY^U\/6EY;2W%W<WUZUW;- KW:B*2&%QS&H"(5[9W#=P,GBH4\&1(;>3^V=5-
MQ!9O9)-NBW>6Q4\CR]I(VC''US7344/^OZ^8+3^OZ[')VW@2&UAT**/6]5V:
M(<VP/V?YA@KA_P!UR-I*\8X.>O-+IL8U_P 5#6Y=&OM/_L^.2UC:]0(T[%L;
MU4,?E #8)Z^8<5U=%.[O=_U<"EJVG#5M)N=/:YGMDN(S&TL&W>%/!QN5AR,C
MIWK$M?!:VNH:;>+KNJM)I]HUG"&%O@QMC.<1<GY5Y_V1ZG/444@,?PYH$?AK
M37L8KZ[O(S*\P:Z\O<I=BS ;$7@L2>1W],"N4\.:2NMWGB%;IM8M[*?4GE>T
MGM&@BNHV50"?,C#$94Y"L/<$$5Z'13OK?^NG^06T_KS_ ,SEM:\!Z=K.M1ZL
MM_JVFW818Y6TV\:W\]%.0KXZ@9/3!]ZNV?AB&R\2W&MQW]ZTL\"6YMW\OREC
M3.T#";N"Q.2Q/-;E%): ]3FK7P;;PW6KR7.IW]_!JV?M=K<B'RWRH48V1JPP
MH Z_7)YJQ9>&([1HW?4]0NY((WCM)+EHV:V5@ =N$&XX Y?<??DYW:* .37P
M';)X0G\-#6-4^QSN[/)^X\PAV+,N?*Q@DD],^A%6AX4;^V8M5_M[5/M,=F;,
M?+;[2IZL1Y7WMP#>F1TQQ7144?U^%OR#^OU_,Y"/P!%%I.G:<FOZP(=/N?M4
M!Q;;M^<@']SR 2Q_X$<YXPZ?P%!<VFMVLFN:L8]9D$ESC[."#@+A?W7 VA1W
MZ>N2>MHH_K\O\E]P?U^?^;/+?%VA:G?Z[:0+K>H6R6\<4<,EQX;34TE<<^:&
M5-L1RV"2%SCT%>B:-%J$.D6\>J7*7-ZJXDF2(1!^>#M!(!QC(!QFKU%.^E@>
MYRMWX%MKFRELX]7U2UMY+[[=LA:(A9-_F8&^-OEW_-SDYXSCBI)O!5G=W^JW
M-]?7UY%JELMM<VTOE",HN=N-J!@1EN=W?V&.FHI?U_7W#OU,#PUX3@\,I*L6
MJ:OJ!?A3J-XT_E+_ '4!P%'X9Z9/%7;_ $=;VY^U17MY9W0B\I9K=Q\JYR?D
M8,C'_>4X[8YK2HH>HCG+OP5I5_H=SIEXUS.;F59YKLR;9VF7&V3<H ##:,8
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.@>*5"CH>C*1@BEJM4-6ZGG,^LMHOC.36U</8:[;206ZC@//!_J\>I<%\'N
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M9N#D-&(Y"SC_ 'F_,*IKK[?P]I]MJ-W?H+II[M2LPEO)I(V'IY;,5'M@# )
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW%03L.1^!]*.EP>]A]%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 50UC3?[3L1$D@CGBD2:"0C.R1#D$^H[$>A-7Z* ,5] L-4E^WZC8&.]E
MMS;SJEPX5TY^5@I <<D@L,C/8YILFB(_]GZ;% (=*L624 N6,C)RB\DG (#$
MGDD#KS6Y10 4444 %%%% %>^LH=1LI;2X,PBD&&\F9XFQ[,A##\#5"P\,Z7I
M>AOHUFEU'8,I3R_MLS,BD8PCERR#V4C%1Z[K_P#9=UIVG6L23ZEJ,ICMXG?:
MH51N=V/7:H].I('>E@;Q#:W-LEZUA>PRRE99;:!X#"NTD?*SONY &<CKTHM?
MYAL">$]#7PW_ ,(\UB)=)VA!;3R/* !T +$D8QQ@\=JK6?@+PSIVC)I-EI@M
MK1)A<+Y,TB2+(.CB0-OSCC.[IQTK6_M?3#J?]F#4;3^T-N_[+YZ^;M]=F<X_
M"DN-:TJT;;<ZG9PMYHAQ).JGS#T3D_>/IUHOU[@5#X5T4VVH6YLLQ:BV^Z!E
M?YVP!N!SE3\J\C'(SUYJ[<:597>E2:9<0"6SD3RWC=B=P]SG.>^<YSSUIT.I
MV%Q=7%K#?6TMQ;8\^))59XL]-P!ROXU'#K>E7%XEG!J=E+=.GF+ EPK.R9QN
M"@Y(SWHW I?\(EHV96\BX,DML+5YC>3>8T8S@%]^[/)^;.<'&<5#'X)T.)=+
M5(KQ5TLYLQ_:-QB+_P ?Y&#C!SQQTXK436-,DU-M,34;-M05=S6HG4R@>I3.
M<?A1+K.EPS)#+J5G'+)+Y"(TZAFDQG8!GEL$''7FFF_Z_KU!D.M>'].\000P
MZBD[QPR"5!#=2PX<<@YC9<D'D9Z&J<O@W19KC4)W2],FHQB*Z(U&X'F*.@P)
M,#TXQP2.A-7HO$&BSW5U:Q:O827%HK-<1)<H7A"]2XSE0.^:DM-8TR_2W>SU
M&TN%N S0&&=7$H4X8K@\X/7'2E_7]?<!ECP1H@EL)0NH!]/39:D:I<_NU]/]
M9SZ'.<@ =!BK4GA?1Y=2DOVM6$TK!I569UBE8=&>,-L=A@<L">!Z5KT47"QD
MQ^'-,BUNYUA$N1?7,8CED^URD%1G "[MH R2, 8)SUK/_P"$!\/?V<;#R;[[
M,;G[44_M.YSYN<[\^9G.?FZ]>>O-=-10!@R>#=#FO+VZFM[B66^B$-R);V9U
MD0=!M+[1CG! R,G'6IX?"^CP3/,+5I)9+86LCSSR2L\8SPQ=CN^\>3S@XS6O
M10!@R>#M%EBTZ-H;H+IK;[7;?3KL8# )(?YCCCYL\<=*GD\+Z/+J4E^UJPFE
M8-*JS.L4K#HSQAMCL,#E@3P/2M>BBX&#-X.T:XN=1N)([TRZDGEW174+A1(H
MZ# ?"CMQC@D=":U-.T^WTK3X;&T$@MX%V1B25Y2!V&YR2?Q-6J* ,R7P]I,\
M&HP26:-'J3;[L;C^]. N>O' '3'KUINK>'=-UL6@ODN"+2020B&ZEAVL.A_=
MLN2.V>G/K6K10!C:AX5T?4Y+Q[JWE+7L:Q7!CN98O,5>!G8PYP2,]2#@\<4R
M'PCH\%]87J)>?:+"+R;9FU"X8(AZ@@OAL\9R#G ]!6Y10M ,N[\.Z;?:U:ZO
M<)<->V@*P.MU*BH#U^16"\]\CD<'BJ6I^!?#&LZ[!K6H:/!/J,&"DS%AG'3<
M <-CMN!Q70T4; 9UUHEA>727%Q%+(T;B01^>XC+#&"T>[8Q&T$$@X(R*Y?PU
MX=:YU/6;O6=&O;0RZBUU LUTICE4JH&^.*5E8@KGYP<9&.^.YHH6@/4Y[7O
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS@DGVJ*WLM?.L>&M1_L-HX["PGMKF*6ZC$@)$>-FTLK9V<9(Z\E:/Z_!_P#
M^\%M_7E_P3=MO&?AZ\A$]OJ220M&\BRJC;&57"':V,$[B!@<G(QU%5]0\<:7
M:^'-1U>W6ZG^P_+);FTE25'(X#1LH91R#D@#'-8FC:9X@LOAO)8#1S'J*W;R
M?9YV@<LC3F0E/F9-X4\;CC<!GBFW'AS6)K#Q=!%939U."-[=KJ[5W=PF"AY(
M4Y'^[SQ1U_KR_P W]P?U^?\ P/O.ND\0V$&GPWD@O LJ[EB6QG:;&<$F()O
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M75]0O5NY6GD2Z$.!(WWF'EQJ><=.GM4U[H$=WJW]IQWUY:7/V8VQ:!DP5)W
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MHHH **** "BJ$.M:;<ZO<:3#>127]L@DF@0Y:,'IN],YZ5?H **** "BBB@
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M=6D0G">2<-\@* ,5^8]23VSCBL7PYI*ZW>>(5NFUBWLI]2>5K2>T:"*ZC95
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MYU76E\66^?M]F]C&F6P0WF2K "\?.5W.>W?%:R2YVEW?X-F<6^1-^7XH]>/
MR:YVS\17^LC[3HNEPW&FB1D^TW%V83*%."T2A&W#((!8KG''!S6W>VYN["XM
M@Y0S1-&&';(QFN*\#ZWIVA>&M.\.:Q=0:;JUBGV9K:Y<1F4J<!H\X\Q6X(*Y
MZXZU"W9;V.QTV];4+%+EK:6V9F93#+C<A5BN#C([=B1[FK=<9XJNK?\ M?1W
MUJ-!X9ECF6Y^U)^Y$IV^690> N-^-W&2,\XKC]7>RT[24\_4$MM(7Q%;MI&Z
M\,:&WS&9-OS -&IWD=0HY&!BFE=_UW2_X(/1?UYO]#V.BO)+^7PPE]X[LC/I
M2VT-I'<QV_F($2?:P:0+G ?=Y?/7)'<U(M[H5YKOAG4=6O[:XL+K095N9+FY
MWVS,IB!W G8#DL#GJ>O(%):_UY/_ "#^OR_S/5Z*\MC6TBTS3]-U.*-M/N=2
MNAIT>HM_HIAY\M75@=W7,:<=!@\5FPW^GP^'_!T-]JB12P:U+;LK7#P*8U>0
M$;"WW5P@&<[<@9YY:5_P_$3T_'\/^&/9**\ML-&\/^*)/&?AR$Z=)%!>K):0
MH$=;:3RDRZIT'[S=GC!.X'J:Z+PI##K5V/$%UI,-K>VT(T],P@-&R$B7:V,[
M=V5'LOO0E_G_ %\]!O3^OZZ'845A>,FU!?"6H-I:R-=",8$6=Y3(W[<<[MN[
M&.^*YBS&@2>(X+GP^=.&AR6=Q_;:Q[1!T7;YH^Z).6SNYQG-+^OP_(/Z_KS.
MDTO5-5UB[6]M39#2!--;R121N)P8V9-X<$J067[I4<'.[M705Y_\)D\/_P#"
M.W#Z0NF?:?M4XG:T$>_9YTGEAMO.-OW<]NE;'CBYLH;"PAU!$:WN+Q8F^T.$
MMN5;B<D$%#_=[MM''6FU:R7E^-@6K?S_  N=17/Z/KE[?^*M>TFZM[>*+3O)
M,+1.S,X<,<MD#!X' ''J:X:RNA8:$MG.Z#1[;7I8M1$43I%#;$,R#;D[8MVS
M(SC!YX-1K<):7_C4>&H'6 V]FUNUE"QC,('[PQ,HVY"L2H!SW I+OY?Y?Y_F
M#V_KN_\ +\CO)M=O8O'UKH)M[?['/827*S;V,A9&5<$8  ^;U.?:M"*^DL[>
MRCU>2V6^N93$JP$[7;D@+NY^Z,GZ&O/$F\,CQ]ILVD^3'I,^D7:S7-D&6)6+
M(6+R)]QL*V6)!R.3FL[3H]"U/PCX(N+U;&_MH-3D@GEG"SA-RRX5V.>K&/@]
M25[XII7LOZW:#K_7:YZY']N_M"?S?L_V+8GD[=WF;N=V[MC[N,>]6:\MN[PI
MXG\=6WA^]$FJMID#PP+<EY X\S>$4DE2 5X  !(XYJY9G1)->TV\\,26T-HT
M,_\ ;9@?RPJ;.#-C&V4-CEL-][WI=+_UU_RW#K_7E_F>C45XKI>IZ!:^&O"E
M^NIV(O$UIX3<R72M*(C(^Y2[$G:59"1G!R">N:TKBZT^3Q)::I;^1%<0:Z;>
MXDE^>\V'>-K$8*1$XVH=V1M-.VO]>7^8KZ7_ *Z_Y'<^']:OM3U77;.]M[>$
MZ==K#'Y+L^Y2BN"20.<,.,<>_6M^N+\'ZC8W?B_QE%;7EO-(+Z)BD<JL0!"B
MDX![,"/J"*T/'%U<V7AW[3#;SW$$=Q$UY';@ES;AQYF .3QU'<9I/1+Y%/=I
M'245Y@E_HMSX5NK_ ,$BY.DO>V[7D5O;20Q+$' E\I"HZJ/FV@YY[T3#1H6U
MFXT&ZM+?PP^D.;B2RN/*@6YW838R$*KD9#8(/W<]11+1-]O\K_\ #"6K2_K>
MQZ?17D^B:CH=MJ7@.6VU"Q2ZO-.>&XD2=3)+^[4*K'.6PX( /0@@>E:.A0HM
MS?\ AVX@TG5DEM97DO+11O<G;@7<9R-[ C#$DG!X%.2Y;^5_P%%\UOE^)Z/V
MXKF=#\3RW&FZA<ZTEK:O:ZBUD%@<LI(*JH!8 DDMZ#KTKAM'N=.6T^&\RHLE
MW9L;.Y:&$R20-Y#*8WV@E<,1D'&.I]:9<S:)K'A+7W=["^@M_$J3R$E)5CB,
MT8+GKA2N_)Z8SVS3Y?>M_6Z5_N8]_P"O*7^1ZRWV[^TH]OV?[!Y3;\[O-\S(
MVX[;<;L]\XJS7F]]=>'K'XCVL']H6]G;OH,\9B%X85C0,A78NX>7\@8@KC@9
M[5@Z+J>B6VD?#^^74K);Y[QH)KAKE3*R%)-R,Q.=NXID'C)'<BDE>W]=6OT!
M_P!?=<]FHKR*_N-(NM>N+ ZGIZ:P^JX;5!J4=O,D D!-O\LBS XR@51M/7(S
M7KBJ$15&2 ,#))/YGK26L;@]'86BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BN2\=ZM<Z?;Z7;0:;=7D=Y?10
MRB$Q .N<F,[W7[P&/3&02,U1E\8>$O ZC3!&E@JGS9[1;F &T+ -CRS)DCG[
ML08>E"U [NBN5U_XA>'_  [<+#=W4;/L6215N(5:-",AMKNK,..B!C[5IQ>(
M;:ZO_LUG#/=((TDDGAV%(PX!4$%@QR#GA2,=2* ->BBLCQ#XETWPS:)/J$\:
M&4E8HVFCB,C 9(#2,JCCU847 UZ*Y$_$/2FT.UUFVM;NZL)9_L\LT#0E;5]P
M7]XQD VY/WE+#WY&;X\764>EWFIWT$^GV-O+Y2W%VT2I/SM#(0Y&TG&"VWK]
M: "ZT&^G\:66NKJ-LEO:V\EO]E-HQ=E<J6/F>8 #E%Q\OKU[;]<OI'C[1-9L
M[J>VD/F6SI') DD<S;G.$ ,3NAW'T;COBENO&L%EI5]>W.D:G$]@Z+=6K+%Y
MD:MT?(DV,O\ NL3[4]=OZU_X<+]31UW2]0U6.WBLM:FTR(2$W/DPH[31D$;
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M.6VOKH6.I-;6%W]ENY3 $\DX4[RKD,5^8= 3WQCFM*#Q%;2:I=V$\%Q:2V\
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M2U\;V%V-)DCLK\6^JH3:3M&H5W +>7C=N#8!.2-O'6A;W7];_P#!#I_7D_\
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MKL#W_KN%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3H7,*.AR-^\Y;/0X QFI)=%\4:[X-U+3?$-WI*7]S&4B_L^.01)CD%BYW')
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M  S^56@RDD @D<$ ]*6CI8#A];\+:W=67BVTL3I[QZV 8FGF=#&3$L;;L(W
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MVV?.,?F#>A+?*#Y?3!Z]>.>PU'P_IFJRP37,#K-;@K%-;SR02*IZJ'C96VG
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M^W(@M59X9=R#YBQ.X?,>,#CWP1UNN74MAH=U<17$$$R1_)+.#L#'@9 R3[
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MC.<8XQ5>?P3H-Q81V36UPEM'/]H1(KV>/:^[<""K@@ G('0'H!575[_UO?\
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MYKHD01QJBEB%  W,6/XD\G\:+Z?UV2_0/^#^;8ZBBBD 4444 %%%% !1110
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MFU)1EW>6G)SN*Y.57.3TKA9+![;PUIMM>Z/J,\]KXC>?>=,>5A%Y[,SXC0@
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M-/@BCEFOK6..52\;O,H#J!DD$GD8!/TI(]6TZ:RBO8M0M7M)2!'.LRE').
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M*&D5-N<!^IX/'4\\7I'B3PGJFM>']!O-2L#_ &5=/Y"7-M*9II3N4*X>((C
MD$D.<L!C%"ULOZW8WHF_ZV/0]!\0.+G4[77-4LA.FJ/:6@(6#S!L1@BJ6)8_
M,>Y/\JT+?Q3H]SXDNM!BO[8ZA;(K/#YJ[B3DD!>I( !/ID5P.IR-/X=\7"+2
M=6-Q<ZK') /[*N-\BCR\,OR9(&Q^>W'3(ST\"--XIUMI;._^R:CIUOY<BPNF
M0!(&&2!M<;A\IPW/3@X6Z^7Z)BV?S_6QT]GJ-CJ*,]E>6]RBL59H)5< @X(.
M#U!XJS7)>$UU2UU"YT^>>:^TZWB5(;RYL6MI@0?]6<@"48Y#* .W)KK:;\@1
M4U#5=.TF$3:E?VME$QVA[F98U)],L1S3Y;ZTMTC>:Z@C23[C/( &XSQGKQS7
M-:BT^E^-GU&]M+J[TNYL%MHVM[9[@P2!V+ H@+ ."O.,?+R1Q7*'1)M,?P<E
MSIES+);:K<3@Q63R_9+5_,V(S*I"@;H_ESV]J25_Z]?^'^8WI_7E_2/5+>XA
MN[>.XMIHYH)%#))&P96!Z$$<$5)4<,$5M"D,$211(,*D:A54>@ Z5#J9==*N
MS';&Z<0OM@#;3*<'Y<]L],TI.R;0TKNQ'::UI5^]PEEJ=E<O;'$ZPSJYB/\
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M; '.>!S4-UIMS=WOCFSTC3KFWEN_(DCW64D,5T5'[U0[*%);D9SSG/(YI?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,74_#JZGKFFZHVIWT#
MZ>Q:*"$1>6Q((;=N0MR#C@CVP>:VJP-;\1S:3K>DZ7#ICW+ZD9%CE,RHBLB%
ML'JW./3'\JR;_P >W%G+Y,7A^]N9X HO8;>&>8QN5#%$:.%HW8;AG<Z4+8'N
M=K4;W$$<T4+S1K++GRT9@&?')P.^*P-1\33VU[<6]CIPN?L=JEW=^;-Y++&V
M[ 0%3N?Y&X)4>]5X/$\5_K'A]6T&>/\ M&&6:WNKAH28@%R0-C,<L-IX.,'K
MD$4?U^?^3!O^ON_S.KHKGM*\2OK3WXL8;-_LTKPA?M9\Q67(_>ILS'D@8QN.
M"#[5A:3XTU>'0=#N-4TF.675KS[/'+;7640L206#*".A  #<+R1FA?U\P>G]
M=COJ*Y35_%>I:/IAN[C188C! ;BZ^T7WEQJ 2-D<FPAWPN=IV\$<BFMKVL3^
M,]-M;2TMFTRXTUKMM]PR2_>3G;L()&< ;@#D\C%"U_KY@]#J(+F"Y1GMYHY5
M5V1C&P8!@<$''<'@BI:Y#2_%EM)H\<T&D"SNKK49K.*R+HI:96;>69<@?=9B
M1NZ=S27?CB73-.UIM0T=AJ.DPK<36MO<*ZO$V<2([!<CY6SE01CH>,G]?E_F
M.VMCL**P;+Q#/-XB32;NP6W\^T-W;2+/YA905#!QM 4@L,8+ CN.E7=8U:/2
M;>%F0RS7$Z6\$0.-\C=!GL  23Z ]:&K"3O_ %\S1JI%JFGSW\UA#?6TE["
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M-K@CH"P.>M5=/\:W=Y<7<;>'=158X'GA<6\\8D"X^1C/%$JN<\ %AP>:7?\
MK:__  1K6W]=C6\/>'E\/0W42:C>WHN9VN&-T(LAV.6(V(O4^OX8K9KB4\;:
MO<:!9Z[;>'H#IMQ'#*TLVH;&C5VVDE1&WW>"?8^U:#>);Y-8UG3GTZU#V-LM
MQ;M]L;_2-V0 ?W7R'@9QNQN'7--I[?UH!T)N(!<K;&:,3LA=8BPW%00"0.N,
MD<^]2US0UO9XM@TZ]T98[O\ LU[G[6CK(  R!XT. Y&2.H7.!P>RZ7XN@O\
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MNW9/I@YKTRA;7_K:X/1_UWL%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 <_K7A^\U3Q#HNIPZA!!%IDCR>2]J9
M&D+*4/S"08&#Z'G\JH7_ (.U-O$LNK:)XGN=(BNV5KZU2VCF69E 4,I<'8Q
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MLN#%:._VB5DVA%10Q4;5P 2?<YKK>V:9#-'<0)-"X>.10RL.A!Z&C=6_K^M
MV=_Z_K4Y(>$KNX^'#^'A?>1=7EN4N+FXC,[#<,-D!ER0, '/8<&K.K>&]3U&
MPT6"+5;2&33IXYV=K%G$K)PH \T;1@G/)_"NGHIWUO\ /[A6TM_6IY#X@?5[
M[QM<II]_X3;]\NRQU2XN8)Y2@ Y@1MLHRI*LRM[< 5VJ:)KMQK4FM-J-C;O/
MIZVOV0V32>2WWLE_-7=AB?X1D8''6NIK%\5:^?#&@3ZK]AEO%B*AHXW5< G&
M23VR1T!/M2MHE_6NGZE=;_UIK^AE:3X-O-,LO#\)U>)Y='5XA(EIM$L3+C&T
MN<,, [LD?[-7KCPS]K\2V>L3S6P>T+-&\5KLG;(8;6EW<I@CY=HY .:WG=A
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M.^?7'2M>FM+?UY@^M_ZZ''V?@S4=,U^:XTWQ1=VVC3SM<2Z7]GC<&1CEMLK
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#C/%]A:W7BOPI)<S7$
M8%Q.,Q7<D(P(7;^!AZ=?3(Z$BL>\U"]N_#VOZVE_>0:YI5W,D-K'<L(P%;$<
M;0YVOO7:<D$G?P1Q7HES96MZ(Q=6T,XB<21^;&&V..C#/0CUJ&31],FU*/4I
M=.M'OXQM2Y:!3*H] V,C\Z%I_7FO^&#K?^NO^96UHW,GA:]>.>:RN?LK.)(2
MN^-@N>-P(]NE<AITMX(/!MW::I?3W&J0K'>AKEI5:/R"QD"L2JLK!?F &2<'
M.:[;6X+NZT2\M[&."2YFB:-%GE,:?,,9+!6(P#GH:S/"_AJ#2M @M[W2],CO
MVMDM[R2V4.+@*NT;F**6R!T(XSCFCO\ UW%V_KL<;IVH:I:_#H>('U74)[I+
MB6VGEEFW*D)NMK2E<;=R(#@X  SQ@ #=-O):>)SI-I>7UUI-_IDT\XDO9)3
MX*A620L74,&;@-CY<C&#756&D:9I5JUMIVG6EG;N<M%;P+&A/N% %+I^DZ;I
M,3Q:;I]K91NVYDMH5C#'U(4#FAZW7];6_/4?G_6]_P#@'E5I?)HW@3PE9)K2
MZ79:C!_I-[>3SRHDGE@K'N$R-$#\Q&UE VXQS6R^M1:5HFC0ZCXI2_TB[O)(
M9]7M9&B15V,4C,P=F W<;]^[C!.<UW+:)I+:?)I[:79&RD8L]L;=/+8DY)*X
MP23S4C:5ISZ;_9K6%JUALV?93"IBV^FS&,>V*<G=M^8,X'5+33=1T[05AU^?
M5+-=;5(;F#4),HC*WR&5'RY'3<3N]^N>B\>P17'PXUQ-\AC%A(ZLDS G"DCY
M@<D<<Y.#WS6T=(TPZ>FGG3K0V4>W9;>0OEK@Y&%Q@8/2K;QI+&T<B*Z,"K*P
MR"/0BD]K?UT_R'%VDI?UN<'_ &?:GQ5X<L(KJZ,/]DW89A>2-*06AR/,+%QU
MZA@1QC%9#^(KZ'P7H\=WK*V5O/?W-E/J5V)'VHCR+&'=)(W!.T#?O!R.>M=^
M/"_A\3PSC0M,$T,?E12"TCW1I@C:IQP,$C ]:?!X<T.UTZ;3[?1=.AL9SF6V
MCM46.0]/F4#!Z#K3;O\ UYM_DQ+IY?Y6*'@PM_8K#_A(K;78Q*WEW5ODJJX'
MR;C)(7QSR6)YYK&T.VO=4U_Q-#<:[JH^P:B!;LDRKL5H =NW;M(!?(!!Y //
M.>UM+2VL+6.UL[>*WMXQA(H4"(H] !P*IP>'M%M?M7V?1]/A^UAA<>7;(OG!
MNN_ ^;/?-)ZM^@+1'':;>:E=?#S1)9KV[F\VY*7LL<C?:98M[@["N&W<+]W!
MP#BJVH1ZC_PAVMS75WJ/]GM=P1Z=%? "18M\?S'>HEW%BP_>$G ''KN>)/ ^
MG:AH,>DV&A:0U@)_.DL3NM$D;& 0\2DH?<*<].E1^'_AMX<TO3Y()?#]BL4Q
M622R>9[V%9 "-ZF8=<'&0HXIKK_7;_+\0Z)?UU_S_ AGCD'B+Q-H[W=[)92:
M1'<['NI"4D8R*Q1LY0$*.%('H!5#3;6^M?!OAF72%N-0M8K1)[NS35)(YV)1
M"&1R_*CG]V2%^:NXM_#^BVM^;^WTC3X;PIL-Q';(LFW &-P&<8 &/04KZ#H\
MEBMB^DV+6BG*P-;(8P<YR%QCKS]:733R_"_^?X ]7?\ K9?Y#=/U.VO/#D&I
MQ2RK;26PF$DR_.%VYRP]:X71KJ]_X2+38QJ=\MOJFD32M/-=[VFD!C"RI"Q=
M(<[R0JG'."O%>EA55 @4!0,  <8K-7PYH20B%=%TX1 . @M4VX?[_&/XN_KW
MH>[_ *[C6B_KR.%T:]U :7X&U*34[V:ZO[DV]R99V*2H8Y6P4^[G*@AL9'3.
M.*H^*[U=5\!>(]3OKV>.[MKQ[3[,+EA'$BS *&C!VDE0'W$9YX.*]"'A'PTJ
M0(OAW20ENQ>%191XC8X)*_+P>!R/05;FT32KB\>\FTRRENG0(TSVZL[*#D L
M1D@$ X]J=_Z^:?Z?B+^OS_S7W$6HO]J\-7$ME>O%OMB\5S;,I(^7(9200?K@
MUQ6DW.H7TW@=)]6OS#?Z0[W,:R[?,=8T.\L!OW'>>=WH1@\UZ%=6=K>VDEI=
MVT,]M(NUX94#(P]"IX(K-B\)>&X)8)8O#VDQR6XQ"Z648,?)/RG''))X]31U
M?]=_\PZ6_KI_D<%<1G5?!]E'?W=Y(+7Q+]ECD^V2H_EK<E%#.K!F(7@,23WS
MGFEUC56NO$E]ILGC2R\/M8F,6*W32[I(VC4B0-]H1)LMN&'5^1[UZ!;^&M!M
M+*:RMM$TV&TG(:6".U14D(Z%E P3]:GNM'TN]N;>YN]-L[B>V_U$LL"NT7^Z
M2,K^%%_Z^2_R_$'NW_6[?Z_@<E#'>ZA\0=5L)M9U$VT=A:7<4<4GE!'WMD
M?=;8,AL]2/3&-X:UB;6=<M+R;QI80:AY[Q7.C%9!*<$@Q>6TY3C^^L0)VYZ9
MKT6+1=*@U*34HM,LH[^7_6720*)7XQR^,GCWIR:1ID>IOJ2:=:+?NNUKI8%$
MK#T+XR1^-"Z?UW![/^OZ[G*Z/<7L&K/I6N0W?FWXE>"]M[]Y(+A0/X5W;H6"
MX.% 7T8FL?0=/O(O &D#1#-=MYAFNK-M5ECDE0%AB-RWR8(!V@JIP<GKGT.#
M2]/M;N6[M[&VAN95"R31PJKN!T!8#) J-M$TE[26T;2[)K:9F>2$VZ%'9OO$
MC&"3W)ZTOZ^YA_7X$6@:G%JVB0WD"7"ABZF.XQYB,K%64D9!P01D$CCJ:X8:
MC?S>%H/$UO>WAUU;Y;>:R^TL8B3/L: PYV A3PP&[@'->E111P1)%#&L<:#:
MJ(,!1Z #I54:/IBZF=3&G6@U KL-T(%\TKZ;\9Q^-/[5_P"OZ>P=+')VNE6[
M?%W49S+>[DTVWF"_;IMFXR2@C9OVE>/ND;1UQDU-XXT^VO=9\*&XEN8U_M)D
M)ANY(< P2'JC#G('/7&1T)ST"^'=#35?[571M.742Q;[6+5!-DC!._&<XXZU
M<NK*TOHUCO+6&XC5UD59HPX# Y# 'N#T-"=N7R_X/^8[ZM]_\K'FNKM)!8>/
M=3M+VYAN+&\CG@:"=D&];>(_, ?G!Z%6R/:E\2:S+=>)KO3;OQ=8^'#;Q12V
MGVGS$\P,O,BLL\:/\V1L<,/EZ<UW#>$O#3+<*WA[22MRP><&RCQ*P.06^7YC
MDDY/K4\GA_1IH[2.72+"1+/'V56MD(@QTV#'RX]J+[?UTL#=W<CU""[O/"MU
M!;7.Z]FLF2.=5V9<I@,!VYY]JR?AW>6DG@/2H(G5)+*V2WNHF.&@E08=7'4'
M(/6NKK.GT#1KK44U"XTFPFOD^Y<R6R-(OT8C(HOJ_/\ X/\ F+HEV,+4)TU+
MQ;;:)-<7%MIL]@]Q UK</;M/+O&<.A#?*,' .#N).:P?M^M2Z;H[2:I>(L?B
M%K 2(RC[7 '8*SG&3]W'! .#G.:]!U#2]/U:W^SZE8VM[!G=Y=S"LBY]<,"*
MAOO#^BZF(!?Z1878M^(1/;))Y73[N1QT'3TI+3^O._\ P >O]>5O^"<)J+75
MMIWCJ.+4]2"Z3BXLC]LD+1.8!)@MNW,N[^%B5YQC%:+^?J'CBUL[O5KY;2\T
M4SFVBN# JN'0$J4VL#R3G/Z9%=&_A/PY(;DOX?TIC='-P39QGSCG=\_'S<\\
M]ZPYO!_G>++=WT31&\.PV1M5MF.2,N'#"'RM@PPQC=WS[4+HG_6C7^02V=OZ
MU7_!^\RK._N]3TW3].N[Z^FF>2\\I8KAK9KB"*3:DSSHP90!MZ9W;LX(S4=C
MJ>IWNG> Y'UBZ#75Q);WB12*1+B*0_,VW)(V#GCKG&<$>A7&EZ?=FW-S8VLQ
MMFW0>9"K>4W3*Y'RGZ56D\,Z!,T#2Z)IKM;L7A+6D9,3$[B5XX)//'>FGKJ#
M\CC$TV_U;1_$FGVNHZGY^E:DPL2NHS([*(XW\IY VYE)9AR21GC&!6SHT]KX
MA^U^(([R^MK)K46Z;KN1%C(4F1]A;:&4G;N(R"AJ[>:%+IEO))X0T_0]/O[B
M53<2S6FU73)R3Y>TLW.1DXZUIVFF1VNC+IWR2KY95S*@*R%L[BR]#DDDCWI=
M'_6MK,.O]=R73A$--M1!=-=PB)0EPT@D,HQPQ8?>)ZY[U9JO8V4&G6,-G;1I
M'#$NU$10JJ/0 < >PJQ3>K$M$%%%%(84444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV0DEG*XR/FSN'(R/>A=7Z?G;^OD.VJC_ %M_7XGJ%%062R)86ZS',HB4.?\
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M$=0 ,C@ T):V_K=+];A_7Y_Y'L-87C'6;SP]X3U'5[&W@GFM(C+LG<JI Z]
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MEO+3N0HR3]!_458KSFZ72]2UGP9JFJZ/;P-)'.BI<Q"0K( "BJQ&3R&*]SU
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MN(E(!:,(6)P2,@X(SD@"ELO%UG>W&G1M9WMM%J<0>SGG5 DQ*[R@PQ(8#)Y
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M!8]CMR-V.3S4T>BZXGB\:A(+"XM!I@L6EDG;S9'SNWM&(]N"W&-W3GVKK**
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MI:PVZ.YD988P@9B<ECCJ2>IIFH:;8:M:FUU*RMKRW)#&*YB61"1T.&!%6J*
M(K:UM[*VCMK6"*"WB4+'%$@54'H . *EHHH **** "BBB@ HHHH :Z)*C)(J
MNC#!5AD$52TW1-)T82#2]+LK$2'+BUMTBW'WV@9J_10 4444 %%%% !1110!
M2U+1M+UF)(M4TVSOHT.Y5NH%E"GU 8&K44,4$210QI'&@PJ(H 4>@ Z4^B@
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MGG= TD.\/Y;$<KN'!QZT[ 34444@"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ K&\1Z=)>6UG=6\7FW.GW2742=WQD,H]RC,![XK9HH Y>^TJ_UO
M7-(US3M5M(;:S5]D,U@[LQ<;7!/FK@X&,;<@@YSTJU%#_:?BJ/4D'^BV%O);
MQOCB21V4N1ZA0@&>A)/I6]10M "BBB@ HHHH YOQ5X>U+Q VGBSU.TLX[.Y2
M[ FLFF+R(<KR)4POJ,9]Q5.;PGK$UWK]P=:L0=7M4MRO]G/^ZV@KG_7<\,WI
MSCTP>PK(_MMAXL&AM8R*K6C72W1==KX95*A0<_Q=3CVS1:^GK_P?R"]M>UOS
MT_$L:+83Z;HEG87-Q'<26\2Q&6.(QJP48'REFQQCO7/Z%X,U+0-3VVWBB\;0
M4=GBTIK>,["23M\TC?L!/ &/3-=?6-KNO-HMSI<7V"6X2_NUM3*KJJPENA.3
MD]^@[<D4[MROU8K)1MT1D0^"KF*>UE.KHS6NHO>K)]D'FR!E=2LC%CN(#D!L
M   #!JY/X3CO/$46JW;VK-%&T8,-KY<LJLI4K+)N.],'(7:.1FK6GZ^U]XEU
M71GL)+<V$<4@E>13YPDW8( S@?+WY]A5_4]1@TG3+B_N2?*@3<VT<GT ]R>*
M71?UOH/^OU.>\,^$]6\/77E2>*KN^T>%=EI82V\8,0[!I1\S@=NGXUK^(-'?
M6K"*"*Y%M-#<Q7,<AC\Q0T;A@"N1D'&.HJ73+K4[AKA-2TV.T,;#RGBN?.25
M3WSM4@CN"/H36A3N]!:'*R^&=7?6]4U%-9L\7MDEFD;V#$QA=Q#$B4;N7;(P
M.W3'.8?A_JL&GZ1_9GBE].U73[461O(+)6CGA'W0\3LPR,=<]2>.<5WM%+^O
MS_S8_P"OZ^X@LH)+:SBAFN9+J5% >>0 -(>Y(4 #Z  5@IX:OM+U&[N= U2&
MSAO)C/<6EU:&>+S#]YTVNA4MWY(SSBNEHHZW#I8Q-8\/'5K2VS>O%?VEP+JW
MNM@;RY "/N="I!((ST/7/-9.K>"[S5M+U1)=4M5U/4X$MKB[%DVQ85W85(_-
MR#EB<EC_ "QV-%']?U]P'+CP[K/_  D4&L?VQ8;XK V?E_V<^"3@[\^=_> .
M/3(SGFN1U*S?PLW@S1+KQ!IWVN/4I'@E:#RL*T4N"T9D)8;VQD$9R!P>:]6H
MIIV=_P"NK_4.G]=K'*77@^>YM99#J47]I7%U%=7$S6NZ"78NT1F+?GR\<XWY
MSSDU5O\ P/?W.FZI9V^M01+?WT=X?,L=XCVA/E $B]XQSG@$C!/-=K12_K\O
M\@_K^OO.3FLY] UW4/%NK:O:_8%L4AGCCL) R+&2VX$2,3RS<;3Q@=LF3P=I
M]NG]HZM:B=;74)S):QS(4,<74X5@"H9S(^",X85U%%-,&4]3M);ZR>"-[<;P
M05N8/.C;CHRY&1GGJ.E<S'X(NK2/0X;#5+:"#3+M[LQ-9%E=G# H@$@\M '8
M ?-CCDX.=?5O$/\ 96NZ+IAL995U.5XA<!U"1E4+X(ZDD*>V/>MNDM-5_5@?
M;^M3B?\ A"=4;^TB^MVC&[U%-0"?V>WEY"A2DBF4[UPJG&5Y&?:I+WP3>7.B
M:_IL6L11KJ\WF%FLMPA!158 !QG[G!SQGH>M=E5:UFNI9;I;BT\A(Y=L+>8&
M\Y, [\#[O)(P?3WH7]?A_D@\_P"NIAQ^'M4_X2G3]:FU6S=;:R:TD@2Q93)N
M*EF#&4[>5&!@X&1SU%[7]#.LQ6CP79M+VRG%Q:S^6) KX*D,I(W*0Q!&0>>"
M*C7Q 3XS;P\;&5,6?VL7+.NUQN"X"C)ZD]<=.];=.^B?];O];AL[?UM_D<7/
M\/S?SZS<7^LSM+JB0[OL\2Q+#+%@I(F=S @C(&['/.3S6GH6B:YIUC+%JWB:
M35[AB DDEG'$B*.VQ?O9Z$D_3%=#12 XBY\ S2:'J=A:7]C9RZE<)-,8=/(@
M7:<_+$)1AC@;F+'..GIIZ=X>U&U\6W6NW6IVLWVFUBMF@BLVCP$W'(8R-U+'
MMTP/>NDID,T<\?F1.'3)7(Z9!P?U!H6G]?('_7YG)Z9X.U/2-<>6R\474>A-
M*TW]DFWC8!V8L0)3\P3))VC'UK<\0:2=<T.YTX7'V=I0I279OV,K!@2,C(R!
MQD?6KYFC6=("X$KJ65>Y QD_J/SJ2CI8.MSG;KP]>_VO%K&GZG#;ZD8!;W+2
MVOF13H"6'R!U*D$G!W=#SFM+1M(M]$TX6=N2P,CRR.W5Y'8LS'ZDFKEQ(\-O
M+)'"\SHI98D(#.0.@)(&3[D"J.@:M_;NA6FIBW:W^T*6\IF#%>2,$CC/%%^@
M,Y5_ &I'5=2U6+7+2'4;F\6ZM[A-.;=;X"HR',OSJR* 1QSSZ 6[_P ':Q-K
M*ZMI?BJ;2KF=(TU!(+-)(KDH,;E60MY;8XSEN .N*[&BA:6\@>IR.L^#]2N=
M9CU70_$UUH]RT20W>+>.X6X1,X)#\!^3\W/TK*:Y+_%.>PT[7;*._CTB*)Q<
M*)F8B1F8%%=2&VD-Z#.<$5Z'1VH_X(%'1]*@T72X;"V+%(\DNWWG9B69CCN2
M2?QK+NO"XOO$=IJMS+:DVNXHT=KLG?(8;'EW<IAON[1R <]JL^'->;7[:\E>
MQDLGM;N2U:*5U9LIC).W([]B?K6M--';PO-,X2-!EF/0"C?4/(Y/P]X.U/P_
M?>4OBF[N-"BR+;3'MX_W0[*9?O,H[#CL.:;HO@S5-!U!EL_%-U_8:LSP:7);
M1L(R23CS?OE 3PHQZ9KKC-&)U@+CS64N%[X! )_44^@#D]*\&-;^%M2T'5+Z
M.\AOY9I'D@MS 5,K%FQEWZ$\>F.]+I/A76(--O['6O%=UJ\-Q"T$(>UCB,*$
M8R2O+MCN3^%=710]= ZW*6D6<^GZ3;6ES<K<RPQK&95B\L'  &%R<=/4_P!*
MYS_A"[H3%QJZ974_[021K3,IY/R.^[Y@ =JG P !@XKL**;=W<5K*W0X:?P/
MJ]QH^M6#:[8C^U+T7;2#37_=],KCSN?N+S]>N1A^N&P\0ZS8>'C/+)K%BZ37
M;P6\D<:0LI#@L<KM<97;N)Y'IFNRFFC@0/*X12RJ"?4D #\20*DI+2W];;#?
M]?/<.E<S;>&;_1[VX?0=5AMK*YG:>6SNK0SHCL<L8RLB%,G)P=PR> *Z:F--
M&DL<3.!))G:O<XZT!T.>U_PW?:PVDF'58H3878O&,UJ93*Z@@ 8=0J\GC![<
M]<U]<\(ZE>ZZNL:'XDN-%N9$2*["6R3I.BDX^5^%89(W<\=JZRB@#E]2\)3W
M]_+.=4S'-IYLG6>W$CIG.7C;< A.?FX.=J],5-:^&KFVU#2;T:F&DLK(V<V;
M<8F4E3D<_(<H/[W!/?FNBHH_K\_\V#5_Z_KL<[H/ARYTVVU:WU*]MKZ+4;B2
M=EBM&A"[^&4YD?(Z>G?K4-KX)M8?!,GAJXO;F=)%(-V3B4$8V,#S@J%4#_=%
M6+'Q)<ZB=>AM](E%WI4IA2"2= ;AM@=<,,A001U/&><=*WHRS1JSIL8@$KG.
M#Z9HZ?=_P![/YLPO#6BZUI*2C6?$T^M,?EAWVL< C7WV\LWN3^ YJ?4=-U.[
MUK3[NVU"TAMK5BSPRV;2/)D$'#B10O!X^4X///2M=V*HS!2Q R%&,GVYK'\+
MZ_\ \)+HHU'['):'SI83#(X9E*.4.2..H[9^II[N_85M/4S)_!*1:/KMCI5V
MEJ^KR.TDD\)F6)'!W*BAUP,L[#G +'@T]?"^H,=%DGU6VEDTU&B9?L1\J12
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 <UXJ75A-8SV$#WEM 6>XLX+QK:9\8VLK
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M4O\ A#O"_D1P?\(WH_DQN9$C^PQ;58XRP&W@G Y]A6U2EJFOZV7]?,(Z._\
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MQ9^+="O8/-M]162'R?.$I1@K)NV9#$8/S<8'/(]10GB_0FL[NZEOQ;1V8#7
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M>22._6K]IH>L76CZ%H-[8/;?V/<02-?I+&8YEB''E@'>"V "&5<9/)[NRO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !65IWAW3M*U*]U"T6Y%S>G=<-)=RRASV.UV*C'0
M8 P..E:M% &4?#NG-XA772MS_:"Q^6'^V3; G]WR]VS'?&.O/7FM6BBCR R]
M.\.Z1I&H7U_8V,4-W?R>9<S#):1OJ>@]AQ6I110 5D6WAK3+2[:X@2YCW9S
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M;RA"OR@<.IR>ZD>AZ51U'2O#TVC^$T'C'P=J-WH ,1@O;J-;:ZB. 0PW.00
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!3U+2=-UFW6WU33[2^@5PZQW4*RJ&P1D!@1G!(S[FL
MO_A!/!__ $*FA_\ @NA_^)KH** .?_X03P?_ -"IH?\ X+H?_B:/^$$\'_\
M0J:'_P""Z'_XFN@HH Y__A!/!_\ T*FA_P#@NA_^)H_X03P?_P!"IH?_ (+H
M?_B:Z"B@#G_^$$\'_P#0J:'_ ."Z'_XFC_A!/!__ $*FA_\ @NA_^)KH** .
M?_X03P?_ -"IH?\ X+H?_B:/^$$\'_\ 0J:'_P""Z'_XFN@HH Y__A!/!_\
MT*FA_P#@NA_^)H_X03P?_P!"IH?_ (+H?_B:Z"B@#G_^$$\'_P#0J:'_ ."Z
M'_XFC_A!/!__ $*FA_\ @NA_^)KH** .?_X03P?_ -"IH?\ X+H?_B:T-,T+
M1]$\W^R=*L;#SL>9]DMTBWXSC.T#.,GKZFM"B@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$$.F0WRZ/JDB-=?8YD40AK:7<$Q)ND QD@94D>]'6P'4T5GPZJ9M;N-,%A=
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M(I/%&GZF8M-@BATR2S=ENWD=)&*MN53$ P!0=2,Y[8P8=(\*ZO:Z[I6K7?V
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M*L],GCNS:6;J\"+?3H5*G*G<KACCMDG&!C%,E\&Z+-<:A.Z7IDU&,171&HW
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MR\<C?>*N7W ')R,X.3D'-)<>"- N;3[*UI.D/VDW>V&\FB_>EMV[*..C<@=
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M>?\ G_D=[=:I8:5I\=UJ6I6MO!A1]HGE6-&)[Y)QS4S7UHB1.UU J2\QL9
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M/7&K92X\4^$3%IVHQQ1Z5-#*YTZ=$C=O+PKDH O*-UQ[]1E6_KY-_I^(>?\
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M/'/09HGL[>?X)?YL4?BMY_JU^B+OAGQ#%J6F+XEG\3VCZ=);JUS:NT/EV4I
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M(&F#!=D0C*YDP<G*AAZ'FL*;2X?^%*Z;!/H-U)JD<,$(C_LN5YT=&#'@(6
M+?-TY(SDT?\  _.W_!#^OPO_ , ]+?7]&CCNI'U:P6.T;9<LUR@$+>CG/RGZ
MU?1TEC62-E=& *LIR"/4&N$-U"/'U]>#3M2^S'14C60:7<;2P9FVCY/O;6''
M7/'7(K6^'AD7P'I$$]O=6\]O;K#+'<V[PNK <C#@$CW'%"6G]>:_0'_7W)E_
M4_%&CZ1J]CI=[J%M!=WN?*2655X'0\GN< #N>G2L_P -Z^SQSVVMZI9F^.HS
MVL PL/FA#P$0L2>/<FI-=6:'Q7X?O%M;B:"/[1&[0Q%]C,@V[L= =I&3QZFN
M*O)FF\*ZH8M(U<7$OB!+A%_LFX$C1B=7#XV9QM5CG\.IQ2CJ]?ZU0-?U\G_D
M>FW>K:;87,%M>:A:V\]P<0Q33*C2GT4$Y/X5<KRS7+8MXIU"#5_#?B75K#5F
MC:VETRYFCA";%4QS1B5%3!!.6'.?:O4(EV0HN-NU0,;MV/Q[T+:X/>P^BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHJ"]CGFL+B*UF\FX>)EBEQG8Q'!Q[&DW97&M63T5YIX:N=.T_4K#1]
M9TB;0_$ 9?\ 25SY6INH()\T?ZTGEMK\@X[BMN]\=&'5S:V>C7U];1S_ &>:
M:"UN&(8$ E"L)C8 YSF12,'@U5M;(FYV%%<I;^*M5U*]U.TTSP^'ET^[^RR_
M:KU8A@IO#_*K\'*\=?FZ<$5-I?B'5-4TG3KI-*LTN+F=H[BW:^8_9U4D,<B+
MYF!&"N ,\9I+4;T.@BN()VE6&:.1HGV2!&!*-@'!QT."#CWJ6N3T_P 4VYCU
M:0:.;.XBU,67D[X]]Q,RIM9BO'(8=R<#\*M-XFN-/T^]GUO2I+66VDCC5;9F
MN$G+D!?+(168Y."-N1[T?U_7W@=%17&0>/772]1O-1T:YLA9^61)+%/' X=M
MH.^6&-AMX+'80 <\UU&FW<E]8QW$B0#> 0;>?SHVX!RK8&1U'0=*+ 6Z*XY_
M&E^T6MSP^'V\O1K@QW2RW:K(R! Y:,*&#'!!VEE^N>*GB\6W-S?:M;6VGV\@
MM+&&^MI#=L!.DF[ ;]W\A^0]-W44=+_/]1VUL=53)H8[B%X9HUDBD4JZ,,A@
M>H(KD8_'%Q<G0([;1'>?6;!KN'=<JL:L$W&/=C.>0,[0.?PJ_I_B9]1UFZTU
M+:VCGM @GA>[_?HS $_)MP4&?O;N<'CU;6MGY_AN)/J;=I:K9VJ6Z22.B<*9
M&W,!V&>IQTYY]S4]<8WC>]30&U.32+</#JG]G7$2WK$+^]$>]&\OYN2#@A>.
M]6]?\6S:%<DR:=&;*.:.&2::Y\IY"Y4#R4*D28W<_,O0]:-_Z]/\T#T.HHKE
M+WQ?>0W>NV]MHI=M'B29VGNEC$J$,Q*[0QSA3@'&>^WO'/X@U:X\6:!;Z?;6
MKZ9?6+W;&:X:.3 ,?8(PX#\#/)/5<<I*^W];_P"0=_Z[?YHZ^BN;\7:IJ^F_
MV2NDP6LINKY(9//G:+C!. 0C<';R<?@<\,O/%-Y&+^6PTI+VWTQBE\PN=CA@
M@=A$I0AR >Y2B_7^OZU#R.GJ-[B&*6**2:-))21&C, 7(&3@=^!FJ%QJC3^&
MGU72A#.7M?M%OYKE$<%=PR0"0/PKBH)[Z_E\":O?6%HVJ3"0*\4NXNC6S-\S
ME 5!/)4 X[9IVUL_ZW_R$Y*U_P"NG^9Z)/<0VL+37$T<,2XR\C!5&3@<FI*X
MN]\8 ^$KR_O=!%PUK>&SN[19D>-&5P-VY@-RY*G[N>>G%:[>(U;Q/)HD*6S3
M11+)(LESY<K!NA1-OSJ.<G<,$8YI+7^O*X_Z_&QNT4C,J*68@*!DD]A7F6B^
M*=,D^(%K>6VNV%VNO0M"]M%=+(T#1DM#\H.5RA8'(^\:%J[ ]%<].HK%U36K
MJVU2+3-.L8[N[:!KEQ-<&%5C#!>"%;+$G@8 XY(K&A\?/>'0_LF@W876#(('
MN9XD V(6YV,YYQZ<<]^";_U_79@=G17%7_CVXLY?)B\/WMS/ %%[#;PSS&-R
MH8HC1PM&[#<,[G2I];\;G3;Q[:PTB]U&2 *UPL5M<,5W+N"J8X77?@CY7*=1
MS0!UU%<J_BV]EU/4-/L]#D\^ULH[Q#>7 A657SQP&92-K#!&<CH!S2V'C%KV
M?09#I_EV.MQ;K:4S9D5]ADVLFW &T'D,>>PIV?\ 7S_R8>?]=/\ -'4T5Q\?
MCIKC6HK:UT6_N+"2;R/M4=K<'#;BN[_4^7Y?'WA)T[4Q?'4[:>=1?17AM(M2
M_L^X$MROFHQD$8954,K?,>1N''0GI26NW]?U</Z_K[F=G17,:?JNLW'CS5M.
MEM[0:;;00,CK<-Y@W;SG;LP22,'YA@ =<UT]'2X=;!17"?$O3K"YAT*XN=&A
MU*5=4AC$1BC9W0YR@,A P<#@D#BK.BZ?;65QJ%YH_@R#1[Z&W"1V[B"W^T;B
M3\S0EUQE0 >HYXYH6S?]=/\ ,'O8[*H;JW%U;/ 998U?@M$VUL=P#VSTR.?3
M%<UX=\5:EK\\2_V-#;1Q*RZ@7NVWVDP)_=;3$-YQ@YR!@]^,Q67CHW^LV]O;
MZ-?2:=<-L2\6UN,+U^=B81'Y9QPPD/4<>A;H%^IUD,,5M!'!!&L<4:A411@*
M!T %25SUIXBO;VXLYH-(\S2;QF6*[CGW.N,X9T"X5#CA@Q/(RH[9K>-[U- ;
M4Y-(MP\.J?V=<1+>L0O[T1[T;R_FY(."%X[T]6_Z]/U"UOZ]?\F=DS*BEF8*
MH&22< "FPS17,"3P2I+%(H9)$8,K ]"".HKD4UW6AK?B:.XTRWN;#3XT\N*&
MY_>."F[&UU"\@G)+#& .>M.M_$UTFF^&)['1+2/3-46%"3=F/[)O7<JA1&01
M@;1R,D@<9S26OX?C?_('I_7I_F=?17-:CXHN-*CG>ZT]&#7)M[%;9Y9WN"%)
M)9$B+(!M.=H?H:M^&M=FUVREEN-,NK"6*3RV2:*5%?@'<AD1&*\XR5'(/%"U
M!Z&U4<-Q#<H7@ECE0$J61@PR."..]8MAXA35=;U#388[5DM'\F53<?O@<<EH
MBO"'L=QSZ5R_AG5V\-Z)#%%ID0TM]<N;,M'*$,)>Y=4V1A<%<D \KCL#32O_
M %W8/17['HU0B[MC-+"+B(RQ*&D3>-R*<X)'8'!_(US>L^,)M&U&..734%D;
MR*S\V6Y\N61Y-N&BC*XD4%AD[@1AN#BJ-II]D_CSQA UG;F&YL+5IXS$NV4G
MS@2PQALX'6ETOY/\-1V[^7YV.TAGBN85F@E26)QE71@RL/8BI*Y;X?,8_AKH
M3)&7*V*$(N 3QT&<"H+'QO/>6FD7TFCF"RU"[:S)>Y!EBDW,J_*%(*DJ03NX
M/8CFJ:M)Q)OI=G84QHD:19&&63.WG@>^/7WKF;_Q;/;PW]]9Z8MWI>FR/'>3
M"XVR H 7,:;2'"Y(.64Y!QFF6&NZK?>.[BRBALGT=;""XCE%PP?$A?#;=F"2
M5QC<,#G)S@2M=AG656.HV(A:8WEN(ED$3/YJ[0Y( 4G/7) Q[BJ.J:O);W\.
MEV%K%=ZA/$TPBFF,4:QJ0"S,%8CE@  IR?09-<'X=U&WT'P7=F30UN+4^(9H
M/LZ^6([?-QA3@]E;;C:#VZ=::5W_ %WL#V_KLW^AZG16%'XC6X\3W6C01VY>
MU">:KW.R8[@#N6,K\R8)^;=U!&*C7Q'>3W"2V6DFZTO[4;1[B.;,JN'*,PCV
MX,88')W \$XQ26H/0W([F"6:2&.:-Y8L>8BL"R9Z9';.#4M<'97EAX<\2>-K
MYH%CA1K61DA0 R2,GIQEF8CD]S6W#XCN8-972]8TY+2:>&2>U:WN#.LJIC<I
MRBD. 0<8(]":+Z7_ *Z_Y!U?]=O\SH:*YG3O&%O>>'9M=D2W-E&C2 VEQY[8
M'1&7:")#TVC//&32^'_%-SK.I3V=QHMY:!$,D<[V]PD;+G&"988\/SG W#WI
MVUL%]+G2T5B:AK=RFIR:7I-E#>W\4"W$J3W!A1$8D+\P1CN.UL#&..2.*R4\
M>BZET:*RTF>1]3DGA_>S(@@FB#;HVQDYRI&0,8YR>E+^OZ^X#L:*PM<UV]T7
MP?/K;:9&UQ;6_GS6<ESMVX&64.JL"1SCC!]13/\ A(YD\30Z5+8H()M/>^2=
M)BS_ "E05*;?]O@ACG'04?U^%_R#^OZ^\Z"BN9T[QA;WGAV;79$MS91HT@-I
M<>>V!T1EV@B0]-HSSQDTOA_Q3<ZSJ4]G<:+>6@1#)'.]O<)&RYQ@F6&/#\YP
M-P]Z=M;!?2YTM%(QVJ6P3@9P.IKE+#QA=7FM+I4NF0V]S<637EM&UV3(H&T;
M9TV Q'YATW]#Z4@L=917.^"=3U75_#,%]JT-M'-*693!,T@8;CU!5=N.F.>
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M73KOPA=%+MIX]/O+FYBNCM(P6MU)3> !ARA/0U["I8HI8;6(Y&<X-+10M(I
M]7<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "LSQ%>7>G^&]3O+"'SKR"VDDACQG<X4D#'>M.BDU=#3L[G Q
MR307_ANZTC5;Z[BU@,EWON3,I3RBWG(K$K&58#A0%^;!'2K/P[2ZO=!M]4O=
M4O[JY$EU PFFRC@3L Q7&-P"X!&."1TQCIH-#TBU:Z:WTJQA:[S]I,=NBF;/
M7?@?-^-/T[2=.TB P:9I]K90D[C';0K&I/KA0!5WW_KJ3;1(X?QY>W 76Y+"
M_O/M&F6"W"K%=-;1VS_.0S%3^]+ #",I7Y>2-U2ZCI]OJ7Q$\-3R7%X3+I]Q
M(WDWTT:[E,6,!' '4Y X/?.*[*YTC3+RY^TW6G6D\YB,/FRP*S>6>J9(SM/<
M=*KR^&/#\]Y#>3:'IDEU"%$4SVD9= OW=K$9&.V.E*+M;^NC7^13=T_Z[?Y?
MB< TP\-Z?XPU*QNIXIUU81R233RW"PQ'R=\GE%^=H8G(P<8&< 57O;NYMO O
MB*[TKQ[%J/E0I+&-.=G:W;/.9))9G&X'ID8V\8YKU1;"S2>XG6T@$UP L\@C
M&Z4 8 8XYP/6J/\ PB_A_P#L\Z?_ &%IGV(OYAMOLD?EE_[VW&,^]):?A^%O
M\A=?FRQIME]DBE/VJZG\]_-/GRE]A*@$+Z+QG'J37FS6-I9>$/$YBN+CS7UA
MDQ+>22@ 7"8(5V(!Y'.,GC.:]3@@AMH$@MXDBAC&U(XU"JH] !TJA>>'-"U#
MS?MNBZ=<^=()9/.M4?>X& QR.2!QGTHZW_K=/] 6UOZV:_4Y6\O]1T77?%,5
MA-=7/DZ/'?0PS2M-B8F4$J&/ .T?*,#C@#-1^"+Q+[5?M=OXXL-7CG@+R6%N
M)"X8X(<B2>0QXY&T!1STZ5V%OX?T6TO_ +?;:180WNW9]HCMD63;@#&X#.,
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MDI)<.YDW;I-N%&&)'J#FL6VU'6M2?P0;S4KR(7LMU!<+"XC%PBI)LE)49R0
MW!QSD#H:[Z?0-&N;6VM;C2;"6WM<&WBDMD9(<=-@(PN/:G7.AZ3>W<%W=:79
M3W-N,0S2VZ,\8Z_*Q&1^%"MU_K?_ #_ ?I_6W_#F'XVL$3X8ZQ:23W,HATY_
MWKS,)'*IP69<9SCGL>XK,_L^U/BKPY8175T8?[)NPS"\D:4@M#D>86+CKU#
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M7J%2ES+:H\B[>F&(R,=J(/#FA6R7:6^BZ=$MX,7(CM443CG[^!\W4]?6B_\
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M8->MK)]1C:R^R3VL$B*Z'?N#IYC*I'4'+ \#K5RM?W=B5>VNYH-XKT%18?\
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MD#K638:7K]OH7@RUD\.WOFZ7>&2Z GMOD4(ZY'[WG.\'CL#[9(ZI+^MW_P
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M["<QCJPR#V/%-;:^7Y/]= >_WG3-XP\/I96MV^J0K%=3"WAW9#M+G&S81N#
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M+X!IDELE^L#6DUT\3PS-$!\KJKLVUB.A7[I.<=*.G]=H_P#!^X2O?7^M9?\
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MF,UOG[/DG!&&_=<@!F';[Q]L6[+PDUC>ZK=1Z_JK/J>6F#K;X5]H4,N(NH4
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M/X8])MM-7Q!K BM[TWR/BVW>86W\_N<8W$G&._I@">?P/;W5SJ\UQJ^IR#5
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%-DC2:)XI45XW!5D
M89# ]01W%5=-TC3=&@:#2].M+&%FWM':P+$I;IDA0.>!0!SD.JWD'Q!CTF35
M9Y8I8)))(+FU6*,$8VBW;:"Y )W?,^/4=*Z^L./1;ZYU:VOM6OK6X^QN[VD=
MM:-#L+*5RQ:1]QVDCC:.>G3%V^T32=4N()]0TNRNYK<YADN+=)&C.<_*2"1R
M!T]*%L@>[+]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
C 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ex10-56_04.jpg
<TEXT>
begin 644 ex10-56_04.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Y Z4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-E?V>I6B7=A=P75L^=DT$@=&P<'# X/-1PZKIUQ(8X=0M9'"LY5)E)"J=K'
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M6\D+/)&NV,,?ECSU('J?7KCCUJS10 4444 %%%% $4ES!%-%#)-&DLI(C1G
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2!C[T@?:>_(C!YK=HI <Y/X:NHM6OKS2M32TCU$+]MAEMO-W,%V[T.Y=K;<
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M\1Z/J,=O=?9C;-]HMC*C1EMQ&S<A5P1W/'0BH=0TB*T\,R^&[ L]SJ(D5Y&
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M[YY/'3CUIZ:_UU_R%_7X/_@"7VOWGV^[L]'TZ*_EL51KH27/DXW D*GRMN?
M!P=HY'-9_P#PG0N[C1HM*TN6Z&K6LMQ;R23+$N47)C/4ALX!XP,]3C%7[GP]
M=QZY<ZII.HQ6;WJ(EY'-;><LFT$!EPRE7P<9.X<#BJ4?@N2SU;P_/I]_!!9:
M-"\26[VI=Y-^ Y+AP 2!_=X))YZ4ETO_ %O_ , 'Y?UM_P $Z*6>[&E-/';1
MK>>3O$$LN%#XSM+ 'C/&0#7*Z'XEUV?P;I5_<Z;:2WE[&) _VME@5=N[?*_E
MGR\\@###.!FNS=0Z,AZ,"*Y*U\&7EK8:):KJ\4J:42BI-9[HY(\87*[Q^\ Z
M/G&2?EYQ1W_KO_P!]/Z[#;7QX+RU\/S0:5)(-8FD@5TN$,<;H&S\V<L#L8@@
M=/? JU#XPVZ/J=U>V/E76GW8LY8(9O,5I&*;-KE5X/F+R0,<^E48O!&HV[:.
M(=<@,6FW\UXJRV!8OYA?Y<B08P)&&<'D X'0U=6TC4=!T#Q+/+JNFRG5;D3*
M9[%TAA)"J1(PD;Y-J#+<8Y/H*;:M_7=?\$23T7]=?^ :O_"57BS:CIU[X?D>
M]L[3[3*EK<Q2PLC;MJAG*,2=K=4 &#STSSUS<0WVN_#[5]/TNWAFN+6<Q0Y"
M!$,&5CWA>%&>P^@IO@VW\0W=OJ2-=^%KB&]A91J6F7-Q>E7' 5S(^6 #'"AQ
MCTQ6];^#+NVTG0(DU6'^TM#0QVUR;0^4ZE=F'B\S)^7'(<<\^U&UGZ?^W7_-
M">J:]?T_R9C^*M3BUWPQ*M[I\<&I:7K%I%)&6$HB<RQD-&^ 2"C]< \D$5L:
MUXX;3=1FM+'1[W4OLK!;G[/;7#D$J&VH4A=&;!&0SI1JO@RXOM(GMK?4X8;R
M[O8KV[NI;0R"1HRI4*H==H&Q1U/ /<YI+SP=JI\0OJND>*;C2ENMC:A;16D<
MJ3NH"[DWY\LD  GGH*%V_K9?@4]OZ[G6&4_9S*D;L=FX1XPQXZ<XP?K7'6?C
M..'P[IM_;^'I(4O=1:S-O')&ODN960LV" 22"?ESR>O>NR97$!2-P'"X5G!;
MG'!/(S^=</'X&UB+0K/31KUCFVU(Z@)3IC_,?,,@7'G]-S'G/3 [9(K7^[\]
M?P)=[>?_  /\RY?>)-2DTGQ+!'I]O%J6EQY*_;&\MD9"P</Y>0V,_+MZC&<<
MU6T+4KFVTG0X#I.GOKMU8#[.%NC@VZ*A+/+Y6Y1EA\H5N2.O)%F?PGK$MSXB
ME36K%1K$:Q;3ISGR0%V=?.&X[2?3G!Z<4]/"5^EII$BZM;IJ^E1F""Z2R/E/
M$0 4>,R$G.T'(<<CMTI+S\OU_P"!^(WO]_Z?\'\"&Y\??9-*DN)=(F-W;ZA'
MI]W;),A$$CE0K;CC<AW*00,\\@<XLGQ1JB:_!HLWA\Q75Q#/+#*UXAA<1L .
M0"PR&4G*\9[XJOJG@>>_TR6"'4H(;JZOXK^\N&M"XE>,J555$@V#Y%');C/<
MYJ_>:!J=UXJT[6DU.S1+.WDA\@V3,7+[=QW>:,<JN!@XYY/9Z?UZ?YA_7X_Y
M%&W\;SRZ=I^H2:4L=M-??V?<G[3EXIO,,7R#9ATW#J2IQSBIM9\83:-J,<<N
MFH+(WD5GYLMSY<LCR;<-%&5Q(H+#)W C#<'%9R^!=870(M,&O6.Z/4_[2\W^
MS'P6\WS=NWS^FXGG/3CKS5N^\%75[+?NVK1 W5S!=*[6>Z2-HV1MF[?S'E.%
MP,9/)IJUU?\ K;_@A_7Y_P# 'VNM:XWB/Q'#-IUO/96")Y,<%U^]?*;@-K*%
MRV>26 & .>M&F>*(KG1-$32-+A2ZU&U:>VL6E\J.*-<9W,JG &Y1PIY/XU?7
M0;R#4]5O;74HU-_$@V2VV_;*J;0Q(9<KC!VC!R.O:LJP\$7FG:3HL<&KPC5-
M(C:&"[%F?+DB; *21^9D] <AQR!]*E;:^7Z_\ ;_ *^Y?\$<_CLQP1A]'G-Z
MNI)IMU DR$02-@@[CC<I# @@<]]M;&C:W-J.H:GI]W:);75A(BL(YC*CHZ[E
M8$JISCJ,<$=3UK'O_!5W<0HUKJ=M#>/J,>HW<\EDT@FD0*%"J)%VJ H&,D^^
M>:TM)T*_L/$FK:I<:A;3Q:AL_<1VC1M'L&U?G,C9XZ_*.?3I37]?<OUN2_+^
MM7^EB35_$2:9K&G:8!;>?>;F4W-QY((7&0AVG<_/W>.,\CO1N-6UL>/;#38K
M2T^P26#SR[[EED!#H"<!""1G &1G).1BM'Q#HIUVP>R<V+02 !X[RS^T+UY(
M&Y<-Z'L><56C\+O;ZAI=S;:E*HLK%K%_-3>\J':0V[/#90<X.<G@=:2_K[F-
M^7]:HK6GB^XEUV#3;G2UA:[@DGMHQ= W&$QD2Q,J^63GCYF'J15:U\=7-QIV
MFZD^B&*TN[UK%U:Z4RQ2>8R+\H&U@2O)W#';<.:=I_@N]T\Z8Z:Q TVG^<%D
M^Q<SAQC=)\^6?(!+9&[G@9S56/P-K$6A6>FC7K'-MJ1U 2G3'^8^89 N//Z;
MF/.>F!VR6K=?ZU_R$^MOZT_SL7+[QK/INFZ_/<Z.9+G1MK2PVUR&5XV7<'W.
M%QQG(P2,<9JZGB>:#5X;/5+!+2&ZMWN+6=+CS P0 NKC:-C '/!8$ \UR_C7
M3+C1O#WC35K_ %BQ-OJ=F8TA^S&%E=4*HH<R$,2,\;>3TQTKHM*T==56SU2^
MU"VU*%;9H[/[/%M01R* Q8[F#L0,9&T8)XI*_+?K_P !_K;\1O\ K[U_P?P*
M^E^.FU#4UB?1K^"PEC,D=X]K<(J*%W9EWPJBY'0J[YK%UZ^EUG5_!>J/ID$5
MM)JB-9W)EW3-&T3G#+M&P'"G 9LX&<$8K:T#P;J6CM)9W/BF[O\ 0UB,-OI\
MMO&IC0C&&E'S. .!T_&H_P#A!;UK?1K23Q!)]FT:Y2:S,=JHEV*I4([$E6.#
MC<%'';/-4K73_KK^(M;/Y_D=%KUOJ-UHMQ%I,MM'?$ Q&Z#&)B""5?;SM(!!
MQZU0FN-1T6XO=4U)[%M+CLU;;"C><LHX*@D[=A[=\GFNAJCK&E6VN:/=Z9=[
M_(N8S&Y0X89[@]B.M3M_7]?\.5N9<GB2ZTV._FUS2OL=O;6YN4G@F,Z.N<;"
M2JXDZ?+R.>":9_PD]]::E#9:GHXADNXY'L?L]T)?.*+N,;;E0(^.<9*\'YJJ
MV'@W47TB_P!+\1>)KK6K2YB,$:-;1PF)#W)499_]HG\*LQ>&]1>2VGU#5;>[
MNK!)%L)#9% C,NW?(!)\[8R/E*#D\#C _P"OQ_&]A+^OP_#<KZ=XVEOHM NI
M-*\BRUES#&YN TD<FUF&4"XVD(>=V0>V.:S8;G5+SQ7XJAO]#L;^RABA5H/M
M?F,RA&9 J/&$.XG)!8 'NU6+7P/JUKIGAVR77+)AHUP9U8Z<_P"]X90#^^XX
M=N>><=,8.A:^'=:M=:UK41K&GL-24 1G3G_=%5*H<^=\V >>!GMMH?EY_I;]
M0_X'YO\ 2PS3?$T,OAW0VTK3(H[C4X2UG8>8(TC55R=S*IVJ!@<*>2.*Y[PU
MJT'AR3Q9++8>5+)K8CCM+2-I,RM#&3M$:%B/O,2%SC)Q6U8^"KVPT71((=9A
M74M&#1V]T+,^6\;#!1XS(2<@#D,.0.G2HIOAXT\6K,VO7<=U?7B7\,T4:+]E
MG50NY>I((&""<8X]33;5W;^M5_P?F'E_77_@"CQ_<QZ2+NY\-W\<@O8;1E*O
M$A\P@*ZF9(V89(!^3K[<U:O/%&HQV_B.V33[:+4M+MA<QAKDO%)&P8JQ.P$-
M\C97!'3YN<BO=>#_ !!?>'H;"]\6+>7BW<5R]U<:<H7$;AU18XW0#D#)))//
M3C%O_A%;V;6M;O;K5+=[?5;-;1H8K1D>,*& 8.9"#]]L_+Z=,<J2NFEY_DK?
MC<<=U?R_/_(KVNO7*R^%+?5]&B>ZOPVR[CG65(6$3-D%E5MS*#G"@#)^8][-
MSXNFM->L[*XTZ.*VN[HVD3R7.V=G&?G$)7F,[?O!B?:HY/"NJR3>')#K5J3H
M[;F#6#?OOD,9QB4;?E)_O<\].*9_PA=R)BXU="5U/^T$D:TS*>3E'?=\P .U
M3@8  P<53LW\W^?^1"NHZ[V7WV$\'V\%KXF\8QV\,<,?]HQMMC4*,F",DX'<
MDDGW-:>H^%M.U&_OKN:VWM>V1L[A?/D43)G(! /RXR>1S\QK/C\.ZW82>(;N
MWUR!)]3E66%HM.+- RA4 P9"'&U0#P.23P.!U47F>2GFX\S:-^WIGOBIW2]+
M?@6W[S:_K8KZ;9?V=I-K8B5Y/L\*Q"1R26P,9.:P;6Q\56]GIPGDTB::"X<W
M01)/WT/\++D\3<<Y.W+&NIILDB11M)(ZHB LS,<  =230WK=B2TL<;;^.[J7
M1X]9FT,P::MVUK=%[H&: B7R]VQ5*LN>N&X[9JY#XMN;C6=4L8]'9(M+GC2Y
MFFN47$;*6\P 9R  #C(.#V(Q7->";-/$_A^Y@75[2XT@:K<R36T*!Y&(N&=0
M9 ^ C#:<;<D'[V#75:9X:N;37==O[R^M[F#5BNZW2U,90*NQ1N,C9^7KP,GT
MZ4._X?HOUO\ (':_S_5_I^)!%XOF!TV[NM,6'2-4=([6Z6XW2!G&4\R,J-@;
MH,,W49Q58^.+T:=JFHG0&2TTJY>&\62[7S515!+JJAE;@YQN''<GBK%EX/EM
M[>QT^[U)+K2--E26S@:WVRKLSL#R;B&"\8PJG@9)YSSWAV&+Q3+XJL;36[*3
M3)]3E%W#"HDD>-D0#:X?"!L,,E6S@X(Q3TO9?UJM_P 1=F_ZWV_ Z2'Q9=WN
MO7^F6.B22_8OL[M(]RB>9'+GYU'/0#."03STXS6L/&%G%X;?41I$MG(]_+:K
M911^8[S!V#$B)6).0S$J&Z$\U>TSPY>:=XHU35_M]L\-[#%"ELMHRF)8P0GS
M>8<_>.>!GCI69'X#NG\.W.FW6M@71OWU"UO;.U,+V\K.7/#.^X98C''!Q[TM
M+?UW_P BEY_UI_F5=0\::W/X:>ZL]%-G>1WUO;.+SSX8W21U7,;20JS=<$E!
MCD\X&=/7_%]YX?@:XNM*@$%ND;73O>% 6<XVP9CQ*1Z$IU'K2GPIJUUX9?3M
M5\2R:AJ!GCG2\>S2-$:-PZCRD(R,KS\V3GJ.,,U?P9=ZJ^K;]7C"ZC:K#NDM
M \D# 8RC;@ AZE,9SGYJK2_S_P O^"+=%B]\4WZ>(KK1-.T-KFZALUNXVFNE
MB292P7 (#$8YZ@=/?-0P>*M6?3M4:;1[.+4K*Z2U6S&H,PD+E=IW^2, A@1\
MI]\8.+-MX<OX?&3:]+JEO+&;-;,VXM"K;02V=_F8SN/]WIQUYJAIS:9XF\:?
MVSIDD[0V,;6]RQA>-)9U8J@^91N* R\CCYA^$KM_6_\ 2^8?U^']?<7+[P?9
M:G%JS7%L$FU6*(7*I=2[2Z8PP(QC&!T SCGVZ2&/R8(XMS/L4+N8\G ZFGT4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'A;6=8UW5YKH65K9W^FQV:RP73O+%(A9PX4QJ"-S?WOX<]\!=/Z[+];CTO\
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M/7FM+IYO[-@O4U@ZK9[+B26-B<@QR9C4@8)&1GKG'&#6G]>J_2_W"U_KY_\
M ^\?X9F>;XF>(Y'MKRU9[&T=K>ZD#M&Q,@.,,R@<#A3C\<UW=<MI&AZQ!XRO
M]>OI;%(KVSA@:UAWR%&0L>)"%R/F/\.3[8YZFA[+T_S'U?\ 71'G?Q*U:*^\
M'ZK!;6]\\=NZJUY"^R)9 Z@H<,&;@D'Y2N>"<BMK7_'^A>&;A;6^N4,RHKRH
M+B%&C0CAMKNK-T/"!C[5DZCX,UR;P_J_AVSN-/6PO+AKF"YD9_-C+R^8R,@7
M##.<,&'88[U:N]"\8V.NM?Z!J6CF.^6+[?#?02[5D50IDB"MGD #:3CCK26U
MOZV_S![_ -=_\C9M?$\=YK<FFQ:;?8%J+N.Z)B\F:,]"A\S=R>.5&.^,C-'4
M?'^EZ3I]K<:C#)9W%RADCL[FYMHI2@.-V6E"$=#@,3[58\0^';S5IM*N+2_^
MS7-K(4N)<8\VW<8E3 Z$X4CT(%5?$>B>)!K,.L^%+S3HKKR/LUQ;:BCF&5 Q
M93E.0RDM]<T?U_7X OZ_K\2CJ-]8ZUXA\#:UI\\DL%S/,(V$C!&7R)#RF<9R
M.N,^];5QXQL;:3S&M;QM.$WV=]214,"2;MA4_-OP&XW;=H/>JNIZ1X@O-5\-
M78&FSG3YFFNW:5X=Q9&0B- C\#=D9;MCOFJ1\(:E_8U[X8+VCZ%<RO(+@RN+
MB-'DWM'LVX/4@-N&,CY3CFM-O-_FOTO87]?G_P  U9O&-LM[J5I;Z9JEU-IN
MPW(B@"X5LG<N]EW@!3]W.>V:%\::=<7T-G86][>S7%C]N@\F':LL?R\*[E5)
M^8=\#N0<5CPKJG_">>)8M+BLWWV]FCFYE9/+&V3YAA6WD?W3MS_>%26'A;5=
M%U[2I+"&QFTW3M+>P1IKMTED)VMN*B(@?,F.O0Y[8,K9?UW_ ,D/O_7;_-FI
M;>,["ZCTR9+6]6UU"3R([AT4+'-R/+8;MV<@C(!7(ZU6U/XB^'=*UD:9<7D?
MF"40RLMQ#^Z<XP&C+B0]1RJ$#N1@UCP>%_%$'A[1K 6VCM/8:F;US]OE"LN]
MG !\C.?G(Z=@><X&A;Z'XOTKQ!.NE:CI)T"[N6N98[J*1KBW+<NL9!"D%LD%
MNF>AZ4UO_7E_P?N%T_KS_P"!]Y<G\=Z=##J,ZV>HR0:9<>1>R>0$$/ )<ARI
M90"#\H)P<@$<U,?$-V?&ZZ(FE7+VOV03FZ5XMO+8!(+AL#!' )R>F.:Y^^\+
M>);O2_%]HL&DJVMS[X&-[)A%V*AW?N>N$!XSUQVR=^+2]53Q%;:LPLD5M/%M
M<Q^:S>6X;<"AVC<#DC)VXX.#TI::/^MO\QOK;^M5^AT=5M1OH=,TZXOKA96A
M@0R.(HVD; ]%4$FH-#GU&XTF&354M5O3D2?9&8Q-@G!4L <$8/-.UJ"ZNM$O
M;>R2%[F:%HT$TA1,L,<L%8CKZ&E.Z3MN.-F]3%/CS28](35+F.XM+26**2WE
MNO+B6?S%+*JLSA0WRG.X@#CG!!I=/\>:-JFC2:C:-)*8[A;4V\31R.9FQM0,
MC%#G(Y#;>N2,&L]O"NNCP5H5I:7=G::[HHC,$FYI8)"J&,AOE4[64GMD>]1Z
MXWB6/PG NIP:7J&O27<;6]K83&V7<IW?NWES\X )R1C'&/6I63=N_P"I*O9&
ME<^.[&TT[4KF33=5\[3$#WMK]G :$8!^^6$3'!!PKDXJ[)K5M>:S_P (_+:W
MB-=6+7*3AE5&3*JP#*^]6&\=A[&N2T73-9UK0?$>CZUHESI.H:E 2][<7T-T
M9B5V MY04+@ 8 4 @'OFME-$\1-KVFZRYTN.2UT^6TEMA)(XD+%2-LFT;1E!
MDE3@$C!ZT-*VO]:/]1W[?UJO^"5O!VK1Z3\/]%#0W-W<7#RQ001$-)*X:1B-
MSL!G"DY9ATZYJS?>-G_LS2[S3-(O;G[9?_8Y8LQ))"RL0Z$,X!;*D<''4YZ9
MJZ9X;\1V?AK2=-E-A_HEPYNH(KR54N(F+$?O!&&!!;.W&&Q@GFEL_!^J6&BV
MUG;G3@UGK#7T$:EDC,32.VWA3M(#\  CCKSP;O7R_0.FGG^O_ -J_P#%EM8-
M<'[!?7,-IC[;-;JC+:G:&PXW!F(!!.P-BF7?C.PM]2_L^"TU"^N39&^1;6#<
M)(L@?(Q(#'YAP#^N :3>'M9L[G6(;![&6RUAFEF:=W1[:1D",44*0ZG ."RX
MYY--L/"]_IGB[2[FUCM/[(L-+_LY"]P_G$94[MNS'\./O=\\=*%Y_P!:/];>
MH/\ K\/^"7+;QBMQ8:M<OHFJ02:8X26VE\CS78@'"@2D'@@\D9SQFNAMY6FM
MXY7AD@9U#&*3;N0GL=I(R/8D5R$D6GZSX\CDTO4[>=8H\:K! ZR#=$^80^#\
MK!BW!ZA3Z5V='2_]?TPZV,_5=7CTI( ;>>YGN9/*@MX N^5MI8@%BJCA2>2.
ME9?_  F^F#3+&^>"^5;N[^Q"+[.6>.8.4*OMRHP01G)SCC-6O$-AJ=^;$6,D
M1@CGW75O),\(F3!&-Z@G@X.W&&Q@G%<O_P (?KMGH=IIMC#I#);:R=013.\*
MB/S3(J@"-L'G&.@QU-"MU_K7_('MI_6YTT/BJQ:/4FNH;FRDTYU2>*=5+_,
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6*[@CBGCX8\%4V,AQMW+Z=<\U:>;7[?Q#H^@0:\_D7>ESRBXDM8FF61"N&)
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MMIMTUPMOJ%I,;8[9Q',K>4?1L'Y?QI+;6-,O;EK:TU*SGN%02&**=78*>0V
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ@GE"F2,_P /?C%.T;2UT71[734N9[F.VC$223[-Y4< ':JC@8'3MS0G:_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ6RV]3E.@^7:<@\U+T^ZY=CH-0U"+3K=9)%>1W<1Q0QXWRN>BKD@9X/4@>I
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M96AB=5)4=3EB!@#GU] :MV]['/';9(26>+S5CSDXXS^6X?G0!9HHHH ****
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M?)T=+Z&&:5IL3$R@E0QX!VK\HP.. ,UT0\&^%Q;O;CPWH_D.XD:/[#%M9@"
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2W=1#*95<7"$?> '*\@C!] >]:% ')>/+B\M+;19K2^N+;.K6L4J1, )4:0
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M/4[I;DW5F<P,EY-&J'O\BL%.<X.0<C@\5JUA^(]3OK 6R6<MG;^=N!N+J,S
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M)%)&WDA $SMQMC#9&6[\[CG/&+>FZ+%I]Y=WK7$]U>76U99YP@8JI.U<(JC
MW'MGU)K3HI7 RM0T*&_U:RU(75U;7-HKQ@PLN'C?&Y&#*>"57D8/'6LJ#P+;
M6LVDO!K&J1II;N\$>Z%E._.X-NC)Q@E>"./?FNJHHV!Z[G*1> [1+6XBDU;4
MYI);S[='<,T2R6\YR"Z%(P.0<$,",<8Y-:&E>%[32M8O-62YO)[Z\1$GDFEX
M?:  =B@+GCKCC) P.*VZY^34]4OM8NK72#9*FGS1QW272/F7<H8[&4_+A2.J
MMD\<=:%V7]?UH#U)]?\ #RZ^;$OJ5[9_8YQ<)]F$7S./NEMZ-TYZ8Z\UG7/@
M:*Z775DUS50NM +<J!;_ "@#;A/W7'R_+SGCGKS733SQ6T$D\TBQQ1J7=V.
MH'))I+>=+JVBN(\^7*@=<^A&11_7]?<%_P"O3_AS'N?#"7FDQZ9=:G?S6@01
MS1MY7^D*!C#8CX[?<VGBBZ\+P7%QJ<T5_?6IU&%8IEA9-HVC;N4,IYVG'.1W
MQGFMVF3&18)#"J-*%)178JI/8$@' _ T2>CN"TV,$>$+3_A%[/03>WICLC&;
M:YR@FB,9!0C";3C ZJ<]\TV3P1I-S+JLEZUW=_VI"L-TLTYV.%  (5<*&XSD
M#([8'%3>#M;N?$7A>UU2[ABAGF:0-'$257:[*,$\G@=?Y5JW5];V<EM'/(%>
MYE\J%2>7;!.!^ )_"G*]]>OZB7ET_0Y[3? EAI^D7^FS:EK&HP7L30,;^]:4
MQQD8VIV4?09X&<XJPWA,/J.D7S:UJ9DTQ"L:GR2)<C#%_P!WGD8'RE1Z8/-=
M#11=CZ6.>'@ZQ$\X6ZO%T^XE\^730R?9VDW;BW*[QD\E0P4\Y')JM<^!HKH:
MZKZWJH76@%N546^%&-N$_=<?+\O.>.>O-=512'?J8=SX:%WI$>F3ZK?O;>4(
M9@?*S.@!!#?N^,@\E-IX'-;4<:Q1I&@VH@"J/0"L'QEKM[X=T1+^RM[>8_:8
M89!,Y&U7<)D #YCEAQD?7M704[MZBM:R"BBBD 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% ' >-9--/CSPA;WEW&K2R
MSI);R7!560Q,!E,X.6XSCOCVKF]>CT2V\52Z)X@U'5],5#&FB"TLTG!BV*,1
M2&&21'# YPP[&O8Z*%I8'J>?WNKV%M\1;F)[PO<1>'V#012*;@L&+X"C^/;S
MC\>E9'AV/2Y/$<$=LFG26.J:)+OBME\P7+JZ F9@-LLF&.3M!&3G.:]7HHZ?
M?^-_\_P#_@?A;_+\3QD/H&F?#+PE(DUI82)J%F9PDH@5I5=1+Y@! =E .[=G
M&.<8IVL7?A^6#XC,^HVD\D 66V,MX)#%+Y7!CW,=K"0X&,8/ QTKV2BFW=M^
MOZ?Y#3L[_P!;M_J>7>(-:T-[FPN=3N]-U&&?2T:UBFO((_)EW']^K2.HYZ;E
M.Y=G .:[?PC;_9O"FFHVH?VA(8%:2Z%T]PLKD?,RNS$D9SCG'IBJ6O>$O[;U
M2.[E&CW,:J%\G5-*6[\L=_+.]=N>^=W;TK;TO2[/1[!+*QMX;>!26$<,81 2
M<G"C@<FB^C_KN3;;^NAP>H6,5OXP\63:796J>()-+CDL)/(7S&?;(&96QGJ%
M!/KM![4:5_9=QK?A^[\*^2MT6*ZRD9Q)Y?E'/V@=?,#[<%_FSGMFO2**$[6_
MKO\ Y_@-]?Z[?Y:'.>/;-+[P#KL#VRW!^Q2LD93?\P4E2!Z@@$5R@N/";^*?
M#>G12Z4M@=(NC]F5D2)@YB/W. 0V'/3!P3VKTZBA.W]>37ZCOI;^NG^1XBFL
MV3>!]*^TZE,?#D-Y>6U[+8Q170@42-Y(D1TD7R]G^SW0BO2_ T>GQ^&(#I-]
M?7NGNS/!->1"([2>BJ$3:@[#:!CIQBNCHHON+^OS_P SA;MX_#/Q)N];U,F+
M2]2L(X!>,/W=O)&S':Y_@#!L@G R"/2M;7=5DU/PAJ<WABX6\N3:N8)K5PZE
MO1&'!;KC&<'&:Z2BETL/K<\YLCHDFO:9>>&)+:&T:*?^VS _EA4V<&;&-LH;
M'+8;[WO7+V-_X>@\(:#>C4K(7,.OO"MT]V#*L)G;>/,+;MI0J3SR"">N:]NH
MIIZ_UWO_ , FVEOZVL>/:U/I!L/B-I6GWEO&D%NMS%;65QY>V01_O&VH1_%C
M<.A/6MM'TU-;@U#P_P#.D6GS_P!L'3SEV(1=@?'6;.<;OFQFNN\4Z/<>(/#=
M[I-O=Q6ANXS$\LD!EPI&#A0R\^AS^!K0L89K>Q@AN98Y9HT"O)'&45B!U"DL
M1],FE]FW];-?K^!77^NZ_P OQ/*-+FT>VU3SH[JQM=.O]!F:62TF*&1U9 7E
MF4J&D&XY; ()//-,T'4=$AM_AS<K?V(O;J)K>ZE:=3)*ODL/+<DY(\S VGHV
M!UKV*BJYM?Z\_P#,FVEOZV7^1YR?#=CI^L7?A*'1[4:5K$JWR[;==B(A'FHP
MQZA-OIYG'W:]!2WA@CVPQI$JH$&Q0-JCH![#L*R]'T6\L;NYO-3U>74[F1F6
M%G@2)8(BV0BA1SVRQY.T5LU/2W]?TEH/K?\ K^F<%X/E;3]>DT<_V;?GRFE;
M4;'Y9<Y7 ND[2,",,3DX/ JU\1(H/L>B7$[RJL6K6P.R5U7:7&=P4X/3N#CM
M79U@>*-"O]=CL$L]0MK,6MTET?.M&FWLA!4<2)@=<]<^U.^J^0/KYW. \1?V
M9!X>\976D74%OX?DT^,V\EI<>5"]YE\^64(!)^0$#@G@Y.:V+Z'2K.+0KR2.
MW;P[>[GU24MOA>3R0D;2]5V<$'/&<$UZ,,X&>M%'_ _7_/\ ! ]?Z]/\OQ9Y
M!JUK%'HU[+:2N/#\6MV+:8;>=Q'L9HQ($"G#1Y)P.0#G'059UK^R8K+Q7>:-
M=6]OH+Z5EYK.X\J%KW<V-C(0-YX#8/)(!S7<>*]"O/$.G06EI?P6?EW,5PS2
MVIFW&-PZ@ .F.5&>O'IUK=7<$4.06QR0, GZ4FKQ:_K9(:=I)_UO?^O5GDVL
M+X?L/!GAC55O+>WEGO-/:247A1)2A17+#=M;: <Y!QCVJ+6Y])NO&]S9>(M6
MUBQU%[D'2?LEE'*)(BJX,,OD.Z'.=V& Z]C7K]%4Y7E?S;^^Q"5HV\K'G%Y#
MH^F^,?%5[-8[;TZ7%-'):P*+IAMD$C1MC.[A03Z[<]JS])DTFUU342MSIUII
MM]H?G,VGRF.,L&8,[3*5#/R,N IKU>BH:NK>5OS_ ,_P*6GWW_+_ "/*?#_@
MW0_%OPQTV[-I976L?8(T2[F E*2I\P#9SW/S#N#@\5U?A6.WUJY?Q1+I4=K>
M21+:1[X@)(U3(<9QG&_<OIA!ZULZW8:CJ-DD.F:Q)I4WF*SSQP)*Q3NH#@@$
M^O:K=E:16-E#:PY\N) @+')..Y/<GJ35N5VW_7]=!6T2..\=K9Q:]X4N[Z5D
M@6^DCFWS,(O+\B0G>N=N,@9)'3/;-<EXD%A9^$=?>RN8[;0Y-0M3I2PW!BB=
MCL\T1 $!HS\QP,KPQQQFO1M>T&^U;5]&O+;4;:VCTVX-P8Y+1I3(Q5D(W"1<
M#:Q['G!]JWZ2T7S_ %3_ $&]?N_S_P SS[5X-$L-:L/[0BLQX3O(9II'F(:U
M:Z9D*M(6RN"N=I/&<]R*H>9<Z?HL2W+/_P (O_;;J78LP6QVG;N/7RO,XYXV
MX_AKU"BA:?UY_P!(/Z_#^F>*ZG::7=+XZM]-T]);-;6TGL_)MMT("+DM&P&T
M8#9&.<'(XKH9[VWF\<7=YX?6.>[O?#[>1<V\19)I0QV%I%&WH, D]L>U>DT4
MNEOZV:_7\ ZW_K=/]/Q/,_"MYX1\0S/'8V=TFK"R:'5+26SD4.2!G[067;(^
M1@$DGD]LU1TNQT^/X<:!/82Z%:_9$$UW;ZC"J6T\R@*WF-_#*K ?,<D'L<<>
MM44V_P"OO_S!;6_K:Q@:1XCL9+71[:Z7[!?:C$[06<A+$[/O8;'([C."0<XJ
MK\2'MH_AYK;W-R;=5M7,;B<Q'S,?(,@C.6P,=^F#72O"LDL;L20AR%[9]?YU
M)2EJ.+Y6F>8/>^'[WQQX>2?4K.XM[C0Y1)#)>!XI!F/;E"VTY'F=N0#UQQDZ
M?XCTRW\*:/+J)2_\,07E[;WODK]HC@&]O($B+G,>SH"".5/I7LM%-N_]>;?Z
MDI627];6/,-2U/P[9Z!X6:QOS#ILFM1RVWVTF']WEB=BR!2(UW #C &.V*JZ
M_;Z7;0_$739;>U26Z@6\M[;RES*?)YE5<<X<$EAT/)KUFBD_Z_#_ "*B[-/T
M_!M_J>;)?:9>:JB:_&OV5M-MWTA+R%D#2X;?L#@'SLA<?Q8QCO6#I&H:?;>'
M/AJ]U>&TG2Z,31W$K0AEV/D[&(##=L ;!Y(P>:]GHJKZW_K=_P"9*5E;^MDO
MT/%+R^T!/#7BJZ34[.2ZM-<#VDTEX))(B3'@HS,2,@...H4CH*W/&.J:(NN2
MM>W>G7AN-/B-@);Z"'[&Y+XG1I'7@Y!WQY8;1QR*]/KEM:\'C6=8%[.NC7<1
MVCRM4TE;IHU'58VWKM!Y/(;D^V*CI;^MK%+=O^M[FMX=MUM?#UA$MX;W$*EK
MDW#SB5B,E@[LQ()SCGI7*+*VE>.S_P @S4O[0N/X/DO[91D?,.?,B4YY^4#/
M<FNTTW3K72;".RLH(X+>/.V.- BC)). .!R3P*M53=Y7)2]VQY-I5UIS>*O#
M^J69MXC<7EU;W+$%[MV*.P2X<8P00,1D$C P>.8K+^Q1J/CU_#2:6VM(Y:T^
MP^5]HV>2GF>7@$_>W>V[KS7KU%+I;^NG^7XCZOY?A?\ S_ \@T.#PQK.B^(G
MT6^U+47>QE2[L[G3HH8EEQD%U2!%:4$=<L:UI-"T,>$M#\2Z-I.GR3:0D=RI
M@MD_>(%S*HP.6Y9AZ./7->DUC:WHU[J]Q:K'K$MIIZ[A=VD<*-]J4XPI=@2H
MZ@XZ@]J=]=/+\+_Y_P!="W?S_0C\,Z=:PP7&K)916]UJLGVF9EB".5/W W?(
M7&?<GUK&UJXL#XW%KXD6#^S7M(SIPN5S&]QO;>!G@RX";?XNN.]=L    , 4
M4F"VU/'] N=-F\%>'-.U*W&V6ZN4$>I(4M6;<Q4.&7$A(8% #R0<'BDM;;2[
MOP[X0.KP6EU%9ZQ/:S/<6^4C7]\JIA\[5W",!23R%'7%>PT52=G?T#_@_C<\
MFUBYTZ37?[1MS;PW=GKEO%-).";Q(RRIM&,&*$YX!W!@3TSQZG<2B.SEEVR$
M+&6P@^8\9X'K4U%2_AY0^U<\@T2?28=<TV\2XM;:POM(N5N98IB)793'\UQ,
MNT&4 MDX!0[N:KZ+J>B6VD?#^^74;);Y[QH)IVN5,K(4DW(S$YV[BF0>,D=R
M*]GHJKZW_K=O]0>J_KM8\8U^XL)_"U[)?Q*_BJ+4T%PHB+7*Q"Z&W: -QBVA
M<8RI..]>RQN)(U==VU@"-RE3^(/(IU%+I;^MK ]7?^M[A1112 **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#&U;Q+::
M1JEAILMO>375]O\ (6&$E254L06.%!P.F<_AS6/JGQ+\/Z.\27LC0R%%DGAD
MEACEM@RAAOC9PY.#T16-6]?TC5=0\4>'[^SCLC::;+)+*9KAD=MZ%,*H0C@'
M/)'I[U2N]$\6V'B>YO/#NH:4--U"19;N#48I':%PH4M%L(SD*."0,BA=+@RM
MK]\-5\;6&@W6A7&I:3-923,A\AHI"6C EPT@.$R>V<G*@]:M6'C[PQ#JEKX?
MM+H, ?LT#BZCFRZY&PKYAES\IY9<'U.1FQ<Z5KC^.[/5H[?3Y+"&S>T9GNW6
M5@[(S/L$17(V$8W<YZBJN@:)XQT*\&G#4=(N/#L&XVY>*0787.5C)SL ' W8
M)P.GHUM;U_-_IM]P/_+\O\R_8>.-,O[-[Y;>^AT^,3F6[N(/+CB,1PP?)W*>
MN 1V/<8JE:_$[P[=1Z@R2NQLH3<.D#QW)>($ NODN^!R.&P0.2 *9H_A+4AX
M-U70]4DMK>6]GGGCFLYFE\LR.7!^9$Y4D?7':F'2_'=]X9U;3M8N= N)I[=[
M:V-N)8@P8;2\C$-@X.=JKC/>D]G;M_7XC5KJ^U_U_P C=LO$]K>:G;6)M;NW
M:ZM3=6TDRJ%E0;=V,,2"-RYW =>,TVV\4VMS?VUN+2\CM[S/V2\=%\F<@%CM
MPQ8< D%E4''!-9$6@:\^MZ!<W%OIJVUCI\EG<[+V1G)<*"4!B ( 0=2,[CTQ
MR>&=!\6:-MT>]U+2KGP];)Y5NZPR"[>/&%5SG8,# R 20.U-VZ>?YO\ X!*V
M5_+^OO+%A\1O#NI:]%I%M>1R2SL5@D2XA=9& )(VJY=> ?OJHKK*XWPOHWC#
M1+B/3+S4M*N= M5V6T@AD^UL@^ZK'.P8&!GDG':NRHTMH/JRAJNK0Z3%"7BD
MGFGD$4$$10/*^"< NRKT!/)'2LC6?$MYI^JZ):6^C7EPM_-(DA5HE9-J,<89
MQZ9STP#C)(%:/B#2H]9TM[2;3[2^0G=Y-TY12P'RD.JDJ<XY R*P[?PQJ]K;
MZ RW<,\VG74LC+<3.^V)U=0@D(W.4##!8#=C^'L1WU"6VAI'Q;:#58K,V=[Y
M$MR;1;W:GD^>,Y3&[>#P>=NWWJM/X[TZ&'49EL]1DATRX\B]D\@((> 2Y#E2
MR@$'Y03@Y (YK.G\*ZW=7\-W<OI]Q<VNJ"ZANI99"QAY&P)MQ'M4@84D-C)(
M)-5K[PMXEN]+\7VBP:2K:W-O@8WLF$78J'=^YZX0' SUQGC)2\_ZV_S?W?>W
MO_7G_P  W_$>K026=]ID5M>W3_9BT[6;!/LZ,IVLS;E/.#PF6]JR/"OB!=-\
M ^&HA9WFH7DVF),(+;9O**J[FR[*O!8<9R<\ U:70==@OM0N+8:<$U:W1;M'
MF<FWE6/9NC.S]XI&."$Z9]JJ:?X1UNTT?1-)N[FPOK&TLVM;B$F2)"> C[?F
M\W &"K%0<YXZ4;)_UW_X'WB[7_K;_@FLWCC3"^F1VUO?W4FI6K7=JL5N?G15
MW$9; W=.,YY&< YK)\<ZY%?>#=;MK:TU)C%9.\TT+>5]DDV;U5SO#9^[D*&Q
MGYL U'I7A/Q!87OA(R+I;P:+:O;RLES(&?>H7*KY>. N>2,YQQC)L:GX5UF2
MU\2Z=836)L=;$DGF3.ZR6\CQA"-H4AU.,YR",]#1-)W2\_ST_#\BH.TDWY?\
M'^O,U=-UN*"UTW3H[:>YG%A%-*(=G[I"N 2"P)R5( 4$UT5<5JGA"\O])TZ$
MQV#:I:P+#'J<4LMM);D#EDVABPR%.PL ><FNBLI=3_M>ZMKG[+)91Q1^3+&6
M\W?CYA(,;1GJ,=NO:JDTVWYLSBK12\D:=8.HZCI47BO2K.YMKE]1:.62UE6)
M_+4;?G^;[I.!TY/(X&<UO5S6M:9K%UXKT74;*"Q>UL!+YGGW3QNQD7;P!&PX
MP#UY]NM3U7]=RNC_ *[#+;QUIUW;VEU'::@+.YNS9_:)(1&L4N_8%=6(<9;C
MA3@]<5:A\3>;J&K61T?48Y=-B$K&0P 3*<[=A\SOM.-VT<<X-<NOA7Q0OAF'
M3OL^C_:(]9_M$G[?+L*>?YVW/D9SD[>GO[5TFL>'KK4-?TO4K:[%LL0,5_&"
M3Y\/#!1QV<#DXX9O6G9?UZ+];@]_Z[O\U8JZO\0M'T)(!J0:VNI(UFDM)KFW
MCEA0Y^9@TH#=#PA8^U:2>)K.YGMXK&*:]$ULMV6@V82)@=K$,P8YP0 H)]0*
MR=:T7Q5!XC;5?"]]I:I=I''>6VI1R,@V9Q(FP@[L'&. <#FI/$OABXUJ.W=(
M;0ZE$@2/4EGDMYK<G.678"6&<'82 ><FD@\OZ_K<>/%-P/$VLZ=<:/>_8;"V
MCE,\023=N#DG8K%SG;@ *3D'..*?IVO:19>%='ETJTNGMKM!'I]FF/-D^4L%
M^=@!\JDY9ATZTO\ 9&K6NO:G?VS6=PEW911 32-&WFQAQSA2 IWYSSC'0YXY
M>\L->T+P7X=TB#3[2]UVS?$,=IJ"QR;50@R1O+'MS\PR&4C!QSFCI]WYO_@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P KG245P&HZKKZOXR"ZNL7]DQ)<6GD6J#CRV?8^_=N!P 2,'TVU>AU75O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR;EKN,0WL\865B26PKCN3[#)QU-2Q^$-$C;4R;668:F<WB7%S+,DI]=KL0,
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MKMN_^)C< 2#TQYG [8&.,CH<5I?VUI0N(;?^T[/SIV9(H_/7=(R_>"C.21W
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MAM6:">2%]O\ =+(P++_LG(]JTE8,H92"",@CO4%[?6>FVKW5]=06MNGWI9Y
MB+]2>!0P,W4O">CZK#90W$-PD5D0;>.UNYK=8R.A C91D=CV[5K&"-K8V[KO
MB*;"KDMN&,8)/7\:PO$GBS3M#\+R:PM_9,DB_P"BN\Z[)F/3:<_-Z\=@:M:
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M]D9-*OM,4""ZMFB,LR*Y:0QN 0<;!D@$[?8&LS4TN;2#P]J-QH^O:KI;Z1%
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M*TM\OPO_ )B:O?Y_C;_(\TO+"^E\/^(/#=U87<NK7EU-/9W8MF:)]S;HI/-
M*H4&!AB"-G /%6M/TZV_X63K37>E2RP2Z=;1RSOIK^5/,A8L=Q3:QQLYR>@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** .6\2ZQ<KXCT/PY93/;R:DTLLUP@!9(8ERP
M7/1F) SC@9[XJ_!H#6%S;/8ZC?B))2\\5S=R7 E!4C&9"Q7!P< @<=*B\0^'
MYM3N].U.PN$MM4TV1G@>12R.K##QN!SM([CH0#[5=T]M9G4?VI;6-J1U2TN7
MGWC'JT:;>_&#]:%MY_U8'OY%!O&-BDT3-:W@T^6;R$U+:GD&3=LV_>WC+# 8
MKM/K4%QX[TZ"#5)Q8ZE)%I4WE7KB )Y0QDOARI90"#\H)(Y (K/C\'ZE_88\
M+S/:/H:3+)'<B5Q<>6LHD$93;CMC?OZ?PU6OO"_B2[L/&-NMOI*G7"/()OI/
MD'EK'EOW/7"[N,\G'O0OZ_#_ (/];O2_]>?Z6.E'BBU749[*6TO8G2U-W$?*
M#_:(A@,8U0EB02!M(!YX!JK9>-["]CTVX%E?Q6.I$);WDL:K&9"2 C#=N4G'
M!*XZ#.>*K)I&O?\ "5Z;JLUMIJVUOIKVDP2\D9PS%6)4&( @%,<D9SGC&#C^
M#])O]:\%^';>Z6UCTRV:.Z$B2L99&1RRJ4V@*-P!SN.<8P,TU:_]=W^EB=;7
M_K;_ #.GB\7V<NJV]F+.]$-S/);07I5/)DFCW;DX;>"-C<E0#C@]*KMXZTX0
M7-RMGJ)MK2\^QW,S0!!"V0-Q#D,5RP' )[XQS6;_ ,(IK<VJ:=J%T^GS7EEJ
M,D_VIY9&:2%E=0H7;B/ 9?D4D';G.:K77A?Q/<:%XAL1;Z0LNIZ@+J,_;I,(
MN5)!_<]?D'_?1Z8Y%;3^NJ_1O[OO;\OZW_R7W_=TT/B99=8U+37TJ_AEL(?/
M,DIA"3(2=I3]YDYVGJ !CG%:.EWYU/3(+UK.XL_.7>(;G;YBCMG:S#D<]:Y7
M7$M=:U_2[.#4+6/68P8=1M;>82L+5EW2*W0A<A,,0.O3FNT93Y95"%.,*<=/
MPI= ZF!9^+[.\OHK<65_%'<1/+:W#QJ4N53&[8%8N#ST95)[9J*S\;Z??1Z;
M/':7ZVFH3M;17,L015E!("LI;>"=IP=N.Q(/%9=AX6UZWU#2=4N!IL^HV:3Q
MW%P]Q(S7(<##9*?)D@?(,JN>,XQ56W\+^*(/#^C6'V;1S-8:H;US]OEVLN]G
M '[GK\Y'3^$=<X#7G_6O^0GUM_6G^9)\2M7CNO!?B"TMK>^D%M PEN[=]D<,
MH 8*Q#AFZC( 9?[V*[(W$=IH8N)4E>..W#,L4;.Y 7H%4$D^PKD=3\(:U/H_
MB'0[.:P%AJSRS)/*SB6%Y""RE0I#+G)#9!&<8/6NM6&^AT(0?Z/<7RV^SJT,
M3OC'^V5&?]X_6I?P/O\ \#_,K[2_KJCEH/$\5C9>$[?P_HMY/I>H@B+:\89(
MUC8A<2.#GC/)Z ]3Q72V.MQ:C=316]M<-!%*T/VGY#&SKD,.&+#!!&2H'3&:
MYK2?"^N6.B^%89#IXN]&=ED"S.R2(8V3<#L!W?-G;C'&,]ZNCPQ,GBZ+5[6&
MVL!O+W<UM<.#> @C:\.T)G[IWDD\8]ZMVO\ ?_P"=?Z^9MZKJ\>E) #;SW,]
MS)Y4%O %WRMM+$ L54<*3R1TKF/$GBYY/A_=:MI=G?;V9K=U'EI);.'V-NRX
M'!RN5+<X(XYK=\0V&IWYL18R1&".?==6\DSPB9,$8WJ">#@[<8;&"<5S$W@_
M6X/ ]YX?L8M))FO9)8\S/"D<33&4<"-N>B[<8'7)Z5*VU\OS7Z%>G]:/];%3
M4%MK'6M)TVW\&7D=GJK2S7E@#:^7,RH1AD\[9D9#'L>#DD8%V:'0#H'BW2]*
MM;ZTDLK7;.6>:(Y5&*;&+;MHQV^4C Y%:6H:?XDO/$6A:FECI*I8I)YR'4),
MEI!M(7]QR !D$XSTP.M5[C0?$+WGBR1+?2RFK0+%;;KV0%=J%,N/)XX)/&>1
MCOD3)-Q:]?TL$-))^G_!)-)O]+1_"5C<V]RVHOIX>UE$;"-!Y0WY;A2<#IR>
M1P.M:-KXMM+K5+>S%E>I%=-(EK=NJ>5.T>=RC#%@1M;[RJ#CBLJ#0O$*7WA6
M5[?2PFDV[0W!%[(22RA,H/*&<  \D<G';)CM?"NM_P!K:/J5ZVG2WMC<S&:[
M,LCO-$Z,H(!4;.2O[L';QUK5V<WVN_S?_ ,XIJ"]%^1;T[QLILM7OM:LI=+M
M+*\:W6:XEA",00H7(<X.>I.!SU.*=IWQ#T35-/NKFV9GEMG2-[9)H9'+.<(
MZ2-&<G_;X[XJO<^$]7FT_5+:"^MK69M2.HZ?<J&8J^X-B12 ,?>4X)R#GCI5
MRTTSQ!J>@3VGBZ'0;Z24X-K;1R" J/5GR=V<'.!BH6VOE^G_  2WN;$VJ-!9
M)</IU\6:6.(PI&'="Q W'!(VC.202  :T*Y&QT[7/#GAMX;.2TDN#=*\5K=7
M4LR0Q'&Z))2-[GABI(ZG&,"NNIL04444AA1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 17-M!>6TEM=0QSP2
MJ4DBE0,KJ>H(/!%1:?IFGZ3:_9M-L;:RM]Q;RK:)8TR>IPH S5JB@ HHHH @
MBLK2"ZFNHK6&.XGQYLJ1@/)@8&X]3@>M3T44 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 445@>*;UH8M.T]':-M3O4M2Z\$)@N^".A*H1GMFCR W(Y8YDWQ2*Z9(W
M*<C(.#^M*)(VD:-74NF"R@\C/3(KF-=\4IH%PFF:=I<MY/%$LC10V\[)'&20
M ###)@_*< A1[TW6=3$>CZ7XFCM9K682P++'<1^7((I75'1P>F-V<>JBA:[
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M&54QM\PXRPX//%8.O7TNLZOX+U1],@BMI-41K.Y,NZ9HVB<X9=HV X4X#-G
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M_P D8!# CY3[XP<=5$9#$AE54D*C>JMN /< X&1[X% #Z*** "BBB@ HHHH
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M"T1+(X<R,"023@KZ>AS8M_"VH-XDT_7=0USSKJSMY+8I;VJQ1S*Q!^8,6(/
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M9U8J@^91N* R\CCYA^'9T44NB0=;A1110 4444 %%%% !1110 4444 %%%%
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M$-GH^GVT5S_KTAMD19?]X ?-U/7UJS8Z?9:7:K:Z?9V]I;J25BMXEC09ZX
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M._;8[(ZG&MU*XCCA9&5W.T/\H(Y&T@Y''/6C_A,M"^R-<FZE6*.;R)MUK*#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*6UBN)=CW4ODPC:3N?:6QP..%/7TKE_^$GU:\\.Z3J"1:?ICZA&90TQ>Z"#
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M<G=D-G%9.F:U)HMCK)M[5[J[NO$,]O;Q(5R7(!_B95X"DX+#/3/-'6W]=/\
M,/3^M_\ (Z[1?#^G>'XYX].2X59Y#+()KN6?+GJW[QFP3WQU[U+;:UIM[JEW
MIEM>12WMF%-Q$AR8MW3/8'CIUKG+?Q+K]M8)'K.D+;7]S>):6;/L5)2P)+,B
M2R[=H#<;SG Z9XSM/N;[3/'/BNZO1'>75MI%M(1:1-&)=OG$!4+,03TQDT_7
ML_P2!*^V_P#F['H=%<;;>*-5@U*TM[Q=-NK>ZL7U$S6QDB,$*[?EV_.)#\PP
MV4!P>*=H'B#Q-JNI6TT^@O%H]W'YBS$P@P@KE3N6=S(#T^XF,T6=[?U_6C%=
M6N=A17/>)M6U#33"EE)9VXDCD?SKF)IRSKC$:Q(RNQ(+'(SC;T.:RI?&\JZ#
MX>U6<1:?;:C"LUQ=2P/-# <*=C%2NS.3AVX&.0<TBK'1:-X=TCP^+G^RK&*V
M-U*9IV7):1R2223D]SQT':M2J;7<AT<W=NL-S+Y'F1B.0!)#MR,,>,'UKG_#
M?B2]U'7[C3;J6RN8Q:)=Q3VD#QJ S$;,LS+)C'WU.#Z"CK872YUE%<KJ6N:X
MOC$:#I\&G*LFG/=PS7#.Q+JZKA@,8'S=B?7M@TX?%/B/4=3632M">YTI;IK:
M1R81D+(4>0.9PPQ@G:8LG'7FA*]OZ\@>AVU%<M;>)WG\4W>C37-M9SJQ2VM;
MFW=9)E )\Q'+;9!T^51D=S65%XNUP^&[#47.G&9M:_LZY5;=PKI]H,.Y/WF4
M.!GDM32OM_5W8'I_7E<Z^QUK3=3O+RTLKR*XGLG$=RL9SY;'/RD],\'CM5^N
M!N)KRWU3Q_/83I!=16T$D<CQ[PI$)/3(]/7\^E=)H<]S:>$K6YU2XBG>.U$K
MR0PF,;0N?NEF.<=\\^@J;KEN^R_7_(.MOZZ?YFU6;J&OZ;I=S%;WD[QO*RJ"
M(7=$+'"[V4%4R>!N(SVKG8_%6J0VVBZQ=K9-I&KRPQ)#$C":V,H^0E]Q63D@
M$!5QGOBF^$QK#>,O%1NKVRDMX[N-&2.T=&)\E"I#&4@  X(P<GGCI56=[/S_
M  M_F'2_]:G;45RUQJ^O3^+;[0K)=-MEBLDNH+B99)BV6*D,@*8Y!Z,>Q]JS
M(?&NK7S^'([:SLHCJ<MS;3M([OY4T(?.T #*[DZYSCC'>DM=OZW_ ,@>F_\
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M7:KN**7 #8Y .0#]:72X^MA:*** "BBB@ HHHH **** "BBB@ HHHH ****
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M617/WN,DKZ#(KM;_ .V_8)O[.\C[9L/D_:,^7N[;MO./I4XSM&[&>^*=^O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ JGJ>H1:78M<R@L=RHD:]9'8A54>Y)
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MU'%-_9:2I^\^S^2,&#/;);=M]]W&*F75(J%FU<].TZX>[TRTN9 H>:%)&"]
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M<<'W-9NJ3^'(M/\ B';17&FJEF1-:0K*@6";R@"T:YPK^9QD8.[WH>C?E?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.N/O'CCGM:*/Z_/_ #8?U^7^2/.[?POXH@\/Z-8?9M',UAJAO7/V^7:R[V<
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M +P!2CC.U1N9BIW<#H*Z.+P9HUM)ITL$5YYFF(5LPVHW!$8],%R".W(/&!T
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MPM>O];A1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]=TOU0GI_7K_ ),]3HKBWO&TCQ?J,3ZA<I9MHYO96FD:81.K$%U4DA1C^%<
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M5R_BF47&HV&EK<W?F3132_9K:X:V+JNWYVF5@RJI(X&<[NF :YJQU/4[W3O
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_:&W9]J\A?-V^F_&<>V:I7&JV7ARTC34;RYGG<-(?+@DGD;&-S!(U)"C(Z#
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MHFDMI\FGMI=D;*1BSVQMT\MB3DDKC!)/-7Z*0%)](TR73UT^33K1[)5V+;-
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MUJD;,,YP2H!/-:5% %:[TZQOY()+RRM[A[=]\+31*YC;U4D<'W%5)/#.@3-
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MXK:6..NM$U"V\417VBI>VK3S*U[^^C:SF08!)C)+JY7H4 Y'S&K_ (TLWNM
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME[-?_98;,J+C[9#);O'N^[E)%#<]N.>U6[/7M-O]0>QMYV-PD8FVO$Z!T/\
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MS@;5R2 ,D G@<UB6^DZQJ,/AZROM->R;1)XYI+E98VCN-D;(!$ VX Y&=P7
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M4=1L])L);[4+F*VM81F265L*HZ=:JV?B+2[^^2RMKEFG>'SXPT3HLD?'S(Q
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MURW3V;^4$+[541>;DD\Y._C'3G%9S>.-2>VTKRK&T6:;5VTF]WR,1'(I/S(
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)*^]O+0N4C0NY ]%')/L* ):*HZ/JMOK>DV^I6JR+!<+N02KM;&2.1VZ5>H
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MIQ4>J_#_ ,+ZY965IJFE_;([(8@::>1I%'H7+;F'L212Z:_UI_PQ3?;^MO\
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M64=!L9BO'...,GU-/1:?ULOU0MU_7?\ R,[7[_5+?Q3X?L;2\C@M+YIDF7R
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M*W!QCIU(K5\2).FO>&[R.UN)X8+N02F",N4W0NJD@=!D@9Z#/.!56U7]=_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[.[%LS1/N;=%)YH!5"@P,,01LX!XKTI65U#*0RD9!!R"*6B_]?=_D%_Z^_\
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M6;4M'\3W>FV5Y*)KVQ6WCE$KX RC."8\@#. ?PIKI?\ K_@;@^MOZ_X):O\
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MSY;0&Y4J!\T<BD"-B1DD*>I Q0OZ^[_/] EOIY_F=!<2/#;RR1PO,Z*66)"
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM;*$G<8[:%8U)]<* *N444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\T<3-C*J0,D\X&6 SBJ/A75KK6_#\-]>Q0Q7#22QND))0%)&3@GD_=ZX'T%
M&S116=KU_=:5HEW?VEK#<R6\9E,4TYB!51D_,%;G XX_$4FTE=C2N[(T:*YC
M3]<\1W<&GW<VAZ9':7GEMF+5'>55< YV&!02 <D;N@-3ZAJ>J7&KW&EZ(;)+
MJTABN)?ML;LDJN7 0%6!0_(?FPW4?*:JSO8E--71T%%<]I6J:KK%TE[;&R&D
MB::WDAD1Q.K1LR;U<$J067[I4<'.[M70TAA15>^OK?3K.2[NI!'#&!DGU)P
M/<D@4C?;O[2CV_9_L'E-OSN\WS,C;CMMQNSWSB@"S1110 45C>*M9NO#WAV[
MU:ULH;S[)&TLL4MP8<H 2<$(V3[$#ZUEW?BK6-&L5U+6M!@33,*99]/OC<-
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M *^27Z#:UO\ UNW^H4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMU6.,F)?)D,F226(4%2#R>U=-8Z[IMOX?T=-*L;N=+JT62SLH2OF^2%7DEW
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M&WOGBU>^$;^[L-4N@UJFK7]W:W;1^8QA7R"A6/?MR0=A^;;WZ<4U:^O];?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
>*** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ex10-56_05.jpg
<TEXT>
begin 644 ex10-56_05.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Y Z4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&)41-@@,<<G.X\KW?I/B+3=/T_5%M]!72_LNI"Q2TB$:F>9@FT_)\HSN'<X
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M +>7S7FCR005VC:^1C + YZU5L?%5[>W^HZ8VGV<>H6UH+J)$OC(I!) 64[
MT;9'(VM]34WTN-?U_7S.FFN(+?R_.FCC\QPB;V W,>@&>I]JDK@=+\47\OAO
MPO=ZWHL%S)J=Q$J313ATB9AE9"&4%6Y; 4-C'WN:U;_Q;/;PW]]9Z8MWI>FR
M/'>3"XVR H 7,:;2'"Y(.64Y!QFJ:L[/^MO\PZV_KK_D=317,/XKN)]7N--T
MW2_/=+%+V&>:Y6.*9&/&"H9AT/5>HZ8YK7T+5HM=T*QU6&-HX[N%90C]5R.A
MHM_7W_Y,/Z_7]30HHHI %%%% !1110 4444 %%%% &-#H#V]X\D>LZD+61F=
MK-FB:,EB2?F*&0=>S\=JV%540*H 51@ = *6B@ HHHH **** "JVH6,>HV4E
MK+)+&CX^:%RC#!R,'\.G0]#Q5FB@#.T_2Y;, W6J7FI.K;D>Z6)2G&.!&B#U
MZ@GDUHT44 %%%% !1110 4444 %%%% !1110 4444 9^MZ4NMZ-=:8]U<6L=
MRACDDM]F_:>"!O5AR..F?3%3:;9?V;IMO9?:)K@0((Q+-MWL!TSM"CIZ 5:H
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q]>\/Q:W]CF%Q):7UC
M+YUK=1 %HVQ@@@\,I!((/7]:FT^UU9%']JZC;73*>/LMHUNI&/X@TCD]^A ]
MJTJ* .2B\%-'9_V.VH))X?$PG2S:V_>*1)Y@3S-V-F[MLSCC=52[\#ZK=Z?X
MEM#KEDJZY+YC,-.;,(VJA _??-\JKSQSDXYP.XHH_K\O\D']?U]YRTWAS6IO
M$6E:M_;&G@V-NT#1?V<_[P/MWD'SOESL&.#C/.ZJJ^"+N6/5EN]8B+WE^FHV
M\EO:&-K>9-NW[TC!QA%XP._KQV=%._\ 7SO^8?U^AR)\$R7NK7FH:QJINC>Z
M=_9]S;P6XBB=<L=P!+,/O=FZ^O01Z=X1\0V>F7UC<^,IM0CDA,%J+FQ3$*D8
MRY4AI&QQDL!WQ7944GJK?U_6H7ZG'VGA'5;:X\-NVLV3IHL)A*C3V!F4KM//
MG':=H'8\Y/0X#;WP5?3^'M1T:VUF&*&[O'N5:6R,AC5I/,*\2+D[NAXXXP3S
M7944VV_Z\[_F)*RLOZW7ZG'ZKX,O=5_M3S=7A!U"T6!F-EN:%P,9C)?Y4)Y*
M<G)/S5>/A_43XOLM;.J6YAM[1[5H#9G<X8JQ._S,#E1CY3QD<]:Z*BA.VW]?
MU<+?U_7H<YXN\/:AXCM;6VM-2M;*.&XCN6\VS:8L\;AUP1(F!D<\'/J*K'PQ
MK+:SJFI'6;#??V*6FP:<^$*[L-_KN>7;CCMSP<]912Z6_K70J_7^NYQ/_"%Z
MRFE>'+*'7;!6T-E9'?3';S2J,BY G&!M;GGD\\=*OS>%;I+S46L-42VM-5RU
M] UKYA+E A>)MPV$@#.X...G6NGHIMWW_JXEIL<OI_A.;3?%2:I;7MNEC%8)
MI\5F+5MR1+R/WGF<G/\ L]..O-9UQX'U>YTKQ!8OKMB/[8N1.SC37_=<*I '
MG<\(O/UZY&.YHHN_Z];_ )A;^OE;\CD+WPEJ]_J\U[)KT$(GTTZ>_P!FLF21
M<\ET<RG:=W(X/''7FK.E^%9[#48;R2^M\)8_8WAMK,0QL V0RC<VWJ>.?J.E
M=-12\OZZ_P";#^OR_P D<6?!>IIH>AZ9;ZW;!-)N$F1Y; MO"<(I E7'!Y/<
M] O2K4_A"8OJ=M::DD&E:JSO>6K6V]]SKAS$^X!-W4Y5N<XQ7544-WW_ *_J
MP>?]?UJ<M_PB^H0>(;C4K+4K*"!M/6P@MFL6;RE7)4EA*-V"3Q@<8''6K'AS
M0-1T'2-)TU]6CGAL8VB<1VGE^>N,)G+,5(ZY!Y]!70T47_K[_P#-A_7Z?H%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 445%!<P7*,]O-'*JNR,8V# ,#@@X[@\$4 2T444 %%%% !1110
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MZC>:CJ-I/9:AIZV$]K'9LC;1N.0YE.#EV/W>F!VR3I_79?K<>E_Z[_Y#-/\
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MK?PKKC63 GSMUIP 2"=OG[N,'H,\5UE>=>"=*NO^$/TV_?Q%>QVD4K3/:2+
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ME>.H/0GZUR&AZA<?\)-H-RFH7<MGJEO.[RW-VQ%S@*4=8"66(>FT@GN,UN>
M/^0-J/\ V%[W_P!'M32WO_6MA/\ 7]'_ )%O_A*<>+!X>.C:EYYB,XN,P>5Y
M6=N__6;L9XQMS[5T%<?("?B\@!*DZ$W(ZC]\*YRTN]1B\-:=J<FKZA<7D7B
MV?F23D*\1NC$5=%PC?+ZC@],415TOZZM ]+O^MKG<:EK=W#?2V.DZ?'J%W;Q
MI-<1/<>21&Y8#82I#-\K<$J..HK;'(!(Q[5YU]A^Q^/?%>H68O9[RUTZ">"$
MWTQ1Y")CM*[]I7(X4C [ 4^UN;B)?"NK:;J5Y>R:M*D5[')<M)&ZF)F=PA)6
M,J5_@ '8T+9?UO?_ "![O^NW^9Z%17F-A'J5YX8\2WLGB+5UN]-O+Z.&99E&
M50#:&7;L[=E&,G&,U=L_M+:QX5C;4=09-4TJ0W:FZ?#E4C(8<_(WS'YEP3GD
MFDM?P_%7!Z?C^#M^IZ#4<TT<"!Y7"*6503ZD@ ?B2!7GVGZE-+X:@L;C4+YY
M'UFXL85CF;SKB-'DPAF+!EPJY+[MV%[D\Y<Z'4_"UO;:C>7+/:>)([=-FHRE
MTC\X* 9 59B >&;GN#GFFE=V]/T_S"7N[^?X7_R/4/.N?[2\C[)_HOE;_M/F
M#[^<;-O7ISFK-</=7>H:=XOOUL;NZO84T$W%M9R2[D\Q6P,'JQ.!RQ)Y//-5
M;:XN(X_"VJZ9J=[=RZM*D5ZDERTB.IB8NZHQ*QE",_( .Q%):_UYO_(/Z_!/
M]3T*D) !). .I->6VEWJ,7AK3M3DU?4+B\B\0&S\R2<A7B-T8BKHN$;Y?4<'
MIBNS\<RW$/@37)+4L)ELI-I7J/E.3^6:;6E_ZZ?YC2][E_K=K]#4TZ__ +2@
M-S'$5MG.8)">95_O8[ ]O4<\5<KF-?>-;71M.BN+B/[3)L2VM)#$TZK&QVB4
M,IC X;(.?EP <UR>GZEJDVD>'5;6+I'&NS64R1W EWQ!Y0H9V7<V @ 8XSSG
M-%M;+^M;$KX;_P!;7/4ZQ%\0$^,V\/&QE3%G]K%RSKM<;@N HR>I/7'3O7)3
M:S?:)9>*H8;NX:"SU.W@CFN)FE:VBE6+S&WODD+O9AG('T%3V2V.G?%Z"TBO
MI)#+HK&,7-TTS,3*&PK.23P"<9X'H*$KM?UTN.6B?]=4OU/0:QM8UYM)U71[
M(V,LR:E<&#[0'4+$VTMR,[B2%/08XY(JAXIE%QJ-AI:W-WYDT4TOV:VN&MBZ
MKM^=IE8,JJ2.!G.[I@&N;MKZ?4=%^']Q=W'GW)U+$KE]Q+"&8<G R>.N*(ZM
M?UW&]/N?Y7.STK7FU/6M7TU["6V;3GC7?(ZMYH<$A@%)P, =3GGD"MFN6T'_
M )'OQ9];3_T4:SO$>MZ<OBN71M=UF31K7[$D]G-]L:U620LP<[P5W%<)\A..
M>0:71>G^8NK_ *['=45Q+7#:GKNFZ)>:I<264NE^?%=VL[6QO9@P!8-&P(P,
M-A3@A^X%8D6H:O-<>'8[K5[U;<ZU=:>6614%W"JR;&8@9+94#((SC/7!#M=V
M_K=K] Z7_K:YZ3?S7-O8336=K]KN$0F.#S!'YA]-QX'UJ<$E02,'N*\RUF?4
M[#POXT@LM6U!+?3&5K.Y\_S)5/EAGB\Q\L0">N=PSC/%.\4:O)+XE;2KOQ59
M^'HXK6*>V>Z,J><QW!F#I/$&P0 4;<.AQS2Z?UVN']?B>F45PFL76JZ=]DU6
M:275=+MK%6N)K&Y-M)&V#NG\K=MD4CG:2<;> :[F.198DD0DJRA@2,<&G8!U
M%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ J*ZM;>]M9+:[@BGMY5VR12H'1QZ$'@BI:K:A>QZ;I]Q>S)*\<$9
MD98HS(Y '90"2:3:2NQK?0RD\#^$HW5T\+:(KJ<JRZ?$"#ZCY:ORZ'I$SW;R
MZ58R/>J$NF>W0F=1T#\?,![YKD?^$E;4[SPCJ\5U?VMI=F19[1X6C5SY#,/E
M90S\X P2I[9-=7::_IM[IAU&WN&:W#F,YB=7#@X*%" P;/&W&?:J:MN2FF]!
MK>&M!?38]-;1---A&V]+4VJ>4K9SD)C .?:K%[I6G:E9BSO["UNK48(AGA5T
M&.GRD8XK.;QEX?CM%N9]16V4SK;[+F-X91*>0IC<!P2.>1TYZ5.WB72Q9&Z6
M2XD02/'LAM)9)=R-M;]VJE\ ]3C%(9;N=*TZ\AAANK"UGB@</$DL*LL;#H5!
M'!'8BDDTG39;9K:33[5[=Y/-:)H5*E\[MQ&,9SSGUJM-XCTJ*PAO1<M-#."8
MA;0O,\F.N$0%CCOQQWQ6-XF\96=EX335-.GEF6YF2".6"WDEVDR!6SM4[6 )
MP&Q\PQC/% (WX]$TF+5'U2/2[)-1<8>[6W02L,8P7QD\ =^U6X[>&*262.&-
M'E8-(RJ 7(  )/<X 'X5REH%\/S6U];ZAJMQIFJ7*1-;ZG)(S6S,,*4\T>8H
M+  JQ/WLC&.>N=UC1G=@JJ,EB< "C9!U*<.D:9;ZC+J$&G6D5],,2W*0*LCC
M_:8#)_&K%Q;6]W"T-S!'-$W!21 RG\#67:>*]%O9)TCO"A@A-PYN(9(08A_R
MT4NH#I_M+D>]):>+-$OYK*.UO?-%Z&^S2")_+E(R2H?&W=@$[<YP,XQ1;H%^
MI-)X:T&46@DT337%F,6NZT0^1SGY./EY Z4Q?"OAU8[F-= TL)=,&N%%G'B4
M@Y!88^8@G/-<U\0/$2PZ28=,U*[M[R&\MUD:WB;RV#2JK1M+M*@X;.T,&X]*
M[RA;7_KN#T=C.G\/Z+=0307&D6$T,[J\L<ELC+(RC"E@1R0  ">F*;%X;T*"
M\@O(=%TZ.ZMT$<,Z6J!XU P%5@,@ <8%1V_B?2+O5!IL-TYN'W",F"18Y2OW
M@DA78Y'.0I.,'TKAKJ[U:+P-XAE&N:B;BRUAXTG+J':,.B["0N ,-_"%_G0M
M_P"NZ7Z@]OZ[-_H=3XNT;4]9FT=;*VT^>WM;P7-PMW<,F\!67: (V!R&/7'3
M'?C4D\.:'-I\.GRZ+ISV4+;XK9K5#'&WJJXP#R>16F.@K(N_%&CV-Z+6XNF1
MS((C)Y+F)'.,*TH78K'(X8@\CUH78-]2Y<:5IUYIXT^YL+6>R "BVEA5HP!T
M&TC&!5>[\.:'?VL%K>:-IUQ;V_\ J8IK5'2+_=!&!^%9DOB2+4-<U;P[!_:%
MK<6]LK"Z2U<!68,<J[(4& !@G@G.,XJOX,\2VUWH&@6EY>RRZG=6*2[Y8WQ,
MP7+8DQM+#J5!R/2FE?7^NO\ D&W]>AKOX5\.R2W$KZ!I;27(VSLUG&3*,@X8
MX^;D \^@K!N_!HE\4Z<T6B:'_P ([;6DMNUJW&?,9')$/E%."G][G.>,<]#_
M ,)#IG]I)8&=UFD)6-V@D$4C#.564KL9N#\H;/!XXJ+3_%>AZK<1PV&H)<M(
M[QHT2LR%D +#?C;D ^OKZ&DO(&:$^G6-S:+:7%G;RVR[2L,D2L@VG(PI&.,#
M%9]YHD-M]MU+0M,TB'7I8V"74]N!O8XXD9!O(X&>>U6=4UW2]%:V74;V*W:Z
MD$4"N?FD<]@!R>OX54;Q?H,=A>7L^H+;0V3!;G[5&\+1$_=RC@-SVXY[9H#R
M+.B:?<6-H[WTL,VH7,GG74L*%$9\  *"20 JJ!D]JMWEE:ZA:O:WMM#<V\@P
M\4T8=&'N#P:SO^$HT<PRRK<NPB<1E$@D9W8IO 1 NY\KS\H/Z5$_C+P]'80W
MDNJ0Q0S3BV02AD?S3_ 4(#!O4$ CO3>H(U(-.L;6-X[>SMX4D #K'$JA@!@
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MFY![L *+]0\B0^'=$-^;XZ/I_P!L*>6;C[*GF;=NW;NQG&.,>G%2Z;I&F:-
MT&EZ=:6,+MO:.U@6)2W3)"@<\58M[B&[MHKFWE26"50\<B'*LI&00?2N9^)%
MQ>6?@:_N[&^N+.>'8PD@(!(+ $9(.!@]L'WHV=OZW#<W]1TG3=8@$&IZ?:7L
M(.1'<PK(H/KA@:FBL[6&T%I%;0QVP78(40! OIMZ8]JS$\4:4?M4?G3^;:1^
M;+%]DE\PI_?1=N9%]T!%)%XLTB?3=/U"*2[>VU"01VS+8SDN3G'R[,J."=Q
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M,]JMUG2ZQ9VDD%O/)*9GCWG9"\@5<'YG*@A!P>6(S@UHTA)WU"BBB@84444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
M!?0M<6%Q"F-\D3(N>F2"*GHI-75F-.SN>?VEGKL'_"%PR>'[K;IB[+J1+B B
M/]R8L\R D9.[C/'OQ5"?P[KFHZ%JB'04$ZZTVHPV6IO"\-Y&>"C;&< XR>>
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M#@D9'L2*X.?P_K']AZYX6-B\UOJ4T\D&I"6/9&LK%CYBDA]RDG&U6!P.1V]
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MT/-._O7\_P!4W^0)65O+]&E^9S6I^'=1\2MK%X]NVFR7.FBQ@@N2CEB'+[I
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@@_>.,<8>G]>O^0OZ_#_ #*.N>*]5T?5$0_8#"EY;VS6XB=Y94E*KYN]7(A
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M15#2>6DW!!785V)QD[,'%2:=!YW@9(&U#2XAIFIW):#4HBMFZ)(X6-@Q/E@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8&F
M:%?V7BK5=7GU&VFAODC06Z6C(T83.WYS(0>&.?E&>.G2M^BCK</(**** ,?7
M=(O]7-M%;:S-I]H&87<4,*,UPA&-N]@2GU'//;K6NB+&BHBA548 '0"EHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM0?,FAG5U##^'()^8GC'7-/L/%&A:DJBTUG3II##YYCBND<B,<%L ] >">E
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M+3:Q!*@,,X! /(SCCFO3*J:C8)J5DUL\TT()#"2%]K*0<@^AY'0@@]Q2;?\
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MQ0'20C36^E2E'D#,S ,J89MI'3)/3KQ7=R7,$4T4,DT:2RDB-&<!G(&3@=^
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MI%PK>4+A9 P41YP$4GVZ=2!7L%1PW$-RA>"6.5 2I9&##(X(X[T)VM_75/\
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MQJ&8+V YZG).:D\&:0-(T!5Q,/.=I42;[\<?2.,CMM0*,>QH7]?U^(/^OZ_
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M3@?,,5:?PWJ;>(M)U0:M;;+"U>W,3V1+2;]NX[A( /N+@8..<DYX2M_7H_\
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M:VS(I9][(LF[ 0G/!4D9.".,=:    , 4=/Z[?Y_@-[_ -?UL%%%% !1110
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M&X<TLE_XJ?Q%I.BW.JV5K+=Z9</,]G ) D\94;@S]1\P^7:.A_!V=[?UI?\
MR8)IJ_\ 6MO\SJ=?UVU\-Z-/JEZEP]O",L+>(R-^0Z#W. .YK25@Z*PZ$9KE
M_B$&7X;:X';<PLF!;&,G'7%9^K:IXBO]>ET70)[2VEM+:&<^==")Y=V[^$P2
M[H^ #M*G.>:7]?A<?;^NIW-%<;K&L7UI+I\6I:Q!HT#69EFO(-C1R7 *CRPT
MJD;3DX& Q[$8-5HM6U^]T/1_MM]]BU"^B>9H=/LPMR  I4*DOF* ,_,S;>JC
M@FA_U_7R!'3ZEKUII>I:;87"7!FU&4Q0LD)*!@"?F;H. >,Y.#@5J5YR=2NM
M7TSP!?WN/M4VI R84+R(9AT!('3MQ6_XZU34]'T2WN],N(H7-];PR>9#YA9'
MD5"!R #\V<X/3\:=OSM^7^8?Y?Y_Y&]<7GV>YM8/LUQ+]H<IYD2;EBPI;+GL
M#C'U(JS7(WUUK>D^(_#MF^K)<VE]=SI,&M561E\MW0;@<87 ' !.,Y[5EW_B
M'6H]1ECMM3CCU4Z@+6'2)($E7R"X'G[05D;"G<6#A1TQFA*]OZ[?U^(/2_\
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M@1HU=)73*-U5@I =?]ELBJ?_  A^A+965HEDT<=C_P >SQ3R))%Z@2*P;!P
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MR&66.XN99\N3DL"[$J<\Y!'//6KLNMZ3;VDUW-JEE';0/Y<LSW"!(V_NLQ.
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M[OK:W;;OQ+*J';D#/)Z9(&?<4]G<.ACR>"-$F34A,E[(=3 %[_Q,+@";\ ^
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M&,;GDD8*JCU)/ H3M_7G_P $;U.,\<):P^(_"%_+:"66+4'&^.#S) GD2$@
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M[%93)N!#8;!7!/MBJ.CV)7Q&NEZSX:\23WT-\]U'J"7LQL&^<LLF/-"*<'E
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M/5%N79+<E9U^TAA(LGW"=F!C(( Y  S7J37,"7$=NTT:SR*62,L S 8R0.I
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M&>WF2)H0A^^9" @SVY8<]J70]+U'3K&ZCU#4+:]NIYGE\^.T,(^;H&7>V<<
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M:)!O*@.IF1'9?FQ]P<@YP.:DNO!NI:CX>AM;_P 474VLV\XN+?54MHXC$X!
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M;9VG*A5S%\I5,*RX8C:01WZ\U9\6:C<"YU*]L;^[,FFW5M&66Z:"&WW%"R;
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MWW^C/',J[%: ';MV[2H+\ @] >O)3T3?;_@/]2K:V_K=K]#T*BO-="O;X0^
M;^34;R:?5(3'=^;.S)(/(:0'9G:&# ?,!GL2:JZ3JTVL^(5EG\:6-CJ$=Z\$
MND,LJS%5<CR@AN-ARN,2+%GOFJ<6GR^OX.Q-]+_U_6AZI6<VL1)X@31VMKL2
M/ 9TN/)/D-@X*[^FX=<>AKC1:R6.HWWA)[W56?4)X[BSN7U"=I%@X,@$A?<I
M3:1P1G>F<Y-=XMK%%L=<EXX_+1Y'+D#ZDY/09/4XYJ>E_P"OZN/R)ZI:KJ<.
MDV7VB89W2)#&O]YW8*HSVR2.:YKPQ>7]GJRZ5K4-R+Z>)YX[I+PSV]V 5!90
MQS$>5^4 +\QQFF_$FPBO-*TLR27*8U6T3]S=21 AIE!SL89/H3R#R,&G;5+N
M&U_(Z72KG4;F"0ZGIT=E.DA4+%<"9'7C#*V%..<8*@Y![8)OUYEXFO\ R?$3
M:%-XKM_#]O;6L4EI)?2S[IB=P+>:+B/>00 5??G@\YJ'7-7GEU>/2K_QI8Z0
M(K*":WN[A)(5NV(8-*I2XC4\@?(VX=.N:6^J_K^NP'J=%<)K%UJNG?9-5FDE
MU72[:Q5KB:QN3;21M@[I_*W;9%(YVDG&W@&NYCD66))$)*LH8$C'!IV =111
M2 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH ***9++'!"\TSK'%&I9W8X"@<DDT 4HM!T>"+RHM)L8XR7.Q+= /G^_
MQC^+OZ]ZJ_\ "'>%_(C@_P"$;T?R8W,B1_88MJL<98#;P3@<^PI(?%VAS1W;
MM>F!;2,2S&ZAD@VQG@./,4;E..&&0?6I;+Q+I&HW=O;6MTSR7,'GP$PNJ2IQ
MDJQ 5B,C(!R.X% 7+$^BZ5=79N[C3+.:Y,?E&:2!6?9_=W$9Q[4MWHVEZ@]N
M][IMG<O;'= TT"N8CZKD?+^%<AXX\1*L5C#IFIW<,\>J6T4I@B812AI0KQF4
MKM)'.55L^O%=O<W,-G;O<7$J10QC+.YP *%M?^OZU![V*RZ)I*:HVJ+IED-0
M;[UV+=/-/&.7QGIQUZ5;FABN(7AFC22*12KHZ@JP/4$'J*SK/Q%I=]#=RQW+
M1"T&;A;F)X'B&,[F60*0" 2#C!Q26/B/2]0N)[>&X=)H5+O'<020-L_O@2*"
MR_[0R/>CH'F(?"_AYIQ.="TPS+%Y(D-I'N$>W;MSC.W;QCICBH_^$/\ #/V>
M*W_X1S2/)B<R1Q_8H]J,<98#;@$X'/L*BU'Q;I]AX=O=96.[EBM8FD*"TE5W
M X! *@[2?XONXYSCFK$'B.QEM+&9A=*]V,I&;*8.,=2R%=RJ#_$P Y'/(IZ_
MU]X%P:7IXOQ?BPM1>*I47 A7S IZC=C.*LNB2##JK#K@C-"R(\0E##RRNX-V
MQZUDCQ1I)FFB$MQYD49EVFTFS*@ZM%\O[T#(^YNZBD!;L-'TS2FF;3M.M+,S
M-OE-O L?F-ZMM R?K1#I&F6^HRZA!IUI%?3#$MRD"K(X_P!I@,G\:SK#QEHF
MIFP%I<7$@OT=[=OL4RJRH<,22@"@'NV.WK38O&_AV=(I8=266"68P+<1Q.T(
MDR!M:0+L7)( R1D],T[.X&I#I.FV^H37\&GVD5[-Q+<)"JR2?[S 9/XU#=>'
M=#O8YH[O1M/G2:432K+:HPDDQC>P(Y;'&3S27WB'3--N%ANIY$).UI!!(T49
MXP)) I5,Y'WB,YJO<^+]"M);Z)[\/)8;?M201/*80>[! < 8Y/;OBD!;N-"T
MB[CM8[G2K&9+3'V=9+=&$..FP$?+CVHN="T>\OXK^ZTJQGO(@%CN);=&D0#H
M Q&1U/YU'J6LV%M;HCW<JO<QDQ&UB:9PI_Y: *K849'S$;1QFL#P1KC#P!8W
M^J7ES=S.\P+[&FEEQ(_14!+<#HHX Z8H[^7_  P=O/\ X<Z73=&TO1HWCTO3
M;.QCD.YUM8%B#'U(4#)J(>'-#75?[4&BZ<-1W;_M8M4\W=C&=^,YQ[TW_A(]
M*.F)J"W+- [&-52)VE+C.4$8&_>,'*XR,'BL/P+J%Q?WOB837]S>10ZGL@-P
M-K(AB1MNW VX+'C /KS35V_3^OU#H=+?:;;:A+:O<00R&VE$T3/&&9''0J3]
MT^X[<59FABN(7AFC22*12KHZ@JP/4$'J*Q?[8T:'7=4=];_?65JAO+=IOW5L
M@)8.1T5B#SST J6S\4Z-J%S:06MX9&O(C+;/Y3B.50,D*Y&TL!SMSG'.*6Z_
MK^N@;:_U_6I(WAK06N8KEM$TTSPQB**4VD>Y$ (V@XR!@D8'K1%X:T&#3I=.
MAT338[&9MTMLEH@C<^I4#!/ ZU:O]1MM,MQ-<LX4MM58XFD=SUPJ*"S' )P
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M YZ]2:Y"S\&ZKHOAJ;PO;VNDZSHC,_D#496B>%6.X*P$<@DVDD@_+T%1^'O
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M>&M7KW_7_+425E\OT_ST/6=!\567B"^U2Q@AN;>\TR80W,-PJ@@D9!!5F!!
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M'>JVD_V)'J7AN74O&/A;R/#=L\-I]GU5"UTS*%#.#CR\ #@%N3UIZ/?^M_\
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M"K129<,%)YSAN/?!'96'BN#5-5N+.RTZ^FA@GDMY+Q?*\I94'S*1OWCD8R5
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MR!C=U&>!US+VNOZ]U/\ /0O2]OZWM^1WVH^.]+TV?04:"\FAUP@6EQ"BE,D
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MFM92J-=&96*[=R_N^!PIY]3Z<FEW_71_K;[Q7=K_ -=/^">BV?Q T2[\*?\
M"19N8;;SC;^3+'^^\[=M\O:"06)]#CWIMYX^T^PT#5-5GL+\-I3JE]9@1&>
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!3U+2=-UFW6WU33[2^@5PZQW4*RJ&P1D!@1G!(S
M[FLO_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/
M!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA
M_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^
M)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?
M_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_
M /0J:'_X+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X
M+H?_ (FC_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC
M_A!/!_\ T*FA_P#@NA_^)KH** .?_P"$$\'_ /0J:'_X+H?_ (FC_A!/!_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUVGB;^V-%OX=.T^5X'9 LI=-BY&(V+Y.XMG& #UX.!Z)_P!=O\T"U:7]=?\
M)G9T5SEGXBMXKK1M+MM(U 6]]:B2VN,Q>4B!0=K$R;L@$<8.>V<'"7_C6PTF
MP>ZU."6Q_?O!!'<SV\9N"O4HQEV <'[S*?:F]/Z^0D[HZ2BLOP_XAT_Q-I2Z
MCILN^$NT;#<K%74X*Y4E3]02#V)J;4M433A$HMY[JYF)$-M;A=\F!DX+$* !
MW8@=.>12>@UJ7J*PD\56DNGV]Q%:WCW-Q(\,=CL59C(F=Z_,P48VGYMVWISR
M*JW'C:UM]$NM272]2E:RE\J]M$6(36QQG+AG"D8(.58C!STR: .GHK(N=?CL
MI&-Y9W-O:QVGVJ:[=HO*A7G*MARV>#T!'O61I_Q(\/ZB;]8969[.%KAD@>.Y
M9X@<%E$+OZC@X;VH ZZBL"P\66=_>:? +2\A34;8W%I-,BA)0 "R\,6# $'D
M 'L326/BZTO]0@M5LKZ*.YC>6TN9$4QW"IC=M"L6!&>C*I/:AZ:!?J=!17+V
MWCK3KNWM+J.TU 6=S=FS^T20B-8I=^P*ZL0XRW'"G!ZXJ.S\8R-J.OI?Z7<V
MMGIDRQ+.SQ%7)5"!P^=S;QCC&,9(.11;^ON_S0?U_7W'6456L;M[RW$DEI/:
MN0"8YMI(R,]49E/X$U'JFIQ:5:">6.65GD6*.*(#=(['"J,D $GN2!ZFC8"[
M17,R>-].M]&FU&ZM-0@\BZ%G-;F#?)%*<8#;"RX^9?FW8Y'.:MQ>*++[7J5M
M=Q3V+V$*W$AN0H#0G.)%VD\?*W!PPQR* _K]#;HKS^2]>^^*7A^<V6H68>SN
M@$N7&V11LVNJ*[!?O-U ;U'2N_9@BEF. !DT;*[#K86BN?TOQ;::IJ$-HMG>
M6XN;<W5I-,J;+F(8RR[6)&-R\.%//2HXO&NGR36P:TU!+>\D\NRN1;F5+H\Y
MVB,LR@ $Y=5&!GI3L]@V.DHKF[7QMIUW)=[+:_6WL[B2WN;B6W*)"43>2V3N
M"XZ''7ZC-?2_B-X=U6]N;6*\C1H(7N-_VB&56B7&Y\QNVW&1PVT^W!I =917
M*:3\1/#VKW]Q:07<8>&%[C<+B&57B7&Y@8W;;U'#;3[<&MS2]3_M.W686=S;
MHPW)YVP[USP049ASUP>?4"@"_16+XMUFX\/^%[[4[:T>ZE@C)5%91C_:.XC@
M=?6L"[N94\=Z+J!T_4%N)]*NMUD959LJ\6!@.8E/)YW#J,FA:_UY7#^OR_S.
MYHKGH_%]G<:597MG9WMS+>.\<5G&J++O3.]3N8("NUL_-VXS5+4?&CC2M'OM
M+TJ\NTU"\%NR QH\1!(92'<#=E6'7'!.>F0+G744BDLBL5*DC)4XR/;BN ^)
M6KQW7@OQ!:6UO?2"V@82W=N^R.&4 ,%8APS=1D ,O][%'D-:GH%%<];>(T2[
MGTH:=>O<VEBETNWRMLZ'CY"7ZY!'S;>GIS5:'Q]IMQ'I7D66I2S:I:O=VT*V
MXR5522N[.W=[!CU'8YIO3^O7_)B6JO\ UT_S1U5%<I;>(]$74];O%LM1BO+2
MTADO2]M)N9,.4"IU)'S9*C'N<<7+#Q99ZA>:? MI>0KJ-L;BTFF10DH !9>&
M+!@"#R #V)HM_7W_ .0K_P!?=_F;]%<W_P )KIZRQ&2TU 6L\QM[:[2W,J7$
M@)!55C+.,;6Y90."0:Z2EYC"BO-?$6M76O\ A7Q=!=:9>V<>G2LD,HG10Q54
M.#Y;[B3N)P1MP0#SQ786OB.UDU*YT^>"YM);>W%SNN%4+)#TWK@D@ C!# $>
ME'2_];7%?6W];V-JBN6T7X@Z!KVM?V597*/.Z&2%EGAD$JC&2!&[,N,]'"GV
MX-;^IW;V&F75W';/<O#$T@AC90SX&< L0!^)H>BNQK5V1:HKD+?QW:VOA#3M
M8UN$V,UY&ICAGG@C,S;0Q*LT@0 ]MS*?4 T^V^(>AWL.F26HNISJ,[V\2PQA
MP)4!+*SJ2F>.,,0>HR.:;5FUV$FFKG645R\7CBVN)+JWAT?6&O+6V2YEM7MA
M$X5L\ NRJ2,'H<<$ D\59M/%UA>W.EQQ070M]4B\RSNG11'*=NXIC=O#;03R
MH''6BS_K^O)C>AOT45SS>,;%)HF:UO!I\LWD)J6U/(,F[9M^]O&6& Q7:?6E
MY =#17!ZA,OB#Q_<Z!JF@7-WI\-G&Z,YAV1,SN/.'[S</N@ @;Q@\#.3V[DV
M]JQCB>4QI\L:L-S8' RQ S]3^-'2X6UL2T5YO)K,^OZ7X8UJ\T^]LY?[64+'
MYH*R*=_18W(;& ,L <@D8S6SJWBK1;CPSK3ZMI^H+;V;FVOK3RMT@R PYC8C
M:5(.[=@9Y(H7]?A_F']?G_D=?165+K<,.HII\-M<7$PA$T@AV?N8SG:6#,"<
ME2,*&-:M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%4Y=4LH=5M],DN%6]N(WEBA.<LJXW'\-PJY
M0 4444 %%%% #9"XC8QJK. =H9L GMDX./R-<UX1TO6M(TR_M]0AT])9;J>Z
MA-O<O*N9'9]K9C3&,@9&<^U=/11W @L_M7V*#[=Y/VORU\[R,^7OQSMSSC/3
M-3T4A900"0">@SUH8"T444 %<IXTUZVT^&"R74]!M[QI(IS%JFIBU/EJX;(&
MUB<E".@'7KC%=710!YSK^H>$-8OM.U:W\8:%9:I;21^:\>I1%9H0X9XFY^8<
M9!QD$=LFB7Q'HNG^(K_4M(\5>%IH=26,7,-UJR1F)T&W>A7=N^7'RG;T^\*[
M'7]?L_#EBEY?+<-$\R0CR8B_S,<#..%&>,D@5JT=/ZZ@>3:=?:'H>M:&UAXG
M\*S:?INGRVK/-K2)+(\C*Q;:%8 ;D_O=&]N8K"U\"ZKX9BTKQCK/A>Y-O>3W
M,(M==RH\QV?DCRSD;B._3/? ]5O[Z'3K;SILG<ZQHBXW2.QPJC.!DD]^*CTO
M4&U*T,SV-Y9.KE&@NT"N"/\ =)5A[J2/>G>_]>=P.-_X2G0M)A%OHWB7PK/I
M\=O';P6-UJRQA N03YGSDC&!@J>G7FLA)/"UGHUDMAXP\,PW]EJ+ZC!&+^,6
MZL^X-$ &R$VN1G'!YQVKU:BB[O?J'D>4ZKJ>BZGI^OW1\3^%$U?5K%; 0_VT
MI@A0;N=^W+'YR?N#H![U.GB'37\2:!?R^(O"*V]C8R6UP%UU6;<^S)0; "!L
M'4C.>V.?3Z*+_P!?>OU8?U^7^2/*_#>O+H%VFF'Q[X.G\.0%C S7:_;-F21&
M3OV #INP21V':LFI:=+H>KVL_BCPA%<W&JKJ5OLUI70XD5]CDHI7[F,@-UZ<
M<^ND@#)X%("& (((/((H3L[_ -='^@?U^?\ FSROQ-J>D>(5U*VF\7>%)K2Z
ML/*@6755"VTV#\VP9#Y)'S$@KC@5HQ>)-&@U^WU-?%?A5Q_9PM9D.J(NUU;<
M-O7(.2"3C'7!Z5Z)12_K\_\ ,/Z_+_(\AT^\TJ+P_91S>+?"<.JZ;J4M_:F/
M5UEBD#LY*.2%(XD9<@'H#[4[7+_2-7L-8NAXF\))JVIV\-H8CK:^3#&C,V=^
MW+,2Q_A';\?7*@O+R&QMFGG8J@(  &2Q)P% '))/ %._]?=_D@_K\_\ -G V
M'B"RN_'MO?KKOA5DFL5L5B@UH2RF4MN 5-@W?,=HY!/7KQ7>V'VW[!!_:/D?
M;-@\[[/GR]W?;NYQ]:HZAXDTW2E1M0>: %0TA\AW6#/_ #T= 5C'NQ ]ZMC4
M(/MR6A+*\B;XF(^24=]K="1Z=<<]*/Z_46W]?(MUROB73->O=?T6]TRUTV6#
M3I7F/VF]>)I&:-DVX6)P -P.<^V.]=512ZW'Y'/%O%CVUXZV&BVUR4 @1;V2
M17<G!9W\E2, < *<]R*H6'AS5-,U6ZM;:.T/AZ^B)N8Y+MS,DS AW0>7C#=Q
MN&3D\=#V%% '&:!H?B^UBDT?6M2TNZT2. P0RPQ2"[E7;M&\D[!@>@.?:I?"
MNE>,-(=-.U74=)N='M(Q';210R"ZE4#"^9D[%P,= <^U==13OU8K(X)?"&O1
MZ18Z;#<:;&NGZJ;R"=]\AD3>[X9 %P1NQ@,0>N1TJ_+H&LQ6?BBVMOL$JZH[
MR6YDE>,@O&J$/A&QC:2,9SG''6NNHJ6KIKO_ ,#_ "0UHT^W_!?ZG(W?AO5;
MWP7IEBEQ;V.M:?Y+03Q.TD:.GRDY*J2&3<",?Q8]ZD\0^'M7DBTN[\-WUM!J
M>FJT<8O59HIXV #*^WD9*J<CG(KJJK7]Y]AMO.^S7%Q\Z)LMTWM\S!<X]!G)
M/8 U3;;OYW"*LDET5B'1TU5=-B_MJ6TDOSS+]C1EB4^B[B21[GK[=*R/%>B:
MQ?3Z?JGAZ]M;?5; N$2\1F@F1P R/M^8=%.1Z5TU([!$9R"0HR< D_D.M)]P
M1REQHGB"X&D:M/<Z=)KU@TA:.-7BMI$=<-&"=S#HIW$'D=.U7=+\/E)-8N]2
M2(W.KE?M,,3EXT58P@0,0"W&><#.>@JYH&O6GB/2QJ-BLRP&1XP)XRC91BIR
MIY'(/7FM&1_+B=]K-M4G:HR3[#WH?6_]7!?U\CD['PC>?\(5=Z'J.J/-=3*T
M4=VN2T:+Q%UZD *3ZG-,L[+QS+HNI6NM7&A7,SPM#:_9A+%YF1C?*Q#8..<*
MOXUU5G<_;+*"Y\F:#S8U?RITVR)D9PP[$=Q4]$E>Z?4$[6:.%M/#WB2&;PH6
MATI5TBV:"=EO)&)+($W(/)&< !L$CDX[9*Z=X6URWU/2-3N_[.FO[19H[FX:
M>1WN X&&!*?)R/N#Y5SP3C%=S13;;=_ZU$DDK?UH><KX5\4+X9AT[[/H_P!H
MCUG^T2?M\NPIY_G;<^1G.3MZ>_M700:!>)?Z_P#:8;"YL-5D24Q2EFS^[6-T
M8;<8PF0>>O08YZ:LK7]?L_#EBEY?+<-$\R0CR8B_S,<#..%&>,D@47Z?UT7Z
M(?G_ %U?^93\*:#<:#!=Q.5AMI) T%E'<O<1VZ@8PKN <'@[0 %Z"K/B.SU.
M]L(H]+EB5UG1Y8I)6B$T8^\GF*"R9X.0#TQWJ_'>>9J$]I]FN%\E$?SF3$;[
ML\*W<C'/ID59I/7<%H>>7?@S6X]#UC3=.ATA4O=2CO(D,TD2HH\MF!Q&W.Z,
M]N=V<YXJSJGA36-<UG69+I;"VL]1TR.S62*Y>22-T+.&V&-01N;'WN@SWP.Y
M5E=0RD%3R"#UK,U;7K31KG3X+F.X9[^X%O"8H2RAC_>;HOXG)P<9HO\ U\K?
MH&W]>=S#70O$5YXHT36;Z73(/[/BGAFCA,DOFA]OS+D+M)V]#G'^UGCK)UD>
MWD6&01RE2$<C.TXX..]244/56!::G#:9X9U2PUC3-:U!M.$UK9S07]P9Y)'F
M#%&#[F48'R'Y>BYXS7.Z$_B./5]+FO/!]P^D03$V<L6KV[PP;\KYD<6U9",,
M<*S' Z 8Q7J=[>06%G)<W+A8D')ZYR< #U)) Q[UD>'[32OM%W=VOA@:->^8
M4F:2TBCDDSSNWQDAP<]0QYSG!IIZW![6,K3/"NHR6'BFRU<6L,6M7$DJ-:7#
MR-&'14YW(O(VY_&BPT/Q=J&D:AH_BK4M*ELY;=K>*:PBD69\C =RQV@]\*.O
M?UZ#4M>M-+U+3;"X2X,VHRF*%DA)0, 3\S=!P#QG)P<"C2=>M-9NM1M[9+A7
MT^?R)O.A,?S8!X!Y(P1SCG/&:6Z_KIH/K?\ K7_AC*\/6?C2&.>W\17NBW4,
M<9C@:VAD#S'& TNXX'N%'X^KO#?AE]"U2]EMX8;#3I5"QV%M<O+%NSGS K*H
MC/;:HP>I-=/13OK<FVEC*\3:5+K?AK4=,@D2.:YA9$>3.T-VSCM63-IOB&7Q
M9I>JFVTLP6ME-!(OVN0-OD*'@>400-@&<C.2<#&#T5[>?8HHW^S7$^^5(ML"
M;BNXXW'T49R3V%6:2T_KRM^H_P"OZ^XX'2?#/B6TTRQL[D::T$=Y<2W-M'>R
MA)DE<N#N\H$E2Q&PC#=21TJ>S\):K8^'--L(CIWFZ=J9NXHU+)&T7F.0N=IV
MG:_0 C(QGO7;T4[_ ->@?U]]_P#,1=VT;B"V.2!@9KA-4\(:U/I'B+0[*>P&
MGZL\LT<\K.)87D(+*5"D,N<D-D$9Q@]:[PD 9/ K,;7;-?$,.B;9S=36[7*/
MY1\HHI .'Z$_,.!GKS2Z_P!>OZ#V_K^NYD+H.L6^O6^HI+8SF335L;HMOCV,
MI+!T7#;@22-I8?6L;1O"'B/3+SPIY[Z5<0:-!+#(Z2R1LPD 7A2C [0,YR,D
M]%KT.BG?6_\ 77_-BZ6_KI_DCC+G0_$#:]XCO8;?3&@U&QCM;??>2*P*;QEP
M(B #YAZ$XVCKGB&ST#Q!:S^$Y)H-*$6C6S0W+"]DR<H$RH,(S@*&Y(Y..V3W
M-(K*ZAE(93T(Y!I?U^?^;!J_]>G^2/)--E\0C5[.YD\)3W.@PW;3VLEOK%N8
M$WLV)DC*B0\.<*6QSP <5ZY6?:Z#H]E?R7UII-C;WDGW[B*V1)'^K 9-:%'1
M(.MSA]6\,:]-I?B:QL?[-D35KCS8FGG>,H&1%8-A&Z;.,==W;',UQX>U?4_$
MDUS?VUA'I]SI)T^817CM(I;YB5!B (R<=1QS[5V55K6\^U2W2?9KB'[/+Y6Z
M9-HDX!W)ZKSC/J#1Y?UM8-G?^M[_ )HY[PM8^,["7[+K^HZ1=:?;H$@EMH9%
MN)L< R9.U>.R@Y/?UZ2[@-S9SP!MIEC9,XZ9&*FHHE[RLP6CNCA9O"_B:'0=
M"?3+W3;?7-(B\A1*'>WGB*A2KG 89VJW XQCGK4M]HOBK49O#=S>'1YKG3[L
MW5T8I)(4SL9 D:E7)'S9W,1TZ<\=7=7JVRV[+!/<+/*L8,";PF?XF]%'<U:I
M\S;OYW%:RMY6.1FTC7_^$NU;5(;;36MKG3UM( ][(KEE+L"P$1 !+D<$XQWS
M@9MAX8\26EGX-@:#26.AY$Y%[)\X\LQY7]SZ-NYQR,>]>@44)V_KU_S8WKO_
M %M_D(0""#T-<1'X/U+^Q!X7F>T?0TF62.Y$KBX\M91((RFW';&_?T_AKN**
M2T=P\CE[?3-<B\?W6KM;:=_9T]K':@B\?SE",[!MGE8R2^,;N,9R>E=0>1BL
MFUU^.\U);:&QO7MWWA+Y45H&9"0RY#%E.0>64 XX)K6HZ)!?4X-/#?B2VTK0
MK"&/294TV^\]G>ZD0NBEMN (S\Q#\CH-O4YXAU+PMXEO;+Q?;)!I*_VW(I@9
MKV3Y%"+'\P\GKA<X&>N,\9/7ZCKMIIEU86\RSN]]/]GB:*(L@?\ VFZ+T/4Y
M.#C.*MW]W]@L)KK[//<>4A;R;=-\C^RCN:%Y?UM_DAWU_KS_ ,V<QX@\,W>N
M6MI)]BL8=4BC")>Q7DJ26C8Y*,J R ''RG:#SG%=;&K)$BNY=@H!8C&X^M*#
ME0<$9[&EIDH****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HZ456O[&#4K&:RN?,,$R[7$<K1L1Z;E((_ T/R
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M[FK-[9PZA936EQYGDS*4?RY6C;!]&4@C\#2G=K3M^B''1W??]3B+;7==N8/
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MU+5]/\*>%=*LK_S;S5+4,ES>SQP%,1J1&C"%U+<\!D8D Y.:]'=%DC9'4,C
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MC@9.!T&3@#)IL_@70+A-226&]9-28/=K_:-QB4CU_><#&!@8& !T&*:?]?\
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M,EQL$,86.0J#@D[1@=R?K6+YLMYXW\,ZA9:#J,5E;6ES;SL]H8?()"84AL9
MP<;<Y_ASS6(L6HR^%'N(-)UF:.UUVXN[BRC2>RN)H':0JT9^1B1N5L \XP>:
M>R_K^;_+\ W_  _)_P!>IZ>NLZ6^EG5%U*S;3PNXW8G4Q >N_.,?C3IM5TZV
MM4NI[^UBMY&")+),JHS'H 2<$GM7%6&EV=[X7EN+&Q\2: \UV+H27>^XNO-5
M<;VC=I"00 ,'D^@X-.=-7O="M=0N[J[T_4K265X+FTTN1UG0X&9+7!<;L\KP
MPP>1G%#$M3O5974,C!E/0@Y!JG#K&F7&H2Z?!J-I+>PC,MLDZM(@_P!I0<C\
M:JZ;_:5WX7C%U%'9:C);E2L8PJ/@@$#MV..W2N/LK*[OM(\,Z4-.N[35]'N8
M6N9Y+9A&BJ")&64C:X<9'RDGYN0.<%M;?U_2%?2_]?TS4M_$D7B/Q->:=I/B
M:UMI=/F11;Q-#-]J7:&DW*?FP,[<J1@@YSTK8O?%&E6WB"+P^VHVL.ISPM)&
MDL@R#D!1MR"2<D@#DA36/X4N]_BWQ0&M-0B6YNTEADGL)HD=5B1"0[H%^\#Q
MG)QD9'-6]1,MIX\L;YK2ZEM3IL\)D@@:0*^]&P=H.. 2/7&!DX%+HK]OT8Y:
M-V_K87PEX@^VZ3:1:KJ5H^K323@1@K&THCE9<K'G.  /7W-;;ZMIL>I)ILFH
M6JW[KN2U:91*P]0F<D?A7F=M*T?AOP__ ,2G5DGBUY[F9?[*N-Z)YCDL1LSC
M:Z\]^1V.)+6Q8>)YM+UKPUXDO+AM0:[M[^"\F%B5\S?&[CS0B%> 5VD_+T.:
M>[_KLO\ ,6R_KN_\E]YZ?/<P6L?F7$T<*9"[I&"C)Z#)JI-KVCVUE]MGU:PB
MM-YC\][E%CW@X*[B<9SQBN:^)MJMWH%E&NGSWDZZC;21B&T>=HPLBEV^53M^
M7=SQGIWQ6;XO@;3]=M=2&@ZYJ&D3VS(T6ARRP30RL^XLT<;H6#Y&=W0K[TO\
M_P"O\BCNK[6-,TNU6ZU#4;2TMW("RW$ZQHQ/3!) I]QJ=A:+ US?6T*W#!83
M)*J^:2,@+D\G'I7%R67V0Z+96.CWVGP'3YH8IC&]U) &*GR6Y9$)P#N?<HVX
M!YJC8V&H6O@WP]=6\NI:;JMA8K;>4^G/<1RYV@I)&HW 94?,"N.IR*;_ *_$
M1Z!?ZMINE6ZW&HZA:6<#D!9+B98U)/0 L0*DEOK2!8VFNH(UD!*%Y -P R2,
M]> 3]*Y!9;_3_$5OJFL:7<&TN]*BMS%:6[7(M)@270J@)VMD?,!CY.2.*P;+
M1WTC5_"2W>F7+O!=7;AH["246L$A?R8V=5(4 E>,_+]!FBVMOZZ_Y7]&)O2_
M]=/^&/3K.]M=1M8[JRN8;FVD&4F@D#HP]B.#7(Z]XVM9='\1Q>']7L1JVD0N
M[*V)3\BAFPFX' SMW<@'L<8J?P)*S+KBM:WMN&U2::,7-I+!N1R""N]1G.#T
M_'K6+KJW5MIWC^V.FZC+)?#=;>1:22B4-;I&-I4'/S*01VZG YI?Y?Y?\$N%
MKZ]_U.ZT_5+.]+6\5[;S7<*(;B*.52\9(R-RCE<^].AU?3;F]GLH-1M);NWY
MF@CF5GB_WE!R/QKBMSS^,M,^Q6FH6Z/H4MNLYTZ9(XY&*,@8E %(VL<'&.G4
MBLKPQ:VK.EOK'A'Q+%>Z;;.DTUW<3W-FP*%7$2M(PDW#^%4/7%.77Y_F_P#)
M?>1'9?+\D>E1:MIL[.L.H6DA1/,8),IVIDC<<'@9!&?8U3N?%&BPZ!<:U'JE
MA-8PJ?WZ7*&,L.B[\XR3QCU-<!IFCWA^$>GQVVCW?]H6;IY]ILDL[B6)9=[1
MH_RL.,$8.,C%:%BUDW@[Q!J%IX=\36,UY;F%DU,3W%S.^TJN$+R. -V,X'Y#
M-3/12MT_K^O,J.K5^_Z_T_0VO#^NP3Z7_P )#=>*K.?39H4,J.T*QVDI +*)
M%Q@#.-KY/OVKHQJ5BUE'>+>VQM9<>7.)5V/GIALX.:X>VFNH8_">K&QU&33[
M&S>VNK?[#*)H92B 2>45#L!M9<JI^]QQFL?7M%D&AWDHTJYEAN]?M[RPMH["
M21X(P8_,<J%)CW8D)!QU]3BM))<UNE_UM^6J\B(WY4WO;]/\U;YGJEM=VU[#
MYUK<13Q;BN^)PPR#@C([@C%9FL>*-'T*_L++4;^VMIKYRL0FE5. "<G/;( ^
MI J5-0M;/4[73H;"YC%ZCSK-';%80W4AS_"YR3@C)P:SO$B3IKOAN\2UN)X8
M+N3S3!&7*;H7520.@R0,]!GG J>J&WH[$>@>('%SJ=KKFJV0G75'M;0$+!Y@
MV(P15+$L?F/<D_I6[>ZMINFR01WVH6MJ\[;(5GF5#(WHH)Y/L*\TU*1KCPYX
MN$6DZL;BYU6.2 ?V5<;Y%'EX8?)D@;'Y[<>HS-XBC8^)KI]3\.^)M7TS588A
M;MI<\\00;<-%-$)(PHSDY<?Q$'I26MOE^2'WOY_G8]#UB2\BTBYEL)8(KF.,
MNC3PF5..2"H92<CW_.N:T74?%>HZ-H^JRZCHFV_2&4VJZ=*C88!F57,Y&0N[
M!*]NE;NI/'I_A>8>1<;4MO+6*&.2XD!*[0,*&9OKSZFN'\(0>'-+T?0FC\+7
MMOKT$$:/)'H$\+F4IL;?,8@,9)R2V.]-;OY?K_P!/9?/]#N)/%/AZ$W0DU[2
MT-H0MR&O(QY))QA^?EYXY[U8N]9TNPMH;F\U*SM[><@12S3JBR$]-I)P<^U<
M3XC5O[8N]>L=+O9/[/>.&\L_L4Q_M,9X*@+A]F<JV",@Y(&#5;Q/-*VO0:M<
M:#XFU+2+ZR2&./2Y+BWFMW#,666)7C.&##ENFWWI+9?U_5^GXCZ_U_6AZ#?:
MMINF0QS:AJ%K:12L%C>XF6,.3T )/)IK:UI27,]L^IV:SV\7GS1&=0T<?7>P
MSD+[GBN%N9+KPMJ=LP\*:IJ&AW.F16,-M:*+B:T*ELHX+?=967+;B,KU/%:4
M=N^F>+=&N4TJ\AL3I#V<<<<;2F%]Z,J.5R%^4?>)VY'6F_+S_7_+\17_ *^X
MU]0\:>'=-CTZ6?6+$0ZC(4MY?M">6X )+;LXVC&,^I [U8DU6STV>_NM1UZR
MCM%,8"3/'&+;(Q\S$\[CR,_A7$Z3;:E;>'/"37.CZA$;#5',R&'<X1DE"OM4
MDA<R*.0,<DX'-:FA65I/XL\86CZ5<06E_P"7N+V,D44QV%9"'*A6.3U!.>HS
MUI-=O/\ 3_,;Z7_K5K]$=4FN:1)+9Q)JEBTEZI>U5;A"9U')*#/S#W&:?!JV
MFW5]/8V^H6DUW;_ZZ".96DC_ -Y0<C\:Y[PW#KD^DW=MJ<9M[FR5[&UG(_UP
M' FQ[C9^*GUKG_!%JC:I96]]X7\26FJZ9&5:[O+V:2S!*[6,1>4A@WH%X]L4
M]+V_K^NXG=+^OZ]#T6[O[/3UC:]NX+99'$:&:0(&8]%&3R3Z5@7>N3:?XS$5
MYJ5I#HITQ[G+J$",KHNYI"<$8;V'UH\6VLQ>UU&SOKVSO;57$;P637<;ABH*
M/&H)() Y&",'FL>VO9SXNTJXU/1[R"6'19%F\BPFDABE)1MBNJD9VJW )_N\
MGBDN_K^3&]M/+\T=G<ZMIMEIXU"ZU"T@LF (N99E6,@]#N)QS6)XCUB\@;P_
M<Z5?6YLKS4(H)BL8D\V-^05?. ./0YSP17,:!)<P^'/#$+:5J$$D,T\;7$FG
MSE[4G.T>60.&5L;R"BXYJ"!+JP\+>'+.?3=6,MKKC2R8T^1V$:RR$N1&A !#
M*1P <\=.&EK\U^8FW;Y/]?\ ([+0M0U*X\4^(K"]N8IH+1X?LRQP[-BNI;!Y
M))Z<Y[=!6Q>:KIVGK(U[?VMLL:[W,TRH%7.,G)X&>]<YX?F9O'?B<FUO8XY?
M(\N6:SECCDV)M;:[*%/)['GJ,BJ,WV:U^)>JWATN\VMI*H]Q%IDSK)(I8D!U
M0AFV%1P3GIU&*F^B]/\ ,I+5^O\ D=C=ZKIVGV(O;V_M;:T.#Y\TRI'ST^8G
M'-4-9\5:-H6GVM]>ZA;1V]U*D4,C3*%?<1R&SC ')/H*XGPS]NTS3_"FHWFG
M:DUE:::]E<0?893+;3$IA_*V[V!"E<JIQ]":M/I%[9>'Y9DL[@VK>(([Z"TB
MA)>&W\U23L'/4,^T#(W=,\5;6MOZWM^6I+>G]=G_ )'H!N[9;/[6UQ$+;9YG
MG%QLVXSNW=,8[TV+4+*>R^V0W=O):[=WGI("FW&<[@<8JCKUDFK:%);R27EO
MO*.LENN98F#!E;&"#@@$C!Z5R4@\0W^A1S3V[WB6>J0SL19M;2W]NH&287Y#
M*<<'&[8,#I4CZ'2ZKK27?A'4=3\.ZI8S/# [QW$9%Q'E1DCY6 )XQUX]^E+8
M7=Q=:?X>N)M4C@EGB626)D3-V3%DJ.F,'YOE';TKFM0BDN9O$FN6=I?)8W>D
M"V$)L95FGN,N WE%=_ (&2O?T&:KL(S>?#ZZ_LJ_\^V4QSR_V9-NA7R6CVN=
MF5&\C@X]>G-.._W?^W?Y+[Q/_/\ 0[[^UM._M/\ LS^T+7^T-F_[+YR^;M]=
MF<X]\5EWVOV?A_3=6U/4]9@FMH)N%&Q3!\JXAX/+$\\\_-Z5S6AW-W'J$7A[
M6?">I375M?27<6IQQK]E;+L5E,FX$-AL%<$^V*I16+R>&O'UCI^D7D)GNY)K
M:'[!) )5,:#*;E 8EE;I]>XR+^OO7^;^X;_K\?\ )?>>EV=[;:A9Q7=G<0W%
MO*-R2PN'1A[$<&H+UV6_T]5U*.V!D;= RJ3<C8?E&3D8^]QZ5!;ZW'+J%K8_
M8K^,SVYF2:2V98^#C82?NOCG:0#BL#Q8D2^-/"EV-.N9I(+B7S;B"QDE\N-H
MG4!G13@%BO!/OT&:.J_KN)?#\CIVUC2TN(K=M2LUFFD,<49G4,[CDJ!G)(]!
M5#Q5K2:1HET8=2LK343!(]JMR03(RJ6P$W MP.U>=B-;?P5J-O::)J<+MX@6
M>*&/2+A6\H7"R!@HCS@(I/MTZD"M[4?MD<WBR"?3+ZZDU2WW:?*EJSHT8A $
M3$#]V0^XX;&=W&3Q42OR-K?_ ("?Z_@:12YE?O\ K8Z'P_XDLKO0K)KW5;/^
MT!I\5W=HTR*Z*4!+LN?E7GK@"M3^V=+&EC5/[2L_[.*[A=^>OE8]=^<8_&N(
MT*&_T[4_#5S>:5?Q*-#-@RB'S#',K(</LR%!"D@D@>I!XK-T]]=T/P[X<U!_
M#>HW,.G2W*75DD:M<8<DI-&F<G&2,'!^8\5I.W,[?UJU_E]YE"_*K_UHG^=S
MTI]5TZ+31J4FH6J6!4.+IIE$6T]#OSC'OFI[:Y@O+:.XM9XYX)%W)+$X96'J
M"."*\WUJ*8:5I&K6?A?78],2XGEN=,M)W@O%,G/F@12 YSN^3=T?) [=!X?O
M+'1M(T]+?0=;LH-2NFQ'=!YI(6;G?,2[E Q]2>2,XR:5MRGT.GN[RVL+62ZO
M+F&VMXQEY9G"(H]23P*HW=_;WNAF[L-:M;>&0 QWZLDD8&><$G:<\CKWJCXM
MDEBBTQXK&6<+>J6GCA>8VORM^\\M/F;KM[@;LG@5Q.I:=*G@+6[.YTK4+JZ&
ML--;$Z<TCL3(&$BB-./EW?, !VSFDOZ^]?Y@_P"ON?\ D>A:_JL6FZ9*!J5G
M9WLL;"U-R00\@!( 4L"Q]@:B\'ZC<ZOX-T?4;QP]S=6D<LK!0 6903P.E8$\
MMQ'K6N/<:;?746J6<8L)%M'90HC.8GXS&=Q)^< '=ZC%:/@RTOXOAMIEC/;S
MZ??Q6(@VS ;D<+M#8!/&>?7U HVBWZ?J&[2_KH;D.L:9<ZA+I\&HVDM[",RV
MR3JTB#_:4'(_&G)JFGRW0MH[ZV>X)8")9E+DKC=QG/&1GTR*X*TLKN]T?PUI
M?]G7=IJ^CW,+7,TEJXC55!\TK*1MD#C(PI).[D#G%[X<V-O#;:J/[)EM-NJW
M$UJ)[![?;$Y^4IO48! / Z=Z=M;?UT%?3^O/_+\3L;C4;&SGA@N;RW@FG)$4
M<LJJTF.3M!/./:J[^(-%C2\>35[!4LF"W3-<H! 3P _/RGZXKGO%EO?6NH?V
MII$]W]N: 0&S:Q:YMKL98A&*C]V>2-Y( W#.:I:C#>Q:OXK#Z==L^IZ5&+<P
MPM(C.L<@9=X& 06'!P3VS4MZ7]2DM4O0[*ZU?3+&SCO+O4;2WM9,;)IIU1&S
MTPQ.#GM4MU?6EC9M=WEU!;VR#<TTT@1%'J6/%>9:QXCM?"-CX6U+58S97::=
M):"VU!7$><1@Y:%)=K?+D<'(SG%5(=5\*Z#X#T+6M/U"TEMK;47E::*U>.&2
M9D<$2A$+K@, &*D\+P:II)OR?Z_U]Y,6VE?JOT/6H[NVEM%NX[B)[9DWB97!
M0KUSNZ8]ZK0:YI-SIKZE;ZI92V$8)>ZCN$:)<=<N#@8^M>7::VG:_P"#]7U'
MPRUMJ5]-J27E_;:<7MI&0,&\I9"L<AP 2K'&3GITK;TG3;#6-"OKJVTOQ3H4
ML\L3-/J#R37)>,Y5@DCR$J.G(Y].AI6W_K^O^ -,ZK5_%FB:)I]M?7FI6J6]
MS,D44AF4*Q8CG.<8 .2?05L12QS1)+$ZR1NH9'0Y# ]"#W%<#</K5YX7@GO[
M22XDM]7MYA+!9/%)/"KH3*8#EU(Y!7K\N<5WZ-O16*LN1G:W4?6G;3^NR%?7
M^NXZBBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH ***IZK/<VNDW=Q9QQ27,43/&DKE4) SR0"0/PI-V5QI7=BY
M6=JFDG4FADBU"]L9X<[);5DR,XSE75D/3J5)&3C&:Y_1O$VJ2Z%HD,]G:S:W
MJ%I]HCB%VPC:-54F1W\O*Y+ 8"MR>IY-:%CXDN=1TV]:WTHMJMC<"WN;$W"@
M*WRDD2$8*[6W X&>F :IQ:=NW_#$IW5^YL6=H;6,"2XEN9MH5YY@H=\=,[0%
M'4] !S4RRQO(\:NK.F-R@Y*YZ9':L[Q)JIT/PUJ6J!=S6MN\JKZL!P/SQ51I
M)] T6SAM+3[9=3'$DLKF./?M+-)+(%8J"1UP>2!2\QFZ98Q*L1=1(P+*A/)
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M?]?+_-#2N[?UV.THKD6\4ZI9W>D:5-HB2:A?VTLJ-'>@P[D7.W>5#9/RY)0
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M^M[?J"U_KU?Z,[JBL^^U1-(T*74]358A;P^9,L+&0 @<A20"W/ X&?05E?\
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M.XMM,^US7@E612@/S(K8#%0<_>"\CISFK5IKM^]R#?Z1]EL9;<W$5TD_F!5
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M( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-@'9BQ E/S*F23M&/K20^"KF*>TE.KHS6NHO>K)]D'FR!E=2LC%CN(#D!L#
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M:ZW:;)=66RYS"9(=C K)QD8(['BJUMX?TBPBN4L-)T^U%R")A%:HHES_ 'P
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M$0^'][K#WL5W=/()A!>30!L02$, C *3P<C!P<9QQ7H]]I&F:F\+ZAIUI=M
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MVD:8VIC4VTZT.H!=@NC OFA?3?C./QJ[2Z6_K;^F-[W_ *_KH%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3
M7=8T9W8*B@EF8X 'J:=6;XATV36?#NHZ9#/Y$MU;/"DO]TLI -)[#6KU&67B
M32M0N);>"Y8211^:1-"\0:/^^I< .G^TN1[TMKXATR\NY;6.>2.:)#(5G@DA
MW(.KJ74!U&1\RY'(YKF+>U\4^(]&U#3==T"QTF<V4EI'J$=VLYE+#&54+E4)
M )!.>,8JMX7T?5;:&],O@#P[HM_%;/%%=V[1$73XP/E1 50G!.XY]O1O2_\
M7?\ X&FXEK;^NW]7.ML/$^D:G<2P6URXDCC\XB:"2(-'_?0NH#I_M+D=.:LV
MFL6-[;O/')(D2*69IX7A^4?Q?.!E>.O0]JX[3-$U0ZU:7EWI%P89-(EL[F*Y
MN8MJ-N0A%2-BBJ0& VCIC..*%\+:O+I.MZ+;S7L.ES6QBM(M4ECG*R9S\K*6
M8Q$<$.2?0 4WI_7G_D)79UUAKMAJ5U+:V\DJW$0RT4]O)"Q7.-RAU&Y<_P 0
MR/>G:GJMGIJ*EQ-*LDV1&D$+32'U8(JL<#(R<8'>N8\$:9=6UQ/->^!=%\.S
M(OE>?8O$S7'(R0$4;5XS@DGVK1U"UU.S\8PZQ:V+W]K+9_8Y(HY41X#OW!P'
M(!4YP<'/ P#2:V0T]S,\$:^(_!:WFK:C<7<AO;J&.5E,LLVV5PH5$&6.U>BK
MVZ5JZGXCT&Y\+75]-K3V-B<PR7*,T,T+_P!W!&Y7_P!DC/M7+Z)X;\2:/;Z=
M?2V$4L]A?WDALX;E2TT4[%MREL*'!/ +8QGD9Q5C6O#^K7/ASQ;/;Z;.]YKN
MP16 EB#18C5,N2X3/!SACVQFGOKZ?^V_\'[@Z_UY_P# ^\ZJ?Q1HMI=3V;7O
MFW5M$)98(8WFE5#T)1 6[YZ9QS4T_B'2X--MM0-R9;>Z -N;>)YFFR,C8B L
MW'/ Z"N;B76/^$ON=3;PYJ"V[Z.ENN9K;)E4LY7'F_[6,],@\XYK!D?5/#/@
MKPJTF@ZK_:^G[H1%:VZ7C)^[*DF-)!N0Y'(8$>W0KU_K5_Y+[P7]?<G_ )GH
M^FZUIFL)(VG7]O=>4=LJQ2 M$W]UUZJ?8X-<AI?B1-(\1>*TUG4KR6UM[V)8
MF>%I%MT:(,<^6N$0%C\S8'J:T/A]>1W6B3C[)JUK<_:9)KA-3LS;.7D8L2J9
M("9)Q@GIR<U7;2]7L-;\2>1IIO(=;*M%,LJ+' 1"(R)0Q#8R,_*K?A0]'\O\
MAJS7S_S-_P#X272_MEW:++.\]I;BYD1+65MT1Z,A"XD'^YGTHB\2:7/86-[!
M/+-#?J&M_*MY'9UX^;:%W #(R2 !GG%<_9>']0T'6[/[-;27UJ-&CTTS"1%,
M;QDD,X8@X.?X02#VJA8^&-1B\%:)!>Z?>P:QIL)CAETF]C\V/.!R7*HP/4J=
MP^7O3=NG]:O_ ('WB6W]=E^MSJ9M6TAO$5I&VLE+M;22<6:RX1XC@^8ZX[8X
M)QU-+:>+]"OFLQ:WXF2]=H[>5(G,3N,Y7S,;0W!P"<D<C-8+6_B)/$_AV]O-
M*FO6M-.FBO+FVDA5#*^PX 9U/\!SQCD8[XRK73/$$/AC0;1O#=]]HL]8-W,@
MGMN(_,=\Y\W!R'QCU!]LB73^M[?EJ$O+^M/Z1W5WXATRQO$MKB>1&=PGF>1(
M8E8XPK2!=B$Y& Q!.14T>KV<M_)9(\AEC(5CY+^7N_NA\;2WJ <CO7 GPQJ-
MKXNNEE\$:'K-G=W;7,>L7+1":V#')5PR%G*G.W;VP,CMN'1;^T\61WFD)?6L
M-Q.9+]7GC>SE7D$A"2ZR'@_* ,YR3272X/2]CHK;5[*\N9+>!Y&:-S&6,+JC
M,,Y"N1M;&#G:3@C%,OM;L=.U&RL+EIUN+YBEN$MI'5F R0652J\ GDC@$U@:
M=HNH:9XI6334OK72Y6>6\M[B>.2W9F!.81DNC;L$CA<$\9K8\365U>:1OL(Q
M)?VLJ7-LFX+O=#G;D\#<,KG_ &J.B8=6AD7BS29[2[N8VO6CLYQ;S+_9]QO6
M0XPH39N/4= 1R*J3^(M(L;K7KV/4;J\FT^W1KNRAW2B#&XC"@<,><_0$X%1V
M>AW]KXH:XPIL+R-+F[PP_P"/I,@8'4Y!7GMY0JC/I>K7?B7Q7_Q*YXK;4--2
MVMKJ26+8[J)!T#EP#Y@QE>QSCC*>VF]F-6OKM=?G^B#_ (2!KK7/#>I"[OX;
M*[M9S+9/;O&&=54@A"@D8_,0.H.!@=ZZW3-3L]8L$O;";S8') )4J00<$%6
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M!P1QG(&]XCM[Y[71]4T]#9ZNKK;"*8J3LEPKJ=I()7 ?@D?N^N*+:+Y?BO\
M,;W_ *Z?\ Z+2]5M-9LA=V1F,)8H#-;R0DD<'Y74'\<5=JA$DNGFPL+2SWV:
MQF-Y?- \D*HV\'EL]/:K])^0!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %9VIZ'8:LT;W23++&"$FM[B2"10<9 >-E;!P.,XXK
M1HH AMK6*TA6*(/M ^\[L[-VR68DL?<DU-110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4R:);B"2%RX612I*.48 ^C*00?<'-/HH S
MM%T.P\/V)LM-2:.WWE]LMQ)-@GDX+L2,GG XR2>]:-%% !67_P ([I'_  D)
MU\V,1U4Q"'[2V2P09X&>!U/(&36I10 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU:LL7F1JW1\B38R_[K$^U6+WQ0MKJ-_IZ:9>2W5M9&]3!B"3IG&%)?(.>/F
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MVU_-_I]PM>77?0S'\8:_'HM[J<MMIJ?8-5^Q36Z>8_F)O1,K)E<$%LY*G/3
MZUHS>*KK2-2UZ#5%MY8M/L%U"-K=#&=A+C8VYCDY3[W YZ#%,?X?Q2:5>Z<_
MB#6&BO+L7DKXMMWF AN/W. "0IQC^$=L@WAX1@?6[K4[K4[ZZ^UV@LY[:80^
M5)& >#MC#=68\'J?3 $]/Z[+]2M+_P!=_P#(S(/$'B]8[^>Z\/(ELEJ]Q!).
M\405A@A&\N:8OD9^8*O3ISQ)IWB35[B[\/BX6Q$6M6+2HL<3[H)%0/DDM\RG
M/3 (]32Z9\/+/2;*\M+;7->:&XC,,:SWOG+:H>JQ*ZE1QQD@G'>K%MX*CMI]
M$D76]4;^QXS%;JP@PZD8(?$63\N%X(X'KDEZ?U\_^ 3K_7R_X)B:1KNNZ=X%
MDU.^N8KR1[V5/.BT^1_(7SG5G=%D)=00.%VX&/3-=IH^HPZMID5[;WEK>0R9
MVSVIRC@''')Q],\56T_P]'I=E+:V=_>QH\TDR'>K&(N68A05P1EB?F!/3G@5
M73PT+,60L[^_1X[LW5Q(LB*+EB,-YJA0"".@4  @'C%'_ _0/^".\8:S?:!X
M>EU&PM[>9XG0.)W90%9@N0 .3DCC(^M9]WK^N-KVN:7:QZ= +"SBNX)I0\V\
M-OR&4%,?<(X)QP>>E;'B+0H_$FD/ILU[=6D,C*SM;>7N;!R!\ZL,9 / SQ6?
M_P (=G4K^_.OZJ9[VT6TE.VWP%7."!Y77YF/I\QXZ8G6S_#[O\RM+K^NO^1K
M:%J?]L^']/U3RO+-W;1S^7G.W<H.,_C7.:;XIU.?Q+::?<_89$O(IF$4$;YM
MGCQE&F#,DAYYP%(]*Z'1=&CT70;;2$N;BY@MXO)1YRN_8!@ E%4<#C.,_C69
M9>"[6P&F"+4M1(TP.EKN=/DC88V'"#(&!@G)XY)JI6YFUM_P_P#P"5?EL]S'
MM?&.MR:38ZK<V^GQQ/JQTZXMXP[L<S&(,DA(Q@C."IR/[M6VUW7;.[UVQOKC
M33=P1)+I@CLY%$JN=J[LRG<=^%(!'8Y^; 4?#Z$:.FF#7]8\I+[[>'Q;;_-W
M^9_SQQC?\V,>W3BI5B'B'Q;;S3:/?VRZ(\BK=W2*BW+$  1@'YD_BR0!E5Q[
M&FW];+];_>-]7_6[_3\CH#)?6VCM),(;F^CA+%8AY22.!T&XG:"?4G%<C9^+
M]5>;58/^)=?26^G"_@DACD@B/)!0L2X?&/OIP?05U^IZ=;ZOI=UIUT&-O=1-
M%(%;:=K#!P>U8LG@V*7<[ZSJAN&LC8M/NBW-'G.2/+VYZC[N.>F>:EW=[?U_
M3L-6T_KM_P $J:9XFU2:]\._;4L_LVLV33!(48/"ZHKGYBQ#*0>F 1ZFL'Q1
MJE_KGAK2]55K5=+N-6L_(A\MO. %P '+[L<X^[M&,]3736W@J.VFT21=;U1A
MH\9B@1A!AU(P0^(LGY<+P1P/7),=Q\/M,N;-K%[W4AIWVA;F*T2X"I!(&W91
M@-X&><;L#MBKNN:ZVO\ K?\ (A)\MGV_1K\S;UR]N-/TJ2YME@WJR O.X5(U
M+ ,[9(R%!)QD$XP.M<9?:]=ZU\/_ !I#>&"26PAG@\^&!X%F!A#AA&Y)7[V.
MI!QD'!KLM9T6'6M/2TEGN(#%*DT4T+#>CH<JWS @\C^($5F77@NUNK/6K8ZG
MJ,8UC'VIU>,G[BHVT%"!N50#QQVQ4]'_ %V_X)I%I-,SS_R/'A+_ +!-S_[1
MK5\3:SJ&CSZ0MG;VLL5Y>I:S--(P9-W0J .>AZD8XX--C\)A-7TO4FUG4I)=
M.MS;QHP@VR*V-V_$0.3M7H1]WC'.;&O^'5U][%GU.^LQ9SBX06PBPSC[I;>C
M=.>!CKSGBJD[M>OZW(6UO+\;&!=^)]>M+'Q,Q.FO-H3"5G\APMQ&8Q)M"[\H
MV"1NRP[[>U3:IXIUN6]-IX=TA[N6"&*><E8F'[P$A/GGB*\#[P#CVXJS<^!H
MKI==637-5"ZT MRH%O\ * -N$_=<?+\O.>.>O-0W_P /+'4);&Y;6-;MKZUB
M6!KRSNQ;RW$:DD))L4 CGL ?>I6RO_6A3MT_K;_@EO\ MK4[_4DTNTAM[*]B
MLXKN\6Z4S"/>2!&NQ@"?E;YLD# X.:Y;P=K5]I?ACPE;0V]L]MJ%]<6\TCNV
M]#OE8;5 P?NGDGTX/;L[GPQ:RZA;W]O=WME<Q1"W=[>0?OX@<A)-X;/)/S##
M#)P1FLN#X>V%G;:5;66IZI;0Z;<M=1(LL;AI""#G>C8&&;Y5VCYB<9YIJU_Z
M[O\ 2Q+V_KM_F1ZIXJU+3M>@A/V(VSW\5F;41O)-M? $ID5BL?)^ZRY..O(K
M1\:7CVN@)$A93>W=O9LRG!599%1B/?:33)O!5G*;A?[0U%(9;Y+]8ED3;%,K
M!B5.S=@D<AB1Z8K3US2O[6T>2T5PDJE)8';G;(C!D)_X$HS25K*_];?\$>MW
M;^M_^ 9?B+6[W2[BSTC1+!KB^GA>2-42-ECC0J"=CRQ CY@.'X]*U-"NM3O-
M)BFU?3_L%[E@\.]6Z$@-\K,!D8.,G&<9/6LO6O#5KXSL+5[XZCI=]:N3%/9S
M^5/ QX8*XR"I_$'V-:-GH4=E!I\4=_J+BS8L6EN6=K@E2/WI.2_7/L0/2FNM
MQ/I8YZ^\6:Q;^?>V]O8R6Z:B--2QFWQS,Y<()#(-V <AMOEGY><UVJ[BBEP
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M2-1@2]M&L8=/AE2V>W8'+-(,;P_!W*"3M/&  ,9-*T\9ZU<:3H=RUCIXEO\
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MUJ5W#<W%Q;K*'2$QX# 'YLL=QSG)&T>PJK9ZOK[MJVFW5]I*ZO;W$<=L%LI
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M=V]W<3:NCHRPM%C/F9W?,V3G/0#TQWKL]-\-PV$\,TU_?7[6RLEK]K9&\A6
M!"E54G@ ;FW-C//)K//@: 6VGVT.M:M!#87)N8$1H2 <DA3NC.5&Y@._/).!
M@Z_UW_R%K;^NW^96'C"]L;36TO[>&ZN].OHK.+[*OE+.90A3AW(4_O,'+8..
MHS5*_P#%7B_2/#&L:E?:#!&]FBR0R3LD2R DAAY<<LQRO'\0W9[8K9/@>PF&
MN1WU[>WL&LL'N(9C&JHP "E"B*P("J!R>@/7FJ@^'5I_PC=WHDNOZ_<176!)
M/<W:S2A!_ N]2JKTZ '@<T+S\OTO^I3M<Z73SJ#1S-?FU.Y\P>0&'R$#[V?X
MLYZ<8QTKSZZEUF?PAXDDU&^MKI5U011+';M$5VS(.2788P  ,9'J:])MXC!;
M1PM,\Q10IDD W-[G: /R KG+_P $6U[:7UJFK:G:P7EU]KD2!XL*^0Q W1MP
M64-SGI@$ D$Z_P!=U_D);6?]:,6+6]777=8TF2*QGGM[..\M2N^)<.778Y^8
MG!3[P R#]T5G6'B_6-0@\)NEI8H-;A=I79W/E,$+85>XX[MSTXSD:P\*$:U=
MZJ-=U,7-S:+:-\MOM55S@@>5]X%F/.1D],8 J67@.&Q&B+%KNK%-&S]F5A;D
M$$8(;]UDC:<=C^/--6Z_UO\ \ 'MI_6B_6Y%#XJU$Z'.TL=J;^'5/[,:=498
M =X42E=Q('(^7=UXSSFEB\3ZS'%KT<UA;74FD;4,UGYA,SE5;(AP2  V2!(Q
MX]Q5'7/#-UI/AZ]MK#6=8=K^]%S-<&RAN_)/5B84C!=6P 5P>W09S8\"Z+JV
MG:;);SZU]JT]@&MPFBKICPL#R!'@<'OE1^-):I_UT7_!!Z?UYO\ X!O>&M:B
MUS3!<Q:A9WVT['DMHVCVOCE6C9F*,/[I.:V:YR?PN5M+G[/J>I"_N9XY9+U'
MCCD;8?E5MJA=F." N2.N>M='38@HHHI#"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "L_7;ZYTS0;^^M(8II[>!I5C
ME<HK;1DY(!/0>E:%9OB&&2X\-:I#"C22R6DJHBC)8E" !4S;46T5!)R28NAW
M\VJ>'=/U"1$$US:QS,JY"AF4' ZG&3[U2\):U>:[I$US?P007$5W/;,D#%D'
MEN5X) )Z=<#Z5QWA^*P=O"<VB- -2M8ECUEHCADB6$@I/CH0^W ;D8XX!JMI
M>J1W'A">6QN8[JP3Q',^H_9I-Y%LT[')VY.T_*3ZKGM6LDN9V_KWK?<9QOR)
MO?\ X#T]=#UBBO- EI$GB23PSJ%I8^&WTG<MS:,/L\-SE\M'M^4?*!NV]\=Z
M3PK+HVI>(I9](N+73[>"S8/9V.IQOYLQ/,YB@D96&#C<XW$XX&*C^OS_ ,OQ
M[%?U^7^?X'IE%>>^&-2A\/37]E>G2YK:QMGN)]4TW/;!;[1&,[92"&SEBV">
M*[RTNH+ZTAN[659;>9!)'(O1E(R"/PIM 345P?C.?2XO''A!+R^BCE>YE1H9
M+K:&1HG RF[!RV%SCG..^*Y&YOO#MOX3\2-;7NF(VFZT/[.V3)_HP+(1Y7/R
M _O/NXSAO2DM?Z\TOU!Z?UY-_H>U45Y#XMU#1;OQ0\7B/5]1M;*YCA?1[BQL
MX[F*4%>3$_DR,LN[)RA'!6MO5V?1_$%KJ&^QU,R)%;K:7GR:@G"[C"P'S9&&
M9  "<\\8II7L#T/0Z*X&[E;2?'/G_P#$MU+^T)T01?<O[9054[>N^)3\Q'R@
M9)YS6'%<V#>*=&U2U,,4G]L7%M=2/E[T@K*0DK#&U<@;8R&XV8/%$5>P/J>M
M45Y%?W&D76O7%@=3T]-8?5<-J@U*.WF2 2 FW^619@<90*HVGKD9I/$\NE/X
MSN=-\3ZKK%A([I_9#6UFD^]"B@^5(8))$DW!LX8=C26MO/\ X'^?X,'I?R/7
MJY]=<O?^$_;07M[=;/\ L\W:2J[&1CO"X(P !R?7/'3I6[$"(4!+D[1DOC=^
M..]<)XBBTJ/XBPS^(4M5TF?26MP][@0O)YH.SYN"V.0.OI1]K[_R#[/W?FCO
MJ*\M@$EA;:+%XE4?\(PTEXI%Z"8T4O\ Z,)MW 79N W< [<\XI_F6VGZ!?Q7
M)!\.RZO''IQDFVVXA*J2'8@CR-^X =#D <$4[?U]W^8?U^?^1Z?2.6",4 +8
MX!. 3]:\2U&>QL/#&H6$E]!;&V\2P"WAMY&MXEC8Q,51-V"NUF..G5@!VZ^^
M@T+3_$UK9:E%:IX>N+=IK03?-;R7;R;FZY7<1@J/<[:+:?UVO_7F%_Z^=OZ\
MCH/!NN7?B'0/MU[!#!<"YGA:.!BRCRY&3@GD_=ZX'T%;]>0Z)"MSX 4"XL[4
M66JW<SPZU PM9U\UV =FP.C AANP1T)''I'AJ^;4= MKI[/[&S[LP[]Z@AB,
MJW&5.,@X&010^_I^2#9_?^;-:BN2\:2Z<]SI%CJ4<#QW,KA5O2/LC,%X60$$
M.W.57C)&<\5Q$-_I\/A_P=#?:HD4L&M2V[*UP\"F-7D!&PM]U<(!G.W(&>>4
MM?Z^0/3^O*Y[)7/6NNWLOCN^T&:WMTMH+*.ZBE1RSON8K\P( 7!4\#/;GM7"
MKJ=K:MXJL-'N(?L%OK%L;BWL6!,-L5C$Y54Y4;MV[ _O=\UJ^&GT:/XGW2Z%
M#"-.FT>(PO91?Z.3YKDX91L'Z9.>^::5VO3]+A+2Z_K<]&HJ.?\ X]Y/G,?R
MGYUZKQU%>86TNJ:?I&MZ+I4>G7FH0V4DD6H:4=K._P N1,G.V=@<@Y);!/%(
M=CU.BO.]._LR;Q'I5WX-^S /',-52#@?<^7S@.DN_'WOF^][U3\':KX=U'4;
M.&XBO;3QA:1LNIJ+>1'=MI#&:7;M9/XERW&!CTIV_K^NA-]+GH]C]N\J3[?]
MG\SS7V>1NQY>X[,Y_BVXSVSTK*\8:S?:!X>EU&PM[>9XG0.)W90%9@N0 .3D
MCC(^M>?Z/JFB-X/6U>[AO+1M?GA)FNP\&PNY3[0[;MR%<8!^\=O/.:2ZO;/3
MOA?K]E<7=K"(-4:&)!F*-1YJLJ(K$X&W)"@].>E+_@?^V_YC>GX_^W?Y'KXZ
M45'!-%<6\<T$B2Q2*&1T8,K C(((ZBN!U>709/BF;74[RT>-]&D\^VNKD&/A
MU/,;':/D!8\<@9[9H>CMZ_@K@MKGH55[J^M[.2VCGD"O<R^5"I/+M@G _ $_
MA7CQUJUE^'OAV6]U*X;P^C36^H3V<4=UY1!/EB5'20%-OJN>5K0ETSPU+I'A
M&XW/J>C_ -J,$N=5M%4"-XI,*%,:!8R^T*-H&=N.U-*[#_@_A?\ R/6:*\XU
M/PKI4NHZQX;BTRUCBUR);V%Q;+B.11MD;I@$90CW<^]3)]KU/P9J&OZ9IL<&
MO?V?]CB,<0$JF,8=$;&?O[@!T^44NE_Z_JX=;?U_5CT&L#QIK5[X=\*7VK6$
M%O/-;)OV3NRKC.">!DGVXSZBN8LSHDFO:;>>&)+:&T:&?^VS _EA4V<&;&-L
MH;'+8;[WO7* Z)_PI'4M1^UV[W8%U:I.]SN9@UP6"$EOF) !&<GOW-.WZ?G8
M%T_KI<]OC8O$C'J0#4-ZUTEJSV<<<DR\B.0D!QW&>Q]^:X#1[_1M5NM4AO+G
M3[7Q/+:$1WUL4=GM64F-X6ZE0O4=<CGC!K5\#7166]TO[/I3"T"@WFD'_1Y2
M2V59>B2 Y+#)ZC)H:$GH=3I]]!J5A#>6Y)BE7(R,$'H01V(.0?<59KCO"^JV
M6EV AO;I8O[1UB\CL0P/[PF5VP#[X8C-=C0^_P#73_,>SL%<]H&NWNJ:YK]A
M=V]O"--N4BC,+EMZL@<$D@<X(X XYY/6N'\4SV,NL7MY$8([[3]6M-\MR=UU
M'&6C5O*Q@QPD$\DD,2_'-3W=OHSZ]XNAUN*/[1>213Z8DJD32L+=0&@'WBX;
MC*\@TEM?U_1CMT]/\CU*BO-Y#%'J-A:>/_LCV3Z3"L;WN# ;L$^;DM\HD/RX
MSSP<=ZI6D+:;<^$-3UK9$L5Y>6\=[=<.+=A((%=VYY&,9/.1WJK:V_KJOT^Y
MDWTO_71_UZ'IM]?6^G6WVBZD$<>]4!)ZLS!5 ]R2!5BO&Y[32)/"&NVTFG0B
MSLO$:3;9;,K%%$9D#$97;C;O#8Z#.<9KUZS2VCLX8[....V5 L21IM55 X '
M88Z4DO=O_6R8WO\ ?^#L,DOX$OTL ZF[DB:98R?X5(!)]!EA6;X5U>\UO1WN
MKZ""&Y2ZGMW2!BR#RY&3@D G[O7 ^E8FJV>CQ?%+3+V_M+,2MITOE3RPJ6\Q
M9$(PQ'W@I8^H&3TS7&#5O#Z>'+/5X]2T\7<?B=_+N?M";DC:Z)< YX4QG) X
M(.3ZT15_G_G8'L_+_*Y[317C]U<:5=^.9K37]6UBTUL7I;3DM;&-Q+#D%/)F
M\AG52,!AO SNSQFO8*2V3!Z.QBZAKSPZJ-(TVT%[J1A\]D>7RHXDS@&1\,1D
M@@ *2<'CBI[#4;V:\:SO].^RS+")?,CF\V%\G!"MA22.^57J.M<L98?"GQ&U
MC5-6D\C3=7M[?RKZ3B*)X\J8W;HF<@@G //>M7Q+JDNH>#M0G\.S&[?R@RRV
MC;@Z9&\1LO5MN[&,\XHZ)_U_2&UK8Z>BO.;;^PF\0177AV>S@T5[*Y_MI[67
MRHT.%VF0J1LE&6R20V,YZ5S>EW^@1>'?!-W_ &C9"[.IO!).UTOFF(^9O1G)
MSM^9"03C+ ]Z:5W;^M["\_ZVN>U45XUJD^DR:#X_TVPNX%BL[M)H+6RN-@C^
M2,/A4(^7>6R,8W9R,UNW,NFPZQ>ZCH&Y[!-+N?[5.ED%FF&W9T_Y;CY^3\P[
M]J72_P#6U_\ @#M[W+_6Z7ZGI%%>06\VDV<VKLEUI]G87N@^<&T^9HXVD#$%
MVE4J'?) + *><&IM&OM!34? ABO-/,]]IKP71\Y"TX\M0J/SEAO#  ]""!Z4
M[=/ZZ_Y?B3?K_73_ #/6:*\XM_#=C9ZK<^#1HUJ=)N[E=30BW7R_*!!=&XY(
M<*!G^%P!]VO1E541410JJ,  8 %'2_\ 7]7'UL+17 :N=)E\5ZI:^+A;"W>.
M$Z2]UPN=IW>43TFW'^'YL;<5@6,4=YXG\+:;XEN1+>W.B3Q7EK/<MELE!'N0
MMPY4GG )(/IPEK;^N_\ E^(/3^O3_,]>JL3>+J!9C;C3Q#DDY\P29_+;C\<U
M.B+'&L:#"J  ,]A7!7+Z3-\5;_3Y;F">6ZT4I+9RS^8&;=]T1L2!E "0 ,CD
M^M)NVWG^5P6VOE^:.WL;V#4;*&\M9!);S+OC<=&4]"/:K%>2Z78Z?'\.- GL
M)="M?LB":[M]1A5+:>90%;S&_AE5@/F.2#V../2- NVO]!L[IK1[1I(P3 S;
MMGT)ZCN#QD$5<E9M+H!I5FZYJHT?3UN-FYY)XK>,'IOD<("?8%LGZ5B>-)=.
M>YTBQU*.!X[F5PJWI'V1F"\+(""';G*KQDC.>*X&^FT%_AUH$.MRZ;)-;ZR(
M!]K55VQK=8D51(20@0 $9.%P#Q4Q5_O7YV!Z?C^5ST%]1\11W<>B//I7]JS1
MRW$-TMO(83$A0?-'OW*Q+XX<CC/M2:[K/B/0?!^IZM/;:5)=VRB1(TED\L(%
M&[)*Y8[MV!P",<BN;GB\$_\ "UM'CCC\/_\ (,;RE40_ZS?%Y.T?WMOW<<XZ
M<5DWFJ:1%X+^(\$6JV[@7KA-]YYC'='& ,LQ)RP8#Z$#I5+^O_ D@Z_UU39Z
MTK7SWT##[/\ 83 3)G=YOF9&W';;C=GOG%6Z\]75-)/Q3TN2WU.&9[G1)"(T
MN]X?YHRNQ-Q&2H8_*.0"><5D^'I=-E\2Z#?6HMEBOXKF"X&/,N)GP"%N7& T
M@YRI!*\\FDU^OYO_ "$GI=^7Y(]0LKZWU&V^T6L@DBWN@<="58J<?B#5BO&E
M6PTCP&GV6!K.RCU6=-;;3K.-I4B#RA=Z,C*RC*9!4X4CMBM?3K#2+WP',- U
MYI=-EN1*DFKV:I:, OS1^6(X@(B!G@ 9]>12\_3]/\_P'_P?U_R_$].JO>WU
MOI\4<ES($625(4S_ !.S!5 _$UD^$-0.I:"LQLX+;;(R 6LOF02 'AXFP,H>
MW K,^(UGI]SHNGRZE:VTUO#J=LTC7$2NL:&0!B<C &#@]L=:=M4O05]&_4UM
M-U>]NO$^L:7<P6\<-FD+P-$[,SJ^_EL@ 'Y>@S]3VVZ\HUB[\,76H>,X9;G3
MC';:5 (HGD51$Z+(!A2?E96* <94D#C-/U&]TOQ!IFDV\\MG>7$VBF6&2]83
M0O)@ F)!R\RE3G# J#[TF[1O_77_ "&KMV_KI_F>F27UO%?P6+2#[3.C.D>>
M2JXR?H,C\ZL5Y;IJ:3?ZSX$U/4(+:YEETAE2YN(0[/.HA9<,1DN/G([CYO>O
M4JJ4>73U_!V$G>S\D%%>7-JNA2>*[G2_$<%Y!XD743)ITT5M(\DD.04\J15(
M5"  PR!][/4TFK&RN%\10ZN(D\4I/,^CLQQ.5V#ROLQZXX&X+WW9ZU/2_P#7
M3\=2K:V_K_ACU*L#6-:OM.\2Z#816]NUGJ,LD4LK.WF*5C9P%7&,?+U)_#O7
M,F"SM/&TRZU!9QS:KH4<<RM&NV[F5CO4#'[P@8XY.,=JQ=#U?3X=,^&4$UU'
M;RI(Z&.X_=-_J'08#8)!8@ C@DC!JHK5?U_,OT);]V_];)_J=_XRUV]\.Z(E
M_96]O,?M,,,@F<C:KN$R !\QRPXR/KVKH*\8U^XL)_"U[)?Q*_BJ+4T%PHB+
M7*Q"Z&W: -QBVA<8RI..]>RQN)(U==VU@"-RE3^(/(I+X;_ULAO?^NXZBBBD
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4456U&^ATS3KB^N%E:&!#(XBC:1L#T502:3=M6"5RS17+GQYI,>D)JE
MS'<6EI+%%);RW7EQ+/YBEE569PH;Y3G<0!QS@@TNG^.]'U31Y-0LO,G,=PMJ
M;>)XY',S8VH&5S&<Y'._;ZG@U5GL!MZI9-J.FSVB3F RC:7"!^,\@@\$$<'V
M/45AZ#X+L=(NDO)=/T%;R(GRIM,TE;,@$8(/SN3U/<#GI5B+Q=:2:;+<FSO(
M[B.Y^QM92>6LWG8SL!W[#D$'.[&.]7;O6HK*VA>6VN/M$\AB@M %\V5P"=HR
MVWH"<EL<=:6VH;Z&BZED*ABA(^\N,C\Z2*-88EC0851@"N;F\=:9:Z=<75W;
M7]O+;3I;W%JUOOEB=_N[MA*[3D88,5[9S5V+Q/9M=ZE;7,%S:2:? +F03JOS
MPG=B1=I/'RMP<-QTH#?^OD;5%<;J^O0:UH&NZ>]GJ-A<)ISW,?F.$,D>#M='
MB<X&1T)!]12^%=?ACT7P]I5W:W=N;JPB6WN9 HCG81 E5(8L&P"?F SCC-%M
M_P"N_P#D%_Z^[_,[&BO.O#FMKX6\(W4S6&HW]O'J]U 6AD1VC'GE5+M+(I(Z
M#<2<=3ZUVD>K&37'TL6%T-D"S/<YC\I=Q("GY]V[@_PXXZT[?U\D_P!0>CL_
MZUL:-%<G\38P_P -]=;?*C1VK2*T<C(<CD<J1D>W0]ZN6/B6V2YBTZ\MKJRD
M^R^=#)<*HCG10-Q4JQQC(R&"GVI=&_ZVN'8S6\ 6EUJ<\^I6^A:A%,69I+C1
MD:[)/K-NP<=!\G3'I78JJHBHHPJC 'H*Y?1?B#H&O:U_95E<H\[H9(66>&02
MJ,9($;LRXST<*?;@UTTLJ0Q/+*P2-%+,QZ #J:-EY!NQ]%8=KXHMKB]%O-9W
MMFKP-<03W**L<T:XW,,,2N,CAPI]N#3+7Q;:7%[:02V5[:Q7PS97,Z*([GY=
MV%PQ93@$X<*3CBBP&_17+IX[TV6V6[2SU'[']M^Q2SO (Q#)N"#<K$-@L0.%
M..^!S6K#K45SJ=S9P6MQ*MLXCEN$V%%<X.W&[=D @D[<>_!H_K^OO!Z&G17%
M+X^-G!X@O-6T?4+>RTRZ,(DC6.7=A5XPCD@G=G) 4 C)SQ6HGBR,Z[:Z7+I.
MIP-=.Z0W$J1B)RJ;SCY]V,=]N,\<$&C?^OF%SH:*YN/QKI8T:[U.]673X[6Z
M:SD2\>)#YH(&-P<ISGJ6 ]<4S2O'NB:OIL]Y;2,6@F6!X$>.5S(WW%4QLR-G
M/9B.N<8. #IZ*X3PS,\WQ,\1R/;7EJSV-H[6]U(':-B9 <89E X'"G'XYKLM
M0OX-+T^>^NF*PPKN<J,G'L*'HDPZLLT5S\'BVT:+4#>6=YI\U@$,T%R(]V'^
MX04=E.X@C[W7KBM>QNWO+<226D]JY )CFVDC(SU1F4_@30!9HJIJ.HP:9:^?
M<%B&=8T1!EI'8X55'<DUP>F7\</C?Q;>7MGJ4,(TVVEFM9<S2+DR@A51G'(
MX0X_6CO\P/1Z*YS2]>TV/3-#MM*LKF2*[M%EMX%*;HH HPS;W&<9 P"Q]CS3
MI_%L":I<Z9;:9JEW?6]NMPT,< 3<C''RM(RJ>_0]B.HQ3:L[ M4=#16 ?%MG
M+I]E=6%K=W[WJN\-O JK(0G#Y\QE4%2<$$YSTS4)\<:8PT@0V]_,^K([6R);
MGG:I8JQ.%#?*1C/Z<T@.EHKFKWQK:6,7FR:;J1BCACFNV$2 V:O]WS%9@Q/7
M(0-C'-6]2\36VG7<EL+2[NV@A%Q<FV52+>([L.P+ G[K<*&;CI0] 6IM45R\
MWB#0K_5/#Q:WOI)KMY)+"5K66)5(C;);<%ZKNP""3G(&.:$\=Z;+;+=I9ZC]
MC^V_8I9W@$8ADW!!N5B&P6('"G'? YIV>W]=@.HHK U+Q99:9<7226MY-!9
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M('+!1DC:&V\D=#4ZM/\ KI_F4FDU?^M?\C$35=72#0(9M5<OKVP"86\8-J1
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M;' Y.,=N*Z6VT#3+?3Y[(6QEAN01.+J1IVE!&,.SEF;CCDFCHW_73_@CV?\
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MKL)8D'C%=78WGVV*23[-<6^R5XMLZ;"VUB-P'=3C(/<4EM<?4LT444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &+I7AU=*UC4M
M2&IWUR^H,'EBG$6Q2!A=NU%/"@#DGWR>:VJ** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3_L?VK9YW[Z23=MSM^^QQC<W3UIWW\W<E+;RT.@HHHI#"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/9107GF?;DW6T@B?RY>,X#XV[L9.W.>#Q6/<)JB?$"?44T.]FLETLVRS)+
M\F[?@ R!N?NY('/MS6!8Z9K]MH/@RU?PY?&;2[PRW2B>V^50CKD'S><[P>/0
M].,N.MK_ -:M?Y,'U_KHG_P#TZJ&MK.VC79MKR:SF6,NLT*HS*0,]'5EYQCD
M4FLWUWIVG_:;33VOG5U#Q+*L9"$_,P+<' R<=\8I=:>==%NQ;6<UY,\91886
M168D8ZNRKQG/)J)WY78J/Q*YPGA;7/[9L-$=/B')=:O=)%)-IZFR89V[Y%9$
MB#J,!AUR.*ZB3QOH,;7RM->;[&9(+A1I]P65W.% &S+9[%<CD>HK*\/3:S8>
M'-$TN?PCJ(NK*"*'SY)[7RHV"["^5F+$ $]%R?2H]9L-9FU9O$EAH<XU.PF%
MO;V^^WQ>6_\ $S,7XZG;D@KCH=Q%:SMS:;7?]?UZ]&9QORZ[_P!?U_PYU.H:
M]I^F(C73S@, Q$=M)*8U/\3A%)1>#RV!P:CO_$VD:;%'+<71,;H)=T$+S!8S
MTD;8#M3@_,V![UQGB'0]4N/$2:PO@?3/$$%[;Q1R6VI20+-8NN<_.0ZE>>0N
M>1Q5R\L_$^@ZT9]&\/V&J:=?6T-O+9+=+;+:% 1QN4AH\-T S[5']?U_F5_7
M]?Y'4?\ "1:9_:$E@LLSW,=M]KVI;2,'BX^9&"X?J.%)//2LNX\=Z6CZ(ULE
M[<P:J[B.6*QF;:%#9R F0<C&",@9)X&:;-IVHVOBW3=3ATY98/[.>RD2WD15
MMV+*P/S$93@CY03T^6L?1M"\0:?IOA@7&F1F73;R<RQQ72L?+D1P')( X+C(
M!/'3/2FM_P"N[_2Q+;M_79?K<WSXDT*QFUN^.K7%REHR+>1Q))<):$ C 5%)
M'0ENN,9.*T4UZPD>Q5?M7^FQF6$FSF"[0,DN2N(_^!XK'T>SOF\7>)9+W2)X
M;&^$2Q32O$R2A$V,,*Y89SD9 XZX/%1:-X?UC_A']3TK5;D#$<MC83(V7%OR
M$=C_ 'L$ _[@J?LW\O\ /3\B^OS_ ,M?S-VT\0:;>Z@;&&:07&TNHE@DC$JC
M&6C9E D R.5)'(J>]U.UT]X4G:4R3-MC2*%Y6/3)P@) &1DG@9&37%>!]$O[
M#4%74? F@:3+:Q[/[5LFBW7)Q@E$5 R@]3N/X'MN^*]'_M%+>Y@M]2^W6V[R
M+C3;B..6,M@$8D8(RGJ0V1\O3-4]+"6M[E2[U8V/CJ&:34+N33YM)DF6UCC,
MB[E=/F1$7>S$$^I],<ULR>)=)CTNVU$7+36]T,P?9X7F>7C/RHBEC@9SQQ@Y
MQ7/6T?B*'Q/I]W?Z1/=&#2'@N+JWD@"23$J^%5I%;^'&< 9/8<U2T73O$%KH
M&@6<^B7$/V>:9;G9+;^?&&)*LC;R AW$-M._C@4=+?UN_P#@"UO?^MD:7B#5
MOML7AG4M(U6<6EQJD43K"0JS*2<A\C<,%<8R.X(JQH\UV/B%XBM9KZXGMTMK
M66**5AMA+&3(4 #CY1UR?>N>CT;7K'P[H5@NA74[V6L-<R>7=0N1$)78,6>0
M$DAP1U/7.#UZ'2[;44^(6MWDVEW$5C<VL$4-RTD15FC+YX#EAG>,97L<XXRU
M:_W_ )1_X(._Y?FS5N_$ND66H2:?+>!KZ.'SVMH8VEEV>NQ 2?H!D\^E.;Q!
MI8TJWU);GS+6Y&8#%&TCR\$X5%!9C@'@#/!XK%O(M3C^(::C%HMW/91Z9);^
M?')  SE@X #2!OX<9(')';FL71=%UZPT?P[>-I,ZW>DR7"3:>\\.Z9)<_,C!
MRFX9&-S+_%T[RMOZ[M?Y?>-[_P!=D_\ ,Z'5/'&EV.@KJMO]HNHVN4MMD5M(
MSQNS!<.@7<A&>A /0 9(%;5QJMC::2=4NYQ:V:QB1Y+A3%L4_P!X, 5/L1FN
M,O\ PWJES8ZUJ,5FXNK^_L[Q-/:5 ZK"8R03G9O(0_Q8Z<UUNL,[>&M09TV,
M;20E<YQ\AXS2F^6#?7_@%))R2_K<KVWBS1+N:***\(,T/GQ/+"\:2IC<2KLH
M5L#D@$D=\4VS\8>'[^(36NI1R0F*283;6$91&VL0Q&#@X[]P>AKF=#M;_5]%
M\)2MIL\$.D0170E\R(_:C]G*A(_FR,[N2^WIWZTS2_#6M3_#9M)ELWL-2BO6
MNXHYY4*R8N#,JDQLPP1@'T]ZTE%*37;_ #M^6OR,XN\4^_\ E?\ KU.MM_%&
ME72W?E27/F6B;YH&LYEF"]F$10.P/8J"#VI+?Q5I5WIUE?V[7DEM>R>7 ZV$
M_P Q]2-F57@_,P ]ZH6=C?:IXJM->N["?3!:6<MMY$TD;M*SLASF-F&T;.,G
M))Z#'*Z!H^J:;K6HQ7!C.CQ2M+IJ@C</,^9P1V"G<%]F/I4_U_7J5_7]>C+6
MD:QHTFFWVHVNLF\LEN7,D\DNY(VXRB''W1D8 SUQ6)I&NM=_$75/^)A>?V:F
MEQ3B"[B: 0-O8,=C*K#A0<MD\\'%48-%UZYTC4Q_9,UK<+KBZI!#<SQ;;A Z
MMLRCM@X7OQG'O@U/P]K_ (AUO5[K^SX["VU#1DM$^U3(SI*KLP5D3<K*<@'G
M&#WY 2[^7Z+_ (/W>8=U_6_^1VMAKMAJ5U+:V\DJW$0RT4]O)"Q7.-RAU&Y<
M_P 0R/>I+S5;2QN(K>=I/-E!(6.%Y-H'5FV@[5]VP*Y;P1IEU;7$\U[X%T7P
M[,B^5Y]B\3-<<C) 11M7C."2?:KGBS1KB\GBO],BU*+5(D\N"ZL;B- ,D\2I
M(=K(#ST8\G S0]+ M37U'Q!INE;3=RRA2 6:.WDD6-3_ !2%5(1>#RV!QUJO
M=^+]!LKJ:UEU&-KB"-998XE:5D1B I(0' .X?@<]*XW6?#>L)XE:^F\':'XI
MCOHX1+)=/'&UI(JA6P9$8F,XR ,G)-;EEI^HP?$<WO\ 9$D6FKI262SQO$(@
MX8O\JA]P7G:/EZ]L<TTOU#I]WZ?U\C4MO%^D7>GWE]";YH+.3RIP=-N ZOZ!
M#'N)&1G ..^*=::II5QXAOA#JTCW4%M']HLVD(2W7E@Q4CY6(/.>< <<53.C
MZG#XU>>W,8T2[19[I3C(N$^5<#K\PVD_]<_>LO5M$U75_$_B&)+*XM;2_P!'
M6QAOR\102 N<[0^_'S@?=['V)7_!&NS_ *U.FLO$FE:A<2V\%RPDBC\TB:%X
M@T?]]2X =/\ :7(]Z6U\0Z9=W<MJD\D<T2&0K/!)#N0=70NH#J,CYER.1S7,
M6]KXI\1Z-J&FZ[H%CI,YLI+2/4([M9S*6&,JH7*H2 2"<\8Q4/A+1+N/[4FI
M?#[0=(D2!H6N;-XB;S(P0H1 44_[1S[>C:_K^OEIN)>?]?UKJ=K8:I:ZDA>V
M,N.O[V!XB1G&0' )![$<'M6<_B>V3Q>OA[[/=^<;?SC*+64Q\G &\+M X.23
MC.!G/%4O"^E:CI.H75N'U!=%1 MO#J,T<SJ^>L;*6;R\=G.<],"K%Q87P\:_
M;([9GLY].^S-.LBCRF#EN03GD'C /(YQUI/=6_K1@MG?^MBVGBC1WU*.P%TP
MFE8I$[0NL4CC.524KL9A@_*&)X/'%7K_ %"VTRU-S=R%(P0HVH79F/ 554$L
M3V !)KA[7P]K$WAS3/"UW9/"NG7,#C4UEC,<D<4@8%1G>'( !!4 $GD]^E\4
M1ZC)I]O_ &=9_:F6YC:5$\OS50'EH_,(0.#CDD<9QSBF_+^M@Z@?&&@+I?\
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M.#QD4NEQ7(-1UG2](6-M3U*SLA(=J&YG6/<?0;B,FK<<L<J[HY%<>JG/;/\
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M$1*Q7+<@GKL-6/ 6KR:OX3MC<F0WMH3:7/FQ-&_F)QDJP!7(PV" ?FI[W?\
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MQA5%.O+RVT^SFN[R>."VA4O)+(V%51U)-4O#]WJMYI2R:UIWV&]#LK1[D(8
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MTN9[>PM9H0ZW-W YBFD.1Y8D#!8R/E/S9SG@<5U7:@5PHHHH&%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %17-M#>
M6LMM<1K)!,A21&'#*1@@U+11N&Q@Z?X5M[![<M?WUVEH"+)+IT86N5V_*0H+
M'!QERQQWY-.\/^&_^$?DO&75]0O5NY6GD2Z$.!(WWF'EQJ><=.GM1>^)H++Q
M38:(\+'[6C?Z1NPJ28)5,=RP5S_P'WK<IZ[AY&;J^BP:P;)I)YX);.X%Q#)
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M[DY_?-'!(58<XW.-Q..!BH?!$^CWNI3W6CZIK,GB&*T<7=E=6,<(63;QY[)
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MRLHYUDC*+S#)Y$CH^[=G:P[&M[49&TCQ?%>%K#4FNWAB%M-A-0@'R ^41]]
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M<(ZNJG:Q!!'.1D9'K6I+XCT+3M6\0W36M\MUI]O"U](+>0[X_GV;%_B ^;+
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M[F+&-YWLN1P>%R>.E(_B>X;Q=8:7;:7<SV5S9&Z^U(T0&-R@'#.&P,\\9Y&
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M57'.<@CZ&NGHE:^@D%%%%(84444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 A 92K $'@@]ZH6&A:/I=Q-/I^E6-G--S+);VZ
M1L_?YB ">O>M"B@ HHHH **** "BBB@""XLK2[>%[FUAF>!_,A:2,,8VQC<N
M>AP3R*GHHH **** "BBB@ HHHH H:AH>D:M+#+J6EV-[)!S$]S;I(8_]TL#C
MH.GI5^BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9HKF!)X)4EBD4,DB,&5@>A!'44 /HHHH **** "BBB@ HHHH **** "BBB@
MHHJ'[7;"66+[1%YD*AY$WC**<X)'8'!Y/H: )J*KB_LVCMY%NX"ESCR&$@Q+
MD9&T_P 7'I5B@ HHHH ***1F5%+,P50,DDX % "T4R&:*Y@2>"5)8I%#)(C!
ME8'H01U%/H **** "BBB@ HHHH **** "BBB@ HJ);B![B2W6:-IXP&>,,"R
M@YP2.H!P<?2I: "BD9@JEF("@9))X%0+?V;) ZW<!2<XA82#$A]%YY_"@"Q1
M110 4444 %%%% !114<EQ#"\:2S1H\IVQJS %SUP/4T 24444 %%%% !114<
MUQ!;^7YTT<?F.$3>P&YCT SU/M0!)1110 45%/<06RJT\T<2LX13(P4%B< #
M/<G@"I: "BBB@ HHJI>ZII^F>3]OO[6T\]Q'%Y\RQ^8Q_A7)Y/L* +=%%1PW
M$-P&,,L<@1BC%&!VL.H..] $E%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[?*%; R" =O)QTK)G\8ZKJ5CX8O=%LK,QZE>/#*DUV5&460X5U1@5)0G=CD
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MQCN:YR'P9JEM;>';:+7+8P:++O026!)E4*R*"1*,'8QR><G!P!Q5Z*;MM?\
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M9_EX(X;!KH],OSJ5BER;2XM&+,K07 4.A5B"#M)';L37-:]_R4KPC_URO?\
MT!*SO&^KO'XBMM(NO$%IH-G+:F:.XN3*BS2!L%1)'-$5*C:<%B#NZ<4KZ??^
M [:_<>@T5YU(;^?7?"5BWB>YO;6]L[I)I[,B%)RJ#;*I7)S\W7<1P"*@O([Z
M"+QO ^N:M-_9MM%-:2-<E&C81,X^X%R,CD'.>^:&[;^?X"2NTO3\3TRH;N[A
ML;26ZN'V0Q*69L9X^G<^U<A97-U%XPT#_3+EUU/2Y9KF.29F0NGE%65"=J'Y
MV^Z!G/.:T/&9D^S:1&!F&35K59L]-N_(S_P(+3:LTO.WXV$GI?RO^%S;@O"T
M4!N8OL\TY.R%F!;H3@XXS@<]AZFJ?A_6FURTN9GLI+-X+F2W:*5U9@4."25)
M'Y$UA^)+"UN/'GAJ:XFN(]L=R<QWDD2_*JL.%8#Z^HX.16#</-9Z+J.J6E[<
MQ3P^)-B".8K&5:X1'5E'#@@G[V<=L4HZO^NZ7ZC?]?<W^AZA4<\T=M!)/,P2
M.-2S,>P'6O,M?U>:\\6:EI]QXRL?#DMFZ?9$N1(K.C(I\Q<3QI)EMPVLC8Q7
MI,EO%>Z>UO=*L\4T6R567 <$8/';/I1]FX:*5F,FU!((9':*4F.$S.BX+*O.
M.,]3@XKG3XWG&K1Z6?"6NB]E@-RD1>TR8P0"<^?@<D<=:T[/PGH>GS:;+:Z>
MD<FF0M;VC[V)BC;JN2>?QS65<?\ )7[#_L"3?^CHZ:6MO7\F'2_]=#IK"[%_
M8070@E@\U QBF #H?1L$C(]B:LUYMXNU9Y/%<VDW7BJS\.Q16\<UJ]UYJ"4G
M<&8.D\0;! &QMPX!QS5EX[^^\:V.F3>(;^2VN-":1GM7$"F0/&/-0#D$YSR6
MZXZ$Y%K_ %Z_Y ]/Z]/\ST"BO*[R;4;?P_XONFUK4Y;G2=3S:2M<%=H"1':5
M3:K+\Q&T@CVSS72PBXA\<WFFQ7]XL-UI0N&+3&0QR[RF] ^53CL!MSVI/;^N
MUPOK_7>QTUA-<W%E'+>6GV2=L[H?,$FWGCYAP>.?QJS7E^F7VJW&E^!GDUF_
M)N[V>"Z^=?WXVRL"QQG(V#&" /3IB[;ZA+:Z7KMA)J5ZL=OK26=J?,:6=U81
M-Y0D=LY;<P#%LJ#G/ IV_K[O\Q;;_P!;_P"1Z!--';PO-,X2-!EF/0"H6GNA
MJ4<"VFZU:)G:Y\P#:X(PFWJ<@DY[8]Z\MOA)<^%?%.FW]S<^78ZI ((VU*65
MXT/DD@RDAV&7/4G!Z'@&NH5KBP^(-G9VNH7D]D='G9;66<R+O22-0=QRS-R0
M2Q)^G-']?A<;TT_K=+]3LZ*\SM]0OIO#FB>);6^O)-8N+R&"[L_M#-$Q:3;)
M%Y1.U"@SR &&W))YJ*[N-1AT#Q+?MK&HRW.F:SMMG:<J%7,7RE4PK+AB-I!'
M?KS1;6W]=/\ -";M_7K_ ),].FD:*"21(GF95)$:$!G/H-Q R?<@5RMEXZ:^
MLI+V+POKOV2*22*24+;OL9&*O\BS%VP0?NJ<]LUUHZ5QO@:[M['PE>W5W/'!
M;Q:E?,\LC!54"XDY)-+N_P"MRNB_KH=-I>J66M:;!J&GSK/:SKNCD7(S]0>0
M>Q!Y%6)IHX$#RN$4LJ@GU)  _$D"O+O#IDA\/2,TUW;V^N:]/-86T!:*2>%M
MQ #Y4Q A2^X$' XR3BHYT.I^%K>VU&\N6>T\21VZ;-1E+I'YP4 R JS$ \,W
M/<'/-.VMO3]/RN2W97]?U_R/6:Q+[Q-%83ZC"VF:I,]E +C]S:EA<*>HB.?G
M8<9'&,UQ/B'53-XDNM)E\8V?AZ.TBA>R:[>7,JE?]8'%Q&LGS9!5P_W<G.:]
M&@@6:S0S2>>\D*J\H!0/QR0,_*#UQ2Z70]G9E>QUF*]N(XO+:,3PBXMF;I-&
M0"2.X(R,@^HZUIUS7B16BU7PL;<!674MF!Q\A@EW#Z8'Z"N@M[JWNU=K:>*9
M4<QL8W#!6!P5..A!ZBGYH+-;DM%<9< CQ[J]I+>WB6D^C+,8_MDBJK;V4LGS
M?(<!>5QZ]37/^&-1NM77P4AUZ\G@N].G6[2.YSND0+DLX^??\Q!^;(P.AYI+
M7^O7_(;5OZ]'^IW7B77F\.V$%W]AENDDN8H&V.JB/>P4,<G.,D= 3S^-;->7
M75S<7'PWF2XGEG-MKRVT;S.7?RTO5506/+$  9/)[T:_J\UYXLU+3[CQE8^'
M);-T^R)<B16=&13YBXGC23+;AM9&QBG;^ODG^H-6_KSL>HT5Q6KWNHZ5K8U.
M\BN+O2 D4?GV5TT;6K'&3) 2 X)(.?F8 X [TY;R_P!,\6$ZG!<2V=]="&TO
M;:\+1)UQ') 3A3G(W*#G')%)$MG9T5SWC;5;G1?"MS?6T@A9'C$D[1F00QEU
M#N5!!("DG@@^]<QI=K;ZCHFK0_\ "?K?6KQJR2:5<S"2S?G#>89Y');(^0G!
MQP.M'?R*[>9Z13(9H[B)98G#QMT8=#7">&89+H:E;:W<ZA'K*6BPRVAOIA'Y
M.W"RQKYAP6QRP.0P(SU)YRTODT;P)X2LDUI=+LM1@_TF]O)YY423RP5CW"9&
MB!^8C:R@;<8YIM?I^O\ E^@DM+_UM_7YGL-%>;F:^BT_PR+;Q<VIPRZO]G>Y
MLL".6,JQ"%BTC-M*XSO.><Y-)+K%[HZ>(+-+VX%I!K-K:K<3S-(UM#*L9<[W
M)/5CC)XSZ#%%NG]=/\PZ7_KK_D==;>(?M'B^\\/M8RQ-;6J7(N'=2LJL2!M
M)/4'K@\=.];=>6W-RGA[QQX@73+B2XO(O#JR6T5Q<-/(S*\C8!=BSXR#C)Z]
MABFZ7K<L.GZGK6E^,K#7)5T^6X_LR!92^\#(<K)/(8\8QM4*.<8Z4NE_+_/_
M "';6W];+_,[G4/$!L/$VD:,;&5QJ(DVW.]0B%%+$8^\3T[ <]>U+XH\0_\
M"-:4E^;&6[5IXX6".JA-[!0QR>F2!P">>E<;</86OC'P-=#5I+G[9Y[F6XNS
M(LC-" "N3M7<> JX'H*W/B<"?!,O48N[4DCL//3FG:UK][?BD2G=OTO^#.PH
MKAYM,EG\3WFB6VIZG_9]U8&XF=+^0O:S[P$*/NW*&&X[0=OR],9RGAII-7N+
M"UN)KZ.YT)&BOE%Y-B2?.%W?/^\!"E_FSPR^IH2O_7K_ %\QLZ+Q'KZ>&](D
MU*6PN[N"(_O1:^7N0?WB'=<C.!QD\]*KV7BN&?5X-*OM-O\ 2[VX1I+>.\$9
M$P7[VUHW=<C/0D'VJK\1\_\ "O=9VD!O(&"1D?>%9L%O+'XZT^7Q3>02W4<+
MC2)((?(@9F $B[69SYN!QEL%2<#@X4=7_7:XG_7WG=T5Y;JFKS7WBO4;2?QG
M8Z!=65R$MK:X60,R%5(8 7"1RAN>&1B,D>E3:K+J'V;QY*VL:BSZ:JSV96<Q
M"%O)\P !,94$_=;((ZYH6U_ZZ?YE)7=D>F45YGXEUR6?6K73;[Q+9Z! ^GQ7
M4,UUYL:SR$MOP\<\7W?E^5B0<]*T)D_L^ZTB_O=:O+^VO[-[*::&ZEABFEV@
MI(B*^U&8*P!7NPP>:=G_ %\_\A)W_KT_S.\H[5PWA6.64QZ1>W5\]WHES*;B
M1KV8F3.&BWDM\ZE7SALC*GBL_3]2G'B;0+Z'4;J6SU*:Y22:>[8)<*$=DV6Y
M)5 -H&X;2<<CDT6N[";LKG8>'->;7[:\E>QDLGM;N2U:*5U9LIC).W([]B?K
M5;7_ !8- 2\F?1-4N[6SA\ZXN;;R-B#!)'SR*Q( S@ ]14'@GIX@_P"PU<_^
MRU)\0_\ DG/B+_KPE_\ 034MZ)^2_0J*O*WG^I=TC7I=4G$4NBZCI^Z$31O=
M&$K(N1T,<C\\C@XZUL5S&O:G<Z/\/GO[1MDL-K&3)LW^4ORAGVY&[:N6QD9Q
M7&37D\?A#Q+?:5X^M]0,=B;A$T]G=H''.2TLTS*&Z;?EZ<8(-5+1M+H*-VD^
MYZU17 ZO;WMC#X>NK?6]47[;J5LL\1G#*P9 "!D9 ^7. 0,D\51U%KJVT[QU
M'%J>I!=)Q<61^V2%HG, DP6W;F7=_"Q*\XQBAZ-K^M+?YA'WK6ZV_$],HKA=
M8U'4M/NH-;NH;BZTA+2/S6LKPQR6K$99VAR%D!!'J1C@=:Z_4HA<Z5<Q[I5#
MPMAHI&C<<=F4A@?H<TI>ZF^P1]YKS+=%>76&KM'8_#>\NM9N$DNT\JX:6]8+
M,3 V-ZEMK-OQ@D$YXIJRWZ^$M8U%=;U*XU;3=4GAM"UT1YI$@58WC7"-NZ8*
M\9XQ5.-G;^MTOU#^OP?^1ZG17G]U<SZH?%$MUJ5YIU]H[DVJ0W+1K''Y2LKL
M@.V0,V[[X(XP,8IUG+J>K^)]/@U*\O[>.\T#[1<644QB$<NY <,F'!Y/.[([
M8&09_K\&_P!!-_U]W^9WU%<]X&O;G4/!FFW%W,\TY1E:1SEFVN5!)[G '-<Q
MJAOB_CP/K&I'[! EQ:;;@Q^0WE,X V;<J#V.<CKFANW]>G^945?3SM^:_0](
MHKA$>X?Q+HL+WMZT>K:1-)=)]ID +J(\,@!'EGYVY3;^E8UGJSP:!\/[Z\UB
MXCEEO#!</-?.!*I23B0%L.=RJ,MD@\=ZKEUM_6[7Z"W5_*_X7/4(YHY7D1'#
M-$VUP/X3@'!_ @_C4E>27UE#I^@^.;VTOM1@O(-09T:/4IQMPL1)V[\?Q'.1
MTP.@%=#>:O;Z9\0+M9M8>WBDT0S^7)<LZ!U;ETB)QD(,D*.1S4]+_P!;7#K;
M^M[';7$CPV\LD<+S.BEEB0@,Y Z D@9/N0*SO#>M?\)#H%KJHMFMO/#'R68,
M5PQ7DCC/%<GX;NKJW\7V]M)=W1MKW23<E;N]:5I9 Z#S A+"+(8_*C8YZ#%;
M'PZ_Y$33?^VG_HQJ=K7_ *ZM?H3>]K?UHF=317GFI:[I]UXBUG3M5\2MH-_9
MRQ_V?ON_(0H44A]A95FRVX$-N QVJS-.^M:IXBM[O4KRPETQ8Y++[/<M#B,Q
M!O.900'!;<,."ORXQUI=+_/^O\B[:V.ZHKSK3KO5]8USPVFIWE[;KJ.ARS75
MG%)Y2B0&/Y@5 =2=Y_BR.,8YRW3[C7K_ ,):;-;^;J/V:\N4GMQ?-;W$\<<K
M*A$@(+$ #(8@-GD^M.-M_P"M6OT)O_7RN>CT5YEK_B9+Y=%@.N+H>FWUK)(+
MG4/,0O*K >69(IHBC#G^(AN>M6K5KZ36_#%H_BB;4[2ZM+H2S6A$44^S&U@5
M);.&QD.>@(P>:FW]??\ Y#._FFC@0/*X12RJ"?4D #\20*DKRJXC.J^#[*._
MN[R06OB7[+')]LE1_+6Y**&=6#,0O 8DGOG/->HP*BV\:Q,7C"@*Q<N2,<'<
M22?J:=M+_P!;)_J#T=OZW:_0DHHHI %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %0W5I;7UK):WEO%<6\HVR13('1
MQZ$'@U-2,RHI9F"JHR23@ 4,#$'@OPJ(1"/#.C>4'WA/L$6T-TSC;U]ZE;PK
MX==[EVT'2V>[&+AC9QDS<@_/Q\W(!Y[BBS\3Z1?WILX+F3SRADC62WDC\Y!U
M:,LH$@Z<IGJ*Y[P_JD/BO6[RY%SK-O+87KI"@BN((6B4*-CJZA&8DDD$;QVP
M*.M@;LCJ8M$TF"*UBATNRCCLV+6R);H! 3G)0 ?*3D]/6H8O"_A^WM;BUAT+
M3([>YP9XDM(PDN.FX 8;\:K^(?%%MX>NM,@GM[N5K^<Q*;>UDFV@*6).Q2<\
M<#KU/0'&+I7B*'2-3\1IK&J74L,6I(D3RQEQ CQ1L VQ<(@+$;FP/4YII-_U
MZ?\  ':R_KS_ ."=+/X=T2ZAEAN-'T^:*4J9$DM497*C"Y!'.!P/2KMO;06=
MM';6T,<$$2A(XHE"JBCH !P!5/4M<L-)Q]KDFYP3Y-O)-L7GYGV*=B\'YFP.
M.M7HYHIH$GCD5XG4.KJ<@J1D$'TI",^[\.:'?Z@NH7FBZ=<7J;=MQ-:H\BXZ
M88C/':K&H:5IVK0"#4K"UO80VX1W,*R*#ZX8'FLJ+QOX=G2*6'4EE@EF,"W$
M<3M"),@;6D"[%R2 ,D9/3-6;KQ/I%EJ*V-Q=,LS2+"6$$C1I(V-J-(%V(QR,
M!B"<CUHL!/+H6CSWT-]-I5C)=P*%BG>W0R1@'("L1D 'TJN_A/PY(]R[^']*
M9KK_ (^&-G&3-SN^?CYN0#SWYIDWB[0H+VYLSJ"O<VSQQS1PQO(8V<D*IV@X
M)(Q^(]16/%XST;7- 2YNKV]TA)+X01,\<EN\CK*=J*67YMVW#!<XR0<4+7^N
MX;&['X7\/0W%M<1:%IB3VH"V\BVD8:$ D@(<97DGIZU<U+3X=4L);.?(1\$,
MO5&!RK#W! (]Q5?4M>T[2"!>2RJ.KM'!)(L0_O2%%(1>#\S8''6GOK-BEXMK
MYKM(R!]T<+NB@]-S@%5)SP"03VHW#85;!;JWMO[6M[2ZN+=MZ2>4" PR ZAL
M[21Z'C)&35+_ (0WPO\ 9FMO^$;T?R&<2&+[#%M+@$!L;<9P3S[UKW$\5K;R
MW%Q*L4,2EWD<X"J!DDGL*P-/\1Z!9:3IF-=^T17K,EI-<R%I+@ACG'&2!ZXQ
MC% &K/HFE74UM-<:9932VHQ;O);JS0_[A(^7\*O51TS5[+5TF:SE=C!(8I4D
MB>)XW !PRN PX(/(Y!!%1W.NV%IK$&E3-<"\GC:6-5M965E7K\X4KD>F<\CU
M% &E68_AO0I-4&J/HNG-J(8/]K-JAEW#@'?C.?QJ"U\5Z3>V"7MNUX\#W)M!
M_H$X82@X(*E-P (()(P".36)H?B"'2KC68-8U2ZGVZN8(I9HRXC#)'M5BB[8
MUR2 3@9]332U_KR_S$WI_7G_ )'4W^D:;JAA.H:?:79A;?$;B%9/+;U7(.#[
MBF'1-);5!J9TNR.H ;1=&W3S0,8QOQGI[U6MK_3)O$U_##JSRWMO;QK<68ES
M' ,DAB,85CGGGH!41U_3=76ZTZQU">&Z:W:2*5860LN/]9$TB[9 ,CE=P&1Z
MU+=E?YE6UL/_ .$/\,>5-%_PCFD>7.P>5/L,>)&&<%AMY(R>OJ:?_P (KX=\
M\3_V!I?G"/R1)]CCW!-NW;G'W=O&.F.*R/!GB6VN] T"TO+V674[JQ27?+&^
M)F"Y;$F-I8=2H.1Z5U<LL=O"\TTBQQ1J6=W. H'4D]A527*[?UV%K<R$\'^&
M(O)\OPYI">0^^+;8QCRVXY7Y>#P.1Z"I$\+^'XXKJ*/0M,6.[P;E5M(P)N<_
M.,?-R2>:2V\3Z1=?:]MTT1M(_-F%S"\&(^?G&\#<G!^89'O19^)](OA>&*Y>
M,V:AYTN()(&13G#;9%!*G!PP&#@T@+7]CZ9Y5Q%_9UIY=RH2=/(7$J@8 88^
M8 <8/:HQH&C+J$6H#2+ 7L*A(KD6R>8B@8 5L9 QQ@5)!JUG<6C70>2*-0"P
MN(7A8 \#*N PS]*9INMV&K/-':R2B6''F0SP20R*#G!*2*&P<'!Q@X.*.H#X
M]'TR'4I-1CTZT2^D&U[E8%$KCT+8R?SJD?!_A@Q2Q'PYI!CF<22)]ACP[#.&
M(V\D9//N:9KGB>WT/5=*L)K>[D:_D9 T%K)*% 4G^!3SD#CTR>@K'T/Q!#I5
MQK,&L:I=3A=7,$4LT9<1ADCVJQ1=L:Y) )P,^IH2O_7FO\P;M_7K_D==]CM?
ML7V+[-#]D\ORO(\L>7LQC;MZ8QQBLJ#P7X5M9TGM_#6C0S(<I)'81*RGU!"\
M4]=1TMO%%Q;KJS&^M[3,UD)<QQ)D'>PQ@-R.2>E7;#5+74D+VQEQU_>P/$2,
MXR X!(/8C@]J/,/(?>Z?9:E;BWO[.WNH0P81SQ*Z[AT.",9%1OH^F26\]N^G
M6C0W#;YHS I61N.6&,$\#D^E69YH[:WDGE8+'&I=V/8 9-<UX4UO4KW4M6TW
M6%"7<+I<P*%"XMI1E%]RI#*3ZBA ]KFY>:/IFH2027NG6=R]NVZ%IH%<Q'U4
MD<'Z5=K)O_$ND:7=&WO;ORF4!I)#$YBA!Z&20#9'GMO(S5>;QIX<AE,?]KV\
MKBV^UXMR9OW.0-_R \<C\,GH#0M=@+O]GO/K"7]TR%;=66UC7^'=C<Y)_B(X
M'H,]<U+8:9:Z:;DVT$$)N9C-+Y,00,YZL0.I..2>2:KS>(M+M[Z.TEG=7D8(
MLGD2>3O)P$,NW8&)XVEL^U$_B'3+:_CLYIY$D=Q&LA@D\G>3@(9=NP-GC:6S
M[4("U<:;87ES!<W-E;3SVY)AEEB5FBSUVDC(S[55;PUH+W,%RVB::T]NH2&4
MVJ%HE&<!3C(')Z>M59?&GAZ)+J3^TEDCM)O(N7AC>18'_P!LJ"% [L< =R*N
MVVN:==ZE+I\,[?:8XQ*5>)T#I_>1F #KTY4D#- /S*W_  AWAC[(;3_A'-(^
MS%_,,/V&+87QC=MVXSCC-7)]$TJZFMIKC3+*:6U&+=Y+=6:'_<)'R_A58>*-
M'^TR0/=F(HAD\R:%XXG4#)9)& 5P!R=I.*9:>+-$OIK*.UO?-%Z&^S2")_+E
M(R2H?&W=@$[<YP,XQ0!?FTO3[F[ANY[&VEN86W13/"K.AQC*L1D''I0-+T\7
MXOQ8VWVT*5%QY*^8 >HW8S@UFZ%XHMM=U'5+2&WNXFL;@PEIK62-6P%R=S*%
MSDGC.<8.,&KEWKEC9:K::9.TXNKL,80MM(ZM@$GYU4J" .A(H[!W-!T61&1U
M#*PP5(R"*S%\-:"FG-IRZ)IJV+N)&MA:((RW7<5QC/O4%OXKTF[L)+V%KUH8
MKC[*X_L^X#B3(&-A3=U(!.,#N:R]0OK2\T+Q5-HWB"Z>Y@#F1X9 XM9$C'R)
ME2!]WD<\D]#2;Y4V-*[2_KL= -#T@:K_ &H-+L1J.,?:Q;IYN,8QOQGIQUZ4
M-HFDMI\FGMI=D;*1BSVQMT\MB3DDKC!)/-<I;75__;7@ACJ5VT-W8OY\!<;)
M&6$$.W&XMENY(Z<9YKI_$&M0^'M O=6GBFECM8C(4AC+L<>PZ#U/0=3525KI
M^:^YDP?-:W6WXH2?PWH5U%:Q7&BZ=-':#%LDEJC"$<?<!'R]!T]*=;^']%M)
M;J6WT?3X9+O(N&CMD4S9.3O('S<GO4*>([$:1;ZA*MX%F7<(EL9S,<<$^4$\
MS )Z[<<@]#4<OC'P_$T"'5(FDN(6GBCC#.[(N=S;5!/&TCIU&.M)Z7N-:VL:
M%EI.FZ:%%CI]I:A4$8$$*IA02=O Z9)./<TEEI&F:;)/)8Z=:6KW#;IF@@5#
M(?5B!R?K66/'/AMK>YGBU-9HK7;]H:")Y1#NY!;:IV@=R>%[XJ_#K^F7&HFP
MCN?WXB\]=T;*CQC&61R-K@9&=I.,C- #[71-)L9/,M-+LK>3>TFZ*W1#N;&Y
ML@=3@9/?%79(TEC:.1%=&&&5AD$>A%<WI_B?PY:Z9%<KX@%S;7EY)'!-/+OW
MR%SE$..57.!C@ =:TK?Q%I5S;WLZW)C2R8K<B>)XFB.,\JX!P0<@XP>V: ZB
M/IATK0[BV\,V6FV5P%8V\30^7!O/=@F#CUQS3]$T^XL;1WOI89M0N9/.NI84
M*(SX  4$D@!54#)[5FWGC?2;?0M4U.(7<O\ 9T>^:W-G+',N1E<QNH8 _P!X
MC&,G/!JXGB.Q&D6^H2K>!9EW");&<S''!/E!/,P">NW'(/0T^[ MZEH^F:S
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MQ+KL7AOP_=ZK-#-,L"9"11,Y)[9V@X'J>@H>G]?(%J6].TK3M(MC;:986ME
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M5HL RE3G!&.#@T^EB4CS.PM+[6M \0Z#!82>5>ZM=HU]YB".%?-Y)!._=C.
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%-D
MC2:)XI45XW!5D89# ]01W%5=-TC3=&@:#2].M+&%FWM':P+$I;IDA0.>!0!@
MV>I7;^+7M]2NM3L"\DBV=D\4!MKA% ^82!6;<>6VEU/'W< UU58L>C7MQJ,%
MUJU_!=+:3-+:1P6QAV$J5!<EVW$*Q'&T<].F+=]HFDZI<03ZAI=E=S6YS#)<
M6Z2-&<Y^4D$CD#IZ4=$#W9?HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
LB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ex10-56_06.jpg
<TEXT>
begin 644 ex10-56_06.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2X Z0# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQOE8KG'H<9'J"*LT <UXIO/$6G66H:CIEQID5I9V;3[+JT>9Y74,2,K*@48
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M '0NH!(=">/0'N*UO"+W]_!)J>JQJMXO^A#:<AA$Q5W'IN?<?H%H2_1_>O\
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M),J?WBJD@4F[*XTKNR-2BN2\/>&=-O="T[4M3MH[W5I[999+^49F5G7)V/\
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M@E6*J00<9!48R#DT 6?^$-TO_GZUS_P>WO\ \>H_X0W2_P#GZUS_ ,'M[_\
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MOFB>10S;/*(+<8VYP1_$.E7M?U#5M+UKP[IVCV=B;2XE>-TDG:' 6)B% 5&
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M%>*12CHPR&!&"#4E%#5P.;TGP]JNAQ16%CK<3:1"-D4-S9F2>).<*LH<# X
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M&.W1<LWWB<#J<#/KBG:?HVEZ3 \&FZ;9V4+_ 'X[:!8U;ZA0,T[[_P!=;_\
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MG.[Y./EYYX[U*_K\?\RGJM/ZV_R.!O8/M^@"TO;N]DCLO%"6L+F]E601^:H
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M@['V%4[.7S_5_P# 9G'2*]/T7ZZ'2S^-M"M].6^DGNO(-Q]F.VPG9TER!L=
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MWEMJ%I'=6DRS02#*.O0UQ7C?P_?3:CIVIV'AK3?$<-O UN^F7IC7:"5(>-I
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M]JY[Q#K6HZ5JNAVUI;VKP:A=&VEDE=MR'8S#:H&#]T\D^G'<'D'F="    ,
M=!4,UI!/+#+)&#)"=T;]"N>N#Z'N.]<1<^+-=M-'\074G]G/+H-SLG*P.%N8
M]BOA1O\ W;8?&27&1TJUXO\ %.I:%#<7%K]B2*VM!=".:-II+KD[D548&,
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MVY+88?+@#W[UKV^L:JOB>[TBX2SE)L!>6QC#1[3N*E'8EMW.#N ''\-+I?\
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M.5W#@X/<4[-"3NO4L(BQH$10J@8 ':J-OKNCW5W-:6^JV,US#_K88[A&>/\
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M8<$=?7!&U11L!R$_@"&XL]5M7U[5_+U.Y6YGP+?(<8X7]SP/E7_OD>IR_4_
M%AJ>JPZH=3UBSOEC2*XFL;PVYNU7H)=@ /?[NVM'Q+XA_P"$<MK.<V,MTMS>
M16I*.JB+S&"AFSR1D]@?PZUMT+O_ %M_D#_K[_\ ,Y^3PJ&UJ?4XM9U*!Y;3
M[(L2>28XT'3;NC)R"2<DGGKD<5=\/:)'X=T2VTJ&[N;F&V79&]QLWA>P^15!
MQ],UIT4 9VNZ0FO:)=:5+=7%M%=1F.22WV;]IZ@;E8<CCIGTQ52Y\-"[TB/3
M)]5OWMO*$,P/E9G0 @AOW?&0>2FT\#FM6\G>ULIYX[=[AXT++#&5#.0.@+$
M?B153P]JZZ_X?L=66$P+=Q"41LVXJ#V)H74>NAH1QK%&D:#:B *H] *Q];\.
MKK=]IMT^I7MJ=/F\^)+<1;6?!&6WHQZ%AP1U]<&MJBCK<72QR5QX"@N;37+:
M37-6\O69!)<X^SY!P%PO[K@;0HYST]<DSW'@JVNUO!/J>HN+ZR%G=_-&/.4
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M],L]8TZ?3[^!9[69=KQMW_'L0>01R#5+3]!DL3LEUK4[VW&-D%TT9" =!N5
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MS ABY9&8D@G//?/7FNCHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=Q'9:-I]LER,3K#:H@EZ_> 'S=3U]:LV.G6.F6BVEA9V]I;+G$,$2QH,]?E
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MW1N9+"9Y)5NY(0Q55.2%8 Y[^O?(KT#3EMEN]1,&HR7<C7 ,L33B06S;%&P
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MXKVXU"Z9&O)U6/Y/NQQJ2549Z\DDGN3["A=/ZZ6_X(/K_76YG^//^1 \0?\
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MZ;J,T$U[I]I<RP-NA>>%7:,^JDC@_2EN-+T^[NHKJYL;::XA5ECEDA5G0'J
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MT\GA;P]+<7-Q)H6F/-= K<2-:1EI@2"0YQEN0#SZ4B>%/#D<EM(F@:4KVO\
MQ[LMG&##SN^0X^7DD\=SFA/:_P#6_P#FON$UV_K;_)_>6-;O(]/T*_NY;K[(
MD-N[FX";_*PI^;;WQUQWK@[>XO[:_P!8LUO[^T671A=Q>=??:)5ERV7 ?>(R
M0!\JDKZ8KTF2-)8VCD171@596&00>Q%9O_"-:#]F%M_8FF_9Q&8A%]E3:$)R
M5QC&,@''3-2U=/\ KH4GM_78Y'2I;H7G@UWU"^E.JZ:ZW@DN7*OB)6# 9PK
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M.^G]?U_PXNO]?U_PP4444AA1110 4444 %%%% !1110 4444 %%%% !1110
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MU;2]!348KNPAM+K3[F\C@DMFC+8;=\RE3O.0,GI26W]=F5_P?T_KY&A?ZO\
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M\.O#ML-&MKF_TE8C+I6H-&T5SMC*,N067/.5)Z$#.*73[OU_X'WCZZ?UHO\
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M<SVHM9#;LF"H)*MAE;YAN;';GD'BLVV\"PVL6A11ZYJI3123;!O(.X8*X?\
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MC]*PM,UJ^NO%^LZ1<V]O'!9102P/$[,SB3?RV0 #\G09^I[;]+I_7I^@^O\
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MU1I+ 2I%([0Y:.0@O&V(P,$@'( 8?WL<5/!X-L;:STRWBO+]?[.G::"3S5W
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M]7U2UMY+[[=LA:(A9-_F8&^-OEW_ #<Y.>,XXJ=O"(.IZIJ US4UFU&W6WE
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MEGJ-W+'+<>')#D3*[#>?(;YHB 2=X ''->EV5G!I]E#9VL:Q00H$C10 %4=
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M *Q9AD;@ @()/)!KUNN/G\!VU[J\UUJ$&AW\,S,SO=Z,DEUST'G;L8' &4/
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MZ-J)2^E\M8V,(>(<Y9QYF,<'@$M[5!X:T?5=-USQ!>7\=DL.I70GB\BX:1E
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M8I!$Z=]Y?))/L ![]K/A31+K0[&>"=PD3R[X+1;E[A+9< ;%D<!B,@G& !G
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M0+JXMM,%M8Z?):7(2]D+$OM!*#RAD (.I&=QZ8YB.W]=I?\  *=OS_\ ;?\
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M7=5UW5K;7(9K;4)9K?\ M6*R>"&&,VR1L0IWNRA_-!)^XQ XR.M/=I+^MO\
M,F]DV_ZW_P CO:*X.UUG76N_$\\^H*\.AW;%;>"T4>?%Y&\1G))!RP^8'MTP
M<"?PY=>++V>'4KB[TJXTN\@+HD=[YN'*Y7R\6\9"]<AF<^_'*Z7*>AVM%<IX
M4URXN[A]/U9[^#5U0RRVE[ B#&0"870!7C'3JQ&1DYJIKFJ>(K_Q+<Z+H$]I
M;2VD,<Y\ZZ$3R[MW\)@EW1\ ':5.<\T,#MJ*X7Q'J^M6]D_DZB(KZUTW[5)!
MID:2[I1G.\RK@1'''*L<-CI0VJZ_J/BFRTV#5(K."\T0WBF.U5FCEW(,DL3N
M'S'CCCWP0TKNW]=?\@V_KT_S.ZZC!JAIVAZ1H[2MI>EV5B9B#*;6W2+?CINV
M@9ZGKZUPT^N^(8-$UW49=60RZ3JH@2.&U1(YH\Q@JP;<V,.>00<]\<5?U?5/
M$VJ>(K_2O#T]E;2:>(V*W%T(VDW+NRR&"0M'VRK(<@C-)?U]UP_K\;'8WUY%
MIUA/>3+*T4"&1A%&TC$ 9X5023]*BTC5+?6M'M-4M0XM[N)9H]XPVUAD9%<Q
M<ZAJ&L2:S:_;OL*Z9;(91 J.L[O$6.2ZD^7R ,;3P>:N> 7$?PTT!RRJ%TV(
M[F. /D'7VHZ-OR_7_(.W]=O\SH7LK26\BO)+6%[J)2L<S1@N@/4!NH!P/RJ>
MO/\ 2-;UR;7[6U;4GN([_3)K@2RVJ"W29"@!AP$D:/Y\_/U&,-UIFD^(-;EL
M/!^I76H>:=5G-O<VX@18R"DC!AQN# H!][&.V>:=NG]=?\@??^MKG7:_K]GX
M<L4O+Y;AHGF2$>3$7^9C@9QPHSQDD"M6O*_%%]>:YX'DUF2^DCMWU**%+ (F
MQ0EVJ DXW[_ER?FQSC'>O5*$M+_ULG^H/?\ KO8****0!1110 4444 %%%%
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M!Z@*3A0>^ ,U9L_"FC6$UG+!:R>99*R6[27$DGEJV,J-S'Y?E&!T&.,5M44
M8,G@OP]-&T4VFI-"UQ]J\F61WC63DDJA)5<DDD  $\XS5T:'8?VA'?&.1IHL
MF,/.[1H3G++&6VAOF(W 9P<9K1HH YVW\">&+3Q(_B&WT:WCU5R29QNZGJP7
M.T,>>0,\FM'1M'M]%MIH+9#''+.\YC\UG"LYRV"QSR<G'3DUHT4>0/74YT^"
M-%-[<WBMJL=Q<L&F>+6+M"Y'3.V4<#H!T Z5<M_#6F6LUE+$ER'LA((2UY,W
MW_O%LM\Y/JV36M10!ST/@CP]#I=]IIL7FLKYS)<0W-S+,K.3DL-[':<\Y&#G
MFDL_ GABP\.S:!;Z-;KI<YW2P-N?>?4LQ+$\#!SD8&*Z*B@+]3!T_P %>'-+
MT";0K+2HH=.GR98@S$N?4L3NSP,'.1@8J6/PGH<=V;LV"2W1MOLK3SNTLC1<
MY4LY).<G)SD]ZV:*'KN"T,$^#M%+Z:WDW0.FG-KMOIQL.,9.'^;CY?FSQQTX
MK3FTNRGU2VU*6V1[RU1XX93U17QN ^N!_DU;HIW8'/:SX%\,>(=6M]4U71X+
MF]M\!)6+#('0, 0& ]&!KH< # ''I112Z6#S,N/P[I$5I:VB6,8@M)_M,"9/
MR29)W#G_ &C^=%[X>T[4=7M-4N5N3=V>?(9+N6-5SU^16"G/0Y!R.#6I10!S
MO_"#:"=,OM.,-ZUI?2>;<HVHW!\QNY),F1GN >>,YQ6C=Z)8WVAMH]R+A[)H
MQ$R_:I0[+Z&0-O.>^3SWS6C11TL'6YBWGA+0]1\/+H-[8BYTU  D4TKN5QTP
MY.X$=CGBHE\$^&U\,'PX-(@_L@];<Y//][=G=N_VLY]ZWZ*'K>_4%I:W0YZ/
MP+X8B\-/X=31K<:4YRUN<G+?WMV=V[@?-G/O4:> /#,6@Q:)!I[V^G1RB<16
M]U-$2XY#,RL&8@@'DGD#T%=+11<"E=Z187\=K'>6ZSK:2I/#YI+%9%^ZV2<D
MCWJCXC\'Z!XMAABUW38KQ83F,LS*R^N&4@X.!QG%;=% %1-,L8]+&EI:Q+8B
M+R1;A?DV8QMQZ8K-B\'Z+#Y+)!<>9# ]M'*;R8R+&Q!*AR^[L,<Y7'&*W:*
M.<C\"Z!#;Z?;QPWJQ:?(9;51J5S^Z8]Q^\Y[C![$^IHTNUU'4M>;5]9TB#3Y
M+1)+:S5;@3.Z,P)D)"@+D*N%Y(R<UT=%.X$%Y9VU_;-;7<$<\#$%HY%RK8.1
MD=^0*H6_AO3;:>6=$N6ED5DWRWDTC1J>HC+,?+'^YCH/2M:BD!S2^ O#Z65M
M9K#?"WMIS<PH-3N?DD/.[/F9Z\_4D]SFS+X/T.9YV>T<B:X6Z=!<2A!*I#!U
M4-A6R,D@#/?-;E%%_P"OZ] ,G3/#>EZ/<WEQ913+)>MON/,N990YP!G#L0.
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MJC  '0"G44>0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\?B&EOX>N&&N26_V)OM-N PC(!)S)D9 R/Z&JE9;>?X-6^]-_<):VOY?K?\
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M]"]_Y.W'_P <KT"B@#S_ /X4E\//^A>_\G;C_P".4?\ "DOAY_T+W_D[<?\
MQRO0** //_\ A27P\_Z%[_R=N/\ XY1_PI+X>?\ 0O?^3MQ_\<KT"B@#S_\
MX4E\//\ H7O_ "=N/_CE'_"DOAY_T+W_ ).W'_QRO0** //_ /A27P\_Z%[_
M ,G;C_XY1_PI+X>?]"]_Y.W'_P <KT"B@#S_ /X4E\//^A>_\G;C_P".4?\
M"DOAY_T+W_D[<?\ QRO0** ,?PWX6T;PCITEAH=G]DM9)3,R>:\F7( )RY)Z
M*/RK8HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<*&(!"Y([].,XR*BB\:^'9X;>>'4DDM[B8P1W"1NT/F XVF0#:N3P,D9[9H
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M:7:5!PV=H8-QZ5WE"VN#T=@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDLR%52I+HQ9/ER H[FC7O#6HQ>*I;R/P7HGB:SO4B7-V\4;V3*NT@%T;]W@
MX7)!S7H-_J%KIEM]HO)?+BWI'NVD_,S!5' [D@59I+2WE_7]=2GU\_Z_KH<7
MJN@WT6J6][H4%W97Y\N.1[::,6;QJ!Q+$QSC&5!1=W Y KIM:M);_0M0LX=O
MFSVTD2;C@;F4@9_.KU%)JZLP3LTT<1'8ZW9W>AZVNDS3/;:>;&YT]9XO-7.P
M[U)8(3E,$;AD8/48K:\,:3/ID>I37 *2:A?27?D;@PA#  +D<9PN3CC)/)ZU
M>CUK39M9FT>*\B?4(8Q++ IRT:G&"WIG(X-7ZIN^O?\ SO\ F2DEIV_1?Y'
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M@32&1F7&,%F))XI?9:6__ 87U5]O^&.;T?6?%FI7I$^BBUL;B O#<RK$1 V
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MXS^QMH\L\D&G65];+.;F[A=XBS#B(R!@(SR/F;(/0"K,W@N.6ZUB<:UJ<?\
M:L"P2QH(-L:+P F8B1@%AR3P3WP1:'AD#0X=)_M?43!'$L#L?)W2QC(VM^[P
M.#C*@' '.>:7_ _7_@!U_KR_X)DZOXFU]M3N;+P[I!OGL=GGMB(H[,N[8"\\
M93@CYMKCGIQ4]_XKEL=?M+&]>#2XYX$9#>1,RS2MG]VLRL$5E/8Y+9XZ<IJ?
MP]TK4-2MK^WO=6TN:&)(&.FWK0>=$GW4?') ]1@^]:VJ>'X=5M/L4UW=)8L
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MDFFZQN=VC./*D*!7!QR P (/KG..,EIX9@TNYM-1?4-2NIK&T>V7>4)>,E6
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M.,#\J2^%+^ME^H/?[_S_ ,AU%%% !1110 4444 %%%% !1110 4444 %%%%
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M,-NQU '3 Q5M>];S_6W_  5Y$MV5_P"NO^1[%17FMBVFW&K^-=#TG5+*R4M
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M(//M@K21^=%+A6S@AHG=3G!XSD=P*EU+Q/!I\UQ''8WU\+0 W;6B(PMP1G+
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M,%(]*Y'7-5&I>+O!UW!9ZC%$UY)Y+R.%CN4,#L"J!^#D#&\*?3BA:M+^NO\
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M \9.:U+GQUHEIX>L]9EG"0W@/D1S2QPN[#.5S(RH",'JPHV5_P"MVOT$G?\
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M+Q[-J:OI:Z'I_P!NU5)))(TBO([>>--A5G0R*R$?,,A@1TX].SJGJ.DZ;K$
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MXS%F:=Y0B$ %4#$A <#(4#.!FIM,TNST>PCLK&(Q6\8PB%V? [#+$G ' '8
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M=8IXR<\G8JJRG'#*,''4URVK:H=-^)NJQK-);-=Z=:6ZWBH"MLS/+AVR".N
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M;^=_Q;_4FVEO*WX6.?\ %TDD6FVKI8RW06\B9FCB>8V^#D2>6GS/@@<#UR>
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M\)ZG-=6U])=Q:G%&OV5LNQ64R;@=V&P5P3[8KT&6XA@*"66.,R,$0.P&YCT
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M"3U# CMWI:V_KM_F/2_]=U^ES'M_%FM:M<^$Y['3[..UU2"2XFCENV#+A1D
MB,Y #9'3)],9JC#<VOAX?$&Z72%N[6&[666SB5%5U-NA<D-@$<DGJ3SP36SI
M?@J?2;30(8M:DE?21)&));=3OC=<%0!C:1@8)W>^:AN?!FJW%OXHA.M6:KKI
MY/\ 9[9@&P1_\]OF.P#TYYZ<53MK;S_-?\$<;7U\OU_X!>/B:Z.L1:/9:-NF
MDT[[9$\MPL<)&5&W(#, ,XSM], ]17?QU"?#VG:A!83R7=^CF*T6.63:4X?<
M8HW;:#QN"'J.F:=!X9UJ'7+;4SK-@S0:>;$)_9S@'.#NSYW]X#CTR,]Q07X?
MZ@GAW3K.'Q&;75=,ED>TU&ULPN%?.Y'C9V#@Y]1T'IR/^OO?Z6(C?K_6B_6Y
MI6OB^:\L+,1Z1/#JMW))'%9W>^ '8,LY9T#"/IAMF>1\M9_P]B\G4O%R?98K
M4_VOEH8B"BL88R<$ 9R23G SGI6C)X6U)[?3+AO$#S:Y8,Y%_/:H4E#C#*T2
ME0%( X!!& <GG-GP_P"&Y-#U#5[Q]2ENFU.X%P\9C54C?:%.WOR .I[#\6K)
MO^NW_!![?UY_\ V[B1XK:62.%YG12RQ(0"Y Z D@9/N0*Y"R\8QQZ'X?N+70
M)(H=5N6MTABDC5;=LM][IR=K'@$=>>F>OG65K>18'1)2I".Z%E4]B0",CVR/
MK7%6_@?5[?2=$L%UVQ(TJ\-TKG37_>?>PI'G<??;GZ=,',K?7R_/4;V^_P#+
M3\3H-"UN759]2M+FT2VN]/N!!*L<QE1LHKJRL54]&'! P<]>M:TQE6"1H51Y
M0I**[%5)[ D X'O@UAZ'H5]I>M:S?W.H6]Q'J4RS"*.U:,Q%5" ;C(V[Y5'8
M<Y/M6^>10]M.P=3S)+S4-8T3PIK&K:?9F^_M93 \$OF-M;?D995V= , G@#G
MM6QJ7C Q>'?$,NH: MS)I4ODW5I'.LD;H55PVYPN5VL,C;GK@&G#P;JL-AI-
ME;:[;+#IMW]I02Z>7+@%MJDB4<@,<GO@<#G,=]X(U6]M?$UN=<LD37'#,?[.
M8F$!0F!^^^8[5'/'.3CM37]?^2_\$>E_Z[R_X!L7?B5;?7[;1H8K8W$MN)]D
M]SY3.IR (AM(<Y'(RN 16_7-ZWX8GU_2(M/OKFPD&Q5E=K#<5('+PY?]VW0@
MDMC'>NBC3RXDC#,P50,L<DX]302N@ZBBBD,**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***;)(D4;22.J(@+,S'
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M 8)8Y&,'C.<#%*-_Z]?\A?U^7^9Z9534+^/3X%=U:221Q'%$GWI'/11^IST
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M>'75OEMYK+[2QB),^QH##G8"%/# ;N <T+>W];V#I?\ K:YZ;17$>&HKR_\
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M #'..FTG8OL*ZFBCI;Y?U]X7/-?!OAK4-(U2"SO_  /H,?V(83Q!"T0DG &
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M#WQZ?12O_7S3_0'K_7DU^IQ975_^$UO-3_X1Z_-K)I*6Z-YMODR!F?;CS?\
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M?V?H_D[/,_MBTV[^F=_?%9_B#PGK>N:7K4VS3H]5U.VCL_*^U.88(D9FSO\
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M_,ZBLR^UZST_4M-L)5G:74)&CA>.(M&&52Q#/T' /&<G!XXJW?(\MA<)'/)
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M#!2U_K^NP/0]!HKSU[KQ)=Z+KT=EK5W]LT6_:-)$@MS)=1!$<HP,>T-AB 5
MYQD&NAT6^DUO5)-2L]5FET@01I'#LCV/(R[BV=F[(#+_ !8SGCBG;^OE<&=#
M16?KLMW!H-_-8S1PW44#/'))'YB@@9Y7(ST]:Y6QUC68%\)WUQJ#WD>LHD=Q
M;-#&HC8P-)O0JH;JO()(YXQ26O\ 7K_D']?U]YW5%<#H.J^*]>N;76;>XTQ-
M)ED9);=[O<8QDC&P0!EE!P"#*1U'<$5;3Q#K_P#85AJUSJ:R2C6SI\T,=NB1
M2QFX,62#E@0.1AA[YII-_P!=P>E_Z[_Y'<ZUJ]KH.CW.J7@F-M;)OD\F)I&
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MGDD2$'J(U9B(Q[* *JW/@G0;JS-I):SK ;G[5LAO)H@)-V[(VN,#<2P X!Y
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M\\8,<14DRC=P1P "01EAUZ5?M-1MM*M[2TU;Q#:7-U<L?LTLS1PO<*3E<*"
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M'$\QM\'(D\M/F?! X'KD\ UQOV76[*RU6:VTR]OS;:^M])!+ L;7</EI]P8
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M2O?!^MS:5JNEVL^GI%<:HNH6]Q*SLW^M61E= !T(X(8Y_P!GK5NW/;I_P?\
M(F-W%7W_ .!_F:]UXWT^V&K,MEJ,RZ2X6]98 @C7&2XWE=R@<_+DD= :J7HC
M/Q/T"ZCDD*SZ;=$@RL4(!C*D*3@'YCR!DYYJC>>&O$US;^+XC#I!;6HUCA?[
M9(H7$8C)8>4<<?-@$\\9_BJ]_8>NS>(="O9[;35MK.PDM;D+>2%\R;02@\H
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MAW0R$!" &/!P=Q;/;'2M#2=6\5:[J":I9SZ:FEI=/!/;27G*(LA4Y3[/N67
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MCP7"!00ID/0#( ^M%OZ^[_-%-6_KU_R9TZ^(+-_$S^'PEQ]L2V^TEFB(CV9
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M56:ZM(IG"] S*"<?G7*KKVK+XGTK;J$ES9WNH3VDJ1PI]E1561DV.5$AD^0
MD%ESN''%4XM2Y24[QYC:F\;Z5!8ZU>/#?^5H\OE7(%H^[. <JN,E<$'<0!CG
M..:WXIUFM4N%#;'0.!C)P1GH.]><:G_R"OBC]#_Z2)7H6F?\@JS_ .N"?^@B
ME;W;^GXHJ2L_O_3_ #,VP\46FIZ%+JUE:7\L4<S0F$6Y$Q97VGY#@C!]<'@U
MN5YC!J&I:5\/M8OM+N8H)H=:NMS20^9E3<E2!R #SU(/3I6EXRUS5M..H7.G
M:A+G3XHY!;6T,;J<G+?:&=>!C& C!L9.#Q0M?P_%)_J*6C?S_-_Y'3V?B"SO
MM?U#18DN!=6*1O,9(BBD/G&TG[W0\CCWJY<7GV>YM8/LUQ+]H<IYD2;EBPI;
M+GL#C'U(KB5MKN]^)7B-+34I=/E_LRS8311HYSNEX(=6&/7C/N*=9>)M:O7\
M%W#RP0PZFTL=W"L',C+&[!E8GA25! QGD<T)7M_7?_(3>_\ 71/]3H+3Q5:7
MUEJMS:6>H2_V;,T$L(MB)7<*&PB'!/##&<9^E;8=3M!.&89"GK7FESJ&HZ5H
M7C_4-+N([>ZMM3:0/)%YG ABR ,@9]SD>QK8OK2]O/B+8B/6]0M$;297\N!8
M2H.^,' >-NN0?P'09!+:+^OLW!NU_P"NJ1VM%<'87FLRI)X>GUZ\_MN+4"'N
M1#;AC;8WAPOE[=I7"YQG?GG Q75ZY=2V&AW5Q#<002I'\DMP"4#=!D 9)] !
MR<<4GM<?6QHU6N[O[)Y'^CW$WG2K%^Y3=LS_ !-Z*.YKSV[\1>(-/TCQ<(;Z
M=Y=+M8KJUGU*TB\PA@Q8%8]HQ\F!E01SD'BM74+W7]._L.Y&L)+!J&H6\<L3
MVBAE1T&55@>!D,>03\V,C%.VWR_$5]'\_P #MJK6MY]JEND^S7$/V>7RMTR;
M1)P#N3U7G&?4&N:EUV\L?%LEMJK7UI:32I%8R"!'M)<XX9PNY)"<CYB >, G
MKC7GB/Q';Z+XAF&HVIN+#68[5'^R?+Y+>4-H&[@_O,Y);ITYX%K_ %YI?J-_
MU]S?Z'H]%<K:ZCJEOXKUG2VN&OUBL(KRW61$0J[-(I0%0/E^08W9(R>367H.
MO:M?:UIEM;ZS%?+/;FXU.*2U5C8L N(AL*&/.YL"3>WR]^:$K_UZ_P"7]7!Z
M?UZ?Y_U8[ZBL/Q/JTVEV]@D!V27U[%:><5W"(,3EL>N!@9XR17*>(-8U[1+7
MQ%IR:Q<RS66EC4K74&@A\P'<P,;@)L()7C"@XSW&:2U_KT_S'8]'I%96&5((
MR1D&N3:^U)O&UIIXU*=;2\T>2<QB.+]W*K1J'4[,Y^8\$D>U/^'<-Q'X-LI+
MG4;J]>8,^;C9E/F.0"J@GGGYLGGK3M_7S:_0F_\ 7RN=55#4]5335C5;:>[N
M9<F*UM]GF2!>6(WLJX ]2.W<BN9N=4U;4_\ A(;BPU)K!M%F:*.V\E'2<K&K
MYEW*6P=W&QEX]:SG>\UWQGX2U%-2O[!;S2YKG[.B0GR^(B5^:,G!SSDYX&,<
MTDKV_KHW^@]K_P!=O\SO[*Z%[90W*PS0B5 WESQE'7/9E/0U/69X@FU*#0[B
M728&GO% VHA4.5R-VW=\N[;G&>,XS7*7'B.YET_2I[#5;]94U:WL[R"[M8XY
M2'*AEE4H,'N"FT<\9IK5V0/17.^K/UO6+;0-'N=4O%G:WMUW.((FD;'K@=O4
M]!WKD[OQ+?:)<>+7N;YIX+&2V^SF>--MN)<9SM"DJI.>3G ZU)XEM]2MO!OB
M;[3JXU&RFTR62W:5$656VMN V*JE,%<<9ZY)XI+57*BKR2??^OS.VBD$L22+
MD!U##/O3JY+3[[4+7QC::7->M<VEWI9N1&T:*(71D7"$#."'Y#%CD<&KWB+5
MFL[S2=-2\^Q-J<[PBY"J63"%@%W KN) QD$=>*;6NG];_P"1">FO]:(MZYKU
MIX?M8;B\2X9)IT@7R82^&<X&XCA1DCDD5J5PGBV+4+?P6T&I7D=Y-'J=H$F5
M0K-']HCV[P  &QUP /84GBC7=5L;R[GL-0D9;*>!#;6\*/$%<J&$[.N0WS$@
M(V0"I(YH2_/_ "_S&]K_ -;G9K>;M2DLOLUP/+B67SRG[ILDC:&[L,9(]"*L
MUQUUJNMKXH\0:?%?6RQ0:9'=6>;7(B8EP=WS9?[GJ!STXYH:9K&MSCP?-+JK
ML-;LR+B/R(PJ.(O,WI\N0W;DE?84)77]>?\ D#T_KT_S/0**Y[PCJ%Y>V6H0
MWMPUS+97\UH)W55:15(P6"@+GGL .*Z&D 4444 %%%% !1110 4444 %%%%
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M)?\ Q_@8 &!CCCIQ6S:64-E8Q6<'F^3$FQ=\SNP'^^Q+'ZDU8HI=+!YG-_\
M"":!_9$^E>3>FRGF^T2QG4KDEGSDDMYF>3R1G!/)YJ>X\':'=_:1/:RR"Z@%
MO<!KJ7$R@8!<;OF<#C>?F]ZW:* ,BZ\+Z1=SQSR6SK*B",O#/)$9$&<+(58>
M8O)X;(Y-+>^&M*O[O3[J:&99-/.;40W4L*1\8^XC!3QQR#P2.E:U% './X&T
M"2UU&V>&]:'4I/,NT.HW'[UO4_O.., @8R  > *OG0=/6:SN1!))<V,1B@D>
MXD9MIQ\K,22_*@_-GD ]:U** .=\/VNH7=_-KNM:3;Z;?R0K;)!'.)V2-6+?
M,X4#))Z#(&!6QJ.G6FK6$MC?0B:WE&'3)'0Y!!&""" 00<@BK5% =;G/77@G
M0+V*YCN+6=Q=0I!<-]MF#RHF<!F#Y/WB"2<D'!R*GO?"NDZA:V-O<I=M'8N'
MM]M].A5AT)*N"Q';)..U;5%%P,^;1+"XO(KJ:.5WB;>J-/(8]V00QCW;"P(R
M"1D=JRI? /A^>*[BDAOF2\G6XG7^T[D!Y!T8_O/I_P!\KZ#'2T4 <_<>&+.W
MGO=4L8;F35);7[.#-J,^UU PJG+$#N<XSDD]237->%/!U_I^IPW)U3QE EN0
MIM]5U*">WD7&"%1"QQZ9VD?I7HM%"T=P>JL5K_3[35+*2SOH$GMY,;D<>AR#
M[$'D$<BJEOX>TNVL;BS%NTT-RGESFYF>=Y5Y&UGD)8CDX!/&>*U** ,:V\)Z
M):W=G=I8B2ZLD,=O/<2O-)&IZ@,Y)]OIQTJYIFD6.CV[06$)BB9R^W>S $DD
M@9)P,D\#@9X%7:*+A8R+WPSI%_?M>W%JQG==DOES21K,OI(JL%D'LP--N_"^
MEWNLV^K3+=B\MUVQ-%?3QJB\9 17"X.!D8YP,YK9HHV CG@CN(C'("5R#\K%
M2".1@CD5EMX6T>33)=/DMI'AED65W>XD:5G7&U_-+;]PP,'=D8&*V** ,=/"
MNAI<7=Q_9D$DUY#Y%S)*#(TL>,;6+9)''/J>3S6;:?#?PE8:5>Z99Z2+>UOC
M_I*PW$J-(/[I<-NV\GY<X]JZJB@#%A\*Z5!JMKJ:+>&[M8?(B=[^=P(_[I4N
M0V< G(.2 >H%6=;T'2_$FF/IVL64=W:.<F-\C!]01@@^X.:T:*'KN"TV.=/@
M7PZ- @T..P>#38)!*D-O<RP_.#D,S(P9CG!Y)Y /45-<>$-#NFNS-:2-]L51
M<+]IE"R%0 &(#8WX ^?[W'6MRBBX&#-X.T:>^N;UH[U;BYA%O*T>H7" QCHH
M"N !UZ =3ZFF0^"=#@.F>5%>K_98Q9C^T;C$0],>9R,<8.>..G%=#11_7]?>
M!S+^!M&2QN;6"&ZVW-PMS(9=0N'(E4[A(-SG#9P>,9P,]*Z:BB@/,**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "L[7M__"/:CY5BU\YMI +57VF;Y3\F>V>E:-%)JZL-.SN>8_8-7OKN_:R2
M\$U]X?\ L]O-+9-;1Q2 MA/F&]>H^\2>XK9\-:C_ &W<;YO"&J:1?V=H;5IK
MJ)8XL<92,AOG7(&#MQCOV/:T4WJFOZZ_YB6G]>G^2/*C"8O"G@=;C1=0-]IM
MW LA&FRR/"J#$ARJ$A<XYZ-U&0*T+ZTNO[.\4Z'>Z==W-[J<\TMC<);,\<@9
M!Y>Z0 K&4P!\Q7[H(S7HM%-N[=^OZV_R'?6_]=?\SSNWA33O'=Y-<V%Y+*NB
M1PSWD6F3,L\RYW8=4(9MN.A.>G48J_X&U0V/A;PSI-UIVJ17$EL8F:6RD1(7
MC ^5RP&W/\)Q@X.#7:TQHD:19&&63.WG@>^/7WHO_7S;_472W];)?H8OBJR^
MUZ?#(EW>V<]K+Y\,]I 9V1@K#F, [P02, 9YXQ7.,^KO+X5U;4]/E/V:\N%G
M:TM'R5=&5)3",NF[@D')7/..<>@44EH#U5CR;5K.XD\(^)8+KP_J#ROK1N+/
M_0S,6RZG<@3<PP%;YB .>"<UU]F91\0+B[^R7?V:]TNW$4I@95!1Y"P8D#8P
M#K\K8/MP:ZJBB.G]>5@?]??<Y;Q$+JS\2Z-JYM[BZTVV2:.>.WA:5XG<+ME"
M+EFP R_*"1NZ8S7':]HL@T.\E&E7,L-WK]O>6%M'822/!&#'YCE0I,>[$A(.
M.OJ<5ZU133M_7FG^@/7^O)K]2M';6CV;QI;1B"<%GC,6T/NY;<I'4YYR/K7F
M&@VRZEX)TO1=/L9XKJ'4_M"3"U98842Z8EA)C;G:"NT'=SC&*]4FC:6"2-)7
MA9E($B %D/J-P(R/<$5F^'-!C\-Z4-/BOKN[B$CR*UUY>Y=QW$?(BC&23R._
MIBA:-OT_!W$]E\_Q5CB-$T9[S2O&EKI^GRZ?=3WL\NG2SV+VX7?$$#H648R=
MPR.>3ZUHV\$NL:CX9EL]-N]-N-*++>>?:M$$C\HJ8E8C;("VT_*6'RYSTKO*
M*+_I^"L-ZW^?XGG7AFXN_M%CH&L^$]2&HZ=/)*NJ+&OV4L2P\X2;@2S!CE<$
MY//J*/AFQ9=<M=-UCPUXD;4[*X>8:BU[,U@3D_O5S+L!8$_(%/7&,9QZG10G
MU!ZW/+-'L2OB-=+UGPUXDGOH;U[J+4$O9C8-\Y99,>:$4X/*!3]*CU:VU-O!
M=YHSZ+J%SK$>J+<NR6Y*SK]I#"19/N$[,#&00!R !FO5Z*2TM_6UO\@>]_ZZ
M_P"9YGJ<-LWBKQ0\FA7IBO=&CC?&E2R+-,"Y(+*A5V 9!D$].O'"Z3(8;OP"
MHTW4XOL]G)%<$Z;.HB9HU7#G9A<NIZ^QZ$&O2Z#R*$[?UZ_Y@]?Z]/\ (\3N
MO$GA.75T\+:KJ-@EO;ZS)<R?;K:5I6<RL?+96B\O:=WWR_W<<"O8K6\%Q<74
M MKB(6SA \D>U)<J&RA[@9QGU!K/LO#S6;E/[8U*>R(*BRG,3(,_[>SS#WZN
M<Y.:VJ:VM_73_('K)O\ KJ%%%%( HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMJMHT:" I'&N=NW,9.1N;DD_>.<\8Z2BCI;^M0,"T\+BR\/6VC0:QJ(@@B$
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M4C;A_P!US\OR\8XYZ\TD7@.T2UN(I-6U.:26\^W1W#-$LEO.<@NA2,#D'!#
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M10JC"@8 ]!2T4=+!YA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.:](HHZ6\FOT7W%7UOZ?G?\ $\B%QHC:IX)O-,C\R\^V$:C)%"SS"7R&4^>
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M$NY+YX9)O/4.8RDFY"<YV[BGR] 2O<BI-)FTJ[\:K!K&K:S;>*H+MV-LEE$
M\0<E<3"#=Y!7'#28QQ7L%%-/^ON_R$]?Z]?\SSOX:P:/?'5+N">.\N+35KH0
M3?:3,ZQ,0!\Q8DJ0O!.<X]JN?$?4-/MTT*VN];CTN5]2BD67SHTD15#9<;P1
M@$@$D$<UW%%+MY6_ ._G?\?^'.+U71[#P]X?UK5[B\U&^N;N%$N+UI464Q@X
M4 HH1$&XDD+TR3FN(U673=/T/QO;Q75A9VLFGV]S:1Z;(T$&]@X!0J0&+,H!
M(P&X&#W]KHH[AV9YCK.B>&6C\*:E+8V$]M<7Z&YGE194<FW9!DG(Y94'NP'>
MKFK:):Z)K]PNG:3;"#Q-#]DD*6R_NY^2688Y4H78@\9C]6KT*L:VT6\77Y]2
MOM7EO( 2;.S,"(EJ" #R!N=NO)/ )%4W=_?^/0%HEY6_X<O6NEV-EI2:9;VD
M,=BD?E" (-FWN,=.>]>:W>AV=GIUU8VND6[3>&+QM1MO]&4[H21*$4X[@NOK
MF,'TKU6BIN[W_KN"M:W0\S\9KI%IX2CUB1H+">_U2VN=XD\@R@RKC?@C?B+)
M(;..3VS5JX7P_8_$?5-5O(]/A=](AG@NY$0$X,H=U?']TH"<]"N>U>A44=&E
MY_BK#3_KYW/'= U#0[2+X;W4%]8QWEQ&;:>03KYCIY+#RV.<D"3: IZ-@#FO
M1O%MFVH>'YK9;RWM2S*=]U'YD+ ')21<C*$#!Y']*W**<WS?C_F);W_KK_F>
M9-JYNM(TN6]L+.#08K]X=2:T?S;.6+RCLD4X ,.XJ#Q@$<\ U!J+VEAX1\<-
M8W%M'X9DLP+ I(!#YK1D.L1^[M)*8"\;B0.<UZI12?\ 7X?Y:>HXNS3['C_B
MC4](DN=+_M_5+J#0+C3X?L-S:6D5W"TXW;@=T,N'QMVE<=Z]0T6)8-"LHHI[
MJ=$@54EO/]<X X+\ Y(ZY /J*T**;=[^?_!_S)2M;R/+O"^JZ%?ZW:6M]!>6
MOC:UD?[4%MI \HRP.^7:083G(!; P,=!5=?*N=)A,8A3X@0WB^9SBY(\_P";
M/\1@V$_[(&/2O6:*$[6_K^O,;UO_ %W_ ,]#QS6;G07A^(_FZA:S36^V2W\Z
M[\PPR^5P4W,=K"0D#&,'@8Z5NVX\/W/C6TU6[%@[7.B+)%>X7<S*Q#NL@YR%
M/+ Y ]!7HU%);6_K9K]1MW_KT_R_$\>\/Q12_#%M4TAFNKZ"XEAFE@F:68VI
MNMTB@@DDF,9!Y/.1UYZ/2'TB#Q5]O\,S6,?A\V$KZDUJZK;K*&4HQQ\JOC?N
M[X'/:N^HIM_U\K?\'U%_7XW_ .!Z'(?#*[MKOP%8&VN(I@C2*YB<-M;>QP<=
M#@@_B*YS5C97"^(H-7$2>*4GF?1V;B<KL'E?9CUQP-P7ONSUKU*BD]7_ %Y?
MY M/Z]?\SS_6K-?#^J:/XI?1K>YU.>-;"^,,2[VDD4!&!QG[X"$_W6]JRO&E
MIH_AQ=,L=3,NF>&&AD\U[+3X98?M)93F2-HI!SSM(7(.:]5HH?\ 7^0+3^OQ
M^[0\HNUT6'5_ =H=5NKF"1[A0-2F,;RPM&^TM$0HQD[02H.,"O4;2TAL;.&T
MMDV00((XUR3A0, 9/)J:BG?05@HHHI#"BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "JNIW;V&F75W';/<O#$T@AC90
MSX&< L0!^)JU4-W ;FSG@#;3+&R9QTR,5,K\KMN.-KJYP"ZI/JMWX(URYL;V
M"YF\P&#S 1(#;LV557*8)Z%L$#K@5TB^,]*70IM6NV>QC@G:VEBNV2-DF!QL
M)W;,Y[[L<]:R+;0/$EN?"D;1:4\6CKMG874BLP\LQ94>4<\'=R1SQ_M&NOA+
MQ'+IE_\ O]/L-2&JMJEA-%,\Z!CP4D!1."I(R,_>]JTE:[2VU_-?H1%/1R\O
MR?ZV.D\,^+-,\5V]Q+I\F7MW"31^;'(4)&1\T;,AR/1C^=<W\2M7CNO!?B"T
MMK>^D%M PEN[=]D<,H 8*Q#AFZC( 9?[V*ZGP\GB%; MXEETUKTMPFG(ZQ*O
MU<DD_D/;N>:U3PAK4^D>(M#LI[ :?JSRS1SRLXEA>0@LI4*0RYR0V01G&#UJ
M7O\ UW1<7U+NK>/]"\,I;VM]<H9EA1Y4%Q"C1H1PVUW5FZ'A Q]JI^(=674O
M%&BZ0VBSZII-[;2SLH\AHIQ\FUL/(,A=V2".X(!(X63P_P",],U87FA:GHS)
M>1Q#4(KVWEV+(BA3)$%;/*@#:6QQUK0U#2M>D\9Z3JEO#ITUI9V\D$C2W;QR
M/YA3<P01,.-G W<YZBGHWKW?Z_\  )6BMY?Y?\$JVGCOPMINI6OARVNDVHXM
M(F%W')MD!VB,J9#+G(QDKCWJXGCO39;9;M+/4?L?VW[%+.\ C$,FX(-RL0V"
MQ X4X[X'-5-'T3Q?HNK-90:CI4WAL2O+'YT4ANT#,6\L$';@$XW')QVK-E\+
M>*)/#5[I_P!FT<3W&KC4 ?M\NT)YHE*Y\C.<J%Z=\]L$6MK_ -:K_@CMO;^M
M'_P#LDUN*75I[""VN)OLY59YH]A2)V (4C=NSA@<A2,=ZQKKXC>';374TF2\
MC,IF%NSK<0G9*6V[#'O\SKW"8]Z-6\,7.H:Y::G;V]I97J.AEU""YD678I!,
M90*%E!^9?F(P"#CM5?3M#\7:-KLMO8ZEI3^&YKA[C%Q%(UU#O8LR)@A2,DX+
M9QGIQ0MU<'L['3:KJD>E6\;O#-/+-((H8(0N^5R"0H+$*. >20/>LA_&^FPZ
M3%J%Q;7\0>\%BT)MR[Q3;MNUMI*@9[Y(.1@G-6_$=AJ=_!:+ILL06.X#W,$D
MS0B>/!!7S%!*\D'ISC!X)KE[GP=KD6@SZ9I\.D;&UA=0C4S/"JHLBR;>(VY)
M7'XYR>E*.^O]:K]+@_+^M_\ @'31>*;$OJB7<5Q8OIJK).MP%),;9VNNQFR#
M@X'WLC! KG(KI[OXN:=,]G?V9?2;C,5U("& DCVLJJ[*,Y/HWJ*DU'PEK.L:
MOKTD_P!@MK;4+:W2"6.=Y'CDA8NI9#&H()/.&Z#WXLMH7B6[\3V&NW$VEVTM
MO8S6KP1&24,7((96(7'*@\@XZ<]::W3_ *V?ZV![-?UNO^":SZK#8B2[D22:
M>\G,-K;Q8\R78#A5R0/X7;)(&#R:IW'CS2[+2[F\O+;4+>2TF2"XM6@W2Q._
MW<[25VG(PV[;VSFI]:\/W$ZZ1<Z7)$E[I,F^!)R1'*I0HR,0"1D'K@X(Z&L'
M7O!^L:OI^JS1IIZ:GJCVPE1KF3RH8X3N 5O+R[$Y_A7K[<I?U^'_  ?0'_7X
M_P# .SM-0%S;SS2VUQ:+"[(PN4"Y"_Q#!.5(Y!JK9>(+>[TU]2D@GM;)8VF$
M\^S:T8YWY5FP".<'!]0*T5\YK4>8D:S%/F4,60-CIG )&?85QL'@7#ZM;QI%
MI>F7UJ]N;6SN'D1G;'[T(RJL3#YN%R#G)-'<%TN36GQ(T;4I+VWTT&[O+>W>
MXBAAN;>3ST7&2I20A>HX?:?;BJUMXVU66U\+N?#M\7U7F7$EOT$1?*_O>AZ\
MX. >,X%7M#T_QG]FNK/Q)J&CSVXA:*"6SAD$LF1C=)N.T?11U[U%;>'-:@T_
MPNI>P-SH[;)%#OL=/*,6X';G=SNQ@#MGO5*U_N_7_@$N]OO_ $_X)#I5S9Z'
MXH\:7=U<-%:1&VFDDGF9@F4)."Q.!D]!P.U20?$_P]/9ZE<*\K_V?'YTL=NT
M=TQC)QO!A=QCUR01U( J*Z\*:QJ5]XF\][.TAU(0M:7$$[R2120XV,R%%'4
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MAH7.J27LLEE>N#+$BB,D1\*$ ^7TSD_[1J"+Q'XC;0+*=M1M3<GQ VGSN+3
M>,3%!M&[Y>G?)]^]"7]?.P/OT_X%ST>BN)_MG6;(>++6.9]0GTT1RVKRQKO
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MV0Y8\#GK2TM?^NO^0=?Z\O\ ,Z:JMY?+:0QR+!/<AYEBQ;IO*Y;;N/HH[GL
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M#)N16W.GD.2G. 5=.AKN8F+Q(S;=Q4$[#D?@?2CI<'O8?1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5!>6=O
MJ%E-9W<*S6\Z&.2-QD,I&"#4]% &1:^&-(M+B.XCMI'FC@-L))KB25C&3G:2
M['=]3DBK>F:79Z/81V5C$8K>,81"[/@=AEB3@#@#L  .*N44!8IZEI=GJ]G]
MEOHC)%O608=D964@JP92""" <@UEOX+T.2:_E,5X&U",17.W4+A0Z#HH ?"@
M=.,<$CH37044 <UJ7P_\+ZQI-GIFI:7]JM;(8M_.GD:2,>@D+;\=.,XX'I6_
M:6EO86<-I:0I#;PH$CC0855'0 4RU^W>;=?:_L_E^;_H_D[L^7@??S_%G=TX
MQBB]^W>5']@^S^9YJ>9Y^['EY^?&/XL9QVSUI_J+]"IJ'A[3=4U2RU*[2=KJ
MR)-NR74L:H3P3M5@I)!(Y!XXZ52UGP+X8\0ZM;ZIJNCP7-[;X"2L6&0.@8 @
M,!Z,#70T4AF#KN@VDRW.IP6$\VI"V:%!:SF)IA@X5AO5' R<;^!SBJ/ASPY'
M-X7\/)K&G3VNI:9;+"!]HVNI"A6&Z)R&1MH.TD@\9%=910G;^O7_ #!ZG/S>
M!O#$^BW&D2:+;&QN)3-+$ 06D/5]P.X-[@YJ>Q\*:-IFC1Z3I]HUG9Q@A5MI
MY(F&>IWJP;)]<YI=8U*ZBOK/2M/>"*^O$DDCEN(C)&BQ[<Y564DG<!U'<]L&
M_;R7,>FI+J"PK<K'NF$!+)N YVY ./K1>R;_ *T_R"VJ*C>'-)9;(?9 /L3L
M\!5V4@MG=D@_-NR<AL@]\UJ5@Z!J&K:LEOJ<ALO[)O;99X(U1UGA+8(5CDJ_
M!Z@+@\8/6CQAK-]H'AZ74;"WMYGB= XG=E 5F"Y  Y.2.,CZTVFG9_UT$3WO
MAG2+^_:]N+5C.Z[)?+FDC69?2158+(/9@:;=^%]+O=9M]6F6[%Y;KMB:*^GC
M5%XR BN%P<#(QS@9S4+:U?)X[@T1K>W%E+82722AV,A9712",  ?-[Y]JWZ6
MR3_KL/R"L;4/"NCZI)>R75O*6O8UBN#%<RQ>8HZ9V,.<$C/4@X/'%;-% 7,.
M'PAH\%]87J)>&>PB,-NSZA<,$0]5(+D,#QG(.<#T%1:3X%\,:'K4^L:9H\%M
M?SYWRH6XSUVJ3A<]]H%$VNWL7CZTT$V]O]BGL9+D3!V,A9&52,8  ^;U.?:N
MAIZ[_P!>86Z?UY!61I7AG3-&OKJ]LENQ/='=.9;Z>8.>.2KN1G  SC.!CI6O
M12 R+_PQI&I7-S<7=JSO=0?9[@+,Z+*G/#*K ,1DX)&1V(IL/A72+?6(=5BA
MN%O((?(C;[7,56/^[LW;3D@$\<GD\ULT4+0##O[)M&CO]4T+1UOM3N75GMS=
M^2LAX4MELJIV@9(&3M'7BK&@:8=,TYA+%#%=7,SW-RL/W?,<Y(!P,XX&<<XJ
MMXQUB]T#PK?ZKI\%O/-:Q^9LN'95VCJ> 23[<9]16W&Q>)&/4@&A; QL[M%!
M)(D3S,JDB-" SGT&X@9/N0*XWP-X:^RZ5#+JNEW5I?PSRLL4]T'C^:1F#JB2
M-&&PV-V W![5UWVZW_M$6 D!N?*\XH.H3.,GZG^1JQ0NX/70RM)\.Z9HCWCV
M,<ZM>2&6?S;J6;>YX)^=C@XP./04W3_#.D:7<B>SMF0J28T:>1XX<Y!\M&8K
M'G)^Z!5Z_P#MOV-_[/\ L_VKC9]HSLZC.<<],_C5F@"I_9=E_:_]J_9D^WB#
M[/Y_\7EYW;?IGFJ0\+Z0-4OM1:"62XOHO)N1+<RR1R)_=,;,4P,G&!QD^IJ3
M6]3?3TM(8=@N;ZX%M TBED1BK-N8 @D *>,C/3(ZU8TP:B+)1JIM6NPQ!>U#
M!&&>#ALE21U&3CU- &;;^#- MKBTN$L-\UGN%M)--)*T(;&0A=CM'' '3MBJ
MX\ >'A:+:B*_$*W/VL+_ &I=<39SOSYF<YY^O/6NFHHN!RFL^$;466KSZ=!>
MO?:D@2X*ZE*K,N1RF]BJL!G;P!VR!FJ?@WPQ?:7>F]EU7Q8R%2CVFNW\-R&]
M"HC+ ?7</I7;TA(52S$  9)/:A: ]1:YY_ WAN0,DFF))"9A<"W>1VA63GE8
MR=BY)). ,GD\UHK>S:C965YI$EM);S.KL\N<-"<Y*8[],9XK0HV#R.=E\">%
MY_$J>(I-&MVU52&$_P P^8=&*YVEO<C-68/"VE6VMSZQ&MW]MG&)6>^G9''.
M 8RY3 W' Q@9XQ6S10!S&G_#OPII-Q?7&G:0EI->H8YI()9$;:>H0ALQ_P#
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MMKU81;[Y+Z9U,8&-I5G*GUY'7GKS532/ 7A;0KV[O-,T6VMY[M2DK#)!4]5
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M@BE(610=O "?>'"^QKV6L#7M!OM6U?1KRVU&VMH]-N#<&.2T:4R,59"-PD7
MVL>QYP?:A/5?UU;_ %L)*R_KLE^ESA-9:QT_P'XU>RFMX/#\P5=-"N%A9C&-
MXA[;2W0+P3NQ3/%^HZ+<:[ OB'5KZWTBYMH6TJYL[2*ZAD<[MVTF&0K)R,%<
M<8]*]=HI?U^%AGG]OINEVWQ LY9+>.6^;1D^R7-[ IGED5BNXG:#OVE=V,$
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **;)&DT3Q2HKQN"K(PR&!Z@CN*JZ;I&F:
M- T&EZ=:6,+-O:.UA6)2W3)"@<\"@#D+/Q9=ZAXBMGN&O+'1Y[I[6Q>**)H[
MJ1=P(D8DNN2K$ *H^7[QSBN[KE;3P<]K<P1-J7F:3:WC7MO:&##I(2QP9-W*
M L2!M!Z<D"MN^T32=4N()]0TNRNYK<YADN+=)&C.<_*2"1R!T]*.B_K^NOX!
MU?\ 7?\ X'XE^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ex10-56_07.jpg
<TEXT>
begin 644 ex10-56_07.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Y Z4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTP S;< Y'.>G?%>J535E;S?YF<6V[^2_(****184444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% &/XDT#_ (2/3H[/^U]5TO9*)?.TRY\B1L C:6P<
MKSG'J!Z5R_\ PJS_ *GWQS_X./\ ["O0** //_\ A5G_ %/OCG_P<?\ V%'_
M  JS_J??'/\ X./_ +"O0** //\ _A5G_4^^.?\ P<?_ &%'_"K/^I]\<_\
M@X_^PKT"B@#S_P#X59_U/OCG_P ''_V%'_"K/^I]\<_^#C_["O0** //_P#A
M5G_4^^.?_!Q_]A7H%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(XI&N81'*0(V,@P^>F#WH>A*9/15*/6=+FT^34(M2LWLHMWF7*SJ8TV]<MG
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M:A:&2UYN$\Y<Q<9^89^7CGGM42>(-%D6S:/5[!EO25M2MRA%P1P0G/S'Z9H
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M6U];3&V8I.(Y5;RFZX;!^4_6@"U15>SO[/4;=;BQNX+J%N1)!('4_B#BDO\
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MJJ!U))X H3LOZ_KY@]7_ %_7R.4EB,/C74I+W3KB:RNM(AC)6W::-MC2ET.
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M-97<8DMYEV2(>C+W!]CTJS10!YI:>#?#$OQ-UBR?P[I)M5TNV=8?L<>U6+R
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M^.I[BPLM1?1F@LYM0.GR^9<@RQ2>88@0J@JPW#GYACMNKH]8U:#1=->]N S
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M](N;^&_GTNREO(0%BN)+=&D0 Y 5B,C!YXJ_10!3N-(TR[OH+ZYTZTFNX/\
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M@K<^V/QJWHFI?VSH.GZGY7D_:[>.?R]V[9N4'&<#.,]<4+74"_1110 4444
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M5T7AR*WT#QA>02C3;]9;>>Z.KH@CN[>,G=LNL]01C:QQPO3BM/\ X1+XA_\
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M\8SBNGO_ (9>+]4U73M3O/B+YMYIS,UK)_8D*^66 !X#@'H.H-:?_")?$/\
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M?_13_P#R@6_^-'_")?$/_HI__E M_P#&B^K?I^#O]WD-;6_K:WWG.Q-IYO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[/R+K3M(DM/*3QU#=PK?C[MR1YG[[S1]XQ;=Q&?EQMV]J+>];^OZ745_=O\
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MVA5QP .W':IMI?\ K9/]0>]OZW:)****0PHHHH **** "BBB@ HHHH ****
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MOLRVT(1QL_O<Y[8KK;;[=]IN_M7V?R-X^S>5NW;-HSOSQG=GIVQ5FBFVWO\
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MKD;@,XSSBETM_6UOR#K=?UK?\SC='T[QW:6=Q9:I?:)?6\-N8K1XTDBEG.,
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MD7'AV#<;<O%(+L+G*QDYV #@;L$X'3TWV\06:>)X_#Y2X^VR6S7*L8B(]BD
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M@#]OEVA?-$I7/D9SE0O3OGM@^B!E)(!!(X(!Z4M"TV_K6_Z!_7X-?JS@[?\
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MS.T4;'.62,ML0G)R5 ZGUI--\,:9I.I7.H68O%N;H[IS)?3RJYX&2KN5R
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ME9VEL^ DT\ZQHV>F&)P:XB*[TZS^(MQJ']FW)%WHL)D,6GR-*S&1E^= N\'
M RPX YQ45CI>H:7;:/ITME<0R-:W2K=0VYG-NLDFY;? RB?+M^9P5^7 ZTNE
M_P"NO^0?U^"_S/09;^SA6-I;N"-9 60M( & &21Z\ GZ52E\4>'X+6VNIM=T
MR.WNL_9Y7NXPDV.NPDX;\*\^TNU\AOAY]JT6_%S90-%<2-ILC&(>5M 9@A"C
M?ZD8Z].:U-&TYM<T/Q'9B"\LYSJLMW92W-G+#L;<&CD7>HS\PYQ^/6FTDWVU
M_!K]'</+^NO^7XG;IJFGR:D^FI?VK7Z)YCVJS*957^\4SD#D<X[U:)"J68@
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M0^)]9N9-,\3VB1V%RR-90M#,L\ "YD)^^,DG#!MHQR#79,0JECG &>!DUYA
ME]JGAOQ':V-CJ*7#ZL;U8;FREMQ<P>8C% 9%4$LJL,9[\X!I+?\ KNAO;^NS
M/0['5],U.*673]1M+N.)BLCV\ZR!".H)!X-/MM2L;V1H[6]MIY%4.RQ2JQ"G
M."0#T.#@^U<9>0Q:QK4NM1Z==IIRZ3-:WL-QITBO<,2I1/**[GVX;D CYL G
M)K1^'-FMKX'T=9;&2UO8K1()A-;-%(".=IW $C)/MR::7]??_7S!G0ZGJ5GH
M^FW&H7\Z06MNA>21S@ "N:'BH7>LZ'=VFJV3:'>6T\DVW:VUT4$YEW8 &<$8
M&".3VK?U^"6Z\.ZG;P(7FEM9411U9BI %<A%>"76_!WF:7J@6WM)!([Z;-MB
M8HBKN.W"G*MUQC&>A!,K?^NS![?UY';+J=@^G?VBE];-8E/,^TB53%M_O;LX
MQ[YI]G?6FHVJ75C=075N_P!R6"0.C?0C@UY4L.H2>$C-;Z1K,L5GKMQ=3V,2
M3V5Q+ [2%6B/R,2-RM@'GH>:[;P3#9C2Y[NST?5]+6[F\V2/5I7>XD; &Y@[
MN1P .3GCI56W_KM_7R!Z:&QK&K6FA:/=ZI?/LMK6,R.>^!V'N>@K+AN/%,]D
M-16/3%#P^9'IK(_F9(R TX; /KB,\]ZD\9Z"WB?PAJ6D1NJ2W$7[IFZ!P0RY
M]L@9IFD^)'N(8K6[TC5+74D0"2!K.0Q[@!G;,!Y1'I\W^%)=0?0T9]:T_3X+
M5M4OK6QDN-JHES,L99R/N@,>3[58GOK.U*BXNH(2P++YD@7( R2,]@ 37*3^
M;I_BC66U73[J\L]4@ACMW@M7N%4*I#0MM!VC)+98!?F.36%8:7+I&L^!XM0L
M+F>^L[66*YNH["241JR_NT:55(X.1UXZ\9S1O_7K^5OQ!Z+^O+_,] 37=(E%
MH8]5L7%Y_P >NVX0^?\ [G/S?AFG7>MZ38.R7FIV5NRLJD37"H06SM')ZG!Q
MZXKS&5W_ .$.U*.+2=6$S^(1<QH-)N YC^T+)O \O.-H8_IU.*UH)M.M/&?B
MH+I,\JW]M:_NX+!F,C.CY$@"_+GC)? ]31TNOZT3_6PWH_Z[M?\ !.YOM8TO
M2Q"=0U*SM!,VV+[1.L?F'T7)&3]*DN=1L;)2UW>6\ 5#(3+*JX0=6Y/0>M>;
MSZ3JMKHJZ%-:W/VH>'Q;&\@MVG^T. V8=Q!1-OJPRV[CI5FU6)/&WAJ]DT>_
M1H]%>*><Z9*=K_NRBLX0@'"R8!.1G'!/+MK;^NO^7X_>OZ_+_/\ KIVLOB/0
MX7M$EUK3HVO #:AKI 9P3@%.?FSGMFJNJ>($1_LVDW%C=WT-W!%=6_FAGAC=
MPI+*IRIP<C-<GHMC<7?P]9X;:YM-3TR^N+RT%Y;20$$2NZCYU!VLC;21V8CJ
M*[+PXLLNF#4;B(Q7.H-]IDC;J@(&Q3[A0H/OFBW]?=_P;B?]?C_P+%Z'4;&X
MNYK6&]MY+F$A984E4O&2,X8 Y''/-6:XO2H-2TSQ.EG:2W-YI4LDDTL=Y9,C
M69;<V4GP%<%N-O+#=G.*[2ET3'UL4YM6TVWU"'3Y]0M(KV89BMWF59)!_LJ3
MD_A3;C6M*M&VW.IV<+>:(<23JI\P]$Y/WCZ=:\YFL6'BN]TS6O#7B343=7_V
MBVO;.]F6S*9#(9%$JHA3 'W23M!P34%];QKH_P 1H+/1-00WK_Z,D>DSKYS&
M)5)7]WS^\#$D?[W0YH6J3_KI_G^ [:V_KJ>HPZG87%U<6L-];2W%MCSXDE5G
MBSTW '*_C4<.MZ5<7B6<&IV4MTZ>8L"7"L[+G&X*#DC/>N-9H;SQII:R:9?/
M8RZ)+;2^=IDPBRS(0CEDVCA6X;IT/6LKPS!_:O@SPGIUC97$5S9W,5TUP;9E
MCBC5V+%9,;267*X4D_-R *=M;?UNU^ER;Z7_ *VO_P  [#PKJ>H7=QX@BU2Z
MBF-CJ+01ND0B58_+1@,9/]X\DG^E:2>(]"DL9[Y-:TYK.W;9-<+=(8XFZ89L
MX!Y'6N$^S:CJ6G>,(;&ROEEDU>.Z2*>UD@%U"HBW(K2!0=WENO7Z\'-;MI;C
M6_&,.L6UG<6]B-/DM;Q;NT>!IV+*44JX!8* _.,?-@$Y-&Z7HOR_I>H]F[]W
M^?\ 3-\>(=$,-I,-8T\Q7K;+5Q<IMG;.,(<_,<\8&:F75M-?4FTU=0M&OU7>
MUJ)E,H7U*9SCWQ7,^&;&\BU&72[D;K30V:*SE)!WAP"F?0HAV>^<USOAJQ9=
M;MM,U?PUXD;5+*=YEU%KV9K G)_>KF78"P)^0*>N,8S@T;T#9'I"ZMIKZDVF
MKJ%HU^J[VM1,IE"^I3.<>^*?;ZC8W5Q-;V][;S30-LECCE5FC;KA@#D'ZUYK
MX9L2NN6NFZQX:\2-J=E</,-1:]F:P8Y/[U<R[ 6!/R!3UQC&<;^@0:EIGB%=
M/@EN;S2=CR'[;9-')9EN0JS8"R@GC R1U+4+H#TN=I63;W\M_J5X(91#96+F
M%V*C][)M!/)Z*N1TZG/0#G6KCM#MHK;0/$5CJ,)N52^NVFA\AIMZ2'S%&P E
MLJXX /I4O9^@TOS-^QO8;;2[07NL6UU(T?\ Q]$I&)R 2S  XZ GCIBK$&I6
M%SIXU""]MI;(J6%Q'*K1D#J=P.,5Y=H<"1I\/?/T745N+&.2&X=])GS#E"H#
M,8^!OQWQWZ<U8B?5/[(U&YL-'O[C[+XA:_>RFM)(&N;<G_EF)% 8@_, .Z^X
MJI;O^NJ7ZB_K\_\ +\3I_%7B"5?!DNL^'-4LY%21/W\86X1U+A2%(; //7GI
MTK<;7M'C-XKZM8JUB ;L-<(#;@]#)S\OXXKA=<NTU3P)JUY:>&-:L)]0N(BT
M$UDS3S.K+ES''O*C:F,G&<?3.C<>?'XNU6[%C?/!J>C11VSI:N070REE?C]V
MV'7A\9Z=>*3T3_KI<%JU_76QUEQJ^FVVFKJ,VI6<-DZ@I=23*(B&^Z0Q."#V
MYYKE_#6LZEJV@S37^M6T%Q%J\EL)UA54E1)=H15).-P&!R3SWK+T%=2TN'PG
M=ZEI&HK:VNE&SDB6#SGMY_D <I'N.&52,XX'7&36,;&XM_#R+=^'=02>'Q0;
MNW*6+3,L/GAF=?+#%1M]0,]!FKLE-K^OB_RU]!7O&_\ 6S_KU/5;O6-+L-_V
MS4K.VV%0_G3JFTM]T')XS@X]:=?:II^F1QR7]_:VB2L$C:>98P['H 2>3[5Y
M]=)!'K/CN2+1[\?;+!$C=-*GQ.^QE;:0GS'+)G&<]>@)%+5_%>G^%[?P]?ZA
M)Y$\ND&T,.IV]Q$N04#?=B9@V0<@K\PQR.ISOI_7G_E^(^O]>7^?X'K(.1D=
M*BN;FWLK:2YNIXH((UW/+*X55'J2> *YOX=QZ+%X(T]-"N;:ZM F&GMX?*$D
MG\1*X!!SZ\^M6?%TDD6G6KI8RW06\B9FCB>8V^#D2>6GS/@@<#UR> :J2L[
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M+?LPN-^-AW>4-H;.!P>00<8H6O\ 7I_F@_K^ON.LHJE<ZBNFZ++J.IA+=;>
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M"0N5VG?Y(P"&!'RGWQ@XZJ(R&)#*JI(5&]5;< >X!P,CWP*0Q]%%% !1110
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M'/XTVV[W%:QA6WAF_P!'O;A]!U6&VLKF=IY;.ZM#.B.QRQC*R(4R<G!W#)X
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M?]:6#HU_6]SDG\&S0W&@'3M1A@@TF9YV6:U,CW#N&#DL'4*3O8]#R?3BF?\
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M&G]LZ9).T-C&UO<L87C26=6*H/F4;B@,O(X^8?AV=%%+HD/K<**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J
M]]9I?V4UK))/&LJ[2\$S1.ON&4@@_0U8HH:N!PGA4KJ4<.CSW6J?;]!D9+R5
MKV;,DF?D9CN^<,/GVMD#@8Q6)/J&KQ^ C.-<U W,'B$VK3EEWRQ_:O+VL=O
MVG^';^7%>HK;6Z-,RP1JTYS*0@!D. ,MZ\ #GL*RE\'^&%MQ;KX<T@0B3S1&
M+&/;OQC=C;C..].^MWY?FF_R#I;^MG_F<S?:!9P?$711-?:F^ZSO) TFI3*1
M^\B(4%6'RC<1CN ,YP,8S:D]EX)L;NYUB\B>T\1M 9IM0D!\D794K(Q;YU"<
M?/G KU!]/LI6MFDL[=VM3FW+1*3"<8RG'R\<<=JB_L72A<37']F6?G3NKRR>
M0NZ1E^Z6.,DCL3TIIVM_76__   EK_7DT>=:GK$NH^*=0MI?&EAH-S9W*I:V
M\ZR!GC*J590+A(Y0V3U1B,X]*[KQ5J%YI?A'4[^P0R7<%LSQ@+GD#KCOCKCV
MJ[<:1IEW?07USIUI-=P?ZF>2!6DC_P!UB,C\*N5/V;!]JYQ,)>R\2:%_9>H7
ME]9:M%*UTLMXTR[0@83(6)V?,0N%POS#CI2?#_2K>TFU^>.6]=UU2>$">]FE
M7:-N/E=B"W^UC/O756>C:7IQG-CIMG:FX):8P0*GF$]2V!R?K46F^'M%T:22
M32M'T^Q>08=K6V2(L/0E0,T[Z_UWN*VG]=CG=:L+6;XGZ#<337*,+"Y8;+N2
M-<J\6!A6 (Y.1C#<9S@5@6SS66A6VIVMY<I*/$\L&U)F$31R7C(ZL@.UL@GD
M@D'H17I=SI]E>O$]U:6\[PDM$TL88H2,$KD<9!(XK,_X0WPO]E%K_P (WH_V
M</Y@B^PQ; ^,;L;<9QQFB+M;^NMRI.ZM_6S7ZG#S:Q-J/BJ\BG\:6&BWME?F
M&*PF602-'D;0%\]8Y=Z]_+8C=@<@5Z+K1L1H=\=456L/(<7 ;IY>/FS[8S2R
M:-I<M_#?R:;9O>0#;%<- IDC'HK8R/PJXRJZE64,IZ@C(I?9L%_>N<%8Q:MX
M4U;2+.'5DUGP_?S>3!'<8:YM?E)4I(/]8@ P<\@$<UE6VL3ZKXGE,_C2QTK4
M+74'@_LN1)!*T:R?*@0W CDWKC#"(GYN#D5Z-;Z-I=G?37UMIMG!>3_ZVXB@
M59)/]Y@,G\:'TC3)-374WTZT:_5=JW30*90OH'QG'XTT]4W_ %_7F2]FE_7]
M>1QOA_3;C7KGQ#!J&MZPXL]7EBB,5XT)V>4F%/E[> 6R,8Y'N<R^%"NHK!I%
MQ<ZF;_0)62\D>]FS*^?D+'?\ZN/GVMD#@8Q76:?HNE:2TK:;IEE9M,<R&V@6
M,N?4[0,_C5I+>"*262.&-'F(:5E4 N< 9)[G  Y["A?I^(WK]YYLNOW.CZ'>
MMJ6J7DEHOB%[.YOI' >&#@ Y4 *,[5R ,;B>#S4FIZY;:3X;EET;Q7%=Z9)J
M$<4E[),UXMA&PP0TBR!V!8#DN&4/UP!7;VGA[1+"&XAL]'T^VBN?]>D-LB++
M_O #YNIZ^M30:3IMKIYT^WT^TALB"IMHX56,@]1M Q2Z6]/T_P OQ'U^_P#7
M_/\  XG38M0N/"]_!HWBRQUYS.GE>3<R($7@O$)_-ED#, 2#NRN>,#&.F\+Z
MFNHZ?,IMKRUGM9C!/;W<HE>)PJG&\$[A@@YR>O-7[?1],M+ 6%MIUI#9C.+>
M.!5CYZ_*!BIK2SM=/M4M;*VAMK>,82*&,(BCV X%.^Y)P1LX+GQIXS-Q?7-D
ML<%I*LL%RT!7$;?,2I&0/0Y'J#61=^(-2O?[*L=>\0VGAV272X;H278EB$TQ
M+!R'CGBP1\OR-D?-TKT^[TG3;^Y@N;S3[2XGMSF&6:%7:,^JDC(_"C4-)TW5
MDC34M/M+Q8VWHMS"L@1O4;@<'WI+9+^NO^?X#[_UV_R_$Y*VFU!/%WAN!M?F
MOX+G2IS(\:JD4SIY8$P49Y.XGDD=,>^+:7>HQ>&M.U.35]0N+R+Q ;/S))R%
M>(W1B*NBX1OE]1P>F*]"GT#1KJ_CO[C2;":\C78EQ);(TB+SP&(R!R>/>JO_
M  AOA?[*+7_A&]'^SA_,$7V&+8'QC=C;C..,U2>M_P"M[_EI_P  'M;^MK',
MZX^KR:EJJ6MQJO\ :@G1-+-D7-O&A1"PE&#$&Y<GS03@C;VKN&@E&F&W-Y.9
MO*V?:<)YF<8W_=VY[_=Q[5P.J_##3];\2S7^J>'M*NQ,^?MB:A<6\B*!A1Y*
M#:Q  YWC/MP*[U-/MQI:Z=,@N;<0B%UN/WGF+C!W;L[LCKGK4VO"P?:N>9V>
MJ:C9_#+3_$<VLW8N)]D%U<W)::**,SD&4Q@KR!QE2I /L*6>XNK;P'KUQIGC
MF+4Q"(WB?3W9S <_,IDDEF;YL]-P(QQBO2+32-,T^R:RLM.M+:T?.Z"&!41L
MC!RH&.E5SX9T Z8-,.AZ:; /O%K]DC\K=Z[,8S[XIWU^[]/\OQ%_7Y_Y_@<K
MJFHW_A_7-:-C+=7>W0FOA!/,T@,RL1E0<[<CJJ@#CI5&YDL+7QAX'NEU:2Y-
MYY\GFW%V9%D=H0 5R=J[CP%7 ]!7=0>'-#M;Z.]M]&TZ&[C01I/':HLBJ!M"
MA@,@8XQZ<5):Z)I-C)YEII=E;R;VDW16Z(=S8W-D#J<#)[XH6EOZ[_Y_@#6C
M7]=/\OQ/._#>KS:UK5K=R^-K&WU SO%<:.$D$W!(,7EM.4R/[ZQ G;GIFBQO
MM4M/ FIZ^^KZA<7EA=7=OYDS>8@B$^TR-$N Q15)&,=QWKT7^Q=*_M"34/[,
ML_MLJ>7)<>0OF.OH6QDCVHT_1M+TF!X--TVSLH7^_';0+&K?4*!FET_KO_7W
ME=;^?^?]?(\^LM8FTW0->U32_&%AKWEV9F6VMO,D^SO_ ,]"9)Y6 Q_!P/EX
M YJ>0:?8?$KPH8]4EN!=6=TRO<WAE\QF$>"A8G&[!PJX'' %=Y8:1INEQ21:
M?I]I:1RL7D6WA6,.Q[D #)IMIHNE:>X>RTRRMF!9@88%0@MC<>!WP,^N*:=G
M?^MG_F3T:_KI_D<Y\0UW6F@Y8JHUNUW.#C:,GG/:J4VCWFH:EX@T&SU74TM(
M[>*:VN%OY=]O<MORGF!MQ7 0["2!GMQ7<W%O!=V[V]S#'-#(-KQR*&5AZ$'@
MUG7EC=Z?H36GA:WTNTG0@0QSQ%;=1D;OECP>F<8[U/1_UV_*URNO]>?_  QB
M>&9U\07=MJ(:^@&G6XM9;<WDI7[1R)%=2V'*X^\V2=V>PIWQ&C:;0;"-)I('
M?5K)1+&%+(?.7D;@1D>X(]JZ'2+!].T]899%EN&9I9Y57:'D8Y8@9.!D\#)P
M,4W4]!T?6O+_ +5TFQO_ "L^7]JMTEV9ZXW XS@?E5-ZK^O,E+1_UY&?#I3V
M<MU#J.OWMXM["(T:9XX94"[BQ5H43'!!SU'KTKFO"\,EMKUK9:IJFJ2I$LCZ
M3/+>R[;^,L23("Y#NH(P",;3N [+UMKX2\-V/G?9/#^E6_G1F*7RK*-/,0]5
M; Y!]#Q4C^&M"D:T:31--<V0 M2UJA\@ Y 3CY<'TQ0M_P"OZ_I^0WM8X#2-
M7GU?Q&D\WC2QLM0BO7AETATD$I59"/*\LW&QLKC#K%GO5_1-=T[5]0BFG\3/
M9:_%?20S:;)=D;T#L!$+<L ?EVD.%W<9SUKN/[(TS^T_[3_LZT_M#;L^U>0O
MF[?3?C./;-']DZ:-3.IC3[3^T"NPW7DKYNWTWXSCVS26E@>MSS;4KJ6S\(>*
MF.JW\3Z?K.+>1M0E#QK^[.W<6R5PS':21[5K6=E9W7CCQ'=VNI74<DUA;/#-
M!>LR_.LOS*A)1N!D94@<D=3792:-I<UU+<RZ;9O<3*JRRM I=PIRH8XR0",C
M/2EN-)TV[=WN=/M)GDA,#M)"K%HSU0Y'*^W2CI\OTM^EPZ_UWN< C75Q\-?#
M_B:XO=3EGL88[J[$-Y+']HBSF3<JL Q ^;D?PXZ$U:U[5A8Z!_PD%GJ,UK::
MK=Q))=W,DTT5O <A7$?F+L#''*%2 X/:NUL])TW3[$V-EI]K;69SFWAA5(SG
MK\H&.:G>UMY+4VKP1-;E-AA9 4*],8Z8]J<G>]OZ[@OZ_3[KG*^#KF"UTR\D
MD\7V&LV:2+MFBD8I;Y&-AD>:1F).#AFR,^A%=?5*#1]+M=/_ +/M]-LX;+.?
MLT<"K'G.?N@8Z\U=H;$CD/B-&TV@V$:320.^K62B6,*60^<O(W C(]P1[5?A
MTI[.6ZAU'7[V\6]A$:-,\<,J!=Q8JT*)C@@YZCUZ5H:GH.CZUY?]JZ38W_E9
M\O[5;I+LSUQN!QG _*J]KX2\-V/G?9/#^E6_G1F*7RK*-/,0]5; Y!]#Q2Z-
M#ZK^NIR7A>&2VUZULM4U35)4B61])GEO9=M_&6))D!<AW4$8!&-IW =EHZ1J
M\^K^(TGF\:6-EJ$5Z\,ND.D@E*K(1Y7EFXV-E<8=8L]Z[]_#6A2-:-)HFFN;
M( 6I:U0^0 <@)Q\N#Z8JQ_9&F?VG_:?]G6G]H;=GVKR%\W;Z;\9Q[9IWUO\
MU_7<3U3_ *_KR.'T37=.U?4(II_$SV6OQ7TD,VFR79&] [ 1"W+ 'Y=I#A=W
M&<]:SM2NI;/PAXJ8ZK?Q/I^LXMY&U"4/&O[L[=Q;)7#,=I)'M7I/]DZ:-3.I
MC3[3^T"NPW7DKYNWTWXSCVS22:-I<UU+<RZ;9O<3*JRRM I=PIRH8XR0",C/
M2DM+?UU3_3\6-Z_UZ_Y_@<CIEE977C_Q!=VVH7*O/96K0RPWKLIWK)\RH6*-
MP,C*D#D@<FLR$W<WPZTCQ'<ZAJL\^G2-/="*]EC-Q"LK;PRHP#87YAQ_#CH<
M5Z'-I>GW$KRS6%K+(\)@9WA5BT9ZH21ROMTIMEH^EZ;9/96&FV=K:N27@@@5
M$8D8.5 P<BC;;R_!M_J)+O\ UHD<7KVK"QT#_A(+/49K6TU6[B22[N9)IHK>
M Y"N(_,78&..4*D!P>U:_@<C[%=K'XIM-?@$@\M[9F=8..4+O+*S>OS-D9],
M5TKVMO):FU>")K<IL,+("A7IC'3'M4=CI]EI=JMKI]G;VENI)6*WB6-!GK@
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M+VR&3&,8W$9Q@D?2H(O"'AF!X'B\.Z1&\#;H62RC!C.<Y7Y>#GGBG?;^N_\
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MQ5>7Q#KNMZ!H5U:W5I93RZP;.??9R,LFQW .PNK*"4R5)SVSP<NWZ?B'2_\
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M"M_JNGP6\\UK'YFRX=E7:.IX!)/MQGU%;<;%XD8]2 ::O;^NW^2!^?\ 6O\
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M-HB5;S/,"C=&WRASN]>V<<5J:MX=L=<CT]=0\R5K&X2YB?(4EU!'.!T.3D#
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M/C76)-7NK2YT^]TVSEB-S<>;%)(6EQY>XE=WRC 7G(..]>HU@6>@WUOXRO\
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M^TZ>RUFSTVZM9+:UU2=88K>166*(G*A0.B_>QVZXKM:*+_U]W^7XB:_K[_\
M/\#@O%4>FQ^/]*NM=6W71VTRY@DEO," NSQD(Q;Y<D X!ZXKG-59]*\/6BZM
M+?VOA5KZZ7?%;+.8H"?W/F1RQN/*^]@%21E*]@HI=+?UO<KK?^MK'E;WGAVQ
M\/>%H8-;GEL+C5UDMY-0*V[-'AL[%VQ[8P2 ,*!R ."*A35=#LU\7:?#<6_V
M"+5K?%O;7")%$&$>_?@$)$7#!^,?>'4UZU13OJ_Z[?Y"Z?UY_P"9Y";BSTOP
M5\0K%I[*WMTW_9XH%\J!!);IM$8)P-S$XQ]XY('-6M7F\'7WBGP7)?R:%<-)
M:OO:=H7WKL CR3U&[.WWSCFO5**+ZI^GX)H'JK>OXV_R_$S/$7]H#PUJ7]D?
M\A 6TGV;_KIM.W'OFN)TO^RKC6O#]WX6\E;HL5UI(SA_+\HY^TCKY@?;@O\
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M.#Q?IM]I5E?::LVH&^#?9H+;;YDFW[W+,%&,<DL!TYY%9/PXX@\1 "< :S.
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M0R;@@W*Q#8+$#A3CO@<U<U/Q1;:9).#9WES#:D"\GMT4I;9 (W98,>"#A Q
M/(%<M+X6\42>&KW3_LVCB>XU<:@#]OEVA/-$I7/D9SE0O3OGM@Z$NA>+M/\
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M52,F2/[.S D9*D2 8()'455E?3^O4GIK_6YWU%<1I<WB'7-7\063Z^;--.U
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M'/"8UR8RCKA9,D'YEQ@'CD5.Y6QT.OZ[:^&]&GU2]2X>WA&6%O$9&_(=![G
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M1[5#JFH7]WH2VNH2_:)M/\2VEJ+KRPGGJ)8V#$#C/S8.,#(/ Z5IR^];S_\
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MG,KE25! .S.W< 2-V,X)YJC/X*T:?4Y]28ZFEY.,22Q:M=1DJ"2%PL@ 4$G
M' SQ6HVL:6EQ%;MJ5FLTTACBC,ZAG<<E0,Y)'H*6[U;3;"Y@MKS4+6WGN#B&
M*:94:4^B@G)_"EV&5(/#.D6]D+06K2Q"8W&;B:29_,(QOWNQ;..ASQVJ;3=$
ML=)>22V29I9.'FN+B2>0@=!OD9FQ[9Q6!K/B:UG\3IX9MO$=MIEX8"_F))"T
MGFEE"1;'!Z@DXQN(Q@BK4_B.S\-:1)=ZYK]I<YNA") $B"NV (\ GIG)).0.
M3TH7?^NP=;?UW-?4-%L-4N+6XNHG,UJQ:&2.9XF7/490@E3QE3P<<BJ%QX*\
M.76AS:+<:7%)I\LK2M"S,<.S%B5.<KRQZ$8SQBM%-9TN26WB34K-I+F/S8$$
MZDRI_>49^8<CD<<U<)"J68@ <DGM0UI8+G-CP!X:33["PAL)+>UL)/-MX[>[
MFA"R?WSL<%F]VR>3ZFG3>!M G@OX'M[OR=0E\ZYB34+A5=\Y)P' &>X& <#T
M%:MGK>DZC!-/9:G97,,#%99(+A76,^C$'@_6GV^J:?=W4EK;7]K-<1HKO%',
MK.JMT) .0#V-']?U^ ?U_7WE&+PKI,.JKJ82[>[6 6VZ6^GD4QXQM96<JWKR
M#D\]>:?IGAK2='E$EE;.FT$1J\\DB0@]1&K,1&/90!6+XK\2R6.H:3::7JED
M)VU*"WO;8;9)1'(?3/R=#R0<YXQ77LP12S$!0,DD\"CI?^OZU#K;^NQ3;2+!
MKVZO&MD-Q=0K!,YS\\8SA<=/XC_D"JUYX:TJ^\/KH4]O)_9JQK&(8[B2/*#@
M*65@Q'U//>GKXCT233KK4(M6L9;.TSY\T5PKK%CJ&(/!]JY^7Q;_ &C)X7U#
M1]2M&TN_N6BND4*[#]R\F"^["E=O(QGGJ.XE?3^O(/\ @E_5_ /AC7TLEU;2
MEO#9*%ADFFD9P!V9]VYQ[,3FKUUX:TB[NH+F2TVS01^4C0R/%F/^XVPC<G^R
MV1[5;M]4T^[T_P"WVU_:S60!/VB.96CP.OS XXID&LZ7<Z?_ &A!J5G+9=/M
M,<ZM'_WT#B@#D/$?@Z.+2].TW0[+5;.QM7>3.@WJ6UPKD8_Y:$*P()R2V>E7
M]+\%VTOAJXTC79]3U>RN2'\G6;A9YHN.1O3H<],$X[&NHMKNVO$9[6XBG5'*
M,T3A@&'!!QW'I4/]K:=_:?\ 9G]H6O\ :&S?]E\Y?-V^NS.<>^*/+N'GV*6E
M^%-$T32%TK2[+[':*Q<+#*ZMN(P6W@[LXXSG-7[#3[73+46]I&4CR6)9V=F8
M]69F)9B?4DFF-K&F)J:Z8^HVBW[+N6U,ZB4CU"9SC\*2[UG2[#S/MFI6=MY6
MWS/.G5-FXX7.3QD@X]<47N%NA2N?"6B7<ET\UHY^U2I-,HN)%0R*05<*&PK9
M4?, "<<YJ.3P9HDL^H3-%>!]0C$5SMU"X4.@Z* 'PH'3C'!(Z$UJQZE82WSV
M,=[;/>(@D>W653(JGHQ7.0/>HEUS26NXK5=4LC<S;A%"+A-[[3AMHSDX/7'2
MCR"_4I#PAHBI8J+:8-8IY<$GVN7S G]QGW;G3_98D>U7=(T73=!LOL>EV<5K
M 6+E(Q]YCU)/4GW-/FU;3;?4(=/GU"TBO9AF*W>95DD'^RI.3^%)<ZQI=D2+
MK4K. AUC(EG5?G;[J\GJ>P[T[L5BC<^$M$NY+IYK1S]JE2:91<2*AD4@JX4-
MA6RH^8 $XYS7):WX0OM3\3SS+/XMT^&4JJR:+JT45L%5< NCL'#<<[5(Z=>:
M[^?4;&VNHK6>]MXKB8%HHI)55W ZE03DX]JCN=8TRSOH+&ZU&T@N[C_4P2SJ
MLDG^ZI.3^%)=!W,^R\+6<&H6FJW,MW<ZM!;BW-U)=2?,O&<H"$Y(!/RC)YJ*
M;P)X8G\3+XBET>W;5E(87&6^\.C%<[2WN1FK$7BK1KCQ!=Z%'J-L-0MHU=XS
M*NX$Y) 7.3M !/ID5/:WL-AH$-UJ.L6T\<<8,NH.4BC?U;@[0/QHOU"W0H7O
M@3PQJ'B*+7[O1K>75(B&6<[ADCH2H.UB.,$@D8%:3Z)827\=X\<KRQ,616GD
M,:L3G<(]VS=R?FQD9ZU-'J=A-9Q7D5];/:RX$<ZRJ4?/ PV<'-+9ZC8ZB)39
M7EO<B&0QR^1*K[''56P>#[&C;3L&^HM]8VVIV$]C>0K-;3H8Y(VZ,IZCBLH>
M$-'&H+?JEZMTL!MQ(NH7 _=D<C&_&3USUSSG/-7IM;TFWOC8SZI917BQF8V[
MW"+($ R6VDYVX!YZ<5''XBT2>V@N8=9TYX+F7R()5ND*RR?W%(.&;V'-']?I
M_P  /Z_4I6W@K0K.VLX+>WN42SD:2W;[;.7C+?> 8ONVGNN=I]*F7PEH:6<5
MJEELABN3=QA97!24DDD,&R =S<9Q@D8P<51\-Z^SQSVVMZI9F^.HSVL PL/F
MA#P$0L2>/<FMJ-G.MSC^THWC$"8L@J[HSDYD)SG!! P>/E]Z=_Z_$"Q<VL5U
M:26LF]8I$*-Y4C1L >.&4@CZ@@UDV_A#1+73[&QBM9?L]A)YEJ'N97,1P1@,
M6)VX)&W.,'&*DN]8@O-,U,:+JMC)>VD;;BK+.(7 )PZ*P.>.A(J/PSKL&IZ1
MIR37]M+JDEC#<3PK(OF#<H.XH.0"3Z8I+NOZW!]C8FA2>(QR E3@\$@\'(Y%
M8MUX-T2]T^2RN(;IX9)1-(WVZ<22,OW=T@?<P'8$X&!@<"F^-=3U+1/"M[JN
MER6BS6D9E9;J!I%=0/NC:ZD'ISS]*;;/XC@OK3[=JFCSV\@9Y8XM/D@<(!RP
M9IW'!*YR.AH7]?F ^7P9H<]Y<W4]O<S2W-N+:;S;V=U>,= 5+D<=0<9R2>I)
MJ9/"ND1R22K#<>=);"U>8W<QD,8SCY]V[(W'YL[N>M+'XL\.311RQ>(-*>.6
M7R(W6\C(>3CY <\MR..O-7+C5M-L[V"RN=0M(+JX_P!3!+,JO)_NJ3D_A0!D
M)X&T&.VTZV2&]6'37\RT4:C<?NF_[^<\9 !S@$CH36_/!%<V\D$\:2PR*4>-
MQE64\$$=Q5>XU;3K2]@LKG4+6&[N/]3!),JO+_NJ3D_A43^(-%C2\>35[!%L
MF"W3-<H! 3P _/RGZXH;ON'4;IWA[3-*D,EK!)O(*JTT\DQC4]53>QV+P/E7
M XZ51TGP+X8T/6I]8TS1X+:_GSOE0MQGKM4G"Y[[0*FD\6Z''K]IHIU.T^V7
M4/G1+YR_,"0% YY+9) '4 T?VWIND0SRZMXCT\1O=,D;S2QPB/@$19SR0.?7
MFGK>XO(U;FUBNXO+EWXZ@QR,C#@CAE((X)Z&LZ3PQH\NFI8/:L84D\U7\Y_-
M$G]_S=V_?_M;L^]6UU;37OOL*ZA:->>5YWV<3*9/+_O[<YV^_2EL-5T[54D?
M3K^UO%B<I(;>99 C>AVDX/M2L,HW/A;2+S1)=(G@F:SF.9@+J57E/3+R!M[Y
MP,Y)SCFJFK^ ?#&OI9+JVE+>&R4+#)--(S@#LS[MSCV8G-=)5%=:TI[B&W74
M[)IY]WE1B=2TFTX;:,Y."#G'2@"LWAO3!K$&L1P3"^MH?)AV74J1JF/N>6&V
M8X'\/8'L*J>'[74+N_FUW6M)M]-OY(5MD@CG$[)&K%OF<*!DD]!D# K8M=3T
M^^MY+BSOK:XAB9DDDAE5U1AU!(. 1WJJOB;07TV34DUO36L8FV27(NXS$C>A
M;. >1QFB_P#7K_F!-J^D66NZ9-IVH))):3#$B1S/%N'H2A!QZC.#5;4?"^C:
MOH0T74;(7>G@ ".:1W88Z$.3N!'KG-3C7M&/V+&K6!^W?\>G^DI_I'_7/GYO
MPS6/XLU?4-)U3PZ+:YABL[N_%O=*\66*[&;(8G"CY3GCOU&*+=.X>?8OV/A3
M1M,T:/2=/M&L[.,$*MM/)$PSU.]6#9/KG-8.OZ#))KGARULM$NY-,M))6GGM
MKA(O+\Q&7(8R+)NR=Q8<\YR3Q76V6IV&HV?VRQOK:ZM>1YT$JNG'7Y@<<4FG
MZII^K0--IU]:WD2L5+V\RR*".V5)YIZWNQ6TL5G\.:3+I!TN2S#VA;>0[LSE
M\YW[R=V_/.[.[/.:AF\)Z/<Z/<:5-#<26MS@3EKR8R2@=GEW[V&.,%NG'2K]
M_JNG:5&DFHW]K9I(P1&N)EC#-Z L1D^U%UJFG6*,]W?VMNJQF5FEF5 $& 6.
M3TY'/3FD,SE\(Z.NH6]_LO&N;>W-M&SW\[#RR,%2"^&SQG(.2 >H%23>&-*N
M(;V*:.Y<7B[)G:\F+E/[BOOW(O\ LJ0.O'-,U;Q=H>B_V<;[4[2)=0?; [S*
MJLN,EMQ.-N,<],D#O27^MV>AQ:MJ>HZS ;*W1'\CY08..F0<L7/0'Z"A[:@M
MU8<_A31WTZTLC#.([-=MO(MW,)HAW"RAO, X QNZ #I1?^$]&U&PM[&>WE6V
MMY1-&D%U+#B0'(8E&!8YYR<\\]:RKOQ%/<ZWX5ETK4;2;2=2EECF$*K)O*Q.
MW$@)& 5P0!G(Z]JZ/^UM-&I_V8=0M/[0V[_LOG+YNWUV9SCWQ3=_Z\A*W0R=
M8\">&-?U2VU+5-'@NKRW $<KLV2!T#8.'Q_M9KH@ !@<"N/\=^)GT?3A'IFJ
M646I)/!YEL^UY3"\BH2%W9'WOO$$<8KL*2V&]PHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *BNITM;66>19&
M2-2Q$4;2,0/15!)/L 34M%)JZ \NTA+\^"_#[1Z?J)&E:AYU]92V4L4DD9,F
M"JNHW[2ROA<]/48IOB?3&U'2/&&HV^F7<EEJ5C%';VIT^3S9;I=W[SRBN]2,
MH-Q ^[GH :]3HI_U^7^0T[?UYM_J9VB10)I5O)%;>0\D2>8&A,3DA0OS @'(
MQCGL*\]A@M%;Q[HMMI$DDE]>-'#';VA,9=K>,_,ZC:GS'=EB.22,FO4ZQ=%\
M.KHM_J=VNI7MT^H3":5+@1;5< +E=B*?NA1R3T]<FFW=N_7_ #0H^ZE;I;\#
MC/$^GZE+I^KZ6MI=M=/H:1?:H+5IOMS(K?)N(*)@D\$;VW<'@5M:VM[8Q:3X
M@TRV;[8$6RE@E&PR)*0J;AZJ^UN>0"WK79UD/X>MY?$:ZU+=W\CH@6.U:Y;[
M/&PR-XCZ;\$C)S1>^_\ 6_YWL"T5OZZ?Y7.9\2:?;Z=J7@T16%U<R65YE[F&
MQDF9(S&RL6=%.W<Y4G)&>O;CGIXDB\*>+;>ST74HY+C5UEMXX](G4NFY&#*!
M'TRCG/8_49]>HHO_ %\T_P! >O\ 7K_F>0^.?%.B:9JFJV%[?0VW]MZ?#&YO
M[:X!B0AQN15B;=C/W&V8.>>P]+\/C35\.V']CM ^G^2OD- @1&7'4   9J.3
M0Y#J;WMMK.I6JRN'EMXS$\<A  _Y:(S*,#HI%:D420QK'&,*.@I+X;?UU_S%
MU_KR_P CS:PCO9-8\-W?]F:A;QVU[=)+9K9N$MBZ.<F1AEP2?O@[.?I5.[EF
ME\%>*8$TS5S-<ZNTL,?]EW :1&=6# ;,XPK<]N,]1GUBBC^OQ3_0&E_7HU^I
M!O2YL-X67RY(L[2C(^".F#@@^QP17GZ0:M9:9JVD"UN=>TN&P>.(7-H]M.#P
M!#O 7S05)Y0#&W&2:]'HHZC1P&DFYMO$^K:E<0ZC-;W.DP%9?[.>,90RY18]
MN_(R/E.6Y]*H>'S=Q>'_  C;-I>H6TD5I);RW3V$IDMWPH\ORR,+N_YZ."HV
MX[YKTZBFW?\ KU_S"_\ 7R2_0\CTVQ:&X\!)<:+?^?8O<1W,KZ:YV(5=1N94
MP 6(XX'?&.:VKO3E3QYJ-OI.GS63W&AFU2[BT]TA$P.4!D"[.%QCGC&.O%>A
M44GJK>OX@M'?T_!W/,/"EI;7LQBO/"GBBPO[.S>"6>\OII(%#+AE@+RD-G Q
MA<# Y&!6WH5SJFC_ -HQ7'VW5M.L+;,,[:<T-TQ7/[H @";CHR@#MR:[2FN@
M="IS@C!P2#^8IMW!)$5E=)?6,%U&DB),@<+*A5E!&<,#R#ZBN'O=)U-+'5+"
MSM)0-+NCJ6FN!\LK$^8(U_X$9%(]"OK7?*JH@1%"JHP .@%+2ZW0+:S.2UE[
MB/P_973Z;/--->QW$H6%Y7M<G(<QI\SE,*N!]3P#7.RQ'3O"GB\ZI]OAA741
M=_:9;0@2+B)@=J ;DR"&P,X!SS7I]4]3T]=3M/(:XN+<A@Z2P, RL.0>00>>
MQ!'M1M>W];?Y EM?^M_\SRG3M4T?QU<>)KS1;W39O$%QIRPPV\"2*PC4MG$L
MD<;?/D*=OW>.3P:V- L=/UNWU$R>&_%>E7!M39S3ZC=32':2,K#YDC[@#SG;
MCZYQ7>6&GR6B+]IU"ZU"9<@37(C# 'MB-%7],U>IZ".-T?5=5TRPU2?4H;W5
M+:T"""YBTUX;JX&2&4Q'!8KP=P !!.!76EA<VFZ/D21Y7/'4<4Z2-98RC@E3
MU )&:>  ,#@4GJK,:T>AYEH>DW<GACPWH)T^ZMM4TFZAFN)Y+9ECB"DEMLA
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M-C02QZ5-MN)0)%?!"8<G<G3.?< X]*HI/5-=U;\$OT*3UO\ UO<\ST^0K<>
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MQ;I'B"Y72M2TIM!O+IKJ1+N%VN(&<Y=8]I"D$Y(+=,]#4QZ7_K^M2GUL6/\
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M[)\X,?EY0>3SQ\V#CGCWI;7P_P"*H;'4(@--B:YU0WICBOI<31-]Z)G$0*=
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M)>Q7DJ26C8Y*,J R ''RG:#SG%=;&K)$BNY=@H!8C&X^M,E=!U%%%(84444
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MMM"[+/&5N(U91D@A6'./?C/?I4M\JOV&DV[?(;K'@/POKVJ6VI:GHUO<7=L
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME>NV+6?B&>WU/PUXDU33+Z"&&W_LF]FVQ +M:*95E0$9R=[==QYK4CCL]/\
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M(Z4I:7OT7Z7&M=5U_P ['HU%>+Z9XS\3Z/\  ]?%IN["\N6G+[+BU?)#S,K
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCJ<G'/7J>M7(/'#P^(9]7/AGXD2^=&(_LDFD1>2BCD;< ,.2?XN>^<#'JU%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC(60H\@<SAAC!.TQ9..O-:=GX:G.N6>OW^J7+ZE%9_9I(HTC6 @X+87:6&6
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MO'VPRT\$6UC!IBVVJZG'<:?#]FCN5:(/)!GB)QLVLHP,';N'KG)IZ6_KS_X
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M"WP%48&W]UP<%ASG[Q[X(GB\(P0C2'34K\7&F1-!'<9B#R1-C,;C9MQ\J\@
M\=>M)>?]:/\ X ?U^7_!,"S\9Z[-:>'M]OIS2:EJ%Q8S3*'0(8VD"LL>3P1'
MSE_\1:O_ !'XH2Y_LW3M*BO=1M(8I+UX$C:(LP/R*))XV0''WL/UZ'%3Q_#S
M3[>2Q:VU3585L[R2]CC\Y)%,KYR?G1L#YFX7 Y)Y/-6-?\#V&OZK!J9O]5TZ
M]C41O-IMV8&FC!)".1U&2>F#SUI]OZZ+];A_7XO]+'06<L\]C!+<VYMKAXU:
M2$L&\MB.5R.#@\9%</IFO:OIEEJESJ-W:WCS:R;"U1;=HMKLX0%F+M\H&.
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M7\[W-JMI+ _E",H,X^[&&!RS'[W?TP!?T;2H]$TJWTZ&XN)XH$$:-.P+!0,
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M:]MK.-FAA\1KY1G#M\K(VT>7(/NK\F<$# SFD,]+HKSGQ#<M =-U_P JP?\
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MJVB[Q'LC96Z9QNW$>^XCO2>++CP_:ZA8VVJ74^G>%Y;2/^S7L-/AGM_.W-N
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MYI?U^3_7\ O_ %\VOT/2J*X?PWXDL-,T:X.H+I=E:VUQ':I=:8Q:SF9L*NP
M?(0>"O(4]^M=Q3:$F%%%%(84444 %%%% !1110 4444 %%%% !1110 4444
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MR&4#W# CGLS5%H&B7>A:==PAX;AP[K9H6**L.YFCC8X.,;B,@'C'6N@HI=+
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ML_\ @,JZ_KY?\$P]*\2:CKMAX9L_M+6=UJFGO=SW4$:$C9L!"!PR@DN#R#@
M_43_  \# >)5>7S6&MS@R8 W$!.>.*U$\%Z%'I5IIJ6LRV]FV^V87<WFP'_8
MEW[U'; ;&.*O:9H.EZ-)=2:=916\ET_F3NH^:1O4D\GJ?I5-J[:_K5,E[+^N
M_P#P#E/%&NZK8WEW/8:A(RV4\"&VMX4>(*Y4,)V=<AOF) 1L@%21S4]Y?ZW/
MXF\0Z:FK?9;>UT^&ZMFM[9/,0L7R"7W!ON>@X/&.M;=WX3T6^FO9+BT9C?;?
MM"K/(J2%<8;:& #<#Y@,\#FF/X/T9[Z\O/+O%GO(1;S,E_<*&C'10 ^%QSC
M&,GU-1TMZ_E_F5=7O_6_^1S\.M:IY/A;Q'>:K-%I5_!&M[:I'$(HY9$!1MQ3
M>%+<$;NI7MD'IO#@O)---W>7T]U]JD::%9DC7RHB?D4;%7^'!YR>:Q[S0IX[
M2U\)Z=HR-X=>(+/=7-\TAA4-_JU1]S,2.AR OX 5UP 4    < "K;3NUY_=_
M7X$I/1,X8WGB&[O?%4(UU;8Z5(CVIAM(PI4Q;]DF_<2.0"05/&01TI-'UK5=
M7U>5'O[FVAO-"@OXX1'%FUE<D'82F3TSA]W/Y4[3O#SZCXL\0W.KZ->P6ES-
M&T#M=*L<ZK&$*ND4IW X)"NN,=<'BNGN]!TV]OX;Z:W;[1#&8E9)70,AZHP4
M@.OLP(%1]GY?H_\ @%-^\_Z[?\'[SB;#Q#X@O+/P+G4T4:Q%(+MQ;(9&<1,P
M8'[HY X"_IQ5VSD\37&K:[I5SXD ?3X+>2&XM[&--Q97)WJV_(.WG&/;;6S!
MX%\.VKZ>UK8/;_V<2UJL%S+&J,>K%58!B<D$D$D<&LF#0)=3\<ZW<ZGH]]#8
MSQPK#.+M427R]P(98I=S*=V0KK@X.0#5/5Z>?Z6%Y^GZ_P# (]&\0ZGXM:TM
M$NYM'E;28+]Y8(D9G>0D87S%8;!MYXR=PY'>K'XIUZ\C\-#[1#;FZU.XTZ\*
M6^3*8_, D0L2%!\O.,'D]>.>RU#P[I>IO;R3V[I+;+MAEMIG@D1>ZAHV4[>!
M\N<<=*BN_"NCWDFGO+;RK_9Q+6JPW,L2QMC&=J, 3@GD@GD^M.Z;VT_X+_33
MY!T_KM_GJ<U8P:GI_CG4I;O7;^^^QZ1!*\0BB5)CF4$;0F5Y7/RD')Y)& #0
M=7\4W4</B"XN--GT6>W,SPPWGF$?)D"("W0@Y'(=V[^E=@^CV+ZNNJM!_IHB
M\GS [ ,F<@%<X."3@D$C)QU-9>E>!/#&B:S<:OINCV]O?7 (>5=QZ]=JDX7/
M?:!FIZ?+_/\ S7W#=K_UY')ZA->Z@W@;5[O46E&H:E#.MJ$01P[H9" A #'@
M\[BV>V.E=WX@O9+#19[B*YAMI 559)5+ 98#  !+,<X48.3@8-41X'\-CR@=
M,1XX9Q<0PR2.\43\\HA)5!ST  SSC-:NIZ79ZQ8/97\/FP.0Q 8H00<@AE(*
MD$ @@@BF[6LN_P#D);Z_UO\ YG'V6K>(C9>(K6#[9?75C+"+<W,<$=PT;JK-
M@*!'N W;<@=LBI9/$%_=^'/-TEM5N9H+E8KY3;1QWT"[<DB-U",V<'A<$$X!
MKHH/#FEVUQ/<10.)[A4660SR%FV?=.2V<^_4]S2Q>'M.@LY+:)+A1(Q9Y?M4
MOG,Q&W)EW;R<<9W< #TI CG[[Q'=2V?AZ]TG45:UNM36UN1-:;92"Q!4@XV,
M-I!&W)[8JIK_ (BU6RU#4DAU)+:_AF2/3=+:))!?(RH2^WAV()?[CJ!MYKH[
MKPAHMY;6=O+!<+':2F>$17DT9\PG)=BK@NV<G+9/)]37):IX0U'4O%%U<&Z\
M7Z>MQ+N$FE:O$EI@#:K,KG>&(49 0CZT=?Z\O^#]X=/Z\_\ @?<:SW>OS>*[
MW1Y=7CAB32H[E9+2T5760L5)'F%QC*G@@\''7FJ.F>(==U5O!SM?0P0ZO92/
M<K%;C?YBIG<&8D <\#;U'<<5T4?A'3S=-?W,M]-J,MJ+6>Y%]-'YBXP<*KA5
MYR?E P22,&HK3P)H%C+826\5\AT\$6H_M.Y*Q ]0%,F,'IC'3CI3]?ZW_P U
M]P/;3^M%^J9SO]OZY!X=;4'U1Y9;#6OL#*88P+F/SQ'F3"\-ALY3:,CIVJUJ
M.J^*=6\0:G8^'I["W.F2*ACN;K89-R*VYT\AR4YP"KIT-:Q\ ^'FT^6Q,-\;
M:6X%TZ'4[G+2@YW9\S.<\]>H!Z@4[5/ /A?6]1M-0U/2(KJ[M5"QS2NY8@=-
M_/S_ / LT+I?^M%^J?WC?E_6O^1C7FJZ_)=^*HEU9(%TZSBNK7[-;H<$H[;2
M7#;@=N"< D=-O=2]]JOC+PK>?VI=VR7&E2W$EO"(S&6!A)&&0G!W8)SG &".
M<[TW@W19[G4;AX[SS-1C$=UMU"X4.HZ  /A0.G&."1T)J>'PQI,"Z<$MY2=.
M5DM6>XD=D4]5+%B67@<-D<#T%$7:U_ZW_P U]PN_S_3_ "?WE?Q>VH6^A/?:
M=J$]HUFPGF$,<;F6)3EU^=6P=N<8P<XK'DU34(_$6I6G]L7+6U]:[M+;RX<1
MRA@KA3Y?."\>-V[^+/2NUD198VC=0R,"K ]P:SX?#^EV\6FQQ6:JFF?\>@W'
M]U\I7UYX/?/KUI+S_K^M/Q!F*]UJT/C>VT5]49[*72990X@03"561?,+8VD_
M,3@*![&N;TR"[7P?X3>74[FZEFU:-P]RJ'9_K,@;54GU^8DY/7M7>2^'M.FU
M^+7'2X.H11F)'%W*$"'JOEAMA!X/3J >H%4G\$: Z6R?9KE$M9S<0+%?3QA'
M))R KC@9.!T&3@#)H72_]:M_D#_K[K?F83^)]3TFS\113W!O)+#4H+2"YFC4
M%5F$?S.$"@A3(>@&0!GUJ74[[6M(U2YT@ZQ=7*7.FSWEO=M!");9XBN5X38R
MG<,94D<\G/&_!X3T:"34G%M++_:?_'XEQ<RS)+QCE78J.,#@#@ =!4^GZ!IN
MEHZ6\,C;T\MFN)Y)VV?W TC,0O\ L@X]J'JK=;?I_GJ.ZO?^MU_P4<U8ZOJL
M]]X,>3493'JE@[74/EQ[6<1!MX.W(.3T!QQTJS\/8+J/2K^6YU2\O2VHW2 7
M C^7;,ZY!5%.3@9R2!V '%:4'@W0+<V)73ED-@Q:T\Z1Y?()Q]S>3@#' ' [
M8J_8:18Z7)<O9P>4;F5II!O8C>W)(!.%R>2!@$Y/6J;5V^]_SN2DU%)^7X)H
MP-6UR\TKQ,!J!OK7265%AN88$EMRS$9\X[2Z'/ .0N#R<UEZEJVLV^G^.Q%K
M%P)-+ FLY?*A+1CR1)L^Y@KGCD$X[YYKL;S1+"_F66YCE?:X<Q^?((W(  W(
M&VOT'W@>E5[WPOH^HW5W<75HSO=P^1<*)G5)4Q@;D#!20#@,1D=C4=/Z\BDU
M>_H8HU/4-;U*XTJRU@Z?>VEE!<J%BC8SLX8Y8,I_=Y !V[3UY%)=Q7=WXXL$
M%Z+6X;19M\]LJMM;S(\E-X(Z^H/':KNI_#WPEK$5C%?:%:R1V "VRJ"@11_#
M\I&5]CD5<D\*:3)JBZEY=U'=+;FV5H;V:-5B(QM5%<*!WX'4 ]1FJ?\ G^O^
M?X$6=K>GZ?Y?B,\':G=:SX3L+Z\96N9$82.J[0Q5BN<=LXS7.:C<>(;:SUVP
M@UZ]DU2UG2XLR(;;=) R$[,>5C^&09QG*CGM78:+HEAX?T\6&FI+';*Q94EN
M))MI/7!=B0/;IUJ9M-LVU-=2:!3>+"8!+SG83G'IUI/>Z_K;]?P92T_KU_0Y
M'7-:U%?"6L^)-%U9O*ALEEMDF@C>/(4.S# #9(('+$ YX[4[4+W7]._L.Y&L
M)+!J&H6\<L3VBAE1T&55@>!D,>03\V,C%;T_A?1[CP\= :U9-+8%3!%/)'D$
MY(W*P.#DY&<&FWOA72=0M;&WN4NVCL7#V^V^G0JPZ$E7!8CMDG':GI?YK[NH
MK:6]?^ <B;;4,?$&4:_J0\IF$:CR<)_HZ."I\O(QDJ.>G/WOFJ1K[7+>TT/P
M]IFHA[NYL/M/VJ[N(X)& VC8F+>1&P#R"F<8YZUV8T'3!>7MU]E!EOD"7.78
MK( NWE<[<XX) R0 #TK-U+P'X9UC1K?2=1TM;FSML>2))9"Z8P.)-V_H .O0
M 4O^!^%_^'*;N[^OZ?Y&6M]XH37=!TK4-0LHGN[:Y^TFRC\PAX\897< 9PPX
MV8R#U'%:W@W4KS4]%F:^F\^>WO;BU\XJ%,@CD90Q"@#) &< #V%2+X.T..ZT
M^XAM9H'T^/RK58+N:-(E/4!%8*<]\CG STJUHN@:?X?@F@TY)TCFD,KB:ZEF
MRY.2<R,Q&3R<=3S3OO\ UU_R%_7X/_@&&^H:GK>K:U::5JRV5UI,R1I;/&C)
M-E%?=+E2VT[B!L*G@\GI39=1U36K[7(M/U1].;2618U6&.19R8Q)N?<I)0[L
M#:5/!Y]-#6/ WAGQ!JUOJFJZ/;W5[  $E?(R!T# '#8[;@<5;OO#6DZA?"]G
MMG%QL$;O#/)%YJ#HL@1@)%Y/#9')I=/Z^_\ X ]+_P!?=_P3E]/\1:SKVJZ
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M#70+=M,U;[1!JL+RPC3+@NBI/YC,5V9QMYSWZ#GBJ2M+[O\ TIK\A-MK[_\
MTG_,[;QWJ6H:/X)U74M+GBAN[6$RJTD7F#CJ,9'/N<X]#6GINK6.H!H;>_MK
MBYA5?M$<4JLT;$9^8 _+^-9WC?3[K6? NLV-C$9;FYM'2*,G:68C@<]/QK"N
M+&ZU^\M+G28+G3Y+/3KFUDGN+5X"7=%"( X!8!ANW#*\<'FIV3_KH_U+WM_7
M5'8VNK:;>W4]K::A:7%S;G$T,4RN\1_V@#D?C4E[?6FG6KW5]=06MNGWI9Y
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI8#G)W;9$#IS@@,>_!J__P *2^'G_0O?^3MQ_P#'*/\ A27P\_Z%[_R=N/\
MXY1?1+^MN7\@>K;_ *WO^94U#P[JMEX^T2\TO0+B72=-TB2S!CN8CABIVJ/,
MD#'& ,GUKGH/ ?B:;X%_\(T^EF'5H+SSA!)/$1*OF;_E96(Z'N1R/QKK/^%)
M?#S_ *%[_P G;C_XY1_PI+X>?]"]_P"3MQ_\<H3:_KSYOS#^OPM^1I:O>:K!
MXF\,E- LI[65GCGGF=#<6C%>-G/IG=MSP#SCD['B.ZU*UTB3^R=-GOKN3]VJ
MPR1H8P>KYD90<>F>3CIU'*_\*2^'G_0O?^3MQ_\ '*/^%)?#S_H7O_)VX_\
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M<W%N0H8_*5_><^OX>M=5_P *2^'G_0O?^3MQ_P#'*/\ A27P\_Z%[_R=N/\
MXY26EO*WX7_S8/7?S_%)?HCFH_ WB/5?"'CC2IM/?3;C5=3-]:&>>)ED4L&V
M$QNV#\O.>.1UK7N?"MU+X UHVOAS4(?$&HV LY8[G5/M+.0,##O*RA!DGJ#C
MM5[_ (4E\//^A>_\G;C_ ..4?\*2^'G_ $+W_D[<?_'*'M;T_!6_(;;;OZ_B
M8^@^'?$5OXX\)ZA<Z%<0VFGZ(NGW,C3P'9)@C.!(25]P._2M#PQX/OK.W\8Z
M7K.E)<V.JZE)<1G[0H6:*3'3!W*1SU Y QZU8_X4E\//^A>_\G;C_P".4?\
M"DOAY_T+W_D[<?\ QRFW>_G?\7?\R5I^'X*QL>"M.U?2[2]MM0ENVLEG_P!
MCOI$DN(XL#(=T)!&<[>2<8S745R_AOX=^%?".HR7^AZ5]DNI(C"S_:)9,H2"
M1AV(ZJ/RKJ*&[CM8****0!1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW[M_W=^_';[O7VYK$L]-U^TTWP59/H%RYTJ<?:GCN("%58GBW#,@)!+!ACG
M.0#Q3C;1O^M9?\ ??^NB_4[C2]7LM9MGGL96=$D:*19(FC=''561P&4^Q ZU
M6U'Q1HNDWC6=Y?HETL#7+0*K/((EZMM4$X_PK-\)6VHV^J>(WOM+N+..[U W
M,#RR1,)$,:)_ [$'*$\@<$>X#-1L]2D^).D:A%ID[V%M93PR7(DB"AI&0CY2
M^XXV'/R]QC-'5>?^7^8N_E_F:\_B32K:XBAEN'7S2%$H@D,2L<85I NQ"<C
M8@G(J=-8LGOI;-9)#)$0&;R7\L'^[YF-I/'(!R.]<"?#&HVOBZZ67P3H6M6=
MW=M<1ZQ<M$)K<,<E7#(6<J<[<=L#([;AT6_M/%D=YI"7UK#<3F2_5YXWLY5Y
M!(0DNLAX/R@#.<DTEK8'I<T(O&_AV=(I8=266"68P+<1Q.T(DR!M:0+L7)(
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M3<>/N)C-+I]_]?@'7[CLZ*YGPGXF_M])5EN[4WD7,]D('@FMB3PKH[$GO\V
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M4C:Z]1SUJS7!R^,M;A\,ZCJ+:?I_VJSU7["T8F<H$WJFX';ECEO1>/ISI?\
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MZ(U\FGRB*?/DXD<HK;=S3HT> PYV.*[)&+1JS*48@$J3G!].*.EP>]AU%%%
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M[MMO4@$]#S@?2A?U^'^2^X'W_KK_ ,$)_"=O/>270U'4(I;B 07GEN@%VH!
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MQ75*H10JC"@8 ]!2T4=+!YA1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5#=W5O96DMS=SQ06\2EI)97"J@]2
M3P!4U%)JZ \S\":)IOB+POIL\NOW6IVMK-YOV 30F&&57+*#L0.<<$*S$<CC
MI5/6KG3WU\ZC";>*\L]=@BGEG^:\2,NJ;01@QPG/ .X,">F>/6**I.S3[?\
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MQW KV&BK;O)OU_%W$E:/+Z?AH>>?"ZWTF\TN6_@E2ZNK:^O(HY_M!E<1-*<
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M'6Y7EOW9WF+MYN[.=O.,=JO_  ^UNPC\)>&-(EF>'4)=.!CMYHGC9A& KXW
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M0_G9W;MVSR\=>,;NG/M61-X7\1+X+T3184TN6?3KFW<L]S)&K)"X8'(C8Y;
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M;=6K#KIF.G$:9>+'>0&<REH=MNH /SXDSW'W0PJCH^E:M;>*M<O[V&Q%G?\
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M*;CP[>V+6VC"XN-66_!%_+L""42;<^3G/RA>G?/;!%\7E_P5_P $-U_79_\
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MOYWV:+[3Y?G[!YGEYV[L<XSSC- $E%%%( HHHH **** "BBB@ HHHH ****
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M$8C1<G)PHX'-6*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB_\ -^W;1+&><8\L[6QGCD<=15F]^(4,6F>'KNUM80=<CWP&_N3;Q(=H.QI
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MM%N_G^%O\Q>GE^)ZC17)Z5XRFN]7M])U#34LKZ\LC?6:+<F19(_[K'8-KCN
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*(^*JZ9XQENX='T>^LX[Z2>*15N$&&8_O$C9PBR8XW>7N]<UZUX@^+?@;6=
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCIAV[_UO^.PK]OZV_P""0:?XBUB_TIYO['LHM02^:T:T;4&P-IP6+^3G./F
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MW]L(=^H17T<CV8:8%'#>6S[@&7C  "[?>H[OP9JUU'XFC.MV877%"$G3F)A
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M48@ B./)V+QG&3R2:>FJ%V9%?:_>?;[NST?3HK^6Q5&NA)<^3C<"0J?*VY\
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M#>&-1T36Y;>?3O%DMY+=V9^UV!OF>0L0/GV;LP%>1\@4?-ZXK-T'3[R+P!I
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M1OYN"5*COMYSGJ1T.*QDM!IG@GQI<Z;J5_:WD5S>.KK>/(P\L[AA9"P&>A(
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444UW6-&=V"HH)9F.
M!ZF@#.G\-Z%<ZF-3N-%TZ6_5E874EJC2@KT.\C.1@8YJY>65KJ%J]K>VT-S;
MR##Q31AT8>X/!JC8^(]*U&YEM[>Y82QIYI6:%XMT?]]"X =/]I<CWIMGXGT>
M^O3:0W3";894$T+Q"5!U:-G4"11QRI(YHZ6#S)9O#NB7-E;V<^CZ?+:VQS!
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M"![9"D1'0JI&%_"M':NS9M&W&,8XQ7%:7XAAT?5/$D>L:I=2PPZDD<3RQEQ
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M@<9R#ZT+^ON7_!!_U]_^0VUU[7K_ ,5ZII,5MI\$=B+67]XSNSQR;MX)& &
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M*T$ 54;S8W6(N&W9P00I&W:,>IK5TCX?66AI<QV&LZXL4D9B@BDO3+'9J?\
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MCC%/O_!MK=V]A!!J%_91V=S]K7[.8F,LV<[W,B,2<D],=?IBY-7TVO\ K?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !6?JMIJ%W%"NGZA'9LLF9?,M_.65,$
M%2-RD=<@@]1W'%:%%&X%/2=,M]&TBTTVU!$%K$L2;CDX QS[U<HHIMW=V 44
M44@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BFR1I-$\4J*\;@JR
M,,A@>H([BJNFZ1IFC0-!I>G6EC"S;VCM85B4MTR0H SP* .?GBU:V\5Z7;)X
MBO9EN'EGN+5H+<1+"HZ+B/>/F9 ,N3C-=96?!IGEZY=:I)-YCRQ)#&FW B1<
MDCKR2Q))XZ =J6^T32=4N()]0TNRNYK<YADN+=)&C.<_*2"1R!T]*%LD#W9?
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
; **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ex10-56_08.jpg
<TEXT>
begin 644 ex10-56_08.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Y Z4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 8_B30/\ A(].CL_[7U72]DHE\[3+GR)&
MP"-I;!RO.<>H'I7+_P#"K/\ J??'/_@X_P#L*] HH \__P"%6?\ 4^^.?_!Q
M_P#84?\ "K/^I]\<_P#@X_\ L*] HH \_P#^%6?]3[XY_P#!Q_\ 84?\*L_Z
MGWQS_P"#C_["O0** //_ /A5G_4^^.?_  <?_858L/AM]AU&VO/^$U\97'D2
MI+Y-QJN^.3:0=KKMY4XP1W%=Q10 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.=H''''S"I8]7TR:[CM(M1M'N94,D<*SJ7=0<%@N<D \9H NT54_M73CJ?\
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M#N[+488[;2TE'E26I=YWE.9'+AP 3U'R\$GJ.*2U2O\ UO\ \ ):-V_K1?\
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MRLJ/'"S. LF3R>3D8&?IUJK>^-;FV3Q \6B,4T-@;CSKE4,D>W>63:&R=N"
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MPFM8[-D;:-QR',A[NW\/3'IDR6WA>^!L?[0U6&]_LS+6#-:;&5]A0-+A\2$
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M/9LJ?2B]M^S_ $*2NON/2Z*\JU;7K^ZNM-T_6_$%GX;>33(+H-=>;&))SGS
M'CGB *G;\C$@YZ5Z/HID.BV7FWZ:A)Y*[KQ$"+.<?? !( /7@XIM6O\ U_6Q
M*=[%B[F>VLYIT@>=XT+")" SD#H"Q R?<@50\-ZTOB+P[9:ND#0+=Q^8(F;<
M5&3U-8E]<C4?%>IZ;>WD]K!8645S;I#<M"9"V_<[;2-X&T#:<KZ@Y%<%I&O(
M?!OA33&\16>D6$UC)NNIFD"M,CC]V9(IHC&P!S@MSD\<4E_E^O\ D4_Z^Y?Y
MGJFL:\VDZKH]D;&69-2N#!]H#J%B;:6Y&=Q)"GH,<<D5H6T]U+<W:3VGDQ1.
M%@D\P-YR[02V!]W!)&#Z9KA[HR&W\#^9J\6KM_:IQ?0IM28>5-@CYFSQ@9R<
MXS3[>PO]<?QGI3ZUJ0DANU%G.ERT3P$PJP ,>WY06Z=QUR>:=K+[_P!/\PM>
MWR_7_([ZBN%TG4QJ^AOK>GQZ@;O2[)[<6LEW*0URJG<CJ6Q(RD ;F!)SUXK(
M\-7S:N7O+3X@6MU+<V3M+9VJ/YR-MX?9+/((BI]$5>>1TI/2_E_P?\A+6QZC
M17E46J7]C\.-#UZ?6[F-]0CMH;V[NF>6*!3N_>;%92"254LK# (/:K4&J3:5
MX8F>V\76FL6LNH6\#7=LS.+*-V"O^\>64D\Y^9OEW>F*;C9M?+^OO%?2_P#7
M7_(["V\0_:/%]YX?:QEB:VM4N1<.ZE958D#: 2>H/7!XZ=ZV9'2*-I)&"HH+
M,QZ #O7 Z,MEIWQ<OK"&\DD9M'A\M;FZ::0_O7) 9R6; (/4XSZ8K;^(4"7'
MP]U])#( +&5_DD9#D*2.5(XXY'0]#2?PI_UNT7%7GR^GY(Z1'61%=3E6&0?4
M4M<+&D4NMZ=X;>\OHM-;33/"Z:A*))IMXW#S=_F?*,';NQAO05L>"[R^N]&G
M%](\QM[V>WAN'QNGB1RJL<=3QC/?&:;6K_KK8A/1?UTN;TDT<3QH[A6E;8@/
M\1P3@?@"?PK,T+6VUHZB'L9+1[*[:U*2.K%L*K;OE) SNZ9/]*P_%]A:W7BO
MPI)<S7$8%Q.,Q7<D(P(7;^!AZ=?3(Z$BL+4&EM=*\5ZK:WES#<6FMJ\7DS,J
M9Q""&4'#@@D$-D>F#0M?Z\TOU"3M_7DW^AZA17F/B?5Y+CQ7>Z7=>+K'PW]F
M2*2T^T^8AD#+S(K+/&C_ #9&QPP^7IS7I%H6-G 7E$SF-=T@3:'..N.V?2DM
M5<;T=B:HQ/$9WA#KYJ*'9<\@'.#^A_*O.?$FHW*:C/J%CJ%VWV35[:U9_M30
MPPJS1J\7E E93\Q)9E&-W!^6IIM+L+CQ?XMD:XNPTFG0$!-0F16W)+G"AP.B
M\<<<XQDTGI'F]?P5QVU2_K>QZ##-'<0)-"X>.10RL.A!Z&GUY&;^/2_"_A/3
M%UU-*T^^L=\M[>3SR+YH2,K'YBSQM%P6( <+QC%:WG7Z'P?'%XLDU."XOYH)
M;BSVK%<)Y<C@9RY;;M"YWGOGGFK<?>:\[?G_ )$IW2?E<]#FFCMXC)*X1!C)
M/N<"H?.N?[2\C[)_HOE;_M/F#[^<;-O7ISFO,=6B-WX>UC3[J[O9+?3_ !';
M0V[/>2^8J,\)(,F[<V-[8R3CC'08Z-);NP\<7-M:WMW=VJ:)YT%K+-O4.K[1
MAC\S$XY+%CR>:EZ*_P#6URFOZ^=CM**\WL[V[;2?#.OV6HWEQJ&HW,,-[;O<
MLT;[@?- B)*QE,$_* 1MYSS54W6I0>&KK4GUC49KRS\0_9HI'G*@Q_:%C*LB
MX5@5)&"..HP:?+K;^MTOU%NKK^M_\F>I445YU?WES?:=XHU)M1O+/5=&GF%M
M#%<LJ(JH#'NC!VR!^OS _>(&,5-QI7.QU759;.:WLK*"*YU&Y5VAAEF,2%4Q
MN)<*Q'4#H>2/J+EK/<3:?'/<6;P7#1[GMMZL5;'W=P.#]<UPU]IXU+X@>%[B
M]-]!<3:;/++%%?31JCKY7 "N .200.&[YQ7H-4U9??\ @["O>WR_$Y2S\:7&
MH+<FU\):[(+:9H)</9C:Z]1S<<]>U=+:7"W=G!<JCHLT:R!'&&7(S@^]<%H.
MC7NH?\)(]OK]]:(=7N5^S1I 8FZ9W%HR_/?##VQ5OQ;%<S7-CJ^@WMY<7BQN
M380W4@BN(,$,X0.J[AG*MW) ]"%?1/T_(.K^?YG<45YGJ^K6VGZ#X?M;+Q&]
MMI%_YBR:KJ4TTK%PN0CR"6-XR?FYWC!7&*D?6HM*T31H=1\4I?Z1=WDD,^KV
MLC1(J[&*1F8.S ;N-^_=Q@G.:=@/2*9--';PO-,X2.-2SLW0 =37GT\T,0\.
M3Z9XDN-2M?[:$"SQ7K.AB=6/E.P8B7! &6R?ZY.M36]UH_Q$TV34[B86LR31
M0M?R,T:F-&./FR$WEN/N]L4)7_KT_P P\_ZZ_P"1Z@\]R-0MX8[3?:R1NTEQ
MY@'EL,;5V]3G)Y[8]ZM5Q3Q26OC;1--@U._?39].NE>W:Z9QN0H-V\GS"WSD
M9+'&!C%5='AC&H7G@^YO-7DNK>Z^V"=]0GWO;'E")-^[&?W97.#M)QFBW]?/
M^F'2_I^*._HKRR;6)M1\4WD4_C2QT6]LKXPQ6$RR"1H\C: OGK'+O7OY;$;L
M#D"O3HKF":26.*:-Y(6"RJK E"0" P['!!Y]:2VN#T=B6L7Q%XD@\,VT=Y>V
M=V]B6"SW4(1DM@2 &<%@V.>JAL8YK:K*\0A&TI5D"E&N;<$-T(,R<4#0NK:U
M_9FG17L%A=:E'(RJ!9M%G#<*WSNH()('!/7TK1B=I(D=HVC9E!*/C*GT."1G
MZ$UY[=QW'@NXAT?RY)?#U]=PBQD&6-E*95/DM_TS/.T]NGI5RZE?6-8\26UY
MJ-YI\VEA'LQ;W30[8S'N\T@$!P6W##@K\N,=:':U^G^6X).]OZU>AVS31I+'
M$S@229VKW..M0VDUS-Y_VFT^S[)62/\ >!_,0='XZ9].U>?6:/J_B;P=JFL&
MYMK^;1Y9942ZDA4.&A/W0P&#N.5(P> <X%,77[G1]#O6U+5+R2T7Q"]G<WTC
M@/#!P <J %&=JY &-Q/!YIM6=G_6MA=K?UHW^AZ;17G=_K5OI/A2]N=$\4)?
M6'VV)&NVE:]%A&Q4,&</O<=^7#*&ZX INF1ZA<>']1AT7Q?I^NLTD7EQP7,J
M!!G+Q^>9I9%9AT^;*]L=EW ]&IDDT<.SS'"[V"+GN3VK&\+ZFNHZ?,IMKRUG
MM9C!/;W<HE>)PJG&\$[A@@YR>O-9'CC3[:]UGPH;B6YC7^TF0F&[DAP#!(>J
M,.<@<]<9'0G+MJD"UN=G17G-[>W%]I?B?4CJ5Y::IH\THM8HKIE1$5 8]T8.
MV0/URP)^8@8Q7?6$LT^G6TUS%Y4[Q*TD?]QB 2/P-+I?^M0(=1U);&TNY8H7
MNI[:'SC;1,H=ASCEB ,X/4]J72-0&JZ-8ZB(_*%U DP3.=NY0<9[]:XTV-I%
MXW\6733W"R_V?"P5KR382R2Y^0MM/"\<<<XQS4.@-/87'@?R;NZ9+[3&2>%Y
MF,;!(59<)]U2#QD $CKFA;?=_P"W?Y";U^_]/\ST6BO+/#.L3:SKEI>3>-+"
M#4//:*YT;;()3@D&+RVG*<?WUB!^7/3->H3*SPR*C;7*D*?0XH>BN/K8QF\2
MQRW<D&G:;?:DL,IAGFM1&(XF'4$NZ[B.X3<1TZ\5I:=J$&J6@N;?S!'O=,2(
M48%6*D$'D<@UR?PNE2#P;#I,S[=3T^26*^A<_.LF]B6(/.&SN![@U9UN^6?Q
M#HVE&>2#2]06<O-;S-"99EV[4$BD,,@NWRG)V^F:=M;(/,ZVBO+]1O-9MM!U
M.&/5;](=.URWMK:Y$@+SPLT89'<@EMI=AG.3CDG!SI302MXD\3:7_:.I"T33
MX;R-1>RAHY6,N2KAMRCY%^4$+[4GHK_ULG^0[:V_K>QWU%>;V5[?:K>^"C>:
MO>K%JNDR-<P13>2LD@C0[@5 8,=QZ-Q@8Q3K:\N7@.D2ZA?S0_VO-;6>R<K-
M=PI'DJ9PRLH1B<OG<=F.2:IQ:;7K^#L2GI?^M5<]&HKRVVU+5)?">CDZQ=1S
MQZ_]CE\JX$I>+[0R!6=EW,  .3@MCG-:G]EW.JW?BS08=5U. 0-#+9RK?S!X
M9'C)(W[MQ3/\).!GC'&)>G]>C_4?6S_K5K]#OJ*X[PS.OB"[MM1#7T TZW%K
M+;F\E*_:.1(KJ6PY7'WFR3NSV%='K"7<FCW:6$\<%XT3+#)(<*KGID]N>]#T
M!:E?Q'K3:!I7VY;&6[42I&RHZKL#,%W$D] 2.@)YZ5K5YIJ6H._@[5=+O+2]
ML+^T:U$L5Q=FZ4AI1M=)6)+ D'[V#P.!6C-?/HOB/Q+#)JMU#91:3'>F29VG
M\B0F16=58G PH.P8'' &:._]=+C2O;^NMCL[R=[6RGGCMWN'C0LL,94,Y Z
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MG)N3?7_@W)2Y8\O3_@6,K2=/N[GQ3<^(KJSFT\2V4=HMI,Z,Y*NS%F\MF7N
M,,>_2I=9L[YO$FAZA:VIN(K?SXYL2*I0.HPQR>1E><9//0UL7EY;:?9S7=Y/
M'!;0J7DED;"JHZDFDL+ZVU.P@OK.42VUP@DBD (#*>AYI=O+_@_YL?KU_P"
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M[C2KA3;V$]M<1&XA"1,3&5$4:-L"':0N.>F[&,UZ#13N_P"OG_F)*VG]=/\
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M+ AA]X 9)(I+HOZZ_H_P^]O=O^ME^IKZ%<ZA>QW5S>2VSV[3N+3R8&C/E!B
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MXIJRW_K5_I8/Z_#_ #+FCZO?3^(]7T>_^S.UHD,\4L$;("DF["L"S9(V'D$
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVM[F-;&]GEBN(O)R[$1.X.\G@94< 9]^U:T6CV,&J2ZE'"1=RHJ2/YC$,%!
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M/^M_\T#VT_K;_@G.RZAK\_A;4[F'6[M)]&U&6*66*" O<P(P+94QE=^PG&T
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MZVO;B%C<VX98Y$E=#M;&5;:1N4X'RMD<=*S$\">'(39?9[![<64QG@%O=2Q
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MQKFF?VJD-K8BTGA2.U4Y1BY=&))))"XR,8XP.N>MM[>*TMHK>% D42!$4=
M, 50M/#VFV.M7>KP).+Z[ $[O=2NK =!L9BH R<8 QDXHZ_U\@W1RWA_5O%6
MNW5IK,-QIJZ1)*4FMFN]QC7)&-@MPRR@X!!E(SGCD4MEKNK'Q1I*G4);NRU"
M:XBD"PQBU38K,GE-M60G"\DEE/.#TK:M_ GA>T\2/XA@T:WCU1R29QGJ>K!<
M[03SR!GDU-!X/T*V:V,5FX^RS-/;JUQ(RQ,P((4%L*N"?E'R^U"MH$M;V,>S
M\27EIJUY:ZR-0@NRTSVUN\"&WGC0$@0R*O+%0"5<EN#P!5:'7-8BTWP]XA_M
M!KJWU>6".:P\E-D0E'!C8*'RI(SN+9 /2NM31+!+]+WRY'F08C\R=W2/@@E4
M)*J<$C( )!Q5>S\+Z/879N+:U9&WETC\^0Q1,0062,ML0G)Y4 \FDNE_Z_X<
M'UM_7_#''_\ "0>((]!GU2?5$>:SUS[$T45LB131F=8B&!W,."2,,#GKD<5Z
M17-'P#X?.GRV)AOC;2W NG0ZG<_-*#G=GS,YSSUZ@'J!71H@CC5%+$* !N8L
M?Q)Y/XT^EOZV7Z@]]//\_P#(=1112 **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *S/$5Q=V?AO4KJQECBNH+=Y8WD
MCWJ"HSRN1GIZUIU0URUEO= U&T@4--/:R1H"<98J0*F=^5V*A;F5S-\/>);&
M]T"SDN]5LVOEL(KF\4S(K1@H"790?E'7G %7!XH\/MIW]HKKNF&Q\SROM(NX
M_*W_ -W=G&?:N3T>QGOH_",$5C=6EQH@ O99[9H@ (2C1JS "0,Q!RN5XSGI
M5ZPTZYM?%$^AB,'1XY1JD1!&$+$_NL>GF N/R[5K*W,[=W^?^6QG&_*K^7]?
M?^9U\T\-O \\TL<<*+N:1V 51ZDG@"HK#4;'5;5;K3KVWO+=B0);>59$)'7E
M2165XP:1=##1V#WFVYA8JD;R&+#@^9L3YGVD [1UQ6=X-M[JUUCQ)]IBNR+B
M]2>.>>W$0D4PQC@ #N",=1CGFI6M_P"NQ3V.CO-5T[3I(([[4+6U>=MD*SS*
MAD;T4$\GV%&H:MINDI&^I:A:6:R-L0W,RQAV]!N(R?:N*UJZN]-\3:M:ZEX6
MU+6]+UB.*.&6PB638H7:T4F67:N<L"3CYC5Z3SM*\5W5QJ.GW5QIM]8P6\'D
M6[W/DLN[?&P0$@'<#N(P<<G@4EM?^O0'HSIVU73DOUL6U"U%XT7G+;F9?,,?
M]X+G.WWZ4V#6M*NK*.]M]3LI;21_+2>.X5D9LXVA@<$YXQZUPNF:5J.@2>$)
M;VVN98K5+N%Q!"TK6XE(,2,$R0  %+=!CDXYK'N[*Y_L2VBN_#VH^?#XI:ZC
M;["TQ\DSEV<; Q4;3WQGMFFE=V_K>WY,'M?^MG_E^)Z$/&?A]M=MM'CU>Q>Z
MN8VDC"W"'.&"A1SRQ.< <_*:V;FZM[*VDN;J>*"",;GEE<*JCU)/ KFY;;[%
MX\TZXM]/E6SEL)XM\$!V+(TJ.=V!A<X8Y.,G/?BG^+(KQ+O1-1A@FNK.QNS+
M=V\*%W*F-E#JHY8J2#@9/H"12Z(75EO5O%6E:=X7N=>2_LYK2.)GBD6X7RY6
M .%5LX))&.*C\,7$FH6[:E'XACU:SN$4JL:Q%8)/XE5X\97D##988Y8URFKV
MD_\ 8GC6_M;*^%IJ]LL=I:I8R^;)-Y15G,07>NXE1E@/NY/K7<Z)<K=Z':21
MQW$6(@A6XMWA<$#!RK@,.1Z<T^C?I^HWT^?Z$JZKISZDVFIJ%JU^B[VM1,IE
M"^I3.<>^*3^U],.I_P!F#4;3^T-N_P"R^>OF[?79G./PKA_#-Q=_:+'0-9\)
MZD-1TZ>25=46-?LI8EAYPDW EF#'*X)R>?45UT_4+GPM#X;DLKN/7K>^6<7I
MMF\HD3[S.)L;,E2<KNW<D8H6MOZ_JP/2_P#7?\_U._N=9TNR+"[U*S@*,J-Y
MLZKM9ON@Y/4X.!WJ2/4["6\FLX[ZV>Z@4--"LJEXU/0LN<@?6O-[R*".7XA)
M;Z-?K]MM@L/EZ3.!/)Y91MI$>&)<CD9S][H,U:!BNM?\,1RZ5?O:'2)[:Y$N
MES^6"_E@))E,#)1L[OQZC,K:_P#6S?Z?B/\ K\O\_P #NH=;TJXO$LX-3LI;
MIT\Q8$N%9V3.-P4')&>].?5M-CU)--DU"T6_==R6K3*)6'J$SDC\*\V\,P?V
MKX,\)Z=8V5Q%<V=S%=-<&V98XHU=BQ63&TEERN%)/S<@"EM;%E\43:5K7AKQ
M)>7!U!KNWOX+V;[ 5\S?&[#S0B%> 5VD_+T.:JVMOZZ?U\A/1/\ KO\ Y?B=
MWI/BK1M;OM0L[#4+:::QD,<J)*I;@#+8SG:"<9Z9!JU;:WI-[;SW%KJEE/!
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M+?VL!9(Y96C8C!(*Y15'!R.F?6MFN)T_QG&NDZ1-;>'9($U+4);3R8Y(P(9
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MW9( S@'\*M:=X<U/3M:UW4EU2T=]3VE$-DP$)1=J9/F_.,=?NY/3%=+12Z6
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MY-X<T.XU1=3FT;3I-05@PNGM4,H(Z'>1G([<U=NK2VOK62UN[>*XMY!M>*9
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M9OHT"K/Z, "1SZ@G/6N*L- U/Q%9>(].;6(+?1[K5+F.:&.S)G*[OF42F3:
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MI QGMG Y#7G_ %H_RT$_+^MO^":NEZYHL>A2ZE;:O+?V+W,FV<EIBSES^[C
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M76M)9'B,C81\G$D9/]S:Q _W1Z59\6Z=J+:#I5II^GW&HS07UM<3&)XD.(Y
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MM=V^L2SR07WFQA(?-7!$H8AOE/3:&XQTI?U_7XL%:YTS^(M-2_O;$R7!N;.
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M(\_,I&7!/&05SD\9ZUWVK^<=&O!!;27,S0LJ0QLH9R1C +$#\R*F6D';7?\
M)%+XU_75G+:UXEM-)\-Z"EK=:C=P7\D$27:6\TTLD)QEMR)D.R_1CDD#(XZ;
M1;*.QTY4AN;Z>%R9(S?.[RHK<A27^?CT;)'>N(:QUV+PAX/LAX<OI+G39K>2
MZC2>V^01+M/)E .>HP>G7'2O148O&K,C(2 2K8ROL<9'Y5<K)RMW?W$+IZ?Y
MCJ***DH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-_&&HIHMOXH"V;:%+,L;6XC;SU1I?+$F_=M/4$IL'?YJ2UM_76WYAW_KI?\
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M:/ 8<['%=DC%HU9E*,0"5)S@^G%+I<;WL.HHHH **** "BBB@ HHHH ****
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M%2T;,.=@92 ,Y."#RQK7JO=7UO9R6T<\@5[F7RH5)Y=L$X'X G\*-] .;MO
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MURSR^3E)&^\1MC P>."".!5W2-'@T>*=8Y99YKB7SKB>7;OE? &XA0%'"CH
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MM/\ A&[O1)=?U^XBNL"2>YNUFE"#^!=ZE57IT / YKK;>(P6T<+3/,44*9)
M-S>YV@#\@*EHHN!FW.BP7.N6NK>?<17%O$\.V-@%D1B#A@1GJH/!'Y'%4(O!
MUC#*R+=7ATXS?:!IK,A@$F_?N'R[_O<[=VWVKH:*2T ",C%<U:>"K.T_LX)J
M.HM'IT[S6J-(F$#*RF/(4%EPQY)+?[5=+50O=Q7T\DS6RZ:L*LK9(D#@G<6[
M;<;<=^M&VH;JQS^F> -,TC6I-0L;[5HH6=I!IRWK?9$=CDL(NF<G.#D9[5&_
M@"*729].?Q#K+1SWHOG<_9]_F!M__/'&-P!QCMCID5U%G=PW]E!>6[;H9XUD
MC;U4C(/Y5/1M\@O?4YP>#K634]3O+S4+V]34[9;6YMIQ$(F0 @8VQA@?F;O_
M !?3"^&?!]MX8,OD:IJ]\K\1IJ%XTRP+_=C7@ ?K[UT5%%P,O3?#]AI6IZIJ
M%LC"?4I%EGW'(R%QA1V'4GW)K)T7P#IN@ZO)>V5_JPMRQ:/3GO6-I$QY)6/Z
M\\YQVQ7544+0'J,FB2>"2&09212K#V(Q7-1>"HH'T8Q:WJH32.+>,M"RL-NW
M#9CR?D^7@CCGKS7457^W6_\ :(L!(#<^5YQ0=0F<9/U/\C0#.;_X0#3YM(U'
M3;W4-1O(;ZY^UEY'C1X9LYWQM&BX.0.N>GUK5\/>'X_#U@;9=1U+4'9LM<:C
M=&>4^@R> !Z "KUC]N^S?\3#[/\ :-[_ /'ONV[=QV]><[<9]\U9HV#<J7UG
M)>0E(KZYLWVE?,@"$C..SJR]NX]:QX_!FGV\T#VES>6R1VK6DD<;KMFC)+?-
ME20=S$Y4KU].*Z.BBP7.7@\$PVUQHLL6M:HHTB'R;>,F%@PQM.[,9))4 <$=
M.,')JNWP^A?2+C36\0:P8I[T7SOBVW>;NW_\\<8W '&.WID'L**=W>_]=_S#
M;^OE^IR>H> +#4-;CU<:IK-I=[46Y-E>& 7FT8'FA ,_\!VUU:J$4*HPH& /
M04M%+R#S"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ K+\2'4%\,ZF=*4MJ M9/LX7J7VG&/?-:E%)ZH:=G<\
MOTG5-#U;3M5N?!$5U;Z^FGR1S6_V62)1/C(,I90KRAA@')/)SD5-IYTB;5M!
MO/#+0Q3_ #+K8C;8XB\HY^TC@B0/MP7^;.>V:]*HJK_U]_X:[$VTM_73\=#P
M]+_P]#X+CO(]4LVN+7Q(4M[I[P/+'$;GG$A8M@Q9).>5Y/K6OJ6H>'K34O'.
MG1:G8V=LVG0SK%;W8@S/B3<PVL#N)\O/KD YS7K-%)ZQ:_K9+]+E7]Z_];M_
MK8\HL+KPX==\&JMWIQ-]I,D=T//0_: %0(LG/S@,' !ST8#H:RUUFQ/@Q$74
M7/A^UU>[BO3IR17/V>W+2>5NC9'4Q=.-O3!'2O:Z*;=VW_6]R8JR2]/RL>.:
MC)X>M?!^@26&N7DUC+KEO);O>-]E5DWKO"1A8QY8 S]W SD5J>(;CPUX=UU=
M/\16!7P[<6RG3G%N\\27#.[28"ABKG<I4@< <8KT^BAO^ODO\A_U^-SSN\NM
M+LO&W@M3J4HE:VEC5+RY*R2+LQ&S1L1\['(SM#$\>U96EW6G'Q5H&J6;6\1N
M+RZM[IC\UV[;'8)<.,8((&(R"1@<\<^LT4)V=_7\1-75O3\#C/A]J-C?CQ#]
MCO+>XQK$[GR95?"MC:>#T.#@]\5FZL=*GU_7;3Q6(%F;8VC/-\K;/+'_ ![G
MKY@?=G9\WW>V*]%HJ;:6\K?AN4G:_K?\3S.TC:Q\2>$[WQ)'!#>W>BRVEW/,
MJCSICY1$;'^)B-^%[_-BL33[/1)M"\,K?Z;;_9;/7[J!_M5GB-$<S%%&Y<%2
M3'C'&<#J*]GHJ^;6_P#6[?ZB_K\+'EU]JN@'Q7>Z7XG@N[?5WNU?1[B*UD>0
MQ;4*^0ZJVSD'<.!R<U+JITVXOO$5OXC$::N'9]&:3B;R_*7;]F/7=O!R$YSU
MXQ7IE%3TM_7KZAUO_7IZ'ERR:>WCK2;7Q)>6;WTGA]UU&VN+H-'YG[LD&-FV
MC(#GIR!GG&:R=/UC0;?PUX3U#^T]/6[AU=K87#7";T@#N"FXG(384XZ8*GN*
M]GHJKZW_ *W;_6PN72W];6_X)X_!/I=YXY:UUO5=9M?$L=\S6T$%E&PEA\PM
M'LF$!<1%< @R =0>*[[QM=6UIX<9[S?]G:>%'(D$<8!<?ZUB"!%V;CH2.]=%
M14]$A]6SQ;4);#3O!GC2Q>[MK2&*]C>UBM':WA4-'&P5!NP026..C<G%;%[J
M=I:>*M6B\+W=DVH77A\S116\JLUQ< DHQ .7?8<@\DC':O4:*/Z_"P=;_P!;
MI_UZGE4-QH!\6^#;G18Q)N>=;R2WB9W$IB"_O\#<'R1DOR.Y%=;XVFEM[73)
M)5+:2+U?[3P"1Y&UN6 _@W[-W;&<\9KJ**;?YB2M]QY)K%@)M \5Q>&8XYO#
MTEM;/;1V7SQ><')E\H+QC:%)"\9]\UT&F0:;?>+%NO#CPMID]C*FI2V4F(Y)
M25"99?\ EJ!OR<[@.O:N[JCJEMJ%S;QC3=0CLIED#,TMOYRNO=2NY3SZ@@C%
M+I;^MFOU_ ?G_71_I^)Y1-=):?#WPV^J7-]%H#-<)?SP0)<E3O;895D20,GW
MLDJ3DK5V6_T71O#VB7$LFHZIX,DDG^T37=H2J;@/+W1+&O[D'> -F <8XQ7I
M>D:7!HNDV^G6V3% NT$]2<Y)_$DFKM,/Z_,\QU.S\,7?AGP[<16XN=$75D,;
MZC;';'$^[Y0)%!6/)4 $ <#'&*L6%MX?U?Q]XKT262VNH;FRM=]I++YA4CS-
MP",3LVY0X &TD<#->C44M-?._P"*7^0:_P!>K?ZG!>$;*&[A2RGT6VBN?#1>
MS@E:!<&7LZ''&4V,<=W]JYWP5-I%]XDMS<ZMK<?BRW!^WVC6,2<[2&\R58 7
MCYRNYS_#WQ7K]%.^MW_7_#A;2R."\'RMI^O2:.?[-OSY32MJ-C\LN<K@72=I
M&!&&)R<'@5:\5RV<?B33E\1+;GPU);2JYNP#;BXW)L\W=\OW=VTGC.>^*[.B
MEV#N>0>(8K"#X:ZM'JS69L%U,C1C>,"?*WK]POSC_68Q_![5Z=IUOI$FAQP:
M9#8MI4D9$<=LJ&!D.<X"_*0<FM&BAZIKO_E8.J?];W/'K"X\-Z7X5\*V@DT^
MPF?5U^THI6%BZ^8K;L8Y'R@YZ9 [BB^OM$B\._$?3[;4;6WMK:4O;PVUV(A&
MYA3A0K#&9001T+9!!Y%>PT4=_P"NW^7XC3L[_P!;M_J>:ZU=10Q:7KUM=:/J
M4*V,<<=E<N [G!YM9!G]XPR, '.!R*[S4-7LM(T>35-2F6TM8HP\C3$+M]OK
MGC'K5ZBG)WN3%6M<\JUY-3C\(KXL.N:*]O;7 U>+9:G>QS_JQ/YVTDJ?+SLY
MX&,UJ^)_$7A_4M*T/5I+VPO=%FE<O:33Q(ES^[;"GS&5"RG'RN1S[@5Z!6#X
ME\.MKZ0#?8.D63]GU&P%W Q./F*;E.X<X.[N>*3[+N/S9YM?R:9!X7TB[DUN
M)OM'B&)XHTUAI8XH?-SY>!(4^1",A>!^&:T?&Z:+HM]96>KSW6G^%Y(&:%[:
MSCNH1<&0LP=9(I<$Y!4J!CYJ]!T/0+'0;=TL[.QMGEPTPLK5;>-F QD(,X_$
MD^]:M-]OZV7^5P7G_6MSQ_Q+-I=A!HUOKVJZRGAE[$"WO)[&.X+2AN/.22!]
MK%=NT[5/!S6A,=#M_$_@NTEU::=7M9X]FIW)626,KB,O$=HRV2!E03T/3%>H
M44?Y_P"?^8/;Y?Y?Y'B9U+P]!X-GN8-0TY9+#Q$$L9%G3-O$;@';&<_*ICW<
M#C;GM5O6+K1[[QI/:Z_K&K6E]+.KZ.UE9Q3++"54J8)?(=U[[L,!U/0U[#10
MG:W]=%_D#U_KS?\ F>2ZK/X?EUCQ[%>7UI,8[&*18[F[#^7*%<94,Q"LKE<8
MQM)&,$U?TK^QM1\6>%M6N8[*[GN-%/E79C61GG5H^CX.77Y_<#=[UZ711%VM
M_7?_ #_ 35_Z]/\ +\3COB!9:9<Q:'-JMI:S6T6J1"1[F)71$8,#G(P 3M'Y
M5R7B"_\ #MU;>/V-Y8-+:PQ&W#2J##*L(52H)^5P^%!'(/'7BO7J*E+^ON_R
M*3U3]/U_S/*_$]YIFNVYB#VEU<G1!<VTUTPE0MAOFMU'+2 CYF##;\O7M>LX
MM'N_&GAG4[JVMIIY]&)AN980SO*K1X*L1DL 6.>H&3TS7HU%5?6_]=?\_P "
M&KJW]=/\CF/&VFVLVFPZS)9PSW.CS+>1,\0=@BD&0+WY4'\0#VK M-(L$\17
MFG?V3:FP\2*E]L-LNW$;#>&!'=3&>?XG8UZ-126G]?UV3^13U_K^O/[SR'Q/
M)I+>,[G3?$VI:KIKLZ?V/]CL8Y59-BC]R_D.\;A@V=K#M6K:0:1J7Q4UFQN+
MA;IA8VD@AFNBS).CLW"AOE8!4)"X]<<\^DT4+3\?Z]0>IY!X7FTJ]\7VZ:CJ
MNM1>+K>5OM%I]AC4, 3G,RP;FA(.0&DZ8[XKJ?BA<65KX9M9KN\6V9-0MC&6
MN#$&_>KN!&0&&W<2#D #/;-=M13OMY!U;[_\'_,\DU.Z\-W6K>/!<:C97"+8
M0S1K->"14D"O\RAF(4ABF,8P6&,$\WK<:/J?B+P5JUW'8WCSZ5(J73HLI>X7
MRBH#8.7!$A&.1\WO7IM%"T_KU7Z_@'?Y_I_E^)X_X8GTJ\\6P)J>JZS#XMMY
M7-S:_88U#*"<YF6#<8,'(W2=,=\52.HZ!#X1N[Z/5+-[FU\2 6US)>"22-#<
M+]UV8G!C#9YY4'.17MM%"=K?UU3_ $_$;UO_ %T:_7\#R?Q/<Z=>Z?XQ75EA
MEU9896TH.N7-N85VM >X)+;BOOGC%5/$.H:;NT=/$UYJ5AHD^FP"SD33DF3[
M0,A@R2P2,DF-NT@ XS7L=%+I;^OZ_45_Z^[_ "^X\Z#Z;#K=C8:_+)<:5_9T
M(TN35%YFG#-N+9 'G8$9 (#<G SFM+X6NLG@"SC,4J%))E998V7K(Q&,CYA@
MCD9'O79T4[[^?^=_U%;;^NECQJ^32K+PEJFG&V@6YT[Q&L\=I%!NDMXVN$*L
MJ*"5!0G! Y!P/2M:X3PW_P )=XHBUID,5Q#:R6\=Z[%C*RR$"(.<A_15P1V
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_7];7=^BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
@% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ex10-56_09.jpg
<TEXT>
begin 644 ex10-56_09.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2X Z0# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK
M*\275_8^'[V]TV6VCN+:)IA]IA:5&"@DC"NIYQUSQZ&N2E\5^)M,T+0]=NUT
M^_L[T(US;6=E)'-&K1ERR$RL&V@$D8YQQZ4KK^O/_A@_X/X'H5%<WJ.KWUTF
MB76@:AIQLM0E"&2:V>;<I1F#*5D3'"D8(/7VP;_B*36(-"N9]#-H;^)#(B74
M3.DF 3M^5E()]<GZ42?*FWT!:M)=35HKSRZ\6Z]#IWA34TO]%^P:O)%#<2/9
M2!HW<$@J/.Z<!<'.#SST'13W6NS^)[BQL;K3H[.&T61C-9O(ZR,6"C(E4$?*
M21@'&!GG--JVGJON$I)J_H_O.AHKA?#6L>+O$6B?:TN=%CE-]+;L_P!AE*QI
M&SJ3M\_+%B%QR, GK2:#J_C+64O95NM$9;/4GLGB73Y5+HC ,X8SD X).,'I
MC-'_  _Y?YH+_P"7Y_Y,[NBN/T'Q7>'Q%>>'O$"6\=ZDA%I=6\;1PW:A58@!
MF8JZ[AD9.>HJOJ6M>*+#1O$U\+S1W.DLWDK_ &?+\ZK$LA#?O^IW@9'IG'.
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MHRJY(1E^]^74XJL=.TG0OBCIKZ5X?DL[=;*:&XFL=(D6(R.T90%TCVG@-SG
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M8E[>WN6CCN 1]V4#[R^U; &!@=*:Z_UV_.R^X5M5_75_E=_>>7>*+22'Q?J
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M32:W/*\DNW. HDD<[1D\\=:[6BBK;N"5@HHHI#"BBB@ HHHH **** "BBB@
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MAJFIS:7KENT&N:3;^1>9'RRY8;)%/<, 36!!-+X$^,.J:?"A-GXD@^TVD?\
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M-;_AW6?%.D^,++P]XTMK.[DD@F>PUBW.W<J@%PXXQQC/ [=>M-6O]UONOO\
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M#I ) 7\OH&QG./>J:LW$B,N9*7<M4444B@HHHH **** "BBB@ HHHH ****
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MG(_ V@1>(SX@2"[_ +5)YN#J%P21G.T@OC;_ +.-OM21> O#,%_?WD>F!7U
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M]G^T9.[R\YVXSC],UHT4"L@HHHH&%%%% !1110 4444 %%%% !1110 4444
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M5W-%% !1110 4444 +1110,**** "BBB@ HHHH **** "BBB@ HHHH ****
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M8Q79PPQ6T$<$$210QJ%2-%"JJC@  =!3Z* *5MH^F65[<7MKIUI!=W!S//%
MJO*<Y^9@,GGUJ[110!S^J>"/#6M:Y#K.I:/;W5_"@1))<D8!R,KG:V,]2#70
M444 %%%% !1110!SVJ>%8M2\9:#XC^U-%+I*SIY00$3"1-N"<\8Y/>NAHHH
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M0'&TN%VJ2>F2,]LT+78;=A/MGC#_ * 6A_\ @YF_^1:/MGC#_H!:'_X.9O\
MY%JSXI:ZB\,:C<65]-9W$$#S)+"J,<JI.,.K#!QSQGZ5R=OK6KZ5J/A0/KDF
MK1:V )H+B*$/$/+WF1#$B?*#P=P/4<TD[NW]:W_R8F[*_P#73_,Z/[9XP_Z
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M10,Y_P"V>,/^@%H?_@YF_P#D6C[9XP_Z 6A_^#F;_P"1:Z"B@#G_ +9XP_Z
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M HHHH **** "BBB@ HHHH **** .)^)=M#!X$U-XHU5YKBW>1AU9O-C&3^
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M8W1$X5Q['&1ZC%>@4NB]%]]E?\2EU]7^84444#"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
L !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>19
<FILENAME>lfmd-20201231.xml
<DESCRIPTION>XBRL INSTANCE FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: LFMD %2D 20201231 10K FY DFN.xfr; Date: 2021%2D03%2D30T19:46:43Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:LFMD="http://lifemd.com/20201231">
    <link:schemaRef xlink:href="lfmd-20201231.xsd" xlink:type="simple" />
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-04-01_custom_ImmudynePrLlcMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:ImmudynePrLlcMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-04-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-06-30_custom_LegalSimpliSoftwareLlcMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:LegalSimpliSoftwareLlcMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_CustomerRelationshipAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">LFMD:CustomerRelationshipAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_PurchasedLicensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">LFMD:PurchasedLicensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-02-28_custom_LeaseAgreementOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:LeaseAgreementOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_ServiceBasedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:ServiceBasedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_ServiceBasedStockOptionsMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:ServiceBasedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_ServiceBasedStockOptionsMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:ServiceBasedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_PerformanceSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_PerformanceSharesMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_PerformanceSharesMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_WarrantMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_WarrantMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_PilarisLaboratoriesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:PilarisLaboratoriesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_CVLBPRMember_custom_PilarisLaboratoriesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:CVLBPRMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:PilarisLaboratoriesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_CVLBPRMember_custom_PilarisLaboratoriesLLCMember_custom_OneEightyDayAnniversaryAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:CVLBPRMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:PilarisLaboratoriesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:OneEightyDayAnniversaryAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_CVLBPRMember_custom_PilarisLaboratoriesLLCMember_custom_ThreeSiXFiveDayAnniversaryAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:CVLBPRMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:PilarisLaboratoriesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:ThreeSiXFiveDayAnniversaryAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-04-01to2017-04-30_custom_SubscriptionAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:SubscriptionAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-04-01</xbrli:startDate>
        <xbrli:endDate>2017-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-04-30_custom_SubscriptionAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:SubscriptionAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-04-01to2017-04-30_custom_SubscriptionAgreementMember_custom_OneEightyDayAnniversaryAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:SubscriptionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:OneEightyDayAnniversaryAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-04-01</xbrli:startDate>
        <xbrli:endDate>2017-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_SubscriptionAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:SubscriptionAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_MALPHABETLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:MALPHABETLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_MALPHABETLLCMember_custom_OneTwentyDayAnniversaryAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:MALPHABETLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:OneTwentyDayAnniversaryAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_MALPHABETLLCMember_custom_ThreeSixtyDayAnniversaryAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:MALPHABETLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:ThreeSixtyDayAnniversaryAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_MALPHABETLLCMember_custom_CommonStockOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:MALPHABETLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">LFMD:CommonStockOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_MALPHABETLLCMember_custom_CommonStockTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:MALPHABETLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">LFMD:CommonStockTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_MALPHABETLLCMember_custom_CommonStockThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:MALPHABETLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">LFMD:CommonStockThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_BVGlobalFulfillmentMember_srt_ChiefExecutiveOfficerMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:BVGlobalFulfillmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:ServiceBasedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoManufacturersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">LFMD:TwoManufacturersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_TwoManufacturersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">LFMD:TwoManufacturersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CustomerRelationshipAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">LFMD:CustomerRelationshipAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PurchasedLicensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">LFMD:PurchasedLicensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-05-29_custom_SecuritiesPurchaseAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-05-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-05-28to2018-05-29_custom_SecuritiesPurchaseAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-05-28</xbrli:startDate>
        <xbrli:endDate>2018-05-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_SecuritiesPurchaseAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-15_custom_SecuritiesPurchaseAgreementMember_custom_TwoAccreditedInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:TwoAccreditedInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-08-14to2019-08-15_custom_SecuritiesPurchaseAgreementMember_custom_TwoAccreditedInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:TwoAccreditedInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-08-14</xbrli:startDate>
        <xbrli:endDate>2019-08-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-25_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:NoteRepaymentAndWarrantAmendmentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:NoteRepaymentAndWarrantAmendmentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:NoteRepaymentAndWarrantAmendmentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-17to2020-02-18_custom_CSixPurchaseAgreementOneMember_custom_CSixCapitalLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:CSixPurchaseAgreementOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:CSixCapitalLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-17</xbrli:startDate>
        <xbrli:endDate>2020-02-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-17to2020-02-18_custom_CSixPurchaseAgreementTwoMember_custom_CSixCapitalLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:CSixPurchaseAgreementTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:CSixCapitalLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-17</xbrli:startDate>
        <xbrli:endDate>2020-02-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-18_custom_CSixPurchaseAgreementsOneMember_custom_CSixCapitalLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:CSixPurchaseAgreementsOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:CSixCapitalLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-18_custom_CSixPurchaseAgreementsTwoMember_custom_CSixCapitalLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:CSixPurchaseAgreementsTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:CSixCapitalLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-17to2020-02-18_custom_CSixPurchaseAgreementsMember_custom_CSixCapitalLLCMember_custom_DailyAveragePaymentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:CSixPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:CSixCapitalLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:DailyAveragePaymentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-17</xbrli:startDate>
        <xbrli:endDate>2020-02-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoCSixPurchaseAgreementsMember_custom_CSixCapitalLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:TwoCSixPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:CSixCapitalLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_PresidentAndCEOMember_custom_OfficeSpaceMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:PresidentAndCEOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">LFMD:OfficeSpaceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_PresidentAndCEOMember_custom_OfficeSpaceMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:PresidentAndCEOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">LFMD:OfficeSpaceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_JLSVenturesLLCMember_custom_PuertoRicoOfficeSpaceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:JLSVenturesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">LFMD:PuertoRicoOfficeSpaceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_JLSVenturesLLCMember_custom_PuertoRicoOfficeSpaceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:JLSVenturesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">LFMD:PuertoRicoOfficeSpaceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_BVGlobalFulfillmentMember_srt_ChiefExecutiveOfficerMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:BVGlobalFulfillmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_BVGlobalFulfillmentMember_srt_ChiefExecutiveOfficerMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:BVGlobalFulfillmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_BVGlobalFulfillmentMember_srt_ChiefExecutiveOfficerMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:BVGlobalFulfillmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_WarrantMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_WarrantMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-19to2020-01-20_custom_MrSeanFitzpatrickMember_custom_ServicesAgreementMember_custom_ServiceBasedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:MrSeanFitzpatrickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:ServicesAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:ServiceBasedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-19</xbrli:startDate>
        <xbrli:endDate>2020-01-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-01-20_custom_MrSeanFitzpatrickMember_custom_ServicesAgreementMember_custom_ServiceBasedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:MrSeanFitzpatrickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:ServicesAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:ServiceBasedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-01-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-25_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_AlphaCapitalAnstaltMember_custom_TwoThousandAndEighteenAlphaNoteMember_custom_TwoThousandAndEighteenAlphaNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:NoteRepaymentAndWarrantAmendmentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:AlphaCapitalAnstaltMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:TwoThousandAndEighteenAlphaNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-25_custom_AlphaCapitalAnstaltMember_custom_TwoThousandAndEighteenAlphaWarrantMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:AlphaCapitalAnstaltMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:TwoThousandAndEighteenAlphaWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-25_custom_AlphaCapitalAnstaltMember_custom_TwoThousandAndEighteenAlphaWarrantMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:AlphaCapitalAnstaltMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:TwoThousandAndEighteenAlphaWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-25_custom_TwoThousandAndNineteenAlphaAmendmentMember_custom_AlphaCapitalAnstaltMember_custom_TwoThousandAndNineteenAlphaWarrantMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:TwoThousandAndNineteenAlphaAmendmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:AlphaCapitalAnstaltMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:TwoThousandAndNineteenAlphaWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-25_custom_TwoThousandAndNineteenAlphaAmendmentMember_custom_AlphaCapitalAnstaltMember_custom_TwoThousandAndNineteenAlphaWarrantMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:TwoThousandAndNineteenAlphaAmendmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:AlphaCapitalAnstaltMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:TwoThousandAndNineteenAlphaWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-25_custom_TwoThousandAndNineteenAlphaAmendmentMember_custom_AlphaCapitalAnstaltMember_custom_TwoThousandAndNineteenAlphaWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:TwoThousandAndNineteenAlphaAmendmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:AlphaCapitalAnstaltMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:TwoThousandAndNineteenAlphaWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-24to2020-02-25_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_AlphaCapitalAnstaltMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:NoteRepaymentAndWarrantAmendmentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:AlphaCapitalAnstaltMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-24</xbrli:startDate>
        <xbrli:endDate>2020-02-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-25_custom_TwoThousandAndEighteenBrioWarrantAmendmentMember_custom_BrioMasterFundMember_custom_TwoThousandAndEighteenBrioWarrantMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:TwoThousandAndEighteenBrioWarrantAmendmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:BrioMasterFundMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:TwoThousandAndEighteenBrioWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-25_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_BrioMasterFundMember_custom_BrioTwoThousandAndNineteenWarrantMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:NoteRepaymentAndWarrantAmendmentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:BrioMasterFundMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:BrioTwoThousandAndNineteenWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-19to2020-01-20_custom_MrSeanFitzpatrickMember_custom_ServicesAgreementMember_custom_ServiceBasedStockOptionsMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:MrSeanFitzpatrickMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:ServicesAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:ServiceBasedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-19</xbrli:startDate>
        <xbrli:endDate>2020-01-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_CVLBPRMember_custom_PilarisLaboratoriesLLCMember_custom_ThreeSiXFiveDayAnniversaryAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:CVLBPRMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:PilarisLaboratoriesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:ThreeSiXFiveDayAnniversaryAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SubscriptionAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:SubscriptionAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_ProductMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_ProductMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_SoftwareRevenuesNetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">LFMD:SoftwareRevenuesNetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_SoftwareRevenuesNetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">LFMD:SoftwareRevenuesNetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_ServiceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_ServiceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ThroughTheNextTwelveMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">LFMD:ThroughTheNextTwelveMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-18_custom_CSixPurchaseAgreementsMember_custom_CSixCapitalLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:CSixPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:CSixCapitalLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-17to2020-02-18_custom_CSixPurchaseAgreementsMember_custom_CSixCapitalLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:CSixPurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:CSixCapitalLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-17</xbrli:startDate>
        <xbrli:endDate>2020-02-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-22to2020-05-27_custom_MayTwoThousandAndTwentyNotesMember_custom_SixAccreditedInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">LFMD:MayTwoThousandAndTwentyNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:SixAccreditedInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-22</xbrli:startDate>
        <xbrli:endDate>2020-05-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-27_custom_MayTwoThousandAndTwentyNotesMember_custom_SixAccreditedInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">LFMD:MayTwoThousandAndTwentyNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:SixAccreditedInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_EmployeesAnddvisoryBoardMembersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:EmployeesAnddvisoryBoardMembersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_EmploymentAndConsultingAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:EmploymentAndConsultingAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:ServiceBasedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:ServiceBasedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_PerformanceSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_PaycheckProtectionProgramLoanMember_custom_USSmallBusinessAdministrationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:USSmallBusinessAdministrationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-04-25_custom_ChiefExecutiveOfficerAndChiefTechnologyOfficerMember_custom_PurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:ChiefExecutiveOfficerAndChiefTechnologyOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:PurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-04-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-04-23to2019-04-25_custom_ChiefExecutiveOfficerAndChiefTechnologyOfficerMember_custom_PurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:ChiefExecutiveOfficerAndChiefTechnologyOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:PurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-04-23</xbrli:startDate>
        <xbrli:endDate>2019-04-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-10-08to2020-10-09_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-10-08</xbrli:startDate>
        <xbrli:endDate>2020-10-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_ProductMember_custom_ShapiroMDMember_custom_CVLBPRMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">LFMD:ShapiroMDMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:CVLBPRMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_ProductMember_custom_ShapiroMDMember_custom_CVLBPRMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">LFMD:ShapiroMDMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:CVLBPRMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_ProductMember_custom_RexMDMember_custom_CVLBPRMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">LFMD:RexMDMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:CVLBPRMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_ProductMember_custom_RexMDMember_custom_CVLBPRMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">LFMD:RexMDMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:CVLBPRMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_ProductMember_custom_INRWellnessMember_custom_CVLBPRMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">LFMD:INRWellnessMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:CVLBPRMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_ProductMember_custom_INRWellnessMember_custom_CVLBPRMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">LFMD:INRWellnessMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:CVLBPRMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_ProductMember_custom_ScarologyMember_custom_CVLBPRMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">LFMD:ScarologyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:CVLBPRMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_ProductMember_custom_ScarologyMember_custom_CVLBPRMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">LFMD:ScarologyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:CVLBPRMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-05-29_custom_SecuritiesPurchaseAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember_custom_PreSplitBasisMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">LFMD:PreSplitBasisMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-05-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_SecuritiesPurchaseAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_CustomerRelationshipAssetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">LFMD:CustomerRelationshipAssetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-07-27_custom_SixAccreditedInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:SixAccreditedInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-07-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-26to2020-07-27_custom_SixAccreditedInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:SixAccreditedInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-26</xbrli:startDate>
        <xbrli:endDate>2020-07-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-28_custom_SixAccreditedInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:SixAccreditedInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-27_custom_SeriesBConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LFMD:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-26to2020-08-27_custom_SeriesBConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LFMD:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-26</xbrli:startDate>
        <xbrli:endDate>2020-08-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-27_custom_SeriesBConvertiblePreferredStockMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LFMD:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-26to2020-08-28_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-26</xbrli:startDate>
        <xbrli:endDate>2020-08-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-28_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SecuritiesPurchaseAgreementMember_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_SecuritiesPurchaseAgreementMember_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-26to2020-08-31_custom_ConsultingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:ConsultingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-26</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_custom_ConsultingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:ConsultingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_custom_ConsultingAgreementMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:ConsultingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-28_custom_WarrantPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:WarrantPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-28_custom_WarrantPurchaseAgreementMember_custom_ClassAWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:WarrantPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LFMD:ClassAWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-26to2020-08-28_custom_WarrantPurchaseAgreementMember_custom_ClassAWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:WarrantPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">LFMD:ClassAWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-26</xbrli:startDate>
        <xbrli:endDate>2020-08-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputExpectedDividendRateMember_custom_WarrantPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:WarrantPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputPriceVolatilityMember_custom_WarrantPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:WarrantPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_WarrantPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:WarrantPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-01to2020-05-30_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-01</xbrli:startDate>
        <xbrli:endDate>2020-05-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WarrantPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:WarrantPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_AugustTwoThousandAndTwentyWarrantInducementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:AugustTwoThousandAndTwentyWarrantInducementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_custom_AugustTwoThousandAndTwentyWarrantInducementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:AugustTwoThousandAndTwentyWarrantInducementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AugustTwoThousandAndTwentyWarrantInducementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:AugustTwoThousandAndTwentyWarrantInducementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AugustTwoThousandAndTwentyWarrantInducementMember_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:AugustTwoThousandAndTwentyWarrantInducementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AugustTwoThousandAndTwentyWarrantInducementMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:AugustTwoThousandAndTwentyWarrantInducementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-07_custom_SecondAlphaWarrantAmendmentMember_custom_AugustTwoThousandAndNineteenWarrantMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:SecondAlphaWarrantAmendmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:AugustTwoThousandAndNineteenWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-07_custom_SecondAlphaWarrantAmendmentMember_custom_AugustTwoThousandAndNineteenWarrantMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:SecondAlphaWarrantAmendmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:AugustTwoThousandAndNineteenWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-07_custom_SecondAlphaWarrantAmendmentMember_custom_AugustTwoThousandAndNineteenWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:SecondAlphaWarrantAmendmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:AugustTwoThousandAndNineteenWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-25_custom_TwoThousandAndEighteenBrioWarrantAmendmentMember_custom_BrioMasterFundMember_custom_TwoThousandAndEighteenBrioWarrantMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:TwoThousandAndEighteenBrioWarrantAmendmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:BrioMasterFundMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:TwoThousandAndEighteenBrioWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_BrioWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">LFMD:BrioWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_BrioWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">LFMD:BrioWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-28to2020-09-29_custom_AmendedConsultingAgreementMember_custom_BlueHorizonConsultingLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:AmendedConsultingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:BlueHorizonConsultingLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-28</xbrli:startDate>
        <xbrli:endDate>2020-09-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-25_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_BrioMasterFundMember_custom_BrioTwoThousandAndNineteenWarrantMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:NoteRepaymentAndWarrantAmendmentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:BrioMasterFundMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:BrioTwoThousandAndNineteenWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-25_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_BrioMasterFundMember_custom_BrioTwoThousandAndNineteenWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:NoteRepaymentAndWarrantAmendmentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:BrioMasterFundMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:BrioTwoThousandAndNineteenWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-07_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_BrioMasterFundMember_custom_BrioTwoThousandAndNineteenWarrantMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:NoteRepaymentAndWarrantAmendmentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:BrioMasterFundMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:BrioTwoThousandAndNineteenWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-07_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_BrioMasterFundMember_custom_BrioTwoThousandAndNineteenWarrantMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:NoteRepaymentAndWarrantAmendmentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:BrioMasterFundMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:BrioTwoThousandAndNineteenWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-06to2020-05-07_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_BrioMasterFundMember_custom_BrioTwoThousandAndNineteenWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:NoteRepaymentAndWarrantAmendmentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:BrioMasterFundMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:BrioTwoThousandAndNineteenWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-06</xbrli:startDate>
        <xbrli:endDate>2020-05-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-10-15to2020-10-16_custom_AmendedConsultingAgreementMember_custom_BlueHorizonConsultingLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:AmendedConsultingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:BlueHorizonConsultingLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-10-15</xbrli:startDate>
        <xbrli:endDate>2020-10-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_LeaseAgreementOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:LeaseAgreementOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-04-25_custom_ConversionLabsPrMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:ConversionLabsPrMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-04-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_WarrantMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_WarrantMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoThousandTwentyPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">LFMD:TwoThousandTwentyPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-22_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-08to2021-02-11_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember_custom_InvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:InvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-08</xbrli:startDate>
        <xbrli:endDate>2021-02-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-11_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember_custom_InvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:InvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_SoftwareRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">LFMD:SoftwareRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_SoftwareRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">LFMD:SoftwareRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_LicensingAgreementsMember_custom_PurchasedLicensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">LFMD:PurchasedLicensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_PaycheckProtectionProgramLoanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">LFMD:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PaycheckProtectionProgramLoanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">LFMD:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_ProductMember_custom_CVLBPRMember_custom_InnateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:CVLBPRMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">LFMD:InnateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_ProductMember_custom_CVLBPRMember_custom_InnateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:CVLBPRMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">LFMD:InnateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_SoftwareRevenueMember_custom_LegalSimpliSoftwareLlcMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">LFMD:SoftwareRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:LegalSimpliSoftwareLlcMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_SoftwareRevenueMember_custom_LegalSimpliSoftwareLlcMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">LFMD:SoftwareRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:LegalSimpliSoftwareLlcMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_SoftwareRevenueMember_custom_CVLBMediaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">LFMD:SoftwareRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:CVLBMediaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_SoftwareRevenueMember_custom_CVLBMediaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">LFMD:SoftwareRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:CVLBMediaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_ConvertibleDebtSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_ConvertibleDebtSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_WarrantMember63245687">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_WarrantMember63245750">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-23to2020-11-24_custom_MayTwoThousandAndTwentyNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">LFMD:MayTwoThousandAndTwentyNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-23</xbrli:startDate>
        <xbrli:endDate>2020-11-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-24_custom_MayTwoThousandAndTwentyNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">LFMD:MayTwoThousandAndTwentyNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-02to2020-11-03_custom_PrivatePlacementOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:PrivatePlacementOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-02</xbrli:startDate>
        <xbrli:endDate>2020-11-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-03_custom_PrivatePlacementOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:PrivatePlacementOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-03_custom_BTIGLLCMember_custom_PrivatePlacementOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:BTIGLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:PrivatePlacementOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-18to2020-11-19_custom_PrivatePlacementOfferingMember_custom_PurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:PurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-18</xbrli:startDate>
        <xbrli:endDate>2020-11-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-19_custom_BTIGLLCMember_custom_PurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:BTIGLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:PurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-27_custom_MayTwoThousandAndTwentyNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">LFMD:MayTwoThousandAndTwentyNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-26to2020-05-27_custom_MayTwoThousandAndTwentyNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">LFMD:MayTwoThousandAndTwentyNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-26</xbrli:startDate>
        <xbrli:endDate>2020-05-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_OptionsAndWarrantsMember74465703">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:OptionsAndWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-30to2019-07-31_custom_MembershipInterestPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:MembershipInterestPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-30</xbrli:startDate>
        <xbrli:endDate>2019-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-07-31_custom_CVLBPRMember_custom_CVLBPRMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:CVLBPRMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-30to2019-07-31_custom_MembershipInterestPurchaseAgreementMember_custom_MrSchreiberMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:MembershipInterestPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:MrSchreiberMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-30</xbrli:startDate>
        <xbrli:endDate>2019-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-30to2019-07-31_custom_MembershipInterestPurchaseAgreementMember_custom_MrGalluppiMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:MembershipInterestPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:MrGalluppiMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-30</xbrli:startDate>
        <xbrli:endDate>2019-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-30to2019-07-31_custom_MembershipInterestPurchaseAgreementMember_custom_FirstMilestoneMember_custom_MrSchreiberMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:MembershipInterestPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:FirstMilestoneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:MrSchreiberMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-30</xbrli:startDate>
        <xbrli:endDate>2019-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-07-31_custom_MembershipInterestPurchaseAgreementMember_custom_FirstMilestoneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:MembershipInterestPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:FirstMilestoneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-30to2019-07-31_custom_MembershipInterestPurchaseAgreementMember_custom_SecondMileSStoneMember_custom_MrSchreiberMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:MembershipInterestPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:SecondMileSStoneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:MrSchreiberMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-30</xbrli:startDate>
        <xbrli:endDate>2019-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-07-31_custom_MembershipInterestPurchaseAgreementMember_custom_SecondMileSStoneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:MembershipInterestPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:SecondMileSStoneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-30to2019-07-31_custom_MembershipInterestPurchaseAgreementMember_custom_FirstMilestoneMember_custom_MrGalluppiMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:MembershipInterestPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:FirstMilestoneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:MrGalluppiMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-30</xbrli:startDate>
        <xbrli:endDate>2019-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-30to2019-07-31_custom_MembershipInterestPurchaseAgreementMember_custom_SecondMileSStoneMember_custom_MrGalluppiMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:MembershipInterestPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:SecondMileSStoneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:MrGalluppiMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-30</xbrli:startDate>
        <xbrli:endDate>2019-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-07to2020-12-09_custom_MembershipInterestPurchaseAgreementMember_custom_MrGalluppiMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:MembershipInterestPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:MrGalluppiMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-07</xbrli:startDate>
        <xbrli:endDate>2020-12-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-07to2020-12-09_custom_MembershipInterestPurchaseAgreementMember_custom_MrSchreiberMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:MembershipInterestPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:MrSchreiberMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-07</xbrli:startDate>
        <xbrli:endDate>2020-12-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_MembershipInterestPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:MembershipInterestPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-23to2020-11-24">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-23</xbrli:startDate>
        <xbrli:endDate>2020-11-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-24">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-10-06to2020-10-07_custom_BoardOfDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:BoardOfDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-10-06</xbrli:startDate>
        <xbrli:endDate>2020-10-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-10-20to2020-10-21_custom_BoardOfDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:BoardOfDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-10-20</xbrli:startDate>
        <xbrli:endDate>2020-10-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-05to2020-11-06_custom_BoardOfDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:BoardOfDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-05</xbrli:startDate>
        <xbrli:endDate>2020-11-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-25to2020-11-27_custom_NewChiefOperatingOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:NewChiefOperatingOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-25</xbrli:startDate>
        <xbrli:endDate>2020-11-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-25to2020-11-27_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-25</xbrli:startDate>
        <xbrli:endDate>2020-11-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-06to2020-12-08_custom_AmendedCAOEmploymentAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:AmendedCAOEmploymentAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-06</xbrli:startDate>
        <xbrli:endDate>2020-12-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-06to2020-12-08_custom_AmendedCAOEmploymentAgreementMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:AmendedCAOEmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-06</xbrli:startDate>
        <xbrli:endDate>2020-12-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-06to2020-12-08_us-gaap_RestrictedStockUnitsRSUMember_custom_AmendedCAOEmploymentAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:AmendedCAOEmploymentAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-06</xbrli:startDate>
        <xbrli:endDate>2020-12-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-08_us-gaap_RestrictedStockUnitsRSUMember_custom_AmendedCAOEmploymentAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:AmendedCAOEmploymentAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-23to2021-02-24_custom_AmendedConsultingAgreementMember_custom_BlueHorizonConsultingLLCMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:AmendedConsultingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:BlueHorizonConsultingLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-23</xbrli:startDate>
        <xbrli:endDate>2021-02-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandTwentyPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">LFMD:TwoThousandTwentyPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_TwoThousandTwentyPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">LFMD:TwoThousandTwentyPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_srt_MinimumMember_custom_TwoThousandTwentyPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">LFMD:TwoThousandTwentyPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_srt_MaximumMember_custom_TwoThousandTwentyPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">LFMD:TwoThousandTwentyPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_srt_MinimumMember_custom_TwoThousandTwentyPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">LFMD:TwoThousandTwentyPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_srt_MaximumMember_custom_TwoThousandTwentyPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">LFMD:TwoThousandTwentyPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ServiceBasedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:ServiceBasedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ServiceBasedStockOptionsMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:ServiceBasedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ServiceBasedStockOptionsMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:ServiceBasedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_PerformanceSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-31_custom_LeaseAgreementTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:LeaseAgreementTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_LeaseAgreementTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:LeaseAgreementTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_LeaseAgreementTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:LeaseAgreementTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-22to2020-07-23_custom_PromissoryNoteMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">LFMD:PromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-22</xbrli:startDate>
        <xbrli:endDate>2020-07-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-22_custom_PromissoryNoteMember_srt_DirectorMember_custom_ExchangeAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">LFMD:PromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:ExchangeAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-21to2020-09-22_custom_PromissoryNoteMember_srt_DirectorMember_custom_ExchangeAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">LFMD:PromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:ExchangeAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-21</xbrli:startDate>
        <xbrli:endDate>2020-09-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_PromissoryNoteMember_srt_DirectorMember_custom_ExchangeAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">LFMD:PromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:DirectorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:ExchangeAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-04to2021-01-05_us-gaap_SubsequentEventMember_custom_ChiefDigitalOfficerMember_custom_EmploymentAgreementMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:ChiefDigitalOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-04</xbrli:startDate>
        <xbrli:endDate>2021-01-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-10to2021-01-11_us-gaap_SubsequentEventMember_custom_ChiefMedicalOfficerMember_custom_EmploymentAgreementMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:ChiefMedicalOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-10</xbrli:startDate>
        <xbrli:endDate>2021-01-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-10to2021-01-11_us-gaap_SubsequentEventMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-10</xbrli:startDate>
        <xbrli:endDate>2021-01-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-22_us-gaap_SubsequentEventMember_custom_CVLBPRMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">LFMD:CVLBPRMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_us-gaap_SubsequentEventMember_custom_PaycheckProtectionProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">LFMD:PaycheckProtectionProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-20to2021-01-22_us-gaap_SubsequentEventMember_custom_ConversionLabsPRLLCMember_custom_LegalSimpliSoftwareLlcMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:ConversionLabsPRLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">LFMD:LegalSimpliSoftwareLlcMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-20</xbrli:startDate>
        <xbrli:endDate>2021-01-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-20to2021-01-22_us-gaap_SubsequentEventMember_custom_FoundingMembersMIPAsMember_custom_LegalSimpliSoftwareLlcMember_custom_ConversionLabsPRLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:FoundingMembersMIPAsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">LFMD:LegalSimpliSoftwareLlcMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:ConversionLabsPRLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-20</xbrli:startDate>
        <xbrli:endDate>2021-01-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-22_us-gaap_SubsequentEventMember_custom_FoundingMembersMIPAsMember_custom_LegalSimpliSoftwareLlcMember_custom_ConversionLabsPRLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:FoundingMembersMIPAsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">LFMD:LegalSimpliSoftwareLlcMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:ConversionLabsPRLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-21_us-gaap_SubsequentEventMember_custom_FoundingMembersMIPAsMember_custom_LegalSimpliSoftwareLlcMember_custom_ConversionLabsPRLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:FoundingMembersMIPAsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">LFMD:LegalSimpliSoftwareLlcMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:ConversionLabsPRLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-29to2021-02-03_us-gaap_SubsequentEventMember_custom_ChiefBusinessOfficerMember_custom_EmploymentAgreementMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:ChiefBusinessOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-29</xbrli:startDate>
        <xbrli:endDate>2021-02-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-02to2021-02-04_us-gaap_SubsequentEventMember_srt_ChiefFinancialOfficerMember_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-02</xbrli:startDate>
        <xbrli:endDate>2021-02-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-02to2021-02-04_us-gaap_SubsequentEventMember_srt_ChiefFinancialOfficerMember_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-02</xbrli:startDate>
        <xbrli:endDate>2021-02-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-01to2021-02-04_us-gaap_SubsequentEventMember_srt_ChiefFinancialOfficerMember_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-01</xbrli:startDate>
        <xbrli:endDate>2021-02-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-02to2021-02-04_us-gaap_SubsequentEventMember_srt_ChiefFinancialOfficerMember_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-02</xbrli:startDate>
        <xbrli:endDate>2021-02-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-02to2021-02-04_us-gaap_SubsequentEventMember_srt_ChiefFinancialOfficerMember_us-gaap_RestrictedStockUnitsRSUMember_custom_VestingOnEffectiveDateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:VestingAxis">LFMD:VestingOnEffectiveDateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-02</xbrli:startDate>
        <xbrli:endDate>2021-02-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-10to2021-02-11_us-gaap_SubsequentEventMember_custom_FebruaryTwoThousandTwentyOnePurchaseAgreementMember_custom_InvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:FebruaryTwoThousandTwentyOnePurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:InvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-10</xbrli:startDate>
        <xbrli:endDate>2021-02-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-11_us-gaap_SubsequentEventMember_custom_FebruaryTwoThousandTwentyOnePurchaseAgreementMember_custom_InvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:FebruaryTwoThousandTwentyOnePurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:InvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-01to2020-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-01</xbrli:startDate>
        <xbrli:endDate>2020-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_LegalSimpliSoftwareLlcMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">LFMD:LegalSimpliSoftwareLlcMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-29_us-gaap_SubsequentEventMember_custom_LegalSimpliSoftwareLlcMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:LegalSimpliSoftwareLlcMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-30_us-gaap_SubsequentEventMember_custom_LegalSimpliSoftwareLlcMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">LFMD:LegalSimpliSoftwareLlcMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_SeriesBPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-18_custom_CSixPurchaseAgreementOneMember_custom_CSixCapitalLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:CSixPurchaseAgreementOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:CSixCapitalLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-18_custom_CSixPurchaseAgreementTwoMember_custom_CSixCapitalLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:CSixPurchaseAgreementTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:CSixCapitalLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PaycheckProtectionProgramLoanMember_custom_USSmallBusinessAdministrationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:USSmallBusinessAdministrationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-01to2020-12-31_custom_WorkingCapitalLoanMember_custom_ChaseBankMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">LFMD:WorkingCapitalLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:ChaseBankMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WorkingCapitalLoanMember_custom_ChaseBankMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">LFMD:WorkingCapitalLoanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">LFMD:ChaseBankMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_WarrantPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:WarrantPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-08_us-gaap_SubsequentEventMember_custom_TwoThousandTwentyPlanMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:TwoThousandTwentyPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-18to2020-11-20_custom_ChiefComplianceOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">LFMD:ChiefComplianceOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-18</xbrli:startDate>
        <xbrli:endDate>2020-11-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-06to2020-12-08_custom_AmendedCAOEmploymentAgreementMember_srt_MaximumMember_custom_DecemberEightTwoThousandAndTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:AmendedCAOEmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:DecemberEightTwoThousandAndTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-06</xbrli:startDate>
        <xbrli:endDate>2020-12-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_LeaseAgreementOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:LeaseAgreementOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-20to2021-01-22_us-gaap_SubsequentEventMember_custom_CVLBPRMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">LFMD:CVLBPRMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-20</xbrli:startDate>
        <xbrli:endDate>2021-01-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_PerformanceSharesMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_PerformanceSharesMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_ParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_ParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_ParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_ParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_ParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_CustomerRelationshipsMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_CustomerRelationshipsMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ConsultingAgreementMember_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:ConsultingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ConsultingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:ConsultingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ConsultingAgreementMember_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:ConsultingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_ConsultingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:ConsultingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_ServiceBasedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">LFMD:ServiceBasedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoThousandTwentyPlanMember18806859">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:TwoThousandTwentyPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_TwoThousandTwentyPlanMember18807312">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:TwoThousandTwentyPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandTwentyPlanMember18807765">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:TwoThousandTwentyPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-26to2020-11-27_custom_ConsultingAgreementMember_srt_ChiefOperatingOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:ConsultingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefOperatingOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-26</xbrli:startDate>
        <xbrli:endDate>2020-11-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-17to2021-03-18_us-gaap_SubsequentEventMember_custom_EmploymentAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">LFMD:EmploymentAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-17</xbrli:startDate>
        <xbrli:endDate>2021-03-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-01to2021-03-31_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-08to2021-02-11_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-08</xbrli:startDate>
        <xbrli:endDate>2021-02-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000948320</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Percent">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2020-12-31" unitRef="USDPShares" decimals="INF">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2021-02-22_us-gaap_SubsequentEventMember" unitRef="USDPShares" decimals="INF">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2021-02-11_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember_custom_InvestorsMember" unitRef="USDPShares" decimals="INF">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2020-11-03_custom_PrivatePlacementOfferingMember" unitRef="USDPShares" decimals="INF">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2020-12-08_us-gaap_RestrictedStockUnitsRSUMember_custom_AmendedCAOEmploymentAgreementMember" unitRef="USDPShares" decimals="INF">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-12-31" unitRef="USDPShares" decimals="INF">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2021-02-11_us-gaap_SubsequentEventMember_custom_FebruaryTwoThousandTwentyOnePurchaseAgreementMember_custom_InvestorsMember" unitRef="USDPShares" decimals="INF">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">23433663</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">10680730</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">23330623</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">10577690</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TreasuryStockCommonShares contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">103040</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">103040</us-gaap:TreasuryStockCommonShares>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">817118</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">622256</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">335612</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">335613</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ShareBasedCompensation contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">18656141</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">733215</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">550973</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-1605</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">314199</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-72557</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-95595</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">172965</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">9496187</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">2182159</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-12131614</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">251408</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-798136</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-100000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">400000</us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">100000</us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2020-02-17to2020-02-18_custom_CSixPurchaseAgreementOneMember_custom_CSixCapitalLLCMember" unitRef="USD" decimals="0">375000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2020-02-17to2020-02-18_custom_CSixPurchaseAgreementTwoMember_custom_CSixCapitalLLCMember" unitRef="USD" decimals="0">375000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2020-02-17to2020-02-18_custom_CSixPurchaseAgreementsMember_custom_CSixCapitalLLCMember_custom_DailyAveragePaymentMember" unitRef="USD" decimals="0">8094</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2020-02-17to2020-02-18_custom_CSixPurchaseAgreementsMember_custom_CSixCapitalLLCMember" unitRef="USD" decimals="0">750000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">2498808</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">295000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2018-01-01to2018-12-31_custom_MALPHABETLLCMember_custom_CommonStockOneMember" unitRef="USD" decimals="0">7500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2018-01-01to2018-12-31_custom_MALPHABETLLCMember_custom_CommonStockTwoMember" unitRef="USD" decimals="0">10000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2018-01-01to2018-12-31_custom_MALPHABETLLCMember_custom_CommonStockThreeMember" unitRef="USD" decimals="0">20000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">350001</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">2338349</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2021-02-10to2021-02-11_us-gaap_SubsequentEventMember_custom_FebruaryTwoThousandTwentyOnePurchaseAgreementMember_custom_InvestorsMember" unitRef="USD" decimals="0">13400000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">242000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2020-07-22to2020-07-23_custom_PromissoryNoteMember_srt_DirectorMember" unitRef="USD" decimals="0">250000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:InterestPaidNet contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">1665171</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">80660</us-gaap:InterestPaidNet>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2016-04-01_custom_ImmudynePrLlcMember" unitRef="Percent" decimals="INF">0.782</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2019-04-25_custom_ChiefExecutiveOfficerAndChiefTechnologyOfficerMember_custom_PurchaseAgreementMember" unitRef="Percent" decimals="INF">1.00</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2019-04-25_custom_ConversionLabsPrMember" unitRef="Percent" decimals="INF">1.00</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2019-07-31_custom_CVLBPRMember_custom_CVLBPRMember" unitRef="Percent" decimals="INF">1.00</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2021-01-22_us-gaap_SubsequentEventMember_custom_FoundingMembersMIPAsMember_custom_LegalSimpliSoftwareLlcMember_custom_ConversionLabsPRLLCMember" unitRef="Percent" decimals="INF">0.8558</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2021-01-21_us-gaap_SubsequentEventMember_custom_FoundingMembersMIPAsMember_custom_LegalSimpliSoftwareLlcMember_custom_ConversionLabsPRLLCMember" unitRef="Percent" decimals="INF">0.51</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2021-03-29_us-gaap_SubsequentEventMember_custom_LegalSimpliSoftwareLlcMember" unitRef="Percent" decimals="INF">0.36</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2021-03-30_us-gaap_SubsequentEventMember_custom_LegalSimpliSoftwareLlcMember" unitRef="Percent" decimals="INF">0.85</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="AsOf2018-06-30_custom_LegalSimpliSoftwareLlcMember" unitRef="Percent" decimals="INF">0.51</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <LFMD:CustomerDiscountsReturnsAndRebates contextRef="From2020-01-01to2020-12-31_us-gaap_ProductMember" unitRef="USD" decimals="0">3321000</LFMD:CustomerDiscountsReturnsAndRebates>
    <LFMD:CustomerDiscountsReturnsAndRebates contextRef="From2019-01-01to2019-12-31_us-gaap_ProductMember" unitRef="USD" decimals="0">1292000</LFMD:CustomerDiscountsReturnsAndRebates>
    <LFMD:CustomerDiscountsReturnsAndRebates contextRef="From2019-01-01to2019-12-31_custom_SoftwareRevenueMember" unitRef="USD" decimals="0">242000</LFMD:CustomerDiscountsReturnsAndRebates>
    <LFMD:CustomerDiscountsReturnsAndRebates contextRef="From2020-01-01to2020-12-31_custom_SoftwareRevenueMember" unitRef="USD" decimals="0">1062000</LFMD:CustomerDiscountsReturnsAndRebates>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_custom_TwoManufacturersMember" unitRef="Percent" decimals="INF">1.00</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_custom_TwoManufacturersMember" unitRef="Percent" decimals="INF">1.00</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_us-gaap_ProductMember" unitRef="Percent" decimals="INF">0.82</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_us-gaap_ProductMember" unitRef="Percent" decimals="INF">0.80</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_us-gaap_ProductMember_custom_ShapiroMDMember_custom_CVLBPRMember" unitRef="Percent" decimals="INF">0.46</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_us-gaap_ProductMember_custom_ShapiroMDMember_custom_CVLBPRMember" unitRef="Percent" decimals="INF">0.72</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_us-gaap_ProductMember_custom_RexMDMember_custom_CVLBPRMember" unitRef="Percent" decimals="INF">0.35</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_us-gaap_ProductMember_custom_RexMDMember_custom_CVLBPRMember" unitRef="Percent" xsi:nil="true" />
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_us-gaap_ProductMember_custom_INRWellnessMember_custom_CVLBPRMember" unitRef="Percent" decimals="INF">0.01</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_us-gaap_ProductMember_custom_INRWellnessMember_custom_CVLBPRMember" unitRef="Percent" decimals="INF">0.06</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_us-gaap_ProductMember_custom_ScarologyMember_custom_CVLBPRMember" unitRef="Percent" xsi:nil="true" />
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_us-gaap_ProductMember_custom_ScarologyMember_custom_CVLBPRMember" unitRef="Percent" xsi:nil="true" />
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31" unitRef="Percent" decimals="INF">1.00</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_us-gaap_ProductMember_custom_CVLBPRMember_custom_InnateMember" unitRef="Percent" xsi:nil="true" />
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_us-gaap_ProductMember_custom_CVLBPRMember_custom_InnateMember" unitRef="Percent" xsi:nil="true" />
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_custom_SoftwareRevenueMember_custom_LegalSimpliSoftwareLlcMember" unitRef="Percent" decimals="INF">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_custom_SoftwareRevenueMember_custom_LegalSimpliSoftwareLlcMember" unitRef="Percent" decimals="INF">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_custom_SoftwareRevenueMember_custom_CVLBMediaMember" unitRef="Percent" xsi:nil="true" />
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_custom_SoftwareRevenueMember_custom_CVLBMediaMember" unitRef="Percent" xsi:nil="true" />
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2019-12-31_custom_CustomerRelationshipAssetMember" unitRef="USD" decimals="0">1006840</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2019-12-31_custom_PurchasedLicensesMember" unitRef="USD" decimals="0">200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2020-12-31_custom_CustomerRelationshipAssetMember" unitRef="USD" decimals="0">1006840</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2020-12-31_custom_PurchasedLicensesMember" unitRef="USD" decimals="0">200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2018-05-28to2018-05-29_custom_SecuritiesPurchaseAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember">2019-05-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-08-14to2019-08-15_custom_SecuritiesPurchaseAgreementMember_custom_TwoAccreditedInvestorsMember">2020-08-15</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2020-07-26to2020-07-27_custom_SixAccreditedInvestorsMember">2021-01-24</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2020-07-22to2020-07-23_custom_PromissoryNoteMember_srt_DirectorMember">2021-07-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2018-05-29_custom_SecuritiesPurchaseAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" unitRef="Percent" decimals="INF">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2019-08-15_custom_SecuritiesPurchaseAgreementMember_custom_TwoAccreditedInvestorsMember" unitRef="Percent" decimals="INF">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2020-05-27_custom_MayTwoThousandAndTwentyNotesMember_custom_SixAccreditedInvestorsMember" unitRef="Percent" decimals="INF">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2020-06-30_custom_PaycheckProtectionProgramLoanMember_custom_USSmallBusinessAdministrationMember" unitRef="Percent" decimals="INF">0.010</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2020-07-27_custom_SixAccreditedInvestorsMember" unitRef="Percent" decimals="INF">0.0125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2020-12-31_custom_PaycheckProtectionProgramLoanMember" unitRef="Percent" decimals="INF">0.01</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2020-12-31_custom_WorkingCapitalLoanMember_custom_ChaseBankMember" unitRef="Percent" decimals="INF">0.0399</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2018-05-29_custom_SecuritiesPurchaseAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" unitRef="USDPShares" decimals="INF">1.15</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2019-08-15_custom_SecuritiesPurchaseAgreementMember_custom_TwoAccreditedInvestorsMember" unitRef="USDPShares" decimals="INF">1.15</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2020-05-27_custom_MayTwoThousandAndTwentyNotesMember_custom_SixAccreditedInvestorsMember" unitRef="USDPShares" decimals="INF">2.50</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2020-11-24_custom_MayTwoThousandAndTwentyNotesMember" unitRef="USDPShares" decimals="INF">2.50</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2020-05-27_custom_MayTwoThousandAndTwentyNotesMember" unitRef="USDPShares" decimals="INF">2.50</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2020-11-24" unitRef="USDPShares" decimals="INF">2.50</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="From2019-01-01to2019-12-31_custom_SecuritiesPurchaseAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" unitRef="USD" decimals="0">344642</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="From2020-08-26to2020-08-28_custom_SecuritiesPurchaseAgreementMember" unitRef="USD" decimals="0">607500</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="From2020-11-23to2020-11-24_custom_MayTwoThousandAndTwentyNotesMember" unitRef="USD" decimals="0">1119408</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="From2020-11-23to2020-11-24" unitRef="USD" decimals="0">1119408</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2018-05-29_custom_SecuritiesPurchaseAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" unitRef="USD" decimals="0">550000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2019-08-15_custom_SecuritiesPurchaseAgreementMember_custom_TwoAccreditedInvestorsMember" unitRef="USD" decimals="0">1291000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2020-02-25_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" unitRef="USD" decimals="0">1291000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2020-02-18_custom_CSixPurchaseAgreementsMember_custom_CSixCapitalLLCMember" unitRef="USD" decimals="0">1020000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2020-05-27_custom_MayTwoThousandAndTwentyNotesMember_custom_SixAccreditedInvestorsMember" unitRef="USD" decimals="0">1000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2020-06-30_custom_PaycheckProtectionProgramLoanMember_custom_USSmallBusinessAdministrationMember" unitRef="USD" decimals="0">259182</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2020-07-27_custom_SixAccreditedInvestorsMember" unitRef="USD" decimals="0">1500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2019-08-15_custom_SecuritiesPurchaseAgreementMember_custom_TwoAccreditedInvestorsMember" unitRef="USD" decimals="0">215250</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2020-02-25_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" unitRef="USD" decimals="0">500145</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2020-12-31_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" unitRef="USD" decimals="0">568322</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2019-12-31_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" unitRef="USD" decimals="0">404393</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2020-02-18_custom_CSixPurchaseAgreementsMember_custom_CSixCapitalLLCMember" unitRef="USD" decimals="0">270000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2020-02-18_custom_CSixPurchaseAgreementOneMember_custom_CSixCapitalLLCMember" unitRef="USD" decimals="0">135000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2020-02-18_custom_CSixPurchaseAgreementTwoMember_custom_CSixCapitalLLCMember" unitRef="USD" decimals="0">135000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2019-08-15_custom_SecuritiesPurchaseAgreementMember_custom_TwoAccreditedInvestorsMember" unitRef="USDPShares" decimals="INF">1.40</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-02-25_custom_AlphaCapitalAnstaltMember_custom_TwoThousandAndEighteenAlphaWarrantMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">0.68</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-02-25_custom_AlphaCapitalAnstaltMember_custom_TwoThousandAndEighteenAlphaWarrantMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">1.40</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-02-25_custom_TwoThousandAndNineteenAlphaAmendmentMember_custom_AlphaCapitalAnstaltMember_custom_TwoThousandAndNineteenAlphaWarrantMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">1.40</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-02-25_custom_TwoThousandAndNineteenAlphaAmendmentMember_custom_AlphaCapitalAnstaltMember_custom_TwoThousandAndNineteenAlphaWarrantMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">1.15</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-02-25_custom_TwoThousandAndEighteenBrioWarrantAmendmentMember_custom_BrioMasterFundMember_custom_TwoThousandAndEighteenBrioWarrantMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">0.68</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-02-25_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_BrioMasterFundMember_custom_BrioTwoThousandAndNineteenWarrantMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">1.15</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-08-28_custom_SecuritiesPurchaseAgreementMember" unitRef="USDPShares" decimals="INF">4.60</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-08-31_custom_ConsultingAgreementMember_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">5.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-08-28_custom_WarrantPurchaseAgreementMember" unitRef="USDPShares" decimals="INF">5.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-08-28_custom_WarrantPurchaseAgreementMember_custom_ClassAWarrantMember" unitRef="USDPShares" decimals="INF">5.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-08-31_custom_AugustTwoThousandAndTwentyWarrantInducementMember" unitRef="USDPShares" decimals="INF">1.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_custom_AugustTwoThousandAndTwentyWarrantInducementMember" unitRef="USDPShares" decimals="INF">2.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-02-25_custom_TwoThousandAndEighteenBrioWarrantAmendmentMember_custom_BrioMasterFundMember_custom_TwoThousandAndEighteenBrioWarrantMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">1.40</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-02-25_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_BrioMasterFundMember_custom_BrioTwoThousandAndNineteenWarrantMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">1.40</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-11-03_custom_BTIGLLCMember_custom_PrivatePlacementOfferingMember" unitRef="USDPShares" decimals="INF">4.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-11-19_custom_BTIGLLCMember_custom_PurchaseAgreementMember" unitRef="USDPShares" decimals="INF">4.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2017-04-01to2017-04-30_custom_SubscriptionAgreementMember" unitRef="Shares" decimals="INF">43478</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">304269</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-04-23to2019-04-25_custom_ChiefExecutiveOfficerAndChiefTechnologyOfficerMember_custom_PurchaseAgreementMember" unitRef="Shares" decimals="INF">1000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2020-08-26to2020-08-27_custom_SeriesBConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">40000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2020-08-26to2020-08-28_custom_SecuritiesPurchaseAgreementMember" unitRef="Shares" decimals="INF">3500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2020-08-26to2020-08-31_custom_ConsultingAgreementMember" unitRef="Shares" decimals="INF">750000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2020-05-01to2020-05-30_us-gaap_InvestorMember" unitRef="Shares" decimals="INF">294120</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2020-01-01to2020-12-31_custom_BrioWarrantsMember" unitRef="Shares" decimals="INF">57547</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2020-09-28to2020-09-29_custom_AmendedConsultingAgreementMember_custom_BlueHorizonConsultingLLCMember" unitRef="Shares" decimals="INF">2000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2020-10-15to2020-10-16_custom_AmendedConsultingAgreementMember_custom_BlueHorizonConsultingLLCMember" unitRef="Shares" decimals="INF">800000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">2000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2021-02-08to2021-02-11_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember_custom_InvestorsMember" unitRef="Shares" decimals="INF">608696</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2020-11-02to2020-11-03_custom_PrivatePlacementOfferingMember" unitRef="Shares" decimals="INF">3044529</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2020-11-18to2020-11-19_custom_PrivatePlacementOfferingMember_custom_PurchaseAgreementMember" unitRef="Shares" decimals="INF">323892</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-07-30to2019-07-31_custom_MembershipInterestPurchaseAgreementMember_custom_MrSchreiberMember" unitRef="Shares" decimals="INF">500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-07-30to2019-07-31_custom_MembershipInterestPurchaseAgreementMember_custom_MrGalluppiMember" unitRef="Shares" decimals="INF">500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-07-30to2019-07-31_custom_MembershipInterestPurchaseAgreementMember_custom_FirstMilestoneMember_custom_MrSchreiberMember" unitRef="Shares" decimals="INF">500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-07-30to2019-07-31_custom_MembershipInterestPurchaseAgreementMember_custom_SecondMileSStoneMember_custom_MrSchreiberMember" unitRef="Shares" decimals="INF">500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-07-30to2019-07-31_custom_MembershipInterestPurchaseAgreementMember_custom_FirstMilestoneMember_custom_MrGalluppiMember" unitRef="Shares" decimals="INF">500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-07-30to2019-07-31_custom_MembershipInterestPurchaseAgreementMember_custom_SecondMileSStoneMember_custom_MrGalluppiMember" unitRef="Shares" decimals="INF">500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2020-12-07to2020-12-09_custom_MembershipInterestPurchaseAgreementMember_custom_MrGalluppiMember" unitRef="Shares" decimals="INF">1000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2020-12-07to2020-12-09_custom_MembershipInterestPurchaseAgreementMember_custom_MrSchreiberMember" unitRef="Shares" decimals="INF">1000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2020-10-06to2020-10-07_custom_BoardOfDirectorsMember" unitRef="Shares" decimals="INF">96923</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2021-02-23to2021-02-24_custom_AmendedConsultingAgreementMember_custom_BlueHorizonConsultingLLCMember_us-gaap_SubsequentEventMember" unitRef="Shares" decimals="INF">1200000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2020-09-21to2020-09-22_custom_PromissoryNoteMember_srt_DirectorMember_custom_ExchangeAgreementMember" unitRef="Shares" decimals="INF">96923</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2021-02-10to2021-02-11_us-gaap_SubsequentEventMember_custom_FebruaryTwoThousandTwentyOnePurchaseAgreementMember_custom_InvestorsMember" unitRef="Shares" decimals="INF">608696</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2021-03-17to2021-03-18_us-gaap_SubsequentEventMember_custom_EmploymentAgreementMember" unitRef="Shares" decimals="INF">3750</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2020-02-25_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_AlphaCapitalAnstaltMember_custom_TwoThousandAndEighteenAlphaNoteMember_custom_TwoThousandAndEighteenAlphaNoteMember" unitRef="USD" decimals="0">224145</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2020-02-25_custom_TwoThousandAndNineteenAlphaAmendmentMember_custom_AlphaCapitalAnstaltMember_custom_TwoThousandAndNineteenAlphaWarrantMember" unitRef="USD" decimals="0">520000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2020-08-28_custom_SixAccreditedInvestorsMember" unitRef="USD" decimals="0">607500</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2020-02-25_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_BrioMasterFundMember_custom_BrioTwoThousandAndNineteenWarrantMember" unitRef="USD" decimals="0">162500</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2020-05-27_custom_MayTwoThousandAndTwentyNotesMember" unitRef="USD" decimals="0">1000000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2018-01-01to2018-12-31_custom_MALPHABETLLCMember" unitRef="Shares" decimals="INF">20000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2018-01-01to2018-12-31_custom_MALPHABETLLCMember_custom_CommonStockOneMember" unitRef="Shares" decimals="INF">20000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2018-01-01to2018-12-31_custom_MALPHABETLLCMember_custom_CommonStockTwoMember" unitRef="Shares" decimals="INF">20000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2018-01-01to2018-12-31_custom_MALPHABETLLCMember_custom_CommonStockThreeMember" unitRef="Shares" decimals="INF">40000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember" unitRef="Shares" decimals="INF">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-01-01to2020-12-31_custom_EmployeesAnddvisoryBoardMembersMember" unitRef="Shares" decimals="INF">1539000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-01-01to2020-12-31_us-gaap_PerformanceSharesMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-01-01to2020-12-31_custom_TwoThousandTwentyPlanMember" unitRef="Shares" decimals="INF">839000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-11-25to2020-11-27_srt_MaximumMember" unitRef="Shares" decimals="INF">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2021-01-04to2021-01-05_us-gaap_SubsequentEventMember_custom_ChiefDigitalOfficerMember_custom_EmploymentAgreementMember_srt_MaximumMember" unitRef="Shares" decimals="INF">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2021-01-10to2021-01-11_us-gaap_SubsequentEventMember_custom_ChiefMedicalOfficerMember_custom_EmploymentAgreementMember_srt_MaximumMember" unitRef="Shares" decimals="INF">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2021-01-29to2021-02-03_us-gaap_SubsequentEventMember_custom_ChiefBusinessOfficerMember_custom_EmploymentAgreementMember_srt_MaximumMember" unitRef="Shares" decimals="INF">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2021-02-02to2021-02-04_us-gaap_SubsequentEventMember_srt_ChiefFinancialOfficerMember_us-gaap_RestrictedStockUnitsRSUMember" unitRef="Shares" decimals="INF">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-11-18to2020-11-20_custom_ChiefComplianceOfficerMember" unitRef="Shares" decimals="INF">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:LeaseAndRentalExpense contextRef="From2020-01-01to2020-12-31_srt_MinimumMember" unitRef="USD" decimals="0">4000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LeaseAndRentalExpense contextRef="From2020-01-01to2020-12-31_srt_MaximumMember" unitRef="USD" decimals="0">5000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:PaymentsForRent contextRef="From2020-01-01to2020-12-31_custom_PresidentAndCEOMember_custom_OfficeSpaceMember_srt_MinimumMember" unitRef="USD" decimals="0">4000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="From2020-01-01to2020-12-31_custom_PresidentAndCEOMember_custom_OfficeSpaceMember_srt_MaximumMember" unitRef="USD" decimals="0">5000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="From2020-01-01to2020-12-31_custom_JLSVenturesLLCMember_custom_PuertoRicoOfficeSpaceMember" unitRef="USD" decimals="0">45000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="From2019-01-01to2019-12-31_custom_JLSVenturesLLCMember_custom_PuertoRicoOfficeSpaceMember" unitRef="USD" decimals="0">52000</us-gaap:PaymentsForRent>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="AsOf2018-02-28_custom_LeaseAgreementOneMember">P3Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="AsOf2021-10-31_custom_LeaseAgreementTwoMember">P3Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:PremiumsPercentageAssumedToNet contextRef="From2016-01-01to2016-12-31_custom_PilarisLaboratoriesLLCMember" unitRef="Percent" decimals="INF">0.10</us-gaap:PremiumsPercentageAssumedToNet>
    <us-gaap:IntercompanyAgreementsDescription contextRef="From2016-01-01to2016-12-31_custom_CVLBPRMember_custom_PilarisLaboratoriesLLCMember">As consideration for granting Conversion Labs PR this license, Pilaris will receive on quarterly basis, 10% of the net income collected by the licensed products based on the following formula: Net Income = total income - cost of goods sold - advertising and operating expenses directly related to the marketing of the licensed products.  In addition, Conversion Labs PR shall pay Pilaris a performance fee of $50,000 on the 180-day anniversary of the agreement and an additional $50,000 performance fee on the 365-day anniversary of the agreement.</us-gaap:IntercompanyAgreementsDescription>
    <us-gaap:IntercompanyAgreementsDescription contextRef="From2018-01-01to2018-12-31_custom_MALPHABETLLCMember">The Company shall pay Alphabet a royalty equal to 13% of Gross Receipts (as defined in the Agreement) realized from the sales of Licensed Products.  Further, so long as the Agreement is not previously terminated, the Company, also agreed to pay Alphabet $50,000 on the 120-day anniversary of the Agreement and an additional $50,000 on the 360-day anniversary of the Agreement.</us-gaap:IntercompanyAgreementsDescription>
    <LFMD:PerformanceFee contextRef="From2016-01-01to2016-12-31_custom_CVLBPRMember_custom_PilarisLaboratoriesLLCMember_custom_OneEightyDayAnniversaryAgreementMember" unitRef="USD" decimals="0">50000</LFMD:PerformanceFee>
    <LFMD:PerformanceFee contextRef="From2016-01-01to2016-12-31_custom_CVLBPRMember_custom_PilarisLaboratoriesLLCMember_custom_ThreeSiXFiveDayAnniversaryAgreementMember" unitRef="USD" decimals="0">50000</LFMD:PerformanceFee>
    <LFMD:PerformanceFee contextRef="From2017-04-01to2017-04-30_custom_SubscriptionAgreementMember_custom_OneEightyDayAnniversaryAgreementMember" unitRef="USD" decimals="0">50000</LFMD:PerformanceFee>
    <LFMD:PerformanceFee contextRef="From2018-01-01to2018-12-31_custom_MALPHABETLLCMember_custom_OneTwentyDayAnniversaryAgreementMember" unitRef="USD" decimals="0">50000</LFMD:PerformanceFee>
    <LFMD:PerformanceFee contextRef="From2018-01-01to2018-12-31_custom_MALPHABETLLCMember_custom_ThreeSixtyDayAnniversaryAgreementMember" unitRef="USD" decimals="0">50000</LFMD:PerformanceFee>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="AsOf2017-04-30_custom_SubscriptionAgreementMember" unitRef="Shares" decimals="INF">21739</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="AsOf2019-08-15_custom_SecuritiesPurchaseAgreementMember_custom_TwoAccreditedInvestorsMember" unitRef="Shares" decimals="INF">935870</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="AsOf2018-05-29_custom_SecuritiesPurchaseAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember_custom_PreSplitBasisMember" unitRef="Shares" decimals="INF">478261</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="AsOf2020-09-22_custom_PromissoryNoteMember_srt_DirectorMember_custom_ExchangeAgreementMember" unitRef="Shares" decimals="INF">500000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <LFMD:PercentageForRoyalty contextRef="From2018-01-01to2018-12-31_custom_MALPHABETLLCMember" unitRef="Percent" decimals="INF">0.13</LFMD:PercentageForRoyalty>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2018-01-01to2018-12-31_custom_MALPHABETLLCMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2018-01-01to2018-12-31_custom_MALPHABETLLCMember" unitRef="USDPShares" decimals="INF">2.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2018-01-01to2018-12-31_custom_MALPHABETLLCMember_custom_CommonStockOneMember" unitRef="USDPShares" decimals="INF">2.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2018-01-01to2018-12-31_custom_MALPHABETLLCMember_custom_CommonStockTwoMember" unitRef="USDPShares" decimals="INF">2.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2018-01-01to2018-12-31_custom_MALPHABETLLCMember_custom_CommonStockThreeMember" unitRef="USDPShares" decimals="INF">3.75</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember" unitRef="USDPShares" decimals="INF">1.11</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31_us-gaap_PerformanceSharesMember" unitRef="USDPShares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">0.96</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2019-12-31_custom_BVGlobalFulfillmentMember_srt_ChiefExecutiveOfficerMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" unitRef="USD" decimals="0">53026</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2020-12-31_custom_BVGlobalFulfillmentMember_srt_ChiefExecutiveOfficerMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" unitRef="USD" decimals="0">58943</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <LFMD:CashlessExerciseOfWarrantsShares contextRef="From2020-02-24to2020-02-25_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_AlphaCapitalAnstaltMember" unitRef="Shares" decimals="INF">90231</LFMD:CashlessExerciseOfWarrantsShares>
    <LFMD:CashlessExerciseOfWarrantsShares contextRef="From2020-05-06to2020-05-07_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_BrioMasterFundMember_custom_BrioTwoThousandAndNineteenWarrantMember" unitRef="Shares" decimals="INF">103562</LFMD:CashlessExerciseOfWarrantsShares>
    <LFMD:CashlessExerciseOfWarrantsShares contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">1472556</LFMD:CashlessExerciseOfWarrantsShares>
    <LFMD:CashlessExerciseOfWarrantsShares contextRef="From2020-01-01to2020-12-31_custom_OptionsAndWarrantsMember74465703" unitRef="Shares" decimals="INF">1472556</LFMD:CashlessExerciseOfWarrantsShares>
    <LFMD:DeemedDistributionFromWarrantPriceAdjustments contextRef="From2020-02-24to2020-02-25_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_AlphaCapitalAnstaltMember" unitRef="USD" decimals="0">915479</LFMD:DeemedDistributionFromWarrantPriceAdjustments>
    <LFMD:DeemedDistributionFromWarrantPriceAdjustments contextRef="From2020-01-01to2020-12-31_custom_AugustTwoThousandAndTwentyWarrantInducementMember" unitRef="USD" decimals="0">73636</LFMD:DeemedDistributionFromWarrantPriceAdjustments>
    <LFMD:DeemedDistributionFromWarrantPriceAdjustments contextRef="From2020-01-01to2020-12-31_custom_BrioWarrantsMember" unitRef="USD" decimals="0">226906</LFMD:DeemedDistributionFromWarrantPriceAdjustments>
    <LFMD:AccelerationOfDebtDiscount contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">500145</LFMD:AccelerationOfDebtDiscount>
    <LFMD:AccelerationOfDebtDiscount contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <LFMD:CashlessExerciseOfWarrantsSupplementalDisclosure contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">49551</LFMD:CashlessExerciseOfWarrantsSupplementalDisclosure>
    <LFMD:CashlessExerciseOfWarrantsSupplementalDisclosure contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <LFMD:StockIssuesForCapitalizedCosts contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">40000</LFMD:StockIssuesForCapitalizedCosts>
    <LFMD:StockIssuesForCapitalizedCosts contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">438136</us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers>
    <us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">0</us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers>
    <us-gaap:CapitalizedComputerSoftwareAmortization1 contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">62153</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1 contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DebtConversionConvertedInstrumentRate contextRef="From2018-05-28to2018-05-29_custom_SecuritiesPurchaseAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" unitRef="Percent" decimals="INF">0.0499</us-gaap:DebtConversionConvertedInstrumentRate>
    <us-gaap:DebtConversionConvertedInstrumentRate contextRef="From2019-08-14to2019-08-15_custom_SecuritiesPurchaseAgreementMember_custom_TwoAccreditedInvestorsMember" unitRef="Percent" decimals="INF">0.0499</us-gaap:DebtConversionConvertedInstrumentRate>
    <LFMD:DebtConversionInterestValue contextRef="From2019-01-01to2019-12-31_custom_SecuritiesPurchaseAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" unitRef="USD" decimals="0">9922</LFMD:DebtConversionInterestValue>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2019-08-15_custom_SecuritiesPurchaseAgreementMember_custom_TwoAccreditedInvestorsMember" unitRef="Shares" decimals="INF">569147</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-08-31_custom_AugustTwoThousandAndTwentyWarrantInducementMember" unitRef="Shares" decimals="INF">526846</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:DeferredFinanceCostsNet contextRef="AsOf2019-08-15_custom_SecuritiesPurchaseAgreementMember_custom_TwoAccreditedInvestorsMember" unitRef="USD" decimals="0">284070</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet contextRef="AsOf2020-02-18_custom_CSixPurchaseAgreementsOneMember_custom_CSixCapitalLLCMember" unitRef="USD" decimals="0">7500</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet contextRef="AsOf2020-02-18_custom_CSixPurchaseAgreementsTwoMember_custom_CSixCapitalLLCMember" unitRef="USD" decimals="0">7500</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet contextRef="AsOf2020-02-18_custom_CSixPurchaseAgreementsMember_custom_CSixCapitalLLCMember" unitRef="USD" decimals="0">15000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2020-01-19to2020-01-20_custom_MrSeanFitzpatrickMember_custom_ServicesAgreementMember_custom_ServiceBasedStockOptionsMember" unitRef="Shares" decimals="INF">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2020-01-19to2020-01-20_custom_MrSeanFitzpatrickMember_custom_ServicesAgreementMember_custom_ServiceBasedStockOptionsMember" unitRef="Shares" decimals="INF">130000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2020-11-25to2020-11-27_custom_NewChiefOperatingOfficerMember" unitRef="Shares" decimals="INF">35000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2020-12-06to2020-12-08_custom_AmendedCAOEmploymentAgreementMember_srt_MaximumMember" unitRef="Shares" decimals="INF">5555</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2021-01-10to2021-01-11_us-gaap_SubsequentEventMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" unitRef="Shares" decimals="INF">5575</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2021-02-02to2021-02-04_us-gaap_SubsequentEventMember_srt_ChiefFinancialOfficerMember_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember" unitRef="Shares" decimals="INF">3750</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2021-02-01to2021-02-04_us-gaap_SubsequentEventMember_srt_ChiefFinancialOfficerMember_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" unitRef="Shares" decimals="INF">3750</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2021-02-02to2021-02-04_us-gaap_SubsequentEventMember_srt_ChiefFinancialOfficerMember_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" unitRef="Shares" decimals="INF">3750</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2020-12-06to2020-12-08_custom_AmendedCAOEmploymentAgreementMember_srt_MaximumMember_custom_DecemberEightTwoThousandAndTwentyThreeMember" unitRef="Shares" decimals="INF">5575</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-12-31_custom_ServiceBasedStockOptionsMember" unitRef="Shares" decimals="INF">3009000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-12-31_us-gaap_PerformanceSharesMember" unitRef="Shares" decimals="INF">1365000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-12-31_custom_TwoThousandTwentyPlanMember" unitRef="Shares" decimals="INF">839000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-12-31_custom_TwoThousandTwentyPlanMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-12-31_custom_ServiceBasedStockOptionsMember" unitRef="Shares" decimals="INF">2228400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-12-31_us-gaap_PerformanceSharesMember" unitRef="Shares" decimals="INF">1165000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2019-12-31_custom_ServiceBasedStockOptionsMember" unitRef="Shares" decimals="INF">2361083</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2019-12-31_us-gaap_PerformanceSharesMember" unitRef="Shares" decimals="INF">635000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2020-12-31_custom_TwoThousandTwentyPlanMember" unitRef="Shares" decimals="INF">839000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2019-12-31_custom_TwoThousandTwentyPlanMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2020-12-31_custom_ServiceBasedStockOptionsMember" unitRef="Shares" decimals="INF">1570428</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2020-12-31_us-gaap_PerformanceSharesMember" unitRef="Shares" decimals="INF">635000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice contextRef="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">1.15</LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice>
    <LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice contextRef="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">7.50</LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice>
    <LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice contextRef="From2020-01-01to2020-12-31_us-gaap_PerformanceSharesMember" unitRef="USDPShares" xsi:nil="true" />
    <LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice contextRef="From2020-01-01to2020-12-31_srt_MinimumMember_custom_TwoThousandTwentyPlanMember" unitRef="USDPShares" decimals="INF">5.80</LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice>
    <LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice contextRef="From2020-01-01to2020-12-31_srt_MaximumMember_custom_TwoThousandTwentyPlanMember" unitRef="USDPShares" decimals="INF">9.24</LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning contextRef="AsOf2019-12-31_custom_ServiceBasedStockOptionsMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">1.00</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning contextRef="AsOf2019-12-31_custom_ServiceBasedStockOptionsMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">2.00</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning contextRef="AsOf2019-12-31_us-gaap_PerformanceSharesMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">1.25</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning contextRef="AsOf2019-12-31_us-gaap_PerformanceSharesMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">2.00</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning contextRef="AsOf2019-12-31_custom_TwoThousandTwentyPlanMember" unitRef="USDPShares" xsi:nil="true" />
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife contextRef="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember">P4Y2M19D</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife contextRef="From2020-01-01to2020-12-31_us-gaap_PerformanceSharesMember">P5Y4M2D</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife contextRef="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember">P7Y9M3D</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife contextRef="From2020-01-01to2020-12-31_us-gaap_PerformanceSharesMember">P9Y2M30D</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife contextRef="From2020-01-01to2020-12-31_custom_TwoThousandTwentyPlanMember">P10Y</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne contextRef="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember">P5Y1M24D</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne contextRef="From2020-01-01to2020-12-31_us-gaap_PerformanceSharesMember">P4Y11M19D</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne contextRef="From2020-01-01to2020-12-31_custom_TwoThousandTwentyPlanMember">P9Y9M0D</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne>
    <LFMD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning contextRef="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember">P3Y9M3D</LFMD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning>
    <LFMD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning contextRef="From2020-01-01to2020-12-31_us-gaap_PerformanceSharesMember">P2Y7M17D</LFMD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember">P2Y6M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2020-01-01to2020-12-31_us-gaap_PerformanceSharesMember">P1Y4M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2020-01-01to2020-12-31_us-gaap_WarrantMember">P7Y7M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2020-01-01to2020-12-31_custom_TwoThousandTwentyPlanMember">P9Y9M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2019-12-31_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">1.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2019-12-31_custom_ServiceBasedStockOptionsMember" unitRef="USDPShares" decimals="INF">1.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2019-12-31_us-gaap_PerformanceSharesMember" unitRef="USDPShares" decimals="INF">1.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2020-12-31_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">4.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2020-12-31_custom_TwoThousandTwentyPlanMember" unitRef="USDPShares" decimals="INF">7.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2019-12-31_custom_TwoThousandTwentyPlanMember" unitRef="USDPShares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2020-12-31_custom_ServiceBasedStockOptionsMember" unitRef="USDPShares" decimals="INF">2.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2020-12-31_us-gaap_PerformanceSharesMember" unitRef="USDPShares" decimals="INF">1.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember" unitRef="USDPShares" decimals="INF">2.85</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31_us-gaap_PerformanceSharesMember" unitRef="USDPShares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">3.87</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31_custom_TwoThousandTwentyPlanMember" unitRef="USDPShares" decimals="INF">7.54</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2019-12-31_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">1.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2019-12-31_custom_ServiceBasedStockOptionsMember" unitRef="USDPShares" decimals="INF">1.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2019-12-31_us-gaap_PerformanceSharesMember" unitRef="USDPShares" decimals="INF">2.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2020-12-31_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">4.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2020-12-31_custom_TwoThousandTwentyPlanMember" unitRef="USDPShares" decimals="INF">7.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2019-12-31_custom_TwoThousandTwentyPlanMember" unitRef="USDPShares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2020-12-31_custom_ServiceBasedStockOptionsMember" unitRef="USDPShares" decimals="INF">1.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2020-12-31_us-gaap_PerformanceSharesMember" unitRef="USDPShares" decimals="INF">2.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2019-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">2265324</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2020-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">3550471</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted contextRef="From2020-01-01to2020-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">4209596</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted contextRef="From2021-02-02to2021-02-04_us-gaap_SubsequentEventMember_srt_ChiefFinancialOfficerMember_us-gaap_RestrictedStockUnitsRSUMember" unitRef="Shares" decimals="INF">15000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted contextRef="From2021-02-02to2021-02-04_us-gaap_SubsequentEventMember_srt_ChiefFinancialOfficerMember_us-gaap_RestrictedStockUnitsRSUMember_custom_VestingOnEffectiveDateMember" unitRef="Shares" decimals="INF">3750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable contextRef="AsOf2019-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">2066049</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable contextRef="AsOf2020-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">2144700</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice contextRef="AsOf2019-12-31_us-gaap_WarrantMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">1.00</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice contextRef="AsOf2019-12-31_us-gaap_WarrantMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">2.50</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice contextRef="AsOf2020-12-31_us-gaap_WarrantMember" unitRef="USDPShares" xsi:nil="true" />
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice contextRef="AsOf2020-12-31_us-gaap_WarrantMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">5.75</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice contextRef="AsOf2020-12-31_us-gaap_WarrantMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">1.40</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice>
    <LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice contextRef="From2020-01-01to2020-12-31_us-gaap_WarrantMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">0.65</LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice>
    <LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice contextRef="From2020-01-01to2020-12-31_us-gaap_WarrantMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">5.75</LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice contextRef="AsOf2019-12-31_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">0.50</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice contextRef="AsOf2019-12-31_us-gaap_WarrantMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">1.00</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice contextRef="AsOf2019-12-31_us-gaap_WarrantMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">2.50</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice contextRef="AsOf2020-12-31_us-gaap_WarrantMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">5.75</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice contextRef="AsOf2020-12-31_us-gaap_WarrantMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">1.40</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife contextRef="From2020-01-01to2020-12-31_us-gaap_WarrantMember">P5Y9M7D</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife contextRef="From2020-01-01to2020-12-31_us-gaap_WarrantMember">P5Y6M21D</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne contextRef="From2020-01-01to2020-12-31_us-gaap_WarrantMember">P5Y7M2D</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne>
    <LFMD:RemainingPerformanceOptions contextRef="From2020-01-19to2020-01-20_custom_MrSeanFitzpatrickMember_custom_ServicesAgreementMember_custom_ServiceBasedStockOptionsMember" unitRef="Shares" decimals="INF">370000</LFMD:RemainingPerformanceOptions>
    <LFMD:RemainingPerformanceOptions contextRef="From2020-11-25to2020-11-27_custom_NewChiefOperatingOfficerMember" unitRef="Shares" decimals="INF">165000</LFMD:RemainingPerformanceOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward contextRef="From2020-01-19to2020-01-20_custom_MrSeanFitzpatrickMember_custom_ServicesAgreementMember_custom_ServiceBasedStockOptionsMember" unitRef="Shares" decimals="INF">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward contextRef="From2020-01-19to2020-01-20_custom_MrSeanFitzpatrickMember_custom_ServicesAgreementMember_custom_ServiceBasedStockOptionsMember_srt_MaximumMember" unitRef="Shares" decimals="INF">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward contextRef="From2020-10-20to2020-10-21_custom_BoardOfDirectorsMember" unitRef="Shares" decimals="INF">20000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward contextRef="From2020-11-05to2020-11-06_custom_BoardOfDirectorsMember" unitRef="Shares" decimals="INF">20000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward contextRef="From2020-12-06to2020-12-08_custom_AmendedCAOEmploymentAgreementMember" unitRef="Shares" decimals="INF">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased contextRef="AsOf2020-01-20_custom_MrSeanFitzpatrickMember_custom_ServicesAgreementMember_custom_ServiceBasedStockOptionsMember" unitRef="USDPShares" decimals="INF">1.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-02-25_custom_AlphaCapitalAnstaltMember_custom_TwoThousandAndEighteenAlphaWarrantMember_srt_MinimumMember" unitRef="Shares" decimals="INF">811594</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-02-25_custom_AlphaCapitalAnstaltMember_custom_TwoThousandAndEighteenAlphaWarrantMember_srt_MaximumMember" unitRef="Shares" decimals="INF">391304</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-02-25_custom_TwoThousandAndNineteenAlphaAmendmentMember_custom_AlphaCapitalAnstaltMember_custom_TwoThousandAndNineteenAlphaWarrantMember_srt_MinimumMember" unitRef="Shares" decimals="INF">365217</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-02-25_custom_TwoThousandAndNineteenAlphaAmendmentMember_custom_AlphaCapitalAnstaltMember_custom_TwoThousandAndNineteenAlphaWarrantMember_srt_MaximumMember" unitRef="Shares" decimals="INF">757488</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-02-25_custom_TwoThousandAndNineteenAlphaAmendmentMember_custom_AlphaCapitalAnstaltMember_custom_TwoThousandAndNineteenAlphaWarrantMember" unitRef="Shares" decimals="INF">267223</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-02-25_custom_TwoThousandAndEighteenBrioWarrantAmendmentMember_custom_BrioMasterFundMember_custom_TwoThousandAndEighteenBrioWarrantMember_srt_MaximumMember" unitRef="Shares" decimals="INF">93398</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-02-25_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_BrioMasterFundMember_custom_BrioTwoThousandAndNineteenWarrantMember_srt_MaximumMember" unitRef="Shares" decimals="INF">236715</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-08-28_custom_SecuritiesPurchaseAgreementMember" unitRef="Shares" decimals="INF">400</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-08-31_custom_ConsultingAgreementMember" unitRef="Shares" decimals="INF">500000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-08-31_custom_ConsultingAgreementMember_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">250000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-08-28_custom_WarrantPurchaseAgreementMember" unitRef="Shares" decimals="INF">500000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-08-28_custom_WarrantPurchaseAgreementMember_custom_ClassAWarrantMember" unitRef="Shares" decimals="INF">250000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-12-31_custom_AugustTwoThousandAndTwentyWarrantInducementMember" unitRef="Shares" decimals="INF">379957</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-05-07_custom_SecondAlphaWarrantAmendmentMember_custom_AugustTwoThousandAndNineteenWarrantMember_srt_MinimumMember" unitRef="Shares" decimals="INF">331401</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-05-07_custom_SecondAlphaWarrantAmendmentMember_custom_AugustTwoThousandAndNineteenWarrantMember_srt_MaximumMember" unitRef="Shares" decimals="INF">1088889</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-05-07_custom_SecondAlphaWarrantAmendmentMember_custom_AugustTwoThousandAndNineteenWarrantMember" unitRef="Shares" decimals="INF">391466</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-02-25_custom_TwoThousandAndEighteenBrioWarrantAmendmentMember_custom_BrioMasterFundMember_custom_TwoThousandAndEighteenBrioWarrantMember_srt_MinimumMember" unitRef="Shares" decimals="INF">86957</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-12-31_custom_BrioWarrantsMember" unitRef="Shares" decimals="INF">100000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-02-25_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_BrioMasterFundMember_custom_BrioTwoThousandAndNineteenWarrantMember_srt_MinimumMember" unitRef="Shares" decimals="INF">114130</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-05-07_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_BrioMasterFundMember_custom_BrioTwoThousandAndNineteenWarrantMember_srt_MinimumMember" unitRef="Shares" decimals="INF">103562</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-05-07_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_BrioMasterFundMember_custom_BrioTwoThousandAndNineteenWarrantMember_srt_MaximumMember" unitRef="Shares" decimals="INF">340278</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-11-03_custom_BTIGLLCMember_custom_PrivatePlacementOfferingMember" unitRef="Shares" decimals="INF">91336</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2020-11-19_custom_BTIGLLCMember_custom_PurchaseAgreementMember" unitRef="Shares" decimals="INF">9717</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">8072451</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">926531</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">3043</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-04-23to2019-04-25_custom_ChiefExecutiveOfficerAndChiefTechnologyOfficerMember_custom_PurchaseAgreementMember" unitRef="USD" decimals="0">900000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2020-08-26to2020-08-28_custom_SecuritiesPurchaseAgreementMember" unitRef="USD" decimals="0">3500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2020-05-01to2020-05-30_us-gaap_InvestorMember" unitRef="USD" decimals="0">250000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">329176</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2020-11-02to2020-11-03_custom_PrivatePlacementOfferingMember" unitRef="USD" decimals="0">14460000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2020-11-18to2020-11-19_custom_PrivatePlacementOfferingMember_custom_PurchaseAgreementMember" unitRef="USD" decimals="0">1540000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">329176</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2021-02-10to2021-02-11_us-gaap_SubsequentEventMember_custom_FebruaryTwoThousandTwentyOnePurchaseAgreementMember_custom_InvestorsMember" unitRef="USD" decimals="0">14000008</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">326133</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-01-01to2019-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-01-01to2019-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">329176</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2019-01-01to2019-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <LFMD:LicenseFee contextRef="From2018-01-01to2018-12-31_custom_CVLBPRMember_custom_PilarisLaboratoriesLLCMember_custom_ThreeSiXFiveDayAnniversaryAgreementMember" unitRef="USD" decimals="0">100000</LFMD:LicenseFee>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2019-12-31_custom_SubscriptionAgreementMember" unitRef="USD" decimals="0">0</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2020-12-31_custom_SubscriptionAgreementMember" unitRef="USD" decimals="0">0</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <LFMD:DeemedDistributionFromDownroundProvisionOnUnissuedShares contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">194022</LFMD:DeemedDistributionFromDownroundProvisionOnUnissuedShares>
    <LFMD:DeemedDistributionFromDownroundProvisionOnUnissuedShares contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <LFMD:SharesIssuedForShareLiability contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">12675</LFMD:SharesIssuedForShareLiability>
    <LFMD:SharesIssuedForShareLiability contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromConvertibleDebt contextRef="From2020-05-22to2020-05-27_custom_MayTwoThousandAndTwentyNotesMember_custom_SixAccreditedInvestorsMember" unitRef="USD" decimals="0">1000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="From2020-07-26to2020-07-27_custom_SixAccreditedInvestorsMember" unitRef="USD" decimals="0">600000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">2350000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="From2020-05-26to2020-05-27_custom_MayTwoThousandAndTwentyNotesMember" unitRef="USD" decimals="0">1000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">1093279</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-01to2020-12-31_custom_EmployeesAnddvisoryBoardMembersMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <LFMD:ExpiringAgreementDescription contextRef="From2020-01-01to2020-12-31_custom_EmploymentAndConsultingAgreementsMember">The Company has entered into various agreements with officers, directors, employees and consultants that expire in terms of one to five years.</LFMD:ExpiringAgreementDescription>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice contextRef="AsOf2019-12-31_custom_ServiceBasedStockOptionsMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">1.00</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice contextRef="AsOf2019-12-31_custom_ServiceBasedStockOptionsMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">2.00</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice contextRef="AsOf2019-12-31_us-gaap_PerformanceSharesMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">1.25</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice contextRef="AsOf2019-12-31_us-gaap_PerformanceSharesMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">2.00</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice contextRef="AsOf2019-12-31_custom_TwoThousandTwentyPlanMember" unitRef="USDPShares" xsi:nil="true" />
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice contextRef="AsOf2020-12-31_srt_MinimumMember_custom_TwoThousandTwentyPlanMember" unitRef="USDPShares" decimals="INF">5.80</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice contextRef="AsOf2020-12-31_srt_MaximumMember_custom_TwoThousandTwentyPlanMember" unitRef="USDPShares" decimals="INF">9.24</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice contextRef="AsOf2020-12-31_custom_ServiceBasedStockOptionsMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">0.80</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice contextRef="AsOf2020-12-31_custom_ServiceBasedStockOptionsMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">7.50</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice contextRef="AsOf2020-12-31_us-gaap_PerformanceSharesMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">1.25</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice contextRef="AsOf2020-12-31_us-gaap_PerformanceSharesMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">2.00</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">9179075</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">1106624</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">648421</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">97448</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">154876</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">442971</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">12063395</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">2747102</us-gaap:AssetsCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">274437</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">23625</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:CapitalizedComputerSoftwareNet contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">375983</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareNet contextRef="AsOf2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">339840</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">675452</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">990260</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">699077</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">13053655</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">3446179</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">11794084</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">3051156</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:NotesPayableCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">779132</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">814734</us-gaap:NotesPayableCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">917000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">110000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">13490096</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">3975442</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiability contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">285323</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">29978</us-gaap:OperatingLeaseLiability>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="AsOf2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">70000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:Liabilities contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">13875419</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">4575420</us-gaap:Liabilities>
    <us-gaap:CommonStockValue contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">234337</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">106807</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">77779370</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">15663626</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">-80151905</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2019-04-25_custom_ChiefExecutiveOfficerAndChiefTechnologyOfficerMember_custom_PurchaseAgreementMember" unitRef="USD" decimals="0">417044</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">-16594917</us-gaap:RetainedEarningsAccumulatedDeficit>
    <LFMD:EquityTotal contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">-2138198</LFMD:EquityTotal>
    <LFMD:EquityTotal contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">-824484</LFMD:EquityTotal>
    <us-gaap:TreasuryStockValue contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">163701</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">163701</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">-2301899</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">-988185</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">-2175687</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">-141056</us-gaap:MinorityInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">13053655</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">3446179</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2019-04-25_custom_ChiefExecutiveOfficerAndChiefTechnologyOfficerMember_custom_PurchaseAgreementMember" unitRef="USDPShares" decimals="INF">0.90</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2020-08-27_custom_SeriesBConvertiblePreferredStockMember" unitRef="USDPShares" decimals="INF">3.25</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2020-08-27_custom_SeriesBConvertiblePreferredStockMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">15.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2020-08-28_custom_SecuritiesPurchaseAgreementMember" unitRef="USDPShares" decimals="INF">1000</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2020-08-31_custom_ConsultingAgreementMember" unitRef="USDPShares" decimals="INF">5.20</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2021-02-11_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember_custom_InvestorsMember" unitRef="USDPShares" decimals="INF">23.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2019-07-31_custom_MembershipInterestPurchaseAgreementMember_custom_FirstMilestoneMember" unitRef="USDPShares" decimals="INF">2.50</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2019-07-31_custom_MembershipInterestPurchaseAgreementMember_custom_SecondMileSStoneMember" unitRef="USDPShares" decimals="INF">3.75</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2020-09-22_custom_PromissoryNoteMember_srt_DirectorMember_custom_ExchangeAgreementMember" unitRef="USDPShares" decimals="INF">4.65</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2021-02-11_us-gaap_SubsequentEventMember_custom_FebruaryTwoThousandTwentyOnePurchaseAgreementMember_custom_InvestorsMember" unitRef="USDPShares" decimals="INF">23.00</us-gaap:SharesIssuedPricePerShare>
    <LFMD:PurchasedRemainingInterestPercentage contextRef="AsOf2019-04-25_custom_ChiefExecutiveOfficerAndChiefTechnologyOfficerMember_custom_PurchaseAgreementMember" unitRef="Percent" decimals="INF">0.218</LFMD:PurchasedRemainingInterestPercentage>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2020-12-31" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2020-12-31_us-gaap_SeriesBPreferredStockMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2020-08-27_custom_SeriesBConvertiblePreferredStockMember" unitRef="USDPShares" decimals="INF">1000</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockValue contextRef="AsOf2020-12-31_custom_SecuritiesPurchaseAgreementMember_us-gaap_SeriesBPreferredStockMember" unitRef="USD" decimals="0">3655822</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-12-31_us-gaap_SeriesBPreferredStockMember" unitRef="Shares" decimals="INF">5000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-08-27_custom_SeriesBConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">5000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-12-31_us-gaap_ProductMember" unitRef="USD" decimals="0">30556163</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-12-31_us-gaap_ProductMember" unitRef="USD" decimals="0">9919506</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-12-31_custom_SoftwareRevenuesNetMember" unitRef="USD" decimals="0">6732747</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-12-31_custom_SoftwareRevenuesNetMember" unitRef="USD" decimals="0">2539129</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-12-31_us-gaap_ServiceMember" unitRef="USD" decimals="0">5000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-12-31_us-gaap_ServiceMember" unitRef="USD" decimals="0">9943</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-12-31_us-gaap_ProductMember_custom_ShapiroMDMember_custom_CVLBPRMember" unitRef="USD" decimals="0">17289687</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-12-31_us-gaap_ProductMember_custom_ShapiroMDMember_custom_CVLBPRMember" unitRef="USD" decimals="0">9019956</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-12-31_us-gaap_ProductMember_custom_RexMDMember_custom_CVLBPRMember" unitRef="USD" decimals="0">12969753</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-12-31_us-gaap_ProductMember_custom_RexMDMember_custom_CVLBPRMember" unitRef="USD" decimals="0">60197</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-12-31_us-gaap_ProductMember_custom_INRWellnessMember_custom_CVLBPRMember" unitRef="USD" decimals="0">247350</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-12-31_us-gaap_ProductMember_custom_INRWellnessMember_custom_CVLBPRMember" unitRef="USD" decimals="0">738965</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-12-31_us-gaap_ProductMember_custom_ScarologyMember_custom_CVLBPRMember" unitRef="USD" decimals="0">44332</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-12-31_us-gaap_ProductMember_custom_ScarologyMember_custom_CVLBPRMember" unitRef="USD" decimals="0">51131</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">37293910</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-12-31_us-gaap_ProductMember_custom_CVLBPRMember_custom_InnateMember" unitRef="USD" decimals="0">5041</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-12-31_us-gaap_ProductMember_custom_CVLBPRMember_custom_InnateMember" unitRef="USD" decimals="0">49258</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-12-31_custom_SoftwareRevenueMember_custom_LegalSimpliSoftwareLlcMember" unitRef="USD" decimals="0">6732747</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-12-31_custom_SoftwareRevenueMember_custom_LegalSimpliSoftwareLlcMember" unitRef="USD" decimals="0">2539129</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-12-31_custom_SoftwareRevenueMember_custom_CVLBMediaMember" unitRef="USD" decimals="0">5000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-12-31_custom_SoftwareRevenueMember_custom_CVLBMediaMember" unitRef="USD" decimals="0">9943</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">12468578</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue contextRef="From2020-01-01to2020-12-31_us-gaap_ProductMember" unitRef="USD" decimals="0">8572490</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2019-01-01to2019-12-31_us-gaap_ProductMember" unitRef="USD" decimals="0">2371295</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2020-01-01to2020-12-31_custom_SoftwareRevenuesNetMember" unitRef="USD" decimals="0">334952</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2019-01-01to2019-12-31_custom_SoftwareRevenuesNetMember" unitRef="USD" decimals="0">154013</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2020-01-01to2020-12-31_us-gaap_ServiceMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:CostOfRevenue contextRef="From2019-01-01to2019-12-31_us-gaap_ServiceMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:CostOfRevenue contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">8907442</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">2525308</us-gaap:CostOfRevenue>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">200</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">18305000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">29000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">16000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">15800</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2019-01-01to2019-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2019-01-01to2019-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">16000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2019-01-01to2019-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">18276000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2020-01-01to2020-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2020-01-01to2020-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">18305000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2020-01-01to2020-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">20000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">2900000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">302400</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">5356</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2020-01-01to2020-12-31_custom_OptionsAndWarrantsMember74465703" unitRef="USD" decimals="0">302400</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">297044</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2020-01-01to2020-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2020-01-01to2020-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">302400</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2020-01-01to2020-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2021-02-01to2021-03-31_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">660645</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember" unitRef="Shares" decimals="INF">1175600</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2020-01-01to2020-12-31_us-gaap_PerformanceSharesMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">535600</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2020-01-01to2020-12-31_custom_TwoThousandTwentyPlanMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2020-01-01to2020-12-31_custom_OptionsAndWarrantsMember74465703" unitRef="Shares" decimals="INF">535600</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">200000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2020-09-28to2020-09-29_custom_AmendedConsultingAgreementMember_custom_BlueHorizonConsultingLLCMember" unitRef="Shares" decimals="INF">2000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">133470</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PaymentsToAcquireSoftware contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">398136</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireSoftware contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromWarrantExercises contextRef="From2020-01-01to2020-12-31_custom_AugustTwoThousandAndTwentyWarrantInducementMember" unitRef="USD" decimals="0">623000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">622763</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">302400</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">25000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">15000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <LFMD:DeemedDistributionFromWarrantsIssuedWithPreferredStock contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">3500000</LFMD:DeemedDistributionFromWarrantsIssuedWithPreferredStock>
    <LFMD:DeemedDistributionFromWarrantsIssuedWithPreferredStock contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <LFMD:WarrantsIssuedInRelationToDebt contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <LFMD:WarrantsIssuedInRelationToDebt contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">569147</LFMD:WarrantsIssuedInRelationToDebt>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following is a summary of&#13;outstanding service-based options activity (prior to the establishment of our 2020 Plan above) for the year ended December 31, 2020:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Options Outstanding Number of Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise Price per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Remaining Contractual Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Exercise Price per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 30%"&gt;&lt;font style="font-size: 10pt"&gt;Balance, December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,009,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.00 - 2.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.22 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;700,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.15 - 7.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.76 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.85&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(1,175,600&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.80 - 2.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.97 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Cancelled/Forfeited/Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(305,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.00 - 2.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6.52 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.54&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Balance at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,228,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.80 - 7.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.15 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercisable December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,361,083&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.00 - 2.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.76 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercisable at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,570,428&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.00 &amp;#8211; 7.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.57 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.67&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2020-01-01to2020-12-31_us-gaap_PerformanceSharesMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following is a summary of&#13;outstanding performance-based options activity for the year ended December 31, 2020:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Options Outstanding Number of Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise Price per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Remaining Contractual Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Exercise Price per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 30%"&gt;&lt;font style="font-size: 10pt"&gt;Balance at December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,365,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.25 &amp;#8211; 2.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.34 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.70&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Cancelled/Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(200,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.06 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Balance at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,165,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.25 &amp;#8211; 2.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.97 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.80&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercisable December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;635,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.25 &amp;#8211; 2.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.63 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercisable at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;635,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.25 &amp;#8211; 2.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.38 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2020-01-01to2020-12-31_custom_TwoThousandTwentyPlanMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following is a summary of&#13;outstanding options activity for our new 2020 Plan for the year ended December 31, 2020:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Options Outstanding Number of Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise Price per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Remaining Contractual Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Exercise Price per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Balance, December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 30%"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;839,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.80 &amp;#8211; 9.24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.54&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Cancelled/Forfeited/Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Balance at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;839,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.80 &amp;#8211; 9.24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.54&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercisable December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercisable at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;76,222&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.80 &amp;#8211; 9.24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9.77&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.74&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2020-10-08to2020-10-09_us-gaap_SubsequentEventMember">1-for-5 reverse stock split</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">867000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">531388</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:NotesPayable contextRef="AsOf2019-08-15_custom_SecuritiesPurchaseAgreementMember_custom_TwoAccreditedInvestorsMember" unitRef="USD" decimals="0">1111500</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2020-12-31_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" unitRef="USD" decimals="0">0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2019-12-31_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" unitRef="USD" decimals="0">627426</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2020-12-31_custom_TwoCSixPurchaseAgreementsMember_custom_CSixCapitalLLCMember" unitRef="USD" decimals="0">0</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2019-12-31_custom_SecuritiesPurchaseAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" unitRef="USD" decimals="0">187308</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2021-01-22_us-gaap_SubsequentEventMember_custom_CVLBPRMember" unitRef="USD" decimals="0">375823</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2020-12-31_custom_PaycheckProtectionProgramLoanMember_custom_USSmallBusinessAdministrationMember" unitRef="USD" decimals="0">259182</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2020-12-31_custom_WorkingCapitalLoanMember_custom_ChaseBankMember" unitRef="USD" decimals="0">519950</us-gaap:NotesPayable>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2016-01-01to2016-12-31_custom_PilarisLaboratoriesLLCMember">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2020-01-01to2020-12-31_custom_CustomerRelationshipAssetMember">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2020-01-01to2020-12-31_us-gaap_LicensingAgreementsMember_custom_PurchasedLicensesMember">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2020-01-01to2020-12-31_us-gaap_CustomerRelationshipsMember_srt_MinimumMember">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2020-01-01to2020-12-31_us-gaap_CustomerRelationshipsMember_srt_MaximumMember">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2020-08-28_custom_SixAccreditedInvestorsMember" unitRef="USD" decimals="0">7500</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestExpenseDebt contextRef="From2020-05-22to2020-05-27_custom_MayTwoThousandAndTwentyNotesMember_custom_SixAccreditedInvestorsMember" unitRef="USD" decimals="0">120000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">1667536</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">761150</us-gaap:InterestExpenseDebt>
    <LFMD:SharesIssuedPricePerSharePreSplit contextRef="AsOf2020-08-27_custom_SeriesBConvertiblePreferredStockMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">3.00</LFMD:SharesIssuedPricePerSharePreSplit>
    <us-gaap:PreferredStockDividendRatePercentage contextRef="From2020-08-26to2020-08-27_custom_SeriesBConvertiblePreferredStockMember" unitRef="Percent" decimals="INF">0.13</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:PreferredStockDividendRatePercentage contextRef="From2020-01-01to2020-12-31_custom_SecuritiesPurchaseAgreementMember_us-gaap_SeriesBPreferredStockMember" unitRef="Percent" decimals="INF">0.13</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:PreferredStockDividendRatePercentage contextRef="From2020-08-26to2020-08-28_custom_WarrantPurchaseAgreementMember_custom_ClassAWarrantMember" unitRef="Percent" decimals="INF">0.50</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="From2020-08-26to2020-08-28_custom_SecuritiesPurchaseAgreementMember" unitRef="USD" decimals="0">2892500</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="From2020-11-02to2020-11-03_custom_PrivatePlacementOfferingMember" unitRef="USD" decimals="0">13500000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="From2020-11-18to2020-11-19_custom_PrivatePlacementOfferingMember_custom_PurchaseAgreementMember" unitRef="USD" decimals="0">1400000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments contextRef="From2020-08-26to2020-08-28_custom_SecuritiesPurchaseAgreementMember" unitRef="USD" decimals="0">3500000</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">4716021</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <LFMD:PutLiabilityIncrease contextRef="AsOf2020-12-31_custom_SecuritiesPurchaseAgreementMember_us-gaap_SeriesBPreferredStockMember" unitRef="USD" decimals="0">155822</LFMD:PutLiabilityIncrease>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">20825</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="AsOf2020-12-31_custom_WarrantPurchaseAgreementMember" unitRef="USD" decimals="0">9467767</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-12-31_us-gaap_MeasurementInputExpectedDividendRateMember_custom_WarrantPurchaseAgreementMember" unitRef="Percent" decimals="INF">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-12-31_us-gaap_MeasurementInputPriceVolatilityMember_custom_WarrantPurchaseAgreementMember" unitRef="Percent" decimals="INF">161.4</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_WarrantPurchaseAgreementMember" unitRef="Percent" decimals="INF">0.28</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-12-31_custom_AugustTwoThousandAndTwentyWarrantInducementMember_us-gaap_MeasurementInputPriceVolatilityMember" unitRef="Percent" decimals="INF">148.49</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-12-31_custom_AugustTwoThousandAndTwentyWarrantInducementMember_us-gaap_MeasurementInputRiskFreeInterestRateMember" unitRef="Percent" decimals="INF">0.14</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-12-31_custom_ConsultingAgreementMember_us-gaap_MeasurementInputExpectedDividendRateMember" unitRef="Percent" decimals="INF">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-12-31_custom_ConsultingAgreementMember_us-gaap_MeasurementInputPriceVolatilityMember" unitRef="Percent" decimals="INF">161.4</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="AsOf2020-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_ConsultingAgreementMember" unitRef="Percent" decimals="INF">0.28</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:AmortizationOfFinancingCosts contextRef="From2020-01-01to2020-12-31_custom_WarrantPurchaseAgreementMember" unitRef="USD" decimals="0">790649</us-gaap:AmortizationOfFinancingCosts>
    <LFMD:UnamortizedCosts contextRef="From2020-01-01to2020-12-31_custom_WarrantPurchaseAgreementMember" unitRef="USD" decimals="0">3953244</LFMD:UnamortizedCosts>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember" unitRef="Shares" decimals="INF">305000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="From2020-01-01to2020-12-31_us-gaap_PerformanceSharesMember" unitRef="Shares" decimals="INF">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="From2020-01-01to2020-12-31_custom_TwoThousandTwentyPlanMember" unitRef="Shares" xsi:nil="true" />
    <LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice contextRef="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">0.80</LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice>
    <LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice contextRef="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">2.00</LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice>
    <LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice contextRef="From2020-01-01to2020-12-31_us-gaap_PerformanceSharesMember" unitRef="USDPShares" xsi:nil="true" />
    <LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice contextRef="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">1.00</LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice>
    <LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice contextRef="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">2.00</LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice>
    <LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice contextRef="From2020-01-01to2020-12-31_us-gaap_PerformanceSharesMember" unitRef="USDPShares" decimals="INF">1.50</LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife contextRef="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember">P2Y11M19D</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife contextRef="From2020-01-01to2020-12-31_us-gaap_PerformanceSharesMember">P0Y</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife contextRef="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember">P6Y6M7D</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife contextRef="From2020-01-01to2020-12-31_us-gaap_PerformanceSharesMember">P8Y22D</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember" unitRef="USDPShares" decimals="INF">1.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31_us-gaap_PerformanceSharesMember" unitRef="USDPShares" decimals="INF">1.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisedAndExpiredWeightedAverageContractualLife contextRef="From2020-01-01to2020-12-31_us-gaap_WarrantMember">P0Y9M25D</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisedAndExpiredWeightedAverageContractualLife>
    <LFMD:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm contextRef="From2020-01-01to2020-12-31_us-gaap_WarrantMember">P6Y2M27D</LFMD:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm>
    <LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice contextRef="From2020-01-01to2020-12-31_us-gaap_WarrantMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">0.65</LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice>
    <LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice contextRef="From2020-01-01to2020-12-31_us-gaap_WarrantMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">0.70</LFMD:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice>
    <us-gaap:LeaseExpirationDate1 contextRef="From2020-01-01to2020-12-31_custom_LeaseAgreementTwoMember">2023-09-30</us-gaap:LeaseExpirationDate1>
    <us-gaap:LeaseExpirationDate1 contextRef="From2020-01-01to2020-12-31_custom_LeaseAgreementOneMember">2021-02-28</us-gaap:LeaseExpirationDate1>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">14900220</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="From2021-02-08to2021-02-11_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember_custom_InvestorsMember" unitRef="USD" decimals="0">14000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="From2020-11-01to2020-11-30" unitRef="USD" decimals="0">14900000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="From2021-02-08to2021-02-11_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">13400000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <LFMD:ContingentConsiderationOnPurchaseOfLegalsimpli contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">100000</LFMD:ContingentConsiderationOnPurchaseOfLegalsimpli>
    <LFMD:ContingentConsiderationOnPurchaseOfLegalsimpli contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">500000</LFMD:ContingentConsiderationOnPurchaseOfLegalsimpli>
    <LFMD:DeemedDividendFromWarrantPriceAdjustment contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">1289657</LFMD:DeemedDividendFromWarrantPriceAdjustment>
    <LFMD:DeemedDividendFromWarrantPriceAdjustment contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2020-08-28_custom_SecuritiesPurchaseAgreementMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2020-12-31_custom_WarrantPurchaseAgreementMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2020-12-31_custom_AugustTwoThousandAndTwentyWarrantInducementMember">P1Y7M6D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2020-12-31_custom_ConsultingAgreementMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <LFMD:NumberOfSharesIssuedForExerciseOfWarrants contextRef="From2020-01-01to2020-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">379957</LFMD:NumberOfSharesIssuedForExerciseOfWarrants>
    <LFMD:NumberOfSharesIssuedForExerciseOfWarrantsValue contextRef="From2020-01-01to2020-12-31_us-gaap_WarrantMember" unitRef="USD" decimals="0">622763</LFMD:NumberOfSharesIssuedForExerciseOfWarrantsValue>
    <LFMD:WarrantDiscountPricePerShare contextRef="AsOf2020-08-31_custom_AugustTwoThousandAndTwentyWarrantInducementMember" unitRef="USDPShares" decimals="INF">0.25</LFMD:WarrantDiscountPricePerShare>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-09-28to2020-09-29_custom_AmendedConsultingAgreementMember_custom_BlueHorizonConsultingLLCMember" unitRef="USD" decimals="0">15900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">36961141</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">733215</us-gaap:AllocatedShareBasedCompensationExpense>
    <LFMD:WarrantPurchasePrice contextRef="AsOf2020-08-28_custom_WarrantPurchaseAgreementMember" unitRef="USD" decimals="0">15000</LFMD:WarrantPurchasePrice>
    <LFMD:WarrantPurchasePrice contextRef="AsOf2020-08-28_custom_WarrantPurchaseAgreementMember_custom_ClassAWarrantMember" unitRef="USD" decimals="0">10000</LFMD:WarrantPurchasePrice>
    <us-gaap:ProceedsFromIssuanceOfDebt contextRef="From2020-01-01to2020-12-31_custom_PaycheckProtectionProgramLoanMember" unitRef="USD" decimals="0">249000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">10700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2020-01-01to2020-12-31" unitRef="Percent" decimals="INF">0.25</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="AsOf2020-12-31_custom_LeaseAgreementOneMember" unitRef="USD" decimals="0">2106</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="AsOf2020-12-31_custom_LeaseAgreementTwoMember" unitRef="USD" decimals="0">8473</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="AsOf2020-12-31_custom_LeaseAgreementOneMember" unitRef="USD" decimals="0">2149</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="AsOf2020-12-31_custom_LeaseAgreementTwoMember" unitRef="USD" decimals="0">8685</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="AsOf2020-12-31_custom_LeaseAgreementOneMember" unitRef="USD" decimals="0">2235</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="AsOf2020-12-31_custom_LeaseAgreementTwoMember" unitRef="USD" decimals="0">8902</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:SecurityDeposit contextRef="AsOf2020-12-31_custom_LeaseAgreementOneMember" unitRef="USD" decimals="0">2235</us-gaap:SecurityDeposit>
    <us-gaap:SecurityDeposit contextRef="AsOf2020-12-31_custom_LeaseAgreementTwoMember" unitRef="USD" xsi:nil="true" />
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2021-03-30" unitRef="Shares" decimals="INF">25906754</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:DeferredRevenue contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">916880</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">109552</us-gaap:DeferredRevenue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">-4477586</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">106807</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">819738</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">-1129241</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">91564</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">13110507</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">15663626</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-12140670</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-16594917</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31_us-gaap_TreasuryStockMember" unitRef="USD" decimals="0">-163701</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31_us-gaap_TreasuryStockMember" unitRef="USD" decimals="0">-163701</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">897700</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">-988185</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" decimals="0">-77962</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" decimals="0">-141056</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">234337</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">77779370</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-80151905</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31_us-gaap_TreasuryStockMember" unitRef="USD" decimals="0">-163701</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">-2301899</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" decimals="0">-2175687</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProfitLoss contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-60524351</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProfitLoss contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-3528258</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProfitLoss contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-3137203</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2019-01-01to2019-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProfitLoss contextRef="From2019-01-01to2019-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">-3137203</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2019-01-01to2019-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" decimals="0">-391055</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProfitLoss contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-58646943</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2020-01-01to2020-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProfitLoss contextRef="From2020-01-01to2020-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">-58646943</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2020-01-01to2020-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" decimals="0">-1877408</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">2722187</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2021-01-20to2021-01-22_us-gaap_SubsequentEventMember_custom_ConversionLabsPRLLCMember_custom_LegalSimpliSoftwareLlcMember" unitRef="Shares" decimals="INF">12000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2021-01-20to2021-01-22_us-gaap_SubsequentEventMember_custom_FoundingMembersMIPAsMember_custom_LegalSimpliSoftwareLlcMember_custom_ConversionLabsPRLLCMember" unitRef="Shares" decimals="INF">2183</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">2181453</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">27222</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2021-01-20to2021-01-22_us-gaap_SubsequentEventMember_custom_ConversionLabsPRLLCMember_custom_LegalSimpliSoftwareLlcMember" unitRef="USD" decimals="0">300000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2021-01-20to2021-01-22_us-gaap_SubsequentEventMember_custom_FoundingMembersMIPAsMember_custom_LegalSimpliSoftwareLlcMember_custom_ConversionLabsPRLLCMember" unitRef="USD" decimals="0">225000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">2154231</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2020-01-01to2020-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2020-01-01to2020-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">2181453</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2020-01-01to2020-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits contextRef="From2020-10-08to2020-10-09_us-gaap_SubsequentEventMember" unitRef="Shares" decimals="INF">632</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
    <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">632</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
    <LFMD:RightOfUseAsset contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">274437</LFMD:RightOfUseAsset>
    <LFMD:RightOfUseAsset contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">2892500</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">21002201</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">775123</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:Cash contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">12000000</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2020-12-31_custom_ThroughTheNextTwelveMonthsMember" unitRef="USD" decimals="0">10000000</us-gaap:Cash>
    <LFMD:MerchantProcessingFees contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">745288</LFMD:MerchantProcessingFees>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">349000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">84000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:DebtInstrumentDescription contextRef="From2020-01-01to2020-12-31_custom_PaycheckProtectionProgramLoanMember">The PPP, established as part of the Coronavirus Aid, Relief and Economic Security Act ("CARES Act"), provides for loans to qualifying businesses for amounts up to 2.5 times of the average monthly payroll expenses of the qualifying business.</us-gaap:DebtInstrumentDescription>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">1172624</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">925017</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">149115</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">37542</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">57481</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">12500</us-gaap:InventoryValuationReserves>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2020-01-01to2020-12-31" unitRef="Shares" decimals="INF">8869511</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2020-01-01to2020-12-31_us-gaap_SeriesBPreferredStockMember" unitRef="Shares" decimals="INF">1076923</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2019-01-01to2019-12-31_us-gaap_ConvertibleDebtSecuritiesMember" unitRef="Shares" decimals="INF">2165126</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2020-01-01to2020-12-31_us-gaap_ConvertibleDebtSecuritiesMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2020-01-01to2020-12-31_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">4232400</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2019-01-01to2019-12-31_us-gaap_EmployeeStockOptionMember" unitRef="Shares" decimals="INF">4374000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2020-01-01to2020-12-31_us-gaap_WarrantMember63245687" unitRef="Shares" decimals="INF">3560188</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2019-01-01to2019-12-31_us-gaap_WarrantMember63245750" unitRef="Shares" decimals="INF">2265324</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2019-01-01to2019-12-31" unitRef="Shares" decimals="INF">8804451</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2019-01-01to2019-12-31_us-gaap_SeriesBPreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate contextRef="AsOf2020-11-03_custom_BTIGLLCMember_custom_PrivatePlacementOfferingMember">2025-11-03</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate contextRef="AsOf2020-11-19_custom_BTIGLLCMember_custom_PurchaseAgreementMember">2025-11-19</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <LFMD:GrossProceedsFromOffering contextRef="From2020-11-18to2020-11-19_custom_PrivatePlacementOfferingMember_custom_PurchaseAgreementMember" unitRef="USD" decimals="0">16000000</LFMD:GrossProceedsFromOffering>
    <LFMD:CashlessExerciseOfOptionsShares contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">534774</LFMD:CashlessExerciseOfOptionsShares>
    <LFMD:CashlessExerciseOfOptionsShares contextRef="From2020-01-01to2020-12-31_custom_OptionsAndWarrantsMember74465703" unitRef="Shares" decimals="INF">534774</LFMD:CashlessExerciseOfOptionsShares>
    <LFMD:IssuedWarrantsInConjunctionWithStock contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">2902631</LFMD:IssuedWarrantsInConjunctionWithStock>
    <LFMD:IssuedWarrantsInConjunctionWithStock contextRef="From2020-01-01to2020-12-31_custom_OptionsAndWarrantsMember74465703" unitRef="USD" decimals="0">20825</LFMD:IssuedWarrantsInConjunctionWithStock>
    <LFMD:IssuedWarrantsInConjunctionWithDebt contextRef="From2020-01-01to2020-12-31_custom_OptionsAndWarrantsMember74465703" unitRef="USD" decimals="0">569146</LFMD:IssuedWarrantsInConjunctionWithDebt>
    <LFMD:MembershipInterestPercentage contextRef="From2019-07-30to2019-07-31_custom_MembershipInterestPurchaseAgreementMember" unitRef="Percent" decimals="INF">0.2183330</LFMD:MembershipInterestPercentage>
    <us-gaap:MinorityInterestOwnershipPercentageByParent contextRef="AsOf2020-12-31_custom_LegalSimpliSoftwareLlcMember" unitRef="Percent" decimals="INF">0.49</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <LFMD:StockIssuedDuringPeriodSharesIssuedForShareLiability contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">2722187</LFMD:StockIssuedDuringPeriodSharesIssuedForShareLiability>
    <LFMD:SharesIssuedForLiability contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">2181453</LFMD:SharesIssuedForLiability>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="From2020-05-22to2020-05-27_custom_MayTwoThousandAndTwentyNotesMember_custom_SixAccreditedInvestorsMember" unitRef="USD" decimals="0">219450</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <LFMD:OptionsVestingDate contextRef="From2020-12-06to2020-12-08_custom_AmendedCAOEmploymentAgreementMember_srt_MaximumMember">2023-12-08</LFMD:OptionsVestingDate>
    <LFMD:OptionsVestingDate contextRef="From2020-12-06to2020-12-08_us-gaap_RestrictedStockUnitsRSUMember_custom_AmendedCAOEmploymentAgreementMember">2023-12-08</LFMD:OptionsVestingDate>
    <LFMD:OptionsVestingDate contextRef="From2021-01-10to2021-01-11_us-gaap_SubsequentEventMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember">2024-01-11</LFMD:OptionsVestingDate>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice contextRef="AsOf2020-12-31_srt_MinimumMember_custom_TwoThousandTwentyPlanMember" unitRef="USDPShares" decimals="INF">5.80</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice contextRef="AsOf2020-12-31_srt_MaximumMember_custom_TwoThousandTwentyPlanMember" unitRef="USDPShares" decimals="INF">9.24</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice contextRef="AsOf2020-12-31_custom_ServiceBasedStockOptionsMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">1.00</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice contextRef="AsOf2020-12-31_custom_ServiceBasedStockOptionsMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">7.50</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice contextRef="AsOf2020-12-31_us-gaap_PerformanceSharesMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">1.25</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice>
    <LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice contextRef="AsOf2020-12-31_us-gaap_PerformanceSharesMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">2.00</LFMD:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-914862</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2020-01-01to2020-12-31_custom_PromissoryNoteMember_srt_DirectorMember_custom_ExchangeAgreementMember" unitRef="USD" decimals="0">914862</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">152100</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-152100</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">40400</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-40400</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">192500</us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-192500</us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-70000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">70000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-70000</us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">70000</us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit>
    <LFMD:ExpectedTaxExpenseBenefit contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-12684000</LFMD:ExpectedTaxExpenseBenefit>
    <LFMD:ExpectedTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-783000</LFMD:ExpectedTaxExpenseBenefit>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">7765000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">7000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">140000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">173000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">1269000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">148000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-25500</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-47500</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">122500</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-122500</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="AsOf2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">70000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="AsOf2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">70000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">70000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">2980000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">1711000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">2980000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">1711000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">2151000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">951000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">716000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">716000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DebtInstrumentDecreaseForgiveness contextRef="From2021-01-01to2021-03-31_us-gaap_SubsequentEventMember_custom_PaycheckProtectionProgramMember" unitRef="USD" decimals="0">125643</us-gaap:DebtInstrumentDecreaseForgiveness>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2021-02-02to2021-02-04_us-gaap_SubsequentEventMember_srt_ChiefFinancialOfficerMember_us-gaap_RestrictedStockUnitsRSUMember">P36M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2021-02-02to2021-02-04_us-gaap_SubsequentEventMember_srt_ChiefFinancialOfficerMember_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2021-02-01to2021-02-04_us-gaap_SubsequentEventMember_srt_ChiefFinancialOfficerMember_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_ShareBasedCompensationAwardTrancheTwoMember">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2021-02-02to2021-02-04_us-gaap_SubsequentEventMember_srt_ChiefFinancialOfficerMember_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_ShareBasedCompensationAwardTrancheThreeMember">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:EntityRegistrantName contextRef="From2020-01-01to2020-12-31">LifeMD, Inc.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2020-01-01to2020-12-31">0000948320</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2020-01-01to2020-12-31">10-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2020-01-01to2020-12-31">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2020-01-01to2020-12-31">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2020-01-01to2020-12-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2020-01-01to2020-12-31">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2020-01-01to2020-12-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2020-01-01to2020-12-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2020-01-01to2020-12-31">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2020-01-01to2020-12-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2020-01-01to2020-12-31">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-01-01to2020-12-31">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2020-01-01to2020-12-31">false</dei:EntityShellCompany>
    <dei:DocumentFiscalPeriodFocus contextRef="From2020-01-01to2020-12-31">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2020-01-01to2020-12-31">2020</dei:DocumentFiscalYearFocus>
    <us-gaap:GrossProfit contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">28386468</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">9943270</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">41669475</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">8916217</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">42206675</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">2398751</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">1166697</us-gaap:OtherGeneralExpense>
    <us-gaap:OtherGeneralExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">724270</us-gaap:OtherGeneralExpense>
    <us-gaap:DevelopmentCosts contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">446749</us-gaap:DevelopmentCosts>
    <us-gaap:DevelopmentCosts contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">222877</us-gaap:DevelopmentCosts>
    <us-gaap:OperatingExpenses contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">86205921</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">12832878</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-57819453</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-2889608</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">1667536</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">761150</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-2582398</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-761150</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-60401851</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-3650758</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-1877408</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-391055</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-58646943</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-3137203</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-63362964</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">-3137203</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="From2020-01-01to2020-12-31" unitRef="USDPShares" decimals="INF">-4.44</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="From2019-01-01to2019-12-31" unitRef="USDPShares" decimals="INF">-0.32</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="From2020-01-01to2020-12-31" unitRef="USDPShares" decimals="INF">-4.44</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="From2019-01-01to2019-12-31" unitRef="USDPShares" decimals="INF">-0.32</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2020-01-01to2020-12-31" unitRef="Shares" decimals="INF">14275153</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2019-01-01to2019-12-31" unitRef="Shares" decimals="INF">9897745</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2020-01-01to2020-12-31" unitRef="Shares" decimals="INF">14275153</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2019-01-01to2019-12-31" unitRef="Shares" decimals="INF">9897745</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">9179075</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">180093</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">1106624</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 3 &amp;#8211; INTANGIBLE ASSETS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2020, the Company&#13;has the following amounts related to intangible assets:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Intangible Assets as at:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Amortizable&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Life&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Amortizable Intangible Assets&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 45%; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Customer Relationship Asset&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,006,840&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,006,840&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;3 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Purchased Licenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;200,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;200,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;10 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Less: Accumulated amortization&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(867,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(531,388&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Total Net Amortizable Intangible Assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;339,840&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;675,452&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;The aggregate amortization expense of the Company&amp;#8217;s intangible assets&#13;for the year ended December 31, 2020 and 2019 was approximately $335,612, respectively. Amortization expense for 2021 will be approximately&#13;$339,840.&lt;/p&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 4 &amp;#8211; NOTES PAYABLE&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On May 29, 2018, the Company entered&#13;into a securities purchase agreement (the &amp;#8220;Purchase Agreement&amp;#8221;) with Alpha Capital Anstalt (&amp;#8220;Alpha&amp;#8221;) and Brio&#13;Capital Master Fund Ltd. (&amp;#8220;Brio&amp;#8221;), (collectively, the &amp;#8220;2018 SPAs&amp;#8221;). Pursuant to the terms of the Purchase Agreement,&#13;the Company issued and sold the 2018 SPAs senior secured convertible notes in the aggregate original principal amount of $550,000 (collectively,&#13;the &amp;#8220;Alpha and Brio Notes&amp;#8221;), and warrants to purchase up to 478,261 shares of the Company&amp;#8217;s common stock (collectively&#13;the &amp;#8220;Alpha and Brio Warrants&amp;#8221;). The Alpha and Brio Notes matured on May 2019. Interest on the outstanding principal amount&#13;of the Alpha and Brio Notes had compounded annually at the annual rate of twelve percent (12%), subject to adjustments through to their&#13;maturity date. The Alpha and Brio Notes were convertible into the Company&amp;#8217;s common stock, at the option of the holder, at any time&#13;following issuance, unless the conversion or share issuance under the conversion would cause the holder to beneficially own in excess&#13;of 4.99% of the Company&amp;#8217;s common stock. The conversion price for the principal and interest, if any, in connection with voluntary&#13;conversion by the Holder shall be $1.15 per share of Common Stock, subject to adjustment as defined in the Alpha and Brio Notes. Alpha&#13;and Brio have converted $344,642 of these notes including $9,922 of interest as of December 31, 2019, leaving a balance of $187,308&lt;b&gt;.&lt;/b&gt;&#13;As of December 31, 2020, these notes have been paid off.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On August 15, 2019, the Company&#13;entered into securities purchase agreements (the &amp;#8220;August 2019 Purchase Agreements&amp;#8221;) with two accredited investor Alpha and&#13;Brio. Pursuant to the terms of the August 2019 Purchase Agreements, the Company issued and sold to the investors convertible promissory&#13;notes for the aggregate original principal amount of $1,291,000 (collectively the &amp;#8220;August 2019 Notes&amp;#8221;), and warrants to purchase&#13;up to 935,870 shares of the Company&amp;#8217;s common stock (the &amp;#8220;August 2019 Warrants&amp;#8221;). The August 2019 Notes matured on August&#13;15, 2020 and accrued interest at a rate of twelve percent (12%) per annum, subject to adjustments, prior to maturity, as defined therein.&#13;The August 2019 Notes may be converted into shares of the Company&amp;#8217;s common stock, at the discretion of the holder, at any time following&#13;issuance, unless the conversion or share issuance under the conversion would cause the holder to beneficially own shares in excess of&#13;4.99% of the Company&amp;#8217;s common stock. The conversion price for the principal and interest, if any, in connection with voluntary conversion&#13;by the investors shall be $1.15 per share of common stock, subject to adjustment as defined therein. In conjunction with the August 2019&#13;Notes, the Company issued the August 2019 Warrants with an exercise price of $1.40 per share. The fair value of August 2019 Warrants was&#13;determined to be $569,147 based on the use of Black-Scholes pricing model. The August 2019 Warrants were evaluated by management and deemed&#13;to be equity-linked awards subject to ASC 815 &lt;i&gt;Derivatives and Hedging.&lt;/i&gt; The August 2019 Notes contained an original issue discount&#13;of 20% or $215,250 which is the difference between the note&amp;#8217;s face amount of $1,111,500 and the cash proceeds received from the&#13;investors. As part of this financing, the Company paid debt issuance costs $284,070 which are placed as a contra-debt account and were&#13;amortized over the life of the loan.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On February 25, 2020, the Company&#13;entered into a Note Repayment and Warrant Amendment Agreement with Alpha and Brio, whereby the Company agreed to repay the outstanding&#13;balance of Alpha and Brio&amp;#8217;s August 2019 Notes in the amount of $1,291,000. As a result of this transaction, the Company accelerated&#13;debt discounts for warrants, issuance costs and original issue discount of $500,145, which was recognized through interest expense on&#13;the accompanying consolidated statement of operations. As of December 31, 2020 and December 31, 2019, the gross balance payable for these&#13;notes was $0 and $1,291,000, respectively. As of December 31, 2020 and December 31, 2019, the Company has cumulatively amortized $568,322&#13;and $404,393 of the debt discounts costs including debt issuance costs, original issue discount, and discount for warrants issued in connection&#13;with the debt transaction, all of which is included in interest expense on the accompanying consolidated statement of operations. As of&#13;December 31, 2020 and December 31, 2019, the net balance payable for these notes was $0 and $627,426, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On February 18, 2020, the Company&#13;entered into two purchase agreements (the &amp;#8220;C6 Purchase Agreements&amp;#8221;) for the purchase and sale of future revenue with C6 Capital,&#13;LLC (&amp;#8220;C6&amp;#8221;). Pursuant to the terms of the C6 Purchase Agreements, the Company issued and sold to C6 two loan agreements in&#13;the aggregate original principal amount of $1,020,000. These loans contain an original purchase discount of 18%, or $270,000, in total,&#13;or $135,000 per each of the two agreements. C6 paid $375,000 per loan agreement for a total of $750,000. The Company paid debt issuance&#13;costs to C6 of $7,500 per agreement, or $15,000 in total, which was placed as a contra-debt account and will be amortized over the life&#13;of the loan. The loan agreements require the Company to pay all future receipts of the Company without recourse until such time as the&#13;purchased amount has been repaid. The loan agreements require the Company to make a daily average payment of $8,094 during the term of&#13;such agreements. As of December 31, 2020, the Company has made $1,020,000 in principal payments under these loan agreements. As of December&#13;31, 2020, the gross balance payable for these loan agreements was $0, and the balance of the loan net of discounts was $0. For the year&#13;ended December 31, 2020, the Company has amortized $285,000 of debt discount through interest expense on the accompanying consolidated&#13;statement of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Beginning May 21, 2020 through&#13;May 27, 2020 the Company, issued convertible promissory notes (the &amp;#8220;May 2020 Notes&amp;#8221;) to five (5) accredited investors (each&#13;a &amp;#8220;May 2020 Investor&amp;#8221;, and collectively, the &amp;#8220;May 2020 Investors&amp;#8221;). The aggregate principal amount of the May&#13;2020 Notes is $1,000,000 for which the Company received gross proceeds of $1,000,000. The May 2020 Notes were due and payable six months&#13;from the date of issuance. The May 2020 Notes entitle each holder to 12% interest upon Maturity, or $120,000. The May 2020 Notes may be&#13;converted into shares of the Company&amp;#8217;s common stock at any time following the date of issuance at a conversion price of $2.50 per&#13;share, subject to adjustment. During the week ended November 6, 2020, all accredited investors exercised their conversion rights under&#13;the May 2020 Notes. On November 24, 2020, the Company issued an aggregate of 447,763 shares of common stock related to the Note Conversions&#13;at $2.50 per share, totaling $1,119,408.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As an inducement to enter into&#13;the transaction, the Company issued an aggregate of 133,000 shares of the Company&amp;#8217;s restricted common stock to the May 2020 Investors&#13;at a fair value of approximately $219,450, which was included in interest expense for the year ended December 31, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In June 2020, the Company and&#13;its subsidiaries received three loans in the aggregate amount of approximately $259,182 (the &amp;#8220;PPP Loan&amp;#8221;) under the new Paycheck&#13;Protection Program legislation administered by the U.S. Small Business Administration. These loans bear interest at one percent per annum&#13;(1.0%) and mature five years from the date of the first disbursement. The proceeds of the PPP Loan must be used for payroll costs, lease&#13;payments on agreements entered into before February 15, 2020 and utility payments under lease agreements entered into before February&#13;1, 2020. At least 60% of the proceeds must be used for payroll costs and certain other expenses and no more than 40% may be used on non-payroll&#13;expenses. Proceeds from the PPP Loan used by the Company for the approved expense categories may be fully forgiven by the Small Business&#13;Administration if the Company satisfies applicable employee headcount and compensation requirements. The Company currently believes that&#13;a majority of the PPP Loan proceeds will qualify for debt forgiveness; however, there can be no assurance that the Company will qualify&#13;for forgiveness from the Small Business Administration until it occurs. As at December 31, 2020, the $259,182 PPP loan proceeds are reflected&#13;on the Company&amp;#8217;s consolidated balance sheet as current liabilities, within notes payable, net.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In December 2020, the Company&#13;received proceeds of $500,000 under a short-term working capital loan with Chase Bank. The terms of the loan include a service charge&#13;of $19,950 (3.99%). The total balance of $519,950 as of December 31, 2020, included in notes payable, net, on the accompanying consolidated&#13;balance sheet, and was repaid in full in January 2021.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On July 27, 2020, the Company&#13;issued a secured convertible promissory note in the principal amount of up to $1,500,000 to an accredited investor. The Company received&#13;$600,000 in aggregate gross proceeds. Any additional advances under this note would require the approval of the lender in its sole discretion.&#13;This note accrues interest at a rate of one and one-quarter percent (1.25%) per month and carried a maturity date of January 24, 2021.&#13;The note balance of $607,500, including accrued interest of $7,500, was repaid in full on August 28, 2020 with the issuance of Series&#13;B Convertible Preferred Stock (see Note 5).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Total interest expense on notes&#13;payable, inclusive of amortization of debt discounts, amounted to $1,667,536 and $761,150 for the year ended December 31, 2020 and 2019,&#13;respectively.&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LeasesOfLessorDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 6&amp;#8211; LEASES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company primarily leases office&#13;space and other equipment using month to month terms. Conversion Labs PR utilizes office space in Puerto Rico, which is subleased from&#13;the Company&amp;#8217;s President and CEO, on a month to month basis, incurring rental expense of approximately $4,000 to $5,000 a month for&#13;this office space.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In February 2016, the FASB issued&#13;ASU 2016-02, Leases (Topic 842), which supersedes all existing guidance on accounting for leases in ASC Topic 840. ASU 2016-02 is intended&#13;to provide enhanced transparency and comparability by requiring lessees to record right-of-use assets and corresponding lease liabilities&#13;on the balance sheet. ASU 2016-02 will continue to classify leases as either finance or operating, with classification affecting the pattern&#13;of expense recognition in the statement of income. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, including&#13;interim periods within those fiscal years. We have reviewed ASC 842 and have determined the following impact on our financial statements:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 73%"&gt;&lt;font style="font-size: 10pt"&gt;Right of Use Asset&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;274,437&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Lease liability&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;285,323&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In February 2018, the Company&#13;entered into a 3-year agreement to lease office space in Huntington Beach, California beginning on March 2, 2018. The rent is payable&#13;on a monthly basis in the amount of $2,106 for the first twelve months, $2,149 for the second twelve months and $2,235 for the third twelve&#13;months; the lease expired on February 28, 2021, and was extended through February 28, 2023. A security deposit of $2,235 was paid for&#13;this lease. The Company has classified this as an operating lease and have recorded the straight-line lease expense in the accompanying&#13;statement of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In October 2021, the Company entered&#13;into a 3-year agreement to lease office space in Greenville, South Carolina beginning on October 1, 2020. The rent is payable on a monthly&#13;basis in the amount of $8,473 for the first twelve months, $8,685 for the second twelve months and $8,902 for the third twelve months;&#13;the lease expires on September 30, 2023. No security deposit was paid for the lease. The Company has classified this as an operating lease&#13;and have recorded the straight-line lease expense in the accompanying statement of operations.&lt;/p&gt;</us-gaap:LeasesOfLessorDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 7 - COMMITMENTS AND CONTINGENCIES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Royalty Agreements&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During 2016, Conversion Labs PR&#13;entered into a sole and exclusive license, royalty and advisory agreement with Pilaris Laboratories, LLC (&amp;#8220;Pilaris&amp;#8221;) relating&#13;to Pilaris&amp;#8217; PilarisMax shampoo formulation and conditioner. The term of the agreement will be the life of the US Patent held by&#13;Pilaris, ten years. As consideration for granting Conversion Labs PR this license, Pilaris will receive on quarterly basis, 10% of the&#13;net income collected by the licensed products based on the following formula: Net Income = total income &amp;#8211; cost of goods sold &amp;#8211;&#13;advertising and operating expenses directly related to the marketing of the licensed products. In addition, Conversion Labs PR shall pay&#13;Pilaris a performance fee of $50,000 on the 180-day anniversary of the agreement and an additional $50,000 performance fee on the 365-day&#13;anniversary of the agreement. For the year ended December 31, 2018, the Company capitalized the license fee in the amount of $100,000,&#13;as the purchase of the fee is deemed an asset purchase under ASC 805. In April 2017, the Company issued 43,478 shares of common stock&#13;and warrants to purchase 21,739 shares of common stock, pursuant to a subscription agreement, for the stated consideration and satisfaction&#13;of obligation to pay $50,000 on the 180-day anniversary of the execution of this agreement. As of December 31, 2020 and 2019, $0 and $0,&#13;respectively was included in accounts payable and accrued expenses in regard to this agreement, as no sales occurred.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During 2018, the Company entered&#13;into a license agreement (the &amp;#8220;Alphabet Agreement&amp;#8221;) with M.ALPHABET, LLC (&amp;#8220;Alphabet&amp;#8221;), pursuant to which Alphabet&#13;agreed to license its PURPUREX business which consists of methods and compositions developed by Alphabet for the treatment of purpura,&#13;bruising, post-procedural bruising and traumatic bruising (the &amp;#8220;Product Line&amp;#8221;). Pursuant to the license granted under the&#13;Alphabet Agreement, Conversion Labs PR obtains an exclusive license to incorporate (i) any intellectual property rights related to the&#13;Product Line and (ii) all designs, drawings, formulas, chemical compositions and specifications used or useable in the Product Line into&#13;one or more products manufactured, sold, and/or distributed by Alphabet for the treatment of purpura, bruising, post-procedural bruising&#13;and traumatic bruising and for all other fields of use or purposes (the &amp;#8220;Licensed Product(s)&amp;#8221;), and to make, have made, advertise,&#13;promote, market, sell, import, export, use, offer to sell and distribute the Licensed Product(s) throughout the world with the exception&#13;of China, Hong Kong, Japan, and Australia (the &amp;#8220;License&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company shall pay Alphabet&#13;a royalty equal to 13% of Gross Receipts (as defined in the Agreement) realized from the sales of Licensed Products. Further, so long&#13;as the Agreement is not previously terminated, the Company, also agreed to pay Alphabet $50,000 on the 120-day anniversary of the Agreement&#13;and an additional $50,000 on the 360-day anniversary of the Agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Upon execution of the Alphabet&#13;Agreement, Alphabet was granted a 10-year stock option to purchase 20,000 shares of the Company&amp;#8217;s common stock at an exercise price&#13;of $2.50. Further, if Licensed Products have gross receipts of $7,500,000 in any calendar year, the Company will grant Alphabet an option&#13;to purchase 20,000 shares of the Company&amp;#8217;s common stock at an exercise price of $2.50; (ii) if Licensed Products have gross receipts&#13;of $10,000,000 in any calendar year, the Company will grant Alphabet an additional option to purchase 20,000 shares of the Company&amp;#8217;s&#13;common stock at an exercise price of $2.50 and (iii) If Licensed Products have gross receipts of $20,000,000 in any calendar year, the&#13;Company will grant Alphabet an option to purchase 40,000 shares of the Company&amp;#8217;s common stock at an exercise price of $3.75. The&#13;likelihood of meeting these performance goals for the licensed products are remote and, therefore, the Company has not recognized any&#13;compensation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Purchase Commitments&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Many of the Company&amp;#8217;s vendors&#13;require product deposits when a purchase order is placed for goods or fulfillment services related to inventory requirements. The Company&amp;#8217;s&#13;history of product deposits with its inventory vendors, creates an implicit purchase commitment equaling the total expected product acceptance&#13;cost in excess of the product deposit. As of December 31, 2020 and December 31, 2019, the Company approximates its implicit purchase commitments&#13;to be $1.6&amp;#160; million and $300,000, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Employment and Consulting Agreements&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company has entered into various&#13;agreements with officers, directors, employees and consultants that expire in terms of one to five years. See Note 8.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Legal Matters&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In the normal course of business&#13;operations, the Company may become involved in various legal matters. As of December 31, 2020, the Company&amp;#8217;s management does not&#13;believe that there are any potential legal matters that could have an adverse effect on the Company&amp;#8217;s consolidated financial position.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 8 &amp;#8211; RELATED PARTY TRANSACTONS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Chief Executive Officer&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Conversion Labs PR utilizes office&#13;space in Puerto Rico, which is subleased from the President and CEO, and incurs expense of approximately $4,000 to $5,000 a month for&#13;this office space for which the Company and the CEO do not have a written lease agreement. Payments to JLS Ventures, an entity wholly&#13;owned by our CEO, for rent on Conversion Labs PR&amp;#8217;s Puerto Rico office space amounted to $45,000 and $52,000 for the year ended December&#13;31, 2020 and 2019, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Conversion Labs PR utilizes BV&#13;Global Fulfillment, owned by a related person of the Company&amp;#8217;s CEO to warehouse a portion of the Company&amp;#8217;s finished goods&#13;inventory and for fulfillment services. The Company pays a monthly fee of $13,000 to $16,000 for fulfillment services and reimburses BV&#13;Global Fulfillment for their direct costs associated with shipping the Company&amp;#8217;s products. As of December 31, 2020 and 2019, the&#13;Company owed BV Global Fulfillment $58,943 and $53,026, respectively, which are included in accounts payable and accrued liabilities on&#13;the accompanying consolidated balance sheets.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Promissory Note with Director&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On July 23, 2020, the Company&#13;received proceeds of $250,000 for a promissory note to a director. The promissory note is non-interest bearing and matures in July 2021.&#13;This promissory note was cancelled in exchange for 96,923 restricted shares of the Company&amp;#8217;s common stock and a common stock purchase&#13;warrant to purchase 500,000 shares of the Company&amp;#8217;s common stock at $4.65 per share as part of an Exchange Agreement dated September&#13;22, 2020. The Company issued the shares of common stock and the purchase warrant on October 7, 2020 and cancelled the note, resulting&#13;in the reduction of notes payable of $250,000 with a loss on debt settlement of $914,862 for the year ended December 31, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;font style="background-color: white"&gt;&lt;i&gt;Consulting&#13;Agreement with Chief Operating Officer&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;font style="background-color: white"&gt;On&#13;November 27, 2020&lt;/font&gt;, the Company entered into a consulting agreement (the &amp;#8220;Consulting Agreement&amp;#8221;) with JDM Investments,&#13;LLC (&amp;#8220;JDM&amp;#8221;), an entity solely owned by our COO, whereby JDM will provide consulting services in support of the Company&amp;#8217;s&#13;day-to-day call center operations. The Consulting Agreement is for a term of thirty-six months and is renewable for additional twelve&#13;month periods upon the mutual agreement of the Company and JDM. As compensation for the services, JDM will receive a monthly fee of $17,000&#13;and shall be eligible to receive a metric based performance bonus for each calendar quarter during the term of the Consulting Agreement&#13;in accordance with metrics to be mutually agreed upon by the Company and JDM.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 9 &amp;#8211; INCOME TAXES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2020, the Company&#13;has approximately $10.7 million of operating loss carryforwards for federal income tax reporting purposes that may be applied against&#13;future taxable income. Portions of the net operating loss carryforwards will begin to expire in the year 2021 if not utilized prior to&#13;that date, expiring during various year through 2038. There is no provision for income taxes because the Company has historically incurred&#13;operating losses and maintains a full valuation allowance against its net deferred tax assets. The net operating loss carryforwards could&#13;be subject to limitation in any given year in the event of a change in ownership as defined by IRC Section 382.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The valuation allowance overall&#13;increased by approximately $1,269,000 and $148,000 during the year ended 2020 and 2019, respectively. The Company has fully reserved the&#13;deferred tax asset resulting from available net operating loss carryforwards.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The income tax provision charged&#13;to continuing operations for the years ended December 31, 2020 and 2019 was as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Current:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 54%; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;U.S. federal&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;152,100&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(152,100&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;State and local&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;40,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(40,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;192,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(192,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Deferred:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;U.S. federal&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(70,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;70,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;State and local&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(70,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;70,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Provision for income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;122,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(122,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The provision for income taxes&#13;differs from the expected amount of income tax expense (benefit) determined by applying a combined U.S. federal and state (Puerto Rico)&#13;income tax rate of 25% to pretax income (loss) for the years ended December 31, 2020 and 2019 as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Computed &amp;#8220;expected&amp;#8221; tax expense (benefit)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(12,684,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(783,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Increase (decrease) in income taxes resulting from:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Permanent differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,765,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Apportionment of Puerto Rico income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,607,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;380,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Nondeductible expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;140,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;173,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Change in valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,269,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;148,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;25,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(47,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;122,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(122,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Net deferred tax liabilities consist&#13;of the following components as of December 31, 2020 and 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;Deferred tax Liability:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 62%; padding-bottom: 1.5pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;70,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;70,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;Deferred tax assets:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 5.4pt; text-indent: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Stock-based compensation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;716,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;716,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 5.4pt; text-indent: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Temporary differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;113,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;44,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 5.4pt; text-indent: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Net operating loss carryforwards&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,151,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;951,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,980,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,711,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;Less valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,980,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(1,711,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 10 &amp;#8211; SUBSEQUENT EVENTS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company has evaluated subsequent&#13;events through the date these consolidated financial statements were issued and has identified the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Appointment of Chief Digital&#13;Officer&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;On January&#13;5, 2021, the board of directors of the Company (the &amp;#8220;Board&amp;#8221;) appointed Mr. Bryant Hussey as the Company&amp;#8217;s Chief Digital&#13;Officer. In connection with the appointment, Mr. Hussey entered into an Employment Agreement (the &amp;#8220;Employment Agreement&amp;#8221;)&#13;with the Company. Pursuant to the Employment Agreement, Mr. Hussey was granted a Stock Option to purchase up to 200,000 shares of the&#13;Company&amp;#8217;s common stock, scheduled to vest in equal monthly tranches, based on the passage of time, over the 36 months following&#13;the Effective Date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Appointment of Chief Medical&#13;Officer&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;On January&#13;11, 2021, the Board appointed Dr. Anthony Puopolo as the Company&amp;#8217;s Chief Medical Officer. In connection with the appointment, Mr.&#13;Puopolo entered into an Employment Agreement. Pursuant to the Employment Agreement, Mr. Puopolo was granted a Stock Option to purchase&#13;up to 200,000 shares of the Company&amp;#8217;s common stock (the &amp;#8220;Stock Options&amp;#8221;). 5,555 of the Stock Options shall vest in equal&#13;monthly tranches, based on the passage of time, over the 30 months following the approval of the Effective Date, with the remaining 5,575&#13;Stock Options scheduled to vest on January 11, 2024.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;LegalSimpli Software Restructuring&#13;Transaction&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;Effective&#13;January 22, 2021, the Company consummated a transaction to restructure the ownership of LegalSimpli Software, LLC, a Puerto Rico limited&#13;liability company (&amp;#8220;LSS&amp;#8221;), a majority-owned subsidiary of the Company (the &amp;#8220;LSS Restructuring&amp;#8221;). To affect the&#13;LSS Restructuring the Company&amp;#8217;s wholly-owned subsidiary Conversion Labs PR LLC, a Puerto Rico limited liability company (&amp;#8220;CVLB&#13;PR&amp;#8221;) entered into a series of membership interest exchange agreements, pursuant to which, CVLB PR exchanged that certain a promissory&#13;note, dated May 8, 2019 with an outstanding balance of $375,823 (the &amp;#8220;CVLBPR Note&amp;#8221;), issued by LSS in favor of CVLB PR, for&#13;37,531 newly issued membership interests of LSS (the &amp;#8220;Exchange&amp;#8221;). Upon consummation of the Exchange the CVLBPR Note was extinguished.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;In furtherance&#13;of the LSS Restructuring, CVLB PR entered into a Membership Interest Purchase Agreement with LSS, (the &amp;#8220;CVLB PR MIPA&amp;#8221;), pursuant&#13;to which CVLB PR purchased 12,000 membership interests of LSS for an aggregate purchase price of $300,000. The CVLB PR MIPA provides that&#13;the transaction may be completed in three (3) tranches with a purchase price of $100,000 per tranche to be made at the sole discretion&#13;of CVLB PR. Payment for the first tranche of $100,000 was made upon execution of the CVLB PR MIPA. Payments for the second and third tranches&#13;are due on the 60-day anniversary and the 120-day anniversary of the Effective Date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;Concurrently,&#13;in furtherance of the LSS Restructuring, CVLB PR entered into two Membership Interest Purchase Agreements (the &amp;#8220;Founding Members&#13;MIPAs&amp;#8221;) with two founding members of LSS (the &amp;#8220;Founding Members&amp;#8221;) whereby CVLB PR purchased from the Founding Members&#13;an aggregate of 2,183 membership interests of LSS for an aggregate purchase price of $225,000.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;Following&#13;the consummation of the LSS Restructuring, CVLB PR increased its ownership of LSS from 51% to approximately 85.58% on a fully diluted&#13;basis. LSS entered into an amendment to its operating agreement (the &amp;#8220;LSS Operating Agreement Amendment&amp;#8221;) to reflect the change&#13;in ownership.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Appointment of Chief Business&#13;Officer&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;On February&#13;3, 2021, the Board appointed Corey Deutsch (&amp;#8220;Deutsch&amp;#8221;), the Company&amp;#8217;s current Head of Corporate Development, to serve&#13;as the Company&amp;#8217;s Chief Business Officer. Pursuant to the Employment Agreement, Mr. Deutsch was granted a stock option to purchase&#13;up to 200,000 shares of the Company&amp;#8217;s common stock (the &amp;#8220;Employee Stock Options&amp;#8221;). The Stock Options were to vest in&#13;equal monthly tranches, based on the passage of time, over the 36 months following the Effective Date. Upon termination of Mr. Deutsch&#13;without cause, the Company shall pay or provide to Mr. Deutsch severance pay equal to his then current monthly base salary for four months&#13;from the date of termination, during which time Mr. Deutsch shall continue to receive all employee benefits and employee benefit plans&#13;as described in the Employment Agreement. As a full-time employee of the Company, Mr. Deutsch will be eligible to participate in all of&#13;the Company&amp;#8217;s benefit programs.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Appointment of Chief Financial&#13;Officer&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;On February&#13;4, 2021, the Board appointed Mr. Marc Benathen as the Company&amp;#8217;s Chief Financial Officer.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;In connection&#13;with the Appointment, Mr. Benathen entered into an Employment Agreement with the Company. To induce Mr. Benathen to enter into the Employment&#13;Agreement, Mr. Benathen was granted a signing bonus of 15,000 restricted stock units of the Company&amp;#8217;s common stock (the &amp;#8220;RSUs&amp;#8221;).&#13;The RSU&amp;#8217;s vest in accordance with the following: (i)3,750 of the RSUs vesting on the Effective Date (ii) 3,750 RSUs on February&#13;4, 2022 (iii) 3,750 RSU&amp;#8217;s on February 4, 2023 and (iv) 3,750 RSU&amp;#8217;s on February 4, 2024. In addition to the RSU&amp;#8217;s, Mr.&#13;Benathen received stock options to purchase up to 200,000 shares of the Company&amp;#8217;s common stock. The Stock Options shall vest in&#13;equal monthly tranches, based on the passage of time, over the 36 months.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;On March&#13;18, 2021, we issued 3,750 common shares under this Employment Agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Securities Purchase Agreement&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;On February&#13;11, 2021, the Company consummated the closing of a private placement offering (the &amp;#8220;February 2021 Offering&amp;#8221;), whereby pursuant&#13;to the securities purchase agreement (the &amp;#8220;February 2021 Purchase Agreement&amp;#8221;) entered into by the Company and certain accredited&#13;investors on February 11, 2021 the Investors purchased 608,696 shares of the Company&amp;#8217;s common stock par value $0.01 per share at&#13;a purchase price of $23.00 per share for aggregate gross proceeds of $14,000,008 (the &amp;#8220;Purchase Price&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The Purchase&#13;Price was funded on the closing date and resulted in net proceeds to the Company of approximately $13.4 million after deducting fees payable&#13;to the placement agent and other estimated offering expenses payable by the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;BTIG,&#13;LLC, the Placement Agent, acted as exclusive placement agent for the February 2021 Offering and received cash compensation equal to 3%&#13;of the Purchase Price.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Registration Rights Agreement&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;On February&#13;11, 2021, in connection with the Purchase Agreement, the Company entered into a registration rights agreement with the Investors (the&#13;&amp;#8220;Registration Rights Agreement&amp;#8221;). The Registration Rights Agreement requires the Company to use its reasonable best efforts&#13;to register the resale of the Shares by the Investors on Form S-1 to be filed with the Securities and Exchange Commission (&amp;#8216;SEC&amp;#8221;),&#13;under the Securities Act of 1933, as amended (the &amp;#8220;Securities Act&amp;#8221;), within 60 business days from the Closing Date, and to&#13;use its reasonable best efforts to have such registration statement declared effective by the SEC as soon as practicable, but not later&#13;than 120 days from the Closing Date (or 150 days from the Closing Date in the event that such registration statement is subject to a full&#13;review by the SEC).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Stock Option Exercise&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;During&#13;February and March 2021, the Company issued an aggregate of approximately 660,645 shares of common stock pursuant to the cashless exercise&#13;of an outstanding stock options.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;PPP Loan Forgiveness&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;During the January, February and March 2021, the Company had a total of&#13;$125,643 of its PPP loans forgiven by the SBA.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2020, the Company&#13;has the following amounts related to intangible assets:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Intangible Assets as at:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Amortizable&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Life&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Amortizable Intangible Assets&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 45%; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Customer Relationship Asset&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,006,840&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,006,840&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;3 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Purchased Licenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;200,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;200,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;10 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Less: Accumulated amortization&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(867,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(531,388&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Total Net Amortizable Intangible Assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;339,840&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;675,452&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:InventoryNet contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">1264258</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">950059</us-gaap:InventoryNet>
    <LFMD:DeferredTaxAssetsTemporaryDifferences contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">-113000</LFMD:DeferredTaxAssetsTemporaryDifferences>
    <LFMD:DeferredTaxAssetsTemporaryDifferences contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">-44000</LFMD:DeferredTaxAssetsTemporaryDifferences>
    <us-gaap:OperatingLeasePayments contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">4533</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">6353</us-gaap:OperatingLeasePayments>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">3655822</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="AsOf2020-12-31" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="AsOf2020-12-31_us-gaap_SeriesBPreferredStockMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="AsOf2019-12-31_us-gaap_SeriesBPreferredStockMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="AsOf2019-12-31" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">4996500</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized contextRef="AsOf2020-12-31_us-gaap_SeriesBPreferredStockMember" unitRef="Shares" decimals="INF">5000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized contextRef="AsOf2019-12-31_us-gaap_SeriesBPreferredStockMember" unitRef="Shares" decimals="INF">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized contextRef="AsOf2019-12-31" unitRef="Shares" decimals="INF">5000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued contextRef="AsOf2020-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:TemporaryEquitySharesIssued contextRef="AsOf2020-12-31_us-gaap_SeriesBPreferredStockMember" unitRef="Shares" decimals="INF">3500</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued contextRef="AsOf2019-12-31_us-gaap_SeriesBPreferredStockMember" unitRef="Shares" decimals="INF">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued contextRef="AsOf2019-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="AsOf2020-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="AsOf2020-12-31_us-gaap_SeriesBPreferredStockMember" unitRef="Shares" decimals="INF">3500</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="AsOf2019-12-31_us-gaap_SeriesBPreferredStockMember" unitRef="Shares" decimals="INF">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="AsOf2019-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:TemporaryEquityLiquidationPreference contextRef="AsOf2020-12-31_us-gaap_SeriesBPreferredStockMember" unitRef="USD" decimals="0">1045</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityLiquidationPreference contextRef="AsOf2019-12-31_us-gaap_SeriesBPreferredStockMember" unitRef="USD" decimals="0">0</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:DepositsAssetsCurrent contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">816765</us-gaap:DepositsAssetsCurrent>
    <us-gaap:DepositsAssetsCurrent contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">150000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">18305000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">16000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">-70000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">66000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:StockIssued1 contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssued1 contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">900000</us-gaap:StockIssued1>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;For the year ended December 31,&#13;2020 and 2019, the Company had the following disaggregated revenue:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year Ended December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;%&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;%&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Product revenues by Brand for CVLB PR:&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 52%"&gt;&lt;font style="font-size: 10pt"&gt;Shapiro MD&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;17,289,687&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 8%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;46&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,019,956&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 8%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;72&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Innate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,041&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;49,258&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;iNR Wellness&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;247,350&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;738,965&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Scarology&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;44,332&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;51,131&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Rex MD&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;12,969,753&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;60,197&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total product revenue for CVLB PR&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;30,556,163&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;82&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,919,507&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;80&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Software revenue for LegalSimpli, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,732,747&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,539,129&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Services revenue for CVLB Media&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,943&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total Revenues, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;37,293,910&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;100&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;12,468,578&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;100&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2020 and 2019,&#13;the Company&amp;#8217;s inventory consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Finished Goods - Products&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,172,624&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;925,017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Raw materials and packaging components&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;149,115&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;37,542&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Inventory reserve&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(57,481&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(12,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total Inventory - net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,264,258&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;950,059&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify; text-indent: 35.65pt"&gt;The following table summarizes&#13;the number of shares of common stock issuable pursuant to our convertible securities that were excluded from the diluted per share calculation&#13;because the effect of including these potential shares was antidilutive even though the exercise price could be less than the average&#13;market price of the common shares:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.8pt; text-align: center"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/p&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.8pt; text-align: center"&gt;&lt;b&gt;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.8pt; text-align: center"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/p&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Series B Preferred Stock&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,076,923&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Convertible notes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,165,126&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Stock options&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,232,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,374,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,560,188&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,265,324&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Potentially dilutive securities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,869,511&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,804,451&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 73%"&gt;&lt;font style="font-size: 10pt"&gt;Right of Use Asset&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;274,437&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Lease liability&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;285,323&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The income tax provision charged&#13;to continuing operations for the years ended December 31, 2020 and 2019 was as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Current:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 54%; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;U.S. federal&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;152,100&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(152,100&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;State and local&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;40,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(40,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;192,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(192,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Deferred:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;U.S. federal&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(70,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;70,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;State and local&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(70,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;70,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Provision for income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;122,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(122,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The provision for income taxes&#13;differs from the expected amount of income tax expense (benefit) determined by applying a combined U.S. federal and state (Puerto Rico)&#13;income tax rate of 25% to pretax income (loss) for the years ended December 31, 2020 and 2019 as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Computed &amp;#8220;expected&amp;#8221; tax expense (benefit)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(12,684,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(783,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Increase (decrease) in income taxes resulting from:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Permanent differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,765,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Apportionment of Puerto Rico income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,607,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;380,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Nondeductible expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;140,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;173,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Change in valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,269,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;148,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;25,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(47,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Net deferred tax liabilities consist&#13;of the following components as of December 31, 2020 and 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;Deferred tax Liability:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 62%; padding-bottom: 1.5pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;70,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;70,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;Deferred tax assets:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 5.4pt; text-indent: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Stock-based compensation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;716,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;716,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 5.4pt; text-indent: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Temporary differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;113,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;44,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 5.4pt; text-indent: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Net operating loss carryforwards&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,151,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;951,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,980,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,711,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 5.4pt"&gt;&lt;font style="font-size: 10pt"&gt;Less valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,980,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(1,711,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;70,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <LFMD:ProceedsFromIssuanceOfPrivatePlacementNet contextRef="From2021-02-08to2021-02-11_us-gaap_SubsequentEventMember_us-gaap_PrivatePlacementMember_custom_SecuritiesPurchaseAgreementMember_custom_InvestorsMember" unitRef="USD" decimals="0">13400000</LFMD:ProceedsFromIssuanceOfPrivatePlacementNet>
    <LFMD:SubscriptionPricePerShare contextRef="AsOf2020-12-31" unitRef="USDPShares" decimals="INF">1.95</LFMD:SubscriptionPricePerShare>
    <us-gaap:PurchaseObligation contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">1600000</us-gaap:PurchaseObligation>
    <us-gaap:PurchaseObligation contextRef="AsOf2019-12-31" unitRef="USD" decimals="0">300000</us-gaap:PurchaseObligation>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2020-12-31_custom_PurchasedLicensesMember" unitRef="USD" decimals="0">200000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2020-12-31_us-gaap_CustomerRelationshipsMember" unitRef="USD" decimals="0">1007000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="AsOf2020-12-31" unitRef="USD" decimals="0">339840</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="AsOf2019-08-15_custom_SecuritiesPurchaseAgreementMember_custom_TwoAccreditedInvestorsMember" unitRef="Percent" decimals="INF">0.20</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="AsOf2020-02-18_custom_CSixPurchaseAgreementsMember_custom_CSixCapitalLLCMember" unitRef="Percent" decimals="INF">0.18</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="AsOf2020-12-31_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" unitRef="USD" decimals="0">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="AsOf2019-12-31_custom_NoteRepaymentAndWarrantAmendmentAgreementMember_custom_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" unitRef="USD" decimals="0">1291000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="AsOf2020-12-31_custom_TwoCSixPurchaseAgreementsMember_custom_CSixCapitalLLCMember" unitRef="USD" decimals="0">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment contextRef="AsOf2020-12-31_custom_TwoCSixPurchaseAgreementsMember_custom_CSixCapitalLLCMember" unitRef="USD" decimals="0">1020000</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="From2020-11-23to2020-11-24_custom_MayTwoThousandAndTwentyNotesMember" unitRef="Shares" decimals="INF">447763</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="From2020-11-23to2020-11-24" unitRef="Shares" decimals="INF">447763</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="From2021-01-20to2021-01-22_us-gaap_SubsequentEventMember_custom_CVLBPRMember" unitRef="Shares" decimals="INF">37531</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross contextRef="From2020-05-22to2020-05-27_custom_MayTwoThousandAndTwentyNotesMember_custom_SixAccreditedInvestorsMember" unitRef="Shares" decimals="INF">133000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:ProceedsFromShortTermDebt contextRef="From2020-12-01to2020-12-31_custom_WorkingCapitalLoanMember_custom_ChaseBankMember" unitRef="USD" decimals="0">500000</us-gaap:ProceedsFromShortTermDebt>
    <LFMD:ServiceCharge contextRef="From2020-12-01to2020-12-31_custom_WorkingCapitalLoanMember_custom_ChaseBankMember" unitRef="USD" decimals="0">19950</LFMD:ServiceCharge>
    <LFMD:UndesignatedPreferredStock contextRef="AsOf2020-12-31" unitRef="Shares" decimals="INF">4996500</LFMD:UndesignatedPreferredStock>
    <LFMD:NumberOfStockIssuedPreSplit contextRef="From2020-08-26to2020-08-27_custom_SeriesBConvertiblePreferredStockMember" unitRef="Shares" decimals="INF">200000</LFMD:NumberOfStockIssuedPreSplit>
    <LFMD:PreferredStockRedemptionFeatureValue contextRef="AsOf2020-12-31_custom_SecuritiesPurchaseAgreementMember_us-gaap_SeriesBPreferredStockMember" unitRef="USD" decimals="0">3500000</LFMD:PreferredStockRedemptionFeatureValue>
    <LFMD:AggregateExpenses contextRef="From2020-01-01to2020-12-31_custom_MembershipInterestPurchaseAgreementMember" unitRef="USD" decimals="0">18060000</LFMD:AggregateExpenses>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="AsOf2021-01-08_us-gaap_SubsequentEventMember_custom_TwoThousandTwentyPlanMember_srt_MaximumMember" unitRef="Shares" decimals="INF">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="From2020-11-25to2020-11-27_custom_NewChiefOperatingOfficerMember" unitRef="USD" decimals="0">1384883</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="From2020-12-06to2020-12-08_custom_AmendedCAOEmploymentAgreementMember_srt_MaximumMember" unitRef="USD" decimals="0">1497885</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="From2020-11-18to2020-11-20_custom_ChiefComplianceOfficerMember" unitRef="USD" decimals="0">1765837</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="From2020-11-25to2020-11-27_custom_NewChiefOperatingOfficerMember" unitRef="Shares" decimals="INF">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="From2020-12-06to2020-12-08_us-gaap_RestrictedStockUnitsRSUMember_custom_AmendedCAOEmploymentAgreementMember" unitRef="Shares" decimals="INF">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <LFMD:MonthlyFees contextRef="From2020-01-01to2020-12-31_custom_BVGlobalFulfillmentMember_srt_ChiefExecutiveOfficerMember_srt_MinimumMember" unitRef="USD" decimals="0">13000</LFMD:MonthlyFees>
    <LFMD:MonthlyFees contextRef="From2020-01-01to2020-12-31_custom_BVGlobalFulfillmentMember_srt_ChiefExecutiveOfficerMember_srt_MaximumMember" unitRef="USD" decimals="0">16000</LFMD:MonthlyFees>
    <LFMD:MonthlyFees contextRef="From2020-11-26to2020-11-27_custom_ConsultingAgreementMember_srt_ChiefOperatingOfficerMember" unitRef="USD" decimals="0">17000</LFMD:MonthlyFees>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Principles of Consolidation&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company evaluates the need&#13;to consolidate affiliates based on standards set forth in ASC 810 Consolidation (&amp;#8220;ASC 810&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The consolidated financial statements&#13;include the accounts of the Company and its wholly owned subsidiary, CLPR and its majority owned subsidiary, LegalSimpli. The non-controlling&#13;interest in LegalSimpli represents the 49 % equity interest held by other members of the subsidiary as of December 31, 2020 and 2019.&#13;Subsequent to year end, the Company purchased an additional 36% of LegalSimpli for a total 85%.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;All significant intercompany&#13;transactions and balances have been eliminated in consolidation.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company prepares its consolidated&#13;financial statements in conformity with accounting principles generally accepted in the United States of America which requires management&#13;to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and&#13;the reported amounts of revenues and expenses during the reporting period. Some of the more significant estimates required to be made&#13;by management include the determination of reserves for accounts receivable, returns and allowances, the valuation of inventory and stockholders&amp;#8217;&#13;equity-based transactions. Actual results could differ from those estimates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The continuing impact on business&#13;activity brought about by the Coronavirus pandemic (&amp;#8220;COVID-19&amp;#8221;) continues to evolve, globally in macro terms, and in micro&#13;terms, as such affects the Company. As a result, many of our estimates and assumptions for the year ended December 31, 2020 were subject&#13;to an increased level of judgment and may carry a higher degree of variability and volatility. In future periods, subsequent to December&#13;31, 2020, when additional information becomes available, which may differ from our current assumptions, may subject our estimates to material&#13;change in future periods.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Reclassifications&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;Certain reclassifications have been made to conform the prior year&amp;#8217;s&#13;data to the current presentation. These reclassifications have no effect on previously reported operating loss, stockholders&amp;#8217; deficit&#13;or cash flows. Given the increase in the Company&amp;#8217;s software business and to conform the Company&amp;#8217;s presentation of operating&#13;results to industry standards, the Company has changed their categories for reporting operations, as result the Company has made reclassifications&#13;to the prior year presentation in order to conform it to the current periods&amp;#8217; presentation. The reclassification includes $745,288&#13;of merchant processing fees reclassified from cost of revenues to selling and marketing expenses for the year ended December 31, 2019.&lt;/p&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Accounts Receivable&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Accounts receivable principally&#13;consist of amounts due from third-party merchant processors, who process our subscription revenues; the merchant accounts balance receivable&#13;represents the charges processed by the merchants that have not yet been deposited with the Company. The unsettled merchant receivable&#13;amount normally represents processed sale transactions from the final one to three days of the month, with collections being made by the&#13;Company within the first week of the following month. As of year end there is also a fully reserved accounts receivable for one wholesale&#13;agent relationship transaction. There will be no further wholesale agent sales in the future. Management determines the need, if any,&#13;for an allowance for future credits to be granted to customers, by regularly evaluating aggregate customer refund activity, coupled with&#13;the consideration and current economic conditions in its evaluation of an allowance for future refunds and chargebacks. As of December&#13;31, 2020 and 2019, the Company had an allowance for bad debt, attributable to the single agent relationship amounting to approximately&#13;$133,000 and $0, respectively. As of December 31, 2020 and December 31, 2019, the reserve for sales returns and allowances was approximately&#13;$349,000 and $84,000, respectively. For all periods presented, as noted above, the sales returns and allowances were recorded as contra&#13;assets in arriving at presented accounts receivable, net.&lt;/p&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Inventory&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2020 and 2019,&#13;inventory primarily consisted of finished goods related to the Company&amp;#8217;s brands included in the product revenue section of the table&#13;above. Inventory is maintained at the Company&amp;#8217;s third-party warehouse location in Wyoming and at the Amazon fulfillment center.&#13;The Company also maintains inventory at a related-party warehouse in Pennsylvania.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Inventory is valued at the lower&#13;of cost or net realizable value with cost determined on a first-in, first-out (&amp;#8220;FIFO&amp;#8221;) basis. Management compares the cost&#13;of inventory with the net realizable value and an allowance is made for writing down inventory to net realizable, if lower. As of December&#13;31, 2020 and December 31, 2019, the Company recorded an inventory reserve in the amount of $57,481 and $12,500, respectively. The increase&#13;in our inventory reserve mainly is attributable to the lack of marketability for our INR Wellness product line.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2020 and 2019,&#13;the Company&amp;#8217;s inventory consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Finished Goods - Products&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,172,624&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;925,017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Raw materials and packaging components&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;149,115&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;37,542&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Inventory reserve&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(57,481&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(12,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total Inventory - net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,264,258&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;950,059&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Intangible Assets&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Intangible assets are comprised&#13;of a customer relationship asset (with original cost of approximately $1,007,000) and a purchased license (with a cost of $200,000) with&#13;an estimated useful life of three and ten years, respectively. Intangible assets are amortized over their estimated lives using the straight-line&#13;method. Costs incurred to renew or extend the term of recognized intangible assets are capitalized and amortized over the useful life&#13;of the asset.&lt;/p&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Impairment of Long-Lived Assets&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Long-lived assets are evaluated&#13;for impairment whenever events or changes in circumstances have indicated that an asset may not be recoverable and are grouped with other&#13;assets to the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities&#13;(asset group). If the sum of the projected undiscounted cash flows (excluding interest charges) of an asset group is less than its carrying&#13;value and the fair value of an asset group is also less than its carrying value, the assets will be written down by the amount by which&#13;the carrying value of the asset group exceeded its fair value. However, the carrying amount of a finite-lived intangible asset can never&#13;be written down below its fair value. Any loss would be recognized in income from continuing operations in the period in which the determination&#13;is made.&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company files corporate federal,&#13;state and local tax returns. Conversion Labs PR and LegalSimpli file tax returns in Puerto Rico, both are limited liability companies&#13;and file separate tax returns with any tax liabilities or benefits passing through to its members.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company records current and&#13;deferred taxes in accordance with Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) 740, &amp;#8220;Accounting for Income Taxes.&amp;#8221;&#13;This ASC requires recognition of deferred tax assets and liabilities for temporary differences between tax basis of assets and liabilities&#13;and the amounts at which they are carried in the financial statements, based upon the enacted rates in effect for the year in which the&#13;differences are expected to reverse. The Company establishes a valuation allowance when necessary to reduce deferred tax assets to the&#13;amount expected to be realized. The Company periodically assesses the value of its deferred tax asset, a majority of which has been generated&#13;by a history of net operating losses and management determines the necessity for a valuation allowance. ASC 740 also provides a recognition&#13;threshold and measurement attribute for the financial statement recognition of a tax position taken or expected to be taken in a tax return.&#13;Using this guidance, a company may recognize the tax benefit from an uncertain tax position in its financial statements only if it is&#13;more likely-than-not (i.e., a likelihood of more than 50%) that the tax position will be sustained on examination by the taxing authorities,&#13;based on the technical merits of the position. The Company&amp;#8217;s tax returns for all years since December 31, 2017, remain open to audit&#13;by all related taxing authorities.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Stock-Based Compensation&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company follows the provisions&#13;of ASC 718, &amp;#8220;Share-Based Payment&amp;#8221;. Under this guidance compensation cost generally is recognized at fair value on the date&#13;of the grant and amortized over the respective vesting or service period. The fair value of options at the date of grant is estimated&#13;using the Black-Scholes option pricing model. The expected option life is derived from assumed exercise rates based upon historical exercise&#13;patterns and represents the period of time that options granted are expected to be outstanding. The expected volatility is based upon&#13;historical volatility of the Company&amp;#8217;s common shares using weekly price observations over an observation period that approximates&#13;the expected life of the options. The risk-free interest rate approximates the U.S. Treasury yield curve rate in effect at the time of&#13;grant for periods similar to the expected option life. Due to limited history of forfeitures, the Company has elected to account for forfeitures&#13;as they occur.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Many of the assumptions require&#13;significant judgment and any changes could have a material impact in the determination of stock-based compensation expense.&lt;/p&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Earnings (Loss) Per Share&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify; text-indent: 35.65pt"&gt;Basic earnings (loss)&#13;per common share is based on the weighted average number of shares outstanding during each period presented. Convertible securities, warrants&#13;and options to purchase common stock are included as common stock equivalents only when dilutive. Potential common stock equivalents are&#13;excluded from dilutive earnings per share when the effects would be antidilutive.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify; text-indent: 35.65pt"&gt;The Company follows the&#13;provisions of ASC 260, &amp;#8220;Diluted Earnings per Share&amp;#8221;. In computing diluted EPS, basic EPS is adjusted for the assumed issuance&#13;of all potentially dilutive securities. The dilutive effect of call options, warrants and share-based payment awards is calculated using&#13;the &amp;#8220;treasury stock method,&amp;#8221; which assumes that the &amp;#8220;proceeds&amp;#8221; from the exercise of these instruments are used&#13;to purchase common shares at the average market price for the period. The dilutive effect of traditional convertible debt and preferred&#13;stock is calculated using the &amp;#8220;if-converted method.&amp;#8221; Under the if-converted method, securities are assumed to be converted&#13;at the beginning of the period, and the resulting common shares are included in the denominator of the diluted EPS calculation for the&#13;entire period being presented.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify; text-indent: 35.65pt"&gt;The following table summarizes&#13;the number of shares of common stock issuable pursuant to our convertible securities that were excluded from the diluted per share calculation&#13;because the effect of including these potential shares was antidilutive even though the exercise price could be less than the average&#13;market price of the common shares:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.8pt; text-align: center"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/p&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.8pt; text-align: center"&gt;&lt;b&gt;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.8pt; text-align: center"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/p&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Series B Preferred Stock&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,076,923&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Convertible notes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,165,126&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Stock options&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,232,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,374,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,560,188&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,265,324&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Potentially dilutive securities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,869,511&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,804,451&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Fair Value of Financial Instruments&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The carrying value of the Company&amp;#8217;s&#13;financial instruments, including cash, accounts receivable, accounts payable and accrued expenses and the face amount of notes payable&#13;approximate fair value for all periods presented.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Concentrations of Risk&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company grants credit in the&#13;normal course of business to its customers. The Company periodically performs credit analysis and monitors the financial condition of&#13;its customers to reduce credit risk.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company monitors its positions&#13;with, and the credit quality of, the financial institutions with which it invests. The Company, at times, maintains balances in various&#13;operating accounts in excess of federally insured limits.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;We are dependent on certain third-party&#13;manufacturers, although we believe that other contract manufacturers could be quickly secured if any of our current manufacturers cease&#13;to perform adequately. As of December 31, 2020 and 2019, we utilized two (2) suppliers for fulfillment services, two (2) suppliers for&#13;manufacturing finished goods, one (1) supplier for packaging and bottles and one (1) supplier for labeling. For the year ended December&#13;31, 2020 and 2019, we purchased 100% of our finished goods from two (2) manufacturers.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Recently Adopted Accounting&#13;Pronouncements&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;In July&#13;2017, the FASB issued ASU No. 2017-11, &amp;#8220;Earnings Per Share (Topic 260) and Derivatives and Hedging (Topic 815)- Accounting for Certain&#13;Financial Instruments with Down Round Features&amp;#8221; (&amp;#8220;ASU 2017-11&amp;#8221;). Equity-linked instruments, such as warrants and convertible&#13;instruments, may contain down round features that result in the strike price being reduced on the basis of the pricing of future equity&#13;offerings. Under ASU 2017-11, a down round feature will no longer require a freestanding equity-linked instrument (or embedded conversion&#13;option) to be classified as a liability that is remeasured at fair value through the income statement (i.e. marked-to-market). However,&#13;other features of the equity-linked instrument (or embedded conversion option) must still be evaluated to determine whether liability&#13;or equity classification is appropriate. Equity classified instruments are not marked-to-market. For earnings per share (&amp;#8220;EPS&amp;#8221;)&#13;reporting, the ASU requires companies to recognize the effect of the down round feature only when it is triggered by treating it as a&#13;dividend and as a reduction of income available to common shareholders in basic EPS. The amendments in this ASU are effective for all&#13;entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. This standard was adopted&#13;on January 1, 2020 and did not have a material impact on the Company&amp;#8217;s financial position, results of operations or cash flows.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <LFMD:ApplicationOfNewOrRevisedAccountingStandardsNotYetAdoptedPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Application of New or Revised Accounting Standards&amp;#8212;Not&#13;Yet Adopted&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In August 2020, the FASB issued&#13;ASU 2020-06, &amp;#8220;&lt;i&gt;Debt &amp;#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &amp;#8211; Contracts&#13;in Entity&amp;#8217;s Own Equity (Subtopic 815-40); Accounting for Convertible Instruments and Contracts in an Entity&amp;#8217;s Own Equity &lt;/i&gt;(&amp;#8220;ASU&#13;2020-06&amp;#8221;)&amp;#8221;, which addresses issues identified as a result of the complexities associated with applying U.S. GAAP for certain&#13;financial instruments with characteristics of liabilities and equity. This update addresses, among other things, the number of accounting&#13;models for convertible debt instruments and convertible preferred stock, targeted improvements to the disclosures for convertible instruments&#13;and earnings-per-share (&amp;#8220;EPS&amp;#8221;) guidance and amendments to the guidance for the derivatives scope exception for contracts in&#13;an entity&amp;#8217;s own equity, as well as the related EPS guidance. This update applies to all entities that issue convertible instruments&#13;and/or contracts in an entity&amp;#8217;s own equity. This guidance is effective for financial statements issued for fiscal years beginning&#13;after December 15, 2021, and interim periods within those fiscal years. Early adoption is permitted, but no earlier than for fiscal years&#13;beginning after December 15, 2020, including interim periods within those fiscal years. FASB specified that an entity should adopt the&#13;guidance as of the beginning of its annual fiscal year, or January 1, 2021, should the Company elect to early adopt. The Company is currently&#13;evaluating the impact the adoption of ASU 2020-06 could have on the Company&amp;#8217;s financial statements and disclosures.&lt;/p&gt;</LFMD:ApplicationOfNewOrRevisedAccountingStandardsNotYetAdoptedPolicyTextBlock>
    <LFMD:OtherRecentAccountingPronouncementsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Other Recent Accounting Pronouncements&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;All other accounting standards&#13;updates that have been issued or proposed by the FASB that do not require adoption until a future date are not expected to have a material&#13;impact on the consolidated financial statements upon adoption.&lt;/p&gt;</LFMD:OtherRecentAccountingPronouncementsPolicyTextBlock>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="From2020-01-01to2020-12-31_custom_WarrantPurchaseAgreementMember" unitRef="USD" decimals="0">4743893</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation contextRef="From2020-01-01to2020-12-31_custom_ServiceBasedStockOptionsMember" unitRef="USD" decimals="0">559512</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation contextRef="From2019-01-01to2019-12-31_custom_ServiceBasedStockOptionsMember" unitRef="USD" decimals="0">76000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation contextRef="From2020-01-01to2020-12-31_custom_TwoThousandTwentyPlanMember18806859" unitRef="USD" decimals="0">341729</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation contextRef="From2019-01-01to2019-12-31_custom_TwoThousandTwentyPlanMember18807312" unitRef="USD" decimals="0">0</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <LFMD:UnamortizedExpense contextRef="AsOf2020-12-31_custom_ServiceBasedStockOptionsMember" unitRef="USD" decimals="0">1548089</LFMD:UnamortizedExpense>
    <LFMD:UnamortizedExpense contextRef="AsOf2020-12-31_custom_TwoThousandTwentyPlanMember18807765" unitRef="USD" decimals="0">5942861</LFMD:UnamortizedExpense>
    <us-gaap:SharesOutstanding contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">10680730</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">9156461</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">23433663</us-gaap:SharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">2000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">18656141</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">733215</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">731215</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">733215</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">18656141</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2020-01-01to2020-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2020-01-01to2020-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">18656141</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="From2020-01-01to2020-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <LFMD:AgreementToIssueSharesForNoncontrollingInterest contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">10000</LFMD:AgreementToIssueSharesForNoncontrollingInterest>
    <LFMD:AgreementToIssueSharesForNoncontrollingInterest contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <LFMD:AgreementToIssueSharesForNoncontrollingInterest contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">890000</LFMD:AgreementToIssueSharesForNoncontrollingInterest>
    <LFMD:AgreementToIssueSharesForNoncontrollingInterest contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-1317044</LFMD:AgreementToIssueSharesForNoncontrollingInterest>
    <LFMD:AgreementToIssueSharesForNoncontrollingInterest contextRef="From2019-01-01to2019-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <LFMD:AgreementToIssueSharesForNoncontrollingInterest contextRef="From2019-01-01to2019-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">-417044</LFMD:AgreementToIssueSharesForNoncontrollingInterest>
    <LFMD:AgreementToIssueSharesForNoncontrollingInterest contextRef="From2019-01-01to2019-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" decimals="0">417044</LFMD:AgreementToIssueSharesForNoncontrollingInterest>
    <LFMD:AgreementToIssueSharesForNoncontrollingInterestShares contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">1000000</LFMD:AgreementToIssueSharesForNoncontrollingInterestShares>
    <LFMD:AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <LFMD:AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">20825</LFMD:AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock>
    <LFMD:AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">20825</LFMD:AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock>
    <LFMD:AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <LFMD:AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock contextRef="From2019-01-01to2019-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <LFMD:AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock contextRef="From2019-01-01to2019-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">20825</LFMD:AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock>
    <LFMD:AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock contextRef="From2019-01-01to2019-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <LFMD:AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <LFMD:AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">569146</LFMD:AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt>
    <LFMD:AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">569146</LFMD:AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt>
    <LFMD:AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <LFMD:AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt contextRef="From2019-01-01to2019-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <LFMD:AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt contextRef="From2019-01-01to2019-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">569146</LFMD:AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt>
    <LFMD:AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt contextRef="From2019-01-01to2019-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">157223</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">89083</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="From2019-01-01to2019-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="From2019-01-01to2019-12-31_us-gaap_ParentMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="From2019-01-01to2019-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" decimals="0">89083</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="From2020-01-01to2020-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="From2020-01-01to2020-12-31_us-gaap_ParentMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="From2020-01-01to2020-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" decimals="0">157223</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">25000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">25000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2020-01-01to2020-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2020-01-01to2020-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">25000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2020-01-01to2020-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <LFMD:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">622763</LFMD:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <LFMD:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">3800</LFMD:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <LFMD:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">618963</LFMD:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <LFMD:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <LFMD:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="From2020-01-01to2020-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <LFMD:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="From2020-01-01to2020-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">622763</LFMD:StockIssuedDuringPeriodValueExerciseOfWarrants>
    <LFMD:StockIssuedDuringPeriodValueExerciseOfWarrants contextRef="From2020-01-01to2020-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <LFMD:StockIssuedDuringPeriodSharesExerciseOfWarrants contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">379957</LFMD:StockIssuedDuringPeriodSharesExerciseOfWarrants>
    <LFMD:CashlessExerciseOfWarrants contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <LFMD:CashlessExerciseOfWarrants contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">14726</LFMD:CashlessExerciseOfWarrants>
    <LFMD:CashlessExerciseOfWarrants contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-14726</LFMD:CashlessExerciseOfWarrants>
    <LFMD:CashlessExerciseOfWarrants contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <LFMD:CashlessExerciseOfWarrants contextRef="From2020-01-01to2020-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <LFMD:CashlessExerciseOfWarrants contextRef="From2020-01-01to2020-12-31_us-gaap_ParentMember" unitRef="USD" xsi:nil="true" />
    <LFMD:CashlessExerciseOfWarrants contextRef="From2020-01-01to2020-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <LFMD:StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <LFMD:StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">5348</LFMD:StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions>
    <LFMD:StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-5348</LFMD:StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions>
    <LFMD:StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <LFMD:StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions contextRef="From2020-01-01to2020-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <LFMD:StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions contextRef="From2020-01-01to2020-12-31_us-gaap_ParentMember" unitRef="USD" xsi:nil="true" />
    <LFMD:StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions contextRef="From2020-01-01to2020-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <LFMD:StockIssuedDuringPeriodSharesCashlessExerciseOfStockOptions contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">534774</LFMD:StockIssuedDuringPeriodSharesCashlessExerciseOfStockOptions>
    <LFMD:StockIssuedDuringPeriodValueSaleOfCommonStock contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">250000</LFMD:StockIssuedDuringPeriodValueSaleOfCommonStock>
    <LFMD:StockIssuedDuringPeriodValueSaleOfCommonStock contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">2941</LFMD:StockIssuedDuringPeriodValueSaleOfCommonStock>
    <LFMD:StockIssuedDuringPeriodValueSaleOfCommonStock contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">247059</LFMD:StockIssuedDuringPeriodValueSaleOfCommonStock>
    <LFMD:StockIssuedDuringPeriodValueSaleOfCommonStock contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <LFMD:StockIssuedDuringPeriodValueSaleOfCommonStock contextRef="From2020-01-01to2020-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <LFMD:StockIssuedDuringPeriodValueSaleOfCommonStock contextRef="From2020-01-01to2020-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">250000</LFMD:StockIssuedDuringPeriodValueSaleOfCommonStock>
    <LFMD:StockIssuedDuringPeriodValueSaleOfCommonStock contextRef="From2020-01-01to2020-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <LFMD:StockIssuedDuringPeriodSharesSaleOfCommonStock contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">294120</LFMD:StockIssuedDuringPeriodSharesSaleOfCommonStock>
    <LFMD:StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">14900220</LFMD:StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet>
    <LFMD:StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">33684</LFMD:StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet>
    <LFMD:StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">14866536</LFMD:StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet>
    <LFMD:StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <LFMD:StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet contextRef="From2020-01-01to2020-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <LFMD:StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet contextRef="From2020-01-01to2020-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">14900220</LFMD:StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet>
    <LFMD:StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet contextRef="From2020-01-01to2020-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <LFMD:StockIssuedDuringperiodSaleOfStockInPrivatePlacementNetShares contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">3368421</LFMD:StockIssuedDuringperiodSaleOfStockInPrivatePlacementNetShares>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">1119408</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">4478</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1114930</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2020-01-01to2020-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2020-01-01to2020-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">1119408</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2020-01-01to2020-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">447763</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <LFMD:StockIssuedDuringPeriodValueReverseStockSplits contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">6</LFMD:StockIssuedDuringPeriodValueReverseStockSplits>
    <LFMD:StockIssuedDuringPeriodValueReverseStockSplits contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">6</LFMD:StockIssuedDuringPeriodValueReverseStockSplits>
    <LFMD:StockIssuedDuringPeriodValueReverseStockSplits contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <LFMD:StockIssuedDuringPeriodValueReverseStockSplits contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <LFMD:StockIssuedDuringPeriodValueReverseStockSplits contextRef="From2020-01-01to2020-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <LFMD:StockIssuedDuringPeriodValueReverseStockSplits contextRef="From2020-01-01to2020-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">6</LFMD:StockIssuedDuringPeriodValueReverseStockSplits>
    <LFMD:StockIssuedDuringPeriodValueReverseStockSplits contextRef="From2020-01-01to2020-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <dei:EntityPublicFloat contextRef="AsOf2020-06-30" unitRef="USD" decimals="0">82837083</dei:EntityPublicFloat>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 5 &amp;#8211; STOCKHOLDERS&amp;#8217; EQUITY&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company has authorized the&#13;issuance of up to 100,000,000 shares of common stock, $0.01 par value, and 5,000,000 shares of preferred stock, $0.0001 par value, of&#13;which 5,000 shares are designated as Series B Convertible Preferred Stock and 4,996,500 shares of preferred stock remain undesignated.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;On October&#13;9, 2020, the Company effectuated a 1-for-5 reverse stock split (the &amp;#8220;Stock Split&amp;#8221;) of the Company&amp;#8217;s issued and outstanding&#13;shares of common stock that became effective in the market on October 14, 2020 (see Note 1). In connection with the Stock Split, the Company&#13;issued approximately 632 shares for rounding.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Series B Convertible Preferred Stock&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;On August&#13;27, 2020, the Secretary of State of the State of Delaware delivered confirmation of the effective filing of the Company&amp;#8217;s Certificate&#13;of Designations of the Series B Convertible Preferred Stock, which established 5,000 shares of the Company&amp;#8217;s Series B Preferred&#13;Stock, having such designations, rights and preferences as set forth therein (the &amp;#8220;Series B Designations&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The shares&#13;of Series B Preferred Stock have a stated value of $1,000 per share (the &amp;#8220;Series B Stated Value&amp;#8221;) and are convertible into&#13;Common Stock at the election of the holder of the Series B Preferred Stock, at a price of $3.25 per share, subject to adjustment (the&#13;&amp;#8220;Conversion Price&amp;#8221;). Each holder of Series B Preferred Stock shall be entitled to receive, with respect to each share of Series&#13;B Preferred Stock then outstanding and held by such holder, dividends at the rate of thirteen percent (13%) per annum (the &amp;#8220;&lt;u&gt;Preferred&#13;Dividends&lt;/u&gt;&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The Preferred&#13;Dividends shall accrue and be cumulative from and after the date of issuance of any share of Series B Preferred Stock on a daily basis&#13;computed on the basis of a 365-day year and compounded quarterly. The Preferred Dividends are payable only when, as, and if declared by&#13;the Board of Directors of the Company (the &amp;#8220;Board&amp;#8221;) and the Company has no obligation to pay such Preferred Dividends; &lt;u&gt;provided&lt;/u&gt;,&#13;&lt;u&gt;however&lt;/u&gt;, if the Board determines to pay any Preferred Dividends, the Company shall pay such dividends in kind in a number of additional&#13;shares of Series B Preferred Stock (the &amp;#8220;PIK Shares&amp;#8221;) equal to the quotient of (i) the aggregate amount of the Preferred Dividends&#13;being paid by the Company in respect of the shares of Series B Preferred Stock held by such holder, &lt;u&gt;divided by&lt;/u&gt; (ii) the Series&#13;B Issue Price (as defined in the Series B Designations); &lt;u&gt;provided&lt;/u&gt;, &lt;u&gt;further&lt;/u&gt;, that, at the election of the purchasers holding&#13;a majority of the shares of Series B Preferred Stock then outstanding, in their sole discretion, such Preferred Dividends shall be paid&#13;in cash or a combination of cash and PIK Shares. Notwithstanding the foregoing, the Preferred Dividends may be paid in cash at the election&#13;of the Company if, and only if, (A) the purchasers holding a majority of the shares of Series B Preferred Stock then outstanding consent&#13;in writing to the payment of any specific dividend in cash, or (B) at any time following the twenty-four (24) month anniversary of the&#13;Closing, (i) the prevailing VWAP of the Common Stock over the trailing ninety (90)-day period is equal to or greater than $15.00 per share&#13;(subject to adjustments for stock splits, stock dividends, recapitalizations, reorganizations, reclassifications, combinations, reverse&#13;stock splits or other similar events), and (ii) the average trading volume of the Common Stock over the trailing ninety (90)-day period&#13;is equal to or greater than 40,000 shares of Common Stock per day, or (C) at any time following the thirty-six (36) month anniversary&#13;of the Closing.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The holders&#13;of Series B Preferred Stock rank senior to the Common Stock with respect to payment of dividends and rights upon liquidation and will&#13;vote together with the holders of the Common Stock on an as-converted basis, subject to beneficial ownership limitations, on each matter&#13;submitted to a vote of holders of Common Stock (whether at a meeting of shareholders or by written consent). In addition, as further described&#13;in the Series B Designations, if at least 30% of the number of shares of Series B Preferred Stock sold at the Closing are outstanding,&#13;the Company will not take certain corporate actions without the affirmative vote at a meeting (or the written consent with or without&#13;a meeting) of the purchasers holding a majority of the shares of Series B Preferred Stock then outstanding.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;If at&#13;any time following the twelve (12)-month anniversary of the Closing (A) the prevailing VWAP (as defined in the Series B Designations)&#13;of the Common Stock over the trailing ninety (90)-day period is equal to or greater than $15.00 per share ($3.00 pre-split)(subject to&#13;adjustments for stock splits, stock dividends, recapitalizations, reorganizations, reclassifications, combinations, reverse stock splits&#13;or other similar events), and (B) the average trading volume of the Common Stock over the trailing ninety (90)-day period is equal to&#13;or greater than 40,000 shares (200,000 pre-split) of Common Stock per day, the Company shall have the right, but not the obligation, in&#13;its sole discretion, to elect to convert all, but not less than all, of the then-outstanding shares of Series B Preferred Stock into Common&#13;Stock by delivering written notice of such election (the &amp;#8220;Forced Conversion Notice&amp;#8221;) to the holders of the Series B Preferred&#13;Stock within ten (10) Business Days following the satisfaction of the criteria of clauses (A) and (B) above (a &amp;#8220;Forced Conversion&amp;#8221;).&#13;On the Forced Conversion Date (as defined in the Series B Designations), each share of Series B Preferred Stock shall be converted into&#13;the number of fully paid and non-assessable shares of Common Stock equal to the quotient of: (x) the sum of (1) the Series B Issue Price,&#13;&lt;u&gt;plus&lt;/u&gt; (2) any accrued but unpaid dividends on such share of Series B Preferred Stock as of immediately prior to the conversion thereof,&#13;including the Preferred Dividends, &lt;u&gt;divided by&lt;/u&gt; (y) the Conversion Price of such share of Series B Preferred Stock in effect at the&#13;time of conversion. The Forced Conversion Notice shall state (i) the number of shares of Series B Preferred Stock held by such Holder&#13;that are proposed to be converted, and (ii) the date on which such Forced Conversion shall occur, which date shall be the thirtieth (30&lt;sup&gt;th&lt;/sup&gt;)&#13;day following the date such Forced Conversion Notice is deemed given (a &amp;#8220;Forced Conversion Date&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;In the&#13;event of a Forced Conversion, a holder may elect, in its sole discretion and in lieu of the Forced Conversion, to have each then-outstanding&#13;share of Series B Preferred Stock held by such holder be redeemed by the Company (a &amp;#8220;&lt;u&gt;Forced Conversion Redemption&lt;/u&gt;&amp;#8221;)&#13;by delivering written notice to the Company (a &amp;#8220;&lt;u&gt;Forced Conversion Redemption Notice&lt;/u&gt;&amp;#8221; and the date such Holder delivers&#13;such notice to the Corporation, a &amp;#8220;&lt;u&gt;Forced Conversion Redemption Notice Date&lt;/u&gt;&amp;#8221;) prior to the Forced Conversion Date,&#13;which notice shall state (A) the number of shares of Series B Preferred Stock that are to be redeemed, (B) the date on which such Forced&#13;Conversion Redemption shall occur, which date shall be the tenth (10th) Business Day following the applicable Forced Conversion Redemption&#13;Notice Date (the &amp;#8220;&lt;u&gt;Forced Conversion Redemption Date&lt;/u&gt;&amp;#8221;) and (C) the wire instructions for the payment of the applicable&#13;amount owed to such holder. Each share of Series B Preferred Stock that is the subject of a Forced Conversion Redemption shall be redeemed&#13;by the Company in cash at a price per share equal to the sum of (1) the Series B Issue Price, &lt;u&gt;plus&lt;/u&gt; (2) any accrued but unpaid dividends&#13;on such share of Series B Preferred Stock, including the Preferred Dividends (the &amp;#8220;&lt;u&gt;Per Share Forced Conversion Redemption Price&lt;/u&gt;&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;At any&#13;time (A) after December 31, 2020, if a sufficient number of shares of Common Stock are not available to effect the conversion of the Series&#13;B Preferred Stock outstanding into Common Stock and the exercise of the Warrants, each holder shall have the right, in its sole and absolute&#13;discretion (in addition to and not to the exclusion of any remedy such holder may have at law or in equity), to require that the Company&#13;redeem (an &amp;#8220;Optional Redemption&amp;#8221;), to the fullest extent permitted by law and out of funds lawfully available therefor, all&#13;or any portion of such holder&amp;#8217;s Series B Preferred Stock then outstanding by delivering written notice thereof.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Securities Purchase Agreement&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;On August&#13;28, 2020, the Company entered into a securities purchase agreement (the &amp;#8220;Purchase Agreement&amp;#8221;) with an investor (the &amp;#8220;Investor&amp;#8221;),&#13;to purchase from the Company an aggregate of 3,500 units (the &amp;#8220;Units&amp;#8221;), at a purchase price of $1,000 per Unit, each consisting&#13;of (i) one share of Series B Convertible Preferred Stock, and (ii) a warrant to purchase 400 shares of common stock of the Company. The&#13;warrants are exercisable immediately upon issuance, have a 5 year term, an exercise price of $4.60 per share, and provide for a cashless&#13;exercise. The aggregate purchase price for the Units is $3,500,000, of which (i) $2,892,500 is being paid in cash at the closing of the&#13;transaction and (ii) $607,500, is being paid by the conversion of the outstanding principal and interest due on the Secured Convertible&#13;Promissory Note (the &amp;#8220;Note&amp;#8221;) issued by the Company to the Investor on July 27, 2020. The Purchase Agreement provides that&#13;the Investor may not sell, transfer or otherwise dispose of the Series B Preferred Stock or warrants (or the shares of Common Stock issuable&#13;thereunder) for a period of one year following the closing.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;As a&#13;result of the Purchase Agreement, the Company recorded a deemed dividend to the holders of the Series B Preferred Stock of $3,500,000&#13;for the value of the warrants and beneficial conversion feature in excess of the purchase price. Additionally, the company recorded this&#13;instrument in the mezzanine section of the accompanying consolidated balance sheet of $3,500,000 for the value of the Series B Preferred&#13;Stock redemption feature. This balance was increased by $155,822 for the 13% dividend accrued for the Series B Preferred stockholders&#13;for a balance of $3,655,822 as of December 31, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Warrant Purchase Agreement&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;Concurrently,&#13;the Company entered into a warrant purchase agreement (the &amp;#8220;Warrant Purchase Agreement&amp;#8221;) with CL1 to purchase from the Company&#13;(i) a warrant to purchase 500,000 shares of Common Stock, at an exercise price equal to the closing price of the Common Stock immediately&#13;prior of $5.20 per share (the &amp;#8220;Class A Warrant&amp;#8221;), for a purchase price of $15,000, and (ii) a warrant to purchase 250,000&#13;shares of Common Stock, at an exercise price of $5.75 per share (the &amp;#8220;Class B Warrant&amp;#8221; and, together with the Class A Warrant,&#13;the &amp;#8220;Purchased Warrants&amp;#8221;), for a purchase price of $10,000. Each of the Purchased Warrants have a five-year term. Each of&#13;the Purchase Warrants is immediately exercisable as to fifty percent (50%) of the shares issuable thereunder and the remaining fifty percent&#13;(50%) shall become exercisable on the date that is six months following the issue date of each Purchased Warrant, subject to a repurchase&#13;right in favor of the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The fair&#13;value of the Purchased Warrants was approximately $4,743,893 (which was included as part of the deemed dividend calculation above), which&#13;was determined by the Black-Scholes Pricing Model with the following assumptions: dividend yield of 0%, term of 5 years, volatility of&#13;161.4%, and risk-free rate of 0.28%.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Consulting Agreement &amp;#8211;&#13;August 2020&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;On August&#13;31, 2020, the Company entered into a consulting agreement (the &amp;#8220;CL1 Consulting Agreement&amp;#8221;) with a consultant (&amp;#8220;CL1&amp;#8221;&#13;or &amp;#8220;Consultant&amp;#8221;), to which Consultant will assist the Company with, among other things, general operations of the business,&#13;marketing and branding, and recruiting talent in connection with the Company&amp;#8217;s men&amp;#8217;s sexual health, hair loss and PDF businesses&#13;(the &amp;#8220;Services&amp;#8221;). As compensation for the Services, Consultant shall receive from the Company two warrants (&amp;#8220;Consulting&#13;Warrant 1&amp;#8221; and &amp;#8220;Consulting Warrant 2&amp;#8221; collectively, the &amp;#8220;Consulting Warrants&amp;#8221;), that entitle Consultant&#13;to purchase up to an aggregate of 750,000 of Common Stock of the Company according to the terms and conditions outlined therein, including&#13;any restrictions on exercisability. During the five-year term of Consulting Warrant 1, Consultant may purchase up to an aggregate of 500,000&#13;shares of Common Stock, at an exercise price equal to the closing price of the Common Stock immediately prior to the Closing of $5.20&#13;per share, and Consulting Warrant 1 becomes exercisable as to such shares of Common Stock in 18 equal monthly installments beginning on&#13;the date that is six months following the issue date or immediately prior to the consummation of a change of control of the Company. During&#13;the five-year term of Consulting Warrant 2, Consultant may purchase up to an aggregate of 250,000 shares of Common Stock, at an exercise&#13;price of $5.75 per share, and Consulting Warrant 2 becomes exercisable as to such shares of Common Stock on the date that is 24 months&#13;following the issue date or immediately prior to the consummation of a change of control of the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The fair value of the warrants&#13;above Consulting Warrants was approximately $4,743,893, which was determined by the Black-Scholes Pricing Model with the following assumptions:&#13;dividend yield of 0%, term of 5 years, volatility of 161.4%, and risk-free rate of 0.28%. Total amortization of the Consulting Warrants&#13;for the year ended December 31, 2020 was $790,649 and is reflected in stock-based compensation, with unamortized costs of $3,953,244 remaining&#13;at December 31, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Private Placement Offering &amp;#8211; November 2020&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On November 3, 2020, the Company&#13;consummated an initial closing of a private placement offering (the &amp;#8220;Offering&amp;#8221;), whereby pursuant to the securities purchase&#13;agreement (the &amp;#8220;Purchase Agreement&amp;#8221;) entered into by the Company and certain accredited investors on October 30, 2020 (each&#13;an &amp;#8220;Investor&amp;#8221; and collectively, the &amp;#8220;Investors&amp;#8221;) the Company sold to such Investors an aggregate of 3,044,529&#13;shares (the &amp;#8220;Shares&amp;#8221;) of the Company&amp;#8217;s common stock, par value $0.01 per share (the &amp;#8220;Common Stock&amp;#8221;), for&#13;an aggregate purchase price of approximately $14.46 million (the &amp;#8220;Purchase Price&amp;#8221;). The Purchase Price was funded on November&#13;3, 2020 (the &amp;#8220;Closing Date&amp;#8221;) and resulted in net proceeds to the Company of approximately $13.5 million.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Pursuant to the Purchase Agreement,&#13;the Company agreed, for a period of 90 days from the closing date, not to issue or enter into any agreement to issue any shares of common&#13;stock or common stock equivalents with the exception of certain exempt issuances as provided therein.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;BTIG, LLC (the &amp;#8220;Placement&#13;Agent&amp;#8221;) acted as exclusive placement agent for the Offering and received cash compensation equal to 6% of the Purchase Price and&#13;warrants to purchase 91,336 shares of the Company&amp;#8217;s common stock, at an initial exercise price of $4.75 per share, subject to adjustment&#13;for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction (the &amp;#8220;PA&#13;Warrants&amp;#8221;). The PA Warrants may be exercised on a &amp;#8220;cashless&amp;#8221; basis and will expire on November 3, 2025.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On November 19, 2020, the Company&#13;consummated the second and final closing (&amp;#8220;Final Closing&amp;#8221;) of the Offering, whereby pursuant to the Purchase Agreement entered&#13;into by the Company and an accredited investor on November 19, 2020 (the &amp;#8220;Investor&amp;#8221;) the Company sold to the Investor 323,892&#13;shares (the &amp;#8220;Shares&amp;#8221;) of the Company&amp;#8217;s common stock for a purchase price of approximately $1.54 million (the &amp;#8220;Purchase&#13;Price&amp;#8221;). The Purchase Price was funded on November 19, 2020 (the &amp;#8220;Closing Date&amp;#8221;) and resulted in net proceeds to the&#13;Company of approximately $1.4 million. The aggregate gross proceeds to the Company from the Offering was $16 million.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Pursuant to the Purchase Agreement,&#13;the Company agreed, for a period of 90 days from the closing date, not to issue or enter into any agreement to issue any shares of common&#13;stock or common stock equivalents with the exception of certain exempt issuances as provided therein.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;BTIG, LLC (the &amp;#8220;Placement&#13;Agent&amp;#8221;) acted as exclusive placement agent for the Offering and received cash compensation equal to 6% of the Purchase Price. In&#13;connection with the Final Closing the Placement Agent received warrants to purchase 9,717 shares of the Company&amp;#8217;s common stock,&#13;at an initial exercise price of $4.75 per share, subject to adjustment for any reorganization, recapitalization, non-cash dividend, stock&#13;split, reverse stock split or other similar transaction (the &amp;#8220;PA Warrants&amp;#8221;). The PA Warrants expire on November 19, 2025 and&#13;may be exercised on a &amp;#8220;cashless&amp;#8221; basis.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Convertible Promissory Notes&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;font style="background-color: white"&gt;Beginning&#13;May 21, 2020 through May 27, 2020 the Company, issued convertible promissory notes (the &amp;#8220;May 2020 Notes&amp;#8221;) to five (5) accredited&#13;investors (each a &amp;#8220;May 2020 Investor&amp;#8221;, and collectively, the &amp;#8220;May 2020 Investors&amp;#8221;). The aggregate principal amount&#13;of the May 2020 Notes is $1,000,000 for which the Company received gross proceeds of $1,000,000. The May 2020 Notes may be converted into&#13;shares of the Company&amp;#8217;s common stock at any time following the date of issuance at a conversion price of $2.50 per share, subject&#13;to adjustment. During the week ended November 6, 2020, all accredited investors agreed to convert the May 2020 Notes (the &amp;#8220;Note&#13;Conversions&amp;#8221;) pursuant to the terms therein. On November 24, 2020, the Company issued an aggregate of 447,763 shares of common stock&#13;related to the Note Conversions at $2.50 per share, resulting in the total principal and interest conversion of $1,119,408.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;font style="background-color: white"&gt;&lt;i&gt;Options&#13;and Warrants&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;font style="background-color: white"&gt;During&#13;the year ended December 31, 2020, the Company issued an aggregate of 535,600 shares of common stock related to the exercise of options&#13;for total proceeds of $302,400.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;font style="background-color: white"&gt;During&#13;the year ended December 31, 2020, the Company issued an aggregate of 534,774 shares of common stock related to cashless exercise of options.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;font style="background-color: white"&gt;During&#13;the year ended December 31, 2020, the Company issued an aggregate of 1,472,556 shares of common stock related to cashless exercise of&#13;warrants.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;font style="background-color: white"&gt;During&#13;the year ended December 31, 2019, the Company issued warrants in conjunction with stock with a value of $20,825.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;font style="background-color: white"&gt;During&#13;the year ended December 31, 2019, the Company issued warrants in conjunction with debt with a value of $569,146.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;font style="background-color: white"&gt;&lt;i&gt;Membership&#13;interest purchase agreement&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;On July&#13;31, 2019 the Company entered into a certain membership interest purchase agreement (the &amp;#8220;MIPA&amp;#8221;) by and between the Company,&#13;Conversion Labs PR, LLC (&amp;#8220;CVLB PR&amp;#8221;), a majority owned subsidiary, Taggart International Trust, an entity controlled by the&#13;Company&amp;#8217;s Chief Executive Officer, Mr. Justin Schreiber, and American Nutra Tech LLC, a company controlled by its Chief Technology&#13;and Operating Officer, Mr. Stefan Galluppi (&amp;#8220;Mr. Schreiber, Taggart International Trust, Mr. Galluppi and American Nutra Tech LLC&#13;each a &amp;#8220;Related Party&amp;#8221; and collectively, the &amp;#8220;Related Parties&amp;#8221;). Pursuant to the MIPA, the Company purchased 21.83333%&#13;of the membership interests (the &amp;#8220;Remaining Interests&amp;#8221;) of CVLB PR from the Related Parties, bringing the Company&amp;#8217;s&#13;ownership of CVLB PR to 100%.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;As consideration&#13;for the Company&amp;#8217;s purchase of the Remaining Interests from the Related Parties, Mr. Schreiber and Mr. Galluppi agreed to cancel&#13;all potential issuances of restricted stock and or options related to their employment with the Company, in exchange for the immediate&#13;issuance of 500,000 shares of the Company&amp;#8217;s restricted common stock to each of Mr. Schreiber and Mr. Galluppi (the &amp;#8220;Initial&#13;Issuances&amp;#8221;) (equal to 1,000,000 shares in the aggregate). Mr. Schreiber and Mr. Galluppi were also entitled to additional issuances&#13;pursuant to certain milestones as follows: (i) 500,000 shares of the Company&amp;#8217;s Common Stock to each of Mr. Schreiber and Mr. Galluppi&#13;(1 million shares in the aggregate) on the business day following a consecutive ninety (90) day period, during which the Company&amp;#8217;s&#13;Common Stock shall have traded at an average price per share equal to or higher than $2.50 (the &amp;#8220;First Milestone&amp;#8221;), and (ii)&#13;an additional 500,000 shares of the Company&amp;#8217;s Common Stock to each of Mr. Schreiber and Mr. Galluppi (1 million shares in the aggregate)&#13;following a consecutive ninety (90) day period during which the Common Stock shall have traded at an average price per share equal to&#13;or higher than $3.75 (the &amp;#8220;Second Milestone&amp;#8221; and, together with the First Milestones, the &amp;#8220;Milestones&amp;#8221;). Having&#13;achieved the Milestones, the Company, on December 9, 2020, issued an aggregate of 1,000,000 shares of the Company&amp;#8217;s Common Stock&#13;to each of Mr. Schreiber and Mr. Galluppi (the &amp;#8220;Milestone Shares&amp;#8221;) (2 million shares in the aggregate). The Milestone Shares&#13;are subject to the previously disclosed 180 day Lock-Up Agreement each of Mr. Schreiber and Mr. Galluppi signed on November 3, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The Company&#13;recorded an aggregate expense of $18,060,000 reflected in general and administrative expenses during the year ended December 31, 2020&#13;for the issuance of these 2,000,000 shares.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Common Stock&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Common Stock Transactions During the Year Ended&#13;December 31, 2020:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;font style="background-color: white"&gt;During&#13;the year ended December 31, 2020, the Company issued an aggregate of 2,900,000 shares of common stock related to stock issued for services&#13;totaling $18,305,000.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In September 2020, the company&#13;received aggregate proceeds of $25,000 for the sale of warrants from the Warrant Purchase Agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December&#13;31, 2020, the Company issued a total of 379,957 shares of common stock from the exercise of warrants and cash proceeds of $622,763.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;font style="background-color: white"&gt;During&#13;the year ended December 31, 2020, the Company issued an aggregate of 535,600 shares of common stock related to the exercise of options&#13;for total proceeds of $302,400.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December&#13;31, 2020, the Company issued a total of 1,472,556 shares of common stock for the cashless exercise of 2,902,631 warrants.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;font style="background-color: white"&gt;During&#13;the year ended December 31, 2020, the Company issued an aggregate of 534,774 shares of common stock related to cashless exercise of options.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In May 2020, the Company issued&#13;294,120 shares of common stock to an investor for $250,000 in cash consideration.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December&#13;31, 2020, the Company issued 2,722,187 shares of common stock for share liability of $2,181,453.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On November 24, 2020, the Company&#13;issued an aggregate of 447,763 shares of common stock related to the Note Conversions at $2.50 per share, totaling $1,119,408.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On October 7, 2020, the Company&#13;issued a noteholder, who is also a director, 96,923 common shares in connection with an Exchange Agreement dated September 22, 2020 (See&#13;Note 8). &amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Effective October 14, 2020, the&#13;Company issued an aggregate of approximately 632 shares for rounding in connection with the 1 for 5 reverse stock split.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Common Stock Transactions During the Year Ended&#13;December 31, 2019&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December&#13;31, 2019, the Company issued 304,269 shares of common stock to various third-party investors for cash proceeds of $350,001. In conjunction&#13;with one of the stock purchases, the Company issued warrants valued at $20,825 which based on the terms of the warrants, the Company has&#13;bifurcated and treated as equity. In addition to the above stock issued, the Company has issued 20,000 shares of common stock to a consultant&#13;for services rendered, which were valued at $16,000.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Noncontrolling Interest&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;For the years ended December 31,&#13;2020 and 2019, the net loss attributed to the non-controlling interest amounted to $1,877,408 and $391,055, respectively. During the year&#13;ended December 31, 2020 and 2019, the Company paid distributions to non-controlling shareholders of $157,223 and $89,083, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On April 25, 2019, the Company&#13;entered into an LLC Membership Unit purchase agreement with entities owned by the Company&amp;#8217;s Chief Executive Officer and Chief Technology&#13;Officer, and Conversion Labs PR, and simultaneously purchased the remaining 21.8% interest of Conversion Labs PR from the Company&amp;#8217;s&#13;Chief Executive officer and Chief Technology Officer. Subsequent to the agreement&amp;#8217;s closing, the Company now wholly-owns 100% of&#13;Conversion Labs PR. In order to consummate this transaction, the Company agreed to issue 1,000,000 shares of common stock based on the&#13;issuance price of $0.90 per share, equal to $900,000 to the Company&amp;#8217;s Chief Executive Officer and Chief Technology Officer. The&#13;shares were issued on August 6, 2019. The difference between the value of the stock issued and net book value of the transfer to accumulated&#13;deficit was recognized in non-controlling interest in 2019 for a charge of $417,044.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Stock Options&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;b&gt;2020 Equity Incentive&#13;Plan (the &amp;#8220;2020 Plan&amp;#8221;)&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;On January&#13;8, 2021, the Company approved the Company&amp;#8217;s 2020 Equity Incentive Plan (the &amp;#8220;2020 Plan&amp;#8221;). Approval of the 2020 Plan&#13;was included as Proposal 1 in the Company&amp;#8217;s definitive proxy statement for its Special Meeting of Shareholders filed with the Securities&#13;and Exchange Commission on December 7, 2020. The 2020 Plan provides for the issuance of up to 1,500,000 shares of the Company&amp;#8217;s&#13;common stock to the Company&amp;#8217;s employees, non-employee directors, consultants and advisors. Awards under the 2020 Plan can be granted&#13;in the form of stock options, non-qualified and incentive options, stock appreciation rights, restricted stock, and restricted stock units.&#13;The 2020 Plan will be administered by the Compensation Committee of the Company&amp;#8217;s Board of Directors.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The forms&#13;of award agreements to be used in connection with awards made under the 2020 Plan to the Company&amp;#8217;s executive officers and non-employee&#13;directors are:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Form of Non-Qualified Option Agreement (Non-Employee Director Awards)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Form of Non-Qualified Option Agreement (Employee Awards); and&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Form of Restricted Stock Award Agreement.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Previously, the Company had granted&#13;service-based stock options and performance-based stock options separate from this plan.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On January 20, 2020, the Company&#13;approved the transition of its Chief Acquisition Officer, to the role of President of LegalSimpli (&amp;#8220;President&amp;#8221;). In connection&#13;with this change in role , the Company amended that certain services agreement entered into on July 23, 2018, by and between the Company&#13;and its President, to (i) decrease the number of options to purchase the Company&amp;#8217;s common stock previously granted from 1,000,000&#13;options to 500,000 options , 130,000 of which are fully vested as of the effective date and (ii) amend the vesting schedule for the remaining&#13;370,000 performance options to include four performance metrics that, if met, each trigger the vesting of 92,500 options. As a result&#13;of amendment, the Company cancelled 500,000 service based options with an exercise price of $1.50.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December&#13;31, 2020, the Company issued an aggregate of 1,539,000 stock options to employees and advisory board members. These stock options have&#13;a contractual term of 10 years and vest in increments which fully vest the options over a two to three year period, dependent on the specific&#13;agreements&amp;#8217; terms.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Director Appointments&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;font style="background-color: white"&gt;On&#13;October 21, 2020, the Board of Directors (the &amp;#8220;Board&amp;#8221;) of the Company, appointed a new director to the Board.&lt;/font&gt; In connection&#13;with the appointment to the Board, the director shall receive a one-time grant of 20,000 shares of the Company&amp;#8217;s common stock. In&#13;addition, the new director will be eligible to participate in any duly authorized stock option plan adopted by the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;font style="background-color: white"&gt;On&#13;November 6, 2020, the Board of the Company, appointed a new director to the Board. &lt;/font&gt;In connection with the appointment to the Board,&#13;the director shall receive a one-time grant of 20,000 of the Company&amp;#8217;s common stock. In addition, the new director will be eligible&#13;to participate in any duly authorized stock option plan adopted by the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;font style="background-color: white"&gt;&lt;i&gt;Appointment&#13;of Chief Compliance Officer&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;font style="background-color: white"&gt;On&#13;November 20, 2020, the board of directors of the Company appointed a new Chief Compliance Officer and General Counsel (our &amp;#8220;CCO&amp;#8221;).&#13;In connection with the CCO appointment, our CCO entered into an employment agreement with the Company, which includes a stock options&#13;to purchase up to 200,000 shares of the Company&amp;#8217;s common stock with an aggregate value of $1,765,837. &lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;font style="background-color: white"&gt;&lt;i&gt;Appointment&#13;of Chief Operating Officer&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;font style="background-color: white"&gt;On&#13;November 27, 2020, we appointed a new Chief Operating Officer (&amp;#8220;COO&amp;#8221;). &lt;/font&gt;In connection with the appointment, our COO&#13;entered into an Employment Agreement (the &amp;#8220;Employment Agreement&amp;#8221;) with the Company. In connection with his appointment, our&#13;COO was granted was granted: (i) Stock Options (the &amp;#8220;Stock Options&amp;#8221;) to purchase up to 200,000 shares of the Company&amp;#8217;s&#13;common stock, with 35,000 of the Stock Options scheduled to vest upon the Company&amp;#8217;s shareholders approving a bona fide employee&#13;stock option plan (the &amp;#8220;Plan&amp;#8221;), and the remaining 165,000 Stock Options to vest in equal monthly tranches, based on the passage&#13;of time, over the 30 months following the approval of the Plan; and (ii) upon the approval of the Plan, a grant of 10,000 restricted stock&#13;units of the Company&amp;#8217;s common stock (the &amp;#8220;RSUs&amp;#8221;), which shall vest upon the one-year anniversary of the Amended and&#13;Restated Employment Agreement. The aggregate value of the Stock Options was $1,384,883.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;font style="background-color: white"&gt;&lt;i&gt;Appointment&#13;of Chief Acquisition Officer&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;On December&#13;8, 2020, the Company entered into an Amended and Restated Employment Agreement (the &amp;#8220;Amended CAO Employment Agreement&amp;#8221;) with&#13;the Company&amp;#8217;s current Chief Acquisition Officer, (our &amp;#8220;CAO&amp;#8221;), amending and restating in its entirety the Employment&#13;Agreement between the Company and our CAO, dated July 26, 2018. Pursuant to the Amended CAO Employment Agreement, our CAO&amp;#8217;s has&#13;been granted options to purchase up to 200,000 shares of Common Stock of the Company (the &amp;#8220;CAO Options&amp;#8221;), which shall vest&#13;at a rate of 5,555 options each month for thirty-five (35) consecutive months beginning on the Effective Date, with the final 5,575 shares&#13;vesting on December 8, 2023. The aggregate value of these options was $1,497,885.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;Additionally,&#13;under the Amended CAO Employment Agreement, our CAO is eligible to receive up to three hundred thousand (300,000) restricted stock units&#13;of the Company&amp;#8217;s common stock, par value $0.01 (the &amp;#8220;RSU&amp;#8217;s&amp;#8221;), subject to the Company&amp;#8217;s Telemedicine Brands&#13;(as defined in the Amended CAO Employment Agreement) achieving certain revenue milestones. The RSU&amp;#8217;s, if, and to the extent issued,&#13;will vest upon the earlier of a Change of Control (as defined in the Amended CAO Employment Agreement) or December 8, 2023.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following is a summary of&#13;outstanding options activity for our new 2020 Plan for the year ended December 31, 2020:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Options Outstanding Number of Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise Price per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Remaining Contractual Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Exercise Price per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Balance, December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 30%"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;839,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.80 &amp;#8211; 9.24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.54&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Cancelled/Forfeited/Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Balance at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;839,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.80 &amp;#8211; 9.24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.54&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercisable December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercisable at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;76,222&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.80 &amp;#8211; 9.24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9.77&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.74&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Total compensation expense under&#13;the above service-based option plan was approximately $341,729 and $0 for the years ended December 31, 2020 and 2019, respectively, with&#13;unamortized expense remaining of approximately $5,942,861 as of December 31, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following is a summary of&#13;outstanding service-based options activity (prior to the establishment of our 2020 Plan above) for the year ended December 31, 2020:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Options Outstanding Number of Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise Price per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Remaining Contractual Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Exercise Price per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 30%"&gt;&lt;font style="font-size: 10pt"&gt;Balance, December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,009,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.00 - 2.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.22 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;700,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.15 - 7.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.76 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.85&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(1,175,600&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.80 - 2.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.97 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Cancelled/Forfeited/Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(305,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.00 - 2.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6.52 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.54&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Balance at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,228,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.80 - 7.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.15 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercisable December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,361,083&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.00 - 2.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.76 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercisable at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,570,428&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.00 &amp;#8211; 7.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.57 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.67&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Total compensation expense under&#13;the above service-based option plan was approximately $559,512 and $76,000 for the year ended December 31, 2020 and 2019, respectively,&#13;with unamortized expense remaining of approximately $1,548,089 as of December 31, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following is a summary of&#13;outstanding performance-based options activity for the year ended December 31, 2020:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Options Outstanding Number of Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise Price per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Remaining Contractual Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Exercise Price per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 30%"&gt;&lt;font style="font-size: 10pt"&gt;Balance at December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,365,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.25 &amp;#8211; 2.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.34 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.70&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Cancelled/Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(200,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.06 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Balance at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,165,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.25 &amp;#8211; 2.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.97 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.80&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercisable December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;635,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.25 &amp;#8211; 2.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.63 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercisable at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;635,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.25 &amp;#8211; 2.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.38 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;No compensation expense was recognized&#13;on the performance-based options above for the years ended December 31, 2020 and 2019, as the performance terms have not been met or are&#13;not probable.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following is a summary of&#13;outstanding and exercisable warrants activity during the year ended December 31, 2020:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Warrants Outstanding Number of Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise Price per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Remaining Contractual Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Exercise Price per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 32%"&gt;&lt;font style="font-size: 10pt"&gt;Balance at December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,265,324&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.00 &amp;#8211; 2.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.77 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,209,596&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.65 &amp;#8211; 5.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.56 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.87&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercised/Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,924,449&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.65 &amp;#8211; 0.70&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.82 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Balance at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,550,471&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.40 &amp;#8211; 5.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.59 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.56&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercisable December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,066,049&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.00 &amp;#8211; 2.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6.24 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.55&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercisable December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,144,700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.40 &amp;#8211; 5.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.67 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.29&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;August 2020 Warrant Inducement&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During August 2020, the Company&#13;offered an inducement to all 26 warrant holders of our $2.00 strike price warrants, which total 526,846 common stock warrants outstanding,&#13;by offering a reduced exercise price of $1.75 (a $0.25 discount) for these warrants if they are immediately exercised. &lt;font style="background-color: white"&gt;For&#13;the year ended December 31, 2020, there were 379,957 of these warrants exercised, and none forfeited or adjusted. The Company accounted&#13;for the warrant inducement as a deemed dividend based on the difference in the Black-Scholes value of the warrants immediately before&#13;and immediately after the inducement. The significant assumptions used in the Company included common stock volatility of 148.49%, risk&#13;free rate of 0.14%, a weighted average term of 1.6 years and the current stock price of the Company as of the date of inducement. Based&#13;on the Black-Scholes valuation method the Company recorded a deemed dividend to additional paid in capital and retained earnings on the&#13;inducement of approximately $73,636 and received proceeds from the warrants exercised of approximately $623,000 during the year ended&#13;December 31, 2020.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Alpha Capital Anstalt (&amp;#8220;Alpha&amp;#8221;) Warrants&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On February 25, 2020, the Company&#13;and Alpha entered into a Note Repayment and Warrant Amendment Agreement (the &amp;#8220;2018 Alpha Amendment&amp;#8221;) whereby the Company agreed&#13;to (i) repay the outstanding balance of the convertible promissory note issued in favor of Alpha, effective on May 29, 2018, in the amount&#13;of $224,145, including principal and interest (the &amp;#8220;2018 Alpha Note&amp;#8221;) and (ii) amend the exercise price of the warrant (the&#13;&amp;#8220;2018 Alpha Warrant&amp;#8221;) issued to Alpha in connection with the 2018 Alpha Note on May 29, 2018. The 2018 Alpha Warrant originally&#13;provided for the purchase of up to 391,304 shares of the Company&amp;#8217;s common stock at an exercise price of $1.40 per share, none of&#13;which have been exercised as of the date of the 2018 Alpha Amendment. Pursuant to the terms of the 2018 Alpha Warrant and in connection&#13;with the 2018 Alpha Amendment, the Company revised the exercise price of the Alpha 2018 Warrant from $1.40 per share to $0.68 per share&#13;and increased the number of shares issuable under the Alpha 2018 Warrant from 391,304 to 811,594 shares.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On February 25, 2020, the Company&#13;and Alpha entered into a Note Repayment and Warrant Amendment Agreement (the &amp;#8220;2019 Alpha Amendment&amp;#8221;) whereby the Company agreed&#13;to (i) repay the outstanding balance of the convertible promissory note issued in favor of Alpha on August 15, 2019 in the amount of $520,000,&#13;including principal and interest (the &amp;#8220;August 2019 Alpha Note&amp;#8221;) and (ii) amend the exercise price of the August 2019 Warrant&#13;issued to Alpha in connection with the 2019 Alpha Note on August 15, 2019. The August 2019 Warrant issued to Alpha originally provided&#13;for the purchase of up to 365,217 shares of the Company&amp;#8217;s common stock at an exercise price of $1.40 per share, none of which have&#13;been exercised as of the date of the 2019 Alpha Amendment. Pursuant to the 2019 Alpha Amendment, Alpha has agreed to the reduction of&#13;the exercise price from $1.40 to $1.15, subject to further adjustment. As a result of the above described reduction of the exercise price&#13;and the application of certain provisions of the 2019 Alpha Warrant, the amount of shares that may be purchased upon exercise of the 2019&#13;Alpha Warrant after giving effect to the foregoing is increased to 757,488 shares of the Company&amp;#8217;s common stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On May 7, 2020, the Company agreed&#13;to further amend August 2019 Warrant issued to Alpha on August 15, 2019, as amended on February 25, 2020 (the &amp;#8220;Second Alpha Warrant&#13;Amendment&amp;#8221;). Specifically, pursuant to anti-dilution provisions contained therein, the Company agreed to amend the August 2019 Warrant&#13;issued to Alpha in order to increase the amount of shares able to be purchased thereunder by an additional 331,401 shares of the Company&amp;#8217;s&#13;common stock or an aggregate of up to 1,088,889 shares (the &amp;#8220;Alpha Warrant Shares&amp;#8221;). On the same day, Alpha exercised, on&#13;a cashless basis, all of the August 2019 Warrants issued to Alpha, as amended, resulting in the issuance of 391,466 shares of the Company&amp;#8217;s&#13;common stock to Alpha, with no effect on the Company&amp;#8217;s statement of operations. Upon Alpha&amp;#8217;s cashless exercise, the August&#13;2019 Warrants issued to Alpha are no longer in force or effect and no additional issuances will be due or owing.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As a result of the above transactions,&#13;the Company has recorded a deemed dividend to Alpha for the price adjustments of the August 2019 Warrant issued to Alpha of $915,479 which&#13;is recorded in the statement of changes in stockholder&amp;#8217;s equity as an increase in additional paid in capital and a reduction of&#13;accumulated deficit. During the month of March 2020, Alpha exercised a portion of their warrants in a cashless exercise, whereby Alpha&#13;exercised 267,223 common stock warrants to obtain 90,231 shares of common stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Brio Master Fund (&amp;#8220;Brio&amp;#8221;) Warrants&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On February 25, 2020, the Company,&#13;and Brio entered into a Warrant Amendment Agreement to amend the exercise price of the warrant issued to Brio on May 29, 2018. The Brio&#13;2018 Warrant originally provided for the purchase of up to 86,957 shares of the Company&amp;#8217;s common stock at an exercise price of $1.40&#13;per share, none of which have been issued as of the date of the 2018 Brio Warrant Amendment. Pursuant to the 2018 Brio Warrant Amendment,&#13;the Company agreed to revise the exercise price of the 2018 Brio Warrant from $1.40 per share to $0.68 per share and increased the number&#13;of shares issuable under the 2018 Brio Warrant from 86,957 to 93,398 shares.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On February 25, 2020, the Company,&#13;and Brio entered into a Note Repayment and Warrant Amendment Agreement whereby the Company agreed to (i) repay the outstanding balance&#13;of the Convertible Promissory Note issued in favor of Brio on August 15, 2019 in the amount of $162,500, including principal and interest&#13;and (ii) amend the exercise price of the warrant issued to Brio in connection with the 2019 Brio Note on August 15, 2019. The Brio 2019&#13;Warrant originally provide for the purchase of up to 114,130 shares of the Company&amp;#8217;s common stock at an exercise price of $1.40&#13;per share, none of which have been exercised as of the date of the 2019 Brio Amendment. Pursuant to the 2019 Brio Amendment, Brio has&#13;agreed to the reduction of the exercise price of $1.40 to $1.15, subject to further adjustment. As a result of the above described reduction&#13;of the exercise price and the application of certain provisions of the 2019 Brio Warrant, the amount of shares that may be purchased upon&#13;exercise of the 2019 Brio Warrant after giving effect to the foregoing is increased to 236,715 shares of the Company&amp;#8217;s common stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On May 7, 2020, the Company agreed&#13;to further amend those certain warrants issued to Brio on August 15, 2019, as amended on February 25, 2020. Specifically, pursuant to&#13;anti-dilution provisions therein, the Company agreed to amend the 2019 Brio Warrant in order to increase the amount of shares able to&#13;be purchased thereunder by an additional 103,562 shares of the Company&amp;#8217;s common stock or an aggregate of up to 340,278. On the same&#13;day, Brio exercised on a cashless basis the Brio Warrants in full resulting in the issuance of 103,562 shares of the Company&amp;#8217;s common&#13;stock to Brio with no effect on the Company&amp;#8217;s statement of operations. Upon Brio&amp;#8217;s cashless exercise, the 2019 Brio Warrants&#13;are no longer in force or effect and no additional issuances will be due or owing.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As a result of the above transactions,&#13;the Company has recorded a deemed dividend to Brio for the price adjustments of the Brio warrants of $226,906 which is recorded in the&#13;statement of changes in stockholder&amp;#8217;s equity as an increase in additional paid in capital and a reduction of accumulated deficit.&#13;During the month of March 2020, Brio exercised a portion of their warrants in a cashless exercise, whereby Alpha exercised 100,000 common&#13;stock warrants to obtain 57,547 shares of common stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Amended Consulting Agreement&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;On September&#13;29, 2020 (the &amp;#8220;Effective Date&amp;#8221;), the parties entered into an amendment to the Consulting Agreement (the &amp;#8220;Amended Consulting&#13;Agreement&amp;#8221;) with Blue Horizon Consulting, LLC (&amp;#8220;Blue Horizon&amp;#8221;) primarily to change the compensation for services provided&#13;by the Consultant. Under the Amended Consulting Agreement, Blue Horizon may receive an aggregate of up to 2,000,000 shares of the Company&amp;#8217;s&#13;common stock, subject to adjustment, upon the Company reaching certain revenue milestones. Happy Walters, a member of the Company&amp;#8217;s&#13;Board, is the sole owner of Blue Horizon. The Amended Consulting Agreement was approved by the Company&amp;#8217;s disinterested directors.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;As a&#13;result of the Amended Consulting Agreement, the Company recorded stock compensation expense of $15,900,000 during the year ended December&#13;31, 2020, representing the fair value of the 2,000,000 shares of common stock earned under the Amended Consulting Agreement during the&#13;year. No shares remain unearned under the Amended Consulting Agreement as of December 31, 2020. A total of 800,000 common shares of the&#13;total 2,000,000 shares earned were issued under the Amended Consulting Agreement on October 16, 2020, with the remaining 1,200,000 shares&#13;issued on February 24, 2021.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Stock-based Compensation&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The total stock-based compensation&#13;expense related to common stock issued for services, Service-Based Stock Options, Performance-Based Stock Options and Warrants issued&#13;for service amounted to approximately $36,961,141 and $733,215 for the year ended December 31, 2020 and 2019, respectively. Such amounts&#13;are included in general and administrative expenses in the consolidated statement of operations.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2020-01-01to2020-12-31_custom_TwoThousandTwentyPlanMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following is a summary of&#13;outstanding and exercisable warrants activity during the year ended December 31, 2020:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Warrants Outstanding Number of Shares&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise Price per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Remaining Contractual Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Exercise Price per Share&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 32%"&gt;&lt;font style="font-size: 10pt"&gt;Balance at December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,265,324&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.00 &amp;#8211; 2.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.77 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,209,596&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.65 &amp;#8211; 5.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.56 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.87&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercised/Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,924,449&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.65 &amp;#8211; 0.70&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.82 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Balance at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,550,471&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.40 &amp;#8211; 5.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.59 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.56&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercisable December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,066,049&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.00 &amp;#8211; 2.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6.24 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.55&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercisable December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,144,700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.40 &amp;#8211; 5.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.67 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.29&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Principles of Consolidation&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company evaluates the need&#13;to consolidate affiliates based on standards set forth in ASC 810 Consolidation (&amp;#8220;ASC 810&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The consolidated financial statements&#13;include the accounts of the Company and its wholly owned subsidiary, CLPR and its majority owned subsidiary, LegalSimpli. The non-controlling&#13;interest in LegalSimpli represents the 49 % equity interest held by other members of the subsidiary as of December 31, 2020 and 2019.&#13;Subsequent to year end, the Company purchased an additional 36% of LegalSimpli for a total 85%.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;All significant intercompany transactions&#13;and balances have been eliminated in consolidation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Variable Interest Entities&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company follows ASC 810-10-15&#13;guidance with respect to accounting for variable interest entities (each, a &amp;#8220;VIE&amp;#8221;). These entities do not have sufficient&#13;equity at risk to finance their activities without additional subordinated financial support from other parties or whose equity investors&#13;lack any of the characteristics of a controlling financial interest. A variable interest is an investment or other interest that will&#13;absorb portions of a VIE&amp;#8217;s expected losses or receive portions of its expected residual returns and are contractual, ownership,&#13;or pecuniary in nature and that change with changes in the fair value of the entity&amp;#8217;s net assets. A reporting entity is the primary&#13;beneficiary of a VIE and must consolidate it when that party has a variable interest, or combination of variable interests, that provides&#13;it with a controlling financial interest. A party is deemed to have a controlling financial interest if it meets both of the power and&#13;losses/benefits criteria. The power criterion is the ability to direct the activities of the VIE that most significantly impact its economic&#13;performance. The losses/benefits criterion is the obligation to absorb losses from, or right to receive benefits from, the VIE that could&#13;potentially be significant to the VIE. The VIE model requires an ongoing reconsideration of whether a reporting entity is the primary&#13;beneficiary of a VIE due to changes in facts and circumstances.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In accordance with ASC 810-10-25-37&#13;and as amended by ASU 2009-17, the Company determines whether any legal entity in which the Company becomes involved is a VIE and subject&#13;to consolidation. The Company conducts an assessment on an ongoing basis for each VIE including (1) the power to direct activities of&#13;the VIE that most significantly impact the VIE&amp;#8217;s economic performance, and (2) the obligation to absorb losses or right to receive&#13;benefits from the VIE that could potentially be significant to the VIE. As a result, the Company determined that three (3) entities were&#13;VIEs and subject to consolidation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&lt;font style="font-size: 10pt"&gt;1.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Conversion Labs Media, LLC (&amp;#8220;CVLB Media&amp;#8221;), a Puerto Rico limited liability company,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;2.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Conversion Labs Rx, LLC (&amp;#8220;CVLB Rx&amp;#8221;), a Puerto Rico limited liability company (dissolved in 2020), and&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;3.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Conversion Labs Asia Limited, a Hong Kong company (&amp;#8220;Conversion Labs Asia&amp;#8221;).&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;CVLB Media, CVLB Rx and Conversion&#13;Labs Asia are all considered immaterial as of December 31, 2020 and 2019. CVLB Rx had no activity during the year ended December 31, 2020&#13;and was dissolved during the period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company prepares its consolidated&#13;financial statements in conformity with accounting principles generally accepted in the United States of America which requires management&#13;to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and&#13;the reported amounts of revenues and expenses during the reporting period. Some of the more significant estimates required to be made&#13;by management include the determination of reserves for accounts receivable, returns and allowances, the valuation of inventory and stockholders&amp;#8217;&#13;equity-based transactions. Actual results could differ from those estimates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The continuing impact on business&#13;activity brought about by the Coronavirus pandemic (&amp;#8220;COVID-19&amp;#8221;) continues to evolve, globally in macro terms, and in micro&#13;terms, as such affects the Company. As a result, many of our estimates and assumptions for the year ended December 31, 2020 were subject&#13;to an increased level of judgment and may carry a higher degree of variability and volatility. In future periods, subsequent to December&#13;31, 2020, when additional information becomes available, which may differ from our current assumptions, may subject our estimates to material&#13;change in future periods.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Reclassifications&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Certain reclassifications have&#13;been made to conform the prior year&amp;#8217;s data to the current presentation. These reclassifications have no effect on previously reported&#13;operating loss, stockholders&amp;#8217; deficit or cash flows. Given the increase in the Company&amp;#8217;s software business and to conform&#13;the Company&amp;#8217;s presentation of operating results to industry standards, the Company has changed their categories for reporting operations,&#13;as result the Company has made reclassifications to the prior year presentation in order to conform it to the current periods&amp;#8217; presentation.&#13;The reclassification includes $745,288 of merchant processing fees reclassified from cost of revenues to selling and marketing expenses&#13;for the year ended December 31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Revenue Recognition&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company records revenue under&#13;the adoption of ASC 606 by analyzing exchanges with its customers using a five-step analysis:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&lt;font style="font-size: 10pt"&gt;1.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Identify the contract&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;2.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Identify performance obligations&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;3.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Determine the transaction price&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;4.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Allocate the transaction price&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;5.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Recognize revenue&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;For the Company&amp;#8217;s product-based&#13;contracts with customers, the Company has determined that there is one performance obligation, which is the delivery of the product; this&#13;performance obligation is transferred at a discrete point in time. The Company generally records sales of finished products once the customer&#13;places and pays for the order, with the product being simultaneously shipped by a third-party fulfillment service provider; in limited&#13;cases, title does not pass until the product reaches the customer&amp;#8217;s delivery site, in these limited cases, recognition of revenue&#13;should be deferred until that time, however the Company does not have a process to properly record the recognition of revenue if orders&#13;are not immediately shipped, and deems the impact to be immaterial. In all cases, delivery is considered to have occurred when title and&#13;risk of loss have transferred to the customer, which is usually commensurate upon shipment of the product. In the case of its product-based&#13;contracts, the Company provides a subscription sensitive service based on the recurring shipment of products and records the related revenue&#13;under the subscription agreements subsequent to receiving the monthly product order, recording the revenue at the time it fulfills the&#13;shipment obligation to the customer.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;For its product-based contracts&#13;with customers, the Company records an estimate for provisions of discounts, returns, allowances, customer rebates and other adjustments&#13;for its product shipments, and are reflected as contra revenues in arriving at reported net revenues. The Company&amp;#8217;s discounts and&#13;customer rebates are known at the time of sale, correspondingly, the Company reduces gross product sales for such discounts and customer&#13;rebates. The Company estimates customer returns and allowances based on information derived from historical transaction detail, and accounts&#13;for such provisions, as contra revenue, during the same period in which the related revenues are earned. The Company has determined that&#13;the population of its product-based contracts with customers are homogenous, supporting the ability to record estimates for returns and&#13;allowances to be applied to the entire product-based portfolio population. Customer discounts, returns and rebates on product revenues&#13;approximated $3,321,000 and $1,292,000, respectively, during the year ended December 31, 2020 and 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company, through its majority-owned&#13;subsidiary LegalSimpli, offers a subscription based service providing a suite of software applications to its subscribers, principally&#13;on a monthly subscription basis. The software suite allows the subscriber/user to convert almost any type of document to another electronic&#13;form of editable document, providing ease of editing. For these subscription-based contracts with customers, the Company offers an initial&#13;14-day trial period which is billed at $1.95, followed by a monthly subscription, or a yearly subscription to the Company&amp;#8217;s software&#13;suite dependent on the subscriber&amp;#8217;s enrollment selection. The Company has estimated that there is one product and one performance&#13;obligation that is delivered over time, as the Company allows the subscriber to access the suite of services for the time period of the&#13;subscription purchased. The Company allows the customer to cancel at any point during the billing cycle, in which case the customers subscription&#13;will not be renewed for the following month or year depending on the original subscription. The Company records the revenue over the customers&#13;subscription period for monthly and yearly subscribers or at the end of the initial 14 day service period for customers who purchased&#13;the initial subscription, as the circumstances dictate. The Company offers a discount for the monthly or yearly subscriptions being purchased,&#13;which is deducted at the time of payment at the initiation of the contract term, therefore the Contract price is fixed and determinable&#13;at the contract initiation. Monthly and annual subscriptions for the service are recorded net of the Company&amp;#8217;s known discount rates.&#13;As of December 31, 2020 and December 31, 2019, the Company has accrued contract liabilities, as deferred revenue, of approximately $917,000&#13;and $110,000, respectively, which represent obligations on in-process monthly or yearly contracts with customers and a portion attributable&#13;to the yet to be recognized initial 14-day trial period collections. Customer discounts and allowances on software revenues approximated&#13;$1,062,000 and $242,000, respectively, during the year ended December 31, 2020 and 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;For the year ended December 31,&#13;2020 and 2019, the Company had the following disaggregated revenue:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year Ended December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;%&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;%&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Product revenues by Brand for CVLB PR:&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 52%"&gt;&lt;font style="font-size: 10pt"&gt;Shapiro MD&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;17,289,687&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 8%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;46&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,019,956&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 8%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;72&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Innate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,041&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;49,258&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;iNR Wellness&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;247,350&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;738,965&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Scarology&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;44,332&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;51,131&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Rex MD&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;12,969,753&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;60,197&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total product revenue for CVLB PR&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;30,556,163&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;82&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,919,507&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;80&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Software revenue for LegalSimpli, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,732,747&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,539,129&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Services revenue for CVLB Media&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,943&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total Revenues, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;37,293,910&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;100&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;12,468,578&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;100&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Accounts Receivable&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Accounts receivable principally&#13;consist of amounts due from third-party merchant processors, who process our subscription revenues; the merchant accounts balance receivable&#13;represents the charges processed by the merchants that have not yet been deposited with the Company. The unsettled merchant receivable&#13;amount normally represents processed sale transactions from the final one to three days of the month, with collections being made by the&#13;Company within the first week of the following month. As of year end there is also a fully reserved accounts receivable for one wholesale&#13;agent relationship transaction. There will be no further wholesale agent sales in the future. Management determines the need, if any,&#13;for an allowance for future credits to be granted to customers, by regularly evaluating aggregate customer refund activity, coupled with&#13;the consideration and current economic conditions in its evaluation of an allowance for future refunds and chargebacks. As of December&#13;31, 2020 and 2019, the Company had an allowance for bad debt, attributable to the single agent relationship amounting to approximately&#13;$133,000 and $0, respectively. As of December 31, 2020 and December 31, 2019, the reserve for sales returns and allowances was approximately&#13;$349,000 and $84,000, respectively. For all periods presented, as noted above, the sales returns and allowances were recorded as contra&#13;assets in arriving at presented accounts receivable, net.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Inventory&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2020 and 2019,&#13;inventory primarily consisted of finished goods related to the Company&amp;#8217;s brands included in the product revenue section of the table&#13;above. Inventory is maintained at the Company&amp;#8217;s third-party warehouse location in Wyoming and at the Amazon fulfillment center.&#13;The Company also maintains inventory at a related-party warehouse in Pennsylvania.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Inventory is valued at the lower&#13;of cost or net realizable value with cost determined on a first-in, first-out (&amp;#8220;FIFO&amp;#8221;) basis. Management compares the cost&#13;of inventory with the net realizable value and an allowance is made for writing down inventory to net realizable, if lower. As of December&#13;31, 2020 and December 31, 2019, the Company recorded an inventory reserve in the amount of $57,481 and $12,500, respectively. The increase&#13;in our inventory reserve mainly is attributable to the lack of marketability for our INR Wellness product line.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2020 and 2019,&#13;the Company&amp;#8217;s inventory consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Finished Goods - Products&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,172,624&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;925,017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Raw materials and packaging components&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;149,115&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;37,542&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Inventory reserve&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(57,481&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(12,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total Inventory - net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,264,258&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;950,059&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Product Deposit&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Many of our vendors require deposits&#13;when a purchase order is placed for goods or fulfillment services. These deposits typically range from 10% to 33% of the total purchased&#13;amount. Our vendors include a credit memo within their final invoice, recognizing the deposit amount previously paid. As of December 31,&#13;2020, and December 31, 2019, the Company has approximately $816,765 and $150,000, respectively, of product deposits with multiple vendors&#13;for the purchase of raw materials or finished goods. The Company&amp;#8217;s history of product deposits with its inventory vendors, creates&#13;an implicit purchase commitment equaling the total expected product acceptance cost in excess of the product deposit. As of December 31,&#13;2020 and December 31, 2019, the Company approximates its implicit purchase commitments to be $1.6 million and $300,000, respectively.&#13;As of December 31, 2020, and December 31, 2019, the vast majority of these product deposits are with one vendor that manufacturers the&#13;Company&amp;#8217;s finished goods inventory for its Shapiro hair care product line.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Capitalized Software Costs&#13;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The Company&#13;capitalizes certain internal payroll costs and third-party costs related to internally developed software and amortizes these costs using&#13;the straight-line method over the estimated useful life of the software, generally three years. The Company does not sell internally developed&#13;software other than through the use of subscription service. Certain development costs not meeting the criteria for capitalization, in&#13;accordance with Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) &lt;i&gt;ASC 350-40 Internal-Use Software&lt;/i&gt;, are expensed as incurred.&#13;As of December 31, 2020 and 2019, the Company capitalized $438,136 and $0 related to internally developed software costs which is amortized&#13;over the useful life and included in development costs on our statement of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Intangible Assets&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Intangible assets are comprised&#13;of a customer relationship asset (with original cost of approximately $1,007,000) and a purchased license (with a cost of $200,000) with&#13;an estimated useful life of three and ten years, respectively. Intangible assets are amortized over their estimated lives using the straight-line&#13;method. Costs incurred to renew or extend the term of recognized intangible assets are capitalized and amortized over the useful life&#13;of the asset.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Impairment of Long-Lived Assets&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Long-lived assets are evaluated&#13;for impairment whenever events or changes in circumstances have indicated that an asset may not be recoverable and are grouped with other&#13;assets to the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities&#13;(asset group). If the sum of the projected undiscounted cash flows (excluding interest charges) of an asset group is less than its carrying&#13;value and the fair value of an asset group is also less than its carrying value, the assets will be written down by the amount by which&#13;the carrying value of the asset group exceeded its fair value. However, the carrying amount of a finite-lived intangible asset can never&#13;be written down below its fair value. Any loss would be recognized in income from continuing operations in the period in which the determination&#13;is made.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Paycheck Protection Program&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December&#13;31, 2020, the Company received aggregate loan proceeds in the amount of approximately $249,000 under the Paycheck Protection Program (&amp;#8220;PPP&amp;#8221;).&#13;The PPP, established as part of the Coronavirus Aid, Relief and Economic Security Act (&amp;#8220;CARES Act&amp;#8221;), provides for loans to&#13;qualifying businesses for amounts up to 2.5 times of the average monthly payroll expenses of the qualifying business. The loans and accrued&#13;interest are forgivable after eight weeks as long as the borrower uses the loan proceeds for eligible purposes, including payroll, benefits,&#13;rent and utilities, and maintains its payroll levels. The amount of loan forgiveness will be reduced if the borrower terminates employees&#13;or reduces salaries during the eight-week period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The unforgiven portion of the&#13;PPP loan is payable over two years at an interest rate of 1%, with a deferral of payments for the first six months. The Company intends&#13;to use the proceeds for purposes consistent with the PPP. While the Company currently believes that its use of the loan proceeds will&#13;meet the conditions for forgiveness of the loan, we cannot assure you that we will not take actions that could cause the Company to be&#13;ineligible for forgiveness of the loan, in whole or in part.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company files corporate federal,&#13;state and local tax returns. Conversion Labs PR and LegalSimpli file tax returns in Puerto Rico, both are limited liability companies&#13;and file separate tax returns with any tax liabilities or benefits passing through to its members.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company records current and&#13;deferred taxes in accordance with Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) 740, &amp;#8220;Accounting for Income Taxes.&amp;#8221;&#13;This ASC requires recognition of deferred tax assets and liabilities for temporary differences between tax basis of assets and liabilities&#13;and the amounts at which they are carried in the financial statements, based upon the enacted rates in effect for the year in which the&#13;differences are expected to reverse. The Company establishes a valuation allowance when necessary to reduce deferred tax assets to the&#13;amount expected to be realized. The Company periodically assesses the value of its deferred tax asset, a majority of which has been generated&#13;by a history of net operating losses and management determines the necessity for a valuation allowance. ASC 740 also provides a recognition&#13;threshold and measurement attribute for the financial statement recognition of a tax position taken or expected to be taken in a tax return.&#13;Using this guidance, a company may recognize the tax benefit from an uncertain tax position in its financial statements only if it is&#13;more likely-than-not (i.e., a likelihood of more than 50%) that the tax position will be sustained on examination by the taxing authorities,&#13;based on the technical merits of the position. The Company&amp;#8217;s tax returns for all years since December 31, 2017, remain open to audit&#13;by all related taxing authorities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Stock-Based Compensation&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company follows the provisions&#13;of ASC 718, &amp;#8220;Share-Based Payment&amp;#8221;. Under this guidance compensation cost generally is recognized at fair value on the date&#13;of the grant and amortized over the respective vesting or service period. The fair value of options at the date of grant is estimated&#13;using the Black-Scholes option pricing model. The expected option life is derived from assumed exercise rates based upon historical exercise&#13;patterns and represents the period of time that options granted are expected to be outstanding. The expected volatility is based upon&#13;historical volatility of the Company&amp;#8217;s common shares using weekly price observations over an observation period that approximates&#13;the expected life of the options. The risk-free interest rate approximates the U.S. Treasury yield curve rate in effect at the time of&#13;grant for periods similar to the expected option life. Due to limited history of forfeitures, the Company has elected to account for forfeitures&#13;as they occur.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Many of the assumptions require&#13;significant judgment and any changes could have a material impact in the determination of stock-based compensation expense.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Earnings (Loss) Per Share&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify; text-indent: 35.65pt"&gt;Basic earnings (loss)&#13;per common share is based on the weighted average number of shares outstanding during each period presented. Convertible securities, warrants&#13;and options to purchase common stock are included as common stock equivalents only when dilutive. Potential common stock equivalents are&#13;excluded from dilutive earnings per share when the effects would be antidilutive.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify; text-indent: 35.65pt"&gt;The Company follows the&#13;provisions of ASC 260, &amp;#8220;Diluted Earnings per Share&amp;#8221;. In computing diluted EPS, basic EPS is adjusted for the assumed issuance&#13;of all potentially dilutive securities. The dilutive effect of call options, warrants and share-based payment awards is calculated using&#13;the &amp;#8220;treasury stock method,&amp;#8221; which assumes that the &amp;#8220;proceeds&amp;#8221; from the exercise of these instruments are used&#13;to purchase common shares at the average market price for the period. The dilutive effect of traditional convertible debt and preferred&#13;stock is calculated using the &amp;#8220;if-converted method.&amp;#8221; Under the if-converted method, securities are assumed to be converted&#13;at the beginning of the period, and the resulting common shares are included in the denominator of the diluted EPS calculation for the&#13;entire period being presented.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify; text-indent: 35.65pt"&gt;The following table summarizes&#13;the number of shares of common stock issuable pursuant to our convertible securities that were excluded from the diluted per share calculation&#13;because the effect of including these potential shares was antidilutive even though the exercise price could be less than the average&#13;market price of the common shares:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.8pt; text-align: center"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/p&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.8pt; text-align: center"&gt;&lt;b&gt;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.8pt; text-align: center"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/p&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Ended&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Series B Preferred Stock&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,076,923&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Convertible notes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,165,126&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Stock options&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,232,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,374,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,560,188&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,265,324&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Potentially dilutive securities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,869,511&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,804,451&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Fair Value of Financial Instruments&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The carrying value of the Company&amp;#8217;s&#13;financial instruments, including cash, accounts receivable, accounts payable and accrued expenses and the face amount of notes payable&#13;approximate fair value for all periods presented.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Concentrations of Risk&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company grants credit in the&#13;normal course of business to its customers. The Company periodically performs credit analysis and monitors the financial condition of&#13;its customers to reduce credit risk.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company monitors its positions&#13;with, and the credit quality of, the financial institutions with which it invests. The Company, at times, maintains balances in various&#13;operating accounts in excess of federally insured limits.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;We are dependent on certain third-party&#13;manufacturers, although we believe that other contract manufacturers could be quickly secured if any of our current manufacturers cease&#13;to perform adequately. As of December 31, 2020 and 2019, we utilized two (2) suppliers for fulfillment services, two (2) suppliers for&#13;manufacturing finished goods, one (1) supplier for packaging and bottles and one (1) supplier for labeling. For the year ended December&#13;31, 2020 and 2019, we purchased 100% of our finished goods from two (2) manufacturers.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Recently Adopted Accounting&#13;Pronouncements&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;In July&#13;2017, the FASB issued ASU No. 2017-11, &amp;#8220;Earnings Per Share (Topic 260) and Derivatives and Hedging (Topic 815)- Accounting for Certain&#13;Financial Instruments with Down Round Features&amp;#8221; (&amp;#8220;ASU 2017-11&amp;#8221;). Equity-linked instruments, such as warrants and convertible&#13;instruments, may contain down round features that result in the strike price being reduced on the basis of the pricing of future equity&#13;offerings. Under ASU 2017-11, a down round feature will no longer require a freestanding equity-linked instrument (or embedded conversion&#13;option) to be classified as a liability that is remeasured at fair value through the income statement (i.e. marked-to-market). However,&#13;other features of the equity-linked instrument (or embedded conversion option) must still be evaluated to determine whether liability&#13;or equity classification is appropriate. Equity classified instruments are not marked-to-market. For earnings per share (&amp;#8220;EPS&amp;#8221;)&#13;reporting, the ASU requires companies to recognize the effect of the down round feature only when it is triggered by treating it as a&#13;dividend and as a reduction of income available to common shareholders in basic EPS. The amendments in this ASU are effective for all&#13;entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. This standard was adopted&#13;on January 1, 2020 and did not have a material impact on the Company&amp;#8217;s financial position, results of operations or cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Application of New or Revised Accounting Standards&amp;#8212;Not&#13;Yet Adopted&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In August 2020, the FASB issued&#13;ASU 2020-06, &amp;#8220;&lt;i&gt;Debt &amp;#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &amp;#8211; Contracts&#13;in Entity&amp;#8217;s Own Equity (Subtopic 815-40); Accounting for Convertible Instruments and Contracts in an Entity&amp;#8217;s Own Equity &lt;/i&gt;(&amp;#8220;ASU&#13;2020-06&amp;#8221;)&amp;#8221;, which addresses issues identified as a result of the complexities associated with applying U.S. GAAP for certain&#13;financial instruments with characteristics of liabilities and equity. This update addresses, among other things, the number of accounting&#13;models for convertible debt instruments and convertible preferred stock, targeted improvements to the disclosures for convertible instruments&#13;and earnings-per-share (&amp;#8220;EPS&amp;#8221;) guidance and amendments to the guidance for the derivatives scope exception for contracts in&#13;an entity&amp;#8217;s own equity, as well as the related EPS guidance. This update applies to all entities that issue convertible instruments&#13;and/or contracts in an entity&amp;#8217;s own equity. This guidance is effective for financial statements issued for fiscal years beginning&#13;after December 15, 2021, and interim periods within those fiscal years. Early adoption is permitted, but no earlier than for fiscal years&#13;beginning after December 15, 2020, including interim periods within those fiscal years. FASB specified that an entity should adopt the&#13;guidance as of the beginning of its annual fiscal year, or January 1, 2021, should the Company elect to early adopt. The Company is currently&#13;evaluating the impact the adoption of ASU 2020-06 could have on the Company&amp;#8217;s financial statements and disclosures.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Other Recent Accounting Pronouncements&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;All other accounting standards&#13;updates that have been issued or proposed by the FASB that do not require adoption until a future date are not expected to have a material&#13;impact on the consolidated financial statements upon adoption.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NatureOfOperations contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 1 &amp;#8211; NATURE OF THE ORGANIZATION AND BUSINESS&#13;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Corporate History&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;LifeMD, Inc. was formed in the&#13;State of Delaware on May 24, 1994, under its prior name, Immudyne, Inc. The Company changed its name to Conversion Labs, Inc. on June&#13;22, 2018 and then subsequently, on February 22, 2021, it changed its name to LifeMD, Inc. Effective February 22, 2021, the trading symbol&#13;for the Company&amp;#8217;s common stock, par value $0.01 per share on The Nasdaq Stock Market LLC changed from &amp;#8220;CVLB&amp;#8221; to &amp;#8220;LFMD&amp;#8221;.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On April 1, 2016, the original&#13;operating agreement of Immudyne PR LLC (&amp;#8220;Immudyne PR&amp;#8221;), a joint venture to market the Company&amp;#8217;s skincare products, was&#13;amended and restated and the Company increased its ownership and voting interest in Immudyne PR to 78.2%. Concurrent with the name change&#13;of the parent company to Conversion Labs, Inc., Immudyne PR was renamed to Conversion Labs PR LLC (now known as &amp;#8220;Conversion Labs&#13;PR&amp;#8221;). On April 25, 2019, the operating agreement of Conversion Labs PR was amended and restated in its entirety to increase the&#13;Company&amp;#8217;s ownership and voting interest in Conversion Labs PR to 100%.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In June 2018, the Company closed&#13;the strategic acquisition of 51% of LegalSimpli Software, LLC (&amp;#8220;LegalSimpli&amp;#8221;), a software as a service (SaaS) application&#13;for converting, editing, signing and sharing PDF documents. In addition to LegalSimpli Software&amp;#8217;s growth business model, this acquisition&#13;added deep search engine optimization and search engine marketing expertise to the Company. Effective January 22, 2021, the Company consummated&#13;a transaction to restructure the ownership of LegalSimpli (the &amp;#8220;LSS Restructuring&amp;#8221;) (See Note 10).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Nature of Business&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;LifeMD is a direct-to-patient&#13;telehealth company that provides a smarter, cost-effective and convenient way of accessing healthcare. The Company believes that the traditional&#13;model of visiting a doctor&amp;#8217;s office, receiving a physical prescription, visiting a local pharmacy, and returning to see a doctor&#13;for follow up care or prescription refills is inefficient, costly to patients, and discourages many patients from seeking much needed&#13;medical care. The U.S. healthcare system is undergoing a paradigm shift, thanks to new technologies and the emergence of direct-to-patient&#13;healthcare. Direct-to-patient telemedicine companies, like the Company, connect consumers to licensed healthcare professionals for care&#13;across numerous indications, including concierge care, men&amp;#8217;s sexual health and dermatology, among others.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company&amp;#8217;s telemedicine&#13;platform helps patients access licensed providers for diagnoses, virtual care, and prescription medications, often delivered on a recurring&#13;basis. In addition to its telemedicine offerings, it sells nutritional supplements and other over-the-counter products. Many of its products&#13;are available on a subscription or membership basis, where a patient can subscribe to receive regular shipments of prescribed medications&#13;or products. This creates convenience and often discounted pricing opportunities for patients and recurring revenue streams for it.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The Company&#13;believes that brand innovation, customer acquisition and service excellence form the heart of its business. As is exemplified with its&#13;first brand, Shapiro MD, it has built a full line of proprietary OTC products for male and female hair loss, FDA approved OTC minoxidil,&#13;an FDA-cleared medical device, and now a personalized telemedicine offering that gives consumers access to virtual medical treatment and,&#13;when appropriate, a full line of oral and topical prescription medications for hair loss. The Company&amp;#8217;s men&amp;#8217;s telemedicine&#13;brand, Rex MD, currently offers treatment for erectile dysfunction, and will soon offer treatments for additional indications present&#13;in men&amp;#8217;s health. The Company has built a platform that allows it to efficiently launch telehealth and wellness product lines wherever&#13;it determines there is a market need.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Business and Subsidiary History &lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In June 2018, Conversion Labs&#13;closed the strategic acquisition of 51% of LegalSimpli Software, LLC (&amp;#8220;LegalSimpli&amp;#8221;), a software as a service (SaaS) application&#13;for converting, editing, signing and sharing PDF documents. In addition to LegalSimpli&amp;#8217;s growth business model, this acquisition&#13;added deep search engine optimization and search engine marketing expertise to the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In early 2019, the Company had&#13;launched a service-based business under the name Conversion Labs Media LLC, which was to be used to run e-commerce marketing campaigns&#13;for other online businesses. However, this business initiative was terminated in early 2019 in order to focus on its core business as&#13;well as the expansion of our telehealth opportunities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In June 2019, a strategic joint&#13;venture with GoGoMeds.com (GoGoMeds) was formed in order to help facilitate the launch of our telemedicine business. GoGoMeds is a nationwide&#13;pharmacy licensed to dispense prescription medications directly to consumers in all 50 states and the District of Columbia. However, on&#13;August 7, 2020, the Company terminated its Strategic Partnership Agreement with GoGoMeds. The joint venture with GoGoMeds had not initiated&#13;activities, and its termination did not have an impact on the Company&amp;#8217;s operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Conversion Labs Rx, LLC (&amp;#8220;CVLB&#13;Rx&amp;#8221;), a Puerto Rico limited liability company, had no activity during the year ended December 31, 2020 and was dissolved during&#13;the period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Unless otherwise indicated, the&#13;terms &amp;#8220;Company,&amp;#8221; &amp;#8220;we,&amp;#8221; &amp;#8220;us,&amp;#8221; and &amp;#8220;our&amp;#8221; refer to LifeMD, Inc. (formerly known as Conversion&#13;Labs, Inc.), our wholly subsidiary Conversion Labs PR, LLC (formerly Immudyne PR LLC, now &amp;#8220;Conversion Labs PR&amp;#8221;), a Puerto&#13;Rico limited liability company (&amp;#8220;Conversion Labs PR&amp;#8221;, or &amp;#8220;CLPR&amp;#8221;) and our majority-owned subsidiaries LegalSimpli&#13;Software, LLC, a Puerto Rico limited liability company (&amp;#8220;LegalSimpli&amp;#8221;). Unless otherwise specified, all dollar amounts are&#13;expressed in United States dollars.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Reverse Stock Split&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;On October&#13;9, 2020, the Company filed a Certificate of Amendment to its Articles of Incorporation with the Secretary of State of Delaware (the &amp;#8220;Amendment&amp;#8221;)&#13;in order to effectuate a 1-for-5 reverse stock split of the Company&amp;#8217;s issued and outstanding shares of common stock (the &amp;#8220;Reverse&#13;Split&amp;#8221; or &amp;#8220;Split&amp;#8221;). The Reverse Split was approved by the Financial Industry Regulatory Authority (FINRA) and became&#13;effective in the market on October 14, 2020 (the &amp;#8220;Effective Date&amp;#8221;). All references to common shares and common share data&#13;in these financial statements and elsewhere in this Form 10-K as of December 31, 2020 and 2019, and for the years then ended, reflect&#13;the Reverse Stock Split.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Liquidity&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company has funded operations&#13;in the past through the sales of its products, issuance of common stock and through loans and advances from officers and directors. The&#13;Company&amp;#8217;s continued operations are dependent upon obtaining an increase in its sale volumes and the continued financial support&#13;from officers and directors, obtaining funding from third-party sources or the issuance of additional shares of common stock. See Note&#13;5 for a further discussion of the private placement offering, which closed in November 2020, yielding approximately $14.9 million in net&#13;proceeds to the Company after deduction of placement fees and other offering expenses. The Company intends to use the net proceeds to&#13;expedite growth initiatives, as well as for general corporate purposes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;On February&#13;11, 2021, the Company consummated the closing of a private placement offering (the &amp;#8220;February 2021 Offering&amp;#8221;), whereby pursuant&#13;to the securities purchase agreement (the &amp;#8220;February 2021 Purchase Agreement&amp;#8221;) entered into by the Company and certain accredited&#13;investors on February 11, 2021 the Investors purchased 608,696 shares of the Company&amp;#8217;s common stock par value $0.01 per share at&#13;a purchase price of $23.00 per share for aggregate gross proceeds of approximately 14.0 million (the &amp;#8220;Purchase Price&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The Purchase&#13;Price was funded on the closing date and resulted in net proceeds to the Company of approximately $13.4 million after deducting fees payable&#13;to the placement agent and other estimated offering expenses payable by the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Going Concern Evaluation&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying consolidated&#13;financial statements have been prepared on the basis that the Company will continue as a going concern, which assumes the realization&#13;of assets and the satisfaction of liabilities in the normal course of business. The Company prepared its financial statements for the&#13;year ended December 31, 2019 assuming the Company would continue as a going concern, with an explanatory note that the Company&amp;#8217;s&#13;significant operating losses raise substantial doubt about its ability to continue as a going concern. As of December 31, 2020, the Company&#13;has an accumulated deficit approximating $80.2 million and has experienced significant losses from its operations. Although the Company&#13;is showing significant positive revenue trends, the Company expects to incur further losses through the end of 2021. Additionally, the&#13;Company expects its burn rate of cash to continue through the first quarter of 2021; however, the Company expects this burn rate to improve&#13;in future quarters. To date, the Company has been funding operations primarily through the sale of equity in private placements. Management&#13;is unable to predict if and when we will be able to generate significant positive cash flow or achieve profitability. There can be no&#13;assurances that we will be successful in increasing revenues, improving operational efficiencies or that financing will be available or,&#13;if available, that such financing will be available under favorable terms.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company has a current cash&#13;balance of approximately $12 million as of the filing date, which includes the $13.4 million of net proceeds from the February 2021 Offering&#13;noted above. Based on the Company&amp;#8217;s projected cash requirements, management estimates that it will utilize approximately $10 million&#13;through the next 12 months from the filing date of this report. The Company reviewed its forecasted operating results and uses and sources&#13;of cash used in management&amp;#8217;s assessment, which included the available financing, consideration of positive and negative evidence&#13;impacting management&amp;#8217;s forecasts, market and industry factors. Positive indicators that lead to its conclusion that it will have&#13;sufficient cash over the next 12 months following the date of this report include (1) its continued strengthening of our revenues and&#13;improvement of operational efficiencies across the business, (2) the expected improvement in its cash burn rate in the first quarter of&#13;2021 and over the next 12 months, (3) overall investor interest in its equity securities which it believes will enable it to successfully&#13;complete future capital raises and (4) the overall market value of the telemedicine industry and how it believes that will continue to&#13;drive interest in the Company.&lt;/p&gt;</us-gaap:NatureOfOperations>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">1164862</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">969</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1163893</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="From2020-01-01to2020-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="From2020-01-01to2020-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">1164862</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="From2020-01-01to2020-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">96923</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:DividendsPreferredStockCash contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsPreferredStockCash contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsPreferredStockCash contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">3500000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-3500000</us-gaap:DividendsPreferredStockCash>
    <us-gaap:DividendsPreferredStockCash contextRef="From2020-01-01to2020-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsPreferredStockCash contextRef="From2020-01-01to2020-12-31_us-gaap_ParentMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsPreferredStockCash contextRef="From2020-01-01to2020-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1216021</us-gaap:WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount>
    <us-gaap:WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-1216021</us-gaap:WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount>
    <us-gaap:WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount contextRef="From2020-01-01to2020-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount contextRef="From2020-01-01to2020-12-31_us-gaap_ParentMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount contextRef="From2020-01-01to2020-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:LiabilitiesAssumed1 contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">76348</us-gaap:LiabilitiesAssumed1>
    <us-gaap:NotesIssued1 contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">219450</us-gaap:NotesIssued1>
    <us-gaap:NotesIssued1 contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:NotesReduction contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">1119408</us-gaap:NotesReduction>
    <us-gaap:NotesReduction contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:TransferToInvestments contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">607500</us-gaap:TransferToInvestments>
    <us-gaap:TransferToInvestments contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:TransferOfLoansHeldForSaleToPortfolioLoans1 contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">250000</us-gaap:TransferOfLoansHeldForSaleToPortfolioLoans1>
    <us-gaap:TransferOfLoansHeldForSaleToPortfolioLoans1 contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CapitalLeaseObligationsIncurred contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">285323</us-gaap:CapitalLeaseObligationsIncurred>
    <us-gaap:CapitalLeaseObligationsIncurred contextRef="From2019-01-01to2019-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Revenue Recognition&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company records revenue under&#13;the adoption of ASC 606 by analyzing exchanges with its customers using a five-step analysis:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&lt;font style="font-size: 10pt"&gt;1.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Identify the contract&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;2.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Identify performance obligations&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;3.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Determine the transaction price&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;4.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Allocate the transaction price&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;5.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Recognize revenue&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;For the Company&amp;#8217;s product-based&#13;contracts with customers, the Company has determined that there is one performance obligation, which is the delivery of the product; this&#13;performance obligation is transferred at a discrete point in time. The Company generally records sales of finished products once the customer&#13;places and pays for the order, with the product being simultaneously shipped by a third-party fulfillment service provider; in limited&#13;cases, title does not pass until the product reaches the customer&amp;#8217;s delivery site, in these limited cases, recognition of revenue&#13;should be deferred until that time, however the Company does not have a process to properly record the recognition of revenue if orders&#13;are not immediately shipped, and deems the impact to be immaterial. In all cases, delivery is considered to have occurred when title and&#13;risk of loss have transferred to the customer, which is usually commensurate upon shipment of the product. In the case of its product-based&#13;contracts, the Company provides a subscription sensitive service based on the recurring shipment of products and records the related revenue&#13;under the subscription agreements subsequent to receiving the monthly product order, recording the revenue at the time it fulfills the&#13;shipment obligation to the customer.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;For its product-based contracts&#13;with customers, the Company records an estimate for provisions of discounts, returns, allowances, customer rebates and other adjustments&#13;for its product shipments, and are reflected as contra revenues in arriving at reported net revenues. The Company&amp;#8217;s discounts and&#13;customer rebates are known at the time of sale, correspondingly, the Company reduces gross product sales for such discounts and customer&#13;rebates. The Company estimates customer returns and allowances based on information derived from historical transaction detail, and accounts&#13;for such provisions, as contra revenue, during the same period in which the related revenues are earned. The Company has determined that&#13;the population of its product-based contracts with customers are homogenous, supporting the ability to record estimates for returns and&#13;allowances to be applied to the entire product-based portfolio population. Customer discounts, returns and rebates on product revenues&#13;approximated $3,321,000 and $1,292,000, respectively, during the year ended December 31, 2020 and 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company, through its majority-owned&#13;subsidiary LegalSimpli, offers a subscription based service providing a suite of software applications to its subscribers, principally&#13;on a monthly subscription basis. The software suite allows the subscriber/user to convert almost any type of document to another electronic&#13;form of editable document, providing ease of editing. For these subscription-based contracts with customers, the Company offers an initial&#13;14-day trial period which is billed at $1.95, followed by a monthly subscription, or a yearly subscription to the Company&amp;#8217;s software&#13;suite dependent on the subscriber&amp;#8217;s enrollment selection. The Company has estimated that there is one product and one performance&#13;obligation that is delivered over time, as the Company allows the subscriber to access the suite of services for the time period of the&#13;subscription purchased. The Company allows the customer to cancel at any point during the billing cycle, in which case the customers subscription&#13;will not be renewed for the following month or year depending on the original subscription. The Company records the revenue over the customers&#13;subscription period for monthly and yearly subscribers or at the end of the initial 14 day service period for customers who purchased&#13;the initial subscription, as the circumstances dictate. The Company offers a discount for the monthly or yearly subscriptions being purchased,&#13;which is deducted at the time of payment at the initiation of the contract term, therefore the Contract price is fixed and determinable&#13;at the contract initiation. Monthly and annual subscriptions for the service are recorded net of the Company&amp;#8217;s known discount rates.&#13;As of December 31, 2020 and December 31, 2019, the Company has accrued contract liabilities, as deferred revenue, of approximately $917,000&#13;and $110,000, respectively, which represent obligations on in-process monthly or yearly contracts with customers and a portion attributable&#13;to the yet to be recognized initial 14-day trial period collections. Customer discounts and allowances on software revenues approximated&#13;$1,062,000 and $242,000, respectively, during the year ended December 31, 2020 and 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;For the year ended December 31,&#13;2020 and 2019, the Company had the following disaggregated revenue:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year Ended December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;%&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;%&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Product revenues by Brand for CVLB PR:&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 52%"&gt;&lt;font style="font-size: 10pt"&gt;Shapiro MD&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;17,289,687&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 8%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;46&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,019,956&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 8%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;72&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Innate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,041&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;49,258&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;iNR Wellness&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;247,350&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;738,965&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Scarology&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;44,332&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;51,131&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Rex MD&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;12,969,753&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;35&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;60,197&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total product revenue for CVLB PR&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;30,556,163&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;82&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,919,507&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;80&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Software revenue for LegalSimpli, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,732,747&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,539,129&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;20&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Services revenue for CVLB Media&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,943&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total Revenues, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;37,293,910&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;100&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;12,468,578&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;100&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Product Deposit&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Many of our vendors require deposits&#13;when a purchase order is placed for goods or fulfillment services. These deposits typically range from 10% to 33% of the total purchased&#13;amount. Our vendors include a credit memo within their final invoice, recognizing the deposit amount previously paid. As of December 31,&#13;2020, and December 31, 2019, the Company has approximately $816,765 and $150,000, respectively, of product deposits with multiple vendors&#13;for the purchase of raw materials or finished goods. The Company&amp;#8217;s history of product deposits with its inventory vendors, creates&#13;an implicit purchase commitment equaling the total expected product acceptance cost in excess of the product deposit. As of December 31,&#13;2020 and December 31, 2019, the Company approximates its implicit purchase commitments to be $1.6 million and $300,000, respectively.&#13;As of December 31, 2020, and December 31, 2019, the vast majority of these product deposits are with one vendor that manufacturers the&#13;Company&amp;#8217;s finished goods inventory for its Shapiro hair care product line.&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:InProcessResearchAndDevelopmentPolicy contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Capitalized Software Costs&#13;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The Company&#13;capitalizes certain internal payroll costs and third-party costs related to internally developed software and amortizes these costs using&#13;the straight-line method over the estimated useful life of the software, generally three years. The Company does not sell internally developed&#13;software other than through the use of subscription service. Certain development costs not meeting the criteria for capitalization, in&#13;accordance with Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) &lt;i&gt;ASC 350-40 Internal-Use Software&lt;/i&gt;, are expensed as incurred.&#13;As of December 31, 2020 and 2019, the Company capitalized $438,136 and $0 related to internally developed software costs which is amortized&#13;over the useful life and included in development costs on our statement of operations.&lt;/p&gt;</us-gaap:InProcessResearchAndDevelopmentPolicy>
    <us-gaap:ConsolidationVariableInterestEntityPolicy contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Variable Interest Entities&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company follows ASC 810-10-15&#13;guidance with respect to accounting for variable interest entities (each, a &amp;#8220;VIE&amp;#8221;). These entities do not have sufficient&#13;equity at risk to finance their activities without additional subordinated financial support from other parties or whose equity investors&#13;lack any of the characteristics of a controlling financial interest. A variable interest is an investment or other interest that will&#13;absorb portions of a VIE&amp;#8217;s expected losses or receive portions of its expected residual returns and are contractual, ownership,&#13;or pecuniary in nature and that change with changes in the fair value of the entity&amp;#8217;s net assets. A reporting entity is the primary&#13;beneficiary of a VIE and must consolidate it when that party has a variable interest, or combination of variable interests, that provides&#13;it with a controlling financial interest. A party is deemed to have a controlling financial interest if it meets both of the power and&#13;losses/benefits criteria. The power criterion is the ability to direct the activities of the VIE that most significantly impact its economic&#13;performance. The losses/benefits criterion is the obligation to absorb losses from, or right to receive benefits from, the VIE that could&#13;potentially be significant to the VIE. The VIE model requires an ongoing reconsideration of whether a reporting entity is the primary&#13;beneficiary of a VIE due to changes in facts and circumstances.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In accordance with ASC 810-10-25-37&#13;and as amended by ASU 2009-17, the Company determines whether any legal entity in which the Company becomes involved is a VIE and subject&#13;to consolidation. The Company conducts an assessment on an ongoing basis for each VIE including (1) the power to direct activities of&#13;the VIE that most significantly impact the VIE&amp;#8217;s economic performance, and (2) the obligation to absorb losses or right to receive&#13;benefits from the VIE that could potentially be significant to the VIE. As a result, the Company determined that three (3) entities were&#13;VIEs and subject to consolidation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 48px"&gt;&lt;font style="font-size: 10pt"&gt;1.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Conversion Labs Media, LLC (&amp;#8220;CVLB Media&amp;#8221;), a Puerto Rico limited liability company,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;2.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Conversion Labs Rx, LLC (&amp;#8220;CVLB Rx&amp;#8221;), a Puerto Rico limited liability company (dissolved in 2020), and&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;3.&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Conversion Labs Asia Limited, a Hong Kong company (&amp;#8220;Conversion Labs Asia&amp;#8221;).&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;CVLB Media, CVLB Rx and Conversion&#13;Labs Asia are all considered immaterial as of December 31, 2020 and 2019. CVLB Rx had no activity during the year ended December 31, 2020&#13;and was dissolved during the period.&lt;/p&gt;</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:DebtPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Paycheck Protection Program&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December&#13;31, 2020, the Company received aggregate loan proceeds in the amount of approximately $249,000 under the Paycheck Protection Program (&amp;#8220;PPP&amp;#8221;).&#13;The PPP, established as part of the Coronavirus Aid, Relief and Economic Security Act (&amp;#8220;CARES Act&amp;#8221;), provides for loans to&#13;qualifying businesses for amounts up to 2.5 times of the average monthly payroll expenses of the qualifying business. The loans and accrued&#13;interest are forgivable after eight weeks as long as the borrower uses the loan proceeds for eligible purposes, including payroll, benefits,&#13;rent and utilities, and maintains its payroll levels. The amount of loan forgiveness will be reduced if the borrower terminates employees&#13;or reduces salaries during the eight-week period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The unforgiven portion of the&#13;PPP loan is payable over two years at an interest rate of 1%, with a deferral of payments for the first six months. The Company intends&#13;to use the proceeds for purposes consistent with the PPP. While the Company currently believes that its use of the loan proceeds will&#13;meet the conditions for forgiveness of the loan, we cannot assure you that we will not take actions that could cause the Company to be&#13;ineligible for forgiveness of the loan, in whole or in part.&lt;/p&gt;</us-gaap:DebtPolicyTextBlock>
    <us-gaap:DividendsCommonStockCash contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">194024</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsCommonStockCash contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsCommonStockCash contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">194024</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="From2020-01-01to2020-12-31_us-gaap_TreasuryStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DividendsCommonStockCash contextRef="From2020-01-01to2020-12-31_us-gaap_ParentMember" unitRef="USD" decimals="0">194024</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="From2020-01-01to2020-12-31_us-gaap_NoncontrollingInterestMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription contextRef="From2021-01-20to2021-01-22_us-gaap_SubsequentEventMember_custom_ConversionLabsPRLLCMember_custom_LegalSimpliSoftwareLlcMember">The CVLB PR MIPA provides that the transaction may be completed in three (3) tranches with a purchase price of $100,000 per tranche to be made at the sole discretion of CVLB PR. Payment for the first tranche of $100,000 was made upon execution of the CVLB PR MIPA. Payments for the second and third tranches are due on the 60-day anniversary and the 120-day anniversary of the Effective Date.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">3607000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">380000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:OperatingLossCarryforwardsLimitationsOnUse contextRef="From2020-01-01to2020-12-31">The net operating loss carryforwards will begin to expire in the year 2021 if not utilized prior to that date, expiring during various year through 2038.</us-gaap:OperatingLossCarryforwardsLimitationsOnUse>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">1269000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">148000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">666765</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">116695</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">807328</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">33568</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:PaymentsToMinorityShareholders contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">157223</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">89085</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsOfLoanCosts contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PaymentsOfLoanCosts contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">284070</us-gaap:PaymentsOfLoanCosts>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31" unitRef="USD" decimals="0">716325</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">570763</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <us-gaap:PercentageOfInterestBearingDomesticDepositsToDeposits contextRef="AsOf2020-12-31_srt_MinimumMember" unitRef="Percent" decimals="INF">0.10</us-gaap:PercentageOfInterestBearingDomesticDepositsToDeposits>
    <us-gaap:PercentageOfInterestBearingDomesticDepositsToDeposits contextRef="AsOf2020-12-31_srt_MaximumMember" unitRef="Percent" decimals="INF">0.33</us-gaap:PercentageOfInterestBearingDomesticDepositsToDeposits>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised contextRef="From2020-01-01to2020-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">-2924449</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <us-gaap:PaymentsForRepurchaseOfEquity contextRef="From2020-01-01to2020-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PaymentsForRepurchaseOfEquity contextRef="From2019-01-01to2019-12-31" unitRef="USD" decimals="0">349999</us-gaap:PaymentsForRepurchaseOfEquity>
    <dei:IcfrAuditorAttestationFlag contextRef="From2020-01-01to2020-12-31">false</dei:IcfrAuditorAttestationFlag>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>20
<FILENAME>lfmd-20201231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: LFMD %2D 20201231 10K FY DFN.xfr; Date: 2021%2D03%2D30T19:46:43Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaGDebP9z5Z8OekhvWB2bZnaryAs23M4zCzvSkpGIakG -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:LFMD="http://lifemd.com/20201231" elementFormDefault="qualified" targetNamespace="http://lifemd.com/20201231">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://lifemd.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
	  <link:definition>00000001 - Document - Document And Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/StatementsOfOperations" id="StatementsOfOperations">
	  <link:definition>00000004 - Statement - Consolidated Statements of Operations</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/StatementsOfChangesInStockholdersDeficit" id="StatementsOfChangesInStockholdersDeficit">
	  <link:definition>00000005 - Statement - Consolidated Statements of Changes in Stockholders' Deficit</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000006 - Statement - Consolidated Statements of Cash Flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/NatureOfOrganizationAndBusiness" id="NatureOfOrganizationAndBusiness">
	  <link:definition>00000007 - Disclosure - Nature of the Organization and Business</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000008 - Disclosure - Summary of Significant Accounting Policies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/IntangibleAssets" id="IntangibleAssets">
	  <link:definition>00000009 - Disclosure - Intangible Assets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/NotesPayable" id="NotesPayable">
	  <link:definition>00000010 - Disclosure - Notes Payable</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/StockholdersEquity" id="StockholdersEquity">
	  <link:definition>00000011 - Disclosure - Stockholders' Equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/Leases" id="Leases">
	  <link:definition>00000012 - Disclosure - Leases</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000013 - Disclosure - Commitments and Contingencies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
	  <link:definition>00000014 - Disclosure - Related Party Transactions</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000015 - Disclosure - Income Taxes</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000016 - Disclosure - Subsequent Events</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000017 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000018 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/IntangibleAssetsTables" id="IntangibleAssetsTables">
	  <link:definition>00000019 - Disclosure - Intangible Assets (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/StockholdersEquityTables" id="StockholdersEquityTables">
	  <link:definition>00000020 - Disclosure - Stockholders' Equity (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/LeasesTables" id="LeasesTables">
	  <link:definition>00000021 - Disclosure - Leases (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
	  <link:definition>00000022 - Disclosure - Income Taxes (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/NatureOfOrganizationAndBusinessDetailsNarrative" id="NatureOfOrganizationAndBusinessDetailsNarrative">
	  <link:definition>00000023 - Disclosure - Nature of the Organization and Business (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000024 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfDisaggregatedRevenueDetails" id="SummaryOfSignificantAccountingPolicies-ScheduleOfDisaggregatedRevenueDetails">
	  <link:definition>00000025 - Disclosure - Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-SummaryOfInventoryDetails" id="SummaryOfSignificantAccountingPolicies-SummaryOfInventoryDetails">
	  <link:definition>00000026 - Disclosure - Summary of Significant Accounting Policies - Summary of Inventory (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfPotentiallyDilutiveSecuritiesDetails" id="SummaryOfSignificantAccountingPolicies-ScheduleOfPotentiallyDilutiveSecuritiesDetails">
	  <link:definition>00000027 - Disclosure - Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/IntangibleAssetsDetailsNarrative" id="IntangibleAssetsDetailsNarrative">
	  <link:definition>00000028 - Disclosure - Intangible Assets (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails" id="IntangibleAssets-ScheduleOfIntangibleAssetsDetails">
	  <link:definition>00000029 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/NotesPayable-DetailsNarrative" id="NotesPayable-DetailsNarrative">
	  <link:definition>00000030 - Disclosure - Notes Payable - (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/StockholdersEquityDetailsNarrative" id="StockholdersEquityDetailsNarrative">
	  <link:definition>00000031 - Disclosure - Stockholders' Equity (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/StockholdersEquity-ScheduleOfOptionActivityDetails" id="StockholdersEquity-ScheduleOfOptionActivityDetails">
	  <link:definition>00000032 - Disclosure - Stockholders' Equity - Schedule of Option Activity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/StockholdersEquity-ScheduleOfWarrantOutstandingAndExercisableDetails" id="StockholdersEquity-ScheduleOfWarrantOutstandingAndExercisableDetails">
	  <link:definition>00000033 - Disclosure - Stockholders' Equity - Schedule of Warrant Outstanding and Exercisable (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/LeasesDetailsNarrative" id="LeasesDetailsNarrative">
	  <link:definition>00000034 - Disclosure - Leases (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/Leases-ScheduleOfLeasesDetails" id="Leases-ScheduleOfLeasesDetails">
	  <link:definition>00000035 - Disclosure - Leases - Schedule of Leases (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000036 - Disclosure - Commitments and Contingencies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
	  <link:definition>00000037 - Disclosure - Related Party Transactions (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/IncomeTaxes-DetailsNarrative" id="IncomeTaxes-DetailsNarrative">
	  <link:definition>00000038 - Disclosure - Income Taxes - (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/IncomeTaxes-ScheduleOfIncomeTaxProvisionChargesDetails" id="IncomeTaxes-ScheduleOfIncomeTaxProvisionChargesDetails">
	  <link:definition>00000039 - Disclosure - Income Taxes - Schedule of Income Tax Provision Charges (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/IncomeTaxes-ScheduleOfProvisionDiffersFromAmountOfIncomeTaxDetails" id="IncomeTaxes-ScheduleOfProvisionDiffersFromAmountOfIncomeTaxDetails">
	  <link:definition>00000040 - Disclosure - Income Taxes - Schedule of Provision Differs from the Amount of Income Tax (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/IncomeTaxes-ScheduleOfNetDeferredTaxLiabilitiesDetails" id="IncomeTaxes-ScheduleOfNetDeferredTaxLiabilitiesDetails">
	  <link:definition>00000041 - Disclosure - Income Taxes - Schedule of Net Deferred Tax Liabilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://lifemd.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
	  <link:definition>00000042 - Disclosure - Subsequent Events (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="lfmd-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="lfmd-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="lfmd-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="lfmd-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
    <element id="LFMD_CustomerDiscountsReturnsAndRebates" name="CustomerDiscountsReturnsAndRebates" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_PerformanceFee" name="PerformanceFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_PercentageForRoyalty" name="PercentageForRoyalty" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_CashlessExerciseOfWarrantsShares" name="CashlessExerciseOfWarrantsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_DeemedDistributionFromWarrantPriceAdjustments" name="DeemedDistributionFromWarrantPriceAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_AccelerationOfDebtDiscount" name="AccelerationOfDebtDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_CashlessExerciseOfWarrantsSupplementalDisclosure" name="CashlessExerciseOfWarrantsSupplementalDisclosure" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_StockIssuesForCapitalizedCosts" name="StockIssuesForCapitalizedCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_DebtConversionInterestValue" name="DebtConversionInterestValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_RemainingPerformanceOptions" name="RemainingPerformanceOptions" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_LicenseFee" name="LicenseFee" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_DeemedDistributionFromDownroundProvisionOnUnissuedShares" name="DeemedDistributionFromDownroundProvisionOnUnissuedShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_SharesIssuedForShareLiability" name="SharesIssuedForShareLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ExpiringAgreementDescription" name="ExpiringAgreementDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_EquityTotal" name="EquityTotal" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_PurchasedRemainingInterestPercentage" name="PurchasedRemainingInterestPercentage" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_DeemedDistributionFromWarrantsIssuedWithPreferredStock" name="DeemedDistributionFromWarrantsIssuedWithPreferredStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_WarrantsIssuedInRelationToDebt" name="WarrantsIssuedInRelationToDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_SharesIssuedPricePerSharePreSplit" name="SharesIssuedPricePerSharePreSplit" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_PutLiabilityIncrease" name="PutLiabilityIncrease" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_UnamortizedCosts" name="UnamortizedCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisedAndExpiredWeightedAverageContractualLife" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisedAndExpiredWeightedAverageContractualLife" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ContingentConsiderationOnPurchaseOfLegalsimpli" name="ContingentConsiderationOnPurchaseOfLegalsimpli" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_DeemedDividendFromWarrantPriceAdjustment" name="DeemedDividendFromWarrantPriceAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_NumberOfSharesIssuedForExerciseOfWarrants" name="NumberOfSharesIssuedForExerciseOfWarrants" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_NumberOfSharesIssuedForExerciseOfWarrantsValue" name="NumberOfSharesIssuedForExerciseOfWarrantsValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_WarrantDiscountPricePerShare" name="WarrantDiscountPricePerShare" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_WarrantPurchasePrice" name="WarrantPurchasePrice" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_RightOfUseAsset" name="RightOfUseAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_MerchantProcessingFees" name="MerchantProcessingFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_GrossProceedsFromOffering" name="GrossProceedsFromOffering" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_CashlessExerciseOfOptionsShares" name="CashlessExerciseOfOptionsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_IssuedWarrantsInConjunctionWithStock" name="IssuedWarrantsInConjunctionWithStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_IssuedWarrantsInConjunctionWithDebt" name="IssuedWarrantsInConjunctionWithDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_MembershipInterestPercentage" name="MembershipInterestPercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_StockIssuedDuringPeriodSharesIssuedForShareLiability" name="StockIssuedDuringPeriodSharesIssuedForShareLiability" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_SharesIssuedForLiability" name="SharesIssuedForLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_OptionsVestingDate" name="OptionsVestingDate" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ExpectedTaxExpenseBenefit" name="ExpectedTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_DeferredTaxAssetsTemporaryDifferences" name="DeferredTaxAssetsTemporaryDifferences" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ProceedsFromIssuanceOfPrivatePlacementNet" name="ProceedsFromIssuanceOfPrivatePlacementNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_SubscriptionPricePerShare" name="SubscriptionPricePerShare" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ServiceCharge" name="ServiceCharge" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_UndesignatedPreferredStock" name="UndesignatedPreferredStock" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_NumberOfStockIssuedPreSplit" name="NumberOfStockIssuedPreSplit" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_PreferredStockRedemptionFeatureValue" name="PreferredStockRedemptionFeatureValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_AggregateExpenses" name="AggregateExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_MonthlyFees" name="MonthlyFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ApplicationOfNewOrRevisedAccountingStandardsNotYetAdoptedPolicyTextBlock" name="ApplicationOfNewOrRevisedAccountingStandardsNotYetAdoptedPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_OtherRecentAccountingPronouncementsPolicyTextBlock" name="OtherRecentAccountingPronouncementsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_UnamortizedExpense" name="UnamortizedExpense" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_AgreementToIssueSharesForNoncontrollingInterest" name="AgreementToIssueSharesForNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_AgreementToIssueSharesForNoncontrollingInterestShares" name="AgreementToIssueSharesForNoncontrollingInterestShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock" name="AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt" name="AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_StockIssuedDuringPeriodValueExerciseOfWarrants" name="StockIssuedDuringPeriodValueExerciseOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_StockIssuedDuringPeriodSharesExerciseOfWarrants" name="StockIssuedDuringPeriodSharesExerciseOfWarrants" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_CashlessExerciseOfWarrants" name="CashlessExerciseOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions" name="StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_StockIssuedDuringPeriodSharesCashlessExerciseOfStockOptions" name="StockIssuedDuringPeriodSharesCashlessExerciseOfStockOptions" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_StockIssuedDuringPeriodValueSaleOfCommonStock" name="StockIssuedDuringPeriodValueSaleOfCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_StockIssuedDuringPeriodSharesSaleOfCommonStock" name="StockIssuedDuringPeriodSharesSaleOfCommonStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet" name="StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_StockIssuedDuringperiodSaleOfStockInPrivatePlacementNetShares" name="StockIssuedDuringperiodSaleOfStockInPrivatePlacementNetShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_StockIssuedDuringPeriodValueReverseStockSplits" name="StockIssuedDuringPeriodValueReverseStockSplits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ImmudynePrLlcMember" name="ImmudynePrLlcMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_LegalSimpliSoftwareLlcMember" name="LegalSimpliSoftwareLlcMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_CustomerRelationshipAssetMember" name="CustomerRelationshipAssetMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_PurchasedLicensesMember" name="PurchasedLicensesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_LeaseAgreementOneMember" name="LeaseAgreementOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ServiceBasedStockOptionsMember" name="ServiceBasedStockOptionsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_PilarisLaboratoriesLLCMember" name="PilarisLaboratoriesLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_CVLBPRMember" name="CVLBPRMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_OneEightyDayAnniversaryAgreementMember" name="OneEightyDayAnniversaryAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ThreeSiXFiveDayAnniversaryAgreementMember" name="ThreeSiXFiveDayAnniversaryAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_SubscriptionAgreementMember" name="SubscriptionAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_MALPHABETLLCMember" name="MALPHABETLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_OneTwentyDayAnniversaryAgreementMember" name="OneTwentyDayAnniversaryAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ThreeSixtyDayAnniversaryAgreementMember" name="ThreeSixtyDayAnniversaryAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_CommonStockOneMember" name="CommonStockOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_CommonStockTwoMember" name="CommonStockTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_CommonStockThreeMember" name="CommonStockThreeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_BVGlobalFulfillmentMember" name="BVGlobalFulfillmentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_TwoManufacturersMember" name="TwoManufacturersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" name="AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_TwoAccreditedInvestorsMember" name="TwoAccreditedInvestorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_NoteRepaymentAndWarrantAmendmentAgreementMember" name="NoteRepaymentAndWarrantAmendmentAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_CSixPurchaseAgreementOneMember" name="CSixPurchaseAgreementOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_CSixCapitalLLCMember" name="CSixCapitalLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_CSixPurchaseAgreementTwoMember" name="CSixPurchaseAgreementTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_CSixPurchaseAgreementsOneMember" name="CSixPurchaseAgreementsOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_CSixPurchaseAgreementsTwoMember" name="CSixPurchaseAgreementsTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_CSixPurchaseAgreementsMember" name="CSixPurchaseAgreementsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_DailyAveragePaymentMember" name="DailyAveragePaymentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_TwoCSixPurchaseAgreementsMember" name="TwoCSixPurchaseAgreementsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_PresidentAndCEOMember" name="PresidentAndCEOMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_OfficeSpaceMember" name="OfficeSpaceMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_JLSVenturesLLCMember" name="JLSVenturesLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_PuertoRicoOfficeSpaceMember" name="PuertoRicoOfficeSpaceMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_MrSeanFitzpatrickMember" name="MrSeanFitzpatrickMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ServicesAgreementMember" name="ServicesAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_AlphaCapitalAnstaltMember" name="AlphaCapitalAnstaltMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_TwoThousandAndEighteenAlphaNoteMember" name="TwoThousandAndEighteenAlphaNoteMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_TwoThousandAndEighteenAlphaWarrantMember" name="TwoThousandAndEighteenAlphaWarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_TwoThousandAndNineteenAlphaAmendmentMember" name="TwoThousandAndNineteenAlphaAmendmentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_TwoThousandAndNineteenAlphaWarrantMember" name="TwoThousandAndNineteenAlphaWarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_TwoThousandAndEighteenBrioWarrantAmendmentMember" name="TwoThousandAndEighteenBrioWarrantAmendmentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_BrioMasterFundMember" name="BrioMasterFundMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_TwoThousandAndEighteenBrioWarrantMember" name="TwoThousandAndEighteenBrioWarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_BrioTwoThousandAndNineteenWarrantMember" name="BrioTwoThousandAndNineteenWarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_SoftwareRevenuesNetMember" name="SoftwareRevenuesNetMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ThroughTheNextTwelveMonthsMember" name="ThroughTheNextTwelveMonthsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_MayTwoThousandAndTwentyNotesMember" name="MayTwoThousandAndTwentyNotesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_SixAccreditedInvestorsMember" name="SixAccreditedInvestorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_EmployeesAnddvisoryBoardMembersMember" name="EmployeesAnddvisoryBoardMembersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_EmploymentAndConsultingAgreementsMember" name="EmploymentAndConsultingAgreementsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_PaycheckProtectionProgramLoanMember" name="PaycheckProtectionProgramLoanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_USSmallBusinessAdministrationMember" name="USSmallBusinessAdministrationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ChiefExecutiveOfficerAndChiefTechnologyOfficerMember" name="ChiefExecutiveOfficerAndChiefTechnologyOfficerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_PurchaseAgreementMember" name="PurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ShapiroMDMember" name="ShapiroMDMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_RexMDMember" name="RexMDMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_INRWellnessMember" name="INRWellnessMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ScarologyMember" name="ScarologyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_PreSplitBasisMember" name="PreSplitBasisMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_SeriesBConvertiblePreferredStockMember" name="SeriesBConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ConsultingAgreementMember" name="ConsultingAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_WarrantPurchaseAgreementMember" name="WarrantPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ClassAWarrantMember" name="ClassAWarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_AugustTwoThousandAndTwentyWarrantInducementMember" name="AugustTwoThousandAndTwentyWarrantInducementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_SecondAlphaWarrantAmendmentMember" name="SecondAlphaWarrantAmendmentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_AugustTwoThousandAndNineteenWarrantMember" name="AugustTwoThousandAndNineteenWarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_BrioWarrantsMember" name="BrioWarrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_AmendedConsultingAgreementMember" name="AmendedConsultingAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_BlueHorizonConsultingLLCMember" name="BlueHorizonConsultingLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ConversionLabsPrMember" name="ConversionLabsPrMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_TwoThousandTwentyPlanMember" name="TwoThousandTwentyPlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_InvestorsMember" name="InvestorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_SoftwareRevenueMember" name="SoftwareRevenueMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_InnateMember" name="InnateMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_CVLBMediaMember" name="CVLBMediaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_PrivatePlacementOfferingMember" name="PrivatePlacementOfferingMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_BTIGLLCMember" name="BTIGLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_OptionsAndWarrantsMember" name="OptionsAndWarrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_MembershipInterestPurchaseAgreementMember" name="MembershipInterestPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_MrSchreiberMember" name="MrSchreiberMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_MrGalluppiMember" name="MrGalluppiMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_FirstMilestoneMember" name="FirstMilestoneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_SecondMileSStoneMember" name="SecondMileSStoneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_BoardOfDirectorsMember" name="BoardOfDirectorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_NewChiefOperatingOfficerMember" name="NewChiefOperatingOfficerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_AmendedCAOEmploymentAgreementMember" name="AmendedCAOEmploymentAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_LeaseAgreementTwoMember" name="LeaseAgreementTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_PromissoryNoteMember" name="PromissoryNoteMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ExchangeAgreementMember" name="ExchangeAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ChiefDigitalOfficerMember" name="ChiefDigitalOfficerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_EmploymentAgreementMember" name="EmploymentAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ChiefMedicalOfficerMember" name="ChiefMedicalOfficerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_PaycheckProtectionProgramMember" name="PaycheckProtectionProgramMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ConversionLabsPRLLCMember" name="ConversionLabsPRLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_FoundingMembersMIPAsMember" name="FoundingMembersMIPAsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ChiefBusinessOfficerMember" name="ChiefBusinessOfficerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_VestingOnEffectiveDateMember" name="VestingOnEffectiveDateMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_FebruaryTwoThousandTwentyOnePurchaseAgreementMember" name="FebruaryTwoThousandTwentyOnePurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_WorkingCapitalLoanMember" name="WorkingCapitalLoanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ChaseBankMember" name="ChaseBankMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_ChiefComplianceOfficerMember" name="ChiefComplianceOfficerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_DecemberEightTwoThousandAndTwentyThreeMember" name="DecemberEightTwoThousandAndTwentyThreeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="LFMD_CashPaidForInterestAbstract" name="CashPaidForInterestAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>21
<FILENAME>lfmd-20201231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: LFMD %2D 20201231 10K FY DFN.xfr; Date: 2021%2D03%2D30T19:46:43Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://lifemd.com/role/DocumentAndEntityInformation" xlink:href="lfmd-20201231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/BalanceSheets" xlink:href="lfmd-20201231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/BalanceSheetsParenthetical" xlink:href="lfmd-20201231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StatementsOfOperations" xlink:href="lfmd-20201231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StatementsOfChangesInStockholdersDeficit" xlink:href="lfmd-20201231.xsd#StatementsOfChangesInStockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StatementsOfCashFlows" xlink:href="lfmd-20201231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/NatureOfOrganizationAndBusiness" xlink:href="lfmd-20201231.xsd#NatureOfOrganizationAndBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="lfmd-20201231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IntangibleAssets" xlink:href="lfmd-20201231.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/NotesPayable" xlink:href="lfmd-20201231.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StockholdersEquity" xlink:href="lfmd-20201231.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/Leases" xlink:href="lfmd-20201231.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/CommitmentsAndContingencies" xlink:href="lfmd-20201231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/RelatedPartyTransactions" xlink:href="lfmd-20201231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IncomeTaxes" xlink:href="lfmd-20201231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SubsequentEvents" xlink:href="lfmd-20201231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="lfmd-20201231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="lfmd-20201231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IntangibleAssetsTables" xlink:href="lfmd-20201231.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StockholdersEquityTables" xlink:href="lfmd-20201231.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/LeasesTables" xlink:href="lfmd-20201231.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IncomeTaxesTables" xlink:href="lfmd-20201231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/NatureOfOrganizationAndBusinessDetailsNarrative" xlink:href="lfmd-20201231.xsd#NatureOfOrganizationAndBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="lfmd-20201231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfDisaggregatedRevenueDetails" xlink:href="lfmd-20201231.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfDisaggregatedRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-SummaryOfInventoryDetails" xlink:href="lfmd-20201231.xsd#SummaryOfSignificantAccountingPolicies-SummaryOfInventoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfPotentiallyDilutiveSecuritiesDetails" xlink:href="lfmd-20201231.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfPotentiallyDilutiveSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IntangibleAssetsDetailsNarrative" xlink:href="lfmd-20201231.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:href="lfmd-20201231.xsd#IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/NotesPayable-DetailsNarrative" xlink:href="lfmd-20201231.xsd#NotesPayable-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StockholdersEquityDetailsNarrative" xlink:href="lfmd-20201231.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StockholdersEquity-ScheduleOfOptionActivityDetails" xlink:href="lfmd-20201231.xsd#StockholdersEquity-ScheduleOfOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StockholdersEquity-ScheduleOfWarrantOutstandingAndExercisableDetails" xlink:href="lfmd-20201231.xsd#StockholdersEquity-ScheduleOfWarrantOutstandingAndExercisableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/LeasesDetailsNarrative" xlink:href="lfmd-20201231.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/Leases-ScheduleOfLeasesDetails" xlink:href="lfmd-20201231.xsd#Leases-ScheduleOfLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="lfmd-20201231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="lfmd-20201231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IncomeTaxes-DetailsNarrative" xlink:href="lfmd-20201231.xsd#IncomeTaxes-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IncomeTaxes-ScheduleOfIncomeTaxProvisionChargesDetails" xlink:href="lfmd-20201231.xsd#IncomeTaxes-ScheduleOfIncomeTaxProvisionChargesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IncomeTaxes-ScheduleOfProvisionDiffersFromAmountOfIncomeTaxDetails" xlink:href="lfmd-20201231.xsd#IncomeTaxes-ScheduleOfProvisionDiffersFromAmountOfIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IncomeTaxes-ScheduleOfNetDeferredTaxLiabilitiesDetails" xlink:href="lfmd-20201231.xsd#IncomeTaxes-ScheduleOfNetDeferredTaxLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SubsequentEventsDetailsNarrative" xlink:href="lfmd-20201231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document And Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaapDepositsAssetsCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapDepositsAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="loc_us-gaapCapitalizedComputerSoftwareNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapCapitalizedComputerSoftwareNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaapDeferredRevenue" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ContingentConsiderationOnPurchaseOfLegalsimpli" xlink:label="loc_LFMDContingentConsiderationOnPurchaseOfLegalsimpli" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_LFMDContingentConsiderationOnPurchaseOfLegalsimpli" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_EquityTotal" xlink:label="loc_LFMDEquityTotal" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_LFMDEquityTotal" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_LFMDEquityTotal" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_LFMDEquityTotal" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" weight="-1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_LFMDEquityTotal" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherGeneralExpense" xlink:label="loc_us-gaapOtherGeneralExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapOtherGeneralExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopmentCosts" xlink:label="loc_us-gaapDevelopmentCosts" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapDevelopmentCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:label="loc_us-gaapPreferredStockDividendsAndOtherAdjustments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapPreferredStockDividendsAndOtherAdjustments" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/StatementsOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Stockholders&apos; Deficit" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:label="loc_us-gaapCapitalizedComputerSoftwareAmortization1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapCapitalizedComputerSoftwareAmortization1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AccelerationOfDebtDiscount" xlink:label="loc_LFMDAccelerationOfDebtDiscount" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_LFMDAccelerationOfDebtDiscount" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerAsset" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerAsset" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireSoftware" xlink:label="loc_us-gaapPaymentsToAcquireSoftware" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireSoftware" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:label="loc_us-gaapPaymentForContingentConsiderationLiabilityInvestingActivities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentForContingentConsiderationLiabilityInvestingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="loc_us-gaapPaymentsToMinorityShareholders" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsToMinorityShareholders" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfEquity" xlink:label="loc_us-gaapPaymentsForRepurchaseOfEquity" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsForRepurchaseOfEquity" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfLoanCosts" xlink:label="loc_us-gaapPaymentsOfLoanCosts" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfLoanCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/NatureOfOrganizationAndBusiness" xlink:title="00000007 - Disclosure - Nature of the Organization and Business" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Summary of Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/IntangibleAssets" xlink:title="00000009 - Disclosure - Intangible Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/NotesPayable" xlink:title="00000010 - Disclosure - Notes Payable" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/StockholdersEquity" xlink:title="00000011 - Disclosure - Stockholders&apos; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/Leases" xlink:title="00000012 - Disclosure - Leases" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/CommitmentsAndContingencies" xlink:title="00000013 - Disclosure - Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/RelatedPartyTransactions" xlink:title="00000014 - Disclosure - Related Party Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/IncomeTaxes" xlink:title="00000015 - Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/SubsequentEvents" xlink:title="00000016 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000017 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000018 - Disclosure - Summary of Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/IntangibleAssetsTables" xlink:title="00000019 - Disclosure - Intangible Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/StockholdersEquityTables" xlink:title="00000020 - Disclosure - Stockholders&apos; Equity (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/LeasesTables" xlink:title="00000021 - Disclosure - Leases (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/IncomeTaxesTables" xlink:title="00000022 - Disclosure - Income Taxes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/NatureOfOrganizationAndBusinessDetailsNarrative" xlink:title="00000023 - Disclosure - Nature of the Organization and Business (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000024 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfDisaggregatedRevenueDetails" xlink:title="00000025 - Disclosure - Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-SummaryOfInventoryDetails" xlink:title="00000026 - Disclosure - Summary of Significant Accounting Policies - Summary of Inventory (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryValuationReserves" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfPotentiallyDilutiveSecuritiesDetails" xlink:title="00000027 - Disclosure - Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/IntangibleAssetsDetailsNarrative" xlink:title="00000028 - Disclosure - Intangible Assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:title="00000029 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/NotesPayable-DetailsNarrative" xlink:title="00000030 - Disclosure - Notes Payable - (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000031 - Disclosure - Stockholders&apos; Equity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/StockholdersEquity-ScheduleOfOptionActivityDetails" xlink:title="00000032 - Disclosure - Stockholders&apos; Equity - Schedule of Option Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/StockholdersEquity-ScheduleOfWarrantOutstandingAndExercisableDetails" xlink:title="00000033 - Disclosure - Stockholders&apos; Equity - Schedule of Warrant Outstanding and Exercisable (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/LeasesDetailsNarrative" xlink:title="00000034 - Disclosure - Leases (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/Leases-ScheduleOfLeasesDetails" xlink:title="00000035 - Disclosure - Leases - Schedule of Leases (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000036 - Disclosure - Commitments and Contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000037 - Disclosure - Related Party Transactions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/IncomeTaxes-DetailsNarrative" xlink:title="00000038 - Disclosure - Income Taxes - (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/IncomeTaxes-ScheduleOfIncomeTaxProvisionChargesDetails" xlink:title="00000039 - Disclosure - Income Taxes - Schedule of Income Tax Provision Charges (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/IncomeTaxes-ScheduleOfProvisionDiffersFromAmountOfIncomeTaxDetails" xlink:title="00000040 - Disclosure - Income Taxes - Schedule of Provision Differs from the Amount of Income Tax (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ExpectedTaxExpenseBenefit" xlink:label="loc_LFMDExpectedTaxExpenseBenefit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_LFMDExpectedTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationPriorYearIncomeTaxes" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationPriorYearIncomeTaxes" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/IncomeTaxes-ScheduleOfNetDeferredTaxLiabilitiesDetails" xlink:title="00000041 - Disclosure - Income Taxes - Schedule of Net Deferred Tax Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_DeferredTaxAssetsTemporaryDifferences" xlink:label="loc_LFMDDeferredTaxAssetsTemporaryDifferences" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_LFMDDeferredTaxAssetsTemporaryDifferences" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://lifemd.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000042 - Disclosure - Subsequent Events (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>22
<FILENAME>lfmd-20201231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: LFMD %2D 20201231 10K FY DFN.xfr; Date: 2021%2D03%2D30T19:46:43Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://lifemd.com/role/DocumentAndEntityInformation" xlink:href="lfmd-20201231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/BalanceSheets" xlink:href="lfmd-20201231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/BalanceSheetsParenthetical" xlink:href="lfmd-20201231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StatementsOfOperations" xlink:href="lfmd-20201231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StatementsOfChangesInStockholdersDeficit" xlink:href="lfmd-20201231.xsd#StatementsOfChangesInStockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StatementsOfCashFlows" xlink:href="lfmd-20201231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/NatureOfOrganizationAndBusiness" xlink:href="lfmd-20201231.xsd#NatureOfOrganizationAndBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="lfmd-20201231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IntangibleAssets" xlink:href="lfmd-20201231.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/NotesPayable" xlink:href="lfmd-20201231.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StockholdersEquity" xlink:href="lfmd-20201231.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/Leases" xlink:href="lfmd-20201231.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/CommitmentsAndContingencies" xlink:href="lfmd-20201231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/RelatedPartyTransactions" xlink:href="lfmd-20201231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IncomeTaxes" xlink:href="lfmd-20201231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SubsequentEvents" xlink:href="lfmd-20201231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="lfmd-20201231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="lfmd-20201231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IntangibleAssetsTables" xlink:href="lfmd-20201231.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StockholdersEquityTables" xlink:href="lfmd-20201231.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/LeasesTables" xlink:href="lfmd-20201231.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IncomeTaxesTables" xlink:href="lfmd-20201231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/NatureOfOrganizationAndBusinessDetailsNarrative" xlink:href="lfmd-20201231.xsd#NatureOfOrganizationAndBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="lfmd-20201231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfDisaggregatedRevenueDetails" xlink:href="lfmd-20201231.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfDisaggregatedRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-SummaryOfInventoryDetails" xlink:href="lfmd-20201231.xsd#SummaryOfSignificantAccountingPolicies-SummaryOfInventoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfPotentiallyDilutiveSecuritiesDetails" xlink:href="lfmd-20201231.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfPotentiallyDilutiveSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IntangibleAssetsDetailsNarrative" xlink:href="lfmd-20201231.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:href="lfmd-20201231.xsd#IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/NotesPayable-DetailsNarrative" xlink:href="lfmd-20201231.xsd#NotesPayable-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StockholdersEquityDetailsNarrative" xlink:href="lfmd-20201231.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StockholdersEquity-ScheduleOfOptionActivityDetails" xlink:href="lfmd-20201231.xsd#StockholdersEquity-ScheduleOfOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StockholdersEquity-ScheduleOfWarrantOutstandingAndExercisableDetails" xlink:href="lfmd-20201231.xsd#StockholdersEquity-ScheduleOfWarrantOutstandingAndExercisableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/LeasesDetailsNarrative" xlink:href="lfmd-20201231.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/Leases-ScheduleOfLeasesDetails" xlink:href="lfmd-20201231.xsd#Leases-ScheduleOfLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="lfmd-20201231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="lfmd-20201231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IncomeTaxes-DetailsNarrative" xlink:href="lfmd-20201231.xsd#IncomeTaxes-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IncomeTaxes-ScheduleOfIncomeTaxProvisionChargesDetails" xlink:href="lfmd-20201231.xsd#IncomeTaxes-ScheduleOfIncomeTaxProvisionChargesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IncomeTaxes-ScheduleOfProvisionDiffersFromAmountOfIncomeTaxDetails" xlink:href="lfmd-20201231.xsd#IncomeTaxes-ScheduleOfProvisionDiffersFromAmountOfIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IncomeTaxes-ScheduleOfNetDeferredTaxLiabilitiesDetails" xlink:href="lfmd-20201231.xsd#IncomeTaxes-ScheduleOfNetDeferredTaxLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SubsequentEventsDetailsNarrative" xlink:href="lfmd-20201231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document And Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesIssued_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="loc_us-gaapTemporaryEquityLiquidationPreference_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityLiquidationPreference_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaapTreasuryStockCommonShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockCommonShares_50" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaapProductMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapProductMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SoftwareRevenuesNetMember" xlink:label="loc_LFMDSoftwareRevenuesNetMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_LFMDSoftwareRevenuesNetMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember" xlink:label="loc_us-gaapServiceMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapServiceMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfRevenue_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGrossProfit_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpensesAbstract_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_90" xlink:to="loc_us-gaapSellingAndMarketingExpense_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_90" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherGeneralExpense" xlink:label="loc_us-gaapOtherGeneralExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_90" xlink:to="loc_us-gaapOtherGeneralExpense_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_90" xlink:to="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopmentCosts" xlink:label="loc_us-gaapDevelopmentCosts_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_90" xlink:to="loc_us-gaapDevelopmentCosts_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_90" xlink:to="loc_us-gaapOperatingExpenses_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_90" xlink:to="loc_us-gaapInterestExpense_90" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_90" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_90" xlink:to="loc_us-gaapNonoperatingIncomeExpense_90" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_90" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_90" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_90" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_90" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:label="loc_us-gaapPreferredStockDividendsAndOtherAdjustments_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockDividendsAndOtherAdjustments_90" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_90" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare_90" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare_90" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareAbstract_90" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareAbstract_90" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_90" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareAbstract_90" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_90" xlink:type="arc" order="27" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/StatementsOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Stockholders&apos; Deficit">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember" xlink:label="loc_us-gaapParentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapParentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AgreementToIssueSharesForNoncontrollingInterest" xlink:label="loc_LFMDAgreementToIssueSharesForNoncontrollingInterest_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDAgreementToIssueSharesForNoncontrollingInterest_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AgreementToIssueSharesForNoncontrollingInterestShares" xlink:label="loc_LFMDAgreementToIssueSharesForNoncontrollingInterestShares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDAgreementToIssueSharesForNoncontrollingInterestShares_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock" xlink:label="loc_LFMDAdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDAdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt" xlink:label="loc_LFMDAdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDAdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt_80" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_80" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_80" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_80" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_80" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:label="loc_LFMDStockIssuedDuringPeriodValueExerciseOfWarrants_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDStockIssuedDuringPeriodValueExerciseOfWarrants_80" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:label="loc_LFMDStockIssuedDuringPeriodSharesExerciseOfWarrants_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDStockIssuedDuringPeriodSharesExerciseOfWarrants_80" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_80" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_80" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CashlessExerciseOfWarrants" xlink:label="loc_LFMDCashlessExerciseOfWarrants_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDCashlessExerciseOfWarrants_80" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CashlessExerciseOfWarrantsShares" xlink:label="loc_LFMDCashlessExerciseOfWarrantsShares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDCashlessExerciseOfWarrantsShares_80" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions" xlink:label="loc_LFMDStockIssuedDuringPeriodValueCashlessExerciseOfStockOptions_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDStockIssuedDuringPeriodValueCashlessExerciseOfStockOptions_80" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodSharesCashlessExerciseOfStockOptions" xlink:label="loc_LFMDStockIssuedDuringPeriodSharesCashlessExerciseOfStockOptions_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDStockIssuedDuringPeriodSharesCashlessExerciseOfStockOptions_80" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodValueSaleOfCommonStock" xlink:label="loc_LFMDStockIssuedDuringPeriodValueSaleOfCommonStock_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDStockIssuedDuringPeriodValueSaleOfCommonStock_80" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodSharesSaleOfCommonStock" xlink:label="loc_LFMDStockIssuedDuringPeriodSharesSaleOfCommonStock_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDStockIssuedDuringPeriodSharesSaleOfCommonStock_80" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet" xlink:label="loc_LFMDStockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDStockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet_80" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringperiodSaleOfStockInPrivatePlacementNetShares" xlink:label="loc_LFMDStockIssuedDuringperiodSaleOfStockInPrivatePlacementNetShares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDStockIssuedDuringperiodSaleOfStockInPrivatePlacementNetShares_80" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_80" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_80" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits_80" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits_80" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_80" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_80" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="loc_us-gaapDividendsCommonStockCash_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsCommonStockCash_80" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount" xlink:label="loc_us-gaapWarrantDownRoundFeatureIncreaseDecreaseInEquityAmount_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantDownRoundFeatureIncreaseDecreaseInEquityAmount_80" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="loc_us-gaapDividendsPreferredStockCash_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPreferredStockCash_80" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodValueReverseStockSplits" xlink:label="loc_LFMDStockIssuedDuringPeriodValueReverseStockSplits_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDStockIssuedDuringPeriodValueReverseStockSplits_80" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits_80" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_80" xlink:type="arc" order="39" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/NatureOfOrganizationAndBusiness" xlink:title="00000007 - Disclosure - Nature of the Organization and Business" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Summary of Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/IntangibleAssets" xlink:title="00000009 - Disclosure - Intangible Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/NotesPayable" xlink:title="00000010 - Disclosure - Notes Payable" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/StockholdersEquity" xlink:title="00000011 - Disclosure - Stockholders&apos; Equity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/Leases" xlink:title="00000012 - Disclosure - Leases" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/CommitmentsAndContingencies" xlink:title="00000013 - Disclosure - Commitments and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/RelatedPartyTransactions" xlink:title="00000014 - Disclosure - Related Party Transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/IncomeTaxes" xlink:title="00000015 - Disclosure - Income Taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/SubsequentEvents" xlink:title="00000016 - Disclosure - Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000017 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000018 - Disclosure - Summary of Significant Accounting Policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/IntangibleAssetsTables" xlink:title="00000019 - Disclosure - Intangible Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/StockholdersEquityTables" xlink:title="00000020 - Disclosure - Stockholders&apos; Equity (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ServiceBasedStockOptionsMember" xlink:label="loc_LFMDServiceBasedStockOptionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDServiceBasedStockOptionsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaapPerformanceSharesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapPerformanceSharesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandTwentyPlanMember" xlink:label="loc_LFMDTwoThousandTwentyPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_LFMDTwoThousandTwentyPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/LeasesTables" xlink:title="00000021 - Disclosure - Leases (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/IncomeTaxesTables" xlink:title="00000022 - Disclosure - Income Taxes (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/NatureOfOrganizationAndBusinessDetailsNarrative" xlink:title="00000023 - Disclosure - Nature of the Organization and Business (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ImmudynePrLlcMember" xlink:label="loc_LFMDImmudynePrLlcMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_LFMDImmudynePrLlcMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ConversionLabsPrMember" xlink:label="loc_LFMDConversionLabsPrMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_LFMDConversionLabsPrMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_LegalSimpliSoftwareLlcMember" xlink:label="loc_LFMDLegalSimpliSoftwareLlcMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_LFMDLegalSimpliSoftwareLlcMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SecuritiesPurchaseAgreementMember" xlink:label="loc_LFMDSecuritiesPurchaseAgreementMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDSecuritiesPurchaseAgreementMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_InvestorsMember" xlink:label="loc_LFMDInvestorsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDInvestorsMember_60" xlink:type="arc" order="64" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardDateAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ThroughTheNextTwelveMonthsMember" xlink:label="loc_LFMDThroughTheNextTwelveMonthsMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_LFMDThroughTheNextTwelveMonthsMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_120" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ProceedsFromIssuanceOfPrivatePlacementNet" xlink:label="loc_LFMDProceedsFromIssuanceOfPrivatePlacementNet_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDProceedsFromIssuanceOfPrivatePlacementNet_120" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_120" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCash_120" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000024 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtOwnershipAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_LegalSimpliSoftwareLlcMember" xlink:label="loc_LFMDLegalSimpliSoftwareLlcMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_LFMDLegalSimpliSoftwareLlcMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_LegalSimpliSoftwareLlcMember" xlink:label="loc_LFMDLegalSimpliSoftwareLlcMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_LFMDLegalSimpliSoftwareLlcMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaapProductMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapProductMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SoftwareRevenueMember" xlink:label="loc_LFMDSoftwareRevenueMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_LFMDSoftwareRevenueMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PurchasedLicensesMember" xlink:label="loc_LFMDPurchasedLicensesMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_LFMDPurchasedLicensesMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PaycheckProtectionProgramLoanMember" xlink:label="loc_LFMDPaycheckProtectionProgramLoanMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_LFMDPaycheckProtectionProgramLoanMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoManufacturersMember" xlink:label="loc_LFMDTwoManufacturersMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_LFMDTwoManufacturersMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByParent_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByParent_220" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_220" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MerchantProcessingFees" xlink:label="loc_LFMDMerchantProcessingFees_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDMerchantProcessingFees_220" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CustomerDiscountsReturnsAndRebates" xlink:label="loc_LFMDCustomerDiscountsReturnsAndRebates_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDCustomerDiscountsReturnsAndRebates_220" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SubscriptionPricePerShare" xlink:label="loc_LFMDSubscriptionPricePerShare_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDSubscriptionPricePerShare_220" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent_220" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts_220" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_220" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInventoryValuationReserves_220" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PercentageOfInterestBearingDomesticDepositsToDeposits" xlink:label="loc_us-gaapPercentageOfInterestBearingDomesticDepositsToDeposits_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPercentageOfInterestBearingDomesticDepositsToDeposits_220" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaapDepositsAssetsCurrent_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepositsAssetsCurrent_220" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaapPurchaseObligation_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPurchaseObligation_220" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" xlink:label="loc_us-gaapCapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers_220" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_220" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_220" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt_220" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription_220" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_220" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_220" xlink:type="arc" order="18" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfDisaggregatedRevenueDetails" xlink:title="00000025 - Disclosure - Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaapProductMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapProductMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SoftwareRevenueMember" xlink:label="loc_LFMDSoftwareRevenueMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_LFMDSoftwareRevenueMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShapiroMDMember" xlink:label="loc_LFMDShapiroMDMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_LFMDShapiroMDMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_InnateMember" xlink:label="loc_LFMDInnateMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_LFMDInnateMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_INRWellnessMember" xlink:label="loc_LFMDINRWellnessMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_LFMDINRWellnessMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ScarologyMember" xlink:label="loc_LFMDScarologyMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_LFMDScarologyMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_RexMDMember" xlink:label="loc_LFMDRexMDMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_LFMDRexMDMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CVLBPRMember" xlink:label="loc_LFMDCVLBPRMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_LFMDCVLBPRMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_LegalSimpliSoftwareLlcMember" xlink:label="loc_LFMDLegalSimpliSoftwareLlcMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_LFMDLegalSimpliSoftwareLlcMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CVLBMediaMember" xlink:label="loc_LFMDCVLBMediaMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_LFMDCVLBMediaMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_180" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_180" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-SummaryOfInventoryDetails" xlink:title="00000026 - Disclosure - Summary of Significant Accounting Policies - Summary of Inventory (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfPotentiallyDilutiveSecuritiesDetails" xlink:title="00000027 - Disclosure - Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="loc_us-gaapConvertibleDebtSecuritiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapConvertibleDebtSecuritiesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapWarrantMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_110" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/IntangibleAssetsDetailsNarrative" xlink:title="00000028 - Disclosure - Intangible Assets (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:title="00000029 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CustomerRelationshipAssetMember" xlink:label="loc_LFMDCustomerRelationshipAssetMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_LFMDCustomerRelationshipAssetMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PurchasedLicensesMember" xlink:label="loc_LFMDPurchasedLicensesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_LFMDPurchasedLicensesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_90" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/NotesPayable-DetailsNarrative" xlink:title="00000030 - Disclosure - Notes Payable - (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SecuritiesPurchaseAgreementMember" xlink:label="loc_LFMDSecuritiesPurchaseAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDSecuritiesPurchaseAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_NoteRepaymentAndWarrantAmendmentAgreementMember" xlink:label="loc_LFMDNoteRepaymentAndWarrantAmendmentAgreementMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDNoteRepaymentAndWarrantAmendmentAgreementMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CSixPurchaseAgreementsMember" xlink:label="loc_LFMDCSixPurchaseAgreementsMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDCSixPurchaseAgreementsMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CSixPurchaseAgreementOneMember" xlink:label="loc_LFMDCSixPurchaseAgreementOneMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDCSixPurchaseAgreementOneMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CSixPurchaseAgreementTwoMember" xlink:label="loc_LFMDCSixPurchaseAgreementTwoMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDCSixPurchaseAgreementTwoMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CSixPurchaseAgreementsOneMember" xlink:label="loc_LFMDCSixPurchaseAgreementsOneMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDCSixPurchaseAgreementsOneMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CSixPurchaseAgreementsTwoMember" xlink:label="loc_LFMDCSixPurchaseAgreementsTwoMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDCSixPurchaseAgreementsTwoMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoCSixPurchaseAgreementsMember" xlink:label="loc_LFMDTwoCSixPurchaseAgreementsMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDTwoCSixPurchaseAgreementsMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PaycheckProtectionProgramLoanMember" xlink:label="loc_LFMDPaycheckProtectionProgramLoanMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDPaycheckProtectionProgramLoanMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" xlink:label="loc_LFMDAlphaCapitalAnstaltBrioCapitalMasterFundLtdMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDAlphaCapitalAnstaltBrioCapitalMasterFundLtdMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CSixCapitalLLCMember" xlink:label="loc_LFMDCSixCapitalLLCMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDCSixCapitalLLCMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ChaseBankMember" xlink:label="loc_LFMDChaseBankMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDChaseBankMember_260" xlink:type="arc" order="262" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PreSplitBasisMember" xlink:label="loc_LFMDPreSplitBasisMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_LFMDPreSplitBasisMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoAccreditedInvestorsMember" xlink:label="loc_LFMDTwoAccreditedInvestorsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDTwoAccreditedInvestorsMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SixAccreditedInvestorsMember" xlink:label="loc_LFMDSixAccreditedInvestorsMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDSixAccreditedInvestorsMember_200" xlink:type="arc" order="202" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_USSmallBusinessAdministrationMember" xlink:label="loc_LFMDUSSmallBusinessAdministrationMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDUSSmallBusinessAdministrationMember_240" xlink:type="arc" order="242" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_DailyAveragePaymentMember" xlink:label="loc_LFMDDailyAveragePaymentMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDDailyAveragePaymentMember_180" xlink:type="arc" order="183" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MayTwoThousandAndTwentyNotesMember" xlink:label="loc_LFMDMayTwoThousandAndTwentyNotesMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_LFMDMayTwoThousandAndTwentyNotesMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_WorkingCapitalLoanMember" xlink:label="loc_LFMDWorkingCapitalLoanMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_LFMDWorkingCapitalLoanMember_260" xlink:type="arc" order="261" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_340" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_340" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_340" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_340" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentRate" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentRate_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentRate_340" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_340" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1_340" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_DebtConversionInterestValue" xlink:label="loc_LFMDDebtConversionInterestValue_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDDebtConversionInterestValue_340" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayable_340" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_340" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_340" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_340" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount_340" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaapDeferredFinanceCostsNet_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredFinanceCostsNet_340" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromNotesPayable_340" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount_340" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRepaymentsOfNotesPayable_340" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="loc_us-gaapDebtInstrumentAnnualPrincipalPayment_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentAnnualPrincipalPayment_340" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt_340" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpenseDebt_340" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_340" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_340" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_340" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="loc_us-gaapProceedsFromShortTermDebt_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromShortTermDebt_340" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ServiceCharge" xlink:label="loc_LFMDServiceCharge_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDServiceCharge_340" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable_340" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent_340" xlink:type="arc" order="26" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000031 - Disclosure - Stockholders&apos; Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SeriesBConvertiblePreferredStockMember" xlink:label="loc_LFMDSeriesBConvertiblePreferredStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_LFMDSeriesBConvertiblePreferredStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ClassAWarrantMember" xlink:label="loc_LFMDClassAWarrantMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_LFMDClassAWarrantMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_600" xlink:type="arc" order="603" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SecuritiesPurchaseAgreementMember" xlink:label="loc_LFMDSecuritiesPurchaseAgreementMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDSecuritiesPurchaseAgreementMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_WarrantPurchaseAgreementMember" xlink:label="loc_LFMDWarrantPurchaseAgreementMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDWarrantPurchaseAgreementMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ConsultingAgreementMember" xlink:label="loc_LFMDConsultingAgreementMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDConsultingAgreementMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PrivatePlacementOfferingMember" xlink:label="loc_LFMDPrivatePlacementOfferingMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDPrivatePlacementOfferingMember_250" xlink:type="arc" order="251" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PurchaseAgreementMember" xlink:label="loc_LFMDPurchaseAgreementMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDPurchaseAgreementMember_280" xlink:type="arc" order="281" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MembershipInterestPurchaseAgreementMember" xlink:label="loc_LFMDMembershipInterestPurchaseAgreementMember_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDMembershipInterestPurchaseAgreementMember_350" xlink:type="arc" order="351" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ServicesAgreementMember" xlink:label="loc_LFMDServicesAgreementMember_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDServicesAgreementMember_610" xlink:type="arc" order="612" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AmendedCAOEmploymentAgreementMember" xlink:label="loc_LFMDAmendedCAOEmploymentAgreementMember_700" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDAmendedCAOEmploymentAgreementMember_700" xlink:type="arc" order="701" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandTwentyPlanMember" xlink:label="loc_LFMDTwoThousandTwentyPlanMember_750" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDTwoThousandTwentyPlanMember_750" xlink:type="arc" order="751" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_NoteRepaymentAndWarrantAmendmentAgreementMember" xlink:label="loc_LFMDNoteRepaymentAndWarrantAmendmentAgreementMember_860" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDNoteRepaymentAndWarrantAmendmentAgreementMember_860" xlink:type="arc" order="861" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandAndNineteenAlphaAmendmentMember" xlink:label="loc_LFMDTwoThousandAndNineteenAlphaAmendmentMember_890" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDTwoThousandAndNineteenAlphaAmendmentMember_890" xlink:type="arc" order="891" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SecondAlphaWarrantAmendmentMember" xlink:label="loc_LFMDSecondAlphaWarrantAmendmentMember_920" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDSecondAlphaWarrantAmendmentMember_920" xlink:type="arc" order="921" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandAndEighteenBrioWarrantAmendmentMember" xlink:label="loc_LFMDTwoThousandAndEighteenBrioWarrantAmendmentMember_960" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDTwoThousandAndEighteenBrioWarrantAmendmentMember_960" xlink:type="arc" order="961" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AmendedConsultingAgreementMember" xlink:label="loc_LFMDAmendedConsultingAgreementMember_1060" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDAmendedConsultingAgreementMember_1060" xlink:type="arc" order="1061" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_200" xlink:type="arc" order="202" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_480" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_480" xlink:type="arc" order="481" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_BrioWarrantsMember" xlink:label="loc_LFMDBrioWarrantsMember_1040" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_LFMDBrioWarrantsMember_1040" xlink:type="arc" order="1041" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_BTIGLLCMember" xlink:label="loc_LFMDBTIGLLCMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDBTIGLLCMember_270" xlink:type="arc" order="271" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AlphaCapitalAnstaltMember" xlink:label="loc_LFMDAlphaCapitalAnstaltMember_860" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDAlphaCapitalAnstaltMember_860" xlink:type="arc" order="862" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_BrioMasterFundMember" xlink:label="loc_LFMDBrioMasterFundMember_960" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDBrioMasterFundMember_960" xlink:type="arc" order="962" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_BlueHorizonConsultingLLCMember" xlink:label="loc_LFMDBlueHorizonConsultingLLCMember_1060" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDBlueHorizonConsultingLLCMember_1060" xlink:type="arc" order="1062" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MayTwoThousandAndTwentyNotesMember" xlink:label="loc_LFMDMayTwoThousandAndTwentyNotesMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_LFMDMayTwoThousandAndTwentyNotesMember_300" xlink:type="arc" order="301" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_OptionsAndWarrantsMember" xlink:label="loc_LFMDOptionsAndWarrantsMember_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDOptionsAndWarrantsMember_340" xlink:type="arc" order="341" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_FirstMilestoneMember" xlink:label="loc_LFMDFirstMilestoneMember_390" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDFirstMilestoneMember_390" xlink:type="arc" order="392" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SecondMileSStoneMember" xlink:label="loc_LFMDSecondMileSStoneMember_420" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDSecondMileSStoneMember_420" xlink:type="arc" order="422" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandTwentyPlanMember" xlink:label="loc_LFMDTwoThousandTwentyPlanMember_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDTwoThousandTwentyPlanMember_600" xlink:type="arc" order="602" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ServiceBasedStockOptionsMember" xlink:label="loc_LFMDServiceBasedStockOptionsMember_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDServiceBasedStockOptionsMember_610" xlink:type="arc" order="613" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_DecemberEightTwoThousandAndTwentyThreeMember" xlink:label="loc_LFMDDecemberEightTwoThousandAndTwentyThreeMember_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDDecemberEightTwoThousandAndTwentyThreeMember_720" xlink:type="arc" order="723" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_730" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_730" xlink:type="arc" order="731" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AugustTwoThousandAndTwentyWarrantInducementMember" xlink:label="loc_LFMDAugustTwoThousandAndTwentyWarrantInducementMember_810" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDAugustTwoThousandAndTwentyWarrantInducementMember_810" xlink:type="arc" order="811" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandAndEighteenAlphaNoteMember" xlink:label="loc_LFMDTwoThousandAndEighteenAlphaNoteMember_860" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDTwoThousandAndEighteenAlphaNoteMember_860" xlink:type="arc" order="863" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandAndEighteenAlphaWarrantMember" xlink:label="loc_LFMDTwoThousandAndEighteenAlphaWarrantMember_870" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDTwoThousandAndEighteenAlphaWarrantMember_870" xlink:type="arc" order="872" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandAndNineteenAlphaWarrantMember" xlink:label="loc_LFMDTwoThousandAndNineteenAlphaWarrantMember_890" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDTwoThousandAndNineteenAlphaWarrantMember_890" xlink:type="arc" order="893" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AugustTwoThousandAndNineteenWarrantMember" xlink:label="loc_LFMDAugustTwoThousandAndNineteenWarrantMember_920" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDAugustTwoThousandAndNineteenWarrantMember_920" xlink:type="arc" order="922" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandAndEighteenBrioWarrantMember" xlink:label="loc_LFMDTwoThousandAndEighteenBrioWarrantMember_960" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDTwoThousandAndEighteenBrioWarrantMember_960" xlink:type="arc" order="963" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_BrioTwoThousandAndNineteenWarrantMember" xlink:label="loc_LFMDBrioTwoThousandAndNineteenWarrantMember_980" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDBrioTwoThousandAndNineteenWarrantMember_980" xlink:type="arc" order="983" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaapPerformanceSharesMember_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapPerformanceSharesMember_1090" xlink:type="arc" order="1091" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CVLBPRMember" xlink:label="loc_LFMDCVLBPRMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDCVLBPRMember_360" xlink:type="arc" order="361" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MrSchreiberMember" xlink:label="loc_LFMDMrSchreiberMember_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDMrSchreiberMember_370" xlink:type="arc" order="372" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MrGalluppiMember" xlink:label="loc_LFMDMrGalluppiMember_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDMrGalluppiMember_380" xlink:type="arc" order="382" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember_510" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_us-gaapInvestorMember_510" xlink:type="arc" order="511" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_BoardOfDirectorsMember" xlink:label="loc_LFMDBoardOfDirectorsMember_540" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDBoardOfDirectorsMember_540" xlink:type="arc" order="541" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ChiefExecutiveOfficerAndChiefTechnologyOfficerMember" xlink:label="loc_LFMDChiefExecutiveOfficerAndChiefTechnologyOfficerMember_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDChiefExecutiveOfficerAndChiefTechnologyOfficerMember_580" xlink:type="arc" order="581" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MrSeanFitzpatrickMember" xlink:label="loc_LFMDMrSeanFitzpatrickMember_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDMrSeanFitzpatrickMember_610" xlink:type="arc" order="611" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_EmployeesAnddvisoryBoardMembersMember" xlink:label="loc_LFMDEmployeesAnddvisoryBoardMembersMember_640" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDEmployeesAnddvisoryBoardMembersMember_640" xlink:type="arc" order="641" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ChiefComplianceOfficerMember" xlink:label="loc_LFMDChiefComplianceOfficerMember_670" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDChiefComplianceOfficerMember_670" xlink:type="arc" order="671" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_NewChiefOperatingOfficerMember" xlink:label="loc_LFMDNewChiefOperatingOfficerMember_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDNewChiefOperatingOfficerMember_680" xlink:type="arc" order="681" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_600" xlink:type="arc" order="601" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_1120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_1120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_1120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_1120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_UndesignatedPreferredStock" xlink:label="loc_LFMDUndesignatedPreferredStock_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDUndesignatedPreferredStock_1120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit_1120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits_1120" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_1120" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SharesIssuedPricePerSharePreSplit" xlink:label="loc_LFMDSharesIssuedPricePerSharePreSplit_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDSharesIssuedPricePerSharePreSplit_1120" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="loc_us-gaapPreferredStockDividendRatePercentage_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockDividendRatePercentage_1120" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_1120" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_NumberOfStockIssuedPreSplit" xlink:label="loc_LFMDNumberOfStockIssuedPreSplit_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDNumberOfStockIssuedPreSplit_1120" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1120" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_1120" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1120" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_1120" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_1120" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1_1120" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:label="loc_us-gaapPreferredStockDividendsAndOtherAdjustments_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockDividendsAndOtherAdjustments_1120" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PreferredStockRedemptionFeatureValue" xlink:label="loc_LFMDPreferredStockRedemptionFeatureValue_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDPreferredStockRedemptionFeatureValue_1120" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PutLiabilityIncrease" xlink:label="loc_LFMDPutLiabilityIncrease_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDPutLiabilityIncrease_1120" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockValue_1120" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_WarrantPurchasePrice" xlink:label="loc_LFMDWarrantPurchasePrice_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDWarrantPurchasePrice_1120" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_1120" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_1120" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding_1120" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfFinancingCosts_1120" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_UnamortizedCosts" xlink:label="loc_LFMDUnamortizedCosts_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDUnamortizedCosts_1120" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate_1120" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_GrossProceedsFromOffering" xlink:label="loc_LFMDGrossProceedsFromOffering_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDGrossProceedsFromOffering_1120" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable_1120" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt_1120" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_1120" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_1120" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_1120" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_1120" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CashlessExerciseOfOptionsShares" xlink:label="loc_LFMDCashlessExerciseOfOptionsShares_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDCashlessExerciseOfOptionsShares_1120" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CashlessExerciseOfWarrantsShares" xlink:label="loc_LFMDCashlessExerciseOfWarrantsShares_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDCashlessExerciseOfWarrantsShares_1120" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_IssuedWarrantsInConjunctionWithStock" xlink:label="loc_LFMDIssuedWarrantsInConjunctionWithStock_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDIssuedWarrantsInConjunctionWithStock_1120" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_IssuedWarrantsInConjunctionWithDebt" xlink:label="loc_LFMDIssuedWarrantsInConjunctionWithDebt_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDIssuedWarrantsInConjunctionWithDebt_1120" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MembershipInterestPercentage" xlink:label="loc_LFMDMembershipInterestPercentage_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDMembershipInterestPercentage_1120" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_1120" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AggregateExpenses" xlink:label="loc_LFMDAggregateExpenses_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDAggregateExpenses_1120" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_1120" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_1120" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_NumberOfSharesIssuedForExerciseOfWarrants" xlink:label="loc_LFMDNumberOfSharesIssuedForExerciseOfWarrants_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDNumberOfSharesIssuedForExerciseOfWarrants_1120" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_NumberOfSharesIssuedForExerciseOfWarrantsValue" xlink:label="loc_LFMDNumberOfSharesIssuedForExerciseOfWarrantsValue_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDNumberOfSharesIssuedForExerciseOfWarrantsValue_1120" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants_1120" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodSharesIssuedForShareLiability" xlink:label="loc_LFMDStockIssuedDuringPeriodSharesIssuedForShareLiability_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDStockIssuedDuringPeriodSharesIssuedForShareLiability_1120" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SharesIssuedForLiability" xlink:label="loc_LFMDSharesIssuedForLiability_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDSharesIssuedForLiability_1120" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_1120" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_1120" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="loc_us-gaapPaymentsToMinorityShareholders_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToMinorityShareholders_1120" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PurchasedRemainingInterestPercentage" xlink:label="loc_LFMDPurchasedRemainingInterestPercentage_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDPurchasedRemainingInterestPercentage_1120" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_1120" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_1120" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_1120" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_1120" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_RemainingPerformanceOptions" xlink:label="loc_LFMDRemainingPerformanceOptions_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDRemainingPerformanceOptions_1120" xlink:type="arc" order="58" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1120" xlink:type="arc" order="59" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1120" xlink:type="arc" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_1120" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1120" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1120" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1120" xlink:type="arc" order="64" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_OptionsVestingDate" xlink:label="loc_LFMDOptionsVestingDate_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDOptionsVestingDate_1120" xlink:type="arc" order="65" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:label="loc_us-gaapEmployeeBenefitsAndShareBasedCompensation_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeBenefitsAndShareBasedCompensation_1120" xlink:type="arc" order="66" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_UnamortizedExpense" xlink:label="loc_LFMDUnamortizedExpense_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDUnamortizedExpense_1120" xlink:type="arc" order="67" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_1120" xlink:type="arc" order="68" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_WarrantDiscountPricePerShare" xlink:label="loc_LFMDWarrantDiscountPricePerShare_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDWarrantDiscountPricePerShare_1120" xlink:type="arc" order="69" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_DeemedDistributionFromWarrantPriceAdjustments" xlink:label="loc_LFMDDeemedDistributionFromWarrantPriceAdjustments_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDDeemedDistributionFromWarrantPriceAdjustments_1120" xlink:type="arc" order="70" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromWarrantExercises_1120" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_1120" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_1120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_1120" xlink:type="arc" order="73" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/StockholdersEquity-ScheduleOfOptionActivityDetails" xlink:title="00000032 - Disclosure - Stockholders&apos; Equity - Schedule of Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandTwentyPlanMember" xlink:label="loc_LFMDTwoThousandTwentyPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_LFMDTwoThousandTwentyPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ServiceBasedStockOptionsMember" xlink:label="loc_LFMDServiceBasedStockOptionsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDServiceBasedStockOptionsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaapPerformanceSharesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapPerformanceSharesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice_100" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice" xlink:label="loc_LFMDShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice_100" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice" xlink:label="loc_LFMDShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice_100" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice" xlink:label="loc_LFMDShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice_100" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning_100" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice_100" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife_100" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife_100" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife_100" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife_100" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne_100" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning" xlink:label="loc_LFMDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning_100" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_100" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_100" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_100" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_100" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_100" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_100" xlink:type="arc" order="26" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/StockholdersEquity-ScheduleOfWarrantOutstandingAndExercisableDetails" xlink:title="00000033 - Disclosure - Stockholders&apos; Equity - Schedule of Warrant Outstanding and Exercisable (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice" xlink:label="loc_LFMDShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice" xlink:label="loc_LFMDShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisedAndExpiredWeightedAverageContractualLife" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisedAndExpiredWeightedAverageContractualLife_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisedAndExpiredWeightedAverageContractualLife_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm" xlink:label="loc_LFMDSharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDSharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_40" xlink:type="arc" order="22" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/LeasesDetailsNarrative" xlink:title="00000034 - Disclosure - Leases (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_LeaseAgreementOneMember" xlink:label="loc_LFMDLeaseAgreementOneMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDLeaseAgreementOneMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_LeaseAgreementTwoMember" xlink:label="loc_LFMDLeaseAgreementTwoMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDLeaseAgreementTwoMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaapLeaseAndRentalExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLeaseAndRentalExpense_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaapLesseeOperatingLeaseTermOfContract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseTermOfContract_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaapLeaseExpirationDate1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLeaseExpirationDate1_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSecurityDeposit_90" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/Leases-ScheduleOfLeasesDetails" xlink:title="00000035 - Disclosure - Leases - Schedule of Leases (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000036 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PilarisLaboratoriesLLCMember" xlink:label="loc_LFMDPilarisLaboratoriesLLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDPilarisLaboratoriesLLCMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MALPHABETLLCMember" xlink:label="loc_LFMDMALPHABETLLCMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDMALPHABETLLCMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CVLBPRMember" xlink:label="loc_LFMDCVLBPRMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_LFMDCVLBPRMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_OneEightyDayAnniversaryAgreementMember" xlink:label="loc_LFMDOneEightyDayAnniversaryAgreementMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDOneEightyDayAnniversaryAgreementMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ThreeSiXFiveDayAnniversaryAgreementMember" xlink:label="loc_LFMDThreeSiXFiveDayAnniversaryAgreementMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDThreeSiXFiveDayAnniversaryAgreementMember_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_OneTwentyDayAnniversaryAgreementMember" xlink:label="loc_LFMDOneTwentyDayAnniversaryAgreementMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDOneTwentyDayAnniversaryAgreementMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ThreeSixtyDayAnniversaryAgreementMember" xlink:label="loc_LFMDThreeSixtyDayAnniversaryAgreementMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDThreeSixtyDayAnniversaryAgreementMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SubscriptionAgreementMember" xlink:label="loc_LFMDSubscriptionAgreementMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDSubscriptionAgreementMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_EmploymentAndConsultingAgreementsMember" xlink:label="loc_LFMDEmploymentAndConsultingAgreementsMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDEmploymentAndConsultingAgreementsMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CommonStockOneMember" xlink:label="loc_LFMDCommonStockOneMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_LFMDCommonStockOneMember_130" xlink:type="arc" order="132" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CommonStockTwoMember" xlink:label="loc_LFMDCommonStockTwoMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_LFMDCommonStockTwoMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CommonStockThreeMember" xlink:label="loc_LFMDCommonStockThreeMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_LFMDCommonStockThreeMember_150" xlink:type="arc" order="152" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_200" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsPercentageAssumedToNet" xlink:label="loc_us-gaapPremiumsPercentageAssumedToNet_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPremiumsPercentageAssumedToNet_200" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntercompanyAgreementsDescription" xlink:label="loc_us-gaapIntercompanyAgreementsDescription_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIntercompanyAgreementsDescription_200" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PerformanceFee" xlink:label="loc_LFMDPerformanceFee_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDPerformanceFee_200" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_LicenseFee" xlink:label="loc_LFMDLicenseFee_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDLicenseFee_200" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_200" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_200" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_200" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PercentageForRoyalty" xlink:label="loc_LFMDPercentageForRoyalty_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDPercentageForRoyalty_200" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_200" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_200" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_200" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_200" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaapPurchaseObligation_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPurchaseObligation_200" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ExpiringAgreementDescription" xlink:label="loc_LFMDExpiringAgreementDescription_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDExpiringAgreementDescription_200" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000037 - Disclosure - Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PresidentAndCEOMember" xlink:label="loc_LFMDPresidentAndCEOMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDPresidentAndCEOMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srtChiefExecutiveOfficerMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefExecutiveOfficerMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefOperatingOfficerMember" xlink:label="loc_srtChiefOperatingOfficerMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefOperatingOfficerMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_OfficeSpaceMember" xlink:label="loc_LFMDOfficeSpaceMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_LFMDOfficeSpaceMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PuertoRicoOfficeSpaceMember" xlink:label="loc_LFMDPuertoRicoOfficeSpaceMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_LFMDPuertoRicoOfficeSpaceMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_JLSVenturesLLCMember" xlink:label="loc_LFMDJLSVenturesLLCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDJLSVenturesLLCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_BVGlobalFulfillmentMember" xlink:label="loc_LFMDBVGlobalFulfillmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDBVGlobalFulfillmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PromissoryNoteMember" xlink:label="loc_LFMDPromissoryNoteMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_LFMDPromissoryNoteMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_srtDirectorMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ExchangeAgreementMember" xlink:label="loc_LFMDExchangeAgreementMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDExchangeAgreementMember_90" xlink:type="arc" order="93" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ConsultingAgreementMember" xlink:label="loc_LFMDConsultingAgreementMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDConsultingAgreementMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRent_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MonthlyFees" xlink:label="loc_LFMDMonthlyFees_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDMonthlyFees_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromNotesPayable_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_140" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_140" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_140" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_140" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_140" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/IncomeTaxes-DetailsNarrative" xlink:title="00000038 - Disclosure - Income Taxes - (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/IncomeTaxes-ScheduleOfIncomeTaxProvisionChargesDetails" xlink:title="00000039 - Disclosure - Income Taxes - Schedule of Income Tax Provision Charges (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/IncomeTaxes-ScheduleOfProvisionDiffersFromAmountOfIncomeTaxDetails" xlink:title="00000040 - Disclosure - Income Taxes - Schedule of Provision Differs from the Amount of Income Tax (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/IncomeTaxes-ScheduleOfNetDeferredTaxLiabilitiesDetails" xlink:title="00000041 - Disclosure - Income Taxes - Schedule of Net Deferred Tax Liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://lifemd.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000042 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ChiefDigitalOfficerMember" xlink:label="loc_LFMDChiefDigitalOfficerMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDChiefDigitalOfficerMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ChiefMedicalOfficerMember" xlink:label="loc_LFMDChiefMedicalOfficerMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDChiefMedicalOfficerMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_FoundingMembersMIPAsMember" xlink:label="loc_LFMDFoundingMembersMIPAsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDFoundingMembersMIPAsMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ChiefBusinessOfficerMember" xlink:label="loc_LFMDChiefBusinessOfficerMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDChiefBusinessOfficerMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefFinancialOfficerMember" xlink:label="loc_srtChiefFinancialOfficerMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefFinancialOfficerMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_InvestorsMember" xlink:label="loc_LFMDInvestorsMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDInvestorsMember_160" xlink:type="arc" order="163" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_EmploymentAgreementMember" xlink:label="loc_LFMDEmploymentAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDEmploymentAgreementMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_FebruaryTwoThousandTwentyOnePurchaseAgreementMember" xlink:label="loc_LFMDFebruaryTwoThousandTwentyOnePurchaseAgreementMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDFebruaryTwoThousandTwentyOnePurchaseAgreementMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_0" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapVestingAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheOneMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheOneMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_VestingOnEffectiveDateMember" xlink:label="loc_LFMDVestingOnEffectiveDateMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_LFMDVestingOnEffectiveDateMember_110" xlink:type="arc" order="114" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheTwoMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheTwoMember_130" xlink:type="arc" order="134" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheThreeMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheThreeMember_140" xlink:type="arc" order="144" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CVLBPRMember" xlink:label="loc_LFMDCVLBPRMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_LFMDCVLBPRMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PaycheckProtectionProgramMember" xlink:label="loc_LFMDPaycheckProtectionProgramMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_LFMDPaycheckProtectionProgramMember_190" xlink:type="arc" order="192" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ConversionLabsPRLLCMember" xlink:label="loc_LFMDConversionLabsPRLLCMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDConversionLabsPRLLCMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtConsolidatedEntitiesAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_LegalSimpliSoftwareLlcMember" xlink:label="loc_LFMDLegalSimpliSoftwareLlcMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_LFMDLegalSimpliSoftwareLlcMember_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_100" xlink:type="arc" order="103" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_210" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_210" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_OptionsVestingDate" xlink:label="loc_LFMDOptionsVestingDate_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDOptionsVestingDate_210" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayable_210" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_210" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_210" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_210" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_210" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_210" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_210" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_210" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_210" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_210" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_210" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_210" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_210" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_210" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_210" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDecreaseForgiveness" xlink:label="loc_us-gaapDebtInstrumentDecreaseForgiveness_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentDecreaseForgiveness_210" xlink:type="arc" order="18" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>23
<FILENAME>lfmd-20201231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: LFMD %2D 20201231 10K FY DFN.xfr; Date: 2021%2D03%2D30T19:46:43Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ImmudynePrLlcMember" xlink:label="LFMD_ImmudynePrLlcMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ImmudynePrLlcMember" xlink:to="LFMD_ImmudynePrLlcMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ImmudynePrLlcMember_lbl" xml:lang="en-US">Immudyne PR LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_LegalSimpliSoftwareLlcMember" xlink:label="LFMD_LegalSimpliSoftwareLlcMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_LegalSimpliSoftwareLlcMember" xlink:to="LFMD_LegalSimpliSoftwareLlcMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_LegalSimpliSoftwareLlcMember_lbl" xml:lang="en-US">LegalSimpli Software, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CustomerRelationshipAssetMember" xlink:label="LFMD_CustomerRelationshipAssetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CustomerRelationshipAssetMember" xlink:to="LFMD_CustomerRelationshipAssetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_CustomerRelationshipAssetMember_lbl" xml:lang="en-US">Customer Relationship Asset [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PurchasedLicensesMember" xlink:label="LFMD_PurchasedLicensesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PurchasedLicensesMember" xlink:to="LFMD_PurchasedLicensesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_PurchasedLicensesMember_lbl" xml:lang="en-US">Purchased Licenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_LeaseAgreementOneMember" xlink:label="LFMD_LeaseAgreementOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_LeaseAgreementOneMember" xlink:to="LFMD_LeaseAgreementOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_LeaseAgreementOneMember_lbl" xml:lang="en-US">Lease Agreement One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ServiceBasedStockOptionsMember" xlink:label="LFMD_ServiceBasedStockOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ServiceBasedStockOptionsMember" xlink:to="LFMD_ServiceBasedStockOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ServiceBasedStockOptionsMember_lbl" xml:lang="en-US">Service-Based Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PerformanceSharesMember" xlink:to="us-gaap_PerformanceSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PerformanceSharesMember_lbl" xml:lang="en-US">Performance-Based Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PilarisLaboratoriesLLCMember" xlink:label="LFMD_PilarisLaboratoriesLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PilarisLaboratoriesLLCMember" xlink:to="LFMD_PilarisLaboratoriesLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_PilarisLaboratoriesLLCMember_lbl" xml:lang="en-US">Pilaris Laboratories, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CVLBPRMember" xlink:label="LFMD_CVLBPRMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CVLBPRMember" xlink:to="LFMD_CVLBPRMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_CVLBPRMember_lbl" xml:lang="en-US">CVLB PR [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_OneEightyDayAnniversaryAgreementMember" xlink:label="LFMD_OneEightyDayAnniversaryAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_OneEightyDayAnniversaryAgreementMember" xlink:to="LFMD_OneEightyDayAnniversaryAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_OneEightyDayAnniversaryAgreementMember_lbl" xml:lang="en-US">180 Day Anniversary Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ThreeSiXFiveDayAnniversaryAgreementMember" xlink:label="LFMD_ThreeSiXFiveDayAnniversaryAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ThreeSiXFiveDayAnniversaryAgreementMember" xlink:to="LFMD_ThreeSiXFiveDayAnniversaryAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ThreeSiXFiveDayAnniversaryAgreementMember_lbl" xml:lang="en-US">365 Day Anniversary Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SubscriptionAgreementMember" xlink:label="LFMD_SubscriptionAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SubscriptionAgreementMember" xlink:to="LFMD_SubscriptionAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_SubscriptionAgreementMember_lbl" xml:lang="en-US">Subscription Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MALPHABETLLCMember" xlink:label="LFMD_MALPHABETLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_MALPHABETLLCMember" xlink:to="LFMD_MALPHABETLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_MALPHABETLLCMember_lbl" xml:lang="en-US">M.Alphabet, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_OneTwentyDayAnniversaryAgreementMember" xlink:label="LFMD_OneTwentyDayAnniversaryAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_OneTwentyDayAnniversaryAgreementMember" xlink:to="LFMD_OneTwentyDayAnniversaryAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_OneTwentyDayAnniversaryAgreementMember_lbl" xml:lang="en-US">120 Day Anniversary Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ThreeSixtyDayAnniversaryAgreementMember" xlink:label="LFMD_ThreeSixtyDayAnniversaryAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ThreeSixtyDayAnniversaryAgreementMember" xlink:to="LFMD_ThreeSixtyDayAnniversaryAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ThreeSixtyDayAnniversaryAgreementMember_lbl" xml:lang="en-US">360 Day Anniversary Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CommonStockOneMember" xlink:label="LFMD_CommonStockOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CommonStockOneMember" xlink:to="LFMD_CommonStockOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_CommonStockOneMember_lbl" xml:lang="en-US">Common Stock One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CommonStockTwoMember" xlink:label="LFMD_CommonStockTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CommonStockTwoMember" xlink:to="LFMD_CommonStockTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_CommonStockTwoMember_lbl" xml:lang="en-US">Common Stock Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CommonStockThreeMember" xlink:label="LFMD_CommonStockThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CommonStockThreeMember" xlink:to="LFMD_CommonStockThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_CommonStockThreeMember_lbl" xml:lang="en-US">Common Stock Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_BVGlobalFulfillmentMember" xlink:label="LFMD_BVGlobalFulfillmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_BVGlobalFulfillmentMember" xlink:to="LFMD_BVGlobalFulfillmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_BVGlobalFulfillmentMember_lbl" xml:lang="en-US">BV Global Fulfillment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesMember_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoManufacturersMember" xlink:label="LFMD_TwoManufacturersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_TwoManufacturersMember" xlink:to="LFMD_TwoManufacturersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_TwoManufacturersMember_lbl" xml:lang="en-US">Two Manufacturers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SecuritiesPurchaseAgreementMember" xlink:label="LFMD_SecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SecuritiesPurchaseAgreementMember" xlink:to="LFMD_SecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_SecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" xlink:label="LFMD_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" xlink:to="LFMD_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember_lbl" xml:lang="en-US">Alpha Capital Anstalt and Brio Capital Master Fund Ltd. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoAccreditedInvestorsMember" xlink:label="LFMD_TwoAccreditedInvestorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_TwoAccreditedInvestorsMember" xlink:to="LFMD_TwoAccreditedInvestorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_TwoAccreditedInvestorsMember_lbl" xml:lang="en-US">Two Accredited Investors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_NoteRepaymentAndWarrantAmendmentAgreementMember" xlink:label="LFMD_NoteRepaymentAndWarrantAmendmentAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_NoteRepaymentAndWarrantAmendmentAgreementMember" xlink:to="LFMD_NoteRepaymentAndWarrantAmendmentAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_NoteRepaymentAndWarrantAmendmentAgreementMember_lbl" xml:lang="en-US">Note Repayment and Warrant Amendment Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CSixPurchaseAgreementOneMember" xlink:label="LFMD_CSixPurchaseAgreementOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CSixPurchaseAgreementOneMember" xlink:to="LFMD_CSixPurchaseAgreementOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_CSixPurchaseAgreementOneMember_lbl" xml:lang="en-US">C6 Purchase Agreement One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CSixCapitalLLCMember" xlink:label="LFMD_CSixCapitalLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CSixCapitalLLCMember" xlink:to="LFMD_CSixCapitalLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_CSixCapitalLLCMember_lbl" xml:lang="en-US">C6 Capital, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CSixPurchaseAgreementTwoMember" xlink:label="LFMD_CSixPurchaseAgreementTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CSixPurchaseAgreementTwoMember" xlink:to="LFMD_CSixPurchaseAgreementTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_CSixPurchaseAgreementTwoMember_lbl" xml:lang="en-US">C6 Purchase Agreement Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CSixPurchaseAgreementsOneMember" xlink:label="LFMD_CSixPurchaseAgreementsOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CSixPurchaseAgreementsOneMember" xlink:to="LFMD_CSixPurchaseAgreementsOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_CSixPurchaseAgreementsOneMember_lbl" xml:lang="en-US">C6 Purchase Agreements One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CSixPurchaseAgreementsTwoMember" xlink:label="LFMD_CSixPurchaseAgreementsTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CSixPurchaseAgreementsTwoMember" xlink:to="LFMD_CSixPurchaseAgreementsTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_CSixPurchaseAgreementsTwoMember_lbl" xml:lang="en-US">C6 Purchase Agreements Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CSixPurchaseAgreementsMember" xlink:label="LFMD_CSixPurchaseAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CSixPurchaseAgreementsMember" xlink:to="LFMD_CSixPurchaseAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_CSixPurchaseAgreementsMember_lbl" xml:lang="en-US">C6 Purchase Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_DailyAveragePaymentMember" xlink:label="LFMD_DailyAveragePaymentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_DailyAveragePaymentMember" xlink:to="LFMD_DailyAveragePaymentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_DailyAveragePaymentMember_lbl" xml:lang="en-US">Daily Average Payment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoCSixPurchaseAgreementsMember" xlink:label="LFMD_TwoCSixPurchaseAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_TwoCSixPurchaseAgreementsMember" xlink:to="LFMD_TwoCSixPurchaseAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_TwoCSixPurchaseAgreementsMember_lbl" xml:lang="en-US">Two C6 Purchase Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PresidentAndCEOMember" xlink:label="LFMD_PresidentAndCEOMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PresidentAndCEOMember" xlink:to="LFMD_PresidentAndCEOMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_PresidentAndCEOMember_lbl" xml:lang="en-US">President and CEO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_OfficeSpaceMember" xlink:label="LFMD_OfficeSpaceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_OfficeSpaceMember" xlink:to="LFMD_OfficeSpaceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_OfficeSpaceMember_lbl" xml:lang="en-US">Office Space [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_JLSVenturesLLCMember" xlink:label="LFMD_JLSVenturesLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_JLSVenturesLLCMember" xlink:to="LFMD_JLSVenturesLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_JLSVenturesLLCMember_lbl" xml:lang="en-US">JLS Ventures, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PuertoRicoOfficeSpaceMember" xlink:label="LFMD_PuertoRicoOfficeSpaceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PuertoRicoOfficeSpaceMember" xlink:to="LFMD_PuertoRicoOfficeSpaceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_PuertoRicoOfficeSpaceMember_lbl" xml:lang="en-US">Puerto Rico Office Space [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MrSeanFitzpatrickMember" xlink:label="LFMD_MrSeanFitzpatrickMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_MrSeanFitzpatrickMember" xlink:to="LFMD_MrSeanFitzpatrickMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_MrSeanFitzpatrickMember_lbl" xml:lang="en-US">Mr.Sean Fitzpatrick [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ServicesAgreementMember" xlink:label="LFMD_ServicesAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ServicesAgreementMember" xlink:to="LFMD_ServicesAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ServicesAgreementMember_lbl" xml:lang="en-US">Services Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AlphaCapitalAnstaltMember" xlink:label="LFMD_AlphaCapitalAnstaltMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AlphaCapitalAnstaltMember" xlink:to="LFMD_AlphaCapitalAnstaltMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_AlphaCapitalAnstaltMember_lbl" xml:lang="en-US">Alpha Capital Anstalt [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandAndEighteenAlphaNoteMember" xlink:label="LFMD_TwoThousandAndEighteenAlphaNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_TwoThousandAndEighteenAlphaNoteMember" xlink:to="LFMD_TwoThousandAndEighteenAlphaNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_TwoThousandAndEighteenAlphaNoteMember_lbl" xml:lang="en-US">2018 Alpha Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandAndEighteenAlphaWarrantMember" xlink:label="LFMD_TwoThousandAndEighteenAlphaWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_TwoThousandAndEighteenAlphaWarrantMember" xlink:to="LFMD_TwoThousandAndEighteenAlphaWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_TwoThousandAndEighteenAlphaWarrantMember_lbl" xml:lang="en-US">2018 Alpha Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandAndNineteenAlphaAmendmentMember" xlink:label="LFMD_TwoThousandAndNineteenAlphaAmendmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_TwoThousandAndNineteenAlphaAmendmentMember" xlink:to="LFMD_TwoThousandAndNineteenAlphaAmendmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_TwoThousandAndNineteenAlphaAmendmentMember_lbl" xml:lang="en-US">2019 Alpha Amendment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandAndNineteenAlphaWarrantMember" xlink:label="LFMD_TwoThousandAndNineteenAlphaWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_TwoThousandAndNineteenAlphaWarrantMember" xlink:to="LFMD_TwoThousandAndNineteenAlphaWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_TwoThousandAndNineteenAlphaWarrantMember_lbl" xml:lang="en-US">2019 Alpha Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandAndEighteenBrioWarrantAmendmentMember" xlink:label="LFMD_TwoThousandAndEighteenBrioWarrantAmendmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_TwoThousandAndEighteenBrioWarrantAmendmentMember" xlink:to="LFMD_TwoThousandAndEighteenBrioWarrantAmendmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_TwoThousandAndEighteenBrioWarrantAmendmentMember_lbl" xml:lang="en-US">2018 Brio Warrant Amendment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_BrioMasterFundMember" xlink:label="LFMD_BrioMasterFundMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_BrioMasterFundMember" xlink:to="LFMD_BrioMasterFundMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_BrioMasterFundMember_lbl" xml:lang="en-US">Brio Master Fund [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandAndEighteenBrioWarrantMember" xlink:label="LFMD_TwoThousandAndEighteenBrioWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_TwoThousandAndEighteenBrioWarrantMember" xlink:to="LFMD_TwoThousandAndEighteenBrioWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_TwoThousandAndEighteenBrioWarrantMember_lbl" xml:lang="en-US">2018 Brio Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_BrioTwoThousandAndNineteenWarrantMember" xlink:label="LFMD_BrioTwoThousandAndNineteenWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_BrioTwoThousandAndNineteenWarrantMember" xlink:to="LFMD_BrioTwoThousandAndNineteenWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_BrioTwoThousandAndNineteenWarrantMember_lbl" xml:lang="en-US">Brio 2019 Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember" xlink:label="us-gaap_ProductMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductMember" xlink:to="us-gaap_ProductMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductMember_lbl" xml:lang="en-US">Product Revenues, Net [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SoftwareRevenuesNetMember" xlink:label="LFMD_SoftwareRevenuesNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SoftwareRevenuesNetMember" xlink:to="LFMD_SoftwareRevenuesNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_SoftwareRevenuesNetMember_lbl" xml:lang="en-US">Software Revenues, Net [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember" xlink:label="us-gaap_ServiceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServiceMember" xlink:to="us-gaap_ServiceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ServiceMember_lbl" xml:lang="en-US">Service Revenues, Net [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="us-gaap_AwardDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardDateAxis_lbl" xml:lang="en-US">Award Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ThroughTheNextTwelveMonthsMember" xlink:label="LFMD_ThroughTheNextTwelveMonthsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ThroughTheNextTwelveMonthsMember" xlink:to="LFMD_ThroughTheNextTwelveMonthsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ThroughTheNextTwelveMonthsMember_lbl" xml:lang="en-US">Through the Next 12 Months [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MayTwoThousandAndTwentyNotesMember" xlink:label="LFMD_MayTwoThousandAndTwentyNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_MayTwoThousandAndTwentyNotesMember" xlink:to="LFMD_MayTwoThousandAndTwentyNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_MayTwoThousandAndTwentyNotesMember_lbl" xml:lang="en-US">May 2020 Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SixAccreditedInvestorsMember" xlink:label="LFMD_SixAccreditedInvestorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SixAccreditedInvestorsMember" xlink:to="LFMD_SixAccreditedInvestorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_SixAccreditedInvestorsMember_lbl" xml:lang="en-US">6 Accredited Investors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_EmployeesAnddvisoryBoardMembersMember" xlink:label="LFMD_EmployeesAnddvisoryBoardMembersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_EmployeesAnddvisoryBoardMembersMember" xlink:to="LFMD_EmployeesAnddvisoryBoardMembersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_EmployeesAnddvisoryBoardMembersMember_lbl" xml:lang="en-US">Employees and Advisory Board Members [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_EmploymentAndConsultingAgreementsMember" xlink:label="LFMD_EmploymentAndConsultingAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_EmploymentAndConsultingAgreementsMember" xlink:to="LFMD_EmploymentAndConsultingAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_EmploymentAndConsultingAgreementsMember_lbl" xml:lang="en-US">Employment and Consulting Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PaycheckProtectionProgramLoanMember" xlink:label="LFMD_PaycheckProtectionProgramLoanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PaycheckProtectionProgramLoanMember" xlink:to="LFMD_PaycheckProtectionProgramLoanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_PaycheckProtectionProgramLoanMember_lbl" xml:lang="en-US">Paycheck Protection Program Loan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_USSmallBusinessAdministrationMember" xlink:label="LFMD_USSmallBusinessAdministrationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_USSmallBusinessAdministrationMember" xlink:to="LFMD_USSmallBusinessAdministrationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_USSmallBusinessAdministrationMember_lbl" xml:lang="en-US">US Small Business Administration [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ChiefExecutiveOfficerAndChiefTechnologyOfficerMember" xlink:label="LFMD_ChiefExecutiveOfficerAndChiefTechnologyOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ChiefExecutiveOfficerAndChiefTechnologyOfficerMember" xlink:to="LFMD_ChiefExecutiveOfficerAndChiefTechnologyOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ChiefExecutiveOfficerAndChiefTechnologyOfficerMember_lbl" xml:lang="en-US">Chief Executive Officer And Chief Technology Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PurchaseAgreementMember" xlink:label="LFMD_PurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PurchaseAgreementMember" xlink:to="LFMD_PurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_PurchaseAgreementMember_lbl" xml:lang="en-US">Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Statement Class Of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xml:lang="en-US">Segments [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShapiroMDMember" xlink:label="LFMD_ShapiroMDMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShapiroMDMember" xlink:to="LFMD_ShapiroMDMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ShapiroMDMember_lbl" xml:lang="en-US">Shapiro MD [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_RexMDMember" xlink:label="LFMD_RexMDMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_RexMDMember" xlink:to="LFMD_RexMDMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_RexMDMember_lbl" xml:lang="en-US">Rex MD [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_INRWellnessMember" xlink:label="LFMD_INRWellnessMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_INRWellnessMember" xlink:to="LFMD_INRWellnessMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_INRWellnessMember_lbl" xml:lang="en-US">iNR Wellness [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ScarologyMember" xlink:label="LFMD_ScarologyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ScarologyMember" xlink:to="LFMD_ScarologyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ScarologyMember_lbl" xml:lang="en-US">Scarology [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PreSplitBasisMember" xlink:label="LFMD_PreSplitBasisMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PreSplitBasisMember" xlink:to="LFMD_PreSplitBasisMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_PreSplitBasisMember_lbl" xml:lang="en-US">Pre-Split Basis [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SeriesBConvertiblePreferredStockMember" xlink:label="LFMD_SeriesBConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SeriesBConvertiblePreferredStockMember" xlink:to="LFMD_SeriesBConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_SeriesBConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series B Convertible Preferred Stock Member</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ConsultingAgreementMember" xlink:label="LFMD_ConsultingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ConsultingAgreementMember" xlink:to="LFMD_ConsultingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ConsultingAgreementMember_lbl" xml:lang="en-US">Consulting Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_WarrantPurchaseAgreementMember" xlink:label="LFMD_WarrantPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_WarrantPurchaseAgreementMember" xlink:to="LFMD_WarrantPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_WarrantPurchaseAgreementMember_lbl" xml:lang="en-US">Warrant Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ClassAWarrantMember" xlink:label="LFMD_ClassAWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ClassAWarrantMember" xlink:to="LFMD_ClassAWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ClassAWarrantMember_lbl" xml:lang="en-US">Class A Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestorMember" xlink:label="us-gaap_InvestorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestorMember" xlink:to="us-gaap_InvestorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestorMember_lbl" xml:lang="en-US">Investor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AugustTwoThousandAndTwentyWarrantInducementMember" xlink:label="LFMD_AugustTwoThousandAndTwentyWarrantInducementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AugustTwoThousandAndTwentyWarrantInducementMember" xlink:to="LFMD_AugustTwoThousandAndTwentyWarrantInducementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_AugustTwoThousandAndTwentyWarrantInducementMember_lbl" xml:lang="en-US">August 2020 Warrant Inducement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SecondAlphaWarrantAmendmentMember" xlink:label="LFMD_SecondAlphaWarrantAmendmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SecondAlphaWarrantAmendmentMember" xlink:to="LFMD_SecondAlphaWarrantAmendmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_SecondAlphaWarrantAmendmentMember_lbl" xml:lang="en-US">Second Alpha Warrant Amendment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AugustTwoThousandAndNineteenWarrantMember" xlink:label="LFMD_AugustTwoThousandAndNineteenWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AugustTwoThousandAndNineteenWarrantMember" xlink:to="LFMD_AugustTwoThousandAndNineteenWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_AugustTwoThousandAndNineteenWarrantMember_lbl" xml:lang="en-US">August 2019 Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_BrioWarrantsMember" xlink:label="LFMD_BrioWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_BrioWarrantsMember" xlink:to="LFMD_BrioWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_BrioWarrantsMember_lbl" xml:lang="en-US">Brio Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AmendedConsultingAgreementMember" xlink:label="LFMD_AmendedConsultingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AmendedConsultingAgreementMember" xlink:to="LFMD_AmendedConsultingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_AmendedConsultingAgreementMember_lbl" xml:lang="en-US">Amended Consulting Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_BlueHorizonConsultingLLCMember" xlink:label="LFMD_BlueHorizonConsultingLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_BlueHorizonConsultingLLCMember" xlink:to="LFMD_BlueHorizonConsultingLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_BlueHorizonConsultingLLCMember_lbl" xml:lang="en-US">Blue Horizon Consulting, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ConversionLabsPrMember" xlink:label="LFMD_ConversionLabsPrMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ConversionLabsPrMember" xlink:to="LFMD_ConversionLabsPrMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ConversionLabsPrMember_lbl" xml:lang="en-US">Conversion Labs PR [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandTwentyPlanMember" xlink:label="LFMD_TwoThousandTwentyPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_TwoThousandTwentyPlanMember" xlink:to="LFMD_TwoThousandTwentyPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_TwoThousandTwentyPlanMember_lbl" xml:lang="en-US">2020 Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_InvestorsMember" xlink:label="LFMD_InvestorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_InvestorsMember" xlink:to="LFMD_InvestorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_InvestorsMember_lbl" xml:lang="en-US">Investors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SoftwareRevenueMember" xlink:label="LFMD_SoftwareRevenueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SoftwareRevenueMember" xlink:to="LFMD_SoftwareRevenueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_SoftwareRevenueMember_lbl" xml:lang="en-US">Software Revenue [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US">Customer Relationships [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PaycheckProtectionProgramLoanMember" xlink:to="LFMD_PaycheckProtectionProgramLoanMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="LFMD_PaycheckProtectionProgramLoanMember_2_lbl" xml:lang="en-US">Paycheck Protection Program [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_InnateMember" xlink:label="LFMD_InnateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_InnateMember" xlink:to="LFMD_InnateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_InnateMember_lbl" xml:lang="en-US">Innate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CVLBMediaMember" xlink:label="LFMD_CVLBMediaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CVLBMediaMember" xlink:to="LFMD_CVLBMediaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_CVLBMediaMember_lbl" xml:lang="en-US">CVLB Media [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="us-gaap_ConvertibleDebtSecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember_lbl" xml:lang="en-US">Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PrivatePlacementOfferingMember" xlink:label="LFMD_PrivatePlacementOfferingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PrivatePlacementOfferingMember" xlink:to="LFMD_PrivatePlacementOfferingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_PrivatePlacementOfferingMember_lbl" xml:lang="en-US">Private Placement Offering [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_BTIGLLCMember" xlink:label="LFMD_BTIGLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_BTIGLLCMember" xlink:to="LFMD_BTIGLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_BTIGLLCMember_lbl" xml:lang="en-US">BTIG, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_OptionsAndWarrantsMember" xlink:label="LFMD_OptionsAndWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_OptionsAndWarrantsMember" xlink:to="LFMD_OptionsAndWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_OptionsAndWarrantsMember_lbl" xml:lang="en-US">Options and Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MembershipInterestPurchaseAgreementMember" xlink:label="LFMD_MembershipInterestPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_MembershipInterestPurchaseAgreementMember" xlink:to="LFMD_MembershipInterestPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_MembershipInterestPurchaseAgreementMember_lbl" xml:lang="en-US">Membership Interest Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MrSchreiberMember" xlink:label="LFMD_MrSchreiberMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_MrSchreiberMember" xlink:to="LFMD_MrSchreiberMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_MrSchreiberMember_lbl" xml:lang="en-US">Mr. Schreiber [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MrGalluppiMember" xlink:label="LFMD_MrGalluppiMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_MrGalluppiMember" xlink:to="LFMD_MrGalluppiMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_MrGalluppiMember_lbl" xml:lang="en-US">Mr. Galluppi [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_FirstMilestoneMember" xlink:label="LFMD_FirstMilestoneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_FirstMilestoneMember" xlink:to="LFMD_FirstMilestoneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_FirstMilestoneMember_lbl" xml:lang="en-US">First Mile Stone [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SecondMileSStoneMember" xlink:label="LFMD_SecondMileSStoneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SecondMileSStoneMember" xlink:to="LFMD_SecondMileSStoneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_SecondMileSStoneMember_lbl" xml:lang="en-US">Second Mile Stone [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_BoardOfDirectorsMember" xlink:label="LFMD_BoardOfDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_BoardOfDirectorsMember" xlink:to="LFMD_BoardOfDirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_BoardOfDirectorsMember_lbl" xml:lang="en-US">Board of Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_NewChiefOperatingOfficerMember" xlink:label="LFMD_NewChiefOperatingOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_NewChiefOperatingOfficerMember" xlink:to="LFMD_NewChiefOperatingOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_NewChiefOperatingOfficerMember_lbl" xml:lang="en-US">New Chief Operating Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AmendedCAOEmploymentAgreementMember" xlink:label="LFMD_AmendedCAOEmploymentAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AmendedCAOEmploymentAgreementMember" xlink:to="LFMD_AmendedCAOEmploymentAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_AmendedCAOEmploymentAgreementMember_lbl" xml:lang="en-US">Amended CAO Employment Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_LeaseAgreementTwoMember" xlink:label="LFMD_LeaseAgreementTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_LeaseAgreementTwoMember" xlink:to="LFMD_LeaseAgreementTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_LeaseAgreementTwoMember_lbl" xml:lang="en-US">Lease Agreement Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PromissoryNoteMember" xlink:label="LFMD_PromissoryNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PromissoryNoteMember" xlink:to="LFMD_PromissoryNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_PromissoryNoteMember_lbl" xml:lang="en-US">Promissory Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_DirectorMember_lbl" xml:lang="en-US">Director [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ExchangeAgreementMember" xlink:label="LFMD_ExchangeAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ExchangeAgreementMember" xlink:to="LFMD_ExchangeAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ExchangeAgreementMember_lbl" xml:lang="en-US">Exchange Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ChiefDigitalOfficerMember" xlink:label="LFMD_ChiefDigitalOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ChiefDigitalOfficerMember" xlink:to="LFMD_ChiefDigitalOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ChiefDigitalOfficerMember_lbl" xml:lang="en-US">Chief Digital Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_EmploymentAgreementMember" xlink:label="LFMD_EmploymentAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_EmploymentAgreementMember" xlink:to="LFMD_EmploymentAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_EmploymentAgreementMember_lbl" xml:lang="en-US">Employment Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ChiefMedicalOfficerMember" xlink:label="LFMD_ChiefMedicalOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ChiefMedicalOfficerMember" xlink:to="LFMD_ChiefMedicalOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ChiefMedicalOfficerMember_lbl" xml:lang="en-US">Chief Medical Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VestingAxis_lbl" xml:lang="en-US">Vesting [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xml:lang="en-US">Share-based Payment Arrangement, Tranche One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PaycheckProtectionProgramMember" xlink:label="LFMD_PaycheckProtectionProgramMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PaycheckProtectionProgramMember" xlink:to="LFMD_PaycheckProtectionProgramMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_PaycheckProtectionProgramMember_lbl" xml:lang="en-US">Paycheck Protection Program [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ConversionLabsPRLLCMember" xlink:label="LFMD_ConversionLabsPRLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ConversionLabsPRLLCMember" xlink:to="LFMD_ConversionLabsPRLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="LFMD_ConversionLabsPRLLCMember_lbl" xml:lang="en-US">CVLB PR [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_FoundingMembersMIPAsMember" xlink:label="LFMD_FoundingMembersMIPAsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_FoundingMembersMIPAsMember" xlink:to="LFMD_FoundingMembersMIPAsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_FoundingMembersMIPAsMember_lbl" xml:lang="en-US">Founding Members MIPAs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ChiefBusinessOfficerMember" xlink:label="LFMD_ChiefBusinessOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ChiefBusinessOfficerMember" xlink:to="LFMD_ChiefBusinessOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ChiefBusinessOfficerMember_lbl" xml:lang="en-US">Chief Business Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefFinancialOfficerMember" xlink:to="srt_ChiefFinancialOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefFinancialOfficerMember_lbl" xml:lang="en-US">Chief Financial Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl" xml:lang="en-US">Share-based Payment Arrangement, Tranche Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_VestingOnEffectiveDateMember" xlink:label="LFMD_VestingOnEffectiveDateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_VestingOnEffectiveDateMember" xlink:to="LFMD_VestingOnEffectiveDateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_VestingOnEffectiveDateMember_lbl" xml:lang="en-US">Vesting On Effective Date [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_FebruaryTwoThousandTwentyOnePurchaseAgreementMember" xlink:label="LFMD_FebruaryTwoThousandTwentyOnePurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_FebruaryTwoThousandTwentyOnePurchaseAgreementMember" xlink:to="LFMD_FebruaryTwoThousandTwentyOnePurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_FebruaryTwoThousandTwentyOnePurchaseAgreementMember_lbl" xml:lang="en-US">February 2021 Purchase Agreement[Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OwnershipAxis_lbl" xml:lang="en-US">Ownership [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_WorkingCapitalLoanMember" xlink:label="LFMD_WorkingCapitalLoanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_WorkingCapitalLoanMember" xlink:to="LFMD_WorkingCapitalLoanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_WorkingCapitalLoanMember_lbl" xml:lang="en-US">Working Capital Loan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ChaseBankMember" xlink:label="LFMD_ChaseBankMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ChaseBankMember" xlink:to="LFMD_ChaseBankMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ChaseBankMember_lbl" xml:lang="en-US">Chase Bank [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ChiefComplianceOfficerMember" xlink:label="LFMD_ChiefComplianceOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ChiefComplianceOfficerMember" xlink:to="LFMD_ChiefComplianceOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ChiefComplianceOfficerMember_lbl" xml:lang="en-US">Chief Compliance Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_DecemberEightTwoThousandAndTwentyThreeMember" xlink:label="LFMD_DecemberEightTwoThousandAndTwentyThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_DecemberEightTwoThousandAndTwentyThreeMember" xlink:to="LFMD_DecemberEightTwoThousandAndTwentyThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_DecemberEightTwoThousandAndTwentyThreeMember_lbl" xml:lang="en-US">December 8, 2023 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated (Deficit) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockMember_lbl" xml:lang="en-US">Treasury Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember" xlink:label="us-gaap_ParentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ParentMember" xlink:to="us-gaap_ParentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ParentMember_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefOperatingOfficerMember" xlink:label="srt_ChiefOperatingOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefOperatingOfficerMember" xlink:to="srt_ChiefOperatingOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefOperatingOfficerMember_lbl" xml:lang="en-US">Chief Operating Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Reporting Status Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="us-gaap_DepositsAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsCurrent" xlink:to="us-gaap_DepositsAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssetsCurrent_lbl" xml:lang="en-US">Product deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventory, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US">Other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">Non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right of use asset, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="us-gaap_CapitalizedComputerSoftwareNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedComputerSoftwareNet" xlink:to="us-gaap_CapitalizedComputerSoftwareNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedComputerSoftwareNet_lbl" xml:lang="en-US">Capitalized software, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableCurrent_lbl" xml:lang="en-US">Notes payable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenue_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrentAbstract" xlink:label="us-gaap_LongTermDebtNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrentAbstract" xlink:to="us-gaap_LongTermDebtNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtNoncurrentAbstract_lbl" xml:lang="en-US">Long-term Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Lease Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ContingentConsiderationOnPurchaseOfLegalsimpli" xlink:label="LFMD_ContingentConsiderationOnPurchaseOfLegalsimpli" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ContingentConsiderationOnPurchaseOfLegalsimpli" xlink:to="LFMD_ContingentConsiderationOnPurchaseOfLegalsimpli_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ContingentConsiderationOnPurchaseOfLegalsimpli_lbl" xml:lang="en-US">Contingent consideration on purchase of LegalSimpli</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xml:lang="en-US">Deferred tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies (Note 7)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="us-gaap_TemporaryEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAbstract" xlink:to="us-gaap_TemporaryEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAbstract_lbl" xml:lang="en-US">Mezzanine Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US">Preferred Stock, $0.0001 per value; 4,996,500 and 5,000,000 shares authorized Series B Preferred Stock, $0.0001 per value; 5,000 and 0 shares authorized, 3,500 and 0 shares issued and outstanding as of December 31, 2020 and 2019, respectively; liquidation value approximately, $1,045 and $0 per share at December 31, 2020 and 2019, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders' Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.01 par value; 100,000,000 shares authorized, 23,433,663 and 10,680,730 shares issued, 23,330,623 and 10,577,690 outstanding as of December 31, 2020 and 2019, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_EquityTotal" xlink:label="LFMD_EquityTotal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_EquityTotal" xlink:to="LFMD_EquityTotal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="LFMD_EquityTotal_lbl" xml:lang="en-US">Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US">Treasury stock, 103,040 and 103,040 shares, at cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total LifeMD, Inc. Stockholders' Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">Non-controlling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total Stockholders' Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Stockholders' Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StatementClassOfStockAxis_2_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, at par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLiquidationPreference" xlink:to="us-gaap_TemporaryEquityLiquidationPreference_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xml:lang="en-US">Preferred stock, liquidation value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonShares" xlink:to="us-gaap_TreasuryStockCommonShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockCommonShares_lbl" xml:lang="en-US">Treasury stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">Net Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Total revenues, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Selling &amp; marketing expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherGeneralExpense" xlink:label="us-gaap_OtherGeneralExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralExpense" xlink:to="us-gaap_OtherGeneralExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherGeneralExpense_lbl" xml:lang="en-US">Other operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Customer service expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopmentCosts" xlink:label="us-gaap_DevelopmentCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DevelopmentCosts" xlink:to="us-gaap_DevelopmentCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DevelopmentCosts_lbl" xml:lang="en-US">Development Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Loss on debt settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Net Loss before provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net (loss) attributable to noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss attributable to LifeMD, Inc.</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:to="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments_lbl" xml:lang="en-US">Deemed distribution to holders of common and Series B Preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net loss attributable to LifeMD, Inc. common stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xml:lang="en-US">Basic loss per share attributable to LifeMD, Inc. common stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_lbl" xml:lang="en-US">Diluted loss per share attributable to LifeMD, Inc. common stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Weighted Average number of common shares outstanding:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Stock issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Stock issued for services, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Stock compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US">Stock compensation, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AgreementToIssueSharesForNoncontrollingInterest" xlink:label="LFMD_AgreementToIssueSharesForNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AgreementToIssueSharesForNoncontrollingInterest" xlink:to="LFMD_AgreementToIssueSharesForNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_AgreementToIssueSharesForNoncontrollingInterest_lbl" xml:lang="en-US">Agreement to issue shares for non-controlling interest in CVLB PR</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AgreementToIssueSharesForNoncontrollingInterestShares" xlink:label="LFMD_AgreementToIssueSharesForNoncontrollingInterestShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AgreementToIssueSharesForNoncontrollingInterestShares" xlink:to="LFMD_AgreementToIssueSharesForNoncontrollingInterestShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_AgreementToIssueSharesForNoncontrollingInterestShares_lbl" xml:lang="en-US">Agreement to issue shares for non-controlling interest in CVLB PR, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock" xlink:label="LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock" xlink:to="LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock_lbl" xml:lang="en-US">Warrants issued in conjunction with stock</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt" xlink:label="LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt" xlink:to="LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt_lbl" xml:lang="en-US">Warrants issued in conjunction with debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Purchase of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Purchase of common stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xml:lang="en-US">Distribution to non-controlling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US">Sale of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:label="LFMD_StockIssuedDuringPeriodValueExerciseOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:to="LFMD_StockIssuedDuringPeriodValueExerciseOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_StockIssuedDuringPeriodValueExerciseOfWarrants_lbl" xml:lang="en-US">Exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:label="LFMD_StockIssuedDuringPeriodSharesExerciseOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="LFMD_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_StockIssuedDuringPeriodSharesExerciseOfWarrants_lbl" xml:lang="en-US">Exercise of warrants, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercise of stock options, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CashlessExerciseOfWarrants" xlink:label="LFMD_CashlessExerciseOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CashlessExerciseOfWarrants" xlink:to="LFMD_CashlessExerciseOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_CashlessExerciseOfWarrants_lbl" xml:lang="en-US">Cashless exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CashlessExerciseOfWarrantsShares" xlink:label="LFMD_CashlessExerciseOfWarrantsShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CashlessExerciseOfWarrantsShares" xlink:to="LFMD_CashlessExerciseOfWarrantsShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_CashlessExerciseOfWarrantsShares_lbl" xml:lang="en-US">Cashless exercise of warrants, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions" xlink:label="LFMD_StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions" xlink:to="LFMD_StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions_lbl" xml:lang="en-US">Cashless exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodSharesCashlessExerciseOfStockOptions" xlink:label="LFMD_StockIssuedDuringPeriodSharesCashlessExerciseOfStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_StockIssuedDuringPeriodSharesCashlessExerciseOfStockOptions" xlink:to="LFMD_StockIssuedDuringPeriodSharesCashlessExerciseOfStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_StockIssuedDuringPeriodSharesCashlessExerciseOfStockOptions_lbl" xml:lang="en-US">Cashless exercise of stock options, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodValueSaleOfCommonStock" xlink:label="LFMD_StockIssuedDuringPeriodValueSaleOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_StockIssuedDuringPeriodValueSaleOfCommonStock" xlink:to="LFMD_StockIssuedDuringPeriodValueSaleOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_StockIssuedDuringPeriodValueSaleOfCommonStock_lbl" xml:lang="en-US">Sale of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodSharesSaleOfCommonStock" xlink:label="LFMD_StockIssuedDuringPeriodSharesSaleOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_StockIssuedDuringPeriodSharesSaleOfCommonStock" xlink:to="LFMD_StockIssuedDuringPeriodSharesSaleOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_StockIssuedDuringPeriodSharesSaleOfCommonStock_lbl" xml:lang="en-US">Sale of common stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet" xlink:label="LFMD_StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet" xlink:to="LFMD_StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet_lbl" xml:lang="en-US">Sale of stock in private placement, net</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringperiodSaleOfStockInPrivatePlacementNetShares" xlink:label="LFMD_StockIssuedDuringperiodSaleOfStockInPrivatePlacementNetShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_StockIssuedDuringperiodSaleOfStockInPrivatePlacementNetShares" xlink:to="LFMD_StockIssuedDuringperiodSaleOfStockInPrivatePlacementNetShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_StockIssuedDuringperiodSaleOfStockInPrivatePlacementNetShares_lbl" xml:lang="en-US">Sale of stock in private placement, net shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Shares issued for share liability (proceeds received in prior period)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Shares issued for share liability (proceeds received in prior period), shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xml:lang="en-US">Common stock issued for debt exchange agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xml:lang="en-US">Common stock issued for debt exchange agreement,shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Common stock issued for conversion of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Common stock issued for conversion of debt ,shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="us-gaap_DividendsCommonStockCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsCommonStockCash" xlink:to="us-gaap_DividendsCommonStockCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DividendsCommonStockCash_lbl" xml:lang="en-US">Deemed dividend from down-round provision in common stock shares yet to be issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount" xlink:label="us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount" xlink:to="us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount_lbl" xml:lang="en-US">Deemed dividend from warrant price adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="us-gaap_DividendsPreferredStockCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStockCash" xlink:to="us-gaap_DividendsPreferredStockCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPreferredStockCash_lbl" xml:lang="en-US">Deemed dividend from warrants issued and BCF with Series B Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodValueReverseStockSplits" xlink:label="LFMD_StockIssuedDuringPeriodValueReverseStockSplits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_StockIssuedDuringPeriodValueReverseStockSplits" xlink:to="LFMD_StockIssuedDuringPeriodValueReverseStockSplits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_StockIssuedDuringPeriodValueReverseStockSplits_lbl" xml:lang="en-US">Rounding due to reverse split</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl" xml:lang="en-US">Rounding due to reverse split, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProfitLoss_3_lbl" xml:lang="en-US">Net Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash (used in) provided by operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">Amortization of debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:label="us-gaap_CapitalizedComputerSoftwareAmortization1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:to="us-gaap_CapitalizedComputerSoftwareAmortization1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedComputerSoftwareAmortization1_lbl" xml:lang="en-US">Amortization of capitalized software</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of intangibles</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AccelerationOfDebtDiscount" xlink:label="LFMD_AccelerationOfDebtDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AccelerationOfDebtDiscount" xlink:to="LFMD_AccelerationOfDebtDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_AccelerationOfDebtDiscount_lbl" xml:lang="en-US">Acceleration of debt discount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xml:lang="en-US">Loss on debt settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Operating Lease Payments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Stock issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in Assets and Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerAsset_lbl" xml:lang="en-US">Product deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xml:lang="en-US">Other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash (used in) provided by operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireSoftware" xlink:label="us-gaap_PaymentsToAcquireSoftware" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireSoftware" xlink:to="us-gaap_PaymentsToAcquireSoftware_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireSoftware_lbl" xml:lang="en-US">Cash paid for capitalized software costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:label="us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:to="us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_lbl" xml:lang="en-US">Payment to seller for contingent consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xml:lang="en-US">Cash proceeds from private placement offering, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl" xml:lang="en-US">Cash proceeds from Series B Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Proceeds from convertible notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Cash proceeds from sale of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xml:lang="en-US">Cash proceeds from exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Cash proceeds from exercise of options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US">Cash proceed from sale of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xml:lang="en-US">Payment of debt issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="us-gaap_PaymentsToMinorityShareholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToMinorityShareholders" xlink:to="us-gaap_PaymentsToMinorityShareholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToMinorityShareholders_lbl" xml:lang="en-US">Distributions to non-controlling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xml:lang="en-US">Proceeds from note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Repayment of notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfEquity" xlink:label="us-gaap_PaymentsForRepurchaseOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfEquity" xlink:to="us-gaap_PaymentsForRepurchaseOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfEquity_lbl" xml:lang="en-US">Purchase of shares and warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfLoanCosts" xlink:label="us-gaap_PaymentsOfLoanCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfLoanCosts" xlink:to="us-gaap_PaymentsOfLoanCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfLoanCosts_lbl" xml:lang="en-US">Debt issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net increase in cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Cash at beginning of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash at end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CashPaidForInterestAbstract" xlink:label="LFMD_CashPaidForInterestAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CashPaidForInterestAbstract" xlink:to="LFMD_CashPaidForInterestAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_CashPaidForInterestAbstract_lbl" xml:lang="en-US">Cash paid for interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Cash paid during the period for interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Non-cash investing and financing activitites:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssued1_lbl" xml:lang="en-US">Issuance of company stock for investment in subsidiary</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CashlessExerciseOfWarrantsSupplementalDisclosure" xlink:label="LFMD_CashlessExerciseOfWarrantsSupplementalDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CashlessExerciseOfWarrantsSupplementalDisclosure" xlink:to="LFMD_CashlessExerciseOfWarrantsSupplementalDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="LFMD_CashlessExerciseOfWarrantsSupplementalDisclosure_lbl" xml:lang="en-US">Cashless exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_DeemedDividendFromWarrantPriceAdjustment" xlink:label="LFMD_DeemedDividendFromWarrantPriceAdjustment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_DeemedDividendFromWarrantPriceAdjustment" xlink:to="LFMD_DeemedDividendFromWarrantPriceAdjustment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="LFMD_DeemedDividendFromWarrantPriceAdjustment_lbl" xml:lang="en-US">Deemed dividend from warrant price adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_DeemedDistributionFromWarrantsIssuedWithPreferredStock" xlink:label="LFMD_DeemedDistributionFromWarrantsIssuedWithPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_DeemedDistributionFromWarrantsIssuedWithPreferredStock" xlink:to="LFMD_DeemedDistributionFromWarrantsIssuedWithPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_DeemedDistributionFromWarrantsIssuedWithPreferredStock_lbl" xml:lang="en-US">Deemed distribution from warrants issued with Series B Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuesForCapitalizedCosts" xlink:label="LFMD_StockIssuesForCapitalizedCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_StockIssuesForCapitalizedCosts" xlink:to="LFMD_StockIssuesForCapitalizedCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_StockIssuesForCapitalizedCosts_lbl" xml:lang="en-US">Stock yet to be issued for capitalized costs</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_DeemedDistributionFromDownroundProvisionOnUnissuedShares" xlink:label="LFMD_DeemedDistributionFromDownroundProvisionOnUnissuedShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_DeemedDistributionFromDownroundProvisionOnUnissuedShares" xlink:to="LFMD_DeemedDistributionFromDownroundProvisionOnUnissuedShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_DeemedDistributionFromDownroundProvisionOnUnissuedShares_lbl" xml:lang="en-US">Deemed distribution from down-round provision on unissued shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAssumed1" xlink:label="us-gaap_LiabilitiesAssumed1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAssumed1" xlink:to="us-gaap_LiabilitiesAssumed1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAssumed1_lbl" xml:lang="en-US">Liability to issue common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesIssued1" xlink:label="us-gaap_NotesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesIssued1" xlink:to="us-gaap_NotesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesIssued1_lbl" xml:lang="en-US">Debt issuance costs for liability to issue shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferToInvestments" xlink:label="us-gaap_TransferToInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransferToInvestments" xlink:to="us-gaap_TransferToInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransferToInvestments_lbl" xml:lang="en-US">Conversion of convertible note payable and interest for Series B Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SharesIssuedForShareLiability" xlink:label="LFMD_SharesIssuedForShareLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SharesIssuedForShareLiability" xlink:to="LFMD_SharesIssuedForShareLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_SharesIssuedForShareLiability_lbl" xml:lang="en-US">Stock issued for capitalized costs</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_WarrantsIssuedInRelationToDebt" xlink:label="LFMD_WarrantsIssuedInRelationToDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_WarrantsIssuedInRelationToDebt" xlink:to="LFMD_WarrantsIssuedInRelationToDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_WarrantsIssuedInRelationToDebt_lbl" xml:lang="en-US">Warrants issued in relation to debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReduction" xlink:label="us-gaap_NotesReduction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesReduction" xlink:to="us-gaap_NotesReduction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesReduction_lbl" xml:lang="en-US">Common stock issued for conversion of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferOfLoansHeldForSaleToPortfolioLoans1" xlink:label="us-gaap_TransferOfLoansHeldForSaleToPortfolioLoans1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransferOfLoansHeldForSaleToPortfolioLoans1" xlink:to="us-gaap_TransferOfLoansHeldForSaleToPortfolioLoans1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransferOfLoansHeldForSaleToPortfolioLoans1_lbl" xml:lang="en-US">Debt Exchange Agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_RightOfUseAsset" xlink:label="LFMD_RightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_RightOfUseAsset" xlink:to="LFMD_RightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_RightOfUseAsset_lbl" xml:lang="en-US">Right of Use asset</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsIncurred" xlink:label="us-gaap_CapitalLeaseObligationsIncurred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalLeaseObligationsIncurred" xlink:to="us-gaap_CapitalLeaseObligationsIncurred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalLeaseObligationsIncurred_lbl" xml:lang="en-US">Right of Use lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">Nature of the Organization and Business</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Notes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesAbstract_lbl" xml:lang="en-US">Leases [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesOfLessorDisclosureTextBlock" xlink:label="us-gaap_LeasesOfLessorDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesOfLessorDisclosureTextBlock" xlink:to="us-gaap_LeasesOfLessorDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesOfLessorDisclosureTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:label="us-gaap_ConsolidationVariableInterestEntityPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="us-gaap_ConsolidationVariableInterestEntityPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationVariableInterestEntityPolicy_lbl" xml:lang="en-US">Variable Interest Entities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xml:lang="en-US">Reclassifications</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Product Deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:label="us-gaap_InProcessResearchAndDevelopmentPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:to="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InProcessResearchAndDevelopmentPolicy_lbl" xml:lang="en-US">Capitalized Software Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="us-gaap_DebtPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtPolicyTextBlock" xlink:to="us-gaap_DebtPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtPolicyTextBlock_lbl" xml:lang="en-US">Paycheck Protection Program</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xml:lang="en-US">Stock-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings (Loss) Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentrations of Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently Adopted Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ApplicationOfNewOrRevisedAccountingStandardsNotYetAdoptedPolicyTextBlock" xlink:label="LFMD_ApplicationOfNewOrRevisedAccountingStandardsNotYetAdoptedPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ApplicationOfNewOrRevisedAccountingStandardsNotYetAdoptedPolicyTextBlock" xlink:to="LFMD_ApplicationOfNewOrRevisedAccountingStandardsNotYetAdoptedPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ApplicationOfNewOrRevisedAccountingStandardsNotYetAdoptedPolicyTextBlock_lbl" xml:lang="en-US">Application of New or Revised Accounting Standards - Not Yet Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_OtherRecentAccountingPronouncementsPolicyTextBlock" xlink:label="LFMD_OtherRecentAccountingPronouncementsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_OtherRecentAccountingPronouncementsPolicyTextBlock" xlink:to="LFMD_OtherRecentAccountingPronouncementsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_OtherRecentAccountingPronouncementsPolicyTextBlock_lbl" xml:lang="en-US">Other Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Schedule of Disaggregated Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Summary of Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US">Schedule of Potentially Dilutive Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xml:lang="en-US">Schedule of Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Option Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Schedule of Warrant Outstanding and Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">Schedule of Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Schedule of Income Tax Provision Charges</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of Provision Differs from the Amount of Income Tax</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Net Deferred Tax Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Common stock per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Percentage of ownership equity interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US">Percentage of purchase business acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Reverse stock split</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_2_lbl" xml:lang="en-US">Proceed from private placement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Number of stock issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Stock issued price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ProceedsFromIssuanceOfPrivatePlacementNet" xlink:label="LFMD_ProceedsFromIssuanceOfPrivatePlacementNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ProceedsFromIssuanceOfPrivatePlacementNet" xlink:to="LFMD_ProceedsFromIssuanceOfPrivatePlacementNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ProceedsFromIssuanceOfPrivatePlacementNet_lbl" xml:lang="en-US">Proceed from private placement, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xml:lang="en-US">Non-controlling interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MerchantProcessingFees" xlink:label="LFMD_MerchantProcessingFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_MerchantProcessingFees" xlink:to="LFMD_MerchantProcessingFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_MerchantProcessingFees_lbl" xml:lang="en-US">Merchant processing fees</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CustomerDiscountsReturnsAndRebates" xlink:label="LFMD_CustomerDiscountsReturnsAndRebates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CustomerDiscountsReturnsAndRebates" xlink:to="LFMD_CustomerDiscountsReturnsAndRebates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_CustomerDiscountsReturnsAndRebates_lbl" xml:lang="en-US">Customer discounts, returns and rebates</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SubscriptionPricePerShare" xlink:label="LFMD_SubscriptionPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SubscriptionPricePerShare" xlink:to="LFMD_SubscriptionPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_SubscriptionPricePerShare_lbl" xml:lang="en-US">Subscription price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xml:lang="en-US">Accrued contract liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Bad debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Sales returns and allowances</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="us-gaap_InventoryValuationReserves" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryValuationReserves_lbl" xml:lang="en-US">Inventory reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PercentageOfInterestBearingDomesticDepositsToDeposits" xlink:label="us-gaap_PercentageOfInterestBearingDomesticDepositsToDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PercentageOfInterestBearingDomesticDepositsToDeposits" xlink:to="us-gaap_PercentageOfInterestBearingDomesticDepositsToDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PercentageOfInterestBearingDomesticDepositsToDeposits_lbl" xml:lang="en-US">Deposits percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="us-gaap_PurchaseObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PurchaseObligation" xlink:to="us-gaap_PurchaseObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PurchaseObligation_lbl" xml:lang="en-US">Purchase commitments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" xlink:label="us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" xlink:to="us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers_lbl" xml:lang="en-US">Capitalized software costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Estimated useful life of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xml:lang="en-US">Proceeds from aggregate loan received</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDescription" xlink:label="us-gaap_DebtInstrumentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescription" xlink:to="us-gaap_DebtInstrumentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentDescription_lbl" xml:lang="en-US">Loan Description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Interest rate on laon</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration risk, percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConcentrationRiskPercentage1_2_lbl" xml:lang="en-US">Net revenue, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished Goods - Products</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US">Raw materials and packaging components</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InventoryValuationReserves_2_lbl" xml:lang="en-US">Inventory reserve</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Total Inventory - net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Potentially dilutive securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AmortizationOfIntangibleAssets_2_lbl" xml:lang="en-US">Amortization expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">Amortization expense 2021</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_2_lbl" xml:lang="en-US">Amortizable Life</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Gross Carrying Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Less: Accumulated amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xml:lang="en-US">Total Net Amortizable Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Debt instrument, face amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US">Number of warrants to purchase common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Debt interest, maturity date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xml:lang="en-US">Debt instrument, interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentRate" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentRate" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate_lbl" xml:lang="en-US">Debt instrument, conversion rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Debt, voluntary conversion price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US">Debt conversion, converted value</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_DebtConversionInterestValue" xlink:label="LFMD_DebtConversionInterestValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_DebtConversionInterestValue" xlink:to="LFMD_DebtConversionInterestValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_DebtConversionInterestValue_lbl" xml:lang="en-US">Debt conversion, interest value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Warrants exercise price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Value of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xml:lang="en-US">Original issue discount, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xml:lang="en-US">Original issue discount, value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="us-gaap_DeferredFinanceCostsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNet" xlink:to="us-gaap_DeferredFinanceCostsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xml:lang="en-US">Debt issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xml:lang="en-US">Gross notes payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_2_lbl" xml:lang="en-US">Repayments of notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:to="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl" xml:lang="en-US">Debt principal payments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromConvertibleDebt_2_lbl" xml:lang="en-US">Proceeds from convertible promissory notes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US">Interest expense on notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xml:lang="en-US">Debt conversion shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xml:lang="en-US">Number of restricted stock issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xml:lang="en-US">Number of restricted stock issued, value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="us-gaap_ProceedsFromShortTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromShortTermDebt" xlink:to="us-gaap_ProceedsFromShortTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromShortTermDebt_lbl" xml:lang="en-US">Proceeds from short term loan</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ServiceCharge" xlink:label="LFMD_ServiceCharge" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ServiceCharge" xlink:to="LFMD_ServiceCharge_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ServiceCharge_lbl" xml:lang="en-US">Service charge</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="us-gaap_ConvertibleNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayable_lbl" xml:lang="en-US">Conertible note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, at par value</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_UndesignatedPreferredStock" xlink:label="LFMD_UndesignatedPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_UndesignatedPreferredStock" xlink:to="LFMD_UndesignatedPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_UndesignatedPreferredStock_lbl" xml:lang="en-US">Undesignated preferred stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_2_lbl" xml:lang="en-US">Shares issued after stok split</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_2_lbl" xml:lang="en-US">Share issue price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SharesIssuedPricePerSharePreSplit" xlink:label="LFMD_SharesIssuedPricePerSharePreSplit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SharesIssuedPricePerSharePreSplit" xlink:to="LFMD_SharesIssuedPricePerSharePreSplit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_SharesIssuedPricePerSharePreSplit_lbl" xml:lang="en-US">Share issue price per share pre-split</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="us-gaap_PreferredStockDividendRatePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendRatePercentage" xlink:to="us-gaap_PreferredStockDividendRatePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendRatePercentage_lbl" xml:lang="en-US">Preferred stock dividend rate percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_NumberOfStockIssuedPreSplit" xlink:label="LFMD_NumberOfStockIssuedPreSplit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_NumberOfStockIssuedPreSplit" xlink:to="LFMD_NumberOfStockIssuedPreSplit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_NumberOfStockIssuedPreSplit_lbl" xml:lang="en-US">Number of stock issued, pre split</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Warrant to purchase of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Fair value term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Warrant exercise price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xml:lang="en-US">Cash consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xml:lang="en-US">Aggregate purchase price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_2_lbl" xml:lang="en-US">Conversion of outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:to="us-gaap_PreferredStockDividendsAndOtherAdjustments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustments_2_lbl" xml:lang="en-US">Deemed dividend</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PreferredStockRedemptionFeatureValue" xlink:label="LFMD_PreferredStockRedemptionFeatureValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PreferredStockRedemptionFeatureValue" xlink:to="LFMD_PreferredStockRedemptionFeatureValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_PreferredStockRedemptionFeatureValue_lbl" xml:lang="en-US">Redemption feature, value</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PutLiabilityIncrease" xlink:label="LFMD_PutLiabilityIncrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PutLiabilityIncrease" xlink:to="LFMD_PutLiabilityIncrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_PutLiabilityIncrease_lbl" xml:lang="en-US">Liability increased</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, value</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_WarrantPurchasePrice" xlink:label="LFMD_WarrantPurchasePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_WarrantPurchasePrice" xlink:to="LFMD_WarrantPurchasePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_WarrantPurchasePrice_lbl" xml:lang="en-US">Warrant purchase price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Fair value of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xml:lang="en-US">Fair value measurement input</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Warrants Purchase</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US">Amortization stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_UnamortizedCosts" xlink:label="LFMD_UnamortizedCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_UnamortizedCosts" xlink:to="LFMD_UnamortizedCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_UnamortizedCosts_lbl" xml:lang="en-US">Unamortized costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xml:lang="en-US">Warrants expiration date</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_GrossProceedsFromOffering" xlink:label="LFMD_GrossProceedsFromOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_GrossProceedsFromOffering" xlink:to="LFMD_GrossProceedsFromOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_GrossProceedsFromOffering_lbl" xml:lang="en-US">Gross proceeds from the offering</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConvertibleNotesPayable_2_lbl" xml:lang="en-US">Convertible promissory note</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromConvertibleDebt_3_lbl" xml:lang="en-US">Proceeds from convertible notes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_2_lbl" xml:lang="en-US">Conversion price per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Number of stock issued for option exercise</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2_lbl" xml:lang="en-US">Number of stock issued for option exercise, value</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CashlessExerciseOfOptionsShares" xlink:label="LFMD_CashlessExerciseOfOptionsShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CashlessExerciseOfOptionsShares" xlink:to="LFMD_CashlessExerciseOfOptionsShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_CashlessExerciseOfOptionsShares_lbl" xml:lang="en-US">Cashless exercise of options shares</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_IssuedWarrantsInConjunctionWithStock" xlink:label="LFMD_IssuedWarrantsInConjunctionWithStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_IssuedWarrantsInConjunctionWithStock" xlink:to="LFMD_IssuedWarrantsInConjunctionWithStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_IssuedWarrantsInConjunctionWithStock_lbl" xml:lang="en-US">Issued warrants in conjunction with stock</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_IssuedWarrantsInConjunctionWithDebt" xlink:label="LFMD_IssuedWarrantsInConjunctionWithDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_IssuedWarrantsInConjunctionWithDebt" xlink:to="LFMD_IssuedWarrantsInConjunctionWithDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_IssuedWarrantsInConjunctionWithDebt_lbl" xml:lang="en-US">Issued warrants in conjunction with debt</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MembershipInterestPercentage" xlink:label="LFMD_MembershipInterestPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_MembershipInterestPercentage" xlink:to="LFMD_MembershipInterestPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_MembershipInterestPercentage_lbl" xml:lang="en-US">Membership interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_2_lbl" xml:lang="en-US">Ownership percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AggregateExpenses" xlink:label="LFMD_AggregateExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AggregateExpenses" xlink:to="LFMD_AggregateExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_AggregateExpenses_lbl" xml:lang="en-US">Aggregate expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xml:lang="en-US">Shares for services, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_2_lbl" xml:lang="en-US">Shares for services, value</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_NumberOfSharesIssuedForExerciseOfWarrants" xlink:label="LFMD_NumberOfSharesIssuedForExerciseOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_NumberOfSharesIssuedForExerciseOfWarrants" xlink:to="LFMD_NumberOfSharesIssuedForExerciseOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_NumberOfSharesIssuedForExerciseOfWarrants_lbl" xml:lang="en-US">Number of shares issued for exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_NumberOfSharesIssuedForExerciseOfWarrantsValue" xlink:label="LFMD_NumberOfSharesIssuedForExerciseOfWarrantsValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_NumberOfSharesIssuedForExerciseOfWarrantsValue" xlink:to="LFMD_NumberOfSharesIssuedForExerciseOfWarrantsValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_NumberOfSharesIssuedForExerciseOfWarrantsValue_lbl" xml:lang="en-US">Number of shares issued for exercise of warrants, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_2_lbl" xml:lang="en-US">Sale of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodSharesIssuedForShareLiability" xlink:label="LFMD_StockIssuedDuringPeriodSharesIssuedForShareLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_StockIssuedDuringPeriodSharesIssuedForShareLiability" xlink:to="LFMD_StockIssuedDuringPeriodSharesIssuedForShareLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_StockIssuedDuringPeriodSharesIssuedForShareLiability_lbl" xml:lang="en-US">Shares issued for share liability</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SharesIssuedForLiability" xlink:label="LFMD_SharesIssuedForLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SharesIssuedForLiability" xlink:to="LFMD_SharesIssuedForLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_SharesIssuedForLiability_lbl" xml:lang="en-US">Shares issued for liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Net loss attributed to non-controlling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PurchasedRemainingInterestPercentage" xlink:label="LFMD_PurchasedRemainingInterestPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PurchasedRemainingInterestPercentage" xlink:to="LFMD_PurchasedRemainingInterestPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_PurchasedRemainingInterestPercentage_lbl" xml:lang="en-US">Purchased remaining interest percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Number of shares authorized to issue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" xml:lang="en-US">Options to purchase shares of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xml:lang="en-US">Options granted fully vested</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_RemainingPerformanceOptions" xlink:label="LFMD_RemainingPerformanceOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_RemainingPerformanceOptions" xlink:to="LFMD_RemainingPerformanceOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_RemainingPerformanceOptions_lbl" xml:lang="en-US">Remaining performance options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Number of shares cancelled during period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xml:lang="en-US">Aggregate value of stock option</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_lbl" xml:lang="en-US">Purchase of common stock exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Number of stock options issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Contractual term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US">Number of restricted stock units granted</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_OptionsVestingDate" xlink:label="LFMD_OptionsVestingDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_OptionsVestingDate" xlink:to="LFMD_OptionsVestingDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_OptionsVestingDate_lbl" xml:lang="en-US">Options vesting date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:label="us-gaap_EmployeeBenefitsAndShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:to="us-gaap_EmployeeBenefitsAndShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeBenefitsAndShareBasedCompensation_lbl" xml:lang="en-US">Compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_UnamortizedExpense" xlink:label="LFMD_UnamortizedExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_UnamortizedExpense" xlink:to="LFMD_UnamortizedExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_UnamortizedExpense_lbl" xml:lang="en-US">Unamortized expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xml:lang="en-US">Warrants outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_WarrantDiscountPricePerShare" xlink:label="LFMD_WarrantDiscountPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_WarrantDiscountPricePerShare" xlink:to="LFMD_WarrantDiscountPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_WarrantDiscountPricePerShare_lbl" xml:lang="en-US">Warrant discount price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_DeemedDistributionFromWarrantPriceAdjustments" xlink:label="LFMD_DeemedDistributionFromWarrantPriceAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_DeemedDistributionFromWarrantPriceAdjustments" xlink:to="LFMD_DeemedDistributionFromWarrantPriceAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_DeemedDistributionFromWarrantPriceAdjustments_lbl" xml:lang="en-US">Deemed distribution from warrant price adjustments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromWarrantExercises_2_lbl" xml:lang="en-US">Proceeds from of warrants exercise</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Stock compensation expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2_lbl" xml:lang="en-US">Shares issued for compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Number of Options, Beginning Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Number of Shares, Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3_lbl" xml:lang="en-US">Number of Shares, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US">Number of Shares, Cancelled/Forfeited/Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Number of Options, Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Number of Options, Exercisable, Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Number of Options, Exercisable, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice_lbl" xml:lang="en-US">Exercise Price per Share, Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice" xlink:label="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice_lbl" xml:lang="en-US">Exercise Price per Share, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice" xlink:label="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice_lbl" xml:lang="en-US">Exercise Price per Share, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice" xlink:label="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice_lbl" xml:lang="en-US">Exercise Price per Share, Cancelled/Forfeited/Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice_2_lbl" xml:lang="en-US">Exercise Price per Share, Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning_lbl" xml:lang="en-US">Exercise Price per Share, Exercisable, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice_lbl" xml:lang="en-US">Exercise Price per Share, Exercisable, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life, Cancelled/Forfeited/Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning" xlink:label="LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning" xlink:to="LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life, Exercisable, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life, Exercisable, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price per Share, Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price per Share, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price per Share, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price per Share, Cancelled/Forfeited/Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price per Share, Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price per Share, Exercisable, Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price per Share, Exercisable, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xml:lang="en-US">Number of Warrants, Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xml:lang="en-US">Number of Warrants, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xml:lang="en-US">Number of Warrants, Exercised/Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xml:lang="en-US">Number of Warrants, Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_lbl" xml:lang="en-US">Number of Warrants, Exercisable, Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_2_lbl" xml:lang="en-US">Number of Warrants, Exercisable, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice_lbl" xml:lang="en-US">Exercise Price per Share, Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice" xlink:label="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice_lbl" xml:lang="en-US">Exercise Price per Share, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice" xlink:label="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice_lbl" xml:lang="en-US">Exercise Price per Share, Exercised/Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice_2_lbl" xml:lang="en-US">Exercise Price per Share, Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice_lbl" xml:lang="en-US">Exercise Price per Share, Exercisable, Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice_2_lbl" xml:lang="en-US">Exercise Price per Share, Exercisable, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisedAndExpiredWeightedAverageContractualLife" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisedAndExpiredWeightedAverageContractualLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisedAndExpiredWeightedAverageContractualLife" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisedAndExpiredWeightedAverageContractualLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisedAndExpiredWeightedAverageContractualLife_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life, Exercised/Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm" xlink:label="LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm" xlink:to="LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life, Exercisable, Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life, Exercisable, Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price per Share, Exercised/Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xml:lang="en-US">Rent expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xml:lang="en-US">Lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">Monthly payment for first twelve months</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">Monthly payment for second twelve months</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">Monthly payment for third twelve months</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xml:lang="en-US">Lease expiration date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityDeposit_lbl" xml:lang="en-US">Security deposit for lease</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_2_lbl" xml:lang="en-US">Right of Use Asset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiability_2_lbl" xml:lang="en-US">Lease liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_3_lbl" xml:lang="en-US">Agreement term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsPercentageAssumedToNet" xlink:label="us-gaap_PremiumsPercentageAssumedToNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PremiumsPercentageAssumedToNet" xlink:to="us-gaap_PremiumsPercentageAssumedToNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PremiumsPercentageAssumedToNet_lbl" xml:lang="en-US">Percentage of net income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntercompanyAgreementsDescription" xlink:label="us-gaap_IntercompanyAgreementsDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntercompanyAgreementsDescription" xlink:to="us-gaap_IntercompanyAgreementsDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntercompanyAgreementsDescription_lbl" xml:lang="en-US">Agreements of performance fees, description</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PerformanceFee" xlink:label="LFMD_PerformanceFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PerformanceFee" xlink:to="LFMD_PerformanceFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_PerformanceFee_lbl" xml:lang="en-US">Performance fee</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_LicenseFee" xlink:label="LFMD_LicenseFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_LicenseFee" xlink:to="LFMD_LicenseFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_LicenseFee_lbl" xml:lang="en-US">License fee</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_2_lbl" xml:lang="en-US">Warrants issued for common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PercentageForRoyalty" xlink:label="LFMD_PercentageForRoyalty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PercentageForRoyalty" xlink:to="LFMD_PercentageForRoyalty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_PercentageForRoyalty_lbl" xml:lang="en-US">Percentage for royalty</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Option term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Option to purchase common stock exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ExpiringAgreementDescription" xlink:label="LFMD_ExpiringAgreementDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ExpiringAgreementDescription" xlink:to="LFMD_ExpiringAgreementDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ExpiringAgreementDescription_lbl" xml:lang="en-US">Expiring agreement description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_2_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="us-gaap_PaymentsForRent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRent_lbl" xml:lang="en-US">Payment for rent</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MonthlyFees" xlink:label="LFMD_MonthlyFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_MonthlyFees" xlink:to="LFMD_MonthlyFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_MonthlyFees_lbl" xml:lang="en-US">Monthly fees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Due to related party</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromNotesPayable_2_lbl" xml:lang="en-US">Proceeds from notes payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentMaturityDate_2_lbl" xml:lang="en-US">Debt instrument maturity date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_3_lbl" xml:lang="en-US">Warrants to purchase</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_3_lbl" xml:lang="en-US">Share price per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_3_lbl" xml:lang="en-US">Loss on debt settlement of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:to="us-gaap_OperatingLossCarryforwardsLimitationsOnUse_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse_lbl" xml:lang="en-US">Operating loss carryforwards expiration, description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xml:lang="en-US">Valuation allowance increased</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Statutory income rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Current: U.S. federal</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">Current: State and local</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred: U.S. federal</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred: State and local</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ExpectedTaxExpenseBenefit" xlink:label="LFMD_ExpectedTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ExpectedTaxExpenseBenefit" xlink:to="LFMD_ExpectedTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ExpectedTaxExpenseBenefit_lbl" xml:lang="en-US">Computed "expected" tax expense (benefit)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Permanent differences</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl" xml:lang="en-US">Apportionment of Puerto Rico income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xml:lang="en-US">Nondeductible expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="us-gaap_DeferredTaxLiabilitiesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl" xml:lang="en-US">Deferred tax Liability,Other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_DeferredTaxAssetsTemporaryDifferences" xlink:label="LFMD_DeferredTaxAssetsTemporaryDifferences" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_DeferredTaxAssetsTemporaryDifferences" xlink:to="LFMD_DeferredTaxAssetsTemporaryDifferences_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="LFMD_DeferredTaxAssetsTemporaryDifferences_lbl" xml:lang="en-US">Temporary differences</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Less valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Total</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_lbl" xml:lang="en-US">Number of shares, granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_lbl" xml:lang="en-US">Number of options vested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesPayable_2_lbl" xml:lang="en-US">Promissory note balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_2_lbl" xml:lang="en-US">Number of shares issued for exchange of debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_2_lbl" xml:lang="en-US">Membership interests purchases</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_2_lbl" xml:lang="en-US">Aggregate purchase price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xml:lang="en-US">Membership interests, description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_3_lbl" xml:lang="en-US">Equity investment percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_2_lbl" xml:lang="en-US">Restricted stock units, granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Restricted stock units, vesting period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_3_lbl" xml:lang="en-US">Number of stock issued, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_3_lbl" xml:lang="en-US">Net proceeds from issuance of common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3_lbl" xml:lang="en-US">Cashless exercise of stock options, value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDecreaseForgiveness" xlink:label="us-gaap_DebtInstrumentDecreaseForgiveness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDecreaseForgiveness" xlink:to="us-gaap_DebtInstrumentDecreaseForgiveness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentDecreaseForgiveness_lbl" xml:lang="en-US">Loan Forgiveness</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AccelerationOfDebtDiscount" xlink:to="LFMD_AccelerationOfDebtDiscount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_AccelerationOfDebtDiscount_doc" xml:lang="en-US">Acceleration of debt discount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" xlink:to="LFMD_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember_doc" xml:lang="en-US">Alpha Capital Anstalt and Brio Capital Master Fund Ltd. [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AlphaCapitalAnstaltMember" xlink:to="LFMD_AlphaCapitalAnstaltMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_AlphaCapitalAnstaltMember_doc" xml:lang="en-US">Alpha Capital Anstalt [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AugustTwoThousandAndNineteenWarrantMember" xlink:to="LFMD_AugustTwoThousandAndNineteenWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_AugustTwoThousandAndNineteenWarrantMember_doc" xml:lang="en-US">August 2019 Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_BVGlobalFulfillmentMember" xlink:to="LFMD_BVGlobalFulfillmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_BVGlobalFulfillmentMember_doc" xml:lang="en-US">BV Global Fulfillment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_BrioMasterFundMember" xlink:to="LFMD_BrioMasterFundMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_BrioMasterFundMember_doc" xml:lang="en-US">Brio Master Fund [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_BrioTwoThousandAndNineteenWarrantMember" xlink:to="LFMD_BrioTwoThousandAndNineteenWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_BrioTwoThousandAndNineteenWarrantMember_doc" xml:lang="en-US">Brio 2019 Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CSixCapitalLLCMember" xlink:to="LFMD_CSixCapitalLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_CSixCapitalLLCMember_doc" xml:lang="en-US">C6 Capital, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CSixPurchaseAgreementOneMember" xlink:to="LFMD_CSixPurchaseAgreementOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_CSixPurchaseAgreementOneMember_doc" xml:lang="en-US">C6 Purchase Agreement One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CSixPurchaseAgreementTwoMember" xlink:to="LFMD_CSixPurchaseAgreementTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_CSixPurchaseAgreementTwoMember_doc" xml:lang="en-US">C6 Purchase Agreement Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CSixPurchaseAgreementsMember" xlink:to="LFMD_CSixPurchaseAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_CSixPurchaseAgreementsMember_doc" xml:lang="en-US">C6 Purchase Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CSixPurchaseAgreementsOneMember" xlink:to="LFMD_CSixPurchaseAgreementsOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_CSixPurchaseAgreementsOneMember_doc" xml:lang="en-US">C6 Purchase Agreements One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CSixPurchaseAgreementsTwoMember" xlink:to="LFMD_CSixPurchaseAgreementsTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_CSixPurchaseAgreementsTwoMember_doc" xml:lang="en-US">C6 Purchase Agreements Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CVLBPRMember" xlink:to="LFMD_CVLBPRMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_CVLBPRMember_doc" xml:lang="en-US">CVLB PR [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CashlessExerciseOfWarrantsShares" xlink:to="LFMD_CashlessExerciseOfWarrantsShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_CashlessExerciseOfWarrantsShares_doc" xml:lang="en-US">Cashless exercise of warrants, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CashlessExerciseOfWarrantsSupplementalDisclosure" xlink:to="LFMD_CashlessExerciseOfWarrantsSupplementalDisclosure_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_CashlessExerciseOfWarrantsSupplementalDisclosure_doc" xml:lang="en-US">Cashless exercise of warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ChiefExecutiveOfficerAndChiefTechnologyOfficerMember" xlink:to="LFMD_ChiefExecutiveOfficerAndChiefTechnologyOfficerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ChiefExecutiveOfficerAndChiefTechnologyOfficerMember_doc" xml:lang="en-US">Chief Executive Officer And Chief Technology Officer [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CommonStockOneMember" xlink:to="LFMD_CommonStockOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_CommonStockOneMember_doc" xml:lang="en-US">Common Stock One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CommonStockThreeMember" xlink:to="LFMD_CommonStockThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_CommonStockThreeMember_doc" xml:lang="en-US">Common Stock Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CommonStockTwoMember" xlink:to="LFMD_CommonStockTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_CommonStockTwoMember_doc" xml:lang="en-US">Common Stock Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CustomerDiscountsReturnsAndRebates" xlink:to="LFMD_CustomerDiscountsReturnsAndRebates_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_CustomerDiscountsReturnsAndRebates_doc" xml:lang="en-US">Customer Discounts Returns And Rebates.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CustomerRelationshipAssetMember" xlink:to="LFMD_CustomerRelationshipAssetMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_CustomerRelationshipAssetMember_doc" xml:lang="en-US">Customer Relationship Asset [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_DailyAveragePaymentMember" xlink:to="LFMD_DailyAveragePaymentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_DailyAveragePaymentMember_doc" xml:lang="en-US">Daily Average Payment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_DebtConversionInterestValue" xlink:to="LFMD_DebtConversionInterestValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_DebtConversionInterestValue_doc" xml:lang="en-US">Debt conversion, interest value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_DeemedDistributionFromDownroundProvisionOnUnissuedShares" xlink:to="LFMD_DeemedDistributionFromDownroundProvisionOnUnissuedShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_DeemedDistributionFromDownroundProvisionOnUnissuedShares_doc" xml:lang="en-US">Deemed distribution from down-round provision on unissued shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_DeemedDistributionFromWarrantPriceAdjustments" xlink:to="LFMD_DeemedDistributionFromWarrantPriceAdjustments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_DeemedDistributionFromWarrantPriceAdjustments_doc" xml:lang="en-US">Deemed distribution from warrant price adjustments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_EmploymentAndConsultingAgreementsMember" xlink:to="LFMD_EmploymentAndConsultingAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_EmploymentAndConsultingAgreementsMember_doc" xml:lang="en-US">Employment and Consulting Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_EquityTotal" xlink:to="LFMD_EquityTotal_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_EquityTotal_doc" xml:lang="en-US">It represents total of common stock, additional paid in capital and accumulated deficit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ExpiringAgreementDescription" xlink:to="LFMD_ExpiringAgreementDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ExpiringAgreementDescription_doc" xml:lang="en-US">Expiring agreement description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_INRWellnessMember" xlink:to="LFMD_INRWellnessMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_INRWellnessMember_doc" xml:lang="en-US">iNR Wellness [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ImmudynePrLlcMember" xlink:to="LFMD_ImmudynePrLlcMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ImmudynePrLlcMember_doc" xml:lang="en-US">Immudyne PR LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_InnateMember" xlink:to="LFMD_InnateMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_InnateMember_doc" xml:lang="en-US">Innate [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_JLSVenturesLLCMember" xlink:to="LFMD_JLSVenturesLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_JLSVenturesLLCMember_doc" xml:lang="en-US">JLS Ventures, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_LegalSimpliSoftwareLlcMember" xlink:to="LFMD_LegalSimpliSoftwareLlcMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_LegalSimpliSoftwareLlcMember_doc" xml:lang="en-US">LegalSimpli Software, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_LicenseFee" xlink:to="LFMD_LicenseFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_LicenseFee_doc" xml:lang="en-US">License fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_MALPHABETLLCMember" xlink:to="LFMD_MALPHABETLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_MALPHABETLLCMember_doc" xml:lang="en-US">M.ALPHABET, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_MayTwoThousandAndTwentyNotesMember" xlink:to="LFMD_MayTwoThousandAndTwentyNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_MayTwoThousandAndTwentyNotesMember_doc" xml:lang="en-US">May 2020 Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_MrSeanFitzpatrickMember" xlink:to="LFMD_MrSeanFitzpatrickMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_MrSeanFitzpatrickMember_doc" xml:lang="en-US">Mr.Sean Fitzpatrick [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_NoteRepaymentAndWarrantAmendmentAgreementMember" xlink:to="LFMD_NoteRepaymentAndWarrantAmendmentAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_NoteRepaymentAndWarrantAmendmentAgreementMember_doc" xml:lang="en-US">Note Repayment and Warrant Amendment Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_OfficeSpaceMember" xlink:to="LFMD_OfficeSpaceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_OfficeSpaceMember_doc" xml:lang="en-US">Office Space [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_OneEightyDayAnniversaryAgreementMember" xlink:to="LFMD_OneEightyDayAnniversaryAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_OneEightyDayAnniversaryAgreementMember_doc" xml:lang="en-US">180 Day Anniversary Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_OneTwentyDayAnniversaryAgreementMember" xlink:to="LFMD_OneTwentyDayAnniversaryAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_OneTwentyDayAnniversaryAgreementMember_doc" xml:lang="en-US">120 Day Anniversary Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_OptionsAndWarrantsMember" xlink:to="LFMD_OptionsAndWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_OptionsAndWarrantsMember_doc" xml:lang="en-US">Options and Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PaycheckProtectionProgramLoanMember" xlink:to="LFMD_PaycheckProtectionProgramLoanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_PaycheckProtectionProgramLoanMember_doc" xml:lang="en-US">Paycheck Protection Program Loan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PercentageForRoyalty" xlink:to="LFMD_PercentageForRoyalty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_PercentageForRoyalty_doc" xml:lang="en-US">Percentage for royalty.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PerformanceFee" xlink:to="LFMD_PerformanceFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_PerformanceFee_doc" xml:lang="en-US">Performance fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PilarisLaboratoriesLLCMember" xlink:to="LFMD_PilarisLaboratoriesLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_PilarisLaboratoriesLLCMember_doc" xml:lang="en-US">Pilaris Laboratories, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PuertoRicoOfficeSpaceMember" xlink:to="LFMD_PuertoRicoOfficeSpaceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_PuertoRicoOfficeSpaceMember_doc" xml:lang="en-US">Puerto Rico Office Space [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PurchaseAgreementMember" xlink:to="LFMD_PurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_PurchaseAgreementMember_doc" xml:lang="en-US">Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PurchasedLicensesMember" xlink:to="LFMD_PurchasedLicensesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_PurchasedLicensesMember_doc" xml:lang="en-US">Purchased Licenses [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PurchasedRemainingInterestPercentage" xlink:to="LFMD_PurchasedRemainingInterestPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_PurchasedRemainingInterestPercentage_doc" xml:lang="en-US">Purchased remaining interest percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_RemainingPerformanceOptions" xlink:to="LFMD_RemainingPerformanceOptions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_RemainingPerformanceOptions_doc" xml:lang="en-US">Remaining performance options.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_RexMDMember" xlink:to="LFMD_RexMDMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_RexMDMember_doc" xml:lang="en-US">Rex MD [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ScarologyMember" xlink:to="LFMD_ScarologyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ScarologyMember_doc" xml:lang="en-US">Scarology [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SecondAlphaWarrantAmendmentMember" xlink:to="LFMD_SecondAlphaWarrantAmendmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_SecondAlphaWarrantAmendmentMember_doc" xml:lang="en-US">Second Alpha Warrant Amendment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SecuritiesPurchaseAgreementMember" xlink:to="LFMD_SecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_SecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ServiceBasedStockOptionsMember" xlink:to="LFMD_ServiceBasedStockOptionsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ServiceBasedStockOptionsMember_doc" xml:lang="en-US">Service-Based Stock Options [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ServicesAgreementMember" xlink:to="LFMD_ServicesAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ServicesAgreementMember_doc" xml:lang="en-US">Services Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShapiroMDMember" xlink:to="LFMD_ShapiroMDMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ShapiroMDMember_doc" xml:lang="en-US">Shapiro MD [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife_doc" xml:lang="en-US">Weighted Average Remaining Contractual Life, Granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife_doc" xml:lang="en-US">Weighted Average Remaining Contractual Life, Beginning.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne_doc" xml:lang="en-US">Weighted Average Remaining Contractual Life, Ending.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife_doc" xml:lang="en-US">Weighted Average Remaining Contractual Life, Granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife_doc" xml:lang="en-US">Weighted Average Remaining Contractual Life.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne_doc" xml:lang="en-US">Weighted Average Remaining Contractual Life, Ending.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_doc" xml:lang="en-US">Number of Warrants, Exercisable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice_doc" xml:lang="en-US">Exercise Price per Share, Exercisable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice_doc" xml:lang="en-US">Exercise Price per Share, Outstanding balance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice_doc" xml:lang="en-US">Exercise Price per Share, Beginning balance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice_doc" xml:lang="en-US">Exercise Price per Share, Exercisable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning_doc" xml:lang="en-US">Exercise Price per Share, Exercisable, Beginning.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice_doc" xml:lang="en-US">Exercise Price per Share, Granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice_doc" xml:lang="en-US">Exercise Price per Share, Granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm" xlink:to="LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Weighted Average Remaining Contractual Life, Exercisable, Beginning.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning" xlink:to="LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning_doc" xml:lang="en-US">Weighted Average Remaining Contractual Life, Exercisable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SharesIssuedForShareLiability" xlink:to="LFMD_SharesIssuedForShareLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_SharesIssuedForShareLiability_doc" xml:lang="en-US">Shares issued for share liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SixAccreditedInvestorsMember" xlink:to="LFMD_SixAccreditedInvestorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_SixAccreditedInvestorsMember_doc" xml:lang="en-US">6 Accredited Investors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SoftwareRevenuesNetMember" xlink:to="LFMD_SoftwareRevenuesNetMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_SoftwareRevenuesNetMember_doc" xml:lang="en-US">Software Revenues, Net [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_StockIssuesForCapitalizedCosts" xlink:to="LFMD_StockIssuesForCapitalizedCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_StockIssuesForCapitalizedCosts_doc" xml:lang="en-US">Stock issues for capitalized costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SubscriptionAgreementMember" xlink:to="LFMD_SubscriptionAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_SubscriptionAgreementMember_doc" xml:lang="en-US">Subscription Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SubscriptionPricePerShare" xlink:to="LFMD_SubscriptionPricePerShare_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_SubscriptionPricePerShare_doc" xml:lang="en-US">Subscription price per share.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ThreeSiXFiveDayAnniversaryAgreementMember" xlink:to="LFMD_ThreeSiXFiveDayAnniversaryAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ThreeSiXFiveDayAnniversaryAgreementMember_doc" xml:lang="en-US">365 Day Anniversary Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ThreeSixtyDayAnniversaryAgreementMember" xlink:to="LFMD_ThreeSixtyDayAnniversaryAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ThreeSixtyDayAnniversaryAgreementMember_doc" xml:lang="en-US">360 Day Anniversary Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ThroughTheNextTwelveMonthsMember" xlink:to="LFMD_ThroughTheNextTwelveMonthsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ThroughTheNextTwelveMonthsMember_doc" xml:lang="en-US">Through the Next 12 Months [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_TwoCSixPurchaseAgreementsMember" xlink:to="LFMD_TwoCSixPurchaseAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_TwoCSixPurchaseAgreementsMember_doc" xml:lang="en-US">Two C6 Purchase Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_TwoManufacturersMember" xlink:to="LFMD_TwoManufacturersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_TwoManufacturersMember_doc" xml:lang="en-US">Two Manufacturers [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_TwoThousandAndEighteenAlphaNoteMember" xlink:to="LFMD_TwoThousandAndEighteenAlphaNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_TwoThousandAndEighteenAlphaNoteMember_doc" xml:lang="en-US">2018 Alpha Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_TwoThousandAndEighteenAlphaWarrantMember" xlink:to="LFMD_TwoThousandAndEighteenAlphaWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_TwoThousandAndEighteenAlphaWarrantMember_doc" xml:lang="en-US">2018 Alpha Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_TwoThousandAndEighteenBrioWarrantAmendmentMember" xlink:to="LFMD_TwoThousandAndEighteenBrioWarrantAmendmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_TwoThousandAndEighteenBrioWarrantAmendmentMember_doc" xml:lang="en-US">2018 Brio Warrant Amendment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_TwoThousandAndEighteenBrioWarrantMember" xlink:to="LFMD_TwoThousandAndEighteenBrioWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_TwoThousandAndEighteenBrioWarrantMember_doc" xml:lang="en-US">2018 Brio Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_TwoThousandAndNineteenAlphaAmendmentMember" xlink:to="LFMD_TwoThousandAndNineteenAlphaAmendmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_TwoThousandAndNineteenAlphaAmendmentMember_doc" xml:lang="en-US">2019 Alpha Amendment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_TwoThousandAndNineteenAlphaWarrantMember" xlink:to="LFMD_TwoThousandAndNineteenAlphaWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_TwoThousandAndNineteenAlphaWarrantMember_doc" xml:lang="en-US">2019 Alpha Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_USSmallBusinessAdministrationMember" xlink:to="LFMD_USSmallBusinessAdministrationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_USSmallBusinessAdministrationMember_doc" xml:lang="en-US">US Small Business Administration [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_DeemedDistributionFromWarrantsIssuedWithPreferredStock" xlink:to="LFMD_DeemedDistributionFromWarrantsIssuedWithPreferredStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_DeemedDistributionFromWarrantsIssuedWithPreferredStock_doc" xml:lang="en-US">Deemed distribution from warrants issued with Series B peferred stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_WarrantsIssuedInRelationToDebt" xlink:to="LFMD_WarrantsIssuedInRelationToDebt_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_WarrantsIssuedInRelationToDebt_doc" xml:lang="en-US">Warrants issued in relation to debt.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_OtherRecentAccountingPronouncementsPolicyTextBlock" xlink:to="LFMD_OtherRecentAccountingPronouncementsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_OtherRecentAccountingPronouncementsPolicyTextBlock_doc" xml:lang="en-US">Other recent accounting pronouncements [Policy Text Block].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PreSplitBasisMember" xlink:to="LFMD_PreSplitBasisMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_PreSplitBasisMember_doc" xml:lang="en-US">Pre-Split Basis [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SeriesBConvertiblePreferredStockMember" xlink:to="LFMD_SeriesBConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_SeriesBConvertiblePreferredStockMember_doc" xml:lang="en-US">Series B Convertible Preferred Stock Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SharesIssuedPricePerSharePreSplit" xlink:to="LFMD_SharesIssuedPricePerSharePreSplit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_SharesIssuedPricePerSharePreSplit_doc" xml:lang="en-US">Share issue price per share pre-split.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PutLiabilityIncrease" xlink:to="LFMD_PutLiabilityIncrease_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_PutLiabilityIncrease_doc" xml:lang="en-US">Liability increased.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ConsultingAgreementMember" xlink:to="LFMD_ConsultingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ConsultingAgreementMember_doc" xml:lang="en-US">Consulting Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_WarrantPurchaseAgreementMember" xlink:to="LFMD_WarrantPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_WarrantPurchaseAgreementMember_doc" xml:lang="en-US">Warrant Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ClassAWarrantMember" xlink:to="LFMD_ClassAWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ClassAWarrantMember_doc" xml:lang="en-US">Class A Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_UnamortizedCosts" xlink:to="LFMD_UnamortizedCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_UnamortizedCosts_doc" xml:lang="en-US">Unamortized costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_StockIssuedDuringPeriodSharesIssuedForShareLiability" xlink:to="LFMD_StockIssuedDuringPeriodSharesIssuedForShareLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_StockIssuedDuringPeriodSharesIssuedForShareLiability_doc" xml:lang="en-US">Shares issued for share liability, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice_doc" xml:lang="en-US">Exercise price per share, exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice_doc" xml:lang="en-US">Exercise price per share, cancelled/forfeited/expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife_doc" xml:lang="en-US">Weighted Average Remaining Contractual Life, Exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife_doc" xml:lang="en-US">Weighted Average Remaining Contractual Life, Cancelled/Forfeited/Expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice_doc" xml:lang="en-US">Exercise Price per Share, Exercised/Expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisedAndExpiredWeightedAverageContractualLife" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisedAndExpiredWeightedAverageContractualLife_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisedAndExpiredWeightedAverageContractualLife_doc" xml:lang="en-US">Weighted Average Remaining Contractual Life, Exercised/Expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PresidentAndCEOMember" xlink:to="LFMD_PresidentAndCEOMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_PresidentAndCEOMember_doc" xml:lang="en-US">President and CEO [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_BlueHorizonConsultingLLCMember" xlink:to="LFMD_BlueHorizonConsultingLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_BlueHorizonConsultingLLCMember_doc" xml:lang="en-US">Blue Horizon Consulting, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_BoardOfDirectorsMember" xlink:to="LFMD_BoardOfDirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_BoardOfDirectorsMember_doc" xml:lang="en-US">Board of Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_InvestorsMember" xlink:to="LFMD_InvestorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_InvestorsMember_doc" xml:lang="en-US">Investors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_BTIGLLCMember" xlink:to="LFMD_BTIGLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_BTIGLLCMember_doc" xml:lang="en-US">BTIG, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ContingentConsiderationOnPurchaseOfLegalsimpli" xlink:to="LFMD_ContingentConsiderationOnPurchaseOfLegalsimpli_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ContingentConsiderationOnPurchaseOfLegalsimpli_doc" xml:lang="en-US">Contingent consideration on purchase of LegalSimpli.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_DeemedDividendFromWarrantPriceAdjustment" xlink:to="LFMD_DeemedDividendFromWarrantPriceAdjustment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_DeemedDividendFromWarrantPriceAdjustment_doc" xml:lang="en-US">Deemed dividend from warrant price adjustments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_NumberOfSharesIssuedForExerciseOfWarrants" xlink:to="LFMD_NumberOfSharesIssuedForExerciseOfWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_NumberOfSharesIssuedForExerciseOfWarrants_doc" xml:lang="en-US">Number of shares issued for exercise of warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_NumberOfSharesIssuedForExerciseOfWarrantsValue" xlink:to="LFMD_NumberOfSharesIssuedForExerciseOfWarrantsValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_NumberOfSharesIssuedForExerciseOfWarrantsValue_doc" xml:lang="en-US">Number of shares issued for exercise of warrants, value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AugustTwoThousandAndTwentyWarrantInducementMember" xlink:to="LFMD_AugustTwoThousandAndTwentyWarrantInducementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_AugustTwoThousandAndTwentyWarrantInducementMember_doc" xml:lang="en-US">August 2020 Warrant Inducement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_WarrantDiscountPricePerShare" xlink:to="LFMD_WarrantDiscountPricePerShare_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_WarrantDiscountPricePerShare_doc" xml:lang="en-US">Warrant discount price per share.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_BrioWarrantsMember" xlink:to="LFMD_BrioWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_BrioWarrantsMember_doc" xml:lang="en-US">Brio Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AmendedConsultingAgreementMember" xlink:to="LFMD_AmendedConsultingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_AmendedConsultingAgreementMember_doc" xml:lang="en-US">Amended Consulting Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SoftwareRevenueMember" xlink:to="LFMD_SoftwareRevenueMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_SoftwareRevenueMember_doc" xml:lang="en-US">Software Revenue [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_WarrantPurchasePrice" xlink:to="LFMD_WarrantPurchasePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_WarrantPurchasePrice_doc" xml:lang="en-US">Warrant purchase price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ConversionLabsPrMember" xlink:to="LFMD_ConversionLabsPrMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ConversionLabsPrMember_doc" xml:lang="en-US">Conversion Labs Pr [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ExpectedTaxExpenseBenefit" xlink:to="LFMD_ExpectedTaxExpenseBenefit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ExpectedTaxExpenseBenefit_doc" xml:lang="en-US">Computed "expected" tax expense (benefit).</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_RightOfUseAsset" xlink:to="LFMD_RightOfUseAsset_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_RightOfUseAsset_doc" xml:lang="en-US">Right of Use asset.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ApplicationOfNewOrRevisedAccountingStandardsNotYetAdoptedPolicyTextBlock" xlink:to="LFMD_ApplicationOfNewOrRevisedAccountingStandardsNotYetAdoptedPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ApplicationOfNewOrRevisedAccountingStandardsNotYetAdoptedPolicyTextBlock_doc" xml:lang="en-US">Application of New or Revised Accounting Standards Not Yet Adopted [Policy text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_TwoThousandTwentyPlanMember" xlink:to="LFMD_TwoThousandTwentyPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_TwoThousandTwentyPlanMember_doc" xml:lang="en-US">Two Thousand Twenty Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_MerchantProcessingFees" xlink:to="LFMD_MerchantProcessingFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_MerchantProcessingFees_doc" xml:lang="en-US">Merrchant processing fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CVLBMediaMember" xlink:to="LFMD_CVLBMediaMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_CVLBMediaMember_doc" xml:lang="en-US">CVLB Media [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ChaseBankMember" xlink:to="LFMD_ChaseBankMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ChaseBankMember_doc" xml:lang="en-US">Chase Bank [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PrivatePlacementOfferingMember" xlink:to="LFMD_PrivatePlacementOfferingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_PrivatePlacementOfferingMember_doc" xml:lang="en-US">Private placement offering [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_GrossProceedsFromOffering" xlink:to="LFMD_GrossProceedsFromOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_GrossProceedsFromOffering_doc" xml:lang="en-US">Gross proceeds from the offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CashlessExerciseOfOptionsShares" xlink:to="LFMD_CashlessExerciseOfOptionsShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_CashlessExerciseOfOptionsShares_doc" xml:lang="en-US">Cashless exercise of options shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_IssuedWarrantsInConjunctionWithStock" xlink:to="LFMD_IssuedWarrantsInConjunctionWithStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_IssuedWarrantsInConjunctionWithStock_doc" xml:lang="en-US">Issued warrants in conjunction with stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_IssuedWarrantsInConjunctionWithDebt" xlink:to="LFMD_IssuedWarrantsInConjunctionWithDebt_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_IssuedWarrantsInConjunctionWithDebt_doc" xml:lang="en-US">Issued warrants in conjunction with debt.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_MembershipInterestPurchaseAgreementMember" xlink:to="LFMD_MembershipInterestPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_MembershipInterestPurchaseAgreementMember_doc" xml:lang="en-US">Membership Interest Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_MembershipInterestPercentage" xlink:to="LFMD_MembershipInterestPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_MembershipInterestPercentage_doc" xml:lang="en-US">Membership interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_MrSchreiberMember" xlink:to="LFMD_MrSchreiberMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_MrSchreiberMember_doc" xml:lang="en-US">Mr. Schreiber [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_MrGalluppiMember" xlink:to="LFMD_MrGalluppiMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_MrGalluppiMember_doc" xml:lang="en-US">Mr. Galluppi [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_FirstMilestoneMember" xlink:to="LFMD_FirstMilestoneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_FirstMilestoneMember_doc" xml:lang="en-US">First Mile Stone [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SecondMileSStoneMember" xlink:to="LFMD_SecondMileSStoneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_SecondMileSStoneMember_doc" xml:lang="en-US">Second Mile Stone [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AggregateExpenses" xlink:to="LFMD_AggregateExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_AggregateExpenses_doc" xml:lang="en-US">Aggregate expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SharesIssuedForLiability" xlink:to="LFMD_SharesIssuedForLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_SharesIssuedForLiability_doc" xml:lang="en-US">Shares issued for liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_NewChiefOperatingOfficerMember" xlink:to="LFMD_NewChiefOperatingOfficerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_NewChiefOperatingOfficerMember_doc" xml:lang="en-US">Chief Operating Officer [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AmendedCAOEmploymentAgreementMember" xlink:to="LFMD_AmendedCAOEmploymentAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_AmendedCAOEmploymentAgreementMember_doc" xml:lang="en-US">Amended CAO Employment Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_OptionsVestingDate" xlink:to="LFMD_OptionsVestingDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_OptionsVestingDate_doc" xml:lang="en-US">Options vesting date.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_LeaseAgreementOneMember" xlink:to="LFMD_LeaseAgreementOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_LeaseAgreementOneMember_doc" xml:lang="en-US">Lease Agreement One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_LeaseAgreementTwoMember" xlink:to="LFMD_LeaseAgreementTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_LeaseAgreementTwoMember_doc" xml:lang="en-US">Lease Agreement Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PromissoryNoteMember" xlink:to="LFMD_PromissoryNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_PromissoryNoteMember_doc" xml:lang="en-US">Promissory Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ExchangeAgreementMember" xlink:to="LFMD_ExchangeAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ExchangeAgreementMember_doc" xml:lang="en-US">Exchange Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_DeferredTaxAssetsTemporaryDifferences" xlink:to="LFMD_DeferredTaxAssetsTemporaryDifferences_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_DeferredTaxAssetsTemporaryDifferences_doc" xml:lang="en-US">Deferred tax rate temporary differences.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ChiefDigitalOfficerMember" xlink:to="LFMD_ChiefDigitalOfficerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ChiefDigitalOfficerMember_doc" xml:lang="en-US">Chief Digital Officer [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_EmploymentAgreementMember" xlink:to="LFMD_EmploymentAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_EmploymentAgreementMember_doc" xml:lang="en-US">Employment Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ChiefMedicalOfficerMember" xlink:to="LFMD_ChiefMedicalOfficerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ChiefMedicalOfficerMember_doc" xml:lang="en-US">Chief Medical Officer [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ConversionLabsPRLLCMember" xlink:to="LFMD_ConversionLabsPRLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ConversionLabsPRLLCMember_doc" xml:lang="en-US">CVLB PR [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_FoundingMembersMIPAsMember" xlink:to="LFMD_FoundingMembersMIPAsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_FoundingMembersMIPAsMember_doc" xml:lang="en-US">Founding Members MIPAs [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ChiefBusinessOfficerMember" xlink:to="LFMD_ChiefBusinessOfficerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ChiefBusinessOfficerMember_doc" xml:lang="en-US">Chief Business Officer [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_VestingOnEffectiveDateMember" xlink:to="LFMD_VestingOnEffectiveDateMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_VestingOnEffectiveDateMember_doc" xml:lang="en-US">Vesting On Effective Date [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PaycheckProtectionProgramMember" xlink:to="LFMD_PaycheckProtectionProgramMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_PaycheckProtectionProgramMember_doc" xml:lang="en-US">Paycheck Protection Program [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_FebruaryTwoThousandTwentyOnePurchaseAgreementMember" xlink:to="LFMD_FebruaryTwoThousandTwentyOnePurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_FebruaryTwoThousandTwentyOnePurchaseAgreementMember_doc" xml:lang="en-US">February 2021 Purchase Agreement[Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CashPaidForInterestAbstract" xlink:to="LFMD_CashPaidForInterestAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_CashPaidForInterestAbstract_doc" xml:lang="en-US">Cash paid for interest [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ProceedsFromIssuanceOfPrivatePlacementNet" xlink:to="LFMD_ProceedsFromIssuanceOfPrivatePlacementNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ProceedsFromIssuanceOfPrivatePlacementNet_doc" xml:lang="en-US">Proceed from private placement, net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_TwoAccreditedInvestorsMember" xlink:to="LFMD_TwoAccreditedInvestorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_TwoAccreditedInvestorsMember_doc" xml:lang="en-US">Two Accredited Investors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ServiceCharge" xlink:to="LFMD_ServiceCharge_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ServiceCharge_doc" xml:lang="en-US">Service charge.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_WorkingCapitalLoanMember" xlink:to="LFMD_WorkingCapitalLoanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_WorkingCapitalLoanMember_doc" xml:lang="en-US">Working Capital Loan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_UndesignatedPreferredStock" xlink:to="LFMD_UndesignatedPreferredStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_UndesignatedPreferredStock_doc" xml:lang="en-US">Undesignated preferred stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_NumberOfStockIssuedPreSplit" xlink:to="LFMD_NumberOfStockIssuedPreSplit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_NumberOfStockIssuedPreSplit_doc" xml:lang="en-US">Number of stock issued, pre split.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_PreferredStockRedemptionFeatureValue" xlink:to="LFMD_PreferredStockRedemptionFeatureValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_PreferredStockRedemptionFeatureValue_doc" xml:lang="en-US">Redemption feature, value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ChiefComplianceOfficerMember" xlink:to="LFMD_ChiefComplianceOfficerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_ChiefComplianceOfficerMember_doc" xml:lang="en-US">Chief Compliance Officer [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_DecemberEightTwoThousandAndTwentyThreeMember" xlink:to="LFMD_DecemberEightTwoThousandAndTwentyThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_DecemberEightTwoThousandAndTwentyThreeMember_doc" xml:lang="en-US">December 8, 2023 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_MonthlyFees" xlink:to="LFMD_MonthlyFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_MonthlyFees_doc" xml:lang="en-US">Monthly fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AgreementToIssueSharesForNoncontrollingInterest" xlink:to="LFMD_AgreementToIssueSharesForNoncontrollingInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_AgreementToIssueSharesForNoncontrollingInterest_doc" xml:lang="en-US">Agreement to issue shares for non-controlling interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AgreementToIssueSharesForNoncontrollingInterestShares" xlink:to="LFMD_AgreementToIssueSharesForNoncontrollingInterestShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_AgreementToIssueSharesForNoncontrollingInterestShares_doc" xml:lang="en-US">Agreement to issue shares for non-controlling interest in CVLB PR, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock" xlink:to="LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock_doc" xml:lang="en-US">Warrants issued in conjunction with stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt" xlink:to="LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt_doc" xml:lang="en-US">Warrants issued in conjunction with debt.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:to="LFMD_StockIssuedDuringPeriodValueExerciseOfWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_StockIssuedDuringPeriodValueExerciseOfWarrants_doc" xml:lang="en-US">Exercise of warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:to="LFMD_StockIssuedDuringPeriodSharesExerciseOfWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_StockIssuedDuringPeriodSharesExerciseOfWarrants_doc" xml:lang="en-US">Exercise of warrants, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CashlessExerciseOfWarrants" xlink:to="LFMD_CashlessExerciseOfWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_CashlessExerciseOfWarrants_doc" xml:lang="en-US">Cashless exercise of warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions" xlink:to="LFMD_StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions_doc" xml:lang="en-US">Cashless exercise of stock options.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_StockIssuedDuringPeriodSharesCashlessExerciseOfStockOptions" xlink:to="LFMD_StockIssuedDuringPeriodSharesCashlessExerciseOfStockOptions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_StockIssuedDuringPeriodSharesCashlessExerciseOfStockOptions_doc" xml:lang="en-US">Cashless exercise of stock options, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_StockIssuedDuringPeriodValueSaleOfCommonStock" xlink:to="LFMD_StockIssuedDuringPeriodValueSaleOfCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_StockIssuedDuringPeriodValueSaleOfCommonStock_doc" xml:lang="en-US">Sale of common stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_StockIssuedDuringPeriodSharesSaleOfCommonStock" xlink:to="LFMD_StockIssuedDuringPeriodSharesSaleOfCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_StockIssuedDuringPeriodSharesSaleOfCommonStock_doc" xml:lang="en-US">Sale of common stock, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet" xlink:to="LFMD_StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet_doc" xml:lang="en-US">Sale of stock in private placement, net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_StockIssuedDuringperiodSaleOfStockInPrivatePlacementNetShares" xlink:to="LFMD_StockIssuedDuringperiodSaleOfStockInPrivatePlacementNetShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_StockIssuedDuringperiodSaleOfStockInPrivatePlacementNetShares_doc" xml:lang="en-US">Sale of stock in private placement, net shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_StockIssuedDuringPeriodValueReverseStockSplits" xlink:to="LFMD_StockIssuedDuringPeriodValueReverseStockSplits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_StockIssuedDuringPeriodValueReverseStockSplits_doc" xml:lang="en-US">Stock Issued During Period Value Reverse Stock Splits.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_EmployeesAnddvisoryBoardMembersMember" xlink:to="LFMD_EmployeesAnddvisoryBoardMembersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_EmployeesAnddvisoryBoardMembersMember_doc" xml:lang="en-US">Employees and Advisory Board Members [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_UnamortizedExpense" xlink:to="LFMD_UnamortizedExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="LFMD_UnamortizedExpense_doc" xml:lang="en-US">Unamortized expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ConversionLabsPRLLCMember" xlink:to="LFMD_ConversionLabsPRLLCMember_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ConversionLabsPRLLCMember_3_lbl" xml:lang="en-US">ConversionLabsPRLLCMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_2_lbl" xml:lang="en-US">Assets, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_EquityTotal" xlink:to="LFMD_EquityTotal_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_EquityTotal_3_lbl" xml:lang="en-US">EquityTotal</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValue_2_lbl" xml:lang="en-US">Treasury Stock, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsCommonStockCash" xlink:to="us-gaap_DividendsCommonStockCash_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsCommonStockCash_2_lbl" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_2_lbl" xml:lang="en-US">Issuance of Stock and Warrants for Services or Claims</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerAsset_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerAsset_2_lbl" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Asset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_2_lbl" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireSoftware" xlink:to="us-gaap_PaymentsToAcquireSoftware_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireSoftware_2_lbl" xml:lang="en-US">Payments to Acquire Software</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:to="us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_2_lbl" xml:lang="en-US">Payment for Contingent Consideration Liability, Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_2_lbl" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToMinorityShareholders" xlink:to="us-gaap_PaymentsToMinorityShareholders_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToMinorityShareholders_2_lbl" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfLoanCosts" xlink:to="us-gaap_PaymentsOfLoanCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfLoanCosts_2_lbl" xml:lang="en-US">Payments of Loan Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_CashlessExerciseOfWarrantsSupplementalDisclosure" xlink:to="LFMD_CashlessExerciseOfWarrantsSupplementalDisclosure_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_CashlessExerciseOfWarrantsSupplementalDisclosure_3_lbl" xml:lang="en-US">CashlessExerciseOfWarrantsSupplementalDisclosure</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_DeemedDividendFromWarrantPriceAdjustment" xlink:to="LFMD_DeemedDividendFromWarrantPriceAdjustment_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_DeemedDividendFromWarrantPriceAdjustment_3_lbl" xml:lang="en-US">DeemedDividendFromWarrantPriceAdjustment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesReduction" xlink:to="us-gaap_NotesReduction_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesReduction_2_lbl" xml:lang="en-US">Notes Reduction</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_2_lbl" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_2_lbl" xml:lang="en-US">Cash [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_2_lbl" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_2_lbl" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice_4_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice_3_lbl" xml:lang="en-US">Exercise Price per Share, Exercisable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_4_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice_4_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice_4_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne" xlink:to="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm" xlink:to="LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm_3_lbl" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_2_lbl" xml:lang="en-US">Current Federal, State and Local, Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred Federal, State and Local, Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LFMD_DeferredTaxAssetsTemporaryDifferences" xlink:to="LFMD_DeferredTaxAssetsTemporaryDifferences_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="LFMD_DeferredTaxAssetsTemporaryDifferences_3_lbl" xml:lang="en-US">Temporary differences</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>24
<FILENAME>lfmd-20201231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.7a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: LFMD %2D 20201231 10K FY DFN.xfr; Date: 2021%2D03%2D30T19:46:43Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://lifemd.com/role/DocumentAndEntityInformation" xlink:href="lfmd-20201231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/BalanceSheets" xlink:href="lfmd-20201231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/BalanceSheetsParenthetical" xlink:href="lfmd-20201231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StatementsOfOperations" xlink:href="lfmd-20201231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StatementsOfChangesInStockholdersDeficit" xlink:href="lfmd-20201231.xsd#StatementsOfChangesInStockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StatementsOfCashFlows" xlink:href="lfmd-20201231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/NatureOfOrganizationAndBusiness" xlink:href="lfmd-20201231.xsd#NatureOfOrganizationAndBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="lfmd-20201231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IntangibleAssets" xlink:href="lfmd-20201231.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/NotesPayable" xlink:href="lfmd-20201231.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StockholdersEquity" xlink:href="lfmd-20201231.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/Leases" xlink:href="lfmd-20201231.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/CommitmentsAndContingencies" xlink:href="lfmd-20201231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/RelatedPartyTransactions" xlink:href="lfmd-20201231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IncomeTaxes" xlink:href="lfmd-20201231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SubsequentEvents" xlink:href="lfmd-20201231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="lfmd-20201231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="lfmd-20201231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IntangibleAssetsTables" xlink:href="lfmd-20201231.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StockholdersEquityTables" xlink:href="lfmd-20201231.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/LeasesTables" xlink:href="lfmd-20201231.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IncomeTaxesTables" xlink:href="lfmd-20201231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/NatureOfOrganizationAndBusinessDetailsNarrative" xlink:href="lfmd-20201231.xsd#NatureOfOrganizationAndBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="lfmd-20201231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfDisaggregatedRevenueDetails" xlink:href="lfmd-20201231.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfDisaggregatedRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-SummaryOfInventoryDetails" xlink:href="lfmd-20201231.xsd#SummaryOfSignificantAccountingPolicies-SummaryOfInventoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfPotentiallyDilutiveSecuritiesDetails" xlink:href="lfmd-20201231.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfPotentiallyDilutiveSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IntangibleAssetsDetailsNarrative" xlink:href="lfmd-20201231.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:href="lfmd-20201231.xsd#IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/NotesPayable-DetailsNarrative" xlink:href="lfmd-20201231.xsd#NotesPayable-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StockholdersEquityDetailsNarrative" xlink:href="lfmd-20201231.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StockholdersEquity-ScheduleOfOptionActivityDetails" xlink:href="lfmd-20201231.xsd#StockholdersEquity-ScheduleOfOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/StockholdersEquity-ScheduleOfWarrantOutstandingAndExercisableDetails" xlink:href="lfmd-20201231.xsd#StockholdersEquity-ScheduleOfWarrantOutstandingAndExercisableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/LeasesDetailsNarrative" xlink:href="lfmd-20201231.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/Leases-ScheduleOfLeasesDetails" xlink:href="lfmd-20201231.xsd#Leases-ScheduleOfLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="lfmd-20201231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="lfmd-20201231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IncomeTaxes-DetailsNarrative" xlink:href="lfmd-20201231.xsd#IncomeTaxes-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IncomeTaxes-ScheduleOfIncomeTaxProvisionChargesDetails" xlink:href="lfmd-20201231.xsd#IncomeTaxes-ScheduleOfIncomeTaxProvisionChargesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IncomeTaxes-ScheduleOfProvisionDiffersFromAmountOfIncomeTaxDetails" xlink:href="lfmd-20201231.xsd#IncomeTaxes-ScheduleOfProvisionDiffersFromAmountOfIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/IncomeTaxes-ScheduleOfNetDeferredTaxLiabilitiesDetails" xlink:href="lfmd-20201231.xsd#IncomeTaxes-ScheduleOfNetDeferredTaxLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://lifemd.com/role/SubsequentEventsDetailsNarrative" xlink:href="lfmd-20201231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document And Entity Information">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiIcfrAuditorAttestationFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaapDepositsAssetsCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDepositsAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="loc_us-gaapCapitalizedComputerSoftwareNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapCapitalizedComputerSoftwareNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaapDeferredRevenue" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrentAbstract" xlink:label="loc_us-gaapLongTermDebtNoncurrentAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLongTermDebtNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongTermDebtNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ContingentConsiderationOnPurchaseOfLegalsimpli" xlink:label="loc_LFMDContingentConsiderationOnPurchaseOfLegalsimpli" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongTermDebtNoncurrentAbstract" xlink:to="loc_LFMDContingentConsiderationOnPurchaseOfLegalsimpli" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongTermDebtNoncurrentAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="loc_us-gaapTemporaryEquityAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapTemporaryEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTemporaryEquityAbstract" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_EquityTotal" xlink:label="loc_LFMDEquityTotal" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_LFMDEquityTotal" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="loc_us-gaapTemporaryEquityLiquidationPreference" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityLiquidationPreference" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaapTreasuryStockCommonShares" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockCommonShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaapProductMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapProductMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SoftwareRevenuesNetMember" xlink:label="loc_LFMDSoftwareRevenuesNetMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_LFMDSoftwareRevenuesNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember" xlink:label="loc_us-gaapServiceMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapServiceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherGeneralExpense" xlink:label="loc_us-gaapOtherGeneralExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOtherGeneralExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOtherSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopmentCosts" xlink:label="loc_us-gaapDevelopmentCosts" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapDevelopmentCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:label="loc_us-gaapPreferredStockDividendsAndOtherAdjustments" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockDividendsAndOtherAdjustments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/StatementsOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Stockholders&apos; Deficit">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="70" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapTreasuryStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParentMember" xlink:label="loc_us-gaapParentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapParentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AgreementToIssueSharesForNoncontrollingInterest" xlink:label="loc_LFMDAgreementToIssueSharesForNoncontrollingInterest" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDAgreementToIssueSharesForNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AgreementToIssueSharesForNoncontrollingInterestShares" xlink:label="loc_LFMDAgreementToIssueSharesForNoncontrollingInterestShares" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDAgreementToIssueSharesForNoncontrollingInterestShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock" xlink:label="loc_LFMDAdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDAdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt" xlink:label="loc_LFMDAdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDAdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodValueExerciseOfWarrants" xlink:label="loc_LFMDStockIssuedDuringPeriodValueExerciseOfWarrants" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDStockIssuedDuringPeriodValueExerciseOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:label="loc_LFMDStockIssuedDuringPeriodSharesExerciseOfWarrants" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDStockIssuedDuringPeriodSharesExerciseOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CashlessExerciseOfWarrants" xlink:label="loc_LFMDCashlessExerciseOfWarrants" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDCashlessExerciseOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CashlessExerciseOfWarrantsShares" xlink:label="loc_LFMDCashlessExerciseOfWarrantsShares" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDCashlessExerciseOfWarrantsShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions" xlink:label="loc_LFMDStockIssuedDuringPeriodValueCashlessExerciseOfStockOptions" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDStockIssuedDuringPeriodValueCashlessExerciseOfStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodSharesCashlessExerciseOfStockOptions" xlink:label="loc_LFMDStockIssuedDuringPeriodSharesCashlessExerciseOfStockOptions" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDStockIssuedDuringPeriodSharesCashlessExerciseOfStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodValueSaleOfCommonStock" xlink:label="loc_LFMDStockIssuedDuringPeriodValueSaleOfCommonStock" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDStockIssuedDuringPeriodValueSaleOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodSharesSaleOfCommonStock" xlink:label="loc_LFMDStockIssuedDuringPeriodSharesSaleOfCommonStock" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDStockIssuedDuringPeriodSharesSaleOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet" xlink:label="loc_LFMDStockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDStockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringperiodSaleOfStockInPrivatePlacementNetShares" xlink:label="loc_LFMDStockIssuedDuringperiodSaleOfStockInPrivatePlacementNetShares" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDStockIssuedDuringperiodSaleOfStockInPrivatePlacementNetShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="loc_us-gaapDividendsCommonStockCash" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsCommonStockCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount" xlink:label="loc_us-gaapWarrantDownRoundFeatureIncreaseDecreaseInEquityAmount" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantDownRoundFeatureIncreaseDecreaseInEquityAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockCash" xlink:label="loc_us-gaapDividendsPreferredStockCash" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPreferredStockCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodValueReverseStockSplits" xlink:label="loc_LFMDStockIssuedDuringPeriodValueReverseStockSplits" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDStockIssuedDuringPeriodValueReverseStockSplits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:label="loc_us-gaapCapitalizedComputerSoftwareAmortization1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapCapitalizedComputerSoftwareAmortization1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AccelerationOfDebtDiscount" xlink:label="loc_LFMDAccelerationOfDebtDiscount" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_LFMDAccelerationOfDebtDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerAsset" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireSoftware" xlink:label="loc_us-gaapPaymentsToAcquireSoftware" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireSoftware" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:label="loc_us-gaapPaymentForContingentConsiderationLiabilityInvestingActivities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentForContingentConsiderationLiabilityInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="loc_us-gaapPaymentsToMinorityShareholders" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToMinorityShareholders" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfEquity" xlink:label="loc_us-gaapPaymentsForRepurchaseOfEquity" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForRepurchaseOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfLoanCosts" xlink:label="loc_us-gaapPaymentsOfLoanCosts" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfLoanCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CashPaidForInterestAbstract" xlink:label="loc_LFMDCashPaidForInterestAbstract" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_LFMDCashPaidForInterestAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssued1" xlink:label="loc_us-gaapStockIssued1" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapStockIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CashlessExerciseOfWarrantsSupplementalDisclosure" xlink:label="loc_LFMDCashlessExerciseOfWarrantsSupplementalDisclosure" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_LFMDCashlessExerciseOfWarrantsSupplementalDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_DeemedDividendFromWarrantPriceAdjustment" xlink:label="loc_LFMDDeemedDividendFromWarrantPriceAdjustment" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_LFMDDeemedDividendFromWarrantPriceAdjustment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_DeemedDistributionFromWarrantsIssuedWithPreferredStock" xlink:label="loc_LFMDDeemedDistributionFromWarrantsIssuedWithPreferredStock" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_LFMDDeemedDistributionFromWarrantsIssuedWithPreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuesForCapitalizedCosts" xlink:label="loc_LFMDStockIssuesForCapitalizedCosts" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_LFMDStockIssuesForCapitalizedCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_DeemedDistributionFromDownroundProvisionOnUnissuedShares" xlink:label="loc_LFMDDeemedDistributionFromDownroundProvisionOnUnissuedShares" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_LFMDDeemedDistributionFromDownroundProvisionOnUnissuedShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAssumed1" xlink:label="loc_us-gaapLiabilitiesAssumed1" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapLiabilitiesAssumed1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesIssued1" xlink:label="loc_us-gaapNotesIssued1" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapNotesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferToInvestments" xlink:label="loc_us-gaapTransferToInvestments" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapTransferToInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SharesIssuedForShareLiability" xlink:label="loc_LFMDSharesIssuedForShareLiability" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_LFMDSharesIssuedForShareLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_WarrantsIssuedInRelationToDebt" xlink:label="loc_LFMDWarrantsIssuedInRelationToDebt" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_LFMDWarrantsIssuedInRelationToDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReduction" xlink:label="loc_us-gaapNotesReduction" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapNotesReduction" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferOfLoansHeldForSaleToPortfolioLoans1" xlink:label="loc_us-gaapTransferOfLoansHeldForSaleToPortfolioLoans1" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapTransferOfLoansHeldForSaleToPortfolioLoans1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_RightOfUseAsset" xlink:label="loc_LFMDRightOfUseAsset" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_LFMDRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsIncurred" xlink:label="loc_us-gaapCapitalLeaseObligationsIncurred" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapCapitalLeaseObligationsIncurred" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/NatureOfOrganizationAndBusiness" xlink:title="00000007 - Disclosure - Nature of the Organization and Business">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaapNatureOfOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNatureOfOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Summary of Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/IntangibleAssets" xlink:title="00000009 - Disclosure - Intangible Assets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/NotesPayable" xlink:title="00000010 - Disclosure - Notes Payable">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/StockholdersEquity" xlink:title="00000011 - Disclosure - Stockholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/Leases" xlink:title="00000012 - Disclosure - Leases">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesOfLessorDisclosureTextBlock" xlink:label="loc_us-gaapLeasesOfLessorDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLeasesOfLessorDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/CommitmentsAndContingencies" xlink:title="00000013 - Disclosure - Commitments and Contingencies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/RelatedPartyTransactions" xlink:title="00000014 - Disclosure - Related Party Transactions">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/IncomeTaxes" xlink:title="00000015 - Disclosure - Income Taxes">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/SubsequentEvents" xlink:title="00000016 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000017 - Disclosure - Summary of Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:label="loc_us-gaapConsolidationVariableInterestEntityPolicy" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationVariableInterestEntityPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:label="loc_us-gaapInProcessResearchAndDevelopmentPolicy" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInProcessResearchAndDevelopmentPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="loc_us-gaapDebtPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDebtPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ApplicationOfNewOrRevisedAccountingStandardsNotYetAdoptedPolicyTextBlock" xlink:label="loc_LFMDApplicationOfNewOrRevisedAccountingStandardsNotYetAdoptedPolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_LFMDApplicationOfNewOrRevisedAccountingStandardsNotYetAdoptedPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_OtherRecentAccountingPronouncementsPolicyTextBlock" xlink:label="loc_LFMDOtherRecentAccountingPronouncementsPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_LFMDOtherRecentAccountingPronouncementsPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000018 - Disclosure - Summary of Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaapDisaggregationOfRevenueTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/IntangibleAssetsTables" xlink:title="00000019 - Disclosure - Intangible Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/StockholdersEquityTables" xlink:title="00000020 - Disclosure - Stockholders&apos; Equity (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ServiceBasedStockOptionsMember" xlink:label="loc_LFMDServiceBasedStockOptionsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDServiceBasedStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaapPerformanceSharesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapPerformanceSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandTwentyPlanMember" xlink:label="loc_LFMDTwoThousandTwentyPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_LFMDTwoThousandTwentyPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/LeasesTables" xlink:title="00000021 - Disclosure - Leases (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaapLeaseCostTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLeaseCostTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/IncomeTaxesTables" xlink:title="00000022 - Disclosure - Income Taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/NatureOfOrganizationAndBusinessDetailsNarrative" xlink:title="00000023 - Disclosure - Nature of the Organization and Business (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ImmudynePrLlcMember" xlink:label="loc_LFMDImmudynePrLlcMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_LFMDImmudynePrLlcMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ConversionLabsPrMember" xlink:label="loc_LFMDConversionLabsPrMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_LFMDConversionLabsPrMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_LegalSimpliSoftwareLlcMember" xlink:label="loc_LFMDLegalSimpliSoftwareLlcMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_LFMDLegalSimpliSoftwareLlcMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SecuritiesPurchaseAgreementMember" xlink:label="loc_LFMDSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_InvestorsMember" xlink:label="loc_LFMDInvestorsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDInvestorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardDateAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ThroughTheNextTwelveMonthsMember" xlink:label="loc_LFMDThroughTheNextTwelveMonthsMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_LFMDThroughTheNextTwelveMonthsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ProceedsFromIssuanceOfPrivatePlacementNet" xlink:label="loc_LFMDProceedsFromIssuanceOfPrivatePlacementNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDProceedsFromIssuanceOfPrivatePlacementNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000024 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtOwnershipAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_LegalSimpliSoftwareLlcMember" xlink:label="loc_LFMDLegalSimpliSoftwareLlcMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_LFMDLegalSimpliSoftwareLlcMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_LegalSimpliSoftwareLlcMember" xlink:label="loc_LFMDLegalSimpliSoftwareLlcMember_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_LFMDLegalSimpliSoftwareLlcMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaapProductMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapProductMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SoftwareRevenueMember" xlink:label="loc_LFMDSoftwareRevenueMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_LFMDSoftwareRevenueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PurchasedLicensesMember" xlink:label="loc_LFMDPurchasedLicensesMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_LFMDPurchasedLicensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PaycheckProtectionProgramLoanMember" xlink:label="loc_LFMDPaycheckProtectionProgramLoanMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_LFMDPaycheckProtectionProgramLoanMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtMajorCustomersAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoManufacturersMember" xlink:label="loc_LFMDTwoManufacturersMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_LFMDTwoManufacturersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByParent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MerchantProcessingFees" xlink:label="loc_LFMDMerchantProcessingFees" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDMerchantProcessingFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CustomerDiscountsReturnsAndRebates" xlink:label="loc_LFMDCustomerDiscountsReturnsAndRebates" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDCustomerDiscountsReturnsAndRebates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SubscriptionPricePerShare" xlink:label="loc_LFMDSubscriptionPricePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDSubscriptionPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInventoryValuationReserves" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PercentageOfInterestBearingDomesticDepositsToDeposits" xlink:label="loc_us-gaapPercentageOfInterestBearingDomesticDepositsToDeposits" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPercentageOfInterestBearingDomesticDepositsToDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaapDepositsAssetsCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepositsAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaapPurchaseObligation" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPurchaseObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" xlink:label="loc_us-gaapCapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfDisaggregatedRevenueDetails" xlink:title="00000025 - Disclosure - Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember" xlink:label="loc_us-gaapProductMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapProductMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SoftwareRevenueMember" xlink:label="loc_LFMDSoftwareRevenueMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_LFMDSoftwareRevenueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShapiroMDMember" xlink:label="loc_LFMDShapiroMDMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_LFMDShapiroMDMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_InnateMember" xlink:label="loc_LFMDInnateMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_LFMDInnateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_INRWellnessMember" xlink:label="loc_LFMDINRWellnessMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_LFMDINRWellnessMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ScarologyMember" xlink:label="loc_LFMDScarologyMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_LFMDScarologyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_RexMDMember" xlink:label="loc_LFMDRexMDMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_LFMDRexMDMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CVLBPRMember" xlink:label="loc_LFMDCVLBPRMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_LFMDCVLBPRMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_LegalSimpliSoftwareLlcMember" xlink:label="loc_LFMDLegalSimpliSoftwareLlcMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_LFMDLegalSimpliSoftwareLlcMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CVLBMediaMember" xlink:label="loc_LFMDCVLBMediaMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_LFMDCVLBMediaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-SummaryOfInventoryDetails" xlink:title="00000026 - Disclosure - Summary of Significant Accounting Policies - Summary of Inventory (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryValuationReserves" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfPotentiallyDilutiveSecuritiesDetails" xlink:title="00000027 - Disclosure - Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="loc_us-gaapConvertibleDebtSecuritiesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapConvertibleDebtSecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/IntangibleAssetsDetailsNarrative" xlink:title="00000028 - Disclosure - Intangible Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:title="00000029 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CustomerRelationshipAssetMember" xlink:label="loc_LFMDCustomerRelationshipAssetMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_LFMDCustomerRelationshipAssetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PurchasedLicensesMember" xlink:label="loc_LFMDPurchasedLicensesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_LFMDPurchasedLicensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/NotesPayable-DetailsNarrative" xlink:title="00000030 - Disclosure - Notes Payable - (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SecuritiesPurchaseAgreementMember" xlink:label="loc_LFMDSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_NoteRepaymentAndWarrantAmendmentAgreementMember" xlink:label="loc_LFMDNoteRepaymentAndWarrantAmendmentAgreementMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDNoteRepaymentAndWarrantAmendmentAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CSixPurchaseAgreementsMember" xlink:label="loc_LFMDCSixPurchaseAgreementsMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDCSixPurchaseAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CSixPurchaseAgreementOneMember" xlink:label="loc_LFMDCSixPurchaseAgreementOneMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDCSixPurchaseAgreementOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CSixPurchaseAgreementTwoMember" xlink:label="loc_LFMDCSixPurchaseAgreementTwoMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDCSixPurchaseAgreementTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CSixPurchaseAgreementsOneMember" xlink:label="loc_LFMDCSixPurchaseAgreementsOneMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDCSixPurchaseAgreementsOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CSixPurchaseAgreementsTwoMember" xlink:label="loc_LFMDCSixPurchaseAgreementsTwoMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDCSixPurchaseAgreementsTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoCSixPurchaseAgreementsMember" xlink:label="loc_LFMDTwoCSixPurchaseAgreementsMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDTwoCSixPurchaseAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PaycheckProtectionProgramLoanMember" xlink:label="loc_LFMDPaycheckProtectionProgramLoanMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDPaycheckProtectionProgramLoanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" xlink:label="loc_LFMDAlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDAlphaCapitalAnstaltBrioCapitalMasterFundLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CSixCapitalLLCMember" xlink:label="loc_LFMDCSixCapitalLLCMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDCSixCapitalLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ChaseBankMember" xlink:label="loc_LFMDChaseBankMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDChaseBankMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PreSplitBasisMember" xlink:label="loc_LFMDPreSplitBasisMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_LFMDPreSplitBasisMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoAccreditedInvestorsMember" xlink:label="loc_LFMDTwoAccreditedInvestorsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDTwoAccreditedInvestorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SixAccreditedInvestorsMember" xlink:label="loc_LFMDSixAccreditedInvestorsMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDSixAccreditedInvestorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_USSmallBusinessAdministrationMember" xlink:label="loc_LFMDUSSmallBusinessAdministrationMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDUSSmallBusinessAdministrationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_DailyAveragePaymentMember" xlink:label="loc_LFMDDailyAveragePaymentMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDDailyAveragePaymentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MayTwoThousandAndTwentyNotesMember" xlink:label="loc_LFMDMayTwoThousandAndTwentyNotesMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_LFMDMayTwoThousandAndTwentyNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_WorkingCapitalLoanMember" xlink:label="loc_LFMDWorkingCapitalLoanMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_LFMDWorkingCapitalLoanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentRate" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentRate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_DebtConversionInterestValue" xlink:label="loc_LFMDDebtConversionInterestValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDDebtConversionInterestValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaapDeferredFinanceCostsNet" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredFinanceCostsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="loc_us-gaapDebtInstrumentAnnualPrincipalPayment" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentAnnualPrincipalPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="loc_us-gaapProceedsFromShortTermDebt" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromShortTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ServiceCharge" xlink:label="loc_LFMDServiceCharge" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDServiceCharge" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000031 - Disclosure - Stockholders&apos; Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="loc_us-gaapSeriesBPreferredStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesBPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SeriesBConvertiblePreferredStockMember" xlink:label="loc_LFMDSeriesBConvertiblePreferredStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_LFMDSeriesBConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ClassAWarrantMember" xlink:label="loc_LFMDClassAWarrantMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_LFMDClassAWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SecuritiesPurchaseAgreementMember" xlink:label="loc_LFMDSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_WarrantPurchaseAgreementMember" xlink:label="loc_LFMDWarrantPurchaseAgreementMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDWarrantPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ConsultingAgreementMember" xlink:label="loc_LFMDConsultingAgreementMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDConsultingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PrivatePlacementOfferingMember" xlink:label="loc_LFMDPrivatePlacementOfferingMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDPrivatePlacementOfferingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PurchaseAgreementMember" xlink:label="loc_LFMDPurchaseAgreementMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MembershipInterestPurchaseAgreementMember" xlink:label="loc_LFMDMembershipInterestPurchaseAgreementMember" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDMembershipInterestPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ServicesAgreementMember" xlink:label="loc_LFMDServicesAgreementMember" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDServicesAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AmendedCAOEmploymentAgreementMember" xlink:label="loc_LFMDAmendedCAOEmploymentAgreementMember" />
      <link:presentationArc order="710" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDAmendedCAOEmploymentAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandTwentyPlanMember" xlink:label="loc_LFMDTwoThousandTwentyPlanMember" />
      <link:presentationArc order="760" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDTwoThousandTwentyPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_NoteRepaymentAndWarrantAmendmentAgreementMember" xlink:label="loc_LFMDNoteRepaymentAndWarrantAmendmentAgreementMember" />
      <link:presentationArc order="870" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDNoteRepaymentAndWarrantAmendmentAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandAndNineteenAlphaAmendmentMember" xlink:label="loc_LFMDTwoThousandAndNineteenAlphaAmendmentMember" />
      <link:presentationArc order="900" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDTwoThousandAndNineteenAlphaAmendmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SecondAlphaWarrantAmendmentMember" xlink:label="loc_LFMDSecondAlphaWarrantAmendmentMember" />
      <link:presentationArc order="930" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDSecondAlphaWarrantAmendmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandAndEighteenBrioWarrantAmendmentMember" xlink:label="loc_LFMDTwoThousandAndEighteenBrioWarrantAmendmentMember" />
      <link:presentationArc order="970" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDTwoThousandAndEighteenBrioWarrantAmendmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AmendedConsultingAgreementMember" xlink:label="loc_LFMDAmendedConsultingAgreementMember" />
      <link:presentationArc order="1070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDAmendedConsultingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_BrioWarrantsMember" xlink:label="loc_LFMDBrioWarrantsMember" />
      <link:presentationArc order="1050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_LFMDBrioWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_BTIGLLCMember" xlink:label="loc_LFMDBTIGLLCMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDBTIGLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AlphaCapitalAnstaltMember" xlink:label="loc_LFMDAlphaCapitalAnstaltMember" />
      <link:presentationArc order="870" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDAlphaCapitalAnstaltMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_BrioMasterFundMember" xlink:label="loc_LFMDBrioMasterFundMember" />
      <link:presentationArc order="970" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDBrioMasterFundMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_BlueHorizonConsultingLLCMember" xlink:label="loc_LFMDBlueHorizonConsultingLLCMember" />
      <link:presentationArc order="1070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDBlueHorizonConsultingLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MayTwoThousandAndTwentyNotesMember" xlink:label="loc_LFMDMayTwoThousandAndTwentyNotesMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_LFMDMayTwoThousandAndTwentyNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_OptionsAndWarrantsMember" xlink:label="loc_LFMDOptionsAndWarrantsMember" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDOptionsAndWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_FirstMilestoneMember" xlink:label="loc_LFMDFirstMilestoneMember" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDFirstMilestoneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SecondMileSStoneMember" xlink:label="loc_LFMDSecondMileSStoneMember" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDSecondMileSStoneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandTwentyPlanMember" xlink:label="loc_LFMDTwoThousandTwentyPlanMember_2" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDTwoThousandTwentyPlanMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ServiceBasedStockOptionsMember" xlink:label="loc_LFMDServiceBasedStockOptionsMember" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDServiceBasedStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_DecemberEightTwoThousandAndTwentyThreeMember" xlink:label="loc_LFMDDecemberEightTwoThousandAndTwentyThreeMember" />
      <link:presentationArc order="730" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDDecemberEightTwoThousandAndTwentyThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="740" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AugustTwoThousandAndTwentyWarrantInducementMember" xlink:label="loc_LFMDAugustTwoThousandAndTwentyWarrantInducementMember" />
      <link:presentationArc order="820" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDAugustTwoThousandAndTwentyWarrantInducementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandAndEighteenAlphaNoteMember" xlink:label="loc_LFMDTwoThousandAndEighteenAlphaNoteMember" />
      <link:presentationArc order="870" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDTwoThousandAndEighteenAlphaNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandAndEighteenAlphaWarrantMember" xlink:label="loc_LFMDTwoThousandAndEighteenAlphaWarrantMember" />
      <link:presentationArc order="880" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDTwoThousandAndEighteenAlphaWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandAndNineteenAlphaWarrantMember" xlink:label="loc_LFMDTwoThousandAndNineteenAlphaWarrantMember" />
      <link:presentationArc order="900" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDTwoThousandAndNineteenAlphaWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AugustTwoThousandAndNineteenWarrantMember" xlink:label="loc_LFMDAugustTwoThousandAndNineteenWarrantMember" />
      <link:presentationArc order="930" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDAugustTwoThousandAndNineteenWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandAndEighteenBrioWarrantMember" xlink:label="loc_LFMDTwoThousandAndEighteenBrioWarrantMember" />
      <link:presentationArc order="970" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDTwoThousandAndEighteenBrioWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_BrioTwoThousandAndNineteenWarrantMember" xlink:label="loc_LFMDBrioTwoThousandAndNineteenWarrantMember" />
      <link:presentationArc order="990" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDBrioTwoThousandAndNineteenWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaapPerformanceSharesMember" />
      <link:presentationArc order="1100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapPerformanceSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="90" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CVLBPRMember" xlink:label="loc_LFMDCVLBPRMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDCVLBPRMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MrSchreiberMember" xlink:label="loc_LFMDMrSchreiberMember" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDMrSchreiberMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MrGalluppiMember" xlink:label="loc_LFMDMrGalluppiMember" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDMrGalluppiMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_us-gaapInvestorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_BoardOfDirectorsMember" xlink:label="loc_LFMDBoardOfDirectorsMember" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDBoardOfDirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ChiefExecutiveOfficerAndChiefTechnologyOfficerMember" xlink:label="loc_LFMDChiefExecutiveOfficerAndChiefTechnologyOfficerMember" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDChiefExecutiveOfficerAndChiefTechnologyOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MrSeanFitzpatrickMember" xlink:label="loc_LFMDMrSeanFitzpatrickMember" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDMrSeanFitzpatrickMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_EmployeesAnddvisoryBoardMembersMember" xlink:label="loc_LFMDEmployeesAnddvisoryBoardMembersMember" />
      <link:presentationArc order="650" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDEmployeesAnddvisoryBoardMembersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ChiefComplianceOfficerMember" xlink:label="loc_LFMDChiefComplianceOfficerMember" />
      <link:presentationArc order="680" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDChiefComplianceOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_NewChiefOperatingOfficerMember" xlink:label="loc_LFMDNewChiefOperatingOfficerMember" />
      <link:presentationArc order="690" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDNewChiefOperatingOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_UndesignatedPreferredStock" xlink:label="loc_LFMDUndesignatedPreferredStock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDUndesignatedPreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SharesIssuedPricePerSharePreSplit" xlink:label="loc_LFMDSharesIssuedPricePerSharePreSplit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDSharesIssuedPricePerSharePreSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="loc_us-gaapPreferredStockDividendRatePercentage" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockDividendRatePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_NumberOfStockIssuedPreSplit" xlink:label="loc_LFMDNumberOfStockIssuedPreSplit" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDNumberOfStockIssuedPreSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments" xlink:label="loc_us-gaapPreferredStockDividendsAndOtherAdjustments" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockDividendsAndOtherAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PreferredStockRedemptionFeatureValue" xlink:label="loc_LFMDPreferredStockRedemptionFeatureValue" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDPreferredStockRedemptionFeatureValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PutLiabilityIncrease" xlink:label="loc_LFMDPutLiabilityIncrease" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDPutLiabilityIncrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_WarrantPurchasePrice" xlink:label="loc_LFMDWarrantPurchasePrice" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDWarrantPurchasePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfFinancingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_UnamortizedCosts" xlink:label="loc_LFMDUnamortizedCosts" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDUnamortizedCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_GrossProceedsFromOffering" xlink:label="loc_LFMDGrossProceedsFromOffering" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDGrossProceedsFromOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CashlessExerciseOfOptionsShares" xlink:label="loc_LFMDCashlessExerciseOfOptionsShares" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDCashlessExerciseOfOptionsShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CashlessExerciseOfWarrantsShares" xlink:label="loc_LFMDCashlessExerciseOfWarrantsShares" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDCashlessExerciseOfWarrantsShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_IssuedWarrantsInConjunctionWithStock" xlink:label="loc_LFMDIssuedWarrantsInConjunctionWithStock" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDIssuedWarrantsInConjunctionWithStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_IssuedWarrantsInConjunctionWithDebt" xlink:label="loc_LFMDIssuedWarrantsInConjunctionWithDebt" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDIssuedWarrantsInConjunctionWithDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MembershipInterestPercentage" xlink:label="loc_LFMDMembershipInterestPercentage" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDMembershipInterestPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_AggregateExpenses" xlink:label="loc_LFMDAggregateExpenses" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDAggregateExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_NumberOfSharesIssuedForExerciseOfWarrants" xlink:label="loc_LFMDNumberOfSharesIssuedForExerciseOfWarrants" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDNumberOfSharesIssuedForExerciseOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_NumberOfSharesIssuedForExerciseOfWarrantsValue" xlink:label="loc_LFMDNumberOfSharesIssuedForExerciseOfWarrantsValue" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDNumberOfSharesIssuedForExerciseOfWarrantsValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_StockIssuedDuringPeriodSharesIssuedForShareLiability" xlink:label="loc_LFMDStockIssuedDuringPeriodSharesIssuedForShareLiability" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDStockIssuedDuringPeriodSharesIssuedForShareLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SharesIssuedForLiability" xlink:label="loc_LFMDSharesIssuedForLiability" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDSharesIssuedForLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="loc_us-gaapPaymentsToMinorityShareholders" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToMinorityShareholders" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PurchasedRemainingInterestPercentage" xlink:label="loc_LFMDPurchasedRemainingInterestPercentage" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDPurchasedRemainingInterestPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_RemainingPerformanceOptions" xlink:label="loc_LFMDRemainingPerformanceOptions" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDRemainingPerformanceOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="630" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:presentationArc order="640" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_OptionsVestingDate" xlink:label="loc_LFMDOptionsVestingDate" />
      <link:presentationArc order="650" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDOptionsVestingDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:label="loc_us-gaapEmployeeBenefitsAndShareBasedCompensation" />
      <link:presentationArc order="660" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeBenefitsAndShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_UnamortizedExpense" xlink:label="loc_LFMDUnamortizedExpense" />
      <link:presentationArc order="670" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDUnamortizedExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="680" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_WarrantDiscountPricePerShare" xlink:label="loc_LFMDWarrantDiscountPricePerShare" />
      <link:presentationArc order="690" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDWarrantDiscountPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_DeemedDistributionFromWarrantPriceAdjustments" xlink:label="loc_LFMDDeemedDistributionFromWarrantPriceAdjustments" />
      <link:presentationArc order="700" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDDeemedDistributionFromWarrantPriceAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:presentationArc order="710" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="720" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:presentationArc order="730" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/StockholdersEquity-ScheduleOfOptionActivityDetails" xlink:title="00000032 - Disclosure - Stockholders&apos; Equity - Schedule of Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_TwoThousandTwentyPlanMember" xlink:label="loc_LFMDTwoThousandTwentyPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_LFMDTwoThousandTwentyPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ServiceBasedStockOptionsMember" xlink:label="loc_LFMDServiceBasedStockOptionsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDServiceBasedStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaapPerformanceSharesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapPerformanceSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice" xlink:label="loc_LFMDShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice" xlink:label="loc_LFMDShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice" xlink:label="loc_LFMDShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning" xlink:label="loc_LFMDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/StockholdersEquity-ScheduleOfWarrantOutstandingAndExercisableDetails" xlink:title="00000033 - Disclosure - Stockholders&apos; Equity - Schedule of Warrant Outstanding and Exercisable (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice" xlink:label="loc_LFMDShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice" xlink:label="loc_LFMDShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisedAndExpiredWeightedAverageContractualLife" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisedAndExpiredWeightedAverageContractualLife" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisedAndExpiredWeightedAverageContractualLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne" xlink:label="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm" xlink:label="loc_LFMDSharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDSharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/LeasesDetailsNarrative" xlink:title="00000034 - Disclosure - Leases (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_LeaseAgreementOneMember" xlink:label="loc_LFMDLeaseAgreementOneMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDLeaseAgreementOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_LeaseAgreementTwoMember" xlink:label="loc_LFMDLeaseAgreementTwoMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDLeaseAgreementTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaapLeaseAndRentalExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLeaseAndRentalExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="loc_us-gaapLesseeOperatingLeaseTermOfContract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseTermOfContract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaapLeaseExpirationDate1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLeaseExpirationDate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/Leases-ScheduleOfLeasesDetails" xlink:title="00000035 - Disclosure - Leases - Schedule of Leases (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000036 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PilarisLaboratoriesLLCMember" xlink:label="loc_LFMDPilarisLaboratoriesLLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDPilarisLaboratoriesLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MALPHABETLLCMember" xlink:label="loc_LFMDMALPHABETLLCMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDMALPHABETLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CVLBPRMember" xlink:label="loc_LFMDCVLBPRMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_LFMDCVLBPRMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_OneEightyDayAnniversaryAgreementMember" xlink:label="loc_LFMDOneEightyDayAnniversaryAgreementMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDOneEightyDayAnniversaryAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ThreeSiXFiveDayAnniversaryAgreementMember" xlink:label="loc_LFMDThreeSiXFiveDayAnniversaryAgreementMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDThreeSiXFiveDayAnniversaryAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_OneTwentyDayAnniversaryAgreementMember" xlink:label="loc_LFMDOneTwentyDayAnniversaryAgreementMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDOneTwentyDayAnniversaryAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ThreeSixtyDayAnniversaryAgreementMember" xlink:label="loc_LFMDThreeSixtyDayAnniversaryAgreementMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_LFMDThreeSixtyDayAnniversaryAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_SubscriptionAgreementMember" xlink:label="loc_LFMDSubscriptionAgreementMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDSubscriptionAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_EmploymentAndConsultingAgreementsMember" xlink:label="loc_LFMDEmploymentAndConsultingAgreementsMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDEmploymentAndConsultingAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CommonStockOneMember" xlink:label="loc_LFMDCommonStockOneMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_LFMDCommonStockOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CommonStockTwoMember" xlink:label="loc_LFMDCommonStockTwoMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_LFMDCommonStockTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CommonStockThreeMember" xlink:label="loc_LFMDCommonStockThreeMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_LFMDCommonStockThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PremiumsPercentageAssumedToNet" xlink:label="loc_us-gaapPremiumsPercentageAssumedToNet" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPremiumsPercentageAssumedToNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntercompanyAgreementsDescription" xlink:label="loc_us-gaapIntercompanyAgreementsDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIntercompanyAgreementsDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PerformanceFee" xlink:label="loc_LFMDPerformanceFee" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDPerformanceFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_LicenseFee" xlink:label="loc_LFMDLicenseFee" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDLicenseFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PercentageForRoyalty" xlink:label="loc_LFMDPercentageForRoyalty" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDPercentageForRoyalty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaapPurchaseObligation" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPurchaseObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ExpiringAgreementDescription" xlink:label="loc_LFMDExpiringAgreementDescription" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDExpiringAgreementDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000037 - Disclosure - Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PresidentAndCEOMember" xlink:label="loc_LFMDPresidentAndCEOMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDPresidentAndCEOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srtChiefExecutiveOfficerMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefExecutiveOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefOperatingOfficerMember" xlink:label="loc_srtChiefOperatingOfficerMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefOperatingOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_OfficeSpaceMember" xlink:label="loc_LFMDOfficeSpaceMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_LFMDOfficeSpaceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PuertoRicoOfficeSpaceMember" xlink:label="loc_LFMDPuertoRicoOfficeSpaceMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_LFMDPuertoRicoOfficeSpaceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_JLSVenturesLLCMember" xlink:label="loc_LFMDJLSVenturesLLCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDJLSVenturesLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_BVGlobalFulfillmentMember" xlink:label="loc_LFMDBVGlobalFulfillmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDBVGlobalFulfillmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PromissoryNoteMember" xlink:label="loc_LFMDPromissoryNoteMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_LFMDPromissoryNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_srtDirectorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ExchangeAgreementMember" xlink:label="loc_LFMDExchangeAgreementMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDExchangeAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ConsultingAgreementMember" xlink:label="loc_LFMDConsultingAgreementMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDConsultingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_MonthlyFees" xlink:label="loc_LFMDMonthlyFees" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDMonthlyFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/IncomeTaxes-DetailsNarrative" xlink:title="00000038 - Disclosure - Income Taxes - (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:label="loc_us-gaapOperatingLossCarryforwardsLimitationsOnUse" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwardsLimitationsOnUse" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/IncomeTaxes-ScheduleOfIncomeTaxProvisionChargesDetails" xlink:title="00000039 - Disclosure - Income Taxes - Schedule of Income Tax Provision Charges (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalStateAndLocalTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/IncomeTaxes-ScheduleOfProvisionDiffersFromAmountOfIncomeTaxDetails" xlink:title="00000040 - Disclosure - Income Taxes - Schedule of Provision Differs from the Amount of Income Tax (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ExpectedTaxExpenseBenefit" xlink:label="loc_LFMDExpectedTaxExpenseBenefit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_LFMDExpectedTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationPriorYearIncomeTaxes" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationPriorYearIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/IncomeTaxes-ScheduleOfNetDeferredTaxLiabilitiesDetails" xlink:title="00000041 - Disclosure - Income Taxes - Schedule of Net Deferred Tax Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="loc_us-gaapDeferredTaxLiabilitiesOther" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_DeferredTaxAssetsTemporaryDifferences" xlink:label="loc_LFMDDeferredTaxAssetsTemporaryDifferences" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_LFMDDeferredTaxAssetsTemporaryDifferences" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://lifemd.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000042 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ChiefDigitalOfficerMember" xlink:label="loc_LFMDChiefDigitalOfficerMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDChiefDigitalOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ChiefMedicalOfficerMember" xlink:label="loc_LFMDChiefMedicalOfficerMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDChiefMedicalOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_FoundingMembersMIPAsMember" xlink:label="loc_LFMDFoundingMembersMIPAsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDFoundingMembersMIPAsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ChiefBusinessOfficerMember" xlink:label="loc_LFMDChiefBusinessOfficerMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDChiefBusinessOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefFinancialOfficerMember" xlink:label="loc_srtChiefFinancialOfficerMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefFinancialOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_InvestorsMember" xlink:label="loc_LFMDInvestorsMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_LFMDInvestorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_EmploymentAgreementMember" xlink:label="loc_LFMDEmploymentAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDEmploymentAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_FebruaryTwoThousandTwentyOnePurchaseAgreementMember" xlink:label="loc_LFMDFebruaryTwoThousandTwentyOnePurchaseAgreementMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_LFMDFebruaryTwoThousandTwentyOnePurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapVestingAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheOneMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_VestingOnEffectiveDateMember" xlink:label="loc_LFMDVestingOnEffectiveDateMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_LFMDVestingOnEffectiveDateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheTwoMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="loc_us-gaapShareBasedCompensationAwardTrancheThreeMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_us-gaapShareBasedCompensationAwardTrancheThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_CVLBPRMember" xlink:label="loc_LFMDCVLBPRMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_LFMDCVLBPRMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_PaycheckProtectionProgramMember" xlink:label="loc_LFMDPaycheckProtectionProgramMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_LFMDPaycheckProtectionProgramMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_ConversionLabsPRLLCMember" xlink:label="loc_LFMDConversionLabsPRLLCMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_LFMDConversionLabsPRLLCMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="loc_srtConsolidatedEntitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtConsolidatedEntitiesAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="loc_srtConsolidatedEntitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesAxis" xlink:to="loc_srtConsolidatedEntitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_LegalSimpliSoftwareLlcMember" xlink:label="loc_LFMDLegalSimpliSoftwareLlcMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidatedEntitiesDomain" xlink:to="loc_LFMDLegalSimpliSoftwareLlcMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="90" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="lfmd-20201231.xsd#LFMD_OptionsVestingDate" xlink:label="loc_LFMDOptionsVestingDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_LFMDOptionsVestingDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDecreaseForgiveness" xlink:label="loc_us-gaapDebtInstrumentDecreaseForgiveness" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentDecreaseForgiveness" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902990435368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LifeMD, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000948320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Reporting Status Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82,837,083<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,906,754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902995537608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="nump">$ 9,179,075<span></span>
</td>
<td class="nump">$ 1,106,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">648,421<span></span>
</td>
<td class="nump">97,448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsCurrent', window );">Product deposit</a></td>
<td class="nump">816,765<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">1,264,258<span></span>
</td>
<td class="nump">950,059<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">154,876<span></span>
</td>
<td class="nump">442,971<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">12,063,395<span></span>
</td>
<td class="nump">2,747,102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use asset, net</a></td>
<td class="nump">274,437<span></span>
</td>
<td class="nump">23,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNet', window );">Capitalized software, net</a></td>
<td class="nump">375,983<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">339,840<span></span>
</td>
<td class="nump">675,452<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="nump">990,260<span></span>
</td>
<td class="nump">699,077<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">13,053,655<span></span>
</td>
<td class="nump">3,446,179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">11,794,084<span></span>
</td>
<td class="nump">3,051,156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes payable, net</a></td>
<td class="nump">779,132<span></span>
</td>
<td class="nump">814,734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">916,880<span></span>
</td>
<td class="nump">109,552<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">13,490,096<span></span>
</td>
<td class="nump">3,975,442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Long-term Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease Liability</a></td>
<td class="nump">285,323<span></span>
</td>
<td class="nump">29,978<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ContingentConsiderationOnPurchaseOfLegalsimpli', window );">Contingent consideration on purchase of LegalSimpli</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">70,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">13,875,419<span></span>
</td>
<td class="nump">4,575,420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 7)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Mezzanine Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Preferred Stock, $0.0001 per value; 4,996,500 and 5,000,000 shares authorized Series B Preferred Stock, $0.0001 per value; 5,000 and 0 shares authorized, 3,500 and 0 shares issued and outstanding as of December 31, 2020 and 2019, respectively; liquidation value approximately, $1,045 and $0 per share at December 31, 2020 and 2019, respectively</a></td>
<td class="nump">3,655,822<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value; 100,000,000 shares authorized, 23,433,663 and 10,680,730 shares issued, 23,330,623 and 10,577,690 outstanding as of December 31, 2020 and 2019, respectively</a></td>
<td class="nump">234,337<span></span>
</td>
<td class="nump">106,807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">77,779,370<span></span>
</td>
<td class="nump">15,663,626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(80,151,905)<span></span>
</td>
<td class="num">(16,594,917)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_EquityTotal', window );">Equity</a></td>
<td class="num">(2,138,198)<span></span>
</td>
<td class="num">(824,484)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, 103,040 and 103,040 shares, at cost</a></td>
<td class="num">(163,701)<span></span>
</td>
<td class="num">(163,701)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total LifeMD, Inc. Stockholders' Deficit</a></td>
<td class="num">(2,301,899)<span></span>
</td>
<td class="num">(988,185)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interest</a></td>
<td class="num">(2,175,687)<span></span>
</td>
<td class="num">(141,056)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total Stockholders' Deficit</a></td>
<td class="num">(4,477,586)<span></span>
</td>
<td class="num">(1,129,241)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Deficit</a></td>
<td class="nump">$ 13,053,655<span></span>
</td>
<td class="nump">$ 3,446,179<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ContingentConsiderationOnPurchaseOfLegalsimpli">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent consideration on purchase of LegalSimpli.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ContingentConsiderationOnPurchaseOfLegalsimpli</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_EquityTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents total of common stock, additional paid in capital and accumulated deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_EquityTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902995650984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Preferred stock, at par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">4,996,500<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">23,433,663<span></span>
</td>
<td class="nump">10,680,730<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">23,330,623<span></span>
</td>
<td class="nump">10,577,690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares</a></td>
<td class="nump">103,040<span></span>
</td>
<td class="nump">103,040<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Preferred stock, at par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">3,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">3,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Preferred stock, liquidation value</a></td>
<td class="nump">$ 1,045<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902995359864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues, net</a></td>
<td class="nump">$ 37,293,910<span></span>
</td>
<td class="nump">$ 12,468,578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenues</a></td>
<td class="nump">8,907,442<span></span>
</td>
<td class="nump">2,525,308<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">28,386,468<span></span>
</td>
<td class="nump">9,943,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling &amp; marketing expenses</a></td>
<td class="nump">41,669,475<span></span>
</td>
<td class="nump">8,916,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">42,206,675<span></span>
</td>
<td class="nump">2,398,751<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherGeneralExpense', window );">Other operating expenses</a></td>
<td class="nump">1,166,697<span></span>
</td>
<td class="nump">724,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSellingGeneralAndAdministrativeExpense', window );">Customer service expenses</a></td>
<td class="nump">716,325<span></span>
</td>
<td class="nump">570,763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DevelopmentCosts', window );">Development Costs</a></td>
<td class="nump">446,749<span></span>
</td>
<td class="nump">222,877<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total expenses</a></td>
<td class="nump">86,205,921<span></span>
</td>
<td class="nump">12,832,878<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Loss</a></td>
<td class="num">(57,819,453)<span></span>
</td>
<td class="num">(2,889,608)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net</a></td>
<td class="num">(1,667,536)<span></span>
</td>
<td class="num">(761,150)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt settlement</a></td>
<td class="num">(914,862)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total</a></td>
<td class="num">(2,582,398)<span></span>
</td>
<td class="num">(761,150)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net Loss before provision for income taxes</a></td>
<td class="num">(60,401,851)<span></span>
</td>
<td class="num">(3,650,758)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">122,500<span></span>
</td>
<td class="num">(122,500)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Loss</a></td>
<td class="num">(60,524,351)<span></span>
</td>
<td class="num">(3,528,258)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net (loss) attributable to noncontrolling interests</a></td>
<td class="num">(1,877,408)<span></span>
</td>
<td class="num">(391,055)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to LifeMD, Inc.</a></td>
<td class="num">(58,646,943)<span></span>
</td>
<td class="num">(3,137,203)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsAndOtherAdjustments', window );">Deemed distribution to holders of common and Series B Preferred stock</a></td>
<td class="num">(4,716,021)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to LifeMD, Inc. common stockholders</a></td>
<td class="num">$ (63,362,964)<span></span>
</td>
<td class="num">$ (3,137,203)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic loss per share attributable to LifeMD, Inc. common stockholders</a></td>
<td class="num">$ (4.44)<span></span>
</td>
<td class="num">$ (0.32)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Diluted loss per share attributable to LifeMD, Inc. common stockholders</a></td>
<td class="num">$ (4.44)<span></span>
</td>
<td class="num">$ (0.32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Weighted Average number of common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">14,275,153<span></span>
</td>
<td class="nump">9,897,745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="nump">14,275,153<span></span>
</td>
<td class="nump">9,897,745<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product Revenues, Net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues, net</a></td>
<td class="nump">$ 30,556,163<span></span>
</td>
<td class="nump">$ 9,919,506<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenues</a></td>
<td class="nump">8,572,490<span></span>
</td>
<td class="nump">2,371,295<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=LFMD_SoftwareRevenuesNetMember', window );">Software Revenues, Net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues, net</a></td>
<td class="nump">6,732,747<span></span>
</td>
<td class="nump">2,539,129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenues</a></td>
<td class="nump">334,952<span></span>
</td>
<td class="nump">154,013<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service Revenues, Net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Net Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues, net</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">9,943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenues</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The capitalized costs incurred during the period (excluded from amortization) to obtain access to proved reserves and to provide facilities for extracting, treating, gathering and storing the oil and gas.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(7)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398226&amp;loc=d3e511914-122862<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of general expenses not normally included in Other Operating Costs and Expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.6)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of selling, general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsAndOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsAndOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=LFMD_SoftwareRevenuesNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=LFMD_SoftwareRevenuesNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902986693064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Stockholders' Deficit - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Accumulated (Deficit) [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Noncontrolling Interest [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2018</a></td>
<td class="nump">$ 91,564<span></span>
</td>
<td class="nump">$ 13,110,507<span></span>
</td>
<td class="num">$ (12,140,670)<span></span>
</td>
<td class="num">$ (163,701)<span></span>
</td>
<td class="nump">$ 897,700<span></span>
</td>
<td class="num">$ (77,962)<span></span>
</td>
<td class="nump">$ 819,738<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2018</a></td>
<td class="nump">9,156,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock issued for services</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">15,800<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">16,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued for services, shares</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock compensation</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">731,215<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">733,215<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">733,215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock compensation, shares</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_AgreementToIssueSharesForNoncontrollingInterest', window );">Agreement to issue shares for non-controlling interest in CVLB PR</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">890,000<span></span>
</td>
<td class="num">(1,317,044)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(417,044)<span></span>
</td>
<td class="nump">417,044<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_AgreementToIssueSharesForNoncontrollingInterestShares', window );">Agreement to issue shares for non-controlling interest in CVLB PR, shares</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock', window );">Warrants issued in conjunction with stock</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">20,825<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">20,825<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">20,825<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt', window );">Warrants issued in conjunction with debt</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">569,146<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">569,146<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">569,146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Purchase of common stock</a></td>
<td class="nump">$ 3,043<span></span>
</td>
<td class="nump">326,133<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">329,176<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">329,176<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Purchase of common stock, shares</a></td>
<td class="nump">304,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distribution to non-controlling interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(89,083)<span></span>
</td>
<td class="num">(89,083)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(3,137,203)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(3,137,203)<span></span>
</td>
<td class="num">(391,055)<span></span>
</td>
<td class="num">(3,528,258)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 106,807<span></span>
</td>
<td class="nump">15,663,626<span></span>
</td>
<td class="num">(16,594,917)<span></span>
</td>
<td class="num">(163,701)<span></span>
</td>
<td class="num">(988,185)<span></span>
</td>
<td class="num">(141,056)<span></span>
</td>
<td class="num">(1,129,241)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2019</a></td>
<td class="nump">10,680,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock issued for services</a></td>
<td class="nump">$ 29,000<span></span>
</td>
<td class="nump">18,276,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">18,305,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">18,305,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued for services, shares</a></td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">18,656,141<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">18,656,141<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">18,656,141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock compensation, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">329,176<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Purchase of common stock, shares</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distribution to non-controlling interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(157,223)<span></span>
</td>
<td class="num">(157,223)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Sale of warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_StockIssuedDuringPeriodValueExerciseOfWarrants', window );">Exercise of warrants</a></td>
<td class="nump">$ 3,800<span></span>
</td>
<td class="nump">618,963<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">622,763<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">622,763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_StockIssuedDuringPeriodSharesExerciseOfWarrants', window );">Exercise of warrants, shares</a></td>
<td class="nump">379,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 5,356<span></span>
</td>
<td class="nump">297,044<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">302,400<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">302,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="nump">535,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_CashlessExerciseOfWarrants', window );">Cashless exercise of warrants</a></td>
<td class="nump">$ 14,726<span></span>
</td>
<td class="num">(14,726)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_CashlessExerciseOfWarrantsShares', window );">Cashless exercise of warrants, shares</a></td>
<td class="nump">1,472,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions', window );">Cashless exercise of stock options</a></td>
<td class="nump">$ 5,348<span></span>
</td>
<td class="num">(5,348)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_StockIssuedDuringPeriodSharesCashlessExerciseOfStockOptions', window );">Cashless exercise of stock options, shares</a></td>
<td class="nump">534,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_StockIssuedDuringPeriodValueSaleOfCommonStock', window );">Sale of common stock</a></td>
<td class="nump">$ 2,941<span></span>
</td>
<td class="nump">247,059<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_StockIssuedDuringPeriodSharesSaleOfCommonStock', window );">Sale of common stock, shares</a></td>
<td class="nump">294,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet', window );">Sale of stock in private placement, net</a></td>
<td class="nump">$ 33,684<span></span>
</td>
<td class="nump">14,866,536<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">14,900,220<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">14,900,220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_StockIssuedDuringperiodSaleOfStockInPrivatePlacementNetShares', window );">Sale of stock in private placement, net shares</a></td>
<td class="nump">3,368,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Shares issued for share liability (proceeds received in prior period)</a></td>
<td class="nump">$ 27,222<span></span>
</td>
<td class="nump">2,154,231<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,181,453<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,181,453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Shares issued for share liability (proceeds received in prior period), shares</a></td>
<td class="nump">2,722,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Common stock issued for debt exchange agreement</a></td>
<td class="nump">$ 969<span></span>
</td>
<td class="nump">1,163,893<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,164,862<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,164,862<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Common stock issued for debt exchange agreement,shares</a></td>
<td class="nump">96,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Common stock issued for conversion of debt</a></td>
<td class="nump">$ 4,478<span></span>
</td>
<td class="nump">1,114,930<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,119,408<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,119,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Common stock issued for conversion of debt ,shares</a></td>
<td class="nump">447,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Deemed dividend from down-round provision in common stock shares yet to be issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(194,024)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(194,024)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(194,024)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount', window );">Deemed dividend from warrant price adjustments</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,216,021<span></span>
</td>
<td class="num">(1,216,021)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockCash', window );">Deemed dividend from warrants issued and BCF with Series B Preferred Stock</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="num">(3,500,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_StockIssuedDuringPeriodValueReverseStockSplits', window );">Rounding due to reverse split</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits', window );">Rounding due to reverse split, shares</a></td>
<td class="nump">632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(58,646,943)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(58,646,943)<span></span>
</td>
<td class="num">(1,877,408)<span></span>
</td>
<td class="num">(60,524,351)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 234,337<span></span>
</td>
<td class="nump">$ 77,779,370<span></span>
</td>
<td class="num">$ (80,151,905)<span></span>
</td>
<td class="num">$ (163,701)<span></span>
</td>
<td class="num">$ (2,301,899)<span></span>
</td>
<td class="num">$ (2,175,687)<span></span>
</td>
<td class="num">$ (4,477,586)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2020</a></td>
<td class="nump">23,433,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued in conjunction with debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued in conjunction with stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_AgreementToIssueSharesForNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreement to issue shares for non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_AgreementToIssueSharesForNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_AgreementToIssueSharesForNoncontrollingInterestShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreement to issue shares for non-controlling interest in CVLB PR, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_AgreementToIssueSharesForNoncontrollingInterestShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_CashlessExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cashless exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_CashlessExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_CashlessExerciseOfWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cashless exercise of warrants, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_CashlessExerciseOfWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of stock in private placement, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_StockIssuedDuringPeriodSharesCashlessExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cashless exercise of stock options, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_StockIssuedDuringPeriodSharesCashlessExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_StockIssuedDuringPeriodSharesExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise of warrants, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_StockIssuedDuringPeriodSharesExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_StockIssuedDuringPeriodSharesSaleOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of common stock, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_StockIssuedDuringPeriodSharesSaleOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cashless exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_StockIssuedDuringPeriodValueExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_StockIssuedDuringPeriodValueExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_StockIssuedDuringPeriodValueReverseStockSplits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period Value Reverse Stock Splits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_StockIssuedDuringPeriodValueReverseStockSplits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_StockIssuedDuringPeriodValueSaleOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_StockIssuedDuringPeriodValueSaleOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_StockIssuedDuringperiodSaleOfStockInPrivatePlacementNetShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of stock in private placement, net shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_StockIssuedDuringperiodSaleOfStockInPrivatePlacementNetShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109126253&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reduction in the number of shares during the period as a result of a reverse stock split.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of (increase) decrease in equity for down round feature triggered for warrant classified as equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=SL109261905-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12B<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL109261756-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902994380360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Loss</a></td>
<td class="num">$ (60,524,351)<span></span>
</td>
<td class="num">$ (3,528,258)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash (used in) provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">817,118<span></span>
</td>
<td class="nump">622,256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAmortization1', window );">Amortization of capitalized software</a></td>
<td class="nump">62,153<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles</a></td>
<td class="nump">335,612<span></span>
</td>
<td class="nump">335,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_AccelerationOfDebtDiscount', window );">Acceleration of debt discount</a></td>
<td class="nump">500,145<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt settlement</a></td>
<td class="nump">914,862<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease Payments</a></td>
<td class="nump">4,533<span></span>
</td>
<td class="nump">6,353<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Stock issued for services</a></td>
<td class="nump">18,305,000<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation expense</a></td>
<td class="nump">18,656,141<span></span>
</td>
<td class="nump">733,215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax liability</a></td>
<td class="num">(70,000)<span></span>
</td>
<td class="nump">66,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in Assets and Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(550,973)<span></span>
</td>
<td class="nump">1,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset', window );">Product deposit</a></td>
<td class="num">(666,765)<span></span>
</td>
<td class="num">(116,695)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(314,199)<span></span>
</td>
<td class="nump">72,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Other current assets</a></td>
<td class="nump">95,595<span></span>
</td>
<td class="num">(172,965)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">807,328<span></span>
</td>
<td class="nump">33,568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">9,496,187<span></span>
</td>
<td class="nump">2,182,159<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash (used in) provided by operating activities</a></td>
<td class="num">(12,131,614)<span></span>
</td>
<td class="nump">251,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireSoftware', window );">Cash paid for capitalized software costs</a></td>
<td class="num">(398,136)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities', window );">Payment to seller for contingent consideration</a></td>
<td class="num">(400,000)<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(798,136)<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Cash proceeds from private placement offering, net</a></td>
<td class="nump">14,900,220<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Cash proceeds from Series B Preferred Stock</a></td>
<td class="nump">2,892,500<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible notes payable</a></td>
<td class="nump">2,350,000<span></span>
</td>
<td class="nump">1,093,279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Cash proceeds from sale of common stock</a></td>
<td class="nump">2,338,349<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Cash proceeds from exercise of warrants</a></td>
<td class="nump">622,763<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Cash proceeds from exercise of options</a></td>
<td class="nump">302,400<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Cash proceed from sale of warrants</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of debt issuance costs</a></td>
<td class="num">(15,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Distributions to non-controlling interest</a></td>
<td class="num">(157,223)<span></span>
</td>
<td class="num">(89,085)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from note payable</a></td>
<td class="nump">242,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of notes payable</a></td>
<td class="num">(2,498,808)<span></span>
</td>
<td class="num">(295,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfEquity', window );">Purchase of shares and warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">349,999<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfLoanCosts', window );">Debt issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(284,070)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">21,002,201<span></span>
</td>
<td class="nump">775,123<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash</a></td>
<td class="nump">8,072,451<span></span>
</td>
<td class="nump">926,531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash at beginning of year</a></td>
<td class="nump">1,106,624<span></span>
</td>
<td class="nump">180,093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash at end of year</a></td>
<td class="nump">9,179,075<span></span>
</td>
<td class="nump">1,106,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_CashPaidForInterestAbstract', window );"><strong>Cash paid for interest</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid during the period for interest</a></td>
<td class="nump">1,665,171<span></span>
</td>
<td class="nump">80,660<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash investing and financing activitites:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of company stock for investment in subsidiary</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_CashlessExerciseOfWarrantsSupplementalDisclosure', window );">Cashless exercise of warrants</a></td>
<td class="nump">49,551<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_DeemedDividendFromWarrantPriceAdjustment', window );">Deemed dividend from warrant price adjustments</a></td>
<td class="nump">1,289,657<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_DeemedDistributionFromWarrantsIssuedWithPreferredStock', window );">Deemed distribution from warrants issued with Series B Preferred Stock</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_StockIssuesForCapitalizedCosts', window );">Stock yet to be issued for capitalized costs</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_DeemedDistributionFromDownroundProvisionOnUnissuedShares', window );">Deemed distribution from down-round provision on unissued shares</a></td>
<td class="nump">194,022<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Liability to issue common stock</a></td>
<td class="nump">76,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesIssued1', window );">Debt issuance costs for liability to issue shares</a></td>
<td class="nump">219,450<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferToInvestments', window );">Conversion of convertible note payable and interest for Series B Preferred Stock</a></td>
<td class="nump">607,500<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_SharesIssuedForShareLiability', window );">Stock issued for capitalized costs</a></td>
<td class="nump">12,675<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_WarrantsIssuedInRelationToDebt', window );">Warrants issued in relation to debt</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">569,147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReduction', window );">Common stock issued for conversion of debt</a></td>
<td class="nump">1,119,408<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransferOfLoansHeldForSaleToPortfolioLoans1', window );">Debt Exchange Agreement</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_RightOfUseAsset', window );">Right of Use asset</a></td>
<td class="nump">274,437<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsIncurred', window );">Right of Use lease liability</a></td>
<td class="nump">$ 285,323<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_AccelerationOfDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acceleration of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_AccelerationOfDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_CashPaidForInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash paid for interest [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_CashPaidForInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_CashlessExerciseOfWarrantsSupplementalDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cashless exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_CashlessExerciseOfWarrantsSupplementalDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_DeemedDistributionFromDownroundProvisionOnUnissuedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deemed distribution from down-round provision on unissued shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_DeemedDistributionFromDownroundProvisionOnUnissuedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_DeemedDistributionFromWarrantsIssuedWithPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deemed distribution from warrants issued with Series B peferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_DeemedDistributionFromWarrantsIssuedWithPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_DeemedDividendFromWarrantPriceAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deemed dividend from warrant price adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_DeemedDividendFromWarrantPriceAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_RightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right of Use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_RightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_SharesIssuedForShareLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shares issued for share liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_SharesIssuedForShareLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_StockIssuesForCapitalizedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issues for capitalized costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_StockIssuesForCapitalizedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_WarrantsIssuedInRelationToDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued in relation to debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_WarrantsIssuedInRelationToDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in lease obligation from new lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAmortization1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for amortization of capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAmortization1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of notes issued in noncash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of notes retired (or transferred to another entity) in noncash investing or financing transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, made soon after acquisition date of business combination, to settle contingent consideration liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfLoanCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan origination associated cost which is usually collected through escrow.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfLoanCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferOfLoansHeldForSaleToPortfolioLoans1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of loans held-for-sale transferred to loans held in the entity's portfolio in noncash transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferOfLoansHeldForSaleToPortfolioLoans1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferToInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of investments transferred to the entity's investments in noncash transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferToInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902992409128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of the Organization and Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of the Organization and Business</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 1 &#8211; NATURE OF THE ORGANIZATION AND BUSINESS
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Corporate History</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">LifeMD, Inc. was formed in the
State of Delaware on May 24, 1994, under its prior name, Immudyne, Inc. The Company changed its name to Conversion Labs, Inc. on June
22, 2018 and then subsequently, on February 22, 2021, it changed its name to LifeMD, Inc. Effective February 22, 2021, the trading symbol
for the Company&#8217;s common stock, par value $0.01 per share on The Nasdaq Stock Market LLC changed from &#8220;CVLB&#8221; to &#8220;LFMD&#8221;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On April 1, 2016, the original
operating agreement of Immudyne PR LLC (&#8220;Immudyne PR&#8221;), a joint venture to market the Company&#8217;s skincare products, was
amended and restated and the Company increased its ownership and voting interest in Immudyne PR to 78.2%. Concurrent with the name change
of the parent company to Conversion Labs, Inc., Immudyne PR was renamed to Conversion Labs PR LLC (now known as &#8220;Conversion Labs
PR&#8221;). On April 25, 2019, the operating agreement of Conversion Labs PR was amended and restated in its entirety to increase the
Company&#8217;s ownership and voting interest in Conversion Labs PR to 100%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In June 2018, the Company closed
the strategic acquisition of 51% of LegalSimpli Software, LLC (&#8220;LegalSimpli&#8221;), a software as a service (SaaS) application
for converting, editing, signing and sharing PDF documents. In addition to LegalSimpli Software&#8217;s growth business model, this acquisition
added deep search engine optimization and search engine marketing expertise to the Company. Effective January 22, 2021, the Company consummated
a transaction to restructure the ownership of LegalSimpli (the &#8220;LSS Restructuring&#8221;) (See Note 10).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Nature of Business</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">LifeMD is a direct-to-patient
telehealth company that provides a smarter, cost-effective and convenient way of accessing healthcare. The Company believes that the traditional
model of visiting a doctor&#8217;s office, receiving a physical prescription, visiting a local pharmacy, and returning to see a doctor
for follow up care or prescription refills is inefficient, costly to patients, and discourages many patients from seeking much needed
medical care. The U.S. healthcare system is undergoing a paradigm shift, thanks to new technologies and the emergence of direct-to-patient
healthcare. Direct-to-patient telemedicine companies, like the Company, connect consumers to licensed healthcare professionals for care
across numerous indications, including concierge care, men&#8217;s sexual health and dermatology, among others.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s telemedicine
platform helps patients access licensed providers for diagnoses, virtual care, and prescription medications, often delivered on a recurring
basis. In addition to its telemedicine offerings, it sells nutritional supplements and other over-the-counter products. Many of its products
are available on a subscription or membership basis, where a patient can subscribe to receive regular shipments of prescribed medications
or products. This creates convenience and often discounted pricing opportunities for patients and recurring revenue streams for it.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company
believes that brand innovation, customer acquisition and service excellence form the heart of its business. As is exemplified with its
first brand, Shapiro MD, it has built a full line of proprietary OTC products for male and female hair loss, FDA approved OTC minoxidil,
an FDA-cleared medical device, and now a personalized telemedicine offering that gives consumers access to virtual medical treatment and,
when appropriate, a full line of oral and topical prescription medications for hair loss. The Company&#8217;s men&#8217;s telemedicine
brand, Rex MD, currently offers treatment for erectile dysfunction, and will soon offer treatments for additional indications present
in men&#8217;s health. The Company has built a platform that allows it to efficiently launch telehealth and wellness product lines wherever
it determines there is a market need.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Business and Subsidiary History </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In June 2018, Conversion Labs
closed the strategic acquisition of 51% of LegalSimpli Software, LLC (&#8220;LegalSimpli&#8221;), a software as a service (SaaS) application
for converting, editing, signing and sharing PDF documents. In addition to LegalSimpli&#8217;s growth business model, this acquisition
added deep search engine optimization and search engine marketing expertise to the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In early 2019, the Company had
launched a service-based business under the name Conversion Labs Media LLC, which was to be used to run e-commerce marketing campaigns
for other online businesses. However, this business initiative was terminated in early 2019 in order to focus on its core business as
well as the expansion of our telehealth opportunities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In June 2019, a strategic joint
venture with GoGoMeds.com (GoGoMeds) was formed in order to help facilitate the launch of our telemedicine business. GoGoMeds is a nationwide
pharmacy licensed to dispense prescription medications directly to consumers in all 50 states and the District of Columbia. However, on
August 7, 2020, the Company terminated its Strategic Partnership Agreement with GoGoMeds. The joint venture with GoGoMeds had not initiated
activities, and its termination did not have an impact on the Company&#8217;s operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Conversion Labs Rx, LLC (&#8220;CVLB
Rx&#8221;), a Puerto Rico limited liability company, had no activity during the year ended December 31, 2020 and was dissolved during
the period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Unless otherwise indicated, the
terms &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to LifeMD, Inc. (formerly known as Conversion
Labs, Inc.), our wholly subsidiary Conversion Labs PR, LLC (formerly Immudyne PR LLC, now &#8220;Conversion Labs PR&#8221;), a Puerto
Rico limited liability company (&#8220;Conversion Labs PR&#8221;, or &#8220;CLPR&#8221;) and our majority-owned subsidiaries LegalSimpli
Software, LLC, a Puerto Rico limited liability company (&#8220;LegalSimpli&#8221;). Unless otherwise specified, all dollar amounts are
expressed in United States dollars.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Reverse Stock Split</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">On October
9, 2020, the Company filed a Certificate of Amendment to its Articles of Incorporation with the Secretary of State of Delaware (the &#8220;Amendment&#8221;)
in order to effectuate a 1-for-5 reverse stock split of the Company&#8217;s issued and outstanding shares of common stock (the &#8220;Reverse
Split&#8221; or &#8220;Split&#8221;). The Reverse Split was approved by the Financial Industry Regulatory Authority (FINRA) and became
effective in the market on October 14, 2020 (the &#8220;Effective Date&#8221;). All references to common shares and common share data
in these financial statements and elsewhere in this Form 10-K as of December 31, 2020 and 2019, and for the years then ended, reflect
the Reverse Stock Split.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Liquidity</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has funded operations
in the past through the sales of its products, issuance of common stock and through loans and advances from officers and directors. The
Company&#8217;s continued operations are dependent upon obtaining an increase in its sale volumes and the continued financial support
from officers and directors, obtaining funding from third-party sources or the issuance of additional shares of common stock. See Note
5 for a further discussion of the private placement offering, which closed in November 2020, yielding approximately $14.9 million in net
proceeds to the Company after deduction of placement fees and other offering expenses. The Company intends to use the net proceeds to
expedite growth initiatives, as well as for general corporate purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">On February
11, 2021, the Company consummated the closing of a private placement offering (the &#8220;February 2021 Offering&#8221;), whereby pursuant
to the securities purchase agreement (the &#8220;February 2021 Purchase Agreement&#8221;) entered into by the Company and certain accredited
investors on February 11, 2021 the Investors purchased 608,696 shares of the Company&#8217;s common stock par value $0.01 per share at
a purchase price of $23.00 per share for aggregate gross proceeds of approximately 14.0 million (the &#8220;Purchase Price&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The Purchase
Price was funded on the closing date and resulted in net proceeds to the Company of approximately $13.4 million after deducting fees payable
to the placement agent and other estimated offering expenses payable by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Going Concern Evaluation</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The accompanying consolidated
financial statements have been prepared on the basis that the Company will continue as a going concern, which assumes the realization
of assets and the satisfaction of liabilities in the normal course of business. The Company prepared its financial statements for the
year ended December 31, 2019 assuming the Company would continue as a going concern, with an explanatory note that the Company&#8217;s
significant operating losses raise substantial doubt about its ability to continue as a going concern. As of December 31, 2020, the Company
has an accumulated deficit approximating $80.2 million and has experienced significant losses from its operations. Although the Company
is showing significant positive revenue trends, the Company expects to incur further losses through the end of 2021. Additionally, the
Company expects its burn rate of cash to continue through the first quarter of 2021; however, the Company expects this burn rate to improve
in future quarters. To date, the Company has been funding operations primarily through the sale of equity in private placements. Management
is unable to predict if and when we will be able to generate significant positive cash flow or achieve profitability. There can be no
assurances that we will be successful in increasing revenues, improving operational efficiencies or that financing will be available or,
if available, that such financing will be available under favorable terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has a current cash
balance of approximately $12 million as of the filing date, which includes the $13.4 million of net proceeds from the February 2021 Offering
noted above. Based on the Company&#8217;s projected cash requirements, management estimates that it will utilize approximately $10 million
through the next 12 months from the filing date of this report. The Company reviewed its forecasted operating results and uses and sources
of cash used in management&#8217;s assessment, which included the available financing, consideration of positive and negative evidence
impacting management&#8217;s forecasts, market and industry factors. Positive indicators that lead to its conclusion that it will have
sufficient cash over the next 12 months following the date of this report include (1) its continued strengthening of our revenues and
improvement of operational efficiencies across the business, (2) the expected improvement in its cash burn rate in the first quarter of
2021 and over the next 12 months, (3) overall investor interest in its equity securities which it believes will enable it to successfully
complete future capital raises and (4) the overall market value of the telemedicine industry and how it believes that will continue to
drive interest in the Company.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902994237304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Principles of Consolidation</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company evaluates the need
to consolidate affiliates based on standards set forth in ASC 810 Consolidation (&#8220;ASC 810&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The consolidated financial statements
include the accounts of the Company and its wholly owned subsidiary, CLPR and its majority owned subsidiary, LegalSimpli. The non-controlling
interest in LegalSimpli represents the 49 % equity interest held by other members of the subsidiary as of December 31, 2020 and 2019.
Subsequent to year end, the Company purchased an additional 36% of LegalSimpli for a total 85%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">All significant intercompany transactions
and balances have been eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Variable Interest Entities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company follows ASC 810-10-15
guidance with respect to accounting for variable interest entities (each, a &#8220;VIE&#8221;). These entities do not have sufficient
equity at risk to finance their activities without additional subordinated financial support from other parties or whose equity investors
lack any of the characteristics of a controlling financial interest. A variable interest is an investment or other interest that will
absorb portions of a VIE&#8217;s expected losses or receive portions of its expected residual returns and are contractual, ownership,
or pecuniary in nature and that change with changes in the fair value of the entity&#8217;s net assets. A reporting entity is the primary
beneficiary of a VIE and must consolidate it when that party has a variable interest, or combination of variable interests, that provides
it with a controlling financial interest. A party is deemed to have a controlling financial interest if it meets both of the power and
losses/benefits criteria. The power criterion is the ability to direct the activities of the VIE that most significantly impact its economic
performance. The losses/benefits criterion is the obligation to absorb losses from, or right to receive benefits from, the VIE that could
potentially be significant to the VIE. The VIE model requires an ongoing reconsideration of whether a reporting entity is the primary
beneficiary of a VIE due to changes in facts and circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In accordance with ASC 810-10-25-37
and as amended by ASU 2009-17, the Company determines whether any legal entity in which the Company becomes involved is a VIE and subject
to consolidation. The Company conducts an assessment on an ongoing basis for each VIE including (1) the power to direct activities of
the VIE that most significantly impact the VIE&#8217;s economic performance, and (2) the obligation to absorb losses or right to receive
benefits from the VIE that could potentially be significant to the VIE. As a result, the Company determined that three (3) entities were
VIEs and subject to consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><font style="font-size: 10pt">1.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Conversion Labs Media, LLC (&#8220;CVLB Media&#8221;), a Puerto Rico limited liability company,</font></td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-size: 10pt">2.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Conversion Labs Rx, LLC (&#8220;CVLB Rx&#8221;), a Puerto Rico limited liability company (dissolved in 2020), and</font></td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-size: 10pt">3.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Conversion Labs Asia Limited, a Hong Kong company (&#8220;Conversion Labs Asia&#8221;).</font></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">CVLB Media, CVLB Rx and Conversion
Labs Asia are all considered immaterial as of December 31, 2020 and 2019. CVLB Rx had no activity during the year ended December 31, 2020
and was dissolved during the period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Use of Estimates</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company prepares its consolidated
financial statements in conformity with accounting principles generally accepted in the United States of America which requires management
to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and
the reported amounts of revenues and expenses during the reporting period. Some of the more significant estimates required to be made
by management include the determination of reserves for accounts receivable, returns and allowances, the valuation of inventory and stockholders&#8217;
equity-based transactions. Actual results could differ from those estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The continuing impact on business
activity brought about by the Coronavirus pandemic (&#8220;COVID-19&#8221;) continues to evolve, globally in macro terms, and in micro
terms, as such affects the Company. As a result, many of our estimates and assumptions for the year ended December 31, 2020 were subject
to an increased level of judgment and may carry a higher degree of variability and volatility. In future periods, subsequent to December
31, 2020, when additional information becomes available, which may differ from our current assumptions, may subject our estimates to material
change in future periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Reclassifications</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Certain reclassifications have
been made to conform the prior year&#8217;s data to the current presentation. These reclassifications have no effect on previously reported
operating loss, stockholders&#8217; deficit or cash flows. Given the increase in the Company&#8217;s software business and to conform
the Company&#8217;s presentation of operating results to industry standards, the Company has changed their categories for reporting operations,
as result the Company has made reclassifications to the prior year presentation in order to conform it to the current periods&#8217; presentation.
The reclassification includes $745,288 of merchant processing fees reclassified from cost of revenues to selling and marketing expenses
for the year ended December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Revenue Recognition</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company records revenue under
the adoption of ASC 606 by analyzing exchanges with its customers using a five-step analysis:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><font style="font-size: 10pt">1.</font></td>
    <td><font style="font-size: 10pt">Identify the contract</font></td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-size: 10pt">2.</font></td>
    <td><font style="font-size: 10pt">Identify performance obligations</font></td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-size: 10pt">3.</font></td>
    <td><font style="font-size: 10pt">Determine the transaction price</font></td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-size: 10pt">4.</font></td>
    <td><font style="font-size: 10pt">Allocate the transaction price</font></td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-size: 10pt">5.</font></td>
    <td><font style="font-size: 10pt">Recognize revenue</font></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For the Company&#8217;s product-based
contracts with customers, the Company has determined that there is one performance obligation, which is the delivery of the product; this
performance obligation is transferred at a discrete point in time. The Company generally records sales of finished products once the customer
places and pays for the order, with the product being simultaneously shipped by a third-party fulfillment service provider; in limited
cases, title does not pass until the product reaches the customer&#8217;s delivery site, in these limited cases, recognition of revenue
should be deferred until that time, however the Company does not have a process to properly record the recognition of revenue if orders
are not immediately shipped, and deems the impact to be immaterial. In all cases, delivery is considered to have occurred when title and
risk of loss have transferred to the customer, which is usually commensurate upon shipment of the product. In the case of its product-based
contracts, the Company provides a subscription sensitive service based on the recurring shipment of products and records the related revenue
under the subscription agreements subsequent to receiving the monthly product order, recording the revenue at the time it fulfills the
shipment obligation to the customer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For its product-based contracts
with customers, the Company records an estimate for provisions of discounts, returns, allowances, customer rebates and other adjustments
for its product shipments, and are reflected as contra revenues in arriving at reported net revenues. The Company&#8217;s discounts and
customer rebates are known at the time of sale, correspondingly, the Company reduces gross product sales for such discounts and customer
rebates. The Company estimates customer returns and allowances based on information derived from historical transaction detail, and accounts
for such provisions, as contra revenue, during the same period in which the related revenues are earned. The Company has determined that
the population of its product-based contracts with customers are homogenous, supporting the ability to record estimates for returns and
allowances to be applied to the entire product-based portfolio population. Customer discounts, returns and rebates on product revenues
approximated $3,321,000 and $1,292,000, respectively, during the year ended December 31, 2020 and 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company, through its majority-owned
subsidiary LegalSimpli, offers a subscription based service providing a suite of software applications to its subscribers, principally
on a monthly subscription basis. The software suite allows the subscriber/user to convert almost any type of document to another electronic
form of editable document, providing ease of editing. For these subscription-based contracts with customers, the Company offers an initial
14-day trial period which is billed at $1.95, followed by a monthly subscription, or a yearly subscription to the Company&#8217;s software
suite dependent on the subscriber&#8217;s enrollment selection. The Company has estimated that there is one product and one performance
obligation that is delivered over time, as the Company allows the subscriber to access the suite of services for the time period of the
subscription purchased. The Company allows the customer to cancel at any point during the billing cycle, in which case the customers subscription
will not be renewed for the following month or year depending on the original subscription. The Company records the revenue over the customers
subscription period for monthly and yearly subscribers or at the end of the initial 14 day service period for customers who purchased
the initial subscription, as the circumstances dictate. The Company offers a discount for the monthly or yearly subscriptions being purchased,
which is deducted at the time of payment at the initiation of the contract term, therefore the Contract price is fixed and determinable
at the contract initiation. Monthly and annual subscriptions for the service are recorded net of the Company&#8217;s known discount rates.
As of December 31, 2020 and December 31, 2019, the Company has accrued contract liabilities, as deferred revenue, of approximately $917,000
and $110,000, respectively, which represent obligations on in-process monthly or yearly contracts with customers and a portion attributable
to the yet to be recognized initial 14-day trial period collections. Customer discounts and allowances on software revenues approximated
$1,062,000 and $242,000, respectively, during the year ended December 31, 2020 and 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For the year ended December 31,
2020 and 2019, the Company had the following disaggregated revenue:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year Ended December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><font style="font-size: 10pt"><b>%</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><font style="font-size: 10pt"><b>%</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Product revenues by Brand for CVLB PR:</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 52%"><font style="font-size: 10pt">Shapiro MD</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font-size: 10pt">17,289,687</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 8%; text-align: right"><font style="font-size: 10pt">46</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font-size: 10pt">9,019,956</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 8%; text-align: right"><font style="font-size: 10pt">72</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Innate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5,041</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">49,258</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">iNR Wellness</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">247,350</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">738,965</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Scarology</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">44,332</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">51,131</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Rex MD</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">12,969,753</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">35</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">60,197</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Total product revenue for CVLB PR</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">30,556,163</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">82</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">9,919,507</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">80</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Software revenue for LegalSimpli, net</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6,732,747</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">18</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,539,129</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">20</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Services revenue for CVLB Media</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">5,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">9,943</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total Revenues, net</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">37,293,910</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">100</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">12,468,578</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">100</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Accounts Receivable</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Accounts receivable principally
consist of amounts due from third-party merchant processors, who process our subscription revenues; the merchant accounts balance receivable
represents the charges processed by the merchants that have not yet been deposited with the Company. The unsettled merchant receivable
amount normally represents processed sale transactions from the final one to three days of the month, with collections being made by the
Company within the first week of the following month. As of year end there is also a fully reserved accounts receivable for one wholesale
agent relationship transaction. There will be no further wholesale agent sales in the future. Management determines the need, if any,
for an allowance for future credits to be granted to customers, by regularly evaluating aggregate customer refund activity, coupled with
the consideration and current economic conditions in its evaluation of an allowance for future refunds and chargebacks. As of December
31, 2020 and 2019, the Company had an allowance for bad debt, attributable to the single agent relationship amounting to approximately
$133,000 and $0, respectively. As of December 31, 2020 and December 31, 2019, the reserve for sales returns and allowances was approximately
$349,000 and $84,000, respectively. For all periods presented, as noted above, the sales returns and allowances were recorded as contra
assets in arriving at presented accounts receivable, net.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Inventory</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2020 and 2019,
inventory primarily consisted of finished goods related to the Company&#8217;s brands included in the product revenue section of the table
above. Inventory is maintained at the Company&#8217;s third-party warehouse location in Wyoming and at the Amazon fulfillment center.
The Company also maintains inventory at a related-party warehouse in Pennsylvania.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Inventory is valued at the lower
of cost or net realizable value with cost determined on a first-in, first-out (&#8220;FIFO&#8221;) basis. Management compares the cost
of inventory with the net realizable value and an allowance is made for writing down inventory to net realizable, if lower. As of December
31, 2020 and December 31, 2019, the Company recorded an inventory reserve in the amount of $57,481 and $12,500, respectively. The increase
in our inventory reserve mainly is attributable to the lack of marketability for our INR Wellness product line.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2020 and 2019,
the Company&#8217;s inventory consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Finished Goods - Products</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,172,624</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">925,017</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Raw materials and packaging components</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">149,115</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">37,542</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Inventory reserve</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(57,481</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(12,500</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total Inventory - net</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,264,258</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">950,059</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Product Deposit</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Many of our vendors require deposits
when a purchase order is placed for goods or fulfillment services. These deposits typically range from 10% to 33% of the total purchased
amount. Our vendors include a credit memo within their final invoice, recognizing the deposit amount previously paid. As of December 31,
2020, and December 31, 2019, the Company has approximately $816,765 and $150,000, respectively, of product deposits with multiple vendors
for the purchase of raw materials or finished goods. The Company&#8217;s history of product deposits with its inventory vendors, creates
an implicit purchase commitment equaling the total expected product acceptance cost in excess of the product deposit. As of December 31,
2020 and December 31, 2019, the Company approximates its implicit purchase commitments to be $1.6 million and $300,000, respectively.
As of December 31, 2020, and December 31, 2019, the vast majority of these product deposits are with one vendor that manufacturers the
Company&#8217;s finished goods inventory for its Shapiro hair care product line.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Capitalized Software Costs
</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company
capitalizes certain internal payroll costs and third-party costs related to internally developed software and amortizes these costs using
the straight-line method over the estimated useful life of the software, generally three years. The Company does not sell internally developed
software other than through the use of subscription service. Certain development costs not meeting the criteria for capitalization, in
accordance with Accounting Standards Codification (&#8220;ASC&#8221;) <i>ASC 350-40 Internal-Use Software</i>, are expensed as incurred.
As of December 31, 2020 and 2019, the Company capitalized $438,136 and $0 related to internally developed software costs which is amortized
over the useful life and included in development costs on our statement of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Intangible Assets</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Intangible assets are comprised
of a customer relationship asset (with original cost of approximately $1,007,000) and a purchased license (with a cost of $200,000) with
an estimated useful life of three and ten years, respectively. Intangible assets are amortized over their estimated lives using the straight-line
method. Costs incurred to renew or extend the term of recognized intangible assets are capitalized and amortized over the useful life
of the asset.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Impairment of Long-Lived Assets</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Long-lived assets are evaluated
for impairment whenever events or changes in circumstances have indicated that an asset may not be recoverable and are grouped with other
assets to the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities
(asset group). If the sum of the projected undiscounted cash flows (excluding interest charges) of an asset group is less than its carrying
value and the fair value of an asset group is also less than its carrying value, the assets will be written down by the amount by which
the carrying value of the asset group exceeded its fair value. However, the carrying amount of a finite-lived intangible asset can never
be written down below its fair value. Any loss would be recognized in income from continuing operations in the period in which the determination
is made.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Paycheck Protection Program</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2020, the Company received aggregate loan proceeds in the amount of approximately $249,000 under the Paycheck Protection Program (&#8220;PPP&#8221;).
The PPP, established as part of the Coronavirus Aid, Relief and Economic Security Act (&#8220;CARES Act&#8221;), provides for loans to
qualifying businesses for amounts up to 2.5 times of the average monthly payroll expenses of the qualifying business. The loans and accrued
interest are forgivable after eight weeks as long as the borrower uses the loan proceeds for eligible purposes, including payroll, benefits,
rent and utilities, and maintains its payroll levels. The amount of loan forgiveness will be reduced if the borrower terminates employees
or reduces salaries during the eight-week period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The unforgiven portion of the
PPP loan is payable over two years at an interest rate of 1%, with a deferral of payments for the first six months. The Company intends
to use the proceeds for purposes consistent with the PPP. While the Company currently believes that its use of the loan proceeds will
meet the conditions for forgiveness of the loan, we cannot assure you that we will not take actions that could cause the Company to be
ineligible for forgiveness of the loan, in whole or in part.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Income Taxes</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company files corporate federal,
state and local tax returns. Conversion Labs PR and LegalSimpli file tax returns in Puerto Rico, both are limited liability companies
and file separate tax returns with any tax liabilities or benefits passing through to its members.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company records current and
deferred taxes in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 740, &#8220;Accounting for Income Taxes.&#8221;
This ASC requires recognition of deferred tax assets and liabilities for temporary differences between tax basis of assets and liabilities
and the amounts at which they are carried in the financial statements, based upon the enacted rates in effect for the year in which the
differences are expected to reverse. The Company establishes a valuation allowance when necessary to reduce deferred tax assets to the
amount expected to be realized. The Company periodically assesses the value of its deferred tax asset, a majority of which has been generated
by a history of net operating losses and management determines the necessity for a valuation allowance. ASC 740 also provides a recognition
threshold and measurement attribute for the financial statement recognition of a tax position taken or expected to be taken in a tax return.
Using this guidance, a company may recognize the tax benefit from an uncertain tax position in its financial statements only if it is
more likely-than-not (i.e., a likelihood of more than 50%) that the tax position will be sustained on examination by the taxing authorities,
based on the technical merits of the position. The Company&#8217;s tax returns for all years since December 31, 2017, remain open to audit
by all related taxing authorities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Stock-Based Compensation</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company follows the provisions
of ASC 718, &#8220;Share-Based Payment&#8221;. Under this guidance compensation cost generally is recognized at fair value on the date
of the grant and amortized over the respective vesting or service period. The fair value of options at the date of grant is estimated
using the Black-Scholes option pricing model. The expected option life is derived from assumed exercise rates based upon historical exercise
patterns and represents the period of time that options granted are expected to be outstanding. The expected volatility is based upon
historical volatility of the Company&#8217;s common shares using weekly price observations over an observation period that approximates
the expected life of the options. The risk-free interest rate approximates the U.S. Treasury yield curve rate in effect at the time of
grant for periods similar to the expected option life. Due to limited history of forfeitures, the Company has elected to account for forfeitures
as they occur.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Many of the assumptions require
significant judgment and any changes could have a material impact in the determination of stock-based compensation expense.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Earnings (Loss) Per Share</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify; text-indent: 35.65pt">Basic earnings (loss)
per common share is based on the weighted average number of shares outstanding during each period presented. Convertible securities, warrants
and options to purchase common stock are included as common stock equivalents only when dilutive. Potential common stock equivalents are
excluded from dilutive earnings per share when the effects would be antidilutive.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify; text-indent: 35.65pt">The Company follows the
provisions of ASC 260, &#8220;Diluted Earnings per Share&#8221;. In computing diluted EPS, basic EPS is adjusted for the assumed issuance
of all potentially dilutive securities. The dilutive effect of call options, warrants and share-based payment awards is calculated using
the &#8220;treasury stock method,&#8221; which assumes that the &#8220;proceeds&#8221; from the exercise of these instruments are used
to purchase common shares at the average market price for the period. The dilutive effect of traditional convertible debt and preferred
stock is calculated using the &#8220;if-converted method.&#8221; Under the if-converted method, securities are assumed to be converted
at the beginning of the period, and the resulting common shares are included in the denominator of the diluted EPS calculation for the
entire period being presented.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify; text-indent: 35.65pt">The following table summarizes
the number of shares of common stock issuable pursuant to our convertible securities that were excluded from the diluted per share calculation
because the effect of including these potential shares was antidilutive even though the exercise price could be less than the average
market price of the common shares:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td colspan="2">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.8pt; text-align: center"><b>Year</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.8pt; text-align: center"><b>Ended</b></p></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.8pt; text-align: center"><b>Year</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Ended</b></p></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Series B Preferred Stock</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,076,923</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Convertible notes</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,165,126</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Stock options</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,232,400</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,374,000</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Warrants</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3,560,188</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,265,324</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Potentially dilutive securities</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">8,869,511</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">8,804,451</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Fair Value of Financial Instruments</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The carrying value of the Company&#8217;s
financial instruments, including cash, accounts receivable, accounts payable and accrued expenses and the face amount of notes payable
approximate fair value for all periods presented.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Concentrations of Risk</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company grants credit in the
normal course of business to its customers. The Company periodically performs credit analysis and monitors the financial condition of
its customers to reduce credit risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company monitors its positions
with, and the credit quality of, the financial institutions with which it invests. The Company, at times, maintains balances in various
operating accounts in excess of federally insured limits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We are dependent on certain third-party
manufacturers, although we believe that other contract manufacturers could be quickly secured if any of our current manufacturers cease
to perform adequately. As of December 31, 2020 and 2019, we utilized two (2) suppliers for fulfillment services, two (2) suppliers for
manufacturing finished goods, one (1) supplier for packaging and bottles and one (1) supplier for labeling. For the year ended December
31, 2020 and 2019, we purchased 100% of our finished goods from two (2) manufacturers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Recently Adopted Accounting
Pronouncements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">In July
2017, the FASB issued ASU No. 2017-11, &#8220;Earnings Per Share (Topic 260) and Derivatives and Hedging (Topic 815)- Accounting for Certain
Financial Instruments with Down Round Features&#8221; (&#8220;ASU 2017-11&#8221;). Equity-linked instruments, such as warrants and convertible
instruments, may contain down round features that result in the strike price being reduced on the basis of the pricing of future equity
offerings. Under ASU 2017-11, a down round feature will no longer require a freestanding equity-linked instrument (or embedded conversion
option) to be classified as a liability that is remeasured at fair value through the income statement (i.e. marked-to-market). However,
other features of the equity-linked instrument (or embedded conversion option) must still be evaluated to determine whether liability
or equity classification is appropriate. Equity classified instruments are not marked-to-market. For earnings per share (&#8220;EPS&#8221;)
reporting, the ASU requires companies to recognize the effect of the down round feature only when it is triggered by treating it as a
dividend and as a reduction of income available to common shareholders in basic EPS. The amendments in this ASU are effective for all
entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. This standard was adopted
on January 1, 2020 and did not have a material impact on the Company&#8217;s financial position, results of operations or cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Application of New or Revised Accounting Standards&#8212;Not
Yet Adopted</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In August 2020, the FASB issued
ASU 2020-06, &#8220;<i>Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8211; Contracts
in Entity&#8217;s Own Equity (Subtopic 815-40); Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity </i>(&#8220;ASU
2020-06&#8221;)&#8221;, which addresses issues identified as a result of the complexities associated with applying U.S. GAAP for certain
financial instruments with characteristics of liabilities and equity. This update addresses, among other things, the number of accounting
models for convertible debt instruments and convertible preferred stock, targeted improvements to the disclosures for convertible instruments
and earnings-per-share (&#8220;EPS&#8221;) guidance and amendments to the guidance for the derivatives scope exception for contracts in
an entity&#8217;s own equity, as well as the related EPS guidance. This update applies to all entities that issue convertible instruments
and/or contracts in an entity&#8217;s own equity. This guidance is effective for financial statements issued for fiscal years beginning
after December 15, 2021, and interim periods within those fiscal years. Early adoption is permitted, but no earlier than for fiscal years
beginning after December 15, 2020, including interim periods within those fiscal years. FASB specified that an entity should adopt the
guidance as of the beginning of its annual fiscal year, or January 1, 2021, should the Company elect to early adopt. The Company is currently
evaluating the impact the adoption of ASU 2020-06 could have on the Company&#8217;s financial statements and disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Other Recent Accounting Pronouncements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">All other accounting standards
updates that have been issued or proposed by the FASB that do not require adoption until a future date are not expected to have a material
impact on the consolidated financial statements upon adoption.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139903072911320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 3 &#8211; INTANGIBLE ASSETS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2020, the Company
has the following amounts related to intangible assets:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Intangible Assets as at:</font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31,</font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31,</font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Amortizable</font></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Life</font></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b><i>Amortizable Intangible Assets</i></b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 45%; padding-left: 10pt"><font style="font-size: 10pt">Customer Relationship Asset</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,006,840</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,006,840</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: center"><font style="font-size: 10pt">3 years</font></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Purchased Licenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">200,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">200,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt">10 years</font></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Less: Accumulated amortization</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(867,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(531,388</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Total Net Amortizable Intangible Assets</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">339,840</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">675,452</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The aggregate amortization expense of the Company&#8217;s intangible assets
for the year ended December 31, 2020 and 2019 was approximately $335,612, respectively. Amortization expense for 2021 will be approximately
$339,840.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902997839080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Notes Payable</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 4 &#8211; NOTES PAYABLE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On May 29, 2018, the Company entered
into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with Alpha Capital Anstalt (&#8220;Alpha&#8221;) and Brio
Capital Master Fund Ltd. (&#8220;Brio&#8221;), (collectively, the &#8220;2018 SPAs&#8221;). Pursuant to the terms of the Purchase Agreement,
the Company issued and sold the 2018 SPAs senior secured convertible notes in the aggregate original principal amount of $550,000 (collectively,
the &#8220;Alpha and Brio Notes&#8221;), and warrants to purchase up to 478,261 shares of the Company&#8217;s common stock (collectively
the &#8220;Alpha and Brio Warrants&#8221;). The Alpha and Brio Notes matured on May 2019. Interest on the outstanding principal amount
of the Alpha and Brio Notes had compounded annually at the annual rate of twelve percent (12%), subject to adjustments through to their
maturity date. The Alpha and Brio Notes were convertible into the Company&#8217;s common stock, at the option of the holder, at any time
following issuance, unless the conversion or share issuance under the conversion would cause the holder to beneficially own in excess
of 4.99% of the Company&#8217;s common stock. The conversion price for the principal and interest, if any, in connection with voluntary
conversion by the Holder shall be $1.15 per share of Common Stock, subject to adjustment as defined in the Alpha and Brio Notes. Alpha
and Brio have converted $344,642 of these notes including $9,922 of interest as of December 31, 2019, leaving a balance of $187,308<b>.</b>
As of December 31, 2020, these notes have been paid off.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On August 15, 2019, the Company
entered into securities purchase agreements (the &#8220;August 2019 Purchase Agreements&#8221;) with two accredited investor Alpha and
Brio. Pursuant to the terms of the August 2019 Purchase Agreements, the Company issued and sold to the investors convertible promissory
notes for the aggregate original principal amount of $1,291,000 (collectively the &#8220;August 2019 Notes&#8221;), and warrants to purchase
up to 935,870 shares of the Company&#8217;s common stock (the &#8220;August 2019 Warrants&#8221;). The August 2019 Notes matured on August
15, 2020 and accrued interest at a rate of twelve percent (12%) per annum, subject to adjustments, prior to maturity, as defined therein.
The August 2019 Notes may be converted into shares of the Company&#8217;s common stock, at the discretion of the holder, at any time following
issuance, unless the conversion or share issuance under the conversion would cause the holder to beneficially own shares in excess of
4.99% of the Company&#8217;s common stock. The conversion price for the principal and interest, if any, in connection with voluntary conversion
by the investors shall be $1.15 per share of common stock, subject to adjustment as defined therein. In conjunction with the August 2019
Notes, the Company issued the August 2019 Warrants with an exercise price of $1.40 per share. The fair value of August 2019 Warrants was
determined to be $569,147 based on the use of Black-Scholes pricing model. The August 2019 Warrants were evaluated by management and deemed
to be equity-linked awards subject to ASC 815 <i>Derivatives and Hedging.</i> The August 2019 Notes contained an original issue discount
of 20% or $215,250 which is the difference between the note&#8217;s face amount of $1,111,500 and the cash proceeds received from the
investors. As part of this financing, the Company paid debt issuance costs $284,070 which are placed as a contra-debt account and were
amortized over the life of the loan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On February 25, 2020, the Company
entered into a Note Repayment and Warrant Amendment Agreement with Alpha and Brio, whereby the Company agreed to repay the outstanding
balance of Alpha and Brio&#8217;s August 2019 Notes in the amount of $1,291,000. As a result of this transaction, the Company accelerated
debt discounts for warrants, issuance costs and original issue discount of $500,145, which was recognized through interest expense on
the accompanying consolidated statement of operations. As of December 31, 2020 and December 31, 2019, the gross balance payable for these
notes was $0 and $1,291,000, respectively. As of December 31, 2020 and December 31, 2019, the Company has cumulatively amortized $568,322
and $404,393 of the debt discounts costs including debt issuance costs, original issue discount, and discount for warrants issued in connection
with the debt transaction, all of which is included in interest expense on the accompanying consolidated statement of operations. As of
December 31, 2020 and December 31, 2019, the net balance payable for these notes was $0 and $627,426, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On February 18, 2020, the Company
entered into two purchase agreements (the &#8220;C6 Purchase Agreements&#8221;) for the purchase and sale of future revenue with C6 Capital,
LLC (&#8220;C6&#8221;). Pursuant to the terms of the C6 Purchase Agreements, the Company issued and sold to C6 two loan agreements in
the aggregate original principal amount of $1,020,000. These loans contain an original purchase discount of 18%, or $270,000, in total,
or $135,000 per each of the two agreements. C6 paid $375,000 per loan agreement for a total of $750,000. The Company paid debt issuance
costs to C6 of $7,500 per agreement, or $15,000 in total, which was placed as a contra-debt account and will be amortized over the life
of the loan. The loan agreements require the Company to pay all future receipts of the Company without recourse until such time as the
purchased amount has been repaid. The loan agreements require the Company to make a daily average payment of $8,094 during the term of
such agreements. As of December 31, 2020, the Company has made $1,020,000 in principal payments under these loan agreements. As of December
31, 2020, the gross balance payable for these loan agreements was $0, and the balance of the loan net of discounts was $0. For the year
ended December 31, 2020, the Company has amortized $285,000 of debt discount through interest expense on the accompanying consolidated
statement of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Beginning May 21, 2020 through
May 27, 2020 the Company, issued convertible promissory notes (the &#8220;May 2020 Notes&#8221;) to five (5) accredited investors (each
a &#8220;May 2020 Investor&#8221;, and collectively, the &#8220;May 2020 Investors&#8221;). The aggregate principal amount of the May
2020 Notes is $1,000,000 for which the Company received gross proceeds of $1,000,000. The May 2020 Notes were due and payable six months
from the date of issuance. The May 2020 Notes entitle each holder to 12% interest upon Maturity, or $120,000. The May 2020 Notes may be
converted into shares of the Company&#8217;s common stock at any time following the date of issuance at a conversion price of $2.50 per
share, subject to adjustment. During the week ended November 6, 2020, all accredited investors exercised their conversion rights under
the May 2020 Notes. On November 24, 2020, the Company issued an aggregate of 447,763 shares of common stock related to the Note Conversions
at $2.50 per share, totaling $1,119,408.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As an inducement to enter into
the transaction, the Company issued an aggregate of 133,000 shares of the Company&#8217;s restricted common stock to the May 2020 Investors
at a fair value of approximately $219,450, which was included in interest expense for the year ended December 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In June 2020, the Company and
its subsidiaries received three loans in the aggregate amount of approximately $259,182 (the &#8220;PPP Loan&#8221;) under the new Paycheck
Protection Program legislation administered by the U.S. Small Business Administration. These loans bear interest at one percent per annum
(1.0%) and mature five years from the date of the first disbursement. The proceeds of the PPP Loan must be used for payroll costs, lease
payments on agreements entered into before February 15, 2020 and utility payments under lease agreements entered into before February
1, 2020. At least 60% of the proceeds must be used for payroll costs and certain other expenses and no more than 40% may be used on non-payroll
expenses. Proceeds from the PPP Loan used by the Company for the approved expense categories may be fully forgiven by the Small Business
Administration if the Company satisfies applicable employee headcount and compensation requirements. The Company currently believes that
a majority of the PPP Loan proceeds will qualify for debt forgiveness; however, there can be no assurance that the Company will qualify
for forgiveness from the Small Business Administration until it occurs. As at December 31, 2020, the $259,182 PPP loan proceeds are reflected
on the Company&#8217;s consolidated balance sheet as current liabilities, within notes payable, net.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In December 2020, the Company
received proceeds of $500,000 under a short-term working capital loan with Chase Bank. The terms of the loan include a service charge
of $19,950 (3.99%). The total balance of $519,950 as of December 31, 2020, included in notes payable, net, on the accompanying consolidated
balance sheet, and was repaid in full in January 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On July 27, 2020, the Company
issued a secured convertible promissory note in the principal amount of up to $1,500,000 to an accredited investor. The Company received
$600,000 in aggregate gross proceeds. Any additional advances under this note would require the approval of the lender in its sole discretion.
This note accrues interest at a rate of one and one-quarter percent (1.25%) per month and carried a maturity date of January 24, 2021.
The note balance of $607,500, including accrued interest of $7,500, was repaid in full on August 28, 2020 with the issuance of Series
B Convertible Preferred Stock (see Note 5).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Total interest expense on notes
payable, inclusive of amortization of debt discounts, amounted to $1,667,536 and $761,150 for the year ended December 31, 2020 and 2019,
respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139903072493224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 5 &#8211; STOCKHOLDERS&#8217; EQUITY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has authorized the
issuance of up to 100,000,000 shares of common stock, $0.01 par value, and 5,000,000 shares of preferred stock, $0.0001 par value, of
which 5,000 shares are designated as Series B Convertible Preferred Stock and 4,996,500 shares of preferred stock remain undesignated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">On October
9, 2020, the Company effectuated a 1-for-5 reverse stock split (the &#8220;Stock Split&#8221;) of the Company&#8217;s issued and outstanding
shares of common stock that became effective in the market on October 14, 2020 (see Note 1). In connection with the Stock Split, the Company
issued approximately 632 shares for rounding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Series B Convertible Preferred Stock</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">On August
27, 2020, the Secretary of State of the State of Delaware delivered confirmation of the effective filing of the Company&#8217;s Certificate
of Designations of the Series B Convertible Preferred Stock, which established 5,000 shares of the Company&#8217;s Series B Preferred
Stock, having such designations, rights and preferences as set forth therein (the &#8220;Series B Designations&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The shares
of Series B Preferred Stock have a stated value of $1,000 per share (the &#8220;Series B Stated Value&#8221;) and are convertible into
Common Stock at the election of the holder of the Series B Preferred Stock, at a price of $3.25 per share, subject to adjustment (the
&#8220;Conversion Price&#8221;). Each holder of Series B Preferred Stock shall be entitled to receive, with respect to each share of Series
B Preferred Stock then outstanding and held by such holder, dividends at the rate of thirteen percent (13%) per annum (the &#8220;<u>Preferred
Dividends</u>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The Preferred
Dividends shall accrue and be cumulative from and after the date of issuance of any share of Series B Preferred Stock on a daily basis
computed on the basis of a 365-day year and compounded quarterly. The Preferred Dividends are payable only when, as, and if declared by
the Board of Directors of the Company (the &#8220;Board&#8221;) and the Company has no obligation to pay such Preferred Dividends; <u>provided</u>,
<u>however</u>, if the Board determines to pay any Preferred Dividends, the Company shall pay such dividends in kind in a number of additional
shares of Series B Preferred Stock (the &#8220;PIK Shares&#8221;) equal to the quotient of (i) the aggregate amount of the Preferred Dividends
being paid by the Company in respect of the shares of Series B Preferred Stock held by such holder, <u>divided by</u> (ii) the Series
B Issue Price (as defined in the Series B Designations); <u>provided</u>, <u>further</u>, that, at the election of the purchasers holding
a majority of the shares of Series B Preferred Stock then outstanding, in their sole discretion, such Preferred Dividends shall be paid
in cash or a combination of cash and PIK Shares. Notwithstanding the foregoing, the Preferred Dividends may be paid in cash at the election
of the Company if, and only if, (A) the purchasers holding a majority of the shares of Series B Preferred Stock then outstanding consent
in writing to the payment of any specific dividend in cash, or (B) at any time following the twenty-four (24) month anniversary of the
Closing, (i) the prevailing VWAP of the Common Stock over the trailing ninety (90)-day period is equal to or greater than $15.00 per share
(subject to adjustments for stock splits, stock dividends, recapitalizations, reorganizations, reclassifications, combinations, reverse
stock splits or other similar events), and (ii) the average trading volume of the Common Stock over the trailing ninety (90)-day period
is equal to or greater than 40,000 shares of Common Stock per day, or (C) at any time following the thirty-six (36) month anniversary
of the Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The holders
of Series B Preferred Stock rank senior to the Common Stock with respect to payment of dividends and rights upon liquidation and will
vote together with the holders of the Common Stock on an as-converted basis, subject to beneficial ownership limitations, on each matter
submitted to a vote of holders of Common Stock (whether at a meeting of shareholders or by written consent). In addition, as further described
in the Series B Designations, if at least 30% of the number of shares of Series B Preferred Stock sold at the Closing are outstanding,
the Company will not take certain corporate actions without the affirmative vote at a meeting (or the written consent with or without
a meeting) of the purchasers holding a majority of the shares of Series B Preferred Stock then outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">If at
any time following the twelve (12)-month anniversary of the Closing (A) the prevailing VWAP (as defined in the Series B Designations)
of the Common Stock over the trailing ninety (90)-day period is equal to or greater than $15.00 per share ($3.00 pre-split)(subject to
adjustments for stock splits, stock dividends, recapitalizations, reorganizations, reclassifications, combinations, reverse stock splits
or other similar events), and (B) the average trading volume of the Common Stock over the trailing ninety (90)-day period is equal to
or greater than 40,000 shares (200,000 pre-split) of Common Stock per day, the Company shall have the right, but not the obligation, in
its sole discretion, to elect to convert all, but not less than all, of the then-outstanding shares of Series B Preferred Stock into Common
Stock by delivering written notice of such election (the &#8220;Forced Conversion Notice&#8221;) to the holders of the Series B Preferred
Stock within ten (10) Business Days following the satisfaction of the criteria of clauses (A) and (B) above (a &#8220;Forced Conversion&#8221;).
On the Forced Conversion Date (as defined in the Series B Designations), each share of Series B Preferred Stock shall be converted into
the number of fully paid and non-assessable shares of Common Stock equal to the quotient of: (x) the sum of (1) the Series B Issue Price,
<u>plus</u> (2) any accrued but unpaid dividends on such share of Series B Preferred Stock as of immediately prior to the conversion thereof,
including the Preferred Dividends, <u>divided by</u> (y) the Conversion Price of such share of Series B Preferred Stock in effect at the
time of conversion. The Forced Conversion Notice shall state (i) the number of shares of Series B Preferred Stock held by such Holder
that are proposed to be converted, and (ii) the date on which such Forced Conversion shall occur, which date shall be the thirtieth (30<sup>th</sup>)
day following the date such Forced Conversion Notice is deemed given (a &#8220;Forced Conversion Date&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">In the
event of a Forced Conversion, a holder may elect, in its sole discretion and in lieu of the Forced Conversion, to have each then-outstanding
share of Series B Preferred Stock held by such holder be redeemed by the Company (a &#8220;<u>Forced Conversion Redemption</u>&#8221;)
by delivering written notice to the Company (a &#8220;<u>Forced Conversion Redemption Notice</u>&#8221; and the date such Holder delivers
such notice to the Corporation, a &#8220;<u>Forced Conversion Redemption Notice Date</u>&#8221;) prior to the Forced Conversion Date,
which notice shall state (A) the number of shares of Series B Preferred Stock that are to be redeemed, (B) the date on which such Forced
Conversion Redemption shall occur, which date shall be the tenth (10th) Business Day following the applicable Forced Conversion Redemption
Notice Date (the &#8220;<u>Forced Conversion Redemption Date</u>&#8221;) and (C) the wire instructions for the payment of the applicable
amount owed to such holder. Each share of Series B Preferred Stock that is the subject of a Forced Conversion Redemption shall be redeemed
by the Company in cash at a price per share equal to the sum of (1) the Series B Issue Price, <u>plus</u> (2) any accrued but unpaid dividends
on such share of Series B Preferred Stock, including the Preferred Dividends (the &#8220;<u>Per Share Forced Conversion Redemption Price</u>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">At any
time (A) after December 31, 2020, if a sufficient number of shares of Common Stock are not available to effect the conversion of the Series
B Preferred Stock outstanding into Common Stock and the exercise of the Warrants, each holder shall have the right, in its sole and absolute
discretion (in addition to and not to the exclusion of any remedy such holder may have at law or in equity), to require that the Company
redeem (an &#8220;Optional Redemption&#8221;), to the fullest extent permitted by law and out of funds lawfully available therefor, all
or any portion of such holder&#8217;s Series B Preferred Stock then outstanding by delivering written notice thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Securities Purchase Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">On August
28, 2020, the Company entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with an investor (the &#8220;Investor&#8221;),
to purchase from the Company an aggregate of 3,500 units (the &#8220;Units&#8221;), at a purchase price of $1,000 per Unit, each consisting
of (i) one share of Series B Convertible Preferred Stock, and (ii) a warrant to purchase 400 shares of common stock of the Company. The
warrants are exercisable immediately upon issuance, have a 5 year term, an exercise price of $4.60 per share, and provide for a cashless
exercise. The aggregate purchase price for the Units is $3,500,000, of which (i) $2,892,500 is being paid in cash at the closing of the
transaction and (ii) $607,500, is being paid by the conversion of the outstanding principal and interest due on the Secured Convertible
Promissory Note (the &#8220;Note&#8221;) issued by the Company to the Investor on July 27, 2020. The Purchase Agreement provides that
the Investor may not sell, transfer or otherwise dispose of the Series B Preferred Stock or warrants (or the shares of Common Stock issuable
thereunder) for a period of one year following the closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">As a
result of the Purchase Agreement, the Company recorded a deemed dividend to the holders of the Series B Preferred Stock of $3,500,000
for the value of the warrants and beneficial conversion feature in excess of the purchase price. Additionally, the company recorded this
instrument in the mezzanine section of the accompanying consolidated balance sheet of $3,500,000 for the value of the Series B Preferred
Stock redemption feature. This balance was increased by $155,822 for the 13% dividend accrued for the Series B Preferred stockholders
for a balance of $3,655,822 as of December 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Warrant Purchase Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">Concurrently,
the Company entered into a warrant purchase agreement (the &#8220;Warrant Purchase Agreement&#8221;) with CL1 to purchase from the Company
(i) a warrant to purchase 500,000 shares of Common Stock, at an exercise price equal to the closing price of the Common Stock immediately
prior of $5.20 per share (the &#8220;Class A Warrant&#8221;), for a purchase price of $15,000, and (ii) a warrant to purchase 250,000
shares of Common Stock, at an exercise price of $5.75 per share (the &#8220;Class B Warrant&#8221; and, together with the Class A Warrant,
the &#8220;Purchased Warrants&#8221;), for a purchase price of $10,000. Each of the Purchased Warrants have a five-year term. Each of
the Purchase Warrants is immediately exercisable as to fifty percent (50%) of the shares issuable thereunder and the remaining fifty percent
(50%) shall become exercisable on the date that is six months following the issue date of each Purchased Warrant, subject to a repurchase
right in favor of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The fair
value of the Purchased Warrants was approximately $4,743,893 (which was included as part of the deemed dividend calculation above), which
was determined by the Black-Scholes Pricing Model with the following assumptions: dividend yield of 0%, term of 5 years, volatility of
161.4%, and risk-free rate of 0.28%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Consulting Agreement &#8211;
August 2020</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">On August
31, 2020, the Company entered into a consulting agreement (the &#8220;CL1 Consulting Agreement&#8221;) with a consultant (&#8220;CL1&#8221;
or &#8220;Consultant&#8221;), to which Consultant will assist the Company with, among other things, general operations of the business,
marketing and branding, and recruiting talent in connection with the Company&#8217;s men&#8217;s sexual health, hair loss and PDF businesses
(the &#8220;Services&#8221;). As compensation for the Services, Consultant shall receive from the Company two warrants (&#8220;Consulting
Warrant 1&#8221; and &#8220;Consulting Warrant 2&#8221; collectively, the &#8220;Consulting Warrants&#8221;), that entitle Consultant
to purchase up to an aggregate of 750,000 of Common Stock of the Company according to the terms and conditions outlined therein, including
any restrictions on exercisability. During the five-year term of Consulting Warrant 1, Consultant may purchase up to an aggregate of 500,000
shares of Common Stock, at an exercise price equal to the closing price of the Common Stock immediately prior to the Closing of $5.20
per share, and Consulting Warrant 1 becomes exercisable as to such shares of Common Stock in 18 equal monthly installments beginning on
the date that is six months following the issue date or immediately prior to the consummation of a change of control of the Company. During
the five-year term of Consulting Warrant 2, Consultant may purchase up to an aggregate of 250,000 shares of Common Stock, at an exercise
price of $5.75 per share, and Consulting Warrant 2 becomes exercisable as to such shares of Common Stock on the date that is 24 months
following the issue date or immediately prior to the consummation of a change of control of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The fair value of the warrants
above Consulting Warrants was approximately $4,743,893, which was determined by the Black-Scholes Pricing Model with the following assumptions:
dividend yield of 0%, term of 5 years, volatility of 161.4%, and risk-free rate of 0.28%. Total amortization of the Consulting Warrants
for the year ended December 31, 2020 was $790,649 and is reflected in stock-based compensation, with unamortized costs of $3,953,244 remaining
at December 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Private Placement Offering &#8211; November 2020</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On November 3, 2020, the Company
consummated an initial closing of a private placement offering (the &#8220;Offering&#8221;), whereby pursuant to the securities purchase
agreement (the &#8220;Purchase Agreement&#8221;) entered into by the Company and certain accredited investors on October 30, 2020 (each
an &#8220;Investor&#8221; and collectively, the &#8220;Investors&#8221;) the Company sold to such Investors an aggregate of 3,044,529
shares (the &#8220;Shares&#8221;) of the Company&#8217;s common stock, par value $0.01 per share (the &#8220;Common Stock&#8221;), for
an aggregate purchase price of approximately $14.46 million (the &#8220;Purchase Price&#8221;). The Purchase Price was funded on November
3, 2020 (the &#8220;Closing Date&#8221;) and resulted in net proceeds to the Company of approximately $13.5 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the Purchase Agreement,
the Company agreed, for a period of 90 days from the closing date, not to issue or enter into any agreement to issue any shares of common
stock or common stock equivalents with the exception of certain exempt issuances as provided therein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">BTIG, LLC (the &#8220;Placement
Agent&#8221;) acted as exclusive placement agent for the Offering and received cash compensation equal to 6% of the Purchase Price and
warrants to purchase 91,336 shares of the Company&#8217;s common stock, at an initial exercise price of $4.75 per share, subject to adjustment
for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction (the &#8220;PA
Warrants&#8221;). The PA Warrants may be exercised on a &#8220;cashless&#8221; basis and will expire on November 3, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On November 19, 2020, the Company
consummated the second and final closing (&#8220;Final Closing&#8221;) of the Offering, whereby pursuant to the Purchase Agreement entered
into by the Company and an accredited investor on November 19, 2020 (the &#8220;Investor&#8221;) the Company sold to the Investor 323,892
shares (the &#8220;Shares&#8221;) of the Company&#8217;s common stock for a purchase price of approximately $1.54 million (the &#8220;Purchase
Price&#8221;). The Purchase Price was funded on November 19, 2020 (the &#8220;Closing Date&#8221;) and resulted in net proceeds to the
Company of approximately $1.4 million. The aggregate gross proceeds to the Company from the Offering was $16 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the Purchase Agreement,
the Company agreed, for a period of 90 days from the closing date, not to issue or enter into any agreement to issue any shares of common
stock or common stock equivalents with the exception of certain exempt issuances as provided therein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">BTIG, LLC (the &#8220;Placement
Agent&#8221;) acted as exclusive placement agent for the Offering and received cash compensation equal to 6% of the Purchase Price. In
connection with the Final Closing the Placement Agent received warrants to purchase 9,717 shares of the Company&#8217;s common stock,
at an initial exercise price of $4.75 per share, subject to adjustment for any reorganization, recapitalization, non-cash dividend, stock
split, reverse stock split or other similar transaction (the &#8220;PA Warrants&#8221;). The PA Warrants expire on November 19, 2025 and
may be exercised on a &#8220;cashless&#8221; basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Convertible Promissory Notes</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="background-color: white">Beginning
May 21, 2020 through May 27, 2020 the Company, issued convertible promissory notes (the &#8220;May 2020 Notes&#8221;) to five (5) accredited
investors (each a &#8220;May 2020 Investor&#8221;, and collectively, the &#8220;May 2020 Investors&#8221;). The aggregate principal amount
of the May 2020 Notes is $1,000,000 for which the Company received gross proceeds of $1,000,000. The May 2020 Notes may be converted into
shares of the Company&#8217;s common stock at any time following the date of issuance at a conversion price of $2.50 per share, subject
to adjustment. During the week ended November 6, 2020, all accredited investors agreed to convert the May 2020 Notes (the &#8220;Note
Conversions&#8221;) pursuant to the terms therein. On November 24, 2020, the Company issued an aggregate of 447,763 shares of common stock
related to the Note Conversions at $2.50 per share, resulting in the total principal and interest conversion of $1,119,408.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="background-color: white"><i>Options
and Warrants</i></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="background-color: white">During
the year ended December 31, 2020, the Company issued an aggregate of 535,600 shares of common stock related to the exercise of options
for total proceeds of $302,400.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="background-color: white">During
the year ended December 31, 2020, the Company issued an aggregate of 534,774 shares of common stock related to cashless exercise of options.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="background-color: white">During
the year ended December 31, 2020, the Company issued an aggregate of 1,472,556 shares of common stock related to cashless exercise of
warrants.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="background-color: white">During
the year ended December 31, 2019, the Company issued warrants in conjunction with stock with a value of $20,825.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="background-color: white">During
the year ended December 31, 2019, the Company issued warrants in conjunction with debt with a value of $569,146.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="background-color: white"><i>Membership
interest purchase agreement</i></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">On July
31, 2019 the Company entered into a certain membership interest purchase agreement (the &#8220;MIPA&#8221;) by and between the Company,
Conversion Labs PR, LLC (&#8220;CVLB PR&#8221;), a majority owned subsidiary, Taggart International Trust, an entity controlled by the
Company&#8217;s Chief Executive Officer, Mr. Justin Schreiber, and American Nutra Tech LLC, a company controlled by its Chief Technology
and Operating Officer, Mr. Stefan Galluppi (&#8220;Mr. Schreiber, Taggart International Trust, Mr. Galluppi and American Nutra Tech LLC
each a &#8220;Related Party&#8221; and collectively, the &#8220;Related Parties&#8221;). Pursuant to the MIPA, the Company purchased 21.83333%
of the membership interests (the &#8220;Remaining Interests&#8221;) of CVLB PR from the Related Parties, bringing the Company&#8217;s
ownership of CVLB PR to 100%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">As consideration
for the Company&#8217;s purchase of the Remaining Interests from the Related Parties, Mr. Schreiber and Mr. Galluppi agreed to cancel
all potential issuances of restricted stock and or options related to their employment with the Company, in exchange for the immediate
issuance of 500,000 shares of the Company&#8217;s restricted common stock to each of Mr. Schreiber and Mr. Galluppi (the &#8220;Initial
Issuances&#8221;) (equal to 1,000,000 shares in the aggregate). Mr. Schreiber and Mr. Galluppi were also entitled to additional issuances
pursuant to certain milestones as follows: (i) 500,000 shares of the Company&#8217;s Common Stock to each of Mr. Schreiber and Mr. Galluppi
(1 million shares in the aggregate) on the business day following a consecutive ninety (90) day period, during which the Company&#8217;s
Common Stock shall have traded at an average price per share equal to or higher than $2.50 (the &#8220;First Milestone&#8221;), and (ii)
an additional 500,000 shares of the Company&#8217;s Common Stock to each of Mr. Schreiber and Mr. Galluppi (1 million shares in the aggregate)
following a consecutive ninety (90) day period during which the Common Stock shall have traded at an average price per share equal to
or higher than $3.75 (the &#8220;Second Milestone&#8221; and, together with the First Milestones, the &#8220;Milestones&#8221;). Having
achieved the Milestones, the Company, on December 9, 2020, issued an aggregate of 1,000,000 shares of the Company&#8217;s Common Stock
to each of Mr. Schreiber and Mr. Galluppi (the &#8220;Milestone Shares&#8221;) (2 million shares in the aggregate). The Milestone Shares
are subject to the previously disclosed 180 day Lock-Up Agreement each of Mr. Schreiber and Mr. Galluppi signed on November 3, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company
recorded an aggregate expense of $18,060,000 reflected in general and administrative expenses during the year ended December 31, 2020
for the issuance of these 2,000,000 shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Common Stock</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Common Stock Transactions During the Year Ended
December 31, 2020:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="background-color: white">During
the year ended December 31, 2020, the Company issued an aggregate of 2,900,000 shares of common stock related to stock issued for services
totaling $18,305,000.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In September 2020, the company
received aggregate proceeds of $25,000 for the sale of warrants from the Warrant Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2020, the Company issued a total of 379,957 shares of common stock from the exercise of warrants and cash proceeds of $622,763.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="background-color: white">During
the year ended December 31, 2020, the Company issued an aggregate of 535,600 shares of common stock related to the exercise of options
for total proceeds of $302,400.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2020, the Company issued a total of 1,472,556 shares of common stock for the cashless exercise of 2,902,631 warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="background-color: white">During
the year ended December 31, 2020, the Company issued an aggregate of 534,774 shares of common stock related to cashless exercise of options.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In May 2020, the Company issued
294,120 shares of common stock to an investor for $250,000 in cash consideration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2020, the Company issued 2,722,187 shares of common stock for share liability of $2,181,453.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On November 24, 2020, the Company
issued an aggregate of 447,763 shares of common stock related to the Note Conversions at $2.50 per share, totaling $1,119,408.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On October 7, 2020, the Company
issued a noteholder, who is also a director, 96,923 common shares in connection with an Exchange Agreement dated September 22, 2020 (See
Note 8). &#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Effective October 14, 2020, the
Company issued an aggregate of approximately 632 shares for rounding in connection with the 1 for 5 reverse stock split.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Common Stock Transactions During the Year Ended
December 31, 2019</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2019, the Company issued 304,269 shares of common stock to various third-party investors for cash proceeds of $350,001. In conjunction
with one of the stock purchases, the Company issued warrants valued at $20,825 which based on the terms of the warrants, the Company has
bifurcated and treated as equity. In addition to the above stock issued, the Company has issued 20,000 shares of common stock to a consultant
for services rendered, which were valued at $16,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Noncontrolling Interest</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For the years ended December 31,
2020 and 2019, the net loss attributed to the non-controlling interest amounted to $1,877,408 and $391,055, respectively. During the year
ended December 31, 2020 and 2019, the Company paid distributions to non-controlling shareholders of $157,223 and $89,083, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On April 25, 2019, the Company
entered into an LLC Membership Unit purchase agreement with entities owned by the Company&#8217;s Chief Executive Officer and Chief Technology
Officer, and Conversion Labs PR, and simultaneously purchased the remaining 21.8% interest of Conversion Labs PR from the Company&#8217;s
Chief Executive officer and Chief Technology Officer. Subsequent to the agreement&#8217;s closing, the Company now wholly-owns 100% of
Conversion Labs PR. In order to consummate this transaction, the Company agreed to issue 1,000,000 shares of common stock based on the
issuance price of $0.90 per share, equal to $900,000 to the Company&#8217;s Chief Executive Officer and Chief Technology Officer. The
shares were issued on August 6, 2019. The difference between the value of the stock issued and net book value of the transfer to accumulated
deficit was recognized in non-controlling interest in 2019 for a charge of $417,044.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Stock Options</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>2020 Equity Incentive
Plan (the &#8220;2020 Plan&#8221;)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">On January
8, 2021, the Company approved the Company&#8217;s 2020 Equity Incentive Plan (the &#8220;2020 Plan&#8221;). Approval of the 2020 Plan
was included as Proposal 1 in the Company&#8217;s definitive proxy statement for its Special Meeting of Shareholders filed with the Securities
and Exchange Commission on December 7, 2020. The 2020 Plan provides for the issuance of up to 1,500,000 shares of the Company&#8217;s
common stock to the Company&#8217;s employees, non-employee directors, consultants and advisors. Awards under the 2020 Plan can be granted
in the form of stock options, non-qualified and incentive options, stock appreciation rights, restricted stock, and restricted stock units.
The 2020 Plan will be administered by the Compensation Committee of the Company&#8217;s Board of Directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The forms
of award agreements to be used in connection with awards made under the 2020 Plan to the Company&#8217;s executive officers and non-employee
directors are:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><font style="font-size: 10pt">&#9679;</font></td>
    <td><font style="font-size: 10pt">Form of Non-Qualified Option Agreement (Non-Employee Director Awards)</font></td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-size: 10pt">&#9679;</font></td>
    <td><font style="font-size: 10pt">Form of Non-Qualified Option Agreement (Employee Awards); and</font></td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-size: 10pt">&#9679;</font></td>
    <td><font style="font-size: 10pt">Form of Restricted Stock Award Agreement.</font></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Previously, the Company had granted
service-based stock options and performance-based stock options separate from this plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On January 20, 2020, the Company
approved the transition of its Chief Acquisition Officer, to the role of President of LegalSimpli (&#8220;President&#8221;). In connection
with this change in role , the Company amended that certain services agreement entered into on July 23, 2018, by and between the Company
and its President, to (i) decrease the number of options to purchase the Company&#8217;s common stock previously granted from 1,000,000
options to 500,000 options , 130,000 of which are fully vested as of the effective date and (ii) amend the vesting schedule for the remaining
370,000 performance options to include four performance metrics that, if met, each trigger the vesting of 92,500 options. As a result
of amendment, the Company cancelled 500,000 service based options with an exercise price of $1.50.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2020, the Company issued an aggregate of 1,539,000 stock options to employees and advisory board members. These stock options have
a contractual term of 10 years and vest in increments which fully vest the options over a two to three year period, dependent on the specific
agreements&#8217; terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Director Appointments</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="background-color: white">On
October 21, 2020, the Board of Directors (the &#8220;Board&#8221;) of the Company, appointed a new director to the Board.</font> In connection
with the appointment to the Board, the director shall receive a one-time grant of 20,000 shares of the Company&#8217;s common stock. In
addition, the new director will be eligible to participate in any duly authorized stock option plan adopted by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="background-color: white">On
November 6, 2020, the Board of the Company, appointed a new director to the Board. </font>In connection with the appointment to the Board,
the director shall receive a one-time grant of 20,000 of the Company&#8217;s common stock. In addition, the new director will be eligible
to participate in any duly authorized stock option plan adopted by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="background-color: white"><i>Appointment
of Chief Compliance Officer</i></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="background-color: white">On
November 20, 2020, the board of directors of the Company appointed a new Chief Compliance Officer and General Counsel (our &#8220;CCO&#8221;).
In connection with the CCO appointment, our CCO entered into an employment agreement with the Company, which includes a stock options
to purchase up to 200,000 shares of the Company&#8217;s common stock with an aggregate value of $1,765,837. </font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="background-color: white"><i>Appointment
of Chief Operating Officer</i></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="background-color: white">On
November 27, 2020, we appointed a new Chief Operating Officer (&#8220;COO&#8221;). </font>In connection with the appointment, our COO
entered into an Employment Agreement (the &#8220;Employment Agreement&#8221;) with the Company. In connection with his appointment, our
COO was granted was granted: (i) Stock Options (the &#8220;Stock Options&#8221;) to purchase up to 200,000 shares of the Company&#8217;s
common stock, with 35,000 of the Stock Options scheduled to vest upon the Company&#8217;s shareholders approving a bona fide employee
stock option plan (the &#8220;Plan&#8221;), and the remaining 165,000 Stock Options to vest in equal monthly tranches, based on the passage
of time, over the 30 months following the approval of the Plan; and (ii) upon the approval of the Plan, a grant of 10,000 restricted stock
units of the Company&#8217;s common stock (the &#8220;RSUs&#8221;), which shall vest upon the one-year anniversary of the Amended and
Restated Employment Agreement. The aggregate value of the Stock Options was $1,384,883.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="background-color: white"><i>Appointment
of Chief Acquisition Officer</i></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">On December
8, 2020, the Company entered into an Amended and Restated Employment Agreement (the &#8220;Amended CAO Employment Agreement&#8221;) with
the Company&#8217;s current Chief Acquisition Officer, (our &#8220;CAO&#8221;), amending and restating in its entirety the Employment
Agreement between the Company and our CAO, dated July 26, 2018. Pursuant to the Amended CAO Employment Agreement, our CAO&#8217;s has
been granted options to purchase up to 200,000 shares of Common Stock of the Company (the &#8220;CAO Options&#8221;), which shall vest
at a rate of 5,555 options each month for thirty-five (35) consecutive months beginning on the Effective Date, with the final 5,575 shares
vesting on December 8, 2023. The aggregate value of these options was $1,497,885.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">Additionally,
under the Amended CAO Employment Agreement, our CAO is eligible to receive up to three hundred thousand (300,000) restricted stock units
of the Company&#8217;s common stock, par value $0.01 (the &#8220;RSU&#8217;s&#8221;), subject to the Company&#8217;s Telemedicine Brands
(as defined in the Amended CAO Employment Agreement) achieving certain revenue milestones. The RSU&#8217;s, if, and to the extent issued,
will vest upon the earlier of a Change of Control (as defined in the Amended CAO Employment Agreement) or December 8, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following is a summary of
outstanding options activity for our new 2020 Plan for the year ended December 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Options Outstanding Number of Shares</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise Price per Share</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Contractual Life</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price per Share</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Balance, December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 30%"><font style="font-size: 10pt">Granted</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">839,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">5.80 &#8211; 9.24</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">10.00</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">7.54</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Cancelled/Forfeited/Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Balance at December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">839,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">5.80 &#8211; 9.24</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">9.75</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">7.54</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Exercisable December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercisable at December 31, 2020</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">76,222</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">5.80 &#8211; 9.24</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9.77</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">7.74</font></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Total compensation expense under
the above service-based option plan was approximately $341,729 and $0 for the years ended December 31, 2020 and 2019, respectively, with
unamortized expense remaining of approximately $5,942,861 as of December 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following is a summary of
outstanding service-based options activity (prior to the establishment of our 2020 Plan above) for the year ended December 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Options Outstanding Number of Shares</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise Price per Share</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Contractual Life</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price per Share</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 30%"><font style="font-size: 10pt">Balance, December 31, 2019</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">3,009,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1.00 - 2.00</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">4.22 years</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1.50</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">700,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1.15 - 7.50</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7.76 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2.85</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(1,175,600</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.80 - 2.00</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2.97 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1.11</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Cancelled/Forfeited/Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(305,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">1.00 - 2.00</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">6.52 years</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">1.54</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Balance at December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,228,400</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">0.80 - 7.50</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">5.15 years</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">2.11</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Exercisable December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,361,083</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.00 - 2.00</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3.76 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.25</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercisable at December 31, 2020</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,570,428</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.00 &#8211; 7.50</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2.57 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.67</font></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Total compensation expense under
the above service-based option plan was approximately $559,512 and $76,000 for the year ended December 31, 2020 and 2019, respectively,
with unamortized expense remaining of approximately $1,548,089 as of December 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following is a summary of
outstanding performance-based options activity for the year ended December 31, 2020:</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Options Outstanding Number of Shares</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise Price per Share</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Contractual Life</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price per Share</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 30%"><font style="font-size: 10pt">Balance at December 31, 2019</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,365,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1.25 &#8211; 2.00</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">5.34 years</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1.70</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Cancelled/Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(200,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">1.50</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">8.06 years</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">1.50</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Balance at December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,165,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">1.25 &#8211; 2.00</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">4.97 years</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">1.80</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Exercisable December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">635,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.25 &#8211; 2.00</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2.63 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">2.00</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercisable at December 31, 2020</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">635,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.25 &#8211; 2.00</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1.38 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">2.00</font></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">No compensation expense was recognized
on the performance-based options above for the years ended December 31, 2020 and 2019, as the performance terms have not been met or are
not probable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Warrants</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following is a summary of
outstanding and exercisable warrants activity during the year ended December 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Warrants Outstanding Number of Shares</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise Price per Share</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Contractual Life</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price per Share</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 32%"><font style="font-size: 10pt">Balance at December 31, 2019</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">2,265,324</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1.00 &#8211; 2.50</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">5.77 years</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1.25</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,209,596</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.65 &#8211; 5.75</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5.56 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3.87</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercised/Expired</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(2,924,449</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.65 &#8211; 0.70</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.82 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.96</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Balance at December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">3,550,471</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">1.40 &#8211; 5.75</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">5.59 years</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">4.56</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercisable December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,066,049</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.00 &#8211; 2.50</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6.24 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.55</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Exercisable December 31, 2020</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,144,700</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.40 &#8211; 5.75</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7.67 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">4.29</font></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>August 2020 Warrant Inducement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During August 2020, the Company
offered an inducement to all 26 warrant holders of our $2.00 strike price warrants, which total 526,846 common stock warrants outstanding,
by offering a reduced exercise price of $1.75 (a $0.25 discount) for these warrants if they are immediately exercised. <font style="background-color: white">For
the year ended December 31, 2020, there were 379,957 of these warrants exercised, and none forfeited or adjusted. The Company accounted
for the warrant inducement as a deemed dividend based on the difference in the Black-Scholes value of the warrants immediately before
and immediately after the inducement. The significant assumptions used in the Company included common stock volatility of 148.49%, risk
free rate of 0.14%, a weighted average term of 1.6 years and the current stock price of the Company as of the date of inducement. Based
on the Black-Scholes valuation method the Company recorded a deemed dividend to additional paid in capital and retained earnings on the
inducement of approximately $73,636 and received proceeds from the warrants exercised of approximately $623,000 during the year ended
December 31, 2020.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Alpha Capital Anstalt (&#8220;Alpha&#8221;) Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On February 25, 2020, the Company
and Alpha entered into a Note Repayment and Warrant Amendment Agreement (the &#8220;2018 Alpha Amendment&#8221;) whereby the Company agreed
to (i) repay the outstanding balance of the convertible promissory note issued in favor of Alpha, effective on May 29, 2018, in the amount
of $224,145, including principal and interest (the &#8220;2018 Alpha Note&#8221;) and (ii) amend the exercise price of the warrant (the
&#8220;2018 Alpha Warrant&#8221;) issued to Alpha in connection with the 2018 Alpha Note on May 29, 2018. The 2018 Alpha Warrant originally
provided for the purchase of up to 391,304 shares of the Company&#8217;s common stock at an exercise price of $1.40 per share, none of
which have been exercised as of the date of the 2018 Alpha Amendment. Pursuant to the terms of the 2018 Alpha Warrant and in connection
with the 2018 Alpha Amendment, the Company revised the exercise price of the Alpha 2018 Warrant from $1.40 per share to $0.68 per share
and increased the number of shares issuable under the Alpha 2018 Warrant from 391,304 to 811,594 shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On February 25, 2020, the Company
and Alpha entered into a Note Repayment and Warrant Amendment Agreement (the &#8220;2019 Alpha Amendment&#8221;) whereby the Company agreed
to (i) repay the outstanding balance of the convertible promissory note issued in favor of Alpha on August 15, 2019 in the amount of $520,000,
including principal and interest (the &#8220;August 2019 Alpha Note&#8221;) and (ii) amend the exercise price of the August 2019 Warrant
issued to Alpha in connection with the 2019 Alpha Note on August 15, 2019. The August 2019 Warrant issued to Alpha originally provided
for the purchase of up to 365,217 shares of the Company&#8217;s common stock at an exercise price of $1.40 per share, none of which have
been exercised as of the date of the 2019 Alpha Amendment. Pursuant to the 2019 Alpha Amendment, Alpha has agreed to the reduction of
the exercise price from $1.40 to $1.15, subject to further adjustment. As a result of the above described reduction of the exercise price
and the application of certain provisions of the 2019 Alpha Warrant, the amount of shares that may be purchased upon exercise of the 2019
Alpha Warrant after giving effect to the foregoing is increased to 757,488 shares of the Company&#8217;s common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On May 7, 2020, the Company agreed
to further amend August 2019 Warrant issued to Alpha on August 15, 2019, as amended on February 25, 2020 (the &#8220;Second Alpha Warrant
Amendment&#8221;). Specifically, pursuant to anti-dilution provisions contained therein, the Company agreed to amend the August 2019 Warrant
issued to Alpha in order to increase the amount of shares able to be purchased thereunder by an additional 331,401 shares of the Company&#8217;s
common stock or an aggregate of up to 1,088,889 shares (the &#8220;Alpha Warrant Shares&#8221;). On the same day, Alpha exercised, on
a cashless basis, all of the August 2019 Warrants issued to Alpha, as amended, resulting in the issuance of 391,466 shares of the Company&#8217;s
common stock to Alpha, with no effect on the Company&#8217;s statement of operations. Upon Alpha&#8217;s cashless exercise, the August
2019 Warrants issued to Alpha are no longer in force or effect and no additional issuances will be due or owing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As a result of the above transactions,
the Company has recorded a deemed dividend to Alpha for the price adjustments of the August 2019 Warrant issued to Alpha of $915,479 which
is recorded in the statement of changes in stockholder&#8217;s equity as an increase in additional paid in capital and a reduction of
accumulated deficit. During the month of March 2020, Alpha exercised a portion of their warrants in a cashless exercise, whereby Alpha
exercised 267,223 common stock warrants to obtain 90,231 shares of common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Brio Master Fund (&#8220;Brio&#8221;) Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On February 25, 2020, the Company,
and Brio entered into a Warrant Amendment Agreement to amend the exercise price of the warrant issued to Brio on May 29, 2018. The Brio
2018 Warrant originally provided for the purchase of up to 86,957 shares of the Company&#8217;s common stock at an exercise price of $1.40
per share, none of which have been issued as of the date of the 2018 Brio Warrant Amendment. Pursuant to the 2018 Brio Warrant Amendment,
the Company agreed to revise the exercise price of the 2018 Brio Warrant from $1.40 per share to $0.68 per share and increased the number
of shares issuable under the 2018 Brio Warrant from 86,957 to 93,398 shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On February 25, 2020, the Company,
and Brio entered into a Note Repayment and Warrant Amendment Agreement whereby the Company agreed to (i) repay the outstanding balance
of the Convertible Promissory Note issued in favor of Brio on August 15, 2019 in the amount of $162,500, including principal and interest
and (ii) amend the exercise price of the warrant issued to Brio in connection with the 2019 Brio Note on August 15, 2019. The Brio 2019
Warrant originally provide for the purchase of up to 114,130 shares of the Company&#8217;s common stock at an exercise price of $1.40
per share, none of which have been exercised as of the date of the 2019 Brio Amendment. Pursuant to the 2019 Brio Amendment, Brio has
agreed to the reduction of the exercise price of $1.40 to $1.15, subject to further adjustment. As a result of the above described reduction
of the exercise price and the application of certain provisions of the 2019 Brio Warrant, the amount of shares that may be purchased upon
exercise of the 2019 Brio Warrant after giving effect to the foregoing is increased to 236,715 shares of the Company&#8217;s common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On May 7, 2020, the Company agreed
to further amend those certain warrants issued to Brio on August 15, 2019, as amended on February 25, 2020. Specifically, pursuant to
anti-dilution provisions therein, the Company agreed to amend the 2019 Brio Warrant in order to increase the amount of shares able to
be purchased thereunder by an additional 103,562 shares of the Company&#8217;s common stock or an aggregate of up to 340,278. On the same
day, Brio exercised on a cashless basis the Brio Warrants in full resulting in the issuance of 103,562 shares of the Company&#8217;s common
stock to Brio with no effect on the Company&#8217;s statement of operations. Upon Brio&#8217;s cashless exercise, the 2019 Brio Warrants
are no longer in force or effect and no additional issuances will be due or owing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As a result of the above transactions,
the Company has recorded a deemed dividend to Brio for the price adjustments of the Brio warrants of $226,906 which is recorded in the
statement of changes in stockholder&#8217;s equity as an increase in additional paid in capital and a reduction of accumulated deficit.
During the month of March 2020, Brio exercised a portion of their warrants in a cashless exercise, whereby Alpha exercised 100,000 common
stock warrants to obtain 57,547 shares of common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Amended Consulting Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">On September
29, 2020 (the &#8220;Effective Date&#8221;), the parties entered into an amendment to the Consulting Agreement (the &#8220;Amended Consulting
Agreement&#8221;) with Blue Horizon Consulting, LLC (&#8220;Blue Horizon&#8221;) primarily to change the compensation for services provided
by the Consultant. Under the Amended Consulting Agreement, Blue Horizon may receive an aggregate of up to 2,000,000 shares of the Company&#8217;s
common stock, subject to adjustment, upon the Company reaching certain revenue milestones. Happy Walters, a member of the Company&#8217;s
Board, is the sole owner of Blue Horizon. The Amended Consulting Agreement was approved by the Company&#8217;s disinterested directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">As a
result of the Amended Consulting Agreement, the Company recorded stock compensation expense of $15,900,000 during the year ended December
31, 2020, representing the fair value of the 2,000,000 shares of common stock earned under the Amended Consulting Agreement during the
year. No shares remain unearned under the Amended Consulting Agreement as of December 31, 2020. A total of 800,000 common shares of the
total 2,000,000 shares earned were issued under the Amended Consulting Agreement on October 16, 2020, with the remaining 1,200,000 shares
issued on February 24, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Stock-based Compensation</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The total stock-based compensation
expense related to common stock issued for services, Service-Based Stock Options, Performance-Based Stock Options and Warrants issued
for service amounted to approximately $36,961,141 and $733,215 for the year ended December 31, 2020 and 2019, respectively. Such amounts
are included in general and administrative expenses in the consolidated statement of operations.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139903072348184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOfLessorDisclosureTextBlock', window );">Leases</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 6&#8211; LEASES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company primarily leases office
space and other equipment using month to month terms. Conversion Labs PR utilizes office space in Puerto Rico, which is subleased from
the Company&#8217;s President and CEO, on a month to month basis, incurring rental expense of approximately $4,000 to $5,000 a month for
this office space.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In February 2016, the FASB issued
ASU 2016-02, Leases (Topic 842), which supersedes all existing guidance on accounting for leases in ASC Topic 840. ASU 2016-02 is intended
to provide enhanced transparency and comparability by requiring lessees to record right-of-use assets and corresponding lease liabilities
on the balance sheet. ASU 2016-02 will continue to classify leases as either finance or operating, with classification affecting the pattern
of expense recognition in the statement of income. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, including
interim periods within those fiscal years. We have reviewed ASC 842 and have determined the following impact on our financial statements:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 73%"><font style="font-size: 10pt">Right of Use Asset</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 24%; text-align: right"><font style="font-size: 10pt">274,437</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Lease liability</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">285,323</font></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In February 2018, the Company
entered into a 3-year agreement to lease office space in Huntington Beach, California beginning on March 2, 2018. The rent is payable
on a monthly basis in the amount of $2,106 for the first twelve months, $2,149 for the second twelve months and $2,235 for the third twelve
months; the lease expired on February 28, 2021, and was extended through February 28, 2023. A security deposit of $2,235 was paid for
this lease. The Company has classified this as an operating lease and have recorded the straight-line lease expense in the accompanying
statement of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In October 2021, the Company entered
into a 3-year agreement to lease office space in Greenville, South Carolina beginning on October 1, 2020. The rent is payable on a monthly
basis in the amount of $8,473 for the first twelve months, $8,685 for the second twelve months and $8,902 for the third twelve months;
the lease expires on September 30, 2023. No security deposit was paid for the lease. The Company has classified this as an operating lease
and have recorded the straight-line lease expense in the accompanying statement of operations.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOfLessorDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for lessor entity's leasing arrangements for operating, capital and leveraged leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -URI http://asc.fasb.org/topic&amp;trid=2208923<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOfLessorDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139903072354568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 7 - COMMITMENTS AND CONTINGENCIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Royalty Agreements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During 2016, Conversion Labs PR
entered into a sole and exclusive license, royalty and advisory agreement with Pilaris Laboratories, LLC (&#8220;Pilaris&#8221;) relating
to Pilaris&#8217; PilarisMax shampoo formulation and conditioner. The term of the agreement will be the life of the US Patent held by
Pilaris, ten years. As consideration for granting Conversion Labs PR this license, Pilaris will receive on quarterly basis, 10% of the
net income collected by the licensed products based on the following formula: Net Income = total income &#8211; cost of goods sold &#8211;
advertising and operating expenses directly related to the marketing of the licensed products. In addition, Conversion Labs PR shall pay
Pilaris a performance fee of $50,000 on the 180-day anniversary of the agreement and an additional $50,000 performance fee on the 365-day
anniversary of the agreement. For the year ended December 31, 2018, the Company capitalized the license fee in the amount of $100,000,
as the purchase of the fee is deemed an asset purchase under ASC 805. In April 2017, the Company issued 43,478 shares of common stock
and warrants to purchase 21,739 shares of common stock, pursuant to a subscription agreement, for the stated consideration and satisfaction
of obligation to pay $50,000 on the 180-day anniversary of the execution of this agreement. As of December 31, 2020 and 2019, $0 and $0,
respectively was included in accounts payable and accrued expenses in regard to this agreement, as no sales occurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During 2018, the Company entered
into a license agreement (the &#8220;Alphabet Agreement&#8221;) with M.ALPHABET, LLC (&#8220;Alphabet&#8221;), pursuant to which Alphabet
agreed to license its PURPUREX business which consists of methods and compositions developed by Alphabet for the treatment of purpura,
bruising, post-procedural bruising and traumatic bruising (the &#8220;Product Line&#8221;). Pursuant to the license granted under the
Alphabet Agreement, Conversion Labs PR obtains an exclusive license to incorporate (i) any intellectual property rights related to the
Product Line and (ii) all designs, drawings, formulas, chemical compositions and specifications used or useable in the Product Line into
one or more products manufactured, sold, and/or distributed by Alphabet for the treatment of purpura, bruising, post-procedural bruising
and traumatic bruising and for all other fields of use or purposes (the &#8220;Licensed Product(s)&#8221;), and to make, have made, advertise,
promote, market, sell, import, export, use, offer to sell and distribute the Licensed Product(s) throughout the world with the exception
of China, Hong Kong, Japan, and Australia (the &#8220;License&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company shall pay Alphabet
a royalty equal to 13% of Gross Receipts (as defined in the Agreement) realized from the sales of Licensed Products. Further, so long
as the Agreement is not previously terminated, the Company, also agreed to pay Alphabet $50,000 on the 120-day anniversary of the Agreement
and an additional $50,000 on the 360-day anniversary of the Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Upon execution of the Alphabet
Agreement, Alphabet was granted a 10-year stock option to purchase 20,000 shares of the Company&#8217;s common stock at an exercise price
of $2.50. Further, if Licensed Products have gross receipts of $7,500,000 in any calendar year, the Company will grant Alphabet an option
to purchase 20,000 shares of the Company&#8217;s common stock at an exercise price of $2.50; (ii) if Licensed Products have gross receipts
of $10,000,000 in any calendar year, the Company will grant Alphabet an additional option to purchase 20,000 shares of the Company&#8217;s
common stock at an exercise price of $2.50 and (iii) If Licensed Products have gross receipts of $20,000,000 in any calendar year, the
Company will grant Alphabet an option to purchase 40,000 shares of the Company&#8217;s common stock at an exercise price of $3.75. The
likelihood of meeting these performance goals for the licensed products are remote and, therefore, the Company has not recognized any
compensation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Purchase Commitments</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Many of the Company&#8217;s vendors
require product deposits when a purchase order is placed for goods or fulfillment services related to inventory requirements. The Company&#8217;s
history of product deposits with its inventory vendors, creates an implicit purchase commitment equaling the total expected product acceptance
cost in excess of the product deposit. As of December 31, 2020 and December 31, 2019, the Company approximates its implicit purchase commitments
to be $1.6&#160; million and $300,000, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Employment and Consulting Agreements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has entered into various
agreements with officers, directors, employees and consultants that expire in terms of one to five years. See Note 8.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Legal Matters</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In the normal course of business
operations, the Company may become involved in various legal matters. As of December 31, 2020, the Company&#8217;s management does not
believe that there are any potential legal matters that could have an adverse effect on the Company&#8217;s consolidated financial position.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139903099345688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 8 &#8211; RELATED PARTY TRANSACTONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Chief Executive Officer</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Conversion Labs PR utilizes office
space in Puerto Rico, which is subleased from the President and CEO, and incurs expense of approximately $4,000 to $5,000 a month for
this office space for which the Company and the CEO do not have a written lease agreement. Payments to JLS Ventures, an entity wholly
owned by our CEO, for rent on Conversion Labs PR&#8217;s Puerto Rico office space amounted to $45,000 and $52,000 for the year ended December
31, 2020 and 2019, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Conversion Labs PR utilizes BV
Global Fulfillment, owned by a related person of the Company&#8217;s CEO to warehouse a portion of the Company&#8217;s finished goods
inventory and for fulfillment services. The Company pays a monthly fee of $13,000 to $16,000 for fulfillment services and reimburses BV
Global Fulfillment for their direct costs associated with shipping the Company&#8217;s products. As of December 31, 2020 and 2019, the
Company owed BV Global Fulfillment $58,943 and $53,026, respectively, which are included in accounts payable and accrued liabilities on
the accompanying consolidated balance sheets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Promissory Note with Director</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On July 23, 2020, the Company
received proceeds of $250,000 for a promissory note to a director. The promissory note is non-interest bearing and matures in July 2021.
This promissory note was cancelled in exchange for 96,923 restricted shares of the Company&#8217;s common stock and a common stock purchase
warrant to purchase 500,000 shares of the Company&#8217;s common stock at $4.65 per share as part of an Exchange Agreement dated September
22, 2020. The Company issued the shares of common stock and the purchase warrant on October 7, 2020 and cancelled the note, resulting
in the reduction of notes payable of $250,000 with a loss on debt settlement of $914,862 for the year ended December 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="background-color: white"><i>Consulting
Agreement with Chief Operating Officer</i></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="background-color: white">On
November 27, 2020</font>, the Company entered into a consulting agreement (the &#8220;Consulting Agreement&#8221;) with JDM Investments,
LLC (&#8220;JDM&#8221;), an entity solely owned by our COO, whereby JDM will provide consulting services in support of the Company&#8217;s
day-to-day call center operations. The Consulting Agreement is for a term of thirty-six months and is renewable for additional twelve
month periods upon the mutual agreement of the Company and JDM. As compensation for the services, JDM will receive a monthly fee of $17,000
and shall be eligible to receive a metric based performance bonus for each calendar quarter during the term of the Consulting Agreement
in accordance with metrics to be mutually agreed upon by the Company and JDM.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139903072871176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 9 &#8211; INCOME TAXES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2020, the Company
has approximately $10.7 million of operating loss carryforwards for federal income tax reporting purposes that may be applied against
future taxable income. Portions of the net operating loss carryforwards will begin to expire in the year 2021 if not utilized prior to
that date, expiring during various year through 2038. There is no provision for income taxes because the Company has historically incurred
operating losses and maintains a full valuation allowance against its net deferred tax assets. The net operating loss carryforwards could
be subject to limitation in any given year in the event of a change in ownership as defined by IRC Section 382.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The valuation allowance overall
increased by approximately $1,269,000 and $148,000 during the year ended 2020 and 2019, respectively. The Company has fully reserved the
deferred tax asset resulting from available net operating loss carryforwards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The income tax provision charged
to continuing operations for the years ended December 31, 2020 and 2019 was as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Current:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 54%; padding-left: 10pt"><font style="font-size: 10pt">U.S. federal</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">152,100</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">(152,100</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">)</font></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">State and local</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">40,400</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(40,400</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">192,500</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(192,500</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Deferred:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">U.S. federal</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(70,000</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">70,000</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">State and local</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(70,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">70,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt; padding-left: 10pt"><font style="font-size: 10pt">Provision for income taxes</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">122,500</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(122,500</font></td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The provision for income taxes
differs from the expected amount of income tax expense (benefit) determined by applying a combined U.S. federal and state (Puerto Rico)
income tax rate of 25% to pretax income (loss) for the years ended December 31, 2020 and 2019 as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Computed &#8220;expected&#8221; tax expense (benefit)</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">(12,684,000</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">)</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">(783,000</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">)</font></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Increase (decrease) in income taxes resulting from:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Permanent differences</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7,765,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7,000</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Apportionment of Puerto Rico income</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3,607,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">380,000</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Nondeductible expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">140,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">173,000</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Change in valuation allowance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,269,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">148,000</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Other</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">25,500</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(47,500</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">122,500</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(122,500</font></td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Net deferred tax liabilities consist
of the following components as of December 31, 2020 and 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt"><font style="font-size: 10pt">Deferred tax Liability:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 62%; padding-bottom: 1.5pt; padding-left: 5.4pt"><font style="font-size: 10pt">Other</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; width: 16%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; width: 16%; text-align: right"><font style="font-size: 10pt">70,000</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">70,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><font style="font-size: 10pt">Deferred tax assets:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt; text-indent: 10pt"><font style="font-size: 10pt">Stock-based compensation</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">716,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">716,000</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt; text-indent: 10pt"><font style="font-size: 10pt">Temporary differences</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">113,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">44,000</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 5.4pt; text-indent: 10pt"><font style="font-size: 10pt">Net operating loss carryforwards</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,151,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">951,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,980,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,711,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 5.4pt"><font style="font-size: 10pt">Less valuation allowance</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(2,980,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,711,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139903072042696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 10 &#8211; SUBSEQUENT EVENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has evaluated subsequent
events through the date these consolidated financial statements were issued and has identified the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Appointment of Chief Digital
Officer</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">On January
5, 2021, the board of directors of the Company (the &#8220;Board&#8221;) appointed Mr. Bryant Hussey as the Company&#8217;s Chief Digital
Officer. In connection with the appointment, Mr. Hussey entered into an Employment Agreement (the &#8220;Employment Agreement&#8221;)
with the Company. Pursuant to the Employment Agreement, Mr. Hussey was granted a Stock Option to purchase up to 200,000 shares of the
Company&#8217;s common stock, scheduled to vest in equal monthly tranches, based on the passage of time, over the 36 months following
the Effective Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Appointment of Chief Medical
Officer</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">On January
11, 2021, the Board appointed Dr. Anthony Puopolo as the Company&#8217;s Chief Medical Officer. In connection with the appointment, Mr.
Puopolo entered into an Employment Agreement. Pursuant to the Employment Agreement, Mr. Puopolo was granted a Stock Option to purchase
up to 200,000 shares of the Company&#8217;s common stock (the &#8220;Stock Options&#8221;). 5,555 of the Stock Options shall vest in equal
monthly tranches, based on the passage of time, over the 30 months following the approval of the Effective Date, with the remaining 5,575
Stock Options scheduled to vest on January 11, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>LegalSimpli Software Restructuring
Transaction</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">Effective
January 22, 2021, the Company consummated a transaction to restructure the ownership of LegalSimpli Software, LLC, a Puerto Rico limited
liability company (&#8220;LSS&#8221;), a majority-owned subsidiary of the Company (the &#8220;LSS Restructuring&#8221;). To affect the
LSS Restructuring the Company&#8217;s wholly-owned subsidiary Conversion Labs PR LLC, a Puerto Rico limited liability company (&#8220;CVLB
PR&#8221;) entered into a series of membership interest exchange agreements, pursuant to which, CVLB PR exchanged that certain a promissory
note, dated May 8, 2019 with an outstanding balance of $375,823 (the &#8220;CVLBPR Note&#8221;), issued by LSS in favor of CVLB PR, for
37,531 newly issued membership interests of LSS (the &#8220;Exchange&#8221;). Upon consummation of the Exchange the CVLBPR Note was extinguished.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">In furtherance
of the LSS Restructuring, CVLB PR entered into a Membership Interest Purchase Agreement with LSS, (the &#8220;CVLB PR MIPA&#8221;), pursuant
to which CVLB PR purchased 12,000 membership interests of LSS for an aggregate purchase price of $300,000. The CVLB PR MIPA provides that
the transaction may be completed in three (3) tranches with a purchase price of $100,000 per tranche to be made at the sole discretion
of CVLB PR. Payment for the first tranche of $100,000 was made upon execution of the CVLB PR MIPA. Payments for the second and third tranches
are due on the 60-day anniversary and the 120-day anniversary of the Effective Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">Concurrently,
in furtherance of the LSS Restructuring, CVLB PR entered into two Membership Interest Purchase Agreements (the &#8220;Founding Members
MIPAs&#8221;) with two founding members of LSS (the &#8220;Founding Members&#8221;) whereby CVLB PR purchased from the Founding Members
an aggregate of 2,183 membership interests of LSS for an aggregate purchase price of $225,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">Following
the consummation of the LSS Restructuring, CVLB PR increased its ownership of LSS from 51% to approximately 85.58% on a fully diluted
basis. LSS entered into an amendment to its operating agreement (the &#8220;LSS Operating Agreement Amendment&#8221;) to reflect the change
in ownership.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Appointment of Chief Business
Officer</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">On February
3, 2021, the Board appointed Corey Deutsch (&#8220;Deutsch&#8221;), the Company&#8217;s current Head of Corporate Development, to serve
as the Company&#8217;s Chief Business Officer. Pursuant to the Employment Agreement, Mr. Deutsch was granted a stock option to purchase
up to 200,000 shares of the Company&#8217;s common stock (the &#8220;Employee Stock Options&#8221;). The Stock Options were to vest in
equal monthly tranches, based on the passage of time, over the 36 months following the Effective Date. Upon termination of Mr. Deutsch
without cause, the Company shall pay or provide to Mr. Deutsch severance pay equal to his then current monthly base salary for four months
from the date of termination, during which time Mr. Deutsch shall continue to receive all employee benefits and employee benefit plans
as described in the Employment Agreement. As a full-time employee of the Company, Mr. Deutsch will be eligible to participate in all of
the Company&#8217;s benefit programs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Appointment of Chief Financial
Officer</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">On February
4, 2021, the Board appointed Mr. Marc Benathen as the Company&#8217;s Chief Financial Officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">In connection
with the Appointment, Mr. Benathen entered into an Employment Agreement with the Company. To induce Mr. Benathen to enter into the Employment
Agreement, Mr. Benathen was granted a signing bonus of 15,000 restricted stock units of the Company&#8217;s common stock (the &#8220;RSUs&#8221;).
The RSU&#8217;s vest in accordance with the following: (i)3,750 of the RSUs vesting on the Effective Date (ii) 3,750 RSUs on February
4, 2022 (iii) 3,750 RSU&#8217;s on February 4, 2023 and (iv) 3,750 RSU&#8217;s on February 4, 2024. In addition to the RSU&#8217;s, Mr.
Benathen received stock options to purchase up to 200,000 shares of the Company&#8217;s common stock. The Stock Options shall vest in
equal monthly tranches, based on the passage of time, over the 36 months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">On March
18, 2021, we issued 3,750 common shares under this Employment Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Securities Purchase Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">On February
11, 2021, the Company consummated the closing of a private placement offering (the &#8220;February 2021 Offering&#8221;), whereby pursuant
to the securities purchase agreement (the &#8220;February 2021 Purchase Agreement&#8221;) entered into by the Company and certain accredited
investors on February 11, 2021 the Investors purchased 608,696 shares of the Company&#8217;s common stock par value $0.01 per share at
a purchase price of $23.00 per share for aggregate gross proceeds of $14,000,008 (the &#8220;Purchase Price&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The Purchase
Price was funded on the closing date and resulted in net proceeds to the Company of approximately $13.4 million after deducting fees payable
to the placement agent and other estimated offering expenses payable by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">BTIG,
LLC, the Placement Agent, acted as exclusive placement agent for the February 2021 Offering and received cash compensation equal to 3%
of the Purchase Price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Registration Rights Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">On February
11, 2021, in connection with the Purchase Agreement, the Company entered into a registration rights agreement with the Investors (the
&#8220;Registration Rights Agreement&#8221;). The Registration Rights Agreement requires the Company to use its reasonable best efforts
to register the resale of the Shares by the Investors on Form S-1 to be filed with the Securities and Exchange Commission (&#8216;SEC&#8221;),
under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), within 60 business days from the Closing Date, and to
use its reasonable best efforts to have such registration statement declared effective by the SEC as soon as practicable, but not later
than 120 days from the Closing Date (or 150 days from the Closing Date in the event that such registration statement is subject to a full
review by the SEC).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Stock Option Exercise</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">During
February and March 2021, the Company issued an aggregate of approximately 660,645 shares of common stock pursuant to the cashless exercise
of an outstanding stock options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>PPP Loan Forgiveness</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">During the January, February and March 2021, the Company had a total of
$125,643 of its PPP loans forgiven by the SBA.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902986611880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Principles of Consolidation</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company evaluates the need
to consolidate affiliates based on standards set forth in ASC 810 Consolidation (&#8220;ASC 810&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The consolidated financial statements
include the accounts of the Company and its wholly owned subsidiary, CLPR and its majority owned subsidiary, LegalSimpli. The non-controlling
interest in LegalSimpli represents the 49 % equity interest held by other members of the subsidiary as of December 31, 2020 and 2019.
Subsequent to year end, the Company purchased an additional 36% of LegalSimpli for a total 85%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">All significant intercompany
transactions and balances have been eliminated in consolidation.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Variable Interest Entities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company follows ASC 810-10-15
guidance with respect to accounting for variable interest entities (each, a &#8220;VIE&#8221;). These entities do not have sufficient
equity at risk to finance their activities without additional subordinated financial support from other parties or whose equity investors
lack any of the characteristics of a controlling financial interest. A variable interest is an investment or other interest that will
absorb portions of a VIE&#8217;s expected losses or receive portions of its expected residual returns and are contractual, ownership,
or pecuniary in nature and that change with changes in the fair value of the entity&#8217;s net assets. A reporting entity is the primary
beneficiary of a VIE and must consolidate it when that party has a variable interest, or combination of variable interests, that provides
it with a controlling financial interest. A party is deemed to have a controlling financial interest if it meets both of the power and
losses/benefits criteria. The power criterion is the ability to direct the activities of the VIE that most significantly impact its economic
performance. The losses/benefits criterion is the obligation to absorb losses from, or right to receive benefits from, the VIE that could
potentially be significant to the VIE. The VIE model requires an ongoing reconsideration of whether a reporting entity is the primary
beneficiary of a VIE due to changes in facts and circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In accordance with ASC 810-10-25-37
and as amended by ASU 2009-17, the Company determines whether any legal entity in which the Company becomes involved is a VIE and subject
to consolidation. The Company conducts an assessment on an ongoing basis for each VIE including (1) the power to direct activities of
the VIE that most significantly impact the VIE&#8217;s economic performance, and (2) the obligation to absorb losses or right to receive
benefits from the VIE that could potentially be significant to the VIE. As a result, the Company determined that three (3) entities were
VIEs and subject to consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><font style="font-size: 10pt">1.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Conversion Labs Media, LLC (&#8220;CVLB Media&#8221;), a Puerto Rico limited liability company,</font></td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-size: 10pt">2.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Conversion Labs Rx, LLC (&#8220;CVLB Rx&#8221;), a Puerto Rico limited liability company (dissolved in 2020), and</font></td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-size: 10pt">3.</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">Conversion Labs Asia Limited, a Hong Kong company (&#8220;Conversion Labs Asia&#8221;).</font></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">CVLB Media, CVLB Rx and Conversion
Labs Asia are all considered immaterial as of December 31, 2020 and 2019. CVLB Rx had no activity during the year ended December 31, 2020
and was dissolved during the period.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Use of Estimates</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company prepares its consolidated
financial statements in conformity with accounting principles generally accepted in the United States of America which requires management
to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and
the reported amounts of revenues and expenses during the reporting period. Some of the more significant estimates required to be made
by management include the determination of reserves for accounts receivable, returns and allowances, the valuation of inventory and stockholders&#8217;
equity-based transactions. Actual results could differ from those estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The continuing impact on business
activity brought about by the Coronavirus pandemic (&#8220;COVID-19&#8221;) continues to evolve, globally in macro terms, and in micro
terms, as such affects the Company. As a result, many of our estimates and assumptions for the year ended December 31, 2020 were subject
to an increased level of judgment and may carry a higher degree of variability and volatility. In future periods, subsequent to December
31, 2020, when additional information becomes available, which may differ from our current assumptions, may subject our estimates to material
change in future periods.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Reclassifications</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Certain reclassifications have been made to conform the prior year&#8217;s
data to the current presentation. These reclassifications have no effect on previously reported operating loss, stockholders&#8217; deficit
or cash flows. Given the increase in the Company&#8217;s software business and to conform the Company&#8217;s presentation of operating
results to industry standards, the Company has changed their categories for reporting operations, as result the Company has made reclassifications
to the prior year presentation in order to conform it to the current periods&#8217; presentation. The reclassification includes $745,288
of merchant processing fees reclassified from cost of revenues to selling and marketing expenses for the year ended December 31, 2019.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Revenue Recognition</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company records revenue under
the adoption of ASC 606 by analyzing exchanges with its customers using a five-step analysis:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48px"><font style="font-size: 10pt">1.</font></td>
    <td><font style="font-size: 10pt">Identify the contract</font></td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-size: 10pt">2.</font></td>
    <td><font style="font-size: 10pt">Identify performance obligations</font></td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-size: 10pt">3.</font></td>
    <td><font style="font-size: 10pt">Determine the transaction price</font></td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-size: 10pt">4.</font></td>
    <td><font style="font-size: 10pt">Allocate the transaction price</font></td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-size: 10pt">5.</font></td>
    <td><font style="font-size: 10pt">Recognize revenue</font></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For the Company&#8217;s product-based
contracts with customers, the Company has determined that there is one performance obligation, which is the delivery of the product; this
performance obligation is transferred at a discrete point in time. The Company generally records sales of finished products once the customer
places and pays for the order, with the product being simultaneously shipped by a third-party fulfillment service provider; in limited
cases, title does not pass until the product reaches the customer&#8217;s delivery site, in these limited cases, recognition of revenue
should be deferred until that time, however the Company does not have a process to properly record the recognition of revenue if orders
are not immediately shipped, and deems the impact to be immaterial. In all cases, delivery is considered to have occurred when title and
risk of loss have transferred to the customer, which is usually commensurate upon shipment of the product. In the case of its product-based
contracts, the Company provides a subscription sensitive service based on the recurring shipment of products and records the related revenue
under the subscription agreements subsequent to receiving the monthly product order, recording the revenue at the time it fulfills the
shipment obligation to the customer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For its product-based contracts
with customers, the Company records an estimate for provisions of discounts, returns, allowances, customer rebates and other adjustments
for its product shipments, and are reflected as contra revenues in arriving at reported net revenues. The Company&#8217;s discounts and
customer rebates are known at the time of sale, correspondingly, the Company reduces gross product sales for such discounts and customer
rebates. The Company estimates customer returns and allowances based on information derived from historical transaction detail, and accounts
for such provisions, as contra revenue, during the same period in which the related revenues are earned. The Company has determined that
the population of its product-based contracts with customers are homogenous, supporting the ability to record estimates for returns and
allowances to be applied to the entire product-based portfolio population. Customer discounts, returns and rebates on product revenues
approximated $3,321,000 and $1,292,000, respectively, during the year ended December 31, 2020 and 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company, through its majority-owned
subsidiary LegalSimpli, offers a subscription based service providing a suite of software applications to its subscribers, principally
on a monthly subscription basis. The software suite allows the subscriber/user to convert almost any type of document to another electronic
form of editable document, providing ease of editing. For these subscription-based contracts with customers, the Company offers an initial
14-day trial period which is billed at $1.95, followed by a monthly subscription, or a yearly subscription to the Company&#8217;s software
suite dependent on the subscriber&#8217;s enrollment selection. The Company has estimated that there is one product and one performance
obligation that is delivered over time, as the Company allows the subscriber to access the suite of services for the time period of the
subscription purchased. The Company allows the customer to cancel at any point during the billing cycle, in which case the customers subscription
will not be renewed for the following month or year depending on the original subscription. The Company records the revenue over the customers
subscription period for monthly and yearly subscribers or at the end of the initial 14 day service period for customers who purchased
the initial subscription, as the circumstances dictate. The Company offers a discount for the monthly or yearly subscriptions being purchased,
which is deducted at the time of payment at the initiation of the contract term, therefore the Contract price is fixed and determinable
at the contract initiation. Monthly and annual subscriptions for the service are recorded net of the Company&#8217;s known discount rates.
As of December 31, 2020 and December 31, 2019, the Company has accrued contract liabilities, as deferred revenue, of approximately $917,000
and $110,000, respectively, which represent obligations on in-process monthly or yearly contracts with customers and a portion attributable
to the yet to be recognized initial 14-day trial period collections. Customer discounts and allowances on software revenues approximated
$1,062,000 and $242,000, respectively, during the year ended December 31, 2020 and 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For the year ended December 31,
2020 and 2019, the Company had the following disaggregated revenue:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year Ended December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><font style="font-size: 10pt"><b>%</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><font style="font-size: 10pt"><b>%</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Product revenues by Brand for CVLB PR:</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 52%"><font style="font-size: 10pt">Shapiro MD</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font-size: 10pt">17,289,687</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 8%; text-align: right"><font style="font-size: 10pt">46</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font-size: 10pt">9,019,956</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 8%; text-align: right"><font style="font-size: 10pt">72</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Innate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5,041</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">49,258</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">iNR Wellness</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">247,350</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">738,965</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Scarology</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">44,332</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">51,131</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Rex MD</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">12,969,753</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">35</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">60,197</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Total product revenue for CVLB PR</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">30,556,163</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">82</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">9,919,507</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">80</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Software revenue for LegalSimpli, net</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6,732,747</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">18</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,539,129</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">20</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Services revenue for CVLB Media</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">5,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">9,943</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total Revenues, net</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">37,293,910</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">100</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">12,468,578</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">100</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Accounts Receivable</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Accounts receivable principally
consist of amounts due from third-party merchant processors, who process our subscription revenues; the merchant accounts balance receivable
represents the charges processed by the merchants that have not yet been deposited with the Company. The unsettled merchant receivable
amount normally represents processed sale transactions from the final one to three days of the month, with collections being made by the
Company within the first week of the following month. As of year end there is also a fully reserved accounts receivable for one wholesale
agent relationship transaction. There will be no further wholesale agent sales in the future. Management determines the need, if any,
for an allowance for future credits to be granted to customers, by regularly evaluating aggregate customer refund activity, coupled with
the consideration and current economic conditions in its evaluation of an allowance for future refunds and chargebacks. As of December
31, 2020 and 2019, the Company had an allowance for bad debt, attributable to the single agent relationship amounting to approximately
$133,000 and $0, respectively. As of December 31, 2020 and December 31, 2019, the reserve for sales returns and allowances was approximately
$349,000 and $84,000, respectively. For all periods presented, as noted above, the sales returns and allowances were recorded as contra
assets in arriving at presented accounts receivable, net.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Inventory</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2020 and 2019,
inventory primarily consisted of finished goods related to the Company&#8217;s brands included in the product revenue section of the table
above. Inventory is maintained at the Company&#8217;s third-party warehouse location in Wyoming and at the Amazon fulfillment center.
The Company also maintains inventory at a related-party warehouse in Pennsylvania.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Inventory is valued at the lower
of cost or net realizable value with cost determined on a first-in, first-out (&#8220;FIFO&#8221;) basis. Management compares the cost
of inventory with the net realizable value and an allowance is made for writing down inventory to net realizable, if lower. As of December
31, 2020 and December 31, 2019, the Company recorded an inventory reserve in the amount of $57,481 and $12,500, respectively. The increase
in our inventory reserve mainly is attributable to the lack of marketability for our INR Wellness product line.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2020 and 2019,
the Company&#8217;s inventory consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Finished Goods - Products</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,172,624</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">925,017</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Raw materials and packaging components</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">149,115</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">37,542</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Inventory reserve</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(57,481</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(12,500</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total Inventory - net</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,264,258</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">950,059</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Product Deposit</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Product Deposit</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Many of our vendors require deposits
when a purchase order is placed for goods or fulfillment services. These deposits typically range from 10% to 33% of the total purchased
amount. Our vendors include a credit memo within their final invoice, recognizing the deposit amount previously paid. As of December 31,
2020, and December 31, 2019, the Company has approximately $816,765 and $150,000, respectively, of product deposits with multiple vendors
for the purchase of raw materials or finished goods. The Company&#8217;s history of product deposits with its inventory vendors, creates
an implicit purchase commitment equaling the total expected product acceptance cost in excess of the product deposit. As of December 31,
2020 and December 31, 2019, the Company approximates its implicit purchase commitments to be $1.6 million and $300,000, respectively.
As of December 31, 2020, and December 31, 2019, the vast majority of these product deposits are with one vendor that manufacturers the
Company&#8217;s finished goods inventory for its Shapiro hair care product line.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InProcessResearchAndDevelopmentPolicy', window );">Capitalized Software Costs</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Capitalized Software Costs
</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The Company
capitalizes certain internal payroll costs and third-party costs related to internally developed software and amortizes these costs using
the straight-line method over the estimated useful life of the software, generally three years. The Company does not sell internally developed
software other than through the use of subscription service. Certain development costs not meeting the criteria for capitalization, in
accordance with Accounting Standards Codification (&#8220;ASC&#8221;) <i>ASC 350-40 Internal-Use Software</i>, are expensed as incurred.
As of December 31, 2020 and 2019, the Company capitalized $438,136 and $0 related to internally developed software costs which is amortized
over the useful life and included in development costs on our statement of operations.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Intangible Assets</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Intangible assets are comprised
of a customer relationship asset (with original cost of approximately $1,007,000) and a purchased license (with a cost of $200,000) with
an estimated useful life of three and ten years, respectively. Intangible assets are amortized over their estimated lives using the straight-line
method. Costs incurred to renew or extend the term of recognized intangible assets are capitalized and amortized over the useful life
of the asset.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Impairment of Long-Lived Assets</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Long-lived assets are evaluated
for impairment whenever events or changes in circumstances have indicated that an asset may not be recoverable and are grouped with other
assets to the lowest level for which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities
(asset group). If the sum of the projected undiscounted cash flows (excluding interest charges) of an asset group is less than its carrying
value and the fair value of an asset group is also less than its carrying value, the assets will be written down by the amount by which
the carrying value of the asset group exceeded its fair value. However, the carrying amount of a finite-lived intangible asset can never
be written down below its fair value. Any loss would be recognized in income from continuing operations in the period in which the determination
is made.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Paycheck Protection Program</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Paycheck Protection Program</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2020, the Company received aggregate loan proceeds in the amount of approximately $249,000 under the Paycheck Protection Program (&#8220;PPP&#8221;).
The PPP, established as part of the Coronavirus Aid, Relief and Economic Security Act (&#8220;CARES Act&#8221;), provides for loans to
qualifying businesses for amounts up to 2.5 times of the average monthly payroll expenses of the qualifying business. The loans and accrued
interest are forgivable after eight weeks as long as the borrower uses the loan proceeds for eligible purposes, including payroll, benefits,
rent and utilities, and maintains its payroll levels. The amount of loan forgiveness will be reduced if the borrower terminates employees
or reduces salaries during the eight-week period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The unforgiven portion of the
PPP loan is payable over two years at an interest rate of 1%, with a deferral of payments for the first six months. The Company intends
to use the proceeds for purposes consistent with the PPP. While the Company currently believes that its use of the loan proceeds will
meet the conditions for forgiveness of the loan, we cannot assure you that we will not take actions that could cause the Company to be
ineligible for forgiveness of the loan, in whole or in part.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Income Taxes</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company files corporate federal,
state and local tax returns. Conversion Labs PR and LegalSimpli file tax returns in Puerto Rico, both are limited liability companies
and file separate tax returns with any tax liabilities or benefits passing through to its members.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company records current and
deferred taxes in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 740, &#8220;Accounting for Income Taxes.&#8221;
This ASC requires recognition of deferred tax assets and liabilities for temporary differences between tax basis of assets and liabilities
and the amounts at which they are carried in the financial statements, based upon the enacted rates in effect for the year in which the
differences are expected to reverse. The Company establishes a valuation allowance when necessary to reduce deferred tax assets to the
amount expected to be realized. The Company periodically assesses the value of its deferred tax asset, a majority of which has been generated
by a history of net operating losses and management determines the necessity for a valuation allowance. ASC 740 also provides a recognition
threshold and measurement attribute for the financial statement recognition of a tax position taken or expected to be taken in a tax return.
Using this guidance, a company may recognize the tax benefit from an uncertain tax position in its financial statements only if it is
more likely-than-not (i.e., a likelihood of more than 50%) that the tax position will be sustained on examination by the taxing authorities,
based on the technical merits of the position. The Company&#8217;s tax returns for all years since December 31, 2017, remain open to audit
by all related taxing authorities.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Stock-Based Compensation</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company follows the provisions
of ASC 718, &#8220;Share-Based Payment&#8221;. Under this guidance compensation cost generally is recognized at fair value on the date
of the grant and amortized over the respective vesting or service period. The fair value of options at the date of grant is estimated
using the Black-Scholes option pricing model. The expected option life is derived from assumed exercise rates based upon historical exercise
patterns and represents the period of time that options granted are expected to be outstanding. The expected volatility is based upon
historical volatility of the Company&#8217;s common shares using weekly price observations over an observation period that approximates
the expected life of the options. The risk-free interest rate approximates the U.S. Treasury yield curve rate in effect at the time of
grant for periods similar to the expected option life. Due to limited history of forfeitures, the Company has elected to account for forfeitures
as they occur.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Many of the assumptions require
significant judgment and any changes could have a material impact in the determination of stock-based compensation expense.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings (Loss) Per Share</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Earnings (Loss) Per Share</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify; text-indent: 35.65pt">Basic earnings (loss)
per common share is based on the weighted average number of shares outstanding during each period presented. Convertible securities, warrants
and options to purchase common stock are included as common stock equivalents only when dilutive. Potential common stock equivalents are
excluded from dilutive earnings per share when the effects would be antidilutive.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify; text-indent: 35.65pt">The Company follows the
provisions of ASC 260, &#8220;Diluted Earnings per Share&#8221;. In computing diluted EPS, basic EPS is adjusted for the assumed issuance
of all potentially dilutive securities. The dilutive effect of call options, warrants and share-based payment awards is calculated using
the &#8220;treasury stock method,&#8221; which assumes that the &#8220;proceeds&#8221; from the exercise of these instruments are used
to purchase common shares at the average market price for the period. The dilutive effect of traditional convertible debt and preferred
stock is calculated using the &#8220;if-converted method.&#8221; Under the if-converted method, securities are assumed to be converted
at the beginning of the period, and the resulting common shares are included in the denominator of the diluted EPS calculation for the
entire period being presented.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify; text-indent: 35.65pt">The following table summarizes
the number of shares of common stock issuable pursuant to our convertible securities that were excluded from the diluted per share calculation
because the effect of including these potential shares was antidilutive even though the exercise price could be less than the average
market price of the common shares:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td colspan="2">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.8pt; text-align: center"><b>Year</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.8pt; text-align: center"><b>Ended</b></p></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.8pt; text-align: center"><b>Year</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Ended</b></p></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Series B Preferred Stock</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,076,923</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Convertible notes</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,165,126</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Stock options</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,232,400</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,374,000</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Warrants</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3,560,188</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,265,324</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Potentially dilutive securities</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">8,869,511</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">8,804,451</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Fair Value of Financial Instruments</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The carrying value of the Company&#8217;s
financial instruments, including cash, accounts receivable, accounts payable and accrued expenses and the face amount of notes payable
approximate fair value for all periods presented.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Risk</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Concentrations of Risk</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company grants credit in the
normal course of business to its customers. The Company periodically performs credit analysis and monitors the financial condition of
its customers to reduce credit risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company monitors its positions
with, and the credit quality of, the financial institutions with which it invests. The Company, at times, maintains balances in various
operating accounts in excess of federally insured limits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We are dependent on certain third-party
manufacturers, although we believe that other contract manufacturers could be quickly secured if any of our current manufacturers cease
to perform adequately. As of December 31, 2020 and 2019, we utilized two (2) suppliers for fulfillment services, two (2) suppliers for
manufacturing finished goods, one (1) supplier for packaging and bottles and one (1) supplier for labeling. For the year ended December
31, 2020 and 2019, we purchased 100% of our finished goods from two (2) manufacturers.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Recently Adopted Accounting
Pronouncements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">In July
2017, the FASB issued ASU No. 2017-11, &#8220;Earnings Per Share (Topic 260) and Derivatives and Hedging (Topic 815)- Accounting for Certain
Financial Instruments with Down Round Features&#8221; (&#8220;ASU 2017-11&#8221;). Equity-linked instruments, such as warrants and convertible
instruments, may contain down round features that result in the strike price being reduced on the basis of the pricing of future equity
offerings. Under ASU 2017-11, a down round feature will no longer require a freestanding equity-linked instrument (or embedded conversion
option) to be classified as a liability that is remeasured at fair value through the income statement (i.e. marked-to-market). However,
other features of the equity-linked instrument (or embedded conversion option) must still be evaluated to determine whether liability
or equity classification is appropriate. Equity classified instruments are not marked-to-market. For earnings per share (&#8220;EPS&#8221;)
reporting, the ASU requires companies to recognize the effect of the down round feature only when it is triggered by treating it as a
dividend and as a reduction of income available to common shareholders in basic EPS. The amendments in this ASU are effective for all
entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. This standard was adopted
on January 1, 2020 and did not have a material impact on the Company&#8217;s financial position, results of operations or cash flows.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ApplicationOfNewOrRevisedAccountingStandardsNotYetAdoptedPolicyTextBlock', window );">Application of New or Revised Accounting Standards - Not Yet Adopted</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Application of New or Revised Accounting Standards&#8212;Not
Yet Adopted</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In August 2020, the FASB issued
ASU 2020-06, &#8220;<i>Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8211; Contracts
in Entity&#8217;s Own Equity (Subtopic 815-40); Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity </i>(&#8220;ASU
2020-06&#8221;)&#8221;, which addresses issues identified as a result of the complexities associated with applying U.S. GAAP for certain
financial instruments with characteristics of liabilities and equity. This update addresses, among other things, the number of accounting
models for convertible debt instruments and convertible preferred stock, targeted improvements to the disclosures for convertible instruments
and earnings-per-share (&#8220;EPS&#8221;) guidance and amendments to the guidance for the derivatives scope exception for contracts in
an entity&#8217;s own equity, as well as the related EPS guidance. This update applies to all entities that issue convertible instruments
and/or contracts in an entity&#8217;s own equity. This guidance is effective for financial statements issued for fiscal years beginning
after December 15, 2021, and interim periods within those fiscal years. Early adoption is permitted, but no earlier than for fiscal years
beginning after December 15, 2020, including interim periods within those fiscal years. FASB specified that an entity should adopt the
guidance as of the beginning of its annual fiscal year, or January 1, 2021, should the Company elect to early adopt. The Company is currently
evaluating the impact the adoption of ASU 2020-06 could have on the Company&#8217;s financial statements and disclosures.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_OtherRecentAccountingPronouncementsPolicyTextBlock', window );">Other Recent Accounting Pronouncements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Other Recent Accounting Pronouncements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">All other accounting standards
updates that have been issued or proposed by the FASB that do not require adoption until a future date are not expected to have a material
impact on the consolidated financial statements upon adoption.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ApplicationOfNewOrRevisedAccountingStandardsNotYetAdoptedPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Application of New or Revised Accounting Standards Not Yet Adopted [Policy text block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ApplicationOfNewOrRevisedAccountingStandardsNotYetAdoptedPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_OtherRecentAccountingPronouncementsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other recent accounting pronouncements [Policy Text Block].</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_OtherRecentAccountingPronouncementsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5728-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=SL6759159-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=SL6759068-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13279-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InProcessResearchAndDevelopmentPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs assigned to identifiable tangible and intangible assets of an acquired entity to be used in the research and development activities of the combined enterprise. An entity also may disclose the appraisal method or significant assumptions used to value acquired research and development assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23199-108380<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InProcessResearchAndDevelopmentPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155638-234783<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902991304088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregated Revenue</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For the year ended December 31,
2020 and 2019, the Company had the following disaggregated revenue:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year Ended December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><font style="font-size: 10pt"><b>%</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"><font style="font-size: 10pt"><b>%</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Product revenues by Brand for CVLB PR:</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 52%"><font style="font-size: 10pt">Shapiro MD</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font-size: 10pt">17,289,687</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 8%; text-align: right"><font style="font-size: 10pt">46</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font-size: 10pt">9,019,956</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 8%; text-align: right"><font style="font-size: 10pt">72</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Innate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5,041</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">49,258</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">iNR Wellness</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">247,350</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">738,965</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Scarology</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">44,332</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">51,131</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Rex MD</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">12,969,753</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">35</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">60,197</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Total product revenue for CVLB PR</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">30,556,163</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">82</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">9,919,507</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">80</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Software revenue for LegalSimpli, net</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6,732,747</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">18</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,539,129</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">20</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Services revenue for CVLB Media</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">5,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">9,943</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total Revenues, net</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">37,293,910</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">100</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">12,468,578</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">100</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Summary of Inventory</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2020 and 2019,
the Company&#8217;s inventory consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Finished Goods - Products</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,172,624</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">925,017</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Raw materials and packaging components</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">149,115</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">37,542</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Inventory reserve</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(57,481</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(12,500</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total Inventory - net</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,264,258</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">950,059</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Potentially Dilutive Securities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.35pt; text-align: justify; text-indent: 35.65pt">The following table summarizes
the number of shares of common stock issuable pursuant to our convertible securities that were excluded from the diluted per share calculation
because the effect of including these potential shares was antidilutive even though the exercise price could be less than the average
market price of the common shares:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td colspan="2">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.8pt; text-align: center"><b>Year</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.8pt; text-align: center"><b>Ended</b></p></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.8pt; text-align: center"><b>Year</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Ended</b></p></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Series B Preferred Stock</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,076,923</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Convertible notes</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,165,126</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Stock options</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,232,400</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,374,000</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Warrants</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3,560,188</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,265,324</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Potentially dilutive securities</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">8,869,511</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">8,804,451</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139903099144440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2020, the Company
has the following amounts related to intangible assets:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Intangible Assets as at:</font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31,</font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31,</font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Amortizable</font></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2020</font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2019</font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Life</font></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b><i>Amortizable Intangible Assets</i></b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 45%; padding-left: 10pt"><font style="font-size: 10pt">Customer Relationship Asset</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,006,840</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,006,840</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: center"><font style="font-size: 10pt">3 years</font></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Purchased Licenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">200,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">200,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt">10 years</font></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Less: Accumulated amortization</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(867,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(531,388</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Total Net Amortizable Intangible Assets</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">339,840</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">675,452</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902990293624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=LFMD_TwoThousandTwentyPlanMember', window );">2020 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Option Activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following is a summary of
outstanding options activity for our new 2020 Plan for the year ended December 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Options Outstanding Number of Shares</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise Price per Share</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Contractual Life</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price per Share</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Balance, December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 30%"><font style="font-size: 10pt">Granted</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">839,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">5.80 &#8211; 9.24</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">10.00</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">7.54</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Cancelled/Forfeited/Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Balance at December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">839,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">5.80 &#8211; 9.24</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">9.75</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">7.54</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Exercisable December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercisable at December 31, 2020</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">76,222</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">5.80 &#8211; 9.24</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9.77</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">7.74</font></td>
    <td>&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Warrant Outstanding and Exercisable</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following is a summary of
outstanding and exercisable warrants activity during the year ended December 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Warrants Outstanding Number of Shares</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise Price per Share</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Contractual Life</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price per Share</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 32%"><font style="font-size: 10pt">Balance at December 31, 2019</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">2,265,324</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1.00 &#8211; 2.50</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">5.77 years</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1.25</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,209,596</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.65 &#8211; 5.75</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5.56 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3.87</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercised/Expired</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(2,924,449</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.65 &#8211; 0.70</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.82 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.96</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Balance at December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">3,550,471</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">1.40 &#8211; 5.75</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">5.59 years</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">4.56</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercisable December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,066,049</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.00 &#8211; 2.50</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6.24 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.55</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Exercisable December 31, 2020</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,144,700</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.40 &#8211; 5.75</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7.67 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">4.29</font></td>
    <td>&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=LFMD_ServiceBasedStockOptionsMember', window );">Service-Based Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Option Activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following is a summary of
outstanding service-based options activity (prior to the establishment of our 2020 Plan above) for the year ended December 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Options Outstanding Number of Shares</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise Price per Share</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Contractual Life</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price per Share</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 30%"><font style="font-size: 10pt">Balance, December 31, 2019</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">3,009,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1.00 - 2.00</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">4.22 years</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1.50</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">700,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1.15 - 7.50</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7.76 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2.85</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(1,175,600</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.80 - 2.00</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2.97 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1.11</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Cancelled/Forfeited/Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(305,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">1.00 - 2.00</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">6.52 years</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">1.54</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Balance at December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,228,400</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">0.80 - 7.50</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">5.15 years</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">2.11</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Exercisable December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,361,083</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.00 - 2.00</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3.76 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.25</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercisable at December 31, 2020</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,570,428</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.00 &#8211; 7.50</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2.57 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.67</font></td>
    <td>&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-Based Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Option Activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following is a summary of
outstanding performance-based options activity for the year ended December 31, 2020:</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Options Outstanding Number of Shares</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise Price per Share</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Contractual Life</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price per Share</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 30%"><font style="font-size: 10pt">Balance at December 31, 2019</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,365,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1.25 &#8211; 2.00</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">5.34 years</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">1.70</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Cancelled/Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(200,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">1.50</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">8.06 years</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">1.50</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Balance at December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,165,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">1.25 &#8211; 2.00</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">4.97 years</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">1.80</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Exercisable December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">635,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.25 &#8211; 2.00</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2.63 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">2.00</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercisable at December 31, 2020</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">635,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.25 &#8211; 2.00</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1.38 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">2.00</font></td>
    <td>&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=LFMD_TwoThousandTwentyPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=LFMD_TwoThousandTwentyPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=LFMD_ServiceBasedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=LFMD_ServiceBasedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139903072870328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Leases</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 73%"><font style="font-size: 10pt">Right of Use Asset</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 24%; text-align: right"><font style="font-size: 10pt">274,437</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Lease liability</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">285,323</font></td>
    <td>&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902992746920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Income Tax Provision Charges</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The income tax provision charged
to continuing operations for the years ended December 31, 2020 and 2019 was as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Current:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 54%; padding-left: 10pt"><font style="font-size: 10pt">U.S. federal</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">152,100</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">(152,100</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">)</font></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">State and local</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">40,400</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(40,400</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">192,500</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(192,500</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Deferred:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">U.S. federal</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(70,000</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">70,000</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">State and local</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(70,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">70,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt; padding-left: 10pt"><font style="font-size: 10pt">Provision for income taxes</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">122,500</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(122,500</font></td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Provision Differs from the Amount of Income Tax</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The provision for income taxes
differs from the expected amount of income tax expense (benefit) determined by applying a combined U.S. federal and state (Puerto Rico)
income tax rate of 25% to pretax income (loss) for the years ended December 31, 2020 and 2019 as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Computed &#8220;expected&#8221; tax expense (benefit)</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">(12,684,000</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">)</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">(783,000</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">)</font></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Increase (decrease) in income taxes resulting from:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Permanent differences</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7,765,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7,000</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Apportionment of Puerto Rico income</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3,607,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">380,000</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Nondeductible expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">140,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">173,000</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Change in valuation allowance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,269,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">148,000</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Other</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">25,500</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(47,500</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Net Deferred Tax Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Net deferred tax liabilities consist
of the following components as of December 31, 2020 and 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt"><font style="font-size: 10pt">Deferred tax Liability:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 62%; padding-bottom: 1.5pt; padding-left: 5.4pt"><font style="font-size: 10pt">Other</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; width: 16%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; width: 16%; text-align: right"><font style="font-size: 10pt">70,000</font></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">70,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt"><font style="font-size: 10pt">Deferred tax assets:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 5.4pt; text-indent: 10pt"><font style="font-size: 10pt">Stock-based compensation</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">716,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">716,000</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt; text-indent: 10pt"><font style="font-size: 10pt">Temporary differences</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">113,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">44,000</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 5.4pt; text-indent: 10pt"><font style="font-size: 10pt">Net operating loss carryforwards</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,151,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">951,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,980,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,711,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 5.4pt"><font style="font-size: 10pt">Less valuation allowance</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(2,980,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,711,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">70,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902986520824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of the Organization and Business (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 11, 2021</div></th>
<th class="th"><div>Oct. 09, 2020</div></th>
<th class="th"><div>Aug. 28, 2020</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Mar. 30, 2021</div></th>
<th class="th"><div>Mar. 29, 2021</div></th>
<th class="th"><div>Feb. 22, 2021</div></th>
<th class="th"><div>Apr. 25, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Apr. 01, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-for-5 reverse stock split<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceed from private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,900,000<span></span>
</td>
<td class="nump">$ 14,900,220<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80,151,905)<span></span>
</td>
<td class="num">$ (16,594,917)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardDateAxis=LFMD_ThroughTheNextTwelveMonthsMember', window );">Through the Next 12 Months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Stock issued price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceed from private placement</a></td>
<td class="nump">$ 13,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Private Placement [Member] | Securities Purchase Agreement [Member] | Investors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock per share</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceed from private placement</a></td>
<td class="nump">$ 14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="nump">608,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Stock issued price per share</a></td>
<td class="nump">$ 23.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ProceedsFromIssuanceOfPrivatePlacementNet', window );">Proceed from private placement, net</a></td>
<td class="nump">$ 13,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LFMD_ImmudynePrLlcMember', window );">Immudyne PR LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of ownership equity interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LFMD_ConversionLabsPrMember', window );">Conversion Labs PR [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of ownership equity interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LFMD_LegalSimpliSoftwareLlcMember', window );">LegalSimpli Software, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of purchase business acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LFMD_LegalSimpliSoftwareLlcMember', window );">LegalSimpli Software, LLC [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of ownership equity interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ProceedsFromIssuanceOfPrivatePlacementNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceed from private placement, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ProceedsFromIssuanceOfPrivatePlacementNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=LFMD_ThroughTheNextTwelveMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=LFMD_ThroughTheNextTwelveMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=LFMD_InvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=LFMD_InvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LFMD_ImmudynePrLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LFMD_ImmudynePrLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LFMD_ConversionLabsPrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LFMD_ConversionLabsPrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LFMD_LegalSimpliSoftwareLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LFMD_LegalSimpliSoftwareLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902987176472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Mar. 30, 2021</div></th>
<th class="th"><div>Mar. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_MerchantProcessingFees', window );">Merchant processing fees</a></td>
<td class="nump">$ 745,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_SubscriptionPricePerShare', window );">Subscription price per share</a></td>
<td class="nump">$ 1.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Accrued contract liabilities</a></td>
<td class="nump">$ 917,000<span></span>
</td>
<td class="nump">$ 110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt</a></td>
<td class="nump">133,470<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Sales returns and allowances</a></td>
<td class="nump">349,000<span></span>
</td>
<td class="nump">84,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory reserve</a></td>
<td class="nump">57,481<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsCurrent', window );">Product deposit</a></td>
<td class="nump">816,765<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Purchase commitments</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers', window );">Capitalized software costs</a></td>
<td class="nump">$ 438,136<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=LFMD_TwoManufacturersMember', window );">Two Manufacturers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=LFMD_PaycheckProtectionProgramLoanMember', window );">Paycheck Protection Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from aggregate loan received</a></td>
<td class="nump">$ 249,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Loan Description</a></td>
<td class="text">The PPP, established as part of the Coronavirus Aid, Relief and Economic Security Act ("CARES Act"), provides for loans to qualifying businesses for amounts up to 2.5 times of the average monthly payroll expenses of the qualifying business.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on laon</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets</a></td>
<td class="nump">$ 1,007,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=LFMD_PurchasedLicensesMember', window );">Purchased Licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of intangible assets</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PercentageOfInterestBearingDomesticDepositsToDeposits', window );">Deposits percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of intangible assets</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PercentageOfInterestBearingDomesticDepositsToDeposits', window );">Deposits percentage</a></td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life of intangible assets</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product Revenues, Net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_CustomerDiscountsReturnsAndRebates', window );">Customer discounts, returns and rebates</a></td>
<td class="nump">$ 3,321,000<span></span>
</td>
<td class="nump">$ 1,292,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">82.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=LFMD_SoftwareRevenueMember', window );">Software Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_CustomerDiscountsReturnsAndRebates', window );">Customer discounts, returns and rebates</a></td>
<td class="nump">$ 1,062,000<span></span>
</td>
<td class="nump">$ 242,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LFMD_LegalSimpliSoftwareLlcMember', window );">LegalSimpli Software, LLC [Member] | Software Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | LegalSimpli Software, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Percentage of ownership equity interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=LFMD_LegalSimpliSoftwareLlcMember', window );">LegalSimpli Software, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Non-controlling interest rate</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_CustomerDiscountsReturnsAndRebates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Customer Discounts Returns And Rebates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_CustomerDiscountsReturnsAndRebates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_MerchantProcessingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Merrchant processing fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_MerchantProcessingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_SubscriptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Subscription price per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_SubscriptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unamortized costs incurred for development of computer software, which is to be sold, leased or otherwise marketed, after establishing technological feasibility through to the general release of the software products. Excludes capitalized costs of developing software for internal use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PercentageOfInterestBearingDomesticDepositsToDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of interest-bearing domestic deposit liabilities to total deposit liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PercentageOfInterestBearingDomesticDepositsToDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=LFMD_TwoManufacturersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=LFMD_TwoManufacturersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=LFMD_PaycheckProtectionProgramLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=LFMD_PaycheckProtectionProgramLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=LFMD_PurchasedLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=LFMD_PurchasedLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=LFMD_SoftwareRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=LFMD_SoftwareRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LFMD_LegalSimpliSoftwareLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LFMD_LegalSimpliSoftwareLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=LFMD_LegalSimpliSoftwareLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=LFMD_LegalSimpliSoftwareLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902987773688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues, net</a></td>
<td class="nump">$ 37,293,910<span></span>
</td>
<td class="nump">$ 12,468,578<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Net revenue, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product Revenues, Net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues, net</a></td>
<td class="nump">$ 30,556,163<span></span>
</td>
<td class="nump">$ 9,919,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Net revenue, percentage</a></td>
<td class="nump">82.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product Revenues, Net [Member] | Shapiro MD [Member] | CVLB PR [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues, net</a></td>
<td class="nump">$ 17,289,687<span></span>
</td>
<td class="nump">$ 9,019,956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Net revenue, percentage</a></td>
<td class="nump">46.00%<span></span>
</td>
<td class="nump">72.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product Revenues, Net [Member] | Innate [Member] | CVLB PR [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues, net</a></td>
<td class="nump">$ 5,041<span></span>
</td>
<td class="nump">$ 49,258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Net revenue, percentage</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product Revenues, Net [Member] | iNR Wellness [Member] | CVLB PR [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues, net</a></td>
<td class="nump">$ 247,350<span></span>
</td>
<td class="nump">$ 738,965<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Net revenue, percentage</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product Revenues, Net [Member] | Scarology [Member] | CVLB PR [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues, net</a></td>
<td class="nump">$ 44,332<span></span>
</td>
<td class="nump">$ 51,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Net revenue, percentage</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product Revenues, Net [Member] | Rex MD [Member] | CVLB PR [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues, net</a></td>
<td class="nump">$ 12,969,753<span></span>
</td>
<td class="nump">$ 60,197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Net revenue, percentage</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=LFMD_SoftwareRevenueMember', window );">Software Revenue [Member] | LegalSimpli Software, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues, net</a></td>
<td class="nump">$ 6,732,747<span></span>
</td>
<td class="nump">$ 2,539,129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Net revenue, percentage</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=LFMD_SoftwareRevenueMember', window );">Software Revenue [Member] | CVLB Media [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues, net</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 9,943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Net revenue, percentage</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=LFMD_ShapiroMDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=LFMD_ShapiroMDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LFMD_CVLBPRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LFMD_CVLBPRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=LFMD_InnateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=LFMD_InnateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=LFMD_INRWellnessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=LFMD_INRWellnessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=LFMD_ScarologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=LFMD_ScarologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=LFMD_RexMDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=LFMD_RexMDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=LFMD_SoftwareRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=LFMD_SoftwareRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LFMD_LegalSimpliSoftwareLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LFMD_LegalSimpliSoftwareLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LFMD_CVLBMediaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LFMD_CVLBMediaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902999418536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Inventory (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished Goods - Products</a></td>
<td class="nump">$ 1,172,624<span></span>
</td>
<td class="nump">$ 925,017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials and packaging components</a></td>
<td class="nump">149,115<span></span>
</td>
<td class="nump">37,542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory reserve</a></td>
<td class="num">(57,481)<span></span>
</td>
<td class="num">(12,500)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total Inventory - net</a></td>
<td class="nump">$ 1,264,258<span></span>
</td>
<td class="nump">$ 950,059<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902987749288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities</a></td>
<td class="nump">8,869,511<span></span>
</td>
<td class="nump">8,804,451<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,165,126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities</a></td>
<td class="nump">4,232,400<span></span>
</td>
<td class="nump">4,374,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities</a></td>
<td class="nump">3,560,188<span></span>
</td>
<td class="nump">2,265,324<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities</a></td>
<td class="nump">1,076,923<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902991389576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 335,612<span></span>
</td>
<td class="nump">$ 335,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization expense 2021</a></td>
<td class="nump">$ 339,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902992714424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: Accumulated amortization</a></td>
<td class="num">$ (867,000)<span></span>
</td>
<td class="num">$ (531,388)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total Net Amortizable Intangible Assets</a></td>
<td class="nump">$ 339,840<span></span>
</td>
<td class="nump">675,452<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=LFMD_CustomerRelationshipAssetMember', window );">Customer Relationship Asset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortizable Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 1,006,840<span></span>
</td>
<td class="nump">1,006,840<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=LFMD_PurchasedLicensesMember', window );">Purchased Licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Amortizable Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=LFMD_CustomerRelationshipAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=LFMD_CustomerRelationshipAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=LFMD_PurchasedLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=LFMD_PurchasedLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902981679096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable - (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 24, 2020</div></th>
<th class="th"><div>Aug. 28, 2020</div></th>
<th class="th"><div>Jul. 27, 2020</div></th>
<th class="th"><div>May 27, 2020</div></th>
<th class="th"><div>May 27, 2020</div></th>
<th class="th"><div>Feb. 18, 2020</div></th>
<th class="th"><div>Aug. 15, 2019</div></th>
<th class="th"><div>May 29, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Feb. 25, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt, voluntary conversion price per share</a></td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion, converted value</a></td>
<td class="nump">$ 1,119,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 242,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,498,808<span></span>
</td>
<td class="nump">295,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,350,000<span></span>
</td>
<td class="nump">1,093,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense on notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,667,536<span></span>
</td>
<td class="nump">761,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion shares issued</a></td>
<td class="nump">447,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=LFMD_MayTwoThousandAndTwentyNotesMember', window );">May 2020 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt, voluntary conversion price per share</a></td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion, converted value</a></td>
<td class="nump">$ 1,119,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion shares issued</a></td>
<td class="nump">447,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Conertible note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=LFMD_SixAccreditedInvestorsMember', window );">6 Accredited Investors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt interest, maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan. 24,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Conertible note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 607,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=LFMD_SixAccreditedInvestorsMember', window );">6 Accredited Investors [Member] | May 2020 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt, voluntary conversion price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense on notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Number of restricted stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Number of restricted stock issued, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 219,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=LFMD_ChaseBankMember', window );">Chase Bank [Member] | Working Capital Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.99%<span></span>
</td>
<td class="nump">3.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 519,950<span></span>
</td>
<td class="nump">$ 519,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ServiceCharge', window );">Service charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion, converted value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 607,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Two Accredited Investors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,291,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of warrants to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">935,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt interest, maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 15,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentRate', window );">Debt instrument, conversion rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt, voluntary conversion price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,111,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">569,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Original issue discount, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 215,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 284,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Alpha Capital Anstalt and Brio Capital Master Fund Ltd. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt interest, maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 31,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentRate', window );">Debt instrument, conversion rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt, voluntary conversion price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion, converted value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">344,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_DebtConversionInterestValue', window );">Debt conversion, interest value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Alpha Capital Anstalt and Brio Capital Master Fund Ltd. [Member] | Pre-Split Basis [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of warrants to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">478,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_NoteRepaymentAndWarrantAmendmentAgreementMember', window );">Note Repayment and Warrant Amendment Agreement [Member] | Alpha Capital Anstalt and Brio Capital Master Fund Ltd. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,291,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">627,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">568,322<span></span>
</td>
<td class="nump">568,322<span></span>
</td>
<td class="nump">404,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1,291,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_CSixPurchaseAgreementsMember', window );">C6 Purchase Agreements [Member] | C6 Capital, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,020,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Original issue discount, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 270,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_CSixPurchaseAgreementsMember', window );">C6 Purchase Agreements [Member] | C6 Capital, LLC [Member] | Daily Average Payment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_CSixPurchaseAgreementOneMember', window );">C6 Purchase Agreement One [Member] | C6 Capital, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_CSixPurchaseAgreementTwoMember', window );">C6 Purchase Agreement Two [Member] | C6 Capital, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_CSixPurchaseAgreementsOneMember', window );">C6 Purchase Agreements One [Member] | C6 Capital, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_CSixPurchaseAgreementsTwoMember', window );">C6 Purchase Agreements Two [Member] | C6 Capital, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_TwoCSixPurchaseAgreementsMember', window );">Two C6 Purchase Agreements [Member] | C6 Capital, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Debt principal payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,020,000<span></span>
</td>
<td class="nump">1,020,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_PaycheckProtectionProgramLoanMember', window );">Paycheck Protection Program Loan [Member] | US Small Business Administration [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 259,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 259,182<span></span>
</td>
<td class="nump">$ 259,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_DebtConversionInterestValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt conversion, interest value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_DebtConversionInterestValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ServiceCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Service charge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ServiceCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAnnualPrincipalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the total principal payments made during the annual reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAnnualPrincipalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=LFMD_MayTwoThousandAndTwentyNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=LFMD_MayTwoThousandAndTwentyNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=LFMD_SixAccreditedInvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=LFMD_SixAccreditedInvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=LFMD_ChaseBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=LFMD_ChaseBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=LFMD_WorkingCapitalLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=LFMD_WorkingCapitalLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=LFMD_TwoAccreditedInvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=LFMD_TwoAccreditedInvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=LFMD_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=LFMD_AlphaCapitalAnstaltBrioCapitalMasterFundLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=LFMD_PreSplitBasisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=LFMD_PreSplitBasisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_NoteRepaymentAndWarrantAmendmentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_NoteRepaymentAndWarrantAmendmentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_CSixPurchaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_CSixPurchaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=LFMD_CSixCapitalLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=LFMD_CSixCapitalLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=LFMD_DailyAveragePaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=LFMD_DailyAveragePaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_CSixPurchaseAgreementOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_CSixPurchaseAgreementOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_CSixPurchaseAgreementTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_CSixPurchaseAgreementTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_CSixPurchaseAgreementsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_CSixPurchaseAgreementsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_CSixPurchaseAgreementsTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_CSixPurchaseAgreementsTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_TwoCSixPurchaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_TwoCSixPurchaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_PaycheckProtectionProgramLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_PaycheckProtectionProgramLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=LFMD_USSmallBusinessAdministrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=LFMD_USSmallBusinessAdministrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902886435656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 24, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 09, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 08, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 27, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 24, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 20, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 19, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 06, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 03, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 21, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 16, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 09, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 07, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 29, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 28, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 27, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 27, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>May 07, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 25, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 20, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 25, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 22, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jan. 08, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, at par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_UndesignatedPreferredStock', window );">Undesignated preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,996,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-for-5 reverse stock split<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits', window );">Shares issued after stok split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Cash consideration | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 329,176<span></span>
</td>
<td class="nump">$ 329,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Conversion of outstanding | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,119,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsAndOtherAdjustments', window );">Deemed dividend | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,716,021<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible notes | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,350,000<span></span>
</td>
<td class="nump">1,093,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">447,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Number of stock issued for option exercise, value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">302,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Shares for services, value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,305,000<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Sale of warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,338,349<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributed to non-controlling interest | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,877,408)<span></span>
</td>
<td class="num">(391,055)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Distributions to non-controlling interest | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(157,223)<span></span>
</td>
<td class="num">(89,085)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80,151,905)<span></span>
</td>
<td class="num">(16,594,917)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from of warrants exercise | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">622,763<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,961,141<span></span>
</td>
<td class="nump">733,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Number of stock issued for option exercise, value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 660,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=LFMD_CVLBPRMember', window );">CVLB PR [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=us-gaap_InvestorMember', window );">Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">294,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Cash consideration | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=LFMD_BoardOfDirectorsMember', window );">Board of Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Options to purchase shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=LFMD_EmployeesAnddvisoryBoardMembersMember', window );">Employees and Advisory Board Members [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock options issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,539,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=LFMD_ChiefComplianceOfficerMember', window );">Chief Compliance Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Aggregate value of stock option | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,765,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock options issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=LFMD_NewChiefOperatingOfficerMember', window );">New Chief Operating Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Options granted fully vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_RemainingPerformanceOptions', window );">Remaining performance options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Aggregate value of stock option | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,384,883<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of restricted stock units granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=LFMD_OptionsAndWarrantsMember', window );">Options and Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of stock issued for option exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">535,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Number of stock issued for option exercise, value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 302,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_CashlessExerciseOfOptionsShares', window );">Cashless exercise of options shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">534,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_CashlessExerciseOfWarrantsShares', window );">Cashless exercise of warrants, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,472,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_IssuedWarrantsInConjunctionWithStock', window );">Issued warrants in conjunction with stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_IssuedWarrantsInConjunctionWithDebt', window );">Issued warrants in conjunction with debt | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 569,146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=LFMD_ServiceBasedStockOptionsMember', window );">Service-Based Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of stock issued for option exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,175,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock options issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation', window );">Compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 559,512<span></span>
</td>
<td class="nump">$ 76,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_UnamortizedExpense', window );">Unamortized expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,548,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=LFMD_AugustTwoThousandAndTwentyWarrantInducementMember', window );">August 2020 Warrant Inducement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">379,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Fair value term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">526,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_WarrantDiscountPricePerShare', window );">Warrant discount price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_DeemedDistributionFromWarrantPriceAdjustments', window );">Deemed distribution from warrant price adjustments | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from of warrants exercise | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 623,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-Based Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of stock issued for option exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock options issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=LFMD_MayTwoThousandAndTwentyNotesMember', window );">May 2020 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Conversion of outstanding | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,119,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible promissory note | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible notes | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">447,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_NumberOfSharesIssuedForExerciseOfWarrants', window );">Number of shares issued for exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">379,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_NumberOfSharesIssuedForExerciseOfWarrantsValue', window );">Number of shares issued for exercise of warrants, value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 622,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits', window );">Shares issued after stok split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">304,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Cash consideration | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants Purchase | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of stock issued for option exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">535,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Number of stock issued for option exercise, value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_CashlessExerciseOfOptionsShares', window );">Cashless exercise of options shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">534,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_CashlessExerciseOfWarrantsShares', window );">Cashless exercise of warrants, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,472,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_IssuedWarrantsInConjunctionWithStock', window );">Issued warrants in conjunction with stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,902,631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares for services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Shares for services, value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,000<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_StockIssuedDuringPeriodSharesIssuedForShareLiability', window );">Shares issued for share liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,722,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_SharesIssuedForLiability', window );">Shares issued for liability | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,181,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares issued for compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=LFMD_BrioWarrantsMember', window );">Brio Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_DeemedDistributionFromWarrantPriceAdjustments', window );">Deemed distribution from warrant price adjustments | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 226,906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility [Member] | August 2020 Warrant Inducement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148.49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member] | August 2020 Warrant Inducement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Fair value term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Cash consideration | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Aggregate purchase price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,892,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Conversion of outstanding | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">607,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsAndOtherAdjustments', window );">Deemed dividend | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_WarrantPurchaseAgreementMember', window );">Warrant Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Fair value term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_WarrantPurchasePrice', window );">Warrant purchase price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,743,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants Purchase | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,467,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization stock-based compensation | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">790,649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_UnamortizedCosts', window );">Unamortized costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,953,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_WarrantPurchaseAgreementMember', window );">Warrant Purchase Agreement [Member] | Measurement Input, Expected Dividend Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_WarrantPurchaseAgreementMember', window );">Warrant Purchase Agreement [Member] | Measurement Input, Price Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_WarrantPurchaseAgreementMember', window );">Warrant Purchase Agreement [Member] | Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_ConsultingAgreementMember', window );">Consulting Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Fair value term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_ConsultingAgreementMember', window );">Consulting Agreement [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_ConsultingAgreementMember', window );">Consulting Agreement [Member] | Measurement Input, Expected Dividend Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_ConsultingAgreementMember', window );">Consulting Agreement [Member] | Measurement Input, Price Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_ConsultingAgreementMember', window );">Consulting Agreement [Member] | Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Fair value measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_PrivatePlacementOfferingMember', window );">Private Placement Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,044,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Cash consideration | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,460,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Aggregate purchase price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_PrivatePlacementOfferingMember', window );">Private Placement Offering [Member] | BTIG, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Warrants expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov.  03,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_PurchaseAgreementMember', window );">Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">323,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Cash consideration | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,540,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Aggregate purchase price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_GrossProceedsFromOffering', window );">Gross proceeds from the offering | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_PurchaseAgreementMember', window );">Purchase Agreement [Member] | Chief Executive Officer And Chief Technology Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Cash consideration | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_PurchasedRemainingInterestPercentage', window );">Purchased remaining interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 417,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_PurchaseAgreementMember', window );">Purchase Agreement [Member] | BTIG, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Warrants expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 19,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_MembershipInterestPurchaseAgreementMember', window );">Membership Interest Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_MembershipInterestPercentage', window );">Membership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.8333%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_AggregateExpenses', window );">Aggregate expenses | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,060,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_MembershipInterestPurchaseAgreementMember', window );">Membership Interest Purchase Agreement [Member] | Mr. Schreiber [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_MembershipInterestPurchaseAgreementMember', window );">Membership Interest Purchase Agreement [Member] | Mr. Galluppi [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_MembershipInterestPurchaseAgreementMember', window );">Membership Interest Purchase Agreement [Member] | First Mile Stone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_MembershipInterestPurchaseAgreementMember', window );">Membership Interest Purchase Agreement [Member] | First Mile Stone [Member] | Mr. Schreiber [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_MembershipInterestPurchaseAgreementMember', window );">Membership Interest Purchase Agreement [Member] | First Mile Stone [Member] | Mr. Galluppi [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_MembershipInterestPurchaseAgreementMember', window );">Membership Interest Purchase Agreement [Member] | Second Mile Stone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_MembershipInterestPurchaseAgreementMember', window );">Membership Interest Purchase Agreement [Member] | Second Mile Stone [Member] | Mr. Schreiber [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_MembershipInterestPurchaseAgreementMember', window );">Membership Interest Purchase Agreement [Member] | Second Mile Stone [Member] | Mr. Galluppi [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_ServicesAgreementMember', window );">Services Agreement [Member] | Service-Based Stock Options [Member] | Mr.Sean Fitzpatrick [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Options to purchase shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Options granted fully vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_RemainingPerformanceOptions', window );">Remaining performance options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of shares cancelled during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased', window );">Purchase of common stock exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_AmendedCAOEmploymentAgreementMember', window );">Amended CAO Employment Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Options to purchase shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_AmendedCAOEmploymentAgreementMember', window );">Amended CAO Employment Agreement [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of restricted stock units granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_OptionsVestingDate', window );">Options vesting date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec.  08,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_TwoThousandTwentyPlanMember', window );">2020 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation', window );">Compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">341,729<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_UnamortizedExpense', window );">Unamortized expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,942,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_NoteRepaymentAndWarrantAmendmentAgreementMember', window );">Note Repayment and Warrant Amendment Agreement [Member] | Alpha Capital Anstalt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_CashlessExerciseOfWarrantsShares', window );">Cashless exercise of warrants, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_DeemedDistributionFromWarrantPriceAdjustments', window );">Deemed distribution from warrant price adjustments | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 915,479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_NoteRepaymentAndWarrantAmendmentAgreementMember', window );">Note Repayment and Warrant Amendment Agreement [Member] | Alpha Capital Anstalt [Member] | 2018 Alpha Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible promissory note | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_NoteRepaymentAndWarrantAmendmentAgreementMember', window );">Note Repayment and Warrant Amendment Agreement [Member] | Brio Master Fund [Member] | Brio 2019 Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible promissory note | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 162,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_CashlessExerciseOfWarrantsShares', window );">Cashless exercise of warrants, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_TwoThousandAndNineteenAlphaAmendmentMember', window );">2019 Alpha Amendment [Member] | Alpha Capital Anstalt [Member] | 2019 Alpha Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">267,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible promissory note | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 520,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_SecondAlphaWarrantAmendmentMember', window );">Second Alpha Warrant Amendment [Member] | August 2019 Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">391,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_AmendedConsultingAgreementMember', window );">Amended Consulting Agreement [Member] | Blue Horizon Consulting, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares issued for compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_AmendedConsultingAgreementMember', window );">Amended Consulting Agreement [Member] | Blue Horizon Consulting, LLC [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Alpha Capital Anstalt [Member] | 2018 Alpha Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">811,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Note Repayment and Warrant Amendment Agreement [Member] | Brio Master Fund [Member] | Brio 2019 Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,562<span></span>
</td>
<td class="nump">114,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | 2019 Alpha Amendment [Member] | Alpha Capital Anstalt [Member] | 2019 Alpha Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">365,217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Second Alpha Warrant Amendment [Member] | August 2019 Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">331,401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | 2018 Brio Warrant Amendment [Member] | Brio Master Fund [Member] | 2018 Brio Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock options issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | 2020 Plan [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized to issue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Alpha Capital Anstalt [Member] | 2018 Alpha Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">391,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Services Agreement [Member] | Service-Based Stock Options [Member] | Mr.Sean Fitzpatrick [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Options to purchase shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Amended CAO Employment Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Options granted fully vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Aggregate value of stock option | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,497,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_OptionsVestingDate', window );">Options vesting date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec.  08,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Amended CAO Employment Agreement [Member] | December 8, 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Options granted fully vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Note Repayment and Warrant Amendment Agreement [Member] | Brio Master Fund [Member] | Brio 2019 Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">340,278<span></span>
</td>
<td class="nump">236,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | 2019 Alpha Amendment [Member] | Alpha Capital Anstalt [Member] | 2019 Alpha Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">757,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Second Alpha Warrant Amendment [Member] | August 2019 Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,088,889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | 2018 Brio Warrant Amendment [Member] | Brio Master Fund [Member] | 2018 Brio Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, at par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Preferred stock dividend rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_PreferredStockRedemptionFeatureValue', window );">Redemption feature, value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_PutLiabilityIncrease', window );">Liability increased | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,655,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=LFMD_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, at par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Preferred stock dividend rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_NumberOfStockIssuedPreSplit', window );">Number of stock issued, pre split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=LFMD_SeriesBConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock Member | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issue price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_SharesIssuedPricePerSharePreSplit', window );">Share issue price per share pre-split | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=LFMD_ClassAWarrantMember', window );">Class A Warrant [Member] | Warrant Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Preferred stock dividend rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_WarrantPurchasePrice', window );">Warrant purchase price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_AggregateExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_AggregateExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_CashlessExerciseOfOptionsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cashless exercise of options shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_CashlessExerciseOfOptionsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_CashlessExerciseOfWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cashless exercise of warrants, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_CashlessExerciseOfWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_DeemedDistributionFromWarrantPriceAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deemed distribution from warrant price adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_DeemedDistributionFromWarrantPriceAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_GrossProceedsFromOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross proceeds from the offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_GrossProceedsFromOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_IssuedWarrantsInConjunctionWithDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issued warrants in conjunction with debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_IssuedWarrantsInConjunctionWithDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_IssuedWarrantsInConjunctionWithStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issued warrants in conjunction with stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_IssuedWarrantsInConjunctionWithStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_MembershipInterestPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Membership interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_MembershipInterestPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_NumberOfSharesIssuedForExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_NumberOfSharesIssuedForExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_NumberOfSharesIssuedForExerciseOfWarrantsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for exercise of warrants, value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_NumberOfSharesIssuedForExerciseOfWarrantsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_NumberOfStockIssuedPreSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of stock issued, pre split.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_NumberOfStockIssuedPreSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_OptionsVestingDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Options vesting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_OptionsVestingDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_PreferredStockRedemptionFeatureValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redemption feature, value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_PreferredStockRedemptionFeatureValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_PurchasedRemainingInterestPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchased remaining interest percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_PurchasedRemainingInterestPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_PutLiabilityIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability increased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_PutLiabilityIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_RemainingPerformanceOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining performance options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_RemainingPerformanceOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_SharesIssuedForLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shares issued for liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_SharesIssuedForLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_SharesIssuedPricePerSharePreSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share issue price per share pre-split.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_SharesIssuedPricePerSharePreSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_StockIssuedDuringPeriodSharesIssuedForShareLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shares issued for share liability, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_StockIssuedDuringPeriodSharesIssuedForShareLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_UnamortizedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unamortized costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_UnamortizedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_UnamortizedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unamortized expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_UnamortizedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_UndesignatedPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Undesignated preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_UndesignatedPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_WarrantDiscountPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant discount price per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_WarrantDiscountPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_WarrantPurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant purchase price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_WarrantPurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for employee benefit and equity-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeBenefitsAndShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsAndOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsAndOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share weighted-average price paid for shares purchased on open market for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares purchased for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reduction in the number of shares during the period as a result of a reverse stock split.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=LFMD_CVLBPRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=LFMD_CVLBPRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=LFMD_BoardOfDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=LFMD_BoardOfDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=LFMD_EmployeesAnddvisoryBoardMembersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=LFMD_EmployeesAnddvisoryBoardMembersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=LFMD_ChiefComplianceOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=LFMD_ChiefComplianceOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=LFMD_NewChiefOperatingOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=LFMD_NewChiefOperatingOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=LFMD_OptionsAndWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=LFMD_OptionsAndWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=LFMD_ServiceBasedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=LFMD_ServiceBasedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=LFMD_AugustTwoThousandAndTwentyWarrantInducementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=LFMD_AugustTwoThousandAndTwentyWarrantInducementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=LFMD_MayTwoThousandAndTwentyNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=LFMD_MayTwoThousandAndTwentyNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=LFMD_BrioWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=LFMD_BrioWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_WarrantPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_WarrantPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_ConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_ConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_PrivatePlacementOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_PrivatePlacementOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=LFMD_BTIGLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=LFMD_BTIGLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_PurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_PurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=LFMD_ChiefExecutiveOfficerAndChiefTechnologyOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=LFMD_ChiefExecutiveOfficerAndChiefTechnologyOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_MembershipInterestPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_MembershipInterestPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=LFMD_MrSchreiberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=LFMD_MrSchreiberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=LFMD_MrGalluppiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=LFMD_MrGalluppiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=LFMD_FirstMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=LFMD_FirstMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=LFMD_SecondMileSStoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=LFMD_SecondMileSStoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_ServicesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_ServicesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=LFMD_MrSeanFitzpatrickMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=LFMD_MrSeanFitzpatrickMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_AmendedCAOEmploymentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_AmendedCAOEmploymentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_TwoThousandTwentyPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_TwoThousandTwentyPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_NoteRepaymentAndWarrantAmendmentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_NoteRepaymentAndWarrantAmendmentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=LFMD_AlphaCapitalAnstaltMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=LFMD_AlphaCapitalAnstaltMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=LFMD_TwoThousandAndEighteenAlphaNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=LFMD_TwoThousandAndEighteenAlphaNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=LFMD_BrioMasterFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=LFMD_BrioMasterFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=LFMD_BrioTwoThousandAndNineteenWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=LFMD_BrioTwoThousandAndNineteenWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_TwoThousandAndNineteenAlphaAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_TwoThousandAndNineteenAlphaAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=LFMD_TwoThousandAndNineteenAlphaWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=LFMD_TwoThousandAndNineteenAlphaWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_SecondAlphaWarrantAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_SecondAlphaWarrantAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=LFMD_AugustTwoThousandAndNineteenWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=LFMD_AugustTwoThousandAndNineteenWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_AmendedConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_AmendedConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=LFMD_BlueHorizonConsultingLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=LFMD_BlueHorizonConsultingLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=LFMD_TwoThousandAndEighteenAlphaWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=LFMD_TwoThousandAndEighteenAlphaWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_TwoThousandAndEighteenBrioWarrantAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_TwoThousandAndEighteenBrioWarrantAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=LFMD_TwoThousandAndEighteenBrioWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=LFMD_TwoThousandAndEighteenBrioWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=LFMD_TwoThousandTwentyPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=LFMD_TwoThousandTwentyPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=LFMD_DecemberEightTwoThousandAndTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=LFMD_DecemberEightTwoThousandAndTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=LFMD_SeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=LFMD_SeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=LFMD_ClassAWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=LFMD_ClassAWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902987351624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Option Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 27, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=LFMD_ServiceBasedStockOptionsMember', window );">Service-Based Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,009,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Shares, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Shares, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,175,600)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Number of Shares, Cancelled/Forfeited/Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(305,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,228,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Exercisable, Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,361,083<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Exercisable, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,570,428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife', window );">Weighted Average Remaining Contractual Life, Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 2 months 19 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife', window );">Weighted Average Remaining Contractual Life, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 9 months 3 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife', window );">Weighted Average Remaining Contractual Life, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 11 months 19 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife', window );">Weighted Average Remaining Contractual Life, Cancelled/Forfeited/Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 6 months 7 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne', window );">Weighted Average Remaining Contractual Life, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 1 month 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning', window );">Weighted Average Remaining Contractual Life, Exercisable, Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 9 months 3 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life, Exercisable, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 6 months 25 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Cancelled/Forfeited/Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Exercisable, Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Exercisable, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-Based Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,365,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Shares, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Shares, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Number of Shares, Cancelled/Forfeited/Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(200,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,165,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Exercisable, Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">635,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Exercisable, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">635,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice', window );">Exercise Price per Share, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice', window );">Exercise Price per Share, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice', window );">Exercise Price per Share, Cancelled/Forfeited/Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife', window );">Weighted Average Remaining Contractual Life, Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 4 months 2 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife', window );">Weighted Average Remaining Contractual Life, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 2 months 30 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife', window );">Weighted Average Remaining Contractual Life, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">0 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife', window );">Weighted Average Remaining Contractual Life, Cancelled/Forfeited/Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 22 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne', window );">Weighted Average Remaining Contractual Life, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 11 months 19 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning', window );">Weighted Average Remaining Contractual Life, Exercisable, Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 7 months 17 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life, Exercisable, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 4 months 17 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Cancelled/Forfeited/Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Exercisable, Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Exercisable, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Service-Based Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice', window );">Exercise Price per Share, Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice', window );">Exercise Price per Share, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice', window );">Exercise Price per Share, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice', window );">Exercise Price per Share, Cancelled/Forfeited/Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice', window );">Exercise Price per Share, Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning', window );">Exercise Price per Share, Exercisable, Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice', window );">Exercise Price per Share, Exercisable, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Performance-Based Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice', window );">Exercise Price per Share, Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice', window );">Exercise Price per Share, Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning', window );">Exercise Price per Share, Exercisable, Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice', window );">Exercise Price per Share, Exercisable, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Shares, Granted</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Service-Based Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice', window );">Exercise Price per Share, Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice', window );">Exercise Price per Share, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice', window );">Exercise Price per Share, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice', window );">Exercise Price per Share, Cancelled/Forfeited/Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice', window );">Exercise Price per Share, Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning', window );">Exercise Price per Share, Exercisable, Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice', window );">Exercise Price per Share, Exercisable, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Performance-Based Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice', window );">Exercise Price per Share, Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice', window );">Exercise Price per Share, Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning', window );">Exercise Price per Share, Exercisable, Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice', window );">Exercise Price per Share, Exercisable, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=LFMD_TwoThousandTwentyPlanMember', window );">2020 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Shares, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">839,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Shares, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Number of Shares, Cancelled/Forfeited/Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">839,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Exercisable, Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Exercisable, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">839,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice', window );">Exercise Price per Share, Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning', window );">Exercise Price per Share, Exercisable, Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife', window );">Weighted Average Remaining Contractual Life, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne', window );">Weighted Average Remaining Contractual Life, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 9 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life, Exercisable, ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 9 months 7 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Exercisable, Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Exercisable, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.54<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=LFMD_TwoThousandTwentyPlanMember', window );">2020 Plan [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice', window );">Exercise Price per Share, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice', window );">Exercise Price per Share, Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice', window );">Exercise Price per Share, Exercisable, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=LFMD_TwoThousandTwentyPlanMember', window );">2020 Plan [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice', window );">Exercise Price per Share, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice', window );">Exercise Price per Share, Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice', window );">Exercise Price per Share, Exercisable, Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.24<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Life, Exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsExercisedWeightedAverageContractualLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Life, Cancelled/Forfeited/Expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsForfeitedAndExpirationsWeightedAverageContractualLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Life, Granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsGrantedWeightedAverageContractualLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Life, Ending.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsWeightedAverageContractualLifeOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise Price per Share, Beginning balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise Price per Share, Exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise Price per Share, Exercisable, Beginning.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceBeginning</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share, exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share, cancelled/forfeited/expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise Price per Share, Granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Life, Exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1Beginning</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=LFMD_ServiceBasedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=LFMD_ServiceBasedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=LFMD_TwoThousandTwentyPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=LFMD_TwoThousandTwentyPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902986496008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Warrant Outstanding and Exercisable (Details) - Warrant [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Number of Warrants, Beginning balance | shares</a></td>
<td class="nump">2,265,324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Number of Warrants, Granted | shares</a></td>
<td class="nump">4,209,596<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Number of Warrants, Exercised/Expired | shares</a></td>
<td class="num">(2,924,449)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Number of Warrants, Ending balance | shares</a></td>
<td class="nump">3,550,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable', window );">Number of Warrants, Exercisable, Beginning | shares</a></td>
<td class="nump">2,066,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable', window );">Number of Warrants, Exercisable, Ending | shares</a></td>
<td class="nump">2,144,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice', window );">Exercise Price per Share, Ending balance</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice', window );">Exercise Price per Share, Exercisable, Beginning</a></td>
<td class="nump">$ 0.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife', window );">Weighted Average Remaining Contractual Life, Beginning</a></td>
<td class="text">5 years 9 months 7 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife', window );">Weighted Average Remaining Contractual Life, Granted</a></td>
<td class="text">5 years 6 months 21 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisedAndExpiredWeightedAverageContractualLife', window );">Weighted Average Remaining Contractual Life, Exercised/Expired</a></td>
<td class="text">9 months 25 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne', window );">Weighted Average Remaining Contractual Life, Ending</a></td>
<td class="text">5 years 7 months 2 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Life, Exercisable, Beginning</a></td>
<td class="text">6 years 2 months 27 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life, Exercisable, Ending</a></td>
<td class="text">7 years 7 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Beginning balance</a></td>
<td class="nump">$ 1.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Granted</a></td>
<td class="nump">3.87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Exercised/Expired</a></td>
<td class="nump">0.96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Ending balance</a></td>
<td class="nump">4.56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Exercisable, Beginning</a></td>
<td class="nump">1.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price per Share, Exercisable, Ending</a></td>
<td class="nump">4.29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice', window );">Exercise Price per Share, Beginning balance</a></td>
<td class="nump">1.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice', window );">Exercise Price per Share, Granted</a></td>
<td class="nump">0.65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice', window );">Exercise Price per Share, Exercised/Expired</a></td>
<td class="nump">0.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice', window );">Exercise Price per Share, Ending balance</a></td>
<td class="nump">1.40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice', window );">Exercise Price per Share, Exercisable, Beginning</a></td>
<td class="nump">1.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice', window );">Exercise Price per Share, Exercisable, Ending</a></td>
<td class="nump">1.40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice', window );">Exercise Price per Share, Beginning balance</a></td>
<td class="nump">2.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice', window );">Exercise Price per Share, Granted</a></td>
<td class="nump">5.75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice', window );">Exercise Price per Share, Exercised/Expired</a></td>
<td class="nump">0.70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice', window );">Exercise Price per Share, Ending balance</a></td>
<td class="nump">5.75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice', window );">Exercise Price per Share, Exercisable, Beginning</a></td>
<td class="nump">2.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice', window );">Exercise Price per Share, Exercisable, Ending</a></td>
<td class="nump">$ 5.75<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisedAndExpiredWeightedAverageContractualLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Life, Exercised/Expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsExercisedAndExpiredWeightedAverageContractualLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Life, Granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsGrantedWeightedAverageContractualLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Life, Beginning.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Life, Ending.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsNonOptionsWeightedAverageContractualLifeOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Warrants, Exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise Price per Share, Exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise Price per Share, Outstanding balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise Price per Share, Exercised/Expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedandExpiredInPeriodExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise Price per Share, Granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Life, Exercisable, Beginning.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902986470872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Feb. 28, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_LeaseAgreementOneMember', window );">Lease Agreement One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Monthly payment for first twelve months</a></td>
<td class="nump">$ 2,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Monthly payment for second twelve months</a></td>
<td class="nump">2,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Monthly payment for third twelve months</a></td>
<td class="nump">$ 2,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">Feb. 28,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security deposit for lease</a></td>
<td class="nump">$ 2,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_LeaseAgreementTwoMember', window );">Lease Agreement Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Monthly payment for first twelve months</a></td>
<td class="nump">8,473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Monthly payment for second twelve months</a></td>
<td class="nump">8,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Monthly payment for third twelve months</a></td>
<td class="nump">$ 8,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">Sep. 30,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security deposit for lease</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Rent expenses</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Rent expenses</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_LeaseAgreementOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_LeaseAgreementOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_LeaseAgreementTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_LeaseAgreementTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902991182728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Leases (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of Use Asset</a></td>
<td class="nump">$ 274,437<span></span>
</td>
<td class="nump">$ 23,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="nump">$ 285,323<span></span>
</td>
<td class="nump">$ 29,978<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902994446232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,338,349<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Purchase commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_SubscriptionAgreementMember', window );">Subscription Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="nump">43,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrants issued for common stock</a></td>
<td class="nump">21,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_EmploymentAndConsultingAgreementsMember', window );">Employment and Consulting Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ExpiringAgreementDescription', window );">Expiring agreement description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company has entered into various agreements with officers, directors, employees and consultants that expire in terms of one to five years.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=LFMD_OneEightyDayAnniversaryAgreementMember', window );">180 Day Anniversary Agreement [Member] | Subscription Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_PerformanceFee', window );">Performance fee</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=LFMD_PilarisLaboratoriesLLCMember', window );">Pilaris Laboratories, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Agreement term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsPercentageAssumedToNet', window );">Percentage of net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=LFMD_PilarisLaboratoriesLLCMember', window );">Pilaris Laboratories, LLC [Member] | CVLB PR [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntercompanyAgreementsDescription', window );">Agreements of performance fees, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">As consideration for granting Conversion Labs PR this license, Pilaris will receive on quarterly basis, 10% of the net income collected by the licensed products based on the following formula: Net Income = total income - cost of goods sold - advertising and operating expenses directly related to the marketing of the licensed products.  In addition, Conversion Labs PR shall pay Pilaris a performance fee of $50,000 on the 180-day anniversary of the agreement and an additional $50,000 performance fee on the 365-day anniversary of the agreement.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=LFMD_PilarisLaboratoriesLLCMember', window );">Pilaris Laboratories, LLC [Member] | CVLB PR [Member] | 180 Day Anniversary Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_PerformanceFee', window );">Performance fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=LFMD_PilarisLaboratoriesLLCMember', window );">Pilaris Laboratories, LLC [Member] | CVLB PR [Member] | 365 Day Anniversary Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_PerformanceFee', window );">Performance fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_LicenseFee', window );">License fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=LFMD_MALPHABETLLCMember', window );">M.Alphabet, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntercompanyAgreementsDescription', window );">Agreements of performance fees, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company shall pay Alphabet a royalty equal to 13% of Gross Receipts (as defined in the Agreement) realized from the sales of Licensed Products.  Further, so long as the Agreement is not previously terminated, the Company, also agreed to pay Alphabet $50,000 on the 120-day anniversary of the Agreement and an additional $50,000 on the 360-day anniversary of the Agreement.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_PercentageForRoyalty', window );">Percentage for royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Option term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock options issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Option to purchase common stock exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=LFMD_MALPHABETLLCMember', window );">M.Alphabet, LLC [Member] | Common Stock One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock options issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Option to purchase common stock exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=LFMD_MALPHABETLLCMember', window );">M.Alphabet, LLC [Member] | Common Stock Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock options issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Option to purchase common stock exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=LFMD_MALPHABETLLCMember', window );">M.Alphabet, LLC [Member] | Common Stock Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of stock options issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Option to purchase common stock exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=LFMD_MALPHABETLLCMember', window );">M.Alphabet, LLC [Member] | 120 Day Anniversary Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_PerformanceFee', window );">Performance fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=LFMD_MALPHABETLLCMember', window );">M.Alphabet, LLC [Member] | 360 Day Anniversary Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_PerformanceFee', window );">Performance fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ExpiringAgreementDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiring agreement description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ExpiringAgreementDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_LicenseFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_LicenseFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_PercentageForRoyalty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage for royalty.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_PercentageForRoyalty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_PerformanceFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Performance fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_PerformanceFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntercompanyAgreementsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of product support, consulting, business, or other advisory service agreements entered into between the managing member or general partner and the LLC or LP, affiliate of the managing member or general partner, or affiliate of the LLC or LP. Includes a description of the key provisions of such agreements and the amount of compensation for such services during the accounting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntercompanyAgreementsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsPercentageAssumedToNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of assumed premium earned to premium earned after effects of reinsurance, as disclosed in supplementary reinsurance information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column F))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsPercentageAssumedToNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_SubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_SubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_EmploymentAndConsultingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_EmploymentAndConsultingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=LFMD_OneEightyDayAnniversaryAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=LFMD_OneEightyDayAnniversaryAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=LFMD_PilarisLaboratoriesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=LFMD_PilarisLaboratoriesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LFMD_CVLBPRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LFMD_CVLBPRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=LFMD_ThreeSiXFiveDayAnniversaryAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=LFMD_ThreeSiXFiveDayAnniversaryAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=LFMD_MALPHABETLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=LFMD_MALPHABETLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=LFMD_CommonStockOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=LFMD_CommonStockOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=LFMD_CommonStockTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=LFMD_CommonStockTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=LFMD_CommonStockThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=LFMD_CommonStockThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=LFMD_OneTwentyDayAnniversaryAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=LFMD_OneTwentyDayAnniversaryAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=LFMD_ThreeSixtyDayAnniversaryAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=LFMD_ThreeSixtyDayAnniversaryAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902987613256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 27, 2020</div></th>
<th class="th"><div>Sep. 22, 2020</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Jul. 23, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 242,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt settlement of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(914,862)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=LFMD_ConsultingAgreementMember', window );">Consulting Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=LFMD_PromissoryNoteMember', window );">Promissory Note [Member] | Director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=LFMD_PromissoryNoteMember', window );">Promissory Note [Member] | Director [Member] | Exchange Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrants to purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt settlement of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">914,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=LFMD_PuertoRicoOfficeSpaceMember', window );">Puerto Rico Office Space [Member] | JLS Ventures, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payment for rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
<td class="nump">52,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=LFMD_PresidentAndCEOMember', window );">President and CEO [Member] | Office Space [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payment for rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=LFMD_PresidentAndCEOMember', window );">President and CEO [Member] | Office Space [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payment for rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer [Member] | BV Global Fulfillment [Member] | Accounts Payable and Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Due to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,943<span></span>
</td>
<td class="nump">$ 53,026<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer [Member] | Minimum [Member] | BV Global Fulfillment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_MonthlyFees', window );">Monthly fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer [Member] | Maximum [Member] | BV Global Fulfillment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_MonthlyFees', window );">Monthly fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefOperatingOfficerMember', window );">Chief Operating Officer [Member] | Consulting Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_MonthlyFees', window );">Monthly fees</a></td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_MonthlyFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Monthly fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_MonthlyFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_ConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_ConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=LFMD_PromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=LFMD_PromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_ExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_ExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=LFMD_PuertoRicoOfficeSpaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=LFMD_PuertoRicoOfficeSpaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=LFMD_JLSVenturesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=LFMD_JLSVenturesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=LFMD_PresidentAndCEOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=LFMD_PresidentAndCEOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=LFMD_OfficeSpaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=LFMD_OfficeSpaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=LFMD_BVGlobalFulfillmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=LFMD_BVGlobalFulfillmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefOperatingOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefOperatingOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902991213800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 10,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse', window );">Operating loss carryforwards expiration, description</a></td>
<td class="text">The net operating loss carryforwards will begin to expire in the year 2021 if not utilized prior to that date, expiring during various year through 2038.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Valuation allowance increased</a></td>
<td class="nump">$ 1,269,000<span></span>
</td>
<td class="nump">$ 148,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory income rate</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLimitationsOnUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902995624504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Income Tax Provision Charges (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current: U.S. federal</a></td>
<td class="nump">$ 152,100<span></span>
</td>
<td class="num">$ (152,100)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">Current: State and local</a></td>
<td class="nump">40,400<span></span>
</td>
<td class="num">(40,400)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">192,500<span></span>
</td>
<td class="num">(192,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred: U.S. federal</a></td>
<td class="num">(70,000)<span></span>
</td>
<td class="nump">70,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">Deferred: State and local</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit', window );">Total</a></td>
<td class="num">(70,000)<span></span>
</td>
<td class="nump">70,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 122,500<span></span>
</td>
<td class="num">$ (122,500)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state, local, and federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state, local, and federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902995649304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Provision Differs from the Amount of Income Tax (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_ExpectedTaxExpenseBenefit', window );">Computed "expected" tax expense (benefit)</a></td>
<td class="num">$ (12,684,000)<span></span>
</td>
<td class="num">$ (783,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Permanent differences</a></td>
<td class="nump">7,765,000<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes', window );">Apportionment of Puerto Rico income</a></td>
<td class="nump">3,607,000<span></span>
</td>
<td class="nump">380,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Nondeductible expenses</a></td>
<td class="nump">140,000<span></span>
</td>
<td class="nump">173,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">1,269,000<span></span>
</td>
<td class="nump">148,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(25,500)<span></span>
</td>
<td class="num">(47,500)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">$ 122,500<span></span>
</td>
<td class="num">$ (122,500)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_ExpectedTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Computed "expected" tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_ExpectedTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902992414920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Net Deferred Tax Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Deferred tax Liability,Other</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 70,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">70,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">716,000<span></span>
</td>
<td class="nump">716,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_DeferredTaxAssetsTemporaryDifferences', window );">Temporary differences</a></td>
<td class="nump">113,000<span></span>
</td>
<td class="nump">44,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">2,151,000<span></span>
</td>
<td class="nump">951,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total</a></td>
<td class="nump">2,980,000<span></span>
</td>
<td class="nump">1,711,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less valuation allowance</a></td>
<td class="num">(2,980,000)<span></span>
</td>
<td class="num">(1,711,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 70,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_DeferredTaxAssetsTemporaryDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax rate temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_DeferredTaxAssetsTemporaryDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139902884840552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 18, 2021</div></th>
<th class="th"><div>Feb. 11, 2021</div></th>
<th class="th"><div>Feb. 04, 2021</div></th>
<th class="th"><div>Feb. 04, 2021</div></th>
<th class="th"><div>Feb. 03, 2021</div></th>
<th class="th"><div>Jan. 22, 2021</div></th>
<th class="th"><div>Jan. 11, 2021</div></th>
<th class="th"><div>Jan. 05, 2021</div></th>
<th class="th"><div>Nov. 27, 2020</div></th>
<th class="th"><div>Nov. 24, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Feb. 22, 2021</div></th>
<th class="th"><div>Jan. 21, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Number of shares issued for exchange of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">447,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,181,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of stock issued, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 329,176<span></span>
</td>
<td class="nump">$ 329,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,338,349<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Cashless exercise of stock options, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 302,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Cashless exercise of stock options, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 660,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | CVLB PR [Member] | LegalSimpli Software, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Membership interests purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription', window );">Membership interests, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The CVLB PR MIPA provides that the transaction may be completed in three (3) tranches with a purchase price of $100,000 per tranche to be made at the sole discretion of CVLB PR. Payment for the first tranche of $100,000 was made upon execution of the CVLB PR MIPA. Payments for the second and third tranches are due on the 60-day anniversary and the 120-day anniversary of the Effective Date.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | CVLB PR [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Promissory note balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Number of shares issued for exchange of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Paycheck Protection Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDecreaseForgiveness', window );">Loan Forgiveness</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Share-based Payment Arrangement, Tranche One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_LFMD_OptionsVestingDate', window );">Options vesting date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan. 11,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Employment Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="nump">3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Chief Digital Officer [Member] | Employment Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Chief Medical Officer [Member] | Employment Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Founding Members MIPAs [Member] | CVLB PR [Member] | LegalSimpli Software, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Membership interests purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity investment percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.58%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Chief Business Officer [Member] | Employment Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Chief Financial Officer [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Restricted stock units, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Restricted stock units, vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Chief Financial Officer [Member] | Share-based Payment Arrangement, Tranche One [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Restricted stock units, vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Chief Financial Officer [Member] | Vesting On Effective Date [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Restricted stock units, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Chief Financial Officer [Member] | Share-based Payment Arrangement, Tranche Two [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Restricted stock units, vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Chief Financial Officer [Member] | Share-based Payment Arrangement, Tranche Three [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Restricted stock units, vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Investors [Member] | February 2021 Purchase Agreement[Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">608,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of stock issued, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_LFMD_OptionsVestingDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Options vesting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">LFMD_OptionsVestingDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>LFMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDecreaseForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDecreaseForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=LFMD_ConversionLabsPRLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=LFMD_ConversionLabsPRLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=LFMD_LegalSimpliSoftwareLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=LFMD_LegalSimpliSoftwareLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=LFMD_CVLBPRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=LFMD_CVLBPRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=LFMD_PaycheckProtectionProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=LFMD_PaycheckProtectionProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_EmploymentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_EmploymentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=LFMD_ChiefDigitalOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=LFMD_ChiefDigitalOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=LFMD_ChiefMedicalOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=LFMD_ChiefMedicalOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=LFMD_FoundingMembersMIPAsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=LFMD_FoundingMembersMIPAsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=LFMD_ChiefBusinessOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=LFMD_ChiefBusinessOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=LFMD_VestingOnEffectiveDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=LFMD_VestingOnEffectiveDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=LFMD_InvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=LFMD_InvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=LFMD_FebruaryTwoThousandTwentyOnePurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=LFMD_FebruaryTwoThousandTwentyOnePurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>67
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M+-2-A8F4XWDLKEV<1#Q:J#PRT0@)\TB_1JIW*G  R]Q>(C"-';"N70R&2;(
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M?Q8TDS)M!SZI9Y:S6[FE/DPMO5Y)$#NP9JAM*+U<IV)X4!H>/,NP7CNEHDG
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M!!Q5M;=G[8.2V^8":B&5DIOFYUJD4/YH _A_):5Z>M =]'>8%_\"4$L#!!0
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MJEO>D!]?@9I:$FD,10O&HO4R:5\R:?^U3+[13)516T+",SJ$A%Z0T E(HOS
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M*VH#_OU3GE=O;^H?L[G\8M/=_P%02P,$%     @ X85^4HY!+\P0"@  6#
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MU$KY=J ;R=N1YMP^GI_$$2>,<GPZ?MPTC4>2<I(2GJX%M[3C:^UXT @7T_^
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MD*(N*6<XR:*DW\OR"/81;6MJ:9?MZ.)N]0W\?+0]M64_%F8_._5T:8HUI&=
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M,Z$JA^=+!UXC5W1QK<6P,AH+ [_:QS$:J[V+LYD[0W<0 !"X=B2L$@>8+>V
M.&RWI$Z+1MM(I/LQ?ASQ4PEU36XPX W]R@/OM<*WLA^(.1EL13/*7]X.[];%
M\1:T 14!>93J1M\-K35HT@Z'W52E&7#V-+1UV*<6QLI!1NL3511_U?::V0#-
M6IX.04+GG$AR[()@B4^(/4%:R'5[:TJ17L+RQG+ C?KT8/9D^@+=?%ER&SQ6
MF2;##;DAH1ES?J67'!P!2FV>.JI>DJ4QHWE3:NG9051"MX>PY$%*%79HPP$,
M=U:#G9GIV3:9U.WTM)QDRJM$JFFTE0%YXQ2N.]K=MO@DVW[NST6SV>PG(_^
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M[JC<$81LB.;*W#2*Y@CO>W9:#(P1[&/Y)A0;B;'9 1%K=JF .#04Z+;ZSD9
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M@-^7#ADP?N$&W?]=>/4_4$L#!!0    ( .&%?E(QC?CKE"4   YK   8
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M-=8'01C3\<[EDB( ]MAU53LQ9L&BRO@H$DG6R"0'@]&V'3);=BAL8)]\X O
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M4GE^IN/M$V#G,8&LK1%/<8Z8E80V"NXF=(RHT*3;O%<\65<5%=HX7_5(2+M
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MV\L03[]L[B&!'W^8Q%'T&1Z>-LNG+P^KQWM8KM?WFS4!@]P!;1B66U3]I@W
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M'IA9DS\!E-.:G+@EB8A\- ==MYB9O>&N,@K/]2PT!?6!HXCO^)F2T;'5[YE
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MS7>,GP!,)+"H7"QA:#28CB],#^$NZFI#W^,MJKJN"OJ)94XH? &>+RMPGKW
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MV]@:<TG#[UEI)_J<G=..9*&EH><,(&7!U^#R76LCKM\2CG;4+X$DVDZ![2R
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M&+@!0> A62D=? >O):?%H<H>Z>)<5J!!#6:4(?3>8SGYM[V=H#YO'WACL9&
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MBSV"]!9%71<[^NLVB4'EX@/P_;H 49+_P 6.1?F9T/OIOP%02P,$%     @
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M=V]R:W-H965T<R]S:&5E=#$U+GAM;)U7VV[C-A!]UU<,7+>P 2>69#MVLDF
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MEV[D,#"/@%#^<TQ$;7 ;?6#T,TEMJF4B<@*?-&JM,0V>IDGJHDR!QZ1EQ$#
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M%J#W"Z7LYH$=M)]AQ_\ 4$L#!!0    ( .&%?E(]*46JY0L  "@C   9
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M%*O&Z9+6 $#$(V17"6#E/CD!S54GA[<;F6Q&# ]!#?UZK)[<,B 2"X"$8P#
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M1;*'3O:=Z+1;]4Q\FAXL/ZG:44&S.4+7A-K<E#Z0G?EU#0R'LG975BL%C!+
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M-<8:=QS"R/"0=7[&@;-55ZQ<49!9@)0-EZAQN/I'/(]XA@G(;#('75L _BJ
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M\!W$_2I!+Y7!]ERBCTDRB;-E47&PAM#W7J8*=#11^/;!OL,ZS_:KO3I<] B
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MOYNC_P""I-_O1'.^VM*?&PN.28T/P/>K"IQ^^0=NX'_1]9?_!E!+ P04
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M X[A:$2"DO$8CGL/RC(!WXG*01%$+DG.6YJG9Z/^<!3#1P\IW.I<TKSV\\E
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M]"4 MD,,?Q&I ; =!_W:\2Q*L>6'KJ'HXS=<XC8"'X@=T!"Q<!!8&(CM6H]
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M7#V!?BN\YR4_;H ))]&@Q**1&%N)B6<DBS'^(B]%_L2P9!4GT&N&9<L,<N^
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M%!'@_5I*4V](03,XS_\%4$L#!!0    ( .&%?E+HYOCS,@4  , 6   9
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MLN?VT!HV- WE$]O?01Z0K?D\%HKL/]KG:ZT>\E(A692#E0=1$!\^Z<\\$14
M'C4 2 X@+P J,_6 80X8=K4PR@&CK@ [!]A= 4X.<+H"QCE@W!7@Y@"W*V"2
M R9= =@Z5L[J#"F*W;G:^%AN_++>S9!CP7%6\<%A+V8;^89*.KW@;(^X7J_X
M]$76#1E>[=\@UHV[E%P]#11.3A^I3#D@MD'2!_25;VD<_$T//16OT2P5"B $
M>G<#D@:A0(^4<ZJ;[3TZ0]^6-^C=+^\O!E*YH@D'7FYV=C!+&LS>PJJ/,/Z
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MCF.7(V)PUZ0/>/@S**Q8DMF^-GU!K"]*IBF!G[BOTVY<QP27ODIPTD;[M,T
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MY% (P@K$83.S[MS;A6L23,1O GO1:2,M9<W8L^Y\3V>6HQD!A41J"*S^=K
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M7<R:7TP^%G5=3)N7$Q:/62D&\.^?"CZ%]HWX$>;JE]F'_P=02P,$%     @
MX85^4@1#Y\SS&0  3[(  !D   !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL
MS5U;;]PXLG[>\RL$8P_.#)#8(G4?) ':=JZ;Q(X]3K)[<![D;MK6IKO5(ZES
M6>R//]2%S5*+9%&R@]D\S#BQ5"I6D5\5B_S()]_RXDMYQUCE?%\MU^73@[NJ
MVOQV=%3.[]@J+0_S#5OSW]SDQ2JM^%^+VZ-R4[!TT;RT6AY1UPV/5FFV/GCV
MI/FW\^+9DWQ;+;,U.R^<<KM:I<6/8[;,OST]( ?B'RZRV[NJ_H>C9T\VZ2V[
M9-75YKS@?SO:25ED*[8NLWSM%.SFZ<&,_#8[I7'S2O/,QXQ]*\'/3MV8ZSS_
M4O_E]>+I@5OKQ)9L7M5"4OZ_K^R$+9>U+*[)'YW8@]U7ZQ?AST+ZBZ;YO#G7
M:<E.\N6G;%'=/3V(#YP%NTFWR^HB__:*=4T*:GGS?%DV_W6^=<^Z!\Y\6U;Y
MJGN9:[#*UNW_T^^=*< +5/<"[5Z@MB]XW0O>W@M>I'G![U[P][^@>R'H7@AL
MOQ!V+X2V7XBZ%R+;+\3="[&ME9+NA<3V"\05GG-MOT%VSK;V-A'N)@-_Q[I7
MA,/)OL?U7Q$N)]8^)\+I9.!U[5>$V\F^W_5&%HXG \]KOR)<3_9]KW]%.)_L
M>[_^C7H4"N_3?>]KVT*%]^F^][6*T=U@W_>^_A7A?6H]WJGP/AUX/]2](KQ/
M][U?MU+]BO ^M?8^%=ZGUN.>"N_3P<CW=:\([]-][^LA57C?:[Q_U,)]$RM.
MTRI]]J3(OSE%_3R75__0!)SF?1XBLG4='2^K@O\VX^]5SRZK?/[E+E\N6%'^
MC_/\CVU6_7!^.655FBU+YWU:%&D=O'Y]<E3QK]7O',T[R<>M9*J1_()='SK4
M?^10EY+R+BU8J1!R8A9RRN:'CILT0ERMD%,;(7$KY.KRU/GEK[_^U3ER6GE:
MJ<_-4M_G7WG[HIY4K:P7-K+\L1J^M)'JVFGXRD(62<9J^-I"JALB[GUC(\0;
MJ]K?S%+/YA4W'D%4>VLAA&#M>V<A!!T#[VV$1(B0,[.02[;A-DGL.M2Y6=9L
M>WOH>)U]+=SUP4(<'3W&+VRD1M9*7IK%O4M_[".&%*H0]SLN#G7IE0U*!V/M
M]M$L]4VZELAC(>X3(FZ[%'V%)!;B/B->W12BS22Q;_/?<6]XEF#[#TQ4L1L;
MI).ED#*;6<0],<3LVSE# CL0.\9\,R34MSV1MHTV#HL9$N^;WM?%>V7F<<23
MI%VF1'>9$FVD^AJI)_EJQ2?S99TP/>J4<])M=9<7V;_80NF?5F+82*SK%%^?
M$;?[\^3H:\_F-H_V]/9V>GLC]-ZDA?,U76Z9\V_';.1.; PT<@]=LJ\W\E1/
M97^GLF]4^;Q@-ZPHV&*<M?V!"0.3 8.=-L$X;=)JC!E;X5'?0*[.1.%.J="H
MU-5ZP<KL=IU67*]-7T.E&N' .'Z2A('..-%.C\BHQP7[RF<.K/VP4VZ66:7*
M<,Q"R..;O'@<. 4FK*=BO%,Q-DJ_;#M/5I9;;J'TIF)%_06#MO' 5J%'U79*
M=DHDYE&8EG?./%^7&9]II4U9D/<<I:=:00'XND<3$H7[(P]]KJ<H<>6,T$4
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M-"#QTAL6@D@4!K&G2<=\B97^.*Q$.\5+7X&9AA*L+S'3-V/F>_;-:;UPMFE
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M(@H #X*8ZG:D  HMQ6ZYW._LF$V&.W:\T*@+ &6$$;OKW7##QWY/;_NOL5,
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M$\#,PO0HVN#6@1@>04>^^I)]!&P<F9Y &UTJP'NS#U<$]!R9'DH[7BK ^W>
M#A0>X13N=.F@Z]-XQ('0(^OG/"RNRD]<*8^ ]"/3YT%L+R5$0\I'(PF\'YUU
MAX[W[A!+$(9H$F' 9\+$]Z B4)!HPC-HA%,U9JC^"#KJ/9XRX1$T,I5Q*_&[
M^]<8=-"I:,KC9K-S38W)]W[H[_;'('CQ9+=RC58Q;LY^'<2@B/%DUW6151"/
M9BV*N\0Q:%X\W3U=K1;&PWH_@A&4,#[/_5R4%W&;#O,!%#*>^BQ9^QS:\.
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MW2P%@.XAA1X*0/_<0SX'\=5!'S7TT1GT"D3>%:H;&Z(=4"$=*GJ-BIZ3R59
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MA@I/<JE*9C!4.ZIK!2QSH%+0P/?O:,EXY26QVUNI))9[(W@%*T7TOBR9>GD
M(9N9-_2.&X]\5QB[09.X9CM8@]G4*X41[5DR7D*EN:R(@GSFS8?WB\CFNX1?
M'!I]LB;6R5;*)QM\SV:>;P6!@-18!H:O RQ "$N$,OYUG%Y?T@)/UT?VK\X[
M>MDR#0LI?O/,%#-OXI$,<K87YE$VWZ#S,[)\J13:/4G3YD:8G.ZUD64'1@4E
MK]HW>^[Z< (81A< 00<(/@H(.T#HC+;*G*TE,RR)E6R(LMG(9A>N-PZ-;GAE
MO^+:*#SEB#/)#\ >:/*%K'$^LKT (G/2;=XLP3 N]"T>;]9+<O/I-J8&BUHH
M3;L"#VV!X$*!):0#$@X_D\ /_#/PQ8?AP^E;.$6KO=^@]QLXOO"ZWS_SK38*
M9^CO%<ZPYPP=9W2!TXV^[=M& YEK#>9<FUJ.D>.P_]8A"<91%(YC>CAMQYFT
M\"X8]5EO%$:]PNBJ0N>:",ZV7'#S<DY>]'_=R2@,PG?RSJ1-I^/).WGT9"#M
M9?"3J1VO-!&0(\X?C)% M3]8&QA9NQG=2H,3[Y8%WDF@; *>YU*:8V#'OK_E
MDE=02P,$%     @ X85^4B3V?BF+!P  FB   !D   !X;"]W;W)K<VAE971S
M+W-H965T,S8N>&ULK5IM;]LV$/XKA+$!+>#&$B4[3I $<!)G*Y!V0;.7#\,^
MT!)M"Y5$C:3C>MB/WQTEBXXM4ZJS?F@MB??<"X_/W4F]6@OY52TYU^1;EN;J
MNK?4NK@<#%2TY!E39Z+@.3R9"YDQ#9=R,5"%Y"PV0EDZH)XW&F0LR7LW5^;>
MD[RY$BN=)CE_DD2MLHS)S2U/Q?JZY_>V-[XDBZ7&&X.;JX(M^#/7OQ5/$JX&
M-4J<9#Q7B<B)Y//KWL2_? A#%# K?D_X6NW\)NC*3(BO>/$QONYY:!%/>:01
M@L$_+_R.IRDB@1U_5Z"]6B<*[O[>HC\8Y\&9&5/\3J1_)+%>7O?&/1+S.5NE
M^HM8_\PKAX:(%XE4F;_)NEKK]4BT4EIDE3!8D"5Y^2_[5@5B1P!PF@5H)4#W
M!(YJ""J!8%]#>$0@K 3"KAJ&E<"PJ\"H$AB9V)?!,I&^9YK=7$FQ)A)7 QK^
M,-MEI"' 28Z9]:PE/$U 3M_<B2Q+-*2*5H3E,;D3N4[R!<^CA"OR[IYKEJ2*
M?&92,LR!]^0#^>WYGKS[X?W50(,!"#.(*F6WI3)Z1)E//@'\4I%I'O.X0?ZN
M19XZ  ;@>>T^W;I_2YV(DT*>D<#K$^KYYTT&N<7O>03B/HI3KT'\OK.X?]$@
M/NTN/FX0?^@N/G+$,JA3*3!XX1&\)RDBSF-%YE)D)%%JQ?*($S$G$209L @D
M<_2U*<@E[M#@(A6^W- @& <AQ.1E-YI._<C!EZI@$;_N <DJ+E]X[X8X' MK
MQT*W8RL9+8&]C!_586ERHT09[;CACSS\L^?&X;K@];)75@YK*X=.*Y]7,Q7)
MI#"$/5E(SM%0\N<GGLVX_,L1AU&M8>34\'F%2+BA9B?-%C<>X]O1@8=A$)Z/
MFQT\K]6?.]7_@1R$/%7J)5!6VS+K]OS $.J?!Q?-AHQK0\9.0R91)%9H2,$V
M;)9R0YPLBB1:Q;]!T5>\,4'&!WF^GQJN%:]LO:AMO7#:.LV*5&Q,)E3TKJ#F
M L-_7XKXGJTGGEOAMR*1B,]J_)C7B=G(^6[ 7Y<<S,X*EF\(G$("B%Q"H)-<
M"_+"9")6RBI34#_U$G)TGD1<JCZ)$PE-C,"?W,2"\[+2164H3$;I)=.X<[ 6
M< DHR!3FN<@Y 2US*'QDPYE49ZX8[=1<W^F2/_;(/=N029X#LE30TC5L!_F7
MG'ZF?6J-H6YVX](TJ,C5<\X;JSH]2,OA<<+R;<'P6RI&DL+^*?+(9@+:"R&A
MY^B3Q\>[3AY:^O;=_&T#AQO;5"A; 'ROW'V7-9:F?3=/0[PCL 7:=LRP'(:'
M) <::PK\0PN4[YUYWH\NJRRU^VYN;]\*2,>[WQ]OR=.73KMC6=UWT_K$'EV(
M1_$Z&_$ .]GCH0U=F8.>Q!S[5SA%6#466$>0HX .\?SA?7!<H6]Z"5%(@3R
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M/5P!"T":!_#^0N [9G9B/J+D'_Y&_P%02P,$%     @ X85^4J8N,POG @
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MCUDF24)AP9'(TA3S/U,@;#>Q7.NX\)*L8ZD7;'^\P6M8@GS;++B:V05+F*1
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M 3J053.O)EH493]<"8W=M1RF^ $$TAC@\T0(_3(Q+;;YI K_ 5!+ P04
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M_W=2'6_7^N?M[\O'9N^YW'%V\)=E]0M02P,$%     @ X85^4B/5;@VH 0
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MD?5E_Q%/CD'ZZO-1.^V,LE]ZA^O]T';5S<.Q;KG^CK_.^*1_80X!DD."Y$A
M<MR Y)B Y+@%R7$'DN,>) <?HP1!(2I'02I'82I'@2I'H2I'P2I'X2I' 2M'
M(:M (:M (:M (:M (:M (:M (:M (:M (:M (:M (:M$(:M$(:M$(:M$(:M$
M(:M$(:M$(:M$(:M$(:M$(6N"0M8$A:S)?Y+U7>O57_]+:->X5F5S]&?=#YOY
M)U!+ 0(4 Q0    ( .&%?E('04UB@0   +$    0              "  0
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ X85^4@PZSPCO    *P(
M !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ X85^4IE<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    " #AA7Y2!.?;Q2L$  "Y#P  &
M        @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ X85^4E186M\K!P  01P  !@              ("!;PP  'AL+W=O<FMS
M:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( .&%?E*0C['J8@,  .P-   8
M              " @= 3  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"
M% ,4    " #AA7Y2?5;3A\4&  #/'   &               @(%H%P  >&PO
M=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ X85^4O.X)=K*"@
MO4D  !@              ("!8QX  'AL+W=O<FMS:&5E=',O<VAE970U+GAM
M;%!+ 0(4 Q0    ( .&%?E*.02_,$ H  %@P   8              " @6,I
M  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " #AA7Y2S2]7
M;( 2  #',   &               @(&I,P  >&PO=V]R:W-H965T<R]S:&5E
M=#<N>&UL4$L! A0#%     @ X85^4C&-^.N4)0  #FL  !@
M ("!7T8  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( .&%
M?E)3<YTF+0,  /P&   8              " @2EL  !X;"]W;W)K<VAE971S
M+W-H965T.2YX;6Q02P$"% ,4    " #AA7Y2MH0AK/,-  "L*0  &0
M        @(&,;P  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0
M   ( .&%?E*ET,))W24  "V)   9              " @;9]  !X;"]W;W)K
M<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ X85^4M1Q9[J7!0  #PT
M !D              ("!RJ,  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q0
M2P$"% ,4    " #AA7Y2$K-O?IH)  #%&   &0              @(&8J0
M>&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( .&%?E*I37Z"
M6 4   L,   9              " @6FS  !X;"]W;W)K<VAE971S+W-H965T
M,30N>&UL4$L! A0#%     @ X85^4H8;&X?&!0  D@T  !D
M ("!^+@  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " #A
MA7Y2/2E%JN4+   H(P  &0              @('UO@  >&PO=V]R:W-H965T
M<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( .&%?E+A,(\ O28  -UU   9
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M970R,2YX;6Q02P$"% ,4    " #AA7Y2<]R^]ID$  !$"P  &0
M    @($W @$ >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    (
M .&%?E+HYOCS,@4  , 6   9              " @0<' 0!X;"]W;W)K<VAE
M971S+W-H965T,C,N>&UL4$L! A0#%     @ X85^4MJB8UW1!@  Q!P  !D
M             ("!< P! 'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"
M% ,4    " #AA7Y2V[&Y<)D$  "-%0  &0              @(%X$P$ >&PO
M=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( .&%?E(WT*L^D0(
M (T&   9              " @4@8 0!X;"]W;W)K<VAE971S+W-H965T,C8N
M>&UL4$L! A0#%     @ X85^4G'K$;L% P  :PD  !D              ("!
M$!L! 'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " #AA7Y2
M!_PJZE,"  "@!0  &0              @(%,'@$ >&PO=V]R:W-H965T<R]S
M:&5E=#(X+GAM;%!+ 0(4 Q0    ( .&%?E+$KAU[Z@(  )D(   9
M      " @=8@ 0!X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%
M  @ X85^4BTCDQQZ"@  I3T  !D              ("!]R,! 'AL+W=O<FMS
M:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    " #AA7Y2!$/GS/,9  !/L@
M&0              @(&H+@$ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+
M 0(4 Q0    ( .&%?E)_H\$.H@@  (]"   9              " @=)( 0!X
M;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ X85^4HL'79G9
M!   SQ@  !D              ("!JU$! 'AL+W=O<FMS:&5E=',O<VAE970S
M,RYX;6Q02P$"% ,4    " #AA7Y2'AI4Y8,#  !\#0  &0
M@(&[5@$ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( .&%
M?E( ?QV\%@(  /$$   9              " @75: 0!X;"]W;W)K<VAE971S
M+W-H965T,S4N>&UL4$L! A0#%     @ X85^4B3V?BF+!P  FB   !D
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M=#0P+GAM;%!+ 0(4 Q0    ( .&%?E*6C[35]@(  %X)   9
M  " @6)S 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @
MX85^4N*:IQUU"   'BP  !D              ("!CW8! 'AL+W=O<FMS:&5E
M=',O<VAE970T,BYX;6Q02P$"% ,4    " #AA7Y22GF$_B(#   0$@  #0
M            @ $[?P$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( .&%?E*7
MBKL<P    !,"   +              "  8B" 0!?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( .&%?E*^:!6UM ,  %4<   /              "  7&# 0!X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    " #AA7Y2OLLS09D!  !U&0  &@
M        @ %2AP$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    " #AA7Y2(]5N#:@!  "X&0  $P              @ $CB0$ 6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     ,@ R )4-  #\B@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>314</ContextCount>
  <ElementCount>466</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>143</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/StatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Changes in Stockholders' Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/StatementsOfChangesInStockholdersDeficit</Role>
      <ShortName>Consolidated Statements of Changes in Stockholders' Deficit</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - Nature of the Organization and Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/NatureOfOrganizationAndBusiness</Role>
      <ShortName>Nature of the Organization and Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Notes Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://lifemd.com/role/NotesPayable</Role>
      <ShortName>Notes Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://lifemd.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://lifemd.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://lifemd.com/role/IntangibleAssets</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://lifemd.com/role/StockholdersEquity</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://lifemd.com/role/Leases</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://lifemd.com/role/IncomeTaxes</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Nature of the Organization and Business (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/NatureOfOrganizationAndBusinessDetailsNarrative</Role>
      <ShortName>Nature of the Organization and Business (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://lifemd.com/role/NatureOfOrganizationAndBusiness</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Summary of Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://lifemd.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfDisaggregatedRevenueDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Summary of Significant Accounting Policies - Summary of Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-SummaryOfInventoryDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfPotentiallyDilutiveSecuritiesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Intangible Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/IntangibleAssetsDetailsNarrative</Role>
      <ShortName>Intangible Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://lifemd.com/role/IntangibleAssetsTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets - Schedule of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Notes Payable - (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://lifemd.com/role/NotesPayable-DetailsNarrative</Role>
      <ShortName>Notes Payable - (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://lifemd.com/role/NotesPayable</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Stockholders' Equity (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/StockholdersEquityDetailsNarrative</Role>
      <ShortName>Stockholders' Equity (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://lifemd.com/role/StockholdersEquityTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Stockholders' Equity - Schedule of Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/StockholdersEquity-ScheduleOfOptionActivityDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Stockholders' Equity - Schedule of Warrant Outstanding and Exercisable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/StockholdersEquity-ScheduleOfWarrantOutstandingAndExercisableDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Warrant Outstanding and Exercisable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Leases (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/LeasesDetailsNarrative</Role>
      <ShortName>Leases (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://lifemd.com/role/LeasesTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Leases - Schedule of Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/Leases-ScheduleOfLeasesDetails</Role>
      <ShortName>Leases - Schedule of Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Commitments and Contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>Commitments and Contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://lifemd.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Related Party Transactions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>Related Party Transactions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://lifemd.com/role/RelatedPartyTransactions</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Income Taxes - (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/IncomeTaxes-DetailsNarrative</Role>
      <ShortName>Income Taxes - (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://lifemd.com/role/IncomeTaxesTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Income Taxes - Schedule of Income Tax Provision Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/IncomeTaxes-ScheduleOfIncomeTaxProvisionChargesDetails</Role>
      <ShortName>Income Taxes - Schedule of Income Tax Provision Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Income Taxes - Schedule of Provision Differs from the Amount of Income Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/IncomeTaxes-ScheduleOfProvisionDiffersFromAmountOfIncomeTaxDetails</Role>
      <ShortName>Income Taxes - Schedule of Provision Differs from the Amount of Income Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Income Taxes - Schedule of Net Deferred Tax Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/IncomeTaxes-ScheduleOfNetDeferredTaxLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Schedule of Net Deferred Tax Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="lfmd-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Subsequent Events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifemd.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent Events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://lifemd.com/role/SubsequentEvents</ParentRole>
      <Position>42</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>lfmd-20201231.xml</File>
    <File>lfmd-20201231.xsd</File>
    <File>lfmd-20201231_cal.xml</File>
    <File>lfmd-20201231_def.xml</File>
    <File>lfmd-20201231_lab.xml</File>
    <File>lfmd-20201231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>72
<FILENAME>0001493152-21-007194-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-21-007194-xbrl.zip
M4$L#!!0    ( .&%?E([?#^'9UD! !ZK#@ 1    ;&9M9"TR,#(P,3(S,2YX
M;6SLO6ESX\BQ+OS]1KS_ ;?M<=@1+37VI>=,WZ"VL>[1PI#4/6?N%P=$%$5X
M0(#&(HGSZ]^JPD( !,#"1BR"P\>'+8*HS*PGL[*J<OFO__.^-JA78#NZ9?[R
MB3FE/U' 7%B:;K[\\NG[X\GL\?SZ^A/U?[[]?_^+@O_YK_]]<D)=Z<#0OE(7
MUN+DVEQ:/U-WZAI\I7X%)K!5U[)_IGZHAH?^8EWI!K"I<VN],8 +X!?^2%\I
MX512J9,3@M?^ *9FV=\?KJ/7KEQW\_7+E[>WMU/3>E7?+/L/YW1AK<G>]VAY
M]@)$+[NYNKV@?F(O*)9F:8;E&(JA_YNZ^IVZN+H[?5]"9BY4%SX'OV;@8S0'
M_X>CGQCE*R]^Y;G_1SBHJ[J>$PU*O]/!?_R?_]?[LVWH7]'_4G!"3.?KNZ/_
M\BG&Z!MW:MDO7UB:9K[\S^W-XV(%UNJ);CJN:B[ I_!7AF[^D?4[1E&4+_C;
M\-&])]'@X1C<%_3UL^KLWHP(+'A^CQ+XK>9&/X@_+'SQOTP\JF<^*OJ/ZN&C
M&D@]YX#%Z8OU^@5^\05-X G-G'!,^+@-EKDDBU_@M^&#NF/Q+",5\><_$?[
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MPS=+VEW'+B#\E(U=P$!K.]JE%+"CS)@)V%E2F8#=.;#C^] #8'8F,UTLEH\
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MD?_\M(+H>M3_YTI_!1?J=F::\(/MJ/8VA;NAZGF(=-P.$VAS.)?;)ZAOCKK
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MGENFXQFN;KZD?;BA@HK$=R44P02MLA=T!)&38\JA[U/LX%2:M67@CB'DMX_
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MQX5JXYNY2;V.?Y"1E/VD7&-;O2;EFI2K7\K5PY4KN&V6<3J@LLL;6'BV[NK
MR8G=*.B8@VK%!W_9%:J_<5.]!N8V>(3R=\]41Q]);'=QR>\# FU&0TJUU2F>
MJ.;".2-[\;@ I@H'C8<&[<.@P_O\0 N.$M?1NJ9-ZC0L=1IXE$IN#MHY_G_
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MNAF-R"_HES6![6LA(30^@L?'MMQINNCB)B;P@1>!(KSOBR"?Y'JZBB$X6YK
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M89PS^AS%.9]9<&-RO[S0;; 8?C_.0VMC-K==+Y!H;DIK%AU;5=NR8/0)2^]
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M T9RVYX#'"/T'";-F31GL)J37IZ46)(M\?(45[ACUSN9%&Y2N"$K7"\W.*A
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M@].(8WGMQ,3B9)R 6-14-'$VF)684WPA)](BGT[Z;F%"_"6W"8M<7&_YL)/
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MM5^3$/*3-0LA1X[M_NL6CKGVUKV>DX,\J.\)'FI/Q#5*%85>5J#?YYYM^Y[
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MEKV&Y7HP/;$W/V_Q*__ILP*EX"_3?V5.&0&AX?]G[TN;VT:R!/\*HL,5(45
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MV$ "S8QN<XCW3(JY^4\!^$8A^4N I"9\7MY$IO+B)@B#,_E!-O?ER^=(-PR
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MZ.,)>307W'I(P5XDE16H6U7\-<I#2;E 3YA3J#Z)?GNV).>')"0Q59(B&@U
M/"!&'_'+ PXHCEW, 'S1;JD;L>/S@HXP6QVX,";I"A%S(E8_C 8<>#X+AV>8
M:.G*#KCTD0A%<,B50AR&,+PITSW+V<%Y^,G'5%W$<=6^#VN@'RNW#Q: \(A/
M.7L0K_@M/:>,?3;U$CCC'&<:#E$SR%#\V$V AP/E(2CFD,E5[.(SG+F;/H^&
M=$Q@6_"WGSB*.:2AN#*D=*^OQ=PA&E1:@\FZA*YA]J@J0J#0$5I:7CB(E?^9
M/(88)#4^?6[]2W#11R2>//$,ATIYILTZ'07]Q4R7?33O.SPX[#Z5=X6IPJ('
M7]:[/7;67GMG[;6T@MC?!I?:'IDPT@J&R.9::BS5^&*5HUKE,%9HMKD?K3\D
MYW0:U3O$W:#>0$'Z/1:[;1&X^)OUYDIMZNJ=IMUL=#:PW[6=^=2.557W^"6G
M\%_VJ(/'@F?5;=F->F-E^%]S6Y"5[.;NW)J"QAFY_5G:(_R6[<FB8_4/-H\3
ML&7>8\*);5WB[408!9YKF%^4;1*!U5UGNXMC>!3O]W0@5QFHT@7"RQ=TITJJ
M!>JV4VOK$ 7?$<J2/DZ;L>F99D\_$X-MB6EPYD,<\*C;]49+/P?F7J0>(WCX
MT=]DN ]1 .:J)XL/,ZQRY,O)0LIP$APU4:ENQ6<;8,BJPM<7L!7'8>RIW2%$
ME.V)<;:<)T@@Y".@E'0OS6U:S^.!&$%FE*L[2669LB,A[5*\%2*/P@=3-=LC
MF>3>9%#]F($WC<>N^DDH+V6<N8U*JK/8[_!$\ 1>F0 8PQ0O9=P(#,:@P&!J
M>7V;7,)BELE>\D:DG,6Z=K/3F,-B7;O=;55@L:[= U>MC,7D8[_IV(O)8G0S
M?RO&B31H:XIOOH63C&.R2\:L2W(*W_.N@UNF5GN4Q4?G!CXG1I^%HY''M<D7
MP8#'5CX(<";%00SUZEAGUN75UZ^?[[Y^_'9W:UU\^P#__G;W^=OO'[]=?GY3
M052-'BI O0E?7!^HVR@:T<6I.P*I@)/M@C)5[,H$3XX&3D:$RXP;NJ9#YA8_
MU9V)SQV0;2N2>*<. H,GCZXNW7SQY+7GNQ%(#E@B!&ZFC!;;*I;AR*=R>5J4
MM*E4*,!2>,;I_*9^]=7]B=F#HW$8HD#CBCJ4W13F"_CN4D39G;RZD31AY2H0
M5?:AGOA^:UV#2,(Z"^%C]@[GB?&ZH+9$H")<%YRRX0VDT"+1^H!E=(CRDO [
M6R@*EPI/!(B\ID6)+F\WE7EG WFH9"<"!4L2.-2G$KZS)"/Y<<IL&*3]),Y7
MGF<A-HFT7ZG#)4_WM?Y+IAW(CYMW-IA"A3 \A!CUHS(GX\^L#@;DR]&%!%U5
M:)6A\ZP&H+3ZF#14R,X%VOXAZ%%U;US<!C4$4'?2980LFQ",W=QQ 34#%+A7
MBL,.A<REX$MPB12G6SL;8-D.6 KX5;1!)ZB%"#XPK\755R86X*\VVBW\JM24
MT[^<KR0IOTDL]G63:2BRS%:CBY8O*1WF.W^^@Y1S#'6MF$HCQ#=CV3N -HKA
M#Z-'&-WC4P2WUJ+#N!A'GH^P=4I3?IL-L(^Z4[*SM?E0VH\,C,-.HS?E51N?
MT_5Z+N64]B./.UT996+:Z$I<3AXV^91+"#$ISLWJ6]'\N >ARH_(4J[JI")^
M@L65M1I!VLN.>%;),!>JJN+3VN15\41VLKQUR8Q6LY^+9C8/\_<>W$ARF0D0
M-64)0BJCC#G'#>3_&W9.,BTYOX.B8K;I71.IU/]>)+.Z)GX]O_AR_8^+]Q_O
M)E6C>C_?=<BD>[ZAT\\1.^EV! I 3+FY_GX#__GX_ZQ[E>G(KQ(_Q%R7.!+)
M(TIU=<^&[@+-\AT((#\0XZ1=]*:TFQ()-U&&.P '_W&9>,&/)S4 ,(/:.*/$
MH@'\%=2M_ N7W$5N.@)NZV>_GLCF9O%O?0'89U?MJDV3^@6(=<HW7WE.G$BI
M#@GO,3LXYN8P!=N'![R"HS,.*27IQ#NE4AV\$2,EG%()+VH]L(]D[4M>SZF$
M<[TE0L.)AU\"W340,1 KT/(@<E%'Q[;2TO!3_U&,,$Z:/R$29" H]$5B+/.5
M(_Q?E]L&<@JNN:PNWL"DJC#BQ&=M,0!;I2@8,5O-)EU/49N_8Y8NILAZ]VFR
M"$U8\^E!*X02FL!?4U4QIE+):U4PS(ATJ9-.1"N%<4D5WA=E1\CMG\2GDZV\
M9%6LS<XL%JK:EC)F!%,TYNF%"?R>+17 "IRYC?>4803_ IE+_YNB61=BZQJ+
MFK;YOFJT(+%&2"H!2@7!L"28:K'"R!]D66+8%VIL*JK+1R\ Q/XC!/S\3XB8
M_:<[1FF(RUVDZ(/[GCL-'3E.>KM"WXQ\:.NQ(%2UPR,PJYS*!!MDC/]..9,W
MJKS[I*2EHQ(UZ-=(8TVGGTO-.YP@!K!T/Z41DCFRGN6'BCGB_$<MSIH$KA5/
M7IC&V,2.+M-1WN1T&!;OQ:'1KL;<Y82!4Y]JX&3*3#%KN3VL[=_Y7WK#Q/=]
M3.V_<S:CR!.?H:OT<:$IJ%2<"_!QD)1KXF2[UYPI7:M89S=9A%IHCZ:SU;%@
MTJ!1KX2$69!R5K'9 $'FR*K\8W)D,$,8=H#;R%M>Y!4_<)LFM7L*1&HYN)F-
MZ@K:WU@S5]U@ELY?T[702^_28*L53I5 JKYA98W IC\O<JKU"ALF4"H=;6ZG
MS?4>:^.\TZ*0$('C>S^$[SV&X8"M8*'RKV*1<^H?0A"@6=A\(L+"-3XC2F$/
M!K)>"8O8)EL_H,0V6F2IVT6SZ.KUR\1\V%2WUS%B]<=8;JG.^(ID-(,)GH#I
M5 FTJLJ05*JN@=#_$WC%E06 (JK0T)US*(9)43Y,%DS](3 K&1RR>BGGU&#)
M"?@2T<OT4L$)@?3HQ?0&>@@3P*'%ZU&G)/5AN2GP@-"W$%R0/L(R1L^(3_4U
M\;"EIIO7A"J[F**D:D'LBC=.<HV'<OU756&I"=U*C=^,I.:8-SAC"[%2;]Q2
MM9U1HS6"TU 1K'<-&=C;::.RO6"9/"@?J;15AVW!T<=>B4@2>W!=M$<V:/'J
M-W</].1&Z%=DL279,PDYE&_@D2DYHD_\J0J*52")D,[!72S3Y2MK<HY4B21&
M'U0S''FE<JLJF]Y UXT\T7X1#S0#!3._C]3)"2,)%>2!&89A+VJ3!E1S;Q:^
M9PD#>7G+!?1TC06J)/2?V"^71(TM'N";(T9VM2YF.4UKM%P>A(+L.HY\<C&\
M+DP'@D?KD.I[0KQ3Q"SVW.+\:)\J*<G )NL?'68A$_>50SVW8CS+DU<!PM(D
MBL5R(HH9%3>L_*_=*'FYR]J^'$0Z13=WI7GS\<O%W<</UO7%S=W_6G<W%]]N
M+R[OKKZ]W:2*RT=/#*V/')0 4KQB,7\41H":N;5TG/:W2#V=C,M/U,UQAW[L
M.['.LK@IC=E4[T-8&409.:@LAJSGR$LPV:'0KN4<^^?(^4:A]<\OM]8?\ _@
M>ZR;#;BY&KCXCZ$O$^C"YX!O"["6AS:(D%#>'6"S)"4E5U:8X3&_FUR);E/B
M (WB5EVWH9MRJ4Y0E5S!'MO]SB7U]W\00+_[X3VHF4^9=VA;^IA=[2!B_6 6
MVRS37TAU>)T)2O(QI&H]"V]2O-EO#;%5RR,V$T0_5=[-*G]171>5N:[%+K0O
ML9%+K9)#G(9F+:>M::G4$\:U(N&-J/?2#.PH:O0B:3"KED1Q'(+"1ER171T_
M>N.Q<EW+=IZEP\S/*"A&W4*LP7O_AU4"WKM6U^XU&Y*!8/_%[M>V,<^@<B:"
M45I9K>=[KNCR#>1*%P)A62\0\H"((CY(_^JH@XU>*XUIO5;*^_K46UEG4G>B
MY0KE="@W5O=.RW=EB:G[E^XT@0W=U,TTMVFC;!L&SN@FXL43G\+[FSX2N>\S
M!XF?_4<7[&^"KM>V>_6&V?1PT<@WLE_^5[GA5#+?*A=C5U<RBP?9WS7/V^:X
M'S<;G@*6P$>UL^S.DME<9ZP32/6ZF8Y?,L-G2H-/9;CH?:B]&9G^'4,H9EA/
M9)L76P[1R&J;Z4^10!$K55"ND5*.FGB*D.7C=0@\2RU$8I$DODYF?]=SFG:W
M79]EB[RIYI$S:_H*A6_SGO6DJ6(>8&&("[LS5SH-M=R=R570[0$>]D/@KN^P
MKECS9TU^.T;9M4)^:=*=RD?O9_';Z3EW94'>R:R[?W[X*EO%\AP' JV8?@</
M%9.$E%N#J?$\M<UP::ZNL@%!N !=;ZJ6%@;PVFP$01.G8S1TYUW>#MR7LR2D
M/(H^)JAP)79N* I+S<G-H]:2PQAT^KL7)2]G6>]L]C3Q0B<0S[I7OG'W7"SS
MTVT?J#TV96ZGE/>6G4MAS@&N #B1N?)&:\FL*(J18F>H4ZGP):9Y!T6OSC_1
M<^<$T#-URN(>(.IM@5I4)L";%[KW89 R<J@%N+ZM5FW%)H<?R#V5D)A4'&C4
M1MP6A0B-UX[E&#C&DJ]G1A'ZBN.D)*;*0G8+!-V*\3I.[;]S?QY"@*Z7"]!]
M_G9Y]?6C=7?Q_]Y4H=.L9MSSH]1TP^K&Q7"14SOOZ,O#K- .Z_G0@,%6>2_
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M%9NIF0W,Y<!L DMVK>.K>NYB/AJ' <U$<.?T93]>[!\O]M_BQ?ZN3NEX>W]
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MBQ;E[,?EX%Q!6&'GET:8(0"__W#O"%]_7]BZ[;1;ME,_C,;+ZZ!.DMA6.,8
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MF3 KNL7%,9>$R/4:?NJ_[$FO%GV![>$/,GSF"^JQDH.:KI(]?<V\1_U5MCN
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M3(#JT7M XV@@T-7#)Y_<2'7VHH<!(< 4^,]SZW-@#5.\KI"\#?N.<U:1 I&
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MGEM?,[=9#ZO.@O"VY0&Q!B\VQT+08S9JR0E@:25S,F,L'?,'O/]C-[TO:V.
MAN]Q_P^I[T:^COB34%890_IA>&Z8HK<C?3D;_>*Q+PE,!Q^(HP92VY%L5]H'
MAP*$Z-K!_[)+03M'"$7.AY^V'P: ]3PS!IIIL3KF4B=&!X.+JGLPN<P]_'(@
M[L'7<Y,D\NY3[FLOE2BJ-WUNN:-G1J% 2H@#Q:/P)SD?4L:\<QK488E >5?#
M8$8\YJ(+_Z4(?#Z*/:'P;!FK(8HEH)F"RN,CUC,8%24 -9J]#"">8UJ$ZA/2
M%9"O-!F4G8#D!]\$28/\<A^BSTW(F0F%H,/KHX6"WC+ISLAE3N*P%] !.+9
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M3*G7T>RI63PL!(!-L=@&JZ&2Y] ZJ9]:<3H> _Q1+,>*99-Q9$$4EHV4/5M
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M@A7#@NW^Y+*O\L>_+JX-^9I9;.&35#=))!\-@!EPP'BO=DI:@7,[:(ZQDA
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MTA8KUT15Y39QGRCJCOMNI[M0$3+(E.YQQ./U2J%,J:D,5E+_99ZHC>@Y<!3
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ME]ZZSNFG+U_UIV;>OY.4IF#5/O<IN 3E&<[F4<B=W'$2'Z$Z3.'!JJ=?3PZ
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MN\=C=[CR?,V-LV:;WSQ^$*_ZZT[^V $>[:S@C5U,#XS7GJ:R SS=MMR-NH_
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M(S,6NNZ@;O2^&0-X18608U]_.IZ4B/:ZR56@D!K'Q-)L5S6G@EQ)>-I' R%
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M2"&#LKI=RJ@<J_O4F"85@BXC.X^72<Z'X"(E_X$_BPY$F#>^SEKY>^T2-CR
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M2EU9.XFN&7L%A:J@92YABT/CSE'+E')8&O9-L8M K^75DO##!H#X$I/IDJ[
MRU6E"7%UBC$*F,S"?JQJ1>D-(C=2O#27H*ZE*HOEVWR:I"5I?:6=$]>O:C&)
M%CIG%%8ULP->V'M#?\3[5Y5^L!JDJ>V:#9N1,-$8^;J2G[8C8(O&-<VE\1!$
M*(:TPR$>;(@GWAQ,4\1.&PO\ZSZO7Y$DDF--++%JH;0\D3\%ML^DB<V9Y8Q+
M#M!/6>+*=3;'DB5"3AVAIHIA0S<H'^D^[1W5E7RA<A(:3E->Y)]-\0I[97@;
M!ZOOZ$-_GK_["3S+":BK*/O;3^V?_KO3&?:/A]V2QK4HV ;Y_R,/_Y]32CS1
M*_X@AWKIPL;#\3XLJG1\OWBA_S$^97E>88&P<[WC<6\?%ODUP$QEX"MP\N;5
M_<C"7^,P^MM/>5H$/SF_;)7$;RE!7=\N$:\GI>\+P76L)A;[<J _@T%&4$@P
MI_#DCZ)(-\I\0L#/'E7U\"O,7?CX^0/IG^[=AW,!?=75O1,$[DP//J?GG:(5
MOY\1N(N?#W_CZGI[B[3<7]WV!FW\OW)'EU#UB M8395:E!_M".D;4+$;I&:9
M0MTB&9O4@3*B&(=PT P.&<'Q44H2W@7\OQ]C1J0^X7%YCZ,_'I.6S6F6K5#Y
M !>OVQE"]%4>W'O1^R2+OH^>VN/E;D"W;87.AVB]K1"X27WXJ;S<.J%;,K^S
MB9!Y-.SUCTLA;7A+#9D6QY&R\[<1"KJ=<7]@V'/S^6N^NS,NWPW_OI>NIU=\
MU=57&\E*P K;QY45ZE>L3< F5OD-L<[ VG]+N'Z&+SDWL-AA>S0PO;/&%]V7
MFDVN_&SZ"<LK_QY$_H<D/?>BX%OR)4GS:1*%"?UI,](]L+W5-5Z_6<HWP3LQ
M]I]0,YY=1.$EY_T^,DZGOQ%^'0]Z9JAYQRL?3N$F^/*54]Y?>785OI'PO6\U
MNO>.8'?KQAA,_!K4'DIA[#M"'$*6^IFN#J#[5-T@8$]K.'6&[2'67M& X[^X
M,HL1:C,-K&,,,2XRQGJ;AM?!498'<ST9^===8WY.=Q>(*Y3-/;P8PQ-*/\^Q
M\EI^MFGKWDW;3>CG5[\2I.QOS@4U[V#96.3-L^!71_WK)TV/0\@C>:K>1 @6
M$R]2B\J3N?EA^;BO/BZOZQ_/?^B#@,2:A!]EX5\!<Y8^T^$;#_R3/A6YW_"2
M51_XD4<;W>J*>1P>L_ =],_TH0Q8E;;NHRU6YO_RQ7JIC7=DW;U-K_N='LXH
M<)D:3I:JA7=DV?U-+_LD0K#.?+=7/=CTJK_J095B)=9;Z"^D7$N=^R)L[(<E
MXPJD-XK!:.1V7,W8XB%MRH36J],TQI>OJR49Z MG=3<K(5T+P@4' CUY6_8!
M$36_42$$M^LT/H9GCK)?+J-E/6HK2O%:?TXP''B7#MRSZU^DCR8JG0W=*::G
M?FL0/2S!9,LA/&"*L):.JP3FWJTN4>5V6+=LM57X:#S^-PMG191[<9 4&7;]
M7X7S.?>6>E;;5<.,=8WU^1NN27K?>:L\@OS,PQRQY1*@"K%"YAZA">%8'Y..
M-/ F5U(GI1=DBH+>C"S$\BK='JJZ[>5M:>G (MO4,:3BERLUP]Y7X_(4'2@>
M(8X&D=))2Y@TZ3)DB"JV&!X00?\(^H#W2TJ4FRC HD7:@Q(GE/!69EBCP955
MPG5!&0Z"&7-#C00C,*5PID8<,?X6%FWPPC5_PDQ7*AFSD9*)!#M4-<E[HFIQ
MTC#[3J726&E#GS:E5]H0U*889Z3("A)6PG2*L3P2Q)L:!A5 :>7D$,WT,(\+
MKXW^QZ8S;A]J$]?:Q%3-X-U<&Z5$\L*LC"LA2DVJ]#$2%%,Z;?QQKDXV):<$
MO[)>K-N@,F/>2XG7JLJGJ(@HNM6B+D>17ZH^I,1$P6J#-&*1CARX3!<,EVLH
MU4UEAUYP3>>')*W+5#F7D2A:9C>4(&#)O11%,N8MBE[&HXFG&B:7U VBCV<N
MXU12>;"!RYH&%QH%2F:G^;B$<G+DU":X1/9E+8!J0EK1>?XI+Z4LI\/N.!!N
M1E#/I3@O\*FR5'UH,9"H7HA6!772@0(!C3$D$YB E@EK(D%'9'#D49"EL-W@
M)@Z5S\IV-UXBF31<.)4L6S38MDQHL&UD6:QJT$J;P!S3^U!J@3 F(\V053AM
M5$TNNB(02P%V+5U4'V]V(MD!GLY6[A817<J#6]\5UX1:RA MCQ&3<+-8=S;H
M&>8TCEH-_#HV:L67T5F'>3+'9@HUIGRQY%>\)7K953)+P., D^^JWFQ%M='^
M(9:M9#LRP> XF[.2ZVRG>*"J-AX\D:9"W%RE)XUEM)Q3M:OU4R:ZF@630@GE
M.S +F92R6MEW7O7<7K?CMMN,_/"JXW;'7?R1!H_/&;8"Q78=<"R:G?YR=:PA
MFZYN\$#1LP&4I-Y8PT<9>$>NPB&N&'(6"]NOY+Q85H1<@ER"FY9 IIDJ?]:8
MZ:C6(<Z,)^'<4V6UA,6N3''UM:$H&?UX?J& #QN&'Y[]2Y$QL(S@IL*G9DF&
M==MP7F[G/'-!4%)IH' LW9JHQ=,D#B=*E\RH'<8/.:6FON,:*P_$3Q)8UI8C
MP5)F>R)WG'9;*RO>Q]+2SW,[.OTCWX,%H&NI])5V]$ ;1!S'O.JTQ@-7ZL-5
MA-#$58+=\N@P5?EMM\G:(QS4$"$6'MR#$HI"_+ER)ZRO!C'>J$ID@JPF;5)5
MI&7+;$-,*.J$K+4=([($&1X7SX4VAQ-0U$ QA$"&ZD[V)B$BP1"4\:O D&\6
M_C)N(W,K^\'.M#Y8FJ&ZQ]U>K_%B;2I1;'%!$06EZ%13-&JH/]QK:O&[G40<
M9PG$A0P1,XR(282X5A"/8%AS@?8MIE8.M9"RI8#$!<6#-"WO+[4*Q!*I\L0[
MZ_'5/A'37V?'6=?N:_H:&,5\)/AYD5G<;%M(47V0\.9F$Q]%8GQ>G$[?P;.B
M%57YU)(W-U=)N2_:7JLGV"=%!&82IJ !L"43!0 [W4!0[85KO:F,HV:O6H^P
MM7+F,HGS-44*NEX..'>A\Q$WG;RY=\N=Y[G! .5NF%EKZB9S^3QA2XN< /DC
MXR*$V$7[0V"TE$>CN]WE%?J!Y;M:SA_&9LEX;GMUB@MJ2]AO1B$17W@)V@-[
MMYJA*;F<1-*"YE8BH];C6T] (6Q%8:AELQ69-EVG(;3C6&\T&W=&Z*\PB\B%
MZ;2;'!C>2O#_&7S?S*RS"WRDTA9U25GL)2*_R4^C<#<'ZW!1Y%6 @MM 92=2
ME?[TC;-2MRMXF\,*.FOR]ZI^/(;XRBZ7WK+AYA$QX-NUA]W2U>OV#X[>9A*S
M"_BD6J=,4#7["/@5Q0\[K#%0M- ?+CCO=\%YD>1P;A;>?MC+;+S44$^691WQ
M$X'$UD"N,U9Z"I .C(K_]E.GK]DBZU-/O(B\R7=^KD-($O;^3 @(:.5[6/P,
MS0G_%PKF^[I@1M8@\;MO=^[+B#4OJW9OQ[I;WC#4%EO;G6VQKO&)F^'7S\^.
M6=N2L\[XV;'N6<C9O51F$Y;4_SD]??_^PX>'W/[KY7^IY!$QJ_$V50"QB,3O
M?/GZZ]H\6G6SUQ4M<\<A5KY:7:R>ZG,'RI\7Y1L[Q08BW-(ZO4'WYY6U6CF=
M<$U=ICSTG]=6]I5OKD#DJWO2AL'#@AU=X:V=D=L]'KO#X]%3L6:;WSQ^$*_Z
MP_WCT<X*WMC%],!XL(<\W;;<C;J/P*-=<KL^QCC%:C=]J!7('[CM?N>)J-_>
M*H^>_0K[8[<[.'[VRWSX1CZ^L[?J6L+/7YU_RH#?O=4?W?[([0W:SU[PGK^.
M'/6.W?%P\.S7N:K3MA_NQ_G$2^%AE[=[JT'Z?;?76]5+W%^Q>_XNR*#C=GK/
M7T_N@PNR0CY[A95^#7ZLGW;:S'W#71<K&W_@@_)073"<8W<TZ#T)KUX@QWNK
MNBD'3C^0T\.VVQFOFU\]</N1;<LNWU=NQO9\2Q DNM(285Y@[K!96F%YZ^:M
M'U69MMW!8.AVA@?SM26.'Z^;%-\_3N_9&1B[X\[8';0/EFY;1V#5E.&3F[KE
M>=[="V%?:!''@?(]+IS91"*TTE-!OJ+5I8E#B5?3.5O>@U7",'?4Z[JC_JKV
M:4>E;865=I[_)6;7'?3&;J<[?OXK??C%X,&.[YU@'"C?,\JW8<<WDQ8Z5PWE
MM8S0'P@\]<@QQ3.(NP;4?OL4;'J!S'[L=.Z!T67ZIK_/V<OM;-DNB_+!S7M9
M+L>!\I?EYG7O<?OW5<\;7SUUL\+['ZI1NZTNJE0_*2ZB8+NW'=:K'W3G-W*[
MXYX[[CS4%[P?7[>[.QM]Y(,*A1[L>N\#N_?N,'2Z;G]X[ Y&JZ8>]WEW7M!A
M:+1W)2A].8#GSMDV"X;AX)0;A0KVSS"_4N!/.SP91X$#O OF21:R57WA4W'^
M8"@Z)RE2![;53U),+_VG0(A7G]DD4,N(->YIU#E&OD8<.$*I9WB%RR3Q"6^O
M 5N>43FS\JD(L(D>%R*NXS =AO'MM']& +)>[V>%\Y9S,92%O^?1M+Z6<V90
M'<:3J/ 1U'V2(L:F,PMF":&@,;Y\F"+P/CPJC*\3($CCR_^E0,2$,H>?[LS3
MX#ID$/VY%_HMIXXA1\2@$+LK \G9D'#'G:$[&@X$T7;0" =7(IR7O"-P-\3Y
M#^=1H%A U"CXO'*CIL#?&T=AS?/^J D$M&.+0:495/EV,0GX#^ G[#-^3.AP
M<0<0>H_W*G;H#G("G-5$(<Q\2-C9#@B;%ZDMX,T.?LP9)5O#>$XFP9S %.&;
M&4U<"'X0 IX-2J^H6[I7JVR5L4T9+W+)$A10\JM.:^C,$',3$?9P1WOMAAU=
M"DBX5)"N/5B[@N:5I6>UQ3,B-&T/0I_RIC#,*>B-8@KZND@1$E !D#;MO"TA
MQAXKE',%S7#EP<&:>"4BM .;&1A0>S5+LZ+AJ)J=C_$71CW\"FOV8!-.8O\=
M/#%*"&6=O_VTUN:.E(PR0S+#CK 5]<W]*<AUI@W ELW2'83OAKU:3J2IPI"L
MB69RYDP@N/="1,X$'8@F8.[=(L(P*1/&J#0GH_!O%:@[ E++]T!C^RQQB&VM
MX:L1XG*&P)I_\="3+)!'T"@XHH8 34'BT4D\P@,"UBF_2OP2ZK9$,RZR .PG
M'*-IH-2;>I=KC)7)K]*  1TKJ/IZQDD61%$C[422II\AK4$_Q!H"'-]9L.VH
MC.<@6]YR3H6C?GD 9<WXXED0:/AY^"X9'L;459LB(WI"QAI&8/[4)_5.:NN$
M@?KQ$>>@]7T/ 8)/$S^<"DRX\UHIJV[[MY/S4_U3Y[<WCCYG.+NO-V@?]=O.
M1^'"T9^P*G7FRH/F,F(_F)TXX^$,H0R4O!L]MFX\)L;Y?M7O';N=WI#M07MU
MJ6)N:E1?)6"\=UIJ3%G!-X@31/,)ZGN#6+\%IKR !#4\!8?>,+9LH\Y>2>O6
MAG3"TS#G3L_]AP>[#U&'FH[\'C8VO]T%=6UK946GHPAUB-(PR YQ@CT]DU%@
M,YJ->=R!/8+_#(BFRR(TCK$X/8*/KDXTZH%KQ>M0\3H07CNO<7@4G$?'..'_
M^/C>/.$JDM#?\9-RIE-63$%+A/ WHBB@Z=XT3P4G(P$I& 3(N"WP7'!,R#4_
M!6E."G V?9_"8$:FIKD^=&3YBPSY31,V.&)A]8F6 Q\"B[NY2I X?G%(\XZ5
M<TY)!(FX2#E>>>@%P<X ]R>D9#S'F"ANO%-Q"ES;!O:%,@1 #5=&.I@P_1%R
M !'5G57N19:D%PH/6MYL\)EQ^)4?CM.D>'$\#BFPOHCNH/XHO"OT$=7;FN22
MEFC@\#>(:6[ C.& '';+<2Q/,"EBFBX!JBNF6>UBF(%L'K<JD-8R>I6C.F>*
M_N>U%Q7:6))8V-XLPH9[L(0\0_;Q9!V:R4 ?53/BYBE8X)3=APNPLRA''D<_
MQ!NB9P8'A89RL8+[_\N[\MZV;2C^581B U(@ART[/HJB@)ND6S"W,9QV_3.@
M;=K1)DN9*"7V/OW>08J4CT1.E#3%"C1U+8E\?'PW7_0C9"?&X4)".8"@1&]]
MEPA' =*&$0J4?O'ZVDV$\( C:80LH@;GP+67$0XF@5X$#T;>HH8]]"RBF@7L
MNQ4>?USGN55\AVA'&AZ&1>&(^8/ M]J_<PS"]^KO-'I>$8-F$B1D$_!;JWMZ
M*F0R)RJ8Y2FP3.3RHQ1\I,9.(V&#E<1S#;[A0#LP#5LHM-04X;:T)F@11Y6F
M?:)ZG@4 DUX^'M]2('>,:'1,39RB4)%7AY3068+!RH"'F$Y\>AY/9&@*+J3#
M<32+<8.P.,'(;[FL@)@Q\-3C)7B22<*-L#HT%08YK8!9\#]^5SIB\:T&I-;3
M^<<'C;8N;%"D*.;\/O71$F[[!N%@K7M0;Q<CPASS2=E-A*]#[-#.M]!%E#(/
MCD *YK11MW&(6%=HZ'-;!.[I+U FSC!BQRJMH6S )0.11X90J;F&87%$CL!S
MR#^C#Z99.)[$BWOUMXXUL(I<4.(\URFAR/JVHL/1BNWBM7!%9,]_^Z#N;M!:
M1Q.TYFY07*^DTO84J9[*PG3+]N90-)B:[37>VA %F,;$P$C*W3QO;>->F^;]
M)"_1_Y$HX9L:%U:3C(<F.R$(*@2B\_H@U]S3N>_U^R>%;-?I]W1"8@R8!QEP
M)/:&P3C.D50-3 D!>Q+,U]85[=@@\5*8Y,_!VN%B"U^'BT<QU=N;!$II QU1
M:> MF:U7PNS20.C/P>R>"H379]8A1W\'=^/]@3]R[KG;L.'I0NZW&TM? H5[
M:R#QFH(::S;V/2WJY(4LOXDHNV-4V:02:8X_; &+,>ZYMR!VF$^"T#%1;,*$
M95G0GCS"NA.$;:JURWF: 8@V%JU*UY]6"U>G<I2^YO-KL1Q?2Z!ID$#$P@"G
M\'&6B/D/JU&%^L7[.9$K4F]I&KTH=5LUX?1> 22"[&'<"J"P)+S9'/@( D\1
M,8:XG.05"7U\O([_Y3>[A&EE(:COV=""51P,!D4CB%1B? \7]O'H  2<C^M
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M=SZ>)KUL$J1QTDM3/!5#;GX*Q:QT%C0%(N3[H_M'@SG?'RU&21B\PY_PW_\
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MO.CCN1?- !&K6HBVCBB-W?F;30"-W)U_7<->R_!:JUIUTCX4PL<"IHY+M"%
M.OF.G4LF=I9<"=56%4M+O&0T3$@\I!Z&^<!3B6]WHU0'TE;&U,QX 7Z#(Y,A
M8RJ"USO2#)=!;K"+[0YF@K8J$>@#XDYP2T9\5@8[I!/%2V3*:E:*M?ZR?>R[
M.JDN_P@15G"7N&F28NT"+PFEA"YKR_$9.JH49N#L>FV397"W9PC$<3_(D1?P
M_ V3Y<K#3@_&)6QKY,$Y1[;G(_>:+.I;Z+-WN^=&)"IMHZC5*,6.(8G7[?U/
M*'@]SV-JRLR#GELB\'DUV_/J>3/#\"WXU43.G G.9YBO3XKG;G,TM$0)^]C>
M"#P!)8.L$29$\F0#K]E)T]7QF;W'I[,G$M=<]]NK/:F+MN\N2C>B.^Y>=+];
MMYL?=LN[8[!L,_J,AJCIHNV&6'LAWG'[1^^[&O3\ Z\^&K8-[7>;$_#G%+^!
M76^SSLV+/=X:)@XG0@8BX>A!3(?+KV&VIB)YS)(J:6TTM#ABWV</%%JA3GRK
M<4R_4"+#H4[Z).,)^*V524"A"OXZ Q8LI=$EOVUJK&J 6LO=U>.&</EL;<FQ
MJNIC87.R"6@)F*N V7>P>;)-\W',%_,L*ILWO)D+\^4Q3WY6*-1TJJ@^?7_P
M0;;/[964=KP(1*<6NW/@^&2X'NR>JGBF@V+M06DXJWPCWFK"PYO&ZCRJUC&K
M#KNUDU*:]B%5CY.@D1F3AU41WY50K>4ON5JHR6 2CFI0T73C$J]H62D#-#R+
M3'PO7NB&% 2G[@!&@Z^PKJWSRA>@FG$O=_I;4/ZG/1:-UBCG94]&*[MI?:2H
MBD/8!2XPD1D@A4H) %LHU<0+'SDW[K;U@FYZMA.;EJ$#O?K]FW>TGYWYT/R
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MGC4*G<?'MG)Q52.3E9F $+2[Q.79'S<DF5$O-T<XTX/GD$3<AF$LN.S?SE0
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MPD%T[#I!EB9Q0>M9&D79.9,7DW7S?\@/ 8+.^%%39@)$L.0E:>_MN6S'F]&
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M<4J\\Y0_<L[FND^]?!7?847XUH'60%V!5ILC\#!@OYY*G#.3O:\BW]O +EV
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M" /WRF\=+>,2!%EF^F-U .S:3(& XXW0,(,W/%1WX9;R!*)=UUT"U=MQXEE
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MZD**0=G:K<!46;I?J7*<K"=FI/18 *$S'+!7T''NQRZOX2U[>JY4-[2R"V8
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MM)U?!(:]K/EHLX".TE<[KCD&F(>T!TWMI34KJPW6*:).VJJHHT_"Z]<K+4E
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MI4X_]=9]/6Q 'J"*VG5:#2/J$N+%ETR8_#S%_0N\9NSJPE#D:91TQ:\(BBR
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M2X5YII_A5V() O>SW?>-SLE#<A7&291F"0/"?:ZJ+>X=#N8.6V[M)J4J#_S
M/>SL:P)9BT#IP,--YK#!O)?MC5_+06YT[L<QC1:W-)%<E%4T'5LJ-"W5?:I
M-R1CR\6C#X_DUN4$ K1NNC^&)UAM;4.'1W)5$<*\&77FD=SZUUCG?D1<-I[H
M'FNSC:U-2_Z4;C6IX#YE-\*0!Z,<WFI"5/CD\%;3X:VFPUM-1O6@U;/8Q8L[
MR\)TE-YI EJ/3[K[](^ (PB#$\.)_Q4O#DG>!0#:6WMOT@ 0$J8@+(YK7^H:
M"I+/J[7$O$P9$97+VVIH[;4,]7(8501#,!A>E6[8:CP+%I>DLNXH;U)J@5B4
ME92"JFS749J2$2V=%K3K02H.@!BM.HR )IOMU)U5H2'N@%Q>= F6)Z '?KC$
ME(-V%*);B1LGX;5E%^>,8]5[B7(?_!C):(=0^BD*8Z-'3X</",E#86RP:C1Z
M_ VQ"*F&W<O[7(MS[<[J)S+ESGXGF-=0%_Q02DC'>9GUC4D@OJ9Q3.)!>/'"
MSXBI'\\XOX,)WUI@J*1=\4.FR(*">[B]8GE7(?N1C)P7$A^I%<C[NET@+Q^B
MEXW!_EE5%&_-6&/$W[LSXJ5Y*8[BM\S>?/*Y#_&,S9LI618 K&;K1,+6<OP>
MG93^U%M]HU=\9,5_RURO"#GW)Q,2949V?\YCYTH2$4G@XSL-":S9+C[7X].F
ME\Q(+__HEI@L">66).>$D1<1C_VI%#(H%,2QAB#8%WK+3V2<EC[2/-?\W7KR
M9\H6F(LGDKVJI#"#/[[?YF\]3"\?YU#9\E#94O_L@::RI3Y*F_-(7KT([(#[
MPEK")S9/9P6YL@ <01<[U] RD4L!0AX=91(CS-?(AG#$G(*R1;0L1J"RN:5:
M1/)Y(\0'8QG+0^7E9JYHT%;K/51>?CU8HMS)7DGEY:Q>ZKD_]1,GD!6,S>)5
MH/;=K, L9,?T"BJ"X(9XOJL!055[&U6#3&$ \@/:$(91N*0IXR&<YI^.;ZZ&
M?3BPD_> .[2>#VP&!PE#X#U6$]/A-(W]D/#K-\7Y4-FA]0!-@Q,"9@@"XL12
MP?%+/W1"UY<O7LORW-4=V&SO'%HJ',&N.\,3YRI\(C%K+%ZVMEJ-C[NY6%6R
M 8K:<L6"0_H.LD"T0_K.(7WGD+[3X?2=^6- \_=BU1)XH/:6/*PF,GA$+)E>
M=:$S$WF(4B=:C)[I:$;3V F]T3,C9#$(R?)9436 :HS4ON5B#KS:[,(6SJ&P
M?$.%Y8T&8Q\*RQ\*R_]TA>5UBY_CKGV.-F_C.SL0\SQ2X=ERHQ'2=;F*5$CD
M=A,L"A)E,1I;S>R< :O$62EPY#$R=62.<D6OAPOJF!>>4G'*;%?OC,X?F7SR
MZK+/3N1QN]B=$6;?2B-AU >Q]6A4]42I2#G18 .<;8:]Q 7M@_!B,B$N#T;F
M^8C"PYFHR_BX[4M'%0S4J 8/4\>6$S"EJL/.C?M/H]4@X^.J=<,VAG7Y %']
M@!Y5]CD#RV-I&&MI7H:0W>8$Q/:C76P/):EQ9+4>2E+CM=L/):G5F6OK'N7L
M^_7I\$X<75-J,K9D)^B4H-ZA%Y2E8<-ZZ"S8EN7^&$8T(=D% /MI&CFPXRNK
MF"WN-3ZV5&-.J^JW"@_@UKU7V-+AO4#5]P+WJ65P>"^PF4WU\%X@MO<"SVCX
M1"+.X;7S$ _O9(\&@NW'G_"];2<F%O2P6P@KI6%, ]_CI>@RIGP2PQ?-<&ND
MR[:09@@&H_6N:Z,@RNH1M6__DEHJ83$8"%.OS.&!<F,PA5FK^T6VE=W[\\?
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M#JS0@;$)EI/:ST8I-V[R+-J'Y3JO=VLE23?$8J[2;JA -HDW1#+>2:,!)HC
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MZ)T,,D1\..TS[>Q&RD]WLS#>MUO\&%,4:4DKV OL$8NYZGP5R(8#(AD05%
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ML"MNZ $W')%+@N"*%MZ8,Y>G%[>HUD ]%=]CT<W^(8G#BR0+Y$N>@8Q;-R*
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ME5_&E%:<?0/336S9;M\$#%Y/QLW5W* -H:JEY7SZ3'OF<1$\/N;XL?Z>ZVB
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MCPJ[$3%EJOZ^?[4Q<C\@U@/#00NPPE%GU\BBAIH "NKV#L5,,H&-Q.'%39B
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MJ=!KSNV:K1]_%&/VQ)<ZRT!N^6Q87[@[@^5#/HV (5/LLBU*O$_CLCVM6.B
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MPD<<Q8BK>#FS?(""]H]_!)8;9?IE/5?*U(\3;8!KCFO\PGX1[]*9*$(;ANU
M*Q;_K!^KM?\[=ICD:PSNUQ*@\.DFTWISRJJ%,6M%?:=5@M9OYH!%D0N[0?F$
MN-:G_6A:*MC3!\A^&U66$\^-;!N!UL'3#>#N^P3%4T*/>-LB>>WW6N]]&WRP
M+L][^^4FSG"5\/2"M!4_XQ0KPE>T>F[/? W-D)<%$2B!F268(N63V <IZHDY
M]C$L1'$5ACC!58+H*N?^65R$XS3$&M&_1%GHK"?(L]A[#F2E)K4X!86R6X5F
M>QY%M<[77GHEV3T%I\$N+H-D19@5).4)\7CU7SX%!7&9%_LTNBJC:B>'[RS;
M%H#UX43X7-?2=E"MANJ66*8HVES[0]4@HBTBTN37Z,]5J\J"B@X[W[R3CZ0S
M)W2:UR[9/^Z+\OXENW_*]@6A#ZV4%J>XQ#BM:_G(NLA4$UB76<+FNI#IHV\_
M?/P!U?)>._#D\T])]A D%_MD$R<)*]XE[C"I)*P.TL$<=\C)9U0IH)Z&WRXA
M#KASY++>$ @!ZP@Y0JX/Z)#3'VI\O_XI#LU0#UXG37=FK-_ N++3N_BU'ANO
MKDXEO202@M4E"H3<HOW[9C+P#A%9[V__IHXN:*NNKU.LZ >Y.+P>T6(5]$VC
M@UHE1+3@]1)Q #:]U(H?02^-L9KU$M&"UTN%31\51]-#A7W_%  [Q]+3%<?D
MZCBPAKT$TMD5EMZN."9WQX$U["GO#N_SU<G-K:Q;>C\"ZP,>&??"B0BZN?7[
M=NNSG>84J*W<7/"W28P4@/6"&5JC$Z^76O-=':CN99-;8=!^MZL*^@8)W;M/
MLF(_+$@]J8&CZ4\5>JO^]=.O3S'>$*O"/:UOM]YLXA#G9,G-_GZ/PZ<T2[+'
MM_H'F3><T BP_IUN 9^EDJB@MBU4ZR#2&JI^Z]IK?_3JBKO8"\6,42 $K OE
M" 5I_&FL")/U/R/L<-\_D=F/O@-Z8F"[@,>H[ 0F#J8;Y+-Q@1#<+M#-NP<=
MX'NVO2_*;(OSYO2_N,7E/D\+XC5O\4-0BF:$6A5@76.*ER^46"FB5A/5JFQ0
MJ97]3!]J:+<XJ4J?/\4[EDE!]@&IY6%VF!JLM+?Z:HCI>?W"SH(X>5L]XSQX
MQ'7TLZ23I)*PND<'DTOK2N51K8!J#;]=,KC)?%G?[6*1DGRGR&6!=8L6*)]O
M]Z%$8:ORKKWE5D5W>G%L9W0;*B(.M\SCASVKFT-^/,M>TIQXX.@FSYYC"G:=
M_IQ6P>.2?8NI#4'KU(.LX'N<-D?#]MKVJHCNB+3XGC5)0[VK-A'YWWW=JL\M
M$/$[J/<!;NC=94DZ?'OM8^A\-73C'J]W/ZK+WRCH&O+2Q^?;79)5-X/(XI^,
MW?N$7NS1'G@9ZL'J5SO0W"W65IN%:';Z4 [%JGN3+%D7WU_=;\#ZA ,V?N^7
M)<KQCCR<O6"6XFQ\_^4=^8ZBF#Z"_+8+XHC63 GK$$W:64%(8.P3FID/17@3
MA[&?T.GSUUV<]RDGR1B@%0;6B7JDW-=4JZ"@/?'O7?#WTCF7U[>_X"2AEQTD
M7H^3@-4-,GCC=Q]?WZ)&T*O'NMQN]]%;BF_RJR24O7->!MA;EP+D/%DM2<\B
M?8>*7:8I\8:R=][[$=C+YI%Q;YF)>'VY__OJ[C.Q8D]>@3P*4B0$ZV4K$(Y?
M.A%%C:S_.,@K_!@D=S&9L,5WV:8D4VXL=S J85C]88"4SQC<JJ!&!T#_D*5/
M6N +S&_[=#\!>_=C7-R;K@30!OO9P/FTNKKYT^KD_%[N<7@16.]8BH]+$/5U
M(^F?RY^"MV'P_OT+L?&-9=J4]8-6!5B_F.+E^BEX0_3R.&*B?KLIO\-!>A&7
M?]\%-*7)K[*^$<L!ZQ E2*X7\J^I..K)>^T*2H9;O N:G9AZ8VU%_C-B?VI6
MA)(NLM2'U773P/.%D\D,MVV&;7$TMW_:EGJQ]#Y[NXKXN=L%H6RUP4G ZC$9
M/*X<*I-#3-#O&T_Q>?SX5+Z=!6^K-(WI,5.0O^D^*S,U8'UC@WG<81__^ $1
M/=13A/+-I+@:8JU[T$ -7 ^:8^9Z\%NP/5CEZ^D<O&PN*!,$UDMJE)PKK#/U
M]\8EO[._F^ M?,+AKS<Y&3A#"H[\ZS$/MC3+C:1G#'1@=9(Y8"[C?ZV).E54
MZR*6!\AKW[6Y8B^R_#9["Y+RC>\L@1"PWI$CY+JC%67)^?-*V,NN H%"(&QI
MTCG1;LWP9W OG,<F>-6-D+>=FYLX"?*XN H>LISF:HM5N\8J86#O7X^4ZXU*
M!?5U_._PW.QQ7F:W<9CIUS(*66"]HP7*=0[30%0%@5GK<+<OI?TBE(/6)RJ0
M?']P=^8A]$14;X3+)KP2.9@](08IZXD(->(P>N(6;X,XC=/')BA57*' 6 EH
M'^D1RSLL;W2[&-RN-H&7V4!K36]J4J^GN$Y3R,+J*SU0/O-XTS&[WA2M3H/K
MJ6->/YU)G%KO-V@O?@R,?]&OZ-.95X=U%P8YNQXJ>;NCWV&]83&X\5MNI?R^
M:$PD(I;!<GSN('OU.@U@G6$(E^L>IH>JW)[\28KG/MOGK$"OZ5Q7JP&NSXS@
M"OJLUA.EC_+;9?DSF0BRNAO]#/#2_E*)0^LL ZQ\3S&E]TRKN85>;Q$#Z*="
M_T$)Y4#VC 2DI$L**%_,4["+\TPZOQK]#NS-"\%Q;[R2\C[7FEHTB*O*U=;K
M:NIS_8+I42R.ZANGIUE:YD%8[H/D*M[P*TYO2,"QQ^MK&/.T46HO#G<KL5X#
MB+;P#M4/\K(>6^+% :#P;YV[RY/V!#_&*?WM-T+;=0J!N03%;YV\W2LXB+_G
M:73\Y 4R=?C'O&'2._C'I*'P/6/X34\7',T5?@L4779V\%N?&OQC7C"QZ'>=
M>#9X2&:DI\G3OA F6I@JKQ7<Q.Z^0SVM(R58T3.AR6K,<ODL0"_IL[XT<ND,
MY;-^U&F@F1 ]VD?L"5\$P=;[LB@#YH07)YCL65\<P32&FA.LUQ!Z"!(:3G)<
M1*M>R/(D4S_G"R&8D9'FY&JW%(^96@Y&R-_&\/B/L='L1;1?C3."M4_\;3!M
M;.XDRH$_,"GTLPBVY5A<IC<XC[/H0.=VV/..C'FS&&O..]![P])WX91EOQV*
M?8G\>M![^0>CY?9H2['=&.SM"][C?"LFGFL4 !GIZ14<ML,+;%2>\@XGO\"/
MFNFB)S!?"+7G>Q-S,=P?K8M+EGO_(LO9?U[%P4.<Q(*L TII@,300!6$K!(=
M5%<BH*D(6#4"E#1Z?KHH?EV%88ZCF)#J,GW&19GETMAZA3"P#M(C'??/]ZC3
M0*V*W_#B.L?H+7[&Z1X7U]+*2%))8-VB@<E],[4\:A3>H6O/A9#8A0OVY1?D
MRS^MTN+'?Z=#1"$HW*$6!]8[)EBY+F(74)A7*YA7"SL]%%)%/WYM_]#FO]?>
M2)'+ NL@+5"N=WH:4&ZG]""Q%259B;*Q4=DO TFXO2*"J>R37;NF9K,!+]\*
M*Y]Y%_^?B_@9V^7(,]:$U6.VL,<]^-WW?P":*:^V[-4VV:&A'LAN- 3-=R+4
M=(?$KFS_^'3_A*_Q:WG_@I-G_(DL[IYD\W*= KAN,T$[[J]:#95/&%%%]/%;
M5*GY[:R7[)1PD+MM+>TKM3RPKC("R_742X9.OQ?<(_?>4Y^"=+^A6R0YEBYR
MQ6+@^D6.4=0= VG?O=#+?<_R#6.<LEP1- ^WO%/T6N#ZR!CRN,N^_?#QCW7^
M#):<'&B'U1&M]GTV4#R:;A.A5O1<D_D$7N>=Y'%FF++&MH%CZ$PM>F&G4BU@
MV6RTYDWMU*/L2\LNA--QUW&*6R=C]T&J5"%WGP%N00_^4'M6B%_?P"*;ST^N
M>#0=:/@!_@!H8/SY[FX;),G)OHAIX<Y5M(U36EV:F2_I-P,=6%UF#GC<6S_?
M(::*&ETT5/;:=\J*XO6I["]Q^723XPW.\SJW%M>=TYJ!U<,'V6!;9;T]O'XA
M+:([3!.*HQ.TJYNNJD=[V<$>&GR9WN*$O;+[[ P_E%S/J\5A]; 15BY*9-1A
M<8KR6@^5&8J(II=^6I=/.+_%-"/P*@RS?4HKOM_D64K^&59;1#=9$H=O]_BU
M/$E$7ZU]$[#Z<S)^KBP,;8AT*VV)EF2OFT*[05OHSU5KB#:'6'O_Y:<N0X[O
M=DE<G@1%+,UFSLO ZCPY0"XI=H[?,U'$9'UG9B2>^N0T2Y]Q7L8/"1X.!_)$
MC09JL#K("K,@C6,UHO744:M?I]JL6O =33<X9VY8R?>@3@-8YQG"%4;654/=
M^#R=_#=^7U!=/TYO7[9A@9=IF..@$!4+X(5@=8P"(5^XN98C<XY*T,_U /()
M%_N$#HBZHV^I)*P^T,$<=T0G#^14NYZ3FN;=5HO#ZALCK)(Y.K1TVZ=)4/S_
MW5U+<^,V$OXKJ%QV4J799),][%5^35SEL5QC)UM;.4S1)"0SH4B%I#QV?OVB
M\2 IXD&0DH66#YOUV-W !WP-$(_N1C5W'V 99' 18@>H#1.0)',<9U)YM"[8
MLL/J3-H7P-7I%G3:T5(K%M(_M/%U32ZVI7A+)2V2D1$+$PK!Q=D>+1@=WS 3
MOPC$][YQDRH*,CE21*J[/F16=)3&6N-2>VO^&:&JN-,T-3;BEC0%7QUX(_CR
M99.*0_=C!4./J_^=F>*DQON;9@SY;+*,)C\L147L)PJ58#76L<D9FZ$<.I>K
M)Y 3,]^W[85#1)N^%T.^4N-S=QH(;=:38+US(]^G3_8R^?-F-F\@_'")>3;W
M2$#3#.-(=N;;+WG'5WYB!GWXEH]./H7=,B>\#]&T;-YT&8(G9T:C.C%;/F*7
M'&8Y$M3N[QA):0)]E"?GEPO[Q;<NA<LN7! -E]]"EK#)C##IH,>J9]F6_E*4
MZ=]%WEZ*W-R<6[APB^,BQ0MKGQU0(E*+M&HSPA3#$E7 -GQYP09K[,A"8A9#
M1HP+HT8("$.&^$8\* U#66!0)W[QR_6"([W+V</U)\<\U/TKKDXV0=.,FLF$
MGU)@6<#F-M88F.C8-TEL#1>YNG5=+&_H*LJJ=+W)4I-OP AU7"1-PF[P(I"%
MD+A;"H'4%>KBFLU<O*1[7E*099;R@WZ&94?2\8'FVZ%Y\L>VJJ&W-(9]%7%Q
M.Q*UU=%;Z.\X><LCZZ@I(\Q]G7@V9;'LW42J1?UBJ5R<-4:]-7%1.A:V_9V9
M2KN(5?=A\%?ERX^;U=\BMDB=3BU7/U%^N]CW)7E&GJ&T(%S/MRLV@^Q&C3U\
M8UWT*EMZG2?;V.4"-KH$7(Q/A=\G791#?OKQIQ\;-Z56%8-/WT5:\? #=SHO
MES NYCR0VKSY$JF#(K%7)SC:NIG61'!18<6G[3<ZL=UAMW4\.AF.3WT]D(<4
M<#'BB5:;Q81:Y\ )B<-K+R>I7X)5C,2X( XE5L7P%5'[4O/MHDD(5_\[$-J^
M%LT6FG\M0@5*0/8[UJ:;Z+&Z*^U1$@8Q7 0X,1I.-J0P 6ER5P8= Y<O&QK7
M-'F(7N#'O*)G-*=+0U"751(7&4,P=3[6FRW<[7U'I>9WI(Y>"!7*Y,.C4/\^
MR"CY A>/B^6O%9U7%=5)Z?T=%Q5F<'T"N!1L'ID<B4 PS+9QL\G26!Q5+F_I
MMT7)/E'\[K@)<;Z'5P:C,JENB_I_M)XGQ8:9RU#@^*$*QL7M@5NEK=K:XL$T
M6 6D*(FL@K1UD*822%A'6#5$UM,$H-<0@/[( ] #9^L1F_ [UM#A!#U]65SL
M#P,U)8-4*D3H$% *^O'[3&$9!!OM(J95Q>SIBE+]9-<LAHL1)\8^&4Q82$/2
M!BE.EC10B,SY;S=GGVF21K8EX.[?<?6[&9RVR&!2A(N%O96$-?]9E-LR+_3^
MCJRGC>"TGN;;&A +VM-L$_8<U93-<.*T=+%<4@ASL_IAN<1Q\>"%5??,XDID
MH[385UVH!:7I4UE4%9\R:5+!=:9JC,:051(7.4,P^[QP>?$58 KB0A82G2MV
MPGP0HNHI8U^E]HY*^G.*.RQ]VG++XV+(#ZPVK4FMG=NV0BB&#&^5F=Y4KC#P
M!OQCF\> "]*_F1/@^2CA(FT$8LWE2Z:N:S*CY>#1HK1%2KMP">P&&F;,8N>A
M<U+L.?+9^9 7+*F=^&Y63^GF.J\IZSGO'"?>FKAX' M;W_8H?:(*P)8%Q=!$
M-M]#IZSTJPF7,'KF^D@=9*52)\PH*^_CIY*F#(QM-/4ED/6]!9[6X>4_22,9
M=A"4GZ(LVVXVJ;7'=P6P=;@1G:F_E6#0[KY*RZK^G&;@F9[;[J%-0KBZW8&P
MW_5<E( L)%?,P]Y"WU,FD0"8^WL' 68Q7!0X,>I9+T$8"POS%?O^KZ*:RDM#
M?9>I2>#J>QL\[69%R:D;SH!YD5IW5._7N;'FLW*C',Y9%?8U[EOZ[?PII<O%
MAL=9Y*O%<IG&UA6/6QP7,UY8]5-DID$:%2)U4+CWS1>7ZTU6B !H3P\_APXN
MMOP!6_W\Y@O2ZB+9ULDCOM_8VH29TP6;?36J=!%<S%CQ:?GAY:GDLY D"1,-
M,JG=T.[)P,*ZLK+(X>I^-T@M&S+=/=)8!%Y=[:*'5R1]J&CD,%/1!SE$!3A"
MA+V9+-9LW5&4KXYG+TU"N$AP(-3O'I5H^$<M+U_ [V(U>$)KD</%@1NDGBE(
M2"/Y)%_(YQ4>HA?NG5@]T/6F**/R]2*%RT_*U/5-H)<6+I;&0-8#=N4;%. 1
M6\*FL5;*)&FUP]P2PQK](EVE=92YMRM625Q$#<$T;U*D HHMBO_&Y$2V(V,W
M(>@V'MQ&P/$L]AHD)DE<C S!- \2J8!BD/2B1;[8,[%8)9%1,@#3Z QY]R7L
MG4>QS9/&::WZ?'TWMT6JVD5QT3"(4[L%D0KR::F*<)7PTY5Z^M-COC**XJ)E
M$*=YQFK>/\4P9<E#GT5^R99\<9T^4SC_L1#C$L9%C0?2/CE2A2QRTB@1T J[
MIX]>XR<:_\EVNC7EKDGLIU49K6W;>[<\+I;\P&J;?JE%6C4B]<)^>.ACN67;
M)RV"9I%37_>M"67@HG1Z [1OF"P)LI3\R^#,%?1C%E5/=U$*]X'*ZVG^6/%L
ML?K7S"Z+B[IAH";79;)A*OR>4_ERD=^56JA3T,9%'FYM(9_Z8MD/;;@U1-QZ
M:^+B;2QLPR$JZ(L(@4T_FF-&\D!ANVP*F<=QR?9W-20N=V<0=0GCHLL#J2G"
MLM4A.%*-WM/RF2U?SY^BTN# NO-77 28H!G>[049$G.A, _0%^6?;#UZ'FW@
M$/"FL(86VP1Q]?H 2BV=B1 G4IZ 0N"7%!-:I:L\@D#WG0>@-4+LHK@H&<2I
MO[/8*L SR/(&(5R,2Y,!L7UST/IRM4,6%RW#0!TY'/F#XL+Y; 84D8 O5>^8
MU!>:T#7W'[FB$;R%9L['Z:.$BZX1B+7\*(TP60KID-DU^>D4Y,S)4K&$'#RC
MLPCCXL<#J?F<KM5!<5)W06->^24DU3&E 'UX8CMC"UUCE''1-P&Y?M4MBB#_
MF<%APL]A(V"*O'[*7LW92-J_X2)!!Z:%O B)<*E&6J^M@G\SA1_V55'>,D5X
MR:?(F,I*G6QH?3]2'Q<_T\#K\0/J7KLNQ!I"Y82&XYV\R#]VR@H;NC>RP9;L
M I-*.6GFG9D(IO$/D=/RWC?H<]SM$P750S%/DA2Z+,K@1/,ZE]O()E"<+Y ]
M<QH<JF!DAG/85EG2D3:!,+AR(QR@\<;\"0<J]]U9BB,/@X^A!,O#T-F"7VPA
M:8YX/9/OZ3S>#1FGCHOU2=BM3XB&?B7$TAKQ.9S.I$W_)*@< ._#9= /OIYN
MR4J?71074X,XO9)'81QI?-[0F\>E95C9J.G3710N5O=NAQ?KXNA7)@[#1+V8
M9P[#O4]9)T'^B(:,9S_HM.RR]OLH8VT\+];K(C=OMD9IGP333NC:O3.3 SIC
M+AEPA^0TV\DT6M1/@D<W=A\B,0Y+T1[QQ]S'26IB.:=!L5\C;%S+R]<<DQ.5
MUM*-5TLM!Z9[E8;<!"8T9:(A()P&^$<*'FXJ*\I%N+O!N"6YKHZ<<1_L&L6<
M6ID\5!1#1#F$%T1D240(BK*","T"%BFMYGF2/*<0),]?A5=!1*[HS0$M7+R.
M@6R.ZF2Z!!ZOF$MUPO6;X*FP;F?1NBCK]&^:R.Q?!G>SO@@N?JSX=/>R1E!E
M,,/P?MFD,,Z?OV:/V=$XV&G)SH'2($#[(V8]C2,SL:T^KJ)H\U4D-CC?EB7=
M?6O=*/#UI^#][L:EW;ERJ1F1<D$[&:Z,A_JYE4'7U09HMMYN18-VN+V;T77N
M0)<&ZD:5C#&EKAE"ET+4O0YP6KZI5C3TA-&!,M#C.+O:IX^#+-K_VJ;UZT-1
M1UFW7_M_P[*\,$'2EMBM3"!C?2AI5&W+5[XET]S.[5*(3-<!3@L6DZ)B!SH3
MV]) /<\A/!59PE:4P@Y,/:]+(>IY!SCCV8 4_0<1PF1>UV7ZN*VCQXR"7]U=
M%'#:UAMSG<?9%E*%W,'.J\B[<!^*8=_9PY;\]=^(>=^K03ZV,B--%436H9G/
M;C7-8R?AEP'S//$;[4,ZB,:^-U3'*H(?+ GQ0"2IA^-Z+W\;_HRHZTVHS"_<
M":% ?=OD$3>]+6 50M3/=FQZ\F>5,EV)ANYS-EL6:WK#C,#9ZZT8QGXWH+/W
MO! F'T#\^T#=KSXYAN-HBPBB;K<ATUZ'4\$-4C!07[.O?;%K*(Y>MPHCZO]A
MC%IL<T>CL7^I%&X(J#$+.5?."WBO?@OIQ@30(J_.Z+(HJ9![B%[ S;8NHZ)D
M:[NH?+VNZ;KR7UN_876(3.,8K=2'>6<^%0EPVHI)6S-YY%4K^^.5SY"MQ6]I
M[?X@[@@@(MZ,2YL':+W[^<.UL]YIQ/PY2C.Q+>QXBLFMPUE4I?$@/\-%8&5P
M!'(/CE5A0+ HCG3+FQ%>8JCC%.['L]C651WQ?*O&DY&^$(+#VV%LYF>M9J0C
M&ZC3/Z=Y4?+C&#'=7M 83CPI?#4NTDK,"3!IV\YD?A&F8^+J4&4C&IL';Y)A
M@6;Z"LZ(JDE\5W?J<IQD$5E?(.NZ2)_3A.9)U9F[P.'>9"TV643L#T+4<F4H
MA=G.=,O^Q;1"+;>;I(8<RSQO'OR^*DJ9J:U:E.=9E*Z-PWI4 8C8FX;;]-(Y
MSV)3+*57(AQ)-G&W$-NORB+L9U%:J.$G<RDUBWRYTSNC.;6<7PZH(*+3%ZGU
MJ99V^Z'.)<@'J1QP*\PG>3797^?S."ZVS+"^T)BFS[!VL^QI!_4043<*KF&7
M*3Z$'Y3Z]^ <KDH@;1%H2(1=,&3PA>#]\VU5,[,KN:>/'Y=6==24#J/V9%85
M)+(7J*)FA!>&AF-((YO7;'%HOK5P*J#FT833D[F.*AJ>%O43+:6[E]UOT$</
M-6L.N)[D\1*48QP)ZIBH-T]]Q"$^)#=[( TJH>;/AM63O&:1(_71$,>M2GVK
M[Z)7^$ZSE3CDX][29, 1<H_B4),]OA6CQG"S-))%B^@<43@)YZ+9.>_DCR64
M!6R6D[/77RM8U3?WM'-X/,9J$_[:B$Q@ FC3Z2Y_,4(50AY?R0<HAQ'_?>=)
M]K:L0/PRJU/IKN*_MFE)[XME_2TJC;.V51@1>\,8#8_L< TXJ9,Z1"F%9>6J
M*,4=W8K]@_U4,5,2UW1J8G@5#R0,#L2]"L3'[I[ML%@ /Q]JRR4[!3=S,?==
M5,_"!Q^_ELG*TRS\M1'9P 30(^=G1/RJR6FQA,2"ZGSSO*C,6R.'."(&?5!:
M9^EB24"+-&>]7"_XYU-=/O';PR?[O9M; R%) T!=7U/+O5=HLA9+>&+%8PPU
M8@AI,:%SC1G^JDS(H6*9MJ_2G(WBJ5\J@S8BKB: 'OFE:HH*_Z4"E/ _" !X
MCC+*+PS@(CRN:0)_8)OFW5]T)$5>$7WS+6-$+E_B)]8K]$M44_%BJ<E&CHL
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M:Q3M2B(</Q: SI&C8L-##!HK?HB2%:OS+"N^0:95+UYT-<PD.=!Z,=;HDZ8
M+/QUIN-;\V-& RJ8>;,@]>+LUO@P4?=7-^PG]FOU*_8?V(^RW_P?4$L#!!0
M   ( .&%?E(2R)DU!ET  #EA!@ 5    ;&9M9"TR,#(P,3(S,5]P<F4N>&UL
M[;U;<^,XLB[Z?B+V?]#I'6?%K(?JZJKNN?1<S@[YULMGV9;"5G7O.2\=- E)
MF*9(#2^VU;]^ R0ED10N"8H0DBY-K#7CLI$@,K]$ D@D,O_^O]Y6X>B%)"F-
MHW]\\^G;[[X9D<B/ QHM_O'-EZ</XZ?+V]MO1FGF18$7QA'YQS=1_,W_^G__
MQ_\U8O_Y^__]X</HAI(P^.OH*O8_W$;S^&^C!V]%_CKZB40D\;(X^=OH9R_,
M^6_B&QJ29'09K]8AR0C[0_GAOX[^^.V?O=&'#X!N?R91$"=?'F]WW2ZS;/W7
MCQ]?7U^_C>(7[S5.?DN_]>,5K+^G.$]\LNOL[N;^:O3_?+X:??[N\W>?/G__
M:?3IN_\>W?QS='7S\.W;G#%SY66L'?OS)];LN^_9?WW_W>S3CW_]X4]__>'[
M_Q_XT<S+\G3WT>_>OJO^4Y+_/:31;W_E__7LI63$((K2O[ZE]!_?U'A]_?[;
M.%E\_/S==Y\^_N_[NR=_25;>!QIQJ'SRS9:*]R*B^_3CCS]^+/ZZ;7K0\NTY
M";??^/[C=CB[GME?J:)];20I_6M:#.\N]KVLT#3M9T;2%OQ?'[;-/O!???CT
M^</WG[Y]2X-OML(O))C$(7DD\Q'_7Z8QNZ^&=$Y6 =>1C_Q/'QD\^8I$V3@*
MKJ.,9AN.5;(JALJ&7_2U3,C\']^$\U7P8:L:_(/_$T*;;=9LWJ24J_TWHX^=
MQGCAA5R:3TM"LE0W*&'CWD<Q]1+&^))DU/="HR$)*?L8'Y]8A,.13N:3-;<_
M# :MN-14?8_K<NE%"Y+>1D]9[/^VC,. 6<$K,J<^S4Q&"NFG][%[Z?(FC%^-
M1'I U,>H'I@%30C#*UEX$?V]@(S-P8L\I1%)M>,#DO<BOWRU\I+-9/Y$%Q%E
M\'C,6OA^G#-S$2VF<<@ (WJ!&O72Q[AO(V:_%_0Y).,T!1@=6?M>T(XSPJS&
MQGOF?6B@%;3M9Q[LI]GUOW-FZO630$;1QWCN"%O_M*@T6_7Q7;9]6]&LF-ML
MQES&A0*R32- B0&D?8SPD83,^@1LE<DVL\2+4L\'K0,ZNGYF%?N1S+PWO;0$
M3?NQ1\\I^7?.0+A^X4CH+8^X_>EL8[\VTH:MA'UYQDU23UPT^[)A[V&C55/9
ML;M .6KH^K/!L/&(VO9L4:"020A.L"^[(IE'P_3!2_@N^T6_F'?K[G1SVI2A
MXWH]'5\?N$,AR$,F^RN:>HM%0A9\<7PD;!'(237 ?K@U^]8I9;!M=AOQI2].
M-CWSK>O?"=Y3MH%F?_/"<'-%PYSKWQ/Q\X1F>\WL'7B3C]I8[4SG,93>QEAK
M8I,,PW3T\![[/LU],%X1(,1V]AW&MA[<@YWQUE"=K(N5DYUG7O;#,!\_M$?K
M_/S")1AEDSPKKB:83>$.V#>2^&P!89K1!X>&W^AO/VFJ9VJJ_L95DTWCD[#Q
MZ:@M^R9,A=JA*YN^"]/AF_;3\TG$V*Q#:/L>8WW1JWX[3>(7RN\D+Y=>L@!K
M^'&]VN-K]^$K.I\S&W>3Q*OQBN_":J,[BL<N7[#'[P/)K@@;1D("]J<[ZCW3
MT&3;>ERO-KQSYN=+&+UJK.N$I(RV.&S?L5\T2,@;VZ@')-AVQ$=]U,TJ^S7O
MH;H!_S3Z,-I2U7]D/8S*+D;U/JIQ;T<>QGYCL"&_<(Z3IM#X6%,VV.):.27^
MMXOXY6- Z$<N2/Y#(=$/WWVJ+I7_)_O5KY?Q"TG&SVF6,$.Z[2_TGDE8?.57
MUJ;5Y./)QE;*Y9$L*/]VE/$@ _$0Q2W;(ZWC/T[\49RP_1%#:-NGE_@-U _O
MZ*L6']?%1>\'?TG#G<+,F860R:R23ZP9<%V,[%.GE_4EXRKQPELV$=[^FVQ4
MPCYH"I3V)W?BEG#G1-Y; S!C_8K%W&P!E.YG%](5\>)4J%.2T)A9YH '-:FE
MVVH*%//W+L4LY,Z)O,=L. $?TDWH+<1R;C4!RO<'%_(5<N-$KI=YPGFYH:GO
MA?\D7J)497EKH+3_Z$+:.AX=KH*_D##\[RA^C9[8>3Z.2'";ICE)5*NAE 0(
MP9_<K8H:;AWB\',<LO.6EVR*^-I4)?^#ID"Y_]F=W"7<N=S]E5/RD:SCA'N%
MRG!>Y2900@&4_E\<[@65O#H$X3;*"!\Y.],R<^A5XU2!(*, @O"C.Q#4O#H$
MH9B2EVPU6L2)\A34:@@^ [F3N9 UAZ)^6GEAV(Y/%8FZU1 J:H?G32%K#D5]
MO2+)@MFZGY+X-5ORYRI>I-1N"0%4]$X.HP!676K[DNVV ))OMH,*W,FQ5,Z8
M$SG?^O-DG >4]3;.,I*64I(?4%7MH7)W<ES5,^I0SZ?Y<TC]FS#VE%N71C.H
MM)T<5Z5LN=ROQZM57#Z3>5HR!M/:E;YRUZZD@\+@\,@*8=RI [+T:I2.NAOV
M.\G&1M$<BH*3 ZR6303"YRXEL.AKC:&"=W)VU; H$/O?/QYP<<=^8>E>5/Q
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MW,^\M^LW/E)R02(RIXJ-@Y;0>5:_$R(-E.+PS<!A<-5.6-6Y5N]0-.G#>>+
M4ZXLQK+%84(.Q\W.3?R0E#)Y$?JBKK8*HW:>>[ #.#ITY5(:_NGBD-M+'L+
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M;KSWEZ5/^7H=%DKFA7P=#>,T%SX1V=ILLVZ@(-ES='8%J1N_1VXX>GA<*-&
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MZ78[*$+X/",2AMP?B/M=E\K0J/2_2%B8!(_7,>7%3>=Q2./B3XI=A%$G4%7
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M 4C!:?2P@ D6!P[T9HD7\'"O1O5R-GA"7[BYUZU_0'+P^W L*!J)!0>2_ U
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M_6R25'GTY><\<4L<,T%[W!,/WLJS%A.Q\X<#U8A2U?E/T=S]25"E0H<0B'A
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M&7I72?ZMW2(>GSO6LL0YN/<DH)Y6;1NM7(=.PS57P!R6M;;PO_"X#-%;F%U
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M,,V<>HX.^>QHMG+]J!,\ T3,X1"[\/1R_<:V2C0EA87=_3&M_IHJK%?'[H!
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ME$NL>@QS4IW=?=/UEM&EJK8$_V[-(R3IK-6O#B<][0F$_V[5#-DJ;' !,X"
MHYX$@N%"O.]W15(1U&X^!*IXU#L9V#?QYY\]@1!P[/Z^%J4SL'I#?50.%<.[
MMG7IJ3)70;Z(/[.L=1$,V\I)PYGWK)\R 2CPJ^\DX6P_PG=91,6BVNV.3UX5
MBWRJ?*)=AO#>D])VAP5;+@*,ZZC!U@W#JVY[0GC?&[=39>*#?/&]I*P]7NI#
MW;D-2=^^AC2W,"F\1PMWX(#<B\)Q[BGX0-Y[,MRC,1KB*:.#,'#DDC0>SWO/
MK=L78E^)%N\.:>/=(0V-1G<8VU>7IK<')+&=NSLO0*=( V@TEJ\N=6\'I+#:
MV6>]/)Y!&WM@=B^5YIY^+$/*]^L*J7=0DKRK^+ZV?(,NDP:CRC<X9$7_"I*\
M#"+Y\#E7X3E78>^Y"ETF,3[G*CR2\7>>JQ!)LN*3(W3>-PQEWV"2B&C SWS.
MR>&Z"VTH.;7>57;C<W*XKU>136SR@!\G?:7)X>X($T1:I5I[X'E.,OJRGZF-
M=&\_M-.]E<2[3&VC';W+G&WEH/0YVMKM,.2@&F1.-K' SSG8L"38.7D.MG,2
M(QLYT\Y)C-Y7$J/^SZ_G)$8.\T/A36(T8Q^8S&M;8'5F2TGS(5AA-0=64LL9
MHU%W=HXC'@#@[7\S8S^E;!/%3R*Z?(K&'>% 4*F-+2"-63QRE9#$X10;W/$B
M(<5W)Y%\@>7-I:U=)_CHJ'GU.!>-)"Q%\#6_.GN-#>1?:^WZY7?O\C^0!([U
MIAQD%#QRX8;7;]P+HSC42IH/)2V=DELL@*0I(9,UX<Z9:%&,F ?63.;;2!L5
M.GK:P>1E@PL"+W!WU'NF(<TVE?,RO<K) WECQH"$+^2>\;%4;.ZZ]SB8O&C'
M"FU8T/^3> E;!XY'?->1ZVU*[T"W1#1 ?-F'E0NH<5?XDWUUYPT7RFR\^[*$
M5XQK1>2QN#7^#%G*X6."XXGX><(4YXJLXY2JZO>T&[H^.\#O/\4L"N3OXIZQ
M5GBJ<?$HOF_\H^2^L5E+JG4)>;YZ-!IRT[0^\AOOR?P+.]$PNZO@0$/F^/ &
MNI$$<3[\T$')V@F%MD;@^IC7 =4#=GO&\[0V]#)>K6BV]1_Q(ROCDT0^A09P
M_*EM4&L]%O7W&GTBB^M0<;_C26][#;O!$)LPR*B03G"=@T:07:59"QI)MS"D
MQ/]V$;]\# @M$6 _M 7/?L7V5@LOO&9:E&TD]Y>LU4&C(8A:-.X^(DB,15P.
M0%I;CS5IMG L7)'<#B3;'+&=^\$I#;V$IFQO$"><B)FXN[M+Y265FL393NM
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MX?_%0S[8;_X/4$L! A0#%     @ X85^4CM\/X=G60$ 'JL. !$
M     ( !     &QF;60M,C R,#$R,S$N>&UL4$L! A0#%     @ X85^4L"-
MFZFA%0  _O@  !$              ( !EED! &QF;60M,C R,#$R,S$N>'-D
M4$L! A0#%     @ X85^4MQ9]LSN$@  A?$  !4              ( !9F\!
M &QF;60M,C R,#$R,S%?8V%L+GAM;%!+ 0(4 Q0    ( .&%?E+^-ERB8TL
M +DS!0 5              "  8>" 0!L9FUD+3(P,C Q,C,Q7V1E9BYX;6Q0
M2P$"% ,4    " #AA7Y21E/T=JF*   -.@@ %0              @ $=S@$
M;&9M9"TR,#(P,3(S,5]L86(N>&UL4$L! A0#%     @ X85^4A+(F34&70
M.6$& !4              ( !^5@" &QF;60M,C R,#$R,S%?<')E+GAM;%!+
4!08     !@ & (H!   RM@(    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
